Citrus Sinensis ID: 000893
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1236 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FPR3 | 933 | Serine/threonine-protein | no | no | 0.152 | 0.202 | 0.409 | 7e-33 | |
| Q05609 | 821 | Serine/threonine-protein | no | no | 0.136 | 0.205 | 0.435 | 5e-30 | |
| P18160 | 2410 | Dual specificity protein | yes | no | 0.148 | 0.075 | 0.406 | 4e-26 | |
| Q23915 | 1094 | Probable serine/threonine | no | no | 0.152 | 0.172 | 0.380 | 8e-26 | |
| Q54TM7 | 1288 | Probable serine/threonine | no | no | 0.130 | 0.125 | 0.392 | 1e-25 | |
| Q54RB7 | 527 | Dual specificity protein | no | no | 0.131 | 0.309 | 0.434 | 7e-25 | |
| Q7T6Y2 | 1624 | Putative serine/threonine | N/A | no | 0.144 | 0.109 | 0.378 | 3e-24 | |
| Q54R58 | 918 | Probable tyrosine-protein | no | no | 0.150 | 0.202 | 0.389 | 8e-24 | |
| Q55GU0 | 916 | Probable serine/threonine | no | no | 0.142 | 0.192 | 0.379 | 1e-23 | |
| Q55A09 | 1331 | Probable serine/threonine | no | no | 0.143 | 0.132 | 0.346 | 5e-23 |
| >sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 143 bits (361), Expect = 7e-33, Method: Compositional matrix adjust.
Identities = 84/205 (40%), Positives = 115/205 (56%), Gaps = 16/205 (7%)
Query: 1027 ALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQE 1086
L + D+ +I N DL + +G G++G VYH W GT+VA+K+ F+G +
Sbjct: 653 VLDDADVGECEIPWN-DLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSGAA---- 707
Query: 1087 RLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLD 1146
EF E I+ +L HPNVV F G V P L+ VTEF+ GSL +L + H+D
Sbjct: 708 --LAEFRSEVRIMRRLRHPNVVFFLGAVTRPPN--LSIVTEFLPRGSLYRILHRPKSHID 763
Query: 1147 RRKRLIIAMDAAFGMEYLHSK--NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 1204
R+R+ +A+D A GM LH+ IVH DLK NLLV+ + KVGDFGLS++K N
Sbjct: 764 ERRRIKMALDVAMGMNCLHTSTPTIVHRDLKTPNLLVDNNWNV----KVGDFGLSRLKHN 819
Query: 1205 TLVTG-GVRGTLPWMAPELLNGSSS 1228
T ++ GT WMAPE+L S
Sbjct: 820 TFLSSKSTAGTPEWMAPEVLRNEPS 844
|
MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 134 bits (337), Expect = 5e-30, Method: Compositional matrix adjust.
Identities = 81/186 (43%), Positives = 112/186 (60%), Gaps = 17/186 (9%)
Query: 1043 DLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
DL +++G+G+FGTV+ +W G+DVA+K + + F ER+ EF RE I+ +L
Sbjct: 550 DLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDF-----HAERVN-EFLREVAIMKRL 603
Query: 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLS--KERHLDRRKRLIIAMDAAFG 1160
HPN+V F G V P L+ VTE++ GSL +L LD R+RL +A D A G
Sbjct: 604 RHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 661
Query: 1161 MEYLHSKN--IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG-GVRGTLPW 1217
M YLH++N IVH DLK NLLV+ K + KV DFGLS++K +T ++ GT W
Sbjct: 662 MNYLHNRNPPIVHRDLKSPNLLVDKKYTV----KVCDFGLSRLKASTFLSSKSAAGTPEW 717
Query: 1218 MAPELL 1223
MAPE+L
Sbjct: 718 MAPEVL 723
|
Acts as a negative regulator in the ethylene response pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P18160|SPLA_DICDI Dual specificity protein kinase splA OS=Dictyostelium discoideum GN=splA PE=1 SV=3 | Back alignment and function description |
|---|
Score = 121 bits (303), Expect = 4e-26, Method: Compositional matrix adjust.
Identities = 83/204 (40%), Positives = 109/204 (53%), Gaps = 21/204 (10%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
I +LE + +G G FG V G WR TDVAIK I + F +SS + F E I
Sbjct: 2110 IDFNELEFGQTIGKGFFGEVKRGYWRETDVAIKIIYRDQFKTKSS-----LVMFQNEVGI 2164
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRK--RLIIAMD 1156
LSKL HPNVV F G G VTE+M GSLR L L++ RL +A+D
Sbjct: 2165 LSKLRHPNVVQFLGACTAGGEDHHCIVTEWMGGGSLRQFLTDHFNLLEQNPHIRLKLALD 2224
Query: 1157 AAFGMEYLH--SKNIVHFDLKCDNLLVNLK-DPIRPI--------CKVGDFGLSKIK--R 1203
A GM YLH + I+H DL N+L++ DP P+ CK+ DFGLS++K +
Sbjct: 2225 IAKGMNYLHGWTPPILHRDLSSRNILLDHNIDPKNPVVSSRQDIKCKISDFGLSRLKMEQ 2284
Query: 1204 NTLVTGGVRGTLPWMAPELLNGSS 1227
+ +T V G +P+MAPE+ G S
Sbjct: 2285 ASQMTQSV-GCIPYMAPEVFKGDS 2307
|
Essential for spore differentiation. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q23915|KINX_DICDI Probable serine/threonine-protein kinase kinX OS=Dictyostelium discoideum GN=kinX PE=3 SV=2 | Back alignment and function description |
|---|
Score = 120 bits (300), Expect = 8e-26, Method: Compositional matrix adjust.
Identities = 78/205 (38%), Positives = 115/205 (56%), Gaps = 16/205 (7%)
Query: 1024 VDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSS 1083
VD ++ +FD + IK EDL+ + E+GSG FG V+ G++ G VAIK+I
Sbjct: 4 VDTSVPSFDRAWS--IKYEDLDFISEIGSGGFGKVFKGEYLGAPVAIKKIH-----ILPD 56
Query: 1084 EQERLTLEFW--REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSK 1141
+ R+ LE + RE E + HPNV+ F G+ ++ G L VTE + G L++ L ++
Sbjct: 57 DPNRVDLEKFLNREIETIKLFTHPNVIQFVGISENN--GILFIVTELIEGGDLQYYLKNQ 114
Query: 1142 ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201
L R IA+D + M YLHSK+IVH DLK NLLV+ I KV DFG ++I
Sbjct: 115 SIDLPWFLRANIALDVSLAMSYLHSKSIVHRDLKSTNLLVDKNWKI----KVCDFGFARI 170
Query: 1202 -KRNTLVTGGVRGTLPWMAPELLNG 1225
+ + + + GT WM+PE++ G
Sbjct: 171 VEEDNNKSMTICGTDNWMSPEMITG 195
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 119 bits (299), Expect = 1e-25, Method: Compositional matrix adjust.
Identities = 69/176 (39%), Positives = 101/176 (57%), Gaps = 15/176 (8%)
Query: 1050 LGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVA 1109
+G G +G V+ G WRGT+VA+K + + +L + +E ++L KL HPN+V
Sbjct: 857 IGRGGYGQVFRGSWRGTEVAVKML------FNDNVNLKLISDLRKEVDLLCKLRHPNIVL 910
Query: 1110 FYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKN- 1168
F G + + VTE++ GSL ++LL + +D RL + D A GM YLHS+N
Sbjct: 911 FMGACTEPSSPCI--VTEYLSRGSLANILLDESIEMDWGLRLQLGFDCARGMTYLHSRNP 968
Query: 1169 -IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELL 1223
I+H DLK DNLLV+ D + KV DFGL+ +K +T + GT W+APE+L
Sbjct: 969 IIIHRDLKTDNLLVD--DSWQ--VKVADFGLATVKSHTFA-KTMCGTTGWVAPEVL 1019
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54RB7|SHKA_DICDI Dual specificity protein kinase shkA OS=Dictyostelium discoideum GN=shkA PE=2 SV=1 | Back alignment and function description |
|---|
Score = 117 bits (292), Expect = 7e-25, Method: Compositional matrix adjust.
Identities = 79/182 (43%), Positives = 103/182 (56%), Gaps = 19/182 (10%)
Query: 1050 LGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVA 1109
LG G+FGTVY G+ R DVA+K + K +Q+ LT +F +E I+SK+ HPN+V
Sbjct: 51 LGDGSFGTVYKGRCRLKDVAVKVMLKQV------DQKTLT-DFRKEVAIMSKIFHPNIVL 103
Query: 1110 FYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKN- 1168
F G P G L TE M G+L +LL L R+ +A DAA G+ +LHS N
Sbjct: 104 FLGACTSTP-GKLMICTELM-KGNLESLLLDPMVKLPLITRMRMAKDAALGVLWLHSSNP 161
Query: 1169 -IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN--TLVTG--GVRGTLPWMAPELL 1223
+H DLK NLLV+ + KV DFGLS+IK+ L G G +GT WMAPE+L
Sbjct: 162 VFIHRDLKTSNLLVDANLTV----KVCDFGLSQIKQRGENLKDGQDGAKGTPLWMAPEVL 217
Query: 1224 NG 1225
G
Sbjct: 218 QG 219
|
Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 114 bits (286), Expect = 3e-24, Method: Compositional matrix adjust.
Identities = 76/201 (37%), Positives = 112/201 (55%), Gaps = 23/201 (11%)
Query: 1038 IIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
II +++ K++G G++G V++GKW+G DVA+K+ K + SE + LEF E
Sbjct: 1358 IINYDEISIGKQIGLGSYGIVFNGKWKGVDVAVKKFVKQ----KLSETQ--LLEFRAEMA 1411
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 1157
LS+L H N+V F G P + VTE+M G+LR VL + + + +L + A
Sbjct: 1412 FLSELKHSNIVTFIGACIKKPN--ICIVTEYMRMGNLRDVLKNPDIKITFANKLKLLYGA 1469
Query: 1158 AFGMEYLHSKN--IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR-NTLVTGGVRGT 1214
A G++YLHS N IVH D+K N+LV+ + K+ DFG ++IK NT +T GT
Sbjct: 1470 AMGIDYLHSSNPMIVHRDIKPANILVDEHFNV----KIADFGFARIKEDNTTMTRC--GT 1523
Query: 1215 LPWMAPELLNGSSSKVSEKVC 1235
W APE++ G EK C
Sbjct: 1524 PCWTAPEVIRG------EKYC 1538
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54R58|YTYK2_DICDI Probable tyrosine-protein kinase DDB_G0283397 OS=Dictyostelium discoideum GN=DDB_G0283397 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 113 bits (283), Expect = 8e-24, Method: Compositional matrix adjust.
Identities = 79/203 (38%), Positives = 102/203 (50%), Gaps = 17/203 (8%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
I + +L KE+G G FG VY +WRG VA+K+I F + T F +E I
Sbjct: 172 IPSRELTVEKEIGQGFFGKVYKARWRGKSVALKKITLIKFRDLTE-----TEIFDKEVSI 226
Query: 1099 LSKLHHPNVVAFYGVVQ-DGPGGTLATVTEFMVNGSLRHVLLSKER-HLDRRKRLIIAMD 1156
+SKL HP V F G DGP + + E+M GSLR +L K HL +L IA D
Sbjct: 227 MSKLCHPTCVMFIGACSLDGPSNDRSIIMEYMEGGSLRRLLDEKSSYHLPPSLQLSIARD 286
Query: 1157 AAFGMEYLHSKN----IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTGGV 1211
A GM YLH+ IVH DL N+L+N + K+ DFGLSK +K
Sbjct: 287 IAEGMNYLHTNFKEGPIVHRDLTSSNILLNSS---YTVAKINDFGLSKEMKPGPTEMTAA 343
Query: 1212 RGTLPWMAPELLNGSSSKVSEKV 1234
G+L WMAPE + +EKV
Sbjct: 344 MGSLAWMAPECFKAEN--YTEKV 364
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 113 bits (282), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 71/187 (37%), Positives = 102/187 (54%), Gaps = 11/187 (5%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
I +L+ +LG GTFG VY G WRG+ VAIK+IK + ++ EF +E I
Sbjct: 657 ISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKIN-----EDVNNQVLEEFRKELTI 711
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
LS+L HPN+V P L +TE++ GSL L SK+ ++ + +A+ A
Sbjct: 712 LSRLRHPNIVLLMAACTAPP--NLCFITEYLPGGSLYDALHSKKIKMNMQLYKKLAIQIA 769
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWM 1218
GM YLH ++H D+K NLL++ ++ IC DFGLSK+K + G+ WM
Sbjct: 770 QGMNYLHLSGVIHRDIKSLNLLLDEHMNVK-IC---DFGLSKLKSKSTEMTKSIGSPIWM 825
Query: 1219 APELLNG 1225
+PELL G
Sbjct: 826 SPELLMG 832
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55A09|Y9963_DICDI Probable serine/threonine-protein kinase DDB_G0272254 OS=Dictyostelium discoideum GN=DDB_G0272254 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 110 bits (276), Expect = 5e-23, Method: Compositional matrix adjust.
Identities = 68/196 (34%), Positives = 105/196 (53%), Gaps = 19/196 (9%)
Query: 1034 STLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFW 1093
S++ +I D++ KE+G G F V G W+G DVA+K++ + + +E + EF
Sbjct: 1063 SSVTMINYSDIKIDKEIGKGHFSKVLKGNWKGKDVAVKKLN----SNKDKAREEMIQEFK 1118
Query: 1094 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH------LDR 1147
E E+L L HPN+V YG + + V EF+ +G+L ++ SK LD
Sbjct: 1119 AEVELLGSLQHPNLVTCYGYSLN----PMCIVMEFLPSGNLFELIHSKPSEQQQSIKLDS 1174
Query: 1148 RKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLV 1207
L IA D A GM++LH++NI+H DLK NLL++ I K+ D G+++ T
Sbjct: 1175 TLILAIAFDIARGMQHLHTRNIIHRDLKSSNLLMDKHFNI----KIADLGIARETSFTQT 1230
Query: 1208 TGGVRGTLPWMAPELL 1223
+ GT+ W APE+L
Sbjct: 1231 MTTI-GTVAWTAPEIL 1245
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1236 | ||||||
| 359472758 | 1338 | PREDICTED: uncharacterized protein LOC10 | 0.991 | 0.916 | 0.648 | 0.0 | |
| 449470682 | 1199 | PREDICTED: uncharacterized protein LOC10 | 0.960 | 0.989 | 0.571 | 0.0 | |
| 449454768 | 1291 | PREDICTED: uncharacterized protein LOC10 | 0.961 | 0.920 | 0.572 | 0.0 | |
| 449503359 | 1291 | PREDICTED: LOW QUALITY PROTEIN: uncharac | 0.961 | 0.920 | 0.571 | 0.0 | |
| 225462248 | 1207 | PREDICTED: uncharacterized protein LOC10 | 0.881 | 0.902 | 0.513 | 0.0 | |
| 224074667 | 1166 | predicted protein [Populus trichocarpa] | 0.871 | 0.923 | 0.531 | 0.0 | |
| 147778419 | 1021 | hypothetical protein VITISV_036659 [Viti | 0.780 | 0.945 | 0.549 | 0.0 | |
| 255544604 | 1240 | serine/threonine protein kinase, putativ | 0.915 | 0.912 | 0.489 | 0.0 | |
| 255544602 | 1240 | serine/threonine protein kinase, putativ | 0.918 | 0.915 | 0.487 | 0.0 | |
| 356555219 | 1243 | PREDICTED: uncharacterized protein LOC10 | 0.917 | 0.912 | 0.483 | 0.0 |
| >gi|359472758|ref|XP_002276237.2| PREDICTED: uncharacterized protein LOC100242423 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1556 bits (4029), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 809/1248 (64%), Positives = 958/1248 (76%), Gaps = 22/1248 (1%)
Query: 1 MERNLGKGMMDQQKNYEQVRYSNVETRNEGPGSANQRFFHDPSSNINTNIRPPDYSMSGG 60
MERNLG+ M+QQKNYEQVRY+ VE RNEG GSANQRF HDPSS INTN+RPPD++++
Sbjct: 1 MERNLGR-EMEQQKNYEQVRYNIVEARNEGLGSANQRFLHDPSSTINTNMRPPDFNITVA 59
Query: 61 VRPVLNYSIQTGEEFALEFMRERVIPRQHFVPNAYGDPNNSPVYMDLKGVLGISHTGSES 120
RPVLNYSIQTGEEFALEFM PRQHFVP+A GDPN++ Y LKG LG SHTGSES
Sbjct: 60 ARPVLNYSIQTGEEFALEFMN----PRQHFVPSASGDPNSATNYAVLKGFLGASHTGSES 115
Query: 121 GSDITMLNAAETGRAQELERKGPSGHEDRSYYDSMRSVPRTSSRNDMGRGTQGYASSGAS 180
G DI ML + E R QE ERK S HED+ YYDS+RSVPR SSRND RG GY SSGAS
Sbjct: 116 GPDIPMLTSVEKSRVQEFERKSSSVHEDKGYYDSVRSVPRISSRNDSSRGLHGYTSSGAS 175
Query: 181 D-SSRKVKFLCSFGGKILPRPSDGKLRYVGGETRIIRISRDISWQELTQKALAIYNQTHT 239
+ SS K KFLCSFGGKILPRPSDGKLRYVGGETRIIR+++DISWQ+L QK + IYNQ+HT
Sbjct: 176 ERSSTKFKFLCSFGGKILPRPSDGKLRYVGGETRIIRMNKDISWQDLMQKTMTIYNQSHT 235
Query: 240 IKYQLPGEDLDALVSVSCDEDLQNMMEECNVLEDRGTQKPRMFLFSSADLEDTQLSLESM 299
IKYQLPGEDLDALVSVSCDEDLQNMMEECNVLED G+QK R+FLFSS+D +D Q L SM
Sbjct: 236 IKYQLPGEDLDALVSVSCDEDLQNMMEECNVLEDGGSQKLRLFLFSSSDFDDGQFGLGSM 295
Query: 300 EGDSEIQYVVAVNCMDLGSRKNSIALASASENNLDELLGLRVEREAGHIAAELAGSGATN 359
EGDSEIQYVVAVN MDL SRKNSI LAS S+NNLDELL L VERE G +A EL G
Sbjct: 296 EGDSEIQYVVAVNGMDLESRKNSIGLASTSDNNLDELLNLNVERETGRVATELPGPSTAP 355
Query: 360 LAYNASSSTIQSSQPVLVSSGSGYESNLQPYQGQRMQHISS---TLYPADGLPP---LDV 413
N SS +QSSQP++ + YESN +PYQGQ+M+H + ++P L LD
Sbjct: 356 STVNVHSSAVQSSQPLVPNFSGAYESNSKPYQGQKMRHGEAEQHQVFPVHHLESVHDLDG 415
Query: 414 KSTTPLSTPLQHDYGSHPSNFATCGENVIPIPIPIHGQLNQQGGLAEEKMYSGFHA--DD 471
+++ P S + YGS P N+ GEN++ +P+ HG + +QGG AE++MYS H
Sbjct: 416 RNSVPFSVQFPYGYGSQPFNYGPFGENLVHMPL--HGHVTRQGGPAEDQMYSDVHVHVQG 473
Query: 472 SEACAQEVKQKIDSLADKIKESEKIRSLDKEASTKEQKIKRDHSLPKINEIDNIRRSEND 531
E A+E K K D+ + K+ E EK RSL+KEAS KE KIK D S+ K+NE++ IR E++
Sbjct: 474 LEVSAKEDKLKRDNSSQKMNEPEKNRSLEKEASVKEAKIKTDSSVQKMNELEKIRSLESE 533
Query: 532 HVVSSHSYVSSVSNYIPREEVSVVSSSPGI-VPSLLPSKSNKMAQEPIQNSMPLEAVNEG 590
H VSSH + SV NYIPR+E SVV+S+ I VP LLP K++K E +Q S P EAV++G
Sbjct: 534 HNVSSHPHDGSVPNYIPRDEASVVNSTADIGVPMLLP-KTSKKHLESVQISKPPEAVSDG 592
Query: 591 RKNN-DDDVRFQASGGAFTSGHGDSEAEPTNFSYNGPSAIPQR-YHSEQIPREQTEKNRL 648
+ N + D F SGGAF+ G+GDSEA+PT SY + IP R +HSE+IPREQ E NRL
Sbjct: 593 KINTFNGDGHFHTSGGAFSPGYGDSEADPTEVSYPEQTLIPPRVFHSERIPREQAELNRL 652
Query: 649 SKSDDSFGSQFLISQALSDGSKPIRESVDKLHSGNMASETEQSVAPAKQQYTNLQKVEDG 708
SKSDDSFGSQFL+S SD S+ + ES+DKLH GN+ S++EQ+ + YTN + VEDG
Sbjct: 653 SKSDDSFGSQFLMSHTRSDVSQQVAESIDKLHGGNVTSQSEQAASSTTALYTNPKTVEDG 712
Query: 709 HAQLRKHKEFADKINKINSNGSEDGLQSSLGKSELTQVVPKSADDCEVTKIRETVKDLSI 768
Q K+K+ AD I K+NSN SEDGL L KSE P S DD E+ +R+ KD ++
Sbjct: 713 LTQFEKYKDVADDIKKLNSNISEDGLGPKLLKSESKWPAPTSVDDHEIAGVRDGNKDPAV 772
Query: 769 NDEEAAGLYHPTANHGTSGKNPEDSSLKQSEYEWNEIAAIKNNGNDNKGQAQSLAQKENS 828
+D EAAGL + TA+ GTS K +DS K + + W+E+A KNN ++ KG AQ +A EN
Sbjct: 773 SDREAAGLNNLTASQGTSSKPHDDSPSKPTGFHWDEMAVKKNNDDNTKGHAQPMAWTENP 832
Query: 829 VRAVSPGDSSIAVVSPEG-DILIDINDRFPRDFLSDIFTKARISENIAGVSPMHGDGAVL 887
+R+V G+SS+ V +PEG DILIDINDRFPRDFLSDIF+KAR SE G+SP+HGDG L
Sbjct: 833 LRSVPGGESSVGVGAPEGGDILIDINDRFPRDFLSDIFSKARTSEGPPGISPLHGDGTGL 892
Query: 888 SWNVENHDPRRWSYFRNLAQDEFSRKDVSLMDQDHLGFSSPLTNIEEGATVDYSYPPLKP 947
S N+ENH+P+ WS+F+ LAQ+EF RK VSLMDQDHLG+ S L NIEEG +DYS+PPLK
Sbjct: 893 SLNLENHEPKHWSFFQKLAQEEFIRKGVSLMDQDHLGYPSSLMNIEEGTPIDYSFPPLKS 952
Query: 948 DGSVMPQSGSRINFDEGSQRESSSIVGPSTMETHPDYSRSELKGNESLQSE-VVNHRIQE 1006
DG + SRINF+E Q+ESSS+V P+T++ H DY S +K +ES+Q + + N R +
Sbjct: 953 DGVALGPMDSRINFEEEIQQESSSMVRPNTIDMHEDYDPSPVKRDESVQMDGMANPRTPD 1012
Query: 1007 SDYEEGRLDLPTAGIPLVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGT 1066
SDYEE + ++ G P VD +LG+ DISTLQIIKNEDLEEL+ELGSGTFGTVYHGKWRGT
Sbjct: 1013 SDYEEVKFEIQNTGAPFVDPSLGDIDISTLQIIKNEDLEELRELGSGTFGTVYHGKWRGT 1072
Query: 1067 DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVT 1126
DVAIKRIKKSCFTGRSSEQERLT+EFWREA+ILSKLHHPNVVAFYGVVQDGPGGTLATVT
Sbjct: 1073 DVAIKRIKKSCFTGRSSEQERLTVEFWREADILSKLHHPNVVAFYGVVQDGPGGTLATVT 1132
Query: 1127 EFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP 1186
EFMVNGSLRHVL+SK+RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP
Sbjct: 1133 EFMVNGSLRHVLVSKDRHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP 1192
Query: 1187 IRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKV 1234
+RPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSS+VSEKV
Sbjct: 1193 LRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSRVSEKV 1240
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449470682|ref|XP_004153045.1| PREDICTED: uncharacterized protein LOC101213632, partial [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1268 bits (3281), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 712/1245 (57%), Positives = 870/1245 (69%), Gaps = 58/1245 (4%)
Query: 1 MERNLGKGMMDQQKNYEQVRYSNVETRNEGPGSANQRFFHDPSSNINTNIRPPDYSM--S 58
MERN+ K +DQ NYEQ+R +++E RN+G GS NQR FHDPSSNI+TNIRPP+Y+M
Sbjct: 1 MERNVKKSTLDQPSNYEQIRLTSMEGRNQGLGSTNQRTFHDPSSNISTNIRPPEYNMLVV 60
Query: 59 GGVRPVLNYSIQTGEEFALEFMRERVIPRQHFVPNAYGDPNNSPVYMDLKGVLGISHTGS 118
G P NYSIQTGEEFALEFMRERV + HFVP DP S YMDLKG+LGI H S
Sbjct: 61 GVASPGHNYSIQTGEEFALEFMRERVNAKHHFVPTNSPDPGVSTGYMDLKGMLGIPHASS 120
Query: 119 ESGSDITMLNAAETGRAQELERKGPSGHEDRSYYDSMRSVPRTSSRNDMGRGTQGYASSG 178
ESGS I MLN E Q ER G HE++S Y+SMR VPR SSRND+ R + SSG
Sbjct: 121 ESGSSIAMLNPVEKDHVQHFER-GSLPHEEKSSYNSMRFVPRASSRNDVSR-LHSFTSSG 178
Query: 179 ASDS-SRKVKFLCSFGGKILPRPSDGKLRYVGGETRIIRISRDISWQELTQKALAIYNQT 237
ASDS SRKVKFLCSFGGK++PRPSDGKLRYVGGETRIIRI++DISW L QK IY+Q
Sbjct: 179 ASDSTSRKVKFLCSFGGKVMPRPSDGKLRYVGGETRIIRITKDISWSNLLQKTSTIYDQV 238
Query: 238 HTIKYQLPGEDLDALVSVSCDEDLQNMMEECNVLEDRGTQKPRMFLFSSADLEDTQLSLE 297
HTIKYQLPGEDLDALVSVSCDEDLQNMMEECN+ E+ G+ KPRMFLFS +DLED+Q+ +
Sbjct: 239 HTIKYQLPGEDLDALVSVSCDEDLQNMMEECNIPENGGSTKPRMFLFSISDLEDSQMGVG 298
Query: 298 SMEGDSEIQYVVAVNCMDLGSRKNSIALASASENNLDELLGLRVEREAGHIAAELAGSGA 357
S EG SEI+YV+AVN MDL SR+NS L + S NNLDELL L V E+G +A L+ +
Sbjct: 299 SAEGGSEIEYVIAVNGMDLSSRRNSTPLGNTSGNNLDELLALNVGLESGQVAP-LSDNMK 357
Query: 358 TNLAYNASSSTIQSSQPVLVSSGSGYESNLQPYQGQRMQH------ISSTLYPADGLPPL 411
++L + S QSSQ + +S SG +S+LQP GQ++Q S+ P P
Sbjct: 358 SSLTI--TPSFPQSSQTIWTNSSSGLKSSLQPLSGQKLQQGELGPPQPSSFRPMQSFPEK 415
Query: 412 DVKSTTPLSTPLQHDYGSHPSNFATCGENVIPIPIPIHGQLNQQGGLAEEKMYSGFHADD 471
K++ S QHDY + + AT ENV P+P +G L + SGFH D
Sbjct: 416 LGKTSVSSSIQSQHDYVLNTN--ATSVENVPPMP--------SKGYLNQHYPVSGFHTQD 465
Query: 472 SEACAQEVKQKIDSLADKIKESEKIRSLDKEASTKEQKIKRDHSLPKINEIDNIRRSEND 531
++ ++E K S + K+ E ++I+SL+KE S + ++KR+ SL KI+E + E++
Sbjct: 466 PDSSSREGKITEISTS-KLSEPDEIQSLEKEVSFNDAQMKRESSLHKIDEANESPNFEHE 524
Query: 532 HVVSSHSYVSSVSNYIPREEVSVVSSSPGIVPSLLPSKSNKMAQEPIQNSMPLEAVNEGR 591
VSS+ +SV NY + + V++S + SLL +K+NK Q+P S+ LEA NEG
Sbjct: 525 CGVSSNLNDASVLNYNTKG-MQVINSDTDVGSSLLLTKNNK-HQDPAPESVSLEASNEGN 582
Query: 592 KNNDDDVRFQASGGAFTSGHGDSEAEPTNFSYNGPSAIPQR-YHSEQIPREQTEKNRLSK 650
+ +D +F +S TSG G S+A+ T FSY P +PQR +HSE+IPREQ E NRLSK
Sbjct: 583 RGTKED-KF-SSDELPTSGFGASKADETGFSYLEP-ILPQRVFHSERIPREQAELNRLSK 639
Query: 651 SDDSFGSQFLISQALSDGSKPIRESVDKLHSGNMASETEQSVAPAKQQYTNLQKVEDGHA 710
SDDSFGSQFL +Q SD S+ I ES + L GNM E+EQ V+ +K N Q +EDG
Sbjct: 640 SDDSFGSQFLRTQGNSDYSQTIIESAETLLDGNMTLESEQFVSSSKLPCGNHQTIEDGLE 699
Query: 711 QLRKHKEFADKINK-INSNGSEDGLQSSLGKSELTQVVPKSADDCEVTKIRETVKDLSIN 769
K+K ADK +K +N +G DG + S +++ + KS C
Sbjct: 700 PFEKYKTSADKNSKTMNISGEHDGSEVS----DMSNI--KSPSACR-------------- 739
Query: 770 DEEAAGLYHPTANHGTSGKNPEDSSLKQSEYEWNEIAAIKNNGNDNKGQAQSLAQKENSV 829
+EA GL H TA K+ E+S + E W E + N+GN+ + Q + + EN
Sbjct: 740 -KEAEGLAHLTAGEEVPDKHKEESLMGPLESGWIEGSTHNNHGNETQEQPEPSSLTENPG 798
Query: 830 RAVSPGDSSIAV-VSPEGDILIDINDRFPRDFLSDIFTKARISENIAGVSPMHGDGAVLS 888
+ + + + + S GDILIDINDRFPRDFLSDIF+KAR SENI+G++P+HG+GA LS
Sbjct: 799 KNATQVEPGVGIGTSEHGDILIDINDRFPRDFLSDIFSKARNSENISGINPLHGNGAGLS 858
Query: 889 WNVENHDPRRWSYFRNLAQDEFSRKDVSLMDQDHLGFSSPLTNIEEGATVDYSYPPLKPD 948
NVENH+P+RWSYFRNLAQ+EF +DVSLMDQDHLGFSS L N+EEG TV+ +P L D
Sbjct: 859 VNVENHEPKRWSYFRNLAQEEFVGRDVSLMDQDHLGFSSSLGNVEEGGTVN-RFPLLNSD 917
Query: 949 GSVMPQSGSRINFDEGSQRESSSIVGPSTMETHPDYSRSELKGNESLQSEVVNHRIQESD 1008
+ + S NFD+ Q ES + GPST + +Y+ S+LKGNE++ + + + +
Sbjct: 918 VGAIYEKESH-NFDDNIQPESRLLTGPSTTNLYTEYNSSQLKGNETMHEP--SSKSPQDE 974
Query: 1009 YEEGRLDLPTAGIPLVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDV 1068
+ +LD G+PLVD L +FDISTLQIIKNEDLEE +ELGSGTFGTVYHGKWRGTDV
Sbjct: 975 NVDAKLDGQDIGVPLVDFYLKDFDISTLQIIKNEDLEEQRELGSGTFGTVYHGKWRGTDV 1034
Query: 1069 AIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEF 1128
AIKRIKKSCFT RSSEQERLT+EFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEF
Sbjct: 1035 AIKRIKKSCFTCRSSEQERLTIEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEF 1094
Query: 1129 MVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIR 1188
MVNGSLR+VLLSKER+LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP R
Sbjct: 1095 MVNGSLRNVLLSKERYLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPFR 1154
Query: 1189 PICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEK 1233
PICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEK
Sbjct: 1155 PICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEK 1199
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449454768|ref|XP_004145126.1| PREDICTED: uncharacterized protein LOC101217445 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1266 bits (3277), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 713/1246 (57%), Positives = 870/1246 (69%), Gaps = 58/1246 (4%)
Query: 1 MERNLGKGMMDQQKNYEQVRYSNVETRNEGPGSANQRFFHDPSSNINTNIRPPDYSM--S 58
MERN+ K +DQ NYEQ+R +++E RN+G GS NQR FHDPSSNI+TNIRPP+Y+M
Sbjct: 1 MERNVKKSTLDQPSNYEQIRLTSMEGRNQGLGSTNQRTFHDPSSNISTNIRPPEYNMLVV 60
Query: 59 GGVRPVLNYSIQTGEEFALEFMRERVIPRQHFVPNAYGDPNNSPVYMDLKGVLGISHTGS 118
G P NYSIQTGEEFALEFMRERV + HFVP DP S YMDLKG+LGI H S
Sbjct: 61 GVASPGHNYSIQTGEEFALEFMRERVNAKHHFVPTNSPDPGVSTGYMDLKGMLGIPHASS 120
Query: 119 ESGSDITMLNAAETGRAQELERKGPSGHEDRSYYDSMRSVPRTSSRNDMGRGTQGYASSG 178
ESGS I MLN E Q ER G HE++S Y+SMR VPR SSRND+ R + SSG
Sbjct: 121 ESGSSIAMLNPVEKDHVQHFER-GSLPHEEKSSYNSMRFVPRASSRNDVSR-LHSFTSSG 178
Query: 179 ASDS-SRKVKFLCSFGGKILPRPSDGKLRYVGGETRIIRISRDISWQELTQKALAIYNQT 237
ASDS SRKVKFLCSFGGK++PRPSDGKLRYVGGETRIIRI++DISW L QK IY+Q
Sbjct: 179 ASDSTSRKVKFLCSFGGKVMPRPSDGKLRYVGGETRIIRITKDISWSNLLQKTSTIYDQV 238
Query: 238 HTIKYQLPGEDLDALVSVSCDEDLQNMMEECNVLEDRGTQKPRMFLFSSADLEDTQLSLE 297
HTIKYQLPGEDLDALVSVSCDEDLQNMMEECN+ E+ G+ KPRMFLFS +DLED+Q+ +
Sbjct: 239 HTIKYQLPGEDLDALVSVSCDEDLQNMMEECNIPENGGSTKPRMFLFSISDLEDSQMGVG 298
Query: 298 SMEGDSEIQYVVAVNCMDLGSRKNSIALASASENNLDELLGLRVEREAGHIAAELAGSGA 357
S EG SEI+YV+AVN MDL SR+NS L + S NNLDELL L V E+G +A L+ +
Sbjct: 299 SAEGGSEIEYVIAVNGMDLSSRRNSTPLGNTSGNNLDELLALNVGLESGQVAP-LSDNMK 357
Query: 358 TNLAYNASSSTIQSSQPVLVSSGSGYESNLQPYQGQRMQH------ISSTLYPADGLPPL 411
++L + S QSSQ + +S SG +S+LQP GQ++Q S+ P P
Sbjct: 358 SSLTI--TPSFPQSSQTIWTNSSSGLKSSLQPLSGQKLQQGELGPPQPSSFRPMQSFPEK 415
Query: 412 DVKSTTPLSTPLQHDYGSHPSNFATCGENVIPIPIPIHGQLNQQGGLAEEKMYSGFHADD 471
K++ S QHDY + + AT ENV P+P +G L + SGFH D
Sbjct: 416 LGKTSVSSSIQSQHDYVLNTN--ATSVENVPPMP--------SKGYLNQHYPVSGFHTQD 465
Query: 472 SEACAQEVKQKIDSLADKIKESEKIRSLDKEASTKEQKIKRDHSLPKINEIDNIRRSEND 531
++ ++E K S + K+ E ++I+SL+KE S + ++KR+ SL KI+E + E++
Sbjct: 466 PDSSSREGKITEISTS-KLSEPDEIQSLEKEVSFNDAQMKRESSLHKIDEANESPNFEHE 524
Query: 532 HVVSSHSYVSSVSNYIPREEVSVVSSSPGIVPSLLPSKSNKMAQEPIQNSMPLEAVNEGR 591
VSS+ +SV NY + + V++S + SLL +K+NK Q+P S+ LEA NEG
Sbjct: 525 CGVSSNLNDASVLNYNTKG-MQVINSDTDVGSSLLLTKNNK-HQDPAPESVSLEASNEGN 582
Query: 592 KNNDDDVRFQASGGAFTSGHGDSEAEPTNFSYNGPSAIPQR-YHSEQIPREQTEKNRLSK 650
+ +D +F +S TSG G S+A+ T FSY P +PQR +HSE+IPREQ E NRLSK
Sbjct: 583 RGTKED-KF-SSDELPTSGFGASKADETGFSYLEP-ILPQRVFHSERIPREQAELNRLSK 639
Query: 651 SDDSFGSQFLISQALSDGSKPIRESVDKLHSGNMASETEQSVAPAKQQYTNLQKVEDGHA 710
SDDSFGSQFL +Q SD S+ I ES + L GNM E+EQ V+ +K N Q +EDG
Sbjct: 640 SDDSFGSQFLRTQGNSDYSQTIIESAETLLDGNMTLESEQFVSSSKLPCGNHQTIEDGLE 699
Query: 711 QLRKHKEFADKINK-INSNGSEDGLQSSLGKSELTQVVPKSADDCEVTKIRETVKDLSIN 769
K+K ADK +K +N +G DG SE++ + +K S
Sbjct: 700 PFEKYKTSADKNSKTMNISGEHDG-------SEVSDM--------------SNIKSPSAC 738
Query: 770 DEEAAGLYHPTANHGTSGKNPEDSSLKQSEYEWNEIAAIKNNGNDNKGQAQSLAQKENSV 829
+EA GL H TA K+ E+S + E W E + N+GN+ + Q + + EN
Sbjct: 739 RKEAEGLAHLTAGEEVPDKHKEESLMGPLESGWIEGSTHNNHGNETQEQPEPSSLTENPG 798
Query: 830 RAVSPGDSSIAV-VSPEGDILIDINDRFPRDFLSDIFTKARISENIAGVSPMHGDGAVLS 888
+ + + + + S GDILIDINDRFPRDFLSDIF+KAR SENI+G++P+HG+GA LS
Sbjct: 799 KNATQVEPGVGIGTSEHGDILIDINDRFPRDFLSDIFSKARNSENISGINPLHGNGAGLS 858
Query: 889 WNVENHDPRRWSYFRNLAQDEFSRKDVSLMDQDHLGFSSPLTNIEEGATVDYSYPPLKPD 948
NVENH+P+RWSYFRNLAQ+EF +DVSLMDQDHLGFSS L N+EEG TV+ +P L D
Sbjct: 859 VNVENHEPKRWSYFRNLAQEEFVGRDVSLMDQDHLGFSSSLGNVEEGGTVN-RFPLLNSD 917
Query: 949 GSVMPQSGSRINFDEGSQRESSSIVGPSTMETHPDYSRSELKGNESLQSEVVNHRIQESD 1008
+ + S NFD+ Q ES + GPST + +Y+ S+LKGNE++ + + + +
Sbjct: 918 VGAIYEKESH-NFDDNIQPESRLLTGPSTTNLYTEYNSSQLKGNETMHEP--SSKSPQDE 974
Query: 1009 YEEGRLDLPTAGIPLVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDV 1068
+ +LD G+PLVD L +FDISTLQIIKNEDLEE +ELGSGTFGTVYHGKWRGTDV
Sbjct: 975 NVDAKLDGQDIGVPLVDFYLKDFDISTLQIIKNEDLEEQRELGSGTFGTVYHGKWRGTDV 1034
Query: 1069 AIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEF 1128
AIKRIKKSCFT RSSEQERLT+EFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEF
Sbjct: 1035 AIKRIKKSCFTCRSSEQERLTIEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEF 1094
Query: 1129 MVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIR 1188
MVNGSLR+VLLSKER+LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP R
Sbjct: 1095 MVNGSLRNVLLSKERYLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPFR 1154
Query: 1189 PICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKV 1234
PICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKV
Sbjct: 1155 PICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKV 1200
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449503359|ref|XP_004161963.1| PREDICTED: LOW QUALITY PROTEIN: uncharacterized protein LOC101223789 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1264 bits (3272), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 712/1246 (57%), Positives = 869/1246 (69%), Gaps = 58/1246 (4%)
Query: 1 MERNLGKGMMDQQKNYEQVRYSNVETRNEGPGSANQRFFHDPSSNINTNIRPPDYSM--S 58
MERN+ K +DQ NYEQ+R +++E RN+G GS NQR FHDPSSNI+TNIRPP+Y+M
Sbjct: 1 MERNVKKSTLDQPSNYEQIRLTSMEGRNQGLGSTNQRTFHDPSSNISTNIRPPEYNMLVV 60
Query: 59 GGVRPVLNYSIQTGEEFALEFMRERVIPRQHFVPNAYGDPNNSPVYMDLKGVLGISHTGS 118
G P NYSIQTGEEFALEFMRERV + HFVP DP S YMDLKG+LGI H S
Sbjct: 61 GVASPGHNYSIQTGEEFALEFMRERVNAKHHFVPTNSPDPGVSTGYMDLKGMLGIPHASS 120
Query: 119 ESGSDITMLNAAETGRAQELERKGPSGHEDRSYYDSMRSVPRTSSRNDMGRGTQGYASSG 178
ESGS I MLN E Q ER G HE++S Y+SMR VPR SSRND+ R + SSG
Sbjct: 121 ESGSSIAMLNPVEKDHVQHFER-GSLPHEEKSSYNSMRFVPRASSRNDVSR-LHSFTSSG 178
Query: 179 ASDS-SRKVKFLCSFGGKILPRPSDGKLRYVGGETRIIRISRDISWQELTQKALAIYNQT 237
ASDS SRKVKFLCSFGGK++PRPSDGKLRYVGGETRIIRI++DISW L QK IY+Q
Sbjct: 179 ASDSTSRKVKFLCSFGGKVMPRPSDGKLRYVGGETRIIRITKDISWSNLLQKTSTIYDQV 238
Query: 238 HTIKYQLPGEDLDALVSVSCDEDLQNMMEECNVLEDRGTQKPRMFLFSSADLEDTQLSLE 297
HTIKYQLPGEDLDALVSVSCDEDLQNMMEECN+ E+ G+ KPRMFLFS +DLED+Q+ +
Sbjct: 239 HTIKYQLPGEDLDALVSVSCDEDLQNMMEECNIPENGGSTKPRMFLFSISDLEDSQMGVG 298
Query: 298 SMEGDSEIQYVVAVNCMDLGSRKNSIALASASENNLDELLGLRVEREAGHIAAELAGSGA 357
S EG SEI+YV+AVN MDL SR+NS L + S NNLDELL L V E+G +A L+ +
Sbjct: 299 SAEGGSEIEYVIAVNGMDLSSRRNSTPLGNTSGNNLDELLALNVGLESGQVAP-LSDNMK 357
Query: 358 TNLAYNASSSTIQSSQPVLVSSGSGYESNLQPYQGQRMQH------ISSTLYPADGLPPL 411
++L + S QSSQ + +S SG +S+LQP GQ++Q S+ P P
Sbjct: 358 SSLTI--TPSFPQSSQTIWTNSSSGLKSSLQPLSGQKLQQGELGPPQPSSFRPMQSFPEK 415
Query: 412 DVKSTTPLSTPLQHDYGSHPSNFATCGENVIPIPIPIHGQLNQQGGLAEEKMYSGFHADD 471
K++ S QHDY + + AT ENV P+P +G L + SGFH D
Sbjct: 416 LGKTSVSSSIQSQHDYVLNTN--ATSVENVPPMP--------SKGYLNQHYPVSGFHTQD 465
Query: 472 SEACAQEVKQKIDSLADKIKESEKIRSLDKEASTKEQKIKRDHSLPKINEIDNIRRSEND 531
++ ++E K S + K+ E ++I+SL+KE S + ++KR+ SL KI+E + E++
Sbjct: 466 PDSSSREGKITEISTS-KLSEPDEIQSLEKEVSFNDAQMKRESSLHKIDEANESPNFEHE 524
Query: 532 HVVSSHSYVSSVSNYIPREEVSVVSSSPGIVPSLLPSKSNKMAQEPIQNSMPLEAVNEGR 591
VSS+ +SV NY + + V++S + SLL +K+NK Q+P S+ LEA NEG
Sbjct: 525 CGVSSNLNDASVLNYNTKG-MQVINSDTDVGSSLLLTKNNK-HQDPAPESVSLEASNEGN 582
Query: 592 KNNDDDVRFQASGGAFTSGHGDSEAEPTNFSYNGPSAIPQR-YHSEQIPREQTEKNRLSK 650
+ +D +F +S TSG G S+A+ T FSY P +PQR +HSE+IPREQ E NRLSK
Sbjct: 583 RGTKED-KF-SSDELPTSGFGASKADETGFSYLEP-ILPQRVFHSERIPREQAELNRLSK 639
Query: 651 SDDSFGSQFLISQALSDGSKPIRESVDKLHSGNMASETEQSVAPAKQQYTNLQKVEDGHA 710
SDDSFGSQFL +Q SD S+ I ES + L GNM E+EQ V+ +K N Q +EDG
Sbjct: 640 SDDSFGSQFLRTQGNSDYSQTIIESAETLLDGNMTLESEQFVSSSKLPCGNHQTIEDGLE 699
Query: 711 QLRKHKEFADKINK-INSNGSEDGLQSSLGKSELTQVVPKSADDCEVTKIRETVKDLSIN 769
K+K ADK +K +N +G DG SE++ + +K S
Sbjct: 700 PFEKYKTSADKNSKTMNISGEHDG-------SEVSDM--------------SNIKSPSAC 738
Query: 770 DEEAAGLYHPTANHGTSGKNPEDSSLKQSEYEWNEIAAIKNNGNDNKGQAQSLAQKENSV 829
+EA GL H TA K+ E+S + E W E + N+GN+ + Q + + EN
Sbjct: 739 RKEAEGLAHLTAGEEVPDKHKEESLMGPLESGWIEGSTHNNHGNETQEQPEPSSLTENPG 798
Query: 830 RAVSPGDSSIAV-VSPEGDILIDINDRFPRDFLSDIFTKARISENIAGVSPMHGDGAVLS 888
+ + + + + S GDILIDINDRFPRDFLSDIF+KAR SENI+G++P+HG+GA LS
Sbjct: 799 KNATQVEPGVGIGTSEHGDILIDINDRFPRDFLSDIFSKARNSENISGINPLHGNGAGLS 858
Query: 889 WNVENHDPRRWSYFRNLAQDEFSRKDVSLMDQDHLGFSSPLTNIEEGATVDYSYPPLKPD 948
NVENH+P+RWSYFRNLAQ+EF +DVSLMDQDHLGFSS L N+EEG TV+ +P L D
Sbjct: 859 VNVENHEPKRWSYFRNLAQEEFVGRDVSLMDQDHLGFSSSLGNVEEGGTVN-RFPLLNSD 917
Query: 949 GSVMPQSGSRINFDEGSQRESSSIVGPSTMETHPDYSRSELKGNESLQSEVVNHRIQESD 1008
+ + S NFD+ Q ES + GPST + +Y+ S+LKGNE++ + + + +
Sbjct: 918 VGAIYEKESH-NFDDNIQPESRLLTGPSTTNLYTEYNSSQLKGNETMHEP--SSKSPQDE 974
Query: 1009 YEEGRLDLPTAGIPLVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDV 1068
+ +LD G+PLVD L +FDISTLQIIKNEDLEE +ELGSGTFGTVYHGKWRGTDV
Sbjct: 975 NVDAKLDGQDIGVPLVDFYLKDFDISTLQIIKNEDLEEQRELGSGTFGTVYHGKWRGTDV 1034
Query: 1069 AIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEF 1128
AIKRIKKSCFT RSSEQERLT+EFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEF
Sbjct: 1035 AIKRIKKSCFTCRSSEQERLTIEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEF 1094
Query: 1129 MVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIR 1188
MVNGSLR+VLLSKER+LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP R
Sbjct: 1095 MVNGSLRNVLLSKERYLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPFR 1154
Query: 1189 PICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKV 1234
PICKVGDFGLSK KRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKV
Sbjct: 1155 PICKVGDFGLSKXKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKV 1200
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225462248|ref|XP_002263264.1| PREDICTED: uncharacterized protein LOC100257013 [Vitis vinifera] gi|147772468|emb|CAN65102.1| hypothetical protein VITISV_021043 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1066 bits (2756), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 624/1216 (51%), Positives = 776/1216 (63%), Gaps = 127/1216 (10%)
Query: 35 NQRFFHDPSSNINTNIRPPDYSMSGGVRPVLNYSIQTGEEFALEFMRERVIPRQHFVPNA 94
+Q F DP++ INT+ RPP+++ + V+PV NYSIQTGEEFALEFM +RV PR F+P+
Sbjct: 12 SQGFMLDPTTAINTDTRPPEFN-NLEVKPVRNYSIQTGEEFALEFMLDRVNPRNQFIPDT 70
Query: 95 YGDPNNSPVYMDLKGVLGISHTGSESGSDITMLNAAETGRAQELERKGPSGHEDRSYYDS 154
GDP+ P Y +LKG+LGI+HTGSESGSDI+ML E G +E ERK + +EDRSYY S
Sbjct: 71 AGDPHYVPKYTELKGILGINHTGSESGSDISMLTIVERG-PKEFERKNSALYEDRSYYGS 129
Query: 155 MRSVPRTSSRNDMGRGT-QGYASSGASDSSR-KVKFLCSFGGKILPRPSDGKLRYVGGET 212
++ VPRTSS +D RG GYASSGASDSS K+K LCSFGGKILPRPSDGKLRYVGGET
Sbjct: 130 VQLVPRTSSGHDSSRGVIHGYASSGASDSSSTKMKVLCSFGGKILPRPSDGKLRYVGGET 189
Query: 213 RIIRISRDISWQELTQKALAIYNQTHTIKYQLPGEDLDALVSVSCDEDLQNMMEECNVLE 272
RIIRI +DISWQEL QK L ++NQ H IKYQLPGEDLDALVSVSCDEDLQNMMEECN LE
Sbjct: 190 RIIRIRKDISWQELVQKTLMVFNQAHIIKYQLPGEDLDALVSVSCDEDLQNMMEECNELE 249
Query: 273 D-RGTQKPRMFLFSSADLEDTQLSLESMEGDSEIQYVVAVNCMDLGSRKNSI--ALASAS 329
D G++K RMFLFS++DL+D L+S +GDSEIQYVVAVN MD+GSRKNS L +S
Sbjct: 250 DGEGSKKLRMFLFSTSDLDDAYFGLDSTDGDSEIQYVVAVNGMDMGSRKNSTLHGLVGSS 309
Query: 330 ENNLDELLGLRVEREAGHIAAELAGSGATNLAYN-ASSSTIQSSQPVLVSSGSGYESNLQ 388
NNL +L G +ER A +A + G L STIQSSQP+L +S S YE++
Sbjct: 310 SNNLADLDGQNIERNATRVATDSVGISTLPLTGTIVPPSTIQSSQPILPNSSSAYEADPP 369
Query: 389 PYQGQRMQHISSTLYPADGLPPLDVKSTTPLSTPLQHDYGSHPSNFATCGENVIPIPIPI 448
Y GQ + H ++ + L + Y SH SN E+ +P+
Sbjct: 370 FYHGQMIYHGETSQHM------------------LHYGYPSHQSNCTPYQESTNLMPV-- 409
Query: 449 HGQLNQQGGLAEEKMYSGFHADDSEACAQEVKQKIDSLADKIKESEKIRSLDKEASTKEQ 508
HG + QQ G AE + Y G D +EV
Sbjct: 410 HGLMTQQEGYAEGQPYIGLQVQDPSVLVKEVT---------------------------- 441
Query: 509 KIKRDHSLPKINEIDNIRRSENDHVVSSHSYVSSVSNYIPREEVSVVSSSPGIVPSLLPS 568
+K D S+ + N +NI S+ND ++ S V + IP EE V SS PS
Sbjct: 442 -LKNDASIQQENIPENISPSKNDCLIPSQPSDGEVMDRIPVEEALVSISSL----DQFPS 496
Query: 569 KSNKMAQEPIQNSMPLEAVNEGRKNNDDDVRFQASGGAFTSGHGDSEAEPTNFSYNGPSA 628
++ +P++ S ++A+N+ + D AS F + D + + SY P
Sbjct: 497 ENKGKHHKPVEISSSVDAMNQAQVPKSDYDHHPASSSPFAPVYADPGSGLMDLSYLEPPV 556
Query: 629 IPQR-YHSEQIPREQTEK-NRLSKSDDSFGSQFLISQALSDGSK--PIRESVDKLHSGNM 684
+PQR Y+SE++PREQ E NRLSKSDDS GSQFLIS + SD K + ES DKL +GN+
Sbjct: 557 LPQRVYYSERVPREQAELLNRLSKSDDSLGSQFLISHSRSDIEKQDSVAESTDKLRNGNL 616
Query: 685 ASETEQSVAPAKQQYTNLQKVEDGHAQLRKHKEFADKINKINSNGSEDGLQSSLGKSELT 744
A +TEQS+ S G++ +
Sbjct: 617 APQTEQSI--------------------------------------------STGEAMVE 632
Query: 745 QVVPKSADDCEVTKIRETVKDLSINDEEAAGLYHPTANHGTSGKNPEDSSLKQSEYEWNE 804
+ K+ D T ++ + L ++ G P N S K+ +D E + E
Sbjct: 633 DMAVKA--DHGTTGTKDIPRKLLLHGTTEPGSELPAMNQVASVKHCQDPLSTPPELDQGE 690
Query: 805 IAA--IKNNGNDNKGQAQSLAQKENSVRAVSPGDSSIAVVSPE-GDILIDINDRFPRDFL 861
++ +N G AQ+ A SS+ V +PE GDILIDINDRFPRDFL
Sbjct: 691 MSGKDFTSNNTLGVGDAQTFAWT----------GSSVGVSTPEQGDILIDINDRFPRDFL 740
Query: 862 SDIFTKARISENIAGVSPMHGDGAVLSWNVENHDPRRWSYFRNLAQDEFSRKDVSLMDQD 921
SDIF+KA + +S DGA LS N+EN +P+ WSYF+ LAQ F + DVSLMDQD
Sbjct: 741 SDIFSKAVHFADSPDISKPQKDGAGLSLNMENREPKHWSYFQKLAQGGFVQNDVSLMDQD 800
Query: 922 HLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQRESS-SIVGPSTMET 980
HLGFSS LT +EE + Y + PL D ++ Q SRI+F E +Q+ES + + +
Sbjct: 801 HLGFSSVLTKVEEEVSKPYQFTPLMADEVLIGQLESRISFGEENQKESPPGRIAADSTDL 860
Query: 981 HPDYSRSELKGNESLQSE--VVNHRIQESDYEEGRLDLPTAGIPLVDLALGNFDISTLQI 1038
H DYS SE+K ++S+Q + + N R +S+ E+G+++ G P +D ++G+FDI+TLQI
Sbjct: 861 HSDYSPSEIKESDSVQFDRMIENLRTPDSEGEDGKMETKNIGRPPLDPSIGDFDINTLQI 920
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
IKNEDLEELKELGSGTFGTVYHGKWRG+DVAIKRIKK CFT RSSEQERLT+EFWREA+I
Sbjct: 921 IKNEDLEELKELGSGTFGTVYHGKWRGSDVAIKRIKKICFTSRSSEQERLTIEFWREADI 980
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
LSKLHHPNVVAFYGVV DGPG TLATVTE+MV+GSLRHVLL K+R+LDRRKRL+IAMDAA
Sbjct: 981 LSKLHHPNVVAFYGVVHDGPGATLATVTEYMVDGSLRHVLLRKDRYLDRRKRLLIAMDAA 1040
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWM 1218
FGMEYLHSKNIVHFDLKCDNLLVNLKDP+RPICKVGDFGLSKIKRNTLV+GGVRGTLPWM
Sbjct: 1041 FGMEYLHSKNIVHFDLKCDNLLVNLKDPLRPICKVGDFGLSKIKRNTLVSGGVRGTLPWM 1100
Query: 1219 APELLNGSSSKVSEKV 1234
APELLNGSS+KVSEKV
Sbjct: 1101 APELLNGSSNKVSEKV 1116
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224074667|ref|XP_002304415.1| predicted protein [Populus trichocarpa] gi|222841847|gb|EEE79394.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1055 bits (2728), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 621/1169 (53%), Positives = 757/1169 (64%), Gaps = 92/1169 (7%)
Query: 9 MMDQQKNYEQVRYSNVETRNEGPGSANQRFFHDPSSNINTNIRPPDYSMSGGVRPVLNYS 68
M+DQQKNYEQ++ +N+E RNEG GS NQRFFHDPS+NINTN+RPPDY+MS G RPVLNYS
Sbjct: 1 MVDQQKNYEQIQSNNMEARNEGKGSVNQRFFHDPSANINTNMRPPDYNMSMGARPVLNYS 60
Query: 69 IQTGEEFALEFMRERVIPRQHFVPNAYGDPNNSPVYMDLKGVLGISHTGSESGSDITMLN 128
IQTGEEFALEFMRERV PRQ F P+A DPN+S Y+ L+GVLGISH GSESG+DI+M++
Sbjct: 61 IQTGEEFALEFMRERVNPRQQFFPSARIDPNSSTGYVGLEGVLGISHMGSESGADISMIS 120
Query: 129 AAETGRAQELERKGPSGHEDRSYYDSMRSVPRTSSRNDMGRGTQGY-ASSGASDSSRKVK 187
+ E R QE +RKG S +ED+SYYD + SVPRTS RND RG GY +S + SS K+K
Sbjct: 121 SVEKARNQESDRKGSSVNEDQSYYDPVPSVPRTSPRNDSSRGIHGYPSSGASDSSSTKLK 180
Query: 188 FLCSFGGKILPRPSDGKLRYVGGETRIIRISRDISWQELTQKALAIYNQTHTIKYQLPGE 247
FLCSFGG ILPRPSDGKLRYVGGETRIIRIS++ISWQEL QK +AIYNQ+HTIKYQLPGE
Sbjct: 181 FLCSFGGTILPRPSDGKLRYVGGETRIIRISKNISWQELMQKTVAIYNQSHTIKYQLPGE 240
Query: 248 DLDALVSVSCDEDLQNMMEECNVLEDRGTQKPRMFLFSSADLEDTQLSLESMEGD-SEIQ 306
DLDALVSVSCDEDLQNMMEECNV ED G++KPRMFLFS DLED+Q +L S EG+ SEIQ
Sbjct: 241 DLDALVSVSCDEDLQNMMEECNVSEDGGSKKPRMFLFSCNDLEDSQFALGSGEGENSEIQ 300
Query: 307 YVVAVNCMDLGSRKNSIALASASENNLDELLGLRVEREAGHIAAELAGSGATNLAYNASS 366
YVVAVN MDLGSRKNS+ LASAS NNLDELL L VERE+G +AAE GS + A N
Sbjct: 301 YVVAVNGMDLGSRKNSMNLASASGNNLDELLCLNVERESGRVAAEFTGSNVPSSAVNMLP 360
Query: 367 STIQSSQPVLVSSGSGYESNLQPYQGQRM------QHISSTLYPADGLPPLDVKSTTPLS 420
STIQSSQPV + S S ESN QPY GQ+M Q +S++ P + +D K PL
Sbjct: 361 STIQSSQPVPMISSSAQESNSQPYHGQKMHRGDNSQRPASSMQPIESFSHVDRKGINPLP 420
Query: 421 TPLQHDYGSHPSNFATCGENVIPIPIPIHGQLNQQGGLAEEKMYSGFHADDSEACAQEVK 480
P+Q + SH + AT GEN++ +P ++ QQG L EEK+YSG H ++E ++ K
Sbjct: 421 VPIQFGFDSHLPDHATVGENLVGVPFHVYPP-TQQGVLGEEKLYSGIHVQNAEVSVKDTK 479
Query: 481 QKIDSLADKIKESEKIRSLDKEASTKEQKIKRDHSLPKINEIDNIRRSENDHVVSSHSYV 540
K DS KI E EK++++DKEA+ KE K+KRD S K+NE IR END VS H +
Sbjct: 480 LKRDSSGKKINEPEKVKTMDKEAAKKEFKMKRDDSFQKLNETFKIRAVEND-TVSLHPHD 538
Query: 541 SSVSNYIPREEVSVVSSSPGIVPSLLPSKSNKMAQEPIQNSMPLEAVNEGRKNNDDDVRF 600
SS NY REEVSV +S + L K+NK QE + +SMP EAV EG KNN DD F
Sbjct: 539 SSAPNYTSREEVSVANSMQEVGSPLQLMKTNKGPQEAVLSSMPTEAVTEGIKNNRDD-HF 597
Query: 601 QASGGAFTSGHGDSEAEPTNFSYNGPSAIPQR-YHSEQIPREQTEKNRLSKSDDSFGSQF 659
+SG F G+G SEA+PT+FSY PS + R +HSE+IPREQ E NRLSKSDDSF Q
Sbjct: 598 HSSGDPFAPGYGGSEADPTDFSYPEPSVVSHRVFHSERIPREQAELNRLSKSDDSFDPQI 657
Query: 660 LISQALSDGSKPIRESVDKLHSGNMASETEQSVAPAKQQYTNLQKVEDGHAQLRKHKEFA 719
LI+QA S GS+P+ ES+DKLH GN+AS+T+Q A+ +Y N Q VEDG AQ K+KEFA
Sbjct: 658 LITQARS-GSQPVIESIDKLHEGNVASQTDQPRTSARSRYANPQTVEDGLAQFEKYKEFA 716
Query: 720 DKINKINSNGSEDGLQSSLGKSELTQVVPKSADDCEVTKIRETVKDLSINDEEAAGLYHP 779
D I+K+N N ++ GL S++ KSEL +VV DD E ++++ D SIND +A GL H
Sbjct: 717 DNISKVNPNIAQ-GLGSNVQKSELRRVVFNPVDDYEGSQVKGNYTDRSINDNKAVGLTHS 775
Query: 780 TANHGTSGKNPEDSSLKQSEYEWNEIAAIKNNGNDNKGQAQSLAQKENSVRAVSPGDSSI 839
TA+ GTS K+PED +L E+E + A NNGN+ K Q LA + VRAVS G+ SI
Sbjct: 776 TASQGTSSKHPEDPALGPQEFERTDFGADNNNGNNTKVSVQPLAWTGSPVRAVSQGEPSI 835
Query: 840 AVVSPE-GDILIDINDRFPRDFLSDIFTKARISENIAGVSPMHGDGAVLSWNVENHD--- 895
V +PE DI IDINDRFP DFLSDIF+KA+I E G+ P + + N +
Sbjct: 836 GVGAPEQKDICIDINDRFPPDFLSDIFSKAKIHE--TGLGPQEFERTDFGADNNNGNNTK 893
Query: 896 ----PRRW--SYFRNLAQDEFS-------RKDVSLMDQDHLGFSSPLTNIEEGATVDYSY 942
P W S R ++Q E S +KD+ + D + + T +
Sbjct: 894 VSVQPLAWTGSPVRAVSQGEPSIGVGAPEQKDICIDINDRFPHDFLSDSFSKAKTHETGV 953
Query: 943 PPLKPDGSVMP------QSGSRINFDEGSQRESSSIVGPSTMETH--------------- 981
P+ DG + R F +Q +S+S V + H
Sbjct: 954 SPVHVDGVGLSLNMENHDPKRRSYFQNLAQDQSASKVFSLIDQDHLSYSSSLTNVEGGAP 1013
Query: 982 PDYSRSELKGN--------ESLQSE---VVNHRIQES--DY--------EEGRLDLPTAG 1020
DYS LK + E ++ E VV +S DY E LD A
Sbjct: 1014 IDYSYPPLKSDGVGLPHIEEDVRQETSGVVGPNTMDSHADYGHFELKGIESAWLDGMNAR 1073
Query: 1021 IPLVDLALGNFDI-----------------STLQIIKNEDLEELKELGSGTFGTVYHGKW 1063
IP + G DI STLQIIKNEDLEEL+ELGSGTFGTVYHGKW
Sbjct: 1074 IPESEYEGGKLDIRNIGTHLVDLSLGEFDISTLQIIKNEDLEELRELGSGTFGTVYHGKW 1133
Query: 1064 RGTDVAIKRIKKSCFTGRSSEQERLTLEF 1092
RGTDVAIKRIKKSCFTGR+SEQERL L +
Sbjct: 1134 RGTDVAIKRIKKSCFTGRTSEQERLHLAY 1162
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147778419|emb|CAN60811.1| hypothetical protein VITISV_036659 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1035 bits (2675), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 571/1040 (54%), Positives = 703/1040 (67%), Gaps = 75/1040 (7%)
Query: 10 MDQQKNYEQVRYSNVETRNEGPGSANQRFFHDPSSNINTNIRPPDYSMSGGVRPVLNYSI 69
M+QQKNYEQVRY+ VE RNEG GSANQRF HDPSS INTN+RPPD++++ RPVLNYSI
Sbjct: 1 MEQQKNYEQVRYNIVEARNEGLGSANQRFLHDPSSTINTNMRPPDFNITVAARPVLNYSI 60
Query: 70 QTGEEFALEFMRERVIPRQHFVPNAYGDPNNSPVYMDLKGVLGISHTGSESGSDITMLNA 129
QTGEEFALEFM PRQHFVP+A GDPN++ Y LKG LG SHTGSESG DI ML +
Sbjct: 61 QTGEEFALEFMN----PRQHFVPSASGDPNSATNYAVLKGFLGASHTGSESGPDIPMLTS 116
Query: 130 AETGRAQELERKGPSGHEDRSYYDSMRSVPRTSSRNDMGRGTQGYASSGASD-SSRKVKF 188
E R QE ERK S HED+ YYDS+RSVPR SSRND RG GY SSGAS+ SS K KF
Sbjct: 117 VEKSRVQEFERKSSSVHEDKGYYDSVRSVPRISSRNDSSRGLHGYTSSGASERSSTKFKF 176
Query: 189 LCSFGGKILPRPSDGKLRYVGGETRIIRISRDISWQELTQKALAIYNQTHTIKYQLPGED 248
LCSFGGKILPRPSDGKLRYVGGETRIIR+++DISWQ+L QK + IYNQ+HTIKYQLPGED
Sbjct: 177 LCSFGGKILPRPSDGKLRYVGGETRIIRMNKDISWQDLMQKTMTIYNQSHTIKYQLPGED 236
Query: 249 LDALVSVSCDEDLQNMMEECNVLEDRGTQKPRMFLFSSADLEDTQLSLESMEGDSEIQYV 308
LDALVSVSCDEDLQNMMEECNVLED G+QK R+FLFSS+D +D Q L SMEGDSEIQYV
Sbjct: 237 LDALVSVSCDEDLQNMMEECNVLEDGGSQKLRLFLFSSSDFDDGQFGLGSMEGDSEIQYV 296
Query: 309 VAVNCMDLGSRKNSIALASASENNLDELLGLRVEREAGHIAAELAGSGATNLAYNASSST 368
VAVN MDL SRKNSI LAS S+NNLDELL L VERE G +A EL G N SS
Sbjct: 297 VAVNGMDLESRKNSIGLASTSDNNLDELLNLNVERETGRVATELPGPSTAPSTVNVHSSA 356
Query: 369 IQSSQPVLVSSGSGYESNLQPYQGQRMQHISS---TLYPADGLPP---LDVKSTTPLSTP 422
+QSSQP++ + YESN +PYQGQ+M+H + ++P L LD +++ P S
Sbjct: 357 VQSSQPLVPNFSGAYESNSKPYQGQKMRHGEAEQHQVFPVHHLESVHDLDGRNSVPFSVQ 416
Query: 423 LQHDYGSHPSNFATCGENVIPIPIPIHGQLNQQGGLAEEKMYSG--FHADDSEACAQEVK 480
+ YGS P N+ GEN+ + +P+HG + +QGG AE++MYS H E A+E K
Sbjct: 417 FPYGYGSQPFNYGPFGENL--VHMPLHGHVTRQGGPAEDQMYSDVHVHVQGLEVSAKEDK 474
Query: 481 QKIDSLADKIKESEKIRSLDKEASTKEQKIKRDHSLPKINEIDNIRRSENDHVVSSHSYV 540
K D+ + K+ E EK RSL+KEAS KE KIK D S+ K+NE++ IR E++H VSSH +
Sbjct: 475 LKRDNSSQKMNEPEKNRSLEKEASVKEAKIKTDSSVQKMNELEKIRSLESEHNVSSHPHD 534
Query: 541 SSVSNYIPREEVSVVSSSPGI-VPSLLPSKSNKMAQEPIQNSMPLEAVNEGRKNNDDDVR 599
SV NYIPR+E SVV+S+ I VP LLP K++K E +Q S P EA R + DD
Sbjct: 535 GSVPNYIPRDEASVVNSTADIGVPMLLP-KTSKKHLESVQISKPPEAAELNRLSKSDD-- 591
Query: 600 FQASGGAFTSGHGDSEAEPTNFSYNGPSAIPQRYHSEQIPREQTEKNRLSKSDDSFGSQF 659
+ G F H S
Sbjct: 592 --SFGSQFLMSHTRS--------------------------------------------- 604
Query: 660 LISQALSDGSKPIRESVDKLHSGNMASETEQSVAPAKQQYTNLQKVEDGHAQLRKHKEFA 719
D S+ + ES+DKLH GN+ S++EQ+ + YTN + VEDG Q K+K+ A
Sbjct: 605 -------DVSQQVAESIDKLHGGNVTSQSEQAASSTTALYTNPKTVEDGLTQFEKYKDVA 657
Query: 720 DKINKINSNGSEDGLQSSLGKSELTQVVPKSADDCEVTKIRETVKDLSINDEEAAGLYHP 779
D I K+NSN SEDGL L KSE P S DD E+ +R+ KD +++D EAAGL +
Sbjct: 658 DDIKKLNSNISEDGLGPKLLKSESKWPAPTSVDDHEIAGVRDGNKDPAVSDREAAGLNNL 717
Query: 780 TANHGTSGKNPEDSSLKQSEYEWNEIAAIKNNGNDNKGQAQSLAQKENSVRAVSPGDSSI 839
TA+ GTS K +DS K + + W+E+A KNN ++ KG AQ +A EN +R+V G+SS+
Sbjct: 718 TASQGTSSKPHDDSPSKPTGFHWDEMAVKKNNDDNTKGHAQPMAWTENPLRSVPGGESSV 777
Query: 840 AVVSPE-GDILIDINDRFPRDFLSDIFTKARISENIAGVSPMHGDGAVLSWNVENHDPRR 898
V +PE GDILIDINDRFPRDFLSDIF+KAR SE G+SP+HGDG LS N+ENH+P+
Sbjct: 778 GVGAPEGGDILIDINDRFPRDFLSDIFSKARTSEGPPGISPLHGDGTGLSLNLENHEPKH 837
Query: 899 WSYFRNLAQDEFSRKDVSLMDQDHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSR 958
WS+F+ LAQ+EF RK VSLMDQDHLG+ S L NIEEG +DYS+PPLK DG + SR
Sbjct: 838 WSFFQKLAQEEFIRKGVSLMDQDHLGYPSSLMNIEEGTPIDYSFPPLKSDGVALGPMDSR 897
Query: 959 INFDEGSQRESSSIVGPSTMETHPDYSRSELKGNESLQSE-VVNHRIQESDYEEGRLDLP 1017
INF+E Q+ESSS+V P+T++ H DY S +K +ES+Q + + N R +SDYEE + ++
Sbjct: 898 INFEEEIQQESSSMVRPNTIDMHEDYDPSPVKRDESVQMDGMANPRTPDSDYEEVKFEIQ 957
Query: 1018 TAGIPLVDLALGNFDISTLQ 1037
G P VD +LG+ DISTLQ
Sbjct: 958 NTGAPFVDPSLGDIDISTLQ 977
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255544604|ref|XP_002513363.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223547271|gb|EEF48766.1| serine/threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1028 bits (2659), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 612/1250 (48%), Positives = 788/1250 (63%), Gaps = 118/1250 (9%)
Query: 1 MERNLGKGMMDQQKNYEQVRYSNVETRNEGPGSANQRFFHDPSSNINTNIRPPDYSMSGG 60
MERNL M+ + + +Y + E +EG A Q F DP+S N N+R PD ++S
Sbjct: 1 MERNLNNIAMENSEVNKPFQYGSREPGHEGTSPAPQAFMLDPASIRNANMRIPDLNVSE- 59
Query: 61 VRPVLNYSIQTGEEFALEFMRERVIPRQHFVPNAYGDPNNSPVYMDLKGVLGISHTGSES 120
V+PV N+SIQTGEEFALEFMR+RV ++ +PN GDPN + Y++LKG+LGISHTGSES
Sbjct: 60 VKPV-NFSIQTGEEFALEFMRDRVNHKKPIIPNTVGDPNYATGYLELKGILGISHTGSES 118
Query: 121 GSDITMLNAAETGRAQELERKGPSGHEDRSYYDSMRSVPRTSSRNDMGRGTQG----YAS 176
GSDI+ML E G+ ++ ER S HE+R Y+S++SVP++S+ G G++G Y S
Sbjct: 119 GSDISMLTIVEKGQ-KDFERTNSSFHEERGNYESIQSVPQSSA----GYGSRGPPVGYTS 173
Query: 177 SGASDS-SRKVKFLCSFGGKILPRPSDGKLRYVGGETRIIRISRDISWQELTQKALAIYN 235
SG SDS S+K+K LCSFGGKILPRPSDGKLRYVGG+TRIIRI+RDISW EL QK LAIY+
Sbjct: 174 SGTSDSLSQKMKVLCSFGGKILPRPSDGKLRYVGGDTRIIRITRDISWMELKQKTLAIYD 233
Query: 236 QTHTIKYQLPGEDLDALVSVSCDEDLQNMMEECNVLEDRG-TQKPRMFLFSSADLEDTQL 294
Q H IKYQLPGEDLD+LVSVSCDEDL NMMEE N +EDRG +QK RMF+FS +DL+D Q
Sbjct: 234 QAHAIKYQLPGEDLDSLVSVSCDEDLLNMMEEWNEVEDRGGSQKLRMFIFSMSDLDDAQF 293
Query: 295 SLESMEGDSEIQYVVAVNCMDLGSRKNSI--ALASASENNLDELLGLRVEREAGHIAAEL 352
L S+E DSEIQYVVAVN MD+GSR+NS+ LAS+S NNLDEL L +++E +A
Sbjct: 294 GLSSVEADSEIQYVVAVNGMDIGSRRNSMLHGLASSSGNNLDELDRLNLDKETSRVATVS 353
Query: 353 AGSGATNLAYNASSSTIQSSQPVLVSSGSGYESNLQPYQGQRMQHISSTLYPADGLPPLD 412
G S+ ++QPV+ SS + YE++ YQG M H
Sbjct: 354 VGV----------STLPSTAQPVIRSSSNAYETHTPYYQGHLMDH--------------- 388
Query: 413 VKSTTPLSTPLQHDYGSHPSNFATCGENVIPIPIPIHGQLNQQGGLAEEKMYSGFHADDS 472
+ T HD H S F +++ +NQQGGL E + + F +S
Sbjct: 389 -RETQQFLLRNHHD-SFHHSPFEETPHSIL---------MNQQGGLNEGQPSTSFQVHNS 437
Query: 473 EACAQEVKQKIDSLADKIKESEKIRSLDKEASTKEQKIKRDHSLPKINEIDNIRRSENDH 532
+ +E K K D+ + + E+ R L+K
Sbjct: 438 QILKKEEKPKFDASMQQEIDPERSRPLEKVYP---------------------------- 469
Query: 533 VVSSHSYVSSVSNYIPREEVSVVSSSPGIVPSLLPSKSNKMAQEPIQNSMPLEAVNEGR- 591
+P +E S+ G + SL PSK+ QE + S +AVN +
Sbjct: 470 --------------VPVDEASLAVGLQGDLHSL-PSKNEGWDQETEKVSSSADAVNSSQV 514
Query: 592 KNNDDDVRFQASGGAFTSGHGDSEAEPTNFSYNGPSAIPQR-YHSEQIPREQTEK-NRLS 649
N+ +D AS G + +G+ D + + SY PS PQR Y+SE+IPREQ E NRLS
Sbjct: 515 PNSSEDGPCSASDGTYGTGNADPVSNLIDLSYLEPSVPPQRVYYSERIPREQAELLNRLS 574
Query: 650 KSDDSFGSQFLISQALSDGSKPIRESVDKLHSGNMASETEQSVAPAKQQYTNLQKVEDGH 709
KSDDS G Q L S I ES +KL S N+AS + S + +KQ + + + DG
Sbjct: 575 KSDDSLGPQLLNS---------IAESTEKLSSSNLASHAKDSTSTSKQS-ADTRTINDGL 624
Query: 710 AQLRKHKEFADKINKINS--NGSEDGLQSSLGKSELTQVVPKSADDCEVTKIRETVKDLS 767
AQL+K KEFAD ++ +N + SED L+S + K D I D
Sbjct: 625 AQLQKFKEFADAVSLMNKKPSDSEDVLESGFKHPVSGNLADK--DSVHRDGILRGDSDTD 682
Query: 768 INDEEAAGLYHPTANHGTSGKNPEDSSLKQSEYEWNEIAAIKNNGNDNKGQAQSLAQKEN 827
A HP TS + D + SE E+ GN+N G + + E+
Sbjct: 683 YTTGIKAESEHPAGGKVTSVMHQMDPASIHSESTRAEMTGKDFTGNNNLGHSLPFSGIES 742
Query: 828 SVRAVSPGDSSIAV-VSPEGDILIDINDRFPRDFLSDIFTKARISENIAGVSPMHGDGAV 886
S + +S G S+ V + + DI +DINDRFPRDFLS+IF+ +E+ GVS MH DG
Sbjct: 743 SAKDISQGIPSVGVPATKQADITVDINDRFPRDFLSEIFSSGVFAED-PGVSTMHKDGVG 801
Query: 887 LSWNVENHDPRRWSYFRNLAQDEFSRKDVSLMDQDHLGFSSPLTNIEEGATVDYSYPPLK 946
+S +++NH+P+ WSYF+ LAQ+ F ++DVSL+DQD +G S N EG Y + PL
Sbjct: 802 VSVHMKNHEPKHWSYFQKLAQEGFVQRDVSLIDQDSVGTPSAPAN-AEGDQKSYHFEPLT 860
Query: 947 PDGSVMPQSGSRINFDEGSQRESSSIVGPSTMETHPDYSRSELKGNESLQ--SEVVNHRI 1004
D + S++NF E ++++ ++G + PD+ S++K +ES+Q + + N +
Sbjct: 861 -DVMSISHEYSQLNFGEDNKKDLPGVIGADSA-VLPDFGHSQVKDSESMQFGAMIENLKS 918
Query: 1005 QESDYEEGRLDLPTAGIPLVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWR 1064
+S YE +L+ G+P +D +L +FDI+TLQ+IKN+DLEEL+ELGSGTFGTVYHGKWR
Sbjct: 919 PDSVYEGAKLENRNVGLPPLDPSLVDFDINTLQVIKNDDLEELRELGSGTFGTVYHGKWR 978
Query: 1065 GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLAT 1124
G+DVAIKR+KK CF+GRSSEQERLT EFWREAEILSKLHHPNVVAFYGVVQDGPGGTLAT
Sbjct: 979 GSDVAIKRLKKICFSGRSSEQERLTSEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLAT 1038
Query: 1125 VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLK 1184
V E+MV+GSLRHVLL K+R+LDRRKRL+IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLK
Sbjct: 1039 VAEYMVDGSLRHVLLKKDRYLDRRKRLLIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLK 1098
Query: 1185 DPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKV 1234
DP RPICKVGDFGLSKIKRNTLV+GGVRGTLPWMAPELLNGSS+KVSEKV
Sbjct: 1099 DPQRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLNGSSNKVSEKV 1148
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255544602|ref|XP_002513362.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223547270|gb|EEF48765.1| serine/threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1000 bits (2585), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 604/1238 (48%), Positives = 780/1238 (63%), Gaps = 103/1238 (8%)
Query: 10 MDQQKNYEQVRYSNVETRNEGPGSANQRFFHDPSSNINTNIRPPDYSMSGGVRPVLNYSI 69
M+Q +++V+Y+ E E A+ +P+S+ NTN+R PD + + V+PVLNYSI
Sbjct: 1 MEQSDVHKKVQYNAREPGRERFQPASHPILLEPASSRNTNMRLPDLN-APEVKPVLNYSI 59
Query: 70 QTGEEFALEFMRERVIPRQHFVPNAYGDPNNSPVYMDLKGVLGISHTGSESGSDITMLNA 129
QTGEEFALEFMR+RV ++ +PN+ G+PN+ +M+LKGVLG SH SE+GSDI+ML++
Sbjct: 60 QTGEEFALEFMRDRVNHKKPLIPNSLGNPNHGTSFMELKGVLGTSHIESENGSDISMLHS 119
Query: 130 AETGRAQELERKGPSGHEDRSYYDSMRSVPRTSSRNDMGRGTQGYASSGASDSSR-KVKF 188
E G ++ ER S +E++S Y+ + SVP+TS+ + GY+SS AS SS K+K
Sbjct: 120 VENG-PRKGERTNLSLYEEKSNYELVHSVPQTSAEYESRELLPGYSSSIASGSSSTKIKV 178
Query: 189 LCSFGGKILPRPSDGKLRYVGGETRIIRISRDISWQELTQKALAIYNQTHTIKYQLPGED 248
LCSFGG ILPRPSDGKLRYVGG+TRIIRISRDISWQEL QK AI NQ H IKYQLPGED
Sbjct: 179 LCSFGGTILPRPSDGKLRYVGGDTRIIRISRDISWQELKQKTFAICNQPHVIKYQLPGED 238
Query: 249 LDALVSVSCDEDLQNMMEECNVLEDR-GTQKPRMFLFSSADLEDTQLSLESMEGDSEIQY 307
LDALVSVSCDEDL+NMMEE ++DR G+QK RMFLFS +DLED Q L SMEGDSE+QY
Sbjct: 239 LDALVSVSCDEDLRNMMEEWIEVDDREGSQKLRMFLFSMSDLEDAQFGLGSMEGDSEVQY 298
Query: 308 VVAVNCMDLGSRKNSI--ALASASENNLDELLGLRVEREAGHIAAELAGSGATNLAYNAS 365
VVA+N MD+ SR+NSI L S+S NNL+EL GL ++RE A G + L
Sbjct: 299 VVAINGMDMRSRRNSILHGLGSSSGNNLNELDGLNIDRETSRAATASVGINTSPL----- 353
Query: 366 SSTIQSSQPVLVSSGSGYESNLQPYQGQRMQHISSTLYPADGLPPLDVKSTTPLSTPLQH 425
+ST QS+QP+L +S + +ES+ Y GQ M + + + AD ++
Sbjct: 354 TSTFQSAQPILQNSSTSHESHPHFYHGQMMDNRETQQFLAD----------------CRN 397
Query: 426 DYGSHPSNFATCGENVIPIPIPIHGQLNQQGGLAEEKMYSGFHADDSEACAQEVKQKIDS 485
D SN++ E IP +H NQQGG+ + +S F +S+ +EV+
Sbjct: 398 D----SSNYSAPKE--IPQSTSLHSLTNQQGGMNAGQSHSNFQVQNSQMLEKEVR----- 446
Query: 486 LADKIKESEKIRSLDKEASTKEQKIKRDHSLPKINEIDNIRRSENDHVVSSHSYVSSVSN 545
I + +D I + H + +++ +
Sbjct: 447 ---PIPDGSVQHGID---------IGKSHPIERVSAV----------------------- 471
Query: 546 YIPREEVSV-VSSSPGIVPSLLPSKSNKMAQEPIQNSMPLEAVNEGR-KNNDDDVRFQAS 603
P +E+SV V++ G + S+ PSK+ + S ++A++ N+ +D +F S
Sbjct: 472 --PVDEISVAVAAQEGALHSM-PSKNEGKQRGSESISFSVDAIDPVHVPNSCEDDQFSTS 528
Query: 604 GGAFTSGHGDSEAEPTNFSYNGPSAIPQR-YHSEQIPREQTE-KNRLSKSDDSFGSQFLI 661
F DS + + SY PSA PQR Y+SE+IPREQ E NRLSKSDDS GSQFLI
Sbjct: 529 SSIFGFDCADSVSNLIDLSYVEPSAPPQRVYYSERIPREQAELMNRLSKSDDSLGSQFLI 588
Query: 662 SQALSDGS--KPIRESVDKLHSGNMASETEQSVAPAKQQYTNLQKVEDGHAQLRKHKEFA 719
+ D + K S +KL N+ +TE A+ + Q + +G AQ +K+ E A
Sbjct: 589 PHSRPDIAEQKSTTASAEKLIQSNLLPQTEDPSTTAEPLLIDPQPI-NGLAQPQKYIELA 647
Query: 720 DKINKINSNGSEDGLQSSLGKSELTQVVPKSADDCEVTKIRETVKDLSINDEEAAGLYHP 779
+ +N N S + V K+ DC ++ V++ A +P
Sbjct: 648 AP-DDVNDNDSVN-----------RNAVLKADHDCAAGNHKKPVEETG-----EARFGNP 690
Query: 780 TANHGTSGKNPEDSSLKQSEYEWNEIAAIKNNGNDNKGQAQSLAQKENSVRAVSPGDSSI 839
A T G D ++ EI N+N G + + E+S VS I
Sbjct: 691 AAPQTTPGMYHRDPVSDHPGHKLGEITGKVFASNENVGYSLPYSLTESSTNDVSQEVPPI 750
Query: 840 AV-VSPEGDILIDINDRFPRDFLSDIFTKARISENIAGVSPMHGDGAVLSWNVENHDPRR 898
V + GDI IDINDRFPRDFLS+IF++ ++E+ AGV+P+H DGA +S +ENH+P+
Sbjct: 751 FVSATKPGDISIDINDRFPRDFLSEIFSRGILTEDRAGVNPLHKDGAGMSVIMENHEPKH 810
Query: 899 WSYFRNLAQDEFSRKDVSLMDQDHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSR 958
WSYF+ LAQ+EF +KD SLMDQDHLG + +EG Y + LK +G M Q SR
Sbjct: 811 WSYFQKLAQEEFVQKDFSLMDQDHLGTPPLIAKFKEGDQNSYHFARLKTEGVSMDQKYSR 870
Query: 959 INFDEGSQRESSSIVGPSTMETHPDYSRSELKGNESLQSEVV--NHRIQESDYEEGRLDL 1016
NF EG+ ++ + + + + S +KG+ES+Q VV N + E E G LD
Sbjct: 871 PNFVEGTNQKVLAGLRAADSTILSGFDHSHVKGSESMQFGVVMDNLKTPEPRAEGGNLDN 930
Query: 1017 PTAGIPLVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKS 1076
+G+P V L++ +FDI TLQIIKNEDLEEL+ELGSGTFGTVYHGKWRG+DVAIKR+KK
Sbjct: 931 RNSGLPPVGLSVVDFDIDTLQIIKNEDLEELRELGSGTFGTVYHGKWRGSDVAIKRLKKI 990
Query: 1077 CFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRH 1136
CFTGRSSEQERLT+EFW EAEILSKLHHPNVVAFYGVVQDGPGGTLATVTE+MV+GSLRH
Sbjct: 991 CFTGRSSEQERLTIEFWHEAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEYMVDGSLRH 1050
Query: 1137 VLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196
VLL K+R+LDRRKRL+IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP RPICKVGDF
Sbjct: 1051 VLLKKDRYLDRRKRLLIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPQRPICKVGDF 1110
Query: 1197 GLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKV 1234
GLSKIKRNTLV+GGVRGTLPWMAPELLNG S+KVSEKV
Sbjct: 1111 GLSKIKRNTLVSGGVRGTLPWMAPELLNGGSNKVSEKV 1148
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356555219|ref|XP_003545932.1| PREDICTED: uncharacterized protein LOC100802996 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 962 bits (2486), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 594/1228 (48%), Positives = 759/1228 (61%), Gaps = 94/1228 (7%)
Query: 20 RYSNVETRNEGPGSANQRFFHDPSSNINTNIRPPDYSMSGGVRPVLNYSIQTGEEFALEF 79
+Y+++E NE SA Q D ++ N RPP ++M+ +PVLNYSIQTGEEFALEF
Sbjct: 5 QYNSMEPNNEEFHSAPQLVPQDLRDGMHINARPPAFNMAEN-KPVLNYSIQTGEEFALEF 63
Query: 80 MRERVIPRQHFVPNAYGDPNNSPVYMDLKGVLGISHTGSESGSDITMLNAAETGRAQELE 139
MR+RV R+ PN GDPN S YM+LKG+LG H GSESGSDI++L E G +E +
Sbjct: 64 MRDRVNLRKPAFPNVVGDPNYSTGYMELKGILG--HPGSESGSDISVLTKVEKG-PKEFD 120
Query: 140 RKGPSGHEDRSYYDSMRSVPRTSSRNDMGRGTQGYASSGASDSS-RKVKFLCSFGGKILP 198
R+ S H+DRS Y S RS+PRTSS D R G ASS S+S+ K+K LCSFGG+ILP
Sbjct: 121 RRNSSQHQDRSNYGSARSIPRTSSNQDSYRVLHGTASSSVSESTPMKMKVLCSFGGRILP 180
Query: 199 RPSDGKLRYVGGETRIIRISRDISWQELTQKALAIYNQTHTIKYQLPGEDLDALVSVSCD 258
RP DGKLRYVGGETRII I RDI + EL K L+IYN+TH IKYQLPGEDLDALVSVS D
Sbjct: 181 RPGDGKLRYVGGETRIISIRRDIRFHELMLKTLSIYNETHVIKYQLPGEDLDALVSVSSD 240
Query: 259 EDLQNMMEECNVLED-RGTQKPRMFLFSSADLEDTQLSLESMEGDSEIQYVVAVNCMDLG 317
EDL+NMMEEC+ L+ RG+ K R+FLFS DL+DTQ + SM+GDSEIQYVVAVN MD+G
Sbjct: 241 EDLRNMMEECHDLQGGRGSNKLRIFLFSLNDLDDTQFGIGSMDGDSEIQYVVAVNGMDMG 300
Query: 318 SRKNSIALA-SASENNLDELLGLRVEREAGHIAAELAGSGATNLAYNASSS-TIQSSQPV 375
SR NSI S S +NL EL ERE + + G ++L N S TIQSSQPV
Sbjct: 301 SRNNSILCGESGSTHNLHELNEQNNERETNRVLMDTFGVSGSSLTDNVKPSLTIQSSQPV 360
Query: 376 LVSSGSGYESNLQPYQGQRMQHISSTLYPADGLPPLDVKSTTPLSTPLQHDYGSHPSNFA 435
L S + YE++ Y ++H ++ YP LQH G PSN +
Sbjct: 361 LPISSNAYETHPLFYDDPVIRHGEASQYP------------------LQHGLG--PSNNS 400
Query: 436 TCGENVIPIPIPIHGQLNQQGGLAEEKMYSGFHADDSEACAQEVKQKIDSLADKIKESEK 495
IP+ +P HG ++Q G + + + S S VK+K D+ + K
Sbjct: 401 AHNIQEIPVSMPTHGHVDQ-GIMNDGQASSELQVQISAMPETLVKRKGDNFIHTDNDPGK 459
Query: 496 IRSLDKEASTKEQKIKRDHSLPKINEIDNIRRSENDHVVSSHSYVSSVSNYIPREEVSVV 555
+ L+ Q + + H+ +S S +
Sbjct: 460 VFPLEATYPIPSQPFEGN----------------------LHANLSEAS--------ATT 489
Query: 556 SSSPGIVPSLLPSKSNKMAQEPIQNSMPLEAVNEGR--KNNDDDVRFQASGGAFTSGHGD 613
+ S G+ P+L PSK+ Q+ S ++N + K+ +DD F S AF+ H D
Sbjct: 490 AISEGLHPAL-PSKNKGKHQQSEDASSLFSSMNPTQTPKSVEDDF-FTTSNDAFSRAHVD 547
Query: 614 SEAEPTNFSYNGPSAIPQR-YHSEQIPREQTEK-NRLSKSDDSFGSQFLISQALSDGSKP 671
+E+ +FSY P +P R Y+SE+IPREQ + NR +KSDD+ GS L+S LSD S+
Sbjct: 548 AESNVIDFSYLEPPPLPNRVYYSERIPREQADLLNRSTKSDDAHGSHLLMSDLLSDFSQK 607
Query: 672 --IRESVDKLHSGNMASETEQSVAPAKQQYTNLQKVEDGHAQLRKHKEFADKINKINSNG 729
I ES D LHSGNM++ S + AK + + D Q +K+ D +K+NS
Sbjct: 608 NSITESSDILHSGNMSNLNMMSSSAAKPLQADGHTINDVLPQ--TYKQLPDTTSKVNS-- 663
Query: 730 SEDGLQSSLGKSELTQVVPKSADDCEVTKIRETVKDLSINDEEAAGLYHPTANHGTSGKN 789
L V +S E K+ + ++ G H + S ++
Sbjct: 664 -----------KLLQHVNSESKQVLEDNKVSRNEDQVLSSENRTKGAEHLAFHRVPSVEH 712
Query: 790 PEDSSLKQSEYEWNEIAAIKNNGNDNKGQAQSLAQKENSVRAVSPGDSSIAVVSP-EGDI 848
++ + K + +E++ + + ND K Q+Q+ N+ + VS A P +GDI
Sbjct: 713 NQNLTSKLPDLNLSEVST-RESDNDTKVQSQTFPLTGNTGQDVSQEFPPEAKSRPTQGDI 771
Query: 849 LIDINDRFPRDFLSDIFTKARISENIAGVSPMHGDGAVLSWNVENHDPRRWSYFRNLAQD 908
LIDI DRFPRDFL D+F+KA ISE+ + + P+ D A LS N+ NH+P+RWSYF+NLA++
Sbjct: 772 LIDIEDRFPRDFLYDMFSKAIISEDSSSIGPLPTDRAGLSLNMGNHEPKRWSYFQNLAKE 831
Query: 909 EFSRKDVSLMDQDHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQRE 968
F +VSL+DQD+LGFSS + ++EG + PL G + + S +N E SQ+
Sbjct: 832 GFD--NVSLIDQDNLGFSSAVRKVQEGDSKSQPSAPLPAAGVLAGHTESHLNVGEESQKN 889
Query: 969 SSSIVGPSTMETHPDYSRSELKGNESLQSEVVNHRIQ--ESDYEEGRLDLPTAGIPLVDL 1026
H Y S+LKGNE+ + V IQ ES+Y++G+ + P +
Sbjct: 890 VPVATKTEATIFHQKYEHSQLKGNENKNMDAVMENIQPQESEYQDGKDE------PRNVV 943
Query: 1027 ALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQE 1086
G FD ST+Q IKNEDLEEL+ELGSGTFGTVYHGKWRG+DVAIKRIKKSCF GRSSEQE
Sbjct: 944 VAGEFDTSTVQFIKNEDLEELRELGSGTFGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQE 1003
Query: 1087 RLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLD 1146
RLT+EFWREA+ILSKLHHPNVVAFYGVVQDGPG TLATV E+MV+GSLR+VLL K+R+LD
Sbjct: 1004 RLTIEFWREADILSKLHHPNVVAFYGVVQDGPGATLATVAEYMVDGSLRNVLLRKDRYLD 1063
Query: 1147 RRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL 1206
RRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP+RPICKVGDFGLSKIKRNTL
Sbjct: 1064 RRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPMRPICKVGDFGLSKIKRNTL 1123
Query: 1207 VTGGVRGTLPWMAPELLNGSSSKVSEKV 1234
V+GGVRGTLPWMAPELLNGSS+KVSEKV
Sbjct: 1124 VSGGVRGTLPWMAPELLNGSSNKVSEKV 1151
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1236 | ||||||
| TAIR|locus:2044702 | 1257 | AT2G35050 [Arabidopsis thalian | 0.405 | 0.398 | 0.497 | 5.8e-248 | |
| TAIR|locus:2032895 | 1147 | AT1G16270 [Arabidopsis thalian | 0.220 | 0.238 | 0.730 | 1.3e-203 | |
| TAIR|locus:2093146 | 1117 | AT3G24715 [Arabidopsis thalian | 0.161 | 0.178 | 0.849 | 7.2e-139 | |
| TAIR|locus:2197788 | 1042 | AT1G04700 [Arabidopsis thalian | 0.199 | 0.237 | 0.696 | 1.3e-127 | |
| TAIR|locus:2206350 | 1248 | AT1G79570 [Arabidopsis thalian | 0.463 | 0.459 | 0.492 | 2e-127 | |
| TAIR|locus:2174552 | 1054 | AT5G57610 [Arabidopsis thalian | 0.213 | 0.250 | 0.584 | 6.6e-113 | |
| TAIR|locus:2102787 | 1171 | AT3G46920 [Arabidopsis thalian | 0.166 | 0.175 | 0.737 | 9.7e-112 | |
| TAIR|locus:2200296 | 765 | AT1G67890 [Arabidopsis thalian | 0.148 | 0.239 | 0.424 | 1.2e-28 | |
| TAIR|locus:2025515 | 933 | EDR1 "ENHANCED DISEASE RESISTA | 0.152 | 0.201 | 0.411 | 3.6e-28 | |
| TAIR|locus:2027794 | 1030 | AT1G73660 [Arabidopsis thalian | 0.144 | 0.173 | 0.430 | 9.2e-27 |
| TAIR|locus:2044702 AT2G35050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1161 (413.8 bits), Expect = 5.8e-248, Sum P(3) = 5.8e-248
Identities = 258/519 (49%), Positives = 337/519 (64%)
Query: 10 MDQQKNYEQVRYSNVETRNEGPGSANQRFFHDPSSNINTNIRPPDYSMSGGVRPVLNYSI 69
MDQ K YE VRY+ + R+EG GS NQRF HD S+N+NT +RPPDY +S RPVLNYSI
Sbjct: 1 MDQAKGYEHVRYTAPDPRDEGLGSINQRFSHDSSTNVNTYVRPPDYGVSTPARPVLNYSI 60
Query: 70 QTGEEFALEFMRERVIPRQHFVPNAYGDPNNSPVYMDLKGVLGISHTGSESGSDITMLNA 129
QTGEEFA EFMR+RVI + F+PN YG+ + PV ++L LG+ H SESG + T+LN
Sbjct: 61 QTGEEFAFEFMRDRVIMKPQFIPNVYGEHSGMPVSVNLSA-LGMVHPMSESGPNATVLNI 119
Query: 130 AETGRAQELERKGPSGHEDRSYYDSMRSVPRTSSRNDMGRGTQGYASSGASDSS-RKVKF 188
E ++ E ERK PS ED++Y++ ++S P SS+ND G+ SS ASDSS + KF
Sbjct: 120 EEKRQSFEHERKPPSRIEDKTYHELVQSAPVISSKNDTGQRRHSLVSSRASDSSLNRAKF 179
Query: 189 LCSFGGKILPRPSDGKLRYVGGETRIIRISRDISWQELTQKALAIYNQTHTIKYQLPGED 248
LCSFGGK++PRP D KLRYVGGETRIIRIS+ IS+QEL K I+ + TIKYQLPGED
Sbjct: 180 LCSFGGKVIPRPRDQKLRYVGGETRIIRISKTISFQELMHKMKEIFPEARTIKYQLPGED 239
Query: 249 LDALVSVSCDEDLQNMMEECNVLEDRGTQKPRMFLFSSADLEDTQLSLESMEGDSEIQYV 308
LDALVSVS DEDLQNMMEEC V + G++KPRMFLFSS+D+E+ Q +E EGDSE+QYV
Sbjct: 240 LDALVSVSSDEDLQNMMEECIVFGNGGSEKPRMFLFSSSDIEEAQFVMEHAEGDSEVQYV 299
Query: 309 VAVNCMDLGSRKNSIALASASENNLDELLGLRVEREAGHIAAELAGSGATNLAYNASSST 368
VAVN MDL SR++S+ L S NNLDELL +R+ A E A + T LA N S
Sbjct: 300 VAVNGMDLSSRRSSLGL-SPPGNNLDELLHGNFDRKIDRAATEPAVASLTPLAGNESLPA 358
Query: 369 IQSSQPVLVSSGSGYESNLQPYQGQRMQHI---SSTLYPADGLPPL---DVKSTTPLSTP 422
Q+SQPV S +G E QPY GQ++Q + +Y + + + D K + PL
Sbjct: 359 SQTSQPVTGFS-TGNEPFSQPYLGQQLQFPGLGNHQIYTSGHMASIGYIDEKRSAPLHVQ 417
Query: 423 LQHDYGSHPSNFATCGENVIPIPIPIHGQLNQQGGLAEEKMYSGFHADDSEACAQEVKQK 482
Q Y + N T E+++P + Q +QG L EE++ FH D E ++E K +
Sbjct: 418 PQPHYIPYSVNPETPLESLVPH----YPQKPEQGFLREEQI---FHVQDPETSSKEAKMR 470
Query: 483 IDSLADKIKESEKIRSLDKEASTKEQKIKRDHSLPKINE 521
D K+ + I +++ S KE K++R+ S P++NE
Sbjct: 471 RDDSFQKVND-HPISTVESNLSAKEPKMRRESSTPRVNE 508
|
|
| TAIR|locus:2032895 AT1G16270 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1017 (363.1 bits), Expect = 1.3e-203, Sum P(3) = 1.3e-203
Identities = 201/275 (73%), Positives = 228/275 (82%)
Query: 960 NFDEGSQRESSSIVGPSTMETHPDYSRSELKGNESLQSEVVNHRIQESDYEEGRLDLPTA 1019
+ ++G + V P T E D + ++ +E + V N R + + E+ + + A
Sbjct: 781 DMEDGGEIARLHQVAPLT-ENRVD-PQMKVTESEEFDAMVENLRTSDCEQEDEKSETRNA 838
Query: 1020 GIPLVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFT 1079
G+P V +L ++D S LQII N+DLEELKELGSGTFGTVYHGKWRG+DVAIKRIKKSCF
Sbjct: 839 GLPPVGPSLADYDTSGLQIIMNDDLEELKELGSGTFGTVYHGKWRGSDVAIKRIKKSCFA 898
Query: 1080 GRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLL 1139
GRSSEQERLT EFW EAEILSKLHHPNVVAFYGVV+DGPG TLATVTE+MV+GSLRHVL+
Sbjct: 899 GRSSEQERLTGEFWGEAEILSKLHHPNVVAFYGVVKDGPGATLATVTEYMVDGSLRHVLV 958
Query: 1140 SKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199
K+RHLDRRKRLIIAMDAAFGMEYLH+KNIVHFDLKCDNLLVNLKDP RPICKVGDFGLS
Sbjct: 959 RKDRHLDRRKRLIIAMDAAFGMEYLHAKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLS 1018
Query: 1200 KIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKV 1234
KIKRNTLV+GGVRGTLPWMAPELLNGSSSKVSEKV
Sbjct: 1019 KIKRNTLVSGGVRGTLPWMAPELLNGSSSKVSEKV 1053
|
|
| TAIR|locus:2093146 AT3G24715 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 900 (321.9 bits), Expect = 7.2e-139, Sum P(4) = 7.2e-139
Identities = 169/199 (84%), Positives = 184/199 (92%)
Query: 1036 LQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWRE 1095
LQIIKN DLE+L ELGSGT+GTVYHG WRGTDVAIKRI+ SCF GRSSEQERLT +FWRE
Sbjct: 828 LQIIKNADLEDLTELGSGTYGTVYHGTWRGTDVAIKRIRNSCFAGRSSEQERLTKDFWRE 887
Query: 1096 AEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM 1155
A+ILS LHHPNVVAFYG+V DG GGTLATVTEFMVNGSLRH LL K+R LD RK++IIAM
Sbjct: 888 AQILSNLHHPNVVAFYGIVPDGTGGTLATVTEFMVNGSLRHALLKKDRLLDTRKKIIIAM 947
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTL 1215
DAAFGMEYLHSKNIVHFDLKC+NLLVNL+DP RPICKVGD GLS+IKRNTLV+GGVRGTL
Sbjct: 948 DAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDLGLSRIKRNTLVSGGVRGTL 1007
Query: 1216 PWMAPELLNGSSSKVSEKV 1234
PWMAPELLNGSS++VSEKV
Sbjct: 1008 PWMAPELLNGSSTRVSEKV 1026
|
|
| TAIR|locus:2197788 AT1G04700 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 898 (321.2 bits), Expect = 1.3e-127, Sum P(3) = 1.3e-127
Identities = 179/257 (69%), Positives = 207/257 (80%)
Query: 979 ETHPDYSRSELKGNESLQSEVVNHRIQESDYEEGR-LDLPTAGIPLVDLALGNFDISTLQ 1037
+ H Y+R + N +SE+ E Y++ R D + +V++ G I LQ
Sbjct: 709 DDHKSYTREKEITNADHESEM------EEKYKKSRNTDDSFSEAAMVEIEAG---IYGLQ 759
Query: 1038 IIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
IIKN DLE+L ELGSGTFGTVY+GKWRGTDVAIKRIK SCF+G SSEQ R T +FWREA
Sbjct: 760 IIKNTDLEDLHELGSGTFGTVYYGKWRGTDVAIKRIKNSCFSGGSSEQARQTKDFWREAR 819
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 1157
IL+ LHHPNVVAFYGVV DGPGGT+ATVTE+MVNGSLRHVL K+R LDRRK+L+I +D+
Sbjct: 820 ILANLHHPNVVAFYGVVPDGPGGTMATVTEYMVNGSLRHVLQRKDRLLDRRKKLMITLDS 879
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPW 1217
AFGMEYLH KNIVHFDLKCDNLLVNL+DP RPICKVGDFGLS+IKRNTLV+GGVRGTLPW
Sbjct: 880 AFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPW 939
Query: 1218 MAPELLNGSSSKVSEKV 1234
MAPELLNGSS++VSEKV
Sbjct: 940 MAPELLNGSSNRVSEKV 956
|
|
| TAIR|locus:2206350 AT1G79570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1251 (445.4 bits), Expect = 2.0e-127, P = 2.0e-127
Identities = 298/605 (49%), Positives = 379/605 (62%)
Query: 639 PREQTEKNRLSKSDDSFGSQFLISQALSDGSKPIRESVDKLHSGNMASETEQSVAPAKQQ 698
PR+ T + D Q +S + D + +HS + ++ + + P +Q
Sbjct: 573 PRQNTTAKPATYRDAVITGQVPLS-GIEDQLSTSSSTYAPVHSDSESNLIDLNY-PEPEQ 630
Query: 699 YTNLQKVEDGHAQLRKHKEFADKINKINSNGSEDGLQSSLGKSELTQVVPKSADDCEVTK 758
+ Q+V R+ E ++++K +++ S + S + Q K A V K
Sbjct: 631 SS--QRVYCSERIPREQLELLNRLSKSDNSLSSQFVTSESPANTAQQDSGKEA----VGK 684
Query: 759 IRETVKDLSINDEEAAGLYHPTANHGTSGKNPEDSSLKQSEYEWNEIAAIKNNGNDNKGQ 818
+ K ++ND+ H T H E + E + I N + NK +
Sbjct: 685 SHDEFK--TVNDDAN----HHT--HKDVETIFEKVGVSDETLESEPLHKIVNPDDANKNR 736
Query: 819 AQSLAQKENSVRAVSPGDSSIAVVSPE------GDILIDINDRFPRDFLSDIFTKARISE 872
+ A E V +S +++++ V PE GDILIDINDRFPRDFLS+IF++A ISE
Sbjct: 737 VVNGADTEIGVSNLSHVNAAMSHVIPEEQASLQGDILIDINDRFPRDFLSEIFSQA-ISE 795
Query: 873 NIAGVSPMHGDGAVLSWNVENHDPRRWSYFRNLAQDEFSRKDVSLMDQDHLGFSSPLTNI 932
+ + V P DGA +S NV+NHD + WSYF+ LA+D+F ++DV ++DQ S +
Sbjct: 796 DTSTVRPYPHDGAAVSMNVQNHDRKNWSYFQQLAEDQFIQRDV-VLDQADSRIPSDRKDG 854
Query: 933 EEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQRESSSIVGPSTMETHPDYSRSELKGN 992
E + + Y PL DG + ++ + S G T P ++K
Sbjct: 855 GESSRLPY-VSPLSRDGISTNLANPQLTLGQDYGGNFSEKDGGGTGSIPPALENEQMKVT 913
Query: 993 ESLQ--SEVVNHRIQESDYEEGRLDLPTAGIPLVDLALGN-FDISTLQIIKNEDLEELKE 1049
ES + + V N R +S+ ++ + + A +P LG+ FD S LQIIKNEDLEEL+E
Sbjct: 914 ESEEFGAMVENLRTPDSEPKDEKTETRHAALP----PLGSEFDYSGLQIIKNEDLEELRE 969
Query: 1050 LGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVA 1109
LGSGTFGTVYHGKWRG+DVAIKRIKKSCF GRSSEQERLT EFW EAEILSKLHHPNVVA
Sbjct: 970 LGSGTFGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTGEFWGEAEILSKLHHPNVVA 1029
Query: 1110 FYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNI 1169
FYGVV+DGPGGTLATVTE+MV+GSLRHVL+ K+RHLDRRKRLIIAMDAAFGMEYLHSKN
Sbjct: 1030 FYGVVKDGPGGTLATVTEYMVDGSLRHVLVRKDRHLDRRKRLIIAMDAAFGMEYLHSKNT 1089
Query: 1170 VHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSK 1229
VHFDLKCDNLLVNLKDP RPICKVGDFGLSKIKRNTLV+GGVRGTLPWMAPELLNGSSSK
Sbjct: 1090 VHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELLNGSSSK 1149
Query: 1230 VSEKV 1234
VSEKV
Sbjct: 1150 VSEKV 1154
|
|
| TAIR|locus:2174552 AT5G57610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 822 (294.4 bits), Expect = 6.6e-113, Sum P(2) = 6.6e-113
Identities = 155/265 (58%), Positives = 203/265 (76%)
Query: 970 SSIVGPSTMETHPDYSRSELKGNESLQSEVVNHRIQESDYEEGRLDLPTAGIPLVDLALG 1029
+++ G + ++ HP+ ++ +++ E +++E + Q+ + D P A
Sbjct: 708 AALEGAAEVKAHPEEAKDQVRP-ELVENESEHMNAQDEPEIDSDSDNPNNFKIEQTKAEA 766
Query: 1030 NFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLT 1089
LQ I+N+DLEE++ELG GT+G+VYHGKW+G+DVAIKRIK SCF G+ SE+ERL
Sbjct: 767 EAKSRGLQSIRNDDLEEIRELGHGTYGSVYHGKWKGSDVAIKRIKASCFAGKPSERERLI 826
Query: 1090 LEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRK 1149
+FW+EA +LS LHHPNVV+FYG+V+DGP G+LATV EFMVNGSL+ L K+R +DRRK
Sbjct: 827 EDFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVAEFMVNGSLKQFLQKKDRTIDRRK 886
Query: 1150 RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG 1209
RLIIAMD AFGMEYLH KNIVHFDLKC+NLLVN++DP RPICK+GD GLSK+K+ TLV+G
Sbjct: 887 RLIIAMDTAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPICKIGDLGLSKVKQKTLVSG 946
Query: 1210 GVRGTLPWMAPELLNGSSSKVSEKV 1234
GVRGTLPWMAPELL+G S+ VSEK+
Sbjct: 947 GVRGTLPWMAPELLSGKSNMVSEKI 971
|
|
| TAIR|locus:2102787 AT3G46920 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 800 (286.7 bits), Expect = 9.7e-112, Sum P(4) = 9.7e-112
Identities = 152/206 (73%), Positives = 172/206 (83%)
Query: 1029 GNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERL 1088
G+ + LQIIK+ DLEEL+ELGSGTFGTVYHGKWRGTDVAIKRI CF G+ SEQER+
Sbjct: 873 GSDSLDQLQIIKDSDLEELRELGSGTFGTVYHGKWRGTDVAIKRINDRCFAGKPSEQERM 932
Query: 1089 TLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR 1148
+FW EA+ L+ LHHPNVVAFYGVV D PGG++ATVTE+MVNGSLR+ L R+ DR
Sbjct: 933 IDDFWNEAQNLAGLHHPNVVAFYGVVLDSPGGSVATVTEYMVNGSLRNALQKNVRNFDRC 992
Query: 1149 KRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVT 1208
KR +IAMD AFGMEYLH K IVHFDLK DNLLVNL+DP RPICKVGD GLSK+K TL++
Sbjct: 993 KRQLIAMDIAFGMEYLHGKKIVHFDLKSDNLLVNLRDPHRPICKVGDLGLSKVKCQTLIS 1052
Query: 1209 GGVRGTLPWMAPELLNGSSSKVSEKV 1234
GGVRGTLPWMAPELLNG+SS VSEKV
Sbjct: 1053 GGVRGTLPWMAPELLNGTSSLVSEKV 1078
|
|
| TAIR|locus:2200296 AT1G67890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 340 (124.7 bits), Expect = 1.2e-28, Sum P(3) = 1.2e-28
Identities = 84/198 (42%), Positives = 114/198 (57%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 1101
EDL +++G G+ GTVYHG W G+DVA+K K ++ E + F +E ++ +
Sbjct: 485 EDLTIGEQIGQGSCGTVYHGLWFGSDVAVKVFSKQEYS------EEIITSFKQEVSLMKR 538
Query: 1102 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGM 1161
L HPNV+ F G V P L VTEF+ GSL +L + LD R+R+ +A D A GM
Sbjct: 539 LRHPNVLLFMGAVAS-PQ-RLCIVTEFLPRGSLFRLLQRNKSKLDLRRRIHMASDIARGM 596
Query: 1162 EYLH--SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMA 1219
YLH S I+H DLK NLLV+ + KV DFGLS+IK T +T RGT WMA
Sbjct: 597 NYLHHCSPPIIHRDLKSSNLLVDRNWTV----KVADFGLSRIKHETYLTTNGRGTPQWMA 652
Query: 1220 PELL-NGSSSKVSEKVCF 1236
PE+L N ++ + S+ F
Sbjct: 653 PEVLRNEAADEKSDVYSF 670
|
|
| TAIR|locus:2025515 EDR1 "ENHANCED DISEASE RESISTANCE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 351 (128.6 bits), Expect = 3.6e-28, Sum P(3) = 3.6e-28
Identities = 84/204 (41%), Positives = 115/204 (56%)
Query: 1028 LGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQER 1087
L + D+ +I N DL + +G G++G VYH W GT+VA+K+ F+G +
Sbjct: 654 LDDADVGECEIPWN-DLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSGAA----- 707
Query: 1088 LTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDR 1147
EF E I+ +L HPNVV F G V P L+ VTEF+ GSL +L + H+D
Sbjct: 708 -LAEFRSEVRIMRRLRHPNVVFFLGAVTRPPN--LSIVTEFLPRGSLYRILHRPKSHIDE 764
Query: 1148 RKRLIIAMDAAFGMEYLHSKN--IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT 1205
R+R+ +A+D A GM LH+ IVH DLK NLLV+ + KVGDFGLS++K NT
Sbjct: 765 RRRIKMALDVAMGMNCLHTSTPTIVHRDLKTPNLLVDNNWNV----KVGDFGLSRLKHNT 820
Query: 1206 LVTG-GVRGTLPWMAPELLNGSSS 1228
++ GT WMAPE+L S
Sbjct: 821 FLSSKSTAGTPEWMAPEVLRNEPS 844
|
|
| TAIR|locus:2027794 AT1G73660 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 353 (129.3 bits), Expect = 9.2e-27, Sum P(2) = 9.2e-27
Identities = 84/195 (43%), Positives = 116/195 (59%)
Query: 1032 DISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLE 1091
D+S +I+ E++ + +G G++G VY G W GT+VA+K+ TG + E E
Sbjct: 737 DVSDCEILW-EEITVGERIGLGSYGEVYRGDWHGTEVAVKKFLDQDLTGEALE------E 789
Query: 1092 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL 1151
F E I+ KL HPN+V F G V P L+ VTEF+ GSL ++ LD R+RL
Sbjct: 790 FRSEVRIMKKLRHPNIVLFMGAVTRPPN--LSIVTEFLPRGSLYRLIHRPNNQLDERRRL 847
Query: 1152 IIAMDAAFGMEYLHSKN--IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG 1209
+A+DAA GM YLHS N IVH DLK NLLV+ K+ + +C DFGLS++K +T ++
Sbjct: 848 RMALDAARGMNYLHSCNPMIVHRDLKSPNLLVD-KNWVVKVC---DFGLSRMKHSTYLSS 903
Query: 1210 -GVRGTLPWMAPELL 1223
GT WMAPE+L
Sbjct: 904 KSTAGTAEWMAPEVL 918
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pg.C_LG_III000881 | hypothetical protein (1166 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1236 | |||
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-52 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-49 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-49 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-46 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-44 | |
| cd06410 | 97 | cd06410, PB1_UP2, Uncharacterized protein 2 | 6e-44 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 9e-44 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-43 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-36 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-33 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-32 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-31 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-31 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-29 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-27 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-27 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-27 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-26 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-26 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-25 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-25 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-25 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-25 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-25 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-24 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-24 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-24 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-24 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-24 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-24 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-23 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-23 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-23 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-22 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-22 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-22 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-21 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-21 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-21 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-20 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-20 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-20 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-20 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 8e-20 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-19 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-19 | |
| pfam00564 | 84 | pfam00564, PB1, PB1 domain | 4e-19 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-19 | |
| smart00666 | 81 | smart00666, PB1, PB1 domain | 6e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-18 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-18 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-18 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 8e-18 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-17 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-17 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-17 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-17 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-17 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-16 | |
| cd05992 | 81 | cd05992, PB1, The PB1 domain is a modular domain m | 1e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-16 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-16 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-15 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-15 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 8e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 9e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-14 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-14 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-14 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-14 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-14 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 9e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-13 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-13 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-13 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-13 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-13 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 9e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-12 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-12 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-12 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 9e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-11 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-11 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-11 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 7e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 8e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 9e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-10 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-10 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-10 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-09 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-09 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 8e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-08 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-08 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-08 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-08 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 8e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-07 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-07 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-07 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-07 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-07 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-07 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 7e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 8e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-06 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-06 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-06 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 9e-05 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-04 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-04 | |
| COG2112 | 201 | COG2112, COG2112, Predicted Ser/Thr protein kinase | 4e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 7e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.002 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 0.002 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 0.002 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.002 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 0.004 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 182 bits (465), Expect = 9e-52
Identities = 76/190 (40%), Positives = 94/190 (49%), Gaps = 22/190 (11%)
Query: 1044 LEELKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
LE K+LG G FG VY G +G T VA+K +K+ +SE+ER EF EA
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEG-----ASEEERE--EFLEEAS 53
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 1157
I+ KL HPN+V GV G L VTE+M G L L L + L +A+
Sbjct: 54 IMKKLSHPNIVRLLGVCTQG--EPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQI 111
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT---LVTGGVRGT 1214
A GMEYL SKN VH DL N LV + K+ DFGLS+ GG +
Sbjct: 112 AKGMEYLESKNFVHRDLAARNCLVTEN----LVVKISDFGLSRDIYEDDYYRKRGGGKLP 167
Query: 1215 LPWMAPELLN 1224
+ WMAPE L
Sbjct: 168 IKWMAPESLK 177
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 1e-49
Identities = 77/199 (38%), Positives = 95/199 (47%), Gaps = 25/199 (12%)
Query: 1044 LEELKELGSGTFGTVYHGKWRGT------DVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
L K+LG G FG VY GK +G +VA+K +K+ SEQ+ EF REA
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA-----SEQQIE--EFLREAR 53
Query: 1098 ILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
I+ KL HPNVV GV ++ P L V E+M G L L L L A+
Sbjct: 54 IMRKLDHPNVVKLLGVCTEEEP---LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQ 110
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 1216
A GMEYL SKN +H DL N LV + K+ DFGLS+ + G LP
Sbjct: 111 IARGMEYLESKNFIHRDLAARNCLVGENL----VVKISDFGLSRDLYDDDYYRKRGGKLP 166
Query: 1217 --WMAPELLNGSSSKVSEK 1233
WMAPE L K + K
Sbjct: 167 IRWMAPESLK--EGKFTSK 183
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 3e-49
Identities = 71/190 (37%), Positives = 90/190 (47%), Gaps = 22/190 (11%)
Query: 1044 LEELKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
L K+LG G FG VY G +G +VA+K +K+ +SEQ+ EF REA
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKED-----ASEQQIE--EFLREAR 53
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH-LDRRKRLIIAMD 1156
I+ KL HPN+V GV + + V E+M G L L L L A+
Sbjct: 54 IMRKLDHPNIVKLLGVCTEEEPLMI--VMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQ 111
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 1216
A GMEYL SKN +H DL N LV + K+ DFGLS+ + G LP
Sbjct: 112 IARGMEYLESKNFIHRDLAARNCLVGENL----VVKISDFGLSRDLYDDDYYKVKGGKLP 167
Query: 1217 --WMAPELLN 1224
WMAPE L
Sbjct: 168 IRWMAPESLK 177
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 2e-46
Identities = 75/188 (39%), Positives = 100/188 (53%), Gaps = 16/188 (8%)
Query: 1050 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 1107
LG G FGTVY + + T VAIK IKK + L E RE EIL KL+HPN+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKE-------DSSSLLEELLREIEILKKLNHPNI 53
Query: 1108 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK 1167
V YGV +D L V E+ GSL+ +L E L + L I + G+EYLHS
Sbjct: 54 VKLYGVFEDENHLYL--VMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN 111
Query: 1168 NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTGGVRGTLPWMAPELLNGS 1226
I+H DLK +N+L++ + K+ DFGLSK + + + + GT +MAPE+L G
Sbjct: 112 GIIHRDLKPENILLDSDN---GKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLG- 167
Query: 1227 SSKVSEKV 1234
SEK
Sbjct: 168 KGYYSEKS 175
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 2e-44
Identities = 67/185 (36%), Positives = 93/185 (50%), Gaps = 16/185 (8%)
Query: 1045 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
E L++LG G+FG VY + + T VAIK IKK ++ER RE +IL KL
Sbjct: 2 EILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKK---KIKKDRER----ILREIKILKKL 54
Query: 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGME 1162
HPN+V Y V +D L V E+ G L +L + R + R + +E
Sbjct: 55 KHPNIVRLYDVFEDE--DKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLR-QILSALE 111
Query: 1163 YLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPEL 1222
YLHSK IVH DLK +N+L++ + K+ DFGL++ GT +MAPE+
Sbjct: 112 YLHSKGIVHRDLKPENILLDEDGHV----KLADFGLARQLDPGEKLTTFVGTPEYMAPEV 167
Query: 1223 LNGSS 1227
L G
Sbjct: 168 LLGKG 172
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|99731 cd06410, PB1_UP2, Uncharacterized protein 2 | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 6e-44
Identities = 57/98 (58%), Positives = 73/98 (74%), Gaps = 3/98 (3%)
Query: 189 LCSFGGKILPRPSDGKLRYVGGETRIIRISRDISWQELTQKALAIYNQTH--TIKYQLPG 246
LCS+GG+ILPRP DG+LRYVGGETRI+ + R IS++EL K ++ T+KYQLP
Sbjct: 1 LCSYGGRILPRPPDGQLRYVGGETRIVSVDRSISFKELVSKLSELFGAGVVVTLKYQLPD 60
Query: 247 EDLDALVSVSCDEDLQNMMEECNVLEDRGTQKPRMFLF 284
EDLDAL+SVS DEDL+NMMEE + L + + R+FLF
Sbjct: 61 EDLDALISVSNDEDLKNMMEEYDRLSGG-SARLRVFLF 97
|
The PB1 domain is a modular domain mediating specific protein-protein interaction which play a role in many critical cell processes such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. Length = 97 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 9e-44
Identities = 73/193 (37%), Positives = 95/193 (49%), Gaps = 31/193 (16%)
Query: 1048 KELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
K+LG G FG VY GK +G T+VA+K +K+ +SE+ER +F +EA ++ KL
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKED-----ASEEERK--DFLKEARVMKKL 53
Query: 1103 HHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSK--------ERHLDRRKRLII 1153
HPNVV GV ++ P L V E+M G L L + L + L
Sbjct: 54 GHPNVVRLLGVCTEEEP---LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSF 110
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLV-TGGVR 1212
A+ A GMEYL SK VH DL N LV + K+ DFGLS+ +
Sbjct: 111 AIQIAKGMEYLASKKFVHRDLAARNCLVGED----LVVKISDFGLSRDVYDDDYYRKKTG 166
Query: 1213 GTLP--WMAPELL 1223
G LP WMAPE L
Sbjct: 167 GKLPIRWMAPESL 179
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 5e-43
Identities = 70/188 (37%), Positives = 103/188 (54%), Gaps = 18/188 (9%)
Query: 1044 LEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 1101
E L++LGSG+FGTVY K +GT VA+K +KK S++++ RE IL +
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKR---SEKSKKDQ---TARREIRILRR 54
Query: 1102 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGM 1161
L HPN+V +D L V E+ G L LS+ L + IA+ G+
Sbjct: 55 LSHPNIVRLIDAFEDK--DHLYLVMEYCEGGDLFD-YLSRGGPLSEDEAKKIALQILRGL 111
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK--IKRNTLVTGGVRGTLPWMA 1219
EYLHS I+H DLK +N+L++ + K+ DFGL+K +K ++ +T V GT +MA
Sbjct: 112 EYLHSNGIIHRDLKPENILLDEN----GVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMA 166
Query: 1220 PELLNGSS 1227
PE+L G +
Sbjct: 167 PEVLLGGN 174
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 69/189 (36%), Positives = 94/189 (49%), Gaps = 26/189 (13%)
Query: 1048 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
+ LG G+FG+VY + T +A+K ++ S + E LE RE ILS L HP
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEA----LE--REIRILSSLQHP 59
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLD-----RRKRLIIAMDAAFG 1160
N+V +YG +D TL E++ GSL LL K L + R I+ G
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSS-LLKKFGKLPEPVIRKYTRQILE-----G 113
Query: 1161 MEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK---RNTLVTGGVRGTLPW 1217
+ YLHS IVH D+K N+LV+ + K+ DFG +K TG VRGT W
Sbjct: 114 LAYLHSNGIVHRDIKGANILVDSDG----VVKLADFGCAKRLGDIETGEGTGSVRGTPYW 169
Query: 1218 MAPELLNGS 1226
MAPE++ G
Sbjct: 170 MAPEVIRGE 178
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 6e-33
Identities = 71/196 (36%), Positives = 97/196 (49%), Gaps = 24/196 (12%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
I +++L+ +G G FG V G +RG VA+K +K ++ F EA +
Sbjct: 3 INSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQA---------FLAEASV 53
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH-LDRRKRLIIAMDA 1157
++ L HPN+V GVV G L VTE+M GSL L S+ R + ++L A+D
Sbjct: 54 MTTLRHPNLVQLLGVVLQGNP--LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDV 111
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP- 1216
GMEYL KN VH DL N+LV+ + KV DFGL+K + G LP
Sbjct: 112 CEGMEYLEEKNFVHRDLAARNVLVSEDL----VAKVSDFGLAKEASQGQDS----GKLPV 163
Query: 1217 -WMAPELL--NGSSSK 1229
W APE L S+K
Sbjct: 164 KWTAPEALREKKFSTK 179
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 3e-32
Identities = 79/199 (39%), Positives = 100/199 (50%), Gaps = 22/199 (11%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGT-DVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
I +DL LKELG+G FG V +GKWRG DVAIK IK+ G SE E F EA+
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE----GSMSEDE-----FIEEAK 51
Query: 1098 ILSKLHHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
++ KL H +V YGV + P + VTE+M NG L + L + + L + D
Sbjct: 52 VMMKLSHEKLVQLYGVCTKQRP---IYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKD 108
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 1216
GM YL SK +H DL N LV+ + KV DFGLS+ + T V P
Sbjct: 109 VCEGMAYLESKQFIHRDLAARNCLVDDQG----CVKVSDFGLSRYVLDDEYTSSVGSKFP 164
Query: 1217 --WMAPELLNGSSSKVSEK 1233
W PE+L SK S K
Sbjct: 165 VRWSPPEVLL--YSKFSSK 181
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 67/190 (35%), Positives = 96/190 (50%), Gaps = 26/190 (13%)
Query: 1043 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100
E L+++G G FG VY + + G +VAIK IK ++E++ E +IL
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLE----SKEKKEKII----NEIQILK 52
Query: 1101 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFG 1160
K HPN+V +YG L V EF GSL+ +L S + L + + + G
Sbjct: 53 KCKHPNIVKYYGSYLKK--DELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKG 110
Query: 1161 MEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-----RNTLVTGGVRGTL 1215
+EYLHS I+H D+K N+L+ + K+ DFGLS RNT+V GT
Sbjct: 111 LEYLHSNGIIHRDIKAANILLTSDGEV----KLIDFGLSAQLSDTKARNTMV-----GTP 161
Query: 1216 PWMAPELLNG 1225
WMAPE++NG
Sbjct: 162 YWMAPEVING 171
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 75/193 (38%), Positives = 100/193 (51%), Gaps = 22/193 (11%)
Query: 1043 DLEELKELGSGTFGTVYHGKWRGT-DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 1101
+L LKELGSG FG V+ GKWRG DVAIK I++ G SE + F EA+++ K
Sbjct: 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIRE----GAMSEDD-----FIEEAKVMMK 55
Query: 1102 LHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFG 1160
L HPN+V YGV + P + VTE+M NG L + L ++ L L + D
Sbjct: 56 LSHPNLVQLYGVCTKQRP---IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEA 112
Query: 1161 MEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVT--GGVRGTLPWM 1218
MEYL S +H DL N LV + KV DFGL++ + T G + + W
Sbjct: 113 MEYLESNGFIHRDLAARNCLVGE----DNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWA 168
Query: 1219 APELLNGS--SSK 1229
PE+ + S SSK
Sbjct: 169 PPEVFDYSRFSSK 181
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 63/182 (34%), Positives = 89/182 (48%), Gaps = 21/182 (11%)
Query: 1048 KELGSGTFGTVYHGKWRGT-----DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
K +G G FG V G+ + DVAIK +K S+++RL +F EA I+ +
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-----SDKQRL--DFLTEASIMGQF 62
Query: 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGME 1162
HPN++ GVV + +TE+M NGSL L + + + + A GM+
Sbjct: 63 DHPNIIRLEGVVTKSR--PVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMK 120
Query: 1163 YLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN---TLVTGGVRGTLPWMA 1219
YL N VH DL N+LVN +CKV DFGLS+ + T T G + + W A
Sbjct: 121 YLSEMNYVHRDLAARNILVNSNL----VCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTA 176
Query: 1220 PE 1221
PE
Sbjct: 177 PE 178
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 1e-28
Identities = 74/197 (37%), Positives = 101/197 (51%), Gaps = 22/197 (11%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGT-DVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
I +L +KELGSG FG V+ GKWR VAIK I + G SE++ F EA+
Sbjct: 1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINE----GAMSEED-----FIEEAK 51
Query: 1098 ILSKLHHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
++ KL HP +V YGV Q P L VTEFM NG L + L ++ L + L + D
Sbjct: 52 VMMKLSHPKLVQLYGVCTQQKP---LYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQD 108
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK--IKRNTLVTGGVRGT 1214
GMEYL + +H DL N LV+ + KV DFG+++ + + G +
Sbjct: 109 VCEGMEYLERNSFIHRDLAARNCLVSSTG----VVKVSDFGMTRYVLDDEYTSSSGAKFP 164
Query: 1215 LPWMAPELLNGS--SSK 1229
+ W PE+ N S SSK
Sbjct: 165 VKWSPPEVFNFSKYSSK 181
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 66/191 (34%), Positives = 97/191 (50%), Gaps = 21/191 (10%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
I E L+ ++LG+G FG V+ G W G T VA+K +K + + F +EA+
Sbjct: 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA---------FLQEAQ 53
Query: 1098 ILSKLHHPNVVAFYGVVQDG-PGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAM 1155
I+ KL H +V Y V + P + VTE+M GSL L S E + L + + +A
Sbjct: 54 IMKKLRHDKLVQLYAVCSEEEP---IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAA 110
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG--GVRG 1213
A GM YL S+N +H DL N+LV +CK+ DFGL+++ + T G +
Sbjct: 111 QIAEGMAYLESRNYIHRDLAARNILVGEN----LVCKIADFGLARLIEDDEYTAREGAKF 166
Query: 1214 TLPWMAPELLN 1224
+ W APE N
Sbjct: 167 PIKWTAPEAAN 177
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 55/187 (29%), Positives = 90/187 (48%), Gaps = 28/187 (14%)
Query: 1049 ELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN 1106
+G G FG VY G G VAIK+I + + + E ++L L HPN
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKI--KEEALKSIMQEI----DLLKNLKHPN 60
Query: 1107 VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF------G 1160
+V + G ++ +L + E+ NGSLR ++ ++ + L+ A + G
Sbjct: 61 IVKYIGSIET--SDSLYIILEYAENGSLRQII---KKFGPFPESLV----AVYVYQVLQG 111
Query: 1161 MEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVTGGVRGTLPWMA 1219
+ YLH + ++H D+K N+L KD + K+ DFG++ K+ + V GT WMA
Sbjct: 112 LAYLHEQGVIHRDIKAANILTT-KD---GVVKLADFGVATKLNDVSKDDASVVGTPYWMA 167
Query: 1220 PELLNGS 1226
PE++ S
Sbjct: 168 PEVIEMS 174
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 63/191 (32%), Positives = 92/191 (48%), Gaps = 21/191 (10%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
I ++ L++LG+G FG V+ G W T VA+K +K G ++ F EA+
Sbjct: 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLK----PGTMDPKD-----FLAEAQ 53
Query: 1098 ILSKLHHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAM 1155
I+ KL HP ++ Y V + P + VTE M GSL L R L + + +A
Sbjct: 54 IMKKLRHPKLIQLYAVCTLEEP---IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAA 110
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTL 1215
A GM YL ++N +H DL N+LV + ICKV DFGL+++ + +
Sbjct: 111 QVASGMAYLEAQNYIHRDLAARNVLVGENN----ICKVADFGLARVIKEDIYEAREGAKF 166
Query: 1216 P--WMAPELLN 1224
P W APE
Sbjct: 167 PIKWTAPEAAL 177
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 60/188 (31%), Positives = 93/188 (49%), Gaps = 21/188 (11%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGT-DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100
E+ ++LGSG FG V+ G W+ VAIK +K S+ +F +E + L
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILK--------SDDLLKQQDFQKEVQALK 57
Query: 1101 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAF 1159
+L H ++++ + V G + +TE M GSL L S E + L + +A A
Sbjct: 58 RLRHKHLISLFAVCSVGE--PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAE 115
Query: 1160 GMEYLHSKNIVHFDLKCDNLLV--NLKDPIRPICKVGDFGLSK-IKRNTLVTGGVRGTLP 1216
GM YL +N +H DL N+LV +L +CKV DFGL++ IK + ++ +
Sbjct: 116 GMAYLEEQNSIHRDLAARNILVGEDL------VCKVADFGLARLIKEDVYLSSDKKIPYK 169
Query: 1217 WMAPELLN 1224
W APE +
Sbjct: 170 WTAPEAAS 177
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 67/194 (34%), Positives = 95/194 (48%), Gaps = 30/194 (15%)
Query: 1042 EDLEELKELGSGTFGTVY---HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
DLE +K LG G+ G VY H K G A+K+I G +++L RE +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRH-KPTGKIYALKKIH---VDGDEEFRKQLL----RELKT 52
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
L P VV YG G ++ V E+M GSL LL K + IA
Sbjct: 53 LRSCESPYVVKCYGAFYKE--GEISIVLEYMDGGSL-ADLLKKVGKIPEPVLAYIARQIL 109
Query: 1159 FGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI------KRNTLVTGGV 1211
G++YLH+K +I+H D+K NLL+N K + K+ DFG+SK+ + NT V
Sbjct: 110 KGLDYLHTKRHIIHRDIKPSNLLINSKGEV----KIADFGISKVLENTLDQCNTFV---- 161
Query: 1212 RGTLPWMAPELLNG 1225
GT+ +M+PE + G
Sbjct: 162 -GTVTYMSPERIQG 174
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 64/196 (32%), Positives = 95/196 (48%), Gaps = 25/196 (12%)
Query: 1036 LQIIKNEDLEELKELGSGTFGTVYHGKWR------GTDVAIKRIKKSCFTGRSSEQERLT 1089
L+I+K +LE++K LGSG FGTVY G W VAIK +++ T + +E L
Sbjct: 1 LRILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE--TSPKANKEIL- 57
Query: 1090 LEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL-RHVLLSKERHLDRR 1148
EA +++ + HP+VV G+ + +T+ M G L +V K+ + +
Sbjct: 58 ----DEAYVMASVDHPHVVRLLGIC---LSSQVQLITQLMPLGCLLDYVRNHKDN-IGSQ 109
Query: 1149 KRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI---KRNT 1205
L + A GM YL K +VH DL N+LV K P K+ DFGL+K+
Sbjct: 110 YLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV--KTP--QHVKITDFGLAKLLDVDEKE 165
Query: 1206 LVTGGVRGTLPWMAPE 1221
G + + WMA E
Sbjct: 166 YHAEGGKVPIKWMALE 181
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 60/190 (31%), Positives = 92/190 (48%), Gaps = 21/190 (11%)
Query: 1044 LEELKELGSGTFGTVYHGKW------RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
L+ +K+LG G FG V ++ G VA+K + S S+ F RE E
Sbjct: 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD-------FEREIE 58
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 1157
IL L H N+V + GV + G +L + E++ +GSLR L ++ ++ L+ +
Sbjct: 59 ILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQI 118
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KRNTLVTGGVRGTL 1215
GM+YL S+ +H DL N+LV +D + K+ DFGL+K+ + G
Sbjct: 119 CKGMDYLGSQRYIHRDLAARNILVESEDLV----KISDFGLAKVLPEDKDYYYVKEPGES 174
Query: 1216 P--WMAPELL 1223
P W APE L
Sbjct: 175 PIFWYAPECL 184
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 67/213 (31%), Positives = 94/213 (44%), Gaps = 48/213 (22%)
Query: 1038 IIKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTL 1090
++ + + +ELG G FG V+ G+ VA+K +K++
Sbjct: 1 HVQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-------SNDARK 53
Query: 1091 EFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH------ 1144
+F REAE+L+ H N+V FYGV + G V E+M +G L L S
Sbjct: 54 DFEREAELLTNFQHENIVKFYGVCTE--GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKS 111
Query: 1145 -------LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV--NLKDPIRPICKVGD 1195
L + L IA+ A GM YL S++ VH DL N LV +L + K+GD
Sbjct: 112 PDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL------VVKIGD 165
Query: 1196 FGLSKIKRNTLVT-----GGVRGTLP--WMAPE 1221
FG+S R+ T GG LP WM PE
Sbjct: 166 FGMS---RDVYTTDYYRVGGHT-MLPIRWMPPE 194
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 3e-25
Identities = 71/183 (38%), Positives = 100/183 (54%), Gaps = 21/183 (11%)
Query: 1048 KELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN 1106
+++G G FG VY G + T+VA+K +C RS+ L +F +EAEIL + HPN
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVK----TC---RSTLPPDLKRKFLQEAEILKQYDHPN 53
Query: 1107 VVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH 1165
+V GV VQ P + V E + GSL L K+ L +K L +++DAA GMEYL
Sbjct: 54 IVKLIGVCVQKQP---IYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE 110
Query: 1166 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL--VTGGVRGTLP--WMAPE 1221
SKN +H DL N LV + + K+ DFG+S+ + + V+ G +P W APE
Sbjct: 111 SKNCIHRDLAARNCLVGENN----VLKISDFGMSREEEGGIYTVSDG-LKQIPIKWTAPE 165
Query: 1222 LLN 1224
LN
Sbjct: 166 ALN 168
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 6e-25
Identities = 57/191 (29%), Positives = 94/191 (49%), Gaps = 28/191 (14%)
Query: 1044 LEELKELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 1101
+ L+++G G G VY R T +VAIK+++ + + L + E I+
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK------QNKELII---NEILIMKD 71
Query: 1102 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGM 1161
HPN+V +Y G L V E+M GSL ++ ++ + + + G+
Sbjct: 72 CKHPNIVDYYDSYLVG--DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGL 129
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS------KIKRNTLVTGGVRGTL 1215
EYLHS+N++H D+K DN+L++ + K+ DFG + K KRN++V GT
Sbjct: 130 EYLHSQNVIHRDIKSDNILLSKDGSV----KLADFGFAAQLTKEKSKRNSVV-----GTP 180
Query: 1216 PWMAPELLNGS 1226
WMAPE++
Sbjct: 181 YWMAPEVIKRK 191
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 7e-25
Identities = 56/188 (29%), Positives = 95/188 (50%), Gaps = 20/188 (10%)
Query: 1045 EELKELGSGTFGTVYHGKWRGTD---VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 1101
E +K++G G+FG VY + R +D +K I S SE+ER E +IL K
Sbjct: 3 EIIKQIGKGSFGKVYLVR-RKSDGKLYVLKEIDLS----NMSEKEREDAL--NEVKILKK 55
Query: 1102 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---RHLDRRKRLIIAMDAA 1158
L+HPN++ +Y ++ G L V E+ G L + ++ + + L +
Sbjct: 56 LNHPNIIKYYESFEE--KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLC 113
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL-VTGGVRGTLPW 1217
++YLHS+ I+H D+K N+ + + K+GDFG+SK+ +T+ + V GT +
Sbjct: 114 LALKYLHSRKILHRDIKPQNIFLTSNG----LVKLGDFGISKVLSSTVDLAKTVVGTPYY 169
Query: 1218 MAPELLNG 1225
++PEL
Sbjct: 170 LSPELCQN 177
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 69/188 (36%), Positives = 99/188 (52%), Gaps = 22/188 (11%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
+ ++L+ L+ +G G FG V G +RG VA+K IK T ++ F EA +
Sbjct: 3 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-TAQA---------FLAEASV 52
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-IAMDA 1157
+++L H N+V GV+ + GG L VTE+M GSL L S+ R + L+ ++D
Sbjct: 53 MTQLRHSNLVQLLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 111
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP- 1216
MEYL + N VH DL N+LV+ + + KV DFGL+K +T T G LP
Sbjct: 112 CEAMEYLEANNFVHRDLAARNVLVSEDN----VAKVSDFGLTKEASSTQDT----GKLPV 163
Query: 1217 -WMAPELL 1223
W APE L
Sbjct: 164 KWTAPEAL 171
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 64/190 (33%), Positives = 99/190 (52%), Gaps = 20/190 (10%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
+ E L+ +K+LG+G FG V+ G + G T VAIK +K+ + + F EA
Sbjct: 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA---------FLAEAN 53
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH-LDRRKRLIIAMD 1156
++ +L HP +V Y VV P + +TE+M NGSL L + E L K + +A
Sbjct: 54 LMKQLQHPRLVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQ 110
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG--GVRGT 1214
A GM ++ KN +H DL+ N+LV+ CK+ DFGL+++ + T G +
Sbjct: 111 IAEGMAFIERKNYIHRDLRAANILVSET----LCCKIADFGLARLIEDNEYTAREGAKFP 166
Query: 1215 LPWMAPELLN 1224
+ W APE +N
Sbjct: 167 IKWTAPEAIN 176
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 55/180 (30%), Positives = 82/180 (45%), Gaps = 18/180 (10%)
Query: 1050 LGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVA 1109
LGSG+FG+VY G D +K+ + + +E +LSKL HPN+V
Sbjct: 8 LGSGSFGSVYEG-LNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 1110 FYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR-----KRLIIAMDAAFGMEYL 1164
+ G ++ L E + GSL LL K R I+ G+EYL
Sbjct: 67 YLGTEREE--DNLYIFLELVPGGSL-AKLLKKYGSFPEPVIRLYTRQILL-----GLEYL 118
Query: 1165 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLN 1224
H +N VH D+K N+LV+ + K+ DFG++K +G+ WMAPE++
Sbjct: 119 HDRNTVHRDIKGANILVDTNGVV----KLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIA 174
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 8e-24
Identities = 69/206 (33%), Positives = 98/206 (47%), Gaps = 34/206 (16%)
Query: 1038 IIKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTL 1090
+ E + ++ELG G+FG VY G +G T VAIK + +S +ER+
Sbjct: 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTV-----NENASMRERI-- 54
Query: 1091 EFWREAEILSKLHHPNVVAFYGVVQDG-PGGTLATVTEFMVNGSLRHVLLS---KERH-- 1144
EF EA ++ + + +VV GVV G P TL V E M G L+ L S + +
Sbjct: 55 EFLNEASVMKEFNCHHVVRLLGVVSTGQP--TL-VVMELMAKGDLKSYLRSRRPEAENNP 111
Query: 1145 ----LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200
+K + +A + A GM YL +K VH DL N +V K+GDFG+++
Sbjct: 112 GLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL----TVKIGDFGMTR 167
Query: 1201 -IKRNTLVTGGVRGTLP--WMAPELL 1223
I G +G LP WMAPE L
Sbjct: 168 DIYETDYYRKGGKGLLPVRWMAPESL 193
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 59/187 (31%), Positives = 84/187 (44%), Gaps = 24/187 (12%)
Query: 1048 KELGSGTFGTVYHGKW-----RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
K+LG G+FG V G+W + VA+K +K + + F +EA I+ L
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDD-------FLKEAAIMHSL 53
Query: 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL-LSKERHLDRRKRLIIAMDAAFGM 1161
H N++ YGVV P L VTE GSL L H A+ A GM
Sbjct: 54 DHENLIRLYGVVLTHP---LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGM 110
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK----IKRNTLVTGGVRGTLPW 1217
YL SK +H DL N+L+ D + K+GDFGL + + + ++ ++ W
Sbjct: 111 RYLESKRFIHRDLAARNILLASDDKV----KIGDFGLMRALPQNEDHYVMEEHLKVPFAW 166
Query: 1218 MAPELLN 1224
APE L
Sbjct: 167 CAPESLR 173
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 67/199 (33%), Positives = 97/199 (48%), Gaps = 22/199 (11%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
I +L ++E+GSG FG V+ G W VAIK I++ G SE++ F EA+
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIRE----GAMSEED-----FIEEAQ 51
Query: 1098 ILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
++ KL HP +V YGV + P + V EFM +G L L ++ + L + +D
Sbjct: 52 VMMKLSHPKLVQLYGVCTERSP---ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLD 108
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 1216
GM YL S N++H DL N LV + KV DFG+++ + T P
Sbjct: 109 VCEGMAYLESSNVIHRDLAARNCLVGENQ----VVKVSDFGMTRFVLDDQYTSSTGTKFP 164
Query: 1217 --WMAPELLNGSSSKVSEK 1233
W +PE+ S SK S K
Sbjct: 165 VKWSSPEVF--SFSKYSSK 181
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 65/188 (34%), Positives = 87/188 (46%), Gaps = 28/188 (14%)
Query: 1048 KELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
KELG G FG+V G + +VA+K +K+ + ++ EF REA ++++L
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQ----EHIAAGKK---EFLREASVMAQL 53
Query: 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGME 1162
HP +V GV + G L V E G L L K R + +A A GM
Sbjct: 54 DHPCIVRLIGVCK-GEPLML--VMELAPLGPL-LKYLKKRREIPVSDLKELAHQVAMGMA 109
Query: 1163 YLHSKNIVHFDLKCDN-LLVNLKDPIRPICKVGDFGLSKIKRN-----TLVTGGVRGTLP 1216
YL SK+ VH DL N LLVN R K+ DFG+S+ T G R L
Sbjct: 110 YLESKHFVHRDLAARNVLLVN-----RHQAKISDFGMSRALGAGSDYYRATTAG-RWPLK 163
Query: 1217 WMAPELLN 1224
W APE +N
Sbjct: 164 WYAPECIN 171
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 63/188 (33%), Positives = 86/188 (45%), Gaps = 22/188 (11%)
Query: 1049 ELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN 1106
+LG G +G VY G W+ VA+K +K E EF +EA ++ ++ HPN
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLK---------EDTMEVEEFLKEAAVMKEIKHPN 63
Query: 1107 VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH-LDRRKRLIIAMDAAFGMEYLH 1165
+V GV P +TEFM G+L L R ++ L +A + MEYL
Sbjct: 64 LVQLLGVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 121
Query: 1166 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVT--GGVRGTLPWMAPELL 1223
KN +H DL N LV + KV DFGLS++ T G + + W APE L
Sbjct: 122 KKNFIHRDLAARNCLVGENH----LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 177
Query: 1224 --NGSSSK 1229
N S K
Sbjct: 178 AYNKFSIK 185
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 62/196 (31%), Positives = 101/196 (51%), Gaps = 31/196 (15%)
Query: 1045 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
E++ ++G GT+G VY + + T VA+K+I+ +E+E + RE ++L KL
Sbjct: 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRME------NEKEGFPITAIREIKLLQKL 55
Query: 1103 HHPNVVAFYGVVQDGPGGTLATVTEFM---VNGSLRHVL----LSKERHLDRRKRLIIAM 1155
HPN+V +V G++ V E+M + G L S+ + K+L+
Sbjct: 56 RHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCY--MKQLLE-- 111
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KRNTLV-TGGVR 1212
G++YLHS I+H D+K N+L+N + K+ DFGL++ KRN+ T V
Sbjct: 112 ----GLQYLHSNGILHRDIKGSNILINNDGVL----KLADFGLARPYTKRNSADYTNRVI 163
Query: 1213 GTLPWMAPELLNGSSS 1228
TL + PELL G++
Sbjct: 164 -TLWYRPPELLLGATR 178
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 4e-23
Identities = 67/189 (35%), Positives = 95/189 (50%), Gaps = 24/189 (12%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
I E L+ +K+LG+G FG V+ G W G T VA+K +K + S F EA+
Sbjct: 3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES---------FLEEAQ 53
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMD 1156
I+ KL H +V Y VV + P + VTE+M GSL L E R L + +A
Sbjct: 54 IMKKLRHDKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQ 110
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLV--NLKDPIRPICKVGDFGLSKIKRNTLVTG--GVR 1212
A GM Y+ N +H DL+ N+LV L +CK+ DFGL+++ + T G +
Sbjct: 111 VAAGMAYIERMNYIHRDLRSANILVGDGL------VCKIADFGLARLIEDNEYTARQGAK 164
Query: 1213 GTLPWMAPE 1221
+ W APE
Sbjct: 165 FPIKWTAPE 173
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 6e-23
Identities = 55/191 (28%), Positives = 86/191 (45%), Gaps = 27/191 (14%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
ED E ++ +GSGT+G VY + T VAIK IK + +E +L
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIK-------LEPGDDFE-IIQQEISML 54
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
+ HPN+VA++G L V E+ GSL+ + L + + +
Sbjct: 55 KECRHPNIVAYFGSYLRR--DKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLK 112
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KI-----KRNTLVTGGVRG 1213
G+ YLH +H D+K N+L+ + K+ DFG+S ++ KR + + G
Sbjct: 113 GLAYLHETGKIHRDIKGANILLTEDGDV----KLADFGVSAQLTATIAKRKSFI-----G 163
Query: 1214 TLPWMAPELLN 1224
T WMAPE+
Sbjct: 164 TPYWMAPEVAA 174
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 7e-23
Identities = 56/194 (28%), Positives = 90/194 (46%), Gaps = 30/194 (15%)
Query: 1042 EDLEELKE-LGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
E++ ++ E LG G++G+VY + G VAIK + E++ + +E I
Sbjct: 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV--------PVEEDLQEII--KEISI 51
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
L + P +V +YG L V E+ GS+ ++ + L + I
Sbjct: 52 LKQCDSPYIVKYYGSYFKN--TDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTL 109
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI------KRNTLVTGGVR 1212
G+EYLHS +H D+K N+L+N + K+ DFG+S KRNT++
Sbjct: 110 KGLEYLHSNKKIHRDIKAGNILLNEEG----QAKLADFGVSGQLTDTMAKRNTVI----- 160
Query: 1213 GTLPWMAPELLNGS 1226
GT WMAPE++
Sbjct: 161 GTPFWMAPEVIQEI 174
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 100 bits (248), Expect = 3e-22
Identities = 69/193 (35%), Positives = 97/193 (50%), Gaps = 21/193 (10%)
Query: 1047 LKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHP 1105
L++LG G+FG VY + VA+K + K +S E ER F RE +IL+ L H P
Sbjct: 5 LRKLGEGSFGEVYLAR-DRKLVALKVLAKK-LESKSKEVER----FLREIQILASLNHPP 58
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH--LDRRKRLIIAMDAAFGMEY 1163
N+V Y QD L V E++ GSL +L R L + L I +EY
Sbjct: 59 NIVKLYDFFQDEGSLYL--VMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116
Query: 1164 LHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR-------GTLP 1216
LHSK I+H D+K +N+L+ D + K+ DFGL+K+ + T + GT
Sbjct: 117 LHSKGIIHRDIKPENILL---DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPG 173
Query: 1217 WMAPELLNGSSSK 1229
+MAPE+L G S
Sbjct: 174 YMAPEVLLGLSLA 186
|
Length = 384 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 3e-22
Identities = 66/200 (33%), Positives = 95/200 (47%), Gaps = 28/200 (14%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTD-------VAIKRIKKSCFTGRSSEQERLTLE 1091
+ + + L+ LG G FG VY G +RG D VA+K + +SC SEQ+ +
Sbjct: 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-----SEQDES--D 55
Query: 1092 FWREAEILSKLHHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDR--- 1147
F EA I+SK +H N+V GV + P + E M G L+ L +R
Sbjct: 56 FLMEALIMSKFNHQNIVRLIGVSFERLP---RFILLELMAGGDLKSFLRENRPRPERPSS 112
Query: 1148 ---RKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKR 1203
+ L A D A G +YL + +H D+ N L+ K P R + K+ DFG+++ I R
Sbjct: 113 LTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGR-VAKIADFGMARDIYR 171
Query: 1204 NTLVTGGVRGTLP--WMAPE 1221
+ G R LP WM PE
Sbjct: 172 ASYYRKGGRAMLPIKWMPPE 191
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 4e-22
Identities = 60/194 (30%), Positives = 90/194 (46%), Gaps = 28/194 (14%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
E L+ +G G+FG VY + T+ VAIK I +E E ++ +E + L
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE-----EAEDEIEDIQ--QEIQFL 53
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
S+ P + +YG G L + E+ GS +L K LD I +
Sbjct: 54 SQCRSPYITKYYGSFLKG--SKLWIIMEYCGGGSCLDLL--KPGKLDETYIAFILREVLL 109
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS------KIKRNTLVTGGVRG 1213
G+EYLH + +H D+K N+L++ + + K+ DFG+S KRNT V G
Sbjct: 110 GLEYLHEEGKIHRDIKAANILLSEEGDV----KLADFGVSGQLTSTMSKRNTFV-----G 160
Query: 1214 TLPWMAPELLNGSS 1227
T WMAPE++ S
Sbjct: 161 TPFWMAPEVIKQSG 174
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 4e-22
Identities = 67/189 (35%), Positives = 94/189 (49%), Gaps = 24/189 (12%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGT-DVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
I E L +LG G FG V+ G W GT VAIK +K + + F +EA+
Sbjct: 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---------FLQEAQ 53
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-IAMD 1156
++ KL H +V Y VV + P + VTE+M GSL L + R +L+ +A
Sbjct: 54 VMKKLRHEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQ 110
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLV--NLKDPIRPICKVGDFGLSKIKRNTLVTG--GVR 1212
A GM Y+ N VH DL+ N+LV NL +CKV DFGL+++ + T G +
Sbjct: 111 IASGMAYVERMNYVHRDLRAANILVGENL------VCKVADFGLARLIEDNEYTARQGAK 164
Query: 1213 GTLPWMAPE 1221
+ W APE
Sbjct: 165 FPIKWTAPE 173
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 1e-21
Identities = 68/206 (33%), Positives = 94/206 (45%), Gaps = 40/206 (19%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWR 1094
+ L+ELG G FG VY G+ G T VAIK +K++ + ++ EF +
Sbjct: 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN-------AEPKVQQEFRQ 57
Query: 1095 EAEILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERH--------- 1144
EAE++S L HPN+V GV ++ P + E++ +G L L+ H
Sbjct: 58 EAELMSDLQHPNIVCLLGVCTKEQP---TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGD 114
Query: 1145 ------LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198
LD L IA+ A GMEYL S + VH DL N LV + K+ DFGL
Sbjct: 115 ETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTV----KISDFGL 170
Query: 1199 SK-IKRNTLVTGGVRGTLP--WMAPE 1221
S+ I + LP WM PE
Sbjct: 171 SRDIYSADYYRVQSKSLLPVRWMPPE 196
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 72/201 (35%), Positives = 98/201 (48%), Gaps = 22/201 (10%)
Query: 1044 LEELKELGSGTFGTV----YH--GKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
L+ +++LG G FG+V Y G VA+K+++ S ++E R +F RE E
Sbjct: 6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-----TAEHLR---DFEREIE 57
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 1157
IL L H N+V + GV L V E++ GSLR L LD RK L+ A
Sbjct: 58 ILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQI 117
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI----KRNTLVTGGVRG 1213
GMEYL SK VH DL N+LV ++ + K+GDFGL+K+ K V
Sbjct: 118 CKGMEYLGSKRYVHRDLATRNILVESENRV----KIGDFGLTKVLPQDKEYYKVREPGES 173
Query: 1214 TLPWMAPELLNGSSSKVSEKV 1234
+ W APE L S V+ V
Sbjct: 174 PIFWYAPESLTESKFSVASDV 194
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 3e-21
Identities = 66/189 (34%), Positives = 94/189 (49%), Gaps = 24/189 (12%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGT-DVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
I E L +LG G FG V+ G W GT VAIK +K + F +EA+
Sbjct: 3 IPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA---------FLQEAQ 53
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMD 1156
I+ KL H +V Y VV + P + VTEFM GSL L + ++L + + +A
Sbjct: 54 IMKKLRHDKLVPLYAVVSEEP---IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQ 110
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLV--NLKDPIRPICKVGDFGLSKIKRNTLVTG--GVR 1212
A GM Y+ N +H DL+ N+LV NL +CK+ DFGL+++ + T G +
Sbjct: 111 IADGMAYIERMNYIHRDLRAANILVGDNL------VCKIADFGLARLIEDNEYTARQGAK 164
Query: 1213 GTLPWMAPE 1221
+ W APE
Sbjct: 165 FPIKWTAPE 173
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 4e-21
Identities = 58/189 (30%), Positives = 93/189 (49%), Gaps = 18/189 (9%)
Query: 1047 LKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
L+ +G G FG V + R T A+K + K + S + L E IL +L+H
Sbjct: 5 LRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVL-----NERRILQELNH 59
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYL 1164
P +V + QD + V + ++ G LR+ L K + + + + I + +EYL
Sbjct: 60 PFLVNLWYSFQDEE--NMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWIC-EIVLALEYL 116
Query: 1165 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVTGGVRGTLPWMAPELL 1223
HSK I+H D+K DN+L++ + + DF ++ K+ +TL T GT +MAPE+L
Sbjct: 117 HSKGIIHRDIKPDNILLDEQGH----VHITDFNIATKVTPDTLTTSTS-GTPGYMAPEVL 171
Query: 1224 N--GSSSKV 1230
G S V
Sbjct: 172 CRQGYSVAV 180
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (235), Expect = 5e-21
Identities = 60/192 (31%), Positives = 93/192 (48%), Gaps = 30/192 (15%)
Query: 1045 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
E+L++LG GT+G VY + + T VA+K+I+ +E+E + RE +L +L
Sbjct: 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLD------NEEEGIPSTALREISLLKEL 55
Query: 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR--KRL---IIAMDA 1157
HPN+V V+ L V E+ + L+ L + L K + ++
Sbjct: 56 KHPNIVKLLDVIHTE--RKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIKSIMYQLLR--- 109
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK---IKRNTLVTGGVRGT 1214
G+ Y HS I+H DLK N+L+N + K+ DFGL++ I T V T
Sbjct: 110 --GLAYCHSHRILHRDLKPQNILINRD----GVLKLADFGLARAFGIPLRTYTHEVV--T 161
Query: 1215 LPWMAPELLNGS 1226
L + APE+L GS
Sbjct: 162 LWYRAPEILLGS 173
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 9e-21
Identities = 66/197 (33%), Positives = 99/197 (50%), Gaps = 19/197 (9%)
Query: 1042 EDLEELKELGSGTFGTVY---HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
+DLE L ELG+G G V H + G +A+K I+ + Q+++ RE +I
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLH-RPTGKIMAVKTIR---LEINEAIQKQIL----RELDI 52
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
L K + P +V FYG + G ++ E+M GSL +L + + R IA+
Sbjct: 53 LHKCNSPYIVGFYGAFYN--NGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVL 110
Query: 1159 FGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPW 1217
G+ YLH K I+H D+K N+LVN + I K+ DFG+S N+L V GT +
Sbjct: 111 KGLTYLHEKHKIIHRDVKPSNILVNSRGQI----KLCDFGVSGQLVNSLAKTFV-GTSSY 165
Query: 1218 MAPELLNGSSSKVSEKV 1234
MAPE + G+ V +
Sbjct: 166 MAPERIQGNDYSVKSDI 182
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 64/187 (34%), Positives = 98/187 (52%), Gaps = 27/187 (14%)
Query: 1043 DLEEL---KELGSGTFGTVYHGKWRGTDVAIKRIKKSC-FTGRSSEQERLTLEFWREAEI 1098
+L++L + +G G FG V G++ G VA+K IK C T ++ F E +
Sbjct: 4 NLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIK--CDVTAQA---------FLEETAV 52
Query: 1099 LSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-IAMD 1156
++KLHH N+V GV+ +G L V E M G+L + L ++ R L +L+ ++D
Sbjct: 53 MTKLHHKNLVRLLGVILHNG----LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLD 108
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 1216
A GMEYL SK +VH DL N+LV+ + KV DFGL+++ + + +
Sbjct: 109 VAEGMEYLESKKLVHRDLAARNILVSEDG----VAKVSDFGLARVGSMGVDNS--KLPVK 162
Query: 1217 WMAPELL 1223
W APE L
Sbjct: 163 WTAPEAL 169
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 3e-20
Identities = 67/201 (33%), Positives = 97/201 (48%), Gaps = 32/201 (15%)
Query: 1032 DISTLQIIKNEDLEELKELGSGTFGTVYHGKW-----RGTDVAIKRIKKSCFTGRSSEQE 1086
D+S ++I EE+ +G+G FG V G+ R VAIK +K +G + +Q
Sbjct: 2 DVSCVKI------EEV--IGAGEFGEVCRGRLKLPGKREIFVAIKTLK----SGYTEKQR 49
Query: 1087 RLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLD 1146
R +F EA I+ + HPN++ GVV + +TEFM NG+L L +
Sbjct: 50 R---DFLSEASIMGQFDHPNIIHLEGVVTKSR--PVMIITEFMENGALDSFLRQNDGQFT 104
Query: 1147 RRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI----K 1202
+ + + A GM+YL N VH DL N+LVN +CKV DFGLS+
Sbjct: 105 VIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSN----LVCKVSDFGLSRFLEDDT 160
Query: 1203 RNTLVTGGVRGTLP--WMAPE 1221
+ T + G +P W APE
Sbjct: 161 SDPTYTSSLGGKIPIRWTAPE 181
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 4e-20
Identities = 59/195 (30%), Positives = 88/195 (45%), Gaps = 23/195 (11%)
Query: 1041 NEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100
N+ E + ELG G FG VY + + T + K E E +F E +ILS
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGL--FAAAKIIQIESEEELE----DFMVEIDILS 57
Query: 1101 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFG 1160
+ HPN+V Y L + EF G+L ++L ER L + +
Sbjct: 58 ECKHPNIVGLYEAYFYEN--KLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEA 115
Query: 1161 MEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS------KIKRNTLVTGGVRGT 1214
+ +LHS ++H DLK N+L+ L + K+ DFG+S KR+T + GT
Sbjct: 116 LNFLHSHKVIHRDLKAGNILLTLDGDV----KLADFGVSAKNKSTLQKRDTFI-----GT 166
Query: 1215 LPWMAPELLNGSSSK 1229
WMAPE++ + K
Sbjct: 167 PYWMAPEVVACETFK 181
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 5e-20
Identities = 57/180 (31%), Positives = 84/180 (46%), Gaps = 17/180 (9%)
Query: 1050 LGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 1107
LG G+FG V + + T A+K +KK + + + E ILS+++HP +
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKK-----KKIIKRKEVEHTLTERNILSRINHPFI 55
Query: 1108 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDR-RKRLIIAMDAAFGMEYLHS 1166
V + Q L V E+ G L LSKE R R A + +EYLHS
Sbjct: 56 VKLHYAFQTE--EKLYLVLEYAPGGELFS-HLSKEGRFSEERARFYAA-EIVLALEYLHS 111
Query: 1167 KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI-KRNTLVTGGVRGTLPWMAPELLNG 1225
I++ DLK +N+L++ I K+ DFGL+K T GT ++APE+L G
Sbjct: 112 LGIIYRDLKPENILLDADGHI----KLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLG 167
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 6e-20
Identities = 59/193 (30%), Positives = 90/193 (46%), Gaps = 21/193 (10%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTLEFW 1093
I+ ED+ + +G G FG VY G + VA+K K + +F
Sbjct: 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-------SPSVREKFL 55
Query: 1094 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 1153
+EA I+ + HP++V GV+ + P + V E G LR L + LD ++
Sbjct: 56 QEAYIMRQFDHPHIVKLIGVITENP---VWIVMELAPLGELRSYLQVNKYSLDLASLILY 112
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRG 1213
+ + + YL SK VH D+ N+LV+ D + K+GDFGLS+ + +G
Sbjct: 113 SYQLSTALAYLESKRFVHRDIAARNVLVSSPDCV----KLGDFGLSRYLEDESYYKASKG 168
Query: 1214 TLP--WMAPELLN 1224
LP WMAPE +N
Sbjct: 169 KLPIKWMAPESIN 181
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 7e-20
Identities = 63/183 (34%), Positives = 95/183 (51%), Gaps = 20/183 (10%)
Query: 1048 KELGSGTFGTVYHGKWRG--TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
+ +G G FG V+ G+ R T VA+K SC R + L +F +EA IL + HP
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVK----SC---RETLPPDLKAKFLQEARILKQYSHP 53
Query: 1106 NVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYL 1164
N+V GV Q P + V E + G L ++ L ++ + + +AA GMEYL
Sbjct: 54 NIVRLIGVCTQKQP---IYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYL 110
Query: 1165 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL--VTGGVRGT-LPWMAPE 1221
SK+ +H DL N LV K+ + K+ DFG+S+ + + + TGG++ + W APE
Sbjct: 111 ESKHCIHRDLAARNCLVTEKNVL----KISDFGMSREEEDGVYASTGGMKQIPVKWTAPE 166
Query: 1222 LLN 1224
LN
Sbjct: 167 ALN 169
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 8e-20
Identities = 57/190 (30%), Positives = 93/190 (48%), Gaps = 21/190 (11%)
Query: 1044 LEELKELGSGTFGTVY------HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
L+ +++LG G FG V G G VA+K +K + +E E
Sbjct: 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-------PESGGNHIADLKKEIE 58
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 1157
IL L+H N+V + G+ + G + + EF+ +GSL+ L + ++ +++L A+
Sbjct: 59 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQI 118
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNT---LVTGGVRG 1213
GM+YL S+ VH DL N+LV + + K+GDFGL+K I+ + V +
Sbjct: 119 CKGMDYLGSRQYVHRDLAARNVLVESEHQV----KIGDFGLTKAIETDKEYYTVKDDLDS 174
Query: 1214 TLPWMAPELL 1223
+ W APE L
Sbjct: 175 PVFWYAPECL 184
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 59/189 (31%), Positives = 87/189 (46%), Gaps = 23/189 (12%)
Query: 1050 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 1107
+ G +G V+ K + T AIK IKK+ ++ + LT E +ILS+ P V
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLT-----ERDILSQAQSPYV 55
Query: 1108 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK 1167
V Y Q L V E++ G L LL LD I + +EYLHS
Sbjct: 56 VKLYYSFQGK--KNLYLVMEYLPGGDLAS-LLENVGSLDEDVARIYIAEIVLALEYLHSN 112
Query: 1168 NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK---IKRNTLV------TGGVRGTLPWM 1218
I+H DLK DN+L++ + K+ DFGLSK ++R + + GT ++
Sbjct: 113 GIIHRDLKPDNILIDSNGHL----KLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168
Query: 1219 APELLNGSS 1227
APE++ G
Sbjct: 169 APEVILGQG 177
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 1e-19
Identities = 66/195 (33%), Positives = 93/195 (47%), Gaps = 28/195 (14%)
Query: 1050 LGSGTFGTVYHGKWRGTD--------VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 1101
LGSG FG VY G VA+K ++K +++QE+ EF +EA ++S
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG-----ATDQEKK--EFLKEAHLMSN 55
Query: 1102 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLS--KERH----LDRRKRLIIAM 1155
+HPN+V GV + + E M G L L ER L ++ L I +
Sbjct: 56 FNHPNIVKLLGVCLLNEPQYI--IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICL 113
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP-ICKVGDFGLSK-IKRNTLVTGGVRG 1213
D A G YL + +H DL N LV+ K + K+GDFGL++ I ++ G
Sbjct: 114 DVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEG 173
Query: 1214 TLP--WMAPE-LLNG 1225
LP WMAPE LL+G
Sbjct: 174 LLPVRWMAPESLLDG 188
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 3e-19
Identities = 59/187 (31%), Positives = 90/187 (48%), Gaps = 18/187 (9%)
Query: 1045 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
++L ++G GT+G VY + + T VAIK+IK E E + RE ++L +L
Sbjct: 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIK------LRFESEGIPKTALREIKLLKEL 55
Query: 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGME 1162
+HPN++ V G L V EFM + L ++ ++R L G+
Sbjct: 56 NHPNIIKLLDVF--RHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLA 112
Query: 1163 YLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR--NTLVTGGVRGTLPWMAP 1220
+ HS I+H DLK +NLL+N + + K+ DFGL++ T V T + AP
Sbjct: 113 FCHSHGILHRDLKPENLLINTEGVL----KLADFGLARSFGSPVRPYTHYV-VTRWYRAP 167
Query: 1221 ELLNGSS 1227
ELL G
Sbjct: 168 ELLLGDK 174
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 4e-19
Identities = 62/202 (30%), Positives = 92/202 (45%), Gaps = 43/202 (21%)
Query: 1045 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
E+ K+LG GT+ VY + + T VAIK+IK R ++ + RE ++L +L
Sbjct: 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLG---ERKEAKDGINFTALREIKLLQEL 59
Query: 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIA-------M 1155
HPN++ V G + V EFM L V+ + K +++ M
Sbjct: 60 KHPNIIGLLDVF--GHKSNINLVFEFM-ETDLEKVI--------KDKSIVLTPADIKSYM 108
Query: 1156 DAAF-GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI----KRN---TLV 1207
G+EYLHS I+H DLK +NLL+ + K+ DFGL++ R +V
Sbjct: 109 LMTLRGLEYLHSNWILHRDLKPNNLLIASDG----VLKLADFGLARSFGSPNRKMTHQVV 164
Query: 1208 TGGVRGTLPWM-APELLNGSSS 1228
T W APELL G+
Sbjct: 165 T-------RWYRAPELLFGARH 179
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|215996 pfam00564, PB1, PB1 domain | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 4e-19
Identities = 31/88 (35%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 200 PSDGKLRYVGGETRIIRISRDISWQELTQKALAIYNQT-HTIKYQLPGEDLDALVSVSCD 258
KLRY GG R + +S IS++EL K + K + P ED D LVS++ D
Sbjct: 1 TVRVKLRYGGGIRRFLSVSPGISFEELRSKVEQRFGLDRVDFKLKYPDEDGD-LVSITSD 59
Query: 259 EDLQNMMEECNVLEDRGTQKPRMFLFSS 286
EDL+ +EE L G++ R+ +F +
Sbjct: 60 EDLEEAIEEARSL---GSKTLRLHVFPA 84
|
Length = 84 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 6e-19
Identities = 61/179 (34%), Positives = 88/179 (49%), Gaps = 18/179 (10%)
Query: 1050 LGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVV 1108
LG G FG V+ G + T VA+K K+ + L ++F EA IL + HPN+V
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDL-------PQELKIKFLSEARILKQYDHPNIV 55
Query: 1109 AFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK 1167
GV Q P + V E + G L K+ L ++ + A+DAA GM YL SK
Sbjct: 56 KLIGVCTQRQP---IYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK 112
Query: 1168 NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP--WMAPELLN 1224
N +H DL N LV + + K+ DFG+S+ + + + + +P W APE LN
Sbjct: 113 NCIHRDLAARNCLVGENN----VLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALN 167
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|214770 smart00666, PB1, PB1 domain | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 6e-19
Identities = 39/88 (44%), Positives = 56/88 (63%), Gaps = 10/88 (11%)
Query: 200 PSDGKLRYVGGETRIIRISRDISWQEL---TQKALAIYNQTHTIKYQLPGEDLDALVSVS 256
D KLRY GGETR + + RDIS+++L K + NQ+ T+KYQ ED D LVS++
Sbjct: 1 TVDVKLRY-GGETRRLSVPRDISFEDLRSKVAKRFGLDNQSFTLKYQ--DEDGD-LVSLT 56
Query: 257 CDEDLQNMMEECNVLEDRGTQKPRMFLF 284
DEDL+ +EE + L G++K R+ +F
Sbjct: 57 SDEDLEEAIEEYDSL---GSKKLRLHVF 81
|
Phox and Bem1p domain, present in many eukaryotic cytoplasmic signalling proteins. The domain adopts a beta-grasp fold, similar to that found in ubiquitin and Ras-binding domains. A motif, variously termed OPR, PC and AID, represents the most conserved region of the majority of PB1 domains, and is necessary for PB1 domain function. This function is the formation of PB1 domain heterodimers, although not all PB1 domain pairs associate. Length = 81 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 6e-19
Identities = 66/201 (32%), Positives = 102/201 (50%), Gaps = 21/201 (10%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
I E ++ +K+LG+G FG V+ G + T VA+K +K G S Q F EA
Sbjct: 3 IPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKP----GTMSVQA-----FLEEAN 53
Query: 1098 ILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-IAM 1155
++ L H +V Y VV ++ P + +TE+M GSL L S E +LI +
Sbjct: 54 LMKTLQHDKLVRLYAVVTKEEP---IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA 110
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG--GVRG 1213
A GM Y+ KN +H DL+ N+LV+ + + +CK+ DFGL+++ + T G +
Sbjct: 111 QIAEGMAYIERKNYIHRDLRAANVLVS--ESL--MCKIADFGLARVIEDNEYTAREGAKF 166
Query: 1214 TLPWMAPELLNGSSSKVSEKV 1234
+ W APE +N S + V
Sbjct: 167 PIKWTAPEAINFGSFTIKSDV 187
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 2e-18
Identities = 62/183 (33%), Positives = 87/183 (47%), Gaps = 22/183 (12%)
Query: 1048 KELGSGTFGTVYHGKW-----RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
K +G+G FG V G+ R VAIK +K G + +Q R +F EA I+ +
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLK----AGYTEKQRR---DFLSEASIMGQF 62
Query: 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGME 1162
HPN++ GVV + VTE+M NGSL L + + + + A GM+
Sbjct: 63 DHPNIIHLEGVVTKSK--PVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMK 120
Query: 1163 YLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN----TLVTGGVRGTLPWM 1218
YL VH DL N+LVN +CKV DFGLS++ + T G + + W
Sbjct: 121 YLSDMGYVHRDLAARNILVNSN----LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 176
Query: 1219 APE 1221
APE
Sbjct: 177 APE 179
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 2e-18
Identities = 55/161 (34%), Positives = 84/161 (52%), Gaps = 20/161 (12%)
Query: 1045 EELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
+ +K+LG GTFG+VY + + G VAIK++KK F S +E + L RE + L KL
Sbjct: 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKK-FY---SWEECMNL---REVKSLRKL 54
Query: 1103 -HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLS-KERHLDRRK-RLIIAMDAAF 1159
HPN+V V ++ L V E+M G+L ++ K + R II
Sbjct: 55 NEHPNIVKLKEVFRE--NDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQ- 110
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200
G+ ++H H DLK +NLLV+ + + K+ DFGL++
Sbjct: 111 GLAHIHKHGFFHRDLKPENLLVSGPE----VVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 50/179 (27%), Positives = 82/179 (45%), Gaps = 16/179 (8%)
Query: 1050 LGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 1107
LG G FG V K + + A+K +KK ++ + E EIL + +HP +
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEH-----IFSEKEILEECNHPFI 55
Query: 1108 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRK-RLIIAMDAAFGMEYLHS 1166
V Y +D + + E+ + G L +L D R IA EYLH+
Sbjct: 56 VKLYRTFKDKK--YIYMLMEYCLGGELWTIL-RDRGLFDEYTARFYIAC-VVLAFEYLHN 111
Query: 1167 KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNG 1225
+ I++ DLK +NLL++ + K+ DFG +K ++ T GT ++APE++
Sbjct: 112 RGIIYRDLKPENLLLDSNGYV----KLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILN 166
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 60/194 (30%), Positives = 97/194 (50%), Gaps = 18/194 (9%)
Query: 1050 LGSGTFGTVYHG--KWRGTDVAIKRIK-KSCFTGRSSEQERLTLEFWR-EAEILSKLHHP 1105
+G GT+G VY G +A+K+++ + GR +++ ++ R E E L L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI--IAMDAAFGMEY 1163
N+V + G + L+ E++ GS+ L + ++L+ G+ Y
Sbjct: 69 NIVQYLGF-ETTEE-YLSIFLEYVPGGSIGSCL---RTYGRFEEQLVRFFTEQVLEGLAY 123
Query: 1164 LHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN---TLVTGGVRGTLPWMAP 1220
LHSK I+H DLK DNLLV+ ICK+ DFG+SK + ++G++ WMAP
Sbjct: 124 LHSKGILHRDLKADNLLVDADG----ICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179
Query: 1221 ELLNGSSSKVSEKV 1234
E+++ S S KV
Sbjct: 180 EVIHSYSQGYSAKV 193
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 5e-18
Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 20/200 (10%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
I E L+ K+LG+G FG V+ + + T VA+K +K + + F EA
Sbjct: 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA---------FLAEAN 53
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-IAMD 1156
++ L H +V + VV P + +TEFM GSL L S E +LI +
Sbjct: 54 VMKTLQHDKLVKLHAVVTKEP---IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ 110
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG--GVRGT 1214
A GM ++ +N +H DL+ N+LV+ +CK+ DFGL+++ + T G +
Sbjct: 111 IAEGMAFIEQRNYIHRDLRAANILVSAS----LVCKIADFGLARVIEDNEYTAREGAKFP 166
Query: 1215 LPWMAPELLNGSSSKVSEKV 1234
+ W APE +N S + V
Sbjct: 167 IKWTAPEAINFGSFTIKSDV 186
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 7e-18
Identities = 56/193 (29%), Positives = 97/193 (50%), Gaps = 32/193 (16%)
Query: 1045 EELKELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
E+++ +G G FG V+ K V IK+I + ++ ERL + E ++L L
Sbjct: 3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIP----VEQMTKDERLAAQ--NECQVLKLL 56
Query: 1103 HHPNVVAFYG----------VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI 1152
HPN++ +Y V++ PGGTLA + + LL ++ L +++
Sbjct: 57 SHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQ-----KRCNSLLDEDTILHFFVQIL 111
Query: 1153 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR 1212
+A+ ++H+K I+H DLK N+L++ + + K+GDFG+SKI + V
Sbjct: 112 LAL------HHVHTKLILHRDLKTQNILLDKH---KMVVKIGDFGISKILSSKSKAYTVV 162
Query: 1213 GTLPWMAPELLNG 1225
GT +++PEL G
Sbjct: 163 GTPCYISPELCEG 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 7e-18
Identities = 58/185 (31%), Positives = 89/185 (48%), Gaps = 18/185 (9%)
Query: 1043 DLEELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100
D E L ++G G+FG V+ K A+K+I S R E E EA +L+
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRRERE------EAIDEARVLA 54
Query: 1101 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI--IAMDAA 1158
KL ++ +Y D G L V E+ NG L H LL +R + + +
Sbjct: 55 KLDSSYIIRYYESFLDK--GKLNIVMEYAENGDL-HKLLKMQRGRPLPEDQVWRFFIQIL 111
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI-KRNTLVTGGVRGTLPW 1217
G+ +LHSK I+H D+K NL ++ D + K+GD G++K+ NT + GT +
Sbjct: 112 LGLAHLHSKKILHRDIKSLNLFLDAYDNV----KIGDLGVAKLLSDNTNFANTIVGTPYY 167
Query: 1218 MAPEL 1222
++PEL
Sbjct: 168 LSPEL 172
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 7e-18
Identities = 61/188 (32%), Positives = 94/188 (50%), Gaps = 24/188 (12%)
Query: 1048 KELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
K LG G FG VY + G ++A+K++ +++E LE E ++L L H
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVP-FDPDSPETKKEVNALE--CEIQLLKNLQHE 64
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLS----KERHLDRRKRLIIAMDAAFGM 1161
+V +YG ++D TL+ E+M GS++ L + E + R I+ G+
Sbjct: 65 RIVQYYGCLRDD--ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILE-----GV 117
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK----IKRNTLVTGGVRGTLPW 1217
EYLHS IVH D+K N+L + + K+GDFG SK I + V GT W
Sbjct: 118 EYLHSNMIVHRDIKGANILRDSAGNV----KLGDFGASKRLQTICSSGTGMKSVTGTPYW 173
Query: 1218 MAPELLNG 1225
M+PE+++G
Sbjct: 174 MSPEVISG 181
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 8e-18
Identities = 62/187 (33%), Positives = 96/187 (51%), Gaps = 23/187 (12%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+LE + +GSG GTVY R T A+K I + ++ + + RE EIL
Sbjct: 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVI-------YGNHEDTVRRQICREIEIL 126
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
++HPNVV + + G + + EFM GSL ++ E+ L R I++
Sbjct: 127 RDVNHPNVVKCHDMFDHN--GEIQVLLEFMDGGSLEGTHIADEQFLADVARQILS----- 179
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL--VTGGVRGTLPW 1217
G+ YLH ++IVH D+K NLL+N + K+ DFG+S+I T+ V GT+ +
Sbjct: 180 GIAYLHRRHIVHRDIKPSNLLINSAKNV----KIADFGVSRILAQTMDPCNSSV-GTIAY 234
Query: 1218 MAPELLN 1224
M+PE +N
Sbjct: 235 MSPERIN 241
|
Length = 353 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 9e-18
Identities = 59/205 (28%), Positives = 87/205 (42%), Gaps = 50/205 (24%)
Query: 1047 LKELGSGTFGTVYHGKWRGTDV------AIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100
++G GTFG VY ++ A+K I+ + E E ++L
Sbjct: 5 GNKIGGGTFGKVY----TAVNLDTGELMAVKEIRIQ------DNDPKTIKEIADEMKVLE 54
Query: 1101 KLHHPNVVAFYGV-VQDG---------PGGTLATVTEFMVNGSLRHVLLSKERHLDR-RK 1149
L HPN+V +YGV V GGTL + L H + E +
Sbjct: 55 LLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEEL--------LEHGRILDEHVIRVYTL 106
Query: 1150 RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVT 1208
+L+ G+ YLHS IVH D+K N+ ++ I K+GDFG + +K NT
Sbjct: 107 QLLE------GLAYLHSHGIVHRDIKPANIFLDHNGVI----KLGDFGCAVKLKNNTTTM 156
Query: 1209 G----GVRGTLPWMAPELLNGSSSK 1229
G + GT +MAPE++ G K
Sbjct: 157 GEEVQSLAGTPAYMAPEVITGGKGK 181
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 1e-17
Identities = 58/188 (30%), Positives = 87/188 (46%), Gaps = 21/188 (11%)
Query: 1045 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
+ L +G G G V+ K R T VA+K++ R E + + RE + L
Sbjct: 3 KILGRIGEGAHGIVFKAKDRETGETVALKKV-----ALRRLE-GGIPNQALREIKALQAC 56
Query: 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRK-RLIIAMDAAFGM 1161
HP VV V G G V E+M L VL +ER L + + + M G+
Sbjct: 57 QHPYVVKLLDVFPHGSG--FVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLK-GV 112
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI---KRNTLVTGGVRGTLPWM 1218
Y+H+ I+H DLK NLL++ + K+ DFGL+++ + L + V T +
Sbjct: 113 AYMHANGIMHRDLKPANLLISADG----VLKIADFGLARLFSEEEPRLYSHQV-ATRWYR 167
Query: 1219 APELLNGS 1226
APELL G+
Sbjct: 168 APELLYGA 175
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 2e-17
Identities = 66/192 (34%), Positives = 89/192 (46%), Gaps = 25/192 (13%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWR 1094
+L K LG+G FG V G VA+K +K T SSE+E L E
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKP---TAHSSEREALMSEL-- 89
Query: 1095 EAEILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLI 1152
+I+S L +H N+V G G G + +TE+ G L + L K E L L
Sbjct: 90 --KIMSHLGNHENIVNLLGACTIG--GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLS 145
Query: 1153 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKR--NTLVTG 1209
+ A GM +L SKN +H DL N+L+ I K+ DFGL++ I N +V G
Sbjct: 146 FSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK----IVKICDFGLARDIMNDSNYVVKG 201
Query: 1210 GVRGTLPWMAPE 1221
R + WMAPE
Sbjct: 202 NARLPVKWMAPE 213
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 59/189 (31%), Positives = 86/189 (45%), Gaps = 32/189 (16%)
Query: 1050 LGSGTFGTVYHGKWRGTD-----VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
+G G FG VYHG +D A+K + R ++ E + +F +E I+ H
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLN------RITDLEEVE-QFLKEGIIMKDFSH 55
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-IAMDAAFGMEY 1163
PNV++ G+ G L V +M +G LR+ + E H K LI + A GMEY
Sbjct: 56 PNVLSLLGICLPSEGSPL-VVLPYMKHGDLRN-FIRSETHNPTVKDLIGFGLQVAKGMEY 113
Query: 1164 LHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS---------KIKRNTLVTGGVRGT 1214
L SK VH DL N +++ + KV DFGL+ + +T G +
Sbjct: 114 LASKKFVHRDLAARNCMLDESFTV----KVADFGLARDIYDKEYYSVHNHT----GAKLP 165
Query: 1215 LPWMAPELL 1223
+ WMA E L
Sbjct: 166 VKWMALESL 174
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 55/187 (29%), Positives = 82/187 (43%), Gaps = 16/187 (8%)
Query: 1045 EELKELGSGTFG--TVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
++ LG G FG T+Y + V K + T S ++ R L E ILS L
Sbjct: 3 IPIRVLGKGAFGEATLYRRTEDDSLVVWKEVN---LTRLSEKERRDALN---EIVILSLL 56
Query: 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLL-SKERHLDRRKRLIIAMDAAFGM 1161
HPN++A+Y D TL E+ G+L ++ K + + L +
Sbjct: 57 QHPNIIAYYNHFMD--DNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAV 114
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI-KRNTLVTGGVRGTLPWMAP 1220
Y+H I+H D+K N+ + I K+GDFG+SKI + V GT +M+P
Sbjct: 115 SYIHKAGILHRDIKTLNIFLTKAGLI----KLGDFGISKILGSEYSMAETVVGTPYYMSP 170
Query: 1221 ELLNGSS 1227
EL G
Sbjct: 171 ELCQGVK 177
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 2e-17
Identities = 68/208 (32%), Positives = 93/208 (44%), Gaps = 52/208 (25%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
++ E+L + GT+G VY + + T VA+K++K E+E + RE IL
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLK------MEKEKEGFPITSLREINIL 58
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
KL HPN+V VV G L + +MV + H L K L+ M F
Sbjct: 59 LKLQHPNIVTVKEVVV---GSNLDKI--YMVMEYVEHDL----------KSLMETMKQPF 103
Query: 1160 --------------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL-----SK 1200
G+ +LH I+H DLK NLL+N R I K+ DFGL S
Sbjct: 104 LQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNN----RGILKICDFGLAREYGSP 159
Query: 1201 IKRNT-LVTGGVRGTLPWMAPELLNGSS 1227
+K T LV TL + APELL G+
Sbjct: 160 LKPYTQLVV-----TLWYRAPELLLGAK 182
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 3e-17
Identities = 61/193 (31%), Positives = 83/193 (43%), Gaps = 27/193 (13%)
Query: 1048 KELGSGTFGTVYHGKWRGTD-----VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
K LG G FG+V G+ D VA+K +K T E EF EA +
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIE------EFLSEAACMKDF 58
Query: 1103 HHPNVVAFYGV-VQDGPGGTLAT---VTEFMVNGSLRHVLLSKE-----RHLDRRKRLII 1153
HPNV+ GV + + + FM +G L LL L + L
Sbjct: 59 DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF 118
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVTGGVR 1212
+D A GMEYL ++N +H DL N + L++ + +C V DFGLS KI G
Sbjct: 119 MVDIALGMEYLSNRNFIHRDLAARNCM--LREDMT-VC-VADFGLSKKIYSGDYYRQGRI 174
Query: 1213 GTLP--WMAPELL 1223
+P W+A E L
Sbjct: 175 AKMPVKWIAIESL 187
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 61/194 (31%), Positives = 87/194 (44%), Gaps = 37/194 (19%)
Query: 1046 ELKEL-GSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
EL E+ G GT+G VY + + T VAIK + E+E + E+ IL K
Sbjct: 9 ELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDI-----IEDEEEEIKEEY----NILRKY 59
Query: 1103 -HHPNVVAFYGV----VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKR--LI--I 1153
+HPN+ FYG G L V E GS+ L+ R +R + I I
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTD-LVKGLRKKGKRLKEEWIAYI 118
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK------IKRNTLV 1207
+ G+ YLH ++H D+K N+L+ + K+ DFG+S +RNT +
Sbjct: 119 LRETLRGLAYLHENKVIHRDIKGQNILLTKNAEV----KLVDFGVSAQLDSTLGRRNTFI 174
Query: 1208 TGGVRGTLPWMAPE 1221
GT WMAPE
Sbjct: 175 -----GTPYWMAPE 183
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 3e-17
Identities = 62/186 (33%), Positives = 85/186 (45%), Gaps = 26/186 (13%)
Query: 1049 ELGSGTFGTVYHG----KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
ELGSG FG V G + + DVAIK +K + ++ + E REAEI+ +L +
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLK-------NENEKSVRDEMMREAEIMHQLDN 54
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYL 1164
P +V GV + L V E G L L K+ + + + + GM+YL
Sbjct: 55 PYIVRMIGVCE---AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYL 111
Query: 1165 HSKNIVHFDLKCDN-LLVNLKDPIRPICKVGDFGLSKI-----KRNTLVTGGVRGTLPWM 1218
KN VH DL N LLVN + K+ DFGLSK + G + L W
Sbjct: 112 EGKNFVHRDLAARNVLLVN-----QHYAKISDFGLSKALGADDSYYKARSAG-KWPLKWY 165
Query: 1219 APELLN 1224
APE +N
Sbjct: 166 APECIN 171
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 4e-17
Identities = 53/187 (28%), Positives = 87/187 (46%), Gaps = 15/187 (8%)
Query: 1048 KELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
++LG+G F + Y + GT +A+K++ SSEQE + +E ++++L+HP
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYV--RNTSSEQEEVVEALRKEIRLMARLNHP 63
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH 1165
+++ G + E+M GS+ H LLSK + G+ YLH
Sbjct: 64 HIIRMLGATCED--SHFNLFVEWMAGGSVSH-LLSKYGAFKEAVIINYTEQLLRGLSYLH 120
Query: 1166 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL-----SKIKRNTLVTGGVRGTLPWMAP 1220
I+H D+K NLL+ D ++ DFG +K G + GT+ +MAP
Sbjct: 121 ENQIIHRDVKGANLLI---DSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177
Query: 1221 ELLNGSS 1227
E+L G
Sbjct: 178 EVLRGEQ 184
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 5e-17
Identities = 71/207 (34%), Positives = 93/207 (44%), Gaps = 38/207 (18%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLE 1091
IK D+ ELG G FG V+ + VA+K +K++ SE R +
Sbjct: 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA------SESARQ--D 53
Query: 1092 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLS---KERHLDRR 1148
F REAE+L+ L H ++V FYGV +G L V E+M +G L L S + L
Sbjct: 54 FQREAELLTVLQHQHIVRFYGVCTEGR--PLLMVFEYMRHGDLNRFLRSHGPDAKILAGG 111
Query: 1149 K-----------RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197
+ L IA A GM YL S + VH DL N LV + K+GDFG
Sbjct: 112 EDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG----LVVKIGDFG 167
Query: 1198 LSK-IKRNTLVTGGVRGTLP--WMAPE 1221
+S+ I G R LP WM PE
Sbjct: 168 MSRDIYSTDYYRVGGRTMLPIRWMPPE 194
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 5e-17
Identities = 63/223 (28%), Positives = 96/223 (43%), Gaps = 53/223 (23%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+D + K +G G+F TV K + T+ AIK + K +E+ E E+L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI-----KEKKVKYVKIEKEVL 55
Query: 1100 SKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR-KRLIIA--M 1155
++L HP ++ Y QD L V E+ NG L + K LD + R A +
Sbjct: 56 TRLNGHPGIIKLYYTFQDE--ENLYFVLEYAPNGELLQ-YIRKYGSLDEKCTRFYAAEIL 112
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI-------------- 1201
A +EYLHSK I+H DLK +N+L++ I K+ DFG +K+
Sbjct: 113 LA---LEYLHSKGIIHRDLKPENILLDKDMHI----KITDFGTAKVLDPNSSPESNKGDA 165
Query: 1202 ------------KRNTLVTGGVRGTLPWMAPELL-NGSSSKVS 1231
+ + V GT +++PELL + K S
Sbjct: 166 TNIDSQIEKNRRRFASFV-----GTAEYVSPELLNEKPAGKSS 203
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 7e-17
Identities = 60/205 (29%), Positives = 102/205 (49%), Gaps = 51/205 (24%)
Query: 1050 LGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLE-FWREAEILSKLHHPN 1106
+GSG+FG+VY G G +A+K+++ + S +++R L+ RE +L +L H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 1107 VVAFYGVVQDG----------PGGTLATV-------TEFMVNGSLRHVLLSKERHLDRRK 1149
+V + G D PGG++A + E +V +R +L
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILK---------- 117
Query: 1150 RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVT 1208
G+ YLH++ I+H D+K N+LV+ K I K+ DFG+S K++ N+L T
Sbjct: 118 ----------GLNYLHNRGIIHRDIKGANILVDNKGGI----KISDFGISKKLEANSLST 163
Query: 1209 G------GVRGTLPWMAPELLNGSS 1227
++G++ WMAPE++ +S
Sbjct: 164 KTNGARPSLQGSVFWMAPEVVKQTS 188
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 7e-17
Identities = 59/199 (29%), Positives = 90/199 (45%), Gaps = 38/199 (19%)
Query: 1042 EDLEELKELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWR-EAEI 1098
+D E ++ +G G VY VAIKRI E+ + +++ R E +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRI--------DLEKCQTSVDELRKEVQA 52
Query: 1099 LSKLHHPNVVAFYG--VVQDGPGGTLATVTEFMVNGSLRHVLLSKERH--LDRRKRLIIA 1154
+S+ +HPNVV +Y VV D L V ++ GSL ++ S LD +
Sbjct: 53 MSQCNHPNVVKYYTSFVVGD----ELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL 108
Query: 1155 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS----------KIKRN 1204
+ G+EYLHS +H D+K N+L+ + K+ DFG+S + R
Sbjct: 109 KEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSV----KIADFGVSASLADGGDRTRKVRK 164
Query: 1205 TLVTGGVRGTLPWMAPELL 1223
T V GT WMAPE++
Sbjct: 165 TFV-----GTPCWMAPEVM 178
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 8e-17
Identities = 63/180 (35%), Positives = 85/180 (47%), Gaps = 18/180 (10%)
Query: 1050 LGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 1107
LG GT+G VY + T V AIK I + R S + E E + S L H N+
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPE-----RDSRYVQPLHE---EIALHSYLKHRNI 67
Query: 1108 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF--GMEYLH 1165
V + G D G E + GSL +L SK L ++ II G++YLH
Sbjct: 68 VQYLG--SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH 125
Query: 1166 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTGGVRGTLPWMAPELLN 1224
IVH D+K DN+LVN + K+ DFG SK + T GTL +MAPE+++
Sbjct: 126 DNQIVHRDIKGDNVLVN---TYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVID 182
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 62/188 (32%), Positives = 95/188 (50%), Gaps = 22/188 (11%)
Query: 1048 KELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
K LG G FG VY + G ++A+K+++ F S E + E ++L L H
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQ---FDPESPETSKEVNALECEIQLLKNLLHE 64
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLS----KERHLDRRKRLIIAMDAAFGM 1161
+V +YG ++D TL+ E M GS++ L S E + R I+ G+
Sbjct: 65 RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILE-----GV 119
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG----GVRGTLPW 1217
YLHS IVH D+K N+ L+D + + K+GDFG SK + ++G V GT W
Sbjct: 120 SYLHSNMIVHRDIKGANI---LRDSVGNV-KLGDFGASKRLQTICLSGTGMKSVTGTPYW 175
Query: 1218 MAPELLNG 1225
M+PE+++G
Sbjct: 176 MSPEVISG 183
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|99716 cd05992, PB1, The PB1 domain is a modular domain mediating specific protein-protein interactions which play a role in many critical cell processes, such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 1e-16
Identities = 29/84 (34%), Positives = 47/84 (55%), Gaps = 5/84 (5%)
Query: 202 DGKLRYVGGETRIIRISRDISWQELTQKALAIYN-QTHTIKYQLPGEDLDALVSVSCDED 260
K++Y G R + +SR IS+++L K + + K + P ED D LV++S DED
Sbjct: 2 RVKVKYGGEIRRFVVVSRSISFEDLRSKIAEKFGLDAVSFKLKYPDEDGD-LVTISSDED 60
Query: 261 LQNMMEECNVLEDRGTQKPRMFLF 284
L+ +EE G++K R+F+F
Sbjct: 61 LEEAIEEA---RRSGSKKLRLFVF 81
|
A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domain, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as a noncanonical PB1-interactions. The PB1 domain module is conserved in amoebas, fungi, animals, and plants. Length = 81 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 69/210 (32%), Positives = 91/210 (43%), Gaps = 43/210 (20%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTD-------VAIKRIKKSCFTGRSSEQERLTLE 1091
IK D+ +ELG G FG V+ + VA+K +K R +
Sbjct: 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK--------D 53
Query: 1092 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL------------- 1138
F REAE+L+ L H ++V FYGV D G L V E+M +G L L
Sbjct: 54 FQREAELLTNLQHEHIVKFYGVCGD--GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDG 111
Query: 1139 --LSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV--NLKDPIRPICKVG 1194
+ L + L IA A GM YL S++ VH DL N LV NL + K+G
Sbjct: 112 QPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL------LVKIG 165
Query: 1195 DFGLSK-IKRNTLVTGGVRGTLP--WMAPE 1221
DFG+S+ + G LP WM PE
Sbjct: 166 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPE 195
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 61/196 (31%), Positives = 87/196 (44%), Gaps = 28/196 (14%)
Query: 1045 EELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
EEL E+G G +GTVY + G VA+K+++ +E + L RE +L +L
Sbjct: 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVP------LSEEGIPLSTLREIALLKQL 55
Query: 1103 ---HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHV------LLSK--ERHLDRRKRL 1151
HPN+V V T E + HV LSK + L
Sbjct: 56 ESFEHPNIVRLLDVCH-----GPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIK 110
Query: 1152 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGV 1211
+ G+++LHS IVH DLK N+LV + K+ DFGL++I + V
Sbjct: 111 DLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQV----KIADFGLARIYSFEMALTSV 166
Query: 1212 RGTLPWMAPELLNGSS 1227
TL + APE+L SS
Sbjct: 167 VVTLWYRAPEVLLQSS 182
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 2e-16
Identities = 54/164 (32%), Positives = 83/164 (50%), Gaps = 21/164 (12%)
Query: 1044 LEELKELGSGTFGTV----YHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWR-EA 1096
L++++ LG G FG V Y GT VA+K +K+ C +Q W+ E
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-----GQQNT---SGWKKEI 57
Query: 1097 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
IL L+H N+V + G + G L + E++ GSLR L + L+ + L+ A
Sbjct: 58 NILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHKLNLAQLLLFAQQ 115
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200
GM YLHS++ +H DL N+L++ + K+GDFGL+K
Sbjct: 116 ICEGMAYLHSQHYIHRDLAARNVLLDNDR----LVKIGDFGLAK 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 61/183 (33%), Positives = 88/183 (48%), Gaps = 22/183 (12%)
Query: 1048 KELGSGTFGTVYHG--KWRG---TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
K +G+G FG V+ G K G VAIK +K +E++R +F EA I+ +
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG-----YTEKQRQ--DFLSEASIMGQF 63
Query: 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGME 1162
H N++ GVV + +TE+M NG+L L + + + + A GM+
Sbjct: 64 SHHNIIRLEGVVTKFKPAMI--ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMK 121
Query: 1163 YLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN----TLVTGGVRGTLPWM 1218
YL N VH DL N+LVN CKV DFGLS++ + T T G + + W
Sbjct: 122 YLSDMNYVHRDLAARNILVNSN----LECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWT 177
Query: 1219 APE 1221
APE
Sbjct: 178 APE 180
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 60/193 (31%), Positives = 89/193 (46%), Gaps = 34/193 (17%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+D E +K LG+G+FG V + +G+ A+K + K+ +Q L E IL
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIV--KLKQVEHVL---NEKRIL 55
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL------II 1153
+ HP +V YG QD L V E++ G L HL + R
Sbjct: 56 QSIRHPFLVNLYGSFQDD--SNLYLVMEYVPGGELFS-------HLRKSGRFPEPVARFY 106
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN---TLVTGG 1210
A +EYLHS +IV+ DLK +NLL++ I K+ DFG +K + TL
Sbjct: 107 AAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYI----KITDFGFAKRVKGRTYTLC--- 159
Query: 1211 VRGTLPWMAPELL 1223
GT ++APE++
Sbjct: 160 --GTPEYLAPEII 170
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 4e-16
Identities = 56/198 (28%), Positives = 89/198 (44%), Gaps = 17/198 (8%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTDVAIKRI--KKSCFTGRSSEQERLTLEFWREAEIL 1099
E + EL LG G G+V + + T I K+ T + + ++ L RE EI
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNT----GMIFALKTITTDPNPDLQKQIL---RELEIN 53
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHV---LLSKERHLDRRKRLIIAMD 1156
P +V +YG D ++ E+ GSL + + + + + IA
Sbjct: 54 KSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAES 113
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 1216
G+ YLHS+ I+H D+K N+L+ K + K+ DFG+S N+L G GT
Sbjct: 114 VLKGLSYLHSRKIIHRDIKPSNILLTRKGQV----KLCDFGVSGELVNSL-AGTFTGTSF 168
Query: 1217 WMAPELLNGSSSKVSEKV 1234
+MAPE + G ++ V
Sbjct: 169 YMAPERIQGKPYSITSDV 186
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 6e-16
Identities = 55/194 (28%), Positives = 87/194 (44%), Gaps = 30/194 (15%)
Query: 1051 GSGTFGTVYHGKW----RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN 1106
G GT+G VY K G + AIK+ K G + ++ RE +L +L H N
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFK-----GDKEQYTGISQSACREIALLRELKHEN 63
Query: 1107 VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLL--------SKERHLDRR--KRLIIAMD 1156
VV+ V + ++ + ++ H L +K + K L+ +
Sbjct: 64 VVSLVEVFLEHADKSVYLLFDYA-----EHDLWQIIKFHRQAKRVSIPPSMVKSLLWQI- 117
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVT----GGVR 1212
G+ YLHS ++H DLK N+LV + P R + K+GD GL+++ L V
Sbjct: 118 -LNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV 176
Query: 1213 GTLPWMAPELLNGS 1226
T+ + APELL G+
Sbjct: 177 VTIWYRAPELLLGA 190
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 59/207 (28%), Positives = 85/207 (41%), Gaps = 58/207 (28%)
Query: 1045 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQER--LTLEFWREAEILS 1100
E+L +G GT+G VY + + VA+K+++ + ER + + RE +L
Sbjct: 10 EKLNRIGEGTYGIVYRARDTTSGEIVALKKVR--------MDNERDGIPISSLREITLLL 61
Query: 1101 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF- 1159
L HPN+V VV G L ++ F+V L S L+ M F
Sbjct: 62 NLRHPNIVELKEVVV---GKHLDSI--FLVMEYCEQDLAS----------LLDNMPTPFS 106
Query: 1160 -------------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL 1206
G++YLH I+H DLK NLL+ K K+ DFGL++
Sbjct: 107 ESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKG----CLKIADFGLAR------ 156
Query: 1207 VTGGVRG-------TLPWMAPELLNGS 1226
G TL + APELL G
Sbjct: 157 TYGLPAKPMTPKVVTLWYRAPELLLGC 183
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 55/193 (28%), Positives = 90/193 (46%), Gaps = 31/193 (16%)
Query: 1047 LKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
L+ +G G +G VY GK T VA+K I + + ++ + RE +LS+L
Sbjct: 6 LELIGRGAYGAVYRGKHVPTGRVVALKIIN------LDTPDDDVS-DIQREVALLSQLRQ 58
Query: 1105 ---PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGM 1161
PN+ +YG GP L + E+ GS+R L K + + +I + +
Sbjct: 59 SQPPNITKYYGSYLKGP--RLWIIMEYAEGGSVR--TLMKAGPIAEKYISVIIREVLVAL 114
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS------KIKRNTLVTGGVRGTL 1215
+Y+H ++H D+K N+LV ++ +C DFG++ KR+T V GT
Sbjct: 115 KYIHKVGVIHRDIKAANILVTNTGNVK-LC---DFGVAALLNQNSSKRSTFV-----GTP 165
Query: 1216 PWMAPELLNGSSS 1228
WMAPE++
Sbjct: 166 YWMAPEVITEGKY 178
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 62/212 (29%), Positives = 90/212 (42%), Gaps = 41/212 (19%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTD-------VAIKRIKKSCFTGRSSEQERLTLE 1091
+ + L K LG G FG V + G D VA+K +K +E++ +
Sbjct: 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-----TEKD--LSD 61
Query: 1092 FWREAEILSKL-HHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVL----------- 1138
E E++ + H N++ GV Q+GP L V E+ +G+LR L
Sbjct: 62 LVSEMEMMKMIGKHKNIINLLGVCTQEGP---LYVVVEYAAHGNLRDFLRARRPPGEYAS 118
Query: 1139 ----LSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194
E L ++ + A A GME+L SK +H DL N+LV + K+
Sbjct: 119 PDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH----VMKIA 174
Query: 1195 DFGLSK-IKRNTLVTGGVRGTLP--WMAPELL 1223
DFGL++ I G LP WMAPE L
Sbjct: 175 DFGLARDIHHIDYYRKTTNGRLPVKWMAPEAL 206
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 3e-15
Identities = 70/204 (34%), Positives = 98/204 (48%), Gaps = 32/204 (15%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLE 1091
+ E + L+ELG G+FG VY G R T VA+K + +S +S +ER +E
Sbjct: 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES-----ASLRER--IE 55
Query: 1092 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLS--------KER 1143
F EA ++ +VV GVV G TL V E M +G L+ L S R
Sbjct: 56 FLNEASVMKGFTCHHVVRLLGVVSKGQ-PTL-VVMELMAHGDLKSYLRSLRPEAENNPGR 113
Query: 1144 HLDRRKRLI-IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-I 1201
+ +I +A + A GM YL++K VH DL N +V + K+GDFG+++ I
Sbjct: 114 PPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTV----KIGDFGMTRDI 169
Query: 1202 KRNTLVTGGVRGTLP--WMAPELL 1223
G +G LP WMAPE L
Sbjct: 170 YETDYYRKGGKGLLPVRWMAPESL 193
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 4e-15
Identities = 62/199 (31%), Positives = 101/199 (50%), Gaps = 25/199 (12%)
Query: 1036 LQIIKNEDLEELKELGSGTFGTVYHGKW------RGTDVAIKRIKKSCFTGRSSEQERLT 1089
L+I+K +L+ +K LGSG FGTVY G W VAIK + ++ TG +
Sbjct: 1 LRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET--TG-----PKAN 53
Query: 1090 LEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRK 1149
+EF EA I++ + HP++V GV T+ VT+ M +G L + + ++ +
Sbjct: 54 VEFMDEALIMASMDHPHLVRLLGVCLS---PTIQLVTQLMPHGCLLDYVHEHKDNIGSQL 110
Query: 1150 RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI----KRNT 1205
L + A GM YL + +VH DL N+LV + + K+ DFGL+++ ++
Sbjct: 111 LLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHV----KITDFGLARLLEGDEKEY 166
Query: 1206 LVTGGVRGTLPWMAPELLN 1224
GG + + WMA E ++
Sbjct: 167 NADGG-KMPIKWMALECIH 184
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-15
Identities = 60/188 (31%), Positives = 92/188 (48%), Gaps = 22/188 (11%)
Query: 1048 KELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
K LG G FG VY + G ++A+K++ F S E + E ++L L H
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVP---FDPDSQETSKEVNALECEIQLLKNLRHD 64
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLS----KERHLDRRKRLIIAMDAAFGM 1161
+V +YG ++D L+ E+M GS++ L + E R R I+ G+
Sbjct: 65 RIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQ-----GV 119
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG----GVRGTLPW 1217
YLHS IVH D+K N+L + + K+GDFG SK + ++G V GT W
Sbjct: 120 SYLHSNMIVHRDIKGANILRDSAGNV----KLGDFGASKRIQTICMSGTGIKSVTGTPYW 175
Query: 1218 MAPELLNG 1225
M+PE+++G
Sbjct: 176 MSPEVISG 183
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 6e-15
Identities = 63/186 (33%), Positives = 88/186 (47%), Gaps = 17/186 (9%)
Query: 1041 NEDLEELKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
NE E + ELG G FG VY K + T A K I+ T E E ++ E EI
Sbjct: 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIE----TKSEEELE----DYMVEIEI 62
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
L+ +HP +V G G L + EF G++ ++L +R L + +I
Sbjct: 63 LATCNHPYIVKLLGAFYWD--GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQML 120
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVT-GGVRGTLPW 1217
++YLHS I+H DLK N+L+ L I K+ DFG+S TL GT W
Sbjct: 121 EALQYLHSMKIIHRDLKAGNVLLTLDGDI----KLADFGVSAKNVKTLQRRDSFIGTPYW 176
Query: 1218 MAPELL 1223
MAPE++
Sbjct: 177 MAPEVV 182
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 7e-15
Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 42/203 (20%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD-------VAIKRIKKSCFTGRSSEQERLTLEFWR 1094
+L+E+ LG G FG V+ K +G + V +K ++K+ + E L EF R
Sbjct: 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-------KDENLQSEFRR 57
Query: 1095 EAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLL--------SKERHLD 1146
E ++ KL H NVV G+ ++ + + E+ G L+ L K L
Sbjct: 58 ELDMFRKLSHKNVVRLLGLCREAEPHYM--ILEYTDLGDLKQFLRATKSKDEKLKPPPLS 115
Query: 1147 RRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK---- 1202
++++ + A GM++L + VH DL N LV+ + KV LSK
Sbjct: 116 TKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQR----EVKVSLLSLSKDVYNSE 171
Query: 1203 ----RNTLVTGGVRGTLPWMAPE 1221
RN L+ L W+APE
Sbjct: 172 YYKLRNALI------PLRWLAPE 188
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 7e-15
Identities = 62/188 (32%), Positives = 94/188 (50%), Gaps = 22/188 (11%)
Query: 1048 KELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
K LG G FG VY + G ++A K+++ F S E + E ++L L H
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQ---FDPESPETSKEVSALECEIQLLKNLQHE 64
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLS----KERHLDRRKRLIIAMDAAFGM 1161
+V +YG ++D TL E+M GS++ L + E + R I+ GM
Sbjct: 65 RIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILE-----GM 119
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG-GVR---GTLPW 1217
YLHS IVH D+K N+L + + K+GDFG SK + ++G G+R GT W
Sbjct: 120 SYLHSNMIVHRDIKGANILRDSAGNV----KLGDFGASKRLQTICMSGTGIRSVTGTPYW 175
Query: 1218 MAPELLNG 1225
M+PE+++G
Sbjct: 176 MSPEVISG 183
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 8e-15
Identities = 65/204 (31%), Positives = 99/204 (48%), Gaps = 32/204 (15%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLE 1091
+ E + +ELG G+FG VY G +G T VAIK + ++ +S +ER +E
Sbjct: 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA-----ASMRER--IE 55
Query: 1092 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDR---- 1147
F EA ++ + + +VV GVV G TL + E M G L+ L S ++
Sbjct: 56 FLNEASVMKEFNCHHVVRLLGVVSQGQ-PTL-VIMELMTRGDLKSYLRSLRPEMENNPVQ 113
Query: 1148 -----RKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-I 1201
+K + +A + A GM YL++ VH DL N +V + K+GDFG+++ I
Sbjct: 114 APPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV----KIGDFGMTRDI 169
Query: 1202 KRNTLVTGGVRGTLP--WMAPELL 1223
G +G LP WM+PE L
Sbjct: 170 YETDYYRKGGKGLLPVRWMSPESL 193
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 9e-15
Identities = 68/207 (32%), Positives = 97/207 (46%), Gaps = 40/207 (19%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLE 1091
IK ++ +ELG G FG V+ + VA+K +K + R +
Sbjct: 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARK--------D 53
Query: 1092 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRH---------VLLSK- 1141
F REAE+L+ L H ++V FYGV + G L V E+M +G L VL+++
Sbjct: 54 FHREAELLTNLQHEHIVKFYGVCVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEG 111
Query: 1142 --ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV--NLKDPIRPICKVGDFG 1197
L + + L IA A GM YL S++ VH DL N LV NL + K+GDFG
Sbjct: 112 NRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL------LVKIGDFG 165
Query: 1198 LSKIKRNT---LVTGGVRGTLPWMAPE 1221
+S+ +T V G + WM PE
Sbjct: 166 MSRDVYSTDYYRVGGHTMLPIRWMPPE 192
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 1e-14
Identities = 51/167 (30%), Positives = 77/167 (46%), Gaps = 17/167 (10%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
D E L +LG GTFG VY + G VA+K+I +E++ + RE +IL
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILM------HNEKDGFPITALREIKIL 61
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEF-MVNGSLRHVL---LSKER-HLDRRKRLIIA 1154
KL HPNVV + + P + MV + H L L L +
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYM 121
Query: 1155 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201
+ G+ YLH +I+H D+K N+L++ + I K+ DFGL++
Sbjct: 122 LQLLEGINYLHENHILHRDIKAANILIDNQG----ILKIADFGLARP 164
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 1e-14
Identities = 67/192 (34%), Positives = 89/192 (46%), Gaps = 29/192 (15%)
Query: 1050 LGSGTFGTVYHGKWRGTD-----VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
LG G FG+V + + D VA+K +K F+ SS+ E EF REA + + H
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS--SSDIE----EFLREAACMKEFDH 60
Query: 1105 PNVVAFYGV-VQDGPGGTLA---TVTEFMVNGSLRHVLLSKER------HLDRRKRLIIA 1154
PNV+ GV ++ G L + FM +G L H L R L + +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDL-HTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 1155 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVTGGVRG 1213
+D A GMEYL SKN +H DL N ++N +C V DFGLS KI G
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNEN---MTVC-VADFGLSKKIYSGDYYRQGCAS 175
Query: 1214 TLP--WMAPELL 1223
LP W+A E L
Sbjct: 176 KLPVKWLALESL 187
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-14
Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 52/207 (25%)
Query: 1047 LKELGSGTFGTVYHGKWR--GTD----VAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100
++ELG FG +Y G G D VAIK +K ++ Q+ EF +EA +++
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI-----NNPQQ--WGEFQQEASLMA 62
Query: 1101 KLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERH--------------- 1144
+LHHPN+V GVV Q+ P + + E++ G L L+ + H
Sbjct: 63 ELHHPNIVCLLGVVTQEQP---VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKS 119
Query: 1145 -LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS---- 1199
LD L IA+ A GMEYL S VH DL N+L+ + + K+ D GLS
Sbjct: 120 SLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHV----KISDLGLSREIY 175
Query: 1200 -----KIKRNTLVTGGVRGTLPWMAPE 1221
+++ +L+ + WM PE
Sbjct: 176 SADYYRVQPKSLL------PIRWMPPE 196
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-14
Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 31/203 (15%)
Query: 1032 DISTLQIIKNEDLEE----LKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQER 1087
D ++ +D E+ L+E+G G+FG VY + T+ + IKK ++G+ S
Sbjct: 1 DPEIAELFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVA-IKKMSYSGKQSN--- 56
Query: 1088 LTLEFW----REAEILSKLHHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSKE 1142
E W +E L +L HPN + + G +++ T V E+ + GS +L +
Sbjct: 57 ---EKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH---TAWLVMEYCL-GSASDILEVHK 109
Query: 1143 RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 1202
+ L + I A G+ YLHS +H D+K N+L L +P K+ DFG + +
Sbjct: 110 KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNIL--LTEP--GTVKLADFGSASLV 165
Query: 1203 R--NTLVTGGVRGTLPWMAPELL 1223
N+ V GT WMAPE++
Sbjct: 166 SPANSFV-----GTPYWMAPEVI 183
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 61/197 (30%), Positives = 94/197 (47%), Gaps = 14/197 (7%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
++NEDLE + +LG+G G+V K T + KK G S + L RE +I
Sbjct: 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMA--KKVVHIGAKSSVRKQIL---RELQI 56
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
+ + P +V+FYG + + EFM GSL + K + IA+
Sbjct: 57 MHECRSPYIVSFYGAFLNEN--NICMCMEFMDCGSLDRI-YKKGGPIPVEILGKIAVAVV 113
Query: 1159 FGMEYLHSKN-IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPW 1217
G+ YL++ + I+H D+K N+LVN + I K+ DFG+S N++ V GT +
Sbjct: 114 EGLTYLYNVHRIMHRDIKPSNILVNSRGQI----KLCDFGVSGELINSIADTFV-GTSTY 168
Query: 1218 MAPELLNGSSSKVSEKV 1234
M+PE + G V V
Sbjct: 169 MSPERIQGGKYTVKSDV 185
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 60/210 (28%), Positives = 83/210 (39%), Gaps = 46/210 (21%)
Query: 1044 LEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTL------------- 1090
L +++LG G FG V+ + D +K+ +++ L
Sbjct: 7 LNFVEKLGEGQFGEVHLCE---ADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAR 63
Query: 1091 -EFWREAEILSKLHHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSKE------ 1142
+F +E +ILS+L PN+ GV D P L + E+M NG L L
Sbjct: 64 EDFLKEVKILSRLSDPNIARLLGVCTVDPP---LCMIMEYMENGDLNQFLQKHVAETSGL 120
Query: 1143 ----RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198
+ L L +A A GM YL S N VH DL N LV I K+ DFG+
Sbjct: 121 ACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTI----KIADFGM 176
Query: 1199 SKIKRNTLVTGG---VRGTLP----WMAPE 1221
S L + V+G P WMA E
Sbjct: 177 S----RNLYSSDYYRVQGRAPLPIRWMAWE 202
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 4e-14
Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 35/204 (17%)
Query: 1048 KELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLT----LEF--WREAEIL 1099
LG GT+G V G VAIK++K + ++ +L + F RE +I+
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 1100 SKLHHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
+++ H N++ V V+ G + V + M L+ V+ K R + + + I+ +
Sbjct: 75 NEIKHENIMGLVDVYVE---GDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCIL-LQIL 129
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK----------------IK 1202
G+ LH +H DL N+ +N K ICK+ DFGL++ ++
Sbjct: 130 NGLNVLHKWYFMHRDLSPANIFINSKG----ICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 1203 RNTLVTGGVRGTLPWMAPELLNGS 1226
R +T V TL + APELL G+
Sbjct: 186 RREEMTSKVV-TLWYRAPELLMGA 208
|
Length = 335 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 5e-14
Identities = 57/195 (29%), Positives = 97/195 (49%), Gaps = 28/195 (14%)
Query: 1043 DLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100
D +++++G GT+G VY G+ + T VA+K+I+ SE+E + RE +L
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIR------LESEEEGVPSTAIREISLLK 54
Query: 1101 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHV-LLSKERHLDRRKRLIIAMDAAF 1159
+L HPN+V V+ L + EF+ +++ L K +++D
Sbjct: 55 ELQHPNIVCLQDVLMQES--RLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQ 112
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-------KIKRNTLVTGGVR 1212
G+ + HS+ ++H DLK NLL++ K I K+ DFGL+ ++ + +V
Sbjct: 113 GILFCHSRRVLHRDLKPQNLLIDNKGVI----KLADFGLARAFGIPVRVYTHEVV----- 163
Query: 1213 GTLPWMAPELLNGSS 1227
TL + APE+L GS
Sbjct: 164 -TLWYRAPEVLLGSP 177
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 5e-14
Identities = 58/192 (30%), Positives = 92/192 (47%), Gaps = 17/192 (8%)
Query: 1036 LQIIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFW 1093
L+I+K + +++K LGSG FGTVY G W G V I K R + + E
Sbjct: 1 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL---REATSPKANKEIL 57
Query: 1094 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 1153
EA +++ + +P+V G+ T+ +T+ M G L + + ++ + L
Sbjct: 58 DEAYVMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 114
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI----KRNTLVTG 1209
+ A GM YL + +VH DL N+LV K P K+ DFGL+K+ ++ G
Sbjct: 115 CVQIAKGMNYLEERRLVHRDLAARNVLV--KTPQH--VKITDFGLAKLLGADEKEYHAEG 170
Query: 1210 GVRGTLPWMAPE 1221
G + + WMA E
Sbjct: 171 G-KVPIKWMALE 181
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 7e-14
Identities = 58/193 (30%), Positives = 97/193 (50%), Gaps = 28/193 (14%)
Query: 1043 DLEELKELGSGTFGTVYHGKWRGTD---VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
D + LK+LG G++G+VY K R +D A+K + G S++ER + E IL
Sbjct: 1 DFKVLKKLGKGSYGSVYKVK-RLSDNQFYALKEVD----LGSMSQKERE--DAVNEIRIL 53
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI------- 1152
+ ++HPN++++ DG L V E+ G L + ++++LI
Sbjct: 54 ASVNHPNIISYKEAFLDG--NKLCIVMEYAPFGDLSKAI----SKRKKKRKLIPEQEIWR 107
Query: 1153 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR 1212
I + G++ LH + I+H DLK N+L+ D + K+GD G+SK+ + +
Sbjct: 108 IFIQLLRGLQALHEQKILHRDLKSANILLVAND----LVKIGDLGISKVLKKNM-AKTQI 162
Query: 1213 GTLPWMAPELLNG 1225
GT +MAPE+ G
Sbjct: 163 GTPHYMAPEVWKG 175
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-14
Identities = 58/182 (31%), Positives = 94/182 (51%), Gaps = 15/182 (8%)
Query: 1047 LKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
++ +G G++G V + R G IK++ +S +ER E +EA++LS+L H
Sbjct: 5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLR----NASRRERKAAE--QEAQLLSQLKH 58
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLL-SKERHLDRRKRLIIAMDAAFGMEY 1163
PN+VA Y +G G L V F G L H L K + L + + + A ++Y
Sbjct: 59 PNIVA-YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQY 117
Query: 1164 LHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL-VTGGVRGTLPWMAPEL 1222
LH K+I+H DLK N+ + + I KVGD G++++ N + + GT +M+PEL
Sbjct: 118 LHEKHILHRDLKTQNVFLTRTN----IIKVGDLGIARVLENQCDMASTLIGTPYYMSPEL 173
Query: 1223 LN 1224
+
Sbjct: 174 FS 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 8e-14
Identities = 64/192 (33%), Positives = 88/192 (45%), Gaps = 25/192 (13%)
Query: 1045 EELKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
E + ELG G FG VY + + T V A K I SE+E ++ E +IL+
Sbjct: 8 EIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK------SEEE--LEDYMVEIDILASC 59
Query: 1103 HHPNVV----AFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
HPN+V AFY L + EF G++ V+L ER L + ++
Sbjct: 60 DHPNIVKLLDAFY------YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTL 113
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVTGGVRGTLPW 1217
+ YLH I+H DLK N+L L I K+ DFG+S K R GT W
Sbjct: 114 EALNYLHENKIIHRDLKAGNILFTLDGDI----KLADFGVSAKNTRTIQRRDSFIGTPYW 169
Query: 1218 MAPELLNGSSSK 1229
MAPE++ +SK
Sbjct: 170 MAPEVVMCETSK 181
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (182), Expect = 9e-14
Identities = 58/198 (29%), Positives = 87/198 (43%), Gaps = 37/198 (18%)
Query: 1047 LKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
LK +GSG +G V K G VAIK+I + RE ++L L H
Sbjct: 5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKI------SNVFDDLIDAKRILREIKLLRHLRH 58
Query: 1105 PNVVAFYGVVQDGPG---GTLATVTEFMVNGSLRHVLLSKERHL--DRRKRLIIAMDAAF 1159
N++ +++ + VTE M + H ++ + L D + + +
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTELM--ETDLHKVIKSPQPLTDDHIQYFLYQI--LR 114
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLSKI-----KRNTLVTGGV- 1211
G++YLHS N++H DLK N+LVN + C K+ DFGL++ +T V
Sbjct: 115 GLKYLHSANVIHRDLKPSNILVN-SN-----CDLKICDFGLARGVDPDEDEKGFLTEYVV 168
Query: 1212 -RGTLPWM-APELLNGSS 1227
R W APELL SS
Sbjct: 169 TR----WYRAPELLLSSS 182
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 9e-14
Identities = 62/188 (32%), Positives = 95/188 (50%), Gaps = 17/188 (9%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTD---VAIKRIKKSCFTGRSSEQERLTLEFWRE 1095
+K ED ++ LG+G+FG V ++ D VAIKR +KS + +Q+++ F E
Sbjct: 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKS----KIIKQKQVDHVF-SE 81
Query: 1096 AEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM 1155
+IL+ ++HP V YG +D L V EF++ G L + + A
Sbjct: 82 RKILNYINHPFCVNLYGSFKDE--SYLYLVLEFVIGGEF-FTFLRRNKRFPNDVGCFYAA 138
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTL 1215
EYL S NIV+ DLK +NLL++ KD K+ DFG +K+ T + GT
Sbjct: 139 QIVLIFEYLQSLNIVYRDLKPENLLLD-KD---GFIKMTDFGFAKVVDTRTYT--LCGTP 192
Query: 1216 PWMAPELL 1223
++APE+L
Sbjct: 193 EYIAPEIL 200
|
Length = 340 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-13
Identities = 58/192 (30%), Positives = 91/192 (47%), Gaps = 25/192 (13%)
Query: 1047 LKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
+ ++G GT+G VY + + T VA+K+++ +E+E + RE +IL +L+H
Sbjct: 12 IGQIGEGTYGQVYKARDKDTGELVALKKVR------LDNEKEGFPITAIREIKILRQLNH 65
Query: 1105 PNVVAFYGVVQDGPG--------GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
N+V +V D G V E+M + L +L S H
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLLESGLVHFSEDHIKSFMKQ 124
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI---KRNTLVTGGVRG 1213
G+ Y H KN +H D+KC N+L+N K I K+ DFGL+++ + + T V
Sbjct: 125 LLEGLNYCHKKNFLHRDIKCSNILLNNKGQI----KLADFGLARLYNSEESRPYTNKVI- 179
Query: 1214 TLPWMAPELLNG 1225
TL + PELL G
Sbjct: 180 TLWYRPPELLLG 191
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 59/196 (30%), Positives = 91/196 (46%), Gaps = 21/196 (10%)
Query: 1043 DLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQER--LTLEFWREAEILS 1100
D E L+ +G G+FGTV + R +D I K+ + G +E+E+ L E IL
Sbjct: 1 DYEVLETIGKGSFGTVRKVR-RKSDGKILVWKEIDY-GNMTEKEKQQLVSEV----NILR 54
Query: 1101 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL--LSKER-HLDRRKRLIIAMDA 1157
+L HPN+V +Y + D TL V E+ G L ++ KER +++ I
Sbjct: 55 ELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQL 114
Query: 1158 AFGMEYLH-----SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI-KRNTLVTGGV 1211
+ H ++H DLK N+ ++ K+GDFGL+KI ++
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLDAN----NNVKLGDFGLAKILGHDSSFAKTY 170
Query: 1212 RGTLPWMAPELLNGSS 1227
GT +M+PE LN S
Sbjct: 171 VGTPYYMSPEQLNHMS 186
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 2e-13
Identities = 59/181 (32%), Positives = 93/181 (51%), Gaps = 19/181 (10%)
Query: 1046 ELKELGSGTFGTVYHGK-WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
+L+E+G G+FG VY + R ++V IKK ++G+ S ++ + +E L KL H
Sbjct: 19 DLREIGHGSFGAVYFARDVRNSEVVA--IKKMSYSGKQSNEK--WQDIIKEVRFLQKLRH 74
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYL 1164
PN + + G L V E+ + GS +L ++ L + + A G+ YL
Sbjct: 75 PNTIQYRGCYLREHTAWL--VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 131
Query: 1165 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KRNTLVTGGVRGTLPWMAPEL 1222
HS N++H D+K N+L L +P + K+GDFG + I N V GT WMAPE+
Sbjct: 132 HSHNMIHRDVKAGNIL--LSEP--GLVKLGDFGSASIMAPANXFV-----GTPYWMAPEV 182
Query: 1223 L 1223
+
Sbjct: 183 I 183
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-13
Identities = 62/190 (32%), Positives = 93/190 (48%), Gaps = 24/190 (12%)
Query: 1040 KNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLE----FW 1093
K D E + LG+G+FG V K +GT AIK +KK +E L ++
Sbjct: 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKK---------REILKMKQVQHVA 66
Query: 1094 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 1153
+E IL +L HP +V QD + + EF+V G L L R + +
Sbjct: 67 QEKSILMELSHPFIVNMMCSFQDE--NRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYH 124
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRG 1213
A + EYLHSK+I++ DLK +NLL++ K + KV DFG + K+ T + G
Sbjct: 125 A-ELVLAFEYLHSKDIIYRDLKPENLLLDNKGHV----KVTDFGFA--KKVPDRTFTLCG 177
Query: 1214 TLPWMAPELL 1223
T ++APE++
Sbjct: 178 TPEYLAPEVI 187
|
Length = 329 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 55/194 (28%), Positives = 94/194 (48%), Gaps = 37/194 (19%)
Query: 1042 EDLEELKELGSGTFGTV--YHGKWRGTDVAIKR--IKKSCFTGRSSEQERLTLEFWREAE 1097
L+ ++G G+ G V K G VA+K+ ++K Q+R L F E
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---------QQRRELLF-NEVV 68
Query: 1098 ILSKLHHPNVVAFYG--VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM 1155
I+ HPN+V Y +V D L V EF+ G+L ++ + ++ + +A+
Sbjct: 69 IMRDYQHPNIVEMYSSYLVGD----ELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAV 124
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG----LSK--IKRNTLVTG 1209
A + +LH++ ++H D+K D++L+ + K+ DFG +SK +R +LV
Sbjct: 125 LKA--LSFLHAQGVIHRDIKSDSILLTSDGRV----KLSDFGFCAQVSKEVPRRKSLV-- 176
Query: 1210 GVRGTLPWMAPELL 1223
GT WMAPE++
Sbjct: 177 ---GTPYWMAPEVI 187
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 58/193 (30%), Positives = 94/193 (48%), Gaps = 31/193 (16%)
Query: 1045 EELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
++++++G GT+G VY + + G VA+K+I+ +E E + RE +L +L
Sbjct: 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIR------LETEDEGVPSTAIREISLLKEL 55
Query: 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLS-KERHLDRR--KRLIIAMDAAF 1159
+HPN+V VV L V EF ++ L+ + S LD K + +
Sbjct: 56 NHPNIVRLLDVVHSE--NKLYLVFEF-LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQ-- 110
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRG------ 1213
G+ Y HS ++H DLK NLL++ + + K+ DFGL++ VR
Sbjct: 111 GIAYCHSHRVLHRDLKPQNLLIDREGAL----KLADFGLARA-----FGVPVRTYTHEVV 161
Query: 1214 TLPWMAPELLNGS 1226
TL + APE+L GS
Sbjct: 162 TLWYRAPEILLGS 174
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 63/194 (32%), Positives = 95/194 (48%), Gaps = 33/194 (17%)
Query: 1045 EELKELGSGTFGTVYH--GKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
E ++ +G GT+G VY K G+ A+K + S E + E+ IL L
Sbjct: 25 EIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-----SDVDEEIEAEY----NILQSL 75
Query: 1103 -HHPNVVAFYGVVQDGP---GGTLATVTEFMVNGSLRHV---LLSKERHLDRRKRLIIAM 1155
+HPNVV FYG+ GG L V E GS+ + LL + LD I
Sbjct: 76 PNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILY 135
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS------KIKRNTLVTG 1209
A G+++LH+ I+H D+K +N+L+ + + K+ DFG+S +++RNT V
Sbjct: 136 GALLGLQHLHNNRIIHRDVKGNNILLTTEGGV----KLVDFGVSAQLTSTRLRRNTSV-- 189
Query: 1210 GVRGTLPWMAPELL 1223
GT WMAPE++
Sbjct: 190 ---GTPFWMAPEVI 200
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 55/185 (29%), Positives = 80/185 (43%), Gaps = 22/185 (11%)
Query: 1048 KELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH 1103
ELGSG FGTV G ++ VA+K +K + L E REA ++ +L
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKND------NNDPALKDELLREANVMQQLD 54
Query: 1104 HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEY 1163
+P +V G+ + + V E G L + L K +H+ + + + GM+Y
Sbjct: 55 NPYIVRMIGICE---AESWMLVMELAELGPL-NKFLQKNKHVTEKNITELVHQVSMGMKY 110
Query: 1164 LHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR--NTLVTGGVRGTLP--WMA 1219
L N VH DL N+L+ + K+ DFGLSK G P W A
Sbjct: 111 LEETNFVHRDLAARNVLLVTQH----YAKISDFGLSKALGADENYYKAKTHGKWPVKWYA 166
Query: 1220 PELLN 1224
PE +N
Sbjct: 167 PECMN 171
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-13
Identities = 58/196 (29%), Positives = 89/196 (45%), Gaps = 39/196 (19%)
Query: 1046 ELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH 1103
+L++LG GT+ TVY G+ R T VA+K I G S RE ++ +L
Sbjct: 4 QLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTA-------IREISLMKELK 56
Query: 1104 HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF---- 1159
H N+V + V+ L V E+M +++ + H R A+D
Sbjct: 57 HENIVRLHDVIH--TENKLMLVFEYMDKDLKKYM----DTHGVRG-----ALDPNTVKSF 105
Query: 1160 ------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK---IKRNTLVTGG 1210
G+ + H ++H DLK NLL+N + + K+ DFGL++ I NT
Sbjct: 106 TYQLLKGIAFCHENRVLHRDLKPQNLLINKRGEL----KLADFGLARAFGIPVNTFSNEV 161
Query: 1211 VRGTLPWMAPELLNGS 1226
V TL + AP++L GS
Sbjct: 162 V--TLWYRAPDVLLGS 175
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 3e-13
Identities = 60/194 (30%), Positives = 87/194 (44%), Gaps = 23/194 (11%)
Query: 1037 QIIKNEDLEELKELGSGTFGTVYHGKW--RGTD----VAIKRIKKSCFTGRSSEQERLTL 1090
+I+K +L +LK LGSG FGTV+ G W G VAIK I+ +GR + Q
Sbjct: 2 RILKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQ----- 54
Query: 1091 EFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKR 1150
E + L H +V G+ PG +L VT+ GSL + LD ++
Sbjct: 55 EITDHMLAMGSLDHAYIVRLLGIC---PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRL 111
Query: 1151 LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI---KRNTLV 1207
L + A GM YL +VH +L N+L LK I ++ DFG++ +
Sbjct: 112 LNWCVQIAKGMYYLEEHRMVHRNLAARNIL--LKSDS--IVQIADFGVADLLYPDDKKYF 167
Query: 1208 TGGVRGTLPWMAPE 1221
+ + WMA E
Sbjct: 168 YSEHKTPIKWMALE 181
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 55/181 (30%), Positives = 81/181 (44%), Gaps = 16/181 (8%)
Query: 1047 LKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
LK + G FG+VY K R T AIK +KKS ++ + + E A ++ +
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKN-QVTNVKAE---RAIMMIQGES 56
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYL 1164
P V Y Q L V E++ NG L+ L + G+E L
Sbjct: 57 PYVAKLYYSFQSK--DYLYLVMEYL-NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDL 113
Query: 1165 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLN 1224
H + I+H D+K +NLL++ + K+ DFGLS RN L GT ++APE +
Sbjct: 114 HQRGIIHRDIKPENLLIDQTGHL----KLTDFGLS---RNGLENKKFVGTPDYLAPETIL 166
Query: 1225 G 1225
G
Sbjct: 167 G 167
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 6e-13
Identities = 65/213 (30%), Positives = 92/213 (43%), Gaps = 43/213 (20%)
Query: 1028 LGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQER 1087
LG + + + E L E G+ F + VA+K + R+ +
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDG------QPVLVAVKML-------RADVTKT 59
Query: 1088 LTLEFWREAEILSKLHHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSKERH-- 1144
+F +E +I+S+L +PN++ GV V D P L +TE+M NG L L +E
Sbjct: 60 ARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDP---LCMITEYMENGDLNQFLSQREIEST 116
Query: 1145 ---------LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195
+ L +A+ A GM+YL S N VH DL N LV I K+ D
Sbjct: 117 FTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTI----KIAD 172
Query: 1196 FGLSKIKRNTLVTGGV-----RGTLP--WMAPE 1221
FG+S RN L +G R LP WMA E
Sbjct: 173 FGMS---RN-LYSGDYYRIQGRAVLPIRWMAWE 201
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 6e-13
Identities = 47/155 (30%), Positives = 74/155 (47%), Gaps = 18/155 (11%)
Query: 1047 LKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQ-ERLTLEFWREAEILSKL- 1102
L ++G GTF V + R G AIK +KK +S EQ L RE + L +L
Sbjct: 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF---KSLEQVNNL-----REIQALRRLS 55
Query: 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGME 1162
HPN++ V+ D G LA V E M + +L ++ ++R L ++ ++
Sbjct: 56 PHPNILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLD 114
Query: 1163 YLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197
++H I H D+K +N+L+ I K+ DFG
Sbjct: 115 HMHRNGIFHRDIKPENILIKDD-----ILKLADFG 144
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 9e-13
Identities = 49/197 (24%), Positives = 79/197 (40%), Gaps = 30/197 (15%)
Query: 1050 LGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQE------------RLTLEFWREAE 1097
LG GTF +Y G R +S QE R +L F+ A
Sbjct: 3 LGQGTFTNIYKGVLR---------VQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETAS 53
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 1157
++S+L H ++V YGV + V E++ G L L ++ ++ +L +A
Sbjct: 54 LMSQLSHKHLVKLYGVCV-RDENIM--VEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQL 110
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIR---PICKVGDFGLSKIKRNTLVTGGVRGT 1214
A + YL K +VH ++ N+LV P K+ D G I L
Sbjct: 111 ASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG---IPITVLSREERVER 167
Query: 1215 LPWMAPELLNGSSSKVS 1231
+PW+APE + + ++
Sbjct: 168 IPWIAPECIRNGQASLT 184
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 38/209 (18%)
Query: 1028 LGNFDISTLQIIKNEDLEELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQ 1085
LGNF I K++G G F VY G VA+K+++ + Q
Sbjct: 1 LGNFKI-------------EKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQ 47
Query: 1086 ERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHL 1145
+ L +E ++L +L HPNV+ + + L V E G L ++ +H
Sbjct: 48 DCL-----KEIDLLKQLDHPNVIKYLASFIEN--NELNIVLELADAGDLSRMI----KHF 96
Query: 1146 DRRKRLI-------IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198
++KRLI + +E++HSK I+H D+K N+ + + K+GD GL
Sbjct: 97 KKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATG----VVKLGDLGL 152
Query: 1199 SKI-KRNTLVTGGVRGTLPWMAPELLNGS 1226
+ T + GT +M+PE ++ +
Sbjct: 153 GRFFSSKTTAAHSLVGTPYYMSPERIHEN 181
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 60/192 (31%), Positives = 92/192 (47%), Gaps = 17/192 (8%)
Query: 1036 LQIIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFW 1093
++I+K +L+++K LGSG FGTVY G W G +V +I + R + + E
Sbjct: 1 MRILKETELKKVKVLGSGAFGTVYKGIWIPDGENV---KIPVAIKVLRENTSPKANKEIL 57
Query: 1094 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGS-LRHVLLSKERHLDRRKRLI 1152
EA +++ + P V G+ T+ VT+ M G L +V +K+R + + L
Sbjct: 58 DEAYVMAGVGSPYVCRLLGICLT---STVQLVTQLMPYGCLLDYVRENKDR-IGSQDLLN 113
Query: 1153 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK---IKRNTLVTG 1209
+ A GM YL +VH DL N+LV K P K+ DFGL++ I
Sbjct: 114 WCVQIAKGMSYLEEVRLVHRDLAARNVLV--KSPNH--VKITDFGLARLLDIDETEYHAD 169
Query: 1210 GVRGTLPWMAPE 1221
G + + WMA E
Sbjct: 170 GGKVPIKWMALE 181
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 56/189 (29%), Positives = 96/189 (50%), Gaps = 17/189 (8%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI- 1098
+DLE ++ELG G +G V + GT +A+KRI+ + S EQ+RL ++ +I
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATV---NSQEQKRLLMDL----DIS 53
Query: 1099 LSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 1157
+ + P V FYG + ++G V + ++ + V K + IA+
Sbjct: 54 MRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKV-YDKGLTIPEDILGKIAVSI 112
Query: 1158 AFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 1216
+EYLHSK +++H D+K N+L+N ++ +C DFG+S +++ G P
Sbjct: 113 VKALEYLHSKLSVIHRDVKPSNVLINRNGQVK-LC---DFGISGYLVDSVAKTIDAGCKP 168
Query: 1217 WMAPELLNG 1225
+MAPE +N
Sbjct: 169 YMAPERINP 177
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 59/213 (27%), Positives = 87/213 (40%), Gaps = 50/213 (23%)
Query: 1043 DLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWRE 1095
++E ++++G G FG V+ + G T VA+K +K+ +S + +F RE
Sbjct: 6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-----ASAD--MQADFQRE 58
Query: 1096 AEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL-------LSKERHLDRR 1148
A ++++ HPN+V GV G + + E+M G L L H
Sbjct: 59 AALMAEFDHPNIVKLLGVCAVGK--PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSS 116
Query: 1149 KR--------------LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194
R L IA A GM YL + VH DL N LV + K+
Sbjct: 117 ARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVV----KIA 172
Query: 1195 DFGLSKIKRNTLVTGGVRGT----LP--WMAPE 1221
DFGLS RN + + +P WM PE
Sbjct: 173 DFGLS---RNIYSADYYKASENDAIPIRWMPPE 202
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 3e-12
Identities = 55/187 (29%), Positives = 93/187 (49%), Gaps = 21/187 (11%)
Query: 1050 LGSGTFGTVYHG-KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVV 1108
LG G +GTVY G +G +A+K+++ ++E+E L+ E ++L L H N+V
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQ--EEVDLLKSLKHVNIV 65
Query: 1109 AFYGVVQDGPGGTLATVTEFMVNGSLRHVLLS----KERHLDRRKRLIIAMDAAFGMEYL 1164
+ G D T++ EF+ GS+ +L E + + I+ G+ YL
Sbjct: 66 QYLGTCLDD--NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD-----GVAYL 118
Query: 1165 HSKNIVHFDLKCDNLLVNLKDPIRPI---C--KVGDFGLSKIKRNTLVTGGVRGTLPWMA 1219
H+ +VH D+K +N+++ I+ I C ++ GL N L + + GT WMA
Sbjct: 119 HNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS--MHGTPYWMA 176
Query: 1220 PELLNGS 1226
PE++N S
Sbjct: 177 PEVINES 183
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 3e-12
Identities = 57/184 (30%), Positives = 82/184 (44%), Gaps = 19/184 (10%)
Query: 1050 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 1107
LG G FG V +++ T AIK +KK R E E L E R E + HP +
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARD-EVESLMCE-KRIFETANSERHPFL 64
Query: 1108 VAFYGVVQDGPGGTLATVTEFMVNGSL-RHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS 1166
V + Q + V E+ G L H+ + + R A G++YLH
Sbjct: 65 VNLFACFQTE--DHVCFVMEYAAGGDLMMHI--HTDVFSEPRAVFYAA-CVVLGLQYLHE 119
Query: 1167 KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK---RNTLVTGGVRGTLPWMAPELL 1223
IV+ DLK DNLL++ + + K+ DFGL K + T GT ++APE+L
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFV----KIADFGLCKEGMGFGDR--TSTFCGTPEFLAPEVL 173
Query: 1224 NGSS 1227
+S
Sbjct: 174 TETS 177
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-12
Identities = 68/217 (31%), Positives = 93/217 (42%), Gaps = 62/217 (28%)
Query: 1048 KELGSGTFGTV-----YHGKWRG--TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100
K LG G FG V + K R T VA+K +K++ SSE L EF +L
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN---ASSSELRDLLSEF----NLLK 58
Query: 1101 KLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVL-LSK----------------- 1141
+++HP+V+ YG QDGP L + E+ GSLR L S+
Sbjct: 59 QVNHPHVIKLYGACSQDGP---LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSY 115
Query: 1142 -----ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196
ER L + A + GM+YL +VH DL N+LV K+ DF
Sbjct: 116 LDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGR----KMKISDF 171
Query: 1197 GLSK--------IKRNTLVTGGVRGTLP--WMAPELL 1223
GLS+ +KR+ +G +P WMA E L
Sbjct: 172 GLSRDVYEEDSYVKRS-------KGRIPVKWMAIESL 201
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-12
Identities = 61/220 (27%), Positives = 94/220 (42%), Gaps = 50/220 (22%)
Query: 1050 LGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 1107
+G G G VY + VA+K+I++ SE L F REA+I + L HP +
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDL-----SENPLLKKRFLREAKIAADLIHPGI 64
Query: 1108 VAFYGVVQDGPGGTLATVTEFMVNG-SLRHVL--------LSKERHLDRRKRLIIAMDAA 1158
V Y + DG T + G +L+ +L LSKE K + A +
Sbjct: 65 VPVYSICSDG---DPVYYTMPYIEGYTLKSLLKSVWQKESLSKELA---EKTSVGAFLSI 118
Query: 1159 F-----GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR---------- 1203
F +EY+HSK ++H DLK DN+L+ L + + D+G + K+
Sbjct: 119 FHKICATIEYVHSKGVLHRDLKPDNILLGLFGEV----VILDWGAAIFKKLEEEDLLDID 174
Query: 1204 ---------NTLVTGGVRGTLPWMAPELLNGSSSKVSEKV 1234
+ + G + GT +MAPE L G + S +
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDI 214
|
Length = 932 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 5e-12
Identities = 58/194 (29%), Positives = 92/194 (47%), Gaps = 33/194 (17%)
Query: 1045 EELKELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
E ++ +G GT+G V+ K G+ A+K + + E E IL L
Sbjct: 21 EIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI---------HDIDEEIEAEYNILKAL 71
Query: 1103 H-HPNVVAFYGVVQDGP---GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM--- 1155
HPNVV FYG+ G L V E GS+ ++ + +R + IIA
Sbjct: 72 SDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILH 131
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS------KIKRNTLVTG 1209
+A G+++LH +H D+K +N+L+ + + K+ DFG+S +++RNT V
Sbjct: 132 EALMGLQHLHVNKTIHRDVKGNNILLTTEGGV----KLVDFGVSAQLTSTRLRRNTSV-- 185
Query: 1210 GVRGTLPWMAPELL 1223
GT WMAPE++
Sbjct: 186 ---GTPFWMAPEVI 196
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 6e-12
Identities = 49/158 (31%), Positives = 77/158 (48%), Gaps = 15/158 (9%)
Query: 1045 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
E+L+++G GT+GTV+ K R T VA+KR++ + E + RE +L +L
Sbjct: 3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLLKEL 56
Query: 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGME 1162
H N+V Y V+ TL V E+ + L+ S +D G+
Sbjct: 57 KHKNIVRLYDVLHSDKKLTL--VFEY-CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLA 113
Query: 1163 YLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200
+ HS N++H DLK NLL+N + K+ DFGL++
Sbjct: 114 FCHSHNVLHRDLKPQNLLINKNGEL----KLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 7e-12
Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 39/197 (19%)
Query: 1045 EELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
+ ++ +GSG +G V G VAIK+I + + L RE +IL
Sbjct: 8 KPIENIGSGAYGVVCSAIDTRSGKKVAIKKI------PHAFDVPTLAKRTLRELKILRHF 61
Query: 1103 HHPNVVAFYGVVQ--DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF- 1159
H N++A +++ + V + M L H++ S + + R F
Sbjct: 62 KHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIR-------YFL 113
Query: 1160 -----GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLSK------IKRNTL 1206
G++Y+HS N++H DLK NLLVN +D C ++GDFG+++ +
Sbjct: 114 YQLLRGLKYIHSANVIHRDLKPSNLLVN-ED-----CELRIGDFGMARGLSSSPTEHKYF 167
Query: 1207 VTGGVRGTLPWMAPELL 1223
+T V T + APELL
Sbjct: 168 MTEYV-ATRWYRAPELL 183
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 9e-12
Identities = 54/200 (27%), Positives = 78/200 (39%), Gaps = 35/200 (17%)
Query: 1043 DLEELKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100
+++K LG G G V+ + +GT A+K + K R+ + LT E EIL+
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLT-----EQEILA 56
Query: 1101 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF- 1159
L HP + Y Q L V ++ G L LL ++ K L A F
Sbjct: 57 TLDHPFLPTLYASFQTET--YLCLVMDYCPGGEL-FRLLQRQPG----KCLSEE-VARFY 108
Query: 1160 ------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRG 1213
+EYLH IV+ DLK +N+L++ I + DF LSK V
Sbjct: 109 AAEVLLALEYLHLLGIVYRDLKPENILLHESGHI----MLSDFDLSK-------QSDVEP 157
Query: 1214 TLPWMAPELLNGSSSKVSEK 1233
+ L GS
Sbjct: 158 PPV--SKALRKGSRRSSVNS 175
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-11
Identities = 56/184 (30%), Positives = 91/184 (49%), Gaps = 19/184 (10%)
Query: 1047 LKELGSGTFGTVY-----HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 1101
LK LG G+FG V+ G G A+K +KK+ R + ++ E +IL++
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM------ERDILAE 54
Query: 1102 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGM 1161
++HP +V + Q G L + +F+ G L LSKE + A +
Sbjct: 55 VNHPFIVKLHYAFQTE--GKLYLILDFLRGGDL-FTRLSKEVMFTEEDVKFYLAELALAL 111
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-RNTLVTGGVRGTLPWMAP 1220
++LHS I++ DLK +N+L++ + I K+ DFGLSK + GT+ +MAP
Sbjct: 112 DHLHSLGIIYRDLKPENILLDEEGHI----KLTDFGLSKESIDHEKKAYSFCGTVEYMAP 167
Query: 1221 ELLN 1224
E++N
Sbjct: 168 EVVN 171
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-11
Identities = 64/200 (32%), Positives = 89/200 (44%), Gaps = 39/200 (19%)
Query: 1050 LGSGTFGTVYHGKWRG----TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HH 1104
+G G FG V + + D AIKR+K+ S + R +F E E+L KL HH
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----SKDDHR---DFAGELEVLCKLGHH 67
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLD----------------RR 1148
PN++ G + G L E+ +G+L L K R L+ +
Sbjct: 68 PNIINLLGACEHR--GYLYLAIEYAPHGNLLD-FLRKSRVLETDPAFAIANSTASTLSSQ 124
Query: 1149 KRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVT 1208
+ L A D A GM+YL K +H DL N+LV + K+ DFGLS+ + +
Sbjct: 125 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN----YVAKIADFGLSRGQE--VYV 178
Query: 1209 GGVRGTLP--WMAPELLNGS 1226
G LP WMA E LN S
Sbjct: 179 KKTMGRLPVRWMAIESLNYS 198
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 59/198 (29%), Positives = 92/198 (46%), Gaps = 34/198 (17%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+ E+++++G GT+G VY + R T+ +A+K+I+ E E + RE +L
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIR------LEQEDEGVPSTAIREISLL 55
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLD------RRKRLII 1153
++ H N+V VV L V E++ L ++H+D + RLI
Sbjct: 56 KEMQHGNIVRLQDVVHSEK--RLYLVFEYLD--------LDLKKHMDSSPDFAKNPRLIK 105
Query: 1154 AM--DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK---IKRNTLVT 1208
G+ Y HS ++H DLK NLL+ D K+ DFGL++ I T
Sbjct: 106 TYLYQILRGIAYCHSHRVLHRDLKPQNLLI---DRRTNALKLADFGLARAFGIPVRTFTH 162
Query: 1209 GGVRGTLPWMAPELLNGS 1226
V TL + APE+L GS
Sbjct: 163 EVV--TLWYRAPEILLGS 178
|
Length = 294 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 61/192 (31%), Positives = 90/192 (46%), Gaps = 33/192 (17%)
Query: 1042 EDLEELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWR----E 1095
+D++ + LG G GTVY +A+K I +T+E + E
Sbjct: 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLD-----------ITVELQKQIMSE 49
Query: 1096 AEILSKLHHPNVVAFYGV--VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 1153
EIL K P ++ FYG V++ ++ TEFM GSL E L R I
Sbjct: 50 LEILYKCDSPYIIGFYGAFFVEN----RISICTEFMDGGSLDVYRKIPEHVLGR-----I 100
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRG 1213
A+ G+ YL S I+H D+K N+LVN + + K+ DFG+S N++ V G
Sbjct: 101 AVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQV----KLCDFGVSTQLVNSIAKTYV-G 155
Query: 1214 TLPWMAPELLNG 1225
T +MAPE ++G
Sbjct: 156 TNAYMAPERISG 167
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 55/196 (28%), Positives = 87/196 (44%), Gaps = 33/196 (16%)
Query: 1045 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQ-ERLTLEFWREAEILSK 1101
E L +G G +G V + + T VAIK+ K+S E ++ L RE ++L +
Sbjct: 4 EVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKES----EDDEDVKKTAL---REVKVLRQ 56
Query: 1102 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR--KRLIIAMDAAF 1159
L H N+V + G L V E+ V +L +L + L + I + A
Sbjct: 57 LRHENIVNLKEAFRRK--GRLYLVFEY-VERTLLELLEASPGGLPPDAVRSYIWQLLQAI 113
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP--- 1216
Y HS NI+H D+K +N+LV+ ++ +C DFG ++ + L
Sbjct: 114 A--YCHSHNIIHRDIKPENILVSESGVLK-LC---DFGFAR-----ALRARPASPLTDYV 162
Query: 1217 ---WM-APELLNGSSS 1228
W APELL G ++
Sbjct: 163 ATRWYRAPELLVGDTN 178
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 56/180 (31%), Positives = 93/180 (51%), Gaps = 17/180 (9%)
Query: 1046 ELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
+L+E+G G+FG VY + T+ + IKK ++G+ S ++ + +E + L ++ HP
Sbjct: 29 DLREIGHGSFGAVYFARDVRTNEVVA-IKKMSYSGKQSNEK--WQDIIKEVKFLQRIKHP 85
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH 1165
N + + G L V E+ + GS +L ++ L + I A G+ YLH
Sbjct: 86 NSIEYKGCYLREHTAWL--VMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH 142
Query: 1166 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR--NTLVTGGVRGTLPWMAPELL 1223
S N++H D+K N+L L +P + K+ DFG + I N+ V GT WMAPE++
Sbjct: 143 SHNMIHRDIKAGNIL--LTEPGQ--VKLADFGSASIASPANSFV-----GTPYWMAPEVI 193
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 51/188 (27%), Positives = 86/188 (45%), Gaps = 26/188 (13%)
Query: 1048 KELGSGTFGTVYHGK-WRGTDVA---IKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH 1103
E+G+G FG V G+ RG A +K ++ S ++ E+L F +E + +L+
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-----ATPDEQLL--FLQEVQPYRELN 53
Query: 1104 HPNVVAFYG-VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHL----DRRKRLIIAMDAA 1158
HPNV+ G ++ P V EF G L++ L S + + +A + A
Sbjct: 54 HPNVLQCLGQCIESIP---YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVA 110
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL--SKIKRNTLVTGGVRGT-L 1215
G+ +LH + +H DL N + + K+GD+GL + + +T L
Sbjct: 111 SGLLWLHQADFIHSDLALRNCQLTADLSV----KIGDYGLALEQYPEDYYITKDCHAVPL 166
Query: 1216 PWMAPELL 1223
W+APEL+
Sbjct: 167 RWLAPELV 174
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 55/181 (30%), Positives = 79/181 (43%), Gaps = 20/181 (11%)
Query: 1050 LGSGTFGTVYHG-----KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
LG+G FG + G R VAI ++ C S +Q R F EA L + H
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC----SDKQRR---GFLAEALTLGQFDH 65
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYL 1164
N+V GV+ G T+ VTE+M NG+L L E L + + + A GM+YL
Sbjct: 66 SNIVRLEGVITRG--NTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL 123
Query: 1165 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP--WMAPEL 1222
VH L +LVN +CK+ F + ++ + + G P W APE
Sbjct: 124 SEMGYVHKGLAAHKVLVNSD----LVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEA 179
Query: 1223 L 1223
+
Sbjct: 180 I 180
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 57/188 (30%), Positives = 93/188 (49%), Gaps = 21/188 (11%)
Query: 1042 EDLEE----LKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
+D EE L E+G G+FG VY T+ + +KK ++G+ + ++ + +E +
Sbjct: 17 DDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVA-VKKMSYSGKQTNEK--WQDIIKEVK 73
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 1157
L +L HPN + + G L V E+ + GS +L ++ L + I A
Sbjct: 74 FLQQLKHPNTIEYKGCYLKEHTAWL--VMEYCL-GSASDLLEVHKKPLQEVEIAAITHGA 130
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR--NTLVTGGVRGTL 1215
G+ YLHS N++H D+K N+L L +P + K+ DFG + N+ V GT
Sbjct: 131 LQGLAYLHSHNMIHRDIKAGNIL--LTEPGQ--VKLADFGSASKSSPANSFV-----GTP 181
Query: 1216 PWMAPELL 1223
WMAPE++
Sbjct: 182 YWMAPEVI 189
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 48/188 (25%), Positives = 93/188 (49%), Gaps = 27/188 (14%)
Query: 1045 EELKELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
E +K++G G+FG +Y K IK I + + E + +E +L+K+
Sbjct: 3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASK------KEVILLAKM 56
Query: 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL-------RHVLLSKERHLDRRKRLIIAM 1155
HPN+V F+ Q+ G L V E+ G L R VL S+++ L ++
Sbjct: 57 KHPNIVTFFASFQE--NGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQI---- 110
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL-VTGGVRGT 1214
+ G++++H + I+H D+K N+ ++ + K+GDFG+++ +++ + GT
Sbjct: 111 --SLGLKHIHDRKILHRDIKSQNIFLSKNG---MVAKLGDFGIARQLNDSMELAYTCVGT 165
Query: 1215 LPWMAPEL 1222
+++PE+
Sbjct: 166 PYYLSPEI 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 54/184 (29%), Positives = 88/184 (47%), Gaps = 16/184 (8%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+DLE +K +G+GTFG V+ + R A+K + EQ E +L
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQH-----VHNEKRVL 55
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
++ HP ++ + D L + E++ G L L + R L A +
Sbjct: 56 KEVSHPFIIRLFWTEHDQ--RFLYMLMEYVPGGELFSYLRNSGR-FSNSTGLFYASEIVC 112
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMA 1219
+EYLHSK IV+ DLK +N+L++ + I K+ DFG +K R+ T + GT ++A
Sbjct: 113 ALEYLHSKEIVYRDLKPENILLDKEGHI----KLTDFGFAKKLRDRTWT--LCGTPEYLA 166
Query: 1220 PELL 1223
PE++
Sbjct: 167 PEVI 170
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 45/205 (21%)
Query: 1040 KNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
K E ++L +LG G++ TVY G+ + T VA+K I R +E REA
Sbjct: 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEI-------RLEHEEGAPFTAIREAS 55
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 1157
+L L H N+V + ++ TL V E++ L + ++D ++M
Sbjct: 56 LLKDLKHANIVTLHDIIHTKK--TLTLVFEYL------DTDLKQ--YMDDCGG-GLSMHN 104
Query: 1158 A--F------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK------- 1202
F G+ Y H + ++H DLK NLL++ + + K+ DFGL++ K
Sbjct: 105 VRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGEL----KLADFGLARAKSVPSKTY 160
Query: 1203 RNTLVTGGVRGTLPWMAPELLNGSS 1227
N +V TL + P++L GS+
Sbjct: 161 SNEVV------TLWYRPPDVLLGST 179
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 5e-11
Identities = 56/192 (29%), Positives = 86/192 (44%), Gaps = 28/192 (14%)
Query: 1045 EELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
E + E+G G +GTVY + G VA+K ++ + ++ L L RE +L +L
Sbjct: 3 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQ------TNEDGLPLSTVREVALLKRL 56
Query: 1103 H---HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA- 1158
HPN+V V T T E V HV +LD+ + +
Sbjct: 57 EAFDHPNIVRLMDVC-----ATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIK 111
Query: 1159 -------FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGV 1211
G+++LH+ IVH DLK +N+LV + K+ DFGL++I + V
Sbjct: 112 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQV----KLADFGLARIYSCQMALTPV 167
Query: 1212 RGTLPWMAPELL 1223
TL + APE+L
Sbjct: 168 VVTLWYRAPEVL 179
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 5e-11
Identities = 55/166 (33%), Positives = 76/166 (45%), Gaps = 23/166 (13%)
Query: 1048 KELGSGTFGTVYHGKWRGTD----VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH 1103
K LG G FG+V G+ D VA+K +K + T SE E +F EA + +
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICT--RSEME----DFLSEAVCMKEFD 58
Query: 1104 HPNVVAFYGVVQDGPGG----TLATVTEFMVNGSLRHVLL-----SKERHLDRRKRLIIA 1154
HPNV+ GV + + FM +G L LL ++L + +
Sbjct: 59 HPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFM 118
Query: 1155 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200
D A GMEYL SK+ +H DL N ++N +C V DFGLSK
Sbjct: 119 TDIASGMEYLSSKSFIHRDLAARNCMLNEN---MNVC-VADFGLSK 160
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 5e-11
Identities = 60/198 (30%), Positives = 91/198 (45%), Gaps = 32/198 (16%)
Query: 1045 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
E+L ++G GTFG V+ + + T VA+K++ +E+E + RE +IL L
Sbjct: 15 EKLAKIGQGTFGEVFKARHKKTKQIVALKKVL------MENEKEGFPITALREIKILQLL 68
Query: 1103 HHPNVVAFYGVV------QDGPGGTLATVTEFMVNGSLRHVLLSKER---HLDRRKRLII 1153
H NVV + + G+ V EF + LLS + L K+++
Sbjct: 69 KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAG--LLSNKNVKFTLSEIKKVMK 126
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL------SKIKRNTLV 1207
+ G+ Y+H I+H D+K N+L+ KD I K+ DFGL SK +
Sbjct: 127 MLLN--GLYYIHRNKILHRDMKAANILIT-KD---GILKLADFGLARAFSLSKNSKPNRY 180
Query: 1208 TGGVRGTLPWMAPELLNG 1225
T V TL + PELL G
Sbjct: 181 TNRVV-TLWYRPPELLLG 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 5e-11
Identities = 61/175 (34%), Positives = 80/175 (45%), Gaps = 42/175 (24%)
Query: 1091 EFWREAEILSKLHHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRK 1149
+F +E +ILS+L PN++ GV V + P L +TE+M NG L L S HLD ++
Sbjct: 65 DFLKEVKILSRLKDPNIIRLLGVCVDEDP---LCMITEYMENGDLNQFLSS--HHLDDKE 119
Query: 1150 R--------------------LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP 1189
L +A+ A GM+YL S N VH DL N LV I
Sbjct: 120 ENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTI-- 177
Query: 1190 ICKVGDFGLSKIKRNTLVTGGV-----RGTLP--WMAPE-LLNGSSSKVSEKVCF 1236
K+ DFG+S RN L G R LP WMA E +L G + S+ F
Sbjct: 178 --KIADFGMS---RN-LYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAF 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 6e-11
Identities = 62/205 (30%), Positives = 86/205 (41%), Gaps = 43/205 (20%)
Query: 1048 KELGSGTFGTVYHGKWRGTD---------VAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
K LG G FG V + G D VA+K +K S E+ + E E+
Sbjct: 24 KPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLK-------SDATEKDLSDLISEMEM 76
Query: 1099 LSKL-HHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSK--------------- 1141
+ + H N++ G QDGP L + E+ G+LR L ++
Sbjct: 77 MKMIGKHKNIINLLGACTQDGP---LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVP 133
Query: 1142 ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK- 1200
E L + + A A GMEYL SK +H DL N+LV + + K+ DFGL++
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN----VMKIADFGLARD 189
Query: 1201 IKRNTLVTGGVRGTLP--WMAPELL 1223
I G LP WMAPE L
Sbjct: 190 IHHIDYYKKTTNGRLPVKWMAPEAL 214
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 7e-11
Identities = 51/171 (29%), Positives = 83/171 (48%), Gaps = 30/171 (17%)
Query: 1046 ELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH 1103
+L+ LG G+ G V+ D VA+K+I T S + L RE +I+ +L
Sbjct: 9 DLRPLGCGSNGLVFSAVDSDCDKRVAVKKI---VLTDPQSVKHAL-----REIKIIRRLD 60
Query: 1104 HPNVVAFYGVVQDGPGGT-----LATVTEF--------MVNGSLRHVLLSKERHLDRRKR 1150
H N+V Y V+ GP G+ + ++TE + L +L + + R
Sbjct: 61 HDNIVKVYEVL--GPSGSDLTEDVGSLTELNSVYIVQEYMETDLA-NVLEQGPLSEEHAR 117
Query: 1151 LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201
L G++Y+HS N++H DLK N+ +N +D + K+GDFGL++I
Sbjct: 118 LF-MYQLLRGLKYIHSANVLHRDLKPANVFINTED---LVLKIGDFGLARI 164
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 7e-11
Identities = 55/181 (30%), Positives = 84/181 (46%), Gaps = 20/181 (11%)
Query: 1050 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 1107
LG G FG V + R T A K+++K R E L E +IL K++ V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN-----EKQILEKVNSRFV 62
Query: 1108 V--AFYGVVQDGPGGTLATVTEFMVNGSLR-HVLLSKERHLDRRKRLIIAMDAAFGMEYL 1164
V A+ +D L V M G L+ H+ D + + A + G+E L
Sbjct: 63 VSLAYAYETKDA----LCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDL 118
Query: 1165 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVTGGVRGTLPWMAPELL 1223
H + IV+ DLK +N+L++ IR + D GL+ +I + G V GT+ +MAPE++
Sbjct: 119 HRERIVYRDLKPENILLDDYGHIR----ISDLGLAVEIPEGETIRGRV-GTVGYMAPEVV 173
Query: 1224 N 1224
Sbjct: 174 K 174
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 8e-11
Identities = 58/184 (31%), Positives = 93/184 (50%), Gaps = 26/184 (14%)
Query: 1046 ELKELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH 1103
+L+ +G G FG V + G +VAIK+I K T +++ +RE ++L L
Sbjct: 14 DLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRT------YRELKLLKHLR 67
Query: 1104 HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEY 1163
H N+++ + P + VTE + G+ H LL R L+++ G++Y
Sbjct: 68 HENIISLSDIFIS-PLEDIYFVTELL--GTDLHRLL-TSRPLEKQFIQYFLYQILRGLKY 123
Query: 1164 LHSKNIVHFDLKCDNLLVN----LKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMA 1219
+HS +VH DLK N+L+N LK IC DFGL++I+ + TG V T + A
Sbjct: 124 VHSAGVVHRDLKPSNILINENCDLK-----IC---DFGLARIQDPQM-TGYV-STRYYRA 173
Query: 1220 PELL 1223
PE++
Sbjct: 174 PEIM 177
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 9e-11
Identities = 59/190 (31%), Positives = 92/190 (48%), Gaps = 28/190 (14%)
Query: 1046 ELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH 1103
+L+ +G G+FG VY G T VAIK I E E + +E +LS+
Sbjct: 8 KLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLE-------EAEDEIEDIQQEITVLSQCD 60
Query: 1104 HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEY 1163
P + +YG G L + E++ GS +L K L+ I + G++Y
Sbjct: 61 SPYITRYYGSYLKG--TKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDY 116
Query: 1164 LHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL------SKIKRNTLVTGGVRGTLPW 1217
LHS+ +H D+K N+L++ + + K+ DFG+ ++IKRNT V GT W
Sbjct: 117 LHSERKIHRDIKAANVLLSEQGDV----KLADFGVAGQLTDTQIKRNTFV-----GTPFW 167
Query: 1218 MAPELLNGSS 1227
MAPE++ S+
Sbjct: 168 MAPEVIKQSA 177
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 9e-11
Identities = 58/197 (29%), Positives = 91/197 (46%), Gaps = 29/197 (14%)
Query: 1040 KNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
K E +L +LG GT+ TV+ G+ + T+ VA+K I R +E RE
Sbjct: 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEI-------RLEHEEGAPCTAIREVS 55
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 1157
+L L H N+V + ++ TL V E++ + L+ L + + I
Sbjct: 56 LLKNLKHANIVTLHDIIHTERCLTL--VFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQL 112
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-------RNTLVTGG 1210
G+ Y H + I+H DLK NLL+N K + K+ DFGL++ K N +V
Sbjct: 113 LRGLSYCHKRKILHRDLKPQNLLINEKGEL----KLADFGLARAKSVPTKTYSNEVV--- 165
Query: 1211 VRGTLPWMAPELLNGSS 1227
TL + P++L GS+
Sbjct: 166 ---TLWYRPPDVLLGST 179
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-10
Identities = 55/189 (29%), Positives = 90/189 (47%), Gaps = 35/189 (18%)
Query: 1046 ELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH 1103
+++G G GTVY G +VAIK++ +Q + L E ++ +
Sbjct: 23 RFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ-------QQPKKEL-IINEILVMRENK 74
Query: 1104 HPNVVAF---YGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFG 1160
HPN+V + Y V G L V E++ GSL V+ E +D + + +
Sbjct: 75 HPNIVNYLDSYLV-----GDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQA 127
Query: 1161 MEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL------SKIKRNTLVTGGVRGT 1214
+E+LHS ++H D+K DN+L+ + + K+ DFG + KR+T+V GT
Sbjct: 128 LEFLHSNQVIHRDIKSDNILLGMDGSV----KLTDFGFCAQITPEQSKRSTMV-----GT 178
Query: 1215 LPWMAPELL 1223
WMAPE++
Sbjct: 179 PYWMAPEVV 187
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 55/191 (28%), Positives = 89/191 (46%), Gaps = 17/191 (8%)
Query: 1040 KNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
K E +L +LG GT+ TVY G+ + TD VA+K I R +E RE
Sbjct: 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEI-------RLEHEEGAPCTAIREVS 56
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 1157
+L L H N+V + ++ +L V E++ + L+ L ++ +
Sbjct: 57 LLKDLKHANIVTLHDIIHTEK--SLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQL 113
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR-NTLVTGGVRGTLP 1216
G+ Y H + ++H DLK NLL+N + + K+ DFGL++ K T TL
Sbjct: 114 LRGLNYCHRRKVLHRDLKPQNLLINERGEL----KLADFGLARAKSIPTKTYSNEVVTLW 169
Query: 1217 WMAPELLNGSS 1227
+ P++L GS+
Sbjct: 170 YRPPDILLGST 180
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 68/212 (32%), Positives = 94/212 (44%), Gaps = 46/212 (21%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG----TDVAIKRIKKSCFTGRSSEQERLTLEFWR 1094
IK ED+ +G G FG V + + AIK +K+ +SE + +F
Sbjct: 4 IKFEDV-----IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-----ASENDHR--DFAG 51
Query: 1095 EAEILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL-----------LSKE 1142
E E+L KL HHPN++ G ++ G L E+ G+L L +KE
Sbjct: 52 ELEVLCKLGHHPNIINLLGACENR--GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKE 109
Query: 1143 R----HLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV--NLKDPIRPICKVGDF 1196
L ++ L A D A GM+YL K +H DL N+LV NL K+ DF
Sbjct: 110 HGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL------ASKIADF 163
Query: 1197 GLSKIKRNTLVTGGVRGTLP--WMAPELLNGS 1226
GLS+ + + G LP WMA E LN S
Sbjct: 164 GLSRGEE--VYVKKTMGRLPVRWMAIESLNYS 193
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 54/184 (29%), Positives = 81/184 (44%), Gaps = 24/184 (13%)
Query: 1050 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 1107
LG G FG V + + T A K++ K R EQ L E +IL K+ +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALN-----EKKILEKVSSRFI 55
Query: 1108 V----AFYGVVQDGPGGTLATVTEFMVNGSLR-HVLLSKERHLDRRKRLIIAMDAAFGME 1162
V AF L V M G L+ H+ E + + A G+E
Sbjct: 56 VSLAYAFETKDD------LCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLE 109
Query: 1163 YLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVTGGVRGTLPWMAPE 1221
+LH + IV+ DLK +N+L++ +R + D GL+ ++K + G GT +MAPE
Sbjct: 110 HLHQRRIVYRDLKPENVLLDDHGNVR----ISDLGLAVELKGGKKIKGRA-GTPGYMAPE 164
Query: 1222 LLNG 1225
+L G
Sbjct: 165 VLQG 168
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-10
Identities = 58/205 (28%), Positives = 87/205 (42%), Gaps = 43/205 (20%)
Query: 1048 KELGSGTFGTVYHGKWRGTD---------VAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
K LG G FG V + G D VA+K +K + ++ + E E+
Sbjct: 18 KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLK-------DNATDKDLADLISEMEL 70
Query: 1099 LSKL-HHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSK--------------- 1141
+ + H N++ GV Q+GP L + E+ G+LR L ++
Sbjct: 71 MKLIGKHKNIINLLGVCTQEGP---LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVP 127
Query: 1142 ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK- 1200
E L + + A A GMEYL S+ +H DL N+LV + + K+ DFGL++
Sbjct: 128 EEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDN----VMKIADFGLARG 183
Query: 1201 IKRNTLVTGGVRGTLP--WMAPELL 1223
+ G LP WMAPE L
Sbjct: 184 VHDIDYYKKTSNGRLPVKWMAPEAL 208
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 59/200 (29%), Positives = 90/200 (45%), Gaps = 30/200 (15%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
ED E +K + +G +G VY + + T A+K+I K R+ Q+ E +IL
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFV-----ERDIL 55
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
+ +P VV+ + + L V E++ G +L + R+ A +
Sbjct: 56 TFAENPFVVSMFCSFETKR--HLCMVMEYVEGGDCATLLKNIGALPVDMARMYFA-ETVL 112
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI---KRNTLVTGG------ 1210
+EYLH+ IVH DLK DNLL+ I K+ DFGLSKI T + G
Sbjct: 113 ALEYLHNYGIVHRDLKPDNLLITSMGHI----KLTDFGLSKIGLMSLTTNLYEGHIEKDT 168
Query: 1211 -------VRGTLPWMAPELL 1223
V GT ++APE++
Sbjct: 169 REFLDKQVCGTPEYIAPEVI 188
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 61/207 (29%), Positives = 89/207 (42%), Gaps = 52/207 (25%)
Query: 1047 LKELGSGTFGTVYHGKWRGTD-------VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
++ELG FG VY G GT VAIK +K + L EF EA +
Sbjct: 10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-------EGPLREEFKHEAMMR 62
Query: 1100 SKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERH-------------- 1144
S+L HPN+V GVV ++ P L+ + + + L L+ + H
Sbjct: 63 SRLQHPNIVCLLGVVTKEQP---LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119
Query: 1145 -LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL----- 1198
L+ + I A GME+L S ++VH DL N+LV K + K+ D GL
Sbjct: 120 TLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNV----KISDLGLFREVY 175
Query: 1199 ----SKIKRNTLVTGGVRGTLPWMAPE 1221
K+ N+L+ + WM+PE
Sbjct: 176 AADYYKLMGNSLL------PIRWMSPE 196
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 64/212 (30%), Positives = 85/212 (40%), Gaps = 47/212 (22%)
Query: 1043 DLEELKE-LGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTL----------- 1090
KE LG G FG V+ + G + K + K S Q L
Sbjct: 5 KRLTFKEKLGEGQFGEVHLCEAEGME---KFMDKDFSLDVSGNQPVLVAVKMLREDANKN 61
Query: 1091 ---EFWREAEILSKLHHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLS---KER 1143
+F +E +I+S+L PN++ V + P L +TE+M NG L L +E
Sbjct: 62 ARNDFLKEIKIMSRLKDPNIIRLLAVCITSDP---LCMITEYMENGDLNQFLSRHEPQEA 118
Query: 1144 HLDRRKRLI-------IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196
I +A A GM+YL S N VH DL N LV I K+ DF
Sbjct: 119 AEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTI----KIADF 174
Query: 1197 GLSKIKRNTLVTGGV-----RGTLP--WMAPE 1221
G+S RN L +G R LP WM+ E
Sbjct: 175 GMS---RN-LYSGDYYRIQGRAVLPIRWMSWE 202
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 56/191 (29%), Positives = 89/191 (46%), Gaps = 17/191 (8%)
Query: 1040 KNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
K E +L++LG GT+ TV+ G+ + T+ VA+K I R +E RE
Sbjct: 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEI-------RLEHEEGAPCTAIREVS 56
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 1157
+L L H N+V + +V TL V E++ + L+ + + I
Sbjct: 57 LLKDLKHANIVTLHDIVHTDKSLTL--VFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQI 113
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR-NTLVTGGVRGTLP 1216
G+ Y H + ++H DLK NLL+N + + K+ DFGL++ K T TL
Sbjct: 114 LRGLAYCHRRKVLHRDLKPQNLLINERGEL----KLADFGLARAKSVPTKTYSNEVVTLW 169
Query: 1217 WMAPELLNGSS 1227
+ P++L GSS
Sbjct: 170 YRPPDVLLGSS 180
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-10
Identities = 54/178 (30%), Positives = 79/178 (44%), Gaps = 16/178 (8%)
Query: 1050 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPN 1106
LG G+FG V + + + A+K +KK + +T E ILS HP
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMT-----EKRILSLARNHPF 57
Query: 1107 VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS 1166
+ Y Q L V EF VNG + K R D + A + + +LH
Sbjct: 58 LTQLYCCFQTPD--RLFFVMEF-VNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHD 114
Query: 1167 KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-RNTLVTGGVRGTLPWMAPELL 1223
K I++ DLK DN+L++ + CK+ DFG+ K N T GT ++APE+L
Sbjct: 115 KGIIYRDLKLDNVLLDHEGH----CKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEIL 168
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 58/194 (29%), Positives = 93/194 (47%), Gaps = 28/194 (14%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
E +L+ +G G+FG V+ G T VAIK I E E + +E +L
Sbjct: 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIID-------LEEAEDEIEDIQQEITVL 56
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
S+ P V +YG G L + E++ GS +L + D + + +
Sbjct: 57 SQCDSPYVTKYYGSYLKG--TKLWIIMEYLGGGSALDLL--RAGPFDEFQIATMLKEILK 112
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL------SKIKRNTLVTGGVRG 1213
G++YLHS+ +H D+K N+L++ + + K+ DFG+ ++IKRNT V G
Sbjct: 113 GLDYLHSEKKIHRDIKAANVLLSEQGDV----KLADFGVAGQLTDTQIKRNTFV-----G 163
Query: 1214 TLPWMAPELLNGSS 1227
T WMAPE++ S+
Sbjct: 164 TPFWMAPEVIQQSA 177
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 3e-10
Identities = 59/197 (29%), Positives = 92/197 (46%), Gaps = 29/197 (14%)
Query: 1040 KNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
K + E+L++LG G++ TVY GK + G VA+K I R E+E REA
Sbjct: 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVI-------RLQEEEGTPFTAIREAS 55
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 1157
+L L H N+V + ++ TL V E+ V+ L + L +
Sbjct: 56 LLKGLKHANIVLLHDIIHTKE--TLTLVFEY-VHTDLCQYMDKHPGGLHPENVKLFLFQL 112
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-------RNTLVTGG 1210
G+ Y+H + I+H DLK NLL++ + K+ DFGL++ K N +V
Sbjct: 113 LRGLSYIHQRYILHRDLKPQNLLISDTGEL----KLADFGLARAKSVPSHTYSNEVV--- 165
Query: 1211 VRGTLPWMAPELLNGSS 1227
TL + P++L GS+
Sbjct: 166 ---TLWYRPPDVLLGST 179
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 3e-10
Identities = 55/174 (31%), Positives = 81/174 (46%), Gaps = 26/174 (14%)
Query: 1065 GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLAT 1124
G +VAIK ++ + E+E F RE + ++L+HPN+VA + P G L
Sbjct: 3 GHEVAIKLLRTD-----APEEEHQRARFRRETALCARLYHPNIVALLDSGEAPP-GLLFA 56
Query: 1125 VTEFMVNGSLRHVL-----LSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNL 1179
V E++ +LR VL L +++ A+ A H++ IVH DLK N+
Sbjct: 57 VFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACA------HNQGIVHRDLKPQNI 110
Query: 1180 LVNLKDPIRPICKVGDFGLS-------KIKRNTLV-TGGVRGTLPWMAPELLNG 1225
+V+ +RP KV DFG+ TL T V GT + APE L G
Sbjct: 111 MVSQTG-VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRG 163
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 3e-10
Identities = 58/204 (28%), Positives = 89/204 (43%), Gaps = 40/204 (19%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTDVAIKR------IKKSCFTGRSSEQERLTLEFWRE 1095
+D E+L ELG+G G V R + + + R IK + + RE
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRN-----------QIIRE 49
Query: 1096 AEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI--- 1152
++L + + P +V FYG G ++ E M GSL VL ++ I
Sbjct: 50 LKVLHECNSPYIVGFYGAFYS--DGEISICMEHMDGGSLDQVL--------KKAGRIPEN 99
Query: 1153 ----IAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLV 1207
I++ G+ YL K I+H D+K N+LVN R K+ DFG+S +++
Sbjct: 100 ILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVN----SRGEIKLCDFGVSGQLIDSMA 155
Query: 1208 TGGVRGTLPWMAPELLNGSSSKVS 1231
V GT +M+PE L G+ V
Sbjct: 156 NSFV-GTRSYMSPERLQGTHYTVQ 178
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-10
Identities = 54/197 (27%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
+K++D E + ELG+G G V + + + + + R K + + + ++ RE ++
Sbjct: 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMAR-KLIHLEIKPAIRNQII----RELQV 56
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
L + + P +V FYG G ++ E M GSL V L + + + +++
Sbjct: 57 LHECNSPYIVGFYGAFYS--DGEISICMEHMDGGSLDQV-LKEAKRIPEEILGKVSIAVL 113
Query: 1159 FGMEYLHSKN-IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPW 1217
G+ YL K+ I+H D+K N+LVN + I K+ DFG+S +++ V GT +
Sbjct: 114 RGLAYLREKHQIMHRDVKPSNILVNSRGEI----KLCDFGVSGQLIDSMANSFV-GTRSY 168
Query: 1218 MAPELLNGSSSKVSEKV 1234
M+PE L G+ V +
Sbjct: 169 MSPERLQGTHYSVQSDI 185
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 55/205 (26%)
Query: 1045 EELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
++++++G GT+G VY + + G VA+K+I+ +E E + RE +L +L
Sbjct: 3 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIR------LDTETEGVPSTAIREISLLKEL 56
Query: 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA---- 1158
+HPN+V V+ L V EF+ H D +K MDA+
Sbjct: 57 NHPNIVKLLDVIHT--ENKLYLVFEFL--------------HQDLKK----FMDASPLSG 96
Query: 1159 --------------FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK---I 1201
G+ + HS ++H DLK NLL+N + I K+ DFGL++ +
Sbjct: 97 IPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAI----KLADFGLARAFGV 152
Query: 1202 KRNTLVTGGVRGTLPWMAPELLNGS 1226
T V TL + APE+L G
Sbjct: 153 PVRTYTHEVV--TLWYRAPEILLGC 175
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 59/200 (29%), Positives = 88/200 (44%), Gaps = 29/200 (14%)
Query: 1042 EDLEELKELGSGTFGTVYHG---KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
+ E + E+G G +G V+ K G VA+KR++ + +E + L RE +
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQ------TGEEGMPLSTIREVAV 54
Query: 1099 LSKLH---HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDR-------R 1148
L L HPNVV + V T E + HV +LD+
Sbjct: 55 LRHLETFEHPNVVRLFDVCT-----VSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT 109
Query: 1149 KRLIIAMDAAF-GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLV 1207
+ + M G+++LHS +VH DLK N+LV I K+ DFGL++I +
Sbjct: 110 ETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQI----KLADFGLARIYSFQMA 165
Query: 1208 TGGVRGTLPWMAPELLNGSS 1227
V TL + APE+L SS
Sbjct: 166 LTSVVVTLWYRAPEVLLQSS 185
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 3e-10
Identities = 54/189 (28%), Positives = 89/189 (47%), Gaps = 29/189 (15%)
Query: 1045 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
+ L +GSG +G V T VAIK++ + S+ + T +RE +L +
Sbjct: 18 QNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ---SAIHAKRT---YRELRLLKHM 71
Query: 1103 HHPNVVAFYGVVQDGPGGTLAT------VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
H NV+ V P +L VT M L +++ ++ D + L+ +
Sbjct: 72 DHENVIGLLDVFT--PASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQI- 127
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLSKIKRNTLVTGGVRGT 1214
G++Y+HS I+H DLK N+ VN +D C K+ DFGL++ + +TG V T
Sbjct: 128 -LRGLKYIHSAGIIHRDLKPSNIAVN-ED-----CELKILDFGLAR-HTDDEMTGYV-AT 178
Query: 1215 LPWMAPELL 1223
+ APE++
Sbjct: 179 RWYRAPEIM 187
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 3e-10
Identities = 55/179 (30%), Positives = 85/179 (47%), Gaps = 15/179 (8%)
Query: 1050 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 1107
+G G+FG V + R T A+K I+K+ RS L E +L++++ P +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLA-----ERTVLAQVNCPFI 55
Query: 1108 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK 1167
V Q L V F+ G L H L + R R R A + +E LH
Sbjct: 56 VPLKFSFQSP--EKLYLVLAFINGGELFHHLQREGRFDLSRARFYTA-ELLCALENLHKF 112
Query: 1168 NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-RNTLVTGGVRGTLPWMAPELLNG 1225
N+++ DLK +N+L++ + I +C DFGL K+ ++ T GT ++APELL G
Sbjct: 113 NVIYRDLKPENILLDYQGHI-ALC---DFGLCKLNMKDDDKTNTFCGTPEYLAPELLLG 167
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 64/202 (31%), Positives = 90/202 (44%), Gaps = 43/202 (21%)
Query: 1050 LGSGTFGTVYHGKWRG----TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HH 1104
+G G FG V + + D AIKR+K+ +S+ + +F E E+L KL HH
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-----ASKDDHR--DFAGELEVLCKLGHH 55
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLD----------------RR 1148
PN++ G + G L E+ +G+L L K R L+ +
Sbjct: 56 PNIINLLGACEHR--GYLYLAIEYAPHGNLLD-FLRKSRVLETDPAFAIANSTASTLSSQ 112
Query: 1149 KRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV--NLKDPIRPICKVGDFGLSKIKRNTL 1206
+ L A D A GM+YL K +H DL N+LV N K+ DFGLS+ + +
Sbjct: 113 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA------KIADFGLSRGQE--V 164
Query: 1207 VTGGVRGTLP--WMAPELLNGS 1226
G LP WMA E LN S
Sbjct: 165 YVKKTMGRLPVRWMAIESLNYS 186
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 3e-10
Identities = 57/196 (29%), Positives = 93/196 (47%), Gaps = 22/196 (11%)
Query: 1042 EDLEELKELGSGTFGTVY---HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
EDL++L E+G G FGTV H GT +A+KRI+ T EQ+RL ++ + +
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKP-SGTIMAVKRIRS---TVDEKEQKRLLMDL--DV-V 56
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL----RHVLLSKERHLDRRKRLIIA 1154
+ P +V FYG + G E M + SL ++V + + IA
Sbjct: 57 MRSSDCPYIVKFYGALFR--EGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIA 113
Query: 1155 MDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRG 1213
+ + YL + I+H D+K N+L++ I K+ DFG+S +++ G
Sbjct: 114 VATVKALNYLKEELKIIHRDVKPSNILLDRNGNI----KLCDFGISGQLVDSIAKTRDAG 169
Query: 1214 TLPWMAPELLNGSSSK 1229
P+MAPE ++ S+
Sbjct: 170 CRPYMAPERIDPSARD 185
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 54/204 (26%), Positives = 91/204 (44%), Gaps = 27/204 (13%)
Query: 1043 DLEELKELGSGTFGTVY-----HGKWRGTDVAIKRIKKSCF-----TGRSSEQERLTLEF 1092
+ E L+ LG+G +G V+ G G A+K +KK+ T + ER LE
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 1093 WREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI 1152
R L LH+ AF + L + +++ G L L +E + R+
Sbjct: 61 VRRCPFLVTLHY----AFQTDTK------LHLILDYVNGGELFTHLYQREHFTESEVRVY 110
Query: 1153 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KRNTLVTGG 1210
IA + +++LH I++ D+K +N+L++ + + + DFGLSK
Sbjct: 111 IA-EIVLALDHLHQLGIIYRDIKLENILLDSEGHV----VLTDFGLSKEFLAEEEERAYS 165
Query: 1211 VRGTLPWMAPELLNGSSSKVSEKV 1234
GT+ +MAPE++ G S + V
Sbjct: 166 FCGTIEYMAPEVIRGGSGGHDKAV 189
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 48/188 (25%), Positives = 93/188 (49%), Gaps = 28/188 (14%)
Query: 1045 EELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
++K++G G+FG K + G IK I S + + E+ R +E +LS +
Sbjct: 3 VKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESR------KEVAVLSNM 56
Query: 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL-------RHVLLSKERHLDRRKRLIIAM 1155
HPN+V + ++ G L V ++ G L R VL +++ LD ++ +A
Sbjct: 57 KHPNIVQYQESFEE--NGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA- 113
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL-VTGGVRGT 1214
++++H + I+H D+K N+ + I K+GDFG++++ +T+ + GT
Sbjct: 114 -----LKHVHDRKILHRDIKSQNIFLTKDGTI----KLGDFGIARVLNSTVELARTCIGT 164
Query: 1215 LPWMAPEL 1222
+++PE+
Sbjct: 165 PYYLSPEI 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 53/187 (28%), Positives = 92/187 (49%), Gaps = 35/187 (18%)
Query: 1048 KELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
+++G G GTV+ G +VAIK+I + ++E + E ++ +L +P
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQ----KQPKKELII----NEILVMKELKNP 76
Query: 1106 NVVAF---YGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGME 1162
N+V F + V G L V E++ GSL V+ E +D + + + +E
Sbjct: 77 NIVNFLDSFLV-----GDELFVVMEYLAGGSLTDVV--TETCMDEAQIAAVCRECLQALE 129
Query: 1163 YLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL------SKIKRNTLVTGGVRGTLP 1216
+LH+ ++H D+K DN+L+ + + K+ DFG + KR+T+V GT
Sbjct: 130 FLHANQVIHRDIKSDNVLLGMDGSV----KLTDFGFCAQITPEQSKRSTMV-----GTPY 180
Query: 1217 WMAPELL 1223
WMAPE++
Sbjct: 181 WMAPEVV 187
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 47/185 (25%), Positives = 86/185 (46%), Gaps = 27/185 (14%)
Query: 1048 KELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
K++G G F VY G VA+K+++ + + + +E ++L +L+HP
Sbjct: 8 KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCI-----KEIDLLKQLNHP 62
Query: 1106 NVVAFYG-VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-------IAMDA 1157
NV+ +Y ++D L V E G L ++ +H ++KRLI +
Sbjct: 63 NVIKYYASFIED---NELNIVLELADAGDLSRMI----KHFKKQKRLIPEKTVWKYFVQL 115
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTGGVRGTLP 1216
+E++HS+ ++H D+K N+ + + K+GD GL + T + GT
Sbjct: 116 CSALEHMHSRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAHSLVGTPY 171
Query: 1217 WMAPE 1221
+M+PE
Sbjct: 172 YMSPE 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 7e-10
Identities = 58/184 (31%), Positives = 86/184 (46%), Gaps = 20/184 (10%)
Query: 1048 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILS-KLHH 1104
K LG G+FG V+ + +GT+ AIK +KK + + E +LS H
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMV-----EKRVLSLAWEH 55
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYL 1164
P + Y Q L V E++ G L + S + D + A + G+++L
Sbjct: 56 PFLTHLYCTFQTKE--NLFFVMEYLNGGDLMFHIQSCHK-FDLPRATFYAAEIICGLQFL 112
Query: 1165 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPE 1221
HSK IV+ DLK DN+L++ I K+ DFG+ K N L T GT ++APE
Sbjct: 113 HSKGIVYRDLKLDNILLDTDGHI----KIADFGMC--KENMLGDAKTCTFCGTPDYIAPE 166
Query: 1222 LLNG 1225
+L G
Sbjct: 167 ILLG 170
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 8e-10
Identities = 60/195 (30%), Positives = 96/195 (49%), Gaps = 30/195 (15%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
E +L+++G G+FG V+ G T VAIK I E E + +E +L
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID-------LEEAEDEIEDIQQEITVL 56
Query: 1100 SKLHHPNVVAFYG-VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
S+ P V +YG ++D L + E++ GS +L + LD + I +
Sbjct: 57 SQCDSPYVTKYYGSYLKDT---KLWIIMEYLGGGSALDLL--EPGPLDETQIATILREIL 111
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL------SKIKRNTLVTGGVR 1212
G++YLHS+ +H D+K N+L++ + K+ DFG+ ++IKRNT V
Sbjct: 112 KGLDYLHSEKKIHRDIKAANVLLSEHGEV----KLADFGVAGQLTDTQIKRNTFV----- 162
Query: 1213 GTLPWMAPELLNGSS 1227
GT WMAPE++ S+
Sbjct: 163 GTPFWMAPEVIKQSA 177
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 1e-09
Identities = 51/184 (27%), Positives = 81/184 (44%), Gaps = 42/184 (22%)
Query: 1031 FDISTLQIIKNEDLEELKELGSGTFGTV---YHGKWRGTDVAIKRIKKSCFTGRSSEQER 1087
FD+ + L +G G +G V H K G VAIK+I S F E +
Sbjct: 1 FDVG-------PRYQNLSYIGEGAYGMVCSATH-KPTGVKVAIKKI--SPF-----EHQT 45
Query: 1088 LTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLAT------VTEFMVNGSLRHVLLSK 1141
RE +IL + H N++ +++ + + V E M L ++ ++
Sbjct: 46 FCQRTLREIKILRRFKHENIIGILDIIR---PPSFESFNDVYIVQELM-ETDLYKLIKTQ 101
Query: 1142 ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVN----LKDPIRPICKVGDFG 1197
D + + + G++Y+HS N++H DLK NLL+N LK IC DFG
Sbjct: 102 HLSNDHIQYFLYQI--LRGLKYIHSANVLHRDLKPSNLLLNTNCDLK-----IC---DFG 151
Query: 1198 LSKI 1201
L++I
Sbjct: 152 LARI 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 56/181 (30%), Positives = 81/181 (44%), Gaps = 19/181 (10%)
Query: 1048 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
K LG GTFG V + + T A+K +KK + LT E+ +L HP
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLT-----ESRVLQNTRHP 55
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH 1165
+ A Q L V E+ NG LS+ER + + + YLH
Sbjct: 56 FLTALKYSFQTH--DRLCFVMEY-ANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLH 112
Query: 1166 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK--IKR-NTLVTGGVRGTLPWMAPEL 1222
S ++V+ DLK +NL+++ I K+ DFGL K I T+ T GT ++APE+
Sbjct: 113 SCDVVYRDLKLENLMLDKDGHI----KITDFGLCKEGISDGATMKT--FCGTPEYLAPEV 166
Query: 1223 L 1223
L
Sbjct: 167 L 167
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 1e-09
Identities = 58/190 (30%), Positives = 88/190 (46%), Gaps = 26/190 (13%)
Query: 1043 DLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100
D + L ++G G +G V+ K + T VA+KR+KKS + + LT E +IL+
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLT-----ERDILT 56
Query: 1101 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR--KRLIIAMDAA 1158
+V QD LA E++ G R LL+ L + + M A
Sbjct: 57 TTKSEWLVKLLYAFQDDEYLYLAM--EYVPGGDFR-TLLNNLGVLSEDHARFYMAEMFEA 113
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK---IKRNTLVTGGVRGTL 1215
++ LH +H DLK +N L++ I K+ DFGLSK N++V G+
Sbjct: 114 --VDALHELGYIHRDLKPENFLIDASGHI----KLTDFGLSKGIVTYANSVV-----GSP 162
Query: 1216 PWMAPELLNG 1225
+MAPE+L G
Sbjct: 163 DYMAPEVLRG 172
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 55/191 (28%), Positives = 89/191 (46%), Gaps = 21/191 (10%)
Query: 1047 LKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
L++LG G++ TVY G R G VA+K I +E + REA +L L H
Sbjct: 10 LEKLGEGSYATVYKGISRINGQLVALKVISMKT-------EEGVPFTAIREASLLKGLKH 62
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYL 1164
N+V + ++ TL V E+M + L ++ L + G+ Y+
Sbjct: 63 ANIVLLHDIIHTKE--TLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYI 119
Query: 1165 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR---NTLVTGGVRGTLPWMAPE 1221
H ++I+H DLK NLL++ + K+ DFGL++ K T + V TL + P+
Sbjct: 120 HGQHILHRDLKPQNLLISYLGEL----KLADFGLARAKSIPSQTYSSEVV--TLWYRPPD 173
Query: 1222 LLNGSSSKVSE 1232
+L G++ S
Sbjct: 174 VLLGATDYSSA 184
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-09
Identities = 60/191 (31%), Positives = 89/191 (46%), Gaps = 29/191 (15%)
Query: 1046 ELKEL-GSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-H 1103
EL EL G+GT+G VY G+ T + IK TG E E +E +L K H
Sbjct: 9 ELVELVGNGTYGQVYKGRHVKTG-QLAAIKVMDVTGDEEE------EIKQEINMLKKYSH 61
Query: 1104 HPNVVAFYGV-VQDGPGGT---LATVTEFMVNGSLRHVLL-SKERHLDRRKRLIIAMDAA 1158
H N+ +YG ++ P G L V EF GS+ ++ +K L I +
Sbjct: 62 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 121
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI------KRNTLVTGGVR 1212
G+ +LH ++H D+K N+L+ + K+ DFG+S +RNT +
Sbjct: 122 RGLSHLHQHKVIHRDIKGQNVLLTENAEV----KLVDFGVSAQLDRTVGRRNTFI----- 172
Query: 1213 GTLPWMAPELL 1223
GT WMAPE++
Sbjct: 173 GTPYWMAPEVI 183
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-09
Identities = 55/197 (27%), Positives = 98/197 (49%), Gaps = 14/197 (7%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
+K++D E++ ELG+G G V+ + + + + R K + + + ++ RE ++
Sbjct: 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMAR-KLIHLEIKPAIRNQII----RELQV 56
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
L + + P +V FYG G ++ E M GSL V L K + + +++
Sbjct: 57 LHECNSPYIVGFYGAFYS--DGEISICMEHMDGGSLDQV-LKKAGRIPEQILGKVSIAVI 113
Query: 1159 FGMEYLHSKN-IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPW 1217
G+ YL K+ I+H D+K N+LVN + I K+ DFG+S +++ V GT +
Sbjct: 114 KGLTYLREKHKIMHRDVKPSNILVNSRGEI----KLCDFGVSGQLIDSMANSFV-GTRSY 168
Query: 1218 MAPELLNGSSSKVSEKV 1234
M+PE L G+ V +
Sbjct: 169 MSPERLQGTHYSVQSDI 185
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 33/203 (16%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+ E+L+++G GT+G VY + + T VA+K+ T ++E + RE +L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKK------TRLEMDEEGIPPTALREISLL 54
Query: 1100 SKLHH-PNVVAFYGVV---QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM 1155
L +V V + +L V E++ + L+ + S R R
Sbjct: 55 QMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIK 113
Query: 1156 DAAF----GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-----IKRNT- 1205
+ G+ + H ++H DLK NLLV D + + K+ D GL + +K T
Sbjct: 114 SFMYQLLKGVAHCHKHGVMHRDLKPQNLLV---DKQKGLLKIADLGLGRAFSIPVKSYTH 170
Query: 1206 -LVTGGVRGTLPWMAPELLNGSS 1227
+V TL + APE+L GS+
Sbjct: 171 EIV------TLWYRAPEVLLGST 187
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 2e-09
Identities = 49/162 (30%), Positives = 77/162 (47%), Gaps = 16/162 (9%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+D E +K +G G FG V+ + + T A+K ++KS R Q E +IL
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKR--NQIAH---VRAERDIL 55
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIA-MDAA 1158
+ P +V Y QD L V E+M G L ++L+ K+ + R IA + A
Sbjct: 56 ADADSPWIVKLYYSFQDE--EHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLA 113
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200
++ +H +H D+K DN+L++ I K+ DFGL K
Sbjct: 114 --LDSVHKLGFIHRDIKPDNILIDADGHI----KLADFGLCK 149
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 59/187 (31%), Positives = 87/187 (46%), Gaps = 20/187 (10%)
Query: 1044 LEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 1101
+ + LG G FG V + R T A KR++K R E L E +IL K
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALN-----EKQILEK 56
Query: 1102 LHHPNVV--AFYGVVQDGPGGTLATVTEFMVNGSLR-HVLLSKERHLDRRKRLIIAMDAA 1158
++ VV A+ +D L V M G L+ H+ + + L A +
Sbjct: 57 VNSQFVVNLAYAYETKDA----LCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEIL 112
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVTGGVRGTLPW 1217
G+E LH +N V+ DLK +N+L++ IR + D GL+ KI + G V GT+ +
Sbjct: 113 CGLEDLHRENTVYRDLKPENILLDDYGHIR----ISDLGLAVKIPEGESIRGRV-GTVGY 167
Query: 1218 MAPELLN 1224
MAPE+LN
Sbjct: 168 MAPEVLN 174
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 52/189 (27%), Positives = 86/189 (45%), Gaps = 26/189 (13%)
Query: 1048 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HH 1104
K LG G+FG V + +GTD A+K +KK + +T E +L+ H
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMT-----EKRVLALAGKH 55
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLR-HVLLSKERHLDRRKRLIIAMDAAFGMEY 1163
P + + Q L V E++ G L H+ + D + A + G+++
Sbjct: 56 PFLTQLHSCFQTKD--RLFFVMEYVNGGDLMFHIQ--RSGRFDEPRARFYAAEIVLGLQF 111
Query: 1164 LHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR-----GTLPWM 1218
LH + I++ DLK DN+L++ + K+ DFG+ K + GGV GT ++
Sbjct: 112 LHERGIIYRDLKLDNVLLDSEGH----IKIADFGMCKEG----ILGGVTTSTFCGTPDYI 163
Query: 1219 APELLNGSS 1227
APE+L+
Sbjct: 164 APEILSYQP 172
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 3e-09
Identities = 54/180 (30%), Positives = 82/180 (45%), Gaps = 16/180 (8%)
Query: 1048 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILS-KLHH 1104
K LG G+FG V + +GTD AIK +KK +T E IL+ H
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMT-----EKRILALAAKH 55
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYL 1164
P + A + Q L V E+ VNG + + R D + A + + +L
Sbjct: 56 PFLTALHCCFQTKD--RLFFVMEY-VNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFL 112
Query: 1165 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-RNTLVTGGVRGTLPWMAPELL 1223
H +++ DLK DN+L++ + CK+ DFG+ K N + T GT ++APE+L
Sbjct: 113 HRHGVIYRDLKLDNILLDAEGH----CKLADFGMCKEGILNGVTTTTFCGTPDYIAPEIL 168
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-09
Identities = 57/186 (30%), Positives = 86/186 (46%), Gaps = 24/186 (12%)
Query: 1048 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
K LG G+FG V + +GT+ AIK +KK + E +E R L+ HP
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVL-EDDDVECTMVE--RRVLALAW-EHP 56
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH 1165
+ + Q L V E++ G L + S R + R R A + G+++LH
Sbjct: 57 FLTHLFCTFQTKE--HLFFVMEYLNGGDLMFHIQSSGRFDEARARFY-AAEIICGLQFLH 113
Query: 1166 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI------KRNTLVTGGVRGTLPWMA 1219
K I++ DLK DN+L++ I K+ DFG+ K K +T GT ++A
Sbjct: 114 KKGIIYRDLKLDNVLLDKDGHI----KIADFGMCKENMNGEGKASTFC-----GTPDYIA 164
Query: 1220 PELLNG 1225
PE+L G
Sbjct: 165 PEILKG 170
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 3e-09
Identities = 61/195 (31%), Positives = 89/195 (45%), Gaps = 35/195 (17%)
Query: 1047 LKELGSGTFGTVY-----HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 1101
LK LG G +G V+ G G A+K +KK+ R+ + T E IL
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIV-RNQKD---TAHTKAERNILEA 56
Query: 1102 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA--- 1158
+ HP +V Q G G L + E++ G L HL+R I D A
Sbjct: 57 VKHPFIVDLIYAFQTG--GKLYLILEYLSGGELF-------MHLEREG--IFMEDTACFY 105
Query: 1159 -----FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK--IKRNTLVTGGV 1211
+E+LH + I++ DLK +N+L++ + + K+ DFGL K I T VT
Sbjct: 106 LSEISLALEHLHQQGIIYRDLKPENILLDAQGHV----KLTDFGLCKESIHEGT-VTHTF 160
Query: 1212 RGTLPWMAPELLNGS 1226
GT+ +MAPE+L S
Sbjct: 161 CGTIEYMAPEILMRS 175
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 50/189 (26%), Positives = 83/189 (43%), Gaps = 16/189 (8%)
Query: 1047 LKELGSGTFGTVYHGKWR---GTDVAIKRI--KKSCFTGRSSEQERLTLEFWREAEILSK 1101
L+ LGSG FG VY + + +A+K I F E+++ + E I+ +
Sbjct: 5 LEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE 64
Query: 1102 -LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLS---KERHLDRRKRLIIAMDA 1157
L HPN+V +Y + L V + + L S K++ + I +
Sbjct: 65 QLRHPNIVRYYKTFLE--NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQM 122
Query: 1158 AFGMEYLH-SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 1216
+ YLH K IVH DL +N+++ D + + DFGL+K K+ V GT+
Sbjct: 123 VLALRYLHKEKRIVHRDLTPNNIMLGEDDKV----TITDFGLAKQKQPESKLTSVVGTIL 178
Query: 1217 WMAPELLNG 1225
+ PE++
Sbjct: 179 YSCPEIVKN 187
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 57/194 (29%), Positives = 92/194 (47%), Gaps = 32/194 (16%)
Query: 1044 LEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 1101
E ++ +G+GT+G VY G+ G AIK + + E+E + LE +L K
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----EDEEEEIKLEI----NMLKK 68
Query: 1102 L-HHPNVVAFYGV-VQDGPGG---TLATVTEFMVNGSLRHVLL-SKERHLDRRKRLIIAM 1155
HH N+ +YG ++ P G L V EF GS+ ++ +K L I
Sbjct: 69 YSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICR 128
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI------KRNTLVTG 1209
+ G+ +LH+ ++H D+K N+L+ + K+ DFG+S +RNT +
Sbjct: 129 EILRGLAHLHAHKVIHRDIKGQNVLLTENAEV----KLVDFGVSAQLDRTVGRRNTFI-- 182
Query: 1210 GVRGTLPWMAPELL 1223
GT WMAPE++
Sbjct: 183 ---GTPYWMAPEVI 193
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 50/186 (26%), Positives = 87/186 (46%), Gaps = 19/186 (10%)
Query: 1042 EDLEELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
E L+ ++G G+ G V K G VA+K++ +Q+R L F E I+
Sbjct: 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR-------KQQRRELLF-NEVVIM 73
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
HH NVV Y G L V EF+ G+L ++ ++ + + +
Sbjct: 74 RDYHHENVVDMYNSYL--VGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCLSVLR 129
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL-SKIKRNTLVTGGVRGTLPWM 1218
+ YLH++ ++H D+K D++L+ I K+ DFG +++ + + GT WM
Sbjct: 130 ALSYLHNQGVIHRDIKSDSILLTSDGRI----KLSDFGFCAQVSKEVPKRKSLVGTPYWM 185
Query: 1219 APELLN 1224
APE+++
Sbjct: 186 APEVIS 191
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 5e-09
Identities = 52/180 (28%), Positives = 85/180 (47%), Gaps = 16/180 (8%)
Query: 1048 KELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
K +G G+FG V K + A+K ++K + EQ+ + E +L + HP
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKK-EQKHIMAE---RNVLLKNVKHP 56
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH 1165
+V + Q L V ++ VNG L +ER + A + A + YLH
Sbjct: 57 FLVGLHYSFQTAD--KLYFVLDY-VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLH 113
Query: 1166 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK--IKRNTLVTGGVRGTLPWMAPELL 1223
S NI++ DLK +N+L++ + + + DFGL K I+ + T GT ++APE+L
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVV----LTDFGLCKEGIEHSK-TTSTFCGTPEYLAPEVL 168
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 5e-09
Identities = 58/193 (30%), Positives = 92/193 (47%), Gaps = 24/193 (12%)
Query: 1048 KELGSGTFGTVYHGKWRGTDVAIKRIK--KSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
+ LG G+FGTVY K + A +R+K K G + E T++ +EA++LSKL HP
Sbjct: 6 QRLGKGSFGTVYLVKDKKAV-AEERLKVLKEIPVGELNPNE--TVQANQEAQLLSKLDHP 62
Query: 1106 NVVAFYG--VVQDGPGGTLATVTEFMVNGSLR---HVLLSKERHLDRRKRLIIAMDAAFG 1160
+V F+ + +D +TE+ L L + L + + G
Sbjct: 63 AIVKFHASFLERD----AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118
Query: 1161 MEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT--LVTGGVRGTLPWM 1218
+ Y+H + I+H DLK N+ + + K+GDFG+S++ + L T GT +M
Sbjct: 119 VHYMHQRRILHRDLKAKNIFLK-----NNLLKIGDFGVSRLLMGSCDLAT-TFTGTPYYM 172
Query: 1219 APELLN--GSSSK 1229
+PE L G SK
Sbjct: 173 SPEALKHQGYDSK 185
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 8e-09
Identities = 57/205 (27%), Positives = 84/205 (40%), Gaps = 43/205 (20%)
Query: 1048 KELGSGTFGTVYHGKWRGTD---------VAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
K LG G FG V + G D VA+K +K E+ + E E+
Sbjct: 21 KPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-------TEKDLSDLVSEMEM 73
Query: 1099 LSKL-HHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSK--------------- 1141
+ + H N++ G QDGP L + E+ G+LR L ++
Sbjct: 74 MKMIGKHKNIINLLGACTQDGP---LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP 130
Query: 1142 ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201
+ + + + A GMEYL S+ +H DL N+LV + + K+ DFGL++
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENN----VMKIADFGLARD 186
Query: 1202 KRNT-LVTGGVRGTLP--WMAPELL 1223
N G LP WMAPE L
Sbjct: 187 VNNIDYYKKTTNGRLPVKWMAPEAL 211
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-08
Identities = 53/183 (28%), Positives = 81/183 (44%), Gaps = 23/183 (12%)
Query: 1048 KELGSGTFGTV--YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
K LG GTFG V K G A+K ++K + +T E+ +L HP
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT-----ESRVLQNTRHP 55
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH 1165
+ A Q L V E+ NG LS+ER + + +EYLH
Sbjct: 56 FLTALKYAFQTH--DRLCFVMEY-ANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 112
Query: 1166 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR-----GTLPWMAP 1220
S+++V+ D+K +NL+++ I K+ DFGL K ++ G GT ++AP
Sbjct: 113 SRDVVYRDIKLENLMLDKDGHI----KITDFGLCK----EGISDGATMKTFCGTPEYLAP 164
Query: 1221 ELL 1223
E+L
Sbjct: 165 EVL 167
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-08
Identities = 59/205 (28%), Positives = 85/205 (41%), Gaps = 43/205 (20%)
Query: 1048 KELGSGTFGTVYHGKWRGTD---------VAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
K LG G FG V + G D VA+K +K ++ + E E+
Sbjct: 18 KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLK-------DDATDKDLSDLVSEMEM 70
Query: 1099 LSKL-HHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSK--------------- 1141
+ + H N++ G QDGP L + E+ G+LR L ++
Sbjct: 71 MKMIGKHKNIINLLGACTQDGP---LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLP 127
Query: 1142 ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201
E L + + A A GMEYL S+ +H DL N+LV + + K+ DFGL++
Sbjct: 128 EEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDN----VMKIADFGLARD 183
Query: 1202 KRNT-LVTGGVRGTLP--WMAPELL 1223
N G LP WMAPE L
Sbjct: 184 VHNIDYYKKTTNGRLPVKWMAPEAL 208
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 1e-08
Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 58/209 (27%)
Query: 1047 LKELGSGTFGTVYHGKWRGTD------VAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100
L++LG G +G V W+ D VA+K+I + F + Q +RE L
Sbjct: 12 LQKLGKGAYGIV----WKAIDRRTKEVVALKKIFDA-FRNATDAQRT-----FREIMFLQ 61
Query: 1101 KL-HHPNVVAFYGVVQDGPGGTLATVTEFM---VNGSLRHVLLSKERHLDRRKRLII--- 1153
+L HPN+V V++ + V E+M ++ +R +L ++ H KR I+
Sbjct: 62 ELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANIL-EDVH----KRYIMYQL 116
Query: 1154 --AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLSKIKRNTLVTG 1209
A+ +Y+HS N++H DLK N+L+N C K+ DFGL++ +L
Sbjct: 117 LKAL------KYIHSGNVIHRDLKPSNILLNSD------CRVKLADFGLAR----SLSEL 160
Query: 1210 GVRGTLPWM----------APELLNGSSS 1228
P + APE+L GS+
Sbjct: 161 EENPENPVLTDYVATRWYRAPEILLGSTR 189
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 55/191 (28%), Positives = 87/191 (45%), Gaps = 32/191 (16%)
Query: 1042 EDLEELKELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
ED E ++ +GSGT+G VY + G AIK IK + Q+ + + +
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIM--------M 60
Query: 1100 SKLHHPNVVAFYG--VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 1157
H N+VA++G + +D L EF GSL+ + L + ++ +
Sbjct: 61 KDCKHSNIVAYFGSYLRRD----KLWICMEFCGGGSLQDI-YHVTGPLSESQIAYVSRET 115
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK------IKRNTLVTGGV 1211
G+ YLHSK +H D+K N+L+ + K+ DFG+S KR + +
Sbjct: 116 LQGLYYLHSKGKMHRDIKGANILLTDNGHV----KLADFGVSAQITATIAKRKSFI---- 167
Query: 1212 RGTLPWMAPEL 1222
GT WMAPE+
Sbjct: 168 -GTPYWMAPEV 177
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 53/182 (29%), Positives = 80/182 (43%), Gaps = 17/182 (9%)
Query: 1050 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 1107
LG G FG V + R T A K++ K R + + E IL+K+H +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMV-----EKRILAKVHSRFI 55
Query: 1108 VAFYGVVQDGPGGTLATVTEFMVNGSLR-HVLLSKERH--LDRRKRLIIAMDAAFGMEYL 1164
V+ Q L V M G LR H+ E + + G+E+L
Sbjct: 56 VSLAYAFQTKT--DLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHL 113
Query: 1165 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVTGGVRGTLPWMAPELL 1223
H + I++ DLK +N+L++ +R + D GL+ ++K T G GT +MAPELL
Sbjct: 114 HQRRIIYRDLKPENVLLDNDGNVR----ISDLGLAVELKDGQSKTKGYAGTPGFMAPELL 169
Query: 1224 NG 1225
G
Sbjct: 170 QG 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-08
Identities = 51/198 (25%), Positives = 90/198 (45%), Gaps = 27/198 (13%)
Query: 1043 DLEELKELGSGTFGTVY-----HGKWRGTDVAIKRIKKSCF-----TGRSSEQERLTLEF 1092
+ E LK LG+G +G V+ G G A+K +KK+ T + ER LE
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 1093 WREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI 1152
R++ L LH+ AF + L + +++ G L L +ER ++ ++
Sbjct: 61 IRQSPFLVTLHY----AFQTDTK------LHLILDYINGGELFTHLSQRERFKEQEVQIY 110
Query: 1153 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK--IKRNTLVTGG 1210
+ +E+LH I++ D+K +N+L++ + + DFGLSK +
Sbjct: 111 SG-EIVLALEHLHKLGIIYRDIKLENILLDSNGHV----VLTDFGLSKEFHEDEVERAYS 165
Query: 1211 VRGTLPWMAPELLNGSSS 1228
GT+ +MAP+++ G
Sbjct: 166 FCGTIEYMAPDIVRGGDG 183
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-08
Identities = 57/185 (30%), Positives = 92/185 (49%), Gaps = 23/185 (12%)
Query: 1046 ELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH 1103
+LK++GSG +GTV R G VAIK++ R + E +RE +L +
Sbjct: 19 DLKQVGSGAYGTVCSALDRRTGAKVAIKKLY------RPFQSELFAKRAYRELRLLKHMK 72
Query: 1104 HPNVVAFYGVVQDGPGGTLATVTEFMV----NGSLRHVLLSKER-HLDRRKRLIIAMDAA 1158
H NV+ V P +L +F + G+ L+ E+ DR + L+ M
Sbjct: 73 HENVIGLLDVFT--PDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQM--L 128
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWM 1218
G++Y+H+ I+H DLK NL VN + K+ DFGL++ + ++ +TG V T +
Sbjct: 129 KGLKYIHAAGIIHRDLKPGNLAVNEDCEL----KILDFGLAR-QTDSEMTGYVV-TRWYR 182
Query: 1219 APELL 1223
APE++
Sbjct: 183 APEVI 187
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-08
Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 14/165 (8%)
Query: 1042 EDLEELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
E+ +K + G FG VY G K A+K +KK+ ++ + R+A L
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQA---ERDALAL 60
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
SK P +V Y +Q L V E+++ G ++ LL + D + + A
Sbjct: 61 SK--SPFIVHLYYSLQSANNVYL--VMEYLIGGDVKS-LLHIYGYFDEEMAVKYISEVAL 115
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 1204
++YLH I+H DLK DN+L++ + I K+ DFGLSK+ N
Sbjct: 116 ALDYLHRHGIIHRDLKPDNMLISNEGHI----KLTDFGLSKVTLN 156
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 51/183 (27%), Positives = 85/183 (46%), Gaps = 19/183 (10%)
Query: 1044 LEELKELGSGTFGTV--YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 1101
LE ++G G+ G V K G VA+K + +Q+R L F E I+
Sbjct: 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMD-------LRKQQRRELLF-NEVVIMRD 74
Query: 1102 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGM 1161
H NVV Y G L + EF+ G+L ++ + L+ + + +
Sbjct: 75 YQHQNVVEMYKSYLVGE--ELWVLMEFLQGGALTDIV--SQTRLNEEQIATVCESVLQAL 130
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL-SKIKRNTLVTGGVRGTLPWMAP 1220
YLHS+ ++H D+K D++L+ L + K+ DFG ++I ++ + GT WMAP
Sbjct: 131 CYLHSQGVIHRDIKSDSILLTLDGRV----KLSDFGFCAQISKDVPKRKSLVGTPYWMAP 186
Query: 1221 ELL 1223
E++
Sbjct: 187 EVI 189
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 3e-08
Identities = 60/201 (29%), Positives = 89/201 (44%), Gaps = 39/201 (19%)
Query: 1043 DLEELKELGSGTFGTVYHGKWRGTD------VAIKRIKKSCFTGRSSEQERLTLEFWREA 1096
D+E + +G G FG V W TD VA+K++ F S + RE
Sbjct: 1 DVEPDRPIGYGAFGVV----WSVTDPRDGKRVALKKMPN-VFQNLVSCKRVF-----REL 50
Query: 1097 EILSKLHHPNVVAFYGVVQD---GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 1153
++L H NV++ ++Q P + VTE M L +++S + ++ +
Sbjct: 51 KMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELM-QSDLHKIIVSPQPLSSDHVKVFL 109
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL--------SKIKRNT 1205
G++YLHS I+H D+K NLLVN + + IC DFGL SK
Sbjct: 110 -YQILRGLKYLHSAGILHRDIKPGNLLVN-SNCVLKIC---DFGLARVEEPDESKHMTQE 164
Query: 1206 LVTGGVRGTLPWMAPELLNGS 1226
+VT R APE+L GS
Sbjct: 165 VVTQYYR------APEILMGS 179
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 54/186 (29%), Positives = 87/186 (46%), Gaps = 23/186 (12%)
Query: 1048 KELGSGTFGTVYHGK-WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN 1106
+E+G+G FG V + + T VA +K+ S EQ EF ++ + L HPN
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQN----EFLQQGDPYRILQHPN 56
Query: 1107 VVAFYG-VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII---AMDAAFGME 1162
++ G V+ P V E+ G L+ L ++ H + L++ A + A G+
Sbjct: 57 ILQCLGQCVEAIP---YLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVT 113
Query: 1163 YLHSKNIVHFDLKCDN--LLVNLKDPIRPICKVGDFGL--SKIKRNTLVT-GGVRGTLPW 1217
++H N +H DL N L +L KVGD+G+ S+ K + + T L W
Sbjct: 114 HMHKHNFLHSDLALRNCFLTSDLT------VKVGDYGIGPSRYKEDYIETEDDKCVPLRW 167
Query: 1218 MAPELL 1223
+APEL+
Sbjct: 168 LAPELV 173
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 56/179 (31%), Positives = 78/179 (43%), Gaps = 15/179 (8%)
Query: 1048 KELGSGTFGTV--YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
K LG GTFG V K G A+K +KK + LT E+ +L HP
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLT-----ESRVLKNTRHP 55
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH 1165
+ + Q L V E+ VNG LS+ER + + ++YLH
Sbjct: 56 FLTSLKYSFQTK--DRLCFVMEY-VNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLH 112
Query: 1166 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR-GTLPWMAPELL 1223
S IV+ DLK +NL+++ I K+ DFGL K T GT ++APE+L
Sbjct: 113 SGKIVYRDLKLENLMLDKDGHI----KITDFGLCKEGITDAATMKTFCGTPEYLAPEVL 167
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 42/147 (28%), Positives = 73/147 (49%), Gaps = 14/147 (9%)
Query: 1088 LTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER-HLD 1146
+ L F+ A ++S++ H ++ +GV G + V EF+ +G L V L KE+ +
Sbjct: 59 IALAFFETASLMSQVSHIHLAFVHGVCVRGSENIM--VEEFVEHGPL-DVCLRKEKGRVP 115
Query: 1147 RRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV---NLKDPIRPICKVGDFGLS--KI 1201
++ +A A + YL KN+VH ++ N+L+ L + P K+ D G+S +
Sbjct: 116 VAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTAL 175
Query: 1202 KRNTLVTGGVRGTLPWMAPELLNGSSS 1228
R V +PW+APE + G +S
Sbjct: 176 SREERVE-----RIPWIAPECVPGGNS 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 4e-08
Identities = 52/188 (27%), Positives = 90/188 (47%), Gaps = 35/188 (18%)
Query: 1047 LKELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
+++G G GTVY G +VAIK++ + +Q+ E ++ + +
Sbjct: 24 FEKIGQGASGTVYTAIDIATGQEVAIKQM--------NLQQQPKKELIINEILVMRENKN 75
Query: 1105 PNVVAF---YGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGM 1161
PN+V + Y V G L V E++ GSL V+ E +D + + + +
Sbjct: 76 PNIVNYLDSYLV-----GDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQAL 128
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL------SKIKRNTLVTGGVRGTL 1215
++LHS ++H D+K DN+L+ + + K+ DFG + KR+T+V GT
Sbjct: 129 DFLHSNQVIHRDIKSDNILLGMDGSV----KLTDFGFCAQITPEQSKRSTMV-----GTP 179
Query: 1216 PWMAPELL 1223
WMAPE++
Sbjct: 180 YWMAPEVV 187
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 31/138 (22%), Positives = 58/138 (42%), Gaps = 13/138 (9%)
Query: 1053 GTFGTVYHGKWRGTDVAIKR--IKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAF 1110
GTFG +++G + K+ S Q L L+ E+ +L L H N++
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQ---ESCLLYGLSHQNILPI 73
Query: 1111 YGVVQDGPGGTLATVTEFMVNGSL-------RHVLLSKERHLDRRKRLIIAMDAAFGMEY 1163
V + + +M G+L R + + L ++ + +A+ A GM Y
Sbjct: 74 LHVCIEDGEPPF-VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSY 132
Query: 1164 LHSKNIVHFDLKCDNLLV 1181
LH + ++H D+ N ++
Sbjct: 133 LHKRGVIHKDIAARNCVI 150
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 5e-08
Identities = 49/164 (29%), Positives = 71/164 (43%), Gaps = 25/164 (15%)
Query: 1047 LKELGSGTFGTV----YHGKWRGTDVAIKRI----KKSCFTGRSSEQERLTLEFWREAEI 1098
+KELG G +G V VAIK+I K R+ + +L L +R
Sbjct: 5 IKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKL-LRHFRG--- 60
Query: 1099 LSKLHHPNVVAFYG--VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
H N+ Y +V G L E M L ++ S + D + I
Sbjct: 61 -----HKNITCLYDMDIVFPGNFNELYLYEELM-EADLHQIIRSGQPLTDAHFQSFI-YQ 113
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200
G++Y+HS N++H DLK NLLVN ++ IC DFGL++
Sbjct: 114 ILCGLKYIHSANVLHRDLKPGNLLVNADCELK-IC---DFGLAR 153
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 7e-08
Identities = 55/186 (29%), Positives = 84/186 (45%), Gaps = 16/186 (8%)
Query: 1050 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 1107
LG G FG V + R T A K+++K R E L E IL K++ V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN-----EKRILEKVNSRFV 62
Query: 1108 VAFYGVVQDGPGGTLATVTEFMVNGSLR-HVLLSKERHLDRRKRLIIAMDAAFGMEYLHS 1166
V+ + L V M G L+ H+ D ++ + A + G+E L
Sbjct: 63 VSLAYAYETKDA--LCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120
Query: 1167 KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVTGGVRGTLPWMAPELLNG 1225
+ IV+ DLK +N+L++ + IR + D GL+ +I V G V GT+ +MAPE++N
Sbjct: 121 ERIVYRDLKPENILLDDRGHIR----ISDLGLAVQIPEGETVRGRV-GTVGYMAPEVINN 175
Query: 1226 SSSKVS 1231
S
Sbjct: 176 EKYTFS 181
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 8e-08
Identities = 53/203 (26%), Positives = 97/203 (47%), Gaps = 32/203 (15%)
Query: 1032 DISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLT 1089
I+ L++ K ED + +K +G G FG V + + + A+K + K RS +
Sbjct: 34 KITKLRM-KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSD-----S 87
Query: 1090 LEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRK 1149
FW E +I++ + +V + QD L V E+M G L +++ + + +
Sbjct: 88 AFFWEERDIMAHANSEWIVQLHYAFQDDK--YLYMVMEYMPGGDLVNLMSNYDIPEKWAR 145
Query: 1150 ----RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT 1205
+++A+DA +HS +H D+K DN+L++ + K+ DFG + +K +
Sbjct: 146 FYTAEVVLALDA------IHSMGFIHRDVKPDNMLLDKSGHL----KLADFG-TCMKMDA 194
Query: 1206 LVTGGVR-----GTLPWMAPELL 1223
G VR GT +++PE+L
Sbjct: 195 --NGMVRCDTAVGTPDYISPEVL 215
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-07
Identities = 49/197 (24%), Positives = 90/197 (45%), Gaps = 27/197 (13%)
Query: 1043 DLEELKELGSGTFGTVY-----HGKWRGTDVAIKRIKKSCFTGRSSEQE-----RLTLEF 1092
+ E LK LG+G +G V+ G G A+K ++K+ ++ E R LE
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 1093 WREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI 1152
R++ L LH+ AF + L + +++ G + L ++ + +
Sbjct: 61 VRQSPFLVTLHY----AFQTEAK------LHLILDYVSGGEMFTHLYQRD-NFSEDEVRF 109
Query: 1153 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK--IKRNTLVTGG 1210
+ + +E+LH IV+ D+K +N+L++ + + + DFGLSK + T
Sbjct: 110 YSGEIILALEHLHKLGIVYRDIKLENILLDSEGHV----VLTDFGLSKEFLSEEKERTYS 165
Query: 1211 VRGTLPWMAPELLNGSS 1227
GT+ +MAPE++ G
Sbjct: 166 FCGTIEYMAPEIIRGKG 182
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 1e-07
Identities = 48/161 (29%), Positives = 77/161 (47%), Gaps = 14/161 (8%)
Query: 1042 EDLEELKELGSGTFGTV--YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+D E +K +G G FG V K G A+K+++KS + EQ E +IL
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEK--EQ---VAHVRAERDIL 55
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
++ +P VV Y QD L + E++ G + +L+ K+ + R IA +
Sbjct: 56 AEADNPWVVKLYYSFQDE--NYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIA-ETIL 112
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200
++ +H +H D+K DNLL++ K I K+ DFGL
Sbjct: 113 AIDSIHKLGYIHRDIKPDNLLLDAKGHI----KLSDFGLCT 149
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 54/195 (27%), Positives = 87/195 (44%), Gaps = 32/195 (16%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQE----RLTLEFWRE 1095
E E+L ++G G++G V+ + R G VAIK+ F SE + ++ L RE
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKK-----FV--ESEDDPVIKKIAL---RE 50
Query: 1096 AEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM 1155
+L +L HPN+V V + L V E+ + ++ + L R + I
Sbjct: 51 IRMLKQLKHPNLVNLIEVFRRKR--KLHLVFEY-CDHTVLNELEKNPRGVPEHLIKKIIW 107
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR--- 1212
+ + H N +H D+K +N+L+ + I K+ DFG ++I L G
Sbjct: 108 QTLQAVNFCHKHNCIHRDVKPENILITKQGQI----KLCDFGFARI----LTGPGDDYTD 159
Query: 1213 --GTLPWMAPELLNG 1225
T + APELL G
Sbjct: 160 YVATRWYRAPELLVG 174
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 46/194 (23%), Positives = 85/194 (43%), Gaps = 30/194 (15%)
Query: 1050 LGSGTFGTVYHG---------KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100
LG GTF ++ G + T+V +K + KS + F+ A ++S
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--------HRNYSESFFEAASMMS 54
Query: 1101 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFG 1160
+L H ++V YGV G + V E++ GSL L + ++ +L +A A+
Sbjct: 55 QLSHKHLVLNYGVCVCGDESIM--VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWA 112
Query: 1161 MEYLHSKNIVHFDLKCDNLLV----NLKDPIRPICKVGDFGLSK--IKRNTLVTGGVRGT 1214
+ +L K + H ++ N+L+ + K P K+ D G+S + + L+
Sbjct: 113 LHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLE-----R 167
Query: 1215 LPWMAPELLNGSSS 1228
+PW+ PE + +
Sbjct: 168 IPWVPPECIENPQN 181
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 52/188 (27%), Positives = 90/188 (47%), Gaps = 35/188 (18%)
Query: 1047 LKELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
+++G G GTVY G +VAI+++ + +Q+ E ++ + +
Sbjct: 25 FEKIGQGASGTVYTAMDVATGQEVAIRQM--------NLQQQPKKELIINEILVMRENKN 76
Query: 1105 PNVVAF---YGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGM 1161
PN+V + Y V G L V E++ GSL V+ E +D + + + +
Sbjct: 77 PNIVNYLDSYLV-----GDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQAL 129
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL------SKIKRNTLVTGGVRGTL 1215
E+LHS ++H D+K DN+L+ + + K+ DFG + KR+T+V GT
Sbjct: 130 EFLHSNQVIHRDIKSDNILLGMDGSV----KLTDFGFCAQITPEQSKRSTMV-----GTP 180
Query: 1216 PWMAPELL 1223
WMAPE++
Sbjct: 181 YWMAPEVV 188
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 57/188 (30%), Positives = 87/188 (46%), Gaps = 24/188 (12%)
Query: 1048 KELGSGTFGTVYHGK----WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH 1103
KE+G+G FG V G+ + V +K ++ S +S QE++ +F EA+ L
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVS-----ASVQEQM--KFLEEAQPYRSLQ 53
Query: 1104 HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH----LDRRKRLIIAMDAAF 1159
H N++ G + L V EF G L+ L S + D +A + A
Sbjct: 54 HSNLLQCLGQCTEVTPYLL--VMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIAL 111
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS--KIKRNTLVTGGVRGT-LP 1216
G+ +LH N +H DL N L+ + K+GD+GLS K K + VT L
Sbjct: 112 GLLHLHKNNFIHSDLALRNCLLTADLTV----KIGDYGLSHNKYKEDYYVTPDQLWVPLR 167
Query: 1217 WMAPELLN 1224
W+APEL++
Sbjct: 168 WIAPELVD 175
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 52/181 (28%), Positives = 88/181 (48%), Gaps = 16/181 (8%)
Query: 1048 KELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
K +G G+FG V + + + A+K ++K + E+ ++ +L + HP
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMS----ERNVLLKNVKHP 56
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH 1165
+V + Q L V +++ G L + L + L+ R R A + A + YLH
Sbjct: 57 FLVGLHFSFQTA--DKLYFVLDYINGGELFYHLQRERCFLEPRARFY-AAEIASALGYLH 113
Query: 1166 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK--IKRNTLVTGGVRGTLPWMAPELL 1223
S NIV+ DLK +N+L++ + I + DFGL K I+ N T GT ++APE+L
Sbjct: 114 SLNIVYRDLKPENILLDSQGHI----VLTDFGLCKENIEHNG-TTSTFCGTPEYLAPEVL 168
Query: 1224 N 1224
+
Sbjct: 169 H 169
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 2e-07
Identities = 59/189 (31%), Positives = 85/189 (44%), Gaps = 32/189 (16%)
Query: 1048 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
K +G G +G V K T+ VAIK+I + F R + L RE ++L L H
Sbjct: 11 KPIGRGAYGIVCSAKNSETNEKVAIKKIANA-FDNRIDAKRTL-----REIKLLRHLDHE 64
Query: 1106 NVVAFYGVVQDGPGGTLA-----TVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFG 1160
NV+A ++ P A V E M + L ++ S + D + + G
Sbjct: 65 NVIAIKDIMP--PPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFL-YQLLRG 120
Query: 1161 MEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLSKIKRNTLVTGGVRG----T 1214
++Y+HS N++H DLK NLL+N C K+ DFGL+ R T G T
Sbjct: 121 LKYIHSANVLHRDLKPSNLLLNAN------CDLKICDFGLA---RTTSEKGDFMTEYVVT 171
Query: 1215 LPWMAPELL 1223
+ APELL
Sbjct: 172 RWYRAPELL 180
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 54/180 (30%), Positives = 84/180 (46%), Gaps = 20/180 (11%)
Query: 1050 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 1107
LG G FG V + R T A K+++K R E L E +IL K++ V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALN-----EKQILEKVNSRFV 62
Query: 1108 V--AFYGVVQDGPGGTLATVTEFMVNGSLR-HVLLSKERHLDRRKRLIIAMDAAFGMEYL 1164
V A+ +D L V M G L+ H+ E + + + A + G+E L
Sbjct: 63 VSLAYAYETKDA----LCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDL 118
Query: 1165 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVTGGVRGTLPWMAPELL 1223
H + IV+ DLK +N+L++ IR + D GL+ + + G V GT+ +MAPE++
Sbjct: 119 HQERIVYRDLKPENILLDDHGHIR----ISDLGLAVHVPEGQTIKGRV-GTVGYMAPEVV 173
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 56/198 (28%), Positives = 85/198 (42%), Gaps = 32/198 (16%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
E E L +G G++G V K + T VAIK+ +S + + + RE +L
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLES------EDDKMVKKIAMREIRML 54
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH----LDRRKRLIIAM 1155
+L H N+V V + L V EF+ H +L LD +
Sbjct: 55 KQLRHENLVNLIEVFRRKK--RLYLVFEFV-----DHTVLDDLEKYPNGLDESRVRKYLF 107
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGG----- 1210
G+E+ HS NI+H D+K +N+LV+ + K+ DFG ++ TL G
Sbjct: 108 QILRGIEFCHSHNIIHRDIKPENILVSQSG----VVKLCDFGFAR----TLAAPGEVYTD 159
Query: 1211 VRGTLPWMAPELLNGSSS 1228
T + APELL G +
Sbjct: 160 YVATRWYRAPELLVGDTK 177
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 49/184 (26%), Positives = 87/184 (47%), Gaps = 19/184 (10%)
Query: 1044 LEELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 1101
L+ ++G G+ G V K G VA+K++ +Q+R L F E I+
Sbjct: 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR-------KQQRRELLF-NEVVIMRD 73
Query: 1102 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGM 1161
H NVV Y G L V EF+ G+L ++ + ++ + +A+ A +
Sbjct: 74 YQHENVVEMYNSYL--VGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSV 131
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL-SKIKRNTLVTGGVRGTLPWMAP 1220
LH++ ++H D+K D++L+ + K+ DFG +++ + + GT WMAP
Sbjct: 132 --LHAQGVIHRDIKSDSILLTHDGRV----KLSDFGFCAQVSKEVPRRKSLVGTPYWMAP 185
Query: 1221 ELLN 1224
EL++
Sbjct: 186 ELIS 189
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-07
Identities = 55/181 (30%), Positives = 86/181 (47%), Gaps = 18/181 (9%)
Query: 1048 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
K +G G+FG V K + G A+K ++K R EQ+ + E +L + HP
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRK-EQKHIMAE---RNVLLKNVKHP 56
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH 1165
+V + Q L V +F VNG L +ER + A + A + YLH
Sbjct: 57 FLVGLHYSFQTTE--KLYFVLDF-VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLH 113
Query: 1166 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK---IKRNTLVTGGVRGTLPWMAPEL 1222
S NIV+ DLK +N+L++ + + + DFGL K + +T T GT ++APE+
Sbjct: 114 SINIVYRDLKPENILLDSQGHV----VLTDFGLCKEGIAQSDTTTT--FCGTPEYLAPEV 167
Query: 1223 L 1223
+
Sbjct: 168 I 168
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-07
Identities = 58/181 (32%), Positives = 81/181 (44%), Gaps = 18/181 (9%)
Query: 1048 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
K LG GTFG V K + T A+K +KK + LT E +L HP
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT-----ENRVLQNSRHP 55
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH 1165
+ A Q L V E+ NG LS+ER + + ++YLH
Sbjct: 56 FLTALKYSFQTH--DRLCFVMEY-ANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH 112
Query: 1166 S-KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK--IKRNTLVTGGVRGTLPWMAPEL 1222
S KN+V+ DLK +NL+++ I K+ DFGL K IK + GT ++APE+
Sbjct: 113 SEKNVVYRDLKLENLMLDKDGHI----KITDFGLCKEGIKDGATMKTFC-GTPEYLAPEV 167
Query: 1223 L 1223
L
Sbjct: 168 L 168
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 4e-07
Identities = 49/207 (23%), Positives = 88/207 (42%), Gaps = 48/207 (23%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
DLE L E+GSGT G VY +++ G +A+K++++ TG E +R+ + +++
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRR---TGNKEENKRIL----MDLDVV 67
Query: 1100 SKLHH-PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI------ 1152
K H P +V YG F+ + + + LD+ + I
Sbjct: 68 LKSHDCPYIVKCYGY--------------FITDSDVFICMELMSTCLDKLLKRIQGPIPE 113
Query: 1153 -----IAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL 1206
+ + + YL K ++H D+K N+L++ + K+ DFG+S L
Sbjct: 114 DILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNV----KLCDFGIS----GRL 165
Query: 1207 VTGGVR----GTLPWMAPELLNGSSSK 1229
V + G +MAPE ++
Sbjct: 166 VDSKAKTRSAGCAAYMAPERIDPPDPN 192
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-07
Identities = 55/190 (28%), Positives = 88/190 (46%), Gaps = 26/190 (13%)
Query: 1043 DLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQ----ERLTLEFWREA 1096
D L LG G+FG V + +GTD AIK +KK + E+ L +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 1097 EILSKLHH--PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIA 1154
L++LH + Y V++ GG L ++ V KE H + A
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMY--------QIQQVGRFKEPH-----AVFYA 107
Query: 1155 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR-NTLVTGGVRG 1213
+ A G+ +LHSK I++ DLK DN++++ + I K+ DFG+ K + + T G
Sbjct: 108 AEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHI----KIADFGMCKENMWDGVTTKTFCG 163
Query: 1214 TLPWMAPELL 1223
T ++APE++
Sbjct: 164 TPDYIAPEII 173
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-07
Identities = 54/189 (28%), Positives = 90/189 (47%), Gaps = 17/189 (8%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREA 1096
+K ED E +K +G G FG V + + T A+K + K RS + FW E
Sbjct: 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSD-----SAFFWEER 94
Query: 1097 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
+I++ + P VV + QD L V E+M G L + L+S ++ R A +
Sbjct: 95 DIMAFANSPWVVQLFYAFQDDR--YLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTA-E 150
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVTGGVR-GT 1214
++ +HS +H D+K DN+L++ + K+ DFG K+ + +V GT
Sbjct: 151 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHL----KLADFGTCMKMNKEGMVRCDTAVGT 206
Query: 1215 LPWMAPELL 1223
+++PE+L
Sbjct: 207 PDYISPEVL 215
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 5e-07
Identities = 54/181 (29%), Positives = 81/181 (44%), Gaps = 20/181 (11%)
Query: 1050 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL---SKLHH 1104
+G GTFG VY + + T A+K + K + + E IL
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIG-----ERNILVRTLLDES 55
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYL 1164
P +V Q L VT++M G L L + R + R + IA + +E+L
Sbjct: 56 PFIVGLKFSFQTD--SDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHL 112
Query: 1165 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK--IKRNTLVTGGVRGTLPWMAPEL 1222
H +IV+ DLK +N+L++ I +C DFGLSK + N T GT ++APE+
Sbjct: 113 HKYDIVYRDLKPENILLDATGHI-ALC---DFGLSKANLTDNKT-TNTFCGTTEYLAPEV 167
Query: 1223 L 1223
L
Sbjct: 168 L 168
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 6e-07
Identities = 55/189 (29%), Positives = 83/189 (43%), Gaps = 19/189 (10%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+++E L ELG G +G+VY R T V A+K I R E + E +IL
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEI-------RLELDESKFNQIIMELDIL 53
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL--LSKERHLDRRKRLIIAMDA 1157
K P +V FYG G + E+M GSL + + I
Sbjct: 54 HKAVSPYIVDFYGAFFI--EGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAV 111
Query: 1158 AFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 1216
G+++L + NI+H D+K N+LVN ++ +C DFG+S +L + G
Sbjct: 112 VKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVK-LC---DFGVSGNLVASLAKTNI-GCQS 166
Query: 1217 WMAPELLNG 1225
+MAPE +
Sbjct: 167 YMAPERIKS 175
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 6e-07
Identities = 51/177 (28%), Positives = 82/177 (46%), Gaps = 14/177 (7%)
Query: 1050 LGSGTFGTV--YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 1107
LG G FG V K G A K++ K +S E+ L E EIL K++ P +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALL-----EKEILEKVNSPFI 55
Query: 1108 VAFYGVVQDGPGGTLATVTEFMVNGSLR-HVLLSKERHLDRRKRLIIAMDAAFGMEYLHS 1166
V + L V M G L+ H+ ER L+ + + + G+ +LHS
Sbjct: 56 VNLAYAFESKT--HLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS 113
Query: 1167 KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELL 1223
+IV+ D+K +N+L++ + C++ D GL+ ++ GT +MAPE+L
Sbjct: 114 MDIVYRDMKPENVLLDDQGN----CRLSDLGLAVELKDGKTITQRAGTNGYMAPEIL 166
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 7e-07
Identities = 53/179 (29%), Positives = 83/179 (46%), Gaps = 14/179 (7%)
Query: 1048 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
K +G G+FG V K + G+ A+K ++K + EQ + E +L L HP
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTIL-KKKEQNHIMAE---RNVLLKNLKHP 56
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH 1165
+V + Q L V ++ VNG L +ER + A + A + YLH
Sbjct: 57 FLVGLHYSFQTAE--KLYFVLDY-VNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLH 113
Query: 1166 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-RNTLVTGGVRGTLPWMAPELL 1223
S NI++ DLK +N+L++ + + + DFGL K T GT ++APE+L
Sbjct: 114 SLNIIYRDLKPENILLDSQGHV----VLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVL 168
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 7e-07
Identities = 42/134 (31%), Positives = 68/134 (50%), Gaps = 10/134 (7%)
Query: 1095 EAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIA 1154
EA +L +L HP V+A V G G T + ++ L L ++ R L + +A
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVG-GLTCLVLPKY--RSDLYTYLGARLRPLGLAQVTAVA 266
Query: 1155 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG---LSKIKRNTLVTGGV 1211
++Y+H + I+H D+K +N+LVN + IC +GDFG ++ +T G+
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPE---DIC-LGDFGAACFARGSWSTPFHYGI 322
Query: 1212 RGTLPWMAPELLNG 1225
GT+ APE+L G
Sbjct: 323 AGTVDTNAPEVLAG 336
|
Length = 461 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 8e-07
Identities = 37/129 (28%), Positives = 63/129 (48%), Gaps = 7/129 (5%)
Query: 1095 EAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIA 1154
EA +L ++HP+V+ + G T + + + L L + R L + LII
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAI-TCMVLPHY--SSDLYTYLTKRSRPLPIDQALIIE 163
Query: 1155 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGT 1214
G+ YLH++ I+H D+K +N+ +N D +C +GD G ++ G+ GT
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFINDVD---QVC-IGDLGAAQFPVVAPAFLGLAGT 219
Query: 1215 LPWMAPELL 1223
+ APE+L
Sbjct: 220 VETNAPEVL 228
|
Length = 357 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-06
Identities = 54/186 (29%), Positives = 83/186 (44%), Gaps = 24/186 (12%)
Query: 1048 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILS-KLHH 1104
K LG G+FG V + +G A+K +KK + + E +L+ +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMV-----EKRVLALAWEN 55
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYL 1164
P + Y Q L V EF+ G L + K R D + A + G+++L
Sbjct: 56 PFLTHLYCTFQTKE--HLFFVMEFLNGGDLMFHIQDKGR-FDLYRATFYAAEIVCGLQFL 112
Query: 1165 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR-----GTLPWMA 1219
HSK I++ DLK DN++++ I K+ DFG+ K V G R GT ++A
Sbjct: 113 HSKGIIYRDLKLDNVMLDRDGHI----KIADFGMCKEN----VFGDNRASTFCGTPDYIA 164
Query: 1220 PELLNG 1225
PE+L G
Sbjct: 165 PEILQG 170
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-06
Identities = 42/179 (23%), Positives = 78/179 (43%), Gaps = 19/179 (10%)
Query: 1030 NFDISTLQIIKNEDLEELKEL--GSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQER 1087
I+ ++ I+++D+++ + ++Y G + +V I+ KK +
Sbjct: 6 RSYINDIKCIESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKF-----HKGHKV 60
Query: 1088 LTLEFWREAEILSKLHHPNVVAFYG----VVQDGPGGTLATVTEFMVNGSLRHVLLSKER 1143
L E + L ++ N++ YG +V D P +L + E+ G LR VL KE+
Sbjct: 61 LIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSL--ILEYCTRGYLREVL-DKEK 117
Query: 1144 HLDRRKRLIIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201
L + +L +A+D G+ L+ N + +L + LV K+ GL KI
Sbjct: 118 DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY----KLKIICHGLEKI 172
|
Length = 283 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 1e-06
Identities = 62/245 (25%), Positives = 88/245 (35%), Gaps = 83/245 (33%)
Query: 1048 KELGSGTFGTVYHGKWRGTD-------VAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100
K LG G FG V G + VA+K +K+ +SE + L E +IL
Sbjct: 13 KPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEG---ATASEYKALMTEL----KILI 65
Query: 1101 KL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNG-------SLRHVLL------------- 1139
+ HH NVV G PGG L + E+ G S R
Sbjct: 66 HIGHHLNVVNLLGACTK-PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMK 124
Query: 1140 ---SKERHLDRR--------------KRLIIA-----------------------MDAAF 1159
K++ LD K L A
Sbjct: 125 QKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVAR 184
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNT--LVTGGVRGTLP 1216
GME+L S+ +H DL N+L++ + + K+ DFGL++ I ++ + G R L
Sbjct: 185 GMEFLASRKCIHRDLAARNILLSENN----VVKICDFGLARDIYKDPDYVRKGDARLPLK 240
Query: 1217 WMAPE 1221
WMAPE
Sbjct: 241 WMAPE 245
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 24/199 (12%)
Query: 1032 DISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLT 1089
I LQ+ K ED + +K +G G FG V + + + A+K + K RS +
Sbjct: 34 KIRKLQM-KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSD-----S 87
Query: 1090 LEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRK 1149
FW E +I++ + P VV + QD L V E+M G L + L+S ++
Sbjct: 88 AFFWEERDIMAFANSPWVVQLFCAFQDDK--YLYMVMEYMPGGDLVN-LMSNYDVPEKWA 144
Query: 1150 RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG 1209
+ A + ++ +HS ++H D+K DN+L++ + K+ DFG + +K + TG
Sbjct: 145 KFYTA-EVVLALDAIHSMGLIHRDVKPDNMLLDKHGHL----KLADFG-TCMKMDE--TG 196
Query: 1210 GVR-----GTLPWMAPELL 1223
VR GT +++PE+L
Sbjct: 197 MVRCDTAVGTPDYISPEVL 215
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-06
Identities = 54/189 (28%), Positives = 84/189 (44%), Gaps = 24/189 (12%)
Query: 1043 DLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100
D L LG G+FG V + +GTD AIK +KK + + E +L+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMV-----EKRVLA 55
Query: 1101 KLHHPN-VVAFYGVVQDGPGGTLATVTEFMVNGSL----RHVLLSKERHLDRRKRLIIAM 1155
P + + Q L V E++ G L + V KE H + A
Sbjct: 56 LPGKPPFLTQLHSCFQTM--DRLYFVMEYVNGGDLMYHIQQVGKFKEPH-----AVFYAA 108
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR-GT 1214
+ A G+ +LHSK I++ DLK DN++++ + I K+ DFG+ K T GT
Sbjct: 109 EIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHI----KIADFGMCKENIFGGKTTRTFCGT 164
Query: 1215 LPWMAPELL 1223
++APE++
Sbjct: 165 PDYIAPEII 173
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 45/185 (24%), Positives = 85/185 (45%), Gaps = 27/185 (14%)
Query: 1048 KELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
K++G G F VY VA+K+++ + Q+ + +E ++L +L+HP
Sbjct: 8 KKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCV-----KEIDLLKQLNHP 62
Query: 1106 NVVAFY-GVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-------IAMDA 1157
NV+ + ++D L V E G L ++ ++ ++KRLI +
Sbjct: 63 NVIKYLDSFIEDN---ELNIVLELADAGDLSQMI----KYFKKQKRLIPERTVWKYFVQL 115
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTGGVRGTLP 1216
+E++HS+ ++H D+K N+ + + K+GD GL + T + GT
Sbjct: 116 CSAVEHMHSRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAHSLVGTPY 171
Query: 1217 WMAPE 1221
+M+PE
Sbjct: 172 YMSPE 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 52/194 (26%), Positives = 85/194 (43%), Gaps = 38/194 (19%)
Query: 1042 EDLEELKELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
D E ++ +GSGT+G VY + G A+K IK S Q+ E ++
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQ--------EIFMV 60
Query: 1100 SKLHHPNVVAFYG----------VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRK 1149
+ H N+VA++G ++ GG+L + + V G L + ++
Sbjct: 61 KECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDI--YHVTGPLSELQIA--------- 109
Query: 1150 RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL-SKIKRNTLVT 1208
+ + G+ YLHSK +H D+K N+L+ + K+ DFG+ +KI
Sbjct: 110 --YVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDV----KLADFGVAAKITATIAKR 163
Query: 1209 GGVRGTLPWMAPEL 1222
GT WMAPE+
Sbjct: 164 KSFIGTPYWMAPEV 177
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 47/189 (24%), Positives = 72/189 (38%), Gaps = 29/189 (15%)
Query: 1048 KELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 1107
K + K T VA+K+I S +E L L +E +L HPN+
Sbjct: 8 KCFEDLMIVHLAKHKPTNTLVAVKKINLD-----SCSKEDLKLLQ-QEIITSRQLQHPNI 61
Query: 1108 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM---DAAFGMEYL 1164
+ + L V+ M GS L K + L IA D ++Y+
Sbjct: 62 LPYVTSFIVD--SELYVVSPLMAYGSCE--DLLKTHFPEGLPELAIAFILKDVLNALDYI 117
Query: 1165 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-------KIKRNTLVTGGVRGT--- 1214
HSK +H +K ++L + KV GL KR +V + +
Sbjct: 118 HSKGFIHRSVKASHIL------LSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN 171
Query: 1215 LPWMAPELL 1223
LPW++PE+L
Sbjct: 172 LPWLSPEVL 180
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 41/162 (25%), Positives = 76/162 (46%), Gaps = 16/162 (9%)
Query: 1043 DLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100
L+ +G G+FG + +D A+K I+ + + E R +EA +L+
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSR------KEAVLLA 53
Query: 1101 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL-RHVLLSKERHLDRRKRLIIAMDAAF 1159
K+ HPN+VAF + G L V E+ G L + + L + + L +
Sbjct: 54 KMKHPNIVAFKESFE--ADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL 111
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201
G++++H K ++H D+K N+ + + K+GDFG +++
Sbjct: 112 GVQHIHEKRVLHRDIKSKNIFLTQNGKV----KLGDFGSARL 149
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 5e-06
Identities = 51/194 (26%), Positives = 84/194 (43%), Gaps = 27/194 (13%)
Query: 1049 ELGSGTFGTVYHGKWRG----TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
++G GT+G VY K + D A+K+I E +++ RE +L +L H
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQI----------EGTGISMSACREIALLRELKH 57
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLL--------SKERHLDRRKRLIIAMD 1156
PNV++ V + + ++ L H++ K L R +
Sbjct: 58 PNVISLQKVFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 116
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVT----GGVR 1212
G+ YLH+ ++H DLK N+LV + P R K+ D G +++ + L V
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 1213 GTLPWMAPELLNGS 1226
T + APELL G+
Sbjct: 177 VTFWYRAPELLLGA 190
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 5e-06
Identities = 52/191 (27%), Positives = 84/191 (43%), Gaps = 21/191 (10%)
Query: 1049 ELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 1107
++G GT+G VY K + G D +K+ TG +++ RE +L +L HPNV
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-------ISMSACREIALLRELKHPNV 60
Query: 1108 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLL--------SKERHLDRRKRLIIAMDAAF 1159
+A V + + ++ L H++ K L R +
Sbjct: 61 IALQKVFLSHSDRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILD 119
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVT----GGVRGTL 1215
G+ YLH+ ++H DLK N+LV + P R K+ D G +++ + L V T
Sbjct: 120 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 1216 PWMAPELLNGS 1226
+ APELL G+
Sbjct: 180 WYRAPELLLGA 190
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 5e-06
Identities = 50/188 (26%), Positives = 82/188 (43%), Gaps = 15/188 (7%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
ED E LK +G G FG V K + D A+K + K R+ T F E ++L
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAE-----TACFREERDVL 55
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
+ + + QD L V ++ V G L +L E L +
Sbjct: 56 VNGDNQWITTLHYAFQDE--NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVI 113
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG--LSKIKRNTLVTGGVRGTLPW 1217
++ +H + VH D+K DN+L+++ IR + DFG L ++ T+ + GT +
Sbjct: 114 AIDSVHQLHYVHRDIKPDNILMDMNGHIR----LADFGSCLKLMEDGTVQSSVAVGTPDY 169
Query: 1218 MAPELLNG 1225
++PE+L
Sbjct: 170 ISPEILQA 177
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 5e-06
Identities = 54/183 (29%), Positives = 82/183 (44%), Gaps = 22/183 (12%)
Query: 1047 LKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
LK++GSG +G+V K G VAIK++ R + E +RE +L + H
Sbjct: 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLS------RPFQSEIFAKRAYRELTLLKHMQH 73
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER--HLDRRKRLIIAMDAAFGME 1162
NV+ V + +F + L K L K + G++
Sbjct: 74 ENVIGLLDVFTSAV--SGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLK 131
Query: 1163 YLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLSKIKRNTLVTGGVRGTLPWMAP 1220
Y+HS I+H DLK NL VN +D C K+ DFGL++ + +TG V T + AP
Sbjct: 132 YIHSAGIIHRDLKPGNLAVN-ED-----CELKILDFGLAR-HADAEMTGYVV-TRWYRAP 183
Query: 1221 ELL 1223
E++
Sbjct: 184 EVI 186
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 6e-06
Identities = 51/190 (26%), Positives = 92/190 (48%), Gaps = 25/190 (13%)
Query: 1042 EDLEELKELGSGTFGTV---YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
E + L +GSG +G+V Y + R VA+K++ + +S R T +RE +
Sbjct: 15 ERYQNLTPVGSGAYGSVCSAYDTRLR-QKVAVKKLSRPF---QSLIHARRT---YRELRL 67
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEF-----MVNGSLRHVLLSKERHLDRRKRLII 1153
L + H NV+ V P ++ E ++ L +++ ++ + + LI
Sbjct: 68 LKHMKHENVIGLLDVFT--PATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIY 125
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRG 1213
+ G++Y+HS I+H DLK N+ VN +R + DFGL++ + + +TG V
Sbjct: 126 QL--LRGLKYIHSAGIIHRDLKPSNVAVNEDCELR----ILDFGLAR-QADDEMTGYV-A 177
Query: 1214 TLPWMAPELL 1223
T + APE++
Sbjct: 178 TRWYRAPEIM 187
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 7e-06
Identities = 31/80 (38%), Positives = 41/80 (51%), Gaps = 7/80 (8%)
Query: 1145 LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR- 1203
LD L + A GM +L SKN +H DL N+L+ I K+ DFGL++ R
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR----ITKICDFGLARDIRN 266
Query: 1204 --NTLVTGGVRGTLPWMAPE 1221
N +V G R + WMAPE
Sbjct: 267 DSNYVVKGNARLPVKWMAPE 286
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-05
Identities = 46/159 (28%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 1042 EDLEELKELGSGTFGTV--YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
ED E LK +G G FG V K G A+K ++K+ E+E++ E +IL
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADML----EKEQVG-HIRAERDIL 55
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
+ VV + QD L + EF+ G + +L+ K+ + + IA +
Sbjct: 56 VEADSLWVVKMFYSFQDKL--NLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVL 112
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198
++ +H +H D+K DNLL++ K + K+ DFGL
Sbjct: 113 AIDSIHQLGFIHRDIKPDNLLLDSKGHV----KLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 2e-05
Identities = 32/90 (35%), Positives = 45/90 (50%), Gaps = 10/90 (11%)
Query: 1138 LLSKERHLDRRK-RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVN-LKDPIRPICKVGD 1195
LL KE L + + II + LH NI+H D+K +N+L + KD I +C D
Sbjct: 99 LLKKEGKLSEAEVKKII-RQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIY-LC---D 153
Query: 1196 FGLSKIKRNTLVTGGVRGTLPWMAPELLNG 1225
+GL KI T GTL + +PE + G
Sbjct: 154 YGLCKI-IGT--PSCYDGTLDYFSPEKIKG 180
|
Length = 267 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 3e-05
Identities = 48/188 (25%), Positives = 84/188 (44%), Gaps = 32/188 (17%)
Query: 1050 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAE---ILSKLHH 1104
+G G++ V + + T A+K IKK + E + W + E + +H
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVN----DDEDID---WVQTEKHVFETASNH 55
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL------IIAMDAA 1158
P +V + Q L V EF+ G L H+ R+++L + + +
Sbjct: 56 PFLVGLHSCFQTE--SRLFFVIEFVSGGDLMF-------HMQRQRKLPEEHARFYSAEIS 106
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-RNTLVTGGVRGTLPW 1217
+ +LH + I++ DLK DN+L++ + I K+ D+G+ K R T GT +
Sbjct: 107 LALNFLHERGIIYRDLKLDNVLLDAEGHI----KLTDYGMCKEGIRPGDTTSTFCGTPNY 162
Query: 1218 MAPELLNG 1225
+APE+L G
Sbjct: 163 IAPEILRG 170
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 4e-05
Identities = 45/159 (28%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 1042 EDLEELKELGSGTFGTV--YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+D E LK +G G FG V K G A+K ++K+ E+E++ E +IL
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML----EKEQVA-HIRAERDIL 55
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
+ VV + QD L + EF+ G + +L+ K+ + + IA +
Sbjct: 56 VEADGAWVVKMFYSFQDKR--NLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVL 112
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198
++ +H +H D+K DNLL++ K + K+ DFGL
Sbjct: 113 AIDAIHQLGFIHRDIKPDNLLLDAKGHV----KLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 4e-05
Identities = 28/80 (35%), Positives = 41/80 (51%), Gaps = 7/80 (8%)
Query: 1145 LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--- 1201
LD L + A GM++L SKN +H D+ N+L+ + K+ DFGL++
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR----VAKICDFGLARDIMN 264
Query: 1202 KRNTLVTGGVRGTLPWMAPE 1221
N +V G R + WMAPE
Sbjct: 265 DSNYVVKGNARLPVKWMAPE 284
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 5e-05
Identities = 50/200 (25%), Positives = 88/200 (44%), Gaps = 18/200 (9%)
Query: 1034 STLQIIKNEDLEELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLE 1091
ST ++K ++LK +GSG G V G +VA+K++ R + +
Sbjct: 15 STFTVLKR--YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKL------SRPFQNQTHAKR 66
Query: 1092 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH--LDRRK 1149
+RE +L ++H N+++ V P +L + + L L + H LD +
Sbjct: 67 AYRELVLLKCVNHKNIISLLNVFT--PQKSLEEFQDVYLVMELMDANLCQVIHMELDHER 124
Query: 1150 RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG 1209
+ G+++LHS I+H DLK N++V + K+ DFGL++ +
Sbjct: 125 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL----KILDFGLARTACTNFMMT 180
Query: 1210 GVRGTLPWMAPELLNGSSSK 1229
T + APE++ G K
Sbjct: 181 PYVVTRYYRAPEVILGMGYK 200
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 5e-05
Identities = 56/197 (28%), Positives = 88/197 (44%), Gaps = 37/197 (18%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTDVA-----------IKRIKKSCFTGRSSEQERLTL 1090
+D E LK +G G FG V K + T +KR + +CF +ER L
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACF-----REERDVL 55
Query: 1091 EFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSK--ERHLDRR 1148
+ ++ LH+ AF QD L V ++ V G L LLSK +R +
Sbjct: 56 VN-GDRRWITNLHY----AF----QD--ENNLYLVMDYYVGGDLL-TLLSKFEDRLPEDM 103
Query: 1149 KRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG--LSKIKRNTL 1206
R +A + ++ +H VH D+K DN+L++ IR + DFG L + T+
Sbjct: 104 ARFYLA-EMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIR----LADFGSCLRLLADGTV 158
Query: 1207 VTGGVRGTLPWMAPELL 1223
+ GT +++PE+L
Sbjct: 159 QSNVAVGTPDYISPEIL 175
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 5e-05
Identities = 50/188 (26%), Positives = 87/188 (46%), Gaps = 22/188 (11%)
Query: 1043 DLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQ----ERLTLEFWREA 1096
D L LG G+FG V + +GTD AIK +KK + E+ L +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 1097 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
L++LH F V + L V E++ G L + + + + + A +
Sbjct: 61 PFLTQLHS----CFQTVDR------LYFVMEYVNGGDLMY-HIQQVGKFKEPQAVFYAAE 109
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR-NTLVTGGVRGTL 1215
+ G+ +LH + I++ DLK DN++++ + I K+ DFG+ K + + T GT
Sbjct: 110 ISVGLFFLHRRGIIYRDLKLDNVMLDSEGHI----KIADFGMCKEHMVDGVTTRTFCGTP 165
Query: 1216 PWMAPELL 1223
++APE++
Sbjct: 166 DYIAPEII 173
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 6e-05
Identities = 54/202 (26%), Positives = 92/202 (45%), Gaps = 30/202 (14%)
Query: 1034 STLQIIKNEDLEELKELGSGTFGTV--YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLE 1091
ST ++K + LK +GSG G V + G +VAIK++ + F + +
Sbjct: 10 STFTVLKR--YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRP-FQNVTHAKRA---- 62
Query: 1092 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLAT------VTEFMVNGSLRHVLLSKERHL 1145
+RE ++ ++H N++ V P +L V E M + +L V+ H
Sbjct: 63 -YRELVLMKLVNHKNIIGLLNVFT--PQKSLEEFQDVYLVMELM-DANLCQVIQMDLDH- 117
Query: 1146 DRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLSKIKR 1203
+R L+ M G+++LHS I+H DLK N++V C K+ DFGL++
Sbjct: 118 ERMSYLLYQM--LCGIKHLHSAGIIHRDLKPSNIVVKSD------CTLKILDFGLARTAG 169
Query: 1204 NTLVTGGVRGTLPWMAPELLNG 1225
+ + T + APE++ G
Sbjct: 170 TSFMMTPYVVTRYYRAPEVILG 191
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 6e-05
Identities = 48/200 (24%), Positives = 88/200 (44%), Gaps = 18/200 (9%)
Query: 1034 STLQIIKNEDLEELKELGSGTFGTV--YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLE 1091
ST ++K + LK +GSG G V + +VAIK++ R + +
Sbjct: 11 STFTVLKR--YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS------RPFQNQTHAKR 62
Query: 1092 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSK--ERHLDRRK 1149
+RE ++ ++H N+++ V P +L + + L L + + LD +
Sbjct: 63 AYRELVLMKCVNHKNIISLLNVFT--PQKSLEEFQDVYLVMELMDANLCQVIQMELDHER 120
Query: 1150 RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG 1209
+ G+++LHS I+H DLK N++V + K+ DFGL++ + +
Sbjct: 121 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL----KILDFGLARTAGTSFMMT 176
Query: 1210 GVRGTLPWMAPELLNGSSSK 1229
T + APE++ G K
Sbjct: 177 PYVVTRYYRAPEVILGMGYK 196
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 7e-05
Identities = 48/186 (25%), Positives = 79/186 (42%), Gaps = 15/186 (8%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+D E +K +G G FG V K + T+ A+K + K R+ T F E +L
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAE-----TACFREERNVL 55
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
+ + QD L V ++ V G L +L E L +
Sbjct: 56 VNGDCQWITTLHYAFQDE--NYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVL 113
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG--LSKIKRNTLVTGGVRGTLPW 1217
+ +H + VH D+K DN+L+++ IR + DFG L + T+ + GT +
Sbjct: 114 AIHSIHQLHYVHRDIKPDNVLLDMNGHIR----LADFGSCLKMNQDGTVQSSVAVGTPDY 169
Query: 1218 MAPELL 1223
++PE+L
Sbjct: 170 ISPEIL 175
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 9e-05
Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 14/160 (8%)
Query: 1042 EDLEELKELGSGTFGTV--YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
ED +K +G G FG V K G A+K + KS ++++L E ++L
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKS----EMFKKDQLA-HVKAERDVL 55
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
++ P VV+ Y QD L + EF+ G L +L+ + + R +A +
Sbjct: 56 AESDSPWVVSLYYSFQDA--QYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMA-ECVL 112
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199
+E +H +H D+K DN+L++ I K+ DFGLS
Sbjct: 113 AIEAVHKLGFIHRDIKPDNILIDRGGHI----KLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-04
Identities = 47/182 (25%), Positives = 83/182 (45%), Gaps = 20/182 (10%)
Query: 1050 LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAE---ILSKLHH 1104
+G G++ V + + T+ A+K +KK ++ E + W + E +H
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELV----NDDEDID---WVQTEKHVFEQASNH 55
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYL 1164
P +V + Q L V E+ VNG + ++R L + + + + YL
Sbjct: 56 PFLVGLHSCFQTE--SRLFFVIEY-VNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 112
Query: 1165 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-RNTLVTGGVRGTLPWMAPELL 1223
H + I++ DLK DN+L++ + I K+ D+G+ K R T GT ++APE+L
Sbjct: 113 HERGIIYRDLKLDNVLLDSEGHI----KLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL 168
Query: 1224 NG 1225
G
Sbjct: 169 RG 170
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-04
Identities = 53/191 (27%), Positives = 90/191 (47%), Gaps = 27/191 (14%)
Query: 1042 EDLEELKELGSGTFGTV---YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
E + L +GSG +G+V + K G VA+K++ + +S + T +RE +
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTK-TGLRVAVKKLSRPF---QSIIHAKRT---YRELRL 69
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLAT------VTEFMVNGSLRHVLLSKERHLDRRKRLI 1152
L + H NV+ V P +L VT M L +++ ++ D + LI
Sbjct: 70 LKHMKHENVIGLLDVFT--PARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 126
Query: 1153 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR 1212
+ G++Y+HS +I+H DLK NL VN + K+ DFGL++ + + G
Sbjct: 127 YQI--LRGLKYIHSADIIHRDLKPSNLAVNEDCEL----KILDFGLARHTDDEMT--GYV 178
Query: 1213 GTLPWMAPELL 1223
T + APE++
Sbjct: 179 ATRWYRAPEIM 189
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 3e-04
Identities = 42/162 (25%), Positives = 71/162 (43%), Gaps = 26/162 (16%)
Query: 1045 EELKELGSGTFGTVYHGKWRGTDV----AIKRIKKSCFTGRSS----EQERLTLEFWREA 1096
++K +G G FG V R D A+K ++K+ R+ + ER
Sbjct: 4 VKIKTIGIGAFGEVCLV--RKVDTNALYAMKTLRKADVLMRNQAAHVKAER--------- 52
Query: 1097 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
+IL++ + VV Y QD L V +++ G + +L+ + R IA +
Sbjct: 53 DILAEADNEWVVKLYYSFQDK--DNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIA-E 109
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198
+E +H +H D+K DN+L++ I K+ DFGL
Sbjct: 110 LTCAIESVHKMGFIHRDIKPDNILIDRDGHI----KLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 3e-04
Identities = 48/180 (26%), Positives = 77/180 (42%), Gaps = 15/180 (8%)
Query: 1050 LGSGTFGTVYHGKWRGT-DV-AIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 1107
+G G FG V + + T D+ A+K +KKS + F E +ILS + P +
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKS-----VLLAQETVSFFEEERDILSISNSPWI 63
Query: 1108 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK 1167
QD L V E+ G L +L E D + + +H
Sbjct: 64 PQLQYAFQDK--DNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM 121
Query: 1168 NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVTGGVR-GTLPWMAPELLNG 1225
VH D+K +N+L++ I K+ DFG + ++ N +V + GT ++APE+L
Sbjct: 122 GYVHRDIKPENVLIDRTGHI----KLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTT 177
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|225023 COG2112, COG2112, Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 4e-04
Identities = 29/72 (40%), Positives = 35/72 (48%), Gaps = 13/72 (18%)
Query: 1044 LEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH 1103
L KEL GT VY G+WRG +VA+K R + R LE +EA+IL L
Sbjct: 24 LRVEKELAKGTTSVVYLGEWRGGEVALKV--------RRRDSPRRNLE--KEAKILEILA 73
Query: 1104 HPNV---VAFYG 1112
V V FYG
Sbjct: 74 GEGVTPEVYFYG 85
|
Length = 201 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 4e-04
Identities = 30/67 (44%), Positives = 38/67 (56%), Gaps = 7/67 (10%)
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKR--NTLVTGGVRGT 1214
A GME+L SKN VH DL N+L+ + + IC DFGL++ I R N + G
Sbjct: 249 ANGMEFLASKNCVHRDLAARNVLI-CEGKLVKIC---DFGLARDIMRDSNYISKGSTFLP 304
Query: 1215 LPWMAPE 1221
L WMAPE
Sbjct: 305 LKWMAPE 311
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 5e-04
Identities = 43/155 (27%), Positives = 69/155 (44%), Gaps = 14/155 (9%)
Query: 1046 ELKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH 1103
++K LG G FG V T A+K ++K R+ E +IL++
Sbjct: 5 KIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQ-----VAHVKAERDILAEAD 59
Query: 1104 HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEY 1163
+ VV Y QD L V +++ G + +L+ E + R IA + +E
Sbjct: 60 NEWVVKLYYSFQDKD--NLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-ELTLAIES 116
Query: 1164 LHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198
+H +H D+K DN+L++L I K+ DFGL
Sbjct: 117 VHKMGFIHRDIKPDNILIDLDGHI----KLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 6e-04
Identities = 48/200 (24%), Positives = 87/200 (43%), Gaps = 18/200 (9%)
Query: 1034 STLQIIKNEDLEELKELGSGTFGTV--YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLE 1091
ST ++K + LK +GSG G V + +VAIK++ R + +
Sbjct: 18 STFTVLKR--YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS------RPFQNQTHAKR 69
Query: 1092 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSK--ERHLDRRK 1149
+RE ++ ++H N++ V P +L + + L L + + LD +
Sbjct: 70 AYRELVLMKCVNHKNIIGLLNVFT--PQKSLEEFQDVYIVMELMDANLCQVIQMELDHER 127
Query: 1150 RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG 1209
+ G+++LHS I+H DLK N++V + K+ DFGL++ + +
Sbjct: 128 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL----KILDFGLARTAGTSFMMT 183
Query: 1210 GVRGTLPWMAPELLNGSSSK 1229
T + APE++ G K
Sbjct: 184 PYVVTRYYRAPEVILGMGYK 203
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 7e-04
Identities = 48/195 (24%), Positives = 80/195 (41%), Gaps = 28/195 (14%)
Query: 1048 KELGSGTFGTVYHGKWR----------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
+ LG GT +Y G + IK I K ++L F+ A
Sbjct: 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVL----DPSHRDISLAFFETAS 56
Query: 1098 ILSKLHHPNVVAFYGV-VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
++ ++ H ++V YGV V+D V EF+ G L + K L + +A
Sbjct: 57 MMRQVSHKHIVLLYGVCVRDVEN---IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQ 113
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLV---NLKDPIRPICKVGDFG--LSKIKRNTLVTGGV 1211
A + YL K++VH ++ N+L+ + P K+ D G ++ + R V
Sbjct: 114 LASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVE--- 170
Query: 1212 RGTLPWMAPELLNGS 1226
+PW+APE + S
Sbjct: 171 --RIPWIAPECVEDS 183
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 8e-04
Identities = 25/67 (37%), Positives = 39/67 (58%), Gaps = 7/67 (10%)
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNT--LVTGGVRGT 1214
A GME+L S+ +H DL N+L++ + + K+ DFGL++ I ++ + G R
Sbjct: 184 ARGMEFLASRKCIHRDLAARNILLSENN----VVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 1215 LPWMAPE 1221
L WMAPE
Sbjct: 240 LKWMAPE 246
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.002
Identities = 25/67 (37%), Positives = 39/67 (58%), Gaps = 7/67 (10%)
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNT--LVTGGVRGT 1214
A GME+L S+ +H DL N+L++ + + K+ DFGL++ I ++ + G R
Sbjct: 189 AKGMEFLASRKCIHRDLAARNILLSENN----VVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 1215 LPWMAPE 1221
L WMAPE
Sbjct: 245 LKWMAPE 251
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.002
Identities = 31/105 (29%), Positives = 50/105 (47%), Gaps = 6/105 (5%)
Query: 1122 LATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV 1181
L V E+ VNG + ++R L A + + +LH + I++ DLK DN+L+
Sbjct: 71 LFLVIEY-VNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLL 129
Query: 1182 NLKDPIRPICKVGDFGLSKIK-RNTLVTGGVRGTLPWMAPELLNG 1225
+ I K+ D+G+ K T GT ++APE+L G
Sbjct: 130 DADGHI----KLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG 170
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.002
Identities = 38/137 (27%), Positives = 62/137 (45%), Gaps = 22/137 (16%)
Query: 1095 EAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVN--GSLRHVLLSKERHLDRRKRLI 1152
EA IL ++HP+++ G T T ++ + + L+ +R++ L
Sbjct: 133 EAHILRAINHPSIIQLKGTF------TYNKFTCLILPRYKTDLYCYLAAKRNIAICDILA 186
Query: 1153 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP--ICKVGDFGLS----KIKRNTL 1206
I ++YLH I+H D+K +N+ +N P +C +GDFG + I N
Sbjct: 187 IERSVLRAIQYLHENRIIHRDIKAENIFIN-----HPGDVC-LGDFGAACFPVDINANKY 240
Query: 1207 VTGGVRGTLPWMAPELL 1223
G GT+ APELL
Sbjct: 241 Y--GWAGTIATNAPELL 255
|
Length = 391 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.002
Identities = 27/67 (40%), Positives = 35/67 (52%), Gaps = 7/67 (10%)
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI---KRNTLVTGGVRGT 1214
A GME+L SKN VH DL N+L+ I K+ DFGL++ N + G
Sbjct: 247 ARGMEFLASKNCVHRDLAARNVLLAQGK----IVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 1215 LPWMAPE 1221
+ WMAPE
Sbjct: 303 VKWMAPE 309
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.004
Identities = 44/165 (26%), Positives = 69/165 (41%), Gaps = 27/165 (16%)
Query: 1050 LGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 1107
+G G++G V G VAIK+I F S L RE ++L L HP++
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKIN-DVFEHVSDATRIL-----REIKLLRLLRHPDI 61
Query: 1108 VAFYGVV--------QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
V ++ +D + V E M S H ++ L
Sbjct: 62 VEIKHIMLPPSRREFKD-----IYVVFELM--ESDLHQVIKANDDLTPEHHQFFLYQLLR 114
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 1204
++Y+H+ N+ H DLK N+L N ++ IC DFGL+++ N
Sbjct: 115 ALKYIHTANVFHRDLKPKNILANADCKLK-IC---DFGLARVAFN 155
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1236 | |||
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| cd06410 | 97 | PB1_UP2 Uncharacterized protein 2. The PB1 domain | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.98 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 99.97 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.97 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.97 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.97 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.96 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.96 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.96 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.96 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.96 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.96 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.95 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.95 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.95 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.95 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.95 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.95 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.95 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.95 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.95 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.95 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.95 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.95 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.95 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.95 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.95 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.95 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.95 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.95 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.95 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.95 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.95 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.95 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.95 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.94 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.94 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.94 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.94 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.94 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.94 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.94 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.94 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.94 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.94 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.94 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.94 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.94 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.94 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.94 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.94 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.94 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.94 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.94 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.94 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.94 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.94 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.94 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.94 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.94 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.94 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.94 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.94 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.94 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.94 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.94 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.93 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.93 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.93 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.93 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.93 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.93 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.93 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.93 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.93 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.93 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.93 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.93 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.93 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.93 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.93 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.93 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.93 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.93 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.93 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.93 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.93 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.93 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.93 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.93 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.93 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.93 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.93 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.93 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.93 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.92 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.92 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.92 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.92 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.92 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.92 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.92 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.92 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.92 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.92 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.92 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.92 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.92 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.92 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.92 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.92 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.92 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.92 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.92 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.92 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.92 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.92 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.92 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.92 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.92 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.92 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.92 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.92 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.92 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.92 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.92 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.92 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.92 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.92 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.92 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.92 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.92 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.92 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.92 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.92 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.92 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.92 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.92 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.92 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.92 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.92 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.92 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.92 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.92 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.92 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.91 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.91 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.91 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.91 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.91 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.91 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.91 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.91 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.91 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.91 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.91 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.91 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.91 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.91 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.91 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.91 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.91 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.91 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.91 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.91 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.91 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.91 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.91 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.91 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.91 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.91 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.91 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.91 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.91 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.91 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.91 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.91 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.91 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.91 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.91 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.91 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.91 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.91 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.91 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.91 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.91 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.91 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.9 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.9 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.9 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.9 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.9 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.9 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.9 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.9 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.9 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.9 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.9 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.9 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.9 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.9 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.9 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.9 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.9 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.9 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.9 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.9 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.9 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.9 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.9 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.9 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.9 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.9 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.9 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.9 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.9 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.9 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.9 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.9 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.9 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.9 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.89 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.89 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.89 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.89 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.89 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.89 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.89 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.89 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.89 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.89 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.89 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.89 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.89 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.89 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.89 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.89 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.89 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.89 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.89 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.88 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.88 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.88 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.88 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.88 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.88 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.88 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.88 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.88 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.88 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.88 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.88 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.88 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.88 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.88 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.88 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.87 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.87 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.87 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.87 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.87 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.87 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.87 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.87 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.87 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.86 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.86 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.86 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.86 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.86 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.86 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.85 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.85 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.85 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.85 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.85 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.84 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.84 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.83 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.83 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.82 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.82 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.82 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.82 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.81 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.81 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.8 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.8 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.79 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.78 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.76 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.76 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.76 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.74 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.73 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.73 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.7 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.68 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.67 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.67 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.66 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.66 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.65 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.64 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.59 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.56 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.56 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.56 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.52 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.47 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.43 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.41 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.36 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.29 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.24 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.16 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.16 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.12 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.1 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.1 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.08 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.03 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.01 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.97 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.92 | |
| smart00666 | 81 | PB1 PB1 domain. Phox and Bem1p domain, present in | 98.8 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 98.77 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.77 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 98.76 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 98.69 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.59 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.58 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.5 | |
| PF00564 | 84 | PB1: PB1 domain; InterPro: IPR000270 The Phox and | 98.29 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.26 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.2 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.18 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.15 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.13 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.11 | |
| cd05992 | 81 | PB1 The PB1 domain is a modular domain mediating s | 98.1 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.08 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.99 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 97.96 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.85 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 97.74 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.71 | |
| cd06407 | 82 | PB1_NLP A PB1 domain is present in NIN like protei | 97.67 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.67 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.66 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.6 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.59 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 97.55 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.53 | |
| cd06405 | 79 | PB1_Mekk2_3 The PB1 domain is present in the two m | 97.31 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.2 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.15 | |
| cd06408 | 86 | PB1_NoxR The PB1 domain is present in the Epichloe | 97.15 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.14 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.77 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.56 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.54 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.49 | |
| cd00173 | 94 | SH2 Src homology 2 domains; Signal transduction, i | 96.35 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.34 | |
| cd06396 | 81 | PB1_NBR1 The PB1 domain is an essential part of NB | 96.18 | |
| cd06398 | 91 | PB1_Joka2 The PB1 domain is present in the Nicotia | 96.11 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.09 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.08 | |
| PF00017 | 77 | SH2: SH2 domain; InterPro: IPR000980 The Src homol | 95.98 | |
| cd06404 | 83 | PB1_aPKC PB1 domain is an essential modular domain | 95.98 | |
| KOG3601 | 222 | consensus Adaptor protein GRB2, contains SH2 and S | 95.93 | |
| cd06401 | 81 | PB1_TFG The PB1 domain found in TFG protein, an on | 95.92 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 95.74 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.46 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.25 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.94 | |
| smart00252 | 84 | SH2 Src homology 2 domains. Src homology 2 domains | 94.92 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 94.45 | |
| PLN02236 | 344 | choline kinase | 94.4 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 94.33 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 94.12 | |
| cd06397 | 82 | PB1_UP1 Uncharacterized protein 1. The PB1 domain | 93.95 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 93.87 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 93.75 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 92.79 |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=351.89 Aligned_cols=332 Identities=28% Similarity=0.359 Sum_probs=247.3
Q ss_pred HHHHHHHhhcccccccccCCCCccccc----cccccCCCcccccccccccccccccchhhhhc----cCCCccccccccc
Q 000893 862 SDIFTKARISENIAGVSPMHGDGAVLS----WNVENHDPRRWSYFRNLAQDEFSRKDVSLMDQ----DHLGFSSPLTNIE 933 (1236)
Q Consensus 862 ~d~~~~~~~s~~~~~~~p~~~~~~~~s----~~v~~~~~~~wsyyhGl~~~~l~R~D~E~LL~----~~GdFLVRLSEiq 933 (1236)
-+||.++....+..++.|.|.-+...+ .+++.++ ||||- |+|+++|++|. ..|.|+||.+|..
T Consensus 45 ~~Ww~ar~~~~~~~g~ip~N~v~~~~~~~~~~~l~~~~-----Wf~~~----isR~~ae~~ll~p~~~~G~flvR~se~~ 115 (468)
T KOG0197|consen 45 GDWWRARSLQLGQEGYIPSNYVARNRGSPAFIKLSDEP-----WFFGK----ISREEAERQLLAPENKEGAFLVRESESD 115 (468)
T ss_pred hhHHHHHHhhcCCCCcCcCceeeccccCCCccccccCC-----chhcc----ccHHHHHHhhcCCCCCccceeeecccCC
Confidence 489999999999999999993333211 6799999 99999 99999996663 3589999999998
Q ss_pred CCccccccCCCCCCCCCCCCCCCCceeeccCccCCCCcccCCCCCcCCCCCCcccccCCccchhHHHhhhccccccccCC
Q 000893 934 EGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQRESSSIVGPSTMETHPDYSRSELKGNESLQSEVVNHRIQESDYEEGR 1013 (1236)
Q Consensus 934 ~G~TlD~S~n~L~~~pSvmP~sgS~lNf~I~S~~esssl~gPSs~eThp~~s~s~L~g~eSLQsElVnhrIqEsd~ee~r 1013 (1236)
.| ||+..-..... ...+..+.|++|..........-+. ...-..+ ..++++++.........+
T Consensus 116 ~g---~yslsv~~~~~--~~~~~~v~hyri~~~~~~~~~~~~~-----------~~~~F~~-l~~lv~~~~~~~~gl~~~ 178 (468)
T KOG0197|consen 116 KG---DYSLSVREGDS--GGLGAKVKHYRIRQLDGGGLYPYID-----------ERELFSS-LQQLVNYYSKNADGLCTR 178 (468)
T ss_pred cC---CeeEEEEeccc--cCCccceeeeeeeEcCCCCeecCCC-----------HHHhhhh-HHHHHhhhhccCcchhhc
Confidence 88 45542222111 1134457899886665543331111 1111112 237778887777777766
Q ss_pred CCCCCCCCCccccccCCCCc-cccccccccCeeEEEEeccCCceEEEEeeecCc-eEEEEeeeccccCCCChHHHHHHHH
Q 000893 1014 LDLPTAGIPLVDLALGNFDI-STLQIIKNEDLEELKELGSGTFGTVYHGKWRGT-DVAIKRIKKSCFTGRSSEQERLTLE 1091 (1236)
Q Consensus 1014 LdLPt~g~PL~dlal~nfd~-seLqiIs~EdYeiLkkLGsGSFGtVYKArlkG~-~VAVKvLkk~~i~~~~~e~er~~ke 1091 (1236)
+..|.....- ......+. ...|.+..+.+++++.||+|-||.||+|.+++. .||||.++..... ...
T Consensus 179 l~~p~~~~~~--~~p~~~~~~~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~---------~~~ 247 (468)
T KOG0197|consen 179 LRDPCSKQGH--TKPQTPDLARDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS---------PEA 247 (468)
T ss_pred ccCchhccCC--CCCCCCccccCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC---------hhH
Confidence 6666542210 00111111 456678888899999999999999999999877 7999999865322 346
Q ss_pred HHHHHHHHhhCCCCceeeEeeeEecCCCCeEEEEEeeccCCCHHHHHhh-hccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 000893 1092 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLS-KERHLDRRKRLIIAMDAAFGMEYLHSKNIV 1170 (1236)
Q Consensus 1092 FlrEIrILskLrHPNIVrLyG~f~t~~~g~L~LVMEYm~GGSL~dlL~~-k~r~LSe~erl~Ia~QIAeALaYLHSkGII 1170 (1236)
|.+|+.+|++|+|+|||+|+++|.... .++||||||+.|+|.++|+. .+..+...+.+.|+.|||+||+||.++++|
T Consensus 248 f~~Ea~iMk~L~H~~lV~l~gV~~~~~--piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~I 325 (468)
T KOG0197|consen 248 FLREAQIMKKLRHEKLVKLYGVCTKQE--PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYI 325 (468)
T ss_pred HHHHHHHHHhCcccCeEEEEEEEecCC--ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCcc
Confidence 889999999999999999999999854 89999999999999999987 566889999999999999999999999999
Q ss_pred cCCCCCCcEEEccCCCCCCcEEEEeccCcccccCcccc--cCcCCCCcccchhhhcC-CCCCCCccccC
Q 000893 1171 HFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVT--GGVRGTLPWMAPELLNG-SSSKVSEKVCF 1236 (1236)
Q Consensus 1171 HRDIKPsNILLDsdG~I~ltVKLsDFGLArii~ns~~t--ss~~GTp~YmAPEVL~G-ss~~~SdDVDI 1236 (1236)
||||.++||||+.+. .|||+|||||+...+...+ ..-.-...|.|||.|.. .....|+.|+|
T Consensus 326 HRDLAARNiLV~~~~----~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSF 390 (468)
T KOG0197|consen 326 HRDLAARNILVDEDL----VVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSF 390 (468)
T ss_pred chhhhhhheeeccCc----eEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeeh
Confidence 999999999999885 8899999999976554432 22233566999999984 44445555654
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=337.17 Aligned_cols=291 Identities=29% Similarity=0.389 Sum_probs=211.2
Q ss_pred cccccccccCCCcccccccccccccccccchhhhhccCCCcccccccccCCccccc-cCCCCCCCCCCCCC-CCCceeec
Q 000893 885 AVLSWNVENHDPRRWSYFRNLAQDEFSRKDVSLMDQDHLGFSSPLTNIEEGATVDY-SYPPLKPDGSVMPQ-SGSRINFD 962 (1236)
Q Consensus 885 ~~~s~~v~~~~~~~wsyyhGl~~~~l~R~D~E~LL~~~GdFLVRLSEiq~G~TlD~-S~n~L~~~pSvmP~-sgS~lNf~ 962 (1236)
..++..+.+.+ ||||+ ++|.|++.||+++||||||.++...|...-+ .. |+++. .....||.
T Consensus 40 ~~~~~~~~~~~-----~yHG~----l~red~~~lL~~~GDfLvR~s~~~~~~~~~~~vl-------Sv~~~~~~~~~h~v 103 (474)
T KOG0194|consen 40 EFIEKDLRELP-----YYHGL----LPREDAEKLLKNDGDFLVRASEPKEGEKREFVVL-------SVKWSVFKKIKHYV 103 (474)
T ss_pred HHhhhHhhcCc-----ccccc----ccHhHHHHHhCCCCceEEEeecccCCcceeEEEE-------EEEeecCCceeEEE
Confidence 34444566678 99999 9999999999999999999999987744322 22 34442 11235777
Q ss_pred cCccCCCCcccCCCCCcCCCCCCcccccCCccchhHHHhhhccccccccCCCCCCCCCCCccccccCCCCcccccccccc
Q 000893 963 EGSQRESSSIVGPSTMETHPDYSRSELKGNESLQSEVVNHRIQESDYEEGRLDLPTAGIPLVDLALGNFDISTLQIIKNE 1042 (1236)
Q Consensus 963 I~S~~esssl~gPSs~eThp~~s~s~L~g~eSLQsElVnhrIqEsd~ee~rLdLPt~g~PL~dlal~nfd~seLqiIs~E 1042 (1236)
+....+.....+ .....++. ++++++.......... . ..+...-...-|++..+
T Consensus 104 i~~~~~~~~~~~--------------~~~F~si~-~li~~~~~~~~~~~~~------~-----~~L~~PI~r~~Wel~H~ 157 (474)
T KOG0194|consen 104 IKRNGNLFFFEG--------------LRKFPTIS-ELVNYYKFSKLEITGK------N-----FFLKRPIPRQKWELSHS 157 (474)
T ss_pred EEEcCCeeEEec--------------cccCCcHH-HHHHHHHhcccceecc------c-----eeecccccccccEEecc
Confidence 755544111111 11112222 5555554332211110 0 01111112345778888
Q ss_pred CeeEEEEeccCCceEEEEeeecC-----ce-EEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEec
Q 000893 1043 DLEELKELGSGTFGTVYHGKWRG-----TD-VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArlkG-----~~-VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t 1116 (1236)
+..+.++||+|+||.||+|+++- .. ||||..+... ...+....+|++|+++|+.++|||||++||++..
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~-----~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~ 232 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSS-----ELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL 232 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccc-----cccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence 88899999999999999999841 13 8999887522 1245567889999999999999999999999988
Q ss_pred CCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEec
Q 000893 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1236)
Q Consensus 1117 ~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDF 1196 (1236)
.. .+++|||+|.||+|.++|...+..++..++..++.+++.||+|||++++|||||..+|+|+..++ ++||+||
T Consensus 233 ~~--Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~----~vKISDF 306 (474)
T KOG0194|consen 233 EE--PLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKG----VVKISDF 306 (474)
T ss_pred CC--ccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCC----eEEeCcc
Confidence 65 89999999999999999988777899999999999999999999999999999999999999875 5799999
Q ss_pred cCcccccCcccccCc-CCCCcccchhhhcCCCC
Q 000893 1197 GLSKIKRNTLVTGGV-RGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1197 GLArii~ns~~tss~-~GTp~YmAPEVL~Gss~ 1228 (1236)
||++........... .-...|+|||.+....+
T Consensus 307 GLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~ 339 (474)
T KOG0194|consen 307 GLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIF 339 (474)
T ss_pred ccccCCcceeeccccccCcceecChhhhccCcc
Confidence 999876532222212 24578999999986544
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=327.22 Aligned_cols=183 Identities=30% Similarity=0.502 Sum_probs=160.6
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
.+|.+.++||+|+|++||+|++ ++..||||.+.+..+ ..+....+..|+.+|+.++|||||+|++++.+++
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l------~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~- 82 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL------NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD- 82 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc------CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC-
Confidence 5788899999999999999998 478899999987643 2344556788999999999999999999999865
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCC--CcEEEEecc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIR--PICKVGDFG 1197 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~--ltVKLsDFG 1197 (1236)
.+|||||||.||+|..+|+.++ .+++..++.++.||+.||++||+++||||||||+||||....... .++||+|||
T Consensus 83 -~i~lVMEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 83 -FIYLVMEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred -eEEEEEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 9999999999999999997654 699999999999999999999999999999999999998862222 589999999
Q ss_pred CcccccCcccccCcCCCCcccchhhhcCCCCCCCcccc
Q 000893 1198 LSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVC 1235 (1236)
Q Consensus 1198 LArii~ns~~tss~~GTp~YmAPEVL~Gss~~~SdDVD 1235 (1236)
+|+.+.......++||+|.|||||+++.. .|+.+.|
T Consensus 161 fAR~L~~~~~a~tlcGSplYMAPEV~~~~--~YdAKAD 196 (429)
T KOG0595|consen 161 FARFLQPGSMAETLCGSPLYMAPEVIMSQ--QYDAKAD 196 (429)
T ss_pred hhhhCCchhHHHHhhCCccccCHHHHHhc--cccchhh
Confidence 99999988888999999999999999865 4555544
|
|
| >cd06410 PB1_UP2 Uncharacterized protein 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=272.15 Aligned_cols=95 Identities=61% Similarity=1.053 Sum_probs=90.9
Q ss_pred EeecCCccccCCCCCCeeeecCceeEEEecCCCChHHHHHHHHHHcCCc--eEEEEecCCCCCCceeeccChHHHHHHHH
Q 000893 189 LCSFGGKILPRPSDGKLRYVGGETRIIRISRDISWQELTQKALAIYNQT--HTIKYQLPGEDLDALVSVSCDEDLQNMME 266 (1236)
Q Consensus 189 mcSyGG~I~pr~~d~~L~YvGGetriv~V~r~~sf~~l~~kl~~~~~~~--~~lKYqLP~edLDaLiSVt~DeDL~~M~~ 266 (1236)
||||||||+|||+||+|+|+||+|||++|+|+++|+||+.||+++++.. ++||||||+||||+||||++||||+|||+
T Consensus 1 ~cs~GG~i~pr~~dg~l~Y~GG~tr~i~V~r~~s~~el~~kl~~~~~~~~~~~lky~Lp~edld~Lisv~~DeDl~~M~~ 80 (97)
T cd06410 1 LCSYGGRILPRPPDGQLRYVGGETRIVSVDRSISFKELVSKLSELFGAGVVVTLKYQLPDEDLDALISVSNDEDLKNMME 80 (97)
T ss_pred CcccCCEEeCcCCCCCEEEcCCceEEEEEcCCCCHHHHHHHHHHHhCCCCceEEEEEcCCCCcceeEEecCcHHHHHHHH
Confidence 8999999999999999999999999999999999999999999999855 59999999999999999999999999999
Q ss_pred HhhhccccCCCCcEEEEc
Q 000893 267 ECNVLEDRGTQKPRMFLF 284 (1236)
Q Consensus 267 Eydr~~~~~~~~~R~fLF 284 (1236)
||||+ +..++|+|+|||
T Consensus 81 e~~~~-~~~~~rirvflf 97 (97)
T cd06410 81 EYDRL-SGGSARLRVFLF 97 (97)
T ss_pred hhccc-cCCCceEEEEEC
Confidence 99999 556679999998
|
The PB1 domain is a modular domain mediating specific protein-protein interaction which play a role in many critical cell processes such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. |
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=312.87 Aligned_cols=185 Identities=30% Similarity=0.422 Sum_probs=161.6
Q ss_pred cccccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEe
Q 000893 1038 IIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 1115 (1236)
Q Consensus 1038 iIs~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~ 1115 (1236)
.+..++|+++++||+|+||+||+++. +++.+|+|++++..+... ........|..+|..++||+||.++..|+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~-----~e~~~~~~Er~IL~~v~hPFiv~l~ysFQ 95 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK-----KEVRHTKAERNILSKIKHPFIVKLIYSFQ 95 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh-----hhHHHHHHHHHHHHhCCCCcEeeeEEecc
Confidence 45678999999999999999999987 577899999999877643 23455678999999999999999999999
Q ss_pred cCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEe
Q 000893 1116 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1236)
Q Consensus 1116 t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsD 1195 (1236)
+.. .+|||+||+.||.|..+|.+ ++.+++..++.++.+|+.||.|||++|||||||||+||||+.+| +++|+|
T Consensus 96 t~~--kLylVld~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~G----Hi~LtD 168 (357)
T KOG0598|consen 96 TEE--KLYLVLDYLNGGELFYHLQR-EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQG----HIKLTD 168 (357)
T ss_pred cCC--eEEEEEeccCCccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCC----cEEEec
Confidence 965 99999999999999999964 55788998888999999999999999999999999999999998 459999
Q ss_pred ccCcccc-cCcccccCcCCCCcccchhhhcCCCCCCCccc
Q 000893 1196 FGLSKIK-RNTLVTGGVRGTLPWMAPELLNGSSSKVSEKV 1234 (1236)
Q Consensus 1196 FGLArii-~ns~~tss~~GTp~YmAPEVL~Gss~~~SdDV 1234 (1236)
||||+.. .....+.++|||+.|||||++.+..+....||
T Consensus 169 FgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDW 208 (357)
T KOG0598|consen 169 FGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDW 208 (357)
T ss_pred cccchhcccCCCccccccCCccccChHHHhcCCCCcccch
Confidence 9999964 45556677999999999999999866655554
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=309.95 Aligned_cols=192 Identities=31% Similarity=0.368 Sum_probs=162.2
Q ss_pred ccccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEec
Q 000893 1039 IKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1236)
Q Consensus 1039 Is~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t 1116 (1236)
...+.|.+.+.||+|+||.|-+|.. +|+.||||++.+........ .........+|+++|++|+|||||+++++|..
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~-~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~ 247 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSR-AIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV 247 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccc-cccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence 3456789999999999999999987 58899999999887655332 11122335789999999999999999999998
Q ss_pred CCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEec
Q 000893 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1236)
Q Consensus 1117 ~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDF 1196 (1236)
++ ..|+||||+.||.|.+.+..++ .+.+...+.+++|++.||.|||++||+||||||+||||..+... ..+||+||
T Consensus 248 ~d--s~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~-~llKItDF 323 (475)
T KOG0615|consen 248 PD--SSYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAED-CLLKITDF 323 (475)
T ss_pred CC--ceEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcc-eEEEeccc
Confidence 76 7899999999999999997654 57788889999999999999999999999999999999877432 47899999
Q ss_pred cCcccccCcccccCcCCCCcccchhhhcCCCCCCCc-ccc
Q 000893 1197 GLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSE-KVC 1235 (1236)
Q Consensus 1197 GLArii~ns~~tss~~GTp~YmAPEVL~Gss~~~Sd-DVD 1235 (1236)
|+|+.........++||||.|.|||++.+....+.. ++|
T Consensus 324 GlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVD 363 (475)
T KOG0615|consen 324 GLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVD 363 (475)
T ss_pred chhhccccceehhhhcCCccccChhheecCCeecccchhe
Confidence 999999888888899999999999999866554444 444
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=306.58 Aligned_cols=191 Identities=50% Similarity=0.771 Sum_probs=161.7
Q ss_pred cccccccCeeEEEEeccCCceEEEEeeecCce-EEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeE
Q 000893 1036 LQIIKNEDLEELKELGSGTFGTVYHGKWRGTD-VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVV 1114 (1236)
Q Consensus 1036 LqiIs~EdYeiLkkLGsGSFGtVYKArlkG~~-VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f 1114 (1236)
.+.+...++.+.+.||+|+||+||+|.++|+. ||||++....... . ....|.+|+.+|.+++|||||+++|+|
T Consensus 35 ~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~-----~-~~~~f~~E~~il~~l~HpNIV~f~G~~ 108 (362)
T KOG0192|consen 35 EEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDD-----E-SRKAFRREASLLSRLRHPNIVQFYGAC 108 (362)
T ss_pred ceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcCh-----H-HHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 34555666777778999999999999999999 9999998653221 1 167899999999999999999999999
Q ss_pred ecCCCCeEEEEEeeccCCCHHHHHhh-hccCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCCCcEEEccCCCCCCcEE
Q 000893 1115 QDGPGGTLATVTEFMVNGSLRHVLLS-KERHLDRRKRLIIAMDAAFGMEYLHSKN-IVHFDLKCDNLLVNLKDPIRPICK 1192 (1236)
Q Consensus 1115 ~t~~~g~L~LVMEYm~GGSL~dlL~~-k~r~LSe~erl~Ia~QIAeALaYLHSkG-IIHRDIKPsNILLDsdG~I~ltVK 1192 (1236)
..+. ..+++|||||++|+|..++.. ....+++..++.|+.+|++||.|||+++ ||||||||+||||+.++ .++|
T Consensus 109 ~~~~-~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~---~~~K 184 (362)
T KOG0192|consen 109 TSPP-GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG---KTLK 184 (362)
T ss_pred cCCC-CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC---CEEE
Confidence 9864 268999999999999999988 4788999999999999999999999999 99999999999999885 3789
Q ss_pred EEeccCcccccCc-ccccCcCCCCcccchhhhcCCCCCCCccccC
Q 000893 1193 VGDFGLSKIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVCF 1236 (1236)
Q Consensus 1193 LsDFGLArii~ns-~~tss~~GTp~YmAPEVL~Gss~~~SdDVDI 1236 (1236)
|+|||+++..... ...+...||+.|||||+|++....++.++|+
T Consensus 185 I~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~Dv 229 (362)
T KOG0192|consen 185 IADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDV 229 (362)
T ss_pred ECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchh
Confidence 9999999987654 3334478999999999999653456666553
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=314.04 Aligned_cols=338 Identities=26% Similarity=0.402 Sum_probs=256.1
Q ss_pred cCCCCCceeEeCCCCCeeeecCCcCChhhHHHHHHHHhhcccccccccCCCCccccccccccCCCccccccccccccccc
Q 000893 832 VSPGDSSIAVVSPEGDILIDINDRFPRDFLSDIFTKARISENIAGVSPMHGDGAVLSWNVENHDPRRWSYFRNLAQDEFS 911 (1236)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~s~~~~~~~p~~~~~~~~s~~v~~~~~~~wsyyhGl~~~~l~ 911 (1236)
|.-||..+-..+-++=-|.+.|.- -+|-+++ +.|-||..|.| +-..-..|++|. ||||. ++
T Consensus 100 vasGdntLSitKGeklRvLGYN~N------gEWcEar--tKNGqGWVPSN--yItPvNSLeKhs-----WYHGp----vS 160 (1157)
T KOG4278|consen 100 VASGDNTLSITKGEKLRVLGYNKN------GEWCEAR--TKNGQGWVPSN--YITPVNSLEKHS-----WYHGP----VS 160 (1157)
T ss_pred eccccceeeeecCceEEEeeecCC------Ccceeec--ccCCCcccccc--ccccccchhhcc-----cccCc----cc
Confidence 455777666666666666777754 3566665 58899999999 666667799999 99999 99
Q ss_pred ccchhhhhcc--CCCcccccccccCCccccccCCCCCCCCCCCCCCCCceeeccCccCCCCcccCCCCCcCCCCCCcccc
Q 000893 912 RKDVSLMDQD--HLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQRESSSIVGPSTMETHPDYSRSEL 989 (1236)
Q Consensus 912 R~D~E~LL~~--~GdFLVRLSEiq~G~TlD~S~n~L~~~pSvmP~sgS~lNf~I~S~~esssl~gPSs~eThp~~s~s~L 989 (1236)
|.++|.+|.. +|+||||.+|..+|+ |++ .|+ ..|.+.||.|........++... +.+
T Consensus 161 RsaaEy~LsSgInGSFLVRESEsSpgQ---~sI-SlR-------yeGRVyHYRINt~~dgK~yvt~E-----srF----- 219 (1157)
T KOG4278|consen 161 RSAAEYILSSGINGSFLVRESESSPGQ---YSI-SLR-------YEGRVYHYRINTDNDGKMYVTQE-----SRF----- 219 (1157)
T ss_pred cchhhhhhhcCcccceEEeeccCCCcc---eeE-EEE-------ecceEEEEEeeccCCccEEEeeh-----hhh-----
Confidence 9999999976 999999999999994 444 222 44567999996666555544111 111
Q ss_pred cCCccchhHHHhhhccccccccCCCCCCCCCCCccccccCCCCccccccccccCeeEEEEeccCCceEEEEeeecC--ce
Q 000893 990 KGNESLQSEVVNHRIQESDYEEGRLDLPTAGIPLVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRG--TD 1067 (1236)
Q Consensus 990 ~g~eSLQsElVnhrIqEsd~ee~rLdLPt~g~PL~dlal~nfd~seLqiIs~EdYeiLkkLGsGSFGtVYKArlkG--~~ 1067 (1236)
.-..+++.|+-...+..-..+-.|......... .+--.....|++...++....+||-|.||.||.|.|+. ..
T Consensus 220 ----~TLaELVHHHStvADGLittLhYPApK~nKptv-ygvSPn~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslT 294 (1157)
T KOG4278|consen 220 ----RTLAELVHHHSTVADGLITTLHYPAPKKNKPTV-YGVSPNADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLT 294 (1157)
T ss_pred ----hHHHHHHhhccccccceeEeeeccCccCCCCce-eeecCCcchhhccchheeeeeccCCCcccceeeeeeecccee
Confidence 123478888766666655555444432211111 11111224677788888999999999999999999964 45
Q ss_pred EEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeEEEEEeeccCCCHHHHHhhhcc-CCC
Q 000893 1068 VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER-HLD 1146 (1236)
Q Consensus 1068 VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~r-~LS 1146 (1236)
||||.|+.. .....+|+.|+.+|+.++|||+|+|+|+|.... .+|||+|||..|+|.+||+.+.+ .++
T Consensus 295 vAVKtLKED---------tMeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep--PFYIiTEfM~yGNLLdYLRecnr~ev~ 363 (1157)
T KOG4278|consen 295 VAVKTLKED---------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP--PFYIITEFMCYGNLLDYLRECNRSEVP 363 (1157)
T ss_pred eehhhhhhc---------chhHHHHHHHHHHHHhhcCccHHHHhhhhccCC--CeEEEEecccCccHHHHHHHhchhhcc
Confidence 999999753 223678999999999999999999999999865 89999999999999999988765 466
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcccccCccccc--CcCCCCcccchhhhc
Q 000893 1147 RRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG--GVRGTLPWMAPELLN 1224 (1236)
Q Consensus 1147 e~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~ns~~ts--s~~GTp~YmAPEVL~ 1224 (1236)
.-..++++.||..||.||..+++|||||..+|+|+..+. .|||+||||++++.....+- +..-..-|.|||-|.
T Consensus 364 avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnh----iVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLA 439 (1157)
T KOG4278|consen 364 AVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH----IVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 439 (1157)
T ss_pred hhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccc----eEEeeccchhhhhcCCceecccCccCcccccCccccc
Confidence 667788899999999999999999999999999998763 78999999999987665443 223456799999997
Q ss_pred CCCCC
Q 000893 1225 GSSSK 1229 (1236)
Q Consensus 1225 Gss~~ 1229 (1236)
-....
T Consensus 440 yNtFS 444 (1157)
T KOG4278|consen 440 YNTFS 444 (1157)
T ss_pred ccccc
Confidence 55333
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=297.50 Aligned_cols=181 Identities=36% Similarity=0.502 Sum_probs=158.8
Q ss_pred ccccCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEec
Q 000893 1039 IKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1236)
Q Consensus 1039 Is~EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t 1116 (1236)
+...+++.+..||+|..|+|||++++ ++.+|+|++.... +....+++.+|+++++.++||+||.+||+|..
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~-------~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNI-------DPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccC-------CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 45567888999999999999999995 7789999995432 34556789999999999999999999999998
Q ss_pred CCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCcEEEccCCCCCCcEEEEe
Q 000893 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1236)
Q Consensus 1117 ~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHS-kGIIHRDIKPsNILLDsdG~I~ltVKLsD 1195 (1236)
... .+.|+||||.+|+|+.++... +.+++...-.|+.+|++||.|||. ++||||||||+||||+..| .|||||
T Consensus 149 ~~~-~isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskG----eVKicD 222 (364)
T KOG0581|consen 149 NGE-EISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKG----EVKICD 222 (364)
T ss_pred CCc-eEEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCC----CEEecc
Confidence 643 599999999999999998654 568999999999999999999996 8999999999999999998 569999
Q ss_pred ccCcccccCcccccCcCCCCcccchhhhcCCCCCCCcc
Q 000893 1196 FGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEK 1233 (1236)
Q Consensus 1196 FGLArii~ns~~tss~~GTp~YmAPEVL~Gss~~~SdD 1233 (1236)
||.++.+-+. ...+++||..|||||.|.|..+..+.|
T Consensus 223 FGVS~~lvnS-~a~tfvGT~~YMsPERi~g~~Ys~~sD 259 (364)
T KOG0581|consen 223 FGVSGILVNS-IANTFVGTSAYMSPERISGESYSVKSD 259 (364)
T ss_pred ccccHHhhhh-hcccccccccccChhhhcCCcCCcccc
Confidence 9999998777 667899999999999999986666554
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=303.00 Aligned_cols=180 Identities=31% Similarity=0.438 Sum_probs=160.6
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
.+|...+.||+|+|++||.++. +|..||+|++.+..+... .......+|+++.+.|+|||||++|++|++.+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~-----~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~- 91 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKP-----KQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN- 91 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCc-----chHHHHHHHHHHHHhcCCCcEEeeeeEeecCC-
Confidence 5799999999999999999998 688999999998766543 23456778999999999999999999999976
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
.+|||.|+|..++|..++. ..+.+++.+++.|+.||+.||.|||+++|||||||..|+||+.+. .|||+|||||
T Consensus 92 -nVYivLELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~----~VKIgDFGLA 165 (592)
T KOG0575|consen 92 -NVYIVLELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENM----NVKIGDFGLA 165 (592)
T ss_pred -ceEEEEEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcC----cEEeccccee
Confidence 9999999999999999996 567899999999999999999999999999999999999999875 6799999999
Q ss_pred ccccC-cccccCcCCCCcccchhhhcCCCCCCCcc
Q 000893 1200 KIKRN-TLVTGGVRGTLPWMAPELLNGSSSKVSEK 1233 (1236)
Q Consensus 1200 rii~n-s~~tss~~GTp~YmAPEVL~Gss~~~SdD 1233 (1236)
..+.. .....++||||.|+|||++.+..+..-.|
T Consensus 166 t~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvD 200 (592)
T KOG0575|consen 166 TQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVD 200 (592)
T ss_pred eeecCcccccceecCCCcccChhHhccCCCCCchh
Confidence 98764 47778899999999999999876666544
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=308.27 Aligned_cols=185 Identities=28% Similarity=0.409 Sum_probs=159.4
Q ss_pred ccccccCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCC-CCceeeEeee
Q 000893 1037 QIIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGV 1113 (1236)
Q Consensus 1037 qiIs~EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLr-HPNIVrLyG~ 1113 (1236)
..+..++|.++++||+|+||+|++++.+ ++.+|||++++..+..+++ ....+.|.+|+.... ||+|+.|+++
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~-----Ve~~~~EkrI~~la~~HPFL~~L~~~ 437 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDE-----VESLMCEKRIFELANRHPFLVNLFSC 437 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceecccc-----HHHHHHHHHHHHHhccCCeEeecccc
Confidence 3567789999999999999999999985 5669999999998876554 334567888888765 9999999999
Q ss_pred EecCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEE
Q 000893 1114 VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193 (1236)
Q Consensus 1114 f~t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKL 1193 (1236)
|++.. ++|+||||+.||++..++ ....+++..+..|+.+|+.||.|||++||||||||.+|||||.+| .+||
T Consensus 438 fQT~~--~l~fvmey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eG----h~ki 509 (694)
T KOG0694|consen 438 FQTKE--HLFFVMEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEG----HVKI 509 (694)
T ss_pred cccCC--eEEEEEEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccC----cEEe
Confidence 99976 999999999999944333 446799999999999999999999999999999999999999998 5699
Q ss_pred EeccCccccc-CcccccCcCCCCcccchhhhcCCCCCCCccc
Q 000893 1194 GDFGLSKIKR-NTLVTGGVRGTLPWMAPELLNGSSSKVSEKV 1234 (1236)
Q Consensus 1194 sDFGLArii~-ns~~tss~~GTp~YmAPEVL~Gss~~~SdDV 1234 (1236)
+|||||+... ....+.++||||.|||||++.+..|..+-||
T Consensus 510 ADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDW 551 (694)
T KOG0694|consen 510 ADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDW 551 (694)
T ss_pred cccccccccCCCCCccccccCChhhcChhhhccCcccchhhH
Confidence 9999999854 5567788999999999999999865555554
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=300.82 Aligned_cols=185 Identities=28% Similarity=0.458 Sum_probs=158.5
Q ss_pred cccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecC
Q 000893 1040 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1236)
Q Consensus 1040 s~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~ 1117 (1236)
..+.|+.+++||+|+||.||+|++ +|+.||+|++..... .+.......||+.||++|+||||++|.+.....
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~------~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~ 188 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE------KEGFPITAIREIKILRRLDHPNIIKLEEIVTSK 188 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC------CCcchHHHHHHHHHHHhcCCCcccceeeEEEec
Confidence 346789999999999999999998 588899999976532 233455668999999999999999999999987
Q ss_pred CCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEecc
Q 000893 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1236)
Q Consensus 1118 ~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFG 1197 (1236)
..+.+|||+||| .-+|.-++...+-.|++.+++.|+.|++.||+|||.+||+|||||.+|||||.+| .+||+|||
T Consensus 189 ~~~siYlVFeYM-dhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G----~LKiaDFG 263 (560)
T KOG0600|consen 189 LSGSIYLVFEYM-DHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNG----VLKIADFG 263 (560)
T ss_pred CCceEEEEEecc-cchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCC----CEEecccc
Confidence 668999999999 6789888877777899999999999999999999999999999999999999988 67999999
Q ss_pred CcccccCcc--cccCcCCCCcccchhhhcCCCCCCCccccC
Q 000893 1198 LSKIKRNTL--VTGGVRGTLPWMAPELLNGSSSKVSEKVCF 1236 (1236)
Q Consensus 1198 LArii~ns~--~tss~~GTp~YmAPEVL~Gss~~~SdDVDI 1236 (1236)
||++..... ..+..+-|+||+|||+|+|. ..|...||+
T Consensus 264 LAr~y~~~~~~~~T~rVvTLWYRpPELLLG~-t~Yg~aVDl 303 (560)
T KOG0600|consen 264 LARFYTPSGSAPYTSRVVTLWYRPPELLLGA-TSYGTAVDL 303 (560)
T ss_pred ceeeccCCCCcccccceEEeeccChHHhcCC-cccccceee
Confidence 999765433 33455669999999999997 466666664
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=283.49 Aligned_cols=182 Identities=29% Similarity=0.429 Sum_probs=160.5
Q ss_pred ccccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEec
Q 000893 1039 IKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1236)
Q Consensus 1039 Is~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t 1116 (1236)
...++|++++.||.|+||+|.+++. .|..+|+|++.+..+. ..+......+|.++|+.+.||+|+++++.|.+
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vV-----klKQveH~~nEk~vL~~v~~PFlv~l~~t~~d 115 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVV-----KLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD 115 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHH-----HHHHHHHHhhHHHHHhhccCceeEEEEEeecc
Confidence 4567899999999999999999998 4778999999886543 34445567889999999999999999999998
Q ss_pred CCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEec
Q 000893 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1236)
Q Consensus 1117 ~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDF 1196 (1236)
.. .+++||||++||-|..++++.+ .+++..++.++.||+.||+|||+++||+|||||+|||||.+|+ +||+||
T Consensus 116 ~~--~lymvmeyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~----iKitDF 188 (355)
T KOG0616|consen 116 NS--NLYMVMEYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGH----IKITDF 188 (355)
T ss_pred CC--eEEEEEeccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCc----EEEEec
Confidence 54 9999999999999999997654 5889999999999999999999999999999999999999984 599999
Q ss_pred cCcccccCcccccCcCCCCcccchhhhcCCCCCCCccc
Q 000893 1197 GLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKV 1234 (1236)
Q Consensus 1197 GLArii~ns~~tss~~GTp~YmAPEVL~Gss~~~SdDV 1234 (1236)
|+|+..... +-++||||.|+|||+++...+..+.||
T Consensus 189 GFAK~v~~r--T~TlCGTPeYLAPEii~sk~ynkavDW 224 (355)
T KOG0616|consen 189 GFAKRVSGR--TWTLCGTPEYLAPEIIQSKGYNKAVDW 224 (355)
T ss_pred cceEEecCc--EEEecCCccccChHHhhcCCCCcchhH
Confidence 999987655 556999999999999998877777765
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=302.97 Aligned_cols=184 Identities=32% Similarity=0.444 Sum_probs=161.5
Q ss_pred ccccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCC-CCceeeEeeeEe
Q 000893 1039 IKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQ 1115 (1236)
Q Consensus 1039 Is~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLr-HPNIVrLyG~f~ 1115 (1236)
+..++|.++++||.|+||.||+|+. .+..||||.+++.... -+ ...-+||+..|++|+ |||||+|+.++.
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-----~e--e~~nLREvksL~kln~hpniikL~Evi~ 79 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-----WE--ECMNLREVKSLRKLNPHPNIIKLKEVIR 79 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-----HH--HHHHHHHHHHHHhcCCCCcchhhHHHhh
Confidence 4567899999999999999999987 5788999999876542 11 123468999999999 999999999998
Q ss_pred cCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEe
Q 000893 1116 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1236)
Q Consensus 1116 t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsD 1195 (1236)
+.+ ..++|||||| ..+|.+++..+++.+++..++.|++||+.||+|+|.+|+.||||||+||||.... .+||+|
T Consensus 80 d~~-~~L~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~----~iKiaD 153 (538)
T KOG0661|consen 80 DND-RILYFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGND----VIKIAD 153 (538)
T ss_pred ccC-ceEeeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccc----eeEecc
Confidence 865 3999999999 8899999999999999999999999999999999999999999999999998643 789999
Q ss_pred ccCcccccCcccccCcCCCCcccchhhhcCCCCCCCccccC
Q 000893 1196 FGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVCF 1236 (1236)
Q Consensus 1196 FGLArii~ns~~tss~~GTp~YmAPEVL~Gss~~~SdDVDI 1236 (1236)
||+||.+......+.++-|.||+|||+|+.+ +.|+..+|+
T Consensus 154 FGLARev~SkpPYTeYVSTRWYRAPEvLLrs-~~Ys~pvD~ 193 (538)
T KOG0661|consen 154 FGLAREVRSKPPYTEYVSTRWYRAPEVLLRS-GYYSSPVDM 193 (538)
T ss_pred cccccccccCCCcchhhhcccccchHHhhhc-cccCCchHH
Confidence 9999999888888888999999999999876 466666664
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=290.30 Aligned_cols=180 Identities=38% Similarity=0.564 Sum_probs=148.0
Q ss_pred cCeeEEEEeccCCceEEEEeeec-CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArlk-G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g 1120 (1236)
++|..-..||+|+||.||+|.+. ++.||||++...... . ..+|.+|+.+|.+++|||||+|+|||.+...
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~------~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~- 145 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQ------G--EREFLNEVEILSRLRHPNLVKLLGYCLEGGE- 145 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCc------c--hhHHHHHHHHHhcCCCcCcccEEEEEecCCc-
Confidence 35555567999999999999996 488999987654211 0 3459999999999999999999999998642
Q ss_pred eEEEEEeeccCCCHHHHHhhhcc-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCCCcEEEccCCCCCCcEEEEec
Q 000893 1121 TLATVTEFMVNGSLRHVLLSKER-HLDRRKRLIIAMDAAFGMEYLHSK---NIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1236)
Q Consensus 1121 ~L~LVMEYm~GGSL~dlL~~k~r-~LSe~erl~Ia~QIAeALaYLHSk---GIIHRDIKPsNILLDsdG~I~ltVKLsDF 1196 (1236)
..+||+|||++|+|.++|+.... .++|..|+.|+.++|.||+|||.. .|||||||++|||||.+. .+||+||
T Consensus 146 ~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~----~aKlsDF 221 (361)
T KOG1187|consen 146 HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF----NAKLSDF 221 (361)
T ss_pred eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC----CEEccCc
Confidence 58999999999999999988766 899999999999999999999984 499999999999999875 7799999
Q ss_pred cCcccccC-cccccCc-CCCCcccchhhhcC-CCCCCCccc
Q 000893 1197 GLSKIKRN-TLVTGGV-RGTLPWMAPELLNG-SSSKVSEKV 1234 (1236)
Q Consensus 1197 GLArii~n-s~~tss~-~GTp~YmAPEVL~G-ss~~~SdDV 1234 (1236)
|+|+.... ....... .||.+|+|||++.. .....++.+
T Consensus 222 GLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVy 262 (361)
T KOG1187|consen 222 GLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVY 262 (361)
T ss_pred cCcccCCccccceeeecCCCCccCChhhhccCCcCcccccc
Confidence 99987654 3332222 79999999999974 444344443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-30 Score=282.92 Aligned_cols=180 Identities=25% Similarity=0.338 Sum_probs=152.2
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
+.|+.+.++|+|+||+||++++ +|+.||||++... ++.....+-.+||+++|++|+|+|||.|+.+|...
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es------edd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrk-- 73 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES------EDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRK-- 73 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccC------CccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhc--
Confidence 5688889999999999999998 5889999998643 22344455678999999999999999999999985
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
+.++||+|||+. ++.+.|......++...++.|++|++.|+.|||++++|||||||+||||+..| ++||||||+|
T Consensus 74 rklhLVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~g----vvKLCDFGFA 148 (396)
T KOG0593|consen 74 RKLHLVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNG----VVKLCDFGFA 148 (396)
T ss_pred ceeEEEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCC----cEEeccchhh
Confidence 489999999954 55555656667799999999999999999999999999999999999999987 7899999999
Q ss_pred cccc-CcccccCcCCCCcccchhhhcCCCCCCCcccc
Q 000893 1200 KIKR-NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVC 1235 (1236)
Q Consensus 1200 rii~-ns~~tss~~GTp~YmAPEVL~Gss~~~SdDVD 1235 (1236)
+.+. .....+.++.|.||+|||.+.|.. .|...+|
T Consensus 149 R~L~~pgd~YTDYVATRWYRaPELLvGDt-qYG~pVD 184 (396)
T KOG0593|consen 149 RTLSAPGDNYTDYVATRWYRAPELLVGDT-QYGKPVD 184 (396)
T ss_pred HhhcCCcchhhhhhhhhhccChhhhcccC-cCCCccc
Confidence 9976 556677788999999999999853 3333333
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=281.70 Aligned_cols=179 Identities=31% Similarity=0.448 Sum_probs=154.3
Q ss_pred ccccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCC-CCceeeEeeeEe
Q 000893 1039 IKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQ 1115 (1236)
Q Consensus 1039 Is~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLr-HPNIVrLyG~f~ 1115 (1236)
.....|.+.+.||+|+||+|++|.+ ++..||||++.+....... ......+.+|+.+++.++ ||||++++.++.
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~---~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~ 90 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKS---QKLDELIKREISILRRLRSHPNIIRLLEVFA 90 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccc---cccchhhHHHHHHHHHhccCCCEeEEEEEEe
Confidence 3456899999999999999999987 5788999987765322111 122334558999999999 999999999999
Q ss_pred cCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccC-CCCCCcEEEE
Q 000893 1116 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLK-DPIRPICKVG 1194 (1236)
Q Consensus 1116 t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsd-G~I~ltVKLs 1194 (1236)
+.. .+++||||+.||+|.+++.. ...+.+..+..+++|++.|++|||++||+||||||+|||++.+ + .+||+
T Consensus 91 t~~--~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~----~~Kl~ 163 (370)
T KOG0583|consen 91 TPT--KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEG----NLKLS 163 (370)
T ss_pred cCC--eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCC----CEEEe
Confidence 976 69999999999999999987 6678899999999999999999999999999999999999998 5 56999
Q ss_pred eccCcccc-cCcccccCcCCCCcccchhhhcCCC
Q 000893 1195 DFGLSKIK-RNTLVTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1195 DFGLArii-~ns~~tss~~GTp~YmAPEVL~Gss 1227 (1236)
|||++... .........|||+.|+|||+|.+..
T Consensus 164 DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~ 197 (370)
T KOG0583|consen 164 DFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKG 197 (370)
T ss_pred ccccccccCCCCCcccCCCCCcccCCHHHhCCCC
Confidence 99999988 4666777899999999999999865
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=289.31 Aligned_cols=185 Identities=29% Similarity=0.387 Sum_probs=157.1
Q ss_pred cccccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEe
Q 000893 1038 IIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 1115 (1236)
Q Consensus 1038 iIs~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~ 1115 (1236)
.+..++|+++++||+|+||.||+|+- +|..+|+|+|++.... ....+.-.+.|..+|...++|+||+||..|+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~-----~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQ 211 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEML-----KKNQVEHVRAERDILAEVDSPWVVKLYYSFQ 211 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHH-----hhhhHHHHHHHHHHhhhcCCCcEEEEEEEec
Confidence 45778999999999999999999986 5888999999987543 3344556778999999999999999999999
Q ss_pred cCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEe
Q 000893 1116 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1236)
Q Consensus 1116 t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsD 1195 (1236)
+.. .+||||||++||++..+|... ..+++..++.++.+++.|++-||+.|+|||||||+|+|||..|+ +||+|
T Consensus 212 D~~--~LYLiMEylPGGD~mTLL~~~-~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GH----iKLSD 284 (550)
T KOG0605|consen 212 DKE--YLYLIMEYLPGGDMMTLLMRK-DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGH----IKLSD 284 (550)
T ss_pred CCC--eeEEEEEecCCccHHHHHHhc-CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCC----Eeecc
Confidence 976 999999999999999999654 56899999999999999999999999999999999999999985 59999
Q ss_pred ccCcccccC----------------------cc-c-------------------------ccCcCCCCcccchhhhcCCC
Q 000893 1196 FGLSKIKRN----------------------TL-V-------------------------TGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1196 FGLArii~n----------------------s~-~-------------------------tss~~GTp~YmAPEVL~Gss 1227 (1236)
||||.-+.. .. . ....+|||.|||||+|.|..
T Consensus 285 FGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg 364 (550)
T KOG0605|consen 285 FGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG 364 (550)
T ss_pred ccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC
Confidence 999853110 00 0 01256999999999999998
Q ss_pred CCCCccc
Q 000893 1228 SKVSEKV 1234 (1236)
Q Consensus 1228 ~~~SdDV 1234 (1236)
+...+||
T Consensus 365 Y~~~cDw 371 (550)
T KOG0605|consen 365 YGKECDW 371 (550)
T ss_pred CCccccH
Confidence 7777775
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=291.18 Aligned_cols=183 Identities=32% Similarity=0.438 Sum_probs=157.8
Q ss_pred ccccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhC-CCCceeeEeeeEe
Q 000893 1039 IKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQ 1115 (1236)
Q Consensus 1039 Is~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskL-rHPNIVrLyG~f~ 1115 (1236)
-...+|.+.+.||.|+|++|++|+. .++.+|||++.+..+. .+...+-..+|..+|.+| .||.|++||..|+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Ii-----ke~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQ 144 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYII-----KEKKVKYVTREKEALTQLSGHPGIVKLYFTFQ 144 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHH-----hhcccchhhHHHHHHHHhhCCCCeEEEEEEee
Confidence 3457899999999999999999987 5788999999987654 334455677899999999 7999999999999
Q ss_pred cCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEe
Q 000893 1116 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1236)
Q Consensus 1116 t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsD 1195 (1236)
+.. .+|+|+||+++|+|.++|... +.+++..++.++.||+.||+|||++|||||||||+||||+.++ ++||+|
T Consensus 145 D~~--sLYFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dm----hikITD 217 (604)
T KOG0592|consen 145 DEE--SLYFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDG----HIKITD 217 (604)
T ss_pred ccc--ceEEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCC----cEEEee
Confidence 965 899999999999999999655 5699999999999999999999999999999999999999998 459999
Q ss_pred ccCcccccCccc--------------ccCcCCCCcccchhhhcCCCCCCCcc
Q 000893 1196 FGLSKIKRNTLV--------------TGGVRGTLPWMAPELLNGSSSKVSEK 1233 (1236)
Q Consensus 1196 FGLArii~ns~~--------------tss~~GTp~YmAPEVL~Gss~~~SdD 1233 (1236)
||.|+.+..... ...++||..|.+||+|......+++|
T Consensus 218 FGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sD 269 (604)
T KOG0592|consen 218 FGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSD 269 (604)
T ss_pred ccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccc
Confidence 999998642211 14589999999999999876666655
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=282.51 Aligned_cols=184 Identities=25% Similarity=0.424 Sum_probs=155.5
Q ss_pred cccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecC
Q 000893 1040 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1236)
Q Consensus 1040 s~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~ 1117 (1236)
...+|+++++||+|+||+||++.. +|..||.|.++-..+ .....+.+..|+.+|+.|+|||||++|++-...
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m------d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~ 90 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM------DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIE 90 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc------cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhc
Confidence 456899999999999999999876 688899999874332 234456788999999999999999999954443
Q ss_pred CCCeEEEEEeeccCCCHHHHHhh---hccCCCHHHHHHHHHHHHHHHHHHHH--CC--cccCCCCCCcEEEccCCCCCCc
Q 000893 1118 PGGTLATVTEFMVNGSLRHVLLS---KERHLDRRKRLIIAMDAAFGMEYLHS--KN--IVHFDLKCDNLLVNLKDPIRPI 1190 (1236)
Q Consensus 1118 ~~g~L~LVMEYm~GGSL~dlL~~---k~r~LSe~erl~Ia~QIAeALaYLHS--kG--IIHRDIKPsNILLDsdG~I~lt 1190 (1236)
+..-++||||||..|+|.+++.. ..+.+++..++.++.|+|.||.+||. .. |+||||||.||+|+..| +
T Consensus 91 ~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g----v 166 (375)
T KOG0591|consen 91 DNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG----V 166 (375)
T ss_pred cchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC----c
Confidence 33458999999999999998854 35679999999999999999999998 44 99999999999999887 7
Q ss_pred EEEEeccCcccccCc-ccccCcCCCCcccchhhhcCCCCCCCcc
Q 000893 1191 CKVGDFGLSKIKRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEK 1233 (1236)
Q Consensus 1191 VKLsDFGLArii~ns-~~tss~~GTp~YmAPEVL~Gss~~~SdD 1233 (1236)
|||+||||++.+... .....++|||.||+||+|.++.+...+|
T Consensus 167 vKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSD 210 (375)
T KOG0591|consen 167 VKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSD 210 (375)
T ss_pred eeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchh
Confidence 899999999998654 3556789999999999999886655544
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=270.12 Aligned_cols=177 Identities=27% Similarity=0.392 Sum_probs=147.4
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
++|++++.||+|+||+||+++. +++.||||++.+.... .......+.+|+.++..++||||+++++.+.+..
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~- 74 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADML-----EKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL- 74 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHH-----HhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC-
Confidence 4789999999999999999987 4778999999764211 2233456788999999999999999999998854
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
.+++|||||++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++ .+||+|||++
T Consensus 75 -~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~----~vkL~DFGla 148 (363)
T cd05628 75 -NLYLIMEFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKG----HVKLSDFGLC 148 (363)
T ss_pred -eEEEEEcCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC----CEEEeeccCc
Confidence 899999999999999998654 4689999999999999999999999999999999999999876 5799999998
Q ss_pred ccccCcc------------------------------------cccCcCCCCcccchhhhcCCCCCC
Q 000893 1200 KIKRNTL------------------------------------VTGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1200 rii~ns~------------------------------------~tss~~GTp~YmAPEVL~Gss~~~ 1230 (1236)
+...... .....+||+.|+|||++.+..+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~ 215 (363)
T cd05628 149 TGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNK 215 (363)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCC
Confidence 7543210 112457999999999998764433
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=280.91 Aligned_cols=180 Identities=30% Similarity=0.486 Sum_probs=161.6
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
.+|++.+.||+|+||+|-+|.. .|+.||||.|++..+.. +.....+.+|++||+.|+||||+.+|.+|...+
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkd-----eqDlvhIRREIeIMSsLNHPhII~IyEVFENkd- 126 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKD-----EQDLVHIRREIEIMSSLNHPHIIQIYEVFENKD- 126 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhccc-----HHHHHHHHHHHHHHhhcCCCceeehhhhhcCCc-
Confidence 5788999999999999999987 48999999999877642 333556889999999999999999999999865
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
.+.|||||..+|.|.+|+..++ .+++.++..|++||+.|+.|||.++++|||||.+|||||.++++ ||+||||+
T Consensus 127 -KIvivMEYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~Ni----KIADFGLS 200 (668)
T KOG0611|consen 127 -KIVIVMEYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNI----KIADFGLS 200 (668)
T ss_pred -eEEEEEEecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCe----eeeccchh
Confidence 8999999999999999996554 69999999999999999999999999999999999999999854 99999999
Q ss_pred ccccCcccccCcCCCCcccchhhhcCCCCCCCcc
Q 000893 1200 KIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEK 1233 (1236)
Q Consensus 1200 rii~ns~~tss~~GTp~YmAPEVL~Gss~~~SdD 1233 (1236)
-.+....+-+++||+|-|.+||++.|..+..-+.
T Consensus 201 Nly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEV 234 (668)
T KOG0611|consen 201 NLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEV 234 (668)
T ss_pred hhhccccHHHHhcCCcccCCccccCCCCCCCCcc
Confidence 9988888888999999999999999987765544
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-28 Score=265.88 Aligned_cols=175 Identities=26% Similarity=0.427 Sum_probs=146.2
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
++|++++.||+|+||+||+|+. +++.||||++.+.... .......+.+|+.+|+.++||||++++++|.+..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~- 74 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML-----EKEQVAHVRAERDILAEADNPWVVKLYYSFQDEN- 74 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC-
Confidence 4789999999999999999998 4788999999764211 1233456788999999999999999999999865
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
.+++|||||++++|.+++... ..+++..++.|+.||+.||+|||++||+||||||+||||+.++ .+||+|||++
T Consensus 75 -~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~----~~kl~Dfg~~ 148 (364)
T cd05599 75 -YLYLIMEYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKG----HIKLSDFGLC 148 (364)
T ss_pred -eEEEEECCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC----CEEEeecccc
Confidence 899999999999999998654 4689999999999999999999999999999999999999887 5699999998
Q ss_pred ccccCcc---------------------------------------cccCcCCCCcccchhhhcCCCC
Q 000893 1200 KIKRNTL---------------------------------------VTGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1200 rii~ns~---------------------------------------~tss~~GTp~YmAPEVL~Gss~ 1228 (1236)
+...... .....+||+.|+|||++.+..+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 216 (364)
T cd05599 149 TGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY 216 (364)
T ss_pred eeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCC
Confidence 7532110 1113569999999999986643
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.7e-29 Score=267.04 Aligned_cols=181 Identities=33% Similarity=0.444 Sum_probs=155.1
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
.+|..+++||+|.||.||+|++ +|+.||||+++..... +......+||+.+|+.++|+||+.|+++|....
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~k------dGi~~talREIK~Lqel~h~nIi~LiD~F~~~~- 74 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAK------DGINRTALREIKLLQELKHPNIIELIDVFPHKS- 74 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccc------cCccHHHHHHHHHHHHccCcchhhhhhhccCCC-
Confidence 4678889999999999999998 5888999999876432 222345689999999999999999999998865
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
.+.||+||| ..+|...++.+...++...++.++.++++||+|||.+.|+||||||.|+||+.+| .+||+|||+|
T Consensus 75 -~l~lVfEfm-~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g----~lKiADFGLA 148 (318)
T KOG0659|consen 75 -NLSLVFEFM-PTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDG----QLKIADFGLA 148 (318)
T ss_pred -ceEEEEEec-cccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCC----cEEeecccch
Confidence 889999999 7799999998889999999999999999999999999999999999999999998 6799999999
Q ss_pred ccccCcccc-cCcCCCCcccchhhhcCCCCCCCccccC
Q 000893 1200 KIKRNTLVT-GGVRGTLPWMAPELLNGSSSKVSEKVCF 1236 (1236)
Q Consensus 1200 rii~ns~~t-ss~~GTp~YmAPEVL~Gss~~~SdDVDI 1236 (1236)
+........ ..-+-|.||+|||.+.|. ..|...+|+
T Consensus 149 r~f~~p~~~~~~~V~TRWYRAPELLfGs-r~Yg~~VDm 185 (318)
T KOG0659|consen 149 RFFGSPNRIQTHQVVTRWYRAPELLFGS-RQYGTGVDM 185 (318)
T ss_pred hccCCCCcccccceeeeeccChHHhccc-hhcCCcchh
Confidence 987643322 223679999999999987 455555553
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-28 Score=262.73 Aligned_cols=182 Identities=29% Similarity=0.422 Sum_probs=145.8
Q ss_pred ccccccCeeEEEEeccCCceEEEEeeec-------CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhC-CCCcee
Q 000893 1037 QIIKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVV 1108 (1236)
Q Consensus 1037 qiIs~EdYeiLkkLGsGSFGtVYKArlk-------G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskL-rHPNIV 1108 (1236)
|.+..++|++.++||+|+||+||+|.+. ++.||||+++... .......+.+|+.+|+.+ +||||+
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~niv 74 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-------TASEHKALMSELKILIHIGNHLNVV 74 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-------chHHHHHHHHHHHHHHHhccCccee
Confidence 4566789999999999999999999752 3569999986432 122345688999999999 899999
Q ss_pred eEeeeEecCCCCeEEEEEeeccCCCHHHHHhhhc----------------------------------------------
Q 000893 1109 AFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------------------------------------------- 1142 (1236)
Q Consensus 1109 rLyG~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~---------------------------------------------- 1142 (1236)
+++++|.... +.+++||||+++|+|.+++....
T Consensus 75 ~~~~~~~~~~-~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (338)
T cd05102 75 NLLGACTKPN-GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPST 153 (338)
T ss_pred eEEeEecCCC-CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCcccccccccc
Confidence 9999987643 57899999999999999986531
Q ss_pred ---------------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcccccCcc-
Q 000893 1143 ---------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL- 1206 (1236)
Q Consensus 1143 ---------------r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~ns~- 1206 (1236)
..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 154 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~----~~kl~DfG~a~~~~~~~~ 229 (338)
T cd05102 154 SGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENN----VVKICDFGLARDIYKDPD 229 (338)
T ss_pred CcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCC----cEEEeecccccccccCcc
Confidence 2477788899999999999999999999999999999999876 57999999998653221
Q ss_pred --cccCcCCCCcccchhhhcCCCCCC
Q 000893 1207 --VTGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1207 --~tss~~GTp~YmAPEVL~Gss~~~ 1230 (1236)
......+++.|+|||++.+.....
T Consensus 230 ~~~~~~~~~~~~y~aPE~~~~~~~~~ 255 (338)
T cd05102 230 YVRKGSARLPLKWMAPESIFDKVYTT 255 (338)
T ss_pred hhcccCCCCCccccCcHHhhcCCCCc
Confidence 122344678899999997664333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=254.52 Aligned_cols=177 Identities=25% Similarity=0.365 Sum_probs=147.9
Q ss_pred CeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g 1120 (1236)
.|+..+.||+|+||+||++.+ .++.||||++.+.... .......+.+|+.+++.++|+||++++++|.+..
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~-- 73 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-----KRKGEAMALNEKRILEKVNSRFVVSLAYAYETKD-- 73 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhh-----hhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCC--
Confidence 377889999999999999987 4788999998764321 1122345778999999999999999999998754
Q ss_pred eEEEEEeeccCCCHHHHHhhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1121 TLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1121 ~L~LVMEYm~GGSL~dlL~~k-~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
.+++||||+++++|..++... ...+++..++.++.|++.||+|||+++|+||||||+|||++.++ .+||+|||++
T Consensus 74 ~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~----~~kl~Dfg~~ 149 (285)
T cd05631 74 ALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRG----HIRISDLGLA 149 (285)
T ss_pred eEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC----CEEEeeCCCc
Confidence 899999999999999887654 34689999999999999999999999999999999999998876 5799999999
Q ss_pred ccccCcccccCcCCCCcccchhhhcCCCCCC
Q 000893 1200 KIKRNTLVTGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1200 rii~ns~~tss~~GTp~YmAPEVL~Gss~~~ 1230 (1236)
............+||+.|+|||++.+..+..
T Consensus 150 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 180 (285)
T cd05631 150 VQIPEGETVRGRVGTVGYMAPEVINNEKYTF 180 (285)
T ss_pred EEcCCCCeecCCCCCCCccCHhhhcCCCCCc
Confidence 8765444444567999999999998764433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-28 Score=266.79 Aligned_cols=148 Identities=28% Similarity=0.397 Sum_probs=128.5
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
++|++++.||+|+||+||+++. .++.||||++.+... ........+.+|+.+++.++||||++++++|.+..
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~- 74 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM-----FKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ- 74 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHH-----HHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC-
Confidence 4789999999999999999987 578899999875321 12234556788999999999999999999998854
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
.+++||||+++++|.+++.. ...+++..++.++.|++.||+|||++||+||||||+||||+.++ .+||+|||++
T Consensus 75 -~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~----~~kl~DfGla 148 (377)
T cd05629 75 -YLYLIMEFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGG----HIKLSDFGLS 148 (377)
T ss_pred -eeEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC----CEEEeecccc
Confidence 89999999999999999864 35688999999999999999999999999999999999999876 5799999998
Q ss_pred cc
Q 000893 1200 KI 1201 (1236)
Q Consensus 1200 ri 1201 (1236)
+.
T Consensus 149 ~~ 150 (377)
T cd05629 149 TG 150 (377)
T ss_pred cc
Confidence 63
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.6e-28 Score=267.10 Aligned_cols=147 Identities=24% Similarity=0.346 Sum_probs=128.0
Q ss_pred CeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g 1120 (1236)
.|++++.||+|+||+||+|++ +++.||||++.+.... .......+.+|+.+++.++||||++++++|.+..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-----~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~-- 74 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVL-----NRNQVAHVKAERDILAEADNEWVVKLYYSFQDKD-- 74 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCC--
Confidence 588999999999999999988 4678999999764321 2233557889999999999999999999999854
Q ss_pred eEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcc
Q 000893 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1236)
Q Consensus 1121 ~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLAr 1200 (1236)
.+++||||+++|+|.+++... ..+++..++.++.||+.||.|||.+||+||||||+||||+.++ .+||+|||+++
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~----~~kL~DFGl~~ 149 (381)
T cd05626 75 NLYFVMDYIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDG----HIKLTDFGLCT 149 (381)
T ss_pred EEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCC----CEEEeeCcCCc
Confidence 899999999999999998654 4688899999999999999999999999999999999999876 67999999976
Q ss_pred c
Q 000893 1201 I 1201 (1236)
Q Consensus 1201 i 1201 (1236)
.
T Consensus 150 ~ 150 (381)
T cd05626 150 G 150 (381)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.4e-28 Score=266.40 Aligned_cols=146 Identities=24% Similarity=0.341 Sum_probs=127.5
Q ss_pred CeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g 1120 (1236)
.|+++++||+|+||+||+|+. .++.||||++.+... ........+.+|+.+++.++||||+++++.|.+..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~-----~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~-- 74 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDV-----LLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD-- 74 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHh-----hhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCC--
Confidence 588999999999999999988 467899999875321 12334557889999999999999999999999854
Q ss_pred eEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcc
Q 000893 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1236)
Q Consensus 1121 ~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLAr 1200 (1236)
.+++|||||++|+|..++... ..+++..++.++.||+.||+|||+++|+||||||+||||+.++ .+||+|||+|.
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g----~~kL~DFGla~ 149 (382)
T cd05625 75 NLYFVMDYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDG----HIKLTDFGLCT 149 (382)
T ss_pred EEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC----CEEEeECCCCc
Confidence 899999999999999998654 4688899999999999999999999999999999999999887 56999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.9e-28 Score=265.59 Aligned_cols=146 Identities=23% Similarity=0.350 Sum_probs=126.9
Q ss_pred CeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g 1120 (1236)
+|++++.||+|+||+||+++. +++.||||++.+.... .......+.+|+.+|+.++||||+++++.|.+..
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~-- 74 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVL-----MRNQAAHVKAERDILAEADNEWVVKLYYSFQDKD-- 74 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHH-----hhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCC--
Confidence 689999999999999999987 4778999998753211 1223456788999999999999999999998754
Q ss_pred eEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcc
Q 000893 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1236)
Q Consensus 1121 ~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLAr 1200 (1236)
.+++|||||++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++ .+||+|||+|.
T Consensus 75 ~~~lv~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~----~ikL~DFG~a~ 149 (376)
T cd05598 75 NLYFVMDYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG----HIKLTDFGLCT 149 (376)
T ss_pred EEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCC----CEEEEeCCCCc
Confidence 999999999999999999654 4688899999999999999999999999999999999999876 57999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-29 Score=274.79 Aligned_cols=184 Identities=32% Similarity=0.438 Sum_probs=158.9
Q ss_pred ccCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCC
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1041 ~EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~ 1118 (1236)
.++|+.+..|++|+||.||+|+++ ++.||+|+++... +.+.+.-.-+||+.+|.+++|||||.+-.+....+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek------ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~ 148 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK------EKEGFPITSLREINILLKARHPNIVEVKEVVVGSN 148 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc------ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc
Confidence 468999999999999999999995 5679999998653 12233445689999999999999999999998777
Q ss_pred CCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccC
Q 000893 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1236)
Q Consensus 1119 ~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGL 1198 (1236)
-..+|+||||| .-+|..++......+...+++.++.|+++||+|||.+.|+|||||++|+|+...| .+||+||||
T Consensus 149 ~d~iy~VMe~~-EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G----~lKiaDFGL 223 (419)
T KOG0663|consen 149 MDKIYIVMEYV-EHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKG----ILKIADFGL 223 (419)
T ss_pred cceeeeeHHHH-HhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCC----cEEecccch
Confidence 77899999999 6799999988888899999999999999999999999999999999999999988 569999999
Q ss_pred cccccCcc-cccCcCCCCcccchhhhcCCCCCCCccccC
Q 000893 1199 SKIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVCF 1236 (1236)
Q Consensus 1199 Arii~ns~-~tss~~GTp~YmAPEVL~Gss~~~SdDVDI 1236 (1236)
||.+.... ..+..+-|.||+|||++.|. ..|+..+|+
T Consensus 224 AR~ygsp~k~~T~lVVTLWYRaPELLLG~-~tyst~iDM 261 (419)
T KOG0663|consen 224 AREYGSPLKPYTPLVVTLWYRAPELLLGA-KTYSTAVDM 261 (419)
T ss_pred hhhhcCCcccCcceEEEeeecCHHHhcCC-cccCcchhh
Confidence 99987653 33456779999999999997 567776663
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=260.10 Aligned_cols=174 Identities=29% Similarity=0.395 Sum_probs=148.2
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
.+|++++.||+|+||.||+|++ .++.||||++++.... .......+.+|+.++..++||||+++++++....
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~- 74 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLF-----KLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE- 74 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHh-----hhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC-
Confidence 3689999999999999999998 4788999999864321 1223456788999999999999999999998754
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
.+++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 75 -~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~----~~kL~Dfg~a 148 (333)
T cd05600 75 -YLYLAMEYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASG----HIKLTDFGLS 148 (333)
T ss_pred -EEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC----CEEEEeCcCC
Confidence 89999999999999999854 34688999999999999999999999999999999999999876 5799999999
Q ss_pred ccccCcccccCcCCCCcccchhhhcCCCCC
Q 000893 1200 KIKRNTLVTGGVRGTLPWMAPELLNGSSSK 1229 (1236)
Q Consensus 1200 rii~ns~~tss~~GTp~YmAPEVL~Gss~~ 1229 (1236)
+.... .....+||+.|+|||++.+....
T Consensus 149 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~ 176 (333)
T cd05600 149 KGIVT--YANSVVGSPDYMAPEVLRGKGYD 176 (333)
T ss_pred ccccc--ccCCcccCccccChhHhcCCCCC
Confidence 86544 33456799999999999876433
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.7e-28 Score=261.72 Aligned_cols=177 Identities=32% Similarity=0.415 Sum_probs=149.8
Q ss_pred cccCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecC
Q 000893 1040 KNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1236)
Q Consensus 1040 s~EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~ 1117 (1236)
...+|++.+.||+|+||+||+|+++ ++.||||++++.... .......+.+|+.+|+.++||||+++++++...
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 90 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL-----KMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE 90 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-----hhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC
Confidence 4578999999999999999999984 678999999764221 122345688999999999999999999999885
Q ss_pred CCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEecc
Q 000893 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1236)
Q Consensus 1118 ~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFG 1197 (1236)
. .+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||
T Consensus 91 ~--~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~----~~kl~Dfg 163 (329)
T PTZ00263 91 N--RVYFLLEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKG----HVKVTDFG 163 (329)
T ss_pred C--EEEEEEcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCC----CEEEeecc
Confidence 4 899999999999999998654 4688899999999999999999999999999999999999886 56999999
Q ss_pred CcccccCcccccCcCCCCcccchhhhcCCCCCC
Q 000893 1198 LSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1198 LArii~ns~~tss~~GTp~YmAPEVL~Gss~~~ 1230 (1236)
+++...... ...+||+.|+|||++.+.....
T Consensus 164 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~ 194 (329)
T PTZ00263 164 FAKKVPDRT--FTLCGTPEYLAPEVIQSKGHGK 194 (329)
T ss_pred CceEcCCCc--ceecCChhhcCHHHHcCCCCCC
Confidence 998764432 2467999999999998765433
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-28 Score=271.25 Aligned_cols=184 Identities=32% Similarity=0.425 Sum_probs=154.5
Q ss_pred ccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCc-eeeEeeeEecC
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN-VVAFYGVVQDG 1117 (1236)
Q Consensus 1041 ~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPN-IVrLyG~f~t~ 1117 (1236)
...|+.+++||+|+||+||+|+. +|+.||+|++....- .+.......+|+.+|+.|+|+| ||.|++++.+.
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~------~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~ 83 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFE------EEGVPSTAIREISLLKRLSHANHIVRLHDVIHTS 83 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEecccc------ccCCCchhhHHHHHHHHhCCCcceEEEEeeeeec
Confidence 35677788899999999999998 588899999986532 1223445678999999999999 99999999875
Q ss_pred C----CCeEEEEEeeccCCCHHHHHhhhc---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCc
Q 000893 1118 P----GGTLATVTEFMVNGSLRHVLLSKE---RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPI 1190 (1236)
Q Consensus 1118 ~----~g~L~LVMEYm~GGSL~dlL~~k~---r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~lt 1190 (1236)
. .+.+++|+||+ ..+|..++.... ..++...++.+++||+.||+|||+++|+||||||+||||+.+| .
T Consensus 84 ~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G----~ 158 (323)
T KOG0594|consen 84 NNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSG----V 158 (323)
T ss_pred ccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCC----c
Confidence 4 24889999999 889999998766 4688889999999999999999999999999999999999987 5
Q ss_pred EEEEeccCccccc-CcccccCcCCCCcccchhhhcCCCCCCCccccC
Q 000893 1191 CKVGDFGLSKIKR-NTLVTGGVRGTLPWMAPELLNGSSSKVSEKVCF 1236 (1236)
Q Consensus 1191 VKLsDFGLArii~-ns~~tss~~GTp~YmAPEVL~Gss~~~SdDVDI 1236 (1236)
+||+|||+|+... ......+.++|.||+|||++.|.. .|+..+|+
T Consensus 159 lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~-~Ys~~vDi 204 (323)
T KOG0594|consen 159 LKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGST-SYSTSVDI 204 (323)
T ss_pred EeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCC-cCCCCcch
Confidence 6999999999765 333356678899999999999984 37776664
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=259.20 Aligned_cols=169 Identities=28% Similarity=0.367 Sum_probs=141.8
Q ss_pred EeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeEEEEE
Q 000893 1049 ELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVT 1126 (1236)
Q Consensus 1049 kLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L~LVM 1126 (1236)
.||+|+||+||+++. .++.||||++++.... .......+++|+.+|+.++||||++++++|.... .+++||
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~--~~~lv~ 74 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVII-----AKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHD--RLCFVM 74 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCC--EEEEEE
Confidence 599999999999987 4788999999864321 2233456788999999999999999999998854 899999
Q ss_pred eeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCccccc-Cc
Q 000893 1127 EFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR-NT 1205 (1236)
Q Consensus 1127 EYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~-ns 1205 (1236)
||+++++|..++.. ...+++..++.|+.||+.||+|||++||+||||||+||||+.++ .+||+|||+++... ..
T Consensus 75 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~----~~kl~DfG~a~~~~~~~ 149 (323)
T cd05571 75 EYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDG----HIKITDFGLCKEGISDG 149 (323)
T ss_pred eCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC----CEEEeeCCCCcccccCC
Confidence 99999999988864 45689999999999999999999999999999999999999876 57999999998642 22
Q ss_pred ccccCcCCCCcccchhhhcCCCCC
Q 000893 1206 LVTGGVRGTLPWMAPELLNGSSSK 1229 (1236)
Q Consensus 1206 ~~tss~~GTp~YmAPEVL~Gss~~ 1229 (1236)
......+||+.|+|||++.+..+.
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~~ 173 (323)
T cd05571 150 ATMKTFCGTPEYLAPEVLEDNDYG 173 (323)
T ss_pred CcccceecCccccChhhhcCCCCC
Confidence 333457799999999999876433
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=261.38 Aligned_cols=177 Identities=26% Similarity=0.401 Sum_probs=146.7
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
++|++++.||+|+||+||+++. .++.||||++++.... .......+.+|+.++..++||||+++++++.+..
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~- 74 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML-----EKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR- 74 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHh-----hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-
Confidence 4689999999999999999988 4778999999753211 2233456788999999999999999999998754
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
.+++|||||++++|.+++... ..+++..++.++.|++.||+|||++||+||||||+||||+.++ .+||+|||++
T Consensus 75 -~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~----~vkL~DfG~~ 148 (360)
T cd05627 75 -NLYLIMEFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKG----HVKLSDFGLC 148 (360)
T ss_pred -EEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC----CEEEeeccCC
Confidence 899999999999999998643 4689999999999999999999999999999999999999876 5699999998
Q ss_pred ccccCcc------------------------------------cccCcCCCCcccchhhhcCCCCCC
Q 000893 1200 KIKRNTL------------------------------------VTGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1200 rii~ns~------------------------------------~tss~~GTp~YmAPEVL~Gss~~~ 1230 (1236)
+...... .....+||+.|+|||++.+..+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~ 215 (360)
T cd05627 149 TGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNK 215 (360)
T ss_pred cccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCC
Confidence 7542110 112457999999999998764443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=259.63 Aligned_cols=175 Identities=28% Similarity=0.456 Sum_probs=148.8
Q ss_pred cCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
++|++++.||+|+||+||+|++. ++.||||++++.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 74 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMI-----KRNQIAHVRAERDILADADSPWIVKLYYSFQDEE- 74 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHh-----hccHHHHHHHHHHHHHhcCCCCccchhhheecCC-
Confidence 47899999999999999999985 888999999864321 1123456788999999999999999999998754
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
.+++||||+++++|..++... ..+++..++.|+.||+.||.|||++||+||||||+||||+.++ .+||+|||++
T Consensus 75 -~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~----~~kL~Dfg~~ 148 (350)
T cd05573 75 -HLYLVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADG----HIKLADFGLC 148 (350)
T ss_pred -eEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC----CEEeecCCCC
Confidence 899999999999999999655 5789999999999999999999999999999999999999886 5699999999
Q ss_pred ccccCcc------------------------------cccCcCCCCcccchhhhcCCCC
Q 000893 1200 KIKRNTL------------------------------VTGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1200 rii~ns~------------------------------~tss~~GTp~YmAPEVL~Gss~ 1228 (1236)
+...... ......||+.|+|||++.+...
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 207 (350)
T cd05573 149 KKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY 207 (350)
T ss_pred ccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCC
Confidence 8654332 2334679999999999987643
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=255.88 Aligned_cols=175 Identities=28% Similarity=0.421 Sum_probs=147.4
Q ss_pred cCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
++|++.+.||+|+||+||+|..+ ++.||||++...... ..+....+.+|+.+++.++||||+++++++.+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 74 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVI-----RLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQR- 74 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-----hhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCC-
Confidence 46889999999999999999984 788999999753211 1223456788999999999999999999988754
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
.+++||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus 75 -~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~----~~kl~Dfg~~ 148 (291)
T cd05612 75 -FLYMLMEYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEG----HIKLTDFGFA 148 (291)
T ss_pred -eEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC----CEEEEecCcc
Confidence 899999999999999998654 4688999999999999999999999999999999999999876 5799999999
Q ss_pred ccccCcccccCcCCCCcccchhhhcCCCCCC
Q 000893 1200 KIKRNTLVTGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1200 rii~ns~~tss~~GTp~YmAPEVL~Gss~~~ 1230 (1236)
+...... ...+||+.|+|||++.+.....
T Consensus 149 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~ 177 (291)
T cd05612 149 KKLRDRT--WTLCGTPEYLAPEVIQSKGHNK 177 (291)
T ss_pred hhccCCc--ccccCChhhcCHHHHcCCCCCc
Confidence 8764432 2467999999999998765433
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=265.57 Aligned_cols=174 Identities=26% Similarity=0.408 Sum_probs=146.7
Q ss_pred cccCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecC
Q 000893 1040 KNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1236)
Q Consensus 1040 s~EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~ 1117 (1236)
..++|++++.||+|+||+||++++. ++.||+|++.+.... .......+.+|+.+++.++||||+++++++.+.
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI-----KRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD 115 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 4578999999999999999999984 678999999753221 112234577899999999999999999999875
Q ss_pred CCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEecc
Q 000893 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1236)
Q Consensus 1118 ~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFG 1197 (1236)
. .+++|||||++|+|.+++.. ..+++..++.++.||+.||+|||+++|+||||||+||||+.++ .+||+|||
T Consensus 116 ~--~~~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~----~~kL~DFG 187 (370)
T cd05621 116 K--YLYMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHG----HLKLADFG 187 (370)
T ss_pred C--EEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC----CEEEEecc
Confidence 4 89999999999999999854 3588899999999999999999999999999999999999876 57999999
Q ss_pred CcccccCcc--cccCcCCCCcccchhhhcCC
Q 000893 1198 LSKIKRNTL--VTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1198 LArii~ns~--~tss~~GTp~YmAPEVL~Gs 1226 (1236)
+|+...... .....+||+.|+|||++.+.
T Consensus 188 ~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~ 218 (370)
T cd05621 188 TCMKMDETGMVRCDTAVGTPDYISPEVLKSQ 218 (370)
T ss_pred cceecccCCceecccCCCCcccCCHHHHhcc
Confidence 998764322 23456799999999999764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=262.37 Aligned_cols=180 Identities=32% Similarity=0.476 Sum_probs=150.4
Q ss_pred ccccccCeeEEEEeccCCceEEEEeeec---CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeee
Q 000893 1037 QIIKNEDLEELKELGSGTFGTVYHGKWR---GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGV 1113 (1236)
Q Consensus 1037 qiIs~EdYeiLkkLGsGSFGtVYKArlk---G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~ 1113 (1236)
..+..++|++.+.||+|+||.||+|.++ +..||||++.+.... .......+.+|+.+++.++||||++++++
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~ 99 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII-----KQKQVDHVFSERKILNYINHPFCVNLYGS 99 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhh-----hhhhHHHHHHHHHHHHhCCCCCCcceEEE
Confidence 3456678999999999999999999864 256999998754321 12334567889999999999999999999
Q ss_pred EecCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEE
Q 000893 1114 VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193 (1236)
Q Consensus 1114 f~t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKL 1193 (1236)
|.+.. .+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||
T Consensus 100 ~~~~~--~~~lv~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~----~ikL 172 (340)
T PTZ00426 100 FKDES--YLYLVLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDG----FIKM 172 (340)
T ss_pred EEeCC--EEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC----CEEE
Confidence 98854 899999999999999998643 4689999999999999999999999999999999999998876 5699
Q ss_pred EeccCcccccCcccccCcCCCCcccchhhhcCCCCCC
Q 000893 1194 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1194 sDFGLArii~ns~~tss~~GTp~YmAPEVL~Gss~~~ 1230 (1236)
+|||+++..... ....+||+.|+|||++.+.....
T Consensus 173 ~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ 207 (340)
T PTZ00426 173 TDFGFAKVVDTR--TYTLCGTPEYIAPEILLNVGHGK 207 (340)
T ss_pred ecCCCCeecCCC--cceecCChhhcCHHHHhCCCCCc
Confidence 999999876432 23467999999999998764433
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=257.43 Aligned_cols=173 Identities=24% Similarity=0.317 Sum_probs=146.4
Q ss_pred cCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
++|++++.||+|+||+||+++.+ ++.||||++.+... ........+..|+.++..++|+||+++++++....
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~- 74 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEM-----LKRAETACFREERNVLVNGDCQWITTLHYAFQDEN- 74 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHH-----HhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-
Confidence 47899999999999999999884 67799999875321 12223445778999999999999999999998754
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
.+++||||+++|+|..++......+++..++.++.|++.||+|||+++|+||||||+||||+.++ .+||+|||++
T Consensus 75 -~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~----~~kl~DfG~a 149 (331)
T cd05624 75 -YLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNG----HIRLADFGSC 149 (331)
T ss_pred -EEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCC----CEEEEeccce
Confidence 89999999999999999977666789999999999999999999999999999999999999876 5699999999
Q ss_pred ccccCcc--cccCcCCCCcccchhhhcC
Q 000893 1200 KIKRNTL--VTGGVRGTLPWMAPELLNG 1225 (1236)
Q Consensus 1200 rii~ns~--~tss~~GTp~YmAPEVL~G 1225 (1236)
+...... .....+||+.|+|||++.+
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 177 (331)
T cd05624 150 LKMNQDGTVQSSVAVGTPDYISPEILQA 177 (331)
T ss_pred eeccCCCceeeccccCCcccCCHHHHhc
Confidence 8754322 2234579999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=265.57 Aligned_cols=182 Identities=30% Similarity=0.448 Sum_probs=149.6
Q ss_pred cCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
.+|...+.||+|+||.||++.+. |..+|||.+.... ... ...+.+|+.+|++++|||||+++|.......
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~-------~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~ 88 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED-------SPT-SESLEREIRILSRLNHPNIVQYYGSSSSREN 88 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeeccc-------chh-HHHHHHHHHHHHhCCCCCEEeeCCccccccC
Confidence 45778889999999999999985 6889999987541 111 5567889999999999999999997544332
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcc-CCCCCCcEEEEeccC
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNL-KDPIRPICKVGDFGL 1198 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDs-dG~I~ltVKLsDFGL 1198 (1236)
..++++|||+++|+|.+++.+.+..+++..++.+++||++||.|||++|||||||||+||||+. ++ .+||+|||+
T Consensus 89 ~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~----~~KlaDFG~ 164 (313)
T KOG0198|consen 89 DEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNG----DVKLADFGL 164 (313)
T ss_pred eeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCC----eEEeccCcc
Confidence 3689999999999999999876657999999999999999999999999999999999999998 45 679999999
Q ss_pred cccccC----cccccCcCCCCcccchhhhcC-CCCC-CCcccc
Q 000893 1199 SKIKRN----TLVTGGVRGTLPWMAPELLNG-SSSK-VSEKVC 1235 (1236)
Q Consensus 1199 Arii~n----s~~tss~~GTp~YmAPEVL~G-ss~~-~SdDVD 1235 (1236)
++.... ......+.||+.|||||++.. .... .++.|+
T Consensus 165 a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWS 207 (313)
T KOG0198|consen 165 AKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWS 207 (313)
T ss_pred ccccccccccccccccccCCccccCchhhcCCCcCCccchhhh
Confidence 987653 222345789999999999994 2221 445554
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-27 Score=257.04 Aligned_cols=173 Identities=25% Similarity=0.321 Sum_probs=146.1
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
++|++++.||+|+||+||+++. .++.||||++.+... ........|.+|+.++..++||||++++++|.+..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 74 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEM-----LKRAETACFREERDVLVNGDRRWITNLHYAFQDEN- 74 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH-----hhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCC-
Confidence 4789999999999999999997 477899999975321 11223456788999999999999999999998754
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
.+++||||+++++|..++......+++..++.++.||+.||+|||+++|+||||||+||||+.++ .+||+|||++
T Consensus 75 -~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~----~~kl~Dfg~~ 149 (331)
T cd05597 75 -NLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNG----HIRLADFGSC 149 (331)
T ss_pred -eEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCC----CEEEEECCce
Confidence 89999999999999999976666799999999999999999999999999999999999998876 5699999998
Q ss_pred ccccCcc--cccCcCCCCcccchhhhcC
Q 000893 1200 KIKRNTL--VTGGVRGTLPWMAPELLNG 1225 (1236)
Q Consensus 1200 rii~ns~--~tss~~GTp~YmAPEVL~G 1225 (1236)
....... .....+||+.|+|||++.+
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 177 (331)
T cd05597 150 LRLLADGTVQSNVAVGTPDYISPEILQA 177 (331)
T ss_pred eecCCCCCccccceeccccccCHHHHhh
Confidence 7654322 2223569999999999974
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-28 Score=280.58 Aligned_cols=178 Identities=34% Similarity=0.493 Sum_probs=154.7
Q ss_pred cCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
++|.+.+.||+|+||.||||+.+ .+.||||.+.+.. ..++..+.+.+|++|++.|+|||||.++.+|.+..
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g------r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~- 74 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG------RNEKELKNLRQEVRILRSLKHPNIVEMLESFETSA- 74 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcC------CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccc-
Confidence 57888899999999999999985 5669999998743 23455677899999999999999999999999965
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
++|+|+|||.| +|..+|.. ...++++.+..|+.+++.||.|||+.+|+|||+||+||||+..+ ++|+||||+|
T Consensus 75 -~~~vVte~a~g-~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~----~~KlcdFg~A 147 (808)
T KOG0597|consen 75 -HLWVVTEYAVG-DLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGG----TLKLCDFGLA 147 (808)
T ss_pred -eEEEEehhhhh-hHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCC----ceeechhhhh
Confidence 99999999966 99999964 45699999999999999999999999999999999999999887 6799999999
Q ss_pred cccc-CcccccCcCCCCcccchhhhcCCCCCCCcc
Q 000893 1200 KIKR-NTLVTGGVRGTLPWMAPELLNGSSSKVSEK 1233 (1236)
Q Consensus 1200 rii~-ns~~tss~~GTp~YmAPEVL~Gss~~~SdD 1233 (1236)
+... +....+.+.|||.|||||++.+..+..+.|
T Consensus 148 r~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sD 182 (808)
T KOG0597|consen 148 RAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSD 182 (808)
T ss_pred hhcccCceeeeeccCcccccCHHHHcCCCccchhh
Confidence 9865 444556788999999999999886655444
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=267.97 Aligned_cols=186 Identities=26% Similarity=0.348 Sum_probs=159.6
Q ss_pred cccccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEe
Q 000893 1038 IIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 1115 (1236)
Q Consensus 1038 iIs~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~ 1115 (1236)
.+..++|++.++||.|..++||+|+. ++..||||++..... ......+.+|+..|+.++||||++++..|.
T Consensus 22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc-------~~~ld~l~kE~~~msl~~HPNIv~~~~sFv 94 (516)
T KOG0582|consen 22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKC-------NNDLDALRKEVQTMSLIDHPNIVTYHCSFV 94 (516)
T ss_pred CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhh-------hhhHHHHHHHHHHhhhcCCCCcceEEEEEE
Confidence 45668999999999999999999988 578899999986542 222567889999999999999999999999
Q ss_pred cCCCCeEEEEEeeccCCCHHHHHhhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEE
Q 000893 1116 DGPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1236)
Q Consensus 1116 t~~~g~L~LVMEYm~GGSL~dlL~~k-~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLs 1194 (1236)
... .+|+||.||.+|++.+++... ...+++..+..|++++++||.|||.+|.||||||+.||||+.+| .|||+
T Consensus 95 v~~--~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG----~VkLa 168 (516)
T KOG0582|consen 95 VDS--ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDG----TVKLA 168 (516)
T ss_pred ecc--eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCC----cEEEc
Confidence 865 999999999999999999664 34699999999999999999999999999999999999999998 66999
Q ss_pred eccCcccccCcc----cc-cCcCCCCcccchhhhcCCCCCCCccccC
Q 000893 1195 DFGLSKIKRNTL----VT-GGVRGTLPWMAPELLNGSSSKVSEKVCF 1236 (1236)
Q Consensus 1195 DFGLArii~ns~----~t-ss~~GTp~YmAPEVL~Gss~~~SdDVDI 1236 (1236)
|||.+..+.... .. ..+.||++|||||++......|+.+.||
T Consensus 169 dFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDI 215 (516)
T KOG0582|consen 169 DFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADI 215 (516)
T ss_pred CceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhh
Confidence 999876543221 11 5678999999999988777888777765
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-27 Score=249.75 Aligned_cols=175 Identities=32% Similarity=0.435 Sum_probs=142.9
Q ss_pred cccCeeEEEEeccCCceEEEEeeec------------------CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhh
Q 000893 1040 KNEDLEELKELGSGTFGTVYHGKWR------------------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 1101 (1236)
Q Consensus 1040 s~EdYeiLkkLGsGSFGtVYKArlk------------------G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILsk 1101 (1236)
...+|++.++||+|+||.||+|.+. +..||||++.... .......|.+|+.+|++
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~ 75 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-------NKNARNDFLKEVKILSR 75 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-------CHHHHHHHHHHHHHHhh
Confidence 4568999999999999999999752 2359999987532 12335578899999999
Q ss_pred CCCCceeeEeeeEecCCCCeEEEEEeeccCCCHHHHHhhhc------------------cCCCHHHHHHHHHHHHHHHHH
Q 000893 1102 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE------------------RHLDRRKRLIIAMDAAFGMEY 1163 (1236)
Q Consensus 1102 LrHPNIVrLyG~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~------------------r~LSe~erl~Ia~QIAeALaY 1163 (1236)
++||||++++++|.... ..++||||+.+++|.+++.... ..+++..++.|+.||+.||.|
T Consensus 76 l~h~niv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~ 153 (304)
T cd05096 76 LKDPNIIRLLGVCVDED--PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKY 153 (304)
T ss_pred cCCCCeeEEEEEEecCC--ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence 99999999999998754 7899999999999999885431 246778889999999999999
Q ss_pred HHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcccccCcc---cccCcCCCCcccchhhhcCCC
Q 000893 1164 LHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1164 LHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~ns~---~tss~~GTp~YmAPEVL~Gss 1227 (1236)
||++||+||||||+||||+.++ .+||+|||+++...... ......++..|+|||++.+..
T Consensus 154 lH~~~ivH~dlkp~Nill~~~~----~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 216 (304)
T cd05096 154 LSSLNFVHRDLATRNCLVGENL----TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK 216 (304)
T ss_pred HHHCCccccCcchhheEEcCCc----cEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCC
Confidence 9999999999999999999876 57999999998653322 223345678899999987654
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-27 Score=256.70 Aligned_cols=168 Identities=29% Similarity=0.387 Sum_probs=141.3
Q ss_pred EeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeEEEEE
Q 000893 1049 ELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVT 1126 (1236)
Q Consensus 1049 kLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L~LVM 1126 (1236)
.||+|+||+||+++. .++.||||++.+.... .......+.+|+.+|+.++||||+++++++.... .+++||
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~lv~ 74 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVII-----AKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD--RLCFVM 74 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC--EEEEEE
Confidence 589999999999987 4788999999864321 2233456788999999999999999999998754 899999
Q ss_pred eeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCccccc-Cc
Q 000893 1127 EFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR-NT 1205 (1236)
Q Consensus 1127 EYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~-ns 1205 (1236)
||+++++|..++.. ...+++..++.|+.||+.||+|||+++|+||||||+||||+.++ .+||+|||+++... ..
T Consensus 75 Ey~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~----~~kL~DfG~~~~~~~~~ 149 (328)
T cd05593 75 EYVNGGELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDG----HIKITDFGLCKEGITDA 149 (328)
T ss_pred eCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCC----cEEEecCcCCccCCCcc
Confidence 99999999988854 45689999999999999999999999999999999999999876 56999999998643 22
Q ss_pred ccccCcCCCCcccchhhhcCCCC
Q 000893 1206 LVTGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1206 ~~tss~~GTp~YmAPEVL~Gss~ 1228 (1236)
......+||+.|+|||++.+...
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~ 172 (328)
T cd05593 150 ATMKTFCGTPEYLAPEVLEDNDY 172 (328)
T ss_pred cccccccCCcCccChhhhcCCCC
Confidence 23345679999999999986543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=250.90 Aligned_cols=173 Identities=30% Similarity=0.421 Sum_probs=144.3
Q ss_pred cccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecC
Q 000893 1040 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1236)
Q Consensus 1040 s~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~ 1117 (1236)
..++|+++++||.|+||+||+|+. ++..||||+++..... .....+.+|+.+++.++||||+++++++.+.
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 75 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-------GAPCTAIREVSLLKNLKHANIVTLHDIIHTE 75 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-------CcchhHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 346899999999999999999987 4778999998754211 1123467899999999999999999999875
Q ss_pred CCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEecc
Q 000893 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1236)
Q Consensus 1118 ~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFG 1197 (1236)
. .+++||||+. ++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||
T Consensus 76 ~--~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~----~~kl~DfG 148 (288)
T cd07871 76 R--CLTLVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKG----ELKLADFG 148 (288)
T ss_pred C--eEEEEEeCCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC----CEEECcCc
Confidence 4 8999999996 599998877666789999999999999999999999999999999999999876 57999999
Q ss_pred CcccccCcc-cccCcCCCCcccchhhhcCC
Q 000893 1198 LSKIKRNTL-VTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1198 LArii~ns~-~tss~~GTp~YmAPEVL~Gs 1226 (1236)
+++...... ......|++.|+|||++.+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 178 (288)
T cd07871 149 LARAKSVPTKTYSNEVVTLWYRPPDVLLGS 178 (288)
T ss_pred ceeeccCCCccccCceecccccChHHhcCC
Confidence 998654322 22345689999999999763
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-27 Score=251.49 Aligned_cols=172 Identities=30% Similarity=0.439 Sum_probs=143.7
Q ss_pred ccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCC
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1041 ~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~ 1118 (1236)
.++|++++.||+|+||+||+|+. +++.||||++...... .....+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 76 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-------GTPFTAIREASLLKGLKHANIVLLHDIIHTKE 76 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-------ccchhHHHHHHHHhhCCCCCcCeEEEEEecCC
Confidence 46899999999999999999998 4788999998753211 11234678999999999999999999998764
Q ss_pred CCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccC
Q 000893 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1236)
Q Consensus 1119 ~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGL 1198 (1236)
.+++||||+ .++|.+++......+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+
T Consensus 77 --~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~----~~kl~Dfg~ 149 (303)
T cd07869 77 --TLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTG----ELKLADFGL 149 (303)
T ss_pred --eEEEEEECC-CcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC----CEEECCCCc
Confidence 899999999 5788888876666789999999999999999999999999999999999999876 569999999
Q ss_pred cccccCc-ccccCcCCCCcccchhhhcCC
Q 000893 1199 SKIKRNT-LVTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1199 Arii~ns-~~tss~~GTp~YmAPEVL~Gs 1226 (1236)
++..... ......+||+.|+|||++.+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 178 (303)
T cd07869 150 ARAKSVPSHTYSNEVVTLWYRPPDVLLGS 178 (303)
T ss_pred ceeccCCCccCCCCcccCCCCChHHHcCC
Confidence 9764322 222345689999999998764
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-27 Score=261.54 Aligned_cols=175 Identities=24% Similarity=0.376 Sum_probs=146.8
Q ss_pred ccccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEec
Q 000893 1039 IKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1236)
Q Consensus 1039 Is~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t 1116 (1236)
+..++|++.+.||+|+||+||+++. +++.||||++.+.... .......+.+|+.+++.++||||+++++++.+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~ 114 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI-----KRSDSAFFWEERDIMAHANSEWIVQLHYAFQD 114 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhhHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 4557899999999999999999988 4778999999753221 11223457789999999999999999999987
Q ss_pred CCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEec
Q 000893 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1236)
Q Consensus 1117 ~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDF 1196 (1236)
.. .+++||||+++|+|..++.. ..+++..+..++.||+.||+|||++||+||||||+||||+.++ .+||+||
T Consensus 115 ~~--~~~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~----~~kL~Df 186 (370)
T cd05596 115 DK--YLYMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG----HLKLADF 186 (370)
T ss_pred CC--EEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCC----CEEEEec
Confidence 54 89999999999999998854 3578888999999999999999999999999999999999886 6799999
Q ss_pred cCcccccCcc--cccCcCCCCcccchhhhcCC
Q 000893 1197 GLSKIKRNTL--VTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1197 GLArii~ns~--~tss~~GTp~YmAPEVL~Gs 1226 (1236)
|++....... .....+||+.|+|||++.+.
T Consensus 187 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 218 (370)
T cd05596 187 GTCMKMDANGMVRCDTAVGTPDYISPEVLKSQ 218 (370)
T ss_pred cceeeccCCCcccCCCCCCCcCeECHHHhccC
Confidence 9998754332 23456799999999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-27 Score=254.36 Aligned_cols=173 Identities=25% Similarity=0.352 Sum_probs=145.4
Q ss_pred cCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
++|+++++||+|+||+||+++++ ++.||||++.+.... .......|.+|+.++..++|+||+++++++.+..
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 74 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML-----KRAETACFREERDVLVNGDNQWITTLHYAFQDEN- 74 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHH-----HhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC-
Confidence 47899999999999999999984 567999998653211 1223345778999999999999999999998754
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
.+++||||+++|+|.+++......+++..++.|+.||+.||.|||+++|+||||||+|||++.++ .+||+|||++
T Consensus 75 -~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~----~~kL~DfG~a 149 (332)
T cd05623 75 -NLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG----HIRLADFGSC 149 (332)
T ss_pred -EEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC----CEEEeecchh
Confidence 89999999999999999977666789999999999999999999999999999999999999876 5799999999
Q ss_pred ccccCc--ccccCcCCCCcccchhhhcC
Q 000893 1200 KIKRNT--LVTGGVRGTLPWMAPELLNG 1225 (1236)
Q Consensus 1200 rii~ns--~~tss~~GTp~YmAPEVL~G 1225 (1236)
...... ......+||+.|+|||++.+
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 177 (332)
T cd05623 150 LKLMEDGTVQSSVAVGTPDYISPEILQA 177 (332)
T ss_pred eecccCCcceecccccCccccCHHHHhc
Confidence 764322 22234679999999999963
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-27 Score=253.09 Aligned_cols=173 Identities=25% Similarity=0.385 Sum_probs=143.7
Q ss_pred CeeEEEEeccCCceEEEEeee-----cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCC-CCceeeEeeeEec
Q 000893 1043 DLEELKELGSGTFGTVYHGKW-----RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQD 1116 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArl-----kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLr-HPNIVrLyG~f~t 1116 (1236)
+|++++.||+|+||+||+++. .++.||||++.+..... .......+.+|+.+++.++ ||||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQ----KAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT 76 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhh----hhhHHHHHHHHHHHHHhccCCCCcccEEEEEec
Confidence 588999999999999999876 46789999997643211 2223456778999999995 9999999999887
Q ss_pred CCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEec
Q 000893 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1236)
Q Consensus 1117 ~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDF 1196 (1236)
.. .+++||||+.+++|..++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+||
T Consensus 77 ~~--~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~----~~kl~Df 149 (332)
T cd05614 77 EA--KLHLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEG----HVVLTDF 149 (332)
T ss_pred CC--EEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCC----CEEEeeC
Confidence 54 89999999999999999864 34689999999999999999999999999999999999999886 5799999
Q ss_pred cCcccccC--cccccCcCCCCcccchhhhcCC
Q 000893 1197 GLSKIKRN--TLVTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1197 GLArii~n--s~~tss~~GTp~YmAPEVL~Gs 1226 (1236)
|+++.... .......+||+.|+|||++.+.
T Consensus 150 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 181 (332)
T cd05614 150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRGK 181 (332)
T ss_pred cCCccccccCCCccccccCCccccCHHHhcCC
Confidence 99986432 2223356799999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-27 Score=252.72 Aligned_cols=169 Identities=28% Similarity=0.383 Sum_probs=141.3
Q ss_pred eccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeEEEEEe
Q 000893 1050 LGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTE 1127 (1236)
Q Consensus 1050 LGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L~LVME 1127 (1236)
||+|+||+||+|++. ++.||||++++.... .......+.+|+.+|+.++||||++++++|.... .+++|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e 73 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIV-----SRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPE--KLYLVLA 73 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCC--eEEEEEc
Confidence 799999999999984 678999999754221 2233456788999999999999999999998754 8999999
Q ss_pred eccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCccccc-Ccc
Q 000893 1128 FMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR-NTL 1206 (1236)
Q Consensus 1128 Ym~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~-ns~ 1206 (1236)
|+++++|.+++.. ...+++..++.++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+++... ...
T Consensus 74 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~----~~kl~Dfg~~~~~~~~~~ 148 (312)
T cd05585 74 FINGGELFHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQG----HIALCDFGLCKLNMKDDD 148 (312)
T ss_pred CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCC----cEEEEECcccccCccCCC
Confidence 9999999999865 34689999999999999999999999999999999999999876 57999999998643 223
Q ss_pred cccCcCCCCcccchhhhcCCCCCC
Q 000893 1207 VTGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1207 ~tss~~GTp~YmAPEVL~Gss~~~ 1230 (1236)
.....+||+.|+|||++.+..+..
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~~~~~ 172 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGHGYTK 172 (312)
T ss_pred ccccccCCcccCCHHHHcCCCCCC
Confidence 344578999999999998764433
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-27 Score=261.15 Aligned_cols=175 Identities=26% Similarity=0.400 Sum_probs=147.0
Q ss_pred ccccCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEec
Q 000893 1039 IKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1236)
Q Consensus 1039 Is~EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t 1116 (1236)
+..++|++.+.||+|+||.||+++++ ++.||+|++.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~-----~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI-----KRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhh-----hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 45579999999999999999999984 678999998753211 12223457789999999999999999999987
Q ss_pred CCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEec
Q 000893 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1236)
Q Consensus 1117 ~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDF 1196 (1236)
.. .+++||||+++++|..++.. ..+++..+..++.||+.||.|||++||+||||||+||||+.++ .+||+||
T Consensus 115 ~~--~~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~----~ikL~Df 186 (371)
T cd05622 115 DR--YLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG----HLKLADF 186 (371)
T ss_pred CC--EEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCC----CEEEEeC
Confidence 54 89999999999999999854 3588888999999999999999999999999999999999876 5799999
Q ss_pred cCcccccCcc--cccCcCCCCcccchhhhcCC
Q 000893 1197 GLSKIKRNTL--VTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1197 GLArii~ns~--~tss~~GTp~YmAPEVL~Gs 1226 (1236)
|+++...... .....+||+.|+|||++.+.
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 218 (371)
T cd05622 187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ 218 (371)
T ss_pred CceeEcCcCCcccccCcccCccccCHHHHhcc
Confidence 9998764322 23456799999999999764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-27 Score=252.95 Aligned_cols=173 Identities=26% Similarity=0.317 Sum_probs=147.2
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
++|++.+.||+|+||+||+++. .++.||||++++.... .......+.+|+.+++.++||||+++++++....
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~- 74 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLL-----AQETVSFFEEERDILSISNSPWIPQLQYAFQDKD- 74 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCC-
Confidence 3689999999999999999987 4788999999864321 2233456788999999999999999999998754
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
.+++||||+++++|.+++......+++..+..++.||+.||.|||+++|+||||||+||||+.++ .+||+|||++
T Consensus 75 -~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~----~~kL~Dfg~a 149 (330)
T cd05601 75 -NLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTG----HIKLADFGSA 149 (330)
T ss_pred -eEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCC----CEEeccCCCC
Confidence 89999999999999999977666799999999999999999999999999999999999999876 5699999999
Q ss_pred ccccCcc--cccCcCCCCcccchhhhcC
Q 000893 1200 KIKRNTL--VTGGVRGTLPWMAPELLNG 1225 (1236)
Q Consensus 1200 rii~ns~--~tss~~GTp~YmAPEVL~G 1225 (1236)
....... ......||+.|+|||++.+
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 177 (330)
T cd05601 150 ARLTANKMVNSKLPVGTPDYIAPEVLTT 177 (330)
T ss_pred eECCCCCceeeecccCCccccCHHHhcc
Confidence 8754332 2233578999999999974
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-27 Score=256.25 Aligned_cols=169 Identities=28% Similarity=0.387 Sum_probs=141.2
Q ss_pred EEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeEEEE
Q 000893 1048 KELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATV 1125 (1236)
Q Consensus 1048 kkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L~LV 1125 (1236)
+.||+|+||+||+++. .+..||+|++++.... .......+.+|+.+++.++||||++++++|.... .+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~--~~~lv 73 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVII-----AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD--RLCFV 73 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCC--EEEEE
Confidence 3599999999999987 4788999999864321 2233456778999999999999999999998754 89999
Q ss_pred EeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcccccC-
Q 000893 1126 TEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN- 1204 (1236)
Q Consensus 1126 MEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~n- 1204 (1236)
|||+++++|..++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||+++....
T Consensus 74 ~E~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~----~~kL~Dfg~~~~~~~~ 148 (323)
T cd05595 74 MEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG----HIKITDFGLCKEGISD 148 (323)
T ss_pred EeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCC----CEEecccHHhccccCC
Confidence 999999999888854 45689999999999999999999999999999999999999876 579999999886422
Q ss_pred cccccCcCCCCcccchhhhcCCCC
Q 000893 1205 TLVTGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1205 s~~tss~~GTp~YmAPEVL~Gss~ 1228 (1236)
.......+||+.|+|||++.+...
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~ 172 (323)
T cd05595 149 GATMKTFCGTPEYLAPEVLEDNDY 172 (323)
T ss_pred CCccccccCCcCcCCcccccCCCC
Confidence 223345679999999999986643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-27 Score=253.04 Aligned_cols=169 Identities=31% Similarity=0.394 Sum_probs=140.5
Q ss_pred EEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeEEEE
Q 000893 1048 KELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATV 1125 (1236)
Q Consensus 1048 kkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L~LV 1125 (1236)
+.||+|+||+||+++. ++..||||++++.... .......+.+|+++++.++||||++++++|.... .+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~-----~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~--~~~lv 73 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV-----AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD--RLCFV 73 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCC--EEEEE
Confidence 3599999999999987 5788999999864321 1223456778999999999999999999998754 89999
Q ss_pred EeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCcEEEccCCCCCCcEEEEeccCccccc-
Q 000893 1126 TEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR- 1203 (1236)
Q Consensus 1126 MEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHS-kGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~- 1203 (1236)
|||+++++|..++.. ...+++..++.|+.||+.||.|||+ +||+||||||+||||+.++ .+||+|||+++...
T Consensus 74 ~E~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~----~~kL~Dfg~~~~~~~ 148 (325)
T cd05594 74 MEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG----HIKITDFGLCKEGIK 148 (325)
T ss_pred EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCC----CEEEecCCCCeecCC
Confidence 999999999988854 4568999999999999999999997 7999999999999999886 57999999997632
Q ss_pred CcccccCcCCCCcccchhhhcCCCC
Q 000893 1204 NTLVTGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1204 ns~~tss~~GTp~YmAPEVL~Gss~ 1228 (1236)
........+||+.|+|||++.+..+
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~ 173 (325)
T cd05594 149 DGATMKTFCGTPEYLAPEVLEDNDY 173 (325)
T ss_pred CCcccccccCCcccCCHHHHccCCC
Confidence 2223345679999999999987543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-26 Score=252.06 Aligned_cols=175 Identities=27% Similarity=0.346 Sum_probs=143.7
Q ss_pred CeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCC-ceeeEeeeEecCCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP-NVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHP-NIVrLyG~f~t~~~ 1119 (1236)
+|++++.||+|+||.||+|+.+ ++.||||++++.... .......+..|.+++..+.|+ +|+++++++....
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~- 74 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVII-----QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD- 74 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC-
Confidence 5889999999999999999884 567999999864321 122345677899999999765 5888998888754
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
.+++||||+++++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 75 -~~~lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~----~~kL~Dfg~~ 148 (324)
T cd05587 75 -RLYFVMEYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEG----HIKIADFGMC 148 (324)
T ss_pred -EEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCC----CEEEeecCcc
Confidence 899999999999999988543 4688999999999999999999999999999999999999886 5799999998
Q ss_pred cccc-CcccccCcCCCCcccchhhhcCCCCC
Q 000893 1200 KIKR-NTLVTGGVRGTLPWMAPELLNGSSSK 1229 (1236)
Q Consensus 1200 rii~-ns~~tss~~GTp~YmAPEVL~Gss~~ 1229 (1236)
+... ........+||+.|+|||++.+....
T Consensus 149 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 179 (324)
T cd05587 149 KENIFGGKTTRTFCGTPDYIAPEIIAYQPYG 179 (324)
T ss_pred eecCCCCCceeeecCCccccChhhhcCCCCC
Confidence 7532 22233456799999999999876443
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=250.19 Aligned_cols=181 Identities=25% Similarity=0.353 Sum_probs=144.2
Q ss_pred CeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC-
Q 000893 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG- 1119 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~- 1119 (1236)
+|++.+.||+|+||.||+|+. ++..||||++..... .......+.+|+.+++.++||||+++++++.....
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 74 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE------HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 74 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc------cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCC
Confidence 588999999999999999987 478899999874321 11223467899999999999999999998865332
Q ss_pred --CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEecc
Q 000893 1120 --GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1236)
Q Consensus 1120 --g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFG 1197 (1236)
..+++||||| +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 75 ~~~~~~lv~e~~-~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~----~~kL~Dfg 148 (338)
T cd07859 75 EFKDIYVVFELM-ESDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADC----KLKICDFG 148 (338)
T ss_pred CCceEEEEEecC-CCCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC----cEEEccCc
Confidence 3589999999 5789888854 34689999999999999999999999999999999999999876 57999999
Q ss_pred CcccccCc----ccccCcCCCCcccchhhhcCCCCCCCcccc
Q 000893 1198 LSKIKRNT----LVTGGVRGTLPWMAPELLNGSSSKVSEKVC 1235 (1236)
Q Consensus 1198 LArii~ns----~~tss~~GTp~YmAPEVL~Gss~~~SdDVD 1235 (1236)
+++..... ......+||+.|+|||++.+....++..+|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~D 190 (338)
T cd07859 149 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAID 190 (338)
T ss_pred cccccccccCccccccCCCCCCCcCCHHHHhccccccCchhH
Confidence 99864322 122346799999999998763334443333
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=250.86 Aligned_cols=176 Identities=27% Similarity=0.352 Sum_probs=144.4
Q ss_pred CeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhC-CCCceeeEeeeEecCCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskL-rHPNIVrLyG~f~t~~~ 1119 (1236)
+|.+++.||+|+||+||+|+.. ++.||||++++.... .......+..|..++..+ .|++|+++++++....
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~- 74 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-----QDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD- 74 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCC-
Confidence 5788999999999999999884 567999999864321 122234566788888877 5899999999998754
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
.+++||||+++++|..++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++ .+||+|||++
T Consensus 75 -~~~lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~----~~kL~DfG~~ 148 (323)
T cd05616 75 -RLYFVMEYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG----HIKIADFGMC 148 (323)
T ss_pred -EEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCC----cEEEccCCCc
Confidence 899999999999999888543 4688999999999999999999999999999999999999887 5699999999
Q ss_pred cccc-CcccccCcCCCCcccchhhhcCCCCCC
Q 000893 1200 KIKR-NTLVTGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1200 rii~-ns~~tss~~GTp~YmAPEVL~Gss~~~ 1230 (1236)
+... ........+||+.|+|||++.+.....
T Consensus 149 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 180 (323)
T cd05616 149 KENMWDGVTTKTFCGTPDYIAPEIIAYQPYGK 180 (323)
T ss_pred eecCCCCCccccCCCChhhcCHHHhcCCCCCC
Confidence 8643 233344578999999999998764433
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=251.90 Aligned_cols=173 Identities=29% Similarity=0.423 Sum_probs=141.3
Q ss_pred eeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHH---hhCCCCceeeEeeeEecCC
Q 000893 1044 LEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL---SKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1044 YeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrIL---skLrHPNIVrLyG~f~t~~ 1118 (1236)
|++++.||+|+||+||+|++ .++.||||++++.... .......+.+|++++ +.++||||+++++++....
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDII-----ARDEVESLMCEKRIFETANSERHPFLVNLFACFQTED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCC
Confidence 67889999999999999988 4778999999864321 112234455565554 5678999999999998754
Q ss_pred CCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccC
Q 000893 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1236)
Q Consensus 1119 ~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGL 1198 (1236)
.+++||||+++++|..++. ...+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||+
T Consensus 76 --~~~lv~E~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~----~~kL~Dfg~ 147 (324)
T cd05589 76 --HVCFVMEYAAGGDLMMHIH--TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEG----FVKIADFGL 147 (324)
T ss_pred --EEEEEEcCCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC----cEEeCcccC
Confidence 8999999999999998874 34689999999999999999999999999999999999999886 569999999
Q ss_pred ccccc-CcccccCcCCCCcccchhhhcCCCCC
Q 000893 1199 SKIKR-NTLVTGGVRGTLPWMAPELLNGSSSK 1229 (1236)
Q Consensus 1199 Arii~-ns~~tss~~GTp~YmAPEVL~Gss~~ 1229 (1236)
++... ........+||+.|+|||++.+....
T Consensus 148 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 179 (324)
T cd05589 148 CKEGMGFGDRTSTFCGTPEFLAPEVLTETSYT 179 (324)
T ss_pred CccCCCCCCcccccccCccccCHhHhcCCCCC
Confidence 87643 22333457899999999999876443
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=244.75 Aligned_cols=177 Identities=25% Similarity=0.352 Sum_probs=147.7
Q ss_pred CeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g 1120 (1236)
.|++.+.||+|+||+||++.. +++.||||++...... .......+.+|+.+++.++||||+++++++....
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 73 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-----KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD-- 73 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhh-----hhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCC--
Confidence 478899999999999999987 4788999999754321 1222345778999999999999999999998754
Q ss_pred eEEEEEeeccCCCHHHHHhhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1121 TLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1121 ~L~LVMEYm~GGSL~dlL~~k~-r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
.+++||||+++++|..++.... ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++ .++|+|||++
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~----~~~l~Dfg~~ 149 (285)
T cd05605 74 ALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYG----HIRISDLGLA 149 (285)
T ss_pred eEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCC----CEEEeeCCCc
Confidence 8999999999999998886543 4689999999999999999999999999999999999999876 5799999999
Q ss_pred ccccCcccccCcCCCCcccchhhhcCCCCCC
Q 000893 1200 KIKRNTLVTGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1200 rii~ns~~tss~~GTp~YmAPEVL~Gss~~~ 1230 (1236)
............+|++.|+|||++.+.....
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 180 (285)
T cd05605 150 VEIPEGETIRGRVGTVGYMAPEVVKNERYTF 180 (285)
T ss_pred eecCCCCccccccCCCCccCcHHhcCCCCCc
Confidence 8765444444567899999999998654333
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=252.92 Aligned_cols=170 Identities=25% Similarity=0.375 Sum_probs=141.6
Q ss_pred EeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhC-CCCceeeEeeeEecCCCCeEEEE
Q 000893 1049 ELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDGPGGTLATV 1125 (1236)
Q Consensus 1049 kLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskL-rHPNIVrLyG~f~t~~~g~L~LV 1125 (1236)
.||+|+||+||++++ .++.||||++++.... .......+.+|..++..+ +||||++++++|.+.. .+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~-----~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~--~~~lv 74 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVN-----DDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTES--RLFFV 74 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCC--EEEEE
Confidence 589999999999998 4778999999864321 222345677899999988 6999999999998764 89999
Q ss_pred EeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcccc-cC
Q 000893 1126 TEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-RN 1204 (1236)
Q Consensus 1126 MEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii-~n 1204 (1236)
||||++++|..++.. ...+++..++.|+.||+.||.|||++||+||||||+||||+.++ .+||+|||+++.. ..
T Consensus 75 ~e~~~~g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~----~~kL~Dfg~~~~~~~~ 149 (329)
T cd05588 75 IEFVSGGDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEG----HIKLTDYGMCKEGIRP 149 (329)
T ss_pred EeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC----CEEECcCccccccccC
Confidence 999999999988854 35699999999999999999999999999999999999999876 5799999999753 22
Q ss_pred cccccCcCCCCcccchhhhcCCCCCC
Q 000893 1205 TLVTGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1205 s~~tss~~GTp~YmAPEVL~Gss~~~ 1230 (1236)
.......+||+.|+|||++.+.....
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~ 175 (329)
T cd05588 150 GDTTSTFCGTPNYIAPEILRGEDYGF 175 (329)
T ss_pred CCccccccCCccccCHHHHcCCCCCC
Confidence 33344578999999999998764443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=251.80 Aligned_cols=171 Identities=30% Similarity=0.427 Sum_probs=140.4
Q ss_pred EEeccCCceEEEEeee-----cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeE
Q 000893 1048 KELGSGTFGTVYHGKW-----RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTL 1122 (1236)
Q Consensus 1048 kkLGsGSFGtVYKArl-----kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L 1122 (1236)
+.||+|+||+||+++. .++.||||++++..... .......+.+|+.+|+.++||||++++++|... +.+
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~----~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~--~~~ 75 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVR----NQKDTAHTKAERNILEAVKHPFIVDLIYAFQTG--GKL 75 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHh----hhhhHHHHHHHHHHHHhCCCCchhceeeEEecC--CeE
Confidence 5799999999999975 36779999997643211 122334567899999999999999999999875 489
Q ss_pred EEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcccc
Q 000893 1123 ATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 1202 (1236)
Q Consensus 1123 ~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii 1202 (1236)
++||||+.+++|..++.. ...+.+..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||+++..
T Consensus 76 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~----~~kl~Dfg~~~~~ 150 (323)
T cd05584 76 YLILEYLSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQG----HVKLTDFGLCKES 150 (323)
T ss_pred EEEEeCCCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC----CEEEeeCcCCeec
Confidence 999999999999998854 34678888889999999999999999999999999999999876 5799999998753
Q ss_pred c-CcccccCcCCCCcccchhhhcCCCCC
Q 000893 1203 R-NTLVTGGVRGTLPWMAPELLNGSSSK 1229 (1236)
Q Consensus 1203 ~-ns~~tss~~GTp~YmAPEVL~Gss~~ 1229 (1236)
. ........+||+.|+|||++.+....
T Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 178 (323)
T cd05584 151 IHEGTVTHTFCGTIEYMAPEILMRSGHG 178 (323)
T ss_pred ccCCCcccccCCCccccChhhccCCCCC
Confidence 2 22333456799999999999876443
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-27 Score=270.21 Aligned_cols=181 Identities=31% Similarity=0.447 Sum_probs=148.6
Q ss_pred cccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCC------hHHHHHHHHHHHHHHHHhhCCCCceeeEe
Q 000893 1040 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRS------SEQERLTLEFWREAEILSKLHHPNVVAFY 1111 (1236)
Q Consensus 1040 s~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~------~e~er~~keFlrEIrILskLrHPNIVrLy 1111 (1236)
...+|++++.||+|.||+|-+|+. .++.||||++.+....... .....-.....+|+.+|++|.|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 457899999999999999999998 5788999999876432111 00001124678899999999999999999
Q ss_pred eeEecCCCCeEEEEEeeccCCCHHHHHhhhccC-CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCc
Q 000893 1112 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH-LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPI 1190 (1236)
Q Consensus 1112 G~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~r~-LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~lt 1190 (1236)
.+..++....+|||+|||..|.+...- .... +++.+++.|++.++.||+|||.+|||||||||+|+||+.+| +
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g----~ 248 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG----T 248 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC----c
Confidence 999999889999999999988876432 2334 89999999999999999999999999999999999999997 6
Q ss_pred EEEEeccCccccc------CcccccCcCCCCcccchhhhcCC
Q 000893 1191 CKVGDFGLSKIKR------NTLVTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1191 VKLsDFGLArii~------ns~~tss~~GTp~YmAPEVL~Gs 1226 (1236)
|||+|||.+.... ....-...+|||.|+|||...+.
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~ 290 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGG 290 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCC
Confidence 7999999998652 22222346799999999999874
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=265.84 Aligned_cols=177 Identities=29% Similarity=0.423 Sum_probs=147.7
Q ss_pred CeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g 1120 (1236)
.|...+++|.|+||.||+|... +..||||+.....- .--+|+.+|+.++|||||+|.-+|....+.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------------~knrEl~im~~l~HpNIV~L~~~f~~~~~~ 92 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------------YKNRELQIMRKLDHPNIVRLLYFFSSSTES 92 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------------cCcHHHHHHHhcCCcCeeeEEEEEEecCCC
Confidence 5777899999999999999984 67799998754320 112599999999999999999988754433
Q ss_pred ---eEEEEEeeccCCCHHHHHhh---hccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEE
Q 000893 1121 ---TLATVTEFMVNGSLRHVLLS---KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1236)
Q Consensus 1121 ---~L~LVMEYm~GGSL~dlL~~---k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLs 1194 (1236)
++.+||||| ..+|.+.++. .+..++...++.+++||++||.|||+.||+||||||+|||+|.+. +.+|||
T Consensus 93 d~~~lnlVleym-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~t---g~LKic 168 (364)
T KOG0658|consen 93 DEVYLNLVLEYM-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDT---GVLKIC 168 (364)
T ss_pred chhHHHHHHHhc-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCC---CeEEec
Confidence 667899999 5688888864 256788888999999999999999999999999999999999874 478999
Q ss_pred eccCcccccCcccccCcCCCCcccchhhhcCCCCCCCccccC
Q 000893 1195 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVCF 1236 (1236)
Q Consensus 1195 DFGLArii~ns~~tss~~GTp~YmAPEVL~Gss~~~SdDVDI 1236 (1236)
|||.|+.+........+..|..|+|||.|.|. ..|+..+|+
T Consensus 169 DFGSAK~L~~~epniSYicSRyYRaPELifga-~~Yt~~IDi 209 (364)
T KOG0658|consen 169 DFGSAKVLVKGEPNISYICSRYYRAPELIFGA-TEYTTSIDI 209 (364)
T ss_pred cCCcceeeccCCCceeEEEeccccCHHHHcCc-cccCceeEE
Confidence 99999998776666777789999999999986 566676664
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=242.28 Aligned_cols=175 Identities=31% Similarity=0.424 Sum_probs=139.6
Q ss_pred cCeeEEEEeccCCceEEEEeee---cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhC---CCCceeeEeeeEe
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW---RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL---HHPNVVAFYGVVQ 1115 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl---kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskL---rHPNIVrLyG~f~ 1115 (1236)
++|++++.||+|+||+||+|++ .++.||||+++...... .....+.+|+.+++.+ +||||++++++|.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~ 74 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE------GMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 74 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC------CchHHHHHHHHHHHhhcccCCCCcceEEEEEe
Confidence 4688999999999999999987 25679999987543211 1122344566666654 6999999999986
Q ss_pred c---CCCCeEEEEEeeccCCCHHHHHhhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcE
Q 000893 1116 D---GPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 1191 (1236)
Q Consensus 1116 t---~~~g~L~LVMEYm~GGSL~dlL~~k-~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltV 1191 (1236)
. .....+++||||+. ++|..++... ...+++..++.|+.||+.||.|||++||+||||||+|||++.++ .+
T Consensus 75 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~----~~ 149 (290)
T cd07862 75 VSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG----QI 149 (290)
T ss_pred cccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCC----CE
Confidence 3 22357899999995 6898888654 34589999999999999999999999999999999999999876 57
Q ss_pred EEEeccCcccccCcccccCcCCCCcccchhhhcCCC
Q 000893 1192 KVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1192 KLsDFGLArii~ns~~tss~~GTp~YmAPEVL~Gss 1227 (1236)
||+|||+++............||+.|+|||++.+..
T Consensus 150 kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 185 (290)
T cd07862 150 KLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS 185 (290)
T ss_pred EEccccceEeccCCcccccccccccccChHHHhCCC
Confidence 999999998765544445567999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=256.19 Aligned_cols=182 Identities=29% Similarity=0.431 Sum_probs=156.3
Q ss_pred cccccCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEe
Q 000893 1038 IIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 1115 (1236)
Q Consensus 1038 iIs~EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~ 1115 (1236)
....++|++.+.||+|.||.||+|+.+ +..||+|++.+..+. ......++.+|++|.+.|+||||+++|++|.
T Consensus 18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~-----~~~v~~qlrREiEIqs~L~hpnilrlY~~fh 92 (281)
T KOG0580|consen 18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQIL-----KTQVEHQLRREIEIQSHLRHPNILRLYGYFH 92 (281)
T ss_pred ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHH-----HhcchhhhhheeEeecccCCccHHhhhhhee
Confidence 345678999999999999999999985 556999999886543 2334567889999999999999999999999
Q ss_pred cCCCCeEEEEEeeccCCCHHHHHhhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEE
Q 000893 1116 DGPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1236)
Q Consensus 1116 t~~~g~L~LVMEYm~GGSL~dlL~~k-~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLs 1194 (1236)
+.. .+||++||...|.|...|+.. ...+++.....++.|++.||.|||.++||||||||+|+|++..+. +||+
T Consensus 93 d~~--riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~----lkiA 166 (281)
T KOG0580|consen 93 DSK--RIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGE----LKIA 166 (281)
T ss_pred ccc--eeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCC----eecc
Confidence 865 899999999999999999754 346899999999999999999999999999999999999999884 4999
Q ss_pred eccCcccccCcccccCcCCCCcccchhhhcCCCCCCC
Q 000893 1195 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVS 1231 (1236)
Q Consensus 1195 DFGLArii~ns~~tss~~GTp~YmAPEVL~Gss~~~S 1231 (1236)
|||.+.... .....++|||..|++||+..+..+...
T Consensus 167 dfGwsV~~p-~~kR~tlcgt~dyl~pEmv~~~~hd~~ 202 (281)
T KOG0580|consen 167 DFGWSVHAP-SNKRKTLCGTLDYLPPEMVEGRGHDKF 202 (281)
T ss_pred CCCceeecC-CCCceeeecccccCCHhhcCCCCccch
Confidence 999988765 444467999999999999998754433
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=262.42 Aligned_cols=177 Identities=35% Similarity=0.469 Sum_probs=155.5
Q ss_pred ccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCC-CCceeeEeeeEecC
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQDG 1117 (1236)
Q Consensus 1041 ~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLr-HPNIVrLyG~f~t~ 1117 (1236)
...|++.+.||+|.||.||+++. +|+.+|+|++++....... ....+.+|+.+|+.+. |||||.++++|.+.
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~-----~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~ 108 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKE-----DREDVRREVAILQQLSGHPNIVQLKDAFEDP 108 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccc-----cHHHHHHHHHHHHhccCCCCEEEEEEEEEcC
Confidence 35788889999999999999998 4788999999987654322 3446778999999999 99999999999997
Q ss_pred CCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEecc
Q 000893 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1236)
Q Consensus 1118 ~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFG 1197 (1236)
. .+++|||+|.||.|.+.+... .+++..+..++.||+.|+.|||+.||+||||||+|+|+.........+|++|||
T Consensus 109 ~--~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 109 D--SVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred C--eEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 6 899999999999999999766 399999999999999999999999999999999999998765433478999999
Q ss_pred CcccccCcccccCcCCCCcccchhhhcCC
Q 000893 1198 LSKIKRNTLVTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1198 LArii~ns~~tss~~GTp~YmAPEVL~Gs 1226 (1236)
++............|||+.|+|||++.+.
T Consensus 185 la~~~~~~~~~~~~~Gtp~y~APEvl~~~ 213 (382)
T KOG0032|consen 185 LAKFIKPGERLHTIVGTPEYVAPEVLGGR 213 (382)
T ss_pred CceEccCCceEeeecCCccccCchhhcCC
Confidence 99998776677789999999999999864
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-27 Score=274.35 Aligned_cols=188 Identities=35% Similarity=0.534 Sum_probs=161.0
Q ss_pred cccccccccCeeEEEEeccCCceEEEEeeecCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeee
Q 000893 1034 STLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGV 1113 (1236)
Q Consensus 1034 seLqiIs~EdYeiLkkLGsGSFGtVYKArlkG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~ 1113 (1236)
...|.|..+++.+...||+|.||+||+|+|.| .||||++..... .....+.|.+|+.+|++-+|-||+-+.|+
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~p------t~~qlqaFKnEVa~lkkTRH~NIlLFMG~ 456 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDP------TPEQLQAFKNEVAVLKKTRHENILLFMGA 456 (678)
T ss_pred ccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCC------CHHHHHHHHHHHHHHhhcchhhheeeehh
Confidence 46788889999999999999999999999987 689999986543 23367889999999999999999999999
Q ss_pred EecCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEE
Q 000893 1114 VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193 (1236)
Q Consensus 1114 f~t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKL 1193 (1236)
|..+. +.||+-+|+|-+|..+|+..+..|+....+.|++||+.||.|||.++|||||||..||+|..++ +|||
T Consensus 457 ~~~p~---~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~----kVkI 529 (678)
T KOG0193|consen 457 CMNPP---LAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDL----KVKI 529 (678)
T ss_pred hcCCc---eeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCC----cEEE
Confidence 99864 4999999999999999988888899999999999999999999999999999999999999875 7799
Q ss_pred EeccCcccccCc---ccccCcCCCCcccchhhhc-CCCCCCCcccc
Q 000893 1194 GDFGLSKIKRNT---LVTGGVRGTLPWMAPELLN-GSSSKVSEKVC 1235 (1236)
Q Consensus 1194 sDFGLArii~ns---~~tss~~GTp~YmAPEVL~-Gss~~~SdDVD 1235 (1236)
+||||+....-. .-.....|...|||||+|+ ....+++...|
T Consensus 530 gDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSD 575 (678)
T KOG0193|consen 530 GDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSD 575 (678)
T ss_pred ecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccc
Confidence 999999764321 1122345788999999997 44555555554
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=248.33 Aligned_cols=169 Identities=30% Similarity=0.401 Sum_probs=141.1
Q ss_pred EEeccCCceEEEEeee-----cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeE
Q 000893 1048 KELGSGTFGTVYHGKW-----RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTL 1122 (1236)
Q Consensus 1048 kkLGsGSFGtVYKArl-----kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L 1122 (1236)
+.||+|+||+||+++. .++.||||++++... .......+.+|+.+|++++||||++++++|.... .+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~ 73 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL------KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEG--KL 73 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh------hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCC--EE
Confidence 5799999999999875 467899999986432 1122345678999999999999999999998754 89
Q ss_pred EEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcccc
Q 000893 1123 ATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 1202 (1236)
Q Consensus 1123 ~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii 1202 (1236)
++||||+++++|.+++.. ...+++..++.|+.||+.||.|||+++|+||||||+||||+.++ .+||+|||+++..
T Consensus 74 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~----~~kL~Dfg~~~~~ 148 (318)
T cd05582 74 YLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG----HIKLTDFGLSKES 148 (318)
T ss_pred EEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCC----cEEEeeccCCccc
Confidence 999999999999998854 44689999999999999999999999999999999999999876 5699999999875
Q ss_pred cCc-ccccCcCCCCcccchhhhcCCCCC
Q 000893 1203 RNT-LVTGGVRGTLPWMAPELLNGSSSK 1229 (1236)
Q Consensus 1203 ~ns-~~tss~~GTp~YmAPEVL~Gss~~ 1229 (1236)
... ......+||+.|+|||++.+....
T Consensus 149 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 176 (318)
T cd05582 149 IDHEKKAYSFCGTVEYMAPEVVNRRGHT 176 (318)
T ss_pred CCCCCceecccCChhhcCHHHHcCCCCC
Confidence 433 333457799999999999875443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=248.81 Aligned_cols=169 Identities=29% Similarity=0.398 Sum_probs=137.4
Q ss_pred EeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHH-HHhhCCCCceeeEeeeEecCCCCeEEEE
Q 000893 1049 ELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE-ILSKLHHPNVVAFYGVVQDGPGGTLATV 1125 (1236)
Q Consensus 1049 kLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIr-ILskLrHPNIVrLyG~f~t~~~g~L~LV 1125 (1236)
+||+|+||+||+|++ .++.||||++.+.... .......+.+|.. +++.++||||++++++|.+.. .+++|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~--~~~lv 74 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTIL-----KKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAE--KLYFV 74 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHH-----HhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCC--EEEEE
Confidence 699999999999998 4778999999764321 1122334555554 678899999999999998754 89999
Q ss_pred EeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcccc-cC
Q 000893 1126 TEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK-RN 1204 (1236)
Q Consensus 1126 MEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii-~n 1204 (1236)
|||+++++|..++.. ...+.+..++.|+.||+.||.|||+++|+||||||+||||+.++ .+||+|||+++.. ..
T Consensus 75 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~----~~kl~Dfg~~~~~~~~ 149 (321)
T cd05603 75 LDYVNGGELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQG----HVVLTDFGLCKEGVEP 149 (321)
T ss_pred EcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC----CEEEccCCCCccCCCC
Confidence 999999999888854 45688889999999999999999999999999999999999887 5699999999863 22
Q ss_pred cccccCcCCCCcccchhhhcCCCCC
Q 000893 1205 TLVTGGVRGTLPWMAPELLNGSSSK 1229 (1236)
Q Consensus 1205 s~~tss~~GTp~YmAPEVL~Gss~~ 1229 (1236)
.......+||+.|+|||++.+....
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~ 174 (321)
T cd05603 150 EETTSTFCGTPEYLAPEVLRKEPYD 174 (321)
T ss_pred CCccccccCCcccCCHHHhcCCCCC
Confidence 3334457799999999999876433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-26 Score=240.17 Aligned_cols=176 Identities=28% Similarity=0.477 Sum_probs=145.1
Q ss_pred ccccCeeEEEEeccCCceEEEEeeec-----CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeee
Q 000893 1039 IKNEDLEELKELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGV 1113 (1236)
Q Consensus 1039 Is~EdYeiLkkLGsGSFGtVYKArlk-----G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~ 1113 (1236)
+...+|++.+.||+|+||.||+|.++ +..||+|.++... .......|.+|+.+++.++||||++++++
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 74 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-------SDKQRRGFLAEALTLGQFDHSNIVRLEGV 74 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-------CHHHHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence 34578999999999999999999763 4569999987532 12224568899999999999999999999
Q ss_pred EecCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEE
Q 000893 1114 VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193 (1236)
Q Consensus 1114 f~t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKL 1193 (1236)
+.... .+++||||+++++|.+++......+++..++.++.||+.||+|||+++++||||||+||||+.++ .+||
T Consensus 75 ~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~----~~~l 148 (266)
T cd05064 75 ITRGN--TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDL----VCKI 148 (266)
T ss_pred EecCC--CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCC----cEEE
Confidence 98754 89999999999999999977666789999999999999999999999999999999999998875 6799
Q ss_pred EeccCcccccCccccc--CcCCCCcccchhhhcCCC
Q 000893 1194 GDFGLSKIKRNTLVTG--GVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1194 sDFGLArii~ns~~ts--s~~GTp~YmAPEVL~Gss 1227 (1236)
+|||++.......... ...++..|+|||++.+..
T Consensus 149 ~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 184 (266)
T cd05064 149 SGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHH 184 (266)
T ss_pred CCCcccccccccchhcccCCCCceeecCHHHHhhCC
Confidence 9999876543222111 233567899999997653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=248.75 Aligned_cols=170 Identities=29% Similarity=0.416 Sum_probs=139.9
Q ss_pred EeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhC-CCCceeeEeeeEecCCCCeEEEE
Q 000893 1049 ELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDGPGGTLATV 1125 (1236)
Q Consensus 1049 kLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskL-rHPNIVrLyG~f~t~~~g~L~LV 1125 (1236)
+||+|+||+||+|++. ++.||||++++.... .......+..|.+++..+ +||||++++++|.... .+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~--~~~lv 74 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVIL-----QDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKD--RLFFV 74 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhh-----hhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC--eEEEE
Confidence 5999999999999884 678999999764321 122344567788888865 7999999999998754 89999
Q ss_pred EeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCccccc-C
Q 000893 1126 TEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR-N 1204 (1236)
Q Consensus 1126 MEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~-n 1204 (1236)
|||+++++|..++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||+++... .
T Consensus 75 ~E~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~----~~kL~Dfg~~~~~~~~ 149 (321)
T cd05591 75 MEYVNGGDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEG----HCKLADFGMCKEGILN 149 (321)
T ss_pred EeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC----CEEEeecccceecccC
Confidence 999999999988854 35688999999999999999999999999999999999999886 57999999998643 2
Q ss_pred cccccCcCCCCcccchhhhcCCCCCC
Q 000893 1205 TLVTGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1205 s~~tss~~GTp~YmAPEVL~Gss~~~ 1230 (1236)
.......+||+.|+|||++.+..+..
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~ 175 (321)
T cd05591 150 GVTTTTFCGTPDYIAPEILQELEYGP 175 (321)
T ss_pred CccccccccCccccCHHHHcCCCCCC
Confidence 23344567999999999998764433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=250.10 Aligned_cols=169 Identities=24% Similarity=0.365 Sum_probs=139.9
Q ss_pred EeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhC-CCCceeeEeeeEecCCCCeEEEE
Q 000893 1049 ELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDGPGGTLATV 1125 (1236)
Q Consensus 1049 kLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskL-rHPNIVrLyG~f~t~~~g~L~LV 1125 (1236)
.||+|+||+||++++ .++.||||++++.... .......+.+|+.++..+ +||||+++++++.... .+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~--~~~lv 74 (329)
T cd05618 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVN-----DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES--RLFFV 74 (329)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhc-----chhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCC--EEEEE
Confidence 599999999999988 4678999999865322 122344567888888776 7999999999998854 89999
Q ss_pred EeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCccccc-C
Q 000893 1126 TEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR-N 1204 (1236)
Q Consensus 1126 MEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~-n 1204 (1236)
|||+++++|..++.. ...+++..++.|+.||+.||.|||+++|+||||||+||||+.++ .+||+|||+++... .
T Consensus 75 ~E~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~----~~kL~DfG~~~~~~~~ 149 (329)
T cd05618 75 IEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG----HIKLTDYGMCKEGLRP 149 (329)
T ss_pred EeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC----CEEEeeCCccccccCC
Confidence 999999999988754 45689999999999999999999999999999999999999887 56999999998632 2
Q ss_pred cccccCcCCCCcccchhhhcCCCCC
Q 000893 1205 TLVTGGVRGTLPWMAPELLNGSSSK 1229 (1236)
Q Consensus 1205 s~~tss~~GTp~YmAPEVL~Gss~~ 1229 (1236)
.......+||+.|+|||++.+....
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~ 174 (329)
T cd05618 150 GDTTSTFCGTPNYIAPEILRGEDYG 174 (329)
T ss_pred CCccccccCCccccCHHHHcCCCCC
Confidence 2233457899999999999876444
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-26 Score=248.55 Aligned_cols=171 Identities=29% Similarity=0.388 Sum_probs=138.5
Q ss_pred EEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHH-HHhhCCCCceeeEeeeEecCCCCeEEE
Q 000893 1048 KELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE-ILSKLHHPNVVAFYGVVQDGPGGTLAT 1124 (1236)
Q Consensus 1048 kkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIr-ILskLrHPNIVrLyG~f~t~~~g~L~L 1124 (1236)
+.||+|+||+||+|+. .++.||||++.+.... .......+.+|.. +++.++||||+++++++.... .+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~--~~~l 73 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVL-----NRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTE--KLYF 73 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCC--EEEE
Confidence 3599999999999987 4788999999764321 1222344555654 467899999999999998754 8999
Q ss_pred EEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCccccc-
Q 000893 1125 VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR- 1203 (1236)
Q Consensus 1125 VMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~- 1203 (1236)
||||+++++|..++.. ...+++..++.++.||+.||+|||++||+||||||+||||+.++ .+||+|||+++...
T Consensus 74 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~----~~kL~DfG~~~~~~~ 148 (325)
T cd05604 74 VLDFVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQG----HVVLTDFGLCKEGIA 148 (325)
T ss_pred EEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC----CEEEeecCCcccCCC
Confidence 9999999999988854 45689999999999999999999999999999999999999887 56999999997632
Q ss_pred CcccccCcCCCCcccchhhhcCCCCCC
Q 000893 1204 NTLVTGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1204 ns~~tss~~GTp~YmAPEVL~Gss~~~ 1230 (1236)
........+||+.|+|||++.+..+..
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ 175 (325)
T cd05604 149 QSDTTTTFCGTPEYLAPEVIRKQPYDN 175 (325)
T ss_pred CCCCcccccCChhhCCHHHHcCCCCCC
Confidence 233334567999999999998764433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-26 Score=248.56 Aligned_cols=170 Identities=28% Similarity=0.400 Sum_probs=138.1
Q ss_pred EeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHH-HHhhCCCCceeeEeeeEecCCCCeEEEE
Q 000893 1049 ELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE-ILSKLHHPNVVAFYGVVQDGPGGTLATV 1125 (1236)
Q Consensus 1049 kLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIr-ILskLrHPNIVrLyG~f~t~~~g~L~LV 1125 (1236)
.||+|+||+||+|++ +++.||||++.+.... .......+..|.. +++.++||||+++++++.... .+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~--~~~lv 74 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAIL-----KKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTAD--KLYFV 74 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHh-----hhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCC--EEEEE
Confidence 599999999999998 4788999999764321 1122334555554 567899999999999998754 89999
Q ss_pred EeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCccccc-C
Q 000893 1126 TEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR-N 1204 (1236)
Q Consensus 1126 MEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~-n 1204 (1236)
|||+++++|..++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||+++... .
T Consensus 75 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~----~~kl~Dfg~~~~~~~~ 149 (323)
T cd05575 75 LDYVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQG----HVVLTDFGLCKEGIEH 149 (323)
T ss_pred EcCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC----cEEEeccCCCcccccC
Confidence 999999999998864 45688999999999999999999999999999999999999886 56999999987632 2
Q ss_pred cccccCcCCCCcccchhhhcCCCCCC
Q 000893 1205 TLVTGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1205 s~~tss~~GTp~YmAPEVL~Gss~~~ 1230 (1236)
.......+||+.|+|||++.+.....
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~ 175 (323)
T cd05575 150 SKTTSTFCGTPEYLAPEVLRKQPYDR 175 (323)
T ss_pred CCccccccCChhhcChhhhcCCCCCc
Confidence 33344567999999999998764433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-27 Score=273.11 Aligned_cols=174 Identities=29% Similarity=0.477 Sum_probs=149.1
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
..|...++||+|+.|.||.|+. +++.||||.+.+.... ...-+++|+.+|+..+|+|||.++..|...+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~--------~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d- 343 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP--------KKELLLNEILVMRDLHHPNIVNFLDSYLVGD- 343 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC--------chhhhHHHHHHHHhccchHHHHHHHHhcccc-
Confidence 4577778999999999999987 4677999999875432 1234678999999999999999999888754
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
.+|+|||||+||+|.+.+ ....+++.++..|+++++.||+|||.+||||||||.+|||++.+| .+||+|||+|
T Consensus 344 -eLWVVMEym~ggsLTDvV--t~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g----~vKltDFGFc 416 (550)
T KOG0578|consen 344 -ELWVVMEYMEGGSLTDVV--TKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDG----SVKLTDFGFC 416 (550)
T ss_pred -eeEEEEeecCCCchhhhh--hcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCC----cEEEeeeeee
Confidence 899999999999999998 445699999999999999999999999999999999999999998 4699999999
Q ss_pred ccccCcc-cccCcCCCCcccchhhhcCCCCCCC
Q 000893 1200 KIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVS 1231 (1236)
Q Consensus 1200 rii~ns~-~tss~~GTp~YmAPEVL~Gss~~~S 1231 (1236)
..+.... ...+++|||+|||||++....+...
T Consensus 417 aqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~K 449 (550)
T KOG0578|consen 417 AQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPK 449 (550)
T ss_pred eccccccCccccccCCCCccchhhhhhcccCcc
Confidence 8875443 4567889999999999987644443
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-26 Score=247.04 Aligned_cols=176 Identities=30% Similarity=0.465 Sum_probs=148.7
Q ss_pred ccccCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEec
Q 000893 1039 IKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1236)
Q Consensus 1039 Is~EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t 1116 (1236)
+..++|++++.||+|+||.||++++. +..||+|++.... .......+.+|+.+|+.++||||+++++++..
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-------KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-------CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 45678999999999999999999984 7779999987531 12345578899999999999999999999987
Q ss_pred CCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCcEEEccCCCCCCcEEEEe
Q 000893 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1236)
Q Consensus 1117 ~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSk-GIIHRDIKPsNILLDsdG~I~ltVKLsD 1195 (1236)
.. .+++||||+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .+||+|
T Consensus 75 ~~--~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~----~~kl~D 147 (331)
T cd06649 75 DG--EISICMEHMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG----EIKLCD 147 (331)
T ss_pred CC--EEEEEeecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCC----cEEEcc
Confidence 54 899999999999999998643 4688999999999999999999986 699999999999999886 579999
Q ss_pred ccCcccccCcccccCcCCCCcccchhhhcCCCCC
Q 000893 1196 FGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSK 1229 (1236)
Q Consensus 1196 FGLArii~ns~~tss~~GTp~YmAPEVL~Gss~~ 1229 (1236)
||+++..... ......||+.|+|||++.+....
T Consensus 148 fg~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~ 180 (331)
T cd06649 148 FGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYS 180 (331)
T ss_pred Cccccccccc-ccccCCCCcCcCCHhHhcCCCCC
Confidence 9999865433 23446799999999999876433
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.7e-27 Score=262.40 Aligned_cols=187 Identities=27% Similarity=0.375 Sum_probs=158.8
Q ss_pred ccccccCeeEEEEeccCCceEEEEeeecC--ceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeE
Q 000893 1037 QIIKNEDLEELKELGSGTFGTVYHGKWRG--TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVV 1114 (1236)
Q Consensus 1037 qiIs~EdYeiLkkLGsGSFGtVYKArlkG--~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f 1114 (1236)
..+..+.|++++.||.|.-|+||++++++ ..+|+|++.+..+. ......+...|.+||+.++||+|+.||..|
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~-----~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f 146 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLA-----SRKKLKRAQTEREILSLLDHPFLPTLYASF 146 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHh-----hhhHHHHHHHHHHHHHhcCCCccchhhhee
Confidence 44566788999999999999999999976 56999999887653 244456778899999999999999999999
Q ss_pred ecCCCCeEEEEEeeccCCCHHHHHhhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEE
Q 000893 1115 QDGPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193 (1236)
Q Consensus 1115 ~t~~~g~L~LVMEYm~GGSL~dlL~~k-~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKL 1193 (1236)
.+.+ .+|+|||||+||+|..+++++ ++.+++..++.++.+++.||+|||..|||+|||||+||||..+|++ .|
T Consensus 147 et~~--~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHI----ML 220 (459)
T KOG0610|consen 147 ETDK--YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHI----ML 220 (459)
T ss_pred eccc--eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcE----Ee
Confidence 9976 999999999999999988765 4689999999999999999999999999999999999999999954 89
Q ss_pred EeccCccccc----------------------------------C-c----------------------ccccCcCCCCc
Q 000893 1194 GDFGLSKIKR----------------------------------N-T----------------------LVTGGVRGTLP 1216 (1236)
Q Consensus 1194 sDFGLArii~----------------------------------n-s----------------------~~tss~~GTp~ 1216 (1236)
+||.|+.... . . ..+..++||-.
T Consensus 221 sDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThE 300 (459)
T KOG0610|consen 221 SDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHE 300 (459)
T ss_pred eeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccc
Confidence 9999864210 0 0 11224679999
Q ss_pred ccchhhhcCCCCCCCccc
Q 000893 1217 WMAPELLNGSSSKVSEKV 1234 (1236)
Q Consensus 1217 YmAPEVL~Gss~~~SdDV 1234 (1236)
|+|||+|.|..+....||
T Consensus 301 YlAPEvI~G~GHgsAVDW 318 (459)
T KOG0610|consen 301 YLAPEVIRGEGHGSAVDW 318 (459)
T ss_pred cccceeeecCCCCchhhH
Confidence 999999999988877775
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=249.30 Aligned_cols=170 Identities=31% Similarity=0.435 Sum_probs=140.0
Q ss_pred EeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhC-CCCceeeEeeeEecCCCCeEEEE
Q 000893 1049 ELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDGPGGTLATV 1125 (1236)
Q Consensus 1049 kLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskL-rHPNIVrLyG~f~t~~~g~L~LV 1125 (1236)
.||+|+||+||+|+++ ++.||||++++.... .......+..|..++..+ +||||+++++++.... .+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~--~~~iv 74 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVIL-----QDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPD--RLFFV 74 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-----hccHHHHHHHHHHHHHhccCCCchhceeeEEEcCC--EEEEE
Confidence 5999999999999984 678999999764321 122344567788888876 6999999999998754 89999
Q ss_pred EeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCccccc-C
Q 000893 1126 TEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR-N 1204 (1236)
Q Consensus 1126 MEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~-n 1204 (1236)
|||+++++|..++... ..+++..++.++.|++.||.|||+++|+||||||+|||++.++ .+||+|||+++... .
T Consensus 75 ~Ey~~~g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~----~~kL~DfG~~~~~~~~ 149 (320)
T cd05590 75 MEFVNGGDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEG----HCKLADFGMCKEGIFN 149 (320)
T ss_pred EcCCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC----cEEEeeCCCCeecCcC
Confidence 9999999999888644 4689999999999999999999999999999999999999886 56999999988632 2
Q ss_pred cccccCcCCCCcccchhhhcCCCCCC
Q 000893 1205 TLVTGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1205 s~~tss~~GTp~YmAPEVL~Gss~~~ 1230 (1236)
.......+||+.|+|||++.+.....
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~ 175 (320)
T cd05590 150 GKTTSTFCGTPDYIAPEILQEMLYGP 175 (320)
T ss_pred CCcccccccCccccCHHHHcCCCCCC
Confidence 33344567999999999998764443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-26 Score=248.69 Aligned_cols=170 Identities=24% Similarity=0.347 Sum_probs=141.3
Q ss_pred EeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhC-CCCceeeEeeeEecCCCCeEEEE
Q 000893 1049 ELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDGPGGTLATV 1125 (1236)
Q Consensus 1049 kLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskL-rHPNIVrLyG~f~t~~~g~L~LV 1125 (1236)
.||+|+||+||+++. .++.||||++++.... .......+.+|+.++.++ +||||+++++++.... .+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~~~lv 74 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVH-----DDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTS--RLFLV 74 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCC--EEEEE
Confidence 699999999999987 4678999999864321 223345678899999887 5999999999998754 89999
Q ss_pred EeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCccccc-C
Q 000893 1126 TEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR-N 1204 (1236)
Q Consensus 1126 MEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~-n 1204 (1236)
|||+++++|..++.. ...+++..++.|+.||+.||+|||++||+||||||+|||++.++ .+||+|||+++... .
T Consensus 75 ~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~----~~kl~Dfg~~~~~~~~ 149 (327)
T cd05617 75 IEYVNGGDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADG----HIKLTDYGMCKEGLGP 149 (327)
T ss_pred EeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCC----CEEEeccccceeccCC
Confidence 999999999988854 35699999999999999999999999999999999999999886 56999999998532 2
Q ss_pred cccccCcCCCCcccchhhhcCCCCCC
Q 000893 1205 TLVTGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1205 s~~tss~~GTp~YmAPEVL~Gss~~~ 1230 (1236)
.......+||+.|+|||++.+..+..
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~ 175 (327)
T cd05617 150 GDTTSTFCGTPNYIAPEILRGEEYGF 175 (327)
T ss_pred CCceecccCCcccCCHHHHCCCCCCc
Confidence 33344578999999999998765443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-26 Score=248.09 Aligned_cols=169 Identities=28% Similarity=0.423 Sum_probs=137.6
Q ss_pred EeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhh-CCCCceeeEeeeEecCCCCeEEEE
Q 000893 1049 ELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK-LHHPNVVAFYGVVQDGPGGTLATV 1125 (1236)
Q Consensus 1049 kLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILsk-LrHPNIVrLyG~f~t~~~g~L~LV 1125 (1236)
.||+|+||+||+|+++ ++.||||++++.... .......+..|..++.. ++||||+++++++.... .+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~--~~~lv 74 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVL-----EDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKE--HLFFV 74 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCC--EEEEE
Confidence 6999999999999884 667999999864321 11223345567777765 58999999999998754 89999
Q ss_pred EeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcccccC-
Q 000893 1126 TEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN- 1204 (1236)
Q Consensus 1126 MEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~n- 1204 (1236)
|||+++++|..++... ..+++..+..|+.||+.||.|||+++|+||||||+||||+.++ .+||+|||+++....
T Consensus 75 ~e~~~gg~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~----~~kL~Dfg~a~~~~~~ 149 (316)
T cd05592 75 MEYLNGGDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDG----HIKIADFGMCKENMNG 149 (316)
T ss_pred EcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCC----CEEEccCcCCeECCCC
Confidence 9999999999988654 4689999999999999999999999999999999999999876 579999999986432
Q ss_pred cccccCcCCCCcccchhhhcCCCCC
Q 000893 1205 TLVTGGVRGTLPWMAPELLNGSSSK 1229 (1236)
Q Consensus 1205 s~~tss~~GTp~YmAPEVL~Gss~~ 1229 (1236)
.......+||+.|+|||++.+....
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~ 174 (316)
T cd05592 150 EGKASTFCGTPDYIAPEILKGQKYN 174 (316)
T ss_pred CCccccccCCccccCHHHHcCCCCC
Confidence 2334457899999999999876443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-26 Score=240.00 Aligned_cols=174 Identities=25% Similarity=0.326 Sum_probs=143.5
Q ss_pred cCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
++|++.+.||+|+||+||+++++ ++.||||+++.... .......+.+|+.+++.++||||++++++|....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 73 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE------NEEVKETTLRELKMLRTLKQENIVELKEAFRRRG- 73 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc------cccchhhHHHHHHHHHhCCCccccchhhhEecCC-
Confidence 36899999999999999999984 67799999975421 1223456778999999999999999999998754
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
.+++||||++++.|..+. .....+++..++.++.||+.||.|||+++|+||||||+|||++.++ .+||+|||++
T Consensus 74 -~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~----~~kl~Dfg~~ 147 (287)
T cd07848 74 -KLYLVFEYVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHND----VLKLCDFGFA 147 (287)
T ss_pred -EEEEEEecCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC----cEEEeeccCc
Confidence 899999999887666544 3445689999999999999999999999999999999999999876 5799999999
Q ss_pred ccccCcc--cccCcCCCCcccchhhhcCCCC
Q 000893 1200 KIKRNTL--VTGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1200 rii~ns~--~tss~~GTp~YmAPEVL~Gss~ 1228 (1236)
+...... ......||+.|+|||++.+...
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 178 (287)
T cd07848 148 RNLSEGSNANYTEYVATRWYRSPELLLGAPY 178 (287)
T ss_pred ccccccccccccccccccccCCcHHHcCCCC
Confidence 8754322 2234578999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-26 Score=247.80 Aligned_cols=169 Identities=28% Similarity=0.376 Sum_probs=135.7
Q ss_pred EeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHH-HHHhhCCCCceeeEeeeEecCCCCeEEEE
Q 000893 1049 ELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREA-EILSKLHHPNVVAFYGVVQDGPGGTLATV 1125 (1236)
Q Consensus 1049 kLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEI-rILskLrHPNIVrLyG~f~t~~~g~L~LV 1125 (1236)
.||+|+||+||+|++. ++.||+|++.+.... .......+..|. .+++.++||||+++++++.... .+++|
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~--~~~lv 74 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAIL-----KKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD--KLYFV 74 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHH-----hhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCC--eEEEE
Confidence 6999999999999984 667999999764221 111223344444 4567899999999999998754 89999
Q ss_pred EeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCccccc-C
Q 000893 1126 TEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR-N 1204 (1236)
Q Consensus 1126 MEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~-n 1204 (1236)
|||+++++|..++.. ...+.+..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||+++... .
T Consensus 75 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~----~~kl~DfG~a~~~~~~ 149 (325)
T cd05602 75 LDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG----HIVLTDFGLCKENIEH 149 (325)
T ss_pred EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC----CEEEccCCCCcccccC
Confidence 999999999998864 34578888888999999999999999999999999999999876 56999999997642 2
Q ss_pred cccccCcCCCCcccchhhhcCCCCC
Q 000893 1205 TLVTGGVRGTLPWMAPELLNGSSSK 1229 (1236)
Q Consensus 1205 s~~tss~~GTp~YmAPEVL~Gss~~ 1229 (1236)
.......+||+.|+|||++.+....
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~ 174 (325)
T cd05602 150 NGTTSTFCGTPEYLAPEVLHKQPYD 174 (325)
T ss_pred CCCcccccCCccccCHHHHcCCCCC
Confidence 3334456799999999999876443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-26 Score=247.41 Aligned_cols=175 Identities=25% Similarity=0.335 Sum_probs=143.3
Q ss_pred CeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCC-CCceeeEeeeEecCCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLr-HPNIVrLyG~f~t~~~ 1119 (1236)
+|++.+.||+|+||+||+|+. +++.||||++.+.... .......+..|..+++.+. |++|+++++++.+..
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~- 74 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-----QDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD- 74 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC-
Confidence 477889999999999999987 4778999999864321 1223455778889998886 577888999888754
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
.+++||||+++++|..++... ..+++..++.|+.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 75 -~~~lv~Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~----~ikL~Dfg~~ 148 (323)
T cd05615 75 -RLYFVMEYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEG----HIKIADFGMC 148 (323)
T ss_pred -EEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC----CEEEeccccc
Confidence 899999999999999988543 4689999999999999999999999999999999999999886 5699999999
Q ss_pred ccccC-cccccCcCCCCcccchhhhcCCCCC
Q 000893 1200 KIKRN-TLVTGGVRGTLPWMAPELLNGSSSK 1229 (1236)
Q Consensus 1200 rii~n-s~~tss~~GTp~YmAPEVL~Gss~~ 1229 (1236)
+.... .......+||+.|+|||++.+....
T Consensus 149 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 179 (323)
T cd05615 149 KEHMVDGVTTRTFCGTPDYIAPEIIAYQPYG 179 (323)
T ss_pred cccCCCCccccCccCCccccCHHHHcCCCCC
Confidence 86432 2233456799999999999876433
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=264.33 Aligned_cols=176 Identities=35% Similarity=0.507 Sum_probs=152.6
Q ss_pred EEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeEEEE
Q 000893 1048 KELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATV 1125 (1236)
Q Consensus 1048 kkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L~LV 1125 (1236)
+.||+|.||+||-|++ +|+.||||+|.+..+....+ ..+.+|+.||..+.||.||.|-..|.+++ .+|+|
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe------sqlR~EVaILq~l~HPGiV~le~M~ET~e--rvFVV 641 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE------SQLRNEVAILQNLHHPGIVNLECMFETPE--RVFVV 641 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchH------HHHHHHHHHHHhcCCCCeeEEEEeecCCc--eEEEE
Confidence 5799999999999987 58999999999877654332 45678999999999999999999999986 89999
Q ss_pred EeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcccccCc
Q 000893 1126 TEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT 1205 (1236)
Q Consensus 1126 MEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~ns 1205 (1236)
||-+.|.-|..+|......+++...+.++.||+.||.|||.++|+||||||+||||.... ....+||||||+||++...
T Consensus 642 MEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~-~FPQvKlCDFGfARiIgEk 720 (888)
T KOG4236|consen 642 MEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASAS-PFPQVKLCDFGFARIIGEK 720 (888)
T ss_pred ehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCC-CCCceeeccccceeecchh
Confidence 999965555555655567899999999999999999999999999999999999998764 3478999999999999988
Q ss_pred ccccCcCCCCcccchhhhcCCCCCCCc
Q 000893 1206 LVTGGVRGTLPWMAPELLNGSSSKVSE 1232 (1236)
Q Consensus 1206 ~~tss~~GTp~YmAPEVL~Gss~~~Sd 1232 (1236)
......+|||.|+|||+++...+..+=
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkGyNrSL 747 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKGYNRSL 747 (888)
T ss_pred hhhhhhcCCccccCHHHHhhccccccc
Confidence 888889999999999999987555443
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-27 Score=272.29 Aligned_cols=179 Identities=35% Similarity=0.557 Sum_probs=158.4
Q ss_pred cccccccccCeeEEEEeccCCceEEEEeeecCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeee
Q 000893 1034 STLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGV 1113 (1236)
Q Consensus 1034 seLqiIs~EdYeiLkkLGsGSFGtVYKArlkG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~ 1113 (1236)
.++|+|.-+.+..++-||.|+.|.||+|+++++.||||+++.. + -.++.-|++|+||||+.+.|+
T Consensus 116 ~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~el-------------k--ETdIKHLRkLkH~NII~FkGV 180 (904)
T KOG4721|consen 116 EELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVREL-------------K--ETDIKHLRKLKHPNIITFKGV 180 (904)
T ss_pred hhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhh-------------h--hhhHHHHHhccCcceeeEeee
Confidence 4567777777788888999999999999999999999987521 0 126778999999999999999
Q ss_pred EecCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEE
Q 000893 1114 VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193 (1236)
Q Consensus 1114 f~t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKL 1193 (1236)
|.... .+|||||||..|-|...|. .++.+.......|..+|+.||.|||.+.|||||||.-||||..+. .|||
T Consensus 181 CtqsP--cyCIiMEfCa~GqL~~VLk-a~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d----~VKI 253 (904)
T KOG4721|consen 181 CTQSP--CYCIIMEFCAQGQLYEVLK-AGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDD----VVKI 253 (904)
T ss_pred ecCCc--eeEEeeeccccccHHHHHh-ccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccc----eEEe
Confidence 99865 9999999999999999995 456788889999999999999999999999999999999999886 6799
Q ss_pred EeccCcccccCcccccCcCCCCcccchhhhcCCCCCCCccccC
Q 000893 1194 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVCF 1236 (1236)
Q Consensus 1194 sDFGLArii~ns~~tss~~GTp~YmAPEVL~Gss~~~SdDVDI 1236 (1236)
+|||.++......+...++||..|||||+|+.. +.+++|||
T Consensus 254 sDFGTS~e~~~~STkMSFaGTVaWMAPEvIrne--PcsEKVDI 294 (904)
T KOG4721|consen 254 SDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNE--PCSEKVDI 294 (904)
T ss_pred ccccchHhhhhhhhhhhhhhhHhhhCHHHhhcC--Ccccccce
Confidence 999999998777777889999999999999987 77788775
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-26 Score=245.15 Aligned_cols=176 Identities=31% Similarity=0.530 Sum_probs=145.1
Q ss_pred cccccCeeEEEEeccCCceEEEEeee--cCc----eEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEe
Q 000893 1038 IIKNEDLEELKELGSGTFGTVYHGKW--RGT----DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 1111 (1236)
Q Consensus 1038 iIs~EdYeiLkkLGsGSFGtVYKArl--kG~----~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLy 1111 (1236)
++...+|++++.||+|+||+||+|++ .+. .||||+++... ......+|.+|+.+++.++||||++++
T Consensus 3 ~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~niv~~~ 75 (316)
T cd05108 3 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-------SPKANKEILDEAYVMASVDNPHVCRLL 75 (316)
T ss_pred ccchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-------CHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 45677899999999999999999986 333 38999886431 123345688899999999999999999
Q ss_pred eeEecCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcE
Q 000893 1112 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 1191 (1236)
Q Consensus 1112 G~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltV 1191 (1236)
++|... ..++|+||+++|+|.+++......+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+
T Consensus 76 g~~~~~---~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~----~~ 148 (316)
T cd05108 76 GICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQ----HV 148 (316)
T ss_pred EEEcCC---CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCC----cE
Confidence 999864 46789999999999999987666789999999999999999999999999999999999998876 57
Q ss_pred EEEeccCcccccCcccc---cCcCCCCcccchhhhcCCC
Q 000893 1192 KVGDFGLSKIKRNTLVT---GGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1192 KLsDFGLArii~ns~~t---ss~~GTp~YmAPEVL~Gss 1227 (1236)
||+|||+++........ ....++..|+|||++.+..
T Consensus 149 kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~ 187 (316)
T cd05108 149 KITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRI 187 (316)
T ss_pred EEccccccccccCCCcceeccCCccceeecChHHhccCC
Confidence 99999999876433221 2233467899999997653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=262.95 Aligned_cols=185 Identities=31% Similarity=0.406 Sum_probs=159.1
Q ss_pred ccccccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeE
Q 000893 1037 QIIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVV 1114 (1236)
Q Consensus 1037 qiIs~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f 1114 (1236)
..+..++|..+++||+|+||+|-+++- +++.+|||++++..+...++ ..--+.|-++|..++||++..|...|
T Consensus 163 ~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdE-----VAHTlTE~RVL~~~~HPFLt~LKYsF 237 (516)
T KOG0690|consen 163 NKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDE-----VAHTLTENRVLQNCRHPFLTSLKYSF 237 (516)
T ss_pred ceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHH-----hhhhhhHHHHHHhccCcHHHHhhhhh
Confidence 356778999999999999999999987 47889999999988764332 23345699999999999999999999
Q ss_pred ecCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEE
Q 000893 1115 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1236)
Q Consensus 1115 ~t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLs 1194 (1236)
++.+ .+|+||||+.||.|..+|. +.+.+++..++.+..+|+.||.|||+++||+||||.+|+|||++|++ ||+
T Consensus 238 Qt~d--rlCFVMeyanGGeLf~HLs-rer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHI----Kit 310 (516)
T KOG0690|consen 238 QTQD--RLCFVMEYANGGELFFHLS-RERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHI----KIT 310 (516)
T ss_pred ccCc--eEEEEEEEccCceEeeehh-hhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCce----Eee
Confidence 9865 9999999999999998885 45678999999999999999999999999999999999999999954 999
Q ss_pred eccCccc-ccCcccccCcCCCCcccchhhhcCCCCCCCcc
Q 000893 1195 DFGLSKI-KRNTLVTGGVRGTLPWMAPELLNGSSSKVSEK 1233 (1236)
Q Consensus 1195 DFGLAri-i~ns~~tss~~GTp~YmAPEVL~Gss~~~SdD 1233 (1236)
|||||+. +.......++||||.|+|||+|...-+....|
T Consensus 311 DFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVD 350 (516)
T KOG0690|consen 311 DFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVD 350 (516)
T ss_pred ecccchhcccccceeccccCChhhcCchhhccccccceee
Confidence 9999997 44555667899999999999998764444433
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-25 Score=238.41 Aligned_cols=177 Identities=27% Similarity=0.360 Sum_probs=146.7
Q ss_pred CeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g 1120 (1236)
.|+..+.||+|+||+||++.+ +++.||+|++.+.... .......+.+|+.+|+.++|+||+.+++++....
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-- 73 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIK-----KRKGESMALNEKQILEKVNSQFVVNLAYAYETKD-- 73 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhh-----hhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCC--
Confidence 367889999999999999988 4778999998764321 1222345678999999999999999999988754
Q ss_pred eEEEEEeeccCCCHHHHHhhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1121 TLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1121 ~L~LVMEYm~GGSL~dlL~~k~-r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
.+++||||+++++|..++.... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++ .+||+|||++
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~----~~kl~Dfg~~ 149 (285)
T cd05632 74 ALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYG----HIRISDLGLA 149 (285)
T ss_pred EEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCC----CEEEecCCcc
Confidence 8999999999999998886543 4699999999999999999999999999999999999998875 5799999999
Q ss_pred ccccCcccccCcCCCCcccchhhhcCCCCCC
Q 000893 1200 KIKRNTLVTGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1200 rii~ns~~tss~~GTp~YmAPEVL~Gss~~~ 1230 (1236)
.............|++.|+|||++.+.....
T Consensus 150 ~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~ 180 (285)
T cd05632 150 VKIPEGESIRGRVGTVGYMAPEVLNNQRYTL 180 (285)
T ss_pred eecCCCCcccCCCCCcCccChHHhcCCCCCc
Confidence 7654333334567899999999998764443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.2e-26 Score=248.15 Aligned_cols=175 Identities=26% Similarity=0.363 Sum_probs=143.2
Q ss_pred ccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCC
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1041 ~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~ 1118 (1236)
.++|++++.||+|+||+||++.+ .+..||||++..... .......+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ------NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQK 93 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc------chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC
Confidence 47899999999999999999987 478899999875421 1223456778999999999999999999987543
Q ss_pred C----CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEE
Q 000893 1119 G----GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1236)
Q Consensus 1119 ~----g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLs 1194 (1236)
. ..+++||||+. ++|...+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+
T Consensus 94 ~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~----~~kl~ 165 (359)
T cd07876 94 SLEEFQDVYLVMELMD-ANLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC----TLKIL 165 (359)
T ss_pred CccccceeEEEEeCCC-cCHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC----CEEEe
Confidence 1 35799999995 56666653 2478888999999999999999999999999999999999886 57999
Q ss_pred eccCcccccCcccccCcCCCCcccchhhhcCCCCC
Q 000893 1195 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSK 1229 (1236)
Q Consensus 1195 DFGLArii~ns~~tss~~GTp~YmAPEVL~Gss~~ 1229 (1236)
|||+++............||+.|+|||++.+....
T Consensus 166 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 200 (359)
T cd07876 166 DFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYK 200 (359)
T ss_pred cCCCccccccCccCCCCcccCCCCCchhccCCCCC
Confidence 99999875544444556789999999999876443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.7e-26 Score=242.03 Aligned_cols=187 Identities=22% Similarity=0.261 Sum_probs=149.8
Q ss_pred ccccccCeeEE--EEeccCCceEEEEeeecCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeE
Q 000893 1037 QIIKNEDLEEL--KELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVV 1114 (1236)
Q Consensus 1037 qiIs~EdYeiL--kkLGsGSFGtVYKArlkG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f 1114 (1236)
+.+..++++.. ..||+|++|.||+|.++++.||||+++.... ........|.+|+.+|++++||||+++++++
T Consensus 13 ~~i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~ 87 (283)
T PHA02988 13 KCIESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHK-----GHKVLIDITENEIKNLRRIDSNNILKIYGFI 87 (283)
T ss_pred eecCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEecccccc-----ccHHHHHHHHHHHHHHHhcCCCCEEEEeeeE
Confidence 33444444433 5799999999999999999999999975421 1233456788999999999999999999998
Q ss_pred ec--CCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCcEEEccCCCCCCcE
Q 000893 1115 QD--GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPIRPIC 1191 (1236)
Q Consensus 1115 ~t--~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHS-kGIIHRDIKPsNILLDsdG~I~ltV 1191 (1236)
.+ .....+++||||+++|+|.+++.. ...+++..++.++.+++.||.|||. .+++||||||+|||++.++ .+
T Consensus 88 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~----~~ 162 (283)
T PHA02988 88 IDIVDDLPRLSLILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY----KL 162 (283)
T ss_pred EecccCCCceEEEEEeCCCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC----cE
Confidence 76 333578999999999999999965 3568899999999999999999998 4999999999999999886 67
Q ss_pred EEEeccCcccccCcccccCcCCCCcccchhhhcCCCCCCCcccc
Q 000893 1192 KVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVC 1235 (1236)
Q Consensus 1192 KLsDFGLArii~ns~~tss~~GTp~YmAPEVL~Gss~~~SdDVD 1235 (1236)
||+|||+++...... ....||+.|+|||++.+....++..+|
T Consensus 163 kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~k~D 204 (283)
T PHA02988 163 KIICHGLEKILSSPP--FKNVNFMVYFSYKMLNDIFSEYTIKDD 204 (283)
T ss_pred EEcccchHhhhcccc--ccccCcccccCHHHhhhccccccchhh
Confidence 999999998754332 234688999999999863334444444
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.6e-26 Score=239.16 Aligned_cols=170 Identities=28% Similarity=0.379 Sum_probs=140.2
Q ss_pred eccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeEEEEEe
Q 000893 1050 LGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTE 1127 (1236)
Q Consensus 1050 LGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L~LVME 1127 (1236)
||+|+||+||++.+ +++.||||++.+.... .......+..|+.+++.++||||++++++|.... .+++|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~--~~~lv~e 73 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLK-----KRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKT--DLCLVMT 73 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHh-----hhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCC--eEEEEEe
Confidence 69999999999987 4778999998754221 1223356778999999999999999999988754 8999999
Q ss_pred eccCCCHHHHHhh---hccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcccccC
Q 000893 1128 FMVNGSLRHVLLS---KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 1204 (1236)
Q Consensus 1128 Ym~GGSL~dlL~~---k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~n 1204 (1236)
|+++++|..++.. ....+++..++.++.||+.||.|||+++|+||||||+|||++.++ .+||+|||++.....
T Consensus 74 ~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~----~~~l~dfg~~~~~~~ 149 (280)
T cd05608 74 IMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDG----NVRISDLGLAVELKD 149 (280)
T ss_pred CCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC----CEEEeeCccceecCC
Confidence 9999999988754 234689999999999999999999999999999999999998876 579999999976543
Q ss_pred cc-cccCcCCCCcccchhhhcCCCCCC
Q 000893 1205 TL-VTGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1205 s~-~tss~~GTp~YmAPEVL~Gss~~~ 1230 (1236)
.. ......||+.|+|||++.+.....
T Consensus 150 ~~~~~~~~~g~~~y~aPE~~~~~~~~~ 176 (280)
T cd05608 150 GQSKTKGYAGTPGFMAPELLQGEEYDF 176 (280)
T ss_pred CCccccccCCCcCccCHHHhcCCCCCc
Confidence 32 233467999999999998765443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=272.14 Aligned_cols=176 Identities=30% Similarity=0.403 Sum_probs=154.8
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
.-|++.+-||.|+.|.|-+|++ +|+.+|||++.+..-. .+.....+-+|+.+|+.+.||||++||++|.+..
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~-----s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~- 85 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSEL-----SSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ- 85 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeecccccc-----ccccccchhhhhHHHHHhcCCCeeeeeeeeccCc-
Confidence 3478889999999999999998 7999999999876311 1222445678999999999999999999999865
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
++|+|.||+++|-|.+++..++ .+.+.++..+++||+.|+.|||..+|+||||||+|+||+..++ +||+|||||
T Consensus 86 -~lylvlEyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~n----IKIADFGMA 159 (786)
T KOG0588|consen 86 -HLYLVLEYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNN----IKIADFGMA 159 (786)
T ss_pred -eEEEEEEecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccC----Eeeecccee
Confidence 9999999999999999997665 5778888889999999999999999999999999999999874 599999999
Q ss_pred ccccCcccccCcCCCCcccchhhhcCCCCC
Q 000893 1200 KIKRNTLVTGGVRGTLPWMAPELLNGSSSK 1229 (1236)
Q Consensus 1200 rii~ns~~tss~~GTp~YmAPEVL~Gss~~ 1229 (1236)
.+-.....-.+.||+|.|+|||++.|..+.
T Consensus 160 sLe~~gklLeTSCGSPHYA~PEIV~G~pYd 189 (786)
T KOG0588|consen 160 SLEVPGKLLETSCGSPHYAAPEIVSGRPYD 189 (786)
T ss_pred ecccCCccccccCCCcccCCchhhcCCCCC
Confidence 998788888889999999999999998654
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.7e-26 Score=260.39 Aligned_cols=174 Identities=20% Similarity=0.287 Sum_probs=144.7
Q ss_pred cCeeEEEEeccCCceEEEEeeec---CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKWR---GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArlk---G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~ 1118 (1236)
..|.+.+.||+|+||.||+|... +..||+|.+... .......+.+|+.+|+.++|||||+++++|....
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--------~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~ 138 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--------DERQAAYARSELHCLAACDHFGIVKHFDDFKSDD 138 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--------CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECC
Confidence 35999999999999999999863 556888876432 1223345778999999999999999999998854
Q ss_pred CCeEEEEEeeccCCCHHHHHhhh---ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEe
Q 000893 1119 GGTLATVTEFMVNGSLRHVLLSK---ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1236)
Q Consensus 1119 ~g~L~LVMEYm~GGSL~dlL~~k---~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsD 1195 (1236)
.++|||||+++++|.+++... ...+++..+..++.||+.||.|||+++|+||||||+||||+.++ .+||+|
T Consensus 139 --~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~----~~kL~D 212 (478)
T PTZ00267 139 --KLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG----IIKLGD 212 (478)
T ss_pred --EEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCC----cEEEEe
Confidence 899999999999999988542 34688999999999999999999999999999999999999876 579999
Q ss_pred ccCcccccCcc---cccCcCCCCcccchhhhcCCCCC
Q 000893 1196 FGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSK 1229 (1236)
Q Consensus 1196 FGLArii~ns~---~tss~~GTp~YmAPEVL~Gss~~ 1229 (1236)
||+++...... .....+||+.|+|||++.+....
T Consensus 213 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 249 (478)
T PTZ00267 213 FGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249 (478)
T ss_pred CcCceecCCccccccccccCCCccccCHhHhCCCCCC
Confidence 99998754322 23457799999999999876433
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.4e-26 Score=242.76 Aligned_cols=173 Identities=29% Similarity=0.413 Sum_probs=143.8
Q ss_pred cccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecC
Q 000893 1040 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1236)
Q Consensus 1040 s~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~ 1117 (1236)
..++|.++++||+|+||+||+|+. .+..||||+++..... .....+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 76 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-------GAPCTAIREVSLLKDLKHANIVTLHDIVHTD 76 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-------CcchhHHHHHHHHHhCCCCCcceEEEEEeeC
Confidence 347899999999999999999987 4677999998754311 1123466899999999999999999999875
Q ss_pred CCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEecc
Q 000893 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1236)
Q Consensus 1118 ~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFG 1197 (1236)
. .+++||||+. ++|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||
T Consensus 77 ~--~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~----~~kl~Dfg 149 (309)
T cd07872 77 K--SLTLVFEYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERG----ELKLADFG 149 (309)
T ss_pred C--eEEEEEeCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC----CEEECccc
Confidence 4 8999999995 588888876666789999999999999999999999999999999999999876 57999999
Q ss_pred CcccccCc-ccccCcCCCCcccchhhhcCC
Q 000893 1198 LSKIKRNT-LVTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1198 LArii~ns-~~tss~~GTp~YmAPEVL~Gs 1226 (1236)
+++..... .......+|+.|+|||++.+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 179 (309)
T cd07872 150 LARAKSVPTKTYSNEVVTLWYRPPDVLLGS 179 (309)
T ss_pred cceecCCCccccccccccccccCCHHHhCC
Confidence 99864332 222345689999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.93 E-value=6e-26 Score=253.40 Aligned_cols=181 Identities=33% Similarity=0.441 Sum_probs=144.7
Q ss_pred cccccCeeEEEEeccCCceEEEEeee-------cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhC-CCCceee
Q 000893 1038 IIKNEDLEELKELGSGTFGTVYHGKW-------RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVA 1109 (1236)
Q Consensus 1038 iIs~EdYeiLkkLGsGSFGtVYKArl-------kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskL-rHPNIVr 1109 (1236)
.+..++|++.+.||+|+||+||+|++ .+..||||+++.... ......+.+|+.+|+.+ +||||++
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-------~~~~~~~~~Ei~il~~l~~HpnIv~ 103 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-------LTEREALMSELKVLSYLGNHINIVN 103 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-------cHHHHHHHHHHHHHHHhcCCcceee
Confidence 45567899999999999999999974 245699999875321 12235678899999999 8999999
Q ss_pred EeeeEecCCCCeEEEEEeeccCCCHHHHHhhhc-----------------------------------------------
Q 000893 1110 FYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE----------------------------------------------- 1142 (1236)
Q Consensus 1110 LyG~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~----------------------------------------------- 1142 (1236)
++++|.... ..++|||||++|+|.+++....
T Consensus 104 l~~~~~~~~--~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 181 (375)
T cd05104 104 LLGACTVGG--PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPT 181 (375)
T ss_pred eeeeeccCC--cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccc
Confidence 999998754 8899999999999999986432
Q ss_pred ---------------------------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEe
Q 000893 1143 ---------------------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1236)
Q Consensus 1143 ---------------------------r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsD 1195 (1236)
..+++..++.|+.||+.||.|||+++|+||||||+|||++.++ .+||+|
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~----~~kl~D 257 (375)
T cd05104 182 KADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR----ITKICD 257 (375)
T ss_pred ccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCC----cEEEec
Confidence 2467888899999999999999999999999999999998765 679999
Q ss_pred ccCcccccCcc---cccCcCCCCcccchhhhcCCCCCCC
Q 000893 1196 FGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVS 1231 (1236)
Q Consensus 1196 FGLArii~ns~---~tss~~GTp~YmAPEVL~Gss~~~S 1231 (1236)
||+++...... ......++..|+|||++.+......
T Consensus 258 fG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 296 (375)
T cd05104 258 FGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFE 296 (375)
T ss_pred CccceeccCcccccccCCCCCCcceeChhHhcCCCCCCC
Confidence 99998654322 1222345677999999987644433
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=246.11 Aligned_cols=175 Identities=30% Similarity=0.475 Sum_probs=147.2
Q ss_pred ccccCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEec
Q 000893 1039 IKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1236)
Q Consensus 1039 Is~EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t 1116 (1236)
+..++|++.++||+|+||.||++.+. +..+|+|++.... .......+.+|+++++.++||||++++++|..
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-------KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-------CHHHHHHHHHHHHHHHHCCCCcccceeEEEEE
Confidence 45678999999999999999999984 6779999887532 12234568899999999999999999999988
Q ss_pred CCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCcEEEccCCCCCCcEEEEe
Q 000893 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1236)
Q Consensus 1117 ~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSk-GIIHRDIKPsNILLDsdG~I~ltVKLsD 1195 (1236)
.. .+++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++ .+||+|
T Consensus 75 ~~--~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~----~~kL~D 147 (333)
T cd06650 75 DG--EISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG----EIKLCD 147 (333)
T ss_pred CC--EEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCC----CEEEee
Confidence 54 899999999999999998643 4588899999999999999999975 799999999999999876 579999
Q ss_pred ccCcccccCcccccCcCCCCcccchhhhcCCCC
Q 000893 1196 FGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1196 FGLArii~ns~~tss~~GTp~YmAPEVL~Gss~ 1228 (1236)
||++...... .....+||+.|+|||++.+...
T Consensus 148 fg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~ 179 (333)
T cd06650 148 FGVSGQLIDS-MANSFVGTRSYMSPERLQGTHY 179 (333)
T ss_pred CCcchhhhhh-ccccCCCCccccCHHHhcCCCC
Confidence 9999765332 2234678999999999987643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=237.15 Aligned_cols=177 Identities=25% Similarity=0.363 Sum_probs=146.4
Q ss_pred CeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g 1120 (1236)
.|+..+.||+|+||.||++.+. ++.||||.+.+.... .......+.+|+.+++.++|+||+.+++.+.+..
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-- 73 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-----KRKGESMALNEKQILEKVNSRFVVSLAYAYETKD-- 73 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhcc-----chHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCC--
Confidence 3678889999999999999884 678999998764322 1222345678999999999999999999998754
Q ss_pred eEEEEEeeccCCCHHHHHhhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1121 TLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1121 ~L~LVMEYm~GGSL~dlL~~k~-r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
.+++||||+++++|.+++.... ..+++..++.++.|++.||.|||+++|+||||||+|||++.++ .++|+|||++
T Consensus 74 ~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~----~~~l~Dfg~~ 149 (285)
T cd05630 74 ALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHG----HIRISDLGLA 149 (285)
T ss_pred EEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC----CEEEeeccce
Confidence 8999999999999999886543 4689999999999999999999999999999999999999876 5699999999
Q ss_pred ccccCcccccCcCCCCcccchhhhcCCCCCC
Q 000893 1200 KIKRNTLVTGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1200 rii~ns~~tss~~GTp~YmAPEVL~Gss~~~ 1230 (1236)
.............|++.|+|||++.+.....
T Consensus 150 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 180 (285)
T cd05630 150 VHVPEGQTIKGRVGTVGYMAPEVVKNERYTF 180 (285)
T ss_pred eecCCCccccCCCCCccccChHHHcCCCCCC
Confidence 7654433334457899999999998764443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=246.92 Aligned_cols=174 Identities=25% Similarity=0.342 Sum_probs=143.8
Q ss_pred ccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCC
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1041 ~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~ 1118 (1236)
.++|++++.||+|+||.||++.+ .++.||||++..... .......+.+|+.+++.++||||+++++++....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 89 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ------NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK 89 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc------ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccc
Confidence 46899999999999999999987 477899999875421 2233456778999999999999999999886532
Q ss_pred ----CCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEE
Q 000893 1119 ----GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1236)
Q Consensus 1119 ----~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLs 1194 (1236)
...+++||||+. ++|.+.+. ..+++..+..++.||+.||.|||++||+||||||+||||+.++ .+||+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~----~~kl~ 161 (355)
T cd07874 90 SLEEFQDVYLVMELMD-ANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC----TLKIL 161 (355)
T ss_pred cccccceeEEEhhhhc-ccHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCC----CEEEe
Confidence 135799999995 56766663 2478889999999999999999999999999999999999876 57999
Q ss_pred eccCcccccCcccccCcCCCCcccchhhhcCCCC
Q 000893 1195 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1195 DFGLArii~ns~~tss~~GTp~YmAPEVL~Gss~ 1228 (1236)
|||+++............||+.|+|||++.+...
T Consensus 162 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 195 (355)
T cd07874 162 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 195 (355)
T ss_pred eCcccccCCCccccCCccccCCccCHHHHcCCCC
Confidence 9999987665555556789999999999987643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=273.79 Aligned_cols=185 Identities=32% Similarity=0.432 Sum_probs=155.9
Q ss_pred CeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCC--
Q 000893 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP-- 1118 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~-- 1118 (1236)
.|..-+.||+|+||.||+|++ +|+.||||.+.+... .+-...+.+|+++|++|+|||||+++++-.+..
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~-------~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~ 86 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS-------LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLG 86 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcc-------cchHHHHHHHHHHHHHcCchhhhhhcccCCccccC
Confidence 455567799999999999997 589999999987542 233456789999999999999999999866554
Q ss_pred --CCeEEEEEeeccCCCHHHHHhhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEE
Q 000893 1119 --GGTLATVTEFMVNGSLRHVLLSKE--RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1236)
Q Consensus 1119 --~g~L~LVMEYm~GGSL~dlL~~k~--r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLs 1194 (1236)
.....+|||||.+|+|...|.+.+ ..+++.+.+.++..++.||.|||++||+||||||.||++-.........||+
T Consensus 87 ~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLt 166 (732)
T KOG4250|consen 87 LVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLT 166 (732)
T ss_pred cccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeee
Confidence 456679999999999999997654 4699999999999999999999999999999999999997655445578999
Q ss_pred eccCcccccCcccccCcCCCCcccchhhhcCCCCCCCcccc
Q 000893 1195 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVC 1235 (1236)
Q Consensus 1195 DFGLArii~ns~~tss~~GTp~YmAPEVL~Gss~~~SdDVD 1235 (1236)
|||.|+.+++......+.||..|++||++.. ...++..+|
T Consensus 167 DfG~Arel~d~s~~~S~vGT~~YLhPel~E~-q~~y~~tVD 206 (732)
T KOG4250|consen 167 DFGAARELDDNSLFTSLVGTEEYLHPELYER-QKKYTATVD 206 (732)
T ss_pred cccccccCCCCCeeeeecCchhhcChHHHhh-ccCcCceee
Confidence 9999999988888888999999999999985 234445444
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=235.08 Aligned_cols=175 Identities=37% Similarity=0.560 Sum_probs=144.3
Q ss_pred ccCeeEEEEeccCCceEEEEeee------cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeE
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKW------RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVV 1114 (1236)
Q Consensus 1041 ~EdYeiLkkLGsGSFGtVYKArl------kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f 1114 (1236)
.++|++++.||+|+||.||++.. .+..||||.++.. .......|.+|+.+++.++||||+++++++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 74 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--------TAEHLRDFEREIEILKSLQHDNIVKYKGVC 74 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--------CHHHHHHHHHHHHHHHhCCCCCeeEEEEEE
Confidence 35789999999999999999874 3667999998653 123345788999999999999999999988
Q ss_pred ecCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEE
Q 000893 1115 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1236)
Q Consensus 1115 ~t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLs 1194 (1236)
.......+++||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+||||+.++ .+||+
T Consensus 75 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~----~~~l~ 150 (284)
T cd05081 75 YSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESEN----RVKIG 150 (284)
T ss_pred ccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCC----eEEEC
Confidence 76555578999999999999999976656789999999999999999999999999999999999998876 57999
Q ss_pred eccCcccccCccc----ccCcCCCCcccchhhhcCCC
Q 000893 1195 DFGLSKIKRNTLV----TGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1195 DFGLArii~ns~~----tss~~GTp~YmAPEVL~Gss 1227 (1236)
|||+++....... .....++..|+|||++.+..
T Consensus 151 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 187 (284)
T cd05081 151 DFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESK 187 (284)
T ss_pred CCcccccccCCCcceeecCCCCCceEeeCHHHhccCC
Confidence 9999987543221 11122345699999998653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.5e-26 Score=252.86 Aligned_cols=181 Identities=31% Similarity=0.432 Sum_probs=145.1
Q ss_pred cccccccCeeEEEEeccCCceEEEEeeec-------CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhC-CCCce
Q 000893 1036 LQIIKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNV 1107 (1236)
Q Consensus 1036 LqiIs~EdYeiLkkLGsGSFGtVYKArlk-------G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskL-rHPNI 1107 (1236)
.|.+..++|++.+.||+|+||.||+|++. +..||||+++.... ......+.+|+.+++.+ +||||
T Consensus 32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~il~~l~~h~nI 104 (374)
T cd05106 32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-------TDEREALMSELKILSHLGQHKNI 104 (374)
T ss_pred cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-------HHHHHHHHHHHHHHHhhccCCce
Confidence 34566778999999999999999998852 24699999975421 12245678899999999 89999
Q ss_pred eeEeeeEecCCCCeEEEEEeeccCCCHHHHHhhhc---------------------------------------------
Q 000893 1108 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE--------------------------------------------- 1142 (1236)
Q Consensus 1108 VrLyG~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~--------------------------------------------- 1142 (1236)
|+++++|.... .+++|||||++|+|.+++....
T Consensus 105 v~~~~~~~~~~--~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (374)
T cd05106 105 VNLLGACTHGG--PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYV 182 (374)
T ss_pred eeEeeEecCCC--CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccccccccccc
Confidence 99999998754 8999999999999999985431
Q ss_pred ------------------------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccC
Q 000893 1143 ------------------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1236)
Q Consensus 1143 ------------------------r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGL 1198 (1236)
..+++..++.|+.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~----~~kL~DfGl 258 (374)
T cd05106 183 EMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR----VAKICDFGL 258 (374)
T ss_pred ccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCC----eEEEeecee
Confidence 2367888899999999999999999999999999999998765 679999999
Q ss_pred cccccCcc---cccCcCCCCcccchhhhcCCCCC
Q 000893 1199 SKIKRNTL---VTGGVRGTLPWMAPELLNGSSSK 1229 (1236)
Q Consensus 1199 Arii~ns~---~tss~~GTp~YmAPEVL~Gss~~ 1229 (1236)
++...... ......+++.|+|||++.+....
T Consensus 259 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 292 (374)
T cd05106 259 ARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYT 292 (374)
T ss_pred eeeccCCcceeeccCCCCccceeCHHHhcCCCCC
Confidence 98654322 12223456789999999765433
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=257.76 Aligned_cols=171 Identities=26% Similarity=0.298 Sum_probs=138.9
Q ss_pred cccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecC
Q 000893 1040 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1236)
Q Consensus 1040 s~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~ 1117 (1236)
...+|++.+.||+|+||+||+|.. .++.||||++.... ....+|+.+|+.++|||||++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------------~~~~~Ei~il~~l~h~niv~l~~~~~~~ 131 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------------QYKNRELLIMKNLNHINIIFLKDYYYTE 131 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------------chHHHHHHHHHhcCCCCCcceeeeEeec
Confidence 456899999999999999999987 47789999885421 1123699999999999999999887532
Q ss_pred ------CCCeEEEEEeeccCCCHHHHHhh---hccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCC
Q 000893 1118 ------PGGTLATVTEFMVNGSLRHVLLS---KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIR 1188 (1236)
Q Consensus 1118 ------~~g~L~LVMEYm~GGSL~dlL~~---k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ 1188 (1236)
....+++||||++ ++|..++.. ....+++..++.|+.||+.||+|||+++||||||||+||||+.++
T Consensus 132 ~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~--- 207 (440)
T PTZ00036 132 CFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNT--- 207 (440)
T ss_pred ccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCC---
Confidence 1235779999996 577666643 345789999999999999999999999999999999999998664
Q ss_pred CcEEEEeccCcccccCcccccCcCCCCcccchhhhcCC
Q 000893 1189 PICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1189 ltVKLsDFGLArii~ns~~tss~~GTp~YmAPEVL~Gs 1226 (1236)
..+||+|||+|+...........+||+.|+|||++.+.
T Consensus 208 ~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~ 245 (440)
T PTZ00036 208 HTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGA 245 (440)
T ss_pred CceeeeccccchhccCCCCcccCCCCcCccCHHHhcCC
Confidence 25799999999876554444556789999999998764
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=253.80 Aligned_cols=168 Identities=24% Similarity=0.307 Sum_probs=141.0
Q ss_pred ccccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEec
Q 000893 1039 IKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1236)
Q Consensus 1039 Is~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t 1116 (1236)
+....|++++.||+|+||.||++.+ +++.||||.... ..+.+|+.+|+.|+||||++++++|..
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------------~~~~~E~~il~~l~HpnIv~~~~~~~~ 154 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------------GGTATEAHILRAINHPSIIQLKGTFTY 154 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------------hhhHHHHHHHHhCCCCCCCCEeEEEEE
Confidence 4557899999999999999999988 477899996532 235689999999999999999999987
Q ss_pred CCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEec
Q 000893 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1236)
Q Consensus 1117 ~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDF 1196 (1236)
.. ..++||||+ +++|..++... ..+++..++.|+.||+.||.|||++|||||||||+||||+.++ .+||+||
T Consensus 155 ~~--~~~lv~e~~-~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~----~vkL~DF 226 (391)
T PHA03212 155 NK--FTCLILPRY-KTDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPG----DVCLGDF 226 (391)
T ss_pred CC--eeEEEEecC-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCC----CEEEEeC
Confidence 54 889999999 57888887543 4688999999999999999999999999999999999999876 5699999
Q ss_pred cCcccccCc--ccccCcCCCCcccchhhhcCCCC
Q 000893 1197 GLSKIKRNT--LVTGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1197 GLArii~ns--~~tss~~GTp~YmAPEVL~Gss~ 1228 (1236)
|+++..... ......+||+.|+|||++.+..+
T Consensus 227 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 260 (391)
T PHA03212 227 GAACFPVDINANKYYGWAGTIATNAPELLARDPY 260 (391)
T ss_pred CcccccccccccccccccCccCCCChhhhcCCCC
Confidence 999754322 22335679999999999987643
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=230.07 Aligned_cols=170 Identities=41% Similarity=0.540 Sum_probs=144.0
Q ss_pred eeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCe
Q 000893 1044 LEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGT 1121 (1236)
Q Consensus 1044 YeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~ 1121 (1236)
|++.+.||+|+||+||+++.. ++.||+|++.... ..........+|+.+++.++||||+++++++.... .
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~------~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--~ 72 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSE------IEEEEREENIREIKILRRLRHPNIVQILDVFQDDN--Y 72 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTT------HHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS--E
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccc------ccccccchhhhhhhccccccccccccccccccccc--c
Confidence 788999999999999999984 5579999998652 12222334456999999999999999999998854 8
Q ss_pred EEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCccc
Q 000893 1122 LATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201 (1236)
Q Consensus 1122 L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLAri 1201 (1236)
+++||||+.+++|.+++. ....+++..++.++.||+.||.|||+++|+||||||+|||++.++ .++|+|||++..
T Consensus 73 ~~~v~~~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~----~~~l~Dfg~~~~ 147 (260)
T PF00069_consen 73 LYIVMEYCPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENG----EVKLIDFGSSVK 147 (260)
T ss_dssp EEEEEEEETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTS----EEEESSGTTTEE
T ss_pred cccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccccc----cccccccccccc
Confidence 999999999999999996 456789999999999999999999999999999999999999776 569999999986
Q ss_pred c-cCcccccCcCCCCcccchhhhc-CC
Q 000893 1202 K-RNTLVTGGVRGTLPWMAPELLN-GS 1226 (1236)
Q Consensus 1202 i-~ns~~tss~~GTp~YmAPEVL~-Gs 1226 (1236)
. ..........++..|+|||++. +.
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~ 174 (260)
T PF00069_consen 148 LSENNENFNPFVGTPEYMAPEVLQQGK 174 (260)
T ss_dssp STSTTSEBSSSSSSGGGSCHHHHTTTS
T ss_pred ccccccccccccccccccccccccccc
Confidence 3 3334445677899999999998 44
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.7e-26 Score=245.13 Aligned_cols=170 Identities=29% Similarity=0.419 Sum_probs=138.3
Q ss_pred EEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhh-CCCCceeeEeeeEecCCCCeEEE
Q 000893 1048 KELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK-LHHPNVVAFYGVVQDGPGGTLAT 1124 (1236)
Q Consensus 1048 kkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILsk-LrHPNIVrLyG~f~t~~~g~L~L 1124 (1236)
+.||+|+||+||+|++ ++..||||++++..... ......+..|..++.. ++||||+++++++.+.. .+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~--~~~l 73 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLI-----DDDVECTMVEKRVLALAWENPFLTHLYCTFQTKE--HLFF 73 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-----cchHHHHHHHHHHHHhccCCCCccCeeEEEEeCC--EEEE
Confidence 3699999999999998 46789999998643211 1123345668888775 58999999999998854 8999
Q ss_pred EEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCccccc-
Q 000893 1125 VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR- 1203 (1236)
Q Consensus 1125 VMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~- 1203 (1236)
||||+.+++|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 74 v~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~----~~kl~Dfg~~~~~~~ 148 (316)
T cd05620 74 VMEFLNGGDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDG----HIKIADFGMCKENVF 148 (316)
T ss_pred EECCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC----CEEeCccCCCeeccc
Confidence 99999999999988653 4688999999999999999999999999999999999999876 57999999987532
Q ss_pred CcccccCcCCCCcccchhhhcCCCCC
Q 000893 1204 NTLVTGGVRGTLPWMAPELLNGSSSK 1229 (1236)
Q Consensus 1204 ns~~tss~~GTp~YmAPEVL~Gss~~ 1229 (1236)
........+||+.|+|||++.+....
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~ 174 (316)
T cd05620 149 GDNRASTFCGTPDYIAPEILQGLKYT 174 (316)
T ss_pred CCCceeccCCCcCccCHHHHcCCCCC
Confidence 22233457799999999999876443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=244.37 Aligned_cols=165 Identities=28% Similarity=0.383 Sum_probs=135.5
Q ss_pred eccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhC---CCCceeeEeeeEecCCCCeEEE
Q 000893 1050 LGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL---HHPNVVAFYGVVQDGPGGTLAT 1124 (1236)
Q Consensus 1050 LGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskL---rHPNIVrLyG~f~t~~~g~L~L 1124 (1236)
||+|+||+||+|++ .++.||||++.+.... .......+..|..++..+ .||||+++++++.+.. .+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~--~~~l 73 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIV-----AKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDS--DLYL 73 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHh-----hhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCC--eEEE
Confidence 79999999999987 4788999999754221 122334456677777665 6999999999998865 8999
Q ss_pred EEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCccccc-
Q 000893 1125 VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR- 1203 (1236)
Q Consensus 1125 VMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~- 1203 (1236)
||||+++++|..++.. ...+++..++.|+.||+.||+|||++||+||||||+||||+.++ .+||+|||+++...
T Consensus 74 v~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~----~~kl~Dfg~a~~~~~ 148 (330)
T cd05586 74 VTDYMSGGELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATG----HIALCDFGLSKANLT 148 (330)
T ss_pred EEcCCCCChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC----CEEEecCCcCcCCCC
Confidence 9999999999988864 45689999999999999999999999999999999999999876 56999999987632
Q ss_pred CcccccCcCCCCcccchhhhcCC
Q 000893 1204 NTLVTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1204 ns~~tss~~GTp~YmAPEVL~Gs 1226 (1236)
........+||+.|+|||++.+.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~ 171 (330)
T cd05586 149 DNKTTNTFCGTTEYLAPEVLLDE 171 (330)
T ss_pred CCCCccCccCCccccCHHHHcCC
Confidence 23334457899999999999754
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=232.41 Aligned_cols=172 Identities=38% Similarity=0.619 Sum_probs=143.0
Q ss_pred ccCeeEEEEeccCCceEEEEeeec-CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1041 ~EdYeiLkkLGsGSFGtVYKArlk-G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
..+|++++.||+|+||.||++.++ +..+|+|.+..... ....|.+|+.+|+.++||||++++++|....
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 72 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM---------SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK- 72 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc---------cHHHHHHHHHHHHHCCCCCceeEEEEEccCC-
Confidence 467899999999999999999985 45799998764321 1245788999999999999999999988754
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
.+++||||+++++|.+++......+++..++.++.|++.||.|||+++|+||||||+||+++.++ .+||+|||++
T Consensus 73 -~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~----~~kl~d~g~~ 147 (256)
T cd05114 73 -PLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTG----VVKVSDFGMT 147 (256)
T ss_pred -CEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCC----eEEECCCCCc
Confidence 88999999999999999976555689999999999999999999999999999999999998776 6799999999
Q ss_pred ccccCcccc--cCcCCCCcccchhhhcCCC
Q 000893 1200 KIKRNTLVT--GGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1200 rii~ns~~t--ss~~GTp~YmAPEVL~Gss 1227 (1236)
+........ ....++..|+|||++.+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 177 (256)
T cd05114 148 RYVLDDEYTSSSGAKFPVKWSPPEVFNFSK 177 (256)
T ss_pred cccCCCceeccCCCCCchhhCChhhcccCc
Confidence 865432221 2233566899999998653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=5e-26 Score=250.16 Aligned_cols=168 Identities=35% Similarity=0.521 Sum_probs=139.8
Q ss_pred cccCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecC
Q 000893 1040 KNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1236)
Q Consensus 1040 s~EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~ 1117 (1236)
...+|+++++||+|+||+||+|++. ++.||||++.... .......|.+|+.+++.++|+||+++++++...
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 144 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-------EDTVRRQICREIEILRDVNHPNVVKCHDMFDHN 144 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-------cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC
Confidence 3467888899999999999999884 7889999986432 223345788999999999999999999999875
Q ss_pred CCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEecc
Q 000893 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1236)
Q Consensus 1118 ~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFG 1197 (1236)
+.+++||||+.+++|.... ...+..+..|+.||+.||.|||++||+||||||+||||+.++ .+||+|||
T Consensus 145 --~~~~lv~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~----~~kL~DfG 213 (353)
T PLN00034 145 --GEIQVLLEFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAK----NVKIADFG 213 (353)
T ss_pred --CeEEEEEecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC----CEEEcccc
Confidence 4899999999999986432 356777888999999999999999999999999999999876 57999999
Q ss_pred CcccccCcc-cccCcCCCCcccchhhhcC
Q 000893 1198 LSKIKRNTL-VTGGVRGTLPWMAPELLNG 1225 (1236)
Q Consensus 1198 LArii~ns~-~tss~~GTp~YmAPEVL~G 1225 (1236)
+++...... ......||..|+|||++..
T Consensus 214 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 242 (353)
T PLN00034 214 VSRILAQTMDPCNSSVGTIAYMSPERINT 242 (353)
T ss_pred cceecccccccccccccCccccCcccccc
Confidence 998764332 2234679999999999854
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.9e-26 Score=249.75 Aligned_cols=169 Identities=26% Similarity=0.368 Sum_probs=143.6
Q ss_pred ccccCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEec
Q 000893 1039 IKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1236)
Q Consensus 1039 Is~EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t 1116 (1236)
+....|++++.||+|+||+||+|++. +..||+|+.... ....|+.+++.++||||++++++|..
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------------~~~~E~~~l~~l~h~~iv~~~~~~~~ 128 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------------TTLIEAMLLQNVNHPSVIRMKDTLVS 128 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------------ccHHHHHHHHhCCCCCCcChhheEEe
Confidence 44467999999999999999999984 567999975432 12358999999999999999999988
Q ss_pred CCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEec
Q 000893 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1236)
Q Consensus 1117 ~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDF 1196 (1236)
.. ..++||||+ .++|..++......+++..++.|+.||+.||.|||++|||||||||+|||++.++ .+||+||
T Consensus 129 ~~--~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~----~~kl~Df 201 (357)
T PHA03209 129 GA--ITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVD----QVCIGDL 201 (357)
T ss_pred CC--eeEEEEEcc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC----CEEEecC
Confidence 54 889999999 5788888877677899999999999999999999999999999999999999876 5799999
Q ss_pred cCcccccCcccccCcCCCCcccchhhhcCCCC
Q 000893 1197 GLSKIKRNTLVTGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1197 GLArii~ns~~tss~~GTp~YmAPEVL~Gss~ 1228 (1236)
|+++............||+.|+|||++.+..+
T Consensus 202 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 233 (357)
T PHA03209 202 GAAQFPVVAPAFLGLAGTVETNAPEVLARDKY 233 (357)
T ss_pred ccccccccCcccccccccccccCCeecCCCCC
Confidence 99986544444455679999999999987643
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-26 Score=263.94 Aligned_cols=182 Identities=26% Similarity=0.449 Sum_probs=157.6
Q ss_pred ccCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCC
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1041 ~EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~ 1118 (1236)
.++|..++++|+|+||.+++.+++ ++.+++|.+....... ........|+.++++++|||||.+++.|....
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~------~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~ 76 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTE------PERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG 76 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCc------hhhHHHHHHHHHHHhccCCCeeeeccchhcCC
Confidence 367889999999999999988874 5679999998764332 22235678999999999999999999999854
Q ss_pred CCeEEEEEeeccCCCHHHHHhhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEecc
Q 000893 1119 GGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1236)
Q Consensus 1119 ~g~L~LVMEYm~GGSL~dlL~~k~-r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFG 1197 (1236)
..++|||+||+||+|.+.+.... ..+++..++.|+.||+.||.|||++.|+|||||+.||+++.++ .|||.|||
T Consensus 77 -~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~----~VkLgDfG 151 (426)
T KOG0589|consen 77 -QLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDK----KVKLGDFG 151 (426)
T ss_pred -ceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccC----ceeecchh
Confidence 34999999999999999997765 6899999999999999999999999999999999999999987 45999999
Q ss_pred CcccccCcc-cccCcCCCCcccchhhhcCCCCCCCcc
Q 000893 1198 LSKIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEK 1233 (1236)
Q Consensus 1198 LArii~ns~-~tss~~GTp~YmAPEVL~Gss~~~SdD 1233 (1236)
+|+.+.... ...+.+||+.||+||++.+..+....|
T Consensus 152 laK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSD 188 (426)
T KOG0589|consen 152 LAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSD 188 (426)
T ss_pred hhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCc
Confidence 999987766 778899999999999999986665554
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.2e-27 Score=263.34 Aligned_cols=185 Identities=29% Similarity=0.379 Sum_probs=160.2
Q ss_pred cccccCeeEEEEeccCCceEEEEeeecCce--EEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhC-CCCceeeEeeeE
Q 000893 1038 IIKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVV 1114 (1236)
Q Consensus 1038 iIs~EdYeiLkkLGsGSFGtVYKArlkG~~--VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskL-rHPNIVrLyG~f 1114 (1236)
.+...+|.++.+||+|+||+|.+|+.+|+. +|||++++..+..+++.... +.|.++|+.. +-|++++|+.+|
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvect-----m~EKrvLAL~~kppFL~qlHScF 419 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECT-----MVEKRVLALPGKPPFLVQLHSCF 419 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccce-----ehhhhheecCCCCchHHHHHHHh
Confidence 466678999999999999999999997755 99999999988776654433 3477888876 478999999999
Q ss_pred ecCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEE
Q 000893 1115 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1236)
Q Consensus 1115 ~t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLs 1194 (1236)
++.+ .+|+||||+.||+|..++++-+ .+.+..+..++.+|+.||-|||++|||+||||.+||||+.+|+ +||+
T Consensus 420 QTmD--RLyFVMEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGH----iKi~ 492 (683)
T KOG0696|consen 420 QTMD--RLYFVMEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH----IKIA 492 (683)
T ss_pred hhhh--heeeEEEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCc----eEee
Confidence 9976 9999999999999999997655 4777888889999999999999999999999999999999985 5999
Q ss_pred eccCcccc-cCcccccCcCCCCcccchhhhcCCCCCCCccc
Q 000893 1195 DFGLSKIK-RNTLVTGGVRGTLPWMAPELLNGSSSKVSEKV 1234 (1236)
Q Consensus 1195 DFGLArii-~ns~~tss~~GTp~YmAPEVL~Gss~~~SdDV 1234 (1236)
|||+|+.. -...++.++||||.|+|||+|.-+++..+.||
T Consensus 493 DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDW 533 (683)
T KOG0696|consen 493 DFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDW 533 (683)
T ss_pred ecccccccccCCcceeeecCCCcccccceEEecccccchhH
Confidence 99999974 34556678999999999999999888877775
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=243.55 Aligned_cols=170 Identities=26% Similarity=0.392 Sum_probs=140.2
Q ss_pred EeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhC-CCCceeeEeeeEecCCCCeEEEE
Q 000893 1049 ELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDGPGGTLATV 1125 (1236)
Q Consensus 1049 kLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskL-rHPNIVrLyG~f~t~~~g~L~LV 1125 (1236)
.||+|+||+||+++++ ++.||||++++.... .......+.+|..+++.+ +||||+++++++.... .+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~--~~~lv 74 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVIL-----QDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKD--RLFFV 74 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHh-----hhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC--EEEEE
Confidence 5999999999999984 678999999864321 122344567888898887 6999999999998754 89999
Q ss_pred EeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCccccc-C
Q 000893 1126 TEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR-N 1204 (1236)
Q Consensus 1126 MEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~-n 1204 (1236)
|||+++++|..++... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+++... .
T Consensus 75 ~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~----~~kl~Dfg~~~~~~~~ 149 (318)
T cd05570 75 MEYVNGGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEG----HIKIADFGMCKEGILG 149 (318)
T ss_pred EcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCC----cEEecccCCCeecCcC
Confidence 9999999999888644 4689999999999999999999999999999999999999886 57999999997632 2
Q ss_pred cccccCcCCCCcccchhhhcCCCCCC
Q 000893 1205 TLVTGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1205 s~~tss~~GTp~YmAPEVL~Gss~~~ 1230 (1236)
.......+||+.|+|||++.+.....
T Consensus 150 ~~~~~~~~g~~~y~aPE~~~~~~~~~ 175 (318)
T cd05570 150 GVTTSTFCGTPDYIAPEILSYQPYGP 175 (318)
T ss_pred CCcccceecCccccCHHHhcCCCCCc
Confidence 23334567999999999998764433
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=243.81 Aligned_cols=169 Identities=31% Similarity=0.431 Sum_probs=137.6
Q ss_pred EEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhh-CCCCceeeEeeeEecCCCCeEEE
Q 000893 1048 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK-LHHPNVVAFYGVVQDGPGGTLAT 1124 (1236)
Q Consensus 1048 kkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILsk-LrHPNIVrLyG~f~t~~~g~L~L 1124 (1236)
+.||+|+||+||+|+++ ++.||||++++..... ......+..|..++.. ++||||+++++++.+.. .+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~--~~~l 73 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLM-----DDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKE--NLFF 73 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-----cchHHHHHHHHHHHHhccCCCcCcceEEEEEeCC--EEEE
Confidence 36999999999999984 6779999998643211 1223345667888875 58999999999998854 8999
Q ss_pred EEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCccccc-
Q 000893 1125 VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR- 1203 (1236)
Q Consensus 1125 VMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~- 1203 (1236)
||||+++++|..++... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+++...
T Consensus 74 v~ey~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~----~~kl~Dfg~~~~~~~ 148 (316)
T cd05619 74 VMEYLNGGDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDG----HIKIADFGMCKENML 148 (316)
T ss_pred EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC----CEEEccCCcceECCC
Confidence 99999999999998643 4688999999999999999999999999999999999999876 57999999987532
Q ss_pred CcccccCcCCCCcccchhhhcCCCC
Q 000893 1204 NTLVTGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1204 ns~~tss~~GTp~YmAPEVL~Gss~ 1228 (1236)
........+||+.|+|||++.+...
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~ 173 (316)
T cd05619 149 GDAKTCTFCGTPDYIAPEILLGQKY 173 (316)
T ss_pred CCCceeeecCCccccCHHHHcCCCC
Confidence 2223345679999999999987643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-25 Score=230.92 Aligned_cols=175 Identities=34% Similarity=0.558 Sum_probs=145.1
Q ss_pred cccCeeEEEEeccCCceEEEEeeec-----CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeE
Q 000893 1040 KNEDLEELKELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVV 1114 (1236)
Q Consensus 1040 s~EdYeiLkkLGsGSFGtVYKArlk-----G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f 1114 (1236)
..++|++.+.||+|+||+||+|.++ ...||||.++... .......|.+|+.+++.++||||+++++++
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 74 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-------SDKQRLDFLTEASIMGQFDHPNIIRLEGVV 74 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-------ChHHHHHHHHHHHHHHhCCCCCcceEeEEE
Confidence 3467999999999999999999874 2469999886532 223345688999999999999999999998
Q ss_pred ecCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEE
Q 000893 1115 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1236)
Q Consensus 1115 ~t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLs 1194 (1236)
.... ..++||||+++++|.+++......+++..++.++.|++.||.|||+++|+||||||+||||+.++ .+||+
T Consensus 75 ~~~~--~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~----~~~l~ 148 (266)
T cd05033 75 TKSR--PVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNL----VCKVS 148 (266)
T ss_pred ecCC--ceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC----CEEEC
Confidence 8754 78999999999999999977666789999999999999999999999999999999999999876 56999
Q ss_pred eccCcccccC--cc-cccCcCCCCcccchhhhcCCC
Q 000893 1195 DFGLSKIKRN--TL-VTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1195 DFGLArii~n--s~-~tss~~GTp~YmAPEVL~Gss 1227 (1236)
|||+++.... .. ......+++.|+|||++.+..
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~ 184 (266)
T cd05033 149 DFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK 184 (266)
T ss_pred ccchhhcccccccceeccCCCCCccccChhhhccCC
Confidence 9999987642 11 112233567899999998653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=239.01 Aligned_cols=168 Identities=29% Similarity=0.442 Sum_probs=134.9
Q ss_pred EEeccCCceEEEEeeec----CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeEE
Q 000893 1048 KELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLA 1123 (1236)
Q Consensus 1048 kkLGsGSFGtVYKArlk----G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L~ 1123 (1236)
++||+|+||+||+|+++ ++.||||.+..... ...+.+|+.+|+.++||||+++++++.......++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 76 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----------SMSACREIALLRELKHPNVISLQKVFLSHADRKVW 76 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEE
Confidence 57999999999999863 46799999865321 12356899999999999999999999766566899
Q ss_pred EEEeeccCCCHHHHHhhh--------ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEe
Q 000893 1124 TVTEFMVNGSLRHVLLSK--------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1236)
Q Consensus 1124 LVMEYm~GGSL~dlL~~k--------~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsD 1195 (1236)
+||||+ +++|..++... ...+++..++.|+.||+.||.|||++||+||||||+|||+...+.....+||+|
T Consensus 77 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07868 77 LLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred EEEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEee
Confidence 999998 56888777432 125888999999999999999999999999999999999965433334789999
Q ss_pred ccCcccccCcc----cccCcCCCCcccchhhhcCC
Q 000893 1196 FGLSKIKRNTL----VTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1196 FGLArii~ns~----~tss~~GTp~YmAPEVL~Gs 1226 (1236)
||+++...... .....+||+.|+|||++.+.
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 190 (317)
T cd07868 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA 190 (317)
T ss_pred cCceeccCCCCccccccCCccccccccCCHHHcCC
Confidence 99998754321 22346789999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=245.20 Aligned_cols=175 Identities=26% Similarity=0.345 Sum_probs=144.2
Q ss_pred ccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCC
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1041 ~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~ 1118 (1236)
.++|++++.||+|+||.||++.. .++.||||++..... .......+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~ 96 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ------NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK 96 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc------CchhHHHHHHHHHHHHhcCCCCccccceeecccc
Confidence 46899999999999999999987 477899999875321 1223456778999999999999999999876432
Q ss_pred ----CCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEE
Q 000893 1119 ----GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1236)
Q Consensus 1119 ----~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLs 1194 (1236)
...+++||||+. ++|..++.. .+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+
T Consensus 97 ~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~----~~kL~ 168 (364)
T cd07875 97 SLEEFQDVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC----TLKIL 168 (364)
T ss_pred cccccCeEEEEEeCCC-CCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCC----cEEEE
Confidence 236799999995 577777642 478888999999999999999999999999999999999876 57999
Q ss_pred eccCcccccCcccccCcCCCCcccchhhhcCCCCC
Q 000893 1195 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSK 1229 (1236)
Q Consensus 1195 DFGLArii~ns~~tss~~GTp~YmAPEVL~Gss~~ 1229 (1236)
|||+++............||+.|+|||++.+....
T Consensus 169 DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 203 (364)
T cd07875 169 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 203 (364)
T ss_pred eCCCccccCCCCcccCCcccCCcCCHHHHhCCCCC
Confidence 99999876655555567799999999999876433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-25 Score=234.62 Aligned_cols=167 Identities=27% Similarity=0.372 Sum_probs=138.6
Q ss_pred eccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeEEEEEe
Q 000893 1050 LGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTE 1127 (1236)
Q Consensus 1050 LGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L~LVME 1127 (1236)
||+|+||+||+++. .++.||+|++....... ......+..|+.+++.++||||+++++++.... .+++|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-----~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~--~~~lv~e 73 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK-----KSGEKMALLEKEILEKVNSPFIVNLAYAFESKT--HLCLVMS 73 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhc-----chhhHHHHHHHHHHHhcCCCcEEEEEEEEecCC--eEEEEEe
Confidence 79999999999987 47889999987543211 111234556999999999999999999998754 8999999
Q ss_pred eccCCCHHHHHhhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcccccCcc
Q 000893 1128 FMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL 1206 (1236)
Q Consensus 1128 Ym~GGSL~dlL~~k~-r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~ns~ 1206 (1236)
|+++++|..++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 74 ~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~----~~~l~Dfg~~~~~~~~~ 149 (277)
T cd05607 74 LMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQG----NCRLSDLGLAVELKDGK 149 (277)
T ss_pred cCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCC----CEEEeeceeeeecCCCc
Confidence 999999998886543 4688999999999999999999999999999999999999876 56999999998765544
Q ss_pred cccCcCCCCcccchhhhcCCC
Q 000893 1207 VTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1207 ~tss~~GTp~YmAPEVL~Gss 1227 (1236)
......|++.|+|||++.+..
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~ 170 (277)
T cd05607 150 TITQRAGTNGYMAPEILKEEP 170 (277)
T ss_pred eeeccCCCCCccCHHHHccCC
Confidence 444567899999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-25 Score=232.22 Aligned_cols=174 Identities=30% Similarity=0.407 Sum_probs=138.2
Q ss_pred CeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhh---CCCCceeeEeeeEecC
Q 000893 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK---LHHPNVVAFYGVVQDG 1117 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILsk---LrHPNIVrLyG~f~t~ 1117 (1236)
+|++++.||+|+||+||+|++ +++.||||.++........ ...+.+|+.+++. ++||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~------~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~ 74 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGL------PLSTVREVALLKRLEAFDHPNIVRLMDVCATS 74 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCC------chHHHHHHHHHHHhhhcCCCCeeeeeeeeccc
Confidence 488899999999999999988 4778999998754321111 1223456666655 4799999999988643
Q ss_pred C---CCeEEEEEeeccCCCHHHHHhhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEE
Q 000893 1118 P---GGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193 (1236)
Q Consensus 1118 ~---~g~L~LVMEYm~GGSL~dlL~~k~-r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKL 1193 (1236)
. ...+++||||+. ++|..++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||
T Consensus 75 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~----~~kl 149 (288)
T cd07863 75 RTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG----QVKL 149 (288)
T ss_pred cCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC----CEEE
Confidence 2 346899999996 58888886543 4589999999999999999999999999999999999999886 5699
Q ss_pred EeccCcccccCcccccCcCCCCcccchhhhcCCC
Q 000893 1194 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1194 sDFGLArii~ns~~tss~~GTp~YmAPEVL~Gss 1227 (1236)
+|||+++............||+.|+|||++.+..
T Consensus 150 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 183 (288)
T cd07863 150 ADFGLARIYSCQMALTPVVVTLWYRAPEVLLQST 183 (288)
T ss_pred CccCccccccCcccCCCccccccccCchHhhCCC
Confidence 9999998765544444567899999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-25 Score=232.53 Aligned_cols=176 Identities=31% Similarity=0.516 Sum_probs=144.9
Q ss_pred cccccCeeEEEEeccCCceEEEEeee--cCc----eEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEe
Q 000893 1038 IIKNEDLEELKELGSGTFGTVYHGKW--RGT----DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 1111 (1236)
Q Consensus 1038 iIs~EdYeiLkkLGsGSFGtVYKArl--kG~----~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLy 1111 (1236)
++...+|++++.||+|+||+||+|++ ++. .||||+++... .......+.+|+.+++.+.||||++++
T Consensus 3 ~l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~i~~~~ 75 (279)
T cd05109 3 ILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-------SPKANKEILDEAYVMAGVGSPYVCRLL 75 (279)
T ss_pred ccchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-------CHHHHHHHHHHHHHHHhcCCCCCceEE
Confidence 46678999999999999999999987 343 48999886432 122345688899999999999999999
Q ss_pred eeEecCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcE
Q 000893 1112 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 1191 (1236)
Q Consensus 1112 G~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltV 1191 (1236)
+++... ..+++|||+++|+|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++.++ .+
T Consensus 76 ~~~~~~---~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~----~~ 148 (279)
T cd05109 76 GICLTS---TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPN----HV 148 (279)
T ss_pred EEEcCC---CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC----cE
Confidence 999763 56789999999999999976666799999999999999999999999999999999999998776 57
Q ss_pred EEEeccCcccccCcccc---cCcCCCCcccchhhhcCCC
Q 000893 1192 KVGDFGLSKIKRNTLVT---GGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1192 KLsDFGLArii~ns~~t---ss~~GTp~YmAPEVL~Gss 1227 (1236)
||+|||+++........ ....+++.|+|||++.+..
T Consensus 149 kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~ 187 (279)
T cd05109 149 KITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRR 187 (279)
T ss_pred EECCCCceeecccccceeecCCCccchhhCCHHHhccCC
Confidence 99999999876432221 1223467899999997653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-25 Score=229.48 Aligned_cols=175 Identities=33% Similarity=0.554 Sum_probs=145.9
Q ss_pred cccccCeeEEEEeccCCceEEEEeeec-CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEec
Q 000893 1038 IIKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1236)
Q Consensus 1038 iIs~EdYeiLkkLGsGSFGtVYKArlk-G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t 1116 (1236)
.+..++|+++++||+|+||.||+|... +..||+|.+.... .....+.+|+.+++.++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT---------MSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc---------hhHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 456789999999999999999999874 5679999876431 123568889999999999999999999887
Q ss_pred CCCCeEEEEEeeccCCCHHHHHhhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEe
Q 000893 1117 GPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1236)
Q Consensus 1117 ~~~g~L~LVMEYm~GGSL~dlL~~k-~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsD 1195 (1236)
.. ..++||||+++++|.+++... ...+++..++.++.|++.||+|||+++++||||||+|||++.++ .+||+|
T Consensus 73 ~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~----~~~l~d 146 (261)
T cd05072 73 EE--PIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESL----MCKIAD 146 (261)
T ss_pred CC--CcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCC----cEEECC
Confidence 54 789999999999999998654 35688889999999999999999999999999999999999876 579999
Q ss_pred ccCcccccCccc--ccCcCCCCcccchhhhcCCC
Q 000893 1196 FGLSKIKRNTLV--TGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1196 FGLArii~ns~~--tss~~GTp~YmAPEVL~Gss 1227 (1236)
||++........ .....++..|+|||++.+..
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 180 (261)
T cd05072 147 FGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 180 (261)
T ss_pred CccceecCCCceeccCCCccceecCCHHHhccCC
Confidence 999987644322 12334567899999997654
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-25 Score=229.18 Aligned_cols=174 Identities=37% Similarity=0.583 Sum_probs=145.5
Q ss_pred cccccCeeEEEEeccCCceEEEEeeecCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecC
Q 000893 1038 IIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1236)
Q Consensus 1038 iIs~EdYeiLkkLGsGSFGtVYKArlkG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~ 1117 (1236)
.+...+|++.+.||+|+||.||++..++..||+|.++... ....|.+|+.+++.++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd05082 2 ALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----------TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 71 (256)
T ss_pred CccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc----------hHHHHHHHHHHHHhCCCCCeeeEEEEEEcC
Confidence 4566789999999999999999999999999999886421 134678899999999999999999987543
Q ss_pred CCCeEEEEEeeccCCCHHHHHhhhcc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEec
Q 000893 1118 PGGTLATVTEFMVNGSLRHVLLSKER-HLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1236)
Q Consensus 1118 ~~g~L~LVMEYm~GGSL~dlL~~k~r-~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDF 1196 (1236)
. ...++||||+++++|.+++..... .+++..++.++.|++.||+|||++||+||||||+||+++.++ .+||+||
T Consensus 72 ~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~----~~kl~df 146 (256)
T cd05082 72 K-GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDN----VAKVSDF 146 (256)
T ss_pred C-CceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCC----cEEecCC
Confidence 2 478999999999999999876443 588999999999999999999999999999999999999876 5699999
Q ss_pred cCcccccCcccccCcCCCCcccchhhhcCCCC
Q 000893 1197 GLSKIKRNTLVTGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1197 GLArii~ns~~tss~~GTp~YmAPEVL~Gss~ 1228 (1236)
|+++...... ....++..|+|||++.+...
T Consensus 147 g~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~ 176 (256)
T cd05082 147 GLTKEASSTQ--DTGKLPVKWTAPEALREKKF 176 (256)
T ss_pred ccceeccccC--CCCccceeecCHHHHccCCC
Confidence 9988654322 22345678999999987643
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-25 Score=231.91 Aligned_cols=178 Identities=32% Similarity=0.484 Sum_probs=142.7
Q ss_pred cccccCeeEEEEeccCCceEEEEeeec-------CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeE
Q 000893 1038 IIKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAF 1110 (1236)
Q Consensus 1038 iIs~EdYeiLkkLGsGSFGtVYKArlk-------G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrL 1110 (1236)
.+..++|++.+.||+|+||.||+|.++ +..||||++.... ......+|.+|+.+++.++||||+++
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~iv~~ 74 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-------SMRERIEFLNEASVMKEFNCHHVVRL 74 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-------CHHHHHHHHHHHHHHHhCCCCCeeeE
Confidence 455678999999999999999998864 3459999875421 11234568899999999999999999
Q ss_pred eeeEecCCCCeEEEEEeeccCCCHHHHHhhhc---------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEE
Q 000893 1111 YGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV 1181 (1236)
Q Consensus 1111 yG~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~---------r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILL 1181 (1236)
++++.... ..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+++++||||||+|||+
T Consensus 75 ~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~ 152 (277)
T cd05062 75 LGVVSQGQ--PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV 152 (277)
T ss_pred EEEEcCCC--CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEE
Confidence 99987654 8899999999999999986532 235677888999999999999999999999999999999
Q ss_pred ccCCCCCCcEEEEeccCcccccCccc---ccCcCCCCcccchhhhcCCCC
Q 000893 1182 NLKDPIRPICKVGDFGLSKIKRNTLV---TGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1182 DsdG~I~ltVKLsDFGLArii~ns~~---tss~~GTp~YmAPEVL~Gss~ 1228 (1236)
+.++ .+||+|||+++....... .....+++.|+|||++.+...
T Consensus 153 ~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 198 (277)
T cd05062 153 AEDF----TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF 198 (277)
T ss_pred cCCC----CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCc
Confidence 9876 579999999876433221 112345778999999986543
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-25 Score=251.40 Aligned_cols=180 Identities=30% Similarity=0.413 Sum_probs=144.9
Q ss_pred ccccccCeeEEEEeccCCceEEEEeeec-------CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCC-CCcee
Q 000893 1037 QIIKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVV 1108 (1236)
Q Consensus 1037 qiIs~EdYeiLkkLGsGSFGtVYKArlk-------G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLr-HPNIV 1108 (1236)
+.+..++|++.++||+|+||+||+|++. +..||||+++... .......|.+|+.+|+.+. ||||+
T Consensus 32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-------~~~~~~~~~~Ei~~l~~l~~HpnIv 104 (400)
T cd05105 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-------RSSEKQALMSELKIMTHLGPHLNIV 104 (400)
T ss_pred eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-------ChHHHHHHHHHHHHHHhcCCCCCee
Confidence 3455678999999999999999999863 2359999986532 1223456889999999996 99999
Q ss_pred eEeeeEecCCCCeEEEEEeeccCCCHHHHHhhhc----------------------------------------------
Q 000893 1109 AFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------------------------------------------- 1142 (1236)
Q Consensus 1109 rLyG~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~---------------------------------------------- 1142 (1236)
+++++|... +.++||||||++|+|.+++....
T Consensus 105 ~l~~~~~~~--~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (400)
T cd05105 105 NLLGACTKS--GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQ 182 (400)
T ss_pred eEEEEEccC--CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccc
Confidence 999999875 48999999999999999886431
Q ss_pred -------------------------------------------------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Q 000893 1143 -------------------------------------------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFD 1173 (1236)
Q Consensus 1143 -------------------------------------------------r~LSe~erl~Ia~QIAeALaYLHSkGIIHRD 1173 (1236)
..+++..++.++.||+.||.|||.++|+|||
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~d 262 (400)
T cd05105 183 ADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRD 262 (400)
T ss_pred ccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCC
Confidence 2367788889999999999999999999999
Q ss_pred CCCCcEEEccCCCCCCcEEEEeccCcccccCcc---cccCcCCCCcccchhhhcCCCCC
Q 000893 1174 LKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSK 1229 (1236)
Q Consensus 1174 IKPsNILLDsdG~I~ltVKLsDFGLArii~ns~---~tss~~GTp~YmAPEVL~Gss~~ 1229 (1236)
|||+|||++.++ .+||+|||+++...... ......+++.|+|||++.+....
T Consensus 263 ikp~Nill~~~~----~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 317 (400)
T cd05105 263 LAARNVLLAQGK----IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYT 317 (400)
T ss_pred CChHhEEEeCCC----EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCC
Confidence 999999999875 67999999998653221 22234567889999999876433
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.9e-25 Score=232.78 Aligned_cols=175 Identities=32% Similarity=0.551 Sum_probs=145.3
Q ss_pred cCeeEEEEeccCCceEEEEeee------cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEe
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW------RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 1115 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl------kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~ 1115 (1236)
..|++++.||+|+||.||++++ .+..||||.++... .......+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 76 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-------GGNHIADLKKEIEILRNLYHENIVKYKGICT 76 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-------cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence 4578899999999999999874 35679999986432 1223456889999999999999999999998
Q ss_pred cCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEe
Q 000893 1116 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1236)
Q Consensus 1116 t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsD 1195 (1236)
......+++||||+++++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|
T Consensus 77 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~----~~~l~d 152 (284)
T cd05079 77 EDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH----QVKIGD 152 (284)
T ss_pred cCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCC----CEEECC
Confidence 7644578999999999999999976555789999999999999999999999999999999999998876 569999
Q ss_pred ccCcccccCcc----cccCcCCCCcccchhhhcCCC
Q 000893 1196 FGLSKIKRNTL----VTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1196 FGLArii~ns~----~tss~~GTp~YmAPEVL~Gss 1227 (1236)
||+++...... ......++..|+|||++.+..
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~ 188 (284)
T cd05079 153 FGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK 188 (284)
T ss_pred CccccccccCccceeecCCCCCCccccCHHHhccCC
Confidence 99998754321 122355677899999987653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-25 Score=232.38 Aligned_cols=175 Identities=37% Similarity=0.560 Sum_probs=143.4
Q ss_pred cccCeeEEEEeccCCceEEEEeeecC-------ceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEee
Q 000893 1040 KNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 1112 (1236)
Q Consensus 1040 s~EdYeiLkkLGsGSFGtVYKArlkG-------~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG 1112 (1236)
..++|++++.||+|+||.||+|...+ ..||+|.++... .......|.+|+.+++.++||||+++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-------~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 75 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-------EPKVQQEFRQEAELMSDLQHPNIVCLLG 75 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-------CHHHHHHHHHHHHHHHhcCCcccceEEE
Confidence 34688999999999999999998743 459999886432 2233456889999999999999999999
Q ss_pred eEecCCCCeEEEEEeeccCCCHHHHHhhhc---------------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCC
Q 000893 1113 VVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCD 1177 (1236)
Q Consensus 1113 ~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~---------------r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPs 1177 (1236)
++... ...+++|||+++++|.+++.... ..+++..++.++.|++.||.|||+++|+||||||+
T Consensus 76 ~~~~~--~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~ 153 (283)
T cd05048 76 VCTKE--QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAAR 153 (283)
T ss_pred EEcCC--CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccc
Confidence 98865 47899999999999999996531 45788889999999999999999999999999999
Q ss_pred cEEEccCCCCCCcEEEEeccCcccccCcc---cccCcCCCCcccchhhhcCCC
Q 000893 1178 NLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1178 NILLDsdG~I~ltVKLsDFGLArii~ns~---~tss~~GTp~YmAPEVL~Gss 1227 (1236)
|||++.++ .+||+|||+++...... ......+++.|+|||++.+..
T Consensus 154 Nil~~~~~----~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 202 (283)
T cd05048 154 NCLVGEGL----TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGK 202 (283)
T ss_pred eEEEcCCC----cEEECCCcceeeccccccccccCCCcccccccCHHHhccCc
Confidence 99999876 57999999998643221 223445688999999987653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-24 Score=223.48 Aligned_cols=174 Identities=30% Similarity=0.461 Sum_probs=147.3
Q ss_pred CeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g 1120 (1236)
+|.+.+.||+|++|.||++.+ .++.|++|.+...... ......+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 72 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN------RREREEAIDEARVLAKLDSSYIIRYYESFLDKG-- 72 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC------HHHHHHHHHHHHHHHhcCCCCeehheeeeccCC--
Confidence 578889999999999999988 4788999998754321 233456889999999999999999999998754
Q ss_pred eEEEEEeeccCCCHHHHHhhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1121 TLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1121 ~L~LVMEYm~GGSL~dlL~~k-~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
.+++||||+++++|.+++... ...+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||++
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~----~~~l~df~~~ 148 (256)
T cd08529 73 KLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYD----NVKIGDLGVA 148 (256)
T ss_pred EEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCC----CEEEcccccc
Confidence 899999999999999999764 45789999999999999999999999999999999999999876 5699999999
Q ss_pred ccccCcc-cccCcCCCCcccchhhhcCCCC
Q 000893 1200 KIKRNTL-VTGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1200 rii~ns~-~tss~~GTp~YmAPEVL~Gss~ 1228 (1236)
+...... .....+|++.|+|||++.+...
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 178 (256)
T cd08529 149 KLLSDNTNFANTIVGTPYYLSPELCEDKPY 178 (256)
T ss_pred eeccCccchhhccccCccccCHHHhcCCCC
Confidence 8754332 2334578999999999987643
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.1e-25 Score=231.91 Aligned_cols=172 Identities=31% Similarity=0.473 Sum_probs=147.1
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
++|++++.||+|+||.||++.+ .++.||||++++.... .......+.+|+.+++.++||||+++++++....
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 74 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIV-----KLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS- 74 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCC-
Confidence 4789999999999999999988 4688999998754221 1233456889999999999999999999998754
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
.+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||+|.||||+.++ .+||+|||++
T Consensus 75 -~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~----~~kl~dfg~~ 148 (290)
T cd05580 75 -NLYLVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDG----YIKITDFGFA 148 (290)
T ss_pred -eEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC----CEEEeeCCCc
Confidence 899999999999999998654 5689999999999999999999999999999999999999886 5799999999
Q ss_pred ccccCcccccCcCCCCcccchhhhcCCC
Q 000893 1200 KIKRNTLVTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1200 rii~ns~~tss~~GTp~YmAPEVL~Gss 1227 (1236)
+..... ....+|++.|+|||++.+..
T Consensus 149 ~~~~~~--~~~~~~~~~y~aPE~~~~~~ 174 (290)
T cd05580 149 KRVKGR--TYTLCGTPEYLAPEIILSKG 174 (290)
T ss_pred cccCCC--CCCCCCCccccChhhhcCCC
Confidence 876544 34467899999999997653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=262.01 Aligned_cols=175 Identities=29% Similarity=0.304 Sum_probs=150.9
Q ss_pred CeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCC-C-----CceeeEeeeE
Q 000893 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-H-----PNVVAFYGVV 1114 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLr-H-----PNIVrLyG~f 1114 (1236)
+|.+++.||+|+||.|.+|.+ +++.||||+++.. .....+-+.|+.+|..|+ | -|||+++++|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---------k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F 257 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---------KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF 257 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---------hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc
Confidence 899999999999999999998 4778999999864 344556678999999997 4 4899999999
Q ss_pred ecCCCCeEEEEEeeccCCCHHHHHhhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEE
Q 000893 1115 QDGPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193 (1236)
Q Consensus 1115 ~t~~~g~L~LVMEYm~GGSL~dlL~~k-~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKL 1193 (1236)
...+ ++|||+|.+ ..+|.++|... ...++...++.|+.||+.||.+||+.+||||||||+||||..-++. .+||
T Consensus 258 ~fr~--HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~--~vKV 332 (586)
T KOG0667|consen 258 YFRN--HLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRS--RIKV 332 (586)
T ss_pred cccc--ceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcC--ceeE
Confidence 9865 999999998 88999999765 3578999999999999999999999999999999999999877654 7899
Q ss_pred EeccCcccccCcccccCcCCCCcccchhhhcCCCCCCCcccc
Q 000893 1194 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVC 1235 (1236)
Q Consensus 1194 sDFGLArii~ns~~tss~~GTp~YmAPEVL~Gss~~~SdDVD 1235 (1236)
+|||.+........ .++.+..|+|||+|.|.. |+..+|
T Consensus 333 IDFGSSc~~~q~vy--tYiQSRfYRAPEVILGlp--Y~~~ID 370 (586)
T KOG0667|consen 333 IDFGSSCFESQRVY--TYIQSRFYRAPEVILGLP--YDTAID 370 (586)
T ss_pred EecccccccCCcce--eeeeccccccchhhccCC--CCCccc
Confidence 99999998765544 577899999999999984 444444
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.1e-25 Score=256.06 Aligned_cols=179 Identities=24% Similarity=0.306 Sum_probs=147.9
Q ss_pred cccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecC
Q 000893 1040 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1236)
Q Consensus 1040 s~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~ 1117 (1236)
..++|++.+.||+|+||+||+|++ +++.||||++..... .......+.+|+.++..++|+||++++..+...
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~------~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM------SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK 103 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC------CHHHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence 346999999999999999999987 578899999976432 123345678899999999999999999877643
Q ss_pred CC------CeEEEEEeeccCCCHHHHHhhh---ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCC
Q 000893 1118 PG------GTLATVTEFMVNGSLRHVLLSK---ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIR 1188 (1236)
Q Consensus 1118 ~~------g~L~LVMEYm~GGSL~dlL~~k---~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ 1188 (1236)
.. ..+++||||+++|+|.+++... ...+++..+..|+.|++.||+|||+++|+||||||+||||+.++
T Consensus 104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~--- 180 (496)
T PTZ00283 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNG--- 180 (496)
T ss_pred cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCC---
Confidence 21 1478999999999999998653 34689999999999999999999999999999999999999876
Q ss_pred CcEEEEeccCcccccC---cccccCcCCCCcccchhhhcCCCC
Q 000893 1189 PICKVGDFGLSKIKRN---TLVTGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1189 ltVKLsDFGLArii~n---s~~tss~~GTp~YmAPEVL~Gss~ 1228 (1236)
.+||+|||+++.... .......+||+.|+|||++.+..+
T Consensus 181 -~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~ 222 (496)
T PTZ00283 181 -LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPY 222 (496)
T ss_pred -CEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCC
Confidence 579999999987542 223345789999999999987643
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.3e-25 Score=230.90 Aligned_cols=175 Identities=33% Similarity=0.495 Sum_probs=142.3
Q ss_pred cccCeeEEEEeccCCceEEEEeee------cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeee
Q 000893 1040 KNEDLEELKELGSGTFGTVYHGKW------RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGV 1113 (1236)
Q Consensus 1040 s~EdYeiLkkLGsGSFGtVYKArl------kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~ 1113 (1236)
...+|++.++||+|+||+||+|.+ .+..||||.++... .......|.+|+.+++.++||||++++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 75 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-------NPQQWGEFQQEASLMAELHHPNIVCLLGV 75 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-------CHHHHHHHHHHHHHHhhCCCCCeeeEEEE
Confidence 346789999999999999999985 24679999987432 12234568889999999999999999999
Q ss_pred EecCCCCeEEEEEeeccCCCHHHHHhhh----------------ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCC
Q 000893 1114 VQDGPGGTLATVTEFMVNGSLRHVLLSK----------------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCD 1177 (1236)
Q Consensus 1114 f~t~~~g~L~LVMEYm~GGSL~dlL~~k----------------~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPs 1177 (1236)
+.... ..++||||+++++|.+++... ...+++..+..++.|++.||.|||+++|+||||||+
T Consensus 76 ~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~ 153 (283)
T cd05090 76 VTQEQ--PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAAR 153 (283)
T ss_pred EecCC--ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccc
Confidence 88754 789999999999999998532 124788888999999999999999999999999999
Q ss_pred cEEEccCCCCCCcEEEEeccCcccccCcc---cccCcCCCCcccchhhhcCCC
Q 000893 1178 NLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1178 NILLDsdG~I~ltVKLsDFGLArii~ns~---~tss~~GTp~YmAPEVL~Gss 1227 (1236)
|||++.++ .+||+|||+++...... ......++..|+|||++.+..
T Consensus 154 nili~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 202 (283)
T cd05090 154 NILIGEQL----HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGK 202 (283)
T ss_pred eEEEcCCC----cEEeccccccccccCCcceecccCCCccceecChHHhccCC
Confidence 99999875 57999999998653221 223345677899999997653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=9e-25 Score=227.99 Aligned_cols=177 Identities=34% Similarity=0.521 Sum_probs=144.9
Q ss_pred cccccCeeEEEEeccCCceEEEEeeecC-------ceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeE
Q 000893 1038 IIKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAF 1110 (1236)
Q Consensus 1038 iIs~EdYeiLkkLGsGSFGtVYKArlkG-------~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrL 1110 (1236)
.+..++|++.+.||+|+||.||+|.+++ ..||||.+.... .......+.+|+.+++.++||||+++
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~i~~~ 74 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-------SMRERIEFLNEASVMKEFNCHHVVRL 74 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-------CHHHHHHHHHHHHHHHhCCCCceeEE
Confidence 4566789999999999999999998742 569999986431 12234568889999999999999999
Q ss_pred eeeEecCCCCeEEEEEeeccCCCHHHHHhhhc---------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEE
Q 000893 1111 YGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV 1181 (1236)
Q Consensus 1111 yG~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~---------r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILL 1181 (1236)
++++... ...++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||+
T Consensus 75 ~~~~~~~--~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill 152 (277)
T cd05032 75 LGVVSTG--QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV 152 (277)
T ss_pred EEEEcCC--CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEE
Confidence 9999875 48899999999999999986532 246788899999999999999999999999999999999
Q ss_pred ccCCCCCCcEEEEeccCcccccCcc---cccCcCCCCcccchhhhcCCC
Q 000893 1182 NLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1182 DsdG~I~ltVKLsDFGLArii~ns~---~tss~~GTp~YmAPEVL~Gss 1227 (1236)
+.++ .+||+|||+++...... ......++..|+|||++.+..
T Consensus 153 ~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 197 (277)
T cd05032 153 AEDL----TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV 197 (277)
T ss_pred cCCC----CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCC
Confidence 9886 56999999998654322 122345678999999997553
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.4e-25 Score=228.63 Aligned_cols=173 Identities=40% Similarity=0.597 Sum_probs=144.0
Q ss_pred cccCeeEEEEeccCCceEEEEeeecC-ceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCC
Q 000893 1040 KNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1040 s~EdYeiLkkLGsGSFGtVYKArlkG-~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~ 1118 (1236)
..++|++++.||+|+||+||++++.+ ..||||.+..... ....|.+|+.++++++||||+++++++....
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---------SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR 72 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc---------cHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 35689999999999999999998865 4599998865321 1245788999999999999999999987654
Q ss_pred CCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccC
Q 000893 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1236)
Q Consensus 1119 ~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGL 1198 (1236)
.+++||||+.+++|.+++......+++..++.++.||+.||.|||++||+|+||||+|||++.++ .+||+|||+
T Consensus 73 --~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~----~~kl~d~g~ 146 (256)
T cd05113 73 --PIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQG----CVKVSDFGL 146 (256)
T ss_pred --CcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC----CEEECCCcc
Confidence 78999999999999999976556789999999999999999999999999999999999999876 679999999
Q ss_pred cccccCcccc--cCcCCCCcccchhhhcCCC
Q 000893 1199 SKIKRNTLVT--GGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1199 Arii~ns~~t--ss~~GTp~YmAPEVL~Gss 1227 (1236)
++........ ....++..|+|||++.+..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~ 177 (256)
T cd05113 147 SRYVLDDEYTSSVGSKFPVRWSPPEVLLYSK 177 (256)
T ss_pred ceecCCCceeecCCCccChhhCCHHHHhcCc
Confidence 8865433221 1233567899999997653
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.8e-25 Score=231.09 Aligned_cols=174 Identities=32% Similarity=0.456 Sum_probs=144.2
Q ss_pred cccCeeEEEEeccCCceEEEEeeecC------------------ceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhh
Q 000893 1040 KNEDLEELKELGSGTFGTVYHGKWRG------------------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 1101 (1236)
Q Consensus 1040 s~EdYeiLkkLGsGSFGtVYKArlkG------------------~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILsk 1101 (1236)
...+|++++.||+|+||.||+|.+.. ..||+|++.... .......|.+|+++++.
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-------~~~~~~~~~~e~~~l~~ 75 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-------SDNAREDFLKEVKILSR 75 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-------CHHHHHHHHHHHHHHHh
Confidence 34688999999999999999987632 348999887542 12345678899999999
Q ss_pred CCCCceeeEeeeEecCCCCeEEEEEeeccCCCHHHHHhhhc----------cCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 000893 1102 LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE----------RHLDRRKRLIIAMDAAFGMEYLHSKNIVH 1171 (1236)
Q Consensus 1102 LrHPNIVrLyG~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~----------r~LSe~erl~Ia~QIAeALaYLHSkGIIH 1171 (1236)
++||||++++++|... +.+++||||+++++|..++.... ..+++..++.++.|++.||.|||+++|+|
T Consensus 76 l~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H 153 (296)
T cd05051 76 LSDPNIARLLGVCTVD--PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVH 153 (296)
T ss_pred cCCCCEeEEEEEEecC--CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Confidence 9999999999999875 48899999999999999996543 26899999999999999999999999999
Q ss_pred CCCCCCcEEEccCCCCCCcEEEEeccCcccccCcc---cccCcCCCCcccchhhhcCC
Q 000893 1172 FDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1172 RDIKPsNILLDsdG~I~ltVKLsDFGLArii~ns~---~tss~~GTp~YmAPEVL~Gs 1226 (1236)
|||||+|||++.++ .++|+|||+++...... ......+++.|+|||++.+.
T Consensus 154 ~dlkp~Nili~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 207 (296)
T cd05051 154 RDLATRNCLVGKNY----TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG 207 (296)
T ss_pred cccchhceeecCCC----ceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC
Confidence 99999999999885 67999999998653322 22344567889999998764
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.5e-25 Score=271.92 Aligned_cols=191 Identities=25% Similarity=0.354 Sum_probs=154.7
Q ss_pred ccccCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEec
Q 000893 1039 IKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1236)
Q Consensus 1039 Is~EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t 1116 (1236)
....+|++++.||+|+||+||+|++. +..||+|++..... .......|..|+.+|+.|+|||||+++++|..
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l------~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d 83 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL------KEREKSQLVIEVNVMRELKHKNIVRYIDRFLN 83 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc------CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe
Confidence 34578999999999999999999984 56799999875432 12234568899999999999999999999976
Q ss_pred CCCCeEEEEEeeccCCCHHHHHhhh---ccCCCHHHHHHHHHHHHHHHHHHHHC-------CcccCCCCCCcEEEccCCC
Q 000893 1117 GPGGTLATVTEFMVNGSLRHVLLSK---ERHLDRRKRLIIAMDAAFGMEYLHSK-------NIVHFDLKCDNLLVNLKDP 1186 (1236)
Q Consensus 1117 ~~~g~L~LVMEYm~GGSL~dlL~~k---~r~LSe~erl~Ia~QIAeALaYLHSk-------GIIHRDIKPsNILLDsdG~ 1186 (1236)
.....+||||||+++++|..+|... ...+++..++.|+.||+.||.|||.. +||||||||+||||+.+..
T Consensus 84 e~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~ 163 (1021)
T PTZ00266 84 KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163 (1021)
T ss_pred cCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence 6556899999999999999998653 34699999999999999999999984 4999999999999975321
Q ss_pred -------------CCCcEEEEeccCcccccCcccccCcCCCCcccchhhhcCCCCCCCcccc
Q 000893 1187 -------------IRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVC 1235 (1236)
Q Consensus 1187 -------------I~ltVKLsDFGLArii~ns~~tss~~GTp~YmAPEVL~Gss~~~SdDVD 1235 (1236)
....+||+|||++............+||+.|+|||++.+....++..+|
T Consensus 164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSD 225 (1021)
T PTZ00266 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSD 225 (1021)
T ss_pred ccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhH
Confidence 1235899999999876555455566899999999999765444444444
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.6e-26 Score=251.63 Aligned_cols=182 Identities=27% Similarity=0.382 Sum_probs=150.4
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEec---
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD--- 1116 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t--- 1116 (1236)
..|..++.||+|+||.|+.+.. +|..||||++.... ......++.+||+.+|+.++|+||+.+++++..
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F------~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF------ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR 95 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh------hchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence 4566689999999999999988 57889999987432 244567788999999999999999999999876
Q ss_pred CCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEec
Q 000893 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1236)
Q Consensus 1117 ~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDF 1196 (1236)
.+-..+|+|+|+| +.+|.+.+. .+..++...+..+++||++||.|+|+.+|+||||||.|+|++.++. +|||||
T Consensus 96 ~~f~DvYiV~elM-etDL~~iik-~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~----lKI~DF 169 (359)
T KOG0660|consen 96 DKFNDVYLVFELM-ETDLHQIIK-SQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCD----LKICDF 169 (359)
T ss_pred cccceeEEehhHH-hhHHHHHHH-cCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCC----EEeccc
Confidence 2345889999999 778888884 4455999999999999999999999999999999999999999974 499999
Q ss_pred cCcccccC---cccccCcCCCCcccchhhhcCCCCCCCccccC
Q 000893 1197 GLSKIKRN---TLVTGGVRGTLPWMAPELLNGSSSKVSEKVCF 1236 (1236)
Q Consensus 1197 GLArii~n---s~~tss~~GTp~YmAPEVL~Gss~~~SdDVDI 1236 (1236)
|||+.... ...-+.++-|.||+|||++... ..|+..+|+
T Consensus 170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~-~~Yt~aiDi 211 (359)
T KOG0660|consen 170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNS-SEYTKAIDI 211 (359)
T ss_pred cceeeccccCcccchhcceeeeeecCHHHHhcc-ccccchhhh
Confidence 99999853 3333456779999999999754 455555553
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-25 Score=242.97 Aligned_cols=184 Identities=29% Similarity=0.419 Sum_probs=146.8
Q ss_pred ccccccCeeEEEEeccCCceEEEEeeec-------CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhC-CCCcee
Q 000893 1037 QIIKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVV 1108 (1236)
Q Consensus 1037 qiIs~EdYeiLkkLGsGSFGtVYKArlk-------G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskL-rHPNIV 1108 (1236)
|.+..++|++.+.||+|+||.||+|.+. ++.||||+++... .......+.+|+.++.++ +||||+
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-------~~~~~~~~~~E~~~~~~l~~h~niv 74 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-------TASEYKALMTELKILIHIGHHLNVV 74 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-------CHHHHHHHHHHHHHHHhhccCcchh
Confidence 4566789999999999999999999753 3579999986432 112234577899999999 799999
Q ss_pred eEeeeEecCCCCeEEEEEeeccCCCHHHHHhhhc----------------------------------------------
Q 000893 1109 AFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------------------------------------------- 1142 (1236)
Q Consensus 1109 rLyG~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~---------------------------------------------- 1142 (1236)
+++++|.... ..++++|||+++++|.+++....
T Consensus 75 ~~~~~~~~~~-~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (337)
T cd05054 75 NLLGACTKPG-GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSL 153 (337)
T ss_pred heeeeEecCC-CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcch
Confidence 9999887643 57899999999999999885421
Q ss_pred --------------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcccccCcc--
Q 000893 1143 --------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL-- 1206 (1236)
Q Consensus 1143 --------------r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~ns~-- 1206 (1236)
..+++..+..++.||+.||.|||+++|+||||||+||||+.++ .+||+|||+++......
T Consensus 154 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~----~vkL~DfG~a~~~~~~~~~ 229 (337)
T cd05054 154 SDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENN----VVKICDFGLARDIYKDPDY 229 (337)
T ss_pred hhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCC----cEEEeccccchhcccCcch
Confidence 2578899999999999999999999999999999999999875 67999999998753221
Q ss_pred -cccCcCCCCcccchhhhcCCCCCCCc
Q 000893 1207 -VTGGVRGTLPWMAPELLNGSSSKVSE 1232 (1236)
Q Consensus 1207 -~tss~~GTp~YmAPEVL~Gss~~~Sd 1232 (1236)
......++..|+|||++.+..+....
T Consensus 230 ~~~~~~~~~~~y~aPE~~~~~~~~~~~ 256 (337)
T cd05054 230 VRKGDARLPLKWMAPESIFDKVYTTQS 256 (337)
T ss_pred hhccCCCCCccccCcHHhcCCCCCccc
Confidence 12234467789999999876544433
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-24 Score=229.20 Aligned_cols=171 Identities=32% Similarity=0.519 Sum_probs=140.0
Q ss_pred eeEEEEeccCCceEEEEeee------cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecC
Q 000893 1044 LEELKELGSGTFGTVYHGKW------RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1236)
Q Consensus 1044 YeiLkkLGsGSFGtVYKArl------kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~ 1117 (1236)
|++++.||+|+||+||++.+ .+..||+|+++... .......|.+|+.+|+.++||||+++++++...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-------GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ 78 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-------ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 48899999999999988653 35679999987532 112345678899999999999999999998775
Q ss_pred CCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEecc
Q 000893 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1236)
Q Consensus 1118 ~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFG 1197 (1236)
....+++||||+++++|.+++.. ..+++..++.++.|++.||.|||+++|+||||||+|||++.++ .+||+|||
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~----~~~l~dfg 152 (283)
T cd05080 79 GGKGLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDR----LVKIGDFG 152 (283)
T ss_pred CCceEEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCC----cEEEeecc
Confidence 55678999999999999999854 3589999999999999999999999999999999999998875 57999999
Q ss_pred CcccccCccc----ccCcCCCCcccchhhhcCCC
Q 000893 1198 LSKIKRNTLV----TGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1198 LArii~ns~~----tss~~GTp~YmAPEVL~Gss 1227 (1236)
+++....... .....++..|+|||++.+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~ 186 (283)
T cd05080 153 LAKAVPEGHEYYRVREDGDSPVFWYAVECLKENK 186 (283)
T ss_pred cccccCCcchhhccCCCCCCCceeeCHhHhcccC
Confidence 9987543221 12234567799999997653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=4e-25 Score=240.88 Aligned_cols=170 Identities=25% Similarity=0.380 Sum_probs=141.1
Q ss_pred ccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCC
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1041 ~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~ 1118 (1236)
.++|++++.||+|+||+||+|.+ .+..||||++..... .......+.+|+.+|+.++||||++++++|....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ------SLIHARRTYRELRLLKHMKHENVIGLLDVFTPAT 87 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh------hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccc
Confidence 46899999999999999999987 467899999875321 1223455778999999999999999999886432
Q ss_pred ----CCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEE
Q 000893 1119 ----GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1236)
Q Consensus 1119 ----~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLs 1194 (1236)
....+++|+++ +++|..++. ...+++..++.|+.||+.||.|||++||+||||||+|||++.++ .+||+
T Consensus 88 ~~~~~~~~~~~~~~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~----~~kl~ 160 (343)
T cd07878 88 SIENFNEVYLVTNLM-GADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDC----ELRIL 160 (343)
T ss_pred cccccCcEEEEeecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCC----CEEEc
Confidence 13578999998 889988774 34689999999999999999999999999999999999999876 56999
Q ss_pred eccCcccccCcccccCcCCCCcccchhhhcC
Q 000893 1195 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNG 1225 (1236)
Q Consensus 1195 DFGLArii~ns~~tss~~GTp~YmAPEVL~G 1225 (1236)
|||+++..... ....+||+.|+|||++.+
T Consensus 161 Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~ 189 (343)
T cd07878 161 DFGLARQADDE--MTGYVATRWYRAPEIMLN 189 (343)
T ss_pred CCccceecCCC--cCCccccccccCchHhcC
Confidence 99999876443 234678999999999976
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-25 Score=258.65 Aligned_cols=176 Identities=33% Similarity=0.488 Sum_probs=155.4
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
..|.+++.||+|.|++|.+|++ ++..||||.+.+.... ......+.+|+.+|+.|+|||||+|+.+..+..
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln------~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~- 128 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLN------PSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA- 128 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccC------hHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc-
Confidence 4688999999999999999998 6899999999886542 233344789999999999999999999999866
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
.+|+||||+.+|.+.+++...++. .+..+..++.|++.|++|||+++|+|||||++||||+.+. .+||+|||++
T Consensus 129 -~lylV~eya~~ge~~~yl~~~gr~-~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~m----nikIaDfgfS 202 (596)
T KOG0586|consen 129 -TLYLVMEYASGGELFDYLVKHGRM-KEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENM----NIKIADFGFS 202 (596)
T ss_pred -eeEEEEEeccCchhHHHHHhcccc-hhhhhhhhhHHHHHHHHHHhhcceeccccchhhccccccc----ceeeeccccc
Confidence 999999999999999999877654 4488888999999999999999999999999999999885 4699999999
Q ss_pred ccccCcccccCcCCCCcccchhhhcCCCCCC
Q 000893 1200 KIKRNTLVTGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1200 rii~ns~~tss~~GTp~YmAPEVL~Gss~~~ 1230 (1236)
..+.......++||++.|+|||++.|..+..
T Consensus 203 ~~~~~~~~lqt~cgsppyAaPEl~~g~~y~g 233 (596)
T KOG0586|consen 203 TFFDYGLMLQTFCGSPPYAAPELFNGKKYDG 233 (596)
T ss_pred eeecccccccccCCCCCccChHhhcCcccCC
Confidence 9988888888999999999999999886443
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=230.07 Aligned_cols=169 Identities=33% Similarity=0.429 Sum_probs=141.9
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
++|++++.||+|+||+||+|.+ .+..||||++.... .......|.+|+.++++++||||++++++|....
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 72 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-------TVELQKQIMSELEILYKCDSPYIIGFYGAFFVEN- 72 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-------ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECC-
Confidence 4678899999999999999987 57789999987532 1223456889999999999999999999998864
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
..++||||+++++|..+. .+++..+..++.|++.||.|||++||+|+||||+|||++.++ .+||+|||++
T Consensus 73 -~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~----~~~l~dfg~~ 142 (279)
T cd06619 73 -RISICTEFMDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRG----QVKLCDFGVS 142 (279)
T ss_pred -EEEEEEecCCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCC----CEEEeeCCcc
Confidence 889999999999997543 467888889999999999999999999999999999999876 5799999999
Q ss_pred ccccCcccccCcCCCCcccchhhhcCCCCC
Q 000893 1200 KIKRNTLVTGGVRGTLPWMAPELLNGSSSK 1229 (1236)
Q Consensus 1200 rii~ns~~tss~~GTp~YmAPEVL~Gss~~ 1229 (1236)
...... .....+||..|+|||++.+....
T Consensus 143 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~ 171 (279)
T cd06619 143 TQLVNS-IAKTYVGTNAYMAPERISGEQYG 171 (279)
T ss_pred eecccc-cccCCCCChhhcCceeecCCCCC
Confidence 865433 23346789999999999876433
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.2e-25 Score=241.67 Aligned_cols=179 Identities=31% Similarity=0.449 Sum_probs=142.7
Q ss_pred ccccccCeeEEEEeccCCceEEEEeee-------cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhC-CCCcee
Q 000893 1037 QIIKNEDLEELKELGSGTFGTVYHGKW-------RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVV 1108 (1236)
Q Consensus 1037 qiIs~EdYeiLkkLGsGSFGtVYKArl-------kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskL-rHPNIV 1108 (1236)
|.+..++|++.+.||+|+||+||+|.+ .++.||||+++... .......+.+|+.+|..+ +||||+
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~niv 74 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-------THSEHRALMSELKILIHIGHHLNVV 74 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-------ChHHHHHHHHHHHHHHhccCCccHh
Confidence 455678999999999999999999974 35679999987532 112245678899999999 689999
Q ss_pred eEeeeEecCCCCeEEEEEeeccCCCHHHHHhhhc----------------------------------------------
Q 000893 1109 AFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------------------------------------------- 1142 (1236)
Q Consensus 1109 rLyG~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~---------------------------------------------- 1142 (1236)
+++++|.... ..+++||||+++|+|.+++....
T Consensus 75 ~~~~~~~~~~-~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (343)
T cd05103 75 NLLGACTKPG-GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFV 153 (343)
T ss_pred hhcceeecCC-CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhcccccccccccccccc
Confidence 9999887643 47889999999999999986431
Q ss_pred --------------------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcccc
Q 000893 1143 --------------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 1202 (1236)
Q Consensus 1143 --------------------r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii 1202 (1236)
..+++..+..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+++..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~----~~kl~dfg~~~~~ 229 (343)
T cd05103 154 EEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENN----VVKICDFGLARDI 229 (343)
T ss_pred CCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCC----cEEEEeccccccc
Confidence 2367778888999999999999999999999999999999776 6799999999864
Q ss_pred cCcc---cccCcCCCCcccchhhhcCCC
Q 000893 1203 RNTL---VTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1203 ~ns~---~tss~~GTp~YmAPEVL~Gss 1227 (1236)
.... ......+++.|+|||++.+..
T Consensus 230 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 257 (343)
T cd05103 230 YKDPDYVRKGDARLPLKWMAPETIFDRV 257 (343)
T ss_pred ccCcchhhcCCCCCCcceECcHHhcCCC
Confidence 3221 122234567899999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=225.69 Aligned_cols=176 Identities=23% Similarity=0.421 Sum_probs=145.9
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
.+|++.+.||+|+||.||+|+. .++.||||.++..... .......|.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 75 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMM-----DAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN- 75 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccC-----CHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC-
Confidence 5789999999999999999987 5788999988653211 2233456888999999999999999999988754
Q ss_pred CeEEEEEeeccCCCHHHHHhh---hccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEec
Q 000893 1120 GTLATVTEFMVNGSLRHVLLS---KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~---k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDF 1196 (1236)
.+++||||+++++|..++.. ....+++..++.++.||+.||.|||+++|+||||||+|||++.++ .++|+||
T Consensus 76 -~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~----~~~l~d~ 150 (267)
T cd08228 76 -ELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATG----VVKLGDL 150 (267)
T ss_pred -eEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCC----CEEECcc
Confidence 88999999999999988853 234588899999999999999999999999999999999998876 5699999
Q ss_pred cCcccccCcc-cccCcCCCCcccchhhhcCCCC
Q 000893 1197 GLSKIKRNTL-VTGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1197 GLArii~ns~-~tss~~GTp~YmAPEVL~Gss~ 1228 (1236)
|++....... ......|++.|+|||++.+...
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 183 (267)
T cd08228 151 GLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183 (267)
T ss_pred ccceeccchhHHHhcCCCCccccChhhhccCCC
Confidence 9988754322 2234568899999999976543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.1e-25 Score=228.32 Aligned_cols=175 Identities=34% Similarity=0.535 Sum_probs=143.5
Q ss_pred cccCeeEEEEeccCCceEEEEeeec-----CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeE
Q 000893 1040 KNEDLEELKELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVV 1114 (1236)
Q Consensus 1040 s~EdYeiLkkLGsGSFGtVYKArlk-----G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f 1114 (1236)
...+|++.+.||+|+||.||+|.+. +..+|||.++... .......|.+|+.+++.++||||+++++++
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 74 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-------TEKQRRDFLSEASIMGQFDHPNIIHLEGVV 74 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-------CHHHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 3467899999999999999999873 2358999886532 122345788899999999999999999999
Q ss_pred ecCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEE
Q 000893 1115 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1236)
Q Consensus 1115 ~t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLs 1194 (1236)
.... ..++||||+++++|.+++......+++..++.|+.|++.||.|||+++++||||||+|||++.++ .+||+
T Consensus 75 ~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~----~~~l~ 148 (267)
T cd05066 75 TKSK--PVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNL----VCKVS 148 (267)
T ss_pred ecCC--ccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCC----eEEeC
Confidence 8754 88999999999999999977666789999999999999999999999999999999999998775 67999
Q ss_pred eccCcccccCccc----ccCcCCCCcccchhhhcCCC
Q 000893 1195 DFGLSKIKRNTLV----TGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1195 DFGLArii~ns~~----tss~~GTp~YmAPEVL~Gss 1227 (1236)
|||+++....... .....++..|+|||++.+..
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~ 185 (267)
T cd05066 149 DFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 185 (267)
T ss_pred CCCcccccccccceeeecCCCccceeecCHhHhccCc
Confidence 9999987543221 11222356799999998653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.5e-25 Score=231.39 Aligned_cols=175 Identities=30% Similarity=0.456 Sum_probs=142.2
Q ss_pred ccccCeeEEEEeccCCceEEEEeee--cCc----eEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEee
Q 000893 1039 IKNEDLEELKELGSGTFGTVYHGKW--RGT----DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 1112 (1236)
Q Consensus 1039 Is~EdYeiLkkLGsGSFGtVYKArl--kG~----~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG 1112 (1236)
+..++|++++.||+|+||+||+|.+ .+. .|++|.+.... ......++..|+.+++.++||||+++++
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~~~~~l~~l~h~~iv~~~~ 76 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-------GRQTFQEITDHMLAMGSLDHAYIVRLLG 76 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc-------chHHHHHHHHHHHHHhcCCCCCcceEEE
Confidence 4557899999999999999999998 344 36666654211 1233456778899999999999999999
Q ss_pred eEecCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEE
Q 000893 1113 VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 1192 (1236)
Q Consensus 1113 ~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVK 1192 (1236)
++.. ...++|+||+++++|.+++......+++..++.|+.||+.||.|||+++++||||||+|||++.++ .+|
T Consensus 77 ~~~~---~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~----~~k 149 (279)
T cd05111 77 ICPG---ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDS----IVQ 149 (279)
T ss_pred EECC---CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC----cEE
Confidence 8754 357889999999999999987677899999999999999999999999999999999999998775 679
Q ss_pred EEeccCcccccCcc---cccCcCCCCcccchhhhcCCC
Q 000893 1193 VGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1193 LsDFGLArii~ns~---~tss~~GTp~YmAPEVL~Gss 1227 (1236)
|+|||+++...... ......++..|+|||++.+..
T Consensus 150 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~ 187 (279)
T cd05111 150 IADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGR 187 (279)
T ss_pred EcCCccceeccCCCcccccCCCCCcccccCHHHhccCC
Confidence 99999998653221 223345778899999997653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=223.84 Aligned_cols=176 Identities=32% Similarity=0.480 Sum_probs=146.0
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
++|++.+.||+|++|.||++.. .++.||||++...... .........+.+|+.++++++||||+++++++....
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~---~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 77 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDS---PETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE- 77 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccc---hhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC-
Confidence 4688899999999999999986 4788999998754321 112233457889999999999999999999998865
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
.+++||||+++++|.+++... ..+++..++.++.|++.||.|||+.||+||||+|+||+++.++ .++|+|||++
T Consensus 78 -~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~----~~~l~dfg~~ 151 (263)
T cd06625 78 -TLSIFMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAG----NVKLGDFGAS 151 (263)
T ss_pred -eEEEEEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC----CEEEeecccc
Confidence 999999999999999988643 4688899999999999999999999999999999999999876 5699999999
Q ss_pred ccccCcccc----cCcCCCCcccchhhhcCCC
Q 000893 1200 KIKRNTLVT----GGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1200 rii~ns~~t----ss~~GTp~YmAPEVL~Gss 1227 (1236)
+........ ....|+..|+|||++.+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 183 (263)
T cd06625 152 KRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183 (263)
T ss_pred eeccccccccccccCCCcCccccCcceeccCC
Confidence 865432111 2356788999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.7e-27 Score=250.22 Aligned_cols=182 Identities=27% Similarity=0.358 Sum_probs=156.6
Q ss_pred cccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecC
Q 000893 1040 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1236)
Q Consensus 1040 s~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~ 1117 (1236)
..++|++.++||+|.|+.|+++.+ +|+.+|+|++....+... ..+++.+|++|-+.|+|||||+|+......
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~------~~e~l~rEarIC~~LqHP~IvrL~~ti~~~ 82 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR------DFQKLEREARICRKLQHPNIVRLHDSIQEE 82 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc------cHHHHHHHHHHHHhcCCCcEeehhhhhccc
Confidence 346788889999999999999887 588899999877655433 244677899999999999999999988874
Q ss_pred CCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEecc
Q 000893 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1236)
Q Consensus 1118 ~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFG 1197 (1236)
+..|+|+|+|.|++|..-+-.+ ..+++..+-.+++||++||.|||.++|||||+||.|+||...... .-+||+|||
T Consensus 83 --~~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~-A~vKL~~FG 158 (355)
T KOG0033|consen 83 --SFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKG-AAVKLADFG 158 (355)
T ss_pred --ceeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCC-Cceeecccc
Confidence 5999999999999998877554 468888899999999999999999999999999999999876543 468999999
Q ss_pred CcccccCcccccCcCCCCcccchhhhcCCCCCCC
Q 000893 1198 LSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVS 1231 (1236)
Q Consensus 1198 LArii~ns~~tss~~GTp~YmAPEVL~Gss~~~S 1231 (1236)
+|..........++.|||+|||||+++...+...
T Consensus 159 vAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kp 192 (355)
T KOG0033|consen 159 LAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKP 192 (355)
T ss_pred eEEEeCCccccccccCCCcccCHHHhhcCCCCCc
Confidence 9999988888889999999999999998744443
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=224.91 Aligned_cols=178 Identities=31% Similarity=0.435 Sum_probs=145.6
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
.+|++.+.||+|+||+||++.+ ++..||||++...... .........+.+|+.++++++||||+++++++.+...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPES---PETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPME 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCC---cccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCC
Confidence 5789999999999999999987 4788999988643211 1122345678889999999999999999999877555
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
..+++||||+++++|.+++... ..+++..++.++.|++.||.|||+++|+|+||||+|||++.++ .+||+|||++
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~----~~~l~Dfg~~ 153 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVG----NVKLGDFGAS 153 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCC----CEEECcCccc
Confidence 5788999999999999998644 4578888999999999999999999999999999999999876 5799999998
Q ss_pred ccccCcc----cccCcCCCCcccchhhhcCCC
Q 000893 1200 KIKRNTL----VTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1200 rii~ns~----~tss~~GTp~YmAPEVL~Gss 1227 (1236)
+...... ......|+..|+|||++.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 185 (265)
T cd06652 154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGEG 185 (265)
T ss_pred cccccccccccccccCCCCccccChhhhcCCC
Confidence 8653211 122356889999999997653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=225.02 Aligned_cols=171 Identities=38% Similarity=0.587 Sum_probs=146.2
Q ss_pred ccccCeeEEEEeccCCceEEEEeeecCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCC
Q 000893 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1039 Is~EdYeiLkkLGsGSFGtVYKArlkG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~ 1118 (1236)
+..++|++.+.||.|+||.||+|...++.||||.++... . ...++.+|+.+++.++|+||+++++++...
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~-------~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~- 72 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDS-------T--AAQAFLAEASVMTTLRHPNLVQLLGVVLQG- 72 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEecCcEEEEEEeccch-------h--HHHHHHHHHHHHHhcCCcceeeeEEEEcCC-
Confidence 456789999999999999999999999999999987532 1 345788999999999999999999998874
Q ss_pred CCeEEEEEeeccCCCHHHHHhhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEecc
Q 000893 1119 GGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1236)
Q Consensus 1119 ~g~L~LVMEYm~GGSL~dlL~~k~-r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFG 1197 (1236)
...++||||+++++|.+++.... ..+++..++.++.|++.||.|||.++|+||||||+|||++.++ .+||+|||
T Consensus 73 -~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~----~~~l~d~g 147 (256)
T cd05039 73 -NPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDL----VAKVSDFG 147 (256)
T ss_pred -CCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCC----CEEEcccc
Confidence 48899999999999999996544 3689999999999999999999999999999999999999876 56999999
Q ss_pred CcccccCcccccCcCCCCcccchhhhcCC
Q 000893 1198 LSKIKRNTLVTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1198 LArii~ns~~tss~~GTp~YmAPEVL~Gs 1226 (1236)
+++....... ...++..|+|||++.+.
T Consensus 148 ~~~~~~~~~~--~~~~~~~~~ape~~~~~ 174 (256)
T cd05039 148 LAKEASQGQD--SGKLPVKWTAPEALREK 174 (256)
T ss_pred cccccccccc--cCCCcccccCchhhcCC
Confidence 9987643322 23346679999998754
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.8e-25 Score=225.60 Aligned_cols=166 Identities=33% Similarity=0.548 Sum_probs=137.1
Q ss_pred EeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeEEEEE
Q 000893 1049 ELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVT 1126 (1236)
Q Consensus 1049 kLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L~LVM 1126 (1236)
.||+|+||.||+|.+ .++.||+|.+.... .......|.+|+.+++.++||||++++++|.... ..++||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~ 72 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETL-------PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ--PIYIVM 72 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccC-------CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC--CeEEEE
Confidence 589999999999988 57889999876431 1233456889999999999999999999998754 889999
Q ss_pred eeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcccccCcc
Q 000893 1127 EFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL 1206 (1236)
Q Consensus 1127 EYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~ns~ 1206 (1236)
||+++++|.+++......+++..++.++.|++.||.|||+++|+||||||+|||++.++ .+||+|||++.......
T Consensus 73 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~----~~kl~dfg~~~~~~~~~ 148 (252)
T cd05084 73 ELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKN----VLKISDFGMSREEEDGV 148 (252)
T ss_pred eeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCC----cEEECccccCccccccc
Confidence 99999999999976666789999999999999999999999999999999999998876 57999999998654322
Q ss_pred ccc---CcCCCCcccchhhhcCCC
Q 000893 1207 VTG---GVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1207 ~ts---s~~GTp~YmAPEVL~Gss 1227 (1236)
... ...++..|+|||++.+..
T Consensus 149 ~~~~~~~~~~~~~y~aPE~~~~~~ 172 (252)
T cd05084 149 YASTGGMKQIPVKWTAPEALNYGR 172 (252)
T ss_pred ccccCCCCCCceeecCchhhcCCC
Confidence 111 112345699999997653
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=229.06 Aligned_cols=178 Identities=32% Similarity=0.496 Sum_probs=145.1
Q ss_pred ccccccCeeEEEEeccCCceEEEEeeecC-------ceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhC-CCCcee
Q 000893 1037 QIIKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVV 1108 (1236)
Q Consensus 1037 qiIs~EdYeiLkkLGsGSFGtVYKArlkG-------~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskL-rHPNIV 1108 (1236)
+.+..++|++.+.||+|+||.||++.+.+ ..+|+|.+.... .......+.+|+.+++++ +||||+
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~i~ 79 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-------TEKDLSDLVSEMEMMKMIGKHKNII 79 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-------CHHHHHHHHHHHHHHHhhcCCCCee
Confidence 45667789999999999999999998742 459999887532 122345688999999999 799999
Q ss_pred eEeeeEecCCCCeEEEEEeeccCCCHHHHHhhh---------------ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Q 000893 1109 AFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSK---------------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFD 1173 (1236)
Q Consensus 1109 rLyG~f~t~~~g~L~LVMEYm~GGSL~dlL~~k---------------~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRD 1173 (1236)
+++++|... +.+++||||+++++|..++... ...+++..++.++.|++.||.|||+++|+|||
T Consensus 80 ~~~~~~~~~--~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~d 157 (293)
T cd05053 80 NLLGVCTQE--GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRD 157 (293)
T ss_pred eEEEEEcCC--CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccc
Confidence 999999875 4899999999999999998642 34688999999999999999999999999999
Q ss_pred CCCCcEEEccCCCCCCcEEEEeccCcccccCccc---ccCcCCCCcccchhhhcCCC
Q 000893 1174 LKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLV---TGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1174 IKPsNILLDsdG~I~ltVKLsDFGLArii~ns~~---tss~~GTp~YmAPEVL~Gss 1227 (1236)
|||+|||++.++ .+||+|||+++....... .....+++.|+|||++.+..
T Consensus 158 lkp~Nil~~~~~----~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 210 (293)
T cd05053 158 LAARNVLVTEDH----VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRV 210 (293)
T ss_pred cceeeEEEcCCC----eEEeCccccccccccccceeccCCCCCCccccCHHHhccCC
Confidence 999999998876 679999999987543221 12223467899999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-26 Score=263.58 Aligned_cols=179 Identities=31% Similarity=0.486 Sum_probs=150.8
Q ss_pred CeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g 1120 (1236)
.|.-++.||.|+||.||-|++ +...||||.+.-. +.. .......+++|++.|++++|||+|.+-|+|....
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsyS---GKQ--s~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~-- 99 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYS---GKQ--SNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREH-- 99 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeecccc---ccc--cHHHHHHHHHHHHHHHhccCCCcccccceeeccc--
Confidence 366678899999999999988 4567999988643 222 3344678899999999999999999999998754
Q ss_pred eEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcc
Q 000893 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1236)
Q Consensus 1121 ~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLAr 1200 (1236)
..||||||| -|+..+++.-..+++-+.++..|+.+.+.||+|||+++.||||||..||||...| .|||+|||.|.
T Consensus 100 TaWLVMEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g----~VKLaDFGSAs 174 (948)
T KOG0577|consen 100 TAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPG----LVKLADFGSAS 174 (948)
T ss_pred hHHHHHHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCC----eeeeccccchh
Confidence 889999999 7788888877788899999999999999999999999999999999999999887 78999999998
Q ss_pred cccCcccccCcCCCCcccchhhhc-CCCCCCCccccC
Q 000893 1201 IKRNTLVTGGVRGTLPWMAPELLN-GSSSKVSEKVCF 1236 (1236)
Q Consensus 1201 ii~ns~~tss~~GTp~YmAPEVL~-Gss~~~SdDVDI 1236 (1236)
+.... ..++|||+|||||+|. -..+.|+.++||
T Consensus 175 i~~PA---nsFvGTPywMAPEVILAMDEGqYdgkvDv 208 (948)
T KOG0577|consen 175 IMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDV 208 (948)
T ss_pred hcCch---hcccCCccccchhHheeccccccCCccce
Confidence 76443 4589999999999997 233456666654
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=232.12 Aligned_cols=168 Identities=29% Similarity=0.436 Sum_probs=134.0
Q ss_pred EEeccCCceEEEEeeec----CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeEE
Q 000893 1048 KELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLA 1123 (1236)
Q Consensus 1048 kkLGsGSFGtVYKArlk----G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L~ 1123 (1236)
.+||+|+||+||+|+.. +..||+|.+..... ...+.+|+.+|+.++||||++++++|.......++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 76 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----------SMSACREIALLRELKHPNVIALQKVFLSHSDRKVW 76 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----------cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEE
Confidence 57999999999999863 36699998865321 12466899999999999999999999766566899
Q ss_pred EEEeeccCCCHHHHHhhh--------ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEe
Q 000893 1124 TVTEFMVNGSLRHVLLSK--------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1236)
Q Consensus 1124 LVMEYm~GGSL~dlL~~k--------~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsD 1195 (1236)
+||||+. ++|.+++... ...+++..++.++.||+.||.|||+++|+||||||+|||+..++.....+||+|
T Consensus 77 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07867 77 LLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred EEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEee
Confidence 9999985 5777776421 225788899999999999999999999999999999999965433334789999
Q ss_pred ccCcccccCcc----cccCcCCCCcccchhhhcCC
Q 000893 1196 FGLSKIKRNTL----VTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1196 FGLArii~ns~----~tss~~GTp~YmAPEVL~Gs 1226 (1236)
||+++...... ......||+.|+|||++.+.
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 190 (317)
T cd07867 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA 190 (317)
T ss_pred ccceeccCCCcccccccCcceecccccCcHHhcCC
Confidence 99998754322 12345689999999999764
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=226.99 Aligned_cols=176 Identities=34% Similarity=0.574 Sum_probs=145.6
Q ss_pred cccccCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEe
Q 000893 1038 IIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 1115 (1236)
Q Consensus 1038 iIs~EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~ 1115 (1236)
.+...+|.+.+.||+|+||.||+|.++ ++.||+|++.... .....+.+|+.+++.++||||++++++|.
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 72 (263)
T cd05052 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---------MEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72 (263)
T ss_pred CCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---------hHHHHHHHHHHHHHhCCCCChhheEEEEc
Confidence 345567999999999999999999884 7789999986431 12356889999999999999999999988
Q ss_pred cCCCCeEEEEEeeccCCCHHHHHhhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEE
Q 000893 1116 DGPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1236)
Q Consensus 1116 t~~~g~L~LVMEYm~GGSL~dlL~~k~-r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLs 1194 (1236)
... .+++||||+++++|.+++.... ..+++..++.++.|++.||.|||+++|+||||||+|||++.++ .+||+
T Consensus 73 ~~~--~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~----~~kl~ 146 (263)
T cd05052 73 REP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH----LVKVA 146 (263)
T ss_pred CCC--CcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC----cEEeC
Confidence 754 8899999999999999986543 4689999999999999999999999999999999999998776 57999
Q ss_pred eccCcccccCccccc--CcCCCCcccchhhhcCCCC
Q 000893 1195 DFGLSKIKRNTLVTG--GVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1195 DFGLArii~ns~~ts--s~~GTp~YmAPEVL~Gss~ 1228 (1236)
|||++.......... ...+++.|+|||++.+...
T Consensus 147 df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 182 (263)
T cd05052 147 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 182 (263)
T ss_pred CCccccccccceeeccCCCCCccccCCHHHhccCCC
Confidence 999998765433221 2234668999999976543
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=232.48 Aligned_cols=172 Identities=31% Similarity=0.447 Sum_probs=145.0
Q ss_pred cCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
++|++.+.||+|+||.||++.+. +..+|+|.++... .......+.+|+++++.++||||++++++|....
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 72 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-------KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDG- 72 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC-
Confidence 36899999999999999999884 6779999886431 1223456888999999999999999999998754
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCcEEEccCCCCCCcEEEEeccC
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHS-kGIIHRDIKPsNILLDsdG~I~ltVKLsDFGL 1198 (1236)
.+++||||+++++|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++ .+||+|||+
T Consensus 73 -~~~lv~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~----~~~l~dfg~ 146 (308)
T cd06615 73 -EISICMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG----EIKLCDFGV 146 (308)
T ss_pred -EEEEEeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCC----cEEEccCCC
Confidence 899999999999999998654 568899999999999999999997 6999999999999999876 569999999
Q ss_pred cccccCcccccCcCCCCcccchhhhcCCCC
Q 000893 1199 SKIKRNTLVTGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1199 Arii~ns~~tss~~GTp~YmAPEVL~Gss~ 1228 (1236)
+...... .....+|++.|+|||++.+...
T Consensus 147 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~ 175 (308)
T cd06615 147 SGQLIDS-MANSFVGTRSYMSPERLQGTHY 175 (308)
T ss_pred ccccccc-ccccCCCCcCccChhHhcCCCC
Confidence 8765432 2345678999999999987643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=233.47 Aligned_cols=177 Identities=33% Similarity=0.503 Sum_probs=141.2
Q ss_pred cccccCeeEEEEeccCCceEEEEeeec--Cc--eEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhC-CCCceeeEee
Q 000893 1038 IIKNEDLEELKELGSGTFGTVYHGKWR--GT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYG 1112 (1236)
Q Consensus 1038 iIs~EdYeiLkkLGsGSFGtVYKArlk--G~--~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskL-rHPNIVrLyG 1112 (1236)
.+...+|++.+.||+|+||.||+|.++ +. .+|+|.++... .......|.+|+.++.++ +||||+++++
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~ 75 (303)
T cd05088 3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-------SKDDHRDFAGELEVLCKLGHHPNIINLLG 75 (303)
T ss_pred ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC-------CHHHHHHHHHHHHHHHHhcCCCCcceEEE
Confidence 345678999999999999999999873 43 36777765321 123345678899999999 8999999999
Q ss_pred eEecCCCCeEEEEEeeccCCCHHHHHhhhc---------------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCC
Q 000893 1113 VVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCD 1177 (1236)
Q Consensus 1113 ~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~---------------r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPs 1177 (1236)
++.... .+++||||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+
T Consensus 76 ~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~ 153 (303)
T cd05088 76 ACEHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAAR 153 (303)
T ss_pred EECCCC--CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchh
Confidence 998754 8999999999999999996532 25788999999999999999999999999999999
Q ss_pred cEEEccCCCCCCcEEEEeccCcccccCcccccCcCCCCcccchhhhcCCC
Q 000893 1178 NLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1178 NILLDsdG~I~ltVKLsDFGLArii~ns~~tss~~GTp~YmAPEVL~Gss 1227 (1236)
|||++.++ .+||+|||+++............++..|+|||++.+..
T Consensus 154 Nili~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 199 (303)
T cd05088 154 NILVGENY----VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV 199 (303)
T ss_pred eEEecCCC----cEEeCccccCcccchhhhcccCCCcccccCHHHHhccC
Confidence 99999876 56999999987532221222223466799999997654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.1e-25 Score=242.21 Aligned_cols=172 Identities=30% Similarity=0.419 Sum_probs=140.6
Q ss_pred CeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC-
Q 000893 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG- 1119 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~- 1119 (1236)
+|++++.||+|+||+||++.. .++.||||++..... ......++.+|+.+|+.++||||+++++++.....
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 74 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ------NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHID 74 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccccc------chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCcc
Confidence 477889999999999999987 578899999864321 12234567899999999999999999999876431
Q ss_pred --CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEecc
Q 000893 1120 --GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1236)
Q Consensus 1120 --g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFG 1197 (1236)
..+++||||+. ++|..++.. ...+++..++.|+.||+.||.|||++||+||||||+||||+.++ .+||+|||
T Consensus 75 ~~~~~~lv~e~~~-~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~----~~kL~Dfg 148 (372)
T cd07853 75 PFEEIYVVTELMQ-SDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNC----VLKICDFG 148 (372)
T ss_pred ccceEEEEeeccc-cCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCC----CEEecccc
Confidence 26899999995 678877743 45689999999999999999999999999999999999999876 57999999
Q ss_pred CcccccCc--ccccCcCCCCcccchhhhcCC
Q 000893 1198 LSKIKRNT--LVTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1198 LArii~ns--~~tss~~GTp~YmAPEVL~Gs 1226 (1236)
+++..... .......+|+.|+|||++.+.
T Consensus 149 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 179 (372)
T cd07853 149 LARVEEPDESKHMTQEVVTQYYRAPEILMGS 179 (372)
T ss_pred ceeecccCccccCCCCCcCCCcCCHHHHcCC
Confidence 99865322 122335679999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=232.77 Aligned_cols=173 Identities=29% Similarity=0.435 Sum_probs=144.0
Q ss_pred cccCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecC
Q 000893 1040 KNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1236)
Q Consensus 1040 s~EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~ 1117 (1236)
..++|+++++||.|+||.||+|+++ ++.||||.++..... .....+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~ 76 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-------GAPCTAIREVSLLKDLKHANIVTLHDIIHTE 76 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-------CchhHHHHHHHHHHhcCCCCcceEEEEEecC
Confidence 3578999999999999999999874 678999998754211 1123466899999999999999999999875
Q ss_pred CCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEecc
Q 000893 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1236)
Q Consensus 1118 ~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFG 1197 (1236)
. .+++||||+. ++|..++......+++..+..++.||+.||.|||+++|+||||||+|||++.++ .+||+|||
T Consensus 77 ~--~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~----~~kl~dfg 149 (301)
T cd07873 77 K--SLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERG----ELKLADFG 149 (301)
T ss_pred C--eEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCC----cEEECcCc
Confidence 4 8999999995 689998877666789999999999999999999999999999999999999876 57999999
Q ss_pred CcccccCcc-cccCcCCCCcccchhhhcCC
Q 000893 1198 LSKIKRNTL-VTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1198 LArii~ns~-~tss~~GTp~YmAPEVL~Gs 1226 (1236)
++....... ......+++.|+|||++.+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~ 179 (301)
T cd07873 150 LARAKSIPTKTYSNEVVTLWYRPPDILLGS 179 (301)
T ss_pred chhccCCCCCcccccceeecccCcHHHhCC
Confidence 997643222 22334578999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=230.38 Aligned_cols=172 Identities=34% Similarity=0.506 Sum_probs=145.9
Q ss_pred cccCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecC
Q 000893 1040 KNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1236)
Q Consensus 1040 s~EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~ 1117 (1236)
..+.|+++++||.|+||.||+|++. +..||+|++... .......+.+|+.+++.++||||+++++++...
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 81 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--------SEEELEDYMVEIEILATCNHPYIVKLLGAFYWD 81 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--------CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC
Confidence 3467999999999999999999884 678999998653 223356688899999999999999999998875
Q ss_pred CCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEecc
Q 000893 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1236)
Q Consensus 1118 ~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFG 1197 (1236)
+.+++||||+++++|..++.+....+++..++.++.|++.||.|||+++|+||||||+|||++.++ .+||+|||
T Consensus 82 --~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~----~~kl~dfg 155 (292)
T cd06644 82 --GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDG----DIKLADFG 155 (292)
T ss_pred --CeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCC----CEEEccCc
Confidence 489999999999999988876667799999999999999999999999999999999999998776 56999999
Q ss_pred CcccccCc-ccccCcCCCCcccchhhhcC
Q 000893 1198 LSKIKRNT-LVTGGVRGTLPWMAPELLNG 1225 (1236)
Q Consensus 1198 LArii~ns-~~tss~~GTp~YmAPEVL~G 1225 (1236)
++...... .......+++.|+|||++.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 184 (292)
T cd06644 156 VSAKNVKTLQRRDSFIGTPYWMAPEVVMC 184 (292)
T ss_pred cceeccccccccceecCCccccCceeecc
Confidence 98764322 22234568899999999964
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=225.98 Aligned_cols=172 Identities=28% Similarity=0.387 Sum_probs=143.7
Q ss_pred ccccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEec
Q 000893 1039 IKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1236)
Q Consensus 1039 Is~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t 1116 (1236)
....+|++.+.||+|+||.||+|+. .++.||||++..... .....+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--------~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~ 77 (267)
T cd06646 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--------DDFSLIQQEIFMVKECKHCNIVAYFGSYLS 77 (267)
T ss_pred CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--------chHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Confidence 3456899999999999999999997 477899999864311 112356789999999999999999999987
Q ss_pred CCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEec
Q 000893 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1236)
Q Consensus 1117 ~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDF 1196 (1236)
.. .+++||||+++++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+||+++.++ .+||+||
T Consensus 78 ~~--~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~----~~~l~df 150 (267)
T cd06646 78 RE--KLWICMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNG----DVKLADF 150 (267)
T ss_pred CC--EEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC----CEEECcC
Confidence 54 899999999999999988643 4689999999999999999999999999999999999998876 5699999
Q ss_pred cCcccccCcc-cccCcCCCCcccchhhhcC
Q 000893 1197 GLSKIKRNTL-VTGGVRGTLPWMAPELLNG 1225 (1236)
Q Consensus 1197 GLArii~ns~-~tss~~GTp~YmAPEVL~G 1225 (1236)
|++....... ......|++.|+|||++.+
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 180 (267)
T cd06646 151 GVAAKITATIAKRKSFIGTPYWMAPEVAAV 180 (267)
T ss_pred ccceeecccccccCccccCccccCHhHccc
Confidence 9998654322 2234568999999999853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=229.64 Aligned_cols=178 Identities=34% Similarity=0.504 Sum_probs=142.1
Q ss_pred ccccccCeeEEEEeccCCceEEEEeeec-------CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceee
Q 000893 1037 QIIKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVA 1109 (1236)
Q Consensus 1037 qiIs~EdYeiLkkLGsGSFGtVYKArlk-------G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVr 1109 (1236)
|.+..++|++.++||+|+||.||+|..+ +..||||.+.... .......+.+|+.+++.++||||++
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~ 73 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-------SLRERIEFLNEASVMKGFTCHHVVR 73 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-------CHHHHHHHHHHHHHHHhCCCCCeee
Confidence 4566789999999999999999998753 3469999876431 1122345788999999999999999
Q ss_pred EeeeEecCCCCeEEEEEeeccCCCHHHHHhhhc---------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEE
Q 000893 1110 FYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLL 1180 (1236)
Q Consensus 1110 LyG~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~---------r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNIL 1180 (1236)
+++++.... ..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+|||
T Consensus 74 ~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nil 151 (288)
T cd05061 74 LLGVVSKGQ--PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCM 151 (288)
T ss_pred EEEEEcCCC--CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEE
Confidence 999988754 7899999999999999996532 23456778889999999999999999999999999999
Q ss_pred EccCCCCCCcEEEEeccCcccccCccc---ccCcCCCCcccchhhhcCCC
Q 000893 1181 VNLKDPIRPICKVGDFGLSKIKRNTLV---TGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1181 LDsdG~I~ltVKLsDFGLArii~ns~~---tss~~GTp~YmAPEVL~Gss 1227 (1236)
++.++ .+||+|||+++....... .....++..|+|||++.+..
T Consensus 152 i~~~~----~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~ 197 (288)
T cd05061 152 VAHDF----TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV 197 (288)
T ss_pred EcCCC----cEEECcCCccccccccccccccCCCcccccccCHHHhccCC
Confidence 99876 579999999986533221 11234567899999997653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=226.17 Aligned_cols=175 Identities=35% Similarity=0.593 Sum_probs=144.5
Q ss_pred cccccCeeEEEEeccCCceEEEEeeec-CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEec
Q 000893 1038 IIKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1236)
Q Consensus 1038 iIs~EdYeiLkkLGsGSFGtVYKArlk-G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t 1116 (1236)
.+..++|++.+.||+|+||.||+|.+. ++.||||.++.... ....|.+|+.++++++||||+++++++..
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM---------DPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc---------cHHHHHHHHHHHHHCCCCCccceeEEEec
Confidence 355678999999999999999999874 56799999875321 13457889999999999999999999887
Q ss_pred CCCCeEEEEEeeccCCCHHHHHhhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEe
Q 000893 1117 GPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1236)
Q Consensus 1117 ~~~g~L~LVMEYm~GGSL~dlL~~k~-r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsD 1195 (1236)
.. .+++||||+++++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 73 ~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~----~~~l~d 146 (261)
T cd05068 73 EE--PIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENN----ICKVAD 146 (261)
T ss_pred CC--CeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCC----CEEECC
Confidence 54 7899999999999999996543 5689999999999999999999999999999999999999876 569999
Q ss_pred ccCcccccCcccc--cCcCCCCcccchhhhcCCC
Q 000893 1196 FGLSKIKRNTLVT--GGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1196 FGLArii~ns~~t--ss~~GTp~YmAPEVL~Gss 1227 (1236)
||+++........ .....+..|+|||++.+..
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 180 (261)
T cd05068 147 FGLARVIKEDIYEAREGAKFPIKWTAPEAALYNR 180 (261)
T ss_pred cceEEEccCCcccccCCCcCceeccCccccccCC
Confidence 9999876532221 1122345799999998654
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.8e-25 Score=224.86 Aligned_cols=163 Identities=28% Similarity=0.456 Sum_probs=134.7
Q ss_pred EeccCCceEEEEeeecCc------------eEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEec
Q 000893 1049 ELGSGTFGTVYHGKWRGT------------DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1236)
Q Consensus 1049 kLGsGSFGtVYKArlkG~------------~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t 1116 (1236)
.||+|+||.||+|.+... .|++|++.... .....|.+|+.+++.++||||+++++++..
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---------RDSLAFFETASLMSQLSHKHLVKLYGVCVR 72 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccch---------hhHHHHHHHHHHHHcCCCcchhheeeEEec
Confidence 589999999999998532 37777765421 114678889999999999999999999887
Q ss_pred CCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCC---CCCcEEE
Q 000893 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP---IRPICKV 1193 (1236)
Q Consensus 1117 ~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~---I~ltVKL 1193 (1236)
. ..++||||+++++|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++.++. ....+||
T Consensus 73 -~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl 149 (259)
T cd05037 73 -D--ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKL 149 (259)
T ss_pred -C--CcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEe
Confidence 3 578999999999999999766657899999999999999999999999999999999999987651 1135899
Q ss_pred EeccCcccccCcccccCcCCCCcccchhhhcCC
Q 000893 1194 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1194 sDFGLArii~ns~~tss~~GTp~YmAPEVL~Gs 1226 (1236)
+|||++..... .....++..|+|||++.+.
T Consensus 150 ~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~ 179 (259)
T cd05037 150 SDPGIPITVLS---REERVERIPWIAPECIRNG 179 (259)
T ss_pred CCCCccccccc---ccccccCCCccChhhhcCC
Confidence 99999987544 2234567889999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-24 Score=221.22 Aligned_cols=172 Identities=23% Similarity=0.390 Sum_probs=144.4
Q ss_pred CeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g 1120 (1236)
+|++.++||+|+||.||++.+ .+..+|+|.++... .......+.+|+.+++.++||||+++++.+.+..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 71 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-------SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG-- 71 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-------chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC--
Confidence 578899999999999999987 47789999986432 1223456778999999999999999999998754
Q ss_pred eEEEEEeeccCCCHHHHHhhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1121 TLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1121 ~L~LVMEYm~GGSL~dlL~~k-~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
.+++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+|||++.++ .++|+|||++
T Consensus 72 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~----~~~l~dfg~~ 147 (255)
T cd08219 72 HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNG----KVKLGDFGSA 147 (255)
T ss_pred EEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCC----cEEEcccCcc
Confidence 899999999999999988653 44688999999999999999999999999999999999998876 5699999999
Q ss_pred ccccCc-ccccCcCCCCcccchhhhcCCC
Q 000893 1200 KIKRNT-LVTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1200 rii~ns-~~tss~~GTp~YmAPEVL~Gss 1227 (1236)
...... .......|++.|+|||++.+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 176 (255)
T cd08219 148 RLLTSPGAYACTYVGTPYYVPPEIWENMP 176 (255)
T ss_pred eeecccccccccccCCccccCHHHHccCC
Confidence 865432 2233466899999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.1e-25 Score=228.68 Aligned_cols=178 Identities=35% Similarity=0.534 Sum_probs=145.3
Q ss_pred cccCeeEEEEeccCCceEEEEeeec-------CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEee
Q 000893 1040 KNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 1112 (1236)
Q Consensus 1040 s~EdYeiLkkLGsGSFGtVYKArlk-------G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG 1112 (1236)
..++|.+++.||+|+||.||+|.+. +..||||+++... .......|.+|+.+|+.++||||+++++
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 75 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-------SNDARKDFEREAELLTNFQHENIVKFYG 75 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-------CHHHHHHHHHHHHHHHhcCCCCchheee
Confidence 3467888999999999999999863 3569999987532 1223457889999999999999999999
Q ss_pred eEecCCCCeEEEEEeeccCCCHHHHHhhhc-------------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcE
Q 000893 1113 VVQDGPGGTLATVTEFMVNGSLRHVLLSKE-------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNL 1179 (1236)
Q Consensus 1113 ~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~-------------r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNI 1179 (1236)
++.... .+++||||+++++|.+++...+ ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 76 ~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~ni 153 (280)
T cd05049 76 VCTEGD--PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNC 153 (280)
T ss_pred EEecCC--CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceE
Confidence 998864 8999999999999999996532 3478889999999999999999999999999999999
Q ss_pred EEccCCCCCCcEEEEeccCcccccCcc---cccCcCCCCcccchhhhcCCCCCC
Q 000893 1180 LVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1180 LLDsdG~I~ltVKLsDFGLArii~ns~---~tss~~GTp~YmAPEVL~Gss~~~ 1230 (1236)
|++.++ .+||+|||+++...... ......+++.|+|||++.+.....
T Consensus 154 li~~~~----~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 203 (280)
T cd05049 154 LVGYDL----VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTT 203 (280)
T ss_pred EEcCCC----eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcch
Confidence 999886 67999999997643221 223344678899999998764433
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.7e-24 Score=220.98 Aligned_cols=174 Identities=28% Similarity=0.439 Sum_probs=146.5
Q ss_pred CeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g 1120 (1236)
+|+.++.||.|+||.||.++. .+..+++|.+..... .......+.+|+.++++++|+||+++++++... .
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~ 72 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL------SEKERRDALNEIVILSLLQHPNIIAYYNHFMDD--N 72 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc------chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC--C
Confidence 588999999999999988876 577899999865432 123345678999999999999999999999885 4
Q ss_pred eEEEEEeeccCCCHHHHHhhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1121 TLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1121 ~L~LVMEYm~GGSL~dlL~~k-~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
.+++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+++||||+|+||+++.++ .+||+|||++
T Consensus 73 ~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~----~~kl~d~~~~ 148 (256)
T cd08221 73 TLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAG----LIKLGDFGIS 148 (256)
T ss_pred eEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCC----CEEECcCcce
Confidence 899999999999999999664 45689999999999999999999999999999999999999876 5799999999
Q ss_pred ccccCcc-cccCcCCCCcccchhhhcCCCC
Q 000893 1200 KIKRNTL-VTGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1200 rii~ns~-~tss~~GTp~YmAPEVL~Gss~ 1228 (1236)
....... ......|++.|+|||++.+...
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~ape~~~~~~~ 178 (256)
T cd08221 149 KILGSEYSMAETVVGTPYYMSPELCQGVKY 178 (256)
T ss_pred EEcccccccccccCCCccccCHhhcCCCCC
Confidence 8754333 3344668999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-24 Score=220.82 Aligned_cols=175 Identities=30% Similarity=0.448 Sum_probs=147.5
Q ss_pred CeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g 1120 (1236)
+|++++.||.|+||.||++.. .+..||+|++..... ......++..|+.+++.++||||+++++++......
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM------TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQ 74 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC------CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCC
Confidence 478899999999999999987 467899999875422 123345678899999999999999999988766556
Q ss_pred eEEEEEeeccCCCHHHHHhhh---ccCCCHHHHHHHHHHHHHHHHHHH-----HCCcccCCCCCCcEEEccCCCCCCcEE
Q 000893 1121 TLATVTEFMVNGSLRHVLLSK---ERHLDRRKRLIIAMDAAFGMEYLH-----SKNIVHFDLKCDNLLVNLKDPIRPICK 1192 (1236)
Q Consensus 1121 ~L~LVMEYm~GGSL~dlL~~k---~r~LSe~erl~Ia~QIAeALaYLH-----SkGIIHRDIKPsNILLDsdG~I~ltVK 1192 (1236)
.++++|||+++++|..++... ...+++..++.++.||+.||.||| ..+|+|+||||+||+++.++ .+|
T Consensus 75 ~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~----~~k 150 (265)
T cd08217 75 TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN----NVK 150 (265)
T ss_pred EEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCC----CEE
Confidence 889999999999999998654 457899999999999999999999 88999999999999999876 569
Q ss_pred EEeccCcccccCccc-ccCcCCCCcccchhhhcCCC
Q 000893 1193 VGDFGLSKIKRNTLV-TGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1193 LsDFGLArii~ns~~-tss~~GTp~YmAPEVL~Gss 1227 (1236)
|+|||++........ .....+++.|+|||++.+..
T Consensus 151 l~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~ 186 (265)
T cd08217 151 LGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMS 186 (265)
T ss_pred EecccccccccCCcccccccccCCCccChhhhcCCC
Confidence 999999987654332 34467899999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=225.66 Aligned_cols=174 Identities=39% Similarity=0.606 Sum_probs=143.0
Q ss_pred ccCeeEEEEeccCCceEEEEeeec-CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1041 ~EdYeiLkkLGsGSFGtVYKArlk-G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
..+|++.+.||+|+||.||++.++ +..+|||++...... ...|.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~---------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 72 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS---------EDDFIEEAKVMMKLSHPNLVQLYGVCTKQR- 72 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC---------HHHHHHHHHHHHhCCCCCEEEEEEEEcCCC-
Confidence 356888999999999999999885 446999998643211 235778999999999999999999987754
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
.+++||||+++++|.+++......+++..++.++.||+.||.|||+++|+||||||+||+++.++ .+||+|||++
T Consensus 73 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~----~~kl~dfg~~ 147 (256)
T cd05059 73 -PIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDN----VVKVSDFGLA 147 (256)
T ss_pred -ceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCC----cEEECCcccc
Confidence 88999999999999999976666789999999999999999999999999999999999999876 5799999999
Q ss_pred ccccCcccc--cCcCCCCcccchhhhcCCCCC
Q 000893 1200 KIKRNTLVT--GGVRGTLPWMAPELLNGSSSK 1229 (1236)
Q Consensus 1200 rii~ns~~t--ss~~GTp~YmAPEVL~Gss~~ 1229 (1236)
+...+.... ....++..|+|||++.+....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~ 179 (256)
T cd05059 148 RYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFS 179 (256)
T ss_pred eecccccccccCCCCCCccccCHHHhccCCCC
Confidence 865432221 122234579999999865433
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-26 Score=278.59 Aligned_cols=175 Identities=27% Similarity=0.335 Sum_probs=151.7
Q ss_pred cccccCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEe
Q 000893 1038 IIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 1115 (1236)
Q Consensus 1038 iIs~EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~ 1115 (1236)
.+..++|.++++||+|+||.|.+++++ ++.+|+|++.+-.... .....-|+.|..+|...+.+.||.|+..|+
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlK-----r~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLK-----RAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhh-----chhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 356789999999999999999999985 6679999998743221 112345899999999999999999999999
Q ss_pred cCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEe
Q 000893 1116 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1236)
Q Consensus 1116 t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsD 1195 (1236)
+.. ++|+|||||+||+|..+|...+ .+++..++.|+.+|+.||.-||+.|+|||||||+|||||..|+ +||+|
T Consensus 146 D~~--~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GH----ikLAD 218 (1317)
T KOG0612|consen 146 DER--YLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGH----IKLAD 218 (1317)
T ss_pred Ccc--ceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCc----Eeecc
Confidence 965 9999999999999999997666 7999999999999999999999999999999999999999985 59999
Q ss_pred ccCcccccC--cccccCcCCCCcccchhhhc
Q 000893 1196 FGLSKIKRN--TLVTGGVRGTLPWMAPELLN 1224 (1236)
Q Consensus 1196 FGLArii~n--s~~tss~~GTp~YmAPEVL~ 1224 (1236)
||.|-.+.. .......+|||.|++||+|.
T Consensus 219 FGsClkm~~dG~V~s~~aVGTPDYISPEvLq 249 (1317)
T KOG0612|consen 219 FGSCLKMDADGTVRSSVAVGTPDYISPEVLQ 249 (1317)
T ss_pred chhHHhcCCCCcEEeccccCCCCccCHHHHH
Confidence 999877653 33445678999999999997
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=227.23 Aligned_cols=175 Identities=33% Similarity=0.539 Sum_probs=144.6
Q ss_pred cccccCeeEEEEeccCCceEEEEeeec--Cc----eEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEe
Q 000893 1038 IIKNEDLEELKELGSGTFGTVYHGKWR--GT----DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 1111 (1236)
Q Consensus 1038 iIs~EdYeiLkkLGsGSFGtVYKArlk--G~----~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLy 1111 (1236)
++...+|++++.||+|+||+||+|.+. +. .||+|.+..... ......+.+|+.+++.++||||++++
T Consensus 3 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~ 75 (279)
T cd05057 3 ILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-------PKANKEILDEAYVMASVDHPHVVRLL 75 (279)
T ss_pred ccCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-------HHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 456678999999999999999999873 32 489998865421 23345688999999999999999999
Q ss_pred eeEecCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcE
Q 000893 1112 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 1191 (1236)
Q Consensus 1112 G~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltV 1191 (1236)
++|.. ...++||||+++++|.+++......+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+
T Consensus 76 ~~~~~---~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~----~~ 148 (279)
T cd05057 76 GICLS---SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQ----HV 148 (279)
T ss_pred EEEec---CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCC----eE
Confidence 99987 378999999999999999977666799999999999999999999999999999999999998776 57
Q ss_pred EEEeccCcccccCcccc---cCcCCCCcccchhhhcCC
Q 000893 1192 KVGDFGLSKIKRNTLVT---GGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1192 KLsDFGLArii~ns~~t---ss~~GTp~YmAPEVL~Gs 1226 (1236)
||+|||+++........ ....++..|+|||++.+.
T Consensus 149 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~ 186 (279)
T cd05057 149 KITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHR 186 (279)
T ss_pred EECCCcccccccCcccceecCCCcccccccCHHHhhcC
Confidence 99999999875432211 112235679999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=225.54 Aligned_cols=174 Identities=33% Similarity=0.534 Sum_probs=142.4
Q ss_pred ccCeeEEEEeccCCceEEEEeeec--C---ceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEe
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKWR--G---TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 1115 (1236)
Q Consensus 1041 ~EdYeiLkkLGsGSFGtVYKArlk--G---~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~ 1115 (1236)
..+|++.+.||+|+||.||+|.++ + ..||||+++... .......|..|+.+++.++||||+++++++.
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~ 75 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-------TEKQRRDFLSEASIMGQFDHPNIIHLEGVVT 75 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-------CHHHHHHHHHHHHHHHhCCCcCcceEEEEEC
Confidence 356889999999999999999874 3 359999986531 1233567889999999999999999999987
Q ss_pred cCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEe
Q 000893 1116 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1236)
Q Consensus 1116 t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsD 1195 (1236)
... .+++||||+++++|..++......+++..++.++.|++.||.|||++|++||||||+|||++.++ .+||+|
T Consensus 76 ~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~----~~kl~d 149 (269)
T cd05065 76 KSR--PVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNL----VCKVSD 149 (269)
T ss_pred CCC--ceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCC----cEEECC
Confidence 754 78999999999999999977666789999999999999999999999999999999999998765 679999
Q ss_pred ccCcccccCcccc----cCcC--CCCcccchhhhcCCC
Q 000893 1196 FGLSKIKRNTLVT----GGVR--GTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1196 FGLArii~ns~~t----ss~~--GTp~YmAPEVL~Gss 1227 (1236)
||+++........ .... .+..|+|||++.+..
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~ 187 (269)
T cd05065 150 FGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK 187 (269)
T ss_pred CccccccccCccccccccccCCCcceeecCHhHhccCc
Confidence 9998765432211 1111 235799999997653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-24 Score=221.47 Aligned_cols=172 Identities=31% Similarity=0.450 Sum_probs=146.9
Q ss_pred ccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCC
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1041 ~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~ 1118 (1236)
.++|++.+.||.|+||.||+|.. .++.+|+|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 73 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP--------GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD 73 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc--------hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCC
Confidence 36899999999999999999987 36779999997542 113457788999999999999999999988754
Q ss_pred CCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccC
Q 000893 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1236)
Q Consensus 1119 ~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGL 1198 (1236)
.++++|||+.+++|..++......+++..++.++.|++.||.|||+++|+|+||||+||+++.++ .+||+|||+
T Consensus 74 --~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~----~~~l~d~g~ 147 (262)
T cd06613 74 --KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDG----DVKLADFGV 147 (262)
T ss_pred --EEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCC----CEEECcccc
Confidence 89999999999999999876656799999999999999999999999999999999999999876 569999999
Q ss_pred cccccCcc-cccCcCCCCcccchhhhcCC
Q 000893 1199 SKIKRNTL-VTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1199 Arii~ns~-~tss~~GTp~YmAPEVL~Gs 1226 (1236)
+....... ......++..|+|||++.+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~ 176 (262)
T cd06613 148 SAQLTATIAKRKSFIGTPYWMAPEVAAVE 176 (262)
T ss_pred chhhhhhhhccccccCCccccCchhhccc
Confidence 88754332 23446788999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=229.09 Aligned_cols=176 Identities=36% Similarity=0.555 Sum_probs=144.2
Q ss_pred ccccCeeEEEEeccCCceEEEEeee-------cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEe
Q 000893 1039 IKNEDLEELKELGSGTFGTVYHGKW-------RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 1111 (1236)
Q Consensus 1039 Is~EdYeiLkkLGsGSFGtVYKArl-------kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLy 1111 (1236)
+...+|.+.+.||+|+||+||++.. .+..+|+|.+... .......+.+|+.++++++||||++++
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~ 73 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--------SDNARKDFHREAELLTNLQHEHIVKFY 73 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--------CHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 3567899999999999999999975 2345899988643 123355688999999999999999999
Q ss_pred eeEecCCCCeEEEEEeeccCCCHHHHHhhhc------------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcE
Q 000893 1112 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKE------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNL 1179 (1236)
Q Consensus 1112 G~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~------------r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNI 1179 (1236)
+++.... .+++||||+++++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+||
T Consensus 74 ~~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Ni 151 (288)
T cd05093 74 GVCVEGD--PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNC 151 (288)
T ss_pred EEEecCC--ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceE
Confidence 9998754 8999999999999999986432 2489999999999999999999999999999999999
Q ss_pred EEccCCCCCCcEEEEeccCcccccCcc---cccCcCCCCcccchhhhcCCCC
Q 000893 1180 LVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1180 LLDsdG~I~ltVKLsDFGLArii~ns~---~tss~~GTp~YmAPEVL~Gss~ 1228 (1236)
|++.++ .+||+|||+++...... ......+++.|+|||++.+...
T Consensus 152 li~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 199 (288)
T cd05093 152 LVGENL----LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF 199 (288)
T ss_pred EEccCC----cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCC
Confidence 999876 56999999998653322 1223445778999999986543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.7e-25 Score=230.70 Aligned_cols=176 Identities=31% Similarity=0.457 Sum_probs=141.8
Q ss_pred cccCeeEEEEeccCCceEEEEeeec-------CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEee
Q 000893 1040 KNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 1112 (1236)
Q Consensus 1040 s~EdYeiLkkLGsGSFGtVYKArlk-------G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG 1112 (1236)
...+|++.++||+|+||+||+|.+. +..||||+++... .......|.+|+.+++.++||||+++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~l~h~~iv~~~~ 75 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-------EGPLREEFKHEAMMRSRLQHPNIVCLLG 75 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-------CHHHHHHHHHHHHHHhcCCCCCcCeEEE
Confidence 3456778889999999999999863 3569999987432 1223456888999999999999999999
Q ss_pred eEecCCCCeEEEEEeeccCCCHHHHHhhh---------------ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCC
Q 000893 1113 VVQDGPGGTLATVTEFMVNGSLRHVLLSK---------------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCD 1177 (1236)
Q Consensus 1113 ~f~t~~~g~L~LVMEYm~GGSL~dlL~~k---------------~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPs 1177 (1236)
++.... .+++++||+.+++|..++... ...+++..++.++.|++.||.|||++||+||||||+
T Consensus 76 ~~~~~~--~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~ 153 (283)
T cd05091 76 VVTKEQ--PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATR 153 (283)
T ss_pred EEcCCC--ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchh
Confidence 998764 789999999999999998532 134788888999999999999999999999999999
Q ss_pred cEEEccCCCCCCcEEEEeccCcccccCcc---cccCcCCCCcccchhhhcCCCC
Q 000893 1178 NLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1178 NILLDsdG~I~ltVKLsDFGLArii~ns~---~tss~~GTp~YmAPEVL~Gss~ 1228 (1236)
|||++.++ .+||+|||+++...... ......+++.|+|||++.+...
T Consensus 154 Nil~~~~~----~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 203 (283)
T cd05091 154 NVLVFDKL----NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKF 203 (283)
T ss_pred heEecCCC----ceEecccccccccccchheeeccCccCCccccCHHHHhcCCC
Confidence 99998775 57999999988653322 1223446789999999976543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=231.15 Aligned_cols=174 Identities=32% Similarity=0.466 Sum_probs=140.9
Q ss_pred cccCeeEEEEeccCCceEEEEeeecC----------------ceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCC
Q 000893 1040 KNEDLEELKELGSGTFGTVYHGKWRG----------------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH 1103 (1236)
Q Consensus 1040 s~EdYeiLkkLGsGSFGtVYKArlkG----------------~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLr 1103 (1236)
...+|++.+.||+|+||.||+++..+ ..||||.++... .......|.+|++++++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~ei~~l~~l~ 75 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-------TKTARNDFLKEIKIMSRLK 75 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-------CHHHHHHHHHHHHHHHhCC
Confidence 45689999999999999999987632 248999987532 1223456889999999999
Q ss_pred CCceeeEeeeEecCCCCeEEEEEeeccCCCHHHHHhhhc-----------cCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Q 000893 1104 HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE-----------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHF 1172 (1236)
Q Consensus 1104 HPNIVrLyG~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~-----------r~LSe~erl~Ia~QIAeALaYLHSkGIIHR 1172 (1236)
||||+++++++.... .+++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+++++||
T Consensus 76 h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~ 153 (295)
T cd05097 76 NPNIIRLLGVCVSDD--PLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHR 153 (295)
T ss_pred CCCcCeEEEEEcCCC--ccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeecc
Confidence 999999999998754 8899999999999999986532 136788889999999999999999999999
Q ss_pred CCCCCcEEEccCCCCCCcEEEEeccCcccccCcc---cccCcCCCCcccchhhhcCC
Q 000893 1173 DLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1173 DIKPsNILLDsdG~I~ltVKLsDFGLArii~ns~---~tss~~GTp~YmAPEVL~Gs 1226 (1236)
||||+|||++.++ .+||+|||+++...... ......+++.|+|||++.+.
T Consensus 154 dlkp~Nill~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 206 (295)
T cd05097 154 DLATRNCLVGNHY----TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG 206 (295)
T ss_pred ccChhhEEEcCCC----cEEecccccccccccCcceeccCcCcCceeecChhhhccC
Confidence 9999999999775 57999999997643221 12223457789999998765
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=227.82 Aligned_cols=170 Identities=32% Similarity=0.487 Sum_probs=143.2
Q ss_pred cCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
+.|++++.||+|+||+||++.+. +..+|+|.+... .......+.+|+.+++.++||||++++++|....
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--------~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~- 75 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--------SEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN- 75 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--------CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCC-
Confidence 34678899999999999999984 567899988643 1233456888999999999999999999998754
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
..++||||+++++|..++......+++..+..++.|++.||.|||+.||+||||||+|||++.++ .+||+|||++
T Consensus 76 -~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~----~~kl~dfg~~ 150 (282)
T cd06643 76 -NLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDG----DIKLADFGVS 150 (282)
T ss_pred -EEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCC----CEEEcccccc
Confidence 89999999999999998876566799999999999999999999999999999999999998876 5799999998
Q ss_pred ccccCc-ccccCcCCCCcccchhhhcC
Q 000893 1200 KIKRNT-LVTGGVRGTLPWMAPELLNG 1225 (1236)
Q Consensus 1200 rii~ns-~~tss~~GTp~YmAPEVL~G 1225 (1236)
...... .......+++.|+|||++..
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~aPE~~~~ 177 (282)
T cd06643 151 AKNTRTIQRRDSFIGTPYWMAPEVVMC 177 (282)
T ss_pred ccccccccccccccccccccCHhhccc
Confidence 764322 22344678999999999853
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-26 Score=258.95 Aligned_cols=179 Identities=30% Similarity=0.438 Sum_probs=152.8
Q ss_pred ccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCC
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1041 ~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~ 1118 (1236)
...|..+++||+|+||.||+|.+ +++.||||++.... .+.....+++|+.+|..++++||.++|+.+..+.
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~-------~~deIediqqei~~Ls~~~~~~it~yygsyl~g~ 84 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE-------AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGT 84 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhh-------cchhhHHHHHHHHHHHhcCcchHHhhhhheeecc
Confidence 35677789999999999999998 47779999997653 2334567788999999999999999999998865
Q ss_pred CCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccC
Q 000893 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1236)
Q Consensus 1119 ~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGL 1198 (1236)
.+|++||||.||++.+++.. +..+.+..+..|+++++.||.|||.++.||||||+.|||+..+| .|||+|||.
T Consensus 85 --~LwiiMey~~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g----~vkl~DfgV 157 (467)
T KOG0201|consen 85 --KLWIIMEYCGGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESG----DVKLADFGV 157 (467)
T ss_pred --cHHHHHHHhcCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccC----cEEEEecce
Confidence 89999999999999999953 34558888888999999999999999999999999999999887 569999999
Q ss_pred cccccCcc-cccCcCCCCcccchhhhcCCCCCCCcc
Q 000893 1199 SKIKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEK 1233 (1236)
Q Consensus 1199 Arii~ns~-~tss~~GTp~YmAPEVL~Gss~~~SdD 1233 (1236)
+..+.+.. ...+++|||.|||||+|.+..+....|
T Consensus 158 a~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KAD 193 (467)
T KOG0201|consen 158 AGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKAD 193 (467)
T ss_pred eeeeechhhccccccccccccchhhhccccccchhh
Confidence 98876544 337799999999999999765555444
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=243.44 Aligned_cols=171 Identities=22% Similarity=0.269 Sum_probs=141.5
Q ss_pred ccccCeeEEEEeccCCceEEEEeeec----CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeE
Q 000893 1039 IKNEDLEELKELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVV 1114 (1236)
Q Consensus 1039 Is~EdYeiLkkLGsGSFGtVYKArlk----G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f 1114 (1236)
+...+|++++.||+|+||.||++... +..||||.+.... .+.+|+.+|+.++||||+++++++
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------------~~~~E~~il~~l~h~~iv~~~~~~ 155 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-------------TPGREIDILKTISHRAIINLIHAY 155 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-------------cHHHHHHHHHhcCCCCccceeeeE
Confidence 34568999999999999999999763 4569999875421 234699999999999999999999
Q ss_pred ecCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEE
Q 000893 1115 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1236)
Q Consensus 1115 ~t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLs 1194 (1236)
.... .+++||||+ +++|..++ .....+++..++.|+.||+.||.|||++|||||||||+||||+.++ .+||+
T Consensus 156 ~~~~--~~~lv~e~~-~~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~----~~~l~ 227 (392)
T PHA03207 156 RWKS--TVCMVMPKY-KCDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPE----NAVLG 227 (392)
T ss_pred eeCC--EEEEEehhc-CCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC----CEEEc
Confidence 8754 899999998 57888888 3445799999999999999999999999999999999999999876 56999
Q ss_pred eccCcccccCcc---cccCcCCCCcccchhhhcCCCCCC
Q 000893 1195 DFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1195 DFGLArii~ns~---~tss~~GTp~YmAPEVL~Gss~~~ 1230 (1236)
|||+++...... ......||+.|+|||++.+..+..
T Consensus 228 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 266 (392)
T PHA03207 228 DFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCA 266 (392)
T ss_pred cCccccccCcccccccccccccccCccCHhHhcCCCCCc
Confidence 999997654322 223467999999999998764433
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.1e-25 Score=227.69 Aligned_cols=169 Identities=31% Similarity=0.443 Sum_probs=142.2
Q ss_pred ccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCC
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1041 ~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~ 1118 (1236)
.++|++.+.||+|+||.||+|++ .++.||||+++... ......+.+|+.+++.++||||+++++++....
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--------~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~ 79 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--------GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD 79 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--------hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Confidence 35788889999999999999987 47789999987532 112345778999999999999999999998754
Q ss_pred CCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccC
Q 000893 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1236)
Q Consensus 1119 ~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGL 1198 (1236)
.+++||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||+
T Consensus 80 --~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~----~~~l~dfg~ 152 (267)
T cd06645 80 --KLWICMEFCGGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNG----HVKLADFGV 152 (267)
T ss_pred --EEEEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC----CEEECccee
Confidence 899999999999999988543 4689999999999999999999999999999999999999876 569999999
Q ss_pred cccccCc-ccccCcCCCCcccchhhhc
Q 000893 1199 SKIKRNT-LVTGGVRGTLPWMAPELLN 1224 (1236)
Q Consensus 1199 Arii~ns-~~tss~~GTp~YmAPEVL~ 1224 (1236)
+...... .......|++.|+|||++.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~ 179 (267)
T cd06645 153 SAQITATIAKRKSFIGTPYWMAPEVAA 179 (267)
T ss_pred eeEccCcccccccccCcccccChhhhc
Confidence 8765332 2223457899999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-24 Score=219.63 Aligned_cols=166 Identities=40% Similarity=0.601 Sum_probs=141.8
Q ss_pred EEeccCCceEEEEeeec-----CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeE
Q 000893 1048 KELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTL 1122 (1236)
Q Consensus 1048 kkLGsGSFGtVYKArlk-----G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L 1122 (1236)
+.||+|+||.||+|... +..||||+++.... ......+.+|+.+++.++|+||+++++++... ..+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~ 71 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS-------EEERKDFLKEARVMKKLGHPNVVRLLGVCTEE--EPL 71 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccc-------hhHHHHHHHHHHHHhhcCCCChheeeeeecCC--Cce
Confidence 35899999999999985 66799999876421 11356788999999999999999999999884 489
Q ss_pred EEEEeeccCCCHHHHHhhh--------ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEE
Q 000893 1123 ATVTEFMVNGSLRHVLLSK--------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1236)
Q Consensus 1123 ~LVMEYm~GGSL~dlL~~k--------~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLs 1194 (1236)
++||||+++++|.+++... ...+++..++.++.|++.||.|||+++|+||||||+||+++.++ .+||+
T Consensus 72 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~----~~~l~ 147 (262)
T cd00192 72 YLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDL----VVKIS 147 (262)
T ss_pred EEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCC----cEEEc
Confidence 9999999999999999765 46799999999999999999999999999999999999999886 56999
Q ss_pred eccCcccccCc---ccccCcCCCCcccchhhhcCC
Q 000893 1195 DFGLSKIKRNT---LVTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1195 DFGLArii~ns---~~tss~~GTp~YmAPEVL~Gs 1226 (1236)
|||++...... .......+++.|+|||.+.+.
T Consensus 148 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 182 (262)
T cd00192 148 DFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDG 182 (262)
T ss_pred ccccccccccccccccccCCCcCccccCHHHhccC
Confidence 99999876543 223445678899999999865
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=231.40 Aligned_cols=177 Identities=31% Similarity=0.465 Sum_probs=142.9
Q ss_pred cccccCeeEEEEeccCCceEEEEeeecC---------ceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhC-CCCce
Q 000893 1038 IIKNEDLEELKELGSGTFGTVYHGKWRG---------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNV 1107 (1236)
Q Consensus 1038 iIs~EdYeiLkkLGsGSFGtVYKArlkG---------~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskL-rHPNI 1107 (1236)
.+..++|.+.+.||+|+||.||++++.+ ..+|+|.++... ......++.+|+.+++.+ +||||
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~e~~~l~~l~~h~~i 86 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-------TEKDLSDLISEMEMMKMIGKHKNI 86 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-------ChHHHHHHHHHHHHHHHhcCCCCE
Confidence 4455789999999999999999998632 359999887531 122345688899999999 79999
Q ss_pred eeEeeeEecCCCCeEEEEEeeccCCCHHHHHhhhc---------------cCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Q 000893 1108 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHF 1172 (1236)
Q Consensus 1108 VrLyG~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~---------------r~LSe~erl~Ia~QIAeALaYLHSkGIIHR 1172 (1236)
++++++|.... .+++||||+++++|.+++.... ..+++..++.++.||+.||+|||++|++||
T Consensus 87 ~~~~~~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~ 164 (307)
T cd05098 87 INLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHR 164 (307)
T ss_pred eeEEEEEecCC--ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 99999998754 8899999999999999996532 247889999999999999999999999999
Q ss_pred CCCCCcEEEccCCCCCCcEEEEeccCcccccCccc---ccCcCCCCcccchhhhcCCC
Q 000893 1173 DLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLV---TGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1173 DIKPsNILLDsdG~I~ltVKLsDFGLArii~ns~~---tss~~GTp~YmAPEVL~Gss 1227 (1236)
||||+|||++.++ .+||+|||+++....... .....+++.|+|||++.+..
T Consensus 165 dlkp~Nill~~~~----~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 218 (307)
T cd05098 165 DLAARNVLVTEDN----VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI 218 (307)
T ss_pred cccHHheEEcCCC----cEEECCCcccccccccchhhccccCCCccceeChHHhccCC
Confidence 9999999999876 579999999986543211 11223456899999998653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-25 Score=246.86 Aligned_cols=186 Identities=23% Similarity=0.349 Sum_probs=160.6
Q ss_pred ccccccCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhC-CCCceeeEeee
Q 000893 1037 QIIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGV 1113 (1236)
Q Consensus 1037 qiIs~EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskL-rHPNIVrLyG~ 1113 (1236)
+.+..++|.++.+||+|+|.+|.+++++ .+.+|+|++++..+..+.+ +.-.+.|..+.... +||++|-|+.+
T Consensus 245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~ndded-----idwvqtek~vfe~asn~pflvglhsc 319 (593)
T KOG0695|consen 245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDED-----IDWVQTEKHVFEQASNNPFLVGLHSC 319 (593)
T ss_pred cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCccc-----chhHHhhHHHHHhccCCCeEEehhhh
Confidence 4566789999999999999999999984 5669999999876643322 33445677777764 69999999999
Q ss_pred EecCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEE
Q 000893 1114 VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193 (1236)
Q Consensus 1114 f~t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKL 1193 (1236)
|++.. .+++|.||++||+|..++++ .++++++.++.+..+|+.||.|||++|||+||||.+|+||+.+|+ +||
T Consensus 320 fqtes--rlffvieyv~ggdlmfhmqr-qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaegh----ikl 392 (593)
T KOG0695|consen 320 FQTES--RLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGH----IKL 392 (593)
T ss_pred hcccc--eEEEEEEEecCcceeeehhh-hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCc----eee
Confidence 99966 99999999999999988854 567999999999999999999999999999999999999999985 499
Q ss_pred EeccCcccc-cCcccccCcCCCCcccchhhhcCCCCCCCccc
Q 000893 1194 GDFGLSKIK-RNTLVTGGVRGTLPWMAPELLNGSSSKVSEKV 1234 (1236)
Q Consensus 1194 sDFGLArii-~ns~~tss~~GTp~YmAPEVL~Gss~~~SdDV 1234 (1236)
+|+|+|+.. .....++++||||.|+|||+++|..+.++.||
T Consensus 393 tdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdw 434 (593)
T KOG0695|consen 393 TDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDW 434 (593)
T ss_pred cccchhhcCCCCCcccccccCCCcccchhhhcccccCceehH
Confidence 999999974 45667788999999999999999999888876
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.5e-25 Score=230.34 Aligned_cols=170 Identities=37% Similarity=0.606 Sum_probs=138.4
Q ss_pred eEEEEeccCCceEEEEeeec------CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCC
Q 000893 1045 EELKELGSGTFGTVYHGKWR------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1045 eiLkkLGsGSFGtVYKArlk------G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~ 1118 (1236)
.+.+.||.|.||.||+|.+. +..|+||.++... .......|++|++++++++||||++++|+|...
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~-------~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~- 73 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS-------SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIEN- 73 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS-------SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESS-
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc-------ccccceeeeeccccccccccccccccccccccc-
Confidence 46788999999999999997 5669999995421 223366789999999999999999999999954
Q ss_pred CCeEEEEEeeccCCCHHHHHhhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEecc
Q 000893 1119 GGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1236)
Q Consensus 1119 ~g~L~LVMEYm~GGSL~dlL~~k-~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFG 1197 (1236)
..+++||||+++|+|.++|... ...+++..++.|+.||+.||.|||+++|+|++|+++|||++.++ .+||+|||
T Consensus 74 -~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~----~~Kl~~f~ 148 (259)
T PF07714_consen 74 -EPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNG----QVKLSDFG 148 (259)
T ss_dssp -SSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTT----EEEEESTT
T ss_pred -ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----cccccccc
Confidence 3699999999999999999876 56799999999999999999999999999999999999999876 77999999
Q ss_pred CcccccCc---ccccCcCCCCcccchhhhcCCC
Q 000893 1198 LSKIKRNT---LVTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1198 LArii~ns---~~tss~~GTp~YmAPEVL~Gss 1227 (1236)
++...... .......+...|+|||++.+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 181 (259)
T PF07714_consen 149 LSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGE 181 (259)
T ss_dssp TGEETTTSSSEEESTTSESGGGGS-HHHHHHSE
T ss_pred ccccccccccccccccccccccccccccccccc
Confidence 99876221 1222344677899999997653
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=228.07 Aligned_cols=170 Identities=32% Similarity=0.495 Sum_probs=145.9
Q ss_pred cCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
++|++++.||.|+||+||++.+. +..||+|++... .......|.+|+.++++++||||+++++++....
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 75 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--------SEEELEDFMVEIDILSECKHPNIVGLYEAYFYEN- 75 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--------CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCC-
Confidence 57889999999999999999884 678999998643 2233457889999999999999999999998754
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
.+++||||+++++|..++...+..+++..++.++.|++.||.|||+++|+|+||||+||+++.++ .++|+|||++
T Consensus 76 -~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~----~~~l~d~g~~ 150 (280)
T cd06611 76 -KLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDG----DVKLADFGVS 150 (280)
T ss_pred -eEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCC----CEEEccCccc
Confidence 89999999999999999977677899999999999999999999999999999999999999876 5799999998
Q ss_pred ccccC-cccccCcCCCCcccchhhhcC
Q 000893 1200 KIKRN-TLVTGGVRGTLPWMAPELLNG 1225 (1236)
Q Consensus 1200 rii~n-s~~tss~~GTp~YmAPEVL~G 1225 (1236)
..... ........+++.|+|||++.+
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~ 177 (280)
T cd06611 151 AKNKSTLQKRDTFIGTPYWMAPEVVAC 177 (280)
T ss_pred hhhcccccccceeecchhhcCHHHHhh
Confidence 76432 222334568999999999863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.3e-24 Score=219.42 Aligned_cols=175 Identities=29% Similarity=0.459 Sum_probs=144.8
Q ss_pred CeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g 1120 (1236)
.|++++.||+|++|.||++.. .++.||||++..... .......+.+|+.+++.++||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~ 73 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA------SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE-DG 73 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc------CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC-CC
Confidence 488999999999999999987 467899999875322 122345678899999999999999999987643 24
Q ss_pred eEEEEEeeccCCCHHHHHhhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1121 TLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1121 ~L~LVMEYm~GGSL~dlL~~k-~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
.+++||||+++++|.+++... ...+++.+++.++.+++.||.|||++||+||||||+||+++.++ .++|+|||++
T Consensus 74 ~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~----~~~l~df~~~ 149 (257)
T cd08223 74 LLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTN----IIKVGDLGIA 149 (257)
T ss_pred EEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCC----cEEEecccce
Confidence 789999999999999998763 34689999999999999999999999999999999999998876 5799999999
Q ss_pred ccccCc-ccccCcCCCCcccchhhhcCCCC
Q 000893 1200 KIKRNT-LVTGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1200 rii~ns-~~tss~~GTp~YmAPEVL~Gss~ 1228 (1236)
...... .......+++.|+|||++.+...
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 179 (257)
T cd08223 150 RVLENQCDMASTLIGTPYYMSPELFSNKPY 179 (257)
T ss_pred EEecccCCccccccCCcCccChhHhcCCCC
Confidence 876432 22334568999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=230.67 Aligned_cols=177 Identities=29% Similarity=0.446 Sum_probs=143.7
Q ss_pred cccccCeeEEEEeccCCceEEEEeeec---------CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhC-CCCce
Q 000893 1038 IIKNEDLEELKELGSGTFGTVYHGKWR---------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNV 1107 (1236)
Q Consensus 1038 iIs~EdYeiLkkLGsGSFGtVYKArlk---------G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskL-rHPNI 1107 (1236)
.+..++|.+.+.||+|+||.||+|++. +..||+|.+.... .......+.+|+.+++.+ +||||
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~i 83 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-------TEKDLSDLVSEMEMMKMIGKHKNI 83 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-------chHHHHHHHHHHHHHHhhccCCCc
Confidence 456788999999999999999999742 2359999886431 122345688899999999 89999
Q ss_pred eeEeeeEecCCCCeEEEEEeeccCCCHHHHHhhhc---------------cCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Q 000893 1108 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHF 1172 (1236)
Q Consensus 1108 VrLyG~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~---------------r~LSe~erl~Ia~QIAeALaYLHSkGIIHR 1172 (1236)
+++++++.... .+++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||
T Consensus 84 ~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~ 161 (304)
T cd05101 84 INLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHR 161 (304)
T ss_pred hheeEEEecCC--ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 99999998754 8899999999999999997532 247788889999999999999999999999
Q ss_pred CCCCCcEEEccCCCCCCcEEEEeccCcccccCcc---cccCcCCCCcccchhhhcCCC
Q 000893 1173 DLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1173 DIKPsNILLDsdG~I~ltVKLsDFGLArii~ns~---~tss~~GTp~YmAPEVL~Gss 1227 (1236)
||||+|||++.++ .+||+|||+++...... ......+++.|+|||++.+..
T Consensus 162 dlkp~Nili~~~~----~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 215 (304)
T cd05101 162 DLAARNVLVTENN----VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRV 215 (304)
T ss_pred ccccceEEEcCCC----cEEECCCccceecccccccccccCCCCCceeeCchhhccCC
Confidence 9999999998776 57999999998764322 122234567899999997653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-24 Score=225.16 Aligned_cols=174 Identities=35% Similarity=0.559 Sum_probs=142.6
Q ss_pred cccccCeeEEEEeccCCceEEEEeeec-CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEec
Q 000893 1038 IIKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1236)
Q Consensus 1038 iIs~EdYeiLkkLGsGSFGtVYKArlk-G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t 1116 (1236)
.+..++|++.++||+|+||.||+|++. ...||||+++.... ....|.+|+.+++.++||||+++++.+..
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~---------~~~~~~~E~~~l~~l~~~~i~~~~~~~~~ 72 (262)
T cd05071 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---------SPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72 (262)
T ss_pred CCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc---------CHHHHHHHHHHHHhCCCCCcceEEEEECC
Confidence 345678999999999999999999884 34699999875321 12357889999999999999999998754
Q ss_pred CCCCeEEEEEeeccCCCHHHHHhhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEe
Q 000893 1117 GPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1236)
Q Consensus 1117 ~~~g~L~LVMEYm~GGSL~dlL~~k-~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsD 1195 (1236)
...++||||+++++|.+++... ...+++..+..++.|++.||+|||+.+|+||||||+|||++.++ .+||+|
T Consensus 73 ---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~----~~~L~d 145 (262)
T cd05071 73 ---EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL----VCKVAD 145 (262)
T ss_pred ---CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCC----cEEecc
Confidence 3578999999999999999753 34688999999999999999999999999999999999999876 569999
Q ss_pred ccCcccccCccc--ccCcCCCCcccchhhhcCCC
Q 000893 1196 FGLSKIKRNTLV--TGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1196 FGLArii~ns~~--tss~~GTp~YmAPEVL~Gss 1227 (1236)
||+++....... .....++..|+|||++.+..
T Consensus 146 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~ 179 (262)
T cd05071 146 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 179 (262)
T ss_pred CCceeeccccccccccCCcccceecCHhHhccCC
Confidence 999986543322 12334677899999987653
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=229.33 Aligned_cols=165 Identities=27% Similarity=0.454 Sum_probs=133.8
Q ss_pred EeccCCceEEEEeeec--------------------------CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhC
Q 000893 1049 ELGSGTFGTVYHGKWR--------------------------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102 (1236)
Q Consensus 1049 kLGsGSFGtVYKArlk--------------------------G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskL 1102 (1236)
.||+|+||.||+|.+. ...||+|++... .......|.+|+.+++.+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--------~~~~~~~~~~~~~~~~~l 73 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--------HRDIALAFFETASLMSQV 73 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--------HHHHHHHHHHHHHHHhcC
Confidence 4899999999998741 124888888643 223345688899999999
Q ss_pred CCCceeeEeeeEecCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEc
Q 000893 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVN 1182 (1236)
Q Consensus 1103 rHPNIVrLyG~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLD 1182 (1236)
+||||++++++|.... ..++||||+++++|..++......+++..+..++.||+.||+|||+++|+||||||+|||++
T Consensus 74 ~h~niv~~~~~~~~~~--~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~ 151 (274)
T cd05076 74 SHIHLAFVHGVCVRGS--ENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLA 151 (274)
T ss_pred CCCCeeeEEEEEEeCC--ceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEe
Confidence 9999999999998754 88999999999999999876666789999999999999999999999999999999999998
Q ss_pred cCCCC---CCcEEEEeccCcccccCcccccCcCCCCcccchhhhcCC
Q 000893 1183 LKDPI---RPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1183 sdG~I---~ltVKLsDFGLArii~ns~~tss~~GTp~YmAPEVL~Gs 1226 (1236)
..+.. ...+||+|||++...... ....++..|+|||++.+.
T Consensus 152 ~~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~ 195 (274)
T cd05076 152 RLGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGG 195 (274)
T ss_pred ccCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCC
Confidence 65421 134799999988653222 123478889999999764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.5e-24 Score=219.31 Aligned_cols=174 Identities=29% Similarity=0.463 Sum_probs=147.0
Q ss_pred CeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g 1120 (1236)
+|++.+.||+|+||.||++.. .+..+|||.+...... ......+.+|+.+|+.++||||+++++.+... .
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~ 72 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT------KDERLAAQNECQVLKLLSHPNIIEYYENFLED--K 72 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc------cHHHHHHHHHHHHHhhCCCCchhheeeeEecC--C
Confidence 588899999999999999887 4777999998754321 12245688899999999999999999998764 4
Q ss_pred eEEEEEeeccCCCHHHHHhhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1121 TLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1121 ~L~LVMEYm~GGSL~dlL~~k-~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
.+++||||+++++|.+++... ...+++..++.++.+++.||.|||+++|+||||||+||+++.++ ..+||+|||++
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~---~~~~l~d~~~~ 149 (256)
T cd08220 73 ALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHK---MVVKIGDFGIS 149 (256)
T ss_pred EEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC---CEEEEccCCCc
Confidence 899999999999999999764 34589999999999999999999999999999999999998654 25799999999
Q ss_pred ccccCcccccCcCCCCcccchhhhcCCC
Q 000893 1200 KIKRNTLVTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1200 rii~ns~~tss~~GTp~YmAPEVL~Gss 1227 (1236)
.............|+..|+|||++.+..
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 177 (256)
T cd08220 150 KILSSKSKAYTVVGTPCYISPELCEGKP 177 (256)
T ss_pred eecCCCccccccccCCcccCchhccCCC
Confidence 8776554444567899999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.6e-24 Score=222.10 Aligned_cols=178 Identities=31% Similarity=0.443 Sum_probs=146.5
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
.+|++.+.||+|+||.||+|.+ ++..||+|++..... ..........+.+|+.+++.++||||+++++++.....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPD---SQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEE 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcc---cchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCC
Confidence 5789999999999999999987 478899998754321 11123345678899999999999999999999887655
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
..+++||||+++++|.+++... ..+++..++.++.|++.||.|||+++|+||||||+||+++.++ .++|+|||++
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~----~~~l~dfg~~ 153 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAG----NVKLGDFGAS 153 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC----CEEECccccc
Confidence 6789999999999999998654 3578899999999999999999999999999999999998876 5699999999
Q ss_pred ccccCc----ccccCcCCCCcccchhhhcCCC
Q 000893 1200 KIKRNT----LVTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1200 rii~ns----~~tss~~GTp~YmAPEVL~Gss 1227 (1236)
+..... .......|+..|+|||++.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 185 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEG 185 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcCCC
Confidence 865321 1123456899999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-24 Score=247.12 Aligned_cols=177 Identities=20% Similarity=0.295 Sum_probs=137.6
Q ss_pred cccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCC------CCceeeEe
Q 000893 1040 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH------HPNVVAFY 1111 (1236)
Q Consensus 1040 s~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLr------HPNIVrLy 1111 (1236)
...+|+++++||+|+||+||+|.+ .++.||||+++... .....+..|+.+++.++ |.+|++++
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---------~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~ 197 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---------KYTRDAKIEIQFMEKVRQADPADRFPLMKIQ 197 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---------hhHHHHHHHHHHHHHHhhcCcccCcceeeeE
Confidence 357899999999999999999987 46779999986421 11223344666665554 45689999
Q ss_pred eeEecCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCcEEEccCCCC---
Q 000893 1112 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPI--- 1187 (1236)
Q Consensus 1112 G~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHS-kGIIHRDIKPsNILLDsdG~I--- 1187 (1236)
++|.... +++++|||++ +++|.+++... ..+++..++.|+.||+.||+|||. .|||||||||+||||+.++..
T Consensus 198 ~~~~~~~-~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 198 RYFQNET-GHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred EEEEcCC-ceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccc
Confidence 9987653 5889999998 88888888644 468999999999999999999998 599999999999999876531
Q ss_pred ---------CCcEEEEeccCcccccCcccccCcCCCCcccchhhhcCCCCCC
Q 000893 1188 ---------RPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1188 ---------~ltVKLsDFGLArii~ns~~tss~~GTp~YmAPEVL~Gss~~~ 1230 (1236)
...+||+|||++..... .....+||+.|+|||++.+..+..
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~~~ 324 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGLGWMY 324 (467)
T ss_pred ccccccCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhcCCCCc
Confidence 12489999998865322 234578999999999998864443
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=250.82 Aligned_cols=168 Identities=27% Similarity=0.360 Sum_probs=141.8
Q ss_pred ccCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCC
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1041 ~EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~ 1118 (1236)
...|.+.+.||+|+||.||+|.+. ++.||||.... ..+.+|+++|++|+|||||++++++...
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------------~~~~~E~~iL~~L~HpnIv~l~~~~~~~- 232 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------------ASSVHEARLLRRLSHPAVLALLDVRVVG- 232 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------------cCHHHHHHHHHHCCCCCCCcEEEEEEEC-
Confidence 457999999999999999999984 67799995421 1345799999999999999999998875
Q ss_pred CCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccC
Q 000893 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1236)
Q Consensus 1119 ~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGL 1198 (1236)
+..++||||+ .++|..++......+++..++.|+.||+.||.|||++|||||||||+||||+.++ .+||+|||+
T Consensus 233 -~~~~lv~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~----~vkL~DFGl 306 (461)
T PHA03211 233 -GLTCLVLPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPE----DICLGDFGA 306 (461)
T ss_pred -CEEEEEEEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCC----CEEEcccCC
Confidence 4889999999 5788888876666799999999999999999999999999999999999999876 569999999
Q ss_pred cccccCcc---cccCcCCCCcccchhhhcCCCCC
Q 000893 1199 SKIKRNTL---VTGGVRGTLPWMAPELLNGSSSK 1229 (1236)
Q Consensus 1199 Arii~ns~---~tss~~GTp~YmAPEVL~Gss~~ 1229 (1236)
++...... .....+||+.|+|||++.+....
T Consensus 307 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~ 340 (461)
T PHA03211 307 ACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYT 340 (461)
T ss_pred ceecccccccccccccCCCcCCcCHHHHcCCCCC
Confidence 98754321 22346799999999999876433
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-24 Score=225.91 Aligned_cols=179 Identities=31% Similarity=0.532 Sum_probs=143.4
Q ss_pred ccccCeeEEEEeccCCceEEEEeeecC-------ceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEe
Q 000893 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 1111 (1236)
Q Consensus 1039 Is~EdYeiLkkLGsGSFGtVYKArlkG-------~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLy 1111 (1236)
+..++|++.+.||+|+||.||+|.+.+ ..||+|.+.... .......|.+|+.+++.++|+||++++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~ 75 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-------SEQDESDFLMEALIMSKFNHQNIVRLI 75 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-------CHHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 345689999999999999999998843 558999875421 122345688999999999999999999
Q ss_pred eeEecCCCCeEEEEEeeccCCCHHHHHhhhc------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCC
Q 000893 1112 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKE------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKD 1185 (1236)
Q Consensus 1112 G~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~------r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG 1185 (1236)
+++.+.. ..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++++||||||+|||++.++
T Consensus 76 ~~~~~~~--~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~ 153 (277)
T cd05036 76 GVSFERL--PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKG 153 (277)
T ss_pred EEEccCC--CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccC
Confidence 9988754 7789999999999999996543 2588999999999999999999999999999999999998765
Q ss_pred CCCCcEEEEeccCcccccCcccc---cCcCCCCcccchhhhcCCC
Q 000893 1186 PIRPICKVGDFGLSKIKRNTLVT---GGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1186 ~I~ltVKLsDFGLArii~ns~~t---ss~~GTp~YmAPEVL~Gss 1227 (1236)
.. ..+||+|||+++........ .....++.|+|||++.+..
T Consensus 154 ~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 197 (277)
T cd05036 154 PG-RVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI 197 (277)
T ss_pred CC-cceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCC
Confidence 32 36899999999876332211 1223356799999997653
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-24 Score=225.66 Aligned_cols=171 Identities=32% Similarity=0.470 Sum_probs=140.6
Q ss_pred CeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g 1120 (1236)
+|++++.||+|++|.||+|+. ++..||||+++.... .+.....+.+|+.+++.++||||+++++++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 72 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE------EEGVPSTAIREISLLKELQHPNIVCLQDVLMQES-- 72 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc------cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCC--
Confidence 578899999999999999987 478899999865321 1122345678999999999999999999998754
Q ss_pred eEEEEEeeccCCCHHHHHhhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccC
Q 000893 1121 TLATVTEFMVNGSLRHVLLSKE--RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1236)
Q Consensus 1121 ~L~LVMEYm~GGSL~dlL~~k~--r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGL 1198 (1236)
.+++||||+. ++|..++.... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+
T Consensus 73 ~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~----~~~l~dfg~ 147 (285)
T cd07861 73 RLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKG----VIKLADFGL 147 (285)
T ss_pred eEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCC----cEEECcccc
Confidence 8999999996 68888875432 5689999999999999999999999999999999999999876 569999999
Q ss_pred cccccCcc-cccCcCCCCcccchhhhcCC
Q 000893 1199 SKIKRNTL-VTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1199 Arii~ns~-~tss~~GTp~YmAPEVL~Gs 1226 (1236)
+....... ......+++.|+|||++.+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 176 (285)
T cd07861 148 ARAFGIPVRVYTHEVVTLWYRAPEVLLGS 176 (285)
T ss_pred eeecCCCcccccCCcccccccChHHhcCC
Confidence 97643221 22334578999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=225.29 Aligned_cols=164 Identities=28% Similarity=0.416 Sum_probs=130.5
Q ss_pred EeccCCceEEEEeeec----CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeEEE
Q 000893 1049 ELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLAT 1124 (1236)
Q Consensus 1049 kLGsGSFGtVYKArlk----G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L~L 1124 (1236)
+||+|+||+||+|... ...+|+|.+.... .......|.+|+.+++.++||||+++++.|.... .+++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~--~~~l 72 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-------TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESI--PYLL 72 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC-------ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCC--ceEE
Confidence 5899999999999752 2357888765321 1223456888999999999999999999998754 8999
Q ss_pred EEeeccCCCHHHHHhhhc----cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcc
Q 000893 1125 VTEFMVNGSLRHVLLSKE----RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1236)
Q Consensus 1125 VMEYm~GGSL~dlL~~k~----r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLAr 1200 (1236)
||||+++++|.+++.... ...++...+.++.||+.||+|||+++|+||||||+|||++.++ .+||+|||++.
T Consensus 73 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~----~~kl~dfg~~~ 148 (269)
T cd05042 73 VLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADL----SVKIGDYGLAL 148 (269)
T ss_pred EEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCC----cEEEecccccc
Confidence 999999999999996643 2346777888999999999999999999999999999999876 57999999987
Q ss_pred cccCcc---cccCcCCCCcccchhhhcC
Q 000893 1201 IKRNTL---VTGGVRGTLPWMAPELLNG 1225 (1236)
Q Consensus 1201 ii~ns~---~tss~~GTp~YmAPEVL~G 1225 (1236)
...... ......+++.|+|||++..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 176 (269)
T cd05042 149 EQYPEDYYITKDCHAVPLRWLAPELVEI 176 (269)
T ss_pred ccccchheeccCCCCCcccccCHHHHhh
Confidence 642211 1223345778999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-24 Score=264.22 Aligned_cols=177 Identities=30% Similarity=0.448 Sum_probs=145.4
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
++|++.++||+|+||+||+|.+ .++.||||++..... .......+|.+|+.+++.++||||+++++++....
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~-----~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~- 75 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLS-----ENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD- 75 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccc-----cCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC-
Confidence 5799999999999999999987 478899999875321 12344567899999999999999999999998754
Q ss_pred CeEEEEEeeccCCCHHHHHhhh----------ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCC
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSK----------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP 1189 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k----------~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~l 1189 (1236)
..++||||++|++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 76 -~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg---- 150 (932)
T PRK13184 76 -PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFG---- 150 (932)
T ss_pred -EEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCC----
Confidence 899999999999999988642 12355677888999999999999999999999999999999887
Q ss_pred cEEEEeccCcccccCc-------------------ccccCcCCCCcccchhhhcCCCCC
Q 000893 1190 ICKVGDFGLSKIKRNT-------------------LVTGGVRGTLPWMAPELLNGSSSK 1229 (1236)
Q Consensus 1190 tVKLsDFGLArii~ns-------------------~~tss~~GTp~YmAPEVL~Gss~~ 1229 (1236)
.+||+|||+++..... ......+||+.|||||++.+....
T Consensus 151 ~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S 209 (932)
T PRK13184 151 EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPAS 209 (932)
T ss_pred CEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCC
Confidence 5699999999865110 111235799999999999876443
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-24 Score=223.29 Aligned_cols=173 Identities=28% Similarity=0.433 Sum_probs=148.5
Q ss_pred CeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g 1120 (1236)
+|++.++||.|+||.||++.+. +..||+|++.+.... .......+.+|+.++++++||||+++++++....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 73 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCV-----EKGSVRNVLNERRILQELNHPFLVNLWYSFQDEE-- 73 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhc-----chhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCC--
Confidence 4889999999999999999984 788999999764321 1234567889999999999999999999988754
Q ss_pred eEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcc
Q 000893 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1236)
Q Consensus 1121 ~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLAr 1200 (1236)
.+++||||+.+++|..++... ..+++..++.|+.||+.||.|||.++|+|+||+|+||+++.++ .++|+|||++.
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~----~~~l~d~~~~~ 148 (258)
T cd05578 74 NMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQG----HVHITDFNIAT 148 (258)
T ss_pred eEEEEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCC----CEEEeeccccc
Confidence 899999999999999998654 5789999999999999999999999999999999999999886 56999999998
Q ss_pred cccCcccccCcCCCCcccchhhhcCCC
Q 000893 1201 IKRNTLVTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1201 ii~ns~~tss~~GTp~YmAPEVL~Gss 1227 (1236)
............|+..|+|||++.+..
T Consensus 149 ~~~~~~~~~~~~~~~~y~~PE~~~~~~ 175 (258)
T cd05578 149 KVTPDTLTTSTSGTPGYMAPEVLCRQG 175 (258)
T ss_pred ccCCCccccccCCChhhcCHHHHcccC
Confidence 765554445567899999999998654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6e-24 Score=222.06 Aligned_cols=177 Identities=32% Similarity=0.461 Sum_probs=145.7
Q ss_pred CeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g 1120 (1236)
+|+..+.||+|+||.||+|.. ++..||+|++...... .........+.+|+.+++.++||||+++++++......
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 79 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPES---PETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEK 79 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCC---chhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCC
Confidence 678889999999999999987 4788999998754321 11233456788999999999999999999998875556
Q ss_pred eEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcc
Q 000893 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1236)
Q Consensus 1121 ~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLAr 1200 (1236)
.++++|||+++++|.+++... ..+++..++.++.|++.||.|||+++|+||||||+||+++.++ .+||+|||+++
T Consensus 80 ~~~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~----~~~l~dfg~~~ 154 (266)
T cd06651 80 TLTIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAG----NVKLGDFGASK 154 (266)
T ss_pred EEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC----CEEEccCCCcc
Confidence 889999999999999998653 3588999999999999999999999999999999999998775 57999999998
Q ss_pred cccCcc----cccCcCCCCcccchhhhcCCC
Q 000893 1201 IKRNTL----VTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1201 ii~ns~----~tss~~GTp~YmAPEVL~Gss 1227 (1236)
...... ......++..|+|||++.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 185 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEG 185 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCC
Confidence 653321 112355889999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6e-24 Score=219.65 Aligned_cols=177 Identities=24% Similarity=0.424 Sum_probs=147.1
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
++|++.+.||+|+||.||+|.. .++.||+|.++..... .......+.+|+.++++++|+||+++++++....
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~- 75 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMM-----DAKARQDCLKEIDLLKQLDHPNVIKYLASFIENN- 75 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeeccccc-----chhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCC-
Confidence 5789999999999999999998 4888999998753221 1223456889999999999999999999998754
Q ss_pred CeEEEEEeeccCCCHHHHHhhh---ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEec
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSK---ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k---~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDF 1196 (1236)
..++||||+++++|..++... ...+++..++.++.+++.||.|||+.||+||||||+||+++.++ .++|+||
T Consensus 76 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~----~~~l~d~ 150 (267)
T cd08224 76 -ELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATG----VVKLGDL 150 (267)
T ss_pred -eEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCC----cEEEecc
Confidence 889999999999999988642 34588999999999999999999999999999999999999876 5699999
Q ss_pred cCcccccCcc-cccCcCCCCcccchhhhcCCCCC
Q 000893 1197 GLSKIKRNTL-VTGGVRGTLPWMAPELLNGSSSK 1229 (1236)
Q Consensus 1197 GLArii~ns~-~tss~~GTp~YmAPEVL~Gss~~ 1229 (1236)
|++....... ......+++.|+|||++.+....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~ 184 (267)
T cd08224 151 GLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN 184 (267)
T ss_pred ceeeeccCCCcccceecCCccccCHHHhccCCCC
Confidence 9988654332 22345688999999999876433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=224.84 Aligned_cols=175 Identities=31% Similarity=0.521 Sum_probs=145.3
Q ss_pred cccCeeEEEEeccCCceEEEEeeec-CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCC
Q 000893 1040 KNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1040 s~EdYeiLkkLGsGSFGtVYKArlk-G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~ 1118 (1236)
...+|++.++||.|+||.||+|.+. +..+|+|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 75 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD--------LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGE 75 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc--------hhhHHHHHHHHHHHhcCCCcchhheeeeEecCC
Confidence 3467889999999999999999985 5779999987542 222446788999999999999999999998764
Q ss_pred CCeEEEEEeeccCCCHHHHHhhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEecc
Q 000893 1119 GGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1236)
Q Consensus 1119 ~g~L~LVMEYm~GGSL~dlL~~k-~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFG 1197 (1236)
.+++||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 76 --~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~----~~kl~d~g 149 (261)
T cd05148 76 --PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDL----VCKVADFG 149 (261)
T ss_pred --CeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCc----eEEEcccc
Confidence 889999999999999999764 34689999999999999999999999999999999999999876 57999999
Q ss_pred CcccccCccc-ccCcCCCCcccchhhhcCCCC
Q 000893 1198 LSKIKRNTLV-TGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1198 LArii~ns~~-tss~~GTp~YmAPEVL~Gss~ 1228 (1236)
++........ .....++..|+|||++.+...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~ 181 (261)
T cd05148 150 LARLIKEDVYLSSDKKIPYKWTAPEAASHGTF 181 (261)
T ss_pred chhhcCCccccccCCCCceEecCHHHHccCCC
Confidence 9987643322 223345678999999976543
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-24 Score=228.74 Aligned_cols=173 Identities=34% Similarity=0.474 Sum_probs=138.5
Q ss_pred cCeeEEEEeccCCceEEEEeeec--Cc--eEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhC-CCCceeeEeeeEec
Q 000893 1042 EDLEELKELGSGTFGTVYHGKWR--GT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQD 1116 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArlk--G~--~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskL-rHPNIVrLyG~f~t 1116 (1236)
++|++.+.||+|+||.||+|.++ +. .+++|.++... .......|.+|+.+++++ +||||+++++++..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 74 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-------SENDHRDFAGELEVLCKLGHHPNIINLLGACEN 74 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC-------CHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc
Confidence 57899999999999999999874 32 47888876321 112245688899999999 79999999999887
Q ss_pred CCCCeEEEEEeeccCCCHHHHHhhhc---------------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEE
Q 000893 1117 GPGGTLATVTEFMVNGSLRHVLLSKE---------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV 1181 (1236)
Q Consensus 1117 ~~~g~L~LVMEYm~GGSL~dlL~~k~---------------r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILL 1181 (1236)
.. .+++||||+++++|.+++.... ..+++..++.|+.||+.||+|||++||+||||||+||||
T Consensus 75 ~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill 152 (297)
T cd05089 75 RG--YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV 152 (297)
T ss_pred CC--cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEE
Confidence 54 7899999999999999996532 247888999999999999999999999999999999999
Q ss_pred ccCCCCCCcEEEEeccCcccccCcccccCcCCCCcccchhhhcCCC
Q 000893 1182 NLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1182 DsdG~I~ltVKLsDFGLArii~ns~~tss~~GTp~YmAPEVL~Gss 1227 (1236)
+.++ .+||+|||++..............+..|+|||++.+..
T Consensus 153 ~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 194 (297)
T cd05089 153 GENL----ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSV 194 (297)
T ss_pred CCCC----eEEECCcCCCccccceeccCCCCcCccccCchhhccCC
Confidence 8875 56999999987543222222223356799999997664
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.8e-24 Score=220.75 Aligned_cols=177 Identities=36% Similarity=0.583 Sum_probs=146.2
Q ss_pred cccccCeeEEEEeccCCceEEEEeeec-CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEec
Q 000893 1038 IIKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1236)
Q Consensus 1038 iIs~EdYeiLkkLGsGSFGtVYKArlk-G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t 1116 (1236)
.+..++|++.++||+|+||.||+|.+. +..||||.+..... ...++.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM---------SPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc---------CHHHHHHHHHHHhhCCCCCEeeeeeeeec
Confidence 456789999999999999999999874 46699999875321 13457889999999999999999999887
Q ss_pred CCCCeEEEEEeeccCCCHHHHHhhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEe
Q 000893 1117 GPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1236)
Q Consensus 1117 ~~~g~L~LVMEYm~GGSL~dlL~~k~-r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsD 1195 (1236)
.. .+++||||+++++|.+++.... ..+++..++.++.+++.||.|||+++|+|+||||+||+|+.++ .+||+|
T Consensus 73 ~~--~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~----~~~l~d 146 (261)
T cd05034 73 EE--PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENL----VCKIAD 146 (261)
T ss_pred CC--ceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCC----CEEECc
Confidence 44 7899999999999999997643 5689999999999999999999999999999999999999886 569999
Q ss_pred ccCcccccCccc--ccCcCCCCcccchhhhcCCCCC
Q 000893 1196 FGLSKIKRNTLV--TGGVRGTLPWMAPELLNGSSSK 1229 (1236)
Q Consensus 1196 FGLArii~ns~~--tss~~GTp~YmAPEVL~Gss~~ 1229 (1236)
||++........ .....++..|+|||.+.+....
T Consensus 147 ~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~ 182 (261)
T cd05034 147 FGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFT 182 (261)
T ss_pred cccceeccchhhhhhhccCCCccccCHHHhccCCcC
Confidence 999887543221 1123346789999999865433
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-24 Score=226.73 Aligned_cols=172 Identities=29% Similarity=0.437 Sum_probs=142.5
Q ss_pred ccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCC
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1041 ~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~ 1118 (1236)
.++|++.+.||+|++|.||+|.. .++.||||.+...... .....+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 76 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-------GAPFTAIREASLLKDLKHANIVTLHDIIHTKK 76 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-------CCchhHHHHHHHHhhCCCcceeeEEEEEecCC
Confidence 47899999999999999999987 4788999998754211 11224568999999999999999999998754
Q ss_pred CCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccC
Q 000893 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1236)
Q Consensus 1119 ~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGL 1198 (1236)
..++||||+. ++|.+++......+++..++.++.|++.||.|||+++|+||||||+|||++.++ .+||+|||+
T Consensus 77 --~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~----~~kl~dfg~ 149 (291)
T cd07844 77 --TLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERG----ELKLADFGL 149 (291)
T ss_pred --eEEEEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCC----CEEECcccc
Confidence 8999999996 599998877666789999999999999999999999999999999999999876 579999999
Q ss_pred cccccCcc-cccCcCCCCcccchhhhcCC
Q 000893 1199 SKIKRNTL-VTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1199 Arii~ns~-~tss~~GTp~YmAPEVL~Gs 1226 (1236)
++...... ......++..|+|||++.+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 178 (291)
T cd07844 150 ARAKSVPSKTYSNEVVTLWYRPPDVLLGS 178 (291)
T ss_pred ccccCCCCccccccccccccCCcHHhhcC
Confidence 87643221 12233568899999998753
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-24 Score=245.19 Aligned_cols=179 Identities=30% Similarity=0.420 Sum_probs=145.1
Q ss_pred ccccccCeeEEEEeccCCceEEEEeeecC-------ceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCC-CCcee
Q 000893 1037 QIIKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVV 1108 (1236)
Q Consensus 1037 qiIs~EdYeiLkkLGsGSFGtVYKArlkG-------~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLr-HPNIV 1108 (1236)
+.+..++|.+.+.||+|+||.||+|++.+ ..||||+++... .......+.+|+.+|.++. |||||
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-------~~~~~~~~~~E~~~l~~l~~H~niv 104 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-------RSSEKQALMSELKIMSHLGPHLNIV 104 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-------ChhHHHHHHHHHHHHHhcCCCCCeE
Confidence 56677889999999999999999998643 469999997532 1122346889999999997 99999
Q ss_pred eEeeeEecCCCCeEEEEEeeccCCCHHHHHhhhc----------------------------------------------
Q 000893 1109 AFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------------------------------------------- 1142 (1236)
Q Consensus 1109 rLyG~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~---------------------------------------------- 1142 (1236)
+++++|.... .+++|||||.+|+|.+++....
T Consensus 105 ~~~~~~~~~~--~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (401)
T cd05107 105 NLLGACTKGG--PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMS 182 (401)
T ss_pred EEEEEEccCC--CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccC
Confidence 9999998754 8999999999999999986432
Q ss_pred ---------------------------------------------------cCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 000893 1143 ---------------------------------------------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVH 1171 (1236)
Q Consensus 1143 ---------------------------------------------------r~LSe~erl~Ia~QIAeALaYLHSkGIIH 1171 (1236)
..+++..++.|+.||+.||.|||+++|+|
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH 262 (401)
T cd05107 183 KDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVH 262 (401)
T ss_pred CccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCc
Confidence 13567778889999999999999999999
Q ss_pred CCCCCCcEEEccCCCCCCcEEEEeccCcccccCcc---cccCcCCCCcccchhhhcCCCC
Q 000893 1172 FDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1172 RDIKPsNILLDsdG~I~ltVKLsDFGLArii~ns~---~tss~~GTp~YmAPEVL~Gss~ 1228 (1236)
|||||+|||++.++ .+||+|||+++...... ......+++.|+|||++.+...
T Consensus 263 rdlkp~NiLl~~~~----~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 318 (401)
T cd05107 263 RDLAARNVLICEGK----LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY 318 (401)
T ss_pred ccCCcceEEEeCCC----EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC
Confidence 99999999998765 67999999998643221 1223457889999999986543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-24 Score=224.13 Aligned_cols=171 Identities=30% Similarity=0.441 Sum_probs=145.9
Q ss_pred CeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g 1120 (1236)
+|++.+.||.|+||.||+|.+ .++.||||++...... ......+.+|+.+++.++||||+++++++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-- 72 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE------GGIPNQALREIKALQACQHPYVVKLLDVFPHGS-- 72 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc------chhhHHHHHHHHHHHhCCCCCCcceeeEEecCC--
Confidence 588999999999999999997 4788999998764321 223456888999999999999999999998754
Q ss_pred eEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcc
Q 000893 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1236)
Q Consensus 1121 ~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLAr 1200 (1236)
.+++||||+ +++|.+++......+++..++.++.||+.||.|||+++|+|+||||+||+++.++ .++|+|||++.
T Consensus 73 ~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~----~~~l~dfg~~~ 147 (286)
T cd07832 73 GFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADG----VLKIADFGLAR 147 (286)
T ss_pred eeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCC----cEEEeeeeecc
Confidence 899999999 9999999977667799999999999999999999999999999999999999876 56999999998
Q ss_pred cccCcc--cccCcCCCCcccchhhhcCC
Q 000893 1201 IKRNTL--VTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1201 ii~ns~--~tss~~GTp~YmAPEVL~Gs 1226 (1236)
...... ......|+..|+|||++.+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 175 (286)
T cd07832 148 LFSEEEPRLYSHQVATRWYRAPELLYGA 175 (286)
T ss_pred cccCCCCCccccccCcccccCceeeecc
Confidence 764432 23345689999999998754
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-24 Score=223.30 Aligned_cols=172 Identities=28% Similarity=0.380 Sum_probs=142.8
Q ss_pred cCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
++|++.+.||+|+||.||+|+++ ++.||+|++...... ......+.+|+.+++.++||||+++++++....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~- 73 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD------PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKR- 73 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC------ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCC-
Confidence 46899999999999999999984 788999998753211 112235678999999999999999999998754
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
.+++||||++++.|..++. ....+++..++.++.||+.||.|||+++|+||||||+||+++.++ .+||+|||++
T Consensus 74 -~~~~v~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~----~~~l~dfg~~ 147 (286)
T cd07847 74 -KLHLVFEYCDHTVLNELEK-NPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQG----QIKLCDFGFA 147 (286)
T ss_pred -EEEEEEeccCccHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCC----cEEECccccc
Confidence 8899999999888877764 344689999999999999999999999999999999999999876 5799999999
Q ss_pred ccccCcc-cccCcCCCCcccchhhhcCC
Q 000893 1200 KIKRNTL-VTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1200 rii~ns~-~tss~~GTp~YmAPEVL~Gs 1226 (1236)
....... ......++..|+|||++.+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 175 (286)
T cd07847 148 RILTGPGDDYTDYVATRWYRAPELLVGD 175 (286)
T ss_pred eecCCCcccccCcccccccCCHHHHhCC
Confidence 8764433 23345678999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.6e-24 Score=222.53 Aligned_cols=174 Identities=35% Similarity=0.592 Sum_probs=143.1
Q ss_pred cccccCeeEEEEeccCCceEEEEeeec-CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEec
Q 000893 1038 IIKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1236)
Q Consensus 1038 iIs~EdYeiLkkLGsGSFGtVYKArlk-G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t 1116 (1236)
.+..++|+++++||+|+||.||+|... +..||+|.+...... ...|.+|+.++++++||||+++++++..
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~---------~~~~~~E~~~l~~l~~~~i~~~~~~~~~ 72 (260)
T cd05070 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS---------PESFLEEAQIMKKLRHDKLVQLYAVVSE 72 (260)
T ss_pred CCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC---------HHHHHHHHHHHHhcCCCceEEEEeEECC
Confidence 456678999999999999999999874 567999998754221 2357889999999999999999998754
Q ss_pred CCCCeEEEEEeeccCCCHHHHHhhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEe
Q 000893 1117 GPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1236)
Q Consensus 1117 ~~~g~L~LVMEYm~GGSL~dlL~~k-~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsD 1195 (1236)
...++||||+++++|.+++... ...+++..++.++.+++.||.|||+++|+||||||+|||++.++ .+||+|
T Consensus 73 ---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~----~~~l~d 145 (260)
T cd05070 73 ---EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGL----VCKIAD 145 (260)
T ss_pred ---CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCc----eEEeCC
Confidence 3578999999999999998654 34589999999999999999999999999999999999999875 679999
Q ss_pred ccCcccccCccc--ccCcCCCCcccchhhhcCCC
Q 000893 1196 FGLSKIKRNTLV--TGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1196 FGLArii~ns~~--tss~~GTp~YmAPEVL~Gss 1227 (1236)
||++........ .....++..|+|||++.+..
T Consensus 146 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 179 (260)
T cd05070 146 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 179 (260)
T ss_pred ceeeeeccCcccccccCCCCCccccChHHHhcCC
Confidence 999987543221 12234567899999987653
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.7e-24 Score=222.36 Aligned_cols=177 Identities=33% Similarity=0.549 Sum_probs=146.4
Q ss_pred ccCeeEEEEeccCCceEEEEeeec------CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeE
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKWR------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVV 1114 (1236)
Q Consensus 1041 ~EdYeiLkkLGsGSFGtVYKArlk------G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f 1114 (1236)
.++|++++.||+|+||.||++++. +..||||+++.... ......|.+|+.+++.+.||||+++++++
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~-------~~~~~~~~~ei~~l~~l~~~~i~~~~~~~ 75 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE-------EQHRSDFEREIEILRTLDHENIVKYKGVC 75 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc-------hHHHHHHHHHHHHHHhCCCCChheEEeee
Confidence 356788899999999999999863 56799999875421 13456788999999999999999999998
Q ss_pred ecCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEE
Q 000893 1115 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1236)
Q Consensus 1115 ~t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLs 1194 (1236)
........++||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+
T Consensus 76 ~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~----~~~l~ 151 (284)
T cd05038 76 EKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESED----LVKIS 151 (284)
T ss_pred ecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC----CEEEc
Confidence 87555588999999999999999977666799999999999999999999999999999999999999875 67999
Q ss_pred eccCcccccCccc----ccCcCCCCcccchhhhcCCCC
Q 000893 1195 DFGLSKIKRNTLV----TGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1195 DFGLArii~ns~~----tss~~GTp~YmAPEVL~Gss~ 1228 (1236)
|||++........ .....++..|+|||++.+...
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~ 189 (284)
T cd05038 152 DFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKF 189 (284)
T ss_pred ccccccccccCCcceeccCCCCCcccccCcHHHccCCC
Confidence 9999987652211 112334567999999976543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-24 Score=223.14 Aligned_cols=175 Identities=31% Similarity=0.511 Sum_probs=143.3
Q ss_pred ccccCeeEEEEeccCCceEEEEeeecC-----ceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeee
Q 000893 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGV 1113 (1236)
Q Consensus 1039 Is~EdYeiLkkLGsGSFGtVYKArlkG-----~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~ 1113 (1236)
+..++|.+.+.||+|+||.||+|.+.. ..||||.+.... .......|.+|+.+++.++||||++++++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-------~~~~~~~~~~e~~~l~~~~h~~i~~~~~~ 75 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-------SPSVREKFLQEAYIMRQFDHPHIVKLIGV 75 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-------CHHHHHHHHHHHHHHHhCCCCchhceeEE
Confidence 445678999999999999999998732 358999886432 12334578899999999999999999999
Q ss_pred EecCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEE
Q 000893 1114 VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193 (1236)
Q Consensus 1114 f~t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKL 1193 (1236)
+... ..++||||+++++|.+++......+++..++.++.+++.||.|||+++++||||||+|||++.++ .+||
T Consensus 76 ~~~~---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~----~~~l 148 (270)
T cd05056 76 ITEN---PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPD----CVKL 148 (270)
T ss_pred EcCC---CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCC----CeEE
Confidence 8753 57899999999999999976666789999999999999999999999999999999999999876 5799
Q ss_pred EeccCcccccCcccc--cCcCCCCcccchhhhcCCC
Q 000893 1194 GDFGLSKIKRNTLVT--GGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1194 sDFGLArii~ns~~t--ss~~GTp~YmAPEVL~Gss 1227 (1236)
+|||+++........ ....+++.|+|||++.+..
T Consensus 149 ~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 184 (270)
T cd05056 149 GDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRR 184 (270)
T ss_pred ccCceeeecccccceecCCCCccccccChhhhccCC
Confidence 999999875443221 1223456899999987653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.1e-24 Score=229.56 Aligned_cols=179 Identities=30% Similarity=0.463 Sum_probs=143.3
Q ss_pred ccccccCeeEEEEeccCCceEEEEeeec---------CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhC-CCCc
Q 000893 1037 QIIKNEDLEELKELGSGTFGTVYHGKWR---------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPN 1106 (1236)
Q Consensus 1037 qiIs~EdYeiLkkLGsGSFGtVYKArlk---------G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskL-rHPN 1106 (1236)
+.+..++|.+.+.||+|+||.||+++.. ...||+|+++... .......+.+|+.+++.+ +|||
T Consensus 7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~ 79 (314)
T cd05099 7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-------TDKDLADLISEMELMKLIGKHKN 79 (314)
T ss_pred ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-------ChHHHHHHHHHHHHHHhccCCCC
Confidence 3455678999999999999999999752 3459999886432 122345688899999999 6999
Q ss_pred eeeEeeeEecCCCCeEEEEEeeccCCCHHHHHhhhc---------------cCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 000893 1107 VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVH 1171 (1236)
Q Consensus 1107 IVrLyG~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~---------------r~LSe~erl~Ia~QIAeALaYLHSkGIIH 1171 (1236)
|++++++|... +.+++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+|
T Consensus 80 iv~~~~~~~~~--~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H 157 (314)
T cd05099 80 IINLLGVCTQE--GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIH 157 (314)
T ss_pred eeeEEEEEccC--CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence 99999998874 47899999999999999996532 34788899999999999999999999999
Q ss_pred CCCCCCcEEEccCCCCCCcEEEEeccCcccccCccc---ccCcCCCCcccchhhhcCCCC
Q 000893 1172 FDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLV---TGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1172 RDIKPsNILLDsdG~I~ltVKLsDFGLArii~ns~~---tss~~GTp~YmAPEVL~Gss~ 1228 (1236)
|||||+|||++.++ .+||+|||+++....... .....+++.|+|||++.+...
T Consensus 158 ~dlkp~Nill~~~~----~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 213 (314)
T cd05099 158 RDLAARNVLVTEDN----VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVY 213 (314)
T ss_pred ccccceeEEEcCCC----cEEEccccccccccccccccccccCCCCccccCHHHHccCCc
Confidence 99999999998876 579999999987543221 112234567999999976543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=227.74 Aligned_cols=171 Identities=30% Similarity=0.424 Sum_probs=141.9
Q ss_pred CeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g 1120 (1236)
+|++.+.||+|+||.||+|++ +|..||+|+++..... ......+.+|+.+++.++||||+++++++....
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~------~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~-- 72 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD------EGVPSSALREICLLKELKHKNIVRLYDVLHSDK-- 72 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc------ccCccchhHHHHHHHhcCCCCeeeHHHHhccCC--
Confidence 478899999999999999998 4788999998754211 112245677999999999999999999998754
Q ss_pred eEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcc
Q 000893 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1236)
Q Consensus 1121 ~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLAr 1200 (1236)
.+++|+||+. ++|..++......+++..++.++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+++
T Consensus 73 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~----~~~l~dfg~~~ 147 (284)
T cd07839 73 KLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNG----ELKLADFGLAR 147 (284)
T ss_pred ceEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCC----cEEECccchhh
Confidence 8999999995 688888866566799999999999999999999999999999999999999876 56999999998
Q ss_pred cccCcc-cccCcCCCCcccchhhhcCC
Q 000893 1201 IKRNTL-VTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1201 ii~ns~-~tss~~GTp~YmAPEVL~Gs 1226 (1236)
...... ......+++.|+|||++.+.
T Consensus 148 ~~~~~~~~~~~~~~~~~y~aPE~~~~~ 174 (284)
T cd07839 148 AFGIPVRCYSAEVVTLWYRPPDVLFGA 174 (284)
T ss_pred ccCCCCCCcCCCccccCCcChHHHhCC
Confidence 653321 22335678999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.3e-24 Score=221.27 Aligned_cols=176 Identities=34% Similarity=0.575 Sum_probs=145.2
Q ss_pred cccccCeeEEEEeccCCceEEEEeee-cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEec
Q 000893 1038 IIKNEDLEELKELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1236)
Q Consensus 1038 iIs~EdYeiLkkLGsGSFGtVYKArl-kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t 1116 (1236)
++..++|+++++||+|+||.||+|.. .++.||+|.+..... ....|.+|+.++++++||||+++++++..
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~---------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 72 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM---------SPEAFLAEANLMKQLQHPRLVRLYAVVTQ 72 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC---------cHHHHHHHHHHHHhcCCcCeeeEEEEEcc
Confidence 45678999999999999999999988 467899999875421 12457889999999999999999998743
Q ss_pred CCCCeEEEEEeeccCCCHHHHHhhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEe
Q 000893 1117 GPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1236)
Q Consensus 1117 ~~~g~L~LVMEYm~GGSL~dlL~~k-~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsD 1195 (1236)
..+++||||+.+++|.+++... +..+++..++.++.|++.||+|||+.|++||||||+||+++.++ .++|+|
T Consensus 73 ---~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~----~~~l~d 145 (260)
T cd05067 73 ---EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETL----CCKIAD 145 (260)
T ss_pred ---CCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCC----CEEEcc
Confidence 3689999999999999988653 34689999999999999999999999999999999999999876 579999
Q ss_pred ccCcccccCcc--cccCcCCCCcccchhhhcCCCCC
Q 000893 1196 FGLSKIKRNTL--VTGGVRGTLPWMAPELLNGSSSK 1229 (1236)
Q Consensus 1196 FGLArii~ns~--~tss~~GTp~YmAPEVL~Gss~~ 1229 (1236)
||++....... ......++..|+|||++.+....
T Consensus 146 fg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~ 181 (260)
T cd05067 146 FGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 181 (260)
T ss_pred CcceeecCCCCcccccCCcccccccCHHHhccCCcC
Confidence 99998755222 12234467789999999765433
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.6e-24 Score=219.50 Aligned_cols=166 Identities=36% Similarity=0.582 Sum_probs=137.0
Q ss_pred EeccCCceEEEEeee-cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeEEEEEe
Q 000893 1049 ELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTE 1127 (1236)
Q Consensus 1049 kLGsGSFGtVYKArl-kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L~LVME 1127 (1236)
+||+|+||.||+|.. .+..||+|++.... .......|.+|+.+++.++||||+++++++.... ..++|||
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e 72 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-------PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQ--PIYIVME 72 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcC-------CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCC--ccEEEEE
Confidence 589999999999987 46779999886532 1223346889999999999999999999998754 7899999
Q ss_pred eccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcccccCccc
Q 000893 1128 FMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLV 1207 (1236)
Q Consensus 1128 Ym~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~ns~~ 1207 (1236)
|+++++|..++......+++..++.++.+++.||.|||.+|++||||||+||+++.++ .+||+|||++........
T Consensus 73 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~----~~~l~d~g~~~~~~~~~~ 148 (250)
T cd05085 73 LVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENN----VLKISDFGMSRQEDDGIY 148 (250)
T ss_pred CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCC----eEEECCCccceecccccc
Confidence 9999999999876666789999999999999999999999999999999999998876 579999999976443322
Q ss_pred c--cCcCCCCcccchhhhcCCC
Q 000893 1208 T--GGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1208 t--ss~~GTp~YmAPEVL~Gss 1227 (1236)
. ....+++.|+|||++.+..
T Consensus 149 ~~~~~~~~~~~y~aPE~~~~~~ 170 (250)
T cd05085 149 SSSGLKQIPIKWTAPEALNYGR 170 (250)
T ss_pred ccCCCCCCcccccCHHHhccCC
Confidence 1 1223466799999997653
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-24 Score=223.43 Aligned_cols=165 Identities=30% Similarity=0.433 Sum_probs=132.9
Q ss_pred EeccCCceEEEEeeec----CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeEEE
Q 000893 1049 ELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLAT 1124 (1236)
Q Consensus 1049 kLGsGSFGtVYKArlk----G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L~L 1124 (1236)
.||+|+||.||+|.+. +..+|+|.++... .......|.+|+.+++.++||||+++++++.... .+++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~l 72 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA-------SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVT--PYLL 72 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCC-------ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC--CcEE
Confidence 5899999999999863 3458999876532 1122346888999999999999999999998754 7899
Q ss_pred EEeeccCCCHHHHHhhhc----cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcc
Q 000893 1125 VTEFMVNGSLRHVLLSKE----RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1236)
Q Consensus 1125 VMEYm~GGSL~dlL~~k~----r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLAr 1200 (1236)
||||+++++|.+++.... ...++..++.++.|++.||+|||+++++||||||+|||++.++ .+||+|||+++
T Consensus 73 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~----~~kL~dfg~~~ 148 (269)
T cd05087 73 VMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADL----TVKIGDYGLSH 148 (269)
T ss_pred EEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC----cEEECCccccc
Confidence 999999999999986532 2456677788999999999999999999999999999998865 67999999997
Q ss_pred cccCcc---cccCcCCCCcccchhhhcCC
Q 000893 1201 IKRNTL---VTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1201 ii~ns~---~tss~~GTp~YmAPEVL~Gs 1226 (1236)
...... ......+++.|+|||++.+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 177 (269)
T cd05087 149 NKYKEDYYVTPDQLWVPLRWIAPELVDEV 177 (269)
T ss_pred cccCcceeecCCCcCCcccccCHhHhccc
Confidence 643322 12235678889999999753
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.92 E-value=5e-24 Score=223.02 Aligned_cols=165 Identities=35% Similarity=0.534 Sum_probs=134.6
Q ss_pred EeccCCceEEEEeeec----CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeEEE
Q 000893 1049 ELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLAT 1124 (1236)
Q Consensus 1049 kLGsGSFGtVYKArlk----G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L~L 1124 (1236)
.||+|+||.||+|.+. +..||||++.... .......|.+|+.+++.++||||+++++++.. ..+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~---~~~~l 71 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-------EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA---EALML 71 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-------ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC---CCeEE
Confidence 3899999999999763 4459999986531 12334568899999999999999999998864 36899
Q ss_pred EEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcccccC
Q 000893 1125 VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 1204 (1236)
Q Consensus 1125 VMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~n 1204 (1236)
||||+++++|.+++......+++..++.++.||+.||.|||++|++||||||+|||++.++ .+||+|||++.....
T Consensus 72 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~----~~kl~dfg~~~~~~~ 147 (257)
T cd05115 72 VMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQH----YAKISDFGLSKALGA 147 (257)
T ss_pred EEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCC----cEEeccCCccccccC
Confidence 9999999999999976666799999999999999999999999999999999999998775 679999999986432
Q ss_pred ccc----ccCcCCCCcccchhhhcCCC
Q 000893 1205 TLV----TGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1205 s~~----tss~~GTp~YmAPEVL~Gss 1227 (1236)
... .....+++.|+|||++.+..
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~ 174 (257)
T cd05115 148 DDSYYKARSAGKWPLKWYAPECINFRK 174 (257)
T ss_pred CccceeccCCCCCCcccCCHHHHccCC
Confidence 211 11122357899999987653
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.2e-24 Score=220.10 Aligned_cols=179 Identities=28% Similarity=0.461 Sum_probs=145.5
Q ss_pred CeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCC-ChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGR-SSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~-~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
+|.+.+.||+|+||.||+|.. .++.||+|.+........ ..........+.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 79 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDAD- 79 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-
Confidence 366778899999999999987 467899998876533221 2223344567889999999999999999999998754
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
..++||||+++++|..++... ..+++..+..++.|++.||.|||++|++||||+|+|||++.++ .+||+|||++
T Consensus 80 -~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~----~~~l~dfg~~ 153 (267)
T cd06628 80 -HLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKG----GIKISDFGIS 153 (267)
T ss_pred -ccEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCC----CEEecccCCC
Confidence 889999999999999999653 4688899999999999999999999999999999999998776 5799999999
Q ss_pred ccccCcc-------cccCcCCCCcccchhhhcCCCC
Q 000893 1200 KIKRNTL-------VTGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1200 rii~ns~-------~tss~~GTp~YmAPEVL~Gss~ 1228 (1236)
+...... ......|+..|+|||++.+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~ 189 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSY 189 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCC
Confidence 8764211 1123468899999999986543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.4e-24 Score=219.19 Aligned_cols=173 Identities=33% Similarity=0.601 Sum_probs=143.9
Q ss_pred ccCeeEEEEeccCCceEEEEeeec-CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1041 ~EdYeiLkkLGsGSFGtVYKArlk-G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
..+|++.+.||+|+||.||++.+. +..+|||+++..... ...|.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~---------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 72 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS---------EEDFIEEAQVMMKLSHPKLVQLYGVCTERS- 72 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC---------HHHHHHHHHHHHhCCCCCeeeEEEEEccCC-
Confidence 457889999999999999999885 778999988754221 235778999999999999999999987754
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
..++||||+++++|.+++......+++..++.++.|++.||.|||+++++||||||+||+++.++ .+||+|||++
T Consensus 73 -~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~----~~~l~d~g~~ 147 (256)
T cd05112 73 -PICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ----VVKVSDFGMT 147 (256)
T ss_pred -ceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCC----eEEECCCcce
Confidence 88999999999999999976666789999999999999999999999999999999999998775 5799999998
Q ss_pred ccccCccc--ccCcCCCCcccchhhhcCCCC
Q 000893 1200 KIKRNTLV--TGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1200 rii~ns~~--tss~~GTp~YmAPEVL~Gss~ 1228 (1236)
........ .....++..|+|||++.+...
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~ 178 (256)
T cd05112 148 RFVLDDQYTSSTGTKFPVKWSSPEVFSFSKY 178 (256)
T ss_pred eecccCcccccCCCccchhhcCHhHhccCCc
Confidence 86543222 122335678999999986543
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.2e-24 Score=220.75 Aligned_cols=178 Identities=27% Similarity=0.472 Sum_probs=145.8
Q ss_pred CeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g 1120 (1236)
+|+..+.||+|+||.||+++. +++.||||++..... ...........+.+|+.+++.++|+||+++++++....
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~--~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 76 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRN--TSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDS-- 76 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccC--CchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCC--
Confidence 467788999999999999987 578899999875421 11223345677889999999999999999999998754
Q ss_pred eEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcc
Q 000893 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1236)
Q Consensus 1121 ~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLAr 1200 (1236)
.+++||||+++++|.+++... ..+++..++.++.||+.||.|||++|++||||||+||+++.++. .+||+|||++.
T Consensus 77 ~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~---~~~l~dfg~~~ 152 (268)
T cd06630 77 HFNLFVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ---RLRIADFGAAA 152 (268)
T ss_pred eEEEEEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC---EEEEccccccc
Confidence 899999999999999998643 46889999999999999999999999999999999999987652 57999999987
Q ss_pred cccCcc-----cccCcCCCCcccchhhhcCCCC
Q 000893 1201 IKRNTL-----VTGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1201 ii~ns~-----~tss~~GTp~YmAPEVL~Gss~ 1228 (1236)
...... ......|+..|+|||++.+...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~ 185 (268)
T cd06630 153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQY 185 (268)
T ss_pred ccccccccCCccccccccccceeCHhHhccCCC
Confidence 654321 1233568899999999976543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-24 Score=228.14 Aligned_cols=174 Identities=31% Similarity=0.441 Sum_probs=145.8
Q ss_pred cCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
++|++.+.||.|+||.||+|.+. ++.||||.++..... ......+.+|+.++++++||||+++++++.....
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 78 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK------EGFPITSLREINILLKLQHPNIVTVKEVVVGSNL 78 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc------ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCC
Confidence 57888999999999999999984 778999999754321 2223456789999999999999999999987644
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
..+++||||+. ++|..++......+++..++.++.||+.||.|||+++|+|+||||+|||++.++ .+||+|||++
T Consensus 79 ~~~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~----~~~l~d~g~~ 153 (293)
T cd07843 79 DKIYMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRG----ILKICDFGLA 153 (293)
T ss_pred CcEEEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC----cEEEeecCce
Confidence 68999999995 599998876666799999999999999999999999999999999999999876 5799999999
Q ss_pred ccccCc-ccccCcCCCCcccchhhhcCC
Q 000893 1200 KIKRNT-LVTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1200 rii~ns-~~tss~~GTp~YmAPEVL~Gs 1226 (1236)
+..... .......+++.|+|||++.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 181 (293)
T cd07843 154 REYGSPLKPYTQLVVTLWYRAPELLLGA 181 (293)
T ss_pred eeccCCccccccccccccccCchhhcCC
Confidence 876543 222345578899999999764
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-24 Score=223.05 Aligned_cols=177 Identities=23% Similarity=0.447 Sum_probs=146.8
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
.+|++.+.||+|+||.||++.. .+..+|||.+..... ........|.+|+.+++.++||||++++++|....
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~- 75 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL-----MDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN- 75 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhh-----hhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC-
Confidence 4678889999999999999996 578899998875321 12233467889999999999999999999998754
Q ss_pred CeEEEEEeeccCCCHHHHHhh---hccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEec
Q 000893 1120 GTLATVTEFMVNGSLRHVLLS---KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~---k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDF 1196 (1236)
.+++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+|+||||+||+++.++ .++|+||
T Consensus 76 -~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~----~~~l~df 150 (267)
T cd08229 76 -ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG----VVKLGDL 150 (267)
T ss_pred -eEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC----CEEECcc
Confidence 88999999999999998864 234689999999999999999999999999999999999998876 5799999
Q ss_pred cCcccccCcc-cccCcCCCCcccchhhhcCCCCC
Q 000893 1197 GLSKIKRNTL-VTGGVRGTLPWMAPELLNGSSSK 1229 (1236)
Q Consensus 1197 GLArii~ns~-~tss~~GTp~YmAPEVL~Gss~~ 1229 (1236)
|++....... ......|+..|+|||++.+....
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~ 184 (267)
T cd08229 151 GLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN 184 (267)
T ss_pred hhhhccccCCcccccccCCcCccCHHHhcCCCcc
Confidence 9988754332 22345789999999999765433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.92 E-value=6e-24 Score=223.30 Aligned_cols=173 Identities=29% Similarity=0.456 Sum_probs=141.3
Q ss_pred cccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhC-CCCceeeEeeeEec
Q 000893 1040 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQD 1116 (1236)
Q Consensus 1040 s~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskL-rHPNIVrLyG~f~t 1116 (1236)
..++|++++.||+|+||+||+++. .++.+|||++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---------~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---------DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---------chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 347899999999999999999987 47789999876421 1123567799999998 69999999998853
Q ss_pred ---CCCCeEEEEEeeccCCCHHHHHhh---hccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCc
Q 000893 1117 ---GPGGTLATVTEFMVNGSLRHVLLS---KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPI 1190 (1236)
Q Consensus 1117 ---~~~g~L~LVMEYm~GGSL~dlL~~---k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~lt 1190 (1236)
..+..+++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++|+||||||+||+++.++ .
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~----~ 162 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEG----G 162 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCC----C
Confidence 223578999999999999998753 234688899999999999999999999999999999999999876 4
Q ss_pred EEEEeccCcccccCcc-cccCcCCCCcccchhhhcC
Q 000893 1191 CKVGDFGLSKIKRNTL-VTGGVRGTLPWMAPELLNG 1225 (1236)
Q Consensus 1191 VKLsDFGLArii~ns~-~tss~~GTp~YmAPEVL~G 1225 (1236)
+||+|||++....... ......|++.|+|||++.+
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 198 (286)
T cd06638 163 VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIAC 198 (286)
T ss_pred EEEccCCceeecccCCCccccccCCCcccChhhhch
Confidence 7999999988654322 2234568999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.92 E-value=5e-24 Score=226.36 Aligned_cols=176 Identities=37% Similarity=0.530 Sum_probs=143.8
Q ss_pred cccCeeEEEEeccCCceEEEEeeec-------CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEee
Q 000893 1040 KNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 1112 (1236)
Q Consensus 1040 s~EdYeiLkkLGsGSFGtVYKArlk-------G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG 1112 (1236)
...+|.+.+.||+|+||.||+++.. +..+++|.++.. .......+.+|+.++++++||||+++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 74 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--------TLAARKDFQREAELLTNLQHEHIVKFYG 74 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc--------cHHHHHHHHHHHHHHhcCCCCCcceEEE
Confidence 4467899999999999999999752 345888887643 1223456889999999999999999999
Q ss_pred eEecCCCCeEEEEEeeccCCCHHHHHhhhc---------------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCC
Q 000893 1113 VVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCD 1177 (1236)
Q Consensus 1113 ~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~---------------r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPs 1177 (1236)
++.... .+++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+
T Consensus 75 ~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~ 152 (291)
T cd05094 75 VCGDGD--PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATR 152 (291)
T ss_pred EEccCC--ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcc
Confidence 998754 8899999999999999996532 24788999999999999999999999999999999
Q ss_pred cEEEccCCCCCCcEEEEeccCcccccCcc---cccCcCCCCcccchhhhcCCCCC
Q 000893 1178 NLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSK 1229 (1236)
Q Consensus 1178 NILLDsdG~I~ltVKLsDFGLArii~ns~---~tss~~GTp~YmAPEVL~Gss~~ 1229 (1236)
|||++.++ .+||+|||++....... ......+++.|+|||++.+....
T Consensus 153 Nil~~~~~----~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 203 (291)
T cd05094 153 NCLVGANL----LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT 203 (291)
T ss_pred eEEEccCC----cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCC
Confidence 99999876 67999999997653322 22345567889999999876433
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-24 Score=227.05 Aligned_cols=178 Identities=29% Similarity=0.394 Sum_probs=142.1
Q ss_pred CeeEEEEeccCCceEEEEeee----cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKW----RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArl----kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~ 1118 (1236)
.|++.+.||+|+||.||+|.. .+..||||.+...... .......+.+|+.+++.++||||++++++|....
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQ-----YTGISQSACREIALLRELKHENVVSLVEVFLEHA 75 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEecccccc-----ccCccHHHHHHHHHHHhcCCCCccceEEEEeCCC
Confidence 478899999999999999998 3578999999864211 1122345678999999999999999999999875
Q ss_pred CCeEEEEEeeccCCCHHHHHhhh----ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEE
Q 000893 1119 GGTLATVTEFMVNGSLRHVLLSK----ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1236)
Q Consensus 1119 ~g~L~LVMEYm~GGSL~dlL~~k----~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLs 1194 (1236)
...+++||||+. ++|..++... ...+++..++.|+.||+.||.|||+++|+||||||+|||++.++.....+||+
T Consensus 76 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~ 154 (316)
T cd07842 76 DKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIG 154 (316)
T ss_pred CceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEEC
Confidence 568999999995 5677666432 13688999999999999999999999999999999999999844333478999
Q ss_pred eccCcccccCcc----cccCcCCCCcccchhhhcCC
Q 000893 1195 DFGLSKIKRNTL----VTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1195 DFGLArii~ns~----~tss~~GTp~YmAPEVL~Gs 1226 (1236)
|||+++...... .....++++.|+|||++.+.
T Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 190 (316)
T cd07842 155 DLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGA 190 (316)
T ss_pred CCccccccCCCcccccccCCccccccccCHHHHhCC
Confidence 999998754322 22345688999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.7e-24 Score=217.68 Aligned_cols=175 Identities=30% Similarity=0.480 Sum_probs=146.1
Q ss_pred CeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g 1120 (1236)
+|+..+.||+|+||+||+|.. .+..|+||.+....... ........+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-- 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQ---TGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREED-- 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccc---cchHHHHHHHHHHHHHHhcCCCCchheeeeEecCC--
Confidence 366778899999999999988 47889999987543211 12334567889999999999999999999988754
Q ss_pred eEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcc
Q 000893 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1236)
Q Consensus 1121 ~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLAr 1200 (1236)
.+++||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++ .+||+|||++.
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~----~~kl~d~~~~~ 150 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNG----VVKLADFGMAK 150 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC----CEEEccCccce
Confidence 899999999999999998654 4588999999999999999999999999999999999999876 57999999998
Q ss_pred cccCcccccCcCCCCcccchhhhcCCC
Q 000893 1201 IKRNTLVTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1201 ii~ns~~tss~~GTp~YmAPEVL~Gss 1227 (1236)
............|++.|+|||.+....
T Consensus 151 ~~~~~~~~~~~~~~~~y~~pe~~~~~~ 177 (258)
T cd06632 151 QVVEFSFAKSFKGSPYWMAPEVIAQQG 177 (258)
T ss_pred eccccccccccCCCcceeCHHHhcCCC
Confidence 765444445567899999999997653
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-25 Score=251.67 Aligned_cols=190 Identities=26% Similarity=0.356 Sum_probs=165.6
Q ss_pred cccccccccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEe
Q 000893 1034 STLQIIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 1111 (1236)
Q Consensus 1034 seLqiIs~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLy 1111 (1236)
-+.+.++...|..-++||+|+||.||-++. +|+-+|.|.+.+..+..+. .....++|..+|.++..++||.+-
T Consensus 177 lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~-----ge~maLnEk~iL~kV~s~FiVsla 251 (591)
T KOG0986|consen 177 LELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRK-----GETMALNEKQILEKVSSPFIVSLA 251 (591)
T ss_pred HHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhh-----hhHHhhHHHHHHHHhccCcEEEEe
Confidence 345677888999999999999999997765 6888999998876544322 123457899999999999999999
Q ss_pred eeEecCCCCeEEEEEeeccCCCHHHHHhhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCc
Q 000893 1112 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPI 1190 (1236)
Q Consensus 1112 G~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~-r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~lt 1190 (1236)
..|.+++ .++|||..|+||+|..+|.+.+ ..+++..++.++.+|+.||++||+.+||+|||||+|||||+.|+
T Consensus 252 YAfeTkd--~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~Gh---- 325 (591)
T KOG0986|consen 252 YAFETKD--ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGH---- 325 (591)
T ss_pred eeecCCC--ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCC----
Confidence 9999976 9999999999999999998765 47999999999999999999999999999999999999999984
Q ss_pred EEEEeccCcccccCcccccCcCCCCcccchhhhcCCCCCCCccc
Q 000893 1191 CKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKV 1234 (1236)
Q Consensus 1191 VKLsDFGLArii~ns~~tss~~GTp~YmAPEVL~Gss~~~SdDV 1234 (1236)
|.|+|+|||..+.........+||.+|||||++.+..+.++.||
T Consensus 326 vRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dw 369 (591)
T KOG0986|consen 326 VRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDW 369 (591)
T ss_pred eEeeccceEEecCCCCccccccCcccccCHHHHcCCcccCCccH
Confidence 58999999999887776667789999999999999988888886
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=6e-24 Score=220.31 Aligned_cols=176 Identities=31% Similarity=0.417 Sum_probs=139.8
Q ss_pred eeEEEEeccCCceEEEEeeec-----CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCC
Q 000893 1044 LEELKELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1044 YeiLkkLGsGSFGtVYKArlk-----G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~ 1118 (1236)
|++.+.||+|+||.||+|.+. +..||||+++.... .......+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 74 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH------TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEAS 74 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC------CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCC
Confidence 467788999999999999873 25699999875321 1233457889999999999999999999887543
Q ss_pred C----CeEEEEEeeccCCCHHHHHhhh-----ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCC
Q 000893 1119 G----GTLATVTEFMVNGSLRHVLLSK-----ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP 1189 (1236)
Q Consensus 1119 ~----g~L~LVMEYm~GGSL~dlL~~k-----~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~l 1189 (1236)
. ...++||||+++++|..++... ...+++..++.++.|++.||.|||+++|+||||||+|||++.++
T Consensus 75 ~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~---- 150 (273)
T cd05035 75 SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDM---- 150 (273)
T ss_pred ccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCC----
Confidence 1 2478999999999999988543 23688999999999999999999999999999999999998875
Q ss_pred cEEEEeccCcccccCccc---ccCcCCCCcccchhhhcCCCCC
Q 000893 1190 ICKVGDFGLSKIKRNTLV---TGGVRGTLPWMAPELLNGSSSK 1229 (1236)
Q Consensus 1190 tVKLsDFGLArii~ns~~---tss~~GTp~YmAPEVL~Gss~~ 1229 (1236)
.+||+|||+++....... .....++..|+|||++.+....
T Consensus 151 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~ 193 (273)
T cd05035 151 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT 193 (273)
T ss_pred eEEECCccceeeccccccccccccccCCccccCHhhcccCCCC
Confidence 679999999987543321 1122346789999998765433
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.6e-24 Score=225.50 Aligned_cols=176 Identities=38% Similarity=0.530 Sum_probs=143.5
Q ss_pred ccccCeeEEEEeccCCceEEEEeee-------cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEe
Q 000893 1039 IKNEDLEELKELGSGTFGTVYHGKW-------RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 1111 (1236)
Q Consensus 1039 Is~EdYeiLkkLGsGSFGtVYKArl-------kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLy 1111 (1236)
+...+|.+.++||+|+||.||++.. .+..+|+|.++.. .......|.+|+++++.++|+||++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~ 73 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--------SESARQDFQREAELLTVLQHQHIVRFY 73 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--------CHHHHHHHHHHHHHHhcCCCCCCceEE
Confidence 3456888999999999999999964 2456899987643 223355788999999999999999999
Q ss_pred eeEecCCCCeEEEEEeeccCCCHHHHHhhhc--------------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCC
Q 000893 1112 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKE--------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCD 1177 (1236)
Q Consensus 1112 G~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~--------------r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPs 1177 (1236)
+++.... ..++||||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+
T Consensus 74 ~~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~ 151 (280)
T cd05092 74 GVCTEGR--PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATR 151 (280)
T ss_pred EEEecCC--ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHh
Confidence 9998754 7899999999999999986543 24788999999999999999999999999999999
Q ss_pred cEEEccCCCCCCcEEEEeccCcccccCcc---cccCcCCCCcccchhhhcCCCC
Q 000893 1178 NLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1178 NILLDsdG~I~ltVKLsDFGLArii~ns~---~tss~~GTp~YmAPEVL~Gss~ 1228 (1236)
|||++.++ .+||+|||+++...... ......+++.|+|||++.+...
T Consensus 152 nil~~~~~----~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 201 (280)
T cd05092 152 NCLVGQGL----VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF 201 (280)
T ss_pred hEEEcCCC----CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCc
Confidence 99998775 67999999997643221 1223345778999999987643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.5e-24 Score=221.74 Aligned_cols=170 Identities=30% Similarity=0.438 Sum_probs=137.7
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHH-HhhCCCCceeeEeeeEecCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI-LSKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrI-LskLrHPNIVrLyG~f~t~~ 1118 (1236)
++|++++.||+|+||.||++++ +++.||||+++..... .....+..|+.+ ++.++||||+++++++....
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~ 73 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS-------QEQKRLLMDLDISMRSVDCPYTVTFYGALFREG 73 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc-------HHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCC
Confidence 4789999999999999999998 4788999998764211 112344456554 66788999999999998754
Q ss_pred CCeEEEEEeeccCCCHHHHHhhh---ccCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCcEEEccCCCCCCcEEEE
Q 000893 1119 GGTLATVTEFMVNGSLRHVLLSK---ERHLDRRKRLIIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1236)
Q Consensus 1119 ~g~L~LVMEYm~GGSL~dlL~~k---~r~LSe~erl~Ia~QIAeALaYLHSk-GIIHRDIKPsNILLDsdG~I~ltVKLs 1194 (1236)
.+++||||++ ++|..++... ...+++..++.++.||+.||.|||++ +++||||||+|||++.++ .+||+
T Consensus 74 --~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~----~~kl~ 146 (283)
T cd06617 74 --DVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNG----QVKLC 146 (283)
T ss_pred --cEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC----CEEEe
Confidence 7999999995 7888777542 34689999999999999999999997 999999999999999876 57999
Q ss_pred eccCcccccCcccccCcCCCCcccchhhhcC
Q 000893 1195 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNG 1225 (1236)
Q Consensus 1195 DFGLArii~ns~~tss~~GTp~YmAPEVL~G 1225 (1236)
|||+++............|+..|+|||++.+
T Consensus 147 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 177 (283)
T cd06617 147 DFGISGYLVDSVAKTIDAGCKPYMAPERINP 177 (283)
T ss_pred ecccccccccccccccccCCccccChhhcCC
Confidence 9999987654433344568999999999865
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-24 Score=221.75 Aligned_cols=170 Identities=34% Similarity=0.567 Sum_probs=142.5
Q ss_pred ccccCeeEEEEeccCCceEEEEeeecCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCC
Q 000893 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1039 Is~EdYeiLkkLGsGSFGtVYKArlkG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~ 1118 (1236)
+..++|++.+.||+|+||.||++...++.||+|.++... ....+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~----------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~- 71 (254)
T cd05083 3 LNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----------TAQAFLEETAVMTKLHHKNLVRLLGVILHN- 71 (254)
T ss_pred ccHHHceeeeeeccCCCCceEecccCCCceEEEeecCcc----------hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-
Confidence 445789999999999999999999999999999986421 124678899999999999999999998753
Q ss_pred CCeEEEEEeeccCCCHHHHHhhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEecc
Q 000893 1119 GGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1236)
Q Consensus 1119 ~g~L~LVMEYm~GGSL~dlL~~k~-r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFG 1197 (1236)
..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+|||++.++ .+||+|||
T Consensus 72 --~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~----~~kl~Dfg 145 (254)
T cd05083 72 --GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDG----VAKVSDFG 145 (254)
T ss_pred --CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC----cEEECCCc
Confidence 4689999999999999997543 3588999999999999999999999999999999999998876 57999999
Q ss_pred CcccccCcccccCcCCCCcccchhhhcCCC
Q 000893 1198 LSKIKRNTLVTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1198 LArii~ns~~tss~~GTp~YmAPEVL~Gss 1227 (1236)
++....... .....+..|+|||++.+..
T Consensus 146 ~~~~~~~~~--~~~~~~~~y~~pe~~~~~~ 173 (254)
T cd05083 146 LARVGSMGV--DNSKLPVKWTAPEALKHKK 173 (254)
T ss_pred cceeccccC--CCCCCCceecCHHHhccCC
Confidence 987643321 1233467899999997653
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.3e-24 Score=219.95 Aligned_cols=175 Identities=32% Similarity=0.518 Sum_probs=144.2
Q ss_pred ccccccCeeEEEEeccCCceEEEEeeec-CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEe
Q 000893 1037 QIIKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 1115 (1236)
Q Consensus 1037 qiIs~EdYeiLkkLGsGSFGtVYKArlk-G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~ 1115 (1236)
|.+..++|++.++||+|+||.||++.+. +..+|+|.++... .....|.+|+.+++.++|+||+++++++.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~---------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 71 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---------MSVEAFLAEANVMKTLQHDKLVKLHAVVT 71 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh---------hHHHHHHHHHHHHHhcCCCCcceEEEEEc
Confidence 3466789999999999999999999874 5669999886431 12456888999999999999999999987
Q ss_pred cCCCCeEEEEEeeccCCCHHHHHhhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEE
Q 000893 1116 DGPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1236)
Q Consensus 1116 t~~~g~L~LVMEYm~GGSL~dlL~~k-~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLs 1194 (1236)
. ...++||||+++++|.+++... ...+++..++.++.|++.||.|||+.|++||||||+||+++.++ .+||+
T Consensus 72 ~---~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~----~~~l~ 144 (260)
T cd05073 72 K---EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL----VCKIA 144 (260)
T ss_pred C---CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC----cEEEC
Confidence 6 3688999999999999999653 34678888999999999999999999999999999999998875 67999
Q ss_pred eccCcccccCcc--cccCcCCCCcccchhhhcCCC
Q 000893 1195 DFGLSKIKRNTL--VTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1195 DFGLArii~ns~--~tss~~GTp~YmAPEVL~Gss 1227 (1236)
|||++....... ......++..|+|||++.+..
T Consensus 145 d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~ 179 (260)
T cd05073 145 DFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 179 (260)
T ss_pred CCcceeeccCCCcccccCCcccccccCHhHhccCC
Confidence 999997654322 122234567799999997653
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.9e-24 Score=220.09 Aligned_cols=177 Identities=28% Similarity=0.430 Sum_probs=145.4
Q ss_pred CeeEEEEeccCCceEEEEeee-cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCe
Q 000893 1043 DLEELKELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGT 1121 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArl-kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~ 1121 (1236)
+|++.+.||.|+||+||+|.. .+..+|||.+...... .....+....+.+|+.+++.++|+||++++++|... ..
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~--~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~ 76 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSN--VLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD--NT 76 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccc--hhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC--Ce
Confidence 477788999999999999987 5778999998754221 122334456788999999999999999999999875 48
Q ss_pred EEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCccc
Q 000893 1122 LATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201 (1236)
Q Consensus 1122 L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLAri 1201 (1236)
+++||||+++++|.+++.+. ..+++..+..++.|++.||+|||+.+|+|+||+|+||+++.++ .+||+|||++..
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~----~~~l~dfg~~~~ 151 (265)
T cd06631 77 ISIFMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNG----IIKLIDFGCARR 151 (265)
T ss_pred EEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCC----eEEeccchhhHh
Confidence 99999999999999999654 4578999999999999999999999999999999999999876 579999999876
Q ss_pred ccC-------cccccCcCCCCcccchhhhcCCCC
Q 000893 1202 KRN-------TLVTGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1202 i~n-------s~~tss~~GTp~YmAPEVL~Gss~ 1228 (1236)
... ........|+..|+|||++.+...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~ 185 (265)
T cd06631 152 LAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGY 185 (265)
T ss_pred hhhccccccccccccccCCCccccChhhhcCCCC
Confidence 421 112234568999999999987643
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-24 Score=223.51 Aligned_cols=171 Identities=29% Similarity=0.429 Sum_probs=141.2
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhC-CCCceeeEeeeEecCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskL-rHPNIVrLyG~f~t~~ 1118 (1236)
..|++.+.||+|+||.||+|.+ .++.||||++.... .....+..|+.+++.+ +||||++++++|....
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 76 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---------DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 76 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---------ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecC
Confidence 4577788899999999999987 46789999986532 1123567799999988 6999999999987532
Q ss_pred ----CCeEEEEEeeccCCCHHHHHhhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEE
Q 000893 1119 ----GGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193 (1236)
Q Consensus 1119 ----~g~L~LVMEYm~GGSL~dlL~~k-~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKL 1193 (1236)
...+++||||+.+++|.+++... ...+++..++.++.|++.||+|||+++|+||||||+||+++.++ .+||
T Consensus 77 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~----~~~l 152 (272)
T cd06637 77 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA----EVKL 152 (272)
T ss_pred CCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCC----CEEE
Confidence 24689999999999999998764 35689999999999999999999999999999999999999876 5799
Q ss_pred EeccCcccccCc-ccccCcCCCCcccchhhhcC
Q 000893 1194 GDFGLSKIKRNT-LVTGGVRGTLPWMAPELLNG 1225 (1236)
Q Consensus 1194 sDFGLArii~ns-~~tss~~GTp~YmAPEVL~G 1225 (1236)
+|||++...... .......|++.|+|||++.+
T Consensus 153 ~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 185 (272)
T cd06637 153 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 185 (272)
T ss_pred ccCCCceecccccccCCcccccccccCHhHhcc
Confidence 999999875432 23345678999999999974
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-24 Score=226.04 Aligned_cols=171 Identities=31% Similarity=0.459 Sum_probs=143.2
Q ss_pred cCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
++|++++.||+|+||.||++++. +..||+|.++... .......+.+|+.+++.++||||+++++++...
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-- 71 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-------DESKFNQIIMELDILHKAVSPYIVDFYGAFFIE-- 71 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-------CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC--
Confidence 46888999999999999999984 7889999886431 122345788999999999999999999998875
Q ss_pred CeEEEEEeeccCCCHHHHHhhh--ccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCcEEEccCCCCCCcEEEEec
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSK--ERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k--~r~LSe~erl~Ia~QIAeALaYLHS-kGIIHRDIKPsNILLDsdG~I~ltVKLsDF 1196 (1236)
+.+++||||+++++|..++... ...+++..+..++.||+.||.|||. .+|+||||||+|||++.++ .+||+||
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~----~~~l~df 147 (286)
T cd06622 72 GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG----QVKLCDF 147 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC----CEEEeec
Confidence 4899999999999999988653 2368999999999999999999997 5999999999999999876 5799999
Q ss_pred cCcccccCcccccCcCCCCcccchhhhcCC
Q 000893 1197 GLSKIKRNTLVTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1197 GLArii~ns~~tss~~GTp~YmAPEVL~Gs 1226 (1236)
|++....... .....+++.|+|||++.+.
T Consensus 148 g~~~~~~~~~-~~~~~~~~~y~aPE~~~~~ 176 (286)
T cd06622 148 GVSGNLVASL-AKTNIGCQSYMAPERIKSG 176 (286)
T ss_pred CCcccccCCc-cccCCCccCccCcchhcCC
Confidence 9997654332 2335688999999998654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.7e-24 Score=220.97 Aligned_cols=175 Identities=33% Similarity=0.529 Sum_probs=142.8
Q ss_pred cccCeeEEEEeccCCceEEEEeeec--Cc---eEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeE
Q 000893 1040 KNEDLEELKELGSGTFGTVYHGKWR--GT---DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVV 1114 (1236)
Q Consensus 1040 s~EdYeiLkkLGsGSFGtVYKArlk--G~---~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f 1114 (1236)
...+|+..+.||+|+||.||+|++. +. .+|||.++... .......+..|+.+++.++||||+++++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 75 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-------TEKQRQDFLSEASIMGQFSHHNIIRLEGVV 75 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-------CHHHHHHHHHHHHHHhcCCCCCeeEEEEEE
Confidence 4467888999999999999999873 32 59999886532 122345688899999999999999999999
Q ss_pred ecCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEE
Q 000893 1115 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1236)
Q Consensus 1115 ~t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLs 1194 (1236)
.... ..++||||+++++|..++......+++..+..++.|++.||+|||+.+|+||||||+|||++.++ .+||+
T Consensus 76 ~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~----~~kl~ 149 (268)
T cd05063 76 TKFK--PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNL----ECKVS 149 (268)
T ss_pred ccCC--CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCC----cEEEC
Confidence 8754 78999999999999999977666789999999999999999999999999999999999998775 57999
Q ss_pred eccCcccccCcccc----cCcCCCCcccchhhhcCCC
Q 000893 1195 DFGLSKIKRNTLVT----GGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1195 DFGLArii~ns~~t----ss~~GTp~YmAPEVL~Gss 1227 (1236)
|||++......... .....++.|+|||++.+..
T Consensus 150 dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~ 186 (268)
T cd05063 150 DFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186 (268)
T ss_pred CCccceecccccccceeccCCCcCceecCHHHhhcCC
Confidence 99999865432111 1122345799999997653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=220.11 Aligned_cols=177 Identities=32% Similarity=0.433 Sum_probs=141.2
Q ss_pred EEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeEE
Q 000893 1046 ELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLA 1123 (1236)
Q Consensus 1046 iLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L~ 1123 (1236)
....||+|+||.||+|++. +..||+|.+.... ......+.+|+.+++.++|+||+++++++.... .++
T Consensus 12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~ 81 (268)
T cd06624 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--------SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG--FFK 81 (268)
T ss_pred ceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--------HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCC--EEE
Confidence 3457999999999999874 5679999886532 223456889999999999999999999998754 899
Q ss_pred EEEeeccCCCHHHHHhhhccCC--CHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCccc
Q 000893 1124 TVTEFMVNGSLRHVLLSKERHL--DRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201 (1236)
Q Consensus 1124 LVMEYm~GGSL~dlL~~k~r~L--Se~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLAri 1201 (1236)
+||||+++++|..++......+ ++..+..++.||+.||.|||+++|+||||||+||+++.+. ..+||+|||++..
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~---~~~~l~dfg~~~~ 158 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYS---GVVKISDFGTSKR 158 (268)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC---CeEEEecchhhee
Confidence 9999999999999997654445 7888888999999999999999999999999999997632 2579999999876
Q ss_pred ccCc-ccccCcCCCCcccchhhhcCCCCCCCcccc
Q 000893 1202 KRNT-LVTGGVRGTLPWMAPELLNGSSSKVSEKVC 1235 (1236)
Q Consensus 1202 i~ns-~~tss~~GTp~YmAPEVL~Gss~~~SdDVD 1235 (1236)
.... .......|++.|+|||++.+....++...|
T Consensus 159 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~D 193 (268)
T cd06624 159 LAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPAD 193 (268)
T ss_pred cccCCCccccCCCCccccChhhhccccccCCchhh
Confidence 5322 222334588999999999765433433333
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.2e-24 Score=229.15 Aligned_cols=177 Identities=32% Similarity=0.452 Sum_probs=144.4
Q ss_pred cccccCeeEEEEeccCCceEEEEeeec-------CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhC-CCCceee
Q 000893 1038 IIKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVA 1109 (1236)
Q Consensus 1038 iIs~EdYeiLkkLGsGSFGtVYKArlk-------G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskL-rHPNIVr 1109 (1236)
.+..++|.+.+.||+|+||.||++... +..||||+++... .......+.+|+.+++++ +||||++
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~iv~ 103 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-------HSSEREALMSELKIMSHLGNHENIVN 103 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-------ChHHHHHHHHHHHHHHhccCCCCcce
Confidence 455678999999999999999999752 3469999886532 122345688999999999 7999999
Q ss_pred EeeeEecCCCCeEEEEEeeccCCCHHHHHhhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCC
Q 000893 1110 FYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIR 1188 (1236)
Q Consensus 1110 LyG~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~-r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ 1188 (1236)
++++|.... .+++||||+.+++|..++.... ..+++.+++.|+.||+.||.|||+++|+|+||||+|||++.++
T Consensus 104 ~~~~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~--- 178 (302)
T cd05055 104 LLGACTIGG--PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK--- 178 (302)
T ss_pred EEEEEecCC--ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCC---
Confidence 999998754 8999999999999999996543 3489999999999999999999999999999999999998765
Q ss_pred CcEEEEeccCcccccCcc---cccCcCCCCcccchhhhcCCC
Q 000893 1189 PICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1189 ltVKLsDFGLArii~ns~---~tss~~GTp~YmAPEVL~Gss 1227 (1236)
.+||+|||+++...... ......+++.|+|||++.+..
T Consensus 179 -~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 219 (302)
T cd05055 179 -IVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV 219 (302)
T ss_pred -eEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCC
Confidence 67999999998653321 122344678899999997664
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-24 Score=229.50 Aligned_cols=176 Identities=34% Similarity=0.571 Sum_probs=143.7
Q ss_pred cccccCeeEEEEeccCCceEEEEeee--cCc----eEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEe
Q 000893 1038 IIKNEDLEELKELGSGTFGTVYHGKW--RGT----DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 1111 (1236)
Q Consensus 1038 iIs~EdYeiLkkLGsGSFGtVYKArl--kG~----~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLy 1111 (1236)
.+..++|+.++.||+|+||.||+|.+ .+. .||+|.+.... ......++.+|+.+++.++||||++++
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~l~h~niv~~~ 75 (303)
T cd05110 3 ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-------GPKANVEFMDEALIMASMDHPHLVRLL 75 (303)
T ss_pred ccchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-------CHHHHHHHHHHHHHHHhCCCCCcccEE
Confidence 45678899999999999999999987 343 47888876432 122334688899999999999999999
Q ss_pred eeEecCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcE
Q 000893 1112 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 1191 (1236)
Q Consensus 1112 G~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltV 1191 (1236)
++|... ..++++||+++|+|.+++......+++..++.++.|++.||.|||+++|+||||||+|||++.++ .+
T Consensus 76 ~~~~~~---~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~----~~ 148 (303)
T cd05110 76 GVCLSP---TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPN----HV 148 (303)
T ss_pred EEEcCC---CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCC----ce
Confidence 998763 46789999999999999977666789999999999999999999999999999999999998776 56
Q ss_pred EEEeccCcccccCcc---cccCcCCCCcccchhhhcCCC
Q 000893 1192 KVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1192 KLsDFGLArii~ns~---~tss~~GTp~YmAPEVL~Gss 1227 (1236)
||+|||+++...... ......++..|+|||++.+..
T Consensus 149 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~ 187 (303)
T cd05110 149 KITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK 187 (303)
T ss_pred EEccccccccccCcccccccCCCccccccCCHHHhccCC
Confidence 999999998754322 122334577899999998654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.7e-24 Score=224.28 Aligned_cols=164 Identities=26% Similarity=0.434 Sum_probs=133.8
Q ss_pred EeccCCceEEEEeeec--------------CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeE
Q 000893 1049 ELGSGTFGTVYHGKWR--------------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVV 1114 (1236)
Q Consensus 1049 kLGsGSFGtVYKArlk--------------G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f 1114 (1236)
.||+|+||.||+|++. ...||+|++... .......|.+|+.+++.++||||+++++++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--------~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~ 73 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--------HRDISLAFFETASMMRQVSHKHIVLLYGVC 73 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--------hhhHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 5899999999999852 124888887542 223345688899999999999999999999
Q ss_pred ecCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCC---CCCcE
Q 000893 1115 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP---IRPIC 1191 (1236)
Q Consensus 1115 ~t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~---I~ltV 1191 (1236)
.... ..++||||+++++|..++......+++..++.|+.||+.||+|||+++|+||||||+||||+.++. ....+
T Consensus 74 ~~~~--~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~ 151 (262)
T cd05077 74 VRDV--ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFI 151 (262)
T ss_pred ecCC--CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCcee
Confidence 8754 778999999999999988766667999999999999999999999999999999999999986542 11247
Q ss_pred EEEeccCcccccCcccccCcCCCCcccchhhhcC
Q 000893 1192 KVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNG 1225 (1236)
Q Consensus 1192 KLsDFGLArii~ns~~tss~~GTp~YmAPEVL~G 1225 (1236)
||+|||++...... ....++..|+|||++.+
T Consensus 152 ~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~ 182 (262)
T cd05077 152 KLSDPGIPITVLSR---QECVERIPWIAPECVED 182 (262)
T ss_pred EeCCCCCCccccCc---ccccccccccChhhhcC
Confidence 99999998754322 23457889999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.3e-24 Score=224.69 Aligned_cols=171 Identities=29% Similarity=0.440 Sum_probs=140.2
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
.+|.+++.||+|+||.||+|.. .+..||||++...... .....+.+|+.+++.++|+||+++++++....
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~- 76 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-------GVPFTAIREASLLKGLKHANIVLLHDIIHTKE- 76 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-------CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCC-
Confidence 6799999999999999999987 4788999998754211 11234568999999999999999999998754
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
..++||||+ .++|..++......+.+..+..++.||+.||.|||+++|+||||||+|||++.++ .+||+|||++
T Consensus 77 -~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~----~~~l~Dfg~~ 150 (291)
T cd07870 77 -TLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLG----ELKLADFGLA 150 (291)
T ss_pred -eEEEEEecc-cCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCC----cEEEeccccc
Confidence 899999999 4777777765555678888899999999999999999999999999999998876 5799999999
Q ss_pred ccccCc-ccccCcCCCCcccchhhhcCC
Q 000893 1200 KIKRNT-LVTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1200 rii~ns-~~tss~~GTp~YmAPEVL~Gs 1226 (1236)
+..... .......+++.|+|||++.+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 178 (291)
T cd07870 151 RAKSIPSQTYSSEVVTLWYRPPDVLLGA 178 (291)
T ss_pred cccCCCCCCCCCccccccccCCceeecC
Confidence 864322 122334578999999998764
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=225.83 Aligned_cols=176 Identities=27% Similarity=0.419 Sum_probs=146.1
Q ss_pred cCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
++|++.+.||+|+||+||+|... +..||||.+.+.... .......+..|+.+++.++||||+++++.+....
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 74 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI-----KRNKVKRVLTEQEILATLDHPFLPTLYASFQTET- 74 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccc-----hHHHHHHHHHHHHHHHhCCCCCchhheeeeecCC-
Confidence 47899999999999999999884 688999999765321 2234567889999999999999999999988754
Q ss_pred CeEEEEEeeccCCCHHHHHhhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccC
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k-~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGL 1198 (1236)
..++||||+.+++|.+++... ...+++..++.++.||+.||.|||..|++||||||+||||+.++ .++|+|||+
T Consensus 75 -~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~----~~~l~dfg~ 149 (316)
T cd05574 75 -YLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESG----HIMLSDFDL 149 (316)
T ss_pred -EEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCC----CEEEeecch
Confidence 899999999999999998653 35689999999999999999999999999999999999999876 569999999
Q ss_pred cccccCcc------------------------------cccCcCCCCcccchhhhcCCCC
Q 000893 1199 SKIKRNTL------------------------------VTGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1199 Arii~ns~------------------------------~tss~~GTp~YmAPEVL~Gss~ 1228 (1236)
+....... ....+.||..|+|||++.+...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 209 (316)
T cd05574 150 SKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH 209 (316)
T ss_pred hhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC
Confidence 87542111 1123468899999999987643
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.5e-24 Score=221.87 Aligned_cols=175 Identities=30% Similarity=0.463 Sum_probs=142.9
Q ss_pred cccCeeEEEEeccCCceEEEEeeec-------CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEee
Q 000893 1040 KNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 1112 (1236)
Q Consensus 1040 s~EdYeiLkkLGsGSFGtVYKArlk-------G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG 1112 (1236)
..++|++++.||+|+||+||+|+.+ ...||+|.+.... .......|.+|++++++++||||+++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 75 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-------DENLQSEFRRELDMFRKLSHKNVVRLLG 75 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-------chHHHHHHHHHHHHHHhcCCcceeeeEE
Confidence 3468899999999999999999863 3459999875431 2234567889999999999999999999
Q ss_pred eEecCCCCeEEEEEeeccCCCHHHHHhhhc--------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccC
Q 000893 1113 VVQDGPGGTLATVTEFMVNGSLRHVLLSKE--------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLK 1184 (1236)
Q Consensus 1113 ~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~--------r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsd 1184 (1236)
++.... ..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+++|+||||||+|||++.+
T Consensus 76 ~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~ 153 (275)
T cd05046 76 LCREAE--PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQ 153 (275)
T ss_pred EECCCC--cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCC
Confidence 987754 7899999999999999996543 158999999999999999999999999999999999999987
Q ss_pred CCCCCcEEEEeccCcccccCcc--cccCcCCCCcccchhhhcCCC
Q 000893 1185 DPIRPICKVGDFGLSKIKRNTL--VTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1185 G~I~ltVKLsDFGLArii~ns~--~tss~~GTp~YmAPEVL~Gss 1227 (1236)
+ .++|+|||+++...... ......++..|+|||.+.+..
T Consensus 154 ~----~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~ 194 (275)
T cd05046 154 R----EVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDD 194 (275)
T ss_pred C----cEEEcccccccccCcccccccCCceeEEeecChhhhccCC
Confidence 6 56999999987543221 122345677899999987654
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.6e-24 Score=225.43 Aligned_cols=172 Identities=31% Similarity=0.424 Sum_probs=138.5
Q ss_pred CeeEEEEeccCCceEEEEeeecC-------ceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEe
Q 000893 1043 DLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 1115 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArlkG-------~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~ 1115 (1236)
+|++.+.||+|+||+||+|.... ..+|+|.+.... .......+.+|+.+++.++||||+++++.|.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 73 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-------SSSELRDLLSEFNLLKQVNHPHVIKLYGACS 73 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-------CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence 46788899999999999998632 458999886532 1122456889999999999999999999988
Q ss_pred cCCCCeEEEEEeeccCCCHHHHHhhh-----------------------ccCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Q 000893 1116 DGPGGTLATVTEFMVNGSLRHVLLSK-----------------------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHF 1172 (1236)
Q Consensus 1116 t~~~g~L~LVMEYm~GGSL~dlL~~k-----------------------~r~LSe~erl~Ia~QIAeALaYLHSkGIIHR 1172 (1236)
... ..++||||+.+++|.+++... ...+++..++.++.|++.||.|||+++|+||
T Consensus 74 ~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~ 151 (290)
T cd05045 74 QDG--PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHR 151 (290)
T ss_pred cCC--CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehh
Confidence 754 789999999999999998542 1347888999999999999999999999999
Q ss_pred CCCCCcEEEccCCCCCCcEEEEeccCcccccCcc---cccCcCCCCcccchhhhcCCC
Q 000893 1173 DLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1173 DIKPsNILLDsdG~I~ltVKLsDFGLArii~ns~---~tss~~GTp~YmAPEVL~Gss 1227 (1236)
||||+||||+.++ .+||+|||+++...... ......++..|+|||++.+..
T Consensus 152 dikp~nill~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~ 205 (290)
T cd05045 152 DLAARNVLVAEGR----KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHI 205 (290)
T ss_pred hhhhheEEEcCCC----cEEeccccccccccCccchhcccCCCCCccccCHHHHccCC
Confidence 9999999998775 67999999998643221 112234577899999987653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=219.91 Aligned_cols=178 Identities=31% Similarity=0.504 Sum_probs=145.1
Q ss_pred CeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccC--CCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFT--GRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~--~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~ 1118 (1236)
+|.+.+.||.|+||.||+|.. .++.||||.++..... ............+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477888999999999999986 4788999988643211 111222334556788999999999999999999988754
Q ss_pred CCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccC
Q 000893 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1236)
Q Consensus 1119 ~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGL 1198 (1236)
.+++||||+++++|.+++... ..+++..++.++.||+.||.|||+++++||||+|+||+++.++ .++|+|||+
T Consensus 82 --~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~----~~~l~d~~~ 154 (272)
T cd06629 82 --YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADG----ICKISDFGI 154 (272)
T ss_pred --ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCC----eEEEeeccc
Confidence 889999999999999998655 4689999999999999999999999999999999999999876 679999999
Q ss_pred cccccCc---ccccCcCCCCcccchhhhcCCC
Q 000893 1199 SKIKRNT---LVTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1199 Arii~ns---~~tss~~GTp~YmAPEVL~Gss 1227 (1236)
++..... .......|+..|+|||++.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~ 186 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYS 186 (272)
T ss_pred cccccccccccccccccCCccccCHHHhcccc
Confidence 9865422 1223456889999999997654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-24 Score=265.91 Aligned_cols=188 Identities=35% Similarity=0.563 Sum_probs=154.9
Q ss_pred cccccccCeeEEEEeccCCceEEEEeeec---Cc----eEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCcee
Q 000893 1036 LQIIKNEDLEELKELGSGTFGTVYHGKWR---GT----DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVV 1108 (1236)
Q Consensus 1036 LqiIs~EdYeiLkkLGsGSFGtVYKArlk---G~----~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIV 1108 (1236)
+..+..+..++...||+|.||.||.|... +. .||||.+++.. .+....+|++|..+|++++|||||
T Consensus 686 lp~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-------~~~~~~~Fl~Ea~~m~~f~HpNiv 758 (1025)
T KOG1095|consen 686 LPEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-------SEQEVSDFLKEALLMSKFDHPNIV 758 (1025)
T ss_pred cccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-------CHHHHHHHHHHHHHHhcCCCccee
Confidence 45577788999999999999999999884 32 38999887642 344567899999999999999999
Q ss_pred eEeeeEecCCCCeEEEEEeeccCCCHHHHHhhh------ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEc
Q 000893 1109 AFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSK------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVN 1182 (1236)
Q Consensus 1109 rLyG~f~t~~~g~L~LVMEYm~GGSL~dlL~~k------~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLD 1182 (1236)
+++|+|.+. +..+|++|||++|+|..+|+.. ...+.....+.|+.+|++|+.||+++++|||||..+|+||+
T Consensus 759 ~liGv~l~~--~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~ 836 (1025)
T KOG1095|consen 759 SLIGVCLDS--GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLD 836 (1025)
T ss_pred eEEEeecCC--CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeec
Confidence 999999984 5889999999999999999887 66799999999999999999999999999999999999999
Q ss_pred cCCCCCCcEEEEeccCcccccCcccc-cCc--CCCCcccchhhhc-CCCCCCCccccC
Q 000893 1183 LKDPIRPICKVGDFGLSKIKRNTLVT-GGV--RGTLPWMAPELLN-GSSSKVSEKVCF 1236 (1236)
Q Consensus 1183 sdG~I~ltVKLsDFGLArii~ns~~t-ss~--~GTp~YmAPEVL~-Gss~~~SdDVDI 1236 (1236)
... +|||+|||||+.+...... ..- .-...|||||.+. +.....++.|.|
T Consensus 837 ~~r----~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsF 890 (1025)
T KOG1095|consen 837 ERR----VVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSF 890 (1025)
T ss_pred ccC----cEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhh
Confidence 873 7899999999954332221 111 1235799999998 555555555654
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.5e-24 Score=221.03 Aligned_cols=174 Identities=31% Similarity=0.400 Sum_probs=137.2
Q ss_pred eEEEEeccCCceEEEEeeec--Cc--eEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCC--
Q 000893 1045 EELKELGSGTFGTVYHGKWR--GT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP-- 1118 (1236)
Q Consensus 1045 eiLkkLGsGSFGtVYKArlk--G~--~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~-- 1118 (1236)
.+.+.||+|+||.||+|.+. +. .||||.++.... .......|.+|+.+++.++||||+++++++....
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 75 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC------TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVES 75 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC------CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcc
Confidence 35678999999999999874 22 589998875421 2233567888999999999999999999875422
Q ss_pred --CCeEEEEEeeccCCCHHHHHhhh-----ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcE
Q 000893 1119 --GGTLATVTEFMVNGSLRHVLLSK-----ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 1191 (1236)
Q Consensus 1119 --~g~L~LVMEYm~GGSL~dlL~~k-----~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltV 1191 (1236)
....++||||+.+++|..++... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+
T Consensus 76 ~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~----~~ 151 (272)
T cd05075 76 EGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENM----NV 151 (272)
T ss_pred cCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCC----CE
Confidence 13578999999999999887432 24588999999999999999999999999999999999998776 57
Q ss_pred EEEeccCcccccCccc---ccCcCCCCcccchhhhcCCCC
Q 000893 1192 KVGDFGLSKIKRNTLV---TGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1192 KLsDFGLArii~ns~~---tss~~GTp~YmAPEVL~Gss~ 1228 (1236)
||+|||+++....... .....+++.|+|||++.+...
T Consensus 152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~ 191 (272)
T cd05075 152 CVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVY 191 (272)
T ss_pred EECCCCcccccCcccceecCCcccCCcccCCHHHccCCCc
Confidence 9999999987543221 122345678999999986643
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.9e-25 Score=263.05 Aligned_cols=188 Identities=34% Similarity=0.487 Sum_probs=153.4
Q ss_pred ccccccccCeeEEEEeccCCceEEEEeeec-------CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCce
Q 000893 1035 TLQIIKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 1107 (1236)
Q Consensus 1035 eLqiIs~EdYeiLkkLGsGSFGtVYKArlk-------G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNI 1107 (1236)
....+...+.++.+.||+|.||+||+|+.. .+.||||.++... .....++|.||+++|+.|+||||
T Consensus 479 ~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-------~~~~~~dF~REaeLla~l~H~nI 551 (774)
T KOG1026|consen 479 KVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-------ENQARQDFRREAELLAELQHPNI 551 (774)
T ss_pred ceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-------cHHHHHHHHHHHHHHHhccCCCe
Confidence 345667778899999999999999999873 2349999998652 34467789999999999999999
Q ss_pred eeEeeeEecCCCCeEEEEEeeccCCCHHHHHhhhc---------c----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Q 000893 1108 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------R----HLDRRKRLIIAMDAAFGMEYLHSKNIVHFDL 1174 (1236)
Q Consensus 1108 VrLyG~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~---------r----~LSe~erl~Ia~QIAeALaYLHSkGIIHRDI 1174 (1236)
|+|+|+|..++ .+++|+|||..|+|.++|+.+. . .++..+.+.|+.||+.||.||-++.+|||||
T Consensus 552 VrLlGVC~~~~--P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDL 629 (774)
T KOG1026|consen 552 VRLLGVCREGD--PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDL 629 (774)
T ss_pred EEEEEEEccCC--eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccch
Confidence 99999999876 8999999999999999997642 2 2788899999999999999999999999999
Q ss_pred CCCcEEEccCCCCCCcEEEEeccCcccccCccccc---CcCCCCcccchhhhcCC-CCCCCcccc
Q 000893 1175 KCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG---GVRGTLPWMAPELLNGS-SSKVSEKVC 1235 (1236)
Q Consensus 1175 KPsNILLDsdG~I~ltVKLsDFGLArii~ns~~ts---s~~GTp~YmAPEVL~Gs-s~~~SdDVD 1235 (1236)
..+|+||..+ +.|||+||||+|-+-...... ...-...|||||.|... ....|+.|.
T Consensus 630 ATRNCLVge~----l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs 690 (774)
T KOG1026|consen 630 ATRNCLVGEN----LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWS 690 (774)
T ss_pred hhhhceeccc----eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhh
Confidence 9999999876 488999999999764433321 22235789999999854 333333343
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.9e-24 Score=231.37 Aligned_cols=179 Identities=29% Similarity=0.427 Sum_probs=143.8
Q ss_pred ccccccCeeEEEEeccCCceEEEEeeec---------CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhC-CCCc
Q 000893 1037 QIIKNEDLEELKELGSGTFGTVYHGKWR---------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPN 1106 (1236)
Q Consensus 1037 qiIs~EdYeiLkkLGsGSFGtVYKArlk---------G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskL-rHPN 1106 (1236)
+.+...+|++.+.||+|+||.||+|++. ...||+|.++... .......+.+|+.+++++ +|||
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~ 79 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-------TDKDLSDLVSEMEMMKMIGKHKN 79 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-------CHHHHHHHHHHHHHHHhhcCCCC
Confidence 4455678999999999999999999752 2358999886431 223356788999999999 7999
Q ss_pred eeeEeeeEecCCCCeEEEEEeeccCCCHHHHHhhhc---------------cCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 000893 1107 VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVH 1171 (1236)
Q Consensus 1107 IVrLyG~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~---------------r~LSe~erl~Ia~QIAeALaYLHSkGIIH 1171 (1236)
|++++++|.... .+++||||+++++|.+++.... ..+++..++.++.||+.||.|||.+||+|
T Consensus 80 iv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH 157 (334)
T cd05100 80 IINLLGACTQDG--PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIH 157 (334)
T ss_pred eeeeeEEEccCC--ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 999999998754 8899999999999999986532 34788888999999999999999999999
Q ss_pred CCCCCCcEEEccCCCCCCcEEEEeccCcccccCccc---ccCcCCCCcccchhhhcCCCC
Q 000893 1172 FDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLV---TGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1172 RDIKPsNILLDsdG~I~ltVKLsDFGLArii~ns~~---tss~~GTp~YmAPEVL~Gss~ 1228 (1236)
|||||+|||++.++ .+||+|||+++....... .....++..|+|||++.+...
T Consensus 158 ~dlkp~Nill~~~~----~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 213 (334)
T cd05100 158 RDLAARNVLVTEDN----VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVY 213 (334)
T ss_pred cccccceEEEcCCC----cEEECCcccceecccccccccccCCCcCceEcCHHHhccCCc
Confidence 99999999998876 579999999987543221 122234567999999977643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.8e-24 Score=225.16 Aligned_cols=174 Identities=33% Similarity=0.442 Sum_probs=144.0
Q ss_pred CeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g 1120 (1236)
+|++.+.||+|+||.||+|.+ .++.||||.++...... ........+..|+.+++.++|+||+++++++.+. .
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKE---AKDGINFTALREIKLLQELKHPNIIGLLDVFGHK--S 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEecccccc---ccchhhHHHHHHHHHHhhcCCCCChhhhheeecC--C
Confidence 478889999999999999987 47889999997654221 1122344567899999999999999999999884 4
Q ss_pred eEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcc
Q 000893 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1236)
Q Consensus 1121 ~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLAr 1200 (1236)
.+++||||+ +++|..++......+++..++.++.||+.||.|||.+||+|+||||+|||++.++ .+||+|||+++
T Consensus 76 ~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~----~~~l~dfg~~~ 150 (298)
T cd07841 76 NINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDG----VLKLADFGLAR 150 (298)
T ss_pred EEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCC----CEEEccceeee
Confidence 899999999 9999999976554799999999999999999999999999999999999999876 57999999998
Q ss_pred cccCcc-cccCcCCCCcccchhhhcCC
Q 000893 1201 IKRNTL-VTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1201 ii~ns~-~tss~~GTp~YmAPEVL~Gs 1226 (1236)
...... ......+++.|+|||++.+.
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~ 177 (298)
T cd07841 151 SFGSPNRKMTHQVVTRWYRAPELLFGA 177 (298)
T ss_pred eccCCCccccccccceeeeCHHHHhCC
Confidence 764432 22334568899999998653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.8e-24 Score=230.76 Aligned_cols=178 Identities=20% Similarity=0.312 Sum_probs=139.8
Q ss_pred EEEEeccC--CceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCe
Q 000893 1046 ELKELGSG--TFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGT 1121 (1236)
Q Consensus 1046 iLkkLGsG--SFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~ 1121 (1236)
++++||+| +|++||++.. +++.||||++..... .......+.+|+.+++.++||||++++++|.... .
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~--~ 73 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC------TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN--E 73 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc------cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC--E
Confidence 45679999 7899999987 478899999875421 1223445678999999999999999999998865 8
Q ss_pred EEEEEeeccCCCHHHHHhhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcc
Q 000893 1122 LATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1236)
Q Consensus 1122 L~LVMEYm~GGSL~dlL~~k-~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLAr 1200 (1236)
+++||||+++++|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++ .++++||+.+.
T Consensus 74 ~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~----~~~l~~~~~~~ 149 (327)
T cd08227 74 LWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG----KVYLSGLRSNL 149 (327)
T ss_pred EEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCC----cEEEcccchhh
Confidence 99999999999999998654 34589999999999999999999999999999999999999876 56899998654
Q ss_pred cccCc--------ccccCcCCCCcccchhhhcCCCCCCCcccc
Q 000893 1201 IKRNT--------LVTGGVRGTLPWMAPELLNGSSSKVSEKVC 1235 (1236)
Q Consensus 1201 ii~ns--------~~tss~~GTp~YmAPEVL~Gss~~~SdDVD 1235 (1236)
..... .......++..|+|||++.+....++...|
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~D 192 (327)
T cd08227 150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSD 192 (327)
T ss_pred ccccccccccccccccccccceecccChHHhhcccCCCCchhh
Confidence 32111 111223567889999999865333444333
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=224.41 Aligned_cols=174 Identities=29% Similarity=0.430 Sum_probs=140.1
Q ss_pred ccCeeEEEEeccCCceEEEEeeec------------------CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhC
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKWR------------------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102 (1236)
Q Consensus 1041 ~EdYeiLkkLGsGSFGtVYKArlk------------------G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskL 1102 (1236)
.++|++.+.||+|+||+||++++. ...||||++.... .......|.+|+.+|+.+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-------~~~~~~~~~~E~~~l~~l 76 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-------NKNARNDFLKEIKIMSRL 76 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-------CHHHHHHHHHHHHHHHhC
Confidence 467999999999999999998642 2358999886431 223345788999999999
Q ss_pred CCCceeeEeeeEecCCCCeEEEEEeeccCCCHHHHHhhhc----------cCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Q 000893 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE----------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHF 1172 (1236)
Q Consensus 1103 rHPNIVrLyG~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~----------r~LSe~erl~Ia~QIAeALaYLHSkGIIHR 1172 (1236)
+||||+++++++.... ..++||||+.+++|.+++.... ..+++..+..++.||+.||+|||++||+||
T Consensus 77 ~~~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~ 154 (296)
T cd05095 77 KDPNIIRLLAVCITSD--PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHR 154 (296)
T ss_pred CCCCcceEEEEEecCC--ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence 9999999999998754 7899999999999999986532 236778899999999999999999999999
Q ss_pred CCCCCcEEEccCCCCCCcEEEEeccCcccccCcc---cccCcCCCCcccchhhhcCCC
Q 000893 1173 DLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1173 DIKPsNILLDsdG~I~ltVKLsDFGLArii~ns~---~tss~~GTp~YmAPEVL~Gss 1227 (1236)
||||+|||++.++ .+||+|||+++...... ......+++.|+|||++.+..
T Consensus 155 dlkp~Nili~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~ 208 (296)
T cd05095 155 DLATRNCLVGKNY----TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK 208 (296)
T ss_pred cCChheEEEcCCC----CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCC
Confidence 9999999998775 57999999998653322 122233467899999887553
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-23 Score=224.07 Aligned_cols=174 Identities=30% Similarity=0.452 Sum_probs=142.9
Q ss_pred cCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
.+|++++.||+|+||.||++... ++.||||.+.+... ........+.+|+.+++.++||||+++++.+....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 74 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNL-----ILRNQIQQVFVERDILTFAENPFVVSMFCSFETKR- 74 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhh-----hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCC-
Confidence 36889999999999999999884 67899999875421 12233457788999999999999999999998754
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
.+++||||+++++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++ .+||+|||++
T Consensus 75 -~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~----~~~l~dfg~~ 148 (305)
T cd05609 75 -HLCMVMEYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMG----HIKLTDFGLS 148 (305)
T ss_pred -EEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCC----CEEEeeCCCc
Confidence 899999999999999999654 4689999999999999999999999999999999999998876 5799999998
Q ss_pred ccccCcc----------------cccCcCCCCcccchhhhcCCC
Q 000893 1200 KIKRNTL----------------VTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1200 rii~ns~----------------~tss~~GTp~YmAPEVL~Gss 1227 (1236)
+...... ......++..|+|||++.+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 192 (305)
T cd05609 149 KIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQG 192 (305)
T ss_pred cccCcCccccccccccccchhhccccCCccCccccCchhccCCC
Confidence 7421110 112346788999999987653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-23 Score=221.15 Aligned_cols=176 Identities=31% Similarity=0.467 Sum_probs=146.1
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
++|..++.||.|++|.||++.+ .++.||+|.+.... ......++.+|+++++.++||||++++++|.....
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 73 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP-------NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESS 73 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC-------chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCC
Confidence 3688999999999999999998 46789999987532 11334568899999999999999999999977655
Q ss_pred CeEEEEEeeccCCCHHHHHhh---hccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEec
Q 000893 1120 GTLATVTEFMVNGSLRHVLLS---KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~---k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDF 1196 (1236)
..+++||||+++++|.+++.. ....+++..+..|+.||+.||.|||..+++|+||+|+||+++.++ .++|+||
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~----~~~l~df 149 (287)
T cd06621 74 SSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKG----QVKLCDF 149 (287)
T ss_pred CeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCC----eEEEeec
Confidence 689999999999999988753 245688899999999999999999999999999999999998876 5799999
Q ss_pred cCcccccCcccccCcCCCCcccchhhhcCCCCC
Q 000893 1197 GLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSK 1229 (1236)
Q Consensus 1197 GLArii~ns~~tss~~GTp~YmAPEVL~Gss~~ 1229 (1236)
|++........ ....++..|+|||.+.+....
T Consensus 150 g~~~~~~~~~~-~~~~~~~~y~~pE~~~~~~~~ 181 (287)
T cd06621 150 GVSGELVNSLA-GTFTGTSFYMAPERIQGKPYS 181 (287)
T ss_pred ccccccccccc-ccccCCccccCHHHhcCCCCC
Confidence 99876543222 235678899999999866433
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.6e-24 Score=224.20 Aligned_cols=176 Identities=30% Similarity=0.504 Sum_probs=142.6
Q ss_pred ccccCeeEEEEeccCCceEEEEeeec-------CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEe
Q 000893 1039 IKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 1111 (1236)
Q Consensus 1039 Is~EdYeiLkkLGsGSFGtVYKArlk-------G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLy 1111 (1236)
+...+|++.+.||+|+||.||++.+. +..||||++.... .......|.+|+.+++.++||||++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~ei~~l~~l~h~~iv~~~ 74 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-------SADMQADFQREAALMAEFDHPNIVKLL 74 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-------CHHHHHHHHHHHHHHHhcCCCchheEE
Confidence 34568999999999999999999863 4669999986432 122345688999999999999999999
Q ss_pred eeEecCCCCeEEEEEeeccCCCHHHHHhhhc---------------------cCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 000893 1112 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------------------RHLDRRKRLIIAMDAAFGMEYLHSKNIV 1170 (1236)
Q Consensus 1112 G~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~---------------------r~LSe~erl~Ia~QIAeALaYLHSkGII 1170 (1236)
+++.... .+++||||+++++|.+++.... ..+++..++.++.||+.||.|||.++++
T Consensus 75 ~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~ 152 (288)
T cd05050 75 GVCAVGK--PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFV 152 (288)
T ss_pred EEEcCCC--ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 9988754 7899999999999999996421 2467888899999999999999999999
Q ss_pred cCCCCCCcEEEccCCCCCCcEEEEeccCcccccCcc---cccCcCCCCcccchhhhcCCC
Q 000893 1171 HFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1171 HRDIKPsNILLDsdG~I~ltVKLsDFGLArii~ns~---~tss~~GTp~YmAPEVL~Gss 1227 (1236)
||||||+|||++.++ .+||+|||++....... ......+++.|+|||++.+..
T Consensus 153 H~dl~p~nil~~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 208 (288)
T cd05050 153 HRDLATRNCLVGENM----VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNR 208 (288)
T ss_pred cccccHhheEecCCC----ceEECccccceecccCccccccCCCccChhhcCHHHHhcCC
Confidence 999999999998876 56999999987643221 122233467799999987654
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.3e-24 Score=216.09 Aligned_cols=170 Identities=40% Similarity=0.597 Sum_probs=141.1
Q ss_pred eeEEEEeccCCceEEEEeeecC------ceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecC
Q 000893 1044 LEELKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1236)
Q Consensus 1044 YeiLkkLGsGSFGtVYKArlkG------~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~ 1117 (1236)
|++.+.||.|+||.||++.+.. ..||+|+++.... ......+..|+.+++.++|+||+++++++.+.
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 73 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-------EQQIEEFLREARIMRKLDHPNIVKLLGVCTEE 73 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-------hHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 3566789999999999999853 7799999865421 11345788899999999999999999999886
Q ss_pred CCCeEEEEEeeccCCCHHHHHhhhccC-CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEec
Q 000893 1118 PGGTLATVTEFMVNGSLRHVLLSKERH-LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1236)
Q Consensus 1118 ~~g~L~LVMEYm~GGSL~dlL~~k~r~-LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDF 1196 (1236)
. ..+++|||+++++|.+++...... +++..+..++.|++.||.|||+.+++||||||+||+++.++ .++|+||
T Consensus 74 ~--~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~----~~~l~df 147 (258)
T smart00219 74 E--PLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENL----VVKISDF 147 (258)
T ss_pred C--eeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCC----eEEEccc
Confidence 4 899999999999999999765444 89999999999999999999999999999999999999886 6799999
Q ss_pred cCcccccCccccc--CcCCCCcccchhhhcCC
Q 000893 1197 GLSKIKRNTLVTG--GVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1197 GLArii~ns~~ts--s~~GTp~YmAPEVL~Gs 1226 (1236)
|++.......... ...+++.|+|||.+.+.
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~ 179 (258)
T smart00219 148 GLSRDLYDDDYYKKKGGKLPIRWMAPESLKDG 179 (258)
T ss_pred CCceecccccccccccCCCcccccChHHhccC
Confidence 9998765432111 23367899999999654
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.3e-24 Score=219.07 Aligned_cols=167 Identities=30% Similarity=0.488 Sum_probs=134.4
Q ss_pred EeccCCceEEEEeeec-----CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeEE
Q 000893 1049 ELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLA 1123 (1236)
Q Consensus 1049 kLGsGSFGtVYKArlk-----G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L~ 1123 (1236)
.||+|+||.||+|.+. ...||||.+.... .......+.+|+.+++.++||||+++++++...+ +..+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~ 73 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-------DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE-GSPL 73 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCccC-------CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCC-CCcE
Confidence 5899999999999863 2459999875321 1223457888999999999999999999876543 4678
Q ss_pred EEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCccccc
Q 000893 1124 TVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR 1203 (1236)
Q Consensus 1124 LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~ 1203 (1236)
+||||+.+++|.+++......+.+..++.++.||+.||.|||+.+|+||||||+|||++.++ .+||+|||+++...
T Consensus 74 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~----~~kl~dfg~~~~~~ 149 (262)
T cd05058 74 VVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESF----TVKVADFGLARDIY 149 (262)
T ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC----cEEECCcccccccc
Confidence 99999999999999976655678888888999999999999999999999999999999875 57999999998643
Q ss_pred Ccc-----cccCcCCCCcccchhhhcCCC
Q 000893 1204 NTL-----VTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1204 ns~-----~tss~~GTp~YmAPEVL~Gss 1227 (1236)
... ......+++.|+|||++.+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 178 (262)
T cd05058 150 DKEYYSVHNHTGAKLPVKWMALESLQTQK 178 (262)
T ss_pred CCcceeecccccCcCCccccChhHhccCc
Confidence 221 112334677899999987653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-25 Score=259.36 Aligned_cols=170 Identities=30% Similarity=0.456 Sum_probs=145.1
Q ss_pred CeeEEEEeccCCceEEEEeeecCc--eEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArlkG~--~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g 1120 (1236)
.|.++-.||.|+||+||+|..+.. ..|-|+|... .+..+..|+.|+.||..|.||+||+|++.|+..+
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--------seEELEDylVEIeILa~CdHP~ivkLl~ayy~en-- 102 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--------SEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN-- 102 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--------chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC--
Confidence 355667899999999999988633 3677877543 3445678999999999999999999999887754
Q ss_pred eEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcc
Q 000893 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1236)
Q Consensus 1121 ~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLAr 1200 (1236)
.+|++.|||.||-.+.++..-++.+.+.++..+++|+|.||.|||+++|||||||..|||++.+|. ++|+|||.+.
T Consensus 103 kLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGd----irLADFGVSA 178 (1187)
T KOG0579|consen 103 KLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGD----IRLADFGVSA 178 (1187)
T ss_pred ceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCc----Eeeecccccc
Confidence 899999999999999999888999999999999999999999999999999999999999999985 4999999875
Q ss_pred cc-cCcccccCcCCCCcccchhhhcCC
Q 000893 1201 IK-RNTLVTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1201 ii-~ns~~tss~~GTp~YmAPEVL~Gs 1226 (1236)
.. ........++|||+|||||++...
T Consensus 179 Kn~~t~qkRDsFIGTPYWMAPEVvmCE 205 (1187)
T KOG0579|consen 179 KNKSTRQKRDSFIGTPYWMAPEVVMCE 205 (1187)
T ss_pred cchhHHhhhccccCCcccccchheeec
Confidence 43 223334568999999999998754
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=215.69 Aligned_cols=170 Identities=32% Similarity=0.504 Sum_probs=147.3
Q ss_pred cCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
++|++.+.||+|+||.||+|.+. +..||+|.+.... ....+.+|+++++.++||||+++++++...
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-- 70 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----------DLQEIIKEISILKQCDSPYIVKYYGSYFKN-- 70 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----------HHHHHHHHHHHHHhCCCCcEeeeeeeeecC--
Confidence 57888999999999999999984 6789999986421 145788999999999999999999999886
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
..++++|||+.+++|.+++......+++..++.++.|++.||.|||..+|+||||+|+||+++.++ .+||+|||++
T Consensus 71 ~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~----~~~l~dfg~~ 146 (256)
T cd06612 71 TDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEG----QAKLADFGVS 146 (256)
T ss_pred CcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCC----cEEEcccccc
Confidence 489999999999999999977677899999999999999999999999999999999999999876 5799999999
Q ss_pred ccccCcc-cccCcCCCCcccchhhhcCCC
Q 000893 1200 KIKRNTL-VTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1200 rii~ns~-~tss~~GTp~YmAPEVL~Gss 1227 (1236)
....... ......++..|+|||++.+..
T Consensus 147 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~ 175 (256)
T cd06612 147 GQLTDTMAKRNTVIGTPFWMAPEVIQEIG 175 (256)
T ss_pred hhcccCccccccccCCccccCHHHHhcCC
Confidence 8765433 233455889999999998763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.4e-24 Score=220.29 Aligned_cols=174 Identities=36% Similarity=0.576 Sum_probs=141.7
Q ss_pred cccccCeeEEEEeccCCceEEEEeeecC-ceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEec
Q 000893 1038 IIKNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1236)
Q Consensus 1038 iIs~EdYeiLkkLGsGSFGtVYKArlkG-~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t 1116 (1236)
++..++|.+.++||+|+||.||++.+.+ ..+|||.+..... ....|.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~---------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 72 (260)
T cd05069 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM---------MPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72 (260)
T ss_pred cCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc---------cHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 3455789999999999999999998854 4699998764321 12457789999999999999999998754
Q ss_pred CCCCeEEEEEeeccCCCHHHHHhhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEe
Q 000893 1117 GPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1236)
Q Consensus 1117 ~~~g~L~LVMEYm~GGSL~dlL~~k-~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsD 1195 (1236)
...++||||+.+++|.+++... ...+++..+..++.|++.||.|||+.||+||||||+|||++.++ .+||+|
T Consensus 73 ---~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~----~~~l~d 145 (260)
T cd05069 73 ---EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNL----VCKIAD 145 (260)
T ss_pred ---CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC----eEEECC
Confidence 3678999999999999999654 34588999999999999999999999999999999999999876 579999
Q ss_pred ccCcccccCccc--ccCcCCCCcccchhhhcCCC
Q 000893 1196 FGLSKIKRNTLV--TGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1196 FGLArii~ns~~--tss~~GTp~YmAPEVL~Gss 1227 (1236)
||+++....... .....++..|+|||++.+..
T Consensus 146 fg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~ 179 (260)
T cd05069 146 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 179 (260)
T ss_pred CccceEccCCcccccCCCccchhhCCHHHhccCC
Confidence 999986543221 12234567899999987653
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=222.70 Aligned_cols=174 Identities=25% Similarity=0.409 Sum_probs=142.5
Q ss_pred CeeEEEEeccCCceEEEEeee-----cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhC-CCCceeeEeeeEec
Q 000893 1043 DLEELKELGSGTFGTVYHGKW-----RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQD 1116 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArl-----kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskL-rHPNIVrLyG~f~t 1116 (1236)
+|++.+.||.|+||.||+++. +|..||+|+++..... ........+.+|+.+++.+ +|+||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~----~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIV----QKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 76 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhh----hcchHHHHHHHHHHHHHhcccCCChhceeeEeec
Confidence 478899999999999999886 4678999998754221 1122345577899999999 59999999999887
Q ss_pred CCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEec
Q 000893 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1236)
Q Consensus 1117 ~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDF 1196 (1236)
. ..+++||||+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||+|+|||++.++ .+||+||
T Consensus 77 ~--~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~----~~kl~df 149 (290)
T cd05613 77 D--TKLHLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNG----HVVLTDF 149 (290)
T ss_pred C--CeEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCC----CEEEeeC
Confidence 5 4889999999999999998654 4688889999999999999999999999999999999999876 5799999
Q ss_pred cCcccccCcc--cccCcCCCCcccchhhhcCCC
Q 000893 1197 GLSKIKRNTL--VTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1197 GLArii~ns~--~tss~~GTp~YmAPEVL~Gss 1227 (1236)
|+++...... ......|+..|+|||++.+..
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 182 (290)
T cd05613 150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGD 182 (290)
T ss_pred ccceecccccccccccccCCcccCChhhccCCC
Confidence 9998754322 223456899999999997643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=220.55 Aligned_cols=177 Identities=23% Similarity=0.330 Sum_probs=144.6
Q ss_pred ccccCeeEEEEeccCCceEEEEeeec------CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEee
Q 000893 1039 IKNEDLEELKELGSGTFGTVYHGKWR------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 1112 (1236)
Q Consensus 1039 Is~EdYeiLkkLGsGSFGtVYKArlk------G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG 1112 (1236)
+..++|++.+.||+|+||.||+|.+. +..|++|.+.... .......+.+|+.++++++||||+++++
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~-------~~~~~~~~~~e~~~l~~l~h~ni~~~~~ 75 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-------SEIQVTLLLQESCLLYGLSHQNILPILH 75 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC-------CHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 45678999999999999999999974 3669999876421 2233566888999999999999999999
Q ss_pred eEecCCCCeEEEEEeeccCCCHHHHHhhhc-------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCC
Q 000893 1113 VVQDGPGGTLATVTEFMVNGSLRHVLLSKE-------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKD 1185 (1236)
Q Consensus 1113 ~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~-------r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG 1185 (1236)
++.... ...++++||+++++|..++.... ..+++..++.++.|++.||+|||+++++||||||+|||++.++
T Consensus 76 ~~~~~~-~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~ 154 (280)
T cd05043 76 VCIEDG-EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEEL 154 (280)
T ss_pred EEecCC-CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCC
Confidence 887642 47889999999999999986532 4588999999999999999999999999999999999998775
Q ss_pred CCCCcEEEEeccCcccccCcc---cccCcCCCCcccchhhhcCCC
Q 000893 1186 PIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1186 ~I~ltVKLsDFGLArii~ns~---~tss~~GTp~YmAPEVL~Gss 1227 (1236)
.+||+|||+++...... ......++..|+|||++.+..
T Consensus 155 ----~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~ 195 (280)
T cd05043 155 ----QVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKE 195 (280)
T ss_pred ----cEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCC
Confidence 67999999998653221 112234677899999997654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=230.73 Aligned_cols=175 Identities=26% Similarity=0.366 Sum_probs=143.5
Q ss_pred ccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCC
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1041 ~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~ 1118 (1236)
..+|++++.||+|+||+||+|.. .++.||||++.+... .......+.+|+.+++.++||||++++++|....
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 88 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ------NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQK 88 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc------ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCC
Confidence 46899999999999999999987 578899999865321 1223345678999999999999999999886432
Q ss_pred ----CCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEE
Q 000893 1119 ----GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1236)
Q Consensus 1119 ----~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLs 1194 (1236)
....++||||+ .++|.+.+... +++..+..++.|++.||+|||.+||+||||||+|||++.++ .+||+
T Consensus 89 ~~~~~~~~~lv~e~~-~~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~----~~kL~ 160 (353)
T cd07850 89 SLEEFQDVYLVMELM-DANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC----TLKIL 160 (353)
T ss_pred CccccCcEEEEEecc-CCCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC----CEEEc
Confidence 13579999999 56888877432 88899999999999999999999999999999999999886 56999
Q ss_pred eccCcccccCcccccCcCCCCcccchhhhcCCCCC
Q 000893 1195 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSK 1229 (1236)
Q Consensus 1195 DFGLArii~ns~~tss~~GTp~YmAPEVL~Gss~~ 1229 (1236)
|||+++............+++.|+|||++.+....
T Consensus 161 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 195 (353)
T cd07850 161 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 195 (353)
T ss_pred cCccceeCCCCCCCCCCcccccccCHHHHhCCCCC
Confidence 99999876554444456689999999999876443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-23 Score=224.64 Aligned_cols=170 Identities=26% Similarity=0.447 Sum_probs=143.3
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
.+|++++.||+|+||.||+|.. .+..||||.+..... .....+.+|+.+++.++||||+++++.|....
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~--------~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~- 90 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--------PKKELIINEILVMRENKNPNIVNYLDSYLVGD- 90 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc--------chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC-
Confidence 5899999999999999999986 477899999875421 11345778999999999999999999988754
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
.+++||||+++++|.+++.. ..+++.++..++.|++.||.|||..||+||||||+|||++.++ .+||+|||++
T Consensus 91 -~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~----~~kl~dfg~~ 163 (296)
T cd06654 91 -ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG----SVKLTDFGFC 163 (296)
T ss_pred -EEEEeecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC----CEEECccccc
Confidence 89999999999999998843 4588999999999999999999999999999999999998876 5799999998
Q ss_pred ccccCcc-cccCcCCCCcccchhhhcCCC
Q 000893 1200 KIKRNTL-VTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1200 rii~ns~-~tss~~GTp~YmAPEVL~Gss 1227 (1236)
....... ......|++.|+|||++.+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 192 (296)
T cd06654 164 AQITPEQSKRSTMVGTPYWMAPEVVTRKA 192 (296)
T ss_pred hhccccccccCcccCCccccCHHHHcCCC
Confidence 8643222 223456899999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=219.34 Aligned_cols=169 Identities=28% Similarity=0.361 Sum_probs=139.3
Q ss_pred eeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCC-CCceeeEeeeEecCCCC
Q 000893 1044 LEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1044 YeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLr-HPNIVrLyG~f~t~~~g 1120 (1236)
|+++++||+|+||.||+|.. .++.||||++++.... . . .....+|+.+++++. ||||+++++++.+...+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~---~-~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 73 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS---L-E---QVNNLREIQALRRLSPHPNILRLIEVLFDRKTG 73 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCC---c-h---hhhHHHHHHHHhhcCCCCCccceEEEEecCCCC
Confidence 57789999999999999987 4778999998754211 0 1 123456888888885 99999999999886556
Q ss_pred eEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcc
Q 000893 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1236)
Q Consensus 1121 ~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLAr 1200 (1236)
.+++||||+. ++|.+++......+++..++.++.||+.||.|||.++|+||||||+||+++. + .+||+|||+++
T Consensus 74 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~----~~kl~dfg~~~ 147 (282)
T cd07831 74 RLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-D----ILKLADFGSCR 147 (282)
T ss_pred cEEEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-C----CeEEEeccccc
Confidence 8999999995 6888888665567899999999999999999999999999999999999998 5 67999999998
Q ss_pred cccCcccccCcCCCCcccchhhhcC
Q 000893 1201 IKRNTLVTGGVRGTLPWMAPELLNG 1225 (1236)
Q Consensus 1201 ii~ns~~tss~~GTp~YmAPEVL~G 1225 (1236)
............+++.|+|||++.+
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~ 172 (282)
T cd07831 148 GIYSKPPYTEYISTRWYRAPECLLT 172 (282)
T ss_pred ccccCCCcCCCCCCcccCChhHhhc
Confidence 7654444344568999999998754
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.1e-24 Score=224.52 Aligned_cols=173 Identities=31% Similarity=0.469 Sum_probs=145.4
Q ss_pred cccCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecC
Q 000893 1040 KNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1236)
Q Consensus 1040 s~EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~ 1117 (1236)
..++|++++.||+|+||+||++.+. ++.||+|++.... .......+.+|+++++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-------KSSVRKQILRELQIMHECRSPYIVSFYGAFLNE 75 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-------cchHHHHHHHHHHHHHHcCCCCcceEeeeEecC
Confidence 4568889999999999999999984 7889999886532 122345788999999999999999999999886
Q ss_pred CCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCcEEEccCCCCCCcEEEEec
Q 000893 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1236)
Q Consensus 1118 ~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHS-kGIIHRDIKPsNILLDsdG~I~ltVKLsDF 1196 (1236)
. .+++||||+++++|..++.. ...+++..+..++.+++.||.|||+ ++|+||||||+||+++.++ .++|+||
T Consensus 76 ~--~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~----~~~l~d~ 148 (284)
T cd06620 76 N--NICMCMEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG----QIKLCDF 148 (284)
T ss_pred C--EEEEEEecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC----cEEEccC
Confidence 4 89999999999999998854 3468999999999999999999997 6999999999999999876 5799999
Q ss_pred cCcccccCcccccCcCCCCcccchhhhcCCC
Q 000893 1197 GLSKIKRNTLVTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1197 GLArii~ns~~tss~~GTp~YmAPEVL~Gss 1227 (1236)
|++...... .....+|+..|+|||++.+..
T Consensus 149 gl~~~~~~~-~~~~~~~~~~~~aPE~~~~~~ 178 (284)
T cd06620 149 GVSGELINS-IADTFVGTSTYMSPERIQGGK 178 (284)
T ss_pred Ccccchhhh-ccCccccCcccCCHHHHccCC
Confidence 998764332 223467899999999997653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=221.99 Aligned_cols=175 Identities=29% Similarity=0.396 Sum_probs=141.6
Q ss_pred ccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCC
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1041 ~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~ 1118 (1236)
.++|++.++||+|+||.||+|+. +++.||||++...... ......+.+|+.++++++||||++++++|....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK------EGFPITALREIKILQLLKHENVVNLIEICRTKA 84 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc------CCchhHHHHHHHHHHhCCCCCccceEEEEeccc
Confidence 35799999999999999999998 4788999998653211 111234567999999999999999999987643
Q ss_pred ------CCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEE
Q 000893 1119 ------GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 1192 (1236)
Q Consensus 1119 ------~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVK 1192 (1236)
....++||||+. ++|..++......+++..++.++.||+.||.|||++||+||||||+|||++.++ .+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~----~~k 159 (310)
T cd07865 85 TPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDG----ILK 159 (310)
T ss_pred ccccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCC----cEE
Confidence 235699999994 688888866655789999999999999999999999999999999999999876 579
Q ss_pred EEeccCcccccCcc-----cccCcCCCCcccchhhhcCC
Q 000893 1193 VGDFGLSKIKRNTL-----VTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1193 LsDFGLArii~ns~-----~tss~~GTp~YmAPEVL~Gs 1226 (1236)
|+|||++....... ......++..|+|||++.+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 198 (310)
T cd07865 160 LADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE 198 (310)
T ss_pred ECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCC
Confidence 99999998653321 11234578899999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=218.63 Aligned_cols=165 Identities=32% Similarity=0.504 Sum_probs=134.5
Q ss_pred EeccCCceEEEEeee----cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeEEE
Q 000893 1049 ELGSGTFGTVYHGKW----RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLAT 1124 (1236)
Q Consensus 1049 kLGsGSFGtVYKArl----kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L~L 1124 (1236)
+||+|+||+||+|.+ .+..+|||+++... ........|.+|+.+++.+.||||+++++++... ..++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~l 72 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN------NDPALKDELLREANVMQQLDNPYIVRMIGICEAE---SWML 72 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC------CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC---CcEE
Confidence 589999999999975 35679999986432 1233456788999999999999999999988642 6789
Q ss_pred EEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcccccC
Q 000893 1125 VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 1204 (1236)
Q Consensus 1125 VMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~n 1204 (1236)
||||+++++|.+++.. ...+++..++.++.|++.||+|||++||+||||||.|||++.++ .+||+|||+++....
T Consensus 73 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~----~~kl~Dfg~~~~~~~ 147 (257)
T cd05116 73 VMELAELGPLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH----YAKISDFGLSKALGA 147 (257)
T ss_pred EEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCC----eEEECCCccccccCC
Confidence 9999999999999864 34689999999999999999999999999999999999999875 579999999987543
Q ss_pred ccc----ccCcCCCCcccchhhhcCCC
Q 000893 1205 TLV----TGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1205 s~~----tss~~GTp~YmAPEVL~Gss 1227 (1236)
... .....+++.|+|||++.+..
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~ 174 (257)
T cd05116 148 DENYYKAKTHGKWPVKWYAPECMNYYK 174 (257)
T ss_pred CCCeeeecCCCCCCccccCHhHhccCC
Confidence 221 11223457899999987653
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.5e-24 Score=226.09 Aligned_cols=176 Identities=30% Similarity=0.421 Sum_probs=143.9
Q ss_pred cccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecC
Q 000893 1040 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1236)
Q Consensus 1040 s~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~ 1117 (1236)
..++|++.+.||+|+||.||+|.+ +++.||+|+++...... .....+.+|+.++++++|+||+++++++...
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD------GIPISSLREITLLLNLRHPNIVELKEVVVGK 78 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC------CCcchhhHHHHHHHhCCCCCCcceEEEEecC
Confidence 346899999999999999999998 47889999987543211 1122356799999999999999999999876
Q ss_pred CCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEecc
Q 000893 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1236)
Q Consensus 1118 ~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFG 1197 (1236)
....+++||||+. ++|..++......+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||
T Consensus 79 ~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~----~~kL~dfg 153 (309)
T cd07845 79 HLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKG----CLKIADFG 153 (309)
T ss_pred CCCeEEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC----CEEECccc
Confidence 5457899999995 588888876556799999999999999999999999999999999999999876 57999999
Q ss_pred CcccccCcc-cccCcCCCCcccchhhhcCC
Q 000893 1198 LSKIKRNTL-VTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1198 LArii~ns~-~tss~~GTp~YmAPEVL~Gs 1226 (1236)
++....... ......+++.|+|||++.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 183 (309)
T cd07845 154 LARTYGLPAKPMTPKVVTLWYRAPELLLGC 183 (309)
T ss_pred eeeecCCccCCCCcccccccccChhhhcCC
Confidence 998764331 22233457889999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-23 Score=214.38 Aligned_cols=172 Identities=31% Similarity=0.462 Sum_probs=144.9
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
++|++.+.||.|+||+||+|.. .+..+|||++..... ......+.+|+.+++.++|+||+++++.+....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 72 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC-------QTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGD- 72 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc-------chHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCC-
Confidence 4789999999999999999987 467899999865321 113557889999999999999999999988754
Q ss_pred CeEEEEEeeccCCCHHHHHhhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEecc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKE--RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~--r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFG 1197 (1236)
..++||||+++++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||
T Consensus 73 -~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~----~~~l~df~ 147 (267)
T cd06610 73 -ELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDG----SVKIADFG 147 (267)
T ss_pred -EEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC----CEEEcccc
Confidence 8999999999999999996542 4689999999999999999999999999999999999999876 56999999
Q ss_pred CcccccCcc-----cccCcCCCCcccchhhhcCC
Q 000893 1198 LSKIKRNTL-----VTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1198 LArii~ns~-----~tss~~GTp~YmAPEVL~Gs 1226 (1236)
++....... ......|+..|+|||++...
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~ 181 (267)
T cd06610 148 VSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV 181 (267)
T ss_pred hHHHhccCccccccccccccCChhhcChHHHccc
Confidence 987654322 12345689999999999765
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-24 Score=223.02 Aligned_cols=165 Identities=27% Similarity=0.462 Sum_probs=136.0
Q ss_pred EeccCCceEEEEeeec---------CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1049 ELGSGTFGTVYHGKWR---------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1049 kLGsGSFGtVYKArlk---------G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
.||+|+||.||+|... ...||+|.+... .......|..|+.+++.+.||||+++++++....
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--------~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~- 72 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--------HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD- 72 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcch--------hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC-
Confidence 5899999999999863 223788877532 2233456888999999999999999999998754
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCC----CCcEEEEe
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPI----RPICKVGD 1195 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I----~ltVKLsD 1195 (1236)
..++||||+.+++|..++......+++..++.++.||+.||+|||+++|+||||||+|||++.++.. ...++|+|
T Consensus 73 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 73 -ESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD 151 (258)
T ss_pred -CcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecc
Confidence 7889999999999999997766678999999999999999999999999999999999999876531 13479999
Q ss_pred ccCcccccCcccccCcCCCCcccchhhhcCC
Q 000893 1196 FGLSKIKRNTLVTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1196 FGLArii~ns~~tss~~GTp~YmAPEVL~Gs 1226 (1236)
||++...... ....+++.|+|||++.+.
T Consensus 152 ~g~~~~~~~~---~~~~~~~~y~aPE~~~~~ 179 (258)
T cd05078 152 PGISITVLPK---EILLERIPWVPPECIENP 179 (258)
T ss_pred cccccccCCc---hhccccCCccCchhccCC
Confidence 9998765432 235678999999999763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-24 Score=246.34 Aligned_cols=177 Identities=27% Similarity=0.372 Sum_probs=156.2
Q ss_pred CeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g 1120 (1236)
-|.+.+-||+|.|..|-+|++ +|..||||++.+..+. ......+..|++.|+.++|||||+||.+..+..
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD------~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQT-- 90 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD------TLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQT-- 90 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccc------hhhhhHHHHHHHHHHHhcCcCeeeeeehhcccc--
Confidence 366677899999999999987 8999999999886543 223345678999999999999999999988754
Q ss_pred eEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcc
Q 000893 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1236)
Q Consensus 1121 ~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLAr 1200 (1236)
.+|||+|+=.+|+|.+||...+..+.+..++.++.||+.|+.|||+..+|||||||+||.+-..- ..|||+|||++-
T Consensus 91 KlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKl---GlVKLTDFGFSN 167 (864)
T KOG4717|consen 91 KLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKL---GLVKLTDFGFSN 167 (864)
T ss_pred eEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeec---CceEeeeccccc
Confidence 89999999999999999999999999999999999999999999999999999999999887653 368999999998
Q ss_pred cccCcccccCcCCCCcccchhhhcCCCCCC
Q 000893 1201 IKRNTLVTGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1201 ii~ns~~tss~~GTp~YmAPEVL~Gss~~~ 1230 (1236)
.+.....-++.||++.|.|||+|.|..+..
T Consensus 168 kf~PG~kL~TsCGSLAYSAPEILLGDsYDA 197 (864)
T KOG4717|consen 168 KFQPGKKLTTSCGSLAYSAPEILLGDSYDA 197 (864)
T ss_pred cCCCcchhhcccchhhccCchhhhcCccCC
Confidence 887777777899999999999999986654
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=219.95 Aligned_cols=171 Identities=31% Similarity=0.453 Sum_probs=145.4
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
++|++.+.||.|+||.||+|.+ .++.||||++.... .......+.+|+.+++.++||||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 72 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-------AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGS- 72 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-------cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECC-
Confidence 3678889999999999999987 47789999986532 1222456788999999999999999999988754
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
.+++|+||+++++|.+++... .+++..++.++.|++.||.|||.++|+||||+|+||+++.++ .++|+|||++
T Consensus 73 -~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~----~~~l~d~g~~ 145 (274)
T cd06609 73 -KLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEG----DVKLADFGVS 145 (274)
T ss_pred -eEEEEEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC----CEEEcccccc
Confidence 899999999999999998643 789999999999999999999999999999999999999876 5699999999
Q ss_pred ccccCc-ccccCcCCCCcccchhhhcCCC
Q 000893 1200 KIKRNT-LVTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1200 rii~ns-~~tss~~GTp~YmAPEVL~Gss 1227 (1236)
+..... .......+++.|+|||++.+..
T Consensus 146 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~ 174 (274)
T cd06609 146 GQLTSTMSKRNTFVGTPFWMAPEVIKQSG 174 (274)
T ss_pred eeecccccccccccCCccccChhhhccCC
Confidence 876543 2334467889999999998764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=220.31 Aligned_cols=167 Identities=35% Similarity=0.513 Sum_probs=132.9
Q ss_pred EeccCCceEEEEeeec--Cc--eEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhC-CCCceeeEeeeEecCCCCeEE
Q 000893 1049 ELGSGTFGTVYHGKWR--GT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDGPGGTLA 1123 (1236)
Q Consensus 1049 kLGsGSFGtVYKArlk--G~--~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskL-rHPNIVrLyG~f~t~~~g~L~ 1123 (1236)
.||+|+||.||+|.+. +. .+|+|.++... .......+.+|+.++.++ +||||++++++|.... .++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~--~~~ 72 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-------SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG--YLY 72 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-------CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCC--Cce
Confidence 5899999999999874 33 47888876421 122345678899999999 7999999999998754 789
Q ss_pred EEEeeccCCCHHHHHhhhc---------------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCC
Q 000893 1124 TVTEFMVNGSLRHVLLSKE---------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIR 1188 (1236)
Q Consensus 1124 LVMEYm~GGSL~dlL~~k~---------------r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ 1188 (1236)
+||||+++++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+|||++.++
T Consensus 73 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~--- 149 (270)
T cd05047 73 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY--- 149 (270)
T ss_pred EEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCC---
Confidence 9999999999999986532 2478899999999999999999999999999999999999876
Q ss_pred CcEEEEeccCcccccCcccccCcCCCCcccchhhhcCCCC
Q 000893 1189 PICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1189 ltVKLsDFGLArii~ns~~tss~~GTp~YmAPEVL~Gss~ 1228 (1236)
.+||+|||++..............++.|+|||++.+...
T Consensus 150 -~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~ 188 (270)
T cd05047 150 -VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVY 188 (270)
T ss_pred -eEEECCCCCccccchhhhccCCCCccccCChHHHccCCC
Confidence 679999999864332222222234667999999976543
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=220.35 Aligned_cols=168 Identities=26% Similarity=0.362 Sum_probs=139.9
Q ss_pred eccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeEEEEEe
Q 000893 1050 LGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTE 1127 (1236)
Q Consensus 1050 LGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L~LVME 1127 (1236)
||+|+||+||++.. +++.||+|++.+.... .......+.+|+.+|+.++||||+++++++.... ..++|||
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~e 73 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLK-----KRKGEQMALNEKKILEKVSSRFIVSLAYAFETKD--DLCLVMT 73 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhh-----hhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCC--eEEEEEe
Confidence 68999999999987 4788999998754321 1122345678999999999999999999998754 8999999
Q ss_pred eccCCCHHHHHhhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcccccCcc
Q 000893 1128 FMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL 1206 (1236)
Q Consensus 1128 Ym~GGSL~dlL~~k~-r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~ns~ 1206 (1236)
|+++++|.+++.... ..+++..++.++.|++.||.|||.+||+||||+|+|||++.++ .+||+|||++.......
T Consensus 74 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~----~~~l~dfg~~~~~~~~~ 149 (277)
T cd05577 74 LMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHG----NVRISDLGLAVELKGGK 149 (277)
T ss_pred cCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC----CEEEccCcchhhhccCC
Confidence 999999999987644 3689999999999999999999999999999999999999876 56999999998765443
Q ss_pred cccCcCCCCcccchhhhcCCCC
Q 000893 1207 VTGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1207 ~tss~~GTp~YmAPEVL~Gss~ 1228 (1236)
......++..|+|||++.+...
T Consensus 150 ~~~~~~~~~~y~~PE~~~~~~~ 171 (277)
T cd05577 150 KIKGRAGTPGYMAPEVLQGEVY 171 (277)
T ss_pred ccccccCCCCcCCHHHhcCCCC
Confidence 3344567889999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.1e-23 Score=214.00 Aligned_cols=172 Identities=31% Similarity=0.515 Sum_probs=145.1
Q ss_pred CeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g 1120 (1236)
+|++.+.||+|+||.||+|.. .++.||||+++.... .......+.+|+.+++.++|+||+++++++....
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-- 72 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN------DPKTIKEIADEMKVLELLKHPNLVKYYGVEVHRE-- 72 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc------chHHHHHHHHHHHHHHhCCCCChhheeeeEecCC--
Confidence 578899999999999999987 477899999876431 1334567889999999999999999999987754
Q ss_pred eEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcc
Q 000893 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1236)
Q Consensus 1121 ~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLAr 1200 (1236)
.+++|+||+++++|.+++... ..+++..+..|+.+++.||.|||+.+|+|+||+|+||+++.++ .+||+|||++.
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~----~~kl~d~g~~~ 147 (264)
T cd06626 73 KVYIFMEYCSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNG----VIKLGDFGCAV 147 (264)
T ss_pred EEEEEEecCCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC----CEEEccccccc
Confidence 899999999999999998653 4578899999999999999999999999999999999999876 57999999998
Q ss_pred cccCcccc-----cCcCCCCcccchhhhcCCC
Q 000893 1201 IKRNTLVT-----GGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1201 ii~ns~~t-----ss~~GTp~YmAPEVL~Gss 1227 (1236)
........ ....+++.|+|||++.+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~ 179 (264)
T cd06626 148 KLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179 (264)
T ss_pred ccCCCCCcccccccCCcCCcCccChhhccCCC
Confidence 76433221 1356789999999998654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.4e-24 Score=220.26 Aligned_cols=173 Identities=36% Similarity=0.530 Sum_probs=146.5
Q ss_pred CeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g 1120 (1236)
+|++.+.||.|+||.||++.++ ++.||+|++..... ......+.+|+.+++.++||||+++++++... .
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~ 72 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-------EAIQKQILRELDILHKCNSPYIVGFYGAFYNN--G 72 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-------hHHHHHHHHHHHHHHHCCCCchhhhheeeecC--C
Confidence 5777889999999999999985 77899999876421 13345688999999999999999999999886 4
Q ss_pred eEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1121 ~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHS-kGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
.+++||||+.+++|.+++......+++..+..++.|++.||+|||+ .+++||||||+||+++.++ .+||+|||++
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~----~~~l~d~g~~ 148 (265)
T cd06605 73 DISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG----QIKLCDFGVS 148 (265)
T ss_pred EEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCC----CEEEeecccc
Confidence 8999999999999999997655678999999999999999999999 9999999999999999876 5699999998
Q ss_pred ccccCcccccCcCCCCcccchhhhcCCCCC
Q 000893 1200 KIKRNTLVTGGVRGTLPWMAPELLNGSSSK 1229 (1236)
Q Consensus 1200 rii~ns~~tss~~GTp~YmAPEVL~Gss~~ 1229 (1236)
.......... ..++..|+|||++.+....
T Consensus 149 ~~~~~~~~~~-~~~~~~y~~PE~~~~~~~~ 177 (265)
T cd06605 149 GQLVNSLAKT-FVGTSSYMAPERIQGNDYS 177 (265)
T ss_pred hhhHHHHhhc-ccCChhccCHHHHcCCCCC
Confidence 7654332222 6789999999999876433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-23 Score=224.03 Aligned_cols=171 Identities=26% Similarity=0.439 Sum_probs=144.0
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
.+|++++.||+|+||.||++.. .+..||||.+..... .....+.+|+.+++.++||||++++++|....
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~- 89 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ--------PKKELIINEILVMRENKNPNIVNYLDSYLVGD- 89 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc--------chHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-
Confidence 6799999999999999999986 578899999875321 11345778999999999999999999998754
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
.+++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++ .+||+|||++
T Consensus 90 -~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~----~~~l~Dfg~~ 162 (297)
T cd06656 90 -ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDG----SVKLTDFGFC 162 (297)
T ss_pred -EEEEeecccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC----CEEECcCccc
Confidence 89999999999999999843 4588899999999999999999999999999999999999876 5799999998
Q ss_pred ccccCcc-cccCcCCCCcccchhhhcCCCC
Q 000893 1200 KIKRNTL-VTGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1200 rii~ns~-~tss~~GTp~YmAPEVL~Gss~ 1228 (1236)
....... ......+++.|+|||++.+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 192 (297)
T cd06656 163 AQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192 (297)
T ss_pred eEccCCccCcCcccCCccccCHHHHcCCCC
Confidence 7654322 2234568899999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-23 Score=216.36 Aligned_cols=167 Identities=28% Similarity=0.424 Sum_probs=141.4
Q ss_pred eccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeEEEEEe
Q 000893 1050 LGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTE 1127 (1236)
Q Consensus 1050 LGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L~LVME 1127 (1236)
||.|+||.||+++.. ++.||||++.+.... .......+.+|+.+++.++||||+++++++.... .+++|||
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e 73 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIV-----ETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKK--YIYMLME 73 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcch-----hhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCC--ccEEEEe
Confidence 689999999999996 788999999764322 1223456889999999999999999999988754 8999999
Q ss_pred eccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcccccCccc
Q 000893 1128 FMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLV 1207 (1236)
Q Consensus 1128 Ym~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~ns~~ 1207 (1236)
|+++++|.+++... ..+++..++.++.||+.||+|||+++++|+||+|+||+++.++ .++|+|||++........
T Consensus 74 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~----~~~l~df~~~~~~~~~~~ 148 (262)
T cd05572 74 YCLGGELWTILRDR-GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNG----YVKLVDFGFAKKLKSGQK 148 (262)
T ss_pred cCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCC----CEEEeeCCcccccCcccc
Confidence 99999999999654 4588999999999999999999999999999999999999876 579999999987655433
Q ss_pred ccCcCCCCcccchhhhcCCCC
Q 000893 1208 TGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1208 tss~~GTp~YmAPEVL~Gss~ 1228 (1236)
.....|++.|+|||++.+...
T Consensus 149 ~~~~~~~~~~~~PE~~~~~~~ 169 (262)
T cd05572 149 TWTFCGTPEYVAPEIILNKGY 169 (262)
T ss_pred cccccCCcCccChhHhcCCCC
Confidence 444678999999999876543
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=236.28 Aligned_cols=178 Identities=27% Similarity=0.338 Sum_probs=152.4
Q ss_pred CeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCC-CCceeeEeeeEecCCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLr-HPNIVrLyG~f~t~~~ 1119 (1236)
.|.-.+.||+|..+.|-++.+ ++..+|+|++....-....+...+....-++|+.||+++. ||+|++|.++++++.
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s- 96 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA- 96 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc-
Confidence 455567799999999999887 4788999999765443333334555666788999999975 999999999999865
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
++++|+|.|+.|-|.++|.. .-.+++.....|++|+.+|+.|||.++||||||||+|||++++. .+||+|||++
T Consensus 97 -F~FlVFdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~----~i~isDFGFa 170 (411)
T KOG0599|consen 97 -FVFLVFDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNM----NIKISDFGFA 170 (411)
T ss_pred -hhhhhhhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeecccc----ceEEecccee
Confidence 99999999999999999953 44689999999999999999999999999999999999999886 5699999999
Q ss_pred ccccCcccccCcCCCCcccchhhhcCCC
Q 000893 1200 KIKRNTLVTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1200 rii~ns~~tss~~GTp~YmAPEVL~Gss 1227 (1236)
..+.....-..+||||+|+|||.|..+-
T Consensus 171 ~~l~~GekLrelCGTPgYLAPEtikC~m 198 (411)
T KOG0599|consen 171 CQLEPGEKLRELCGTPGYLAPETIKCSM 198 (411)
T ss_pred eccCCchhHHHhcCCCcccChhheeeec
Confidence 9988887778899999999999998553
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=219.34 Aligned_cols=170 Identities=29% Similarity=0.430 Sum_probs=140.7
Q ss_pred CeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g 1120 (1236)
+|+++++||.|++|+||+|++ .+..||||+++..... .....+.+|+.+++.++||||++++++|....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 71 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-------GTPSTAIREISLMKELKHENIVRLHDVIHTEN-- 71 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-------cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC--
Confidence 588999999999999999998 4788999998754211 11235668999999999999999999998854
Q ss_pred eEEEEEeeccCCCHHHHHhhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccC
Q 000893 1121 TLATVTEFMVNGSLRHVLLSKE--RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1236)
Q Consensus 1121 ~L~LVMEYm~GGSL~dlL~~k~--r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGL 1198 (1236)
.+++||||++ ++|..++.... ..+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||+
T Consensus 72 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~----~~~l~d~g~ 146 (284)
T cd07836 72 KLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRG----ELKLADFGL 146 (284)
T ss_pred cEEEEEecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC----cEEEeecch
Confidence 8899999996 58888886544 4689999999999999999999999999999999999999876 569999999
Q ss_pred cccccCcc-cccCcCCCCcccchhhhcCC
Q 000893 1199 SKIKRNTL-VTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1199 Arii~ns~-~tss~~GTp~YmAPEVL~Gs 1226 (1236)
++...... ......+++.|++||++.+.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~ 175 (284)
T cd07836 147 ARAFGIPVNTFSNEVVTLWYRAPDVLLGS 175 (284)
T ss_pred hhhhcCCccccccccccccccChHHhcCC
Confidence 98653322 22334578899999998764
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-23 Score=219.40 Aligned_cols=164 Identities=26% Similarity=0.407 Sum_probs=130.3
Q ss_pred EeccCCceEEEEeeec-Cc---eEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeEEE
Q 000893 1049 ELGSGTFGTVYHGKWR-GT---DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLAT 1124 (1236)
Q Consensus 1049 kLGsGSFGtVYKArlk-G~---~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L~L 1124 (1236)
+||+|+||+||+++.. +. .+++|.+.... .......|.+|+.+++.++||||+++++.|.... ..++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~--~~~l 72 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-------SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAI--PYLL 72 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-------ChHHHHHHHHHHHHHhccCCcchhheEEEecCCC--ccEE
Confidence 5999999999999763 32 35566654321 1223467889999999999999999999998754 8899
Q ss_pred EEeeccCCCHHHHHhhhc---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCccc
Q 000893 1125 VTEFMVNGSLRHVLLSKE---RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201 (1236)
Q Consensus 1125 VMEYm~GGSL~dlL~~k~---r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLAri 1201 (1236)
||||+++++|.+++.... ..+.+..++.++.||+.||.|||+++|+||||||+|||++.++ .+||+|||++..
T Consensus 73 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~----~~~l~Dfg~~~~ 148 (268)
T cd05086 73 VFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDL----TVKVGDYGIGPS 148 (268)
T ss_pred EEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCc----cEEecccccccc
Confidence 999999999999997542 3456677788999999999999999999999999999998876 579999999865
Q ss_pred ccCc---ccccCcCCCCcccchhhhcC
Q 000893 1202 KRNT---LVTGGVRGTLPWMAPELLNG 1225 (1236)
Q Consensus 1202 i~ns---~~tss~~GTp~YmAPEVL~G 1225 (1236)
.... ......+++..|+|||++.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~ 175 (268)
T cd05086 149 RYKEDYIETEDDKCVPLRWLAPELVGE 175 (268)
T ss_pred cCcchhhhcccCCcCcccccCchhccc
Confidence 3211 12234568899999999853
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=219.04 Aligned_cols=172 Identities=28% Similarity=0.362 Sum_probs=143.2
Q ss_pred cCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
++|++.+.||+|+||.||+|.+. ++.||||+++.... .......+.+|+.+++.++|+||++++++|....
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 73 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED------DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKG- 73 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc------cccchhHHHHHHHHHHhcCCCCeeehhheEEECC-
Confidence 36899999999999999999884 67899999875421 1223456788999999999999999999998754
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
.+++||||+.++.|..++ .....+++..++.++.||+.||.|||.++|+||||+|+||+++.++ .+||+|||++
T Consensus 74 -~~~iv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~----~~kl~d~g~~ 147 (288)
T cd07833 74 -RLYLVFEYVERTLLELLE-ASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESG----VLKLCDFGFA 147 (288)
T ss_pred -EEEEEEecCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC----CEEEEeeecc
Confidence 899999999876666554 4445689999999999999999999999999999999999999876 5799999999
Q ss_pred ccccCcc--cccCcCCCCcccchhhhcCC
Q 000893 1200 KIKRNTL--VTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1200 rii~ns~--~tss~~GTp~YmAPEVL~Gs 1226 (1236)
....... ......++..|+|||++.+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~ 176 (288)
T cd07833 148 RALRARPASPLTDYVATRWYRAPELLVGD 176 (288)
T ss_pred cccCCCccccccCcccccCCcCCchhcCC
Confidence 8765433 33446788999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-23 Score=215.88 Aligned_cols=165 Identities=35% Similarity=0.562 Sum_probs=138.4
Q ss_pred EeccCCceEEEEeeec---C--ceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeEE
Q 000893 1049 ELGSGTFGTVYHGKWR---G--TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLA 1123 (1236)
Q Consensus 1049 kLGsGSFGtVYKArlk---G--~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L~ 1123 (1236)
+||+|++|.||+|.+. + ..||||.+...... .....|.+|+.++++++||||+++++++.. ..++
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~ 71 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-------DIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLM 71 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-------HHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEE
Confidence 5899999999999873 2 25999998765321 446678899999999999999999999887 4889
Q ss_pred EEEeeccCCCHHHHHhhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcccc
Q 000893 1124 TVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 1202 (1236)
Q Consensus 1124 LVMEYm~GGSL~dlL~~k~-r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii 1202 (1236)
+||||+++++|.+++.... ..+++..++.++.|++.||.|||.++++||||||+|||++.++ .+||+|||+++..
T Consensus 72 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~----~~kl~dfg~~~~~ 147 (257)
T cd05040 72 MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDD----KVKIGDFGLMRAL 147 (257)
T ss_pred EEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCC----EEEeccccccccc
Confidence 9999999999999997654 5789999999999999999999999999999999999999886 6799999999875
Q ss_pred cCcc----cccCcCCCCcccchhhhcCCC
Q 000893 1203 RNTL----VTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1203 ~ns~----~tss~~GTp~YmAPEVL~Gss 1227 (1236)
.... ......++..|+|||++.+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~ 176 (257)
T cd05040 148 PQNEDHYVMEEHLKVPFAWCAPESLRTRT 176 (257)
T ss_pred cccccceecccCCCCCceecCHHHhcccC
Confidence 4321 112345778899999997654
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.3e-23 Score=218.33 Aligned_cols=173 Identities=32% Similarity=0.485 Sum_probs=142.6
Q ss_pred ccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhC-CCCceeeEeeeEecC
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDG 1117 (1236)
Q Consensus 1041 ~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskL-rHPNIVrLyG~f~t~ 1117 (1236)
.++|++.+.||+|+||.||++.. .++.+|+|++.... .....+.+|+.+++++ +||||++++++|...
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---------~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---------DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---------cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 46799999999999999999988 47789999986431 1123466788899988 799999999998754
Q ss_pred C---CCeEEEEEeeccCCCHHHHHhh---hccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcE
Q 000893 1118 P---GGTLATVTEFMVNGSLRHVLLS---KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 1191 (1236)
Q Consensus 1118 ~---~g~L~LVMEYm~GGSL~dlL~~---k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltV 1191 (1236)
. .+.+++||||+++++|.+++.. ....+++..++.++.|++.||+|||+++|+||||||+||+++.++ .+
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~----~~ 167 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEG----GV 167 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC----CE
Confidence 3 2468999999999999998853 345689999999999999999999999999999999999998876 56
Q ss_pred EEEeccCcccccCcc-cccCcCCCCcccchhhhcCC
Q 000893 1192 KVGDFGLSKIKRNTL-VTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1192 KLsDFGLArii~ns~-~tss~~GTp~YmAPEVL~Gs 1226 (1236)
||+|||++....... ......|+..|+|||++...
T Consensus 168 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 203 (291)
T cd06639 168 KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACE 203 (291)
T ss_pred EEeecccchhcccccccccCccCCccccChhhhcCC
Confidence 999999988754322 23345689999999998653
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=221.07 Aligned_cols=172 Identities=31% Similarity=0.397 Sum_probs=142.6
Q ss_pred cCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
++|+++++||+|+||.||+|.++ ++.||||++.+.... ......+.+|+.+++.++||||++++++|...
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 72 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD------KMVKKIAMREIRMLKQLRHENLVNLIEVFRRK-- 72 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc------chhhHHHHHHHHHHHhcCCcchhhHHHhcccC--
Confidence 47889999999999999999984 788999998654211 12234577899999999999999999999875
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
..+++||||+.+++|..+... ...+++..++.++.||+.||.|||+.+|+||||+|+||+++.++ .++|+|||++
T Consensus 73 ~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~----~~~l~dfg~~ 147 (286)
T cd07846 73 KRLYLVFEFVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSG----VVKLCDFGFA 147 (286)
T ss_pred CeEEEEEecCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC----cEEEEeeeee
Confidence 489999999998888877643 34589999999999999999999999999999999999999876 5699999998
Q ss_pred ccccCc-ccccCcCCCCcccchhhhcCC
Q 000893 1200 KIKRNT-LVTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1200 rii~ns-~~tss~~GTp~YmAPEVL~Gs 1226 (1236)
...... .......++..|+|||++.+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 175 (286)
T cd07846 148 RTLAAPGEVYTDYVATRWYRAPELLVGD 175 (286)
T ss_pred eeccCCccccCcccceeeccCcHHhccc
Confidence 875432 222345688999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.6e-23 Score=207.61 Aligned_cols=171 Identities=37% Similarity=0.576 Sum_probs=147.4
Q ss_pred CeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g 1120 (1236)
+|+..+.||+|++|.||++.+. +..+++|++..... .....+.+|+.+++.++||||+++++++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 70 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--------EKKEKIINEIQILKKCKHPNIVKYYGSYLKKD-- 70 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--------hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC--
Confidence 4778899999999999999985 77899999976421 23457888999999999999999999998754
Q ss_pred eEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcc
Q 000893 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1236)
Q Consensus 1121 ~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLAr 1200 (1236)
..++++||+++++|.+++......+++..+..++.|++.||.|||.++++||||+|+||+++.++ .++|+|||++.
T Consensus 71 ~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~----~~~l~d~~~~~ 146 (253)
T cd05122 71 ELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDG----EVKLIDFGLSA 146 (253)
T ss_pred eEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCC----eEEEeeccccc
Confidence 88999999999999999976656799999999999999999999999999999999999999876 56999999998
Q ss_pred cccCcccccCcCCCCcccchhhhcCCC
Q 000893 1201 IKRNTLVTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1201 ii~ns~~tss~~GTp~YmAPEVL~Gss 1227 (1236)
............++..|+|||++.+..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~PE~~~~~~ 173 (253)
T cd05122 147 QLSDTKARNTMVGTPYWMAPEVINGKP 173 (253)
T ss_pred cccccccccceecCCcccCHHHHcCCC
Confidence 765543234567899999999998664
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-24 Score=245.73 Aligned_cols=170 Identities=33% Similarity=0.435 Sum_probs=143.8
Q ss_pred ccCeeEEEEeccCCceEEEEeeecCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhh--CCCCceeeEeeeEecCC
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK--LHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1041 ~EdYeiLkkLGsGSFGtVYKArlkG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILsk--LrHPNIVrLyG~f~t~~ 1118 (1236)
...++++++||+|.||.||+|.++++.||||++.. .....|+.|.+|.+. ++|+||++++++-....
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~-----------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t 277 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPE-----------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT 277 (534)
T ss_pred CCchhhHHHhhcCccceeehhhccCceeEEEecCH-----------HHHHHHHhHHHHHhccCccchhHHHhhchhccCC
Confidence 45567788899999999999999999999999963 235678889888875 68999999998765432
Q ss_pred --CCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHH---------CCcccCCCCCCcEEEccCCCC
Q 000893 1119 --GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS---------KNIVHFDLKCDNLLVNLKDPI 1187 (1236)
Q Consensus 1119 --~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHS---------kGIIHRDIKPsNILLDsdG~I 1187 (1236)
...++||+||.+.|+|.++|. ...++|....+|+.-+++||+|||+ ..|+|||||.+||||..|.
T Consensus 278 ~~~~eywLVt~fh~kGsL~dyL~--~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl-- 353 (534)
T KOG3653|consen 278 ADRMEYWLVTEFHPKGSLCDYLK--ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL-- 353 (534)
T ss_pred ccccceeEEeeeccCCcHHHHHH--hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC--
Confidence 347899999999999999994 5579999999999999999999996 3699999999999999885
Q ss_pred CCcEEEEeccCcccccCcc---cccCcCCCCcccchhhhcCCC
Q 000893 1188 RPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1188 ~ltVKLsDFGLArii~ns~---~tss~~GTp~YmAPEVL~Gss 1227 (1236)
++.|+|||||..+.... ..-+.+||..|||||+|.|..
T Consensus 354 --TccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgai 394 (534)
T KOG3653|consen 354 --TCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAI 394 (534)
T ss_pred --cEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhc
Confidence 78999999998865332 223467999999999998864
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-24 Score=249.29 Aligned_cols=190 Identities=32% Similarity=0.460 Sum_probs=158.5
Q ss_pred cccccccccCeeEEEEeccCCceEEEEeeecC-ceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEee
Q 000893 1034 STLQIIKNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 1112 (1236)
Q Consensus 1034 seLqiIs~EdYeiLkkLGsGSFGtVYKArlkG-~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG 1112 (1236)
..+.++..+.+.+.++||+|-||.|.+++..+ ..||||.++... +......|.+|+++|.+|+|||||+|+|
T Consensus 530 ~al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a-------~~~~r~~F~kEIkiLsqLkhPNIveLvG 602 (807)
T KOG1094|consen 530 PALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA-------TKNARNDFLKEIKILSRLKHPNIVELLG 602 (807)
T ss_pred cchhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCccc-------chhHHHHHHHHHHHHhccCCCCeeEEEe
Confidence 45566777788899999999999999999976 889999998653 4455678999999999999999999999
Q ss_pred eEecCCCCeEEEEEeeccCCCHHHHHhhhccCC-CHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcE
Q 000893 1113 VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHL-DRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 1191 (1236)
Q Consensus 1113 ~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~r~L-Se~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltV 1191 (1236)
+|..++ .+++|+|||++|+|.+++..++.+. .......|+.||+.||+||.+.++|||||.+.|+|++.++ ++
T Consensus 603 VC~~De--PicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~----~i 676 (807)
T KOG1094|consen 603 VCVQDD--PLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEF----TI 676 (807)
T ss_pred eeecCC--chHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcc----cE
Confidence 999866 8999999999999999998875433 4555677999999999999999999999999999999886 67
Q ss_pred EEEeccCcccccCc---ccccCcCCCCcccchhhhc-CCCCCCCccccC
Q 000893 1192 KVGDFGLSKIKRNT---LVTGGVRGTLPWMAPELLN-GSSSKVSEKVCF 1236 (1236)
Q Consensus 1192 KLsDFGLArii~ns---~~tss~~GTp~YmAPEVL~-Gss~~~SdDVDI 1236 (1236)
||+|||++|.+-.. ......+-...|||||.|. |.....++.|.|
T Consensus 677 KiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWaf 725 (807)
T KOG1094|consen 677 KIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAF 725 (807)
T ss_pred EecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhh
Confidence 99999999965332 2333445578999999986 666666666643
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-23 Score=222.52 Aligned_cols=170 Identities=27% Similarity=0.459 Sum_probs=143.6
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
.+|++.+.||.|+||.||+|.. .++.||||.+..... .....+.+|+.+++.++||||++++++|....
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~- 89 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--------PKKELIINEILVMKELKNPNIVNFLDSFLVGD- 89 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--------chHHHHHHHHHHHHhcCCCceeeeeeeEecCc-
Confidence 5699999999999999999986 578899999865321 12345778999999999999999999998754
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
.+++||||+++++|..++.. ..+++.+++.++.+++.||.|||++|++||||||+||+++.++ .+||+|||++
T Consensus 90 -~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~----~~kl~dfg~~ 162 (296)
T cd06655 90 -ELFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDG----SVKLTDFGFC 162 (296)
T ss_pred -eEEEEEEecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC----CEEEccCccc
Confidence 89999999999999998853 3589999999999999999999999999999999999998876 5799999998
Q ss_pred ccccCcc-cccCcCCCCcccchhhhcCCC
Q 000893 1200 KIKRNTL-VTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1200 rii~ns~-~tss~~GTp~YmAPEVL~Gss 1227 (1236)
....... ......+++.|+|||++.+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 191 (296)
T cd06655 163 AQITPEQSKRSTMVGTPYWMAPEVVTRKA 191 (296)
T ss_pred hhcccccccCCCcCCCccccCcchhcCCC
Confidence 8654322 223456899999999997653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=252.80 Aligned_cols=191 Identities=24% Similarity=0.307 Sum_probs=150.4
Q ss_pred cccccccccCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCC-CCceeeE
Q 000893 1034 STLQIIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAF 1110 (1236)
Q Consensus 1034 seLqiIs~EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLr-HPNIVrL 1110 (1236)
...-.+...++++.+.|.+|||+.||+|+.. |..||+|++-.. .+.....+.+|+.+|++|. |+|||.+
T Consensus 29 G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--------de~~L~~v~~EI~~MK~L~gh~nIV~y 100 (738)
T KOG1989|consen 29 GQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--------DEEALNAVKREIDIMKLLSGHKNIVSY 100 (738)
T ss_pred ceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--------CHHHHHHHHHHHHHHHHhcCCCceeeE
Confidence 3444566678899999999999999999984 378999988543 3445667889999999998 9999999
Q ss_pred eeeEe-c--CCC--CeEEEEEeeccCCCHHHHHhhh-ccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCcEEEc
Q 000893 1111 YGVVQ-D--GPG--GTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKN--IVHFDLKCDNLLVN 1182 (1236)
Q Consensus 1111 yG~f~-t--~~~--g~L~LVMEYm~GGSL~dlL~~k-~r~LSe~erl~Ia~QIAeALaYLHSkG--IIHRDIKPsNILLD 1182 (1236)
++... . ... -.++|+||||.||.|-++|..+ ...|++.+++.|+.++|+|+.+||... |||||||-+||||.
T Consensus 101 idss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls 180 (738)
T KOG1989|consen 101 IDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS 180 (738)
T ss_pred eccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc
Confidence 99322 1 111 2678999999999999999654 345999999999999999999999886 99999999999999
Q ss_pred cCCCCCCcEEEEeccCcccccCcc-ccc---------CcCCCCcccchhhhc-CCCCCCCccccC
Q 000893 1183 LKDPIRPICKVGDFGLSKIKRNTL-VTG---------GVRGTLPWMAPELLN-GSSSKVSEKVCF 1236 (1236)
Q Consensus 1183 sdG~I~ltVKLsDFGLArii~ns~-~ts---------s~~GTp~YmAPEVL~-Gss~~~SdDVDI 1236 (1236)
.++ ..||||||.+...-... ... ..--|+.|+|||+|. -....++++.||
T Consensus 181 ~~g----~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDI 241 (738)
T KOG1989|consen 181 ADG----NYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDI 241 (738)
T ss_pred CCC----CEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHH
Confidence 998 45999999986532111 100 012589999999995 555677777765
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-24 Score=253.23 Aligned_cols=179 Identities=32% Similarity=0.479 Sum_probs=149.6
Q ss_pred eEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeE
Q 000893 1045 EELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTL 1122 (1236)
Q Consensus 1045 eiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L 1122 (1236)
++..+||+|+|-+||+|.+ .|..||--.++...+.. ..+...+|..|+.+|+.|+|||||++|.+|.+.....+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q----~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~i 118 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQ----SPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTI 118 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhc----ChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCcee
Confidence 3445799999999999998 46677765555443322 34446789999999999999999999999998887889
Q ss_pred EEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCCCcEEEccCCCCCCcEEEEeccCcc
Q 000893 1123 ATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK--NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1236)
Q Consensus 1123 ~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSk--GIIHRDIKPsNILLDsdG~I~ltVKLsDFGLAr 1200 (1236)
.+|+|.|..|+|..|+.+. +.++....+.|++||++||.|||++ .|||||||.+||+|+..- ..|||+|+|||.
T Consensus 119 n~iTEL~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~---G~VKIGDLGLAt 194 (632)
T KOG0584|consen 119 NFITELFTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNL---GEVKIGDLGLAT 194 (632)
T ss_pred eeeeecccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCc---CceeecchhHHH
Confidence 9999999999999999654 4588899999999999999999987 699999999999998653 478999999999
Q ss_pred cccCcccccCcCCCCcccchhhhcCCCCCCCcccc
Q 000893 1201 IKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVC 1235 (1236)
Q Consensus 1201 ii~ns~~tss~~GTp~YmAPEVL~Gss~~~SdDVD 1235 (1236)
++....... .+|||.|||||++... |.+-+|
T Consensus 195 l~r~s~aks-vIGTPEFMAPEmYEE~---YnE~VD 225 (632)
T KOG0584|consen 195 LLRKSHAKS-VIGTPEFMAPEMYEEN---YNELVD 225 (632)
T ss_pred Hhhccccce-eccCccccChHHHhhh---cchhhh
Confidence 987766555 8899999999999854 444444
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-23 Score=214.17 Aligned_cols=173 Identities=31% Similarity=0.457 Sum_probs=144.1
Q ss_pred ccCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhC-CCCceeeEeeeEecC
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDG 1117 (1236)
Q Consensus 1041 ~EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskL-rHPNIVrLyG~f~t~ 1117 (1236)
.++|++.+.||+|+||.||+|..+ ++.+++|++.... .....|.+|+.+++++ .|+||++++++|...
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 75 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---------DEEEEIKEEYNILRKYSNHPNIATFYGAFIKK 75 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---------hhHHHHHHHHHHHHHhcCCCChheEEEEEEec
Confidence 468999999999999999999984 6779999987532 1234678899999998 699999999999764
Q ss_pred C----CCeEEEEEeeccCCCHHHHHhhh---ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCc
Q 000893 1118 P----GGTLATVTEFMVNGSLRHVLLSK---ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPI 1190 (1236)
Q Consensus 1118 ~----~g~L~LVMEYm~GGSL~dlL~~k---~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~lt 1190 (1236)
. ...+++||||+++++|.+++... ...+++..++.++.|++.||.|||+++|+|+||+|+||+++.++ .
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~----~ 151 (275)
T cd06608 76 NPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNA----E 151 (275)
T ss_pred CCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCC----e
Confidence 3 34689999999999999988653 35789999999999999999999999999999999999999876 5
Q ss_pred EEEEeccCcccccCcc-cccCcCCCCcccchhhhcCC
Q 000893 1191 CKVGDFGLSKIKRNTL-VTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1191 VKLsDFGLArii~ns~-~tss~~GTp~YmAPEVL~Gs 1226 (1236)
+||+|||++....... ......|++.|+|||++.+.
T Consensus 152 ~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 188 (275)
T cd06608 152 VKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACD 188 (275)
T ss_pred EEECCCccceecccchhhhcCccccccccCHhHhccc
Confidence 6999999987654322 22345689999999998643
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-23 Score=213.20 Aligned_cols=167 Identities=38% Similarity=0.599 Sum_probs=138.4
Q ss_pred EeccCCceEEEEeeec-CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeEEEEEe
Q 000893 1049 ELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTE 1127 (1236)
Q Consensus 1049 kLGsGSFGtVYKArlk-G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L~LVME 1127 (1236)
+||+|+||.||++.+. ++.||+|++..... ......|.+|+.+++.++||||+++++++.... ..++|||
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~v~e 72 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLP-------PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQ--PIYIVME 72 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEEeccccCC-------HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCC--CeEEEEE
Confidence 5899999999999985 78899998875421 123456888999999999999999999998754 8899999
Q ss_pred eccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcccccCccc
Q 000893 1128 FMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLV 1207 (1236)
Q Consensus 1128 Ym~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~ns~~ 1207 (1236)
|+.+++|.+++......+++..++.++.+++.||.|||+++++||||||+||||+.++ .+||+|||++........
T Consensus 73 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~----~~~l~d~g~~~~~~~~~~ 148 (251)
T cd05041 73 LVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENN----VLKISDFGMSREEEGGIY 148 (251)
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCC----cEEEeeccccccccCCcc
Confidence 9999999999976666788999999999999999999999999999999999999876 579999999986542221
Q ss_pred c---cCcCCCCcccchhhhcCCCC
Q 000893 1208 T---GGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1208 t---ss~~GTp~YmAPEVL~Gss~ 1228 (1236)
. ....++..|+|||++.+...
T Consensus 149 ~~~~~~~~~~~~y~~PE~~~~~~~ 172 (251)
T cd05041 149 TVSDGLKQIPIKWTAPEALNYGRY 172 (251)
T ss_pred eeccccCcceeccCChHhhccCCC
Confidence 1 12234567999999976543
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.6e-23 Score=219.26 Aligned_cols=173 Identities=28% Similarity=0.395 Sum_probs=139.4
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
++|++.+.||+|++|+||+|++ .++.||||.+..... .......+.+|+.+++.++||||+++++++....
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 74 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE------DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK- 74 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc------cccchHHHHHHHHHHHhccCCCEeeEEEEEecCC-
Confidence 5799999999999999999987 477899999865421 1122345778999999999999999999998754
Q ss_pred CeEEEEEeeccCCCHHHHHhhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccC
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~-r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGL 1198 (1236)
..++||||+. ++|..++.... ..+++..++.++.||+.||+|||+++|+||||+|+||+++.++ ..+||+|||+
T Consensus 75 -~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~---~~~kl~dfg~ 149 (294)
T PLN00009 75 -RLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT---NALKLADFGL 149 (294)
T ss_pred -eEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCC---CEEEEccccc
Confidence 8999999995 57877775433 3467888889999999999999999999999999999998654 2579999999
Q ss_pred cccccCcc-cccCcCCCCcccchhhhcCC
Q 000893 1199 SKIKRNTL-VTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1199 Arii~ns~-~tss~~GTp~YmAPEVL~Gs 1226 (1236)
+....... ......+++.|+|||++.+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~ 178 (294)
T PLN00009 150 ARAFGIPVRTFTHEVVTLWYRAPEILLGS 178 (294)
T ss_pred ccccCCCccccccCceeecccCHHHHhCC
Confidence 97653321 22334578999999998764
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.4e-23 Score=211.73 Aligned_cols=172 Identities=35% Similarity=0.543 Sum_probs=146.3
Q ss_pred cCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
.+|++.+.||+|++|.||+|... ++.||||++..... ......+.+|+.++..++|+||+++++++....
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 72 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD-------EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEG- 72 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc-------hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCC-
Confidence 36888999999999999999884 78899999875421 133567889999999999999999999998864
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCcEEEccCCCCCCcEEEEeccC
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHS-kGIIHRDIKPsNILLDsdG~I~ltVKLsDFGL 1198 (1236)
.+++||||+++++|.+++... ..+++..++.++.|++.||.|||+ .+++||||+|+||+++.++ .++|+|||+
T Consensus 73 -~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~----~~~l~df~~ 146 (264)
T cd06623 73 -EISIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKG----EVKIADFGI 146 (264)
T ss_pred -eEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCC----CEEEccCcc
Confidence 899999999999999999654 568999999999999999999999 9999999999999999876 569999999
Q ss_pred cccccCcccc-cCcCCCCcccchhhhcCCC
Q 000893 1199 SKIKRNTLVT-GGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1199 Arii~ns~~t-ss~~GTp~YmAPEVL~Gss 1227 (1236)
+......... ....++..|+|||++.+..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~ 176 (264)
T cd06623 147 SKVLENTLDQCNTFVGTVTYMSPERIQGES 176 (264)
T ss_pred ceecccCCCcccceeecccccCHhhhCCCC
Confidence 9876443322 2456889999999998763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.8e-23 Score=209.17 Aligned_cols=174 Identities=30% Similarity=0.546 Sum_probs=147.7
Q ss_pred CeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g 1120 (1236)
+|.+.+.||.|+||.||++.+. +..||+|++..... .......+.+|+++++.++|||++++++.+... .
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~--~ 72 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM------SEKEREDALNEVKILKKLNHPNIIKYYESFEEK--G 72 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC------ChHHHHHHHHHHHHHHhcCCCChhheEEEEecC--C
Confidence 5788999999999999999985 78899999875432 123345678899999999999999999998875 4
Q ss_pred eEEEEEeeccCCCHHHHHhhh---ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEecc
Q 000893 1121 TLATVTEFMVNGSLRHVLLSK---ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1236)
Q Consensus 1121 ~L~LVMEYm~GGSL~dlL~~k---~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFG 1197 (1236)
.+++||||+++++|..++... ...+++..++.++.+++.||.|||++|++|+||+|+||+++.++ .++|+|||
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~----~~~l~d~~ 148 (258)
T cd08215 73 KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNG----LVKLGDFG 148 (258)
T ss_pred EEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCC----cEEECCcc
Confidence 899999999999999999765 36799999999999999999999999999999999999999876 56999999
Q ss_pred CcccccCcc-cccCcCCCCcccchhhhcCCCC
Q 000893 1198 LSKIKRNTL-VTGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1198 LArii~ns~-~tss~~GTp~YmAPEVL~Gss~ 1228 (1236)
++....... ......|++.|+|||++.+...
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~ 180 (258)
T cd08215 149 ISKVLSSTVDLAKTVVGTPYYLSPELCQNKPY 180 (258)
T ss_pred ceeecccCcceecceeeeecccChhHhccCCC
Confidence 998764433 3344578999999999876643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-23 Score=249.56 Aligned_cols=172 Identities=26% Similarity=0.394 Sum_probs=146.1
Q ss_pred ccCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCC
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1041 ~EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~ 1118 (1236)
.++|+++++||+|+||+||+|.+. ++.||||+++..... .......+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMI-----NKNMVHQVQAERDALALSKSPFIVHLYYSLQSAN 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhcc-----CHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECC
Confidence 468999999999999999999985 788999999764321 2334566888999999999999999999988754
Q ss_pred CCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccC
Q 000893 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1236)
Q Consensus 1119 ~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGL 1198 (1236)
.++|||||+.+++|..++... ..+++..++.|+.||+.||.|||.++||||||||+||||+.++ .+||+|||+
T Consensus 78 --~~~lVmEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g----~vkL~DFGl 150 (669)
T cd05610 78 --NVYLVMEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEG----HIKLTDFGL 150 (669)
T ss_pred --EEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCC----CEEEEeCCC
Confidence 899999999999999998643 4688999999999999999999999999999999999999876 579999999
Q ss_pred cccccCcc-cccCcCCCCcccchhhhc
Q 000893 1199 SKIKRNTL-VTGGVRGTLPWMAPELLN 1224 (1236)
Q Consensus 1199 Arii~ns~-~tss~~GTp~YmAPEVL~ 1224 (1236)
++...... .....++|+.|++||...
T Consensus 151 s~~~~~~~~~~~~~~~t~~~~~pe~~~ 177 (669)
T cd05610 151 SKVTLNRELNMMDILTTPSMAKPKNDY 177 (669)
T ss_pred CccccCCcccccccccCccccCccccc
Confidence 99754332 334567899999998654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-25 Score=243.37 Aligned_cols=174 Identities=28% Similarity=0.465 Sum_probs=151.7
Q ss_pred ccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCC
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1041 ~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~ 1118 (1236)
.+-|.++.+||+|+||.||+|.+ .|..||||.+... ..++++++|+.+|.+|+.|++|++||.+....
T Consensus 32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----------sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~s 101 (502)
T KOG0574|consen 32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----------TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHS 101 (502)
T ss_pred HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----------chHHHHHHHHHHHHHcCCchhhhhhhhhccCC
Confidence 34577888999999999999988 4888999988643 22567889999999999999999999887644
Q ss_pred CCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccC
Q 000893 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1236)
Q Consensus 1119 ~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGL 1198 (1236)
.+|+|||||--|+..++++.+.+.+.+.++..|++..++||+|||...-||||||..||||+.+| ++||+|||.
T Consensus 102 --DLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G----~AKLADFGV 175 (502)
T KOG0574|consen 102 --DLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDG----IAKLADFGV 175 (502)
T ss_pred --ceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccc----hhhhhhccc
Confidence 89999999999999999999999999999999999999999999999999999999999999998 669999999
Q ss_pred cccccCcc-cccCcCCCCcccchhhhcCCCCCC
Q 000893 1199 SKIKRNTL-VTGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1199 Arii~ns~-~tss~~GTp~YmAPEVL~Gss~~~ 1230 (1236)
|..+.+.- ...+..|||.|||||+|....+..
T Consensus 176 AGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~ 208 (502)
T KOG0574|consen 176 AGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDT 208 (502)
T ss_pred cchhhhhHHhhCccccCcccccHHHHHHhccch
Confidence 98765433 235678999999999998664443
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.6e-23 Score=211.68 Aligned_cols=174 Identities=23% Similarity=0.419 Sum_probs=144.5
Q ss_pred CeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g 1120 (1236)
+|++++.||+|+||+||+++. .++.||||.+...... .....++.+|+.++++++||||+++++++....
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 72 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS------PKEREESRKEVAVLSNMKHPNIVQYQESFEENG-- 72 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC------hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCC--
Confidence 588999999999999999987 4788999998753221 223456788999999999999999999988754
Q ss_pred eEEEEEeeccCCCHHHHHhhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1121 TLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1121 ~L~LVMEYm~GGSL~dlL~~k-~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
..++||||+.+++|.+++... ...+++..++.++.|++.||.|||+++++|+||+|+|||++.++ .++|+|||++
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~----~~~l~d~~~~ 148 (256)
T cd08218 73 NLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG----TIKLGDFGIA 148 (256)
T ss_pred eEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC----CEEEeeccce
Confidence 899999999999999988653 33578999999999999999999999999999999999998876 5799999999
Q ss_pred ccccCcc-cccCcCCCCcccchhhhcCCCC
Q 000893 1200 KIKRNTL-VTGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1200 rii~ns~-~tss~~GTp~YmAPEVL~Gss~ 1228 (1236)
....... ......|++.|+|||++.+...
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~ 178 (256)
T cd08218 149 RVLNSTVELARTCIGTPYYLSPEICENRPY 178 (256)
T ss_pred eecCcchhhhhhccCCccccCHHHhCCCCC
Confidence 8654322 2223458899999999986543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-23 Score=218.14 Aligned_cols=171 Identities=30% Similarity=0.458 Sum_probs=143.8
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
+.|+.++.||.|+||.||+|.+ .+..||||++.... .......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 75 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-------AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGT- 75 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-------cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-
Confidence 3577788999999999999987 46789999987532 1233567889999999999999999999998854
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
.+++||||+++++|.+++.. ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++ .++|+|||++
T Consensus 76 -~~~lv~e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~----~~~l~dfg~~ 148 (277)
T cd06640 76 -KLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQG----DVKLADFGVA 148 (277)
T ss_pred -EEEEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCC----CEEEcccccc
Confidence 89999999999999998853 4688899999999999999999999999999999999999876 5699999999
Q ss_pred ccccCcc-cccCcCCCCcccchhhhcCCC
Q 000893 1200 KIKRNTL-VTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1200 rii~ns~-~tss~~GTp~YmAPEVL~Gss 1227 (1236)
....... ......++..|+|||++.+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~ 177 (277)
T cd06640 149 GQLTDTQIKRNTFVGTPFWMAPEVIQQSA 177 (277)
T ss_pred eeccCCccccccccCcccccCHhHhccCC
Confidence 7754332 223456888999999997654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-23 Score=218.70 Aligned_cols=174 Identities=28% Similarity=0.367 Sum_probs=138.3
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCC-CCceeeEeeeEecCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLr-HPNIVrLyG~f~t~~ 1118 (1236)
++|++.+.||+|+||.||+|.+ +++.||||+++.... .......+.+|+.+++.+. ||||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~------~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 74 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD------EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEE 74 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc------ccCCchHHHHHHHHHHHccCCCCccceeeeEeecC
Confidence 4688999999999999999997 478899998865421 1112345778999999995 699999999987643
Q ss_pred C---CeEEEEEeeccCCCHHHHHhhhc----cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcc-CCCCCCc
Q 000893 1119 G---GTLATVTEFMVNGSLRHVLLSKE----RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNL-KDPIRPI 1190 (1236)
Q Consensus 1119 ~---g~L~LVMEYm~GGSL~dlL~~k~----r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDs-dG~I~lt 1190 (1236)
. ..+++||||+.+ +|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+||+++. ++ .
T Consensus 75 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~----~ 149 (295)
T cd07837 75 KNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKG----L 149 (295)
T ss_pred CCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCC----e
Confidence 1 237999999975 8888876532 35899999999999999999999999999999999999997 43 6
Q ss_pred EEEEeccCcccccCcc-cccCcCCCCcccchhhhcCC
Q 000893 1191 CKVGDFGLSKIKRNTL-VTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1191 VKLsDFGLArii~ns~-~tss~~GTp~YmAPEVL~Gs 1226 (1236)
+||+|||+++...... ......+++.|+|||++.+.
T Consensus 150 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 186 (295)
T cd07837 150 LKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGS 186 (295)
T ss_pred EEEeecccceecCCCccccCCcccccCCCChHHhhCC
Confidence 7999999998653221 12234578899999998753
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.3e-23 Score=216.92 Aligned_cols=171 Identities=29% Similarity=0.418 Sum_probs=140.3
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhC-CCCceeeEeeeEecC-
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDG- 1117 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskL-rHPNIVrLyG~f~t~- 1117 (1236)
..|++.+.||.|+||.||+|++ .++.||+|++.... .....+..|+.+++++ +||||++++++|...
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---------DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---------HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 5788889999999999999998 46789999886431 1234567899999988 699999999998642
Q ss_pred ---CCCeEEEEEeeccCCCHHHHHhhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEE
Q 000893 1118 ---PGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193 (1236)
Q Consensus 1118 ---~~g~L~LVMEYm~GGSL~dlL~~k-~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKL 1193 (1236)
....+++||||+.+++|..++... ...+++..++.++.||+.||.|||+++|+||||||+||+++.++ .++|
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~----~~~l 162 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENA----EVKL 162 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC----CEEE
Confidence 235789999999999999998653 34588888899999999999999999999999999999999876 5699
Q ss_pred EeccCcccccCc-ccccCcCCCCcccchhhhcC
Q 000893 1194 GDFGLSKIKRNT-LVTGGVRGTLPWMAPELLNG 1225 (1236)
Q Consensus 1194 sDFGLArii~ns-~~tss~~GTp~YmAPEVL~G 1225 (1236)
+|||++...... .......|++.|+|||++..
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~ 195 (282)
T cd06636 163 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 195 (282)
T ss_pred eeCcchhhhhccccCCCcccccccccCHhhcCc
Confidence 999998865422 22334678999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.8e-23 Score=206.64 Aligned_cols=174 Identities=36% Similarity=0.527 Sum_probs=148.5
Q ss_pred CeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g 1120 (1236)
+|.+.+.||+|++|.||+|... ++.|+||++..... .......+.+|+.++++++||||+++++.+......
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD------SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKN 74 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCC
Confidence 4778899999999999999985 78899999876432 133456788999999999999999999999876335
Q ss_pred eEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcc
Q 000893 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1236)
Q Consensus 1121 ~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLAr 1200 (1236)
.+++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++ .+||+|||.+.
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~----~~~l~d~~~~~ 149 (260)
T cd06606 75 TLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDG----VVKLADFGCAK 149 (260)
T ss_pred eEEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC----CEEEcccccEE
Confidence 8999999999999999986554 789999999999999999999999999999999999999876 56999999998
Q ss_pred cccCccc---ccCcCCCCcccchhhhcCCC
Q 000893 1201 IKRNTLV---TGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1201 ii~ns~~---tss~~GTp~YmAPEVL~Gss 1227 (1236)
....... .....++..|+|||++.+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~ 179 (260)
T cd06606 150 RLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179 (260)
T ss_pred ecccccccccccCCCCCccccCHhhhcCCC
Confidence 7655442 34567899999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.7e-24 Score=246.30 Aligned_cols=185 Identities=23% Similarity=0.330 Sum_probs=152.2
Q ss_pred cccccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEe
Q 000893 1038 IIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 1115 (1236)
Q Consensus 1038 iIs~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~ 1115 (1236)
.+...-|..++-||-|+||+|.+++. +...+|+|.|.+..+.. .....-...|..||...+.+.||+||..|+
T Consensus 625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~-----rnQvaHVKAERDILAEADn~WVVrLyySFQ 699 (1034)
T KOG0608|consen 625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLM-----RNQVAHVKAERDILAEADNEWVVRLYYSFQ 699 (1034)
T ss_pred hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHh-----hhhhhhhhhhhhhHhhcCCcceEEEEEEec
Confidence 34456688999999999999999876 45569999998765432 223344567999999999999999999999
Q ss_pred cCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEe
Q 000893 1116 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1236)
Q Consensus 1116 t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsD 1195 (1236)
+++ .+||||+|++||++..+|.+.+ .|.+..++.++.++..|+++.|..|+|||||||+|||||.+|++ ||+|
T Consensus 700 Dkd--nLYFVMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHI----KLTD 772 (1034)
T KOG0608|consen 700 DKD--NLYFVMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHI----KLTD 772 (1034)
T ss_pred cCC--ceEEEEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCce----eeee
Confidence 976 9999999999999999997665 57888888888899999999999999999999999999999955 9999
Q ss_pred ccCccccc-----------Cc--------------------------------ccccCcCCCCcccchhhhcCCCCCCCc
Q 000893 1196 FGLSKIKR-----------NT--------------------------------LVTGGVRGTLPWMAPELLNGSSSKVSE 1232 (1236)
Q Consensus 1196 FGLArii~-----------ns--------------------------------~~tss~~GTp~YmAPEVL~Gss~~~Sd 1232 (1236)
||||.-+. ++ .....++||+.|+|||+|....+.-.+
T Consensus 773 FGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~c 852 (1034)
T KOG0608|consen 773 FGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLC 852 (1034)
T ss_pred ccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccc
Confidence 99985311 00 011135699999999999988777777
Q ss_pred cc
Q 000893 1233 KV 1234 (1236)
Q Consensus 1233 DV 1234 (1236)
||
T Consensus 853 dw 854 (1034)
T KOG0608|consen 853 DW 854 (1034)
T ss_pred hh
Confidence 76
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.5e-24 Score=221.84 Aligned_cols=171 Identities=30% Similarity=0.459 Sum_probs=142.7
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
+.|+.++.||+|+||.||+|.+ .+..||||.+.... .......+.+|+.+++.++||||++++++|....
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 75 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-------AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT- 75 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-------chHHHHHHHHHHHHHHcCCCCccHhhhcccccCC-
Confidence 3466677899999999999987 46789999886432 1233457889999999999999999999998754
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
..++||||+++++|.+++. ...+++..++.++.|++.||.|||+++|+|+||+|+||+++.++ .++|+|||++
T Consensus 76 -~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~----~~~l~dfg~~ 148 (277)
T cd06642 76 -KLWIIMEYLGGGSALDLLK--PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQG----DVKLADFGVA 148 (277)
T ss_pred -ceEEEEEccCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCC----CEEEcccccc
Confidence 8999999999999999884 34688999999999999999999999999999999999999876 5799999999
Q ss_pred ccccCcc-cccCcCCCCcccchhhhcCCC
Q 000893 1200 KIKRNTL-VTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1200 rii~ns~-~tss~~GTp~YmAPEVL~Gss 1227 (1236)
....... ......|+..|+|||++.+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 177 (277)
T cd06642 149 GQLTDTQIKRNTFVGTPFWMAPEVIKQSA 177 (277)
T ss_pred ccccCcchhhhcccCcccccCHHHhCcCC
Confidence 8754332 223456889999999998764
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.5e-23 Score=216.56 Aligned_cols=171 Identities=30% Similarity=0.457 Sum_probs=142.8
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
+-|++++.||+|+||.||+|.+ .+..||||++.... .......|.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~- 75 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-------AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT- 75 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc-------chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC-
Confidence 3477888999999999999987 46789999876432 1223457889999999999999999999998754
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
.+++||||+.+++|..++.. ..+++..+..++.|++.||.|||+++++|+||||+||+++.++ .++|+|||++
T Consensus 76 -~~~lv~e~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~----~~~l~dfg~~ 148 (277)
T cd06641 76 -KLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG----EVKLADFGVA 148 (277)
T ss_pred -eEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCC----CEEEeecccc
Confidence 89999999999999998853 4688999999999999999999999999999999999999876 5699999998
Q ss_pred ccccCcc-cccCcCCCCcccchhhhcCCC
Q 000893 1200 KIKRNTL-VTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1200 rii~ns~-~tss~~GTp~YmAPEVL~Gss 1227 (1236)
....... ......++..|+|||++.+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~ 177 (277)
T cd06641 149 GQLTDTQIKRNTFVGTPFWMAPEVIKQSA 177 (277)
T ss_pred eecccchhhhccccCCccccChhhhccCC
Confidence 7654332 223456889999999997653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-23 Score=215.67 Aligned_cols=172 Identities=32% Similarity=0.477 Sum_probs=143.0
Q ss_pred eeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCe
Q 000893 1044 LEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGT 1121 (1236)
Q Consensus 1044 YeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~ 1121 (1236)
|++++.||.|+||.||+|... ++.+|||++..... .......+.+|+.+++.++||||+++++++.....+.
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 74 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENE------KEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGS 74 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccc------cccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCc
Confidence 578899999999999999884 67899999986531 1223346778999999999999999999998763358
Q ss_pred EEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCccc
Q 000893 1122 LATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201 (1236)
Q Consensus 1122 L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLAri 1201 (1236)
+++||||++ ++|..++......+++..++.++.||+.||+|||..+++|+||||+|||++.++ .+||+|||++..
T Consensus 75 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~----~~~l~d~g~~~~ 149 (287)
T cd07840 75 IYMVFEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDG----VLKLADFGLARP 149 (287)
T ss_pred EEEEecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCC----CEEEccccceee
Confidence 999999996 589888866556799999999999999999999999999999999999999876 579999999987
Q ss_pred ccCcc--cccCcCCCCcccchhhhcCC
Q 000893 1202 KRNTL--VTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1202 i~ns~--~tss~~GTp~YmAPEVL~Gs 1226 (1236)
..... ......++..|+|||++.+.
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~PE~~~~~ 176 (287)
T cd07840 150 YTKRNSADYTNRVITLWYRPPELLLGA 176 (287)
T ss_pred ccCCCcccccccccccccCCceeeEcc
Confidence 65432 22334578899999988754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=244.65 Aligned_cols=181 Identities=20% Similarity=0.328 Sum_probs=134.6
Q ss_pred ccCeeEEEEeccCCceEEEEeeecC---ceEEEEeeeccc---------cCCCChHHHHHHHHHHHHHHHHhhCCCCcee
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKWRG---TDVAIKRIKKSC---------FTGRSSEQERLTLEFWREAEILSKLHHPNVV 1108 (1236)
Q Consensus 1041 ~EdYeiLkkLGsGSFGtVYKArlkG---~~VAVKvLkk~~---------i~~~~~e~er~~keFlrEIrILskLrHPNIV 1108 (1236)
.++|+++++||+|+||+||++.++. ..+++|.+.... +.............+.+|+.+|+.++|||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 4689999999999999999987632 222222111000 0000001123345678999999999999999
Q ss_pred eEeeeEecCCCCeEEEEEeeccCCCHHHHHhhhc----cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccC
Q 000893 1109 AFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE----RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLK 1184 (1236)
Q Consensus 1109 rLyG~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~----r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsd 1184 (1236)
++++++.... ..++|||++ +++|..++.... .......++.|+.||+.||.|||++|||||||||+||||+.+
T Consensus 227 ~l~~~~~~~~--~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 227 KIEEILRSEA--NTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD 303 (501)
T ss_pred cEeEEEEECC--eeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 9999998865 789999998 567777764432 123356677899999999999999999999999999999988
Q ss_pred CCCCCcEEEEeccCcccccCcc--cccCcCCCCcccchhhhcCCCC
Q 000893 1185 DPIRPICKVGDFGLSKIKRNTL--VTGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1185 G~I~ltVKLsDFGLArii~ns~--~tss~~GTp~YmAPEVL~Gss~ 1228 (1236)
+ .+||+|||+++...... .....+||+.|+|||++.+..+
T Consensus 304 ~----~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 345 (501)
T PHA03210 304 G----KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGY 345 (501)
T ss_pred C----CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCC
Confidence 6 56999999998764332 2334679999999999987643
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-23 Score=225.54 Aligned_cols=170 Identities=27% Similarity=0.412 Sum_probs=138.7
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCC-
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP- 1118 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~- 1118 (1236)
++|++.+.||+|+||.||+|.+ +++.||||++.... .......+.+|+.+++.++||||+++++++....
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 77 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-------HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSF 77 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-------cchhHHHHHHHHHHHHhCCCCCcCchhheeecccc
Confidence 6899999999999999999987 57889999986421 1123455778999999999999999999876432
Q ss_pred --CCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEec
Q 000893 1119 --GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1236)
Q Consensus 1119 --~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDF 1196 (1236)
...+++||||+. ++|..++. ...+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 78 ~~~~~~~lv~e~~~-~~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~----~~kl~df 150 (336)
T cd07849 78 ESFNDVYIVQELME-TDLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNC----DLKICDF 150 (336)
T ss_pred cccceEEEEehhcc-cCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC----CEEECcc
Confidence 236899999995 58887773 34689999999999999999999999999999999999999876 5699999
Q ss_pred cCcccccCcc----cccCcCCCCcccchhhhcC
Q 000893 1197 GLSKIKRNTL----VTGGVRGTLPWMAPELLNG 1225 (1236)
Q Consensus 1197 GLArii~ns~----~tss~~GTp~YmAPEVL~G 1225 (1236)
|++....... .....+||+.|+|||++.+
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 183 (336)
T cd07849 151 GLARIADPEHDHTGFLTEYVATRWYRAPEIMLN 183 (336)
T ss_pred cceeeccccccccCCcCCcCcCCCccChHHhhC
Confidence 9987653221 1233568999999999865
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.2e-23 Score=216.01 Aligned_cols=169 Identities=29% Similarity=0.530 Sum_probs=141.2
Q ss_pred CeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCC---CCceeeEeeeEecC
Q 000893 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH---HPNVVAFYGVVQDG 1117 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLr---HPNIVrLyG~f~t~ 1117 (1236)
.|++++.||+|+||.||+|.+ .++.||||++.... .......+.+|+.+++.++ ||||++++++|...
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~ 74 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-------PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG 74 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-------CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC
Confidence 467788899999999999997 47889999986532 1122446778999999987 99999999998875
Q ss_pred CCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEecc
Q 000893 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1236)
Q Consensus 1118 ~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFG 1197 (1236)
. ..++||||+++++|.+++.. ..+++..++.++.|++.||.|||+.||+||||+|+||+++.++ .++|+|||
T Consensus 75 ~--~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~----~~~l~dfg 146 (277)
T cd06917 75 P--RLWIIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTG----NVKLCDFG 146 (277)
T ss_pred C--EEEEEEecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCC----CEEEccCC
Confidence 4 89999999999999998854 3689999999999999999999999999999999999999876 57999999
Q ss_pred CcccccCcc-cccCcCCCCcccchhhhcCC
Q 000893 1198 LSKIKRNTL-VTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1198 LArii~ns~-~tss~~GTp~YmAPEVL~Gs 1226 (1236)
++....... ......|+..|+|||++.+.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 176 (277)
T cd06917 147 VAALLNQNSSKRSTFVGTPYWMAPEVITEG 176 (277)
T ss_pred ceeecCCCccccccccCCcceeCHHHhccC
Confidence 998754332 23345789999999998753
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.8e-23 Score=219.77 Aligned_cols=168 Identities=30% Similarity=0.482 Sum_probs=140.9
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
+.|++++.||+|+||+||+|.. .++.||||++...... .......+.+|+.+++.++||||++++++|....
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~- 88 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ-----SNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH- 88 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccC-----cHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC-
Confidence 4588899999999999999987 4788999998643211 2233456889999999999999999999998754
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
..++||||+. ++|.+++......+++..+..++.|++.||.|||..+|+||||+|+||+++.++ .+||+|||++
T Consensus 89 -~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~----~~kL~dfg~~ 162 (307)
T cd06607 89 -TAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPG----TVKLADFGSA 162 (307)
T ss_pred -eEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCC----CEEEeecCcc
Confidence 7899999995 677777765566799999999999999999999999999999999999999886 5799999998
Q ss_pred ccccCcccccCcCCCCcccchhhhc
Q 000893 1200 KIKRNTLVTGGVRGTLPWMAPELLN 1224 (1236)
Q Consensus 1200 rii~ns~~tss~~GTp~YmAPEVL~ 1224 (1236)
...... ....+++.|+|||++.
T Consensus 163 ~~~~~~---~~~~~~~~y~aPE~~~ 184 (307)
T cd06607 163 SLVSPA---NSFVGTPYWMAPEVIL 184 (307)
T ss_pred eecCCC---CCccCCccccCceeee
Confidence 765432 2356888999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=7e-23 Score=212.59 Aligned_cols=166 Identities=34% Similarity=0.503 Sum_probs=134.4
Q ss_pred EEeccCCceEEEEeeec-----CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeE
Q 000893 1048 KELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTL 1122 (1236)
Q Consensus 1048 kkLGsGSFGtVYKArlk-----G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L 1122 (1236)
++||+|+||.||+|.+. +..||+|.+..... .....++.+|+.+++.+.||||+++++++.. ...
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~ 70 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI-------AAGKKEFLREASVMAQLDHPCIVRLIGVCKG---EPL 70 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccc-------hHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC---Cce
Confidence 36999999999999873 25699999875432 1334578899999999999999999998764 267
Q ss_pred EEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcccc
Q 000893 1123 ATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 1202 (1236)
Q Consensus 1123 ~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii 1202 (1236)
++||||+++++|.+++.... .+++..++.++.|++.||.|||.++++||||||+|||++.++ .+||+|||+++..
T Consensus 71 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~----~~kl~df~~~~~~ 145 (257)
T cd05060 71 MLVMELAPLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRH----QAKISDFGMSRAL 145 (257)
T ss_pred EEEEEeCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCC----cEEecccccccee
Confidence 99999999999999996544 689999999999999999999999999999999999999876 5699999999865
Q ss_pred cCccc--c--cCcCCCCcccchhhhcCCCC
Q 000893 1203 RNTLV--T--GGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1203 ~ns~~--t--ss~~GTp~YmAPEVL~Gss~ 1228 (1236)
..... . ....++..|+|||.+.+...
T Consensus 146 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 175 (257)
T cd05060 146 GAGSDYYRATTAGRWPLKWYAPECINYGKF 175 (257)
T ss_pred ecCCcccccccCccccccccCHHHhcCCCC
Confidence 33221 1 11223467999999976543
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.2e-23 Score=219.13 Aligned_cols=176 Identities=24% Similarity=0.387 Sum_probs=143.9
Q ss_pred ccccccCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCC-CCceeeEeee
Q 000893 1037 QIIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGV 1113 (1236)
Q Consensus 1037 qiIs~EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLr-HPNIVrLyG~ 1113 (1236)
+.+..++|++.+.||+|+||+||+|.+. ++.||||++++... .....++.+|+.++.++. ||||++++++
T Consensus 10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-------~~~~~~~~~e~~~~~~~~~~~~i~~~~~~ 82 (296)
T cd06618 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-------KEENKRILMDLDVVLKSHDCPYIVKCYGY 82 (296)
T ss_pred ccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-------hHHHHHHHHHHHHHHhccCCCchHhhhee
Confidence 3456688999999999999999999985 88899999975421 112345666777666665 9999999999
Q ss_pred EecCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCcEEEccCCCCCCcEE
Q 000893 1114 VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPIRPICK 1192 (1236)
Q Consensus 1114 f~t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHS-kGIIHRDIKPsNILLDsdG~I~ltVK 1192 (1236)
|.... .+++||||+ +++|..++......+++..+..++.||+.||.|||+ ++|+||||+|+|||++.++ .+|
T Consensus 83 ~~~~~--~~~~v~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~----~~k 155 (296)
T cd06618 83 FITDS--DVFICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG----NVK 155 (296)
T ss_pred eecCC--eEEEEeecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC----CEE
Confidence 98854 899999998 567888776656689999999999999999999997 6999999999999998776 679
Q ss_pred EEeccCcccccCcccccCcCCCCcccchhhhcCC
Q 000893 1193 VGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1193 LsDFGLArii~ns~~tss~~GTp~YmAPEVL~Gs 1226 (1236)
|+|||++.............+++.|+|||++.+.
T Consensus 156 L~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 189 (296)
T cd06618 156 LCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPP 189 (296)
T ss_pred ECccccchhccCCCcccCCCCCccccCHhhcCCC
Confidence 9999999876544433445678899999999765
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.1e-24 Score=250.96 Aligned_cols=186 Identities=32% Similarity=0.528 Sum_probs=156.4
Q ss_pred cccccCeeEEEEeccCCceEEEEeeec--C---ceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEee
Q 000893 1038 IIKNEDLEELKELGSGTFGTVYHGKWR--G---TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 1112 (1236)
Q Consensus 1038 iIs~EdYeiLkkLGsGSFGtVYKArlk--G---~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG 1112 (1236)
+|......+.++||.|.||.||+|+++ + ..||||.||... .++...+|+.|+.||.++.||||++|.|
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-------tekqrrdFL~EAsIMGQFdHPNIIrLEG 697 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-------TEKQRRDFLSEASIMGQFDHPNIIRLEG 697 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-------cHHHHhhhhhhhhhcccCCCCcEEEEEE
Confidence 455667788999999999999999984 3 349999998653 4566788999999999999999999999
Q ss_pred eEecCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEE
Q 000893 1113 VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 1192 (1236)
Q Consensus 1113 ~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVK 1192 (1236)
+..... .++||+|||++|+|+.+|+.+...+++.+...+++.|+.||.||-+.++|||||.++|||++.+ +++|
T Consensus 698 VVTks~--PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsn----LvCK 771 (996)
T KOG0196|consen 698 VVTKSK--PVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSN----LVCK 771 (996)
T ss_pred EEecCc--eeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccc----eEEE
Confidence 988754 8999999999999999999988889999999999999999999999999999999999999987 5999
Q ss_pred EEeccCcccccCcc-c-ccCc--CCCCcccchhhhcC-CCCCCCccccC
Q 000893 1193 VGDFGLSKIKRNTL-V-TGGV--RGTLPWMAPELLNG-SSSKVSEKVCF 1236 (1236)
Q Consensus 1193 LsDFGLArii~ns~-~-tss~--~GTp~YmAPEVL~G-ss~~~SdDVDI 1236 (1236)
++||||+|.+.+.. . .++. .-...|.|||.|.. .....|+.|+|
T Consensus 772 VsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSy 820 (996)
T KOG0196|consen 772 VSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSY 820 (996)
T ss_pred eccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhcccc
Confidence 99999999886543 1 1111 12467999999974 44444555653
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=223.63 Aligned_cols=171 Identities=26% Similarity=0.470 Sum_probs=140.8
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
+.|.....||+|+||.||++.. ++..||||.+... .......+.+|+.+++.++||||+++++.+....
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--------~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~- 92 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--------KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGD- 92 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc--------hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCC-
Confidence 3445556799999999999987 4778999998643 1223456789999999999999999999988754
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
..++||||+++++|..++.. ..+++..++.++.||+.||.|||+++|+||||||+||+++.++ .+||+|||++
T Consensus 93 -~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~----~~kL~dfg~~ 165 (292)
T cd06658 93 -ELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDG----RIKLSDFGFC 165 (292)
T ss_pred -eEEEEEeCCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC----CEEEccCcch
Confidence 89999999999999998843 3588999999999999999999999999999999999999876 5799999998
Q ss_pred ccccCcc-cccCcCCCCcccchhhhcCCCC
Q 000893 1200 KIKRNTL-VTGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1200 rii~ns~-~tss~~GTp~YmAPEVL~Gss~ 1228 (1236)
....... ......|++.|+|||++.+...
T Consensus 166 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 195 (292)
T cd06658 166 AQVSKEVPKRKSLVGTPYWMAPEVISRLPY 195 (292)
T ss_pred hhcccccccCceeecCccccCHHHHccCCC
Confidence 7643222 2234568999999999976533
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.8e-23 Score=211.10 Aligned_cols=166 Identities=33% Similarity=0.481 Sum_probs=139.3
Q ss_pred eccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeEEEEEe
Q 000893 1050 LGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTE 1127 (1236)
Q Consensus 1050 LGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L~LVME 1127 (1236)
||.|+||.||++++. ++.||||++..... ........+.+|+.++++++||||+++++.+.... .+++|||
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~lv~e 73 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM-----IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKK--NLYLVME 73 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhh-----hhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCc--EEEEEEe
Confidence 689999999999984 78899999875432 12344567888999999999999999999988754 8999999
Q ss_pred eccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcccccCcc-
Q 000893 1128 FMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL- 1206 (1236)
Q Consensus 1128 Ym~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~ns~- 1206 (1236)
|+++++|..++.... .+++..+..++.||+.||.|||.++|+||||+|+||+++.++ .+||+|||++.......
T Consensus 74 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~----~~~l~dfg~~~~~~~~~~ 148 (265)
T cd05579 74 YLPGGDLASLLENVG-SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNG----HLKLTDFGLSKVGLVRRQ 148 (265)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCC----CEEEEecccchhcccCcc
Confidence 999999999986544 689999999999999999999999999999999999999886 56999999988643221
Q ss_pred --------cccCcCCCCcccchhhhcCCC
Q 000893 1207 --------VTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1207 --------~tss~~GTp~YmAPEVL~Gss 1227 (1236)
......++..|+|||++.+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~ 177 (265)
T cd05579 149 INLNDDEKEDKRIVGTPDYIAPEVILGQG 177 (265)
T ss_pred cccccccccccCcccCccccCHHHhcCCC
Confidence 223456888999999997664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.2e-24 Score=262.02 Aligned_cols=184 Identities=32% Similarity=0.499 Sum_probs=147.7
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCC-
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP- 1118 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~- 1118 (1236)
.+|+.++.||+|+||.||+++. +|+.+|||+|.... .......+.+|+.+|++|+|||||++|..|.+..
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-------s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~ 551 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-------SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTA 551 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-------HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCC
Confidence 4788889999999999999987 59999999997642 3445667889999999999999999986432100
Q ss_pred --------------------------------------------------------------------------------
Q 000893 1119 -------------------------------------------------------------------------------- 1118 (1236)
Q Consensus 1119 -------------------------------------------------------------------------------- 1118 (1236)
T Consensus 552 ~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S 631 (1351)
T KOG1035|consen 552 ELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLS 631 (1351)
T ss_pred ccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccc
Confidence
Q ss_pred ----------------------------C--------CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHH
Q 000893 1119 ----------------------------G--------GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGME 1162 (1236)
Q Consensus 1119 ----------------------------~--------g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALa 1162 (1236)
+ ..+||-||||+..+|.+++.+....-.....++++++|++||.
T Consensus 632 ~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 632 NTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLA 711 (1351)
T ss_pred cccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHH
Confidence 0 3578999999888888888554322257788999999999999
Q ss_pred HHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCccccc-------------------CcccccCcCCCCcccchhhh
Q 000893 1163 YLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR-------------------NTLVTGGVRGTLPWMAPELL 1223 (1236)
Q Consensus 1163 YLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~-------------------ns~~tss~~GTp~YmAPEVL 1223 (1236)
|+|++|||||||||.||+|+.++ .|||+|||+|.... +....+..+||.-|+|||++
T Consensus 712 YIH~~giIHRDLKP~NIFLd~~~----~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll 787 (1351)
T KOG1035|consen 712 YIHDQGIIHRDLKPRNIFLDSRN----SVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL 787 (1351)
T ss_pred HHHhCceeeccCCcceeEEcCCC----CeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence 99999999999999999999887 56999999998611 11133457899999999999
Q ss_pred cCCCC-CCCccccC
Q 000893 1224 NGSSS-KVSEKVCF 1236 (1236)
Q Consensus 1224 ~Gss~-~~SdDVDI 1236 (1236)
.+... .|+.++|+
T Consensus 788 ~~~~~~~Yn~KiDm 801 (1351)
T KOG1035|consen 788 SDTSSNKYNSKIDM 801 (1351)
T ss_pred cccccccccchhhh
Confidence 87653 67888775
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-22 Score=206.10 Aligned_cols=172 Identities=30% Similarity=0.514 Sum_probs=145.8
Q ss_pred CeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g 1120 (1236)
+|++.+.||+|++|.||++.. .+..||||.+...... +.....+.+|++++++++||||+++++++... .
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~ 72 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK------EEALKSIMQEIDLLKNLKHPNIVKYIGSIETS--D 72 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC------HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC--C
Confidence 478899999999999999987 4678999999765321 23456788999999999999999999998875 4
Q ss_pred eEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcc
Q 000893 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1236)
Q Consensus 1121 ~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLAr 1200 (1236)
..++||||+.+++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++ .++|+|||++.
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~----~~~l~d~~~~~ 147 (254)
T cd06627 73 SLYIILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDG----VVKLADFGVAT 147 (254)
T ss_pred EEEEEEecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCC----CEEEeccccce
Confidence 899999999999999998654 5689999999999999999999999999999999999999865 57999999998
Q ss_pred cccCccc-ccCcCCCCcccchhhhcCCC
Q 000893 1201 IKRNTLV-TGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1201 ii~ns~~-tss~~GTp~YmAPEVL~Gss 1227 (1236)
....... .....++..|+|||++.+..
T Consensus 148 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~ 175 (254)
T cd06627 148 KLNDVSKDDASVVGTPYWMAPEVIEMSG 175 (254)
T ss_pred ecCCCcccccccccchhhcCHhhhcCCC
Confidence 7654322 23456899999999987654
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.8e-23 Score=218.12 Aligned_cols=176 Identities=31% Similarity=0.457 Sum_probs=142.3
Q ss_pred cccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecC
Q 000893 1040 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1236)
Q Consensus 1040 s~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~ 1117 (1236)
..++|++.+.||+|+||.||+|.+ .++.||||+++..... ......+.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~------~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~ 78 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK------EGFPITAIREIKILRQLNHRNIVNLKEIVTDK 78 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc------cCchHHHHHHHHHHHhCCCCCeeeeeheecCc
Confidence 356899999999999999999998 4778999998754211 11223566799999999999999999998764
Q ss_pred C--------CCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCC
Q 000893 1118 P--------GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP 1189 (1236)
Q Consensus 1118 ~--------~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~l 1189 (1236)
. .+.+++||||+++ +|..++......+++..++.++.||+.||.|||+.+|+||||||+||+++.++
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~---- 153 (302)
T cd07864 79 QDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG---- 153 (302)
T ss_pred chhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC----
Confidence 3 2478999999965 77777765555789999999999999999999999999999999999999876
Q ss_pred cEEEEeccCcccccCcc--cccCcCCCCcccchhhhcCC
Q 000893 1190 ICKVGDFGLSKIKRNTL--VTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1190 tVKLsDFGLArii~ns~--~tss~~GTp~YmAPEVL~Gs 1226 (1236)
.+||+|||++....... ......++..|+|||++.+.
T Consensus 154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~ 192 (302)
T cd07864 154 QIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGE 192 (302)
T ss_pred cEEeCcccccccccCCcccccccceeccCccChHHhcCC
Confidence 67999999998754322 22233467889999998653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-22 Score=215.45 Aligned_cols=168 Identities=24% Similarity=0.322 Sum_probs=131.3
Q ss_pred EeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeEEEEE
Q 000893 1049 ELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVT 1126 (1236)
Q Consensus 1049 kLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L~LVM 1126 (1236)
.||+|+||.||+++. .++.||||++.+....... .......-...+.+++...||+|+++++++.... .+++||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--~~~~v~ 76 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--GETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD--KLSFIL 76 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccch--hHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCC--EEEEEE
Confidence 389999999999987 4778999998765332111 1111111122334455568999999999998754 899999
Q ss_pred eeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcccccCcc
Q 000893 1127 EFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL 1206 (1236)
Q Consensus 1127 EYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~ns~ 1206 (1236)
||+.+++|..++.. ...+++..++.|+.|++.||.|||+++|+||||||+|||++.++ .+||+|||++......
T Consensus 77 e~~~g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~----~~kl~dfg~~~~~~~~- 150 (278)
T cd05606 77 DLMNGGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG----HVRISDLGLACDFSKK- 150 (278)
T ss_pred ecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCC----CEEEccCcCccccCcc-
Confidence 99999999988854 44689999999999999999999999999999999999999876 5799999998765332
Q ss_pred cccCcCCCCcccchhhhcCC
Q 000893 1207 VTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1207 ~tss~~GTp~YmAPEVL~Gs 1226 (1236)
.....+|+..|+|||++.+.
T Consensus 151 ~~~~~~~~~~y~aPE~~~~~ 170 (278)
T cd05606 151 KPHASVGTHGYMAPEVLQKG 170 (278)
T ss_pred CCcCcCCCcCCcCcHHhcCC
Confidence 22345789999999999743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.5e-23 Score=208.99 Aligned_cols=174 Identities=29% Similarity=0.513 Sum_probs=146.1
Q ss_pred CeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g 1120 (1236)
+|++.+.||+|+||.||+++. .+..+|||.+..... .......+.+|+.+++.++||||+++++++... .
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~ 72 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM------SQKEREDAVNEIRILASVNHPNIISYKEAFLDG--N 72 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc------cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC--C
Confidence 478899999999999999987 467899999876432 122345677899999999999999999998875 4
Q ss_pred eEEEEEeeccCCCHHHHHhhh---ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEecc
Q 000893 1121 TLATVTEFMVNGSLRHVLLSK---ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1236)
Q Consensus 1121 ~L~LVMEYm~GGSL~dlL~~k---~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFG 1197 (1236)
..++||||+++++|..++... ...+++..++.++.|++.||.|||+.|++|+||+|.||+++.++ .+||+|||
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~----~~kl~d~g 148 (256)
T cd08530 73 KLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAND----LVKIGDLG 148 (256)
T ss_pred EEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCC----cEEEeecc
Confidence 899999999999999998652 35688999999999999999999999999999999999999865 56999999
Q ss_pred CcccccCcccccCcCCCCcccchhhhcCCCCC
Q 000893 1198 LSKIKRNTLVTGGVRGTLPWMAPELLNGSSSK 1229 (1236)
Q Consensus 1198 LArii~ns~~tss~~GTp~YmAPEVL~Gss~~ 1229 (1236)
++...... ......+++.|+|||++.+....
T Consensus 149 ~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~ 179 (256)
T cd08530 149 ISKVLKKN-MAKTQIGTPHYMAPEVWKGRPYS 179 (256)
T ss_pred chhhhccC-CcccccCCccccCHHHHCCCCCC
Confidence 99876554 33345688999999999876443
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.5e-23 Score=210.39 Aligned_cols=174 Identities=24% Similarity=0.462 Sum_probs=143.4
Q ss_pred CeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g 1120 (1236)
+|.+.+.||+|+||.||++..+ +..||+|.+....... .....+.+|+.+++.++|+||+++++.+....
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~-- 72 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV------KEKEASKKEVILLAKMKHPNIVTFFASFQENG-- 72 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc------hhhHHHHHHHHHHHhCCCCChhhhhheeccCC--
Confidence 4788999999999999999984 6789999987542211 12345678999999999999999999988754
Q ss_pred eEEEEEeeccCCCHHHHHhhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1121 TLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1121 ~L~LVMEYm~GGSL~dlL~~k~-r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
.+++|+||+++++|.+++.... ..+++..++.++.|++.||.|||+.+|+|+||||+||+++.++. .+||+|||++
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~---~~~l~d~~~~ 149 (257)
T cd08225 73 RLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGM---VAKLGDFGIA 149 (257)
T ss_pred eEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCC---eEEecccccc
Confidence 8999999999999999986543 35789999999999999999999999999999999999987752 4699999999
Q ss_pred ccccCcc-cccCcCCCCcccchhhhcCCC
Q 000893 1200 KIKRNTL-VTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1200 rii~ns~-~tss~~GTp~YmAPEVL~Gss 1227 (1236)
....... ......|++.|+|||++.+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~ape~~~~~~ 178 (257)
T cd08225 150 RQLNDSMELAYTCVGTPYYLSPEICQNRP 178 (257)
T ss_pred hhccCCcccccccCCCccccCHHHHcCCC
Confidence 8764432 222345899999999987653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.8e-23 Score=218.01 Aligned_cols=175 Identities=33% Similarity=0.476 Sum_probs=140.6
Q ss_pred ccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCC
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1041 ~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~ 1118 (1236)
.++|++.++||+|+||.||+|.+ +++.||||++....... .....+.+|+.+++.++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD------GFPITALREIKILKKLKHPNVVPLIDMAVERP 80 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC------CcchhHHHHHHHHHhcCCCCccchhhheeccc
Confidence 47899999999999999999998 47789999987543211 11224567999999999999999999876533
Q ss_pred ------CCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEE
Q 000893 1119 ------GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 1192 (1236)
Q Consensus 1119 ------~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVK 1192 (1236)
...+++||||+. ++|...+......+++..++.++.||+.||.|||++||+||||||+|||++.++ .+|
T Consensus 81 ~~~~~~~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~----~~~ 155 (311)
T cd07866 81 DKSKRKRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQG----ILK 155 (311)
T ss_pred ccccccCceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC----CEE
Confidence 236799999994 577777766566799999999999999999999999999999999999999886 569
Q ss_pred EEeccCcccccCccc------------ccCcCCCCcccchhhhcCC
Q 000893 1193 VGDFGLSKIKRNTLV------------TGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1193 LsDFGLArii~ns~~------------tss~~GTp~YmAPEVL~Gs 1226 (1236)
|+|||+++....... .....+++.|+|||++.+.
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 201 (311)
T cd07866 156 IADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE 201 (311)
T ss_pred ECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCC
Confidence 999999986432211 1234578889999998754
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-24 Score=222.45 Aligned_cols=179 Identities=28% Similarity=0.412 Sum_probs=150.4
Q ss_pred CeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g 1120 (1236)
+|..+++||+|+||+||+|+. ++..||+|.+.... +.+......++|+-+|+.++|.|||+++++....+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldd------ddegvpssalreicllkelkhknivrl~dvlhsdk-- 74 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDD------DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK-- 74 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccC------CCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCc--
Confidence 466678899999999999987 46779999987642 12334456789999999999999999999988765
Q ss_pred eEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcc
Q 000893 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1236)
Q Consensus 1121 ~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLAr 1200 (1236)
.+.+|+||| ..+|..+....+..++...++.++.|+++||.|||+++++||||||+|+||+.+| .+||+|||+++
T Consensus 75 kltlvfe~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ng----elkladfglar 149 (292)
T KOG0662|consen 75 KLTLVFEFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNG----ELKLADFGLAR 149 (292)
T ss_pred eeEEeHHHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCC----cEEecccchhh
Confidence 889999999 7799999988888899999999999999999999999999999999999999998 55999999999
Q ss_pred cccCcc-cccCcCCCCcccchhhhcCCCCCCCcccc
Q 000893 1201 IKRNTL-VTGGVRGTLPWMAPELLNGSSSKVSEKVC 1235 (1236)
Q Consensus 1201 ii~ns~-~tss~~GTp~YmAPEVL~Gss~~~SdDVD 1235 (1236)
...-.. ..+..+-|.||++|.++-|. .-++..+|
T Consensus 150 afgipvrcysaevvtlwyrppdvlfga-kly~tsid 184 (292)
T KOG0662|consen 150 AFGIPVRCYSAEVVTLWYRPPDVLFGA-KLYSTSID 184 (292)
T ss_pred hcCCceEeeeceeeeeeccCcceeeee-ehhccchH
Confidence 865443 33445679999999999876 34444444
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.9e-23 Score=213.52 Aligned_cols=179 Identities=27% Similarity=0.450 Sum_probs=144.3
Q ss_pred CeeEEEEeccCCceEEEEeeec---CceEEEEeeeccccCCC--ChHHHHHHHHHHHHHHHHhh-CCCCceeeEeeeEec
Q 000893 1043 DLEELKELGSGTFGTVYHGKWR---GTDVAIKRIKKSCFTGR--SSEQERLTLEFWREAEILSK-LHHPNVVAFYGVVQD 1116 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArlk---G~~VAVKvLkk~~i~~~--~~e~er~~keFlrEIrILsk-LrHPNIVrLyG~f~t 1116 (1236)
.|++.+.||+|+||.||++.+. ++.+|||.+........ .........++.+|+.++.+ ++||||++++++|..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 3777889999999999999985 46799998864332111 01123345567789988875 799999999999987
Q ss_pred CCCCeEEEEEeeccCCCHHHHHhh---hccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCcEEEccCCCCCCcEE
Q 000893 1117 GPGGTLATVTEFMVNGSLRHVLLS---KERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPIRPICK 1192 (1236)
Q Consensus 1117 ~~~g~L~LVMEYm~GGSL~dlL~~---k~r~LSe~erl~Ia~QIAeALaYLHS-kGIIHRDIKPsNILLDsdG~I~ltVK 1192 (1236)
. +.+++||||+++++|.+++.. ....+++..++.++.|++.||.|||. .+|+|+||+|+|||++.++ .+|
T Consensus 81 ~--~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~----~~~ 154 (269)
T cd08528 81 N--DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD----KVT 154 (269)
T ss_pred C--CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC----cEE
Confidence 5 489999999999999988743 34568999999999999999999996 7899999999999999876 579
Q ss_pred EEeccCcccccCcccccCcCCCCcccchhhhcCCC
Q 000893 1193 VGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1193 LsDFGLArii~ns~~tss~~GTp~YmAPEVL~Gss 1227 (1236)
|+|||++.............|+..|+|||++.+..
T Consensus 155 l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~ 189 (269)
T cd08528 155 ITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEP 189 (269)
T ss_pred EecccceeecccccccccccCcccCcChhhhcCCC
Confidence 99999998765544445567899999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.2e-23 Score=216.92 Aligned_cols=171 Identities=29% Similarity=0.417 Sum_probs=137.6
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCC-CCceeeEeeeEecCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLr-HPNIVrLyG~f~t~~ 1118 (1236)
++|+.++.||+|+||.||++.+ .++.||||.+..... ......+.+|+.++.++. ||||+++++++..+.
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~ 76 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD-------EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREG 76 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC-------hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCC
Confidence 4667778899999999999988 467899999875321 123456788999999996 999999999988754
Q ss_pred CCeEEEEEeeccCCCHHHHH---hh-hccCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCcEEEccCCCCCCcEEE
Q 000893 1119 GGTLATVTEFMVNGSLRHVL---LS-KERHLDRRKRLIIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKV 1193 (1236)
Q Consensus 1119 ~g~L~LVMEYm~GGSL~dlL---~~-k~r~LSe~erl~Ia~QIAeALaYLHSk-GIIHRDIKPsNILLDsdG~I~ltVKL 1193 (1236)
..+++|||+. ++|..+. .. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||
T Consensus 77 --~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~----~~kl 149 (288)
T cd06616 77 --DCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG----NIKL 149 (288)
T ss_pred --cEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCC----cEEE
Confidence 7889999984 5555443 22 235689999999999999999999974 999999999999999876 5799
Q ss_pred EeccCcccccCcccccCcCCCCcccchhhhcCC
Q 000893 1194 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1194 sDFGLArii~ns~~tss~~GTp~YmAPEVL~Gs 1226 (1236)
+|||+++............|++.|+|||++.+.
T Consensus 150 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 182 (288)
T cd06616 150 CDFGISGQLVDSIAKTRDAGCRPYMAPERIDPS 182 (288)
T ss_pred eecchhHHhccCCccccccCccCccCHHHhccc
Confidence 999999876544443445689999999999765
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=214.94 Aligned_cols=164 Identities=24% Similarity=0.317 Sum_probs=130.1
Q ss_pred EeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHH---HHhhCCCCceeeEeeeEecCCCCeEE
Q 000893 1049 ELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE---ILSKLHHPNVVAFYGVVQDGPGGTLA 1123 (1236)
Q Consensus 1049 kLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIr---ILskLrHPNIVrLyG~f~t~~~g~L~ 1123 (1236)
.||+|+||.||++.. +++.||||++.+....... . ...+.+|.. ++....||||+.+++++.... ..+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--~~~ 73 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--G---ETLALNERIMLSLVSTGDCPFIVCMTYAFHTPD--KLC 73 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccch--H---HHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCC--eEE
Confidence 389999999999987 4788999999765432111 1 112333443 344457999999999998754 889
Q ss_pred EEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCccccc
Q 000893 1124 TVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR 1203 (1236)
Q Consensus 1124 LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~ 1203 (1236)
+||||+++++|..++... ..+++..+..|+.|++.||.|||+++|+||||||+|||++.++ .+||+|||++....
T Consensus 74 lv~e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~----~~~l~dfg~~~~~~ 148 (279)
T cd05633 74 FILDLMNGGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHG----HVRISDLGLACDFS 148 (279)
T ss_pred EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCC----CEEEccCCcceecc
Confidence 999999999999888644 4689999999999999999999999999999999999999876 57999999987654
Q ss_pred CcccccCcCCCCcccchhhhcC
Q 000893 1204 NTLVTGGVRGTLPWMAPELLNG 1225 (1236)
Q Consensus 1204 ns~~tss~~GTp~YmAPEVL~G 1225 (1236)
... .....||+.|+|||++.+
T Consensus 149 ~~~-~~~~~~~~~y~aPE~~~~ 169 (279)
T cd05633 149 KKK-PHASVGTHGYMAPEVLQK 169 (279)
T ss_pred ccC-ccCcCCCcCccCHHHhcC
Confidence 322 233568999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.3e-23 Score=222.50 Aligned_cols=168 Identities=26% Similarity=0.435 Sum_probs=138.9
Q ss_pred EEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeEE
Q 000893 1046 ELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLA 1123 (1236)
Q Consensus 1046 iLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L~ 1123 (1236)
....||+|+||.||++.. .++.||||++..... .....+.+|+.+++.++||||++++++|.... ..+
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--------~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~--~~~ 94 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--------QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGE--ELW 94 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--------chHHHHHHHHHHHHhCCCCchhhhhhheeeCC--eEE
Confidence 344699999999999987 478899999865321 11345778999999999999999999988754 899
Q ss_pred EEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCccccc
Q 000893 1124 TVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR 1203 (1236)
Q Consensus 1124 LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~ 1203 (1236)
+||||+++++|..++.. ..+++..++.++.|++.||.|||+++|+||||||+|||++.++ .+||+|||++....
T Consensus 95 iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~----~~kL~dfg~~~~~~ 168 (297)
T cd06659 95 VLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDG----RVKLSDFGFCAQIS 168 (297)
T ss_pred EEEecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCC----cEEEeechhHhhcc
Confidence 99999999999987743 4689999999999999999999999999999999999999886 56999999987654
Q ss_pred Ccc-cccCcCCCCcccchhhhcCCCCC
Q 000893 1204 NTL-VTGGVRGTLPWMAPELLNGSSSK 1229 (1236)
Q Consensus 1204 ns~-~tss~~GTp~YmAPEVL~Gss~~ 1229 (1236)
... ......|++.|+|||++.+....
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~ 195 (297)
T cd06659 169 KDVPKRKSLVGTPYWMAPEVISRTPYG 195 (297)
T ss_pred cccccccceecCccccCHHHHccCCCC
Confidence 322 22346689999999999875433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.2e-23 Score=217.67 Aligned_cols=171 Identities=29% Similarity=0.441 Sum_probs=140.6
Q ss_pred CeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g 1120 (1236)
+|++++.||.|+||.||+|+. .++.||||++...... ......+.+|+.++++++||||+++++++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 72 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET------EGVPSTAIREISLLKELNHPNIVKLLDVIHTEN-- 72 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccc------cccchHHHHHHHHHHhcCCCCCcchhhhcccCC--
Confidence 478899999999999999988 4788999988654211 112346778999999999999999999988754
Q ss_pred eEEEEEeeccCCCHHHHHhhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1121 TLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1121 ~L~LVMEYm~GGSL~dlL~~k-~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
.+++||||+. ++|..++... ...+++..++.++.|++.||+|||.++++||||+|+||+++.++ .+||+|||++
T Consensus 73 ~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~----~~~l~dfg~~ 147 (284)
T cd07860 73 KLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG----AIKLADFGLA 147 (284)
T ss_pred cEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC----CEEEeeccch
Confidence 8999999995 6888888653 35689999999999999999999999999999999999999886 5699999998
Q ss_pred ccccCcc-cccCcCCCCcccchhhhcCC
Q 000893 1200 KIKRNTL-VTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1200 rii~ns~-~tss~~GTp~YmAPEVL~Gs 1226 (1236)
....... ......+++.|+|||++.+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 175 (284)
T cd07860 148 RAFGVPVRTYTHEVVTLWYRAPEILLGC 175 (284)
T ss_pred hhcccCccccccccccccccCCeEEecC
Confidence 7654322 22334578899999998764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.9e-23 Score=212.66 Aligned_cols=174 Identities=32% Similarity=0.460 Sum_probs=145.5
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCC-CCceeeEeeeEecCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLr-HPNIVrLyG~f~t~~ 1118 (1236)
++|++.+.||+|+||.||++.. .+..||||++.+.... .......+.+|+.++++++ ||||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI-----KEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhcc-----chHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCc
Confidence 4789999999999999999988 5788999998764321 1223456788999999999 999999999988754
Q ss_pred CCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccC
Q 000893 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1236)
Q Consensus 1119 ~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGL 1198 (1236)
.+++||||+++++|.+++... ..+++..++.|+.|++.||.|||++|++|+||+|+||+++.++ .++|+|||+
T Consensus 76 --~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~----~~~l~df~~ 148 (280)
T cd05581 76 --NLYFVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDM----HIKITDFGT 148 (280)
T ss_pred --eEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC----CEEecCCcc
Confidence 899999999999999999654 4699999999999999999999999999999999999999876 569999999
Q ss_pred cccccCcc---------------------cccCcCCCCcccchhhhcCCC
Q 000893 1199 SKIKRNTL---------------------VTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1199 Arii~ns~---------------------~tss~~GTp~YmAPEVL~Gss 1227 (1236)
+....... ......++..|+|||++.+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~ 198 (280)
T cd05581 149 AKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP 198 (280)
T ss_pred ccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCC
Confidence 88654322 223356789999999987653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-23 Score=245.17 Aligned_cols=171 Identities=34% Similarity=0.470 Sum_probs=143.8
Q ss_pred EEeccCCceEEEEeeecC--ceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeEEEE
Q 000893 1048 KELGSGTFGTVYHGKWRG--TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATV 1125 (1236)
Q Consensus 1048 kkLGsGSFGtVYKArlkG--~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L~LV 1125 (1236)
-+||+|+||+||-|++.. ..+|||.+.... .+..+-+..|+.+.+.|+|.|||+++|.|.. +|++-|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd--------sr~~QPLhEEIaLH~~LrHkNIVrYLGs~se--nGf~kIF 650 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD--------SREVQPLHEEIALHSTLRHKNIVRYLGSVSE--NGFFKIF 650 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccccc--------chhhccHHHHHHHHHHHhhHhHHHHhhccCC--CCeEEEE
Confidence 369999999999999854 448999886532 2223446679999999999999999999876 4699999
Q ss_pred EeeccCCCHHHHHhhhccCC--CHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCccccc
Q 000893 1126 TEFMVNGSLRHVLLSKERHL--DRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR 1203 (1236)
Q Consensus 1126 MEYm~GGSL~dlL~~k~r~L--Se~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~ 1203 (1236)
||-++||+|..+|+.+-.++ .+...-.+..||++||.|||.+.|||||||-+||||+.-. .++||+|||.++.+-
T Consensus 651 MEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTyS---GvlKISDFGTsKRLA 727 (1226)
T KOG4279|consen 651 MEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYS---GVLKISDFGTSKRLA 727 (1226)
T ss_pred eecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeecc---ceEEecccccchhhc
Confidence 99999999999998887777 7888889999999999999999999999999999998643 378999999998753
Q ss_pred -CcccccCcCCCCcccchhhhcCCCCCCC
Q 000893 1204 -NTLVTGGVRGTLPWMAPELLNGSSSKVS 1231 (1236)
Q Consensus 1204 -ns~~tss~~GTp~YmAPEVL~Gss~~~S 1231 (1236)
-...+.++.||+.|||||+|....-.|.
T Consensus 728 ginP~TETFTGTLQYMAPEvIDqG~RGYG 756 (1226)
T KOG4279|consen 728 GINPCTETFTGTLQYMAPEVIDQGPRGYG 756 (1226)
T ss_pred cCCccccccccchhhhChHhhccCCcCCC
Confidence 4556778999999999999975444443
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.6e-23 Score=213.80 Aligned_cols=169 Identities=33% Similarity=0.475 Sum_probs=140.5
Q ss_pred eeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCC-CCceeeEeeeEecCCCC
Q 000893 1044 LEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1044 YeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLr-HPNIVrLyG~f~t~~~g 1120 (1236)
|++.+.||.|+||+||+|.. .++.||||++...... .......+|+..+++++ ||||+++++++... .
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~--~ 71 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-------WEECMNLREVKSLRKLNEHPNIVKLKEVFREN--D 71 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-------hhHHHHHHHHHHHHhccCCCCchhHHHHhhcC--C
Confidence 56788999999999999998 4678999998754211 11123456899999999 99999999999874 4
Q ss_pred eEEEEEeeccCCCHHHHHhhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1121 TLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1121 ~L~LVMEYm~GGSL~dlL~~k~-r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
..++||||+ +++|.+++.... ..+++..++.++.|++.+|.|||+++++|+||+|+||+++.++ .++|+|||++
T Consensus 72 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~----~~~l~d~~~~ 146 (283)
T cd07830 72 ELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPE----VVKIADFGLA 146 (283)
T ss_pred cEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC----CEEEeecccc
Confidence 899999999 889998886654 4789999999999999999999999999999999999999876 5699999999
Q ss_pred ccccCcccccCcCCCCcccchhhhcCC
Q 000893 1200 KIKRNTLVTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1200 rii~ns~~tss~~GTp~YmAPEVL~Gs 1226 (1236)
.............++..|+|||++.+.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~aPE~~~~~ 173 (283)
T cd07830 147 REIRSRPPYTDYVSTRWYRAPEILLRS 173 (283)
T ss_pred eeccCCCCcCCCCCcccccCceeeecC
Confidence 876554444456689999999998643
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.6e-23 Score=224.26 Aligned_cols=173 Identities=29% Similarity=0.407 Sum_probs=141.6
Q ss_pred ccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhC-CCCceeeEeeeEecC
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDG 1117 (1236)
Q Consensus 1041 ~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskL-rHPNIVrLyG~f~t~ 1117 (1236)
.++|++.+.||+|+||.||+|.+ .++.||||++..... .......+.+|+.+++++ +||||++++++|...
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~------~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~ 79 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR------NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE 79 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC------cchhhhhhhHHHHHHHHhcCCCCccceeeeeccC
Confidence 36788899999999999999987 477899998864321 112234567899999999 999999999998765
Q ss_pred CCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEecc
Q 000893 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1236)
Q Consensus 1118 ~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFG 1197 (1236)
....+++||||+. ++|..++... .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 80 ~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~----~~kl~d~g 152 (337)
T cd07852 80 NDKDIYLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDC----RVKLADFG 152 (337)
T ss_pred CCceEEEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC----cEEEeecc
Confidence 5557899999995 6998888543 788999999999999999999999999999999999999886 56999999
Q ss_pred CcccccCcc------cccCcCCCCcccchhhhcCC
Q 000893 1198 LSKIKRNTL------VTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1198 LArii~ns~------~tss~~GTp~YmAPEVL~Gs 1226 (1236)
++....... ....+.||+.|+|||++.+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 187 (337)
T cd07852 153 LARSLSELEENPENPVLTDYVATRWYRAPEILLGS 187 (337)
T ss_pred chhccccccccccCcchhcccccccccCceeeecc
Confidence 998653321 22345689999999998653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=217.16 Aligned_cols=170 Identities=27% Similarity=0.464 Sum_probs=142.3
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
.+|++++.||+|+||+||++.. .+..||+|.+.... ......+.+|+.+++.++||||++++++|....
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--------~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~- 89 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--------QPKKELIINEILVMRENKHPNIVNYLDSYLVGD- 89 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--------chHHHHHHHHHHHHhhcCCCCeeehhheeeeCC-
Confidence 6889999999999999999976 56789999985421 122356788999999999999999999998754
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
..++|+||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++
T Consensus 90 -~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~----~~kL~dfg~~ 162 (293)
T cd06647 90 -ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG----SVKLTDFGFC 162 (293)
T ss_pred -cEEEEEecCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCC----CEEEccCcce
Confidence 88999999999999999854 3578889999999999999999999999999999999999876 5799999998
Q ss_pred ccccCcc-cccCcCCCCcccchhhhcCCC
Q 000893 1200 KIKRNTL-VTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1200 rii~ns~-~tss~~GTp~YmAPEVL~Gss 1227 (1236)
....... ......|++.|+|||++.+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~ 191 (293)
T cd06647 163 AQITPEQSKRSTMVGTPYWMAPEVVTRKA 191 (293)
T ss_pred ecccccccccccccCChhhcCchhhccCC
Confidence 7643322 223456889999999987653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=213.98 Aligned_cols=174 Identities=25% Similarity=0.402 Sum_probs=142.4
Q ss_pred CeeEEEEeccCCceEEEEeee-----cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhC-CCCceeeEeeeEec
Q 000893 1043 DLEELKELGSGTFGTVYHGKW-----RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQD 1116 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArl-----kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskL-rHPNIVrLyG~f~t 1116 (1236)
+|++.+.||+|+||.||+++. +++.||||++++.... ........+.+|+.++..+ +||||+++++++..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~----~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~ 76 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIV----QKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT 76 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHH----hhhhHHHHHHHHHHHHHhccCCcchhhhheeeec
Confidence 478899999999999999875 3567999998754221 1223345678899999999 59999999999887
Q ss_pred CCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEec
Q 000893 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1236)
Q Consensus 1117 ~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDF 1196 (1236)
.. .+++||||+.+++|..++... ..+++..++.++.|++.||.|||..+++||||||.|||++.++ .++|+||
T Consensus 77 ~~--~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~----~~~l~df 149 (288)
T cd05583 77 DT--KLHLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEG----HVVLTDF 149 (288)
T ss_pred CC--EEEEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC----CEEEEEC
Confidence 54 889999999999999998643 4688999999999999999999999999999999999999876 5799999
Q ss_pred cCcccccCcc--cccCcCCCCcccchhhhcCCC
Q 000893 1197 GLSKIKRNTL--VTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1197 GLArii~ns~--~tss~~GTp~YmAPEVL~Gss 1227 (1236)
|+++...... ......|++.|+|||++.+..
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 182 (288)
T cd05583 150 GLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGS 182 (288)
T ss_pred ccccccccccccccccccCCccccCHHHhcCCC
Confidence 9988653322 223456899999999987654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-22 Score=217.25 Aligned_cols=168 Identities=30% Similarity=0.497 Sum_probs=140.5
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
+.|..++.||+|+||.||+++. .+..||||++...... .......+.+|+.+++.++||||+++++++....
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~- 98 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ-----SNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH- 98 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCC-----chHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC-
Confidence 3477788999999999999987 4778999998754221 2233456888999999999999999999998754
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
..++||||+. ++|.+++......+++..+..++.+|+.||.|||.++|+||||+|+||+++.++ .+||+|||++
T Consensus 99 -~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~----~~kl~dfg~~ 172 (317)
T cd06635 99 -TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG----QVKLADFGSA 172 (317)
T ss_pred -eEEEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCC----CEEEecCCCc
Confidence 7899999995 578887766667799999999999999999999999999999999999998876 5699999998
Q ss_pred ccccCcccccCcCCCCcccchhhhc
Q 000893 1200 KIKRNTLVTGGVRGTLPWMAPELLN 1224 (1236)
Q Consensus 1200 rii~ns~~tss~~GTp~YmAPEVL~ 1224 (1236)
...... ....|++.|+|||++.
T Consensus 173 ~~~~~~---~~~~~~~~y~aPE~~~ 194 (317)
T cd06635 173 SIASPA---NSFVGTPYWMAPEVIL 194 (317)
T ss_pred cccCCc---ccccCCccccChhhhh
Confidence 764332 3356889999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=209.02 Aligned_cols=165 Identities=29% Similarity=0.397 Sum_probs=133.3
Q ss_pred EEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHH-HhhCCCCceeeEeeeEecCCCCeEEE
Q 000893 1048 KELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI-LSKLHHPNVVAFYGVVQDGPGGTLAT 1124 (1236)
Q Consensus 1048 kkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrI-LskLrHPNIVrLyG~f~t~~~g~L~L 1124 (1236)
+.||.|+||.||+|.. .++.||||++.+.... .......+..|..+ ...++||||+++++++.... .+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~~~l 74 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMI-----AKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKD--YLYL 74 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhh-----HHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCC--eEEE
Confidence 5699999999999988 4788999998754221 11222334455544 44568999999999998754 8999
Q ss_pred EEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcccccC
Q 000893 1125 VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 1204 (1236)
Q Consensus 1125 VMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~n 1204 (1236)
||||+++++|..++... ..+++..+..++.||+.||.|||+.+|+||||+|+|||++.++ .+||+|||+++....
T Consensus 75 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~----~~~l~dfg~~~~~~~ 149 (260)
T cd05611 75 VMEYLNGGDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTG----HLKLTDFGLSRNGLE 149 (260)
T ss_pred EEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC----cEEEeecccceeccc
Confidence 99999999999998643 4688999999999999999999999999999999999999876 579999999886433
Q ss_pred cccccCcCCCCcccchhhhcCCC
Q 000893 1205 TLVTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1205 s~~tss~~GTp~YmAPEVL~Gss 1227 (1236)
.....|++.|+|||++.+..
T Consensus 150 ---~~~~~~~~~y~~pe~~~~~~ 169 (260)
T cd05611 150 ---NKKFVGTPDYLAPETILGVG 169 (260)
T ss_pred ---cccCCCCcCccChhhhcCCC
Confidence 23456889999999998764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.3e-23 Score=222.85 Aligned_cols=172 Identities=28% Similarity=0.416 Sum_probs=141.0
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecC--
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG-- 1117 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~-- 1117 (1236)
++|++.+.||+|+||.||+|.. ++..||||++..... .......+.+|+.+|+.++||||++++++|...
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 78 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD------VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGA 78 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc------cccchHHHHHHHHHHHhcCCCCccCHHHhccccCC
Confidence 6899999999999999999987 478899999875421 112245567899999999999999999988643
Q ss_pred CCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEecc
Q 000893 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1236)
Q Consensus 1118 ~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFG 1197 (1236)
....+++||||+ +++|.+++... ..+++..++.++.||+.||.|||.++|+||||||+|||++.++ .+||+|||
T Consensus 79 ~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~----~~kl~dfg 152 (334)
T cd07855 79 DFKDVYVVMDLM-ESDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDC----ELRIGDFG 152 (334)
T ss_pred CCceEEEEEehh-hhhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC----cEEecccc
Confidence 234789999999 46898888543 4589999999999999999999999999999999999999886 56999999
Q ss_pred CcccccCcc-----cccCcCCCCcccchhhhcC
Q 000893 1198 LSKIKRNTL-----VTGGVRGTLPWMAPELLNG 1225 (1236)
Q Consensus 1198 LArii~ns~-----~tss~~GTp~YmAPEVL~G 1225 (1236)
++....... .....+|+..|+|||++.+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 185 (334)
T cd07855 153 MARGLSSSPTEHKYFMTEYVATRWYRAPELLLS 185 (334)
T ss_pred cceeecccCcCCCcccccccccccccChHHhcC
Confidence 998653322 1134578999999999865
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.5e-23 Score=212.35 Aligned_cols=171 Identities=33% Similarity=0.487 Sum_probs=135.7
Q ss_pred EeccCCceEEEEeeecC--------ceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCC
Q 000893 1049 ELGSGTFGTVYHGKWRG--------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1049 kLGsGSFGtVYKArlkG--------~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g 1120 (1236)
.||+|+||.||+|+... ..||||.+.... .......|.+|+.+++.++||||++++++|....
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 72 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-------TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNE-- 72 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc-------chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCC--
Confidence 58999999999998742 469999886431 1122456888999999999999999999988754
Q ss_pred eEEEEEeeccCCCHHHHHhhh------ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCC-CCCCcEEE
Q 000893 1121 TLATVTEFMVNGSLRHVLLSK------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKD-PIRPICKV 1193 (1236)
Q Consensus 1121 ~L~LVMEYm~GGSL~dlL~~k------~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG-~I~ltVKL 1193 (1236)
..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+++|+||||+|||++.++ .....+||
T Consensus 73 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l 152 (269)
T cd05044 73 PQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKI 152 (269)
T ss_pred CeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEE
Confidence 789999999999999999653 23478889999999999999999999999999999999998764 11236799
Q ss_pred EeccCcccccCccc---ccCcCCCCcccchhhhcCCCC
Q 000893 1194 GDFGLSKIKRNTLV---TGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1194 sDFGLArii~ns~~---tss~~GTp~YmAPEVL~Gss~ 1228 (1236)
+|||+++....... .....++..|+|||++.+...
T Consensus 153 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 190 (269)
T cd05044 153 GDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKF 190 (269)
T ss_pred CCcccccccccccccccCcccCCCccccCHHHHccCCc
Confidence 99999986533221 122345788999999986543
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=221.64 Aligned_cols=172 Identities=28% Similarity=0.373 Sum_probs=140.8
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
.+|.+++.||+|+||+||+++. +++.||||.++.... .......+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~ 78 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD------NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHR 78 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc------ccchhHHHHHHHHHHHhcCCCCccchHHheecccc
Confidence 4799999999999999999987 478899999875421 11123456789999999999999999998865421
Q ss_pred ---CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEec
Q 000893 1120 ---GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1236)
Q Consensus 1120 ---g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDF 1196 (1236)
..+++||||+ +++|.+++.. ...+++..++.++.||+.||.|||+++++||||||+|||++.++ .+||+||
T Consensus 79 ~~~~~~~lv~e~~-~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~----~~kL~Df 152 (337)
T cd07858 79 EAFNDVYIVYELM-DTDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC----DLKICDF 152 (337)
T ss_pred cccCcEEEEEeCC-CCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC----CEEECcC
Confidence 3589999999 5788888854 35689999999999999999999999999999999999999876 5699999
Q ss_pred cCcccccCc-ccccCcCCCCcccchhhhcC
Q 000893 1197 GLSKIKRNT-LVTGGVRGTLPWMAPELLNG 1225 (1236)
Q Consensus 1197 GLArii~ns-~~tss~~GTp~YmAPEVL~G 1225 (1236)
|+++..... .......++..|+|||++.+
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 182 (337)
T cd07858 153 GLARTTSEKGDFMTEYVVTRWYRAPELLLN 182 (337)
T ss_pred ccccccCCCcccccccccccCccChHHHhc
Confidence 999875433 22334568899999999864
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-23 Score=243.09 Aligned_cols=182 Identities=31% Similarity=0.510 Sum_probs=150.4
Q ss_pred ccccCeeEEEEeccCCceEEEEeeec----Cc--eEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEee
Q 000893 1039 IKNEDLEELKELGSGTFGTVYHGKWR----GT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 1112 (1236)
Q Consensus 1039 Is~EdYeiLkkLGsGSFGtVYKArlk----G~--~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG 1112 (1236)
+..+...+.++||.|-||.||+|.++ |. .||||.++...- ......|+.|+.+|++++|||||+|+|
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t-------~d~tekflqEa~iMrnfdHphIikLIG 458 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT-------PDDTEKFLQEASIMRNFDHPHIIKLIG 458 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC-------hhhHHHHHHHHHHHHhCCCcchhheee
Confidence 34455667788999999999999984 22 399999987531 222567999999999999999999999
Q ss_pred eEecCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEE
Q 000893 1113 VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 1192 (1236)
Q Consensus 1113 ~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVK 1192 (1236)
+|.+. ..|||||.++-|-|..+|+.....++......+++||+.||.|||+..+|||||..+|||+.... .||
T Consensus 459 v~~e~---P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~----CVK 531 (974)
T KOG4257|consen 459 VCVEQ---PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQ----CVK 531 (974)
T ss_pred eeecc---ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcc----eee
Confidence 99974 69999999999999999988888899999999999999999999999999999999999999875 679
Q ss_pred EEeccCcccccCcccccCcCC--CCcccchhhhcCC-CCCCCccc
Q 000893 1193 VGDFGLSKIKRNTLVTGGVRG--TLPWMAPELLNGS-SSKVSEKV 1234 (1236)
Q Consensus 1193 LsDFGLArii~ns~~tss~~G--Tp~YmAPEVL~Gs-s~~~SdDV 1234 (1236)
|+||||+|.+.+........| ..-|||||-|.-. ....++.|
T Consensus 532 LaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVW 576 (974)
T KOG4257|consen 532 LADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVW 576 (974)
T ss_pred ecccchhhhccccchhhccccccceeecCccccchhcccchhhHH
Confidence 999999999877655433333 4569999999744 33444444
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.5e-22 Score=212.62 Aligned_cols=172 Identities=24% Similarity=0.451 Sum_probs=141.6
Q ss_pred CeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g 1120 (1236)
.|...+.||+|++|.||++.. .++.||||++.... ......+.+|+.+++.+.||||+++++++....
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--------~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~-- 89 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--------QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGD-- 89 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--------hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCC--
Confidence 455567899999999999987 46789999886431 122345788999999999999999999988754
Q ss_pred eEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcc
Q 000893 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1236)
Q Consensus 1121 ~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLAr 1200 (1236)
..++|+||+.+++|.+++.. ..+++..++.++.|++.||+|||++||+||||+|+||+++.++ .++|+|||++.
T Consensus 90 ~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~----~~~l~d~g~~~ 163 (285)
T cd06648 90 ELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDG----RVKLSDFGFCA 163 (285)
T ss_pred eEEEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCC----cEEEcccccch
Confidence 88999999999999999865 4688999999999999999999999999999999999999876 57999999887
Q ss_pred cccCcc-cccCcCCCCcccchhhhcCCCCCC
Q 000893 1201 IKRNTL-VTGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1201 ii~ns~-~tss~~GTp~YmAPEVL~Gss~~~ 1230 (1236)
...... ......|++.|+|||++.+.....
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 194 (285)
T cd06648 164 QVSKEVPRRKSLVGTPYWMAPEVISRLPYGT 194 (285)
T ss_pred hhccCCcccccccCCccccCHHHhcCCCCCC
Confidence 654322 223456899999999998764333
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-22 Score=209.56 Aligned_cols=175 Identities=31% Similarity=0.418 Sum_probs=137.1
Q ss_pred eeEEEEeccCCceEEEEeeec-----CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCC
Q 000893 1044 LEELKELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1044 YeiLkkLGsGSFGtVYKArlk-----G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~ 1118 (1236)
|.+.+.||+|+||.||+|.++ +..||||+++.... ......++.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 74 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF------SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSR 74 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC------ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 456788999999999999863 57799999875421 1223456889999999999999999999886532
Q ss_pred C----CeEEEEEeeccCCCHHHHHhhh-----ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCC
Q 000893 1119 G----GTLATVTEFMVNGSLRHVLLSK-----ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP 1189 (1236)
Q Consensus 1119 ~----g~L~LVMEYm~GGSL~dlL~~k-----~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~l 1189 (1236)
. ...++++||+.+++|..++... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++
T Consensus 75 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~---- 150 (273)
T cd05074 75 AKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENM---- 150 (273)
T ss_pred CCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCC----
Confidence 1 1347899999999999887532 12478888999999999999999999999999999999998765
Q ss_pred cEEEEeccCcccccCcc---cccCcCCCCcccchhhhcCCCC
Q 000893 1190 ICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1190 tVKLsDFGLArii~ns~---~tss~~GTp~YmAPEVL~Gss~ 1228 (1236)
.+||+|||+++...... ......+++.|++||.+.+...
T Consensus 151 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~ 192 (273)
T cd05074 151 TVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVY 192 (273)
T ss_pred CEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCcc
Confidence 57999999998653322 1122345678999999876543
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.7e-22 Score=208.47 Aligned_cols=174 Identities=34% Similarity=0.437 Sum_probs=138.8
Q ss_pred eeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhC---CCCceeeEeeeEecCC
Q 000893 1044 LEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL---HHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1044 YeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskL---rHPNIVrLyG~f~t~~ 1118 (1236)
|++.+.||+|+||.||+|+++ ++.||||+++.... .......+.+|+.+++.+ +||||+++++++....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 74 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS------EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPR 74 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc------cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeecc
Confidence 678899999999999999984 78899999975421 111123455677766655 6999999999998754
Q ss_pred C---CeEEEEEeeccCCCHHHHHhhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEE
Q 000893 1119 G---GTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1236)
Q Consensus 1119 ~---g~L~LVMEYm~GGSL~dlL~~k~-r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLs 1194 (1236)
. ..++++|||+. ++|.+++.... ..+++..++.++.|++.||.|||+++|+|+||+|+|||++.++ .+||+
T Consensus 75 ~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~----~~~l~ 149 (287)
T cd07838 75 TDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDG----QVKIA 149 (287)
T ss_pred CCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCC----CEEEe
Confidence 1 23899999995 58888886543 3689999999999999999999999999999999999999886 67999
Q ss_pred eccCcccccCcccccCcCCCCcccchhhhcCCCC
Q 000893 1195 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1195 DFGLArii~ns~~tss~~GTp~YmAPEVL~Gss~ 1228 (1236)
|||++.............++..|+|||++.+...
T Consensus 150 dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~ 183 (287)
T cd07838 150 DFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSY 183 (287)
T ss_pred ccCcceeccCCcccccccccccccChHHhccCCC
Confidence 9999987654443344567899999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.3e-23 Score=233.22 Aligned_cols=171 Identities=31% Similarity=0.500 Sum_probs=143.5
Q ss_pred ccccCeeEEEEeccCCceEEEEeeecCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhh--CCCCceeeEeeeEec
Q 000893 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK--LHHPNVVAFYGVVQD 1116 (1236)
Q Consensus 1039 Is~EdYeiLkkLGsGSFGtVYKArlkG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILsk--LrHPNIVrLyG~f~t 1116 (1236)
....+.++.+.||+|.||.||+|+|+|..||||++... . ...+.+|.+|... |+|+||+.+++.-..
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~sr--------d---E~SWfrEtEIYqTvmLRHENILgFIaaD~~ 276 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSR--------D---ERSWFRETEIYQTVMLRHENILGFIAADNK 276 (513)
T ss_pred hhhheeEEEEEecCccccceeeccccCCceEEEEeccc--------c---hhhhhhHHHHHHHHHhccchhhhhhhcccc
Confidence 34567899999999999999999999999999999642 1 2357788888885 699999999986443
Q ss_pred CC--CCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHH--------CCcccCCCCCCcEEEccCCC
Q 000893 1117 GP--GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS--------KNIVHFDLKCDNLLVNLKDP 1186 (1236)
Q Consensus 1117 ~~--~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHS--------kGIIHRDIKPsNILLDsdG~ 1186 (1236)
.. -..+|||++|-+.|+|.++|.+ ..++....+.++.-++.||+|||. ..|.|||||.+|||+.+++
T Consensus 277 ~~gs~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~- 353 (513)
T KOG2052|consen 277 DNGSWTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG- 353 (513)
T ss_pred CCCceEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC-
Confidence 22 2489999999999999999954 578999999999999999999995 2599999999999999987
Q ss_pred CCCcEEEEeccCcccccCcc-----cccCcCCCCcccchhhhcCC
Q 000893 1187 IRPICKVGDFGLSKIKRNTL-----VTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1187 I~ltVKLsDFGLArii~ns~-----~tss~~GTp~YmAPEVL~Gs 1226 (1236)
++.|+|+|||-...... .....+||-.|||||+|...
T Consensus 354 ---~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdet 395 (513)
T KOG2052|consen 354 ---TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDET 395 (513)
T ss_pred ---cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhh
Confidence 78999999998754332 23456899999999999754
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.2e-22 Score=219.76 Aligned_cols=170 Identities=28% Similarity=0.426 Sum_probs=140.7
Q ss_pred ccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCC
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1041 ~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~ 1118 (1236)
.++|++++.||+|+||.||++.. .+..||||++..... .......+.+|+.+|+.++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ------SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDL 87 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc------chHHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence 46799999999999999999987 478899999864321 2223456778999999999999999999987643
Q ss_pred C----CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEE
Q 000893 1119 G----GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1236)
Q Consensus 1119 ~----g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLs 1194 (1236)
. ..+++||||+ +++|..++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+
T Consensus 88 ~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~----~~kl~ 160 (343)
T cd07880 88 SLDRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDC----ELKIL 160 (343)
T ss_pred cccccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC----CEEEe
Confidence 2 2468999999 8899888743 4689999999999999999999999999999999999999876 56999
Q ss_pred eccCcccccCcccccCcCCCCcccchhhhcC
Q 000893 1195 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNG 1225 (1236)
Q Consensus 1195 DFGLArii~ns~~tss~~GTp~YmAPEVL~G 1225 (1236)
|||++...... .....+++.|+|||++.+
T Consensus 161 dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~ 189 (343)
T cd07880 161 DFGLARQTDSE--MTGYVVTRWYRAPEVILN 189 (343)
T ss_pred ecccccccccC--ccccccCCcccCHHHHhC
Confidence 99999865432 233567899999999875
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=212.27 Aligned_cols=170 Identities=32% Similarity=0.450 Sum_probs=139.3
Q ss_pred eeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCe
Q 000893 1044 LEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGT 1121 (1236)
Q Consensus 1044 YeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~ 1121 (1236)
|++++.||.|++|.||+|.+ .++.||||++...... ......+.+|+.+++.++||||+++++++... ..
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~--~~ 72 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED------EGVPSTAIREISLLKELNHPNIVRLLDVVHSE--NK 72 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc------ccchhHHHHHHHHHHhcCCCCccCHhheeccC--Ce
Confidence 56788999999999999987 4888999998754321 11234577899999999999999999999875 48
Q ss_pred EEEEEeeccCCCHHHHHhhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcc
Q 000893 1122 LATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1236)
Q Consensus 1122 L~LVMEYm~GGSL~dlL~~k~-r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLAr 1200 (1236)
.++||||+ +++|..++.... ..+++..++.++.|++.||.|||+++++||||+|+||+++.++ .++|+|||+++
T Consensus 73 ~~iv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~----~~~l~df~~~~ 147 (283)
T cd07835 73 LYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREG----ALKLADFGLAR 147 (283)
T ss_pred EEEEEecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC----cEEEeeccccc
Confidence 99999999 578999886543 3689999999999999999999999999999999999999876 57999999997
Q ss_pred cccCcc-cccCcCCCCcccchhhhcCC
Q 000893 1201 IKRNTL-VTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1201 ii~ns~-~tss~~GTp~YmAPEVL~Gs 1226 (1236)
...... ......+++.|+|||++.+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~aPE~~~~~ 174 (283)
T cd07835 148 AFGVPVRTYTHEVVTLWYRAPEILLGS 174 (283)
T ss_pred ccCCCccccCccccccCCCCCceeecC
Confidence 643221 12233568899999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-22 Score=214.84 Aligned_cols=174 Identities=20% Similarity=0.231 Sum_probs=138.7
Q ss_pred EEEEeccCCceEEEEeeecCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeEEEE
Q 000893 1046 ELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATV 1125 (1236)
Q Consensus 1046 iLkkLGsGSFGtVYKArlkG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L~LV 1125 (1236)
+.+.+|.|+++.||+++.+++.||||++..... .......+.+|+.+++.++||||+++++++.... ..+++
T Consensus 6 i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~------~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~--~~~~~ 77 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSC------SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDS--ELYVV 77 (314)
T ss_pred hhHhhcCCceEEEEEecCCCCEEEEEEEecccc------chhHHHHHHHHHHHHHhcCCcchhhhhheeecCC--eEEEE
Confidence 344566677777777777899999999976421 1223557889999999999999999999998754 88999
Q ss_pred EeeccCCCHHHHHhhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcccccC
Q 000893 1126 TEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 1204 (1236)
Q Consensus 1126 MEYm~GGSL~dlL~~k-~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~n 1204 (1236)
|||+++++|.+++... ...+++..+..++.|++.||.|||+++|+||||||+|||++.++ .+||+|||.+.....
T Consensus 78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~----~~kl~d~~~~~~~~~ 153 (314)
T cd08216 78 SPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDG----KVVLSGLRYSVSMIK 153 (314)
T ss_pred EeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCC----ceEEecCccceeecc
Confidence 9999999999998754 34688999999999999999999999999999999999999876 569999998875422
Q ss_pred cc--------cccCcCCCCcccchhhhcCCCCCCC
Q 000893 1205 TL--------VTGGVRGTLPWMAPELLNGSSSKVS 1231 (1236)
Q Consensus 1205 s~--------~tss~~GTp~YmAPEVL~Gss~~~S 1231 (1236)
.. ......++..|+|||++.+....++
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 188 (314)
T cd08216 154 HGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYN 188 (314)
T ss_pred ccccccccccccccccccccccCHHHhcCCCCCCC
Confidence 11 1223457788999999976533333
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.2e-23 Score=240.21 Aligned_cols=182 Identities=25% Similarity=0.331 Sum_probs=151.6
Q ss_pred cCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCC---CCceeeEeeeEec
Q 000893 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH---HPNVVAFYGVVQD 1116 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLr---HPNIVrLyG~f~t 1116 (1236)
.+|..+++||.|+||+|++|.++ ...|+||.|.+..+.-+.=.+++..-..-.|+.||..|+ |+||++++++|.+
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 47899999999999999999995 456999999887654333222233334456999999998 9999999999998
Q ss_pred CCCCeEEEEEeec-cCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEe
Q 000893 1117 GPGGTLATVTEFM-VNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1236)
Q Consensus 1117 ~~~g~L~LVMEYm-~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsD 1195 (1236)
.. ++||+||-- ++.+|.+++.. ...+++.+++.|+.||+.|+++||.+||||||||-+|++++.+| .+||+|
T Consensus 641 dd--~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g----~~klid 713 (772)
T KOG1152|consen 641 DD--YYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNG----FVKLID 713 (772)
T ss_pred CC--eeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCC----eEEEee
Confidence 54 999999976 45688888854 45699999999999999999999999999999999999999998 679999
Q ss_pred ccCcccccCcccccCcCCCCcccchhhhcCCCCCCC
Q 000893 1196 FGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVS 1231 (1236)
Q Consensus 1196 FGLArii~ns~~tss~~GTp~YmAPEVL~Gss~~~S 1231 (1236)
||.|....+... -.++||..|+|||++.|+.+...
T Consensus 714 fgsaa~~ksgpf-d~f~gtv~~aapevl~g~~y~gk 748 (772)
T KOG1152|consen 714 FGSAAYTKSGPF-DVFVGTVDYAAPEVLGGEKYLGK 748 (772)
T ss_pred ccchhhhcCCCc-ceeeeeccccchhhhCCCccCCC
Confidence 999988766654 34889999999999999866544
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.9e-24 Score=231.90 Aligned_cols=185 Identities=29% Similarity=0.425 Sum_probs=149.8
Q ss_pred cCeeEEEEeccCCceEEEEeeec------CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEe
Q 000893 1042 EDLEELKELGSGTFGTVYHGKWR------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 1115 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArlk------G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~ 1115 (1236)
..|+.+..||+|+||.||+|..+ ...+|||.++...- ....-...+||+.+++.++||||+.|..+|.
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd------~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl 97 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD------GTGISMSACREIALLRELKHPNVISLVKVFL 97 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC------CCCcCHHHHHHHHHHHHhcCCcchhHHHHHh
Confidence 57888999999999999999652 23589999875421 1112335678999999999999999999988
Q ss_pred cCCCCeEEEEEeeccCCCHHHHHhh----hccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcE
Q 000893 1116 DGPGGTLATVTEFMVNGSLRHVLLS----KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 1191 (1236)
Q Consensus 1116 t~~~g~L~LVMEYm~GGSL~dlL~~----k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltV 1191 (1236)
.. +..+++++||+ .-+|.++++- ..+.++...++.|+.||+.|+.|||++=|+||||||.||||..++..+..|
T Consensus 98 ~~-d~~v~l~fdYA-EhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~V 175 (438)
T KOG0666|consen 98 SH-DKKVWLLFDYA-EHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRV 175 (438)
T ss_pred cc-CceEEEEehhh-hhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCee
Confidence 75 46999999998 5577777743 235788999999999999999999999999999999999999998777799
Q ss_pred EEEeccCcccccCcccc----cCcCCCCcccchhhhcCCCCCCCcccc
Q 000893 1192 KVGDFGLSKIKRNTLVT----GGVRGTLPWMAPELLNGSSSKVSEKVC 1235 (1236)
Q Consensus 1192 KLsDFGLArii~ns~~t----ss~~GTp~YmAPEVL~Gss~~~SdDVD 1235 (1236)
||+|||++|++.+.... ...+-|.||+|||.+.|.. .|+..+|
T Consensus 176 KIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~-hYT~AiD 222 (438)
T KOG0666|consen 176 KIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGAR-HYTKAID 222 (438)
T ss_pred EeecccHHHHhhccccccccCCceEEEEEecChHHhcccc-cccchhh
Confidence 99999999997654322 2456799999999999974 4444444
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-22 Score=218.43 Aligned_cols=176 Identities=22% Similarity=0.315 Sum_probs=137.2
Q ss_pred EEeccC--CceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeEE
Q 000893 1048 KELGSG--TFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLA 1123 (1236)
Q Consensus 1048 kkLGsG--SFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L~ 1123 (1236)
..||+| +||+||++++ .++.||||++..... .......+.+|+.+++.++||||++++++|.... .++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~--~~~ 75 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC------TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGS--WLW 75 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC------CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCC--ceE
Confidence 346666 9999999988 588999999875321 1223467888999999999999999999998854 889
Q ss_pred EEEeeccCCCHHHHHhhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcccc
Q 000893 1124 TVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 1202 (1236)
Q Consensus 1124 LVMEYm~GGSL~dlL~~k-~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii 1202 (1236)
+||||+.+++|.+++... ...+++..+..++.||+.||+|||+++|+||||||+|||++.++ .+|++||+.+...
T Consensus 76 ~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~----~~~~~~~~~~~~~ 151 (328)
T cd08226 76 VISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDG----LVSLSGLSHLYSL 151 (328)
T ss_pred EEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCC----cEEEechHHHhhh
Confidence 999999999999988654 24588999999999999999999999999999999999999876 5699999865432
Q ss_pred cCcc--------cccCcCCCCcccchhhhcCCCCCCCcccc
Q 000893 1203 RNTL--------VTGGVRGTLPWMAPELLNGSSSKVSEKVC 1235 (1236)
Q Consensus 1203 ~ns~--------~tss~~GTp~YmAPEVL~Gss~~~SdDVD 1235 (1236)
.... ......++..|+|||++.+....++..+|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~D 192 (328)
T cd08226 152 VRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSD 192 (328)
T ss_pred hccCccccccccccccccCccCccChhhhcCCCCCCCchhh
Confidence 1110 01112346679999999876444444444
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-22 Score=218.35 Aligned_cols=172 Identities=31% Similarity=0.380 Sum_probs=143.0
Q ss_pred CeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCC--
Q 000893 1043 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP-- 1118 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~-- 1118 (1236)
+|++.+.||.|+||.||+|+.. +..||||++..... .......+.+|+.+++.++||||+++++++....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD------DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPE 74 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc------cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcc
Confidence 5788999999999999999974 68899999875421 1233456888999999999999999999987642
Q ss_pred -CCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEecc
Q 000893 1119 -GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1236)
Q Consensus 1119 -~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFG 1197 (1236)
...+++||||+. ++|..++... ..+++..++.++.||+.||+|||++||+||||||.|||++.++ .++|+|||
T Consensus 75 ~~~~~~lv~e~~~-~~l~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~----~~~L~dfg 148 (330)
T cd07834 75 DFNDVYIVTELME-TDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNC----DLKICDFG 148 (330)
T ss_pred cccceEEEecchh-hhHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC----CEEEcccC
Confidence 236899999996 5888888543 3799999999999999999999999999999999999999886 67999999
Q ss_pred CcccccCcc----cccCcCCCCcccchhhhcCC
Q 000893 1198 LSKIKRNTL----VTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1198 LArii~ns~----~tss~~GTp~YmAPEVL~Gs 1226 (1236)
++....... ......+++.|+|||++.+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 181 (330)
T cd07834 149 LARGVDPDEDEKGFLTEYVVTRWYRAPELLLSS 181 (330)
T ss_pred ceEeecccccccccccccccccCcCCceeeecc
Confidence 998765442 23345689999999999876
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.8e-22 Score=209.91 Aligned_cols=171 Identities=31% Similarity=0.509 Sum_probs=144.7
Q ss_pred cCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
+.|+..+.||+|+||.||++.+. +..||+|++..... ....+.+|+.+++.++|+||+++++++....
T Consensus 19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 88 (286)
T cd06614 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---------NKELIINEILIMKDCKHPNIVDYYDSYLVGD- 88 (286)
T ss_pred ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---------hHHHHHHHHHHHHHCCCCCeeEEEEEEEECC-
Confidence 45777888999999999999985 78899999975321 3456788999999999999999999998864
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
..++|+||+++++|.+++......+++..+..++.|++.||.|||..||+|+||+|+||+++.++ .++|+|||++
T Consensus 89 -~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~----~~~l~d~~~~ 163 (286)
T cd06614 89 -ELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDG----SVKLADFGFA 163 (286)
T ss_pred -EEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCC----CEEECccchh
Confidence 89999999999999999976555799999999999999999999999999999999999999876 5699999998
Q ss_pred ccccCcc-cccCcCCCCcccchhhhcCCC
Q 000893 1200 KIKRNTL-VTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1200 rii~ns~-~tss~~GTp~YmAPEVL~Gss 1227 (1236)
....... ......+++.|+|||++.+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~ 192 (286)
T cd06614 164 AQLTKEKSKRNSVVGTPYWMAPEVIKRKD 192 (286)
T ss_pred hhhccchhhhccccCCcccCCHhHhcCCC
Confidence 7643221 223345788999999997653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.8e-22 Score=212.97 Aligned_cols=166 Identities=30% Similarity=0.472 Sum_probs=139.0
Q ss_pred eeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCe
Q 000893 1044 LEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGT 1121 (1236)
Q Consensus 1044 YeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~ 1121 (1236)
|..+++||+|+||+||+|+. .+..||||++...... .......+.+|+.+++.++||||+++++++.+.. .
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~ 95 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQ-----TNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEH--T 95 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccC-----chHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCC--E
Confidence 66678899999999999987 5788999998754221 2233456788999999999999999999998864 8
Q ss_pred EEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCccc
Q 000893 1122 LATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201 (1236)
Q Consensus 1122 L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLAri 1201 (1236)
.++||||+ .++|..++......+++..++.++.||+.||.|||++||+||||+|+||+++.++ .+||+|||++..
T Consensus 96 ~~lv~e~~-~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~----~~kL~dfg~~~~ 170 (313)
T cd06633 96 AWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG----QVKLADFGSASK 170 (313)
T ss_pred EEEEEecC-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCC----CEEEeecCCCcc
Confidence 89999999 4678887766666789999999999999999999999999999999999998876 569999999865
Q ss_pred ccCcccccCcCCCCcccchhhhc
Q 000893 1202 KRNTLVTGGVRGTLPWMAPELLN 1224 (1236)
Q Consensus 1202 i~ns~~tss~~GTp~YmAPEVL~ 1224 (1236)
... .....|+..|+|||++.
T Consensus 171 ~~~---~~~~~~~~~y~aPE~~~ 190 (313)
T cd06633 171 SSP---ANSFVGTPYWMAPEVIL 190 (313)
T ss_pred cCC---CCCccccccccChhhcc
Confidence 322 23456899999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.2e-24 Score=244.74 Aligned_cols=183 Identities=26% Similarity=0.340 Sum_probs=159.6
Q ss_pred ccccCeeEEEEeccCCceEEEEeeecCce--EEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEec
Q 000893 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1236)
Q Consensus 1039 Is~EdYeiLkkLGsGSFGtVYKArlkG~~--VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t 1116 (1236)
+...+++++.-||-|+||.|=+++.++.. +|+|++++..+.... ...-+..|.++|..++.|+||+||..|.+
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtk-----QqeHv~sEr~Im~~~~s~fIvrLYrTfrd 491 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTK-----QQEHVFSERNIMMECRSDFIVRLYRTFRD 491 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchh-----HHHHHHhHHHHHHhcCchHHHHHHHHhcc
Confidence 34466777888999999999999887655 899999998776432 23345679999999999999999999998
Q ss_pred CCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEec
Q 000893 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1236)
Q Consensus 1117 ~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDF 1196 (1236)
.+ ++|++||-|-||.|-..|+.++ .++...++.|+..+++|++|||++|||+|||||+|+||+.+| .+||.||
T Consensus 492 ~k--yvYmLmEaClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~G----y~KLVDF 564 (732)
T KOG0614|consen 492 SK--YVYMLMEACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRG----YLKLVDF 564 (732)
T ss_pred ch--hhhhhHHhhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCC----ceEEeeh
Confidence 65 9999999999999999997654 578888888899999999999999999999999999999988 5699999
Q ss_pred cCcccccCcccccCcCCCCcccchhhhcCCCCCCCcc
Q 000893 1197 GLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEK 1233 (1236)
Q Consensus 1197 GLArii~ns~~tss~~GTp~YmAPEVL~Gss~~~SdD 1233 (1236)
|+|+.+.....+-++||||.|.|||+|.+..+..+.|
T Consensus 565 GFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avD 601 (732)
T KOG0614|consen 565 GFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVD 601 (732)
T ss_pred hhHHHhccCCceeeecCCcccccchhhhccCcchhhH
Confidence 9999999888888999999999999999887766654
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.8e-22 Score=217.31 Aligned_cols=170 Identities=27% Similarity=0.403 Sum_probs=139.3
Q ss_pred ccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCC
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1041 ~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~ 1118 (1236)
.++|++.+.||+|+||.||++.. +++.||||+++.... .......+.+|+.++++++||||+++++++....
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ------SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch------hhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 47899999999999999999986 478899999875321 1222445778999999999999999999886432
Q ss_pred ----CCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEE
Q 000893 1119 ----GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1236)
Q Consensus 1119 ----~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLs 1194 (1236)
....+++++++ +++|..++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~----~~kl~ 162 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC----ELKIL 162 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCC----CEEEe
Confidence 13578888887 8899887743 3589999999999999999999999999999999999999886 57999
Q ss_pred eccCcccccCcccccCcCCCCcccchhhhcC
Q 000893 1195 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNG 1225 (1236)
Q Consensus 1195 DFGLArii~ns~~tss~~GTp~YmAPEVL~G 1225 (1236)
|||+++..... .....+++.|+|||++.+
T Consensus 163 dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~ 191 (345)
T cd07877 163 DFGLARHTDDE--MTGYVATRWYRAPEIMLN 191 (345)
T ss_pred ccccccccccc--ccccccCCCccCHHHHhC
Confidence 99998865332 234568999999999865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=3e-22 Score=208.79 Aligned_cols=170 Identities=33% Similarity=0.477 Sum_probs=141.8
Q ss_pred eeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCe
Q 000893 1044 LEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGT 1121 (1236)
Q Consensus 1044 YeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~ 1121 (1236)
|++.+.||.|++|.||++.. .++.+|+|.++..... ......+.+|+.+++.++|+||+++++++... ..
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~ 72 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES------EGIPKTALREIKLLKELNHPNIIKLLDVFRHK--GD 72 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc------chhHHHHHHHHHHHHHhcCCCcchHHHhhccC--CC
Confidence 45678899999999999987 4778999998754321 12345677899999999999999999998875 48
Q ss_pred EEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCccc
Q 000893 1122 LATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201 (1236)
Q Consensus 1122 L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLAri 1201 (1236)
+++||||+. ++|.+++......+++..++.++.||+.||.|||.++|+|+||||+||+++.++ .+||+|||.+..
T Consensus 73 ~~~v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~----~~~l~df~~~~~ 147 (283)
T cd05118 73 LYLVFEFMD-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEG----VLKLADFGLARS 147 (283)
T ss_pred EEEEEeccC-CCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCC----cEEEeeeeeeEe
Confidence 999999995 588888877667899999999999999999999999999999999999999876 579999999887
Q ss_pred ccCcc-cccCcCCCCcccchhhhcCC
Q 000893 1202 KRNTL-VTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1202 i~ns~-~tss~~GTp~YmAPEVL~Gs 1226 (1236)
..... ......++..|+|||.+.+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~PE~~~~~ 173 (283)
T cd05118 148 FGSPVRPYTHYVVTRWYRAPELLLGD 173 (283)
T ss_pred cCCCcccccCccCcccccCcHHHhcC
Confidence 65433 22335578899999999764
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-22 Score=207.98 Aligned_cols=175 Identities=27% Similarity=0.425 Sum_probs=139.7
Q ss_pred CeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g 1120 (1236)
+|.+.+.||+|+||+||++++. +..+++|+++........ ......+.+|+.+++.++||||+++++++....
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELN---PNETVQANQEAQLLSKLDHPAIVKFHASFLERD-- 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccC---cchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC--
Confidence 4788899999999999999885 345677776643321111 112334667999999999999999999988754
Q ss_pred eEEEEEeeccCCCHHHHHhh---hccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEecc
Q 000893 1121 TLATVTEFMVNGSLRHVLLS---KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1236)
Q Consensus 1121 ~L~LVMEYm~GGSL~dlL~~---k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFG 1197 (1236)
..++||||+++++|..++.. ....+++..++.++.|++.||.|||++|++|+||||+||+++.+ .+||+|||
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~-----~~~l~d~g 150 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN-----LLKIGDFG 150 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecC-----CEeecccC
Confidence 78999999999999998864 24568999999999999999999999999999999999999753 47999999
Q ss_pred CcccccCc-ccccCcCCCCcccchhhhcCCC
Q 000893 1198 LSKIKRNT-LVTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1198 LArii~ns-~~tss~~GTp~YmAPEVL~Gss 1227 (1236)
+++..... .......|++.|+|||++.+..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~ 181 (260)
T cd08222 151 VSRLLMGSCDLATTFTGTPYYMSPEALKHQG 181 (260)
T ss_pred ceeecCCCcccccCCCCCcCccCHHHHccCC
Confidence 98875432 2334466899999999987653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-23 Score=259.12 Aligned_cols=172 Identities=31% Similarity=0.456 Sum_probs=146.6
Q ss_pred CeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g 1120 (1236)
+|+....||.|.||+||-|.. +|...|+|.++..... .+....+.+|+.+|..|+|||||++||+-.+.+
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~------~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe-- 1307 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD------HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE-- 1307 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc------cccCcchHHHHHHHHhccCccccccCceeecHH--
Confidence 567778899999999999987 6888999998754321 334556788999999999999999999988755
Q ss_pred eEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcc
Q 000893 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1236)
Q Consensus 1121 ~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLAr 1200 (1236)
.++|.||||.+|+|.+++. .++..++.....+..|++.||.|||++|||||||||.||||+.+| .+|++|||.|.
T Consensus 1308 kv~IFMEyC~~GsLa~ll~-~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g----~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1308 KVYIFMEYCEGGSLASLLE-HGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNG----LIKYGDFGSAV 1382 (1509)
T ss_pred HHHHHHHHhccCcHHHHHH-hcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCC----cEEeeccccee
Confidence 7889999999999999984 566788888888999999999999999999999999999999987 67999999998
Q ss_pred cccCcc-----cccCcCCCCcccchhhhcCCC
Q 000893 1201 IKRNTL-----VTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1201 ii~ns~-----~tss~~GTp~YmAPEVL~Gss 1227 (1236)
.+.+.. -...+.||+.|||||+|.|..
T Consensus 1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~ 1414 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTK 1414 (1509)
T ss_pred EecCchhcCCHHHHhhcCCchhcCchhhcccc
Confidence 765542 123577999999999998764
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.6e-22 Score=211.72 Aligned_cols=183 Identities=19% Similarity=0.203 Sum_probs=130.4
Q ss_pred cccccCeeEEEEeccCCceEEEEeeecC-----ceEEEEeeeccccCCCChHHHHH------HHHHHHHHHHHhhCCCCc
Q 000893 1038 IIKNEDLEELKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERL------TLEFWREAEILSKLHHPN 1106 (1236)
Q Consensus 1038 iIs~EdYeiLkkLGsGSFGtVYKArlkG-----~~VAVKvLkk~~i~~~~~e~er~------~keFlrEIrILskLrHPN 1106 (1236)
.+...+|++.++||+|+||+||+|.+.+ ..+|+|+..... .....+.. ......+...+..+.|+|
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~---~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~ 84 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLEN---ETIVMETLVYNNIYDIDKIALWKNIHNIDHLG 84 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccC---CchhhHHHHHHhhhhHHHHHHHHHhccCCCCC
Confidence 3455789999999999999999999753 346777543221 11111110 112334455666788999
Q ss_pred eeeEeeeEecCCC--CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccC
Q 000893 1107 VVAFYGVVQDGPG--GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLK 1184 (1236)
Q Consensus 1107 IVrLyG~f~t~~~--g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsd 1184 (1236)
|+++++++..... ...+++||++ ..++..++.. ....++..++.|+.|++.||.|||+++|+||||||+|||++.+
T Consensus 85 i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 85 IPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGN 162 (294)
T ss_pred CCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 9999997665432 1346788877 4566666643 2346788889999999999999999999999999999999876
Q ss_pred CCCCCcEEEEeccCcccccCc--------ccccCcCCCCcccchhhhcCCCCC
Q 000893 1185 DPIRPICKVGDFGLSKIKRNT--------LVTGGVRGTLPWMAPELLNGSSSK 1229 (1236)
Q Consensus 1185 G~I~ltVKLsDFGLArii~ns--------~~tss~~GTp~YmAPEVL~Gss~~ 1229 (1236)
+ .+||+|||+|+..... .......||+.|+|||++.+....
T Consensus 163 ~----~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~ 211 (294)
T PHA02882 163 N----RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVT 211 (294)
T ss_pred C----cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCC
Confidence 5 5699999999865321 112235699999999999876443
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.2e-22 Score=207.53 Aligned_cols=170 Identities=34% Similarity=0.465 Sum_probs=141.3
Q ss_pred eeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCe
Q 000893 1044 LEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGT 1121 (1236)
Q Consensus 1044 YeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~ 1121 (1236)
|++.+.||+|.||.||+|+.. ++.||+|++..... .+.....+..|+.+++.++|+||+++++++... ..
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~ 72 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE------EEGIPSTALREISLLKELKHPNIVKLLDVIHTE--RK 72 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc------cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC--Cc
Confidence 566788999999999999984 78899999976431 122344567899999999999999999999875 48
Q ss_pred EEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCccc
Q 000893 1122 LATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201 (1236)
Q Consensus 1122 L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLAri 1201 (1236)
+++||||+. ++|.+++......+++..++.++.|++.||.|||.+||+||||+|+||+++.++ .+||+|||+++.
T Consensus 73 ~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~----~~~l~d~g~~~~ 147 (282)
T cd07829 73 LYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDG----VLKLADFGLARA 147 (282)
T ss_pred eEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCC----CEEEecCCcccc
Confidence 999999996 699999976655799999999999999999999999999999999999999876 679999999987
Q ss_pred ccCcc-cccCcCCCCcccchhhhcCC
Q 000893 1202 KRNTL-VTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1202 i~ns~-~tss~~GTp~YmAPEVL~Gs 1226 (1236)
..... ......++..|+|||++.+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~aPE~~~~~ 173 (282)
T cd07829 148 FGIPLRTYTHEVVTLWYRAPEILLGS 173 (282)
T ss_pred cCCCccccCccccCcCcCChHHhcCC
Confidence 54332 22334567889999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.9e-22 Score=214.58 Aligned_cols=171 Identities=29% Similarity=0.365 Sum_probs=136.6
Q ss_pred CeeEEEEeccCCceEEEEeeec----CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhC-CCCceeeEeeeEecC
Q 000893 1043 DLEELKELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDG 1117 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArlk----G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskL-rHPNIVrLyG~f~t~ 1117 (1236)
+|++.+.||+|+||.||+++.. +..||||++..... .......+.+|+.+++.+ .||||+++++.+...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 74 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS------KKILAKRALRELKLLRHFRGHKNITCLYDMDIVF 74 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc------cchhHHHHHHHHHHHHHhcCCCChheeeeeeeec
Confidence 4788999999999999999985 55799999864321 112244577899999998 599999999875432
Q ss_pred --CCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEe
Q 000893 1118 --PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1236)
Q Consensus 1118 --~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsD 1195 (1236)
....++++|||+ +++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 75 ~~~~~~~~~~~e~~-~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~----~~kl~D 148 (332)
T cd07857 75 PGNFNELYLYEELM-EADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADC----ELKICD 148 (332)
T ss_pred cccCCcEEEEEecc-cCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCC----CEEeCc
Confidence 224678899998 5789888854 45689999999999999999999999999999999999999876 569999
Q ss_pred ccCcccccCcc-----cccCcCCCCcccchhhhcC
Q 000893 1196 FGLSKIKRNTL-----VTGGVRGTLPWMAPELLNG 1225 (1236)
Q Consensus 1196 FGLArii~ns~-----~tss~~GTp~YmAPEVL~G 1225 (1236)
||+++...... ......||+.|+|||++.+
T Consensus 149 fg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 183 (332)
T cd07857 149 FGLARGFSENPGENAGFMTEYVATRWYRAPEIMLS 183 (332)
T ss_pred CCCceecccccccccccccCcccCccccCcHHHhC
Confidence 99998654221 1233578999999999865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.3e-22 Score=238.30 Aligned_cols=172 Identities=31% Similarity=0.479 Sum_probs=144.0
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhC-CCCceeeEeeeEecC-
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDG- 1117 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskL-rHPNIVrLyG~f~t~- 1117 (1236)
+.|++.+.||.|.+|+||+++. .++.+|||++.... +. ..++..|.++|+.+ .|||++.+||+|...
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~---d~------deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE---DE------EEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc---cc------cHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 4688899999999999999876 58889999987542 11 12344578888875 599999999998742
Q ss_pred --CCCeEEEEEeeccCCCHHHHHhhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEE
Q 000893 1118 --PGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1236)
Q Consensus 1118 --~~g~L~LVMEYm~GGSL~dlL~~k-~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLs 1194 (1236)
.++.+|||||||.+|+..+++... +..+.|..+.+|+++++.||.+||.+.+||||||-.|||++.++ .|||+
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~----~VKLv 165 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENA----EVKLV 165 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccC----cEEEe
Confidence 346999999999999999999653 56799999999999999999999999999999999999999998 56999
Q ss_pred eccCcccccCcc-cccCcCCCCcccchhhhcCC
Q 000893 1195 DFGLSKIKRNTL-VTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1195 DFGLArii~ns~-~tss~~GTp~YmAPEVL~Gs 1226 (1236)
|||++..+.... ...+.+|||.|||||++...
T Consensus 166 DFGvSaQldsT~grRnT~iGtP~WMAPEViac~ 198 (953)
T KOG0587|consen 166 DFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACD 198 (953)
T ss_pred eeeeeeeeecccccccCcCCCcccccceeeecc
Confidence 999988765443 44567899999999999754
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5e-22 Score=213.29 Aligned_cols=166 Identities=25% Similarity=0.437 Sum_probs=137.8
Q ss_pred EEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeEE
Q 000893 1046 ELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLA 1123 (1236)
Q Consensus 1046 iLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L~ 1123 (1236)
...+||+|+||.||++.. ++..||||++.... ......+.+|+.+++.++|+||++++++|...+ ..+
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~ 93 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--------QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD--ELW 93 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--------hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCC--EEE
Confidence 345699999999999987 47889999875321 123456888999999999999999999998754 899
Q ss_pred EEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCccccc
Q 000893 1124 TVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR 1203 (1236)
Q Consensus 1124 LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~ 1203 (1236)
+||||+++++|.+++.. ..+++..++.++.|++.||+|||++||+|+||+|+||+++.++ .++|+|||++....
T Consensus 94 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~----~~~l~dfg~~~~~~ 167 (292)
T cd06657 94 VVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDG----RVKLSDFGFCAQVS 167 (292)
T ss_pred EEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC----CEEEcccccceecc
Confidence 99999999999998743 4588999999999999999999999999999999999999876 56999999987654
Q ss_pred Ccc-cccCcCCCCcccchhhhcCCC
Q 000893 1204 NTL-VTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1204 ns~-~tss~~GTp~YmAPEVL~Gss 1227 (1236)
... ......|++.|+|||++.+..
T Consensus 168 ~~~~~~~~~~~~~~y~~pE~~~~~~ 192 (292)
T cd06657 168 KEVPRRKSLVGTPYWMAPELISRLP 192 (292)
T ss_pred cccccccccccCccccCHHHhcCCC
Confidence 322 223456899999999987653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.5e-22 Score=212.26 Aligned_cols=169 Identities=31% Similarity=0.513 Sum_probs=139.7
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
..|+..+.||+|+||.||+|+. .+..||||.+...... ......++.+|+.+++.++|+||+++++++....
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 88 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ-----SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH- 88 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEeccccc-----ChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCC-
Confidence 3467778899999999999998 4677999988643211 1223456788999999999999999999998754
Q ss_pred CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
..++||||+. ++|..++......+++..++.++.|++.||.|||+++++||||||+|||++.++ .+||+|||++
T Consensus 89 -~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~----~~kl~dfg~~ 162 (308)
T cd06634 89 -TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG----LVKLGDFGSA 162 (308)
T ss_pred -eeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCC----cEEECCcccc
Confidence 8899999995 688887766566789999999999999999999999999999999999998876 5799999998
Q ss_pred ccccCcccccCcCCCCcccchhhhcC
Q 000893 1200 KIKRNTLVTGGVRGTLPWMAPELLNG 1225 (1236)
Q Consensus 1200 rii~ns~~tss~~GTp~YmAPEVL~G 1225 (1236)
...... ....+++.|+|||++.+
T Consensus 163 ~~~~~~---~~~~~~~~y~aPE~~~~ 185 (308)
T cd06634 163 SIMAPA---NXFVGTPYWMAPEVILA 185 (308)
T ss_pred eeecCc---ccccCCccccCHHHHhh
Confidence 765432 23568899999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.5e-23 Score=232.47 Aligned_cols=191 Identities=28% Similarity=0.374 Sum_probs=154.6
Q ss_pred ccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccc-cCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecC
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSC-FTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1236)
Q Consensus 1041 ~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~-i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~ 1117 (1236)
.++|-++.+||+|+|+.||+|.+ ..+.||||+-.... +. ++..+...+-.++|.+|.+.|.||.||++|++|.-+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~Wr--dEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWR--DEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchh--hHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 46788889999999999999987 46779999865432 11 122234455678999999999999999999999765
Q ss_pred CCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCCCcEEEccCCCCCCcEEEEe
Q 000893 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK--NIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1236)
Q Consensus 1118 ~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSk--GIIHRDIKPsNILLDsdG~I~ltVKLsD 1195 (1236)
. ..+|.|+|||+|.+|+.+|.. .+.+++.+++.|+.||+.||.||.+. .|||-||||.||||... ..+..+||+|
T Consensus 540 t-dsFCTVLEYceGNDLDFYLKQ-hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~G-tacGeIKITD 616 (775)
T KOG1151|consen 540 T-DSFCTVLEYCEGNDLDFYLKQ-HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNG-TACGEIKITD 616 (775)
T ss_pred c-ccceeeeeecCCCchhHHHHh-hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecC-cccceeEeee
Confidence 3 578999999999999999954 45789999999999999999999974 69999999999999754 4446789999
Q ss_pred ccCcccccCcc--------cccCcCCCCcccchhhhc--CCCCCCCccccC
Q 000893 1196 FGLSKIKRNTL--------VTGGVRGTLPWMAPELLN--GSSSKVSEKVCF 1236 (1236)
Q Consensus 1196 FGLArii~ns~--------~tss~~GTp~YmAPEVL~--Gss~~~SdDVDI 1236 (1236)
|||+++++... .+....||+||++||.|. ..+...+.++|+
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDV 667 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDV 667 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceee
Confidence 99999975432 345578999999999996 336677777764
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.1e-22 Score=214.39 Aligned_cols=177 Identities=28% Similarity=0.405 Sum_probs=137.8
Q ss_pred cCee-EEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHH------HHHHHHHHHHHHHhhCCCCceeeEee
Q 000893 1042 EDLE-ELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQE------RLTLEFWREAEILSKLHHPNVVAFYG 1112 (1236)
Q Consensus 1042 EdYe-iLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~e------r~~keFlrEIrILskLrHPNIVrLyG 1112 (1236)
++|. +.+.||.|+||+||+|.+ .++.||||+++............ .....+.+|+.+++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3454 456799999999999987 47889999987643221000000 01124678999999999999999999
Q ss_pred eEecCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEE
Q 000893 1113 VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 1192 (1236)
Q Consensus 1113 ~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVK 1192 (1236)
++.... .+++||||+. ++|.+++.. ...+++...+.++.|++.||.|||++||+||||||+|||++.++ .+|
T Consensus 88 ~~~~~~--~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~----~~k 159 (335)
T PTZ00024 88 VYVEGD--FINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKG----ICK 159 (335)
T ss_pred EEecCC--cEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCC----CEE
Confidence 998754 8999999995 689888854 44689999999999999999999999999999999999999876 579
Q ss_pred EEeccCcccccC---------------cccccCcCCCCcccchhhhcCC
Q 000893 1193 VGDFGLSKIKRN---------------TLVTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1193 LsDFGLArii~n---------------s~~tss~~GTp~YmAPEVL~Gs 1226 (1236)
|+|||+++.... ........+++.|+|||++.+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 208 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA 208 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccC
Confidence 999999876541 1111234568899999999764
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=200.51 Aligned_cols=166 Identities=31% Similarity=0.428 Sum_probs=139.8
Q ss_pred eccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeEEEEEe
Q 000893 1050 LGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTE 1127 (1236)
Q Consensus 1050 LGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L~LVME 1127 (1236)
||.|+||.||++... ++.||+|++.+.... .......+..|+.+++.++||||+++++.+.... .+++|||
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~v~e 73 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKII-----KRKEVEHTLTERNILSRINHPFIVKLHYAFQTEE--KLYLVLE 73 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhc-----chHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCC--eeEEEEe
Confidence 689999999999984 788999998765322 1223556788999999999999999999988754 8999999
Q ss_pred eccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcccccCc-c
Q 000893 1128 FMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT-L 1206 (1236)
Q Consensus 1128 Ym~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~ns-~ 1206 (1236)
|+++++|.+++... ..+++..++.++.|++.||.|||.++++|+||+|.||+++.++ .++|+|||++...... .
T Consensus 74 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~----~~~l~d~~~~~~~~~~~~ 148 (250)
T cd05123 74 YAPGGELFSHLSKE-GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADG----HIKLTDFGLAKELSSEGS 148 (250)
T ss_pred cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCC----cEEEeecCcceecccCCC
Confidence 99999999998654 3689999999999999999999999999999999999999876 5699999999876443 2
Q ss_pred cccCcCCCCcccchhhhcCCC
Q 000893 1207 VTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1207 ~tss~~GTp~YmAPEVL~Gss 1227 (1236)
......++..|+|||.+.+..
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~~ 169 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGKG 169 (250)
T ss_pred cccCCcCCccccChHHhCCCC
Confidence 334566899999999998754
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=214.07 Aligned_cols=170 Identities=30% Similarity=0.448 Sum_probs=138.7
Q ss_pred cccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecC
Q 000893 1040 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1236)
Q Consensus 1040 s~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~ 1117 (1236)
..++|++++.||.|+||.||++.. +++.||||++.+.... ......+.+|+.+++.++||||++++++|...
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 81 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST------PVLAKRTYRELKLLKHLRHENIISLSDIFISP 81 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc------cchhHHHHHHHHHHHhcCCCCeeeEeeeEecC
Confidence 346799999999999999999986 4778999988654211 11234567899999999999999999998764
Q ss_pred CCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEecc
Q 000893 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1236)
Q Consensus 1118 ~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFG 1197 (1236)
. ...++||||+ +++|..++. ...+++..+..++.|++.||.|||+++|+||||+|+|||++.++ .+||+|||
T Consensus 82 ~-~~~~lv~e~~-~~~L~~~~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~----~~~l~dfg 153 (328)
T cd07856 82 L-EDIYFVTELL-GTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENC----DLKICDFG 153 (328)
T ss_pred C-CcEEEEeehh-ccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCC----CEEeCccc
Confidence 3 4788999998 678988874 34578888889999999999999999999999999999999775 57999999
Q ss_pred CcccccCcccccCcCCCCcccchhhhcC
Q 000893 1198 LSKIKRNTLVTGGVRGTLPWMAPELLNG 1225 (1236)
Q Consensus 1198 LArii~ns~~tss~~GTp~YmAPEVL~G 1225 (1236)
++...... .....+++.|+|||++.+
T Consensus 154 ~~~~~~~~--~~~~~~~~~y~aPE~~~~ 179 (328)
T cd07856 154 LARIQDPQ--MTGYVSTRYYRAPEIMLT 179 (328)
T ss_pred cccccCCC--cCCCcccccccCceeeec
Confidence 98865332 233567889999999865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.9e-22 Score=231.90 Aligned_cols=182 Identities=24% Similarity=0.287 Sum_probs=152.2
Q ss_pred cccccccccCeeEEEEeccCCceEEEEeeec-CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCC-CCceeeEe
Q 000893 1034 STLQIIKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFY 1111 (1236)
Q Consensus 1034 seLqiIs~EdYeiLkkLGsGSFGtVYKArlk-G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLr-HPNIVrLy 1111 (1236)
..+..++...|+++++||+||.++||++... .+.+|+|.+.... .....+..|+.|+.+|.+|+ |-+||+||
T Consensus 353 ~~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~------~D~qtl~gy~nEI~lL~KLkg~~~IIqL~ 426 (677)
T KOG0596|consen 353 NEIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLE------ADNQTLDGYRNEIALLNKLKGHDKIIQLY 426 (677)
T ss_pred CeeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhh------cCHHHHHHHHHHHHHHHHhcCCceEEEEe
Confidence 4566788889999999999999999999985 4557888765432 23456788999999999997 99999999
Q ss_pred eeEecCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcE
Q 000893 1112 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 1191 (1236)
Q Consensus 1112 G~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltV 1191 (1236)
+|-.++ +.+|+||||= ..+|..+|......+....++.|..||+.|+.++|.+||||.||||.|+|+-.. .+
T Consensus 427 DYEv~d--~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVkG-----~L 498 (677)
T KOG0596|consen 427 DYEVTD--GYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVKG-----RL 498 (677)
T ss_pred eeeccC--ceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEee-----eE
Confidence 998874 6999999974 789999998776666645777888999999999999999999999999999864 67
Q ss_pred EEEeccCcccccCccc---ccCcCCCCcccchhhhcCCCCC
Q 000893 1192 KVGDFGLSKIKRNTLV---TGGVRGTLPWMAPELLNGSSSK 1229 (1236)
Q Consensus 1192 KLsDFGLArii~ns~~---tss~~GTp~YmAPEVL~Gss~~ 1229 (1236)
||+|||+|..+..+.+ ...-+||+.||+||.+....+.
T Consensus 499 KLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~ 539 (677)
T KOG0596|consen 499 KLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSS 539 (677)
T ss_pred EeeeechhcccCccccceeeccccCcccccCHHHHhhcccc
Confidence 9999999998876543 3467899999999999866544
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.3e-22 Score=216.04 Aligned_cols=170 Identities=29% Similarity=0.416 Sum_probs=136.9
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
.+|.+.+.||.|+||.||+|.. ++..||||++..... .....+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--------~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~ 76 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--------QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGS 76 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--------chHHHHHHHHHHHHhcCCCcchhhHhhhccccc
Confidence 6899999999999999999988 477899999865421 123457789999999999999999987665321
Q ss_pred ------------CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCC
Q 000893 1120 ------------GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPI 1187 (1236)
Q Consensus 1120 ------------g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I 1187 (1236)
..+++||||+. ++|..++. ...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 77 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~-- 151 (342)
T cd07854 77 DLTEDVGSLTELNSVYIVQEYME-TDLANVLE--QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTED-- 151 (342)
T ss_pred ccccccccccccceEEEEeeccc-ccHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC--
Confidence 25789999995 68888774 34588999999999999999999999999999999999998654
Q ss_pred CCcEEEEeccCcccccCcc----cccCcCCCCcccchhhhcC
Q 000893 1188 RPICKVGDFGLSKIKRNTL----VTGGVRGTLPWMAPELLNG 1225 (1236)
Q Consensus 1188 ~ltVKLsDFGLArii~ns~----~tss~~GTp~YmAPEVL~G 1225 (1236)
..+||+|||+++...... ......++..|+|||++.+
T Consensus 152 -~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 192 (342)
T cd07854 152 -LVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS 192 (342)
T ss_pred -ceEEECCcccceecCCccccccccccccccccccCHHHHhC
Confidence 257999999998653221 1123457889999998764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=7e-22 Score=224.40 Aligned_cols=168 Identities=22% Similarity=0.144 Sum_probs=126.6
Q ss_pred ccCeeEEEEeccCCceEEEEeee---cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceee-EeeeEec
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKW---RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVA-FYGVVQD 1116 (1236)
Q Consensus 1041 ~EdYeiLkkLGsGSFGtVYKArl---kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVr-LyG~f~t 1116 (1236)
...|.+.+.||+|+||+||+|.+ .++.||||++........ .......|.+|+++|+.++|+||+. ++.+
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~---~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWS---KPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccc---cHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 46799999999999999999987 356689998753211000 1223456889999999999999985 4432
Q ss_pred CCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC-CCCcEEEccCCCCCCcEEEEe
Q 000893 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDL-KCDNLLVNLKDPIRPICKVGD 1195 (1236)
Q Consensus 1117 ~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDI-KPsNILLDsdG~I~ltVKLsD 1195 (1236)
+..++|||||+|++|.. +. . .. ...++.+++.||.|||++||+|||| ||+|||++.++ .+||+|
T Consensus 91 ---~~~~LVmE~~~G~~L~~-~~-~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~----~ikLiD 155 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLHL-AR-P---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDG----EAAVID 155 (365)
T ss_pred ---CCcEEEEEccCCCCHHH-hC-c---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCC----CEEEEE
Confidence 25799999999999963 21 1 11 1457889999999999999999999 99999998765 579999
Q ss_pred ccCcccccCcc---------cccCcCCCCcccchhhhcCCCCC
Q 000893 1196 FGLSKIKRNTL---------VTGGVRGTLPWMAPELLNGSSSK 1229 (1236)
Q Consensus 1196 FGLArii~ns~---------~tss~~GTp~YmAPEVL~Gss~~ 1229 (1236)
||+|+...... ...+.++++.|+|||++.-....
T Consensus 156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~ 198 (365)
T PRK09188 156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERK 198 (365)
T ss_pred CccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhc
Confidence 99998653221 11356789999999999754333
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-21 Score=205.80 Aligned_cols=165 Identities=25% Similarity=0.339 Sum_probs=131.0
Q ss_pred CeeEEEE--eccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhh-CCCCceeeEeeeEecC
Q 000893 1043 DLEELKE--LGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK-LHHPNVVAFYGVVQDG 1117 (1236)
Q Consensus 1043 dYeiLkk--LGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILsk-LrHPNIVrLyG~f~t~ 1117 (1236)
+|++.+. ||.|+||.||++.. .+..+|+|++....... .|+.+... .+||||++++++|...
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------------~e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------------IEPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------------hhHHHHHHhhcCCCEEEEEEEEecC
Confidence 4444444 59999999999987 46779999987542210 02222222 2699999999999886
Q ss_pred CCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEecc
Q 000893 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1236)
Q Consensus 1118 ~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFG 1197 (1236)
. .+++||||+++++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+||+++.++. .++|+|||
T Consensus 82 ~--~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~---~~~l~dfg 155 (267)
T PHA03390 82 K--GHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKD---RIYLCDYG 155 (267)
T ss_pred C--eeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCC---eEEEecCc
Confidence 5 8999999999999999996543 7899999999999999999999999999999999999988751 47999999
Q ss_pred CcccccCcccccCcCCCCcccchhhhcCCCCC
Q 000893 1198 LSKIKRNTLVTGGVRGTLPWMAPELLNGSSSK 1229 (1236)
Q Consensus 1198 LArii~ns~~tss~~GTp~YmAPEVL~Gss~~ 1229 (1236)
+++..... ....++..|+|||++.+....
T Consensus 156 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~ 184 (267)
T PHA03390 156 LCKIIGTP---SCYDGTLDYFSPEKIKGHNYD 184 (267)
T ss_pred cceecCCC---ccCCCCCcccChhhhcCCCCC
Confidence 98865433 234689999999999875443
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=213.58 Aligned_cols=168 Identities=29% Similarity=0.436 Sum_probs=137.1
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~ 1119 (1236)
.+|.+.+.||+|+||.||+|.+ +++.||||++++... .+.....+.+|+.+++.++||||++++++|.....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 88 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ------SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVS 88 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc------cccchhHHHHHHHHHHhcCCCCccchhheeccccc
Confidence 5799999999999999999987 478899999875321 11223457789999999999999999999875421
Q ss_pred ----CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEe
Q 000893 1120 ----GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1236)
Q Consensus 1120 ----g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsD 1195 (1236)
..+++||||+. .+|..++ ...+++..+..++.|++.||+|||+++|+||||||+|||++.++ .+||+|
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~----~~kL~d 160 (342)
T cd07879 89 GDEFQDFYLVMPYMQ-TDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDC----ELKILD 160 (342)
T ss_pred CCCCceEEEEecccc-cCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC----CEEEee
Confidence 35689999994 4776655 23588999999999999999999999999999999999999876 579999
Q ss_pred ccCcccccCcccccCcCCCCcccchhhhcC
Q 000893 1196 FGLSKIKRNTLVTGGVRGTLPWMAPELLNG 1225 (1236)
Q Consensus 1196 FGLArii~ns~~tss~~GTp~YmAPEVL~G 1225 (1236)
||+++..... .....+++.|+|||++.+
T Consensus 161 fg~~~~~~~~--~~~~~~~~~y~aPE~~~~ 188 (342)
T cd07879 161 FGLARHADAE--MTGYVVTRWYRAPEVILN 188 (342)
T ss_pred CCCCcCCCCC--CCCceeeecccChhhhcC
Confidence 9999865332 234567899999999876
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.6e-21 Score=213.89 Aligned_cols=171 Identities=26% Similarity=0.408 Sum_probs=140.8
Q ss_pred ccCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCC
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1041 ~EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~ 1118 (1236)
.++|++.+.||+|+||.||+|++. +..||||++..... .......+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ------SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPAS 87 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc------hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccc
Confidence 457999999999999999999984 67899998865321 1223455778999999999999999998876543
Q ss_pred C----CeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEE
Q 000893 1119 G----GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1236)
Q Consensus 1119 ~----g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLs 1194 (1236)
. ..+++|+||+ +++|.+++.. ..+++..++.++.|++.||.|||+.||+||||||+||+++.++ .+||+
T Consensus 88 ~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~----~~kL~ 160 (343)
T cd07851 88 SLEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC----ELKIL 160 (343)
T ss_pred cccccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC----CEEEc
Confidence 1 2489999998 7799998854 4689999999999999999999999999999999999999876 57999
Q ss_pred eccCcccccCcccccCcCCCCcccchhhhcCC
Q 000893 1195 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1195 DFGLArii~ns~~tss~~GTp~YmAPEVL~Gs 1226 (1236)
|||++...... .....++..|+|||++.+.
T Consensus 161 dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~ 190 (343)
T cd07851 161 DFGLARHTDDE--MTGYVATRWYRAPEIMLNW 190 (343)
T ss_pred ccccccccccc--ccCCcccccccCHHHHhCC
Confidence 99999875432 2345688999999998653
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.2e-22 Score=236.47 Aligned_cols=187 Identities=33% Similarity=0.478 Sum_probs=151.9
Q ss_pred ccccccccCeeEEEEeccCCceEEEEeeec---Cc--eEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceee
Q 000893 1035 TLQIIKNEDLEELKELGSGTFGTVYHGKWR---GT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVA 1109 (1236)
Q Consensus 1035 eLqiIs~EdYeiLkkLGsGSFGtVYKArlk---G~--~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVr 1109 (1236)
..-.|..+++.+.++||+|.||.|++|.|+ |+ .||||+++..... .....|++|+.+|.+|+|||+++
T Consensus 103 lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~-------~~mddflrEas~M~~L~H~hliR 175 (1039)
T KOG0199|consen 103 LKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN-------AIMDDFLREASHMLKLQHPHLIR 175 (1039)
T ss_pred cceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc-------hhHHHHHHHHHHHHhccCcceeE
Confidence 344566778888999999999999999995 33 4999999865432 14678999999999999999999
Q ss_pred EeeeEecCCCCeEEEEEeeccCCCHHHHHhh-hccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCC
Q 000893 1110 FYGVVQDGPGGTLATVTEFMVNGSLRHVLLS-KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIR 1188 (1236)
Q Consensus 1110 LyG~f~t~~~g~L~LVMEYm~GGSL~dlL~~-k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ 1188 (1236)
|||+..+. .+.+|||+++.|+|.+.|++ ....|-....+.|+.||+.||.||..+++|||||..+||||....
T Consensus 176 LyGvVl~q---p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllaspr--- 249 (1039)
T KOG0199|consen 176 LYGVVLDQ---PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPR--- 249 (1039)
T ss_pred Eeeeeccc---hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccc---
Confidence 99999874 57899999999999999987 455678888899999999999999999999999999999998754
Q ss_pred CcEEEEeccCcccccCcc----cccCcCCCCcccchhhhcCC-CCCCCcccc
Q 000893 1189 PICKVGDFGLSKIKRNTL----VTGGVRGTLPWMAPELLNGS-SSKVSEKVC 1235 (1236)
Q Consensus 1189 ltVKLsDFGLArii~ns~----~tss~~GTp~YmAPEVL~Gs-s~~~SdDVD 1235 (1236)
+||||||||.+.+.... +.....-.+.|.|||.|+.. ....++.|.
T Consensus 250 -tVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWm 300 (1039)
T KOG0199|consen 250 -TVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWM 300 (1039)
T ss_pred -eeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhh
Confidence 78999999999764322 22223345679999999854 344444453
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.1e-22 Score=209.17 Aligned_cols=175 Identities=29% Similarity=0.475 Sum_probs=144.4
Q ss_pred ccccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhh-CCCCceeeEeeeEe
Q 000893 1039 IKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK-LHHPNVVAFYGVVQ 1115 (1236)
Q Consensus 1039 Is~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILsk-LrHPNIVrLyG~f~ 1115 (1236)
+..+++.-+..||+|++|.|=+.++ .|+..|+|.+.... ..+..++.++|+.+..+ ..+|++|++||.+.
T Consensus 43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-------n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~ 115 (282)
T KOG0984|consen 43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-------NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALF 115 (282)
T ss_pred cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-------ChHHHHHHHHhhhhhccCCCCCeEEEeehhhh
Confidence 3445666677899999999877666 69999999997643 23345567788888665 46999999999877
Q ss_pred cCCCCeEEEEEeeccCCCHHHHHh---hhccCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCCCcEEEccCCCCCCcE
Q 000893 1116 DGPGGTLATVTEFMVNGSLRHVLL---SKERHLDRRKRLIIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPIC 1191 (1236)
Q Consensus 1116 t~~~g~L~LVMEYm~GGSL~dlL~---~k~r~LSe~erl~Ia~QIAeALaYLHSk-GIIHRDIKPsNILLDsdG~I~ltV 1191 (1236)
.. +..|+.||.| ..+|..+.. .++..+++...-+|+..++.||.|||++ .|||||+||+||||+.+| .|
T Consensus 116 re--gdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G----qV 188 (282)
T KOG0984|consen 116 RE--GDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG----QV 188 (282)
T ss_pred cc--ccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC----cE
Confidence 63 5899999999 677776653 3567899999999999999999999986 899999999999999998 66
Q ss_pred EEEeccCcccccCcccccCcCCCCcccchhhhcCCC
Q 000893 1192 KVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1192 KLsDFGLArii~ns~~tss~~GTp~YmAPEVL~Gss 1227 (1236)
|+||||++..+.++...+...|.-.|||||.+..+.
T Consensus 189 KiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~ 224 (282)
T KOG0984|consen 189 KICDFGISGYLVDSIAKTMDAGCKPYMAPERINPEL 224 (282)
T ss_pred EEcccccceeehhhhHHHHhcCCCccCChhhcCccc
Confidence 999999999988877777677999999999997543
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.5e-23 Score=221.76 Aligned_cols=185 Identities=26% Similarity=0.420 Sum_probs=149.5
Q ss_pred ccccccccCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhh-CCCCceeeEe
Q 000893 1035 TLQIIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK-LHHPNVVAFY 1111 (1236)
Q Consensus 1035 eLqiIs~EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILsk-LrHPNIVrLy 1111 (1236)
.+..+..++++-+..||.|+||+|++..++ |+..|||.|.... .+....+++.|.++..+ -+.||||++|
T Consensus 57 ~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n-------~~keq~rll~e~d~~mks~~cp~IVkfy 129 (361)
T KOG1006|consen 57 HLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN-------IEKEQKRLLMEHDTVMKSSNCPNIVKFY 129 (361)
T ss_pred cccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeecc-------chHHHHHHHHHHHHHHhhcCCcHHHHHh
Confidence 445556677777888999999999999884 8889999998653 23445678888887554 5699999999
Q ss_pred eeEecCCCCeEEEEEeeccCCCHHHHHhh----hccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCcEEEccCCC
Q 000893 1112 GVVQDGPGGTLATVTEFMVNGSLRHVLLS----KERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDP 1186 (1236)
Q Consensus 1112 G~f~t~~~g~L~LVMEYm~GGSL~dlL~~----k~r~LSe~erl~Ia~QIAeALaYLHS-kGIIHRDIKPsNILLDsdG~ 1186 (1236)
|.+.. +|..|+.||+| ..+|+.+... ....+++.-.-.|+...+.||.||.. ..||||||||+||||+..|
T Consensus 130 Ga~F~--EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G- 205 (361)
T KOG1006|consen 130 GALFS--EGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHG- 205 (361)
T ss_pred hhhhc--CCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCC-
Confidence 99887 36899999999 7777765432 24568888888888889999999986 4899999999999999988
Q ss_pred CCCcEEEEeccCcccccCcccccCcCCCCcccchhhhcCCCCCCCcc
Q 000893 1187 IRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEK 1233 (1236)
Q Consensus 1187 I~ltVKLsDFGLArii~ns~~tss~~GTp~YmAPEVL~Gss~~~SdD 1233 (1236)
.+||||||+|..+.++...+.-.|...|||||.|..+...++-+
T Consensus 206 ---~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiR 249 (361)
T KOG1006|consen 206 ---DVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIR 249 (361)
T ss_pred ---CEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchh
Confidence 45999999999888777777788999999999998655444433
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.8e-22 Score=219.23 Aligned_cols=174 Identities=25% Similarity=0.382 Sum_probs=142.4
Q ss_pred EEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCC-CCceeeEeeeEecCCCCeEEE
Q 000893 1048 KELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQDGPGGTLAT 1124 (1236)
Q Consensus 1048 kkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLr-HPNIVrLyG~f~t~~~g~L~L 1124 (1236)
+.||+|+|+.|-.+.. ++.++|||++.+.. .....+..+|++++..++ |+||++|+.+|.+.. .+||
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--------gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~--~FYL 153 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--------GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT--RFYL 153 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCC--------chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc--eEEE
Confidence 4699999999998876 78999999998742 233557789999999997 999999999999865 8999
Q ss_pred EEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCccccc-
Q 000893 1125 VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR- 1203 (1236)
Q Consensus 1125 VMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~- 1203 (1236)
|||-|.||+|..+|++ .+.+++.++..+..+|+.||.|||.+||.||||||+|||......+. -||||||.|..-+.
T Consensus 154 VfEKm~GGplLshI~~-~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vs-PvKiCDfDLgSg~k~ 231 (463)
T KOG0607|consen 154 VFEKMRGGPLLSHIQK-RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVS-PVKICDFDLGSGIKL 231 (463)
T ss_pred EEecccCchHHHHHHH-hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcC-ceeeecccccccccc
Confidence 9999999999999964 45799999999999999999999999999999999999998877664 47999998865432
Q ss_pred Cc-------ccccCcCCCCcccchhhhc---CCCCCCCcc
Q 000893 1204 NT-------LVTGGVRGTLPWMAPELLN---GSSSKVSEK 1233 (1236)
Q Consensus 1204 ns-------~~tss~~GTp~YmAPEVL~---Gss~~~SdD 1233 (1236)
+. ..-.+.+|+..|||||+.. +....|+-.
T Consensus 232 ~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKr 271 (463)
T KOG0607|consen 232 NNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKR 271 (463)
T ss_pred CCCCCCCCCccccCcccchhhcchhHHhhhcccccccccc
Confidence 11 1112467888999999874 554444443
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.9e-22 Score=216.00 Aligned_cols=178 Identities=28% Similarity=0.313 Sum_probs=145.5
Q ss_pred cCeeEE-EEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhC-CCCceeeEeeeEecC
Q 000893 1042 EDLEEL-KELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDG 1117 (1236)
Q Consensus 1042 EdYeiL-kkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskL-rHPNIVrLyG~f~t~ 1117 (1236)
++|.+- ++||-|-.|+|..+.+ ++..+|+|++... ....+|+++.-.. .|||||.++++|...
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------------~KARrEVeLHw~~s~h~~iV~IidVyeNs 127 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------------PKARREVELHWMASGHPHIVSIIDVYENS 127 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------------HHHHhHhhhhhhhcCCCceEEeehhhhhh
Confidence 345443 5799999999999987 4777999998532 1234677775444 599999999988642
Q ss_pred C--CCeEEEEEeeccCCCHHHHHhhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEE
Q 000893 1118 P--GGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1236)
Q Consensus 1118 ~--~g~L~LVMEYm~GGSL~dlL~~k~-r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLs 1194 (1236)
- ..++.+|||+|+||.|...++.++ ..+++.++..|+.||+.|+.|||+.+|.||||||+|+|...... ...+||+
T Consensus 128 ~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~-na~lKLt 206 (400)
T KOG0604|consen 128 YQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSP-NAPLKLT 206 (400)
T ss_pred ccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCC-CcceEec
Confidence 2 347889999999999999998765 47999999999999999999999999999999999999987653 3588999
Q ss_pred eccCcccccCcccccCcCCCCcccchhhhcCCCCCCCcc
Q 000893 1195 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEK 1233 (1236)
Q Consensus 1195 DFGLArii~ns~~tss~~GTp~YmAPEVL~Gss~~~SdD 1233 (1236)
|||+|+.......-.+.|-||+|.|||++..+.+..++|
T Consensus 207 DfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscd 245 (400)
T KOG0604|consen 207 DFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCD 245 (400)
T ss_pred ccccccccCCCccccCCcccccccCHHHhCchhcCCCCC
Confidence 999999877555556788999999999998876666665
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.5e-21 Score=235.67 Aligned_cols=159 Identities=24% Similarity=0.339 Sum_probs=128.5
Q ss_pred CeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCC
Q 000893 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g 1120 (1236)
.|...+.||+|+||.||+|++ .+..||||+++.... ....|+.++++++|||||+++++|.+..
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------~~~~~~~~l~~l~HpnIv~~~~~~~~~~-- 756 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------------IPSSEIADMGKLQHPNIVKLIGLCRSEK-- 756 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------------ccHHHHHHHhhCCCCCcceEEEEEEcCC--
Confidence 466778899999999999997 578899998864311 0123578899999999999999998764
Q ss_pred eEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCCCcEEEccCCCCCCcEEEEecc
Q 000893 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH---SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1236)
Q Consensus 1121 ~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLH---SkGIIHRDIKPsNILLDsdG~I~ltVKLsDFG 1197 (1236)
..++|||||++|+|.+++. .++|..+..|+.||+.||+||| ..+|+||||||+|||++.++. .++. ||
T Consensus 757 ~~~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~----~~~~-~~ 827 (968)
T PLN00113 757 GAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDE----PHLR-LS 827 (968)
T ss_pred CCEEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCc----eEEE-ec
Confidence 7899999999999999994 3889999999999999999999 669999999999999997763 3443 66
Q ss_pred CcccccCcccccCcCCCCcccchhhhcCCC
Q 000893 1198 LSKIKRNTLVTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1198 LArii~ns~~tss~~GTp~YmAPEVL~Gss 1227 (1236)
........ ....||+.|+|||++.+..
T Consensus 828 ~~~~~~~~---~~~~~t~~y~aPE~~~~~~ 854 (968)
T PLN00113 828 LPGLLCTD---TKCFISSAYVAPETRETKD 854 (968)
T ss_pred cccccccC---CCccccccccCcccccCCC
Confidence 65543221 2236789999999998653
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.8e-21 Score=223.69 Aligned_cols=184 Identities=22% Similarity=0.244 Sum_probs=132.9
Q ss_pred ccccCeeEEEEeccCCceEEEEeee------------------cCceEEEEeeeccccCCCChHH------HHHHHHHHH
Q 000893 1039 IKNEDLEELKELGSGTFGTVYHGKW------------------RGTDVAIKRIKKSCFTGRSSEQ------ERLTLEFWR 1094 (1236)
Q Consensus 1039 Is~EdYeiLkkLGsGSFGtVYKArl------------------kG~~VAVKvLkk~~i~~~~~e~------er~~keFlr 1094 (1236)
+..++|.+.++||+|+||+||+|.+ .++.||||++............ ......+..
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 4567999999999999999999964 2456999998643210000000 001123445
Q ss_pred HHHHHhhCCCCce-----eeEeeeEecC------CCCeEEEEEeeccCCCHHHHHhhhc---------------------
Q 000893 1095 EAEILSKLHHPNV-----VAFYGVVQDG------PGGTLATVTEFMVNGSLRHVLLSKE--------------------- 1142 (1236)
Q Consensus 1095 EIrILskLrHPNI-----VrLyG~f~t~------~~g~L~LVMEYm~GGSL~dlL~~k~--------------------- 1142 (1236)
|+.++.+++|.++ ++++++|... ..+..+|||||+++++|.+++....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7777888876654 6777776532 1246899999999999999986421
Q ss_pred --cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcccccCcccccCc--CCCCccc
Q 000893 1143 --RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGV--RGTLPWM 1218 (1236)
Q Consensus 1143 --r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~ns~~tss~--~GTp~Ym 1218 (1236)
..+++..++.|+.|++.||.|||.++|+||||||+|||++.++ .+||+|||+++........... .+|+.|+
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~----~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~ 377 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDG----QVKIIDFGAAVDMCTGINFNPLYGMLDPRYS 377 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCC----cEEEEeCcCccccccCCccCccccCCCccee
Confidence 1245677888999999999999999999999999999999876 5799999999765433222222 2478999
Q ss_pred chhhhcCC
Q 000893 1219 APELLNGS 1226 (1236)
Q Consensus 1219 APEVL~Gs 1226 (1236)
|||++...
T Consensus 378 aPE~l~~~ 385 (507)
T PLN03224 378 PPEELVMP 385 (507)
T ss_pred ChhhhcCC
Confidence 99998643
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.4e-21 Score=197.86 Aligned_cols=154 Identities=19% Similarity=0.171 Sum_probs=126.2
Q ss_pred CCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeEEEEEeecc
Q 000893 1053 GTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMV 1130 (1236)
Q Consensus 1053 GSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L~LVMEYm~ 1130 (1236)
|.||+||++++ +++.||+|++++.. .+.+|...+....||||+++++++.... ..++||||++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------------~~~~~~~~~~~~~~~~i~~~~~~~~~~~--~~~lv~e~~~ 68 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------------EYSRERLTIIPHCVPNMVCLHKYIVSED--SVFLVLQHAE 68 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------------hhhhHHHHHHhcCCCceeehhhheecCC--eEEEEEecCC
Confidence 89999999998 57789999987532 1223455555667999999999998754 8999999999
Q ss_pred CCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcccccCcccccC
Q 000893 1131 NGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGG 1210 (1236)
Q Consensus 1131 GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~ns~~tss 1210 (1236)
+++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+||+++.++ .++|+|||++....... ..
T Consensus 69 ~~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~----~~~l~df~~~~~~~~~~--~~ 141 (237)
T cd05576 69 GGKLWSHISKF-LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRG----HIQLTYFSRWSEVEDSC--DG 141 (237)
T ss_pred CCCHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC----CEEEecccchhcccccc--cc
Confidence 99999998654 4589999999999999999999999999999999999999886 56999999887654332 23
Q ss_pred cCCCCcccchhhhcCCCC
Q 000893 1211 VRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1211 ~~GTp~YmAPEVL~Gss~ 1228 (1236)
..++..|+|||++.+...
T Consensus 142 ~~~~~~y~aPE~~~~~~~ 159 (237)
T cd05576 142 EAVENMYCAPEVGGISEE 159 (237)
T ss_pred CCcCccccCCcccCCCCC
Confidence 456778999999876533
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.7e-22 Score=214.08 Aligned_cols=174 Identities=24% Similarity=0.394 Sum_probs=146.1
Q ss_pred ccccCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCC-CCceeeEeeeEe
Q 000893 1039 IKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQ 1115 (1236)
Q Consensus 1039 Is~EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLr-HPNIVrLyG~f~ 1115 (1236)
....+++.+..||.|+.|.||+++.+ |...|||.+.+.. +.+..++++..++++.+.. .|+||+.+|+|.
T Consensus 89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-------Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi 161 (391)
T KOG0983|consen 89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-------NKEENKRILMDLDVVLKSHDCPYIVQCFGYFI 161 (391)
T ss_pred cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-------CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe
Confidence 34466777888999999999999985 6889999987642 3344567788888877765 899999999999
Q ss_pred cCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCcEEEccCCCCCCcEEEE
Q 000893 1116 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1236)
Q Consensus 1116 t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHS-kGIIHRDIKPsNILLDsdG~I~ltVKLs 1194 (1236)
+.. ..++.||.| ...++.++.+...++++..+-.+..-++.||.||.. ++|||||+||+|||||..| .+|||
T Consensus 162 ~n~--dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~G----niKlC 234 (391)
T KOG0983|consen 162 TNT--DVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG----NIKLC 234 (391)
T ss_pred eCc--hHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCC----CEEee
Confidence 865 778899998 667777887777889998888899999999999986 5999999999999999988 45999
Q ss_pred eccCcccccCcccccCcCCCCcccchhhhcCC
Q 000893 1195 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1195 DFGLArii~ns~~tss~~GTp~YmAPEVL~Gs 1226 (1236)
|||++..+-+....+.-.|.+.|||||.|.-.
T Consensus 235 DFGIsGrlvdSkAhtrsAGC~~YMaPERidp~ 266 (391)
T KOG0983|consen 235 DFGISGRLVDSKAHTRSAGCAAYMAPERIDPP 266 (391)
T ss_pred cccccceeecccccccccCCccccCccccCCC
Confidence 99999988777666667899999999999743
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3e-21 Score=207.95 Aligned_cols=187 Identities=25% Similarity=0.276 Sum_probs=150.6
Q ss_pred cccccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEe
Q 000893 1038 IIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 1115 (1236)
Q Consensus 1038 iIs~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~ 1115 (1236)
.++.++|.+.++||+|+|+.||+++. ++..+|+|++.-.. .+.....++|++..++++||||++++++..
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--------~~~~e~~~rEid~~rkf~s~~vl~l~dh~l 88 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--------QEDIEEALREIDNHRKFNSPNVLRLVDHQL 88 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--------hHHHHHHHHHHHHHHhhCCcchHHHHHHHH
Confidence 57789999999999999999999885 67789999986542 233456789999999999999999998765
Q ss_pred cCC---CCeEEEEEeeccCCCHHHHHhhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCCCcEEEccCCCC
Q 000893 1116 DGP---GGTLATVTEFMVNGSLRHVLLSK---ERHLDRRKRLIIAMDAAFGMEYLHSKN--IVHFDLKCDNLLVNLKDPI 1187 (1236)
Q Consensus 1116 t~~---~g~L~LVMEYm~GGSL~dlL~~k---~r~LSe~erl~Ia~QIAeALaYLHSkG--IIHRDIKPsNILLDsdG~I 1187 (1236)
... ....||+++|...|+|.+.+... +..+++.+.+.|+.+|++||++||+.. +.||||||.|||+...+
T Consensus 89 ~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~-- 166 (302)
T KOG2345|consen 89 REEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSG-- 166 (302)
T ss_pred HhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCC--
Confidence 322 24789999999999999988653 458999999999999999999999988 99999999999999866
Q ss_pred CCcEEEEeccCcccccCcc----------cccCcCCCCcccchhhhc-CCCCCCCccccC
Q 000893 1188 RPICKVGDFGLSKIKRNTL----------VTGGVRGTLPWMAPELLN-GSSSKVSEKVCF 1236 (1236)
Q Consensus 1188 ~ltVKLsDFGLArii~ns~----------~tss~~GTp~YmAPEVL~-Gss~~~SdDVDI 1236 (1236)
.++|.|||.+....-.. .......|..|+|||.+. ......++++||
T Consensus 167 --~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDI 224 (302)
T KOG2345|consen 167 --LPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDI 224 (302)
T ss_pred --ceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccch
Confidence 56999999987532111 111234689999999997 444455666554
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.2e-20 Score=183.36 Aligned_cols=168 Identities=39% Similarity=0.572 Sum_probs=141.4
Q ss_pred eeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCe
Q 000893 1044 LEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGT 1121 (1236)
Q Consensus 1044 YeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~ 1121 (1236)
|.+.+.||.|++|.||++... +..+|||.+...... .....+.+|+..++.++|+||+++++++.... .
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~--~ 71 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-------KQREEFLREIRILKKLKHPNIVKLYGVFEDPE--P 71 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-------HHHHHHHHHHHHHHhCCCCChhhheeeeecCC--c
Confidence 456788999999999999985 588999998764311 23567888999999999999999999988754 7
Q ss_pred EEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCccc
Q 000893 1122 LATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201 (1236)
Q Consensus 1122 L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLAri 1201 (1236)
.++++||+.+++|.+++......+++..+..++.+++.+|.|||.++++|+||+|.||+++.++ .++|+|||++..
T Consensus 72 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~----~~~l~d~g~~~~ 147 (225)
T smart00221 72 LYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDG----LVKLADFGLARF 147 (225)
T ss_pred eEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC----CEEEeeCceeeE
Confidence 8999999999999999865433388999999999999999999999999999999999999875 579999999987
Q ss_pred ccCcc--cccCcCCCCcccchhhhc
Q 000893 1202 KRNTL--VTGGVRGTLPWMAPELLN 1224 (1236)
Q Consensus 1202 i~ns~--~tss~~GTp~YmAPEVL~ 1224 (1236)
..... ......++..|++||.+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~pe~~~ 172 (225)
T smart00221 148 IHRDLAALLKTVKGTPFYLAPEVLL 172 (225)
T ss_pred ecCcccccccceeccCCcCCHhHhc
Confidence 65442 334456788999999984
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-22 Score=218.64 Aligned_cols=182 Identities=27% Similarity=0.423 Sum_probs=144.9
Q ss_pred cCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCC-
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP- 1118 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~- 1118 (1236)
..|+.+.+||+|.||.||+|+. .++.||+|++.... +.+......++|+.+|..|+|+|++.++.+|.+..
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen------eKeGfpitalreikiL~~lkHenv~nliEic~tk~T 90 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN------EKEGFPITALREIKILQLLKHENVVNLIEICRTKAT 90 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc------cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccC
Confidence 4567778899999999999987 46779998764321 12223345678999999999999999998886432
Q ss_pred -----CCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEE
Q 000893 1119 -----GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193 (1236)
Q Consensus 1119 -----~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKL 1193 (1236)
...+++||.+| ..+|.-+|......++..+++.++.+++.||.|+|+..|+|||+||.|+||+.+| ++||
T Consensus 91 p~~r~r~t~ylVf~~c-ehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dg----ilkl 165 (376)
T KOG0669|consen 91 PTNRDRATFYLVFDFC-EHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDG----ILKL 165 (376)
T ss_pred CcccccceeeeeHHHh-hhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCc----eEEe
Confidence 24689999999 5688888877767899999999999999999999999999999999999999987 7799
Q ss_pred EeccCcccccCc-----ccccCcCCCCcccchhhhcCCCCCCCcccc
Q 000893 1194 GDFGLSKIKRNT-----LVTGGVRGTLPWMAPELLNGSSSKVSEKVC 1235 (1236)
Q Consensus 1194 sDFGLArii~ns-----~~tss~~GTp~YmAPEVL~Gss~~~SdDVD 1235 (1236)
+|||+++..... ...+..+-|+||++||.|.|.. .+...+|
T Consensus 166 ADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r-~yg~~iD 211 (376)
T KOG0669|consen 166 ADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDR-EYGPPID 211 (376)
T ss_pred eccccccceecccccCCCCcccceeeeecCCHHHhhccc-ccCCcch
Confidence 999999865322 1233445699999999999863 4444444
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.7e-20 Score=221.42 Aligned_cols=173 Identities=22% Similarity=0.223 Sum_probs=120.2
Q ss_pred ccccCeeEEEEeccCCceEEEEeeec------CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEee
Q 000893 1039 IKNEDLEELKELGSGTFGTVYHGKWR------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 1112 (1236)
Q Consensus 1039 Is~EdYeiLkkLGsGSFGtVYKArlk------G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG 1112 (1236)
+..++|++.++||+|+||+||+|++. +..||||++.... ..+ .+..| .++...+.+++.++.
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~------~~e----~~~~e--~l~~~~~~~~~~~~~ 196 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG------AVE----IWMNE--RVRRACPNSCADFVY 196 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc------hhH----HHHHH--HHHhhchhhHHHHHH
Confidence 45678999999999999999999984 5679999876421 011 11111 112222233332222
Q ss_pred eEe----cCCCCeEEEEEeeccCCCHHHHHhhhccC-------------------CCHHHHHHHHHHHHHHHHHHHHCCc
Q 000893 1113 VVQ----DGPGGTLATVTEFMVNGSLRHVLLSKERH-------------------LDRRKRLIIAMDAAFGMEYLHSKNI 1169 (1236)
Q Consensus 1113 ~f~----t~~~g~L~LVMEYm~GGSL~dlL~~k~r~-------------------LSe~erl~Ia~QIAeALaYLHSkGI 1169 (1236)
.+. ......+++||||+.+++|.+++...... .....+..|+.||+.||.|||+++|
T Consensus 197 ~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gI 276 (566)
T PLN03225 197 GFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGI 276 (566)
T ss_pred hhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCE
Confidence 211 12245889999999999999998654211 1123455789999999999999999
Q ss_pred ccCCCCCCcEEEccCCCCCCcEEEEeccCcccccCc--ccccCcCCCCcccchhhhcCC
Q 000893 1170 VHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT--LVTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1170 IHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~ns--~~tss~~GTp~YmAPEVL~Gs 1226 (1236)
|||||||+||||+.+. ..+||+|||+|+..... .....+++|+.|||||.+...
T Consensus 277 iHRDLKP~NILl~~~~---~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~ 332 (566)
T PLN03225 277 VHRDVKPQNIIFSEGS---GSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMS 332 (566)
T ss_pred EeCcCCHHHEEEeCCC---CcEEEEeCCCccccccccccCCcccccCCCccChHHhhcc
Confidence 9999999999998642 26799999999865322 233457899999999987543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.9e-19 Score=174.07 Aligned_cols=164 Identities=44% Similarity=0.659 Sum_probs=138.4
Q ss_pred eccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeEEEEEe
Q 000893 1050 LGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTE 1127 (1236)
Q Consensus 1050 LGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L~LVME 1127 (1236)
||+|.+|.||++... +..++||++...... .....+.+|+.+++.+.|++|+++++++... ...+++||
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~-------~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~~~~e 71 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSS-------SLLEELLREIEILKKLNHPNIVKLYGVFEDE--NHLYLVME 71 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccch-------hHHHHHHHHHHHHHhcCCCCeeeEeeeeecC--CeEEEEEe
Confidence 689999999999996 888999999764311 0345688999999999999999999999875 48899999
Q ss_pred eccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEcc-CCCCCCcEEEEeccCcccccCcc
Q 000893 1128 FMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNL-KDPIRPICKVGDFGLSKIKRNTL 1206 (1236)
Q Consensus 1128 Ym~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDs-dG~I~ltVKLsDFGLArii~ns~ 1206 (1236)
|+.+++|..++......+++..++.++.+++.+|.|||++|++|+||+|.||+++. ++ .++|+|||++.......
T Consensus 72 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~----~~~l~d~~~~~~~~~~~ 147 (215)
T cd00180 72 YCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNG----KVKLADFGLSKLLTSDK 147 (215)
T ss_pred cCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCC----cEEEecCCceEEccCCc
Confidence 99989999999665456899999999999999999999999999999999999998 54 56999999998764432
Q ss_pred -cccCcCCCCcccchhhhcCC
Q 000893 1207 -VTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1207 -~tss~~GTp~YmAPEVL~Gs 1226 (1236)
......+...|++||.+...
T Consensus 148 ~~~~~~~~~~~~~~pe~~~~~ 168 (215)
T cd00180 148 SLLKTIVGTPAYMAPEVLLGK 168 (215)
T ss_pred chhhcccCCCCccChhHhccc
Confidence 12335578899999999764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.6e-20 Score=224.82 Aligned_cols=169 Identities=33% Similarity=0.431 Sum_probs=132.6
Q ss_pred EEeccCCceE-EEEeeecCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCC-CCceeeEeeeEecCCCCeEEEE
Q 000893 1048 KELGSGTFGT-VYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQDGPGGTLATV 1125 (1236)
Q Consensus 1048 kkLGsGSFGt-VYKArlkG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLr-HPNIVrLyG~f~t~~~g~L~LV 1125 (1236)
+.+|.|+.|+ ||+|.+.++.||||++-.. ......+|+..|+..+ |||||++|+.-.+. .++||.
T Consensus 515 eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e-----------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~--qF~YIa 581 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVYEGREVAVKRLLEE-----------FFDFAQREIQLLQESDEHPNVIRYYCSEQDR--QFLYIA 581 (903)
T ss_pred HHcccCCCCcEEEEEeeCCceehHHHHhhH-----------hHHHHHHHHHHHHhccCCCceEEEEeeccCC--ceEEEE
Confidence 4689998875 7999999999999988532 2334578999999875 99999999876664 599999
Q ss_pred EeeccCCCHHHHHhhhccC---CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccC-CCCCCcEEEEeccCccc
Q 000893 1126 TEFMVNGSLRHVLLSKERH---LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLK-DPIRPICKVGDFGLSKI 1201 (1236)
Q Consensus 1126 MEYm~GGSL~dlL~~k~r~---LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsd-G~I~ltVKLsDFGLAri 1201 (1236)
.|.| ..+|.+++...... ......+.++.|++.||++||+.+||||||||+||||... ......++|+|||+|+.
T Consensus 582 lELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 582 LELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred ehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 9999 78999999763111 1112345678899999999999999999999999999872 12235899999999998
Q ss_pred ccCcc----cccCcCCCCcccchhhhcCCCCCC
Q 000893 1202 KRNTL----VTGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1202 i~ns~----~tss~~GTp~YmAPEVL~Gss~~~ 1230 (1236)
..... ...+..||-+|+|||++.......
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~ 693 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQ 693 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHhccccCc
Confidence 65332 234567999999999999875544
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-20 Score=224.93 Aligned_cols=187 Identities=34% Similarity=0.506 Sum_probs=152.1
Q ss_pred cccccccCeeEEEEeccCCceEEEEeee--cC----ceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceee
Q 000893 1036 LQIIKNEDLEELKELGSGTFGTVYHGKW--RG----TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVA 1109 (1236)
Q Consensus 1036 LqiIs~EdYeiLkkLGsGSFGtVYKArl--kG----~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVr 1109 (1236)
+.+....+++..++||.|+||+||+|.| +| .+||||++..... .....+|+.|+.+|.+|+||||++
T Consensus 690 lrI~kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~-------~~~s~e~LdeAl~masldHpnl~R 762 (1177)
T KOG1025|consen 690 LRILKETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS-------PKASIELLDEALRMASLDHPNLLR 762 (1177)
T ss_pred eeechhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC-------chhhHHHHHHHHHHhcCCCchHHH
Confidence 4445555677889999999999999998 33 4599999875432 233467899999999999999999
Q ss_pred EeeeEecCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCC
Q 000893 1110 FYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP 1189 (1236)
Q Consensus 1110 LyG~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~l 1189 (1236)
|+|+|... .+.||++||+.|.|.++++.....+.....+.|..||++||.|||.++++||||-.+|||+..-.
T Consensus 763 LLgvc~~s---~~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~---- 835 (1177)
T KOG1025|consen 763 LLGVCMLS---TLQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPN---- 835 (1177)
T ss_pred Hhhhcccc---hHHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCC----
Confidence 99999975 48899999999999999998888899999999999999999999999999999999999998775
Q ss_pred cEEEEeccCcccccCcccc---cCcCCCCcccchhhhcCC-CCCCCccccC
Q 000893 1190 ICKVGDFGLSKIKRNTLVT---GGVRGTLPWMAPELLNGS-SSKVSEKVCF 1236 (1236)
Q Consensus 1190 tVKLsDFGLArii~ns~~t---ss~~GTp~YmAPEVL~Gs-s~~~SdDVDI 1236 (1236)
.+||+|||+++........ ....-.+.|||=|.++.. ....++.|.|
T Consensus 836 hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsf 886 (1177)
T KOG1025|consen 836 HVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSF 886 (1177)
T ss_pred eEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhh
Confidence 6799999999987543322 222335679999999744 3444555543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.5e-19 Score=180.79 Aligned_cols=159 Identities=37% Similarity=0.532 Sum_probs=134.8
Q ss_pred CceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeEEEEEeeccC
Q 000893 1054 TFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVN 1131 (1236)
Q Consensus 1054 SFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L~LVMEYm~G 1131 (1236)
+||.||+|.+. +..+|+|++...... .....+.+|++++++++|+||+++++++.... ..+++|||+.+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~-------~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--~~~l~~e~~~~ 71 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIK-------KKRERILREISILKKLKHPNIVRLYDVFEDED--KLYLVMEYCDG 71 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccc-------cHHHHHHHHHHHHHhCCCCcHHHHHhheeeCC--EEEEEEeCCCC
Confidence 58999999985 588999998754311 11467889999999999999999999998754 88999999999
Q ss_pred CCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcccccCcccccCc
Q 000893 1132 GSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGV 1211 (1236)
Q Consensus 1132 GSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~ns~~tss~ 1211 (1236)
++|..++..... +++..++.++.+++.+|.|||..+|+|+||+|.||+++.++ .++|+|||++............
T Consensus 72 ~~L~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~----~~~l~d~~~~~~~~~~~~~~~~ 146 (244)
T smart00220 72 GDLFDLLKKRGR-LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDG----HVKLADFGLARQLDPGGLLTTF 146 (244)
T ss_pred CCHHHHHHhccC-CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCC----cEEEccccceeeeccccccccc
Confidence 999999865433 88999999999999999999999999999999999999875 5699999999887655444556
Q ss_pred CCCCcccchhhhcCC
Q 000893 1212 RGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1212 ~GTp~YmAPEVL~Gs 1226 (1236)
.++..|++||.+.+.
T Consensus 147 ~~~~~~~~pE~~~~~ 161 (244)
T smart00220 147 VGTPEYMAPEVLLGK 161 (244)
T ss_pred cCCcCCCCHHHHccC
Confidence 789999999999754
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.5e-20 Score=218.30 Aligned_cols=181 Identities=32% Similarity=0.450 Sum_probs=148.4
Q ss_pred cccccccCeeEEEEeccCCceEEEEeeec---------CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCC-CC
Q 000893 1036 LQIIKNEDLEELKELGSGTFGTVYHGKWR---------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HP 1105 (1236)
Q Consensus 1036 LqiIs~EdYeiLkkLGsGSFGtVYKArlk---------G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLr-HP 1105 (1236)
.+++..+++.+.+.||+|.||+||+|... ...||||.++... .......+..|+.+|+.+. ||
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~-------~~~~~~~~~~El~~m~~~g~H~ 362 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA-------SSSEKKDLMSELNVLKELGKHP 362 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEeccccc-------CcHHHHHHHHHHHHHHHhcCCc
Confidence 67788888888889999999999999863 2349999998653 2234567889999999885 99
Q ss_pred ceeeEeeeEecCCCCeEEEEEeeccCCCHHHHHhhhc---------------cCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 000893 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------------RHLDRRKRLIIAMDAAFGMEYLHSKNIV 1170 (1236)
Q Consensus 1106 NIVrLyG~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~---------------r~LSe~erl~Ia~QIAeALaYLHSkGII 1170 (1236)
||+.++|+|.. .+.+++|+||+..|+|..+++.+. ..+.....+.++.||+.|++||++..+|
T Consensus 363 niv~llG~~t~--~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~v 440 (609)
T KOG0200|consen 363 NIVNLLGACTQ--DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCV 440 (609)
T ss_pred chhhheeeecc--CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCcc
Confidence 99999999988 468999999999999999998766 3488889999999999999999999999
Q ss_pred cCCCCCCcEEEccCCCCCCcEEEEeccCcccccCcccc--cCcCC--CCcccchhhhcCCCCC
Q 000893 1171 HFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVT--GGVRG--TLPWMAPELLNGSSSK 1229 (1236)
Q Consensus 1171 HRDIKPsNILLDsdG~I~ltVKLsDFGLArii~ns~~t--ss~~G--Tp~YmAPEVL~Gss~~ 1229 (1236)
||||..+||||..+. ++||+|||+|+........ ..-.| ...|||||.|....+.
T Consensus 441 HRDLAaRNVLi~~~~----~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft 499 (609)
T KOG0200|consen 441 HRDLAARNVLITKNK----VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFT 499 (609)
T ss_pred chhhhhhhEEecCCC----EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCccc
Confidence 999999999999874 7899999999965433222 22222 2349999999874333
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-21 Score=211.92 Aligned_cols=176 Identities=29% Similarity=0.435 Sum_probs=139.7
Q ss_pred EEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCC---eE
Q 000893 1048 KELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG---TL 1122 (1236)
Q Consensus 1048 kkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g---~L 1122 (1236)
+.||.|+||.||-..+ .|+.||+|++.... ..-...+++.+|+.+|..++|.|++.++++.+-+.-. .+
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf------q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF------QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHH------HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 5699999999999988 58899999886532 2344567889999999999999999999887754321 34
Q ss_pred EEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcccc
Q 000893 1123 ATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 1202 (1236)
Q Consensus 1123 ~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii 1202 (1236)
|+|+|.| ..+|..++- ....++...++-+++||++||.|||+.+|+||||||.|+|++.+. ++||||||+++..
T Consensus 133 YV~TELm-QSDLHKIIV-SPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNC----vLKICDFGLARve 206 (449)
T KOG0664|consen 133 YVLTELM-QSDLHKIIV-SPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNC----ILKICDFGLARTW 206 (449)
T ss_pred HHHHHHH-Hhhhhheec-cCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCc----eEEeccccccccc
Confidence 6677777 556666653 356788899999999999999999999999999999999999886 7899999999986
Q ss_pred cCccc--ccCcCCCCcccchhhhcCCCCCCCccccC
Q 000893 1203 RNTLV--TGGVRGTLPWMAPELLNGSSSKVSEKVCF 1236 (1236)
Q Consensus 1203 ~ns~~--tss~~GTp~YmAPEVL~Gss~~~SdDVDI 1236 (1236)
+.... -+..+-|.+|+|||++.|.. .|+..+||
T Consensus 207 e~d~~~hMTqEVVTQYYRAPEiLMGaR-hYs~AvDi 241 (449)
T KOG0664|consen 207 DQRDRLNMTHEVVTQYYRAPELLMGAR-RYTGAVDI 241 (449)
T ss_pred chhhhhhhHHHHHHHHhccHHHhhcch-hhcCccce
Confidence 53322 22334588999999999874 55555553
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.3e-21 Score=225.44 Aligned_cols=169 Identities=30% Similarity=0.453 Sum_probs=144.1
Q ss_pred ccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCC
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1041 ~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~ 1118 (1236)
.++|+++..+|.|++|.|||+++ ++...|||+++...-. ...-++.|+-+++.++|||||.++|.+....
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d--------d~~~iqqei~~~~dc~h~nivay~gsylr~d 85 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD--------DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD 85 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc--------cccccccceeeeecCCCcChHHHHhhhhhhc
Confidence 46899999999999999999998 4778999999875311 1234567999999999999999999988754
Q ss_pred CCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccC
Q 000893 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1236)
Q Consensus 1119 ~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGL 1198 (1236)
.+|++||||.+|+|++..+- ...+++.++.+++++.+.||+|||+.|-+|||||-.|||+++.|+ +||+|||.
T Consensus 86 --klwicMEycgggslQdiy~~-TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gD----vklaDfgv 158 (829)
T KOG0576|consen 86 --KLWICMEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGD----VKLADFGV 158 (829)
T ss_pred --CcEEEEEecCCCcccceeee-cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCc----eeecccCc
Confidence 89999999999999987643 457999999999999999999999999999999999999999985 59999999
Q ss_pred cccccCcc-cccCcCCCCcccchhhhc
Q 000893 1199 SKIKRNTL-VTGGVRGTLPWMAPELLN 1224 (1236)
Q Consensus 1199 Arii~ns~-~tss~~GTp~YmAPEVL~ 1224 (1236)
+..+.... ....++||++|||||+..
T Consensus 159 saqitati~KrksfiGtpywmapEvaa 185 (829)
T KOG0576|consen 159 SAQITATIAKRKSFIGTPYWMAPEVAA 185 (829)
T ss_pred hhhhhhhhhhhhcccCCccccchhHHH
Confidence 87665433 234688999999999974
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.7e-20 Score=200.41 Aligned_cols=172 Identities=22% Similarity=0.331 Sum_probs=146.1
Q ss_pred cccccccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCC-CCceeeEee
Q 000893 1036 LQIIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYG 1112 (1236)
Q Consensus 1036 LqiIs~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLr-HPNIVrLyG 1112 (1236)
+..-..++|++.+++|+|.++.||.|.. +...|+||++++.. .+.+.+|+.+|..|. ||||++|++
T Consensus 32 i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk-----------kkKIkREikIL~nL~gg~NIi~L~D 100 (338)
T KOG0668|consen 32 IDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK-----------KKKIKREIKILQNLRGGPNIIKLLD 100 (338)
T ss_pred eeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH-----------HHHHHHHHHHHHhccCCCCeeehhh
Confidence 3445668999999999999999999985 57789999998642 456789999999998 999999999
Q ss_pred eEecCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEE
Q 000893 1113 VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 1192 (1236)
Q Consensus 1113 ~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVK 1192 (1236)
+..++......||+||+.+.+...+. ..++...+..++.+++.||.|||+.||+|||+||.|++|+...+ .++
T Consensus 101 iV~Dp~SktpaLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~r---kLr 173 (338)
T KOG0668|consen 101 IVKDPESKTPSLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELR---KLR 173 (338)
T ss_pred hhcCccccCchhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhc---eee
Confidence 99998888889999999998887765 24777888899999999999999999999999999999997753 579
Q ss_pred EEeccCcccccCcccccCcCCCCcccchhhhcC
Q 000893 1193 VGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNG 1225 (1236)
Q Consensus 1193 LsDFGLArii~ns~~tss~~GTp~YmAPEVL~G 1225 (1236)
|+|+|||.+.-...-..-.+.+..|--||.+..
T Consensus 174 lIDWGLAEFYHp~~eYnVRVASRyfKGPELLVd 206 (338)
T KOG0668|consen 174 LIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 206 (338)
T ss_pred eeecchHhhcCCCceeeeeeehhhcCCchheee
Confidence 999999998755544444556778899999864
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.6e-20 Score=211.09 Aligned_cols=184 Identities=27% Similarity=0.306 Sum_probs=153.7
Q ss_pred ccccccccccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCC------C
Q 000893 1033 ISTLQIIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH------H 1104 (1236)
Q Consensus 1033 ~seLqiIs~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLr------H 1104 (1236)
-..+.++-..+|.+....|+|-|++|.+|.+ .|..||||+|.. ++.+.+.=++|+++|++|+ -
T Consensus 423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn---------NE~M~KtGl~EleiLkKL~~AD~Edk 493 (752)
T KOG0670|consen 423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN---------NEVMHKTGLKELEILKKLNDADPEDK 493 (752)
T ss_pred EEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeec---------chHHhhhhhHHHHHHHHhhccCchhh
Confidence 3456777788999999999999999999998 478899999976 3445556678999999996 3
Q ss_pred CceeeEeeeEecCCCCeEEEEEeeccCCCHHHHHhhhcc--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEc
Q 000893 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER--HLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVN 1182 (1236)
Q Consensus 1105 PNIVrLyG~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~r--~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLD 1182 (1236)
-|+++|+..|...+ ++|||+|.+ ..+|.++|..-++ .+....+..++.|+..||..|..+||+|+||||+|||++
T Consensus 494 ~Hclrl~r~F~hkn--HLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVN 570 (752)
T KOG0670|consen 494 FHCLRLFRHFKHKN--HLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVN 570 (752)
T ss_pred hHHHHHHHHhhhcc--eeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEec
Confidence 58999999998865 999999998 7899999976554 577788899999999999999999999999999999999
Q ss_pred cCCCCCCcEEEEeccCcccccCcccccCcCCCCcccchhhhcCCCCCCCc
Q 000893 1183 LKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSE 1232 (1236)
Q Consensus 1183 sdG~I~ltVKLsDFGLArii~ns~~tss~~GTp~YmAPEVL~Gss~~~Sd 1232 (1236)
... .++||||||.|........+. ++-+..|.|||+|+|-.+.+.-
T Consensus 571 E~k---~iLKLCDfGSA~~~~eneitP-YLVSRFYRaPEIiLG~~yd~~i 616 (752)
T KOG0670|consen 571 ESK---NILKLCDFGSASFASENEITP-YLVSRFYRAPEIILGLPYDYPI 616 (752)
T ss_pred cCc---ceeeeccCccccccccccccH-HHHHHhccCcceeecCcccCCc
Confidence 765 368999999998876655543 3346779999999998655543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.9e-18 Score=170.90 Aligned_cols=172 Identities=36% Similarity=0.543 Sum_probs=142.7
Q ss_pred eeEEEEeccCCceEEEEeeecCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCC-ceeeEeeeEecCCCCeE
Q 000893 1044 LEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP-NVVAFYGVVQDGPGGTL 1122 (1236)
Q Consensus 1044 YeiLkkLGsGSFGtVYKArlkG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHP-NIVrLyG~f~t~~~g~L 1122 (1236)
|.+.+.||.|+||.||++.+. ..+++|.+....... ......|.+|+.+++.+.|+ +|+++++.+.... ..
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~-----~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESK-----SKEVERFLREIQILASLNHPPNIVKLYDFFQDEG--SL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccc-----hhHHHHHHHHHHHHHHccCCcceeeEEEEEecCC--EE
Confidence 677889999999999999988 778999987654221 12456788999999999988 7999999996543 58
Q ss_pred EEEEeeccCCCHHHHHhhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcc
Q 000893 1123 ATVTEFMVNGSLRHVLLSKE--RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1236)
Q Consensus 1123 ~LVMEYm~GGSL~dlL~~k~--r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLAr 1200 (1236)
+++++|+.+++|..++.... ..+.......++.|++.+|.|+|..+++||||||+|||++..+. .++++|||+++
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~---~~~l~dfg~~~ 150 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR---VVKLIDFGLAK 150 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCC---eEEEeccCcce
Confidence 99999999999997665433 26889999999999999999999999999999999999998752 46999999998
Q ss_pred cccCcc-------cccCcCCCCcccchhhhcCC
Q 000893 1201 IKRNTL-------VTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1201 ii~ns~-------~tss~~GTp~YmAPEVL~Gs 1226 (1236)
...... .....+||..|+|||.+.+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~ 183 (384)
T COG0515 151 LLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGL 183 (384)
T ss_pred ecCCCCccccccccccccccccccCCHHHhcCC
Confidence 654332 34567899999999999874
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.9e-19 Score=181.82 Aligned_cols=146 Identities=21% Similarity=0.178 Sum_probs=108.1
Q ss_pred EEeccCCceEEEEeee-cCceEEEEeeeccccCCCChH------------------HHHHHHHHHHHHHHHhhCCCCcee
Q 000893 1048 KELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRSSE------------------QERLTLEFWREAEILSKLHHPNVV 1108 (1236)
Q Consensus 1048 kkLGsGSFGtVYKArl-kG~~VAVKvLkk~~i~~~~~e------------------~er~~keFlrEIrILskLrHPNIV 1108 (1236)
..||+|+||.||+|.+ +|+.||||+++.......... .........+|+.+|..+.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 4699999999999998 588999999986532111100 000112234599999999888774
Q ss_pred eEeeeEecCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHH-HHCCcccCCCCCCcEEEccCCCC
Q 000893 1109 AFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYL-HSKNIVHFDLKCDNLLVNLKDPI 1187 (1236)
Q Consensus 1109 rLyG~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYL-HSkGIIHRDIKPsNILLDsdG~I 1187 (1236)
..+.+... ..+|||||+++++|...+. ....++...++.++.|++.+|.|| |+.||+||||||+|||++. +
T Consensus 83 ~p~~~~~~----~~~iVmE~i~g~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~-~-- 154 (190)
T cd05147 83 CPEPILLK----SHVLVMEFIGDDGWAAPRL-KDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD-G-- 154 (190)
T ss_pred CCcEEEec----CCEEEEEEeCCCCCcchhh-hcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC-C--
Confidence 43333222 2379999998877765432 235688999999999999999999 6999999999999999984 3
Q ss_pred CCcEEEEeccCccccc
Q 000893 1188 RPICKVGDFGLSKIKR 1203 (1236)
Q Consensus 1188 ~ltVKLsDFGLArii~ 1203 (1236)
.++|+|||+|....
T Consensus 155 --~v~LiDFG~a~~~~ 168 (190)
T cd05147 155 --KLYIIDVSQSVEHD 168 (190)
T ss_pred --cEEEEEccccccCC
Confidence 57999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.1e-18 Score=176.93 Aligned_cols=148 Identities=19% Similarity=0.143 Sum_probs=110.7
Q ss_pred EEEeccCCceEEEEeee-cCceEEEEeeeccccCCCC------------------hHHHHHHHHHHHHHHHHhhCCCCce
Q 000893 1047 LKELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRS------------------SEQERLTLEFWREAEILSKLHHPNV 1107 (1236)
Q Consensus 1047 LkkLGsGSFGtVYKArl-kG~~VAVKvLkk~~i~~~~------------------~e~er~~keFlrEIrILskLrHPNI 1107 (1236)
+..||+|+||.||+|.+ +|+.||||+++........ .........+.+|...+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 45799999999999998 4899999999875311000 0001112234679999999999988
Q ss_pred eeEeeeEecCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCcEEEccCCC
Q 000893 1108 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDP 1186 (1236)
Q Consensus 1108 VrLyG~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHS-kGIIHRDIKPsNILLDsdG~ 1186 (1236)
.....+... ..+|||||++++++..... ....++......++.|++.+|.+||. +||+||||||+|||++ ++
T Consensus 82 ~~p~~~~~~----~~~lVmE~~~g~~~~~~~l-~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~- 154 (190)
T cd05145 82 PVPEPILLK----KNVLVMEFIGDDGSPAPRL-KDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG- 154 (190)
T ss_pred CCceEEEec----CCEEEEEEecCCCchhhhh-hhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC-
Confidence 554444333 2379999998875544322 23457788889999999999999999 9999999999999998 44
Q ss_pred CCCcEEEEeccCcccccC
Q 000893 1187 IRPICKVGDFGLSKIKRN 1204 (1236)
Q Consensus 1187 I~ltVKLsDFGLArii~n 1204 (1236)
.++|+|||++.....
T Consensus 155 ---~~~liDFG~a~~~~~ 169 (190)
T cd05145 155 ---KPYIIDVSQAVELDH 169 (190)
T ss_pred ---CEEEEEcccceecCC
Confidence 579999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.7e-19 Score=198.65 Aligned_cols=179 Identities=24% Similarity=0.274 Sum_probs=143.6
Q ss_pred ccCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCC--C----ceeeEee
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH--P----NVVAFYG 1112 (1236)
Q Consensus 1041 ~EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrH--P----NIVrLyG 1112 (1236)
..+|+++..||+|+||+|-.+.+. +..||||+++.. .+.....+-|+++|.++.+ | -+|++.+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---------~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~ 158 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---------DKYREAALIEIEVLQKINESDPNGKFRCVQMRD 158 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---------HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence 578999999999999999999874 567999999753 1223334569999999842 2 3678888
Q ss_pred eEecCCCCeEEEEEeeccCCCHHHHHhhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCC----
Q 000893 1113 VVQDGPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPI---- 1187 (1236)
Q Consensus 1113 ~f~t~~~g~L~LVMEYm~GGSL~dlL~~k-~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I---- 1187 (1236)
||... ++++||+|.+ |-++.++|... ...++...+..|++|++.+++|||+.+++|.||||+|||+......
T Consensus 159 wFdyr--ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~ 235 (415)
T KOG0671|consen 159 WFDYR--GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYN 235 (415)
T ss_pred hhhcc--CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEec
Confidence 88774 5999999998 77999999764 4579999999999999999999999999999999999999643211
Q ss_pred ------------CCcEEEEeccCcccccCcccccCcCCCCcccchhhhcCCCCCCCcc
Q 000893 1188 ------------RPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEK 1233 (1236)
Q Consensus 1188 ------------~ltVKLsDFGLArii~ns~~tss~~GTp~YmAPEVL~Gss~~~SdD 1233 (1236)
...+||+|||.|....... ..++-|..|+|||+|+|-++.+.+|
T Consensus 236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLGwS~pCD 291 (415)
T KOG0671|consen 236 PKKKVCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLGWSQPCD 291 (415)
T ss_pred cCCccceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccCcCCccC
Confidence 1358999999998765444 4467899999999999876655554
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.3e-19 Score=197.31 Aligned_cols=179 Identities=27% Similarity=0.366 Sum_probs=146.9
Q ss_pred ccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCC
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1041 ~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~ 1118 (1236)
..+|.-++.+|.|.- .|..+.+ .++.||||.+.... . .....++..+|+.++..++|+||++++.+|.-..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf-~-----n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~ 88 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPF-Q-----NQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQK 88 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcc-c-----cCccchhhhhhhhhhhhhcccceeeeeeccCccc
Confidence 357888899999998 6766665 58899999887652 2 1233456778999999999999999999876322
Q ss_pred ----CCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEE
Q 000893 1119 ----GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1236)
Q Consensus 1119 ----~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLs 1194 (1236)
....|+||||| ..+|.+.+. -.++-.....|++|++.|+.|||+.||+||||||+||++..++ ++||.
T Consensus 89 ~l~~~~e~y~v~e~m-~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~----~lKi~ 160 (369)
T KOG0665|consen 89 TLEEFQEVYLVMELM-DANLCQVIL---MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDC----TLKIL 160 (369)
T ss_pred cHHHHHhHHHHHHhh-hhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchh----heeec
Confidence 13568999999 788888886 2367788889999999999999999999999999999999887 67999
Q ss_pred eccCcccccCcccccCcCCCCcccchhhhcCCCCCCCccccC
Q 000893 1195 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVCF 1236 (1236)
Q Consensus 1195 DFGLArii~ns~~tss~~GTp~YmAPEVL~Gss~~~SdDVDI 1236 (1236)
|||+|+........+.++.|..|.|||++.|.. +++.+||
T Consensus 161 dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~--~ke~vdi 200 (369)
T KOG0665|consen 161 DFGLARTEDTDFMMTPYVVTRYYRAPEVILGMG--YKENVDI 200 (369)
T ss_pred cchhhcccCcccccCchhheeeccCchheeccC--Ccccchh
Confidence 999999877666667788999999999999985 6666654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=8.9e-19 Score=206.22 Aligned_cols=172 Identities=27% Similarity=0.309 Sum_probs=137.6
Q ss_pred ccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhC-CCCceeeEeeeEecC
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDG 1117 (1236)
Q Consensus 1041 ~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskL-rHPNIVrLyG~f~t~ 1117 (1236)
.+.|.+...+|.|+|+.|-++.+ +++..+||++.+... .-.+|+.++... .||||+++++.+.+.
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------------~~~~e~~~~~~~~~h~niv~~~~v~~~~ 388 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD------------DNQDEIPISLLVRDHPNIVKSHDVYEDG 388 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc------------ccccccchhhhhcCCCcceeecceecCC
Confidence 46778888899999999999988 577799999986521 122466555554 699999999999986
Q ss_pred CCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEc-cCCCCCCcEEEEec
Q 000893 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVN-LKDPIRPICKVGDF 1196 (1236)
Q Consensus 1118 ~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLD-sdG~I~ltVKLsDF 1196 (1236)
. ..|+|||++.|+-|.+.+..... +. .++..|+.+|+.|+.|||.+|||||||||+|||++ ..+ +++|+||
T Consensus 389 ~--~~~~v~e~l~g~ell~ri~~~~~-~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g----~lrltyF 460 (612)
T KOG0603|consen 389 K--EIYLVMELLDGGELLRRIRSKPE-FC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAG----HLRLTYF 460 (612)
T ss_pred c--eeeeeehhccccHHHHHHHhcch-hH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCC----cEEEEEe
Confidence 5 99999999999988887754432 22 67778999999999999999999999999999995 555 5699999
Q ss_pred cCcccccCcccccCcCCCCcccchhhhcCCCCCCCccc
Q 000893 1197 GLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKV 1234 (1236)
Q Consensus 1197 GLArii~ns~~tss~~GTp~YmAPEVL~Gss~~~SdDV 1234 (1236)
|.++..... ..+.|-|..|.|||++....+...+||
T Consensus 461 G~a~~~~~~--~~tp~~t~~y~APEvl~~~~yt~acD~ 496 (612)
T KOG0603|consen 461 GFWSELERS--CDTPALTLQYVAPEVLAIQEYTEACDW 496 (612)
T ss_pred chhhhCchh--hcccchhhcccChhhhccCCCCcchhh
Confidence 999987666 233466899999999997755555553
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=1e-17 Score=171.17 Aligned_cols=143 Identities=22% Similarity=0.274 Sum_probs=114.8
Q ss_pred EEeccCCceEEEEeeecCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeEEEEEe
Q 000893 1048 KELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTE 1127 (1236)
Q Consensus 1048 kkLGsGSFGtVYKArlkG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L~LVME 1127 (1236)
+.||+|++|.||+|.+.+..|+||+...................+.+|+.++..+.|++|+....++.... ..++|||
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE--NFIIVME 79 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC--CCEEEEE
Confidence 56999999999999999999999987654332211222233456789999999999999887776665543 6789999
Q ss_pred eccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcccc
Q 000893 1128 FMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 1202 (1236)
Q Consensus 1128 Ym~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii 1202 (1236)
|++|++|.+++.... . .+..++.+++.+|.+||..+++|||++|.|||++ ++ .++|+|||+++..
T Consensus 80 ~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~----~~~liDf~~a~~~ 144 (211)
T PRK14879 80 YIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GG----KIYLIDFGLAEFS 144 (211)
T ss_pred EeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CC----CEEEEECCcccCC
Confidence 999999999885422 2 7778899999999999999999999999999998 43 5689999998864
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.6e-18 Score=178.51 Aligned_cols=142 Identities=21% Similarity=0.248 Sum_probs=106.2
Q ss_pred EEEeccCCceEEEEeeecCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhC-----CCCceeeEeeeEecCCC-C
Q 000893 1047 LKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-----HHPNVVAFYGVVQDGPG-G 1120 (1236)
Q Consensus 1047 LkkLGsGSFGtVYKArlkG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskL-----rHPNIVrLyG~f~t~~~-g 1120 (1236)
.+.||+|+||.||....... .+||++..... .....+.+|+.+++.+ .||||+++||++.+..+ +
T Consensus 7 ~~~LG~G~~~~Vy~hp~~~~-k~IKv~~~~~~--------~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g 77 (210)
T PRK10345 7 QSPLGTGRHRKCYAHPEDAQ-RCIKIVYHRGD--------GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTG 77 (210)
T ss_pred cceecCCCceEEEECCCCcC-eEEEEEecccc--------chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCe
Confidence 46799999999997332333 36888765321 1234578999999999 67999999999998642 3
Q ss_pred eEE-EEEee--ccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHH-HHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEe-
Q 000893 1121 TLA-TVTEF--MVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGM-EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD- 1195 (1236)
Q Consensus 1121 ~L~-LVMEY--m~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeAL-aYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsD- 1195 (1236)
.++ +|||| +.+++|.+++.+. .+++. ..++.+++.++ +|||+++||||||||+|||++..+.....++|+|
T Consensus 78 ~v~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 78 YVYDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEEEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 434 78999 5579999999543 35555 35677888888 9999999999999999999986543334789999
Q ss_pred ccCccc
Q 000893 1196 FGLSKI 1201 (1236)
Q Consensus 1196 FGLAri 1201 (1236)
||....
T Consensus 154 ~G~~~~ 159 (210)
T PRK10345 154 IGESTF 159 (210)
T ss_pred CCCcce
Confidence 555444
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.9e-17 Score=182.88 Aligned_cols=181 Identities=23% Similarity=0.255 Sum_probs=139.7
Q ss_pred CeeEEEEeccCCceEEEEeeecC---ceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCC----CceeeEeeeEe
Q 000893 1043 DLEELKELGSGTFGTVYHGKWRG---TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH----PNVVAFYGVVQ 1115 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArlkG---~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrH----PNIVrLyG~f~ 1115 (1236)
+|.+.++||+|+||.||++.... ..+|+|+......... ..+..|+.+|..+.. +++..+++...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--------~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~ 90 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--------SVLKIEIQVLKKLEKKNGPSHFPKLLDHGR 90 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--------ccchhHHHHHHHHhhhcCCCCCCEEEEecc
Confidence 89999999999999999999854 3589998765421110 134458888888763 68888888874
Q ss_pred cCCCCeEEEEEeeccCCCHHHHHhhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCC-CCCCcEEE
Q 000893 1116 DGPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKD-PIRPICKV 1193 (1236)
Q Consensus 1116 t~~~g~L~LVMEYm~GGSL~dlL~~k~-r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG-~I~ltVKL 1193 (1236)
......++||+.+ |.+|.++..... +.++...++.|+.|++.+|.+||+.|+|||||||.|+++.... .....+.|
T Consensus 91 -~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~l 168 (322)
T KOG1164|consen 91 -STEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYL 168 (322)
T ss_pred -CCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEE
Confidence 1234889999988 999999886554 7899999999999999999999999999999999999998764 21136899
Q ss_pred EeccCcc--ccc-Cc--------ccccCcCCCCcccchhhhcCCCCCCCcc
Q 000893 1194 GDFGLSK--IKR-NT--------LVTGGVRGTLPWMAPELLNGSSSKVSEK 1233 (1236)
Q Consensus 1194 sDFGLAr--ii~-ns--------~~tss~~GTp~YmAPEVL~Gss~~~SdD 1233 (1236)
.|||+++ ... .. .....+.||..|+++.+..+......+|
T Consensus 169 lDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DD 219 (322)
T KOG1164|consen 169 LDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDD 219 (322)
T ss_pred EecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchh
Confidence 9999998 311 11 1123466999999999998876655554
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.6e-18 Score=187.23 Aligned_cols=167 Identities=27% Similarity=0.375 Sum_probs=133.5
Q ss_pred cCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCC-CCceeeEeeeEecCC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLr-HPNIVrLyG~f~t~~ 1118 (1236)
+.|.+.+.||+|.||++-+++++ .+.+++|.++... ....+|.+|...--.|. |.||+..|.+.....
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---------tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~ 94 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---------TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTS 94 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---------hhHHHHHHHhccceeeccchhhhHHHHHHhhcC
Confidence 56888899999999999999996 4569999887642 33568999987755554 999999887644332
Q ss_pred CCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccC
Q 000893 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1236)
Q Consensus 1119 ~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGL 1198 (1236)
+..+++|||++-|+|..-+.. ..+.+...+.++.|++.||.|+|++++||||||.+||||-..+. ..|||||||+
T Consensus 95 -d~YvF~qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df--~rvKlcDFG~ 169 (378)
T KOG1345|consen 95 -DAYVFVQEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADF--YRVKLCDFGL 169 (378)
T ss_pred -ceEEEeeccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCc--cEEEeeeccc
Confidence 488899999999999987743 45888999999999999999999999999999999999976543 3899999999
Q ss_pred cccccCcccccCcCCCCcccchhhhc
Q 000893 1199 SKIKRNTLVTGGVRGTLPWMAPELLN 1224 (1236)
Q Consensus 1199 Arii~ns~~tss~~GTp~YmAPEVL~ 1224 (1236)
.+........ ..-+..|-+||...
T Consensus 170 t~k~g~tV~~--~~~~~~y~~pe~~~ 193 (378)
T KOG1345|consen 170 TRKVGTTVKY--LEYVNNYHAPELCD 193 (378)
T ss_pred ccccCceehh--hhhhcccCCcHHHh
Confidence 8765433221 22366789999875
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.8e-17 Score=166.81 Aligned_cols=140 Identities=22% Similarity=0.258 Sum_probs=108.7
Q ss_pred EeccCCceEEEEeeecCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeEEEEEee
Q 000893 1049 ELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEF 1128 (1236)
Q Consensus 1049 kLGsGSFGtVYKArlkG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L~LVMEY 1128 (1236)
.||+|+||+||+|.+.+..|+||+..................++.+|++++..++|+++.....++.... ..++||||
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD--NKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC--CCEEEEEE
Confidence 3899999999999999999999997654332222222333467889999999999887654444444432 56899999
Q ss_pred ccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCccccc
Q 000893 1129 MVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR 1203 (1236)
Q Consensus 1129 m~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~ 1203 (1236)
++|++|.+++..... .++.+++.+|.+||+.|++|+|++|.|||++ ++ .++|+|||+++...
T Consensus 79 ~~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~----~~~liDfg~a~~~~ 140 (199)
T TIGR03724 79 IEGKPLKDVIEEGND--------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DD----KLYLIDFGLGKYSD 140 (199)
T ss_pred ECCccHHHHHhhcHH--------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CC----cEEEEECCCCcCCC
Confidence 999999988743211 6788999999999999999999999999998 44 56999999988743
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1e-16 Score=172.91 Aligned_cols=175 Identities=23% Similarity=0.323 Sum_probs=141.7
Q ss_pred cccccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCC-CceeeEeeeE
Q 000893 1038 IIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH-PNVVAFYGVV 1114 (1236)
Q Consensus 1038 iIs~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrH-PNIVrLyG~f 1114 (1236)
.+....|.++++||.|+||.+|+|.. .|..||||+-....- ...+..|..+.+.|+| ..|..+.-++
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~----------hpqL~yEskvY~iL~~g~GiP~i~~y~ 80 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK----------HPQLLYESKVYRILQGGVGIPHIRHYG 80 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC----------CcchhHHHHHHHHhccCCCCchhhhhc
Confidence 45667899999999999999999987 689999998765431 1235568899998885 5677777666
Q ss_pred ecCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEE
Q 000893 1115 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1236)
Q Consensus 1115 ~t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLs 1194 (1236)
.+.. +-.+||+.+ |.+|.+++.-+.+.++...++.++-|++.-++|+|.+++|||||||+|+|..-+-+ +..+.|+
T Consensus 81 ~e~~--ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh-~~kl~LI 156 (341)
T KOG1163|consen 81 TEKD--YNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRH-CNKLYLI 156 (341)
T ss_pred cccc--cceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccc-cceEEEE
Confidence 6644 778999998 99999999888899999999999999999999999999999999999999986643 3478899
Q ss_pred eccCcccccCccc--------ccCcCCCCcccchhhhcCC
Q 000893 1195 DFGLSKIKRNTLV--------TGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1195 DFGLArii~ns~~--------tss~~GTp~YmAPEVL~Gs 1226 (1236)
|||||+...+... .....||..|++--...|.
T Consensus 157 DFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~ 196 (341)
T KOG1163|consen 157 DFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGI 196 (341)
T ss_pred eccchhhhccccccccCccccCCccceeeeehhhhhhhhh
Confidence 9999987543221 2346799999987666554
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.3e-17 Score=189.32 Aligned_cols=144 Identities=24% Similarity=0.228 Sum_probs=113.7
Q ss_pred eeEEEEeccCCceEEEEeeecCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeEE
Q 000893 1044 LEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLA 1123 (1236)
Q Consensus 1044 YeiLkkLGsGSFGtVYKArlkG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L~ 1123 (1236)
|...++||+|+||+||+|.+.+..+++|+..................++.+|+++++.++|++|+..+.++.... ..+
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~ 412 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE--EKT 412 (535)
T ss_pred cCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC--CCE
Confidence 345678999999999999998777777765433222111112233456889999999999999988877776643 568
Q ss_pred EEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCccccc
Q 000893 1124 TVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR 1203 (1236)
Q Consensus 1124 LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~ 1203 (1236)
+||||+++++|.+++. ....++.+++.+|.|||+++|+||||||+|||++ ++ .++|+|||+++...
T Consensus 413 lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~----~~~liDFGla~~~~ 478 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DD----RLYLIDFGLGKYSD 478 (535)
T ss_pred EEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CC----cEEEEeCcccccCC
Confidence 9999999999999884 3466889999999999999999999999999994 43 56999999998754
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.4e-16 Score=181.49 Aligned_cols=151 Identities=24% Similarity=0.298 Sum_probs=126.5
Q ss_pred cccccCCCCccccccccc-cCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHh
Q 000893 1024 VDLALGNFDISTLQIIKN-EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100 (1236)
Q Consensus 1024 ~dlal~nfd~seLqiIs~-EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILs 1100 (1236)
.++..+.|.+..+..... .+|.+.++||.|.|++||+|.++ .+.||+|+.+.. +......+.|+.+|+
T Consensus 59 ~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---------qhYtEaAlDEIklL~ 129 (590)
T KOG1290|consen 59 EDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---------QHYTEAALDEIKLLQ 129 (590)
T ss_pred hhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---------hHHHHHHHHHHHHHH
Confidence 355667787777777666 89999999999999999999984 567999998753 344556678999999
Q ss_pred hCC-----C---CceeeEeeeEec--CCCCeEEEEEeeccCCCHHHHHhhhc-cCCCHHHHHHHHHHHHHHHHHHHH-CC
Q 000893 1101 KLH-----H---PNVVAFYGVVQD--GPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHS-KN 1168 (1236)
Q Consensus 1101 kLr-----H---PNIVrLyG~f~t--~~~g~L~LVMEYm~GGSL~dlL~~k~-r~LSe~erl~Ia~QIAeALaYLHS-kG 1168 (1236)
.++ | .+||+|++.|.. +++.++++|+|++ |.+|..+|.... +.++...++.|++||+.||.|||+ .|
T Consensus 130 ~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecg 208 (590)
T KOG1290|consen 130 QVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECG 208 (590)
T ss_pred HHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcC
Confidence 884 3 479999999873 4566999999999 889998887654 579999999999999999999997 59
Q ss_pred cccCCCCCCcEEEccC
Q 000893 1169 IVHFDLKCDNLLVNLK 1184 (1236)
Q Consensus 1169 IIHRDIKPsNILLDsd 1184 (1236)
|||.||||+||||...
T Consensus 209 IIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 209 IIHTDLKPENVLLCST 224 (590)
T ss_pred ccccCCCcceeeeecc
Confidence 9999999999999754
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.8e-16 Score=176.54 Aligned_cols=175 Identities=23% Similarity=0.325 Sum_probs=141.5
Q ss_pred cccCeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCC-CCceeeEeeeEec
Q 000893 1040 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQD 1116 (1236)
Q Consensus 1040 s~EdYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLr-HPNIVrLyG~f~t 1116 (1236)
..-.|.+.++||+|+||.+|.|+. ++..||||.-.... + .-++..|.+..+.|. .++|...|.+..+
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS------~----APQLrdEYr~YKlL~g~~GIP~vYYFGqe 95 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS------E----APQLRDEYRTYKLLGGTEGIPQVYYFGQE 95 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccccC------C----cchHHHHHHHHHHHcCCCCCCceeeeccc
Confidence 345799999999999999999986 78999999755432 1 223445777777775 6899999887776
Q ss_pred CCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCC-CCcEEEEe
Q 000893 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPI-RPICKVGD 1195 (1236)
Q Consensus 1117 ~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I-~ltVKLsD 1195 (1236)
+. +-.||||++ |.+|+++..-+++.|+...++.|+.|++.-++|+|++.+|+|||||+|+||..-+.. ...+.|+|
T Consensus 96 G~--~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiD 172 (449)
T KOG1165|consen 96 GK--YNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIID 172 (449)
T ss_pred cc--hhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEe
Confidence 54 677899998 999999999999999999999999999999999999999999999999999764422 23678999
Q ss_pred ccCcccccCccccc--------CcCCCCcccchhhhcCCC
Q 000893 1196 FGLSKIKRNTLVTG--------GVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1196 FGLArii~ns~~ts--------s~~GTp~YmAPEVL~Gss 1227 (1236)
||+|+...+..+.. .+.||..||+----.|..
T Consensus 173 FGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE 212 (449)
T KOG1165|consen 173 FGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGRE 212 (449)
T ss_pred ccchhhhcCccccccCccccccccccceeeeEeeccccch
Confidence 99999876544332 466999999976666553
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=5.8e-16 Score=167.13 Aligned_cols=145 Identities=11% Similarity=0.066 Sum_probs=116.5
Q ss_pred ccccCeeEEEEeccCCceEEEEeeecCceEEEEeeeccccCCCChHHHHHHHH------HHHHHHHHhhCCCCceeeEee
Q 000893 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLE------FWREAEILSKLHHPNVVAFYG 1112 (1236)
Q Consensus 1039 Is~EdYeiLkkLGsGSFGtVYKArlkG~~VAVKvLkk~~i~~~~~e~er~~ke------FlrEIrILskLrHPNIVrLyG 1112 (1236)
+-..+|..+++||.|+||.||+....+..+|||++...... .+..... +.+|+..+.+|+||+|..+..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~-----~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d 102 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKR-----TERFLKSFVKGDYYENLIVQTDRVRSEGLASLND 102 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCc-----hHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceE
Confidence 44678999999999999999998777778999999765321 2333333 578999999999999999988
Q ss_pred eEecCC------CCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCC
Q 000893 1113 VVQDGP------GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP 1186 (1236)
Q Consensus 1113 ~f~t~~------~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~ 1186 (1236)
++.... .+..+|||||++|.+|.++.. +++ ....+++.+|..||..|++||||||.|||++.++
T Consensus 103 ~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 103 FYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred eeeecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-
Confidence 866432 235789999999999988741 222 2456999999999999999999999999998775
Q ss_pred CCCcEEEEeccCcccc
Q 000893 1187 IRPICKVGDFGLSKIK 1202 (1236)
Q Consensus 1187 I~ltVKLsDFGLArii 1202 (1236)
++|+|||.....
T Consensus 173 ----i~liDfg~~~~~ 184 (232)
T PRK10359 173 ----LRIIDLSGKRCT 184 (232)
T ss_pred ----EEEEECCCcccc
Confidence 599999988764
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.9e-16 Score=166.70 Aligned_cols=151 Identities=19% Similarity=0.139 Sum_probs=111.0
Q ss_pred CeeEEEEeccCCceEEEEee-e--cCceEEEEeeeccccCCC----------------ChHHHHHHHHHHHHHHHHhhCC
Q 000893 1043 DLEELKELGSGTFGTVYHGK-W--RGTDVAIKRIKKSCFTGR----------------SSEQERLTLEFWREAEILSKLH 1103 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKAr-l--kG~~VAVKvLkk~~i~~~----------------~~e~er~~keFlrEIrILskLr 1103 (1236)
-|.+.+.||+|+||.||+|. . +|+.||||+++....... ..........+.+|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46778899999999999998 3 689999999976431100 0001112234668999999997
Q ss_pred CCc--eeeEeeeEecCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCCCcEE
Q 000893 1104 HPN--VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKN-IVHFDLKCDNLL 1180 (1236)
Q Consensus 1104 HPN--IVrLyG~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkG-IIHRDIKPsNIL 1180 (1236)
+.+ +.+++.+ . ..++||||+.+.+|...+.. ...+.......++.||+.+|.+||.+| |+||||||+|||
T Consensus 109 ~~~i~~p~~~~~--~----~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIl 181 (237)
T smart00090 109 EAGVPVPKPIAW--R----RNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNIL 181 (237)
T ss_pred hcCCCCCeeeEe--c----CceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEE
Confidence 633 3445542 1 24799999998888765432 234556667789999999999999999 999999999999
Q ss_pred EccCCCCCCcEEEEeccCcccccCc
Q 000893 1181 VNLKDPIRPICKVGDFGLSKIKRNT 1205 (1236)
Q Consensus 1181 LDsdG~I~ltVKLsDFGLArii~ns 1205 (1236)
++ ++ .++|+|||++......
T Consensus 182 i~-~~----~i~LiDFg~a~~~~~~ 201 (237)
T smart00090 182 VH-DG----KVVIIDVSQSVELDHP 201 (237)
T ss_pred EE-CC----CEEEEEChhhhccCCc
Confidence 98 44 5699999999865443
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.9e-16 Score=179.98 Aligned_cols=140 Identities=24% Similarity=0.353 Sum_probs=118.9
Q ss_pred cCeeEEEEeccCCceEEEEeeec-----CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCC-CCceeeEeeeEe
Q 000893 1042 EDLEELKELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQ 1115 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArlk-----G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLr-HPNIVrLyG~f~ 1115 (1236)
..|...++||.|+|+.||++.+. .+.||+|.+..... ..++..|+++|..+. +-||+++.+++.
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----------p~ri~~El~~L~~~gG~~ni~~~~~~~r 105 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----------PSRILNELEMLYRLGGSDNIIKLNGCFR 105 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----------chHHHHHHHHHHHhccchhhhcchhhhc
Confidence 46788899999999999999863 45699999865432 335778999999986 899999999988
Q ss_pred cCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEe
Q 000893 1116 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1236)
Q Consensus 1116 t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsD 1195 (1236)
..+ ...+||||++.....+++. .++...+..+++.++.||.|+|.+|||||||||.|+|.+... ....|+|
T Consensus 106 nnd--~v~ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t---~rg~LvD 176 (418)
T KOG1167|consen 106 NND--QVAIVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRT---QRGVLVD 176 (418)
T ss_pred cCC--eeEEEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhccCccccCCCcccccccccc---CCceEEe
Confidence 754 8899999999999988884 367888999999999999999999999999999999998653 2457999
Q ss_pred ccCcc
Q 000893 1196 FGLSK 1200 (1236)
Q Consensus 1196 FGLAr 1200 (1236)
||||-
T Consensus 177 FgLA~ 181 (418)
T KOG1167|consen 177 FGLAQ 181 (418)
T ss_pred chhHH
Confidence 99986
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.1e-15 Score=163.69 Aligned_cols=157 Identities=17% Similarity=0.049 Sum_probs=115.4
Q ss_pred EEEEeccCCceEEEEeeecCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCC-CCceeeEeeeEecCCCCeEEE
Q 000893 1046 ELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQDGPGGTLAT 1124 (1236)
Q Consensus 1046 iLkkLGsGSFGtVYKArlkG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLr-HPNIVrLyG~f~t~~~g~L~L 1124 (1236)
+...|++|+||+||++...+..++.+.+.....- ........|.+|+++|++|. |++|++++++ ...++
T Consensus 6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~----~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~------~~~~l 75 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWW----LRGVAWWLARREALALRQLDGLPRTPRLLHW------DGRHL 75 (218)
T ss_pred cceeecCCCcceEEEeecCCceeeecccccchhh----hhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE------cCEEE
Confidence 3457999999999988888888988877654211 01112235789999999996 5889999886 14689
Q ss_pred EEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC-CCCcEEEccCCCCCCcEEEEeccCccccc
Q 000893 1125 VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDL-KCDNLLVNLKDPIRPICKVGDFGLSKIKR 1203 (1236)
Q Consensus 1125 VMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDI-KPsNILLDsdG~I~ltVKLsDFGLArii~ 1203 (1236)
+|||+.|.+|.+.+.. ....++.|++.+|.+||++||+|||| ||.|||++.++ .++|+|||+|....
T Consensus 76 vmeyI~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g----~i~LIDFG~A~~~~ 143 (218)
T PRK12274 76 DRSYLAGAAMYQRPPR--------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDG----SPAVIDFQLAVRGN 143 (218)
T ss_pred EEeeecCccHHhhhhh--------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCC----CEEEEECCCceecC
Confidence 9999999998754421 11346789999999999999999999 79999998776 46999999998543
Q ss_pred Ccccc--------------cCcCCCCcccchhhhc
Q 000893 1204 NTLVT--------------GGVRGTLPWMAPELLN 1224 (1236)
Q Consensus 1204 ns~~t--------------ss~~GTp~YmAPEVL~ 1224 (1236)
..... .-...++.|++|+...
T Consensus 144 ~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~ 178 (218)
T PRK12274 144 PRARWMRLLAREDLRHLLKHKRMYCPAALTPVERR 178 (218)
T ss_pred CcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHh
Confidence 22210 0012577888887643
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=1e-15 Score=157.19 Aligned_cols=144 Identities=19% Similarity=0.057 Sum_probs=106.7
Q ss_pred eeEEEEeccCCceEEEEeee-cCceEEEEeeeccccCCC--Ch------------HHHHHHHHHHHHHHHHhhCCCCc--
Q 000893 1044 LEELKELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGR--SS------------EQERLTLEFWREAEILSKLHHPN-- 1106 (1236)
Q Consensus 1044 YeiLkkLGsGSFGtVYKArl-kG~~VAVKvLkk~~i~~~--~~------------e~er~~keFlrEIrILskLrHPN-- 1106 (1236)
|.+.+.||+|+||.||++.. .|+.||||++........ .. ........+.+|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 66778899999999999988 588999999775321000 00 00011223677899999998874
Q ss_pred eeeEeeeEecCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCC
Q 000893 1107 VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP 1186 (1236)
Q Consensus 1107 IVrLyG~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~ 1186 (1236)
++..++. ...++||||+++++|..+... .....++.+++.++.++|..||+||||||+||||+.++
T Consensus 97 v~~~~~~------~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~- 162 (198)
T cd05144 97 VPKPIDW------NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE- 162 (198)
T ss_pred CCceeec------CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC-
Confidence 4444432 245899999999998765421 23456788999999999999999999999999998765
Q ss_pred CCCcEEEEeccCcccccC
Q 000893 1187 IRPICKVGDFGLSKIKRN 1204 (1236)
Q Consensus 1187 I~ltVKLsDFGLArii~n 1204 (1236)
.++|+|||++.....
T Consensus 163 ---~~~liDfg~~~~~~~ 177 (198)
T cd05144 163 ---KIYIIDWPQMVSTDH 177 (198)
T ss_pred ---cEEEEECCccccCCC
Confidence 679999999976443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.59 E-value=7.1e-16 Score=189.16 Aligned_cols=127 Identities=20% Similarity=0.187 Sum_probs=94.4
Q ss_pred hCCC-CceeeEeeeEecCC-----CCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Q 000893 1101 KLHH-PNVVAFYGVVQDGP-----GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDL 1174 (1236)
Q Consensus 1101 kLrH-PNIVrLyG~f~t~~-----~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDI 1174 (1236)
.++| +||++++++|.... ...++++|||+ +++|.++|......+++..++.|+.||+.||+|||++|||||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 4456 68888888873211 13677889987 77999999766667999999999999999999999999999999
Q ss_pred CCCcEEEccCCC---------------CCCcEEEEeccCcccccCc-----------------ccccCcCCCCcccchhh
Q 000893 1175 KCDNLLVNLKDP---------------IRPICKVGDFGLSKIKRNT-----------------LVTGGVRGTLPWMAPEL 1222 (1236)
Q Consensus 1175 KPsNILLDsdG~---------------I~ltVKLsDFGLArii~ns-----------------~~tss~~GTp~YmAPEV 1222 (1236)
||+||||+..+. ....+||+|||+++..... ......+||++|||||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 999999964321 1125688888887643210 00112468999999999
Q ss_pred hcCCCC
Q 000893 1223 LNGSSS 1228 (1236)
Q Consensus 1223 L~Gss~ 1228 (1236)
+.+..+
T Consensus 187 ~~~~~~ 192 (793)
T PLN00181 187 DNGSSS 192 (793)
T ss_pred hccCCC
Confidence 987644
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.7e-14 Score=145.03 Aligned_cols=144 Identities=19% Similarity=0.083 Sum_probs=96.5
Q ss_pred EEEeccCCceEEEEeeec-CceEEEEeeeccccCCCChHHH---------------H-HHHHHHHHHHHHhhCCCCc--e
Q 000893 1047 LKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQE---------------R-LTLEFWREAEILSKLHHPN--V 1107 (1236)
Q Consensus 1047 LkkLGsGSFGtVYKArlk-G~~VAVKvLkk~~i~~~~~e~e---------------r-~~keFlrEIrILskLrHPN--I 1107 (1236)
.+.||+|+||+||+|.+. ++.||||++............. . .......|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 457999999999999985 8899999987643211100000 0 0001134666666665443 4
Q ss_pred eeEeeeEecCCCCeEEEEEeeccCCCHHHH-HhhhccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCcEEEccCC
Q 000893 1108 VAFYGVVQDGPGGTLATVTEFMVNGSLRHV-LLSKERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKD 1185 (1236)
Q Consensus 1108 VrLyG~f~t~~~g~L~LVMEYm~GGSL~dl-L~~k~r~LSe~erl~Ia~QIAeALaYLHS-kGIIHRDIKPsNILLDsdG 1185 (1236)
.+.+++. ..++||||++++.+... +.... .. ..+..++.+++.++.++|. ++|+||||||+||+++ ++
T Consensus 82 ~~~~~~~------~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 82 PKPIDLN------RHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CceEecC------CCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC
Confidence 4444431 35899999988543211 11110 11 5567889999999999999 9999999999999999 54
Q ss_pred CCCCcEEEEeccCcccccC
Q 000893 1186 PIRPICKVGDFGLSKIKRN 1204 (1236)
Q Consensus 1186 ~I~ltVKLsDFGLArii~n 1204 (1236)
.++|+|||++.....
T Consensus 152 ----~~~liDfg~a~~~~~ 166 (187)
T cd05119 152 ----KVYIIDVPQAVEIDH 166 (187)
T ss_pred ----cEEEEECcccccccC
Confidence 569999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.7e-14 Score=152.38 Aligned_cols=146 Identities=14% Similarity=0.146 Sum_probs=107.2
Q ss_pred EEec-cCCceEEEEeeecCceEEEEeeeccccC-----CCChHHHHHHHHHHHHHHHHhhCCCCce--eeEeeeEecCCC
Q 000893 1048 KELG-SGTFGTVYHGKWRGTDVAIKRIKKSCFT-----GRSSEQERLTLEFWREAEILSKLHHPNV--VAFYGVVQDGPG 1119 (1236)
Q Consensus 1048 kkLG-sGSFGtVYKArlkG~~VAVKvLkk~~i~-----~~~~e~er~~keFlrEIrILskLrHPNI--VrLyG~f~t~~~ 1119 (1236)
..|| .|+.|+||++...+..++||.+....+. ...........++.+|+.++..|+|++| +..++++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 3576 7888899998888889999988643211 0000111233567889999999998885 677776544321
Q ss_pred C--eEEEEEeeccC-CCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEec
Q 000893 1120 G--TLATVTEFMVN-GSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1236)
Q Consensus 1120 g--~L~LVMEYm~G-GSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDF 1196 (1236)
. ..++||||++| .+|.+++.. ..++.. .+.+|+.+|.+||.+||+||||||.|||++.++ .++|+||
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~----~v~LIDf 186 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDG----KFWLIDF 186 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC----CEEEEEC
Confidence 1 23599999987 689888743 234443 356899999999999999999999999998775 5699999
Q ss_pred cCccccc
Q 000893 1197 GLSKIKR 1203 (1236)
Q Consensus 1197 GLArii~ 1203 (1236)
|.+....
T Consensus 187 g~~~~~~ 193 (239)
T PRK01723 187 DRGELRT 193 (239)
T ss_pred CCcccCC
Confidence 9988743
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.5e-14 Score=133.64 Aligned_cols=133 Identities=23% Similarity=0.162 Sum_probs=108.6
Q ss_pred EEEEeccCCceEEEEeeecCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCC--CceeeEeeeEecCCCCeEE
Q 000893 1046 ELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH--PNVVAFYGVVQDGPGGTLA 1123 (1236)
Q Consensus 1046 iLkkLGsGSFGtVYKArlkG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrH--PNIVrLyG~f~t~~~g~L~ 1123 (1236)
+++.||.|.++.||++...+..++||....... ...+.+|+.+++.++| .++++++.++... +..+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~----------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~--~~~~ 69 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK----------GADREREVAILQLLARKGLPVPKVLASGESD--GWSY 69 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc----------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC--CccE
Confidence 356799999999999999888899999865321 2357789999999986 5888998877654 4789
Q ss_pred EEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCCCcEEEccCCCCCCcEEEEeccCcc
Q 000893 1124 TVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK---NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1236)
Q Consensus 1124 LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSk---GIIHRDIKPsNILLDsdG~I~ltVKLsDFGLAr 1200 (1236)
++|||+.+..+..+ +......++.+++.+|.+||.. +++|+||+|.|||++..+ .++|+|||+++
T Consensus 70 ~v~e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~----~~~l~Df~~~~ 137 (155)
T cd05120 70 LLMEWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK----ILGIIDWEYAG 137 (155)
T ss_pred EEEEecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc----EEEEEeccccc
Confidence 99999988877643 4455667788999999999984 799999999999999754 57999999988
Q ss_pred cc
Q 000893 1201 IK 1202 (1236)
Q Consensus 1201 ii 1202 (1236)
..
T Consensus 138 ~~ 139 (155)
T cd05120 138 YG 139 (155)
T ss_pred CC
Confidence 64
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=2.8e-14 Score=177.13 Aligned_cols=186 Identities=22% Similarity=0.210 Sum_probs=139.4
Q ss_pred ccccccccccCeeEEEEeccCCceEEEEeee-cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCC---CCcee
Q 000893 1033 ISTLQIIKNEDLEELKELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH---HPNVV 1108 (1236)
Q Consensus 1033 ~seLqiIs~EdYeiLkkLGsGSFGtVYKArl-kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLr---HPNIV 1108 (1236)
+.+...+..+.|.+.+.||+|+||+||+|.. +|+.||||+=++... -+|.-=.+++.+|+ -+.|.
T Consensus 689 ~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~-----------WEfYI~~q~~~RLk~~~~~~~~ 757 (974)
T KOG1166|consen 689 PNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP-----------WEFYICLQVMERLKPQMLPSIM 757 (974)
T ss_pred ccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc-----------eeeeehHHHHHhhchhhhcchH
Confidence 3444567778999999999999999999987 688899998776431 12222233444444 23444
Q ss_pred eEeeeEecCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCC--
Q 000893 1109 AFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP-- 1186 (1236)
Q Consensus 1109 rLyG~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~-- 1186 (1236)
.+..+....+ .-+||+||.+.|+|.+++. ..+.+++..+..|+.|++.-+++||..+|||+||||+|+||...-.
T Consensus 758 ~~~~a~~~~~--~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~ 834 (974)
T KOG1166|consen 758 HISSAHVFQN--ASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICAD 834 (974)
T ss_pred HHHHHHccCC--cceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCC
Confidence 4444433332 4578999999999999996 6678999999999999999999999999999999999999964321
Q ss_pred -CCCcEEEEeccCcccc---cCcccccCcCCCCcccchhhhcCCCCCCCc
Q 000893 1187 -IRPICKVGDFGLSKIK---RNTLVTGGVRGTLPWMAPELLNGSSSKVSE 1232 (1236)
Q Consensus 1187 -I~ltVKLsDFGLArii---~ns~~tss~~GTp~YmAPEVL~Gss~~~Sd 1232 (1236)
....++|+|||.+.-+ .+.......++|-.+-++|+..|.++.|-.
T Consensus 835 ~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~ 884 (974)
T KOG1166|consen 835 SDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQI 884 (974)
T ss_pred CcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhh
Confidence 1246899999988643 344444567889999999999998665543
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.47 E-value=6.7e-14 Score=158.50 Aligned_cols=184 Identities=23% Similarity=0.316 Sum_probs=142.9
Q ss_pred cccCeeEEEEeccCCceEEEEeeecC-------ceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEee
Q 000893 1040 KNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 1112 (1236)
Q Consensus 1040 s~EdYeiLkkLGsGSFGtVYKArlkG-------~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG 1112 (1236)
...++++...+-+|+||.||+|.|.. +.|-+|.++... .+.....|+.|.-+|..+.||||..+.+
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A-------S~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA-------SQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc-------cHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 34567788889999999999997742 347788776542 3455677899999999999999999999
Q ss_pred eEecCCCCeEEEEEeeccCCCHHHHHhhh-------ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCC
Q 000893 1113 VVQDGPGGTLATVTEFMVNGSLRHVLLSK-------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKD 1185 (1236)
Q Consensus 1113 ~f~t~~~g~L~LVMEYm~GGSL~dlL~~k-------~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG 1185 (1236)
++.+.. ...+.++.++.-|+|..+|..+ .+.++..+...++.|++.|++|||++||||.||..+|++|++.
T Consensus 355 V~ie~~-~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~- 432 (563)
T KOG1024|consen 355 VSIEDY-ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQ- 432 (563)
T ss_pred EEeecc-CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhh-
Confidence 987643 5778899999999999999743 2456777888899999999999999999999999999999976
Q ss_pred CCCCcEEEEeccCcccccCcc---cccCcCCCCcccchhhhcCCCC-CCCcccc
Q 000893 1186 PIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSS-KVSEKVC 1235 (1236)
Q Consensus 1186 ~I~ltVKLsDFGLArii~ns~---~tss~~GTp~YmAPEVL~Gss~-~~SdDVD 1235 (1236)
+.|||+|=.++|-+-... .-...-....||+||.|..+.+ ..++.|.
T Consensus 433 ---LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWs 483 (563)
T KOG1024|consen 433 ---LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWS 483 (563)
T ss_pred ---eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHH
Confidence 588999999998643221 1112224567999999986533 3333343
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.2e-13 Score=166.26 Aligned_cols=175 Identities=28% Similarity=0.389 Sum_probs=130.8
Q ss_pred EEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeEE
Q 000893 1046 ELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLA 1123 (1236)
Q Consensus 1046 iLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L~ 1123 (1236)
....+|.|++|.|+.... ....++.|..... ...... .......+..|+.+-..|.|||++..+..+.... ...
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~~~~s-~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~--~~~ 397 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VKPTES-ERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID--GIL 397 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcc-cCCccc-HHHHhhhhhhheeecccccCCchhhhHHHHhhcc--cch
Confidence 456799999997776654 2333455543321 111122 2223333778888889999999988887777644 334
Q ss_pred EEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCccccc
Q 000893 1124 TVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR 1203 (1236)
Q Consensus 1124 LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~ 1203 (1236)
.+||||+. +|..++... ..+....+..++.|++.||+|||..||.|||||++|+|+...| .+||+|||.+....
T Consensus 398 ~~mE~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g----~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 398 QSMEYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENG----ILKIIDFGAASVFR 471 (601)
T ss_pred hhhhcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCC----ceEEeecCcceeec
Confidence 45999988 999888543 4688889999999999999999999999999999999999987 67999999988753
Q ss_pred Cc-----ccccCcCCCCcccchhhhcCCCCCC
Q 000893 1204 NT-----LVTGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1204 ns-----~~tss~~GTp~YmAPEVL~Gss~~~ 1230 (1236)
.. .....++|+-.|+|||++.+..+..
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydp 503 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDP 503 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccccccCc
Confidence 22 3456789999999999999875543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=5.6e-14 Score=166.32 Aligned_cols=160 Identities=30% Similarity=0.415 Sum_probs=130.0
Q ss_pred eccCCceEEEEeee-----cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCC-CCceeeEeeeEecCCCCeEE
Q 000893 1050 LGSGTFGTVYHGKW-----RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQDGPGGTLA 1123 (1236)
Q Consensus 1050 LGsGSFGtVYKArl-----kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLr-HPNIVrLyG~f~t~~~g~L~ 1123 (1236)
+|+|+||+|++++- .+.-+|+|++++......... ....|..++..++ ||++|+++..|+++. .++
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~------~t~~er~il~~~~~~~f~v~lhyafqt~~--kl~ 73 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT------HTKQERIILAFVHNTPFLVKLHYAFQTDG--KLY 73 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhccccccccccccc------ccccHHHHHhhccCCCceeeeeeeecccc--chh
Confidence 79999999998653 466699999987765433322 2345778888887 999999999999864 889
Q ss_pred EEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCccccc
Q 000893 1124 TVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR 1203 (1236)
Q Consensus 1124 LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~ 1203 (1236)
++++|+.+|.|...+.... .+.+.....+..+++.+++++|..+|+|||+|++||+++.+|++ |+.|||+++..-
T Consensus 74 l~ld~~rgg~lft~l~~~~-~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi----~~tdfglske~v 148 (612)
T KOG0603|consen 74 LILDFLRGGDLFTRLSKEV-MFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHI----KLTDFGLSKEAV 148 (612)
T ss_pred HhhhhcccchhhhccccCC-chHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCcc----ccCCchhhhHhH
Confidence 9999999999988875443 45555566667799999999999999999999999999999854 999999999865
Q ss_pred CcccccCcCCCCcccchhhhcC
Q 000893 1204 NTLVTGGVRGTLPWMAPELLNG 1225 (1236)
Q Consensus 1204 ns~~tss~~GTp~YmAPEVL~G 1225 (1236)
..... |||.-|||||++.|
T Consensus 149 ~~~~~---cgt~eymApEI~~g 167 (612)
T KOG0603|consen 149 KEKIA---CGTYEYRAPEIING 167 (612)
T ss_pred hhhhc---ccchhhhhhHhhhc
Confidence 44433 89999999999994
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.2e-12 Score=148.96 Aligned_cols=189 Identities=25% Similarity=0.289 Sum_probs=131.9
Q ss_pred ccccccccCeeEEEEeccCCceEEEEeeecC-------------------------------------ceEEEEeeeccc
Q 000893 1035 TLQIIKNEDLEELKELGSGTFGTVYHGKWRG-------------------------------------TDVAIKRIKKSC 1077 (1236)
Q Consensus 1035 eLqiIs~EdYeiLkkLGsGSFGtVYKArlkG-------------------------------------~~VAVKvLkk~~ 1077 (1236)
-...+..++|++.+.||+|-...||-++... -+.|||.+..-.
T Consensus 150 ~dskFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~ 229 (598)
T KOG4158|consen 150 IDSKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFE 229 (598)
T ss_pred hhcccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccc
Confidence 3445677899999999999999999875420 025666654332
Q ss_pred cCCCChHHHHHHHHHHHHH-------H-------HHhh--------CCCCceeeEeeeEecCC-----------------
Q 000893 1078 FTGRSSEQERLTLEFWREA-------E-------ILSK--------LHHPNVVAFYGVVQDGP----------------- 1118 (1236)
Q Consensus 1078 i~~~~~e~er~~keFlrEI-------r-------ILsk--------LrHPNIVrLyG~f~t~~----------------- 1118 (1236)
... ......+.+.+|. . ..+. .+|||||+++++|.+.-
T Consensus 230 ~~s---~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R 306 (598)
T KOG4158|consen 230 HDS---GDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPAR 306 (598)
T ss_pred cCC---chHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccce
Confidence 221 1222233333332 0 0111 25999999998775421
Q ss_pred --------CCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCc
Q 000893 1119 --------GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPI 1190 (1236)
Q Consensus 1119 --------~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~lt 1190 (1236)
...+|+||.-+ ..+|.+++.. +..+......|+.|+++|+.|||++||.|||+|.+||||..+......
T Consensus 307 ~~p~g~g~~~tlylvMkrY-~~tLr~yl~~--~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~ 383 (598)
T KOG4158|consen 307 WYPSGAGEPKTLYLVMKRY-RQTLREYLWT--RHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQ 383 (598)
T ss_pred ecccccCCCceEEEehhcc-hhhHHHHHhc--CCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcE
Confidence 24789999877 6799999954 346677777888999999999999999999999999999877666678
Q ss_pred EEEEeccCcccccCcccc-------cCcCCCCcccchhhhcCCCCC
Q 000893 1191 CKVGDFGLSKIKRNTLVT-------GGVRGTLPWMAPELLNGSSSK 1229 (1236)
Q Consensus 1191 VKLsDFGLArii~ns~~t-------ss~~GTp~YmAPEVL~Gss~~ 1229 (1236)
+.|+|||.|-.-+++... -..-|.-..||||+......+
T Consensus 384 LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp 429 (598)
T KOG4158|consen 384 LVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP 429 (598)
T ss_pred EEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence 899999988654332211 123477789999999876544
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.2e-11 Score=144.12 Aligned_cols=147 Identities=22% Similarity=0.235 Sum_probs=97.3
Q ss_pred EEeccCCceEEEEeee-cCceEEEEeeeccccCCCChH--------------------------HHH------HHHHHHH
Q 000893 1048 KELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRSSE--------------------------QER------LTLEFWR 1094 (1236)
Q Consensus 1048 kkLGsGSFGtVYKArl-kG~~VAVKvLkk~~i~~~~~e--------------------------~er------~~keFlr 1094 (1236)
+.||.|++|.||+|++ .|+.||||+.++.....-..+ -+. ....|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5699999999999998 589999999876421100000 000 0113566
Q ss_pred HHHHHhhCC-----CCceeeEeeeEecCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHH-HHHHHHHCC
Q 000893 1095 EAEILSKLH-----HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF-GMEYLHSKN 1168 (1236)
Q Consensus 1095 EIrILskLr-----HPNIVrLyG~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAe-ALaYLHSkG 1168 (1236)
|++.+.+++ +++| .+-.++.+-. +..+|||||++|++|.++........+ ...++..++. .+..+|..|
T Consensus 203 Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~-~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGV-YVPEVYWDRT-SERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCE-EeCCEehhhc-CCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC
Confidence 766666653 3332 2222222111 245899999999999887643322222 3345556655 478899999
Q ss_pred cccCCCCCCcEEEccCCCCCCcEEEEeccCccccc
Q 000893 1169 IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR 1203 (1236)
Q Consensus 1169 IIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~ 1203 (1236)
++|+|+||.||+++.++ .++|+|||++..+.
T Consensus 278 ~~H~D~hPgNilv~~~g----~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDG----KIIALDFGIVGRLS 308 (437)
T ss_pred ceeCCCCcccEEECCCC----cEEEEeCCCeeECC
Confidence 99999999999998876 56999999998754
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.2e-11 Score=119.94 Aligned_cols=130 Identities=18% Similarity=0.107 Sum_probs=95.5
Q ss_pred EEEeccCCceEEEEeeecCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCcee-eEeeeEecCCCCeEEEE
Q 000893 1047 LKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVV-AFYGVVQDGPGGTLATV 1125 (1236)
Q Consensus 1047 LkkLGsGSFGtVYKArlkG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIV-rLyG~f~t~~~g~L~LV 1125 (1236)
++.|+.|.++.||+++..+..|+||+...... ....+.+|+.+++.+.+.+++ +++.+... ..++|
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~---------~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~----~~~lv 69 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE---------LLINRENEAENSKLAAEAGIGPKLYYFDPE----TGVLI 69 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCcc---------cccCHHHHHHHHHHHHHhCCCCceEEEeCC----CCeEE
Confidence 46789999999999999889999998764321 012345688888888655544 55554332 23789
Q ss_pred EeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCc-----ccCCCCCCcEEEccCCCCCCcEEEEeccCcc
Q 000893 1126 TEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNI-----VHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1236)
Q Consensus 1126 MEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGI-----IHRDIKPsNILLDsdG~I~ltVKLsDFGLAr 1200 (1236)
|||++|.++.... .....++.+++.+|+.||..++ +|+|++|.||+++ ++ .++|+||+.+.
T Consensus 70 ~e~i~G~~l~~~~---------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~----~~~liDf~~a~ 135 (170)
T cd05151 70 TEFIEGSELLTED---------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DG----RLWLIDWEYAG 135 (170)
T ss_pred EEecCCCcccccc---------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CC----eEEEEeccccc
Confidence 9999998876431 1112356789999999999875 9999999999998 33 46899999988
Q ss_pred ccc
Q 000893 1201 IKR 1203 (1236)
Q Consensus 1201 ii~ 1203 (1236)
...
T Consensus 136 ~~~ 138 (170)
T cd05151 136 MND 138 (170)
T ss_pred CCC
Confidence 643
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.16 E-value=7.6e-11 Score=140.78 Aligned_cols=152 Identities=20% Similarity=0.246 Sum_probs=91.9
Q ss_pred CeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCC--------------------C------ChHHHHHHH----
Q 000893 1043 DLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTG--------------------R------SSEQERLTL---- 1090 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~--------------------~------~~e~er~~k---- 1090 (1236)
+|.. +.||+|++|.||+|+++ |+.||||++++..... . ...-++...
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 3444 67999999999999983 8999999998642100 0 000011111
Q ss_pred --HHHHHHHHHhhCC----CCceeeEeeeEecCCCCeEEEEEeeccCCCHHHHHhhhccC-----CCHHHHHHHHHHHHH
Q 000893 1091 --EFWREAEILSKLH----HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH-----LDRRKRLIIAMDAAF 1159 (1236)
Q Consensus 1091 --eFlrEIrILskLr----HPNIVrLyG~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~r~-----LSe~erl~Ia~QIAe 1159 (1236)
.|.+|+..+.+++ +...+.+-.++.+- ....+|||||+.|+.+.++..-.... +....+..++.|
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q--- 275 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ--- 275 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH---
Confidence 2445554444442 33333322222211 12457999999999998743211112 222222233333
Q ss_pred HHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCccccc
Q 000893 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR 1203 (1236)
Q Consensus 1160 ALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~ 1203 (1236)
++..|++|+|+||.||+++.++.....++++|||++..+.
T Consensus 276 ----if~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 276 ----VFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred ----HHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 3468999999999999999886434467999999988654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.16 E-value=8.4e-11 Score=116.54 Aligned_cols=83 Identities=24% Similarity=0.326 Sum_probs=69.8
Q ss_pred CCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcccccCcccccCc
Q 000893 1132 GSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGV 1211 (1236)
Q Consensus 1132 GSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~ns~~tss~ 1211 (1236)
|+|.+++...+..+++..++.|+.||+.||.|||+++ ||+|||++.++ .+|+ ||+++...... .
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~----~~~~--fG~~~~~~~~~----~ 64 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDG----LLKL--DGSVAFKTPEQ----S 64 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCcc----ceee--ccceEeecccc----C
Confidence 6899999776778999999999999999999999998 99999999876 4577 99998764432 2
Q ss_pred CCCCcccchhhhcCCCCCC
Q 000893 1212 RGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1212 ~GTp~YmAPEVL~Gss~~~ 1230 (1236)
.||+.|||||++.+..+..
T Consensus 65 ~g~~~y~aPE~~~~~~~~~ 83 (176)
T smart00750 65 RVDPYFMAPEVIQGQSYTE 83 (176)
T ss_pred CCcccccChHHhcCCCCcc
Confidence 5899999999998764433
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=5.6e-10 Score=118.15 Aligned_cols=139 Identities=21% Similarity=0.199 Sum_probs=107.4
Q ss_pred EeccCCceEEEEeeecCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeEEEEEee
Q 000893 1049 ELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEF 1128 (1236)
Q Consensus 1049 kLGsGSFGtVYKArlkG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L~LVMEY 1128 (1236)
.+++|+-+.||.+.+.|.++++|.-.++.+....-+..-...+-.+|++++.+++--.|..-+=++.++. ...|+|||
T Consensus 3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~--~~~I~me~ 80 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPD--NGLIVMEY 80 (204)
T ss_pred hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCC--CCEEEEEE
Confidence 5789999999999998888999976666665544444445566789999999987555443333344443 45679999
Q ss_pred ccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcccc
Q 000893 1129 MVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 1202 (1236)
Q Consensus 1129 m~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii 1202 (1236)
++|..|.+++... ...++..+-.-+.-||..||||+||.++||++..++ +.++||||+..-
T Consensus 81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-----i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-----IYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-----EEEEECCccccc
Confidence 9999999888543 245677888888999999999999999999998764 589999999863
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=2.5e-11 Score=150.19 Aligned_cols=171 Identities=22% Similarity=0.192 Sum_probs=125.8
Q ss_pred CeeEEEEeccCCceEEEEeeecCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeE
Q 000893 1043 DLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTL 1122 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArlkG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L 1122 (1236)
++...+.||++.|=+|.+|+++.-.|+||++-+..-.-. -+...+.++|++ .+.++|||.+.+.-+..+.. ..
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~s----L~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~k--AA 96 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTIS----LRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDK--AA 96 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCC----chHHHHHHHHHH-HHhhcCCcccchHHHHHhhH--HH
Confidence 677788899999999999999765699999876532111 111233344555 66789999999988766643 66
Q ss_pred EEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcccc
Q 000893 1123 ATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 1202 (1236)
Q Consensus 1123 ~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii 1202 (1236)
|||-+|+ .-+|.+.+. ....+...+.+.|+.|++.||.-||..||.|+|||.+||||+.=. ++.|+||..-+..
T Consensus 97 ylvRqyv-khnLyDRlS-TRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWN----W~~LtDFAsFKPt 170 (1431)
T KOG1240|consen 97 YLVRQYV-KHNLYDRLS-TRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWN----WLYLTDFASFKPT 170 (1431)
T ss_pred HHHHHHH-hhhhhhhhc-cchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeec----hhhhhcccccCCc
Confidence 7788887 678888873 345677888889999999999999999999999999999999755 5689999866542
Q ss_pred ----cCccccc----CcCCCCcccchhhhcCC
Q 000893 1203 ----RNTLVTG----GVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1203 ----~ns~~ts----s~~GTp~YmAPEVL~Gs 1226 (1236)
++..... +-..-.+|+|||.+...
T Consensus 171 YLPeDNPadf~fFFDTSrRRtCYiAPERFv~~ 202 (1431)
T KOG1240|consen 171 YLPEDNPADFTFFFDTSRRRTCYIAPERFVSA 202 (1431)
T ss_pred cCCCCCcccceEEEecCCceeeecChHhhhcc
Confidence 1111111 11123479999999753
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=9.4e-10 Score=116.56 Aligned_cols=154 Identities=21% Similarity=0.203 Sum_probs=115.2
Q ss_pred EEEEeccCCceEEEEeeecCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeEEEE
Q 000893 1046 ELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATV 1125 (1236)
Q Consensus 1046 iLkkLGsGSFGtVYKArlkG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L~LV 1125 (1236)
.+..|-+|+-+.|+++.+.|+.+.||.-....+.-..-++.-...+..+|+++|.+|+--.|.--.-+|.+.. .-+|+
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~--~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY--GGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC--CCeEE
Confidence 4567889999999999999999999976655555444445556677889999999987544432222343433 33569
Q ss_pred EeeccC-CCHHHHHhhhccC-CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcccc
Q 000893 1126 TEFMVN-GSLRHVLLSKERH-LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 1202 (1236)
Q Consensus 1126 MEYm~G-GSL~dlL~~k~r~-LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii 1202 (1236)
|||++| .++.+++...-.. ........++..|-..+.-||..+|||+||..+||+|..++.. +.+.|+|||++...
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~-~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQ-ITPILIDFGLSSVS 166 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCc-CceEEEeecchhcc
Confidence 999966 3788888665333 3333336788899999999999999999999999999988754 56689999998763
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.3e-09 Score=121.67 Aligned_cols=170 Identities=19% Similarity=0.230 Sum_probs=106.0
Q ss_pred CeeEEEEeccCCceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCC-----------Cceee
Q 000893 1043 DLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH-----------PNVVA 1109 (1236)
Q Consensus 1043 dYeiLkkLGsGSFGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrH-----------PNIVr 1109 (1236)
.+...+.||.|+++.||.+++ +++.+|||++.... .......+.+.+|......+.+ ..++.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~-----~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P 87 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA-----DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVP 87 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS-----TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEeccc-----ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEee
Confidence 456778999999999999999 46889999987543 1123335566666655555433 12222
Q ss_pred Eee--------eEecCCC-C-----eEEEEEeeccCCCHHHHHhh---hcc---CCCHHHHHHHHHHHHHHHHHHHHCCc
Q 000893 1110 FYG--------VVQDGPG-G-----TLATVTEFMVNGSLRHVLLS---KER---HLDRRKRLIIAMDAAFGMEYLHSKNI 1169 (1236)
Q Consensus 1110 LyG--------~f~t~~~-g-----~L~LVMEYm~GGSL~dlL~~---k~r---~LSe~erl~Ia~QIAeALaYLHSkGI 1169 (1236)
+-- ++....+ . ..+++|+-+ .++|..++.- ... .+....++.+..|+++.+++||..||
T Consensus 88 ~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~Gl 166 (288)
T PF14531_consen 88 LDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGL 166 (288)
T ss_dssp SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred eEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcce
Confidence 111 1111110 1 235677766 7788877532 222 23445567778999999999999999
Q ss_pred ccCCCCCCcEEEccCCCCCCcEEEEeccCcccccCcccccCcCCCCcccchhhhc
Q 000893 1170 VHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLN 1224 (1236)
Q Consensus 1170 IHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~ns~~tss~~GTp~YmAPEVL~ 1224 (1236)
+|+||||+|+|++.+| .++|+||+........... ...+..|.+||...
T Consensus 167 VHgdi~~~nfll~~~G----~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~ 215 (288)
T PF14531_consen 167 VHGDIKPENFLLDQDG----GVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELES 215 (288)
T ss_dssp EEST-SGGGEEE-TTS-----EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHH
T ss_pred EecccceeeEEEcCCC----CEEEcChHHHeecCceeec--cCCCcccCChhhhh
Confidence 9999999999999998 5699999876654433222 22457799999874
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.6e-10 Score=127.05 Aligned_cols=176 Identities=26% Similarity=0.451 Sum_probs=133.0
Q ss_pred ccccccCeeEEEEeccCCceEEEEeeecCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEec
Q 000893 1037 QIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1236)
Q Consensus 1037 qiIs~EdYeiLkkLGsGSFGtVYKArlkG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t 1116 (1236)
..+...++.++.+|.+...|..|+|+|.|..+++|++...... .+.-..|..|+-.|+.+.||||..++|.|..
T Consensus 185 ~gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t------~risrdfneefp~lrifshpnilpvlgacns 258 (448)
T KOG0195|consen 185 TGIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVT------ARISRDFNEEFPALRIFSHPNILPVLGACNS 258 (448)
T ss_pred cCcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcc------hhhcchhhhhCcceeeecCCchhhhhhhccC
Confidence 3445556667778999999999999999999999999765432 3334568889999999999999999999999
Q ss_pred CCCCeEEEEEeeccCCCHHHHHhhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC-cc-cCCCCCCcEEEccCCCCCCcEEE
Q 000893 1117 GPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKN-IV-HFDLKCDNLLVNLKDPIRPICKV 1193 (1236)
Q Consensus 1117 ~~~g~L~LVMEYm~GGSL~dlL~~k~-r~LSe~erl~Ia~QIAeALaYLHSkG-II-HRDIKPsNILLDsdG~I~ltVKL 1193 (1236)
+. .+.++..||+.|+|...|+... -.++..++..++.+|++|++|||+.. +| ---|....++||++-.. .+..
T Consensus 259 pp--nlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedlta--rism 334 (448)
T KOG0195|consen 259 PP--NLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTA--RISM 334 (448)
T ss_pred CC--CceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhh--heec
Confidence 76 8899999999999999997653 35778899999999999999999853 33 34578889999987421 2222
Q ss_pred EeccCcccccCcccccCcCCCCcccchhhhcCCCC
Q 000893 1194 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1194 sDFGLArii~ns~~tss~~GTp~YmAPEVL~Gss~ 1228 (1236)
+|--++- ...+..-.|.||+||.+.....
T Consensus 335 ad~kfsf------qe~gr~y~pawmspealqrkpe 363 (448)
T KOG0195|consen 335 ADTKFSF------QEVGRAYSPAWMSPEALQRKPE 363 (448)
T ss_pred ccceeee------eccccccCcccCCHHHHhcCch
Confidence 3321111 1111223688999999986543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.7e-10 Score=141.14 Aligned_cols=143 Identities=34% Similarity=0.452 Sum_probs=98.0
Q ss_pred cccCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecC
Q 000893 1040 KNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1236)
Q Consensus 1040 s~EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~ 1117 (1236)
...+|..++.|-.|++|.||+.+++ .+.+|+|+-+... ++|- ++.....|++|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l--------------ilRn--ilt~a~npfvv--------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL--------------ILRN--ILTFAGNPFVV--------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcccccch--------------hhhc--cccccCCccee---------
Confidence 3468899999999999999999885 7779996543221 1111 23333344433
Q ss_pred CCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEecc
Q 000893 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1236)
Q Consensus 1118 ~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFG 1197 (1236)
|+...++...+ .++. +++.+++|||+.||+|||+||+|.||+.-|++ |++|||
T Consensus 136 --------------gDc~tllk~~g-~lPv--------dmvla~Eylh~ygivhrdlkpdnllIT~mGhi----KlTDfg 188 (1205)
T KOG0606|consen 136 --------------GDCATLLKNIG-PLPV--------DMVLAVEYLHSYGIVHRDLKPDNLLITSMGHI----KLTDFG 188 (1205)
T ss_pred --------------chhhhhcccCC-CCcc--------hhhHHhHhhccCCeecCCCCCCcceeeecccc----cccchh
Confidence 44444442222 2222 23788999999999999999999999998854 999999
Q ss_pred CcccccCc----------------ccccCcCCCCcccchhhhcCCCCCCCccc
Q 000893 1198 LSKIKRNT----------------LVTGGVRGTLPWMAPELLNGSSSKVSEKV 1234 (1236)
Q Consensus 1198 LArii~ns----------------~~tss~~GTp~YmAPEVL~Gss~~~SdDV 1234 (1236)
+.+..... ......||||.|+|||++....|..-.||
T Consensus 189 Lsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdw 241 (1205)
T KOG0606|consen 189 LSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDW 241 (1205)
T ss_pred hhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccH
Confidence 98763210 11234789999999999987755555554
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.97 E-value=6.8e-09 Score=110.35 Aligned_cols=142 Identities=18% Similarity=0.110 Sum_probs=96.6
Q ss_pred EeccCCceEEEEeeec--------CceEEEEeeecccc--C-------CCCh--------HHHHHH-HHHHHHHHHHhhC
Q 000893 1049 ELGSGTFGTVYHGKWR--------GTDVAIKRIKKSCF--T-------GRSS--------EQERLT-LEFWREAEILSKL 1102 (1236)
Q Consensus 1049 kLGsGSFGtVYKArlk--------G~~VAVKvLkk~~i--~-------~~~~--------e~er~~-keFlrEIrILskL 1102 (1236)
.||.|.-+.||.|... +..+|||+++.... . ++.. ...... ....+|++.|++|
T Consensus 4 ~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~rl 83 (197)
T cd05146 4 CISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKRM 83 (197)
T ss_pred ccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 5899999999999764 36899999874321 1 1100 001111 1123799999998
Q ss_pred CC--CceeeEeeeEecCCCCeEEEEEeeccCCCHHH-HHhhhccCCCHHHHHHHHHHHHHHHHHH-HHCCcccCCCCCCc
Q 000893 1103 HH--PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRH-VLLSKERHLDRRKRLIIAMDAAFGMEYL-HSKNIVHFDLKCDN 1178 (1236)
Q Consensus 1103 rH--PNIVrLyG~f~t~~~g~L~LVMEYm~GGSL~d-lL~~k~r~LSe~erl~Ia~QIAeALaYL-HSkGIIHRDIKPsN 1178 (1236)
.- -++..++++ . .-+|||||+.+..+.. .+. ...++......+..+++.+|..| |..||||+||++.|
T Consensus 84 ~~~Gv~vP~pi~~--~----~~~lvME~Ig~~~~~~~~Lk--d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N 155 (197)
T cd05146 84 QKAGIPCPEVVVL--K----KHVLVMSFIGDDQVPAPKLK--DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN 155 (197)
T ss_pred HHcCCCCCeEEEe--c----CCEEEEEEcCCCCccchhhh--ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 63 456666654 2 3478999996543322 221 22345555667788999999998 89999999999999
Q ss_pred EEEccCCCCCCcEEEEeccCccccc
Q 000893 1179 LLVNLKDPIRPICKVGDFGLSKIKR 1203 (1236)
Q Consensus 1179 ILLDsdG~I~ltVKLsDFGLArii~ 1203 (1236)
||+..+ .+.|+|||.+-...
T Consensus 156 IL~~~~-----~v~iIDF~qav~~~ 175 (197)
T cd05146 156 MLWHDG-----KVWFIDVSQSVEPT 175 (197)
T ss_pred EEEECC-----cEEEEECCCceeCC
Confidence 999743 46899999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.92 E-value=4.8e-09 Score=106.82 Aligned_cols=144 Identities=24% Similarity=0.283 Sum_probs=101.7
Q ss_pred EEeccCCceEEEEeeecC-ceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCC--ceeeEeeeEecCC-CCeEE
Q 000893 1048 KELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP--NVVAFYGVVQDGP-GGTLA 1123 (1236)
Q Consensus 1048 kkLGsGSFGtVYKArlkG-~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHP--NIVrLyG~f~t~~-~g~L~ 1123 (1236)
+.|+.|.++.||+++..+ ..++||+....... .....+.+|+.+++.+.+. .+.+++.+..... .+..+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-------~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~ 76 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-------PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPF 76 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-------cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCce
Confidence 568999999999998865 88999987653210 1123466799999998763 4567777665421 13568
Q ss_pred EEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 000893 1124 TVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS------------------------------------- 1166 (1236)
Q Consensus 1124 LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHS------------------------------------- 1166 (1236)
+||||++|.+|...+.. ..++......++.+++.+|.+||+
T Consensus 77 ~v~e~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (223)
T cd05154 77 YVMERVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEP 154 (223)
T ss_pred EEEEEeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhccccc
Confidence 99999999887765421 245666666677777777777773
Q ss_pred -------------------CCcccCCCCCCcEEEccCCCCCCcEEEEeccCcccc
Q 000893 1167 -------------------KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 1202 (1236)
Q Consensus 1167 -------------------kGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii 1202 (1236)
..++|+|++|.|||++.++. ..+.|+||+.+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~--~~~~iID~e~~~~g 207 (223)
T cd05154 155 PAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEP--RVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCC--cEEEEEeccccccC
Confidence 23689999999999987311 14689999988764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >smart00666 PB1 PB1 domain | Back alignment and domain information |
|---|
Probab=98.80 E-value=2.4e-08 Score=90.60 Aligned_cols=75 Identities=47% Similarity=0.754 Sum_probs=66.2
Q ss_pred CCeeeecCceeEEEecCCCChHHHHHHHHHHcCC---ceEEEEecCCCCCCceeeccChHHHHHHHHHhhhccccCCCCc
Q 000893 203 GKLRYVGGETRIIRISRDISWQELTQKALAIYNQ---THTIKYQLPGEDLDALVSVSCDEDLQNMMEECNVLEDRGTQKP 279 (1236)
Q Consensus 203 ~~L~YvGGetriv~V~r~~sf~~l~~kl~~~~~~---~~~lKYqLP~edLDaLiSVt~DeDL~~M~~Eydr~~~~~~~~~ 279 (1236)
.+++| ||++|.+.|++.++|.+|+.++...++. .+.|||+ .||-| +|++++|+||..|++.+.+.. ...+
T Consensus 4 vK~~~-~~~~~~~~~~~~~s~~dL~~~i~~~~~~~~~~~~l~Y~--Dedgd-~v~l~sd~Dl~~a~~~~~~~~---~~~l 76 (81)
T smart00666 4 VKLRY-GGETRRLSVPRDISFEDLRSKVAKRFGLDNQSFTLKYQ--DEDGD-LVSLTSDEDLEEAIEEYDSLG---SKKL 76 (81)
T ss_pred EEEEE-CCEEEEEEECCCCCHHHHHHHHHHHhCCCCCCeEEEEE--CCCCC-EEEecCHHHHHHHHHHHHHcC---CceE
Confidence 46777 8999999999999999999999999985 6899999 67767 999999999999999998754 3578
Q ss_pred EEEEc
Q 000893 280 RMFLF 284 (1236)
Q Consensus 280 R~fLF 284 (1236)
|+++|
T Consensus 77 ~l~v~ 81 (81)
T smart00666 77 RLHVF 81 (81)
T ss_pred EEEeC
Confidence 99886
|
Phox and Bem1p domain, present in many eukaryotic cytoplasmic signalling proteins. The domain adopts a beta-grasp fold, similar to that found in ubiquitin and Ras-binding domains. A motif, variously termed OPR, PC and AID, represents the most conserved region of the majority of PB1 domains, and is necessary for PB1 domain function. This function is the formation of PB1 domain heterodimers, although not all PB1 domain pairs associate. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.3e-09 Score=127.90 Aligned_cols=108 Identities=30% Similarity=0.344 Sum_probs=88.2
Q ss_pred CeEEEEEeeccCCCHHHHHhhh--ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEecc
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSK--ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dlL~~k--~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFG 1197 (1236)
.+++|.|++|...+|.++|.++ ....++...+.++.|++.|++| ++.+|||+||.||+...+. .+||.|||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~----q~kIgDFg 401 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDD----QLKIGDFG 401 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccch----hhhhhhhh
Confidence 3689999999999999999643 3456777888999999999999 9999999999999998876 56999999
Q ss_pred CcccccCcc-------cccCcCCCCcccchhhhcCCCCCCCccccC
Q 000893 1198 LSKIKRNTL-------VTGGVRGTLPWMAPELLNGSSSKVSEKVCF 1236 (1236)
Q Consensus 1198 LArii~ns~-------~tss~~GTp~YmAPEVL~Gss~~~SdDVDI 1236 (1236)
+........ ..+.-+||.+||+||.|.|. .++.++||
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~--~y~~kvdI 445 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ--QYSEKVDI 445 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhh--hhhhhcch
Confidence 987654433 23446799999999999998 45555553
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.6e-07 Score=103.92 Aligned_cols=145 Identities=18% Similarity=0.099 Sum_probs=96.9
Q ss_pred EEEEeeecCceEEEEeeeccccCC---CChHHHHHHHHHHHHHHHHhhCCCCce--eeEeeeEecCC---CCeEEEEEee
Q 000893 1057 TVYHGKWRGTDVAIKRIKKSCFTG---RSSEQERLTLEFWREAEILSKLHHPNV--VAFYGVVQDGP---GGTLATVTEF 1128 (1236)
Q Consensus 1057 tVYKArlkG~~VAVKvLkk~~i~~---~~~e~er~~keFlrEIrILskLrHPNI--VrLyG~f~t~~---~g~L~LVMEY 1128 (1236)
.|++.++.|+.+.||......... .......-...+.+|.+.+.+|..-+| +.+.+++.... ...-+||||+
T Consensus 37 rvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~ 116 (268)
T PRK15123 37 RTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITED 116 (268)
T ss_pred eEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEee
Confidence 366788888899999764322100 000000001136788888888854333 34444443321 1246899999
Q ss_pred ccCC-CHHHHHhhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccC---CCCCCcEEEEeccCccc
Q 000893 1129 MVNG-SLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLK---DPIRPICKVGDFGLSKI 1201 (1236)
Q Consensus 1129 m~GG-SL~dlL~~k-~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsd---G~I~ltVKLsDFGLAri 1201 (1236)
+++. +|.+++... ....+...+..++.+++..+.-||..||+|+|+++.||||+.+ +.....+.|+||+.++.
T Consensus 117 l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 117 LAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred CCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 9876 899888532 2345666777899999999999999999999999999999852 11124689999998864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.76 E-value=9.4e-10 Score=133.14 Aligned_cols=173 Identities=23% Similarity=0.287 Sum_probs=132.4
Q ss_pred cCeeEEEEeccCCceEEEEeeec---CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCC-CCceeeEeeeEecC
Q 000893 1042 EDLEELKELGSGTFGTVYHGKWR---GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQDG 1117 (1236)
Q Consensus 1042 EdYeiLkkLGsGSFGtVYKArlk---G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLr-HPNIVrLyG~f~t~ 1117 (1236)
..|.+.+.||+|+|+.|-+.... ...+|+|.+.... ...........|..+-+.+. |+|++.+++....+
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~------~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~ 93 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP------KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSP 93 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC------CccchhhhcCccccccccccccccccccCCccCCC
Confidence 45666777999999999887663 3347777665432 01222334445777777777 99999999988876
Q ss_pred CCCeEEEEEeeccCCCHHHHH-hhhccCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCCCcEEEccCCCCCCcEEEEe
Q 000893 1118 PGGTLATVTEFMVNGSLRHVL-LSKERHLDRRKRLIIAMDAAFGMEYLH-SKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1236)
Q Consensus 1118 ~~g~L~LVMEYm~GGSL~dlL-~~k~r~LSe~erl~Ia~QIAeALaYLH-SkGIIHRDIKPsNILLDsdG~I~ltVKLsD 1195 (1236)
. ..+++++|..++++..-+ .......+...+..++.|+..+|.|+| ..++.||||||+|.+++..+. ..|++|
T Consensus 94 ~--~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~---~l~~~d 168 (601)
T KOG0590|consen 94 R--SYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGS---ALKIAD 168 (601)
T ss_pred c--ccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCC---cccCCC
Confidence 5 788999999999998877 332225666777788999999999999 999999999999999998872 349999
Q ss_pred ccCcccccC-c---ccccCcCC-CCcccchhhhcC
Q 000893 1196 FGLSKIKRN-T---LVTGGVRG-TLPWMAPELLNG 1225 (1236)
Q Consensus 1196 FGLArii~n-s---~~tss~~G-Tp~YmAPEVL~G 1225 (1236)
||+|..... . ......+| ++.|+|||...+
T Consensus 169 f~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~ 203 (601)
T KOG0590|consen 169 FGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSG 203 (601)
T ss_pred chhhccccccCCcceeeecccCCCCCCCCcccccc
Confidence 999987544 2 22345678 999999999987
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.9e-08 Score=118.94 Aligned_cols=122 Identities=35% Similarity=0.524 Sum_probs=101.4
Q ss_pred HhhCCCCceeeEeeeEecCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCc-ccCCCCCC
Q 000893 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNI-VHFDLKCD 1177 (1236)
Q Consensus 1099 LskLrHPNIVrLyG~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGI-IHRDIKPs 1177 (1236)
|+.+.|.||.+++|.+... ..++.|.+||..|+|.+.+......+++.-...++++|+.||.|||.-.| .|+.|+..
T Consensus 1 l~~l~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 4678899999999999987 48899999999999999998877788998888999999999999998755 99999999
Q ss_pred cEEEccCCCCCCcEEEEeccCcccccCc---ccccCcCCCCcccchhhhcCC
Q 000893 1178 NLLVNLKDPIRPICKVGDFGLSKIKRNT---LVTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1178 NILLDsdG~I~ltVKLsDFGLArii~ns---~~tss~~GTp~YmAPEVL~Gs 1226 (1236)
|++++.. |.+||+|||+..+.... .......-..-|.|||.+++.
T Consensus 79 nClvd~~----w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~ 126 (484)
T KOG1023|consen 79 NCLVDSR----WVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGA 126 (484)
T ss_pred cceeeee----EEEEechhhhcccccccccccccchhHHHHhccCHHHhccc
Confidence 9999976 68999999998876421 011111123459999999875
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.59 E-value=4.4e-07 Score=95.67 Aligned_cols=112 Identities=23% Similarity=0.166 Sum_probs=84.0
Q ss_pred HHHHHHHHHHhhCCCCc--eeeEeeeEecCCC--CeEEEEEeeccCC-CHHHHHhhhccCCCHHHHHHHHHHHHHHHHHH
Q 000893 1090 LEFWREAEILSKLHHPN--VVAFYGVVQDGPG--GTLATVTEFMVNG-SLRHVLLSKERHLDRRKRLIIAMDAAFGMEYL 1164 (1236)
Q Consensus 1090 keFlrEIrILskLrHPN--IVrLyG~f~t~~~--g~L~LVMEYm~GG-SL~dlL~~k~r~LSe~erl~Ia~QIAeALaYL 1164 (1236)
.++.+|...+..|..-. ++..+++...... ...+||+|++++. +|.+++..... .+......++.+++..+.-|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence 35677888877776433 3455555554322 2457999999874 89998865333 56667788999999999999
Q ss_pred HHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCccccc
Q 000893 1165 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR 1203 (1236)
Q Consensus 1165 HSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~ 1203 (1236)
|.+||+|+|+++.|||++.++ ....+.|+||+-++...
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~-~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDD-GQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCC-CceeEEEEcchhceeCC
Confidence 999999999999999999875 22467899999887643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.58 E-value=4.1e-07 Score=96.15 Aligned_cols=133 Identities=24% Similarity=0.154 Sum_probs=82.2
Q ss_pred EEEEeee-cCceEEEEeeecccc-----------CCC-------ChHHHHHHHHHHHHHHHHhhCCCC--ceeeEeeeEe
Q 000893 1057 TVYHGKW-RGTDVAIKRIKKSCF-----------TGR-------SSEQERLTLEFWREAEILSKLHHP--NVVAFYGVVQ 1115 (1236)
Q Consensus 1057 tVYKArl-kG~~VAVKvLkk~~i-----------~~~-------~~e~er~~keFlrEIrILskLrHP--NIVrLyG~f~ 1115 (1236)
.||.|.. .+..||||+.+.... ..+ ............+|++.|.++..- ++.+++.+-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899987 688899999864311 000 111222334567899999999865 456666542
Q ss_pred cCCCCeEEEEEeecc--CCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHH-HHHCCcccCCCCCCcEEEccCCCCCCcEE
Q 000893 1116 DGPGGTLATVTEFMV--NGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEY-LHSKNIVHFDLKCDNLLVNLKDPIRPICK 1192 (1236)
Q Consensus 1116 t~~~g~L~LVMEYm~--GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaY-LHSkGIIHRDIKPsNILLDsdG~I~ltVK 1192 (1236)
. -+|||||+. |..+..+.... ++......++.+++..+.. +|..||||+||.+.|||++.+ .+.
T Consensus 80 -~----~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-----~~~ 146 (188)
T PF01163_consen 80 -R----NVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-----KVY 146 (188)
T ss_dssp -T----TEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-----CEE
T ss_pred -C----CEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-----eEE
Confidence 2 268999998 65555443221 1133445567788886655 579999999999999999876 368
Q ss_pred EEeccCccccc
Q 000893 1193 VGDFGLSKIKR 1203 (1236)
Q Consensus 1193 LsDFGLArii~ 1203 (1236)
|+|||.+....
T Consensus 147 iIDf~qav~~~ 157 (188)
T PF01163_consen 147 IIDFGQAVDSS 157 (188)
T ss_dssp E--GTTEEETT
T ss_pred EEecCcceecC
Confidence 99999887644
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.50 E-value=5.6e-08 Score=115.65 Aligned_cols=181 Identities=26% Similarity=0.245 Sum_probs=136.4
Q ss_pred ccccCeeEEEEecc--CCceEEEEeee----cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCC-CCceeeEe
Q 000893 1039 IKNEDLEELKELGS--GTFGTVYHGKW----RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFY 1111 (1236)
Q Consensus 1039 Is~EdYeiLkkLGs--GSFGtVYKArl----kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLr-HPNIVrLy 1111 (1236)
.....|.+.+.+|. |.+|.||.+.. .+..+|+|.-+... .... ...+=++|+...++++ |+|.++.+
T Consensus 111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~-s~p~-----~~~~k~~~~~s~~~i~~~~~~v~~~ 184 (524)
T KOG0601|consen 111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF-SPPL-----DSKRKLREFLSHHKIDSHENPVRDS 184 (524)
T ss_pred hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCC-CCcc-----ccccccchhhcccccCccccccccC
Confidence 33456677788999 99999998776 35668998743221 1000 0112235676777775 99999988
Q ss_pred eeEecCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHH----HHHHHHHCCcccCCCCCCcEEEccCCCC
Q 000893 1112 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF----GMEYLHSKNIVHFDLKCDNLLVNLKDPI 1187 (1236)
Q Consensus 1112 G~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAe----ALaYLHSkGIIHRDIKPsNILLDsdG~I 1187 (1236)
..+... +.+|+-+|+| +.+|..+.......++....+.++.+... ||.++|..+++|-|+||.||++..+.
T Consensus 185 ~~~e~~--~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~-- 259 (524)
T KOG0601|consen 185 PAWEGS--GILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDW-- 259 (524)
T ss_pred cccccC--Ccceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheeccccc--
Confidence 888875 4889999988 78998888776677888889999999999 99999999999999999999999884
Q ss_pred CCcEEEEeccCcccccCccccc------CcCCCCcccchhhhcCCCCCCC
Q 000893 1188 RPICKVGDFGLSKIKRNTLVTG------GVRGTLPWMAPELLNGSSSKVS 1231 (1236)
Q Consensus 1188 ~ltVKLsDFGLArii~ns~~ts------s~~GTp~YmAPEVL~Gss~~~S 1231 (1236)
..++++|||+...+....... ...|..-|++||.+.+-....+
T Consensus 260 -~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~ 308 (524)
T KOG0601|consen 260 -TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFAS 308 (524)
T ss_pred -ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHh
Confidence 267999999988765443222 1246677999999988754443
|
|
| >PF00564 PB1: PB1 domain; InterPro: IPR000270 The Phox and Bem1p domain, is present in many eukaryotic cytoplasmic signalling proteins | Back alignment and domain information |
|---|
Probab=98.29 E-value=2.5e-06 Score=77.59 Aligned_cols=75 Identities=35% Similarity=0.593 Sum_probs=61.1
Q ss_pred eeeecCceeEEEecCCCChHHHHHHHHHHcCC---ceEEEEecCCCCCCceeeccChHHHHHHHHHhhhccccCCCCcEE
Q 000893 205 LRYVGGETRIIRISRDISWQELTQKALAIYNQ---THTIKYQLPGEDLDALVSVSCDEDLQNMMEECNVLEDRGTQKPRM 281 (1236)
Q Consensus 205 L~YvGGetriv~V~r~~sf~~l~~kl~~~~~~---~~~lKYqLP~edLDaLiSVt~DeDL~~M~~Eydr~~~~~~~~~R~ 281 (1236)
++|.|+..|++.+++.++|.+|+.++.+.++. .+.|+|+ .+|- .+|+|++|+||..|++.+.+. +..++||
T Consensus 6 ~~~~~~~~~~~~~~~~~s~~~L~~~i~~~~~~~~~~~~l~Y~--D~dg-D~V~i~sd~Dl~~a~~~~~~~---~~~~lrl 79 (84)
T PF00564_consen 6 VRYGGDIRRIISLPSDVSFDDLRSKIREKFGLLDEDFQLKYK--DEDG-DLVTISSDEDLQEAIEQAKES---GSKTLRL 79 (84)
T ss_dssp EEETTEEEEEEEECSTSHHHHHHHHHHHHHTTSTSSEEEEEE--ETTS-SEEEESSHHHHHHHHHHHHHC---TTSCEEE
T ss_pred EEECCeeEEEEEcCCCCCHHHHHHHHHHHhCCCCccEEEEee--CCCC-CEEEeCCHHHHHHHHHHHHhc---CCCcEEE
Confidence 44444445569999999999999999999985 6788987 4444 799999999999999999986 3458899
Q ss_pred EEcc
Q 000893 282 FLFS 285 (1236)
Q Consensus 282 fLF~ 285 (1236)
++..
T Consensus 80 ~v~~ 83 (84)
T PF00564_consen 80 FVQD 83 (84)
T ss_dssp EEEE
T ss_pred EEEe
Confidence 8853
|
The domain adopts a beta-grasp fold, similar to that found in ubiquitin and Ras-binding domains. A motif, variously termed OPR, PC and AID, represents the most conserved region of the majority of PB1 domains, and is necessary for PB1 domain function. This function is the formation of PB1 domain heterodimers, although not all PB1 domain pairs associate.; GO: 0005515 protein binding; PDB: 1IPG_A 1IP9_A 2KFK_A 1WMH_A 1VD2_A 1WI0_A 1OEY_C 1PQS_A 1Q1O_A 1TZ1_A .... |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.26 E-value=7.8e-07 Score=106.18 Aligned_cols=151 Identities=24% Similarity=0.207 Sum_probs=115.4
Q ss_pred ccccCeeEEEEeccCCceEEEEeeec---CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCC-CCceeeEeeeE
Q 000893 1039 IKNEDLEELKELGSGTFGTVYHGKWR---GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVV 1114 (1236)
Q Consensus 1039 Is~EdYeiLkkLGsGSFGtVYKArlk---G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLr-HPNIVrLyG~f 1114 (1236)
....+|.++..||.|.|+.|+....+ +..+++|.+.+....... .. .-+.|+.+...+. |.+++.++..|
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~--di----~sl~ev~l~~~l~~~~~~~g~~~~W 335 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFAS--DI----FSLGEVILEAILGSHLPSVGKNSSW 335 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHh--hh----cchhhhhHhhHhhcccccCCCCCCc
Confidence 34467899999999999999987653 566899988765432111 11 1134666666654 88999888777
Q ss_pred ecCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEE
Q 000893 1115 QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1236)
Q Consensus 1115 ~t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLs 1194 (1236)
..-. ..++-.|||+++++...+ .....+++..++.+..|++.++.++|+..++|+|+||+||++..++ +..++.
T Consensus 336 ~~~r--~~~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~---~~~~~~ 409 (524)
T KOG0601|consen 336 SQLR--QGYIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG---FFSKLG 409 (524)
T ss_pred cccc--cccCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch---hhhhcc
Confidence 6643 566899999999887666 3344678888899999999999999999999999999999998865 356899
Q ss_pred eccCccc
Q 000893 1195 DFGLSKI 1201 (1236)
Q Consensus 1195 DFGLAri 1201 (1236)
|||++..
T Consensus 410 ~~~~~t~ 416 (524)
T KOG0601|consen 410 DFGCWTR 416 (524)
T ss_pred ccccccc
Confidence 9998864
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.20 E-value=2.1e-05 Score=85.43 Aligned_cols=148 Identities=16% Similarity=0.058 Sum_probs=103.2
Q ss_pred eccCCceEEEEeeecCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCc--eeeEeeeEe--cCCCCeEEEE
Q 000893 1050 LGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN--VVAFYGVVQ--DGPGGTLATV 1125 (1236)
Q Consensus 1050 LGsGSFGtVYKArlkG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPN--IVrLyG~f~--t~~~g~L~LV 1125 (1236)
-|+|+.+-|++-.+.|..+=||.-.......-. ...-...|.+|+..|..|..-+ +.+...... .+..-.-+||
T Consensus 26 ~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r--~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVR--YPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeCCcEEEEEeccCccccccc--CCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence 467899999999888887888865422111000 0112346889999999886322 344442211 2212346789
Q ss_pred EeeccC-CCHHHHHhhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCccc
Q 000893 1126 TEFMVN-GSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201 (1236)
Q Consensus 1126 MEYm~G-GSL~dlL~~k~-r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLAri 1201 (1236)
+|-+.+ .+|.+++.... ...+...+..+..+|+..|.-||..|+.|+|+-+.|||++.++. ..|+++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~--~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGK--AEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCC--eeEEEEEhhccch
Confidence 998843 58888875432 24577777889999999999999999999999999999987663 3689999987765
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.18 E-value=2e-05 Score=85.05 Aligned_cols=135 Identities=26% Similarity=0.282 Sum_probs=97.2
Q ss_pred cCeeEEEEeccCCc-eEEEEeeecCceEEEEeeeccccCCCC------hHHH-------HHHHHHHHHHHHHhhCC---C
Q 000893 1042 EDLEELKELGSGTF-GTVYHGKWRGTDVAIKRIKKSCFTGRS------SEQE-------RLTLEFWREAEILSKLH---H 1104 (1236)
Q Consensus 1042 EdYeiLkkLGsGSF-GtVYKArlkG~~VAVKvLkk~~i~~~~------~e~e-------r~~keFlrEIrILskLr---H 1104 (1236)
.+++.++.||.|.- |.||+++..|+.+|||+++.-.+.... ...+ ....-|..|+++..+|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 68999999999999 999999999999999994322111111 0001 23345889999988886 4
Q ss_pred Cce--eeEeeeEecC----------------CCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHH
Q 000893 1105 PNV--VAFYGVVQDG----------------PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS 1166 (1236)
Q Consensus 1105 PNI--VrLyG~f~t~----------------~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHS 1166 (1236)
.++ |+.|||+.-. ......||.||++... .+... -+.+|++-|..+|.
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~----~~~~~~~dl~~~~k 182 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIR----DIPQMLRDLKILHK 182 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchh----HHHHHHHHHHHHHH
Confidence 466 8999987422 1124578999885544 11111 24578888999999
Q ss_pred CCcccCCCCCCcEEEccCCCCCCcEEEEeccCc
Q 000893 1167 KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1167 kGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLA 1199 (1236)
.||+-+|+++.|.. +| ||+|||.+
T Consensus 183 ~gI~~~Dv~~~ny~---~G------~lvDfs~~ 206 (207)
T PF13095_consen 183 LGIVPRDVKPRNYR---GG------KLVDFSSS 206 (207)
T ss_pred CCeeeccCcccccc---CC------EEEecccC
Confidence 99999999999997 44 89999864
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.15 E-value=8e-06 Score=99.21 Aligned_cols=119 Identities=25% Similarity=0.326 Sum_probs=94.5
Q ss_pred cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCCCCeEEEEEeeccCCCHHHHHhhhcc
Q 000893 1064 RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER 1143 (1236)
Q Consensus 1064 kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~r 1143 (1236)
.+.+|.|.+++... ........+-+.-|+.++||||++++..+... +.+|||+|-+ ..|..++...
T Consensus 36 ~~~~vsVF~~~~~~--------~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~--~~~ylvTErV--~Pl~~~lk~l-- 101 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSN--------GEVTELAKRAVKRLKTLRHPNILSYLDTTEEE--GTLYLVTERV--RPLETVLKEL-- 101 (690)
T ss_pred cCCceEEEEEeCCC--------chhhHHHHHHHHHhhhccCchhhhhhhhhccc--CceEEEeecc--ccHHHHHHHh--
Confidence 46778888887542 11223345677889999999999999998875 4999999988 6777777543
Q ss_pred CCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcccc
Q 000893 1144 HLDRRKRLIIAMDAAFGMEYLH-SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 1202 (1236)
Q Consensus 1144 ~LSe~erl~Ia~QIAeALaYLH-SkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii 1202 (1236)
........+.||+.||-||| .++++|++|.-+-|+|+..|+. ||++|.++...
T Consensus 102 --~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeW----kLggle~v~~~ 155 (690)
T KOG1243|consen 102 --GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEW----KLGGLELVSKA 155 (690)
T ss_pred --HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcE----EEeeeEEEecc
Confidence 35566667889999999998 5789999999999999999854 99999887654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.13 E-value=7e-06 Score=98.60 Aligned_cols=145 Identities=19% Similarity=0.236 Sum_probs=92.5
Q ss_pred EEeccCCceEEEEeeec-CceEEEEeeeccccC--------------------CC---C---hHHH------HHHHHHHH
Q 000893 1048 KELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFT--------------------GR---S---SEQE------RLTLEFWR 1094 (1236)
Q Consensus 1048 kkLGsGSFGtVYKArlk-G~~VAVKvLkk~~i~--------------------~~---~---~e~e------r~~keFlr 1094 (1236)
+.|+.++-|.||+|+++ |+.||||+.++..-. .. . ..-+ .....+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 46899999999999996 999999998764310 00 0 0000 11122556
Q ss_pred HHHHHhhCC-----CCce--eeEeeeEecCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHH-HHHHHH
Q 000893 1095 EAEILSKLH-----HPNV--VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFG-MEYLHS 1166 (1236)
Q Consensus 1095 EIrILskLr-----HPNI--VrLyG~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeA-LaYLHS 1166 (1236)
|+..+.+++ .++| .++|--+.+ .-.|+|||+.|..+.+...-....++... ++..++.+ +.-+-.
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~----~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~---ia~~~~~~f~~q~~~ 283 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTT----RRVLTMEWIDGIKISDIAALKSAGIDRKE---LAELLVRAFLRQLLR 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccC----CcEEEEEeeCCEecccHHHHHhcCCCHHH---HHHHHHHHHHHHHHh
Confidence 666666553 2332 233322222 45789999999998888543444455333 33333332 333445
Q ss_pred CCcccCCCCCCcEEEccCCCCCCcEEEEeccCccccc
Q 000893 1167 KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR 1203 (1236)
Q Consensus 1167 kGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~ 1203 (1236)
.|++|.|.+|.||+++.+|. +.+.|||+...+.
T Consensus 284 dgffHaDpHpGNi~v~~~g~----i~~lDfGi~g~l~ 316 (517)
T COG0661 284 DGFFHADPHPGNILVRSDGR----IVLLDFGIVGRLD 316 (517)
T ss_pred cCccccCCCccceEEecCCc----EEEEcCcceecCC
Confidence 89999999999999999974 4799999987654
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.11 E-value=1.2e-05 Score=96.75 Aligned_cols=149 Identities=15% Similarity=0.139 Sum_probs=93.8
Q ss_pred EEeccCCceEEEEeeec-CceEEEEeeeccccCCC---------------------------ChHHHH--HHHHHHHHHH
Q 000893 1048 KELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGR---------------------------SSEQER--LTLEFWREAE 1097 (1236)
Q Consensus 1048 kkLGsGSFGtVYKArlk-G~~VAVKvLkk~~i~~~---------------------------~~e~er--~~keFlrEIr 1097 (1236)
+.||.-+.|.||+|+++ |+.||||+-++..-..- ++-.+. ....|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 45899999999999994 78899999875421100 000000 0112555554
Q ss_pred HHhhC----CCCc------eeeEeeeEecCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHH-HHHH
Q 000893 1098 ILSKL----HHPN------VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGME-YLHS 1166 (1236)
Q Consensus 1098 ILskL----rHPN------IVrLyG~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALa-YLHS 1166 (1236)
-..++ .|-+ |.++|-.+.+ ...|+||||+|..+.++-.-....++...+.. .+.++.. -+-.
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st----~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~---~l~~~~~~qIf~ 319 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLST----KRVLTMEYVDGIKINDLDAIDKRGISPHDILN---KLVEAYLEQIFK 319 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCc----ceEEEEEecCCccCCCHHHHHHcCCCHHHHHH---HHHHHHHHHHHh
Confidence 44433 3544 5555554444 45899999999877665443444566664333 3333321 2234
Q ss_pred CCcccCCCCCCcEEEccCCCCCCcEEEEeccCccccc
Q 000893 1167 KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR 1203 (1236)
Q Consensus 1167 kGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~ 1203 (1236)
.|++|+|-+|.|||+..++.....+.+.|||+...+.
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 6899999999999999654333578999999987654
|
|
| >cd05992 PB1 The PB1 domain is a modular domain mediating specific protein-protein interactions which play a role in many critical cell processes, such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity | Back alignment and domain information |
|---|
Probab=98.10 E-value=1.5e-05 Score=72.13 Aligned_cols=73 Identities=37% Similarity=0.651 Sum_probs=57.7
Q ss_pred eeeecCceeEEEec-CCCChHHHHHHHHHHcCC---ceEEEEecCCCCCCceeeccChHHHHHHHHHhhhccccCCCCcE
Q 000893 205 LRYVGGETRIIRIS-RDISWQELTQKALAIYNQ---THTIKYQLPGEDLDALVSVSCDEDLQNMMEECNVLEDRGTQKPR 280 (1236)
Q Consensus 205 L~YvGGetriv~V~-r~~sf~~l~~kl~~~~~~---~~~lKYqLP~edLDaLiSVt~DeDL~~M~~Eydr~~~~~~~~~R 280 (1236)
++|- |++|.+.|+ +.++|.+|+.++.+.++. .+.|||. .||- .+|++++|+||..|++.+.+ ....++|
T Consensus 5 ~~~~-~~~~~~~~~~~~~s~~~L~~~i~~~~~~~~~~~~l~y~--D~e~-d~v~l~sd~Dl~~a~~~~~~---~~~~~l~ 77 (81)
T cd05992 5 VKYG-GEIRRFVVVSRSISFEDLRSKIAEKFGLDAVSFKLKYP--DEDG-DLVTISSDEDLEEAIEEARR---SGSKKLR 77 (81)
T ss_pred EEec-CCCEEEEEecCCCCHHHHHHHHHHHhCCCCCcEEEEee--CCCC-CEEEeCCHHHHHHHHHHHhh---cCCccEE
Confidence 4454 566777777 999999999999999985 5667776 4444 78999999999999999987 2345788
Q ss_pred EEEc
Q 000893 281 MFLF 284 (1236)
Q Consensus 281 ~fLF 284 (1236)
++++
T Consensus 78 l~v~ 81 (81)
T cd05992 78 LFVF 81 (81)
T ss_pred EEeC
Confidence 8875
|
A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domain, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as a noncanonical PB1-interactions. The PB1 domain module is conserved in amoebas, fungi, animals, and plants. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.08 E-value=1.6e-05 Score=89.11 Aligned_cols=141 Identities=24% Similarity=0.120 Sum_probs=98.4
Q ss_pred eEEEEeccCCceEEEEeee-cCceEEEEeeeccc--cCCCC------------hHHHHHHHHHHHHHHHHhhCCCC--ce
Q 000893 1045 EELKELGSGTFGTVYHGKW-RGTDVAIKRIKKSC--FTGRS------------SEQERLTLEFWREAEILSKLHHP--NV 1107 (1236)
Q Consensus 1045 eiLkkLGsGSFGtVYKArl-kG~~VAVKvLkk~~--i~~~~------------~e~er~~keFlrEIrILskLrHP--NI 1107 (1236)
.+..+||-|.-+.||.|.. +|.++|||.-+... +.... .-.........+|..+|..|.-. .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 4567899999999999998 59999999764321 10000 00012233457899999998754 66
Q ss_pred eeEeeeEecCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCC
Q 000893 1108 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPI 1187 (1236)
Q Consensus 1108 VrLyG~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I 1187 (1236)
.+.+++ +..++||||++|..|...- ++......|+..|++-+.-+-..||||+|+.+=|||++.+|.
T Consensus 174 P~P~~~------nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~- 240 (304)
T COG0478 174 PKPIAW------NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD- 240 (304)
T ss_pred CCcccc------ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC-
Confidence 677764 2557899999886665432 133344456666677666666899999999999999999974
Q ss_pred CCcEEEEeccCccc
Q 000893 1188 RPICKVGDFGLSKI 1201 (1236)
Q Consensus 1188 ~ltVKLsDFGLAri 1201 (1236)
+.++||=-+..
T Consensus 241 ---~~vIDwPQ~v~ 251 (304)
T COG0478 241 ---IVVIDWPQAVP 251 (304)
T ss_pred ---EEEEeCccccc
Confidence 48999966544
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.99 E-value=0.0001 Score=80.73 Aligned_cols=145 Identities=16% Similarity=0.127 Sum_probs=96.5
Q ss_pred cccccCeeEEEEeccCCceEEEEeeecCceEEEEeeeccccCCCChHHHHHHHHH------HHHHHHHhhCC---CCcee
Q 000893 1038 IIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEF------WREAEILSKLH---HPNVV 1108 (1236)
Q Consensus 1038 iIs~EdYeiLkkLGsGSFGtVYKArlkG~~VAVKvLkk~~i~~~~~e~er~~keF------lrEIrILskLr---HPNIV 1108 (1236)
.+...+|..++++-......|.+-...+..+++|....... ..++....| .+++..+.+++ --.++
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~-----r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~ 101 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENR-----RPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPA 101 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhh-----hHHHHHHHHhccHHHHHHHHHHHHHHHcCccccc
Confidence 34557889999999888899999999999999998865421 122333322 22333333332 22333
Q ss_pred eEeeeEecCC---CCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCC
Q 000893 1109 AFYGVVQDGP---GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKD 1185 (1236)
Q Consensus 1109 rLyG~f~t~~---~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG 1185 (1236)
.++.+..... ....+|||||++|..|.++.. +++ .+...|+.+|.-||..|+.|+|+.|.|+++..++
T Consensus 102 ~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~ 172 (229)
T PF06176_consen 102 DPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG 172 (229)
T ss_pred cceeeeeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc
Confidence 3333222111 124568999999988876542 222 2445677889999999999999999999999764
Q ss_pred CCCCcEEEEeccCccc
Q 000893 1186 PIRPICKVGDFGLSKI 1201 (1236)
Q Consensus 1186 ~I~ltVKLsDFGLAri 1201 (1236)
++++||+..+.
T Consensus 173 -----i~iID~~~k~~ 183 (229)
T PF06176_consen 173 -----IRIIDTQGKRM 183 (229)
T ss_pred -----EEEEECccccc
Confidence 68999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=97.96 E-value=5.3e-05 Score=90.39 Aligned_cols=139 Identities=17% Similarity=0.168 Sum_probs=104.4
Q ss_pred ceEEEEeee--cCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEecCC--CCeEEEEEeecc
Q 000893 1055 FGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP--GGTLATVTEFMV 1130 (1236)
Q Consensus 1055 FGtVYKArl--kG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~t~~--~g~L~LVMEYm~ 1130 (1236)
-.+.|++.. +|..|++|+++........ ....-+++++++.|+|||++..+|.+.. ...++||++|++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n--------k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP 360 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTN--------KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYP 360 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcc--------cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCC
Confidence 356788876 5888999999543222111 1112466889999999999999887432 247889999997
Q ss_pred C-CCHHHHHhh--------------hccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEe
Q 000893 1131 N-GSLRHVLLS--------------KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1236)
Q Consensus 1131 G-GSL~dlL~~--------------k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsD 1195 (1236)
+ ++|.++... .+...++...|.|+.|+..||.++|+.|+..+-|.|.+||++.+. +++|..
T Consensus 361 ~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~----RIriS~ 436 (655)
T KOG3741|consen 361 SSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM----RIRISG 436 (655)
T ss_pred CCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc----eEEEec
Confidence 5 477766532 134577899999999999999999999999999999999999774 568888
Q ss_pred ccCcccccCc
Q 000893 1196 FGLSKIKRNT 1205 (1236)
Q Consensus 1196 FGLArii~ns 1205 (1236)
.|+..++...
T Consensus 437 C~i~Dvl~~d 446 (655)
T KOG3741|consen 437 CGIMDVLQED 446 (655)
T ss_pred ccceeeecCC
Confidence 7777665443
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00022 Score=72.74 Aligned_cols=80 Identities=18% Similarity=0.192 Sum_probs=55.9
Q ss_pred EEEeccCCceEEEEeeecCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCC--ceeeEeeeEecC-CCCeEE
Q 000893 1047 LKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP--NVVAFYGVVQDG-PGGTLA 1123 (1236)
Q Consensus 1047 LkkLGsGSFGtVYKArlkG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHP--NIVrLyG~f~t~-~~g~L~ 1123 (1236)
++.|+.|..+.||+....+..+++|..... .....+.+|..+++.+... .+.+++.++... ..+..+
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~----------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~ 71 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP----------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPY 71 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH----------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEE
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC----------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccce
Confidence 467999999999999997789999987532 2234556788887777533 355666644322 234678
Q ss_pred EEEeeccCCCHHH
Q 000893 1124 TVTEFMVNGSLRH 1136 (1236)
Q Consensus 1124 LVMEYm~GGSL~d 1136 (1236)
++|+|++|..+..
T Consensus 72 ~~~~~i~g~~~~~ 84 (239)
T PF01636_consen 72 LLMEYIPGRPLDD 84 (239)
T ss_dssp EEEEEESSEEHHH
T ss_pred EEEEEeccccccc
Confidence 9999999987777
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.74 E-value=5.2e-06 Score=104.33 Aligned_cols=185 Identities=21% Similarity=0.178 Sum_probs=127.4
Q ss_pred cccccCeeEEEEeccCCceEEEEeeec--CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceeeEeeeEe
Q 000893 1038 IIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 1115 (1236)
Q Consensus 1038 iIs~EdYeiLkkLGsGSFGtVYKArlk--G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVrLyG~f~ 1115 (1236)
....+.+.+.+.+-+|+++.++.++-. +...++|+..+....... ......++-.++-..++|.++.....+.
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~-----~~~s~r~~s~~~i~p~~P~v~~~~~s~~ 874 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTN-----DYESIRSKSNILITPRSPAVVRSFPSFP 874 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccc-----cccccCCccCccccCCCCceecccCCCC
Confidence 345678888889999999999988764 333556655433211110 1122233444444455677776665533
Q ss_pred cCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEe
Q 000893 1116 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1236)
Q Consensus 1116 t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsD 1195 (1236)
. ...++|||+|+.+++|...|+..+ ..+...+..+...+..+++|||...++|||++|.|+|+..+++. +++|
T Consensus 875 ~--rsP~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~----~l~~ 947 (1205)
T KOG0606|consen 875 C--RSPLPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHR----PLTD 947 (1205)
T ss_pred C--CCCcchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCc----ccCc
Confidence 3 237899999999999999987655 34545555566688999999999999999999999999999865 8999
Q ss_pred ccCccccc-------C-------------------------cccccCcCCCCcccchhhhcCCCCCCCccc
Q 000893 1196 FGLSKIKR-------N-------------------------TLVTGGVRGTLPWMAPELLNGSSSKVSEKV 1234 (1236)
Q Consensus 1196 FGLArii~-------n-------------------------s~~tss~~GTp~YmAPEVL~Gss~~~SdDV 1234 (1236)
||+..... . ........||+.|++||.+.|.......+|
T Consensus 948 ~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~ 1018 (1205)
T KOG0606|consen 948 FGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADW 1018 (1205)
T ss_pred cccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchh
Confidence 98432100 0 011223568999999999998877776664
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.71 E-value=6.7e-05 Score=80.04 Aligned_cols=134 Identities=28% Similarity=0.320 Sum_probs=94.0
Q ss_pred eeEEEEeccCCceEEEEeeecCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCcee-eEeeeEecCCCCeE
Q 000893 1044 LEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVV-AFYGVVQDGPGGTL 1122 (1236)
Q Consensus 1044 YeiLkkLGsGSFGtVYKArlkG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIV-rLyG~f~t~~~g~L 1122 (1236)
....+.|++|++|.||+|.+.+..+|+|+-.... ....+..|+++|..+.--++. ++|.+-. .
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds----------~r~~l~kEakiLeil~g~~~~p~vy~yg~------~ 87 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDS----------PRRNLEKEAKILEILAGEGVTPEVYFYGE------D 87 (201)
T ss_pred hhhhhhhhcccccEEEEeeccCceEEEEEecCCc----------chhhHHHHHHHHHHhhhcCCCceEEEech------h
Confidence 3456789999999999999999999999876542 134567899999998876664 5555433 3
Q ss_pred EEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC-C-CcEEEccCCCCCCcEEEEeccCcc
Q 000893 1123 ATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLK-C-DNLLVNLKDPIRPICKVGDFGLSK 1200 (1236)
Q Consensus 1123 ~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIK-P-sNILLDsdG~I~ltVKLsDFGLAr 1200 (1236)
++.|||+.|..|..+-... +... ...++++-.-|-..||-|..|. | .||++.. + .+.|+||.-|.
T Consensus 88 ~i~me~i~G~~L~~~~~~~----~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~-~----~~~iIDFd~At 154 (201)
T COG2112 88 FIRMEYIDGRPLGKLEIGG----DRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVND-R----DVYIIDFDSAT 154 (201)
T ss_pred hhhhhhhcCcchhhhhhcc----cHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEecC-C----cEEEEEccchh
Confidence 5579999988998765321 2222 2345555455667799999998 4 4555554 3 34799999998
Q ss_pred cccCcc
Q 000893 1201 IKRNTL 1206 (1236)
Q Consensus 1201 ii~ns~ 1206 (1236)
....+.
T Consensus 155 ~k~~p~ 160 (201)
T COG2112 155 FKKKPR 160 (201)
T ss_pred hccCCc
Confidence 655443
|
|
| >cd06407 PB1_NLP A PB1 domain is present in NIN like proteins (NLP), a key enzyme in a process of establishment of symbiosis betweeen legumes and nitrogen fixing bacteria (Rhizobium) | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00022 Score=67.04 Aligned_cols=71 Identities=23% Similarity=0.464 Sum_probs=60.9
Q ss_pred ecCceeEEEecCCCChHHHHHHHHHHcC----CceEEEEecCCCCCCceeeccChHHHHHHHHHhhhccccCCCCcEEEE
Q 000893 208 VGGETRIIRISRDISWQELTQKALAIYN----QTHTIKYQLPGEDLDALVSVSCDEDLQNMMEECNVLEDRGTQKPRMFL 283 (1236)
Q Consensus 208 vGGetriv~V~r~~sf~~l~~kl~~~~~----~~~~lKYqLP~edLDaLiSVt~DeDL~~M~~Eydr~~~~~~~~~R~fL 283 (1236)
.||+++.+.|+.+++|.+|..++++.|+ ..++|||. .+| .-.|+++||+||+.-++-|... ...++|+|+
T Consensus 7 ~~~d~~r~~l~~~~~~~~L~~~i~~r~~~~~~~~f~LkY~--Dde-gd~v~ltsd~DL~eai~i~~~~---~~~~v~l~v 80 (82)
T cd06407 7 YGEEKIRFRLPPSWGFTELKQEIAKRFKLDDMSAFDLKYL--DDD-EEWVLLTCDADLEECIDVYRSS---GSHTIRLLV 80 (82)
T ss_pred eCCeEEEEEcCCCCCHHHHHHHHHHHhCCCCCCeeEEEEE--CCC-CCeEEeecHHHHHHHHHHHHHC---CCCeEEEEe
Confidence 3889999999999999999999999997 36899999 556 8899999999999888877664 345888887
Q ss_pred c
Q 000893 284 F 284 (1236)
Q Consensus 284 F 284 (1236)
.
T Consensus 81 ~ 81 (82)
T cd06407 81 H 81 (82)
T ss_pred e
Confidence 4
|
The PB1 domain is a modular domain mediating specific protein-protein interaction which play a role in many critical cell processes like osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-inte |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00064 Score=73.46 Aligned_cols=136 Identities=17% Similarity=0.182 Sum_probs=79.7
Q ss_pred EEeccCCceEEEEeeecCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCce--eeEeeeEecCCCCeEEEE
Q 000893 1048 KELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV--VAFYGVVQDGPGGTLATV 1125 (1236)
Q Consensus 1048 kkLGsGSFGtVYKArlkG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNI--VrLyG~f~t~~~g~L~LV 1125 (1236)
.+||.|..+.||+. .+..+++|...... ......+|.++++.+..-.+ .+.+.+..... ...+|
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~----------~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~--~~glv 72 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF----------DKETIKREFDASRKVFSLGIPTPHPFDLVEDGG--RLGLI 72 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC----------CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCC--eeeee
Confidence 56899999999984 35567888876422 01234678888888764333 56666665533 57789
Q ss_pred EeeccCCC-HHHHH--------------hh-----hc---cCCCHHHHH-HHHH----------HHHH-HHHHHHH----
Q 000893 1126 TEFMVNGS-LRHVL--------------LS-----KE---RHLDRRKRL-IIAM----------DAAF-GMEYLHS---- 1166 (1236)
Q Consensus 1126 MEYm~GGS-L~dlL--------------~~-----k~---r~LSe~erl-~Ia~----------QIAe-ALaYLHS---- 1166 (1236)
||+++|.. +...+ .. +. ......... .+.. .+.. ...+|..
T Consensus 73 ~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~ 152 (226)
T TIGR02172 73 YELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDT 152 (226)
T ss_pred eeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCC
Confidence 99998863 21111 00 00 001111100 0100 0111 1223321
Q ss_pred CCcccCCCCCCcEEEccCCCCCCcEEEEeccCcccc
Q 000893 1167 KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 1202 (1236)
Q Consensus 1167 kGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii 1202 (1236)
..++|+|+.|.||+++.++ +.|+||+.+...
T Consensus 153 ~~~~HgD~~~~Nii~~~~~-----~~iIDwe~a~~G 183 (226)
T TIGR02172 153 STCLHGDFQIGNLITSGKG-----TYWIDLGDFGYG 183 (226)
T ss_pred CceEecCCCCCcEEEcCCC-----cEEEechhcCcC
Confidence 2478999999999998765 379999988764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00036 Score=88.07 Aligned_cols=80 Identities=16% Similarity=0.231 Sum_probs=55.4
Q ss_pred EEEeccCCceEEEEeeecC----ceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCC-CCce--eeEeeeEecCC-
Q 000893 1047 LKELGSGTFGTVYHGKWRG----TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNV--VAFYGVVQDGP- 1118 (1236)
Q Consensus 1047 LkkLGsGSFGtVYKArlkG----~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLr-HPNI--VrLyG~f~t~~- 1118 (1236)
++.|+.|.+..+|+....+ ..+++|+........ ....+.+|+++|+.+. |++| .+++.+|.+..
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~-------~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v 115 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ-------SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASV 115 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc-------cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc
Confidence 4668999999999987643 357777764432110 1234668999999986 6665 78888876532
Q ss_pred CCeEEEEEeeccCCC
Q 000893 1119 GGTLATVTEFMVNGS 1133 (1236)
Q Consensus 1119 ~g~L~LVMEYm~GGS 1133 (1236)
.+..|+||||++|..
T Consensus 116 ~G~~flVME~v~G~~ 130 (822)
T PLN02876 116 IGTAFYIMEYLEGRI 130 (822)
T ss_pred CCCceEEEEecCCcc
Confidence 246789999998764
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00062 Score=72.57 Aligned_cols=76 Identities=22% Similarity=0.142 Sum_probs=51.0
Q ss_pred EeccCCc-eEEEEeeecCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCC-CCceeeEeeeEecCCCCeEEEEE
Q 000893 1049 ELGSGTF-GTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQDGPGGTLATVT 1126 (1236)
Q Consensus 1049 kLGsGSF-GtVYKArlkG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLr-HPNIVrLyG~f~t~~~g~L~LVM 1126 (1236)
.|-.|.. ..||+....+..+.||+..... ...+.+|+++++.+. +--+.+++++.... +..++||
T Consensus 5 ~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-----------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~lv~ 71 (244)
T cd05150 5 RVTEGQSGATVYRLDGKNPGLYLKIAPSGP-----------TYELEREAERLRWLAGKLPVPEVIDYGSDD--GRAWLLT 71 (244)
T ss_pred ecCCCCCcCeEEEEcCCCCcEEEEecCCCc-----------ccchHHHHHHHHHHHhcCCCCeEEEEEecC--CccEEEE
Confidence 3445555 7899998777778888875431 123446787877764 33355777766553 3578899
Q ss_pred eeccCCCHHHH
Q 000893 1127 EFMVNGSLRHV 1137 (1236)
Q Consensus 1127 EYm~GGSL~dl 1137 (1236)
||++|.+|...
T Consensus 72 e~i~G~~l~~~ 82 (244)
T cd05150 72 SAVPGVPAAAL 82 (244)
T ss_pred EeeCCccHhHh
Confidence 99999877644
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00063 Score=75.82 Aligned_cols=143 Identities=22% Similarity=0.140 Sum_probs=91.0
Q ss_pred EEeccCCceEEEEeee-cCceEEEEeeeccccCCCC---------------hHHHHHHHH-HHHHHHHHhhCC--CCcee
Q 000893 1048 KELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRS---------------SEQERLTLE-FWREAEILSKLH--HPNVV 1108 (1236)
Q Consensus 1048 kkLGsGSFGtVYKArl-kG~~VAVKvLkk~~i~~~~---------------~e~er~~ke-FlrEIrILskLr--HPNIV 1108 (1236)
-.|..|.-+.||+|.. .+..+|||+++........ ......... ..+|+.-|+++. +-.+.
T Consensus 54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 3678899999999987 5888999999754321100 011111111 245777777664 33344
Q ss_pred eEeeeEecCCCCeEEEEEeeccCCCH-HHHHhhhccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCCCcEEEccCCC
Q 000893 1109 AFYGVVQDGPGGTLATVTEFMVNGSL-RHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDP 1186 (1236)
Q Consensus 1109 rLyG~f~t~~~g~L~LVMEYm~GGSL-~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHS-kGIIHRDIKPsNILLDsdG~ 1186 (1236)
+-+.+.. -.|||||+....+ .-.| ..-.+.......+..++++.+.-|-. .++||+||..=|||+..+
T Consensus 134 ~Pi~~~~------nVLvMEfIg~~g~pAP~L--kDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~~~-- 203 (268)
T COG1718 134 EPIAFRN------NVLVMEFIGDDGLPAPRL--KDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVHDG-- 203 (268)
T ss_pred CceeecC------CeEEEEeccCCCCCCCCc--ccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEECC--
Confidence 5554432 2679999943311 0011 11123333566677788888888766 899999999999999943
Q ss_pred CCCcEEEEeccCccccc
Q 000893 1187 IRPICKVGDFGLSKIKR 1203 (1236)
Q Consensus 1187 I~ltVKLsDFGLArii~ 1203 (1236)
.+.|+|||-|....
T Consensus 204 ---~p~iID~~QaV~~~ 217 (268)
T COG1718 204 ---EPYIIDVSQAVTID 217 (268)
T ss_pred ---eEEEEECccccccC
Confidence 46899999887654
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.55 E-value=7.6e-05 Score=85.23 Aligned_cols=89 Identities=27% Similarity=0.413 Sum_probs=73.9
Q ss_pred HHHhhCCCCceeeEeeeEecCC---CCeEEEEEeeccCCCHHHHHhhh---ccCCCHHHHHHHHHHHHHHHHHHHHC--C
Q 000893 1097 EILSKLHHPNVVAFYGVVQDGP---GGTLATVTEFMVNGSLRHVLLSK---ERHLDRRKRLIIAMDAAFGMEYLHSK--N 1168 (1236)
Q Consensus 1097 rILskLrHPNIVrLyG~f~t~~---~g~L~LVMEYm~GGSL~dlL~~k---~r~LSe~erl~Ia~QIAeALaYLHSk--G 1168 (1236)
.-|-.+.|-|||+++.||.+.+ .....|++|||..|+|.++|++. ...+....-.+|+-||+.||.|||+. -
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 3455667999999999987643 24678999999999999999764 34566677778999999999999986 6
Q ss_pred cccCCCCCCcEEEccCC
Q 000893 1169 IVHFDLKCDNLLVNLKD 1185 (1236)
Q Consensus 1169 IIHRDIKPsNILLDsdG 1185 (1236)
|||+++..+-|++..+|
T Consensus 199 iihgnlTc~tifiq~ng 215 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNG 215 (458)
T ss_pred cccCCcchhheeecCCc
Confidence 99999999999999776
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.0013 Score=70.74 Aligned_cols=143 Identities=20% Similarity=0.191 Sum_probs=93.1
Q ss_pred EEeccCCceEEEEeeecCceEEEEeeeccccCCCChH--------HHHHHHHHHHHHHHHhhCC------CCceeeEeee
Q 000893 1048 KELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSE--------QERLTLEFWREAEILSKLH------HPNVVAFYGV 1113 (1236)
Q Consensus 1048 kkLGsGSFGtVYKArlkG~~VAVKvLkk~~i~~~~~e--------~er~~keFlrEIrILskLr------HPNIVrLyG~ 1113 (1236)
..||+|+.=.||.--.. ...+||+............ ......++.+|+.....+. +.+|.++||+
T Consensus 7 ~~i~~G~~R~cy~HP~d-p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 7 DLIAQGGERDCYQHPDD-PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred cccccCCCceEEECCCC-CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 45999999999965443 3468898876541000000 0011344556666555554 8899999999
Q ss_pred EecCCCCeEEEEEeeccC------CCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCC
Q 000893 1114 VQDGPGGTLATVTEFMVN------GSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPI 1187 (1236)
Q Consensus 1114 f~t~~~g~L~LVMEYm~G------GSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I 1187 (1236)
..+.. -+.+|+|.+.+ .+|.+++... .++. .. ...+-+-..||-.+.|+.+||+|.||++......
T Consensus 86 veT~~--G~Glv~e~I~d~dG~~s~TL~~~l~~~--~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 86 VETNL--GLGLVVELIRDADGNISPTLEDYLKEG--GLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred EecCC--ceEEEEEEEECCCCCcCccHHHHHHcC--CccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 99965 56788887643 3788888433 3554 22 2233344568889999999999999999876654
Q ss_pred CCcEEEEe-ccCc
Q 000893 1188 RPICKVGD-FGLS 1199 (1236)
Q Consensus 1188 ~ltVKLsD-FGLA 1199 (1236)
...+.|+| ||-.
T Consensus 158 ~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 158 EFRLVLIDGLGEK 170 (199)
T ss_pred ceEEEEEeCCCCc
Confidence 33677777 3543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd06405 PB1_Mekk2_3 The PB1 domain is present in the two mitogen-activated protein kinase kinases MEKK2 and MEKK3 which are two members of the signaling kinase cascade involved in angiogenesis and early cardiovascular development | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.00094 Score=62.02 Aligned_cols=70 Identities=26% Similarity=0.447 Sum_probs=60.5
Q ss_pred cCceeEEEecCCCChHHHHHHHHHHcCCceEEEEecCCCCCCceeeccChHHHHHHHHHhhhccccCCCCcEEEEc
Q 000893 209 GGETRIIRISRDISWQELTQKALAIYNQTHTIKYQLPGEDLDALVSVSCDEDLQNMMEECNVLEDRGTQKPRMFLF 284 (1236)
Q Consensus 209 GGetriv~V~r~~sf~~l~~kl~~~~~~~~~lKYqLP~edLDaLiSVt~DeDL~~M~~Eydr~~~~~~~~~R~fLF 284 (1236)
-||-||+.++|.++|.||..|+...||..+.+-|-.- + -||.+.|-+||++-|+-.|+- ..-+.+|+.|-
T Consensus 8 ~gEKRIi~f~RPvkf~dl~~kv~~afGq~mdl~ytn~--e--L~iPl~~Q~DLDkAie~ld~s--~~~ksLRilL~ 77 (79)
T cd06405 8 NGEKRIIQFPRPVKFKDLQQKVTTAFGQPMDLHYTNN--E--LLIPLKNQEDLDRAIELLDRS--PHMKSLRILLS 77 (79)
T ss_pred cCceEEEecCCCccHHHHHHHHHHHhCCeeeEEEecc--c--EEEeccCHHHHHHHHHHHccC--ccccceeEeEe
Confidence 4899999999999999999999999999999999743 2 799999999999999999982 22346787763
|
The PB1 domain of MEKK2 (and/or MEKK3) interacts with the PB1 domain of another member of the kinase cascade Map2k5. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. The PB1 domain module is conserved in amoebas, f |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.00013 Score=88.82 Aligned_cols=158 Identities=20% Similarity=0.184 Sum_probs=109.7
Q ss_pred eEEEEeccCCceEEEEeeecCce-EEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCc-eeeEeeeEecCCCCeE
Q 000893 1045 EELKELGSGTFGTVYHGKWRGTD-VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN-VVAFYGVVQDGPGGTL 1122 (1236)
Q Consensus 1045 eiLkkLGsGSFGtVYKArlkG~~-VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPN-IVrLyG~f~t~~~g~L 1122 (1236)
.....++++++++++|.+...+. ...+.+... ....-++++|.+++||| .+..++-+... ...
T Consensus 245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~~-------------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E--~~~ 309 (829)
T KOG0576|consen 245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------------LSRRLAIELLDKVNNPNPVVRYLEDYDGE--DYL 309 (829)
T ss_pred HHHHHHHHHHhcCCCccCCChhhheeceeeccc-------------hhhHHHHHHHHHccCCCCcccccccCCcc--ccc
Confidence 34456789999999998764322 234433211 12334788999999999 66666655543 488
Q ss_pred EEEEeeccCC-CHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEeccCccc
Q 000893 1123 ATVTEFMVNG-SLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201 (1236)
Q Consensus 1123 ~LVMEYm~GG-SL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLAri 1201 (1236)
+++|+|+.++ +-...+...+-.+...+...+.+.-+++|++||+---+||| |||.... ..|+.||+....
T Consensus 310 ~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~-----~~~~~~~~v~~~ 380 (829)
T KOG0576|consen 310 WIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEE-----EVKLLDFAVPPQ 380 (829)
T ss_pred chhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccccc-----ccccccccCCcc
Confidence 9999999766 22222212222344455556777888999999987778999 8888764 358999999887
Q ss_pred ccCcccccCcCCCCcccchhhhcCC
Q 000893 1202 KRNTLVTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1202 i~ns~~tss~~GTp~YmAPEVL~Gs 1226 (1236)
+........+.+|+.++|||++.++
T Consensus 381 L~~~~~~~t~~~~~~~~~pev~~~~ 405 (829)
T KOG0576|consen 381 LTRTMKPRTAIGTPEPLAPEVIQEN 405 (829)
T ss_pred cCcccccccCCCCCCCCCchhhccc
Confidence 6655556678899999999988765
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0012 Score=69.80 Aligned_cols=99 Identities=22% Similarity=0.137 Sum_probs=76.8
Q ss_pred HHHHHHhhCCC-CceeeEeeeEecCCCCeEEEEEeeccCCCHHHHHh--hhccCCCHHHHHHHHHHHHHHHHHHHH---C
Q 000893 1094 REAEILSKLHH-PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLL--SKERHLDRRKRLIIAMDAAFGMEYLHS---K 1167 (1236)
Q Consensus 1094 rEIrILskLrH-PNIVrLyG~f~t~~~g~L~LVMEYm~GGSL~dlL~--~k~r~LSe~erl~Ia~QIAeALaYLHS---k 1167 (1236)
.|..+|+.+++ +++++++|+|-. ++|.||+..+++..... ..-...+|..+..|+.++++.+++|+. .
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~------~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR------FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC------EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 47888888886 699999999943 56999997665531100 011246899999999999999999987 3
Q ss_pred CcccCCCCCCcEEEccCCCCCCcEEEEeccCcccc
Q 000893 1168 NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 1202 (1236)
Q Consensus 1168 GIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii 1202 (1236)
.+.-+|++++|+-++.++ .+|++|.......
T Consensus 82 ~~~lcDv~~~nfgv~~~~----~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDG----RLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCC----cEEEEechhcchh
Confidence 577899999999999886 5699999876553
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd06408 PB1_NoxR The PB1 domain is present in the Epichloe festucae NoxR protein (NADPH oxidase regulator), a key regulator of NADPH oxidase isoform, NoxA | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0016 Score=62.01 Aligned_cols=60 Identities=17% Similarity=0.335 Sum_probs=53.9
Q ss_pred cCceeEEEecCCCChHHHHHHHHHHcC--CceEEEEecCCCCCCceeeccChHHHHHHHHHhhhcc
Q 000893 209 GGETRIIRISRDISWQELTQKALAIYN--QTHTIKYQLPGEDLDALVSVSCDEDLQNMMEECNVLE 272 (1236)
Q Consensus 209 GGetriv~V~r~~sf~~l~~kl~~~~~--~~~~lKYqLP~edLDaLiSVt~DeDL~~M~~Eydr~~ 272 (1236)
+|++|++.|+.+|+|.+|..|+.+.|+ ..++|||+ .| ...|++++++||+-.|.-+...+
T Consensus 10 ~~Dv~~i~v~~~i~f~dL~~kIrdkf~~~~~~~iKyk--DE--GD~iti~sq~DLd~Ai~~a~~~~ 71 (86)
T cd06408 10 QDDTRYIMIGPDTGFADFEDKIRDKFGFKRRLKIKMK--DD--GDMITMGDQDDLDMAIDTARSEA 71 (86)
T ss_pred cCcEEEEEcCCCCCHHHHHHHHHHHhCCCCceEEEEE--cC--CCCccccCHHHHHHHHHHHHHHH
Confidence 789999999999999999999999998 67899999 44 89999999999999998876544
|
NoxA is essential for growth control of the fungal endophyte in plant tissue in the process of symbiotic interaction between a fungi and its plant host. The Epichloe festucae p67(phox)-like regulator, NoxR, dispensable in culture but essential in plants for the symbiotic interaction. Plants infected with a noxR deletion mutant show severe stunting and premature senescence, whereas hyphae in the meristematic tissues show increased branching leading to increased fungal colonization of pseudostem and leaf blade tissue. The PB1 domain is a modular domain mediating specific protein-protein interactions which a play role in many critical cell processes such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0022 Score=68.62 Aligned_cols=75 Identities=16% Similarity=0.188 Sum_probs=44.1
Q ss_pred EEeccCCce-EEEEeeecCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCC---ceeeEeeeEecCCC-CeE
Q 000893 1048 KELGSGTFG-TVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP---NVVAFYGVVQDGPG-GTL 1122 (1236)
Q Consensus 1048 kkLGsGSFG-tVYKArlkG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHP---NIVrLyG~f~t~~~-g~L 1122 (1236)
+.|+.|+.. .||+. +..+++|..+... ....+.+|..+|+.|... -+.++++....... +..
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~~----------~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~ 69 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAAG----------YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWP 69 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCccc----------hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcc
Confidence 457766665 58975 2357778654311 123566788888877532 23444544333211 245
Q ss_pred EEEEeeccCCCHH
Q 000893 1123 ATVTEFMVNGSLR 1135 (1236)
Q Consensus 1123 ~LVMEYm~GGSL~ 1135 (1236)
++||++++|.++.
T Consensus 70 ~~l~~~i~G~~l~ 82 (235)
T cd05155 70 WSVYRWLEGETAT 82 (235)
T ss_pred eEEEEeecCCCCC
Confidence 7899999886653
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.0086 Score=63.35 Aligned_cols=73 Identities=16% Similarity=0.178 Sum_probs=45.7
Q ss_pred EEEeccCCceEEEEeeec---CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCC-ceeeEeeeEecCCCCeE
Q 000893 1047 LKELGSGTFGTVYHGKWR---GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP-NVVAFYGVVQDGPGGTL 1122 (1236)
Q Consensus 1047 LkkLGsGSFGtVYKArlk---G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHP-NIVrLyG~f~t~~~g~L 1122 (1236)
++.|..|-...+|+.... +..|++|+....... .....+|+.+++.+... -.+++++.+. .
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~---------~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~---- 67 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL---------IIDRERELRIHKLLSKHGLAPKLYATFQ--N---- 67 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc---------eecHHHHHHHHHHHHhCCCCCeEEEEeC--C----
Confidence 456888888899998875 467899976542110 00112577777777533 3345554432 1
Q ss_pred EEEEeeccCCCH
Q 000893 1123 ATVTEFMVNGSL 1134 (1236)
Q Consensus 1123 ~LVMEYm~GGSL 1134 (1236)
.+||||++|.++
T Consensus 68 ~~l~e~i~G~~l 79 (235)
T cd05157 68 GLIYEFIPGRTL 79 (235)
T ss_pred cEEEEeeCCCcC
Confidence 369999988765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.56 E-value=0.039 Score=61.42 Aligned_cols=31 Identities=26% Similarity=0.323 Sum_probs=25.6
Q ss_pred CCcccCCCCCCcEEEccCCCCCCcEEEEeccCccc
Q 000893 1167 KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201 (1236)
Q Consensus 1167 kGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLAri 1201 (1236)
.++||+|+.|.|||++.+. ..-|+||+.|..
T Consensus 187 ~~liHgD~~~~Nil~~~~~----~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDR----LSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCc----eEEEEecccccC
Confidence 4899999999999998553 346999998865
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.013 Score=64.37 Aligned_cols=140 Identities=19% Similarity=0.147 Sum_probs=79.9
Q ss_pred EEEeccCCceEEEEeeecCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCc--eeeEeeeE----ecCCCC
Q 000893 1047 LKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN--VVAFYGVV----QDGPGG 1120 (1236)
Q Consensus 1047 LkkLGsGSFGtVYKArlkG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPN--IVrLyG~f----~t~~~g 1120 (1236)
++.|..|....+|+....+..+++|+.... . ...+..|+.++..|.+.. +.+++... .....+
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~~-----~------~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~ 87 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEKV-----S------AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAG 87 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCCC-----C------hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCC
Confidence 456788888899998877778999987531 1 112334666666664322 34444321 101124
Q ss_pred eEEEEEeeccCCCHHH----H-------H---hhhcc----------CCCHHHHH----------HHHHHHHHHHHHHHH
Q 000893 1121 TLATVTEFMVNGSLRH----V-------L---LSKER----------HLDRRKRL----------IIAMDAAFGMEYLHS 1166 (1236)
Q Consensus 1121 ~L~LVMEYm~GGSL~d----l-------L---~~k~r----------~LSe~erl----------~Ia~QIAeALaYLHS 1166 (1236)
..++|++|++|..+.. . + +.... ...|.... .....+..++.++-.
T Consensus 88 ~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~ 167 (296)
T cd05153 88 KPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDA 167 (296)
T ss_pred ceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHh
Confidence 6689999998865421 1 1 11000 01111110 011123334455443
Q ss_pred -------CCcccCCCCCCcEEEccCCCCCCcEEEEeccCccc
Q 000893 1167 -------KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201 (1236)
Q Consensus 1167 -------kGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLAri 1201 (1236)
.+++|+|+.|.|||++.++ .+.|+||+.|..
T Consensus 168 ~~~~~~~~~l~HgD~~~~Nil~~~~~----~~~iIDfe~a~~ 205 (296)
T cd05153 168 FDPSDLPRGVIHADLFRDNVLFDGDE----LSGVIDFYFACT 205 (296)
T ss_pred hhhhcCCCcCCccCcCcccEEEeCCc----eEEEeehhhhcC
Confidence 4799999999999998764 347999998765
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.024 Score=67.09 Aligned_cols=81 Identities=19% Similarity=0.094 Sum_probs=51.3
Q ss_pred EEEeccCCceEEEEeeecC--ceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCC---CCceeeEeeeEecCCCCe
Q 000893 1047 LKELGSGTFGTVYHGKWRG--TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH---HPNVVAFYGVVQDGPGGT 1121 (1236)
Q Consensus 1047 LkkLGsGSFGtVYKArlkG--~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLr---HPNIVrLyG~f~t~~~g~ 1121 (1236)
.+.||.|.+..||++...+ +.|+||.-.... ......-.....++..|.+.|..+. ..++++++.+... .
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~-r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~~----~ 105 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYV-RVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDEE----L 105 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCccc-ccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECCC----C
Confidence 3579999999999999853 479999854221 1000000112334566777777653 3567788876432 4
Q ss_pred EEEEEeeccCC
Q 000893 1122 LATVTEFMVNG 1132 (1236)
Q Consensus 1122 L~LVMEYm~GG 1132 (1236)
.++||||+++.
T Consensus 106 ~~lVME~L~~~ 116 (401)
T PRK09550 106 AVTVMEDLSDH 116 (401)
T ss_pred CEEEEecCCCc
Confidence 67899999764
|
|
| >cd00173 SH2 Src homology 2 domains; Signal transduction, involved in recognition of phosphorylated tyrosine (pTyr) | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.0013 Score=60.53 Aligned_cols=55 Identities=13% Similarity=0.167 Sum_probs=41.1
Q ss_pred cccccccccccccchhhhhc--cCCCcccccccccCCccccccCCCCCCCCCCCCCCCCceeeccCccCCCC
Q 000893 901 YFRNLAQDEFSRKDVSLMDQ--DHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQRESS 970 (1236)
Q Consensus 901 yyhGl~~~~l~R~D~E~LL~--~~GdFLVRLSEiq~G~TlD~S~n~L~~~pSvmP~sgS~lNf~I~S~~ess 970 (1236)
||||. |+|.+||.||+ .+|+||+|.++...+. +.. ++...+ .+.|+.|....+..
T Consensus 2 w~~g~----i~r~~Ae~~L~~~~~G~FLiR~s~~~~~~---~~L-------sv~~~~-~v~H~~I~~~~~~~ 58 (94)
T cd00173 2 WYHGP----ISREEAEELLKKKPDGTFLVRDSESSPGD---YVL-------SVRVKG-KVKHYRIERTDDGY 58 (94)
T ss_pred ccccC----CCHHHHHHHHhcCCCceEEEEecCCCCCC---EEE-------EEEECC-EEEEEEEEECCCCe
Confidence 99999 99999999998 8999999999965552 222 233333 57899886555433
|
SH2 domains typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.014 Score=63.10 Aligned_cols=134 Identities=18% Similarity=0.155 Sum_probs=75.2
Q ss_pred eccCCceEEEEeeecCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCce-eeEeeeEecCCCCeEEEEEee
Q 000893 1050 LGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV-VAFYGVVQDGPGGTLATVTEF 1128 (1236)
Q Consensus 1050 LGsGSFGtVYKArlkG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNI-VrLyG~f~t~~~g~L~LVMEY 1128 (1236)
+..|-...+|+....+..+++|+....... ......+|..+++.+....+ .+++..+. -++||||
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~--------~~~~r~~E~~~l~~l~~~g~~P~~i~~~~------~~~v~e~ 69 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKA--------LGVDRQREYQILQALSALGLAPKPILVNE------HWLLVEW 69 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCccccc--------ccCcHHHHHHHHHHHHhcCCCCceEEEeC------CEEEEEe
Confidence 456778889998877778899976532110 00113457777777754333 34444332 1579999
Q ss_pred ccCCCHHH--------------HH---hhh---ccCCCHHHH-HHHHHHH---------HHHHHHHHH--------CCcc
Q 000893 1129 MVNGSLRH--------------VL---LSK---ERHLDRRKR-LIIAMDA---------AFGMEYLHS--------KNIV 1170 (1236)
Q Consensus 1129 m~GGSL~d--------------lL---~~k---~r~LSe~er-l~Ia~QI---------AeALaYLHS--------kGII 1170 (1236)
++|..+.. .+ +.. ...++.... ..+..++ ...+..+-. ..++
T Consensus 70 i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 149 (256)
T TIGR02721 70 LEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPL 149 (256)
T ss_pred ccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeee
Confidence 98866532 11 111 111221111 1111111 111222211 2589
Q ss_pred cCCCCCCcEEEccCCCCCCcEEEEeccCcccc
Q 000893 1171 HFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 1202 (1236)
Q Consensus 1171 HRDIKPsNILLDsdG~I~ltVKLsDFGLArii 1202 (1236)
|+|+.|.|||++.++ +.|+||..|...
T Consensus 150 H~Dl~~~Nil~~~~~-----~~lIDwE~a~~g 176 (256)
T TIGR02721 150 HMDVHAYNLVVTPQG-----LKLIDWEYASDG 176 (256)
T ss_pred cCCCCcCcEEEeCCC-----CEEEeccccCcC
Confidence 999999999998764 379999988764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd06396 PB1_NBR1 The PB1 domain is an essential part of NBR1 protein, next to BRCA1, a scaffold protein mediating specific protein-protein interaction with both titin protein kinase and with another scaffold protein p62 | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.018 Score=54.52 Aligned_cols=69 Identities=17% Similarity=0.361 Sum_probs=55.1
Q ss_pred cCceeEEEecC--CCChHHHHHHHHHHcC-CceEEEEecCCCCCCceeeccChHHHHHHHHHhhhccccCCCCcEEEEc
Q 000893 209 GGETRIIRISR--DISWQELTQKALAIYN-QTHTIKYQLPGEDLDALVSVSCDEDLQNMMEECNVLEDRGTQKPRMFLF 284 (1236)
Q Consensus 209 GGetriv~V~r--~~sf~~l~~kl~~~~~-~~~~lKYqLP~edLDaLiSVt~DeDL~~M~~Eydr~~~~~~~~~R~fLF 284 (1236)
||+++.+.++. ..+|.+|...+.+.|+ ..++|||- +|=.--|+++||.||+.-++-|. +++..+|+++-
T Consensus 8 ~~d~~rf~~~~~~~~~~~~L~~ev~~rf~l~~f~lKYl---Dde~e~v~lssd~eLeE~~rl~~----~~~~~l~~~v~ 79 (81)
T cd06396 8 NGESQSFLVSDSENTTWASVEAMVKVSFGLNDIQIKYV---DEENEEVSVNSQGEYEEALKSAV----RQGNLLQMNVY 79 (81)
T ss_pred CCeEEEEEecCCCCCCHHHHHHHHHHHhCCCcceeEEE---cCCCCEEEEEchhhHHHHHHHHH----hCCCEEEEEEe
Confidence 67888999988 7899999999999998 56889997 44455899999999976555544 45567888763
|
A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domain, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. The NBR1 protein contains a type I PB1 domain. |
| >cd06398 PB1_Joka2 The PB1 domain is present in the Nicotiana plumbaginifolia Joka2 protein which interacts with sulfur stress inducible UP9 protein | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.034 Score=53.58 Aligned_cols=70 Identities=17% Similarity=0.295 Sum_probs=54.2
Q ss_pred cCceeEEEecC-----CCChHHHHHHHHHHcC----CceEEEEecCCCCCCceeeccChHHHHHHHHHhhhccccCCCCc
Q 000893 209 GGETRIIRISR-----DISWQELTQKALAIYN----QTHTIKYQLPGEDLDALVSVSCDEDLQNMMEECNVLEDRGTQKP 279 (1236)
Q Consensus 209 GGetriv~V~r-----~~sf~~l~~kl~~~~~----~~~~lKYqLP~edLDaLiSVt~DeDL~~M~~Eydr~~~~~~~~~ 279 (1236)
||++|-+.++. +++|.+|..|+.+.+. ..+.|+|. ++=..+|.++||+||..-|+...+.. ...-+
T Consensus 8 ~~~~rRf~l~~~~~~~d~~~~~L~~kI~~~f~l~~~~~~~l~Y~---Dedgd~V~l~~D~DL~~a~~~~~~~~--~~~~l 82 (91)
T cd06398 8 GGTLRRFTFPVAENQLDLNMDGLREKVEELFSLSPDADLSLTYT---DEDGDVVTLVDDNDLTDAIQYFCSGS--RLNPL 82 (91)
T ss_pred CCEEEEEEeccccccCCCCHHHHHHHHHHHhCCCCCCcEEEEEE---CCCCCEEEEccHHHHHHHHHHHhccC--CCceE
Confidence 88899999985 6999999999999986 36889998 34455999999999998887743322 22356
Q ss_pred EEEE
Q 000893 280 RMFL 283 (1236)
Q Consensus 280 R~fL 283 (1236)
|+++
T Consensus 83 rl~v 86 (91)
T cd06398 83 RIDV 86 (91)
T ss_pred EEEE
Confidence 6665
|
The PB1 domain is a modular domain mediating specific protein-protein interactions which play a role in many critical cell processes, such as osteoclastogenesis, angiogenesis, early cardiovascular development and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domain, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. The PB1 domain module |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.023 Score=62.79 Aligned_cols=74 Identities=19% Similarity=0.329 Sum_probs=44.6
Q ss_pred EEEeccCCceEEEEeeec--------CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCc-eeeEeeeEecC
Q 000893 1047 LKELGSGTFGTVYHGKWR--------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN-VVAFYGVVQDG 1117 (1236)
Q Consensus 1047 LkkLGsGSFGtVYKArlk--------G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPN-IVrLyG~f~t~ 1117 (1236)
++.|..|-...||+.... +..+++|+....... .....+|..+++.+.... ..++++++..
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~---------~~~r~~E~~~~~~l~~~g~~P~~~~~~~~- 72 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL---------LIDRERELVVFARLSERNLGPKLYGIFPN- 72 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc---------eechHHHHHHHHHHHhCCCCCceEEEeCC-
Confidence 345666777789988764 367999987643210 112345777777765322 3455655532
Q ss_pred CCCeEEEEEeeccCCCHH
Q 000893 1118 PGGTLATVTEFMVNGSLR 1135 (1236)
Q Consensus 1118 ~~g~L~LVMEYm~GGSL~ 1135 (1236)
.+|+||++|..+.
T Consensus 73 -----~~v~e~i~G~~l~ 85 (302)
T cd05156 73 -----GRIEEFIPSRTLT 85 (302)
T ss_pred -----CchhheeCCCcCC
Confidence 2489999886653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.08 E-value=0.066 Score=59.75 Aligned_cols=142 Identities=19% Similarity=0.152 Sum_probs=77.8
Q ss_pred EEEEeccCCceEEEEeeecCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCc--eeeEeee----EecCCC
Q 000893 1046 ELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN--VVAFYGV----VQDGPG 1119 (1236)
Q Consensus 1046 iLkkLGsGSFGtVYKArlkG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPN--IVrLyG~----f~t~~~ 1119 (1236)
.++.++.|....+|+....+..+++|+..... .. .....|..++..|.... +.+++.. ......
T Consensus 26 ~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~----~~------~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~ 95 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTTDVGRYILTLYEKRV----KA------EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLA 95 (307)
T ss_pred eccccCCccccceEEEEeCCCcEEEEEecCCC----CH------HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcC
Confidence 35567788778999987765578889765421 00 11223455555553211 3333332 111123
Q ss_pred CeEEEEEeeccCCCHH-----------HHH---hhhccCC-----------CHHHHH------------HHHHHHHHHHH
Q 000893 1120 GTLATVTEFMVNGSLR-----------HVL---LSKERHL-----------DRRKRL------------IIAMDAAFGME 1162 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~-----------dlL---~~k~r~L-----------Se~erl------------~Ia~QIAeALa 1162 (1236)
+..++||+|++|..+. ..+ +.....+ .|.... .....+...++
T Consensus 96 g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~ 175 (307)
T TIGR00938 96 GKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELD 175 (307)
T ss_pred CeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHH
Confidence 5678999999885421 111 1100100 011000 00112334455
Q ss_pred HHHH-------CCcccCCCCCCcEEEccCCCCCCcEEEEeccCccc
Q 000893 1163 YLHS-------KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201 (1236)
Q Consensus 1163 YLHS-------kGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLAri 1201 (1236)
++.. .+++|+|+.+.||+++.++ .+.|+||+.+..
T Consensus 176 ~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~----~~~vIDfd~~~~ 217 (307)
T TIGR00938 176 YLDKFWPRDLPRGVIHADLFPDNVLFDGDS----VKGVIDFYFACT 217 (307)
T ss_pred HHHhhhhhcCCCccCCCCCCcCcEEEECCc----eEEEeecccccC
Confidence 5542 5899999999999998764 357999999854
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF00017 SH2: SH2 domain; InterPro: IPR000980 The Src homology 2 (SH2) domain is a protein domain of about 100 amino-acid residues first identified as a conserved sequence region between the oncoproteins Src and Fps [] | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.0013 Score=59.22 Aligned_cols=54 Identities=17% Similarity=0.233 Sum_probs=41.7
Q ss_pred cccccccccccccchhhhhcc---CCCcccccccccCCccccccCCCCCCCCCCCCCCCCceeeccCccCCC
Q 000893 901 YFRNLAQDEFSRKDVSLMDQD---HLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQRES 969 (1236)
Q Consensus 901 yyhGl~~~~l~R~D~E~LL~~---~GdFLVRLSEiq~G~TlD~S~n~L~~~pSvmP~sgS~lNf~I~S~~es 969 (1236)
||||. |+|.+||.||.. +|+||||.+...++. ++. ++...+ .+.|+.|......
T Consensus 1 W~~g~----isr~~Ae~~L~~~~~~G~FLvR~s~~~~~~---~~L-------sv~~~~-~v~h~~I~~~~~~ 57 (77)
T PF00017_consen 1 WFHGF----ISRQEAERLLMQGKPDGTFLVRPSSSKPGK---YVL-------SVRFDG-KVKHFRINRTENG 57 (77)
T ss_dssp TBEES----SHHHHHHHHHHTTSSTTEEEEEEESSSTTS---EEE-------EEEETT-EEEEEEEEEETTS
T ss_pred CcCCC----CCHHHHHHHHHhcCCCCeEEEEeccccccc---ccc-------cccccc-ccEEEEEEecCCc
Confidence 89999 999999999987 999999999986663 333 233333 5789988666554
|
Similar sequences were later found in many other intracellular signal-transducing proteins []. SH2 domains function as regulatory modules of intracellular signalling cascades by interacting with high affinity to phosphotyrosine-containing target peptides in a sequence-specific, SH2 domains recognise between 3-6 residues C-terminal to the phosphorylated tyrosine in a fashion that differs from one SH2 domain to another, and strictly phosphorylation-dependent manner [, , , ]. They are found in a wide variety of protein contexts e.g., in association with catalytic domains of phospholipase Cy (PLCy) and the non-receptor protein tyrosine kinases; within structural proteins such as fodrin and tensin; and in a group of small adaptor molecules, i.e Crk and Nck. The domains are frequently found as repeats in a single protein sequence and will then often bind both mono- and di-phosphorylated substrates. The structure of the SH2 domain belongs to the alpha+beta class, its overall shape forming a compact flattened hemisphere. The core structural elements comprise a central hydrophobic anti-parallel beta-sheet, flanked by 2 short alpha-helices. The loop between strands 2 and 3 provides many of the binding interactions with the phosphate group of its phosphopeptide ligand, and is hence designated the phosphate binding loop, the phosphorylated ligand binds perpendicular to the beta-sheet and typically interacts with the phosphate binding loop and a hydrophobic binding pocket that interacts with a pY+3 side chain. The N- and C-termini of the domain are close together in space and on the opposite face from the phosphopeptide binding surface and it has been speculated that this has facilitated their integration into surface-exposed regions of host proteins [].; GO: 0005515 protein binding; PDB: 1M27_A 1KA6_A 1D4W_B 1D4T_A 1D1Z_B 1KA7_A 1UUR_A 1UUS_A 1BLJ_A 1BLK_A .... |
| >cd06404 PB1_aPKC PB1 domain is an essential modular domain of the atypical protein kinase C (aPKC) which in complex with Par6 and Par3 proteins is crucial for establishment of apical-basal polarity of animal cells | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.049 Score=51.94 Aligned_cols=72 Identities=19% Similarity=0.335 Sum_probs=58.8
Q ss_pred ecCceeEEEecCCCChHHHHHHHHHHcC----CceEEEEecCCCCCCceeeccChHHHHHHHHHhhhccccCCCCcEEEE
Q 000893 208 VGGETRIIRISRDISWQELTQKALAIYN----QTHTIKYQLPGEDLDALVSVSCDEDLQNMMEECNVLEDRGTQKPRMFL 283 (1236)
Q Consensus 208 vGGetriv~V~r~~sf~~l~~kl~~~~~----~~~~lKYqLP~edLDaLiSVt~DeDL~~M~~Eydr~~~~~~~~~R~fL 283 (1236)
-+|+-+|..++.+++|.+|..|+.++|. .++++||- .|| .-+|++++|++|..-+..|..-. .+-+-+-+
T Consensus 7 y~gdi~it~~d~~~s~e~L~~~v~~~c~~~~~q~ft~kw~--DEE-GDp~tiSS~~EL~EA~rl~~~n~---~~~l~ihv 80 (83)
T cd06404 7 YNGDIMITSIDPSISLEELCNEVRDMCRFHNDQPFTLKWI--DEE-GDPCTISSQMELEEAFRLYELNK---DSELNIHV 80 (83)
T ss_pred ecCcEEEEEcCCCcCHHHHHHHHHHHhCCCCCCcEEEEEE--CCC-CCceeecCHHHHHHHHHHHHhcC---cccEEEEe
Confidence 4788899999999999999999999995 57999998 333 34899999999998888887643 23566777
Q ss_pred cc
Q 000893 284 FS 285 (1236)
Q Consensus 284 F~ 285 (1236)
||
T Consensus 81 fp 82 (83)
T cd06404 81 FP 82 (83)
T ss_pred cC
Confidence 76
|
PB1 domain is a modular domain mediating specific protein-protein interaction which play roles in many critical cell processes. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. The PB1 domain module is conserved in amoebas, fungi, |
| >KOG3601 consensus Adaptor protein GRB2, contains SH2 and SH3 domains [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.93 E-value=0.017 Score=62.93 Aligned_cols=73 Identities=22% Similarity=0.272 Sum_probs=55.9
Q ss_pred HHHHhhcccccccccCCCCccccccccccCCCcccccccccccccccccchhhhh--ccCCCcccccccccCCccccccC
Q 000893 865 FTKARISENIAGVSPMHGDGAVLSWNVENHDPRRWSYFRNLAQDEFSRKDVSLMD--QDHLGFSSPLTNIEEGATVDYSY 942 (1236)
Q Consensus 865 ~~~~~~s~~~~~~~p~~~~~~~~s~~v~~~~~~~wsyyhGl~~~~l~R~D~E~LL--~~~GdFLVRLSEiq~G~TlD~S~ 942 (1236)
|+++- -.+..+++|.| ...++.|+ ||+|+ ++|.++|+|| +..|+|++|++++.+| +++.
T Consensus 36 w~~ae-l~g~~g~~P~N------ai~~~~~~-----wve~~----i~r~~ae~~l~~~~~G~fl~r~s~sSPg---~fsg 96 (222)
T KOG3601|consen 36 WYKAE-LDGPEGFIPKN------AIRMKPHE-----WVEGL----IPRPLAEDLLSKKRDGDFLIRLSESSPG---DFSG 96 (222)
T ss_pred hhhHh-hcCccccCccc------cccccccc-----ceecc----cccchhhhhhhccCcchhhhhhhhcCcc---cccc
Confidence 66555 47888999999 22367899 99999 9999999999 4699999999999888 5555
Q ss_pred CCCCCCCCCCCCCCCceeeccC
Q 000893 943 PPLKPDGSVMPQSGSRINFDEG 964 (1236)
Q Consensus 943 n~L~~~pSvmP~sgS~lNf~I~ 964 (1236)
++.-..+ +.||+.-
T Consensus 97 -------svr~~d~-vqhfkvv 110 (222)
T KOG3601|consen 97 -------SVRFPDG-VQHFKVV 110 (222)
T ss_pred -------cccCCCC-ceecccc
Confidence 4444444 4566554
|
|
| >cd06401 PB1_TFG The PB1 domain found in TFG protein, an oncogenic gene product and fusion partner to nerve growth factor tyrosine kinase receptor TrkA and to the tyrosine kinase ALK | Back alignment and domain information |
|---|
Probab=95.92 E-value=0.025 Score=53.63 Aligned_cols=53 Identities=26% Similarity=0.374 Sum_probs=44.7
Q ss_pred cCceeEEEecC-CCChHHHHHHHHHHcC------CceEEEEecCCCCCCceeeccChHHHHHH
Q 000893 209 GGETRIIRISR-DISWQELTQKALAIYN------QTHTIKYQLPGEDLDALVSVSCDEDLQNM 264 (1236)
Q Consensus 209 GGetriv~V~r-~~sf~~l~~kl~~~~~------~~~~lKYqLP~edLDaLiSVt~DeDL~~M 264 (1236)
|||.|.+.++. .++|.+|+..+..++. .+|.|||.=+ =..||+||+++||.--
T Consensus 8 g~DiR~~~~~~~~~t~~~L~~~v~~~F~~~~~~~~~flIKYkD~---dGDlVTIts~~dL~~A 67 (81)
T cd06401 8 GDDIRRIPIHNEDITYDELLLMMQRVFRGKLGSSDDVLIKYKDE---DGDLITIFDSSDLSFA 67 (81)
T ss_pred CCeEEEEeccCccccHHHHHHHHHHHhccccCCcccEEEEEECC---CCCEEEeccHHHHHHH
Confidence 99999999998 5899999999988775 3689999833 2458999999999765
|
The PB1 domain is a modular domain mediating specific protein-protein interaction in many critical cell processes, such as osteoclastogenesis, angiogenesis, early cardiovascular development and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. The PB1 domains of TFG represent a type I/II PB1 domain. The physiological function of TFG remains unknown. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.74 E-value=0.066 Score=63.86 Aligned_cols=163 Identities=18% Similarity=0.117 Sum_probs=101.9
Q ss_pred EEEeccCCceEEEEeeecCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCceee----EeeeEecCCCC-e
Q 000893 1047 LKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVA----FYGVVQDGPGG-T 1121 (1236)
Q Consensus 1047 LkkLGsGSFGtVYKArlkG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIVr----LyG~f~t~~~g-~ 1121 (1236)
...||+|+-+.+|-.-.-+ ..+-|++...-. ...... -..+.+.-.||-+-. -.......+.+ .
T Consensus 16 gr~LgqGgea~ly~l~e~~-d~VAKIYh~Ppp----a~~aqk------~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~ 84 (637)
T COG4248 16 GRPLGQGGEADLYTLGEVR-DQVAKIYHAPPP----AAQAQK------VAELAATPDAPLLNYRVAWPQATLHGGRRGKV 84 (637)
T ss_pred CccccCCccceeeecchhh-chhheeecCCCc----hHHHHH------HHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence 4569999999999533222 234577765321 111111 111222334664332 11112222222 3
Q ss_pred EEEEEeeccCC-CHHHHHhh-----hccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCCCCCcEEEEe
Q 000893 1122 LATVTEFMVNG-SLRHVLLS-----KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1236)
Q Consensus 1122 L~LVMEYm~GG-SL~dlL~~-----k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~I~ltVKLsD 1195 (1236)
+-|+|..+.+. ....++.. .-....|.-.++++++++.+.+-||..|.+-+|+.++|+|+.+++ .|.|.|
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~----~V~LVd 160 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDS----KVVLVD 160 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCc----eEEEEc
Confidence 67888888665 22222211 123578899999999999999999999999999999999999887 457777
Q ss_pred ccCcccccCcccccCcCCCCcccchhhhc
Q 000893 1196 FGLSKIKRNTLVTGGVRGTLPWMAPELLN 1224 (1236)
Q Consensus 1196 FGLArii~ns~~tss~~GTp~YmAPEVL~ 1224 (1236)
=..-.+..+.......+|...|.+||.-+
T Consensus 161 sDsfqi~~ng~~~~cpVg~~eftPPElQ~ 189 (637)
T COG4248 161 SDSFQINANGTLHLCPVGVSEFTPPELQT 189 (637)
T ss_pred ccceeeccCCceEecccCccccCCHHHhc
Confidence 54433444555555677899999999865
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.46 E-value=0.08 Score=62.57 Aligned_cols=144 Identities=22% Similarity=0.195 Sum_probs=90.4
Q ss_pred EEeccCCceEEEEeee-cCceEEEEeeeccccCCCCh----------------HHH-HHHHHH-HHHHHHHhhCCCCcee
Q 000893 1048 KELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRSS----------------EQE-RLTLEF-WREAEILSKLHHPNVV 1108 (1236)
Q Consensus 1048 kkLGsGSFGtVYKArl-kG~~VAVKvLkk~~i~~~~~----------------e~e-r~~keF-lrEIrILskLrHPNIV 1108 (1236)
-.|..|.-+.||.|.- .|..+|||+++...+.-.+. .+. .+.+.| -.|++-|++|+...|.
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 3577888899999987 58889999997543211110 011 222222 3567777777654443
Q ss_pred eEeeeEecCCCCeEEEEEeeccCCCHH-HHHhhhccCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCCCcEEEccCCC
Q 000893 1109 AFYGVVQDGPGGTLATVTEFMVNGSLR-HVLLSKERHLDRRKRLIIAMDAAFGMEYLH-SKNIVHFDLKCDNLLVNLKDP 1186 (1236)
Q Consensus 1109 rLyG~f~t~~~g~L~LVMEYm~GGSL~-dlL~~k~r~LSe~erl~Ia~QIAeALaYLH-SkGIIHRDIKPsNILLDsdG~ 1186 (1236)
----+... ...|||+|+-..... -.| +...++...+..+-.+++.-|.-|. .+++||.||.-=|+|+-.+
T Consensus 230 ~PePIlLk----~hVLVM~FlGrdgw~aPkL--Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~LyhdG-- 301 (520)
T KOG2270|consen 230 CPEPILLK----NHVLVMEFLGRDGWAAPKL--KDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHDG-- 301 (520)
T ss_pred CCCceeee----cceEeeeeccCCCCcCccc--ccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEECC--
Confidence 22222222 336899999322111 011 2234666666666678888888775 5799999999999999754
Q ss_pred CCCcEEEEeccCcccc
Q 000893 1187 IRPICKVGDFGLSKIK 1202 (1236)
Q Consensus 1187 I~ltVKLsDFGLArii 1202 (1236)
.+.|+|.+-+...
T Consensus 302 ---~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 302 ---KLYIIDVSQSVEH 314 (520)
T ss_pred ---EEEEEEccccccC
Confidence 5689999877653
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.25 E-value=0.011 Score=68.63 Aligned_cols=140 Identities=18% Similarity=0.067 Sum_probs=90.3
Q ss_pred eeEEEEeccCCceEEEEeee-cCceEEEEeeecccc--CCCChHH------------HHHHHHHHHHHHHHhhCC-CCc-
Q 000893 1044 LEELKELGSGTFGTVYHGKW-RGTDVAIKRIKKSCF--TGRSSEQ------------ERLTLEFWREAEILSKLH-HPN- 1106 (1236)
Q Consensus 1044 YeiLkkLGsGSFGtVYKArl-kG~~VAVKvLkk~~i--~~~~~e~------------er~~keFlrEIrILskLr-HPN- 1106 (1236)
+.+.+.||-|.-+.||.+-+ .|++.++|.-..... ....... .-......+|+..|+.|. |-+
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 45778899999999999888 499999986543211 0000000 011122467888888775 322
Q ss_pred eeeEeeeEecCCCCeEEEEEeeccCCCHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCCCcEEEccCCC
Q 000893 1107 VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP 1186 (1236)
Q Consensus 1107 IVrLyG~f~t~~~g~L~LVMEYm~GGSL~dlL~~k~r~LSe~erl~Ia~QIAeALaYLHSkGIIHRDIKPsNILLDsdG~ 1186 (1236)
+.+.++++ ..++|||++.+..|.+.-+ ..+... +...+..-+--|..+|+||+|..-=||+|+.++
T Consensus 174 VPkpiD~~------RH~Vvmelv~g~Pl~~v~~----v~d~~~---ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~- 239 (465)
T KOG2268|consen 174 VPKPIDHN------RHCVVMELVDGYPLRQVRH----VEDPPT---LYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDD- 239 (465)
T ss_pred CCCccccc------ceeeHHHhhcccceeeeee----cCChHH---HHHHHHHHHHHHHHcCceecccchheeEEecCC-
Confidence 34445433 4578999998888865431 122232 233444445567789999999999999999876
Q ss_pred CCCcEEEEeccCcc
Q 000893 1187 IRPICKVGDFGLSK 1200 (1236)
Q Consensus 1187 I~ltVKLsDFGLAr 1200 (1236)
.++++||=-+.
T Consensus 240 ---~i~vIDFPQmv 250 (465)
T KOG2268|consen 240 ---KIVVIDFPQMV 250 (465)
T ss_pred ---CEEEeechHhh
Confidence 45899996543
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.94 E-value=0.28 Score=54.05 Aligned_cols=30 Identities=27% Similarity=0.355 Sum_probs=24.7
Q ss_pred CCcccCCCCCCcEEEccCCCCCCcEEEEeccCccc
Q 000893 1167 KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201 (1236)
Q Consensus 1167 kGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLAri 1201 (1236)
.+++|+|+.+.|||++.+ .+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~-----~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKDN-----EVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeCC-----cEEEEECccccc
Confidence 478999999999999863 247999997654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >smart00252 SH2 Src homology 2 domains | Back alignment and domain information |
|---|
Probab=94.92 E-value=0.01 Score=54.18 Aligned_cols=52 Identities=17% Similarity=0.296 Sum_probs=38.2
Q ss_pred cccccccccccccchhhhhccC--CCcccccccccCCccccccCCCCCCCCCCCCCCCCceeeccCccC
Q 000893 901 YFRNLAQDEFSRKDVSLMDQDH--LGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQR 967 (1236)
Q Consensus 901 yyhGl~~~~l~R~D~E~LL~~~--GdFLVRLSEiq~G~TlD~S~n~L~~~pSvmP~sgS~lNf~I~S~~ 967 (1236)
||||. |+|++||.||.+. |+||+|.++...+. +.. +++.. +.+.|+.|....
T Consensus 3 w~~g~----i~r~~Ae~lL~~~~~G~FLvR~s~~~~~~---~~L-------sv~~~-~~~~h~~I~~~~ 56 (84)
T smart00252 3 WYHGF----ISREEAEKLLKNEGDGDFLVRDSESEPGD---YVL-------SVRVK-GKVKHYRIRRNE 56 (84)
T ss_pred eeccc----CCHHHHHHHHhcCCCcEEEEEcCCCCCCC---EEE-------EEEEC-CEEEEEEEEECC
Confidence 99999 9999999999764 99999999975553 122 12222 457898885544
|
Src homology 2 domains bind phosphotyrosine-containing polypeptides via 2 surface pockets. Specificity is provided via interaction with residues that are distinct from the phosphotyrosine. Only a single occurrence of a SH2 domain has been found in S. cerevisiae. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.45 E-value=0.18 Score=56.86 Aligned_cols=82 Identities=15% Similarity=0.066 Sum_probs=57.7
Q ss_pred eeEEEEeccCCceEEEEeeecCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCC---CceeeEeeeEecC-CC
Q 000893 1044 LEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH---PNVVAFYGVVQDG-PG 1119 (1236)
Q Consensus 1044 YeiLkkLGsGSFGtVYKArlkG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrH---PNIVrLyG~f~t~-~~ 1119 (1236)
..-.+.||.|..+.||+....+..+.+|..+... ....|.+|...|+.|.- -.+.+++++|... ..
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~----------~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~ 85 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQGNPMPLMARSFS----------TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSP 85 (297)
T ss_pred hheeeecCCccceeEEEEEcCCCCEEEEEecccc----------cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcC
Confidence 3445679999999999987755567778754210 01356778888888753 3577888887643 23
Q ss_pred CeEEEEEeeccCCCHH
Q 000893 1120 GTLATVTEFMVNGSLR 1135 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~ 1135 (1236)
+..+||||++++.++.
T Consensus 86 g~~~LVmE~i~G~~~~ 101 (297)
T PRK10593 86 GPDVLLLERLRGVSVE 101 (297)
T ss_pred CCeEEEEeccCCEecC
Confidence 5689999999887663
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=94.40 E-value=0.16 Score=58.43 Aligned_cols=138 Identities=16% Similarity=0.203 Sum_probs=76.1
Q ss_pred EEEeccCCceEEEEeeec------CceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCCCcee-eEeeeEecCCC
Q 000893 1047 LKELGSGTFGTVYHGKWR------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVV-AFYGVVQDGPG 1119 (1236)
Q Consensus 1047 LkkLGsGSFGtVYKArlk------G~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrHPNIV-rLyG~f~t~~~ 1119 (1236)
++.|-.|-.-.+|+.... ++.|++|+..... +.... ..+|+.+++.+..-+|. ++++.+..
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--------~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~--- 108 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--------ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPN--- 108 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--------Ceeec-hHHHHHHHHHHHHcCCCCceEEEECC---
Confidence 345655888899998752 2568999876431 01111 13577777777644443 55665532
Q ss_pred CeEEEEEeeccCCCHHHH----------H-------hhhc----c-CCCHHHHHHHHHH-----------------HHHH
Q 000893 1120 GTLATVTEFMVNGSLRHV----------L-------LSKE----R-HLDRRKRLIIAMD-----------------AAFG 1160 (1236)
Q Consensus 1120 g~L~LVMEYm~GGSL~dl----------L-------~~k~----r-~LSe~erl~Ia~Q-----------------IAeA 1160 (1236)
+ .|++|+++.+|... + +... . ..-+.....+..+ +...
T Consensus 109 g---~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~ 185 (344)
T PLN02236 109 G---RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDE 185 (344)
T ss_pred c---eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHH
Confidence 2 48999987665421 0 1111 0 1111222222211 1111
Q ss_pred HHHH----H----HCCcccCCCCCCcEEEccCCCCCCcEEEEeccCcccc
Q 000893 1161 MEYL----H----SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 1202 (1236)
Q Consensus 1161 LaYL----H----SkGIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii 1202 (1236)
+..| . ...++|+|+++.|||++.+.. .+.|+||..|...
T Consensus 186 ~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~---~~~lID~Eya~~~ 232 (344)
T PLN02236 186 INLLEKELSGDDQEIGFCHNDLQYGNIMIDEETR---AITIIDYEYASYN 232 (344)
T ss_pred HHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCC---cEEEEeehhcccc
Confidence 2222 1 125899999999999986421 4689999998764
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=94.33 E-value=0.037 Score=68.66 Aligned_cols=71 Identities=23% Similarity=0.385 Sum_probs=52.2
Q ss_pred HHHHHHHHHHHC-CcccCCCCCCcEEEccCCCCCCcEEEEeccCcccccCccc----------ccCcCCCCcccchhhhc
Q 000893 1156 DAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLV----------TGGVRGTLPWMAPELLN 1224 (1236)
Q Consensus 1156 QIAeALaYLHSk-GIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~ns~~----------tss~~GTp~YmAPEVL~ 1224 (1236)
+++.||.|+|.. ++||++|.|++|.++..+. .||+.|+++........ ..-..-...|.|||++.
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~----wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGD----WKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcc----eeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 555999999975 8999999999999999874 49999998876443111 11122456799999998
Q ss_pred CCCCCC
Q 000893 1225 GSSSKV 1230 (1236)
Q Consensus 1225 Gss~~~ 1230 (1236)
+.....
T Consensus 183 ~~~~~~ 188 (700)
T KOG2137|consen 183 GTTNTP 188 (700)
T ss_pred cccccc
Confidence 754333
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=94.12 E-value=0.33 Score=54.43 Aligned_cols=33 Identities=21% Similarity=0.306 Sum_probs=26.5
Q ss_pred CcccCCCCCCcEEEccCCCCCCcEEEEeccCccccc
Q 000893 1168 NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR 1203 (1236)
Q Consensus 1168 GIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~ 1203 (1236)
.++|+|++|.|||++.++. ..-|+||+.+...+
T Consensus 186 ~lvHGD~~~~Nilv~~~~~---~~gviDWe~a~iGD 218 (276)
T cd05152 186 VLVHGDLHPGHILIDEDAR---VTGLIDWTEAKVGD 218 (276)
T ss_pred eeEeCCCCCCcEEEeCCCC---EEEEECcHhcccCC
Confidence 4899999999999986442 34699999988753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >cd06397 PB1_UP1 Uncharacterized protein 1 | Back alignment and domain information |
|---|
Probab=93.95 E-value=0.18 Score=48.01 Aligned_cols=59 Identities=24% Similarity=0.385 Sum_probs=47.8
Q ss_pred cCceeEEEecCCCChHHHHHHHHHHcCC---ceEEEEecCCCCCCceeeccChHHHHHHHHHhhh
Q 000893 209 GGETRIIRISRDISWQELTQKALAIYNQ---THTIKYQLPGEDLDALVSVSCDEDLQNMMEECNV 270 (1236)
Q Consensus 209 GGetriv~V~r~~sf~~l~~kl~~~~~~---~~~lKYqLP~edLDaLiSVt~DeDL~~M~~Eydr 270 (1236)
||+||=+.+++.-+|.+|..||..++.- ++.|+|- .||- -+|++++|+||+..+....+
T Consensus 8 ~g~~RRf~~~~~pt~~~L~~kl~~Lf~lp~~~~~vtYi--DeD~-D~ITlssd~eL~d~~~~~~~ 69 (82)
T cd06397 8 LGDTRRIVFPDIPTWEALASKLENLYNLPEIKVGVTYI--DNDN-DEITLSSNKELQDFYRLSHR 69 (82)
T ss_pred CCceEEEecCCCccHHHHHHHHHHHhCCChhHeEEEEE--cCCC-CEEEecchHHHHHHHHhccc
Confidence 5677777799999999999999999972 5889997 4433 58999999999987765444
|
The PB1 domain is a modular domain mediating specific protein-protein interaction which play a role in many critical cell processes, such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domain, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=93.87 E-value=0.2 Score=59.04 Aligned_cols=77 Identities=19% Similarity=0.151 Sum_probs=45.2
Q ss_pred EeccCCceEEEEeeecC--ceEEEEeeeccccC-CCChHHHHHHHHHHHHHHHHhhCC--CC-ceeeEeeeEecCCCCeE
Q 000893 1049 ELGSGTFGTVYHGKWRG--TDVAIKRIKKSCFT-GRSSEQERLTLEFWREAEILSKLH--HP-NVVAFYGVVQDGPGGTL 1122 (1236)
Q Consensus 1049 kLGsGSFGtVYKArlkG--~~VAVKvLkk~~i~-~~~~e~er~~keFlrEIrILskLr--HP-NIVrLyG~f~t~~~g~L 1122 (1236)
.||.|....||++...+ +.|+||.-...... +.. -.-...+...|...|+... -| .+.++|.+-.. ..
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~--wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~e----~~ 75 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGES--WPLTLDRARIESSALIRQGEHVPHLVPRIFHFDTE----MA 75 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCC--CCCCccHHHHHHHHHHHhhccCccccCeEEEEccc----cc
Confidence 47999999999998854 57999975432211 100 0111223335677776653 24 45566654332 45
Q ss_pred EEEEeeccC
Q 000893 1123 ATVTEFMVN 1131 (1236)
Q Consensus 1123 ~LVMEYm~G 1131 (1236)
.+|||+++.
T Consensus 76 ~~vMEdL~~ 84 (370)
T TIGR01767 76 VTVMEDLSH 84 (370)
T ss_pred eehHhhCcc
Confidence 689999954
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=93.75 E-value=0.95 Score=54.31 Aligned_cols=80 Identities=16% Similarity=0.095 Sum_probs=50.4
Q ss_pred EEEeccCCceEEEEeeecCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCC---CCceeeEeeeEecCCCCeEE
Q 000893 1047 LKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH---HPNVVAFYGVVQDGPGGTLA 1123 (1236)
Q Consensus 1047 LkkLGsGSFGtVYKArlkG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLr---HPNIVrLyG~f~t~~~g~L~ 1123 (1236)
.+.||.|....||+....+..++||.-....... ...-.....+-..|...|+.+. ..++.++|.++.+ .-+
T Consensus 37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~v-ga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded----~~v 111 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCI-GESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT----MAL 111 (418)
T ss_pred EEEcCCCceeeEEEEEcCCccEEEEeCCccccCC-CccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC----CCE
Confidence 5678999999999988877779999765322110 0000000112223555665543 3578889998875 347
Q ss_pred EEEeeccC
Q 000893 1124 TVTEFMVN 1131 (1236)
Q Consensus 1124 LVMEYm~G 1131 (1236)
++|||+++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 79999976
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.79 E-value=0.7 Score=53.64 Aligned_cols=149 Identities=19% Similarity=0.173 Sum_probs=80.3
Q ss_pred eEEEEeccCCceEEEEeeecCceEEEEeeeccccCCCChHHHHHHHHHHHHHHHHhhCCC--CceeeEeeeEecCCCCeE
Q 000893 1045 EELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH--PNVVAFYGVVQDGPGGTL 1122 (1236)
Q Consensus 1045 eiLkkLGsGSFGtVYKArlkG~~VAVKvLkk~~i~~~~~e~er~~keFlrEIrILskLrH--PNIVrLyG~f~t~~~g~L 1122 (1236)
.+.+.+-.|.--.+|+...+++.+++. .... ... -.......+|..+|+.+.- --+...+++|....-+..
T Consensus 28 ~~v~~~~~G~sn~t~~~~~~~~~~vlR-~P~~-~~~-----~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~p 100 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGDTGQKYVLR-KPPR-GDP-----VESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTP 100 (321)
T ss_pred ceeeeccCCcccceEEEecCCceEEEe-cCCc-ccc-----chhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCc
Confidence 334445445444566665667778888 3211 110 1112334467777776542 233456677766544677
Q ss_pred EEEEeeccCC---------CHH-HHHh--------h---h--------cc--CCCHHHHHHHHH--------------HH
Q 000893 1123 ATVTEFMVNG---------SLR-HVLL--------S---K--------ER--HLDRRKRLIIAM--------------DA 1157 (1236)
Q Consensus 1123 ~LVMEYm~GG---------SL~-dlL~--------~---k--------~r--~LSe~erl~Ia~--------------QI 1157 (1236)
|.||+|++|. ++. ++.. . - +. .....+...+.. ..
T Consensus 101 f~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~ 180 (321)
T COG3173 101 FYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA 180 (321)
T ss_pred eEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence 9999999872 222 1211 0 0 00 000001111111 11
Q ss_pred HHHHHHHHHC--------CcccCCCCCCcEEEccCCCCCCcEEEEeccCcccccC
Q 000893 1158 AFGMEYLHSK--------NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 1204 (1236)
Q Consensus 1158 AeALaYLHSk--------GIIHRDIKPsNILLDsdG~I~ltVKLsDFGLArii~n 1204 (1236)
..-..||+.+ .++|+|+.+.||||+.++. +-|.||+++.+.+.
T Consensus 181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~----~gVlDwe~~~lGDP 231 (321)
T COG3173 181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRP----TGVLDWELATLGDP 231 (321)
T ss_pred HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCe----eEEEeccccccCCc
Confidence 2224455532 5899999999999998864 46899999987543
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1236 | ||||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-30 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-30 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-23 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-23 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-23 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-23 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-22 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-22 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-22 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-22 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-22 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-22 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-21 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-21 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-21 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-20 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-20 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 8e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 9e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-18 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-18 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-18 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-18 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-18 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-18 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-17 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-17 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-17 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-17 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 8e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-17 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-17 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-16 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-16 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-16 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-16 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-16 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-16 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-16 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-16 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-16 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-16 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-16 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-16 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-16 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-16 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-16 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-16 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-16 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-16 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-16 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 7e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 8e-16 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-16 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-15 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-15 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-15 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-15 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-15 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-15 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 8e-15 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-14 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-14 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-14 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-14 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-14 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 7e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 7e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 8e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-14 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 8e-14 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 8e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 9e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 9e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-13 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-13 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-13 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-13 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-13 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-13 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-13 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-13 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-13 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-13 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-13 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 9e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-12 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-12 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-12 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-12 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-12 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-12 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-12 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 8e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 8e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 8e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-11 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-11 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-11 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 8e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 8e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 9e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 9e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-10 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-10 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-10 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-10 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-10 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-10 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-10 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-10 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-10 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-10 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-10 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-10 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 9e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 9e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 7e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 7e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 8e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 8e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 8e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 8e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 8e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 8e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 9e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 9e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 9e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 9e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 9e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-08 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-08 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 6e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 7e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 9e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 9e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-07 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-07 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-07 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-07 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-07 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-07 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-07 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-07 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-07 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 7e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 8e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 9e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 9e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-06 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-06 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-06 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 8e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 8e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-05 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 1e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-05 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-05 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-05 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-05 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-05 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-05 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-05 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 4e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-05 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-05 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-05 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-05 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 5e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-05 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 7e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 8e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-05 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 1e-04 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-04 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-04 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-04 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-04 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-04 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 2e-04 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 2e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-04 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 2e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-04 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-04 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 4e-04 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-04 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-04 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 5e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 5e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 6e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 6e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 6e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 6e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 8e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-04 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 8e-04 |
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 270 bits (693), Expect = 1e-82
Identities = 72/210 (34%), Positives = 109/210 (51%), Gaps = 12/210 (5%)
Query: 1030 NFDISTLQIIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQER 1087
F S L + + ++E K++G G FG V+ G+ + VAIK + G + E+
Sbjct: 7 EFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEK 66
Query: 1088 LTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDR 1147
EF RE I+S L+HPN+V YG++ + P V EF+ G L H LL K +
Sbjct: 67 FQ-EFQREVFIMSNLNHPNIVKLYGLMHNPP----RMVMEFVPCGDLYHRLLDKAHPIKW 121
Query: 1148 RKRLIIAMDAAFGMEYLHSKN--IVHFDLKCDNLLVNLKDPIRPIC-KVGDFGLSKIKRN 1204
+L + +D A G+EY+ ++N IVH DL+ N+ + D P+C KV DFGLS+ +
Sbjct: 122 SVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH 181
Query: 1205 TLVTGGVRGTLPWMAPELLNGSSSKVSEKV 1234
+ G+ G WMAPE + +EK
Sbjct: 182 S--VSGLLGNFQWMAPETIGAEEESYTEKA 209
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 256 bits (655), Expect = 1e-77
Identities = 61/203 (30%), Positives = 89/203 (43%), Gaps = 18/203 (8%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
I +L + +G G FG VY W G +VA+K + + + +EA++
Sbjct: 4 IDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARH----DPDEDISQTIENVRQEAKL 59
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
+ L HPN++A GV P L V EF G L VL + + + A+ A
Sbjct: 60 FAMLKHPNIIALRGVCLKEP--NLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQIA 115
Query: 1159 FGMEYLHSKN---IVHFDLKCDNLLVN----LKDPIRPICKVGDFGLSKIKRNTLVTGGV 1211
GM YLH + I+H DLK N+L+ D I K+ DFGL++ T
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA 175
Query: 1212 RGTLPWMAPELLNGSSSKVSEKV 1234
G WMAPE++ S S+
Sbjct: 176 -GAYAWMAPEVIRA--SMFSKGS 195
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 254 bits (651), Expect = 5e-77
Identities = 46/200 (23%), Positives = 80/200 (40%), Gaps = 18/200 (9%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
I + L L +L G ++ G+W+G D+ +K +K ++ R S +F E
Sbjct: 7 IDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSR------DFNEECPR 60
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH-LDRRKRLIIAMDA 1157
L HPNV+ G Q P +T +M GSL +VL +D+ + + A+D
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120
Query: 1158 AFGMEYLHSKN--IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTL 1215
A GM +LH+ I L +++++ ++ + ++ G
Sbjct: 121 ARGMAFLHTLEPLIPRHALNSRSVMIDEDMT----ARISMADVKFSFQSP----GRMYAP 172
Query: 1216 PWMAPELLNGSSSKV-SEKV 1234
W+APE L
Sbjct: 173 AWVAPEALQKKPEDTNRRSA 192
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 255 bits (654), Expect = 6e-77
Identities = 81/201 (40%), Positives = 113/201 (56%), Gaps = 19/201 (9%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
I DL +++G+G+FGTV+ +W G+DVA+K + + F EF RE I
Sbjct: 34 IPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVN------EFLREVAI 87
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH--LDRRKRLIIAMD 1156
+ +L HPN+V F G V P L+ VTE++ GSL +L LD R+RL +A D
Sbjct: 88 MKRLRHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYD 145
Query: 1157 AAFGMEYLHSKN--IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG-GVRG 1213
A GM YLH++N IVH +LK NLLV+ + KV DFGLS++K +T ++ G
Sbjct: 146 VAKGMNYLHNRNPPIVHRNLKSPNLLVD----KKYTVKVCDFGLSRLKASTFLSSKSAAG 201
Query: 1214 TLPWMAPELLNGSSSKVSEKV 1234
T WMAPE+L S +EK
Sbjct: 202 TPEWMAPEVLRDEPS--NEKS 220
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 251 bits (642), Expect = 1e-75
Identities = 66/200 (33%), Positives = 103/200 (51%), Gaps = 18/200 (9%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
I + + + +GSG+FGTVY GKW G DVA+K + + T + + F E +
Sbjct: 21 IPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQ------AFKNEVGV 73
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
L K H N++ F G LA VT++ SL H L + E + +K + IA A
Sbjct: 74 LRKTRHVNILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTA 130
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTL 1215
GM+YLH+K+I+H DLK +N+ ++ + K+GDFGL+ K + G++
Sbjct: 131 RGMDYLHAKSIIHRDLKSNNIFLHEDN----TVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
Query: 1216 PWMAPELLNG-SSSKVSEKV 1234
WMAPE++ S+ S +
Sbjct: 187 LWMAPEVIRMQDSNPYSFQS 206
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 241 bits (617), Expect = 7e-72
Identities = 64/205 (31%), Positives = 97/205 (47%), Gaps = 26/205 (12%)
Query: 1035 TLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWR 1094
+L +I +++E + +G G FG V KWR DVAIK+I+ E F
Sbjct: 1 SLHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIE----------SESERKAFIV 50
Query: 1095 EAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER--HLDRRKRLI 1152
E LS+++HPN+V YG + + V E+ GSL +VL E + +
Sbjct: 51 ELRQLSRVNHPNIVKLYGACLN----PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMS 106
Query: 1153 IAMDAAFGMEYLHS---KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG 1209
+ + G+ YLHS K ++H DLK NLL+ + K+ DFG + + +
Sbjct: 107 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGG---TVLKICDFGTACDIQTHMTNN 163
Query: 1210 GVRGTLPWMAPELLNGSSSKVSEKV 1234
+G+ WMAPE+ G S SEK
Sbjct: 164 --KGSAAWMAPEVFEG--SNYSEKC 184
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 241 bits (618), Expect = 7e-72
Identities = 63/209 (30%), Positives = 84/209 (40%), Gaps = 27/209 (12%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
I E LE + +G G FG VYHG+W G +VAI+ I + E F RE
Sbjct: 30 IPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIE------RDNEDQLKAFKREVMA 82
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
+ H NVV F G P LA +T +L V+ + LD K IA +
Sbjct: 83 YRQTRHENVVLFMGACMSPP--HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIV 140
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG------GVR 1212
GM YLH+K I+H DLK N+ + + DFGL I
Sbjct: 141 KGMGYLHAKGILHKDLKSKNVFYDNGK-----VVITDFGLFSISGVLQAGRREDKLRIQN 195
Query: 1213 GTLPWMAPELLNGSSSKV-------SEKV 1234
G L +APE++ S S+
Sbjct: 196 GWLCHLAPEIIRQLSPDTEEDKLPFSKHS 224
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 2e-62
Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 34/214 (15%)
Query: 1036 LQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWRE 1095
+Q + ++ +K++G G +G V+ GKWRG VA+K + ++RE
Sbjct: 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEA-----------SWFRE 79
Query: 1096 AEI--LSKLHHPNVVAFYGVVQDGPGGT--LATVTEFMVNGSLRHVLLSKERHLDRRKRL 1151
EI + H N++ F G G L +T++ NGSL L K LD + L
Sbjct: 80 TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSML 137
Query: 1152 IIAMDAAFGMEYLHSKN--------IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR 1203
+A + G+ +LH++ I H DLK N+LV C + D GL+
Sbjct: 138 KLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN----GTCCIADLGLAVKFI 193
Query: 1204 NT-----LVTGGVRGTLPWMAPELLNGSSSKVSE 1232
+ + GT +M PE+L+ S ++
Sbjct: 194 SDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHF 227
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 2e-61
Identities = 66/214 (30%), Positives = 95/214 (44%), Gaps = 33/214 (15%)
Query: 1038 IIKNEDLEELKELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWRE 1095
I + DL + LG G FG R T + +K + + E +R F +E
Sbjct: 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-----DEETQR---TFLKE 57
Query: 1096 AEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM 1155
+++ L HPNV+ F GV+ L +TE++ G+LR ++ S + +R+ A
Sbjct: 58 VKVMRCLEHPNVLKFIGVLYKDK--RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAK 115
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT---------- 1205
D A GM YLHS NI+H DL N LV V DFGL+++ +
Sbjct: 116 DIASGMAYLHSMNIIHRDLNSHNCLVRENK----NVVVADFGLARLMVDEKTQPEGLRSL 171
Query: 1206 -----LVTGGVRGTLPWMAPELLNGSSSKVSEKV 1234
V G WMAPE++NG S EKV
Sbjct: 172 KKPDRKKRYTVVGNPYWMAPEMINGRSY--DEKV 203
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 8e-55
Identities = 59/207 (28%), Positives = 88/207 (42%), Gaps = 34/207 (16%)
Query: 1037 QIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREA 1096
Q + + +G G FG V+ GKWRG +VA+K S +ER ++REA
Sbjct: 37 QRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFS--------SREER---SWFREA 85
Query: 1097 EI--LSKLHHPNVVAFYGVVQDGPGGT--LATVTEFMVNGSLRHVLLSKERHLDRRKRLI 1152
EI L H N++ F G L V+++ +GSL L + +
Sbjct: 86 EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIK 143
Query: 1153 IAMDAAFGMEYLHSK--------NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 1204
+A+ A G+ +LH + I H DLK N+LV C + D GL+ +
Sbjct: 144 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG----TCCIADLGLAVRHDS 199
Query: 1205 TLVTG-----GVRGTLPWMAPELLNGS 1226
T GT +MAPE+L+ S
Sbjct: 200 ATDTIDIAPNHRVGTKRYMAPEVLDDS 226
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 2e-54
Identities = 56/209 (26%), Positives = 89/209 (42%), Gaps = 34/209 (16%)
Query: 1035 TLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWR 1094
++Q D+ L+ +G G +G V+ G W+G +VA+K SS E+ ++R
Sbjct: 1 SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIF--------SSRDEK---SWFR 49
Query: 1095 EAEI--LSKLHHPNVVAFYGVVQDGPGGT--LATVTEFMVNGSLRHVLLSKERHLDRRKR 1150
E E+ L H N++ F + L +T + GSL L + LD
Sbjct: 50 ETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSC 107
Query: 1151 LIIAMDAAFGMEYLHSK--------NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 1202
L I + A G+ +LH + I H DLK N+LV C + D GL+ +
Sbjct: 108 LRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG----QCCIADLGLAVMH 163
Query: 1203 RNTLVTG-----GVRGTLPWMAPELLNGS 1226
+ GT +MAPE+L+ +
Sbjct: 164 SQSTNQLDVGNNPRVGTKRYMAPEVLDET 192
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 4e-49
Identities = 63/192 (32%), Positives = 92/192 (47%), Gaps = 20/192 (10%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG--TDVAIKRIKKSCFTGRSSEQERLTLEFWREA 1096
+ +EDL +++G G FG V+ G+ R T VA+K +++ + +F +EA
Sbjct: 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-----LPPDLKA--KFLQEA 163
Query: 1097 EILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM 1155
IL + HPN+V GV Q P + V E + G L ++ L + L +
Sbjct: 164 RILKQYSHPNIVRLIGVCTQKQP---IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVG 220
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTGGVRGT 1214
DAA GMEYL SK +H DL N LV K+ + K+ DFG+S+ G
Sbjct: 221 DAAAGMEYLESKCCIHRDLAARNCLVTEKN----VLKISDFGMSREEADGVYAASGGLRQ 276
Query: 1215 LP--WMAPELLN 1224
+P W APE LN
Sbjct: 277 VPVKWTAPEALN 288
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 2e-48
Identities = 57/193 (29%), Positives = 86/193 (44%), Gaps = 21/193 (10%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTLEFW 1093
I ED+ + LG G FG VY G + +VA+K KK + + +F
Sbjct: 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-----CTLDNKE--KFM 61
Query: 1094 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 1153
EA I+ L HP++V G++++ P + E G L H L + L ++
Sbjct: 62 SEAVIMKNLDHPHIVKLIGIIEEEP---TWIIMELYPYGELGHYLERNKNSLKVLTLVLY 118
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRG 1213
++ M YL S N VH D+ N+LV + K+GDFGLS+ +
Sbjct: 119 SLQICKAMAYLESINCVHRDIAVRNILVASPE----CVKLGDFGLSRYIEDEDYYKASVT 174
Query: 1214 TLP--WMAPELLN 1224
LP WM+PE +N
Sbjct: 175 RLPIKWMSPESIN 187
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 2e-48
Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 23/202 (11%)
Query: 1032 DISTLQIIKNEDLEELKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQ 1085
+ + L+I+K + +++K LGSG FGTVY G W VAIK ++++ +S +
Sbjct: 5 NQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-----TSPK 59
Query: 1086 ERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHL 1145
E EA +++ + +P+V G+ + +T+ M G L + + ++
Sbjct: 60 ANK--EILDEAYVMASVDNPHVCRLLGICLTST---VQLITQLMPFGCLLDYVREHKDNI 114
Query: 1146 DRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRN 1204
+ L + A GM YL + +VH DL N+LV K+ DFGL+K +
Sbjct: 115 GSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ----HVKITDFGLAKLLGAE 170
Query: 1205 TLVTGGVRGTLP--WMAPELLN 1224
G +P WMA E +
Sbjct: 171 EKEYHAEGGKVPIKWMALESIL 192
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 4e-48
Identities = 69/190 (36%), Positives = 101/190 (53%), Gaps = 20/190 (10%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
+K E++ LKELGSG FG V GKW+G DVA+K IK+ S ++ EF++EA+
Sbjct: 5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG-----SMSED----EFFQEAQ 55
Query: 1098 ILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
+ KL HP +V FYGV ++ P + VTE++ NG L + L S + L+ + L + D
Sbjct: 56 TMMKLSHPKLVKFYGVCSKEYP---IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYD 112
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 1216
GM +L S +H DL N LV+ KV DFG+++ + V P
Sbjct: 113 VCEGMAFLESHQFIHRDLAARNCLVDRDL----CVKVSDFGMTRYVLDDQYVSSVGTKFP 168
Query: 1217 --WMAPELLN 1224
W APE+ +
Sbjct: 169 VKWSAPEVFH 178
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 6e-48
Identities = 60/193 (31%), Positives = 93/193 (48%), Gaps = 21/193 (10%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTLEFW 1093
I+ E +E + +G G FG V+ G + VAIK K +S+ R +F
Sbjct: 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-----TSDSVRE--KFL 64
Query: 1094 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 1153
+EA + + HP++V GV+ + P + + E G LR L ++ LD ++
Sbjct: 65 QEALTMRQFDHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILY 121
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRG 1213
A + + YL SK VH D+ N+LV+ D K+GDFGLS+ ++ +G
Sbjct: 122 AYQLSTALAYLESKRFVHRDIAARNVLVSSND----CVKLGDFGLSRYMEDSTYYKASKG 177
Query: 1214 TLP--WMAPELLN 1224
LP WMAPE +N
Sbjct: 178 KLPIKWMAPESIN 190
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 1e-47
Identities = 72/190 (37%), Positives = 96/190 (50%), Gaps = 20/190 (10%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
I +DL LKELG+G FG V +GKWRG DVAIK IK+ S ++ EF EA+
Sbjct: 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-----SMSED----EFIEEAK 71
Query: 1098 ILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
++ L H +V YGV + P + +TE+M NG L + L ++ L + D
Sbjct: 72 VMMNLSHEKLVQLYGVCTKQRP---IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKD 128
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 1216
MEYL SK +H DL N LVN + + KV DFGLS+ + T V P
Sbjct: 129 VCEAMEYLESKQFLHRDLAARNCLVNDQG----VVKVSDFGLSRYVLDDEYTSSVGSKFP 184
Query: 1217 --WMAPELLN 1224
W PE+L
Sbjct: 185 VRWSPPEVLM 194
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 4e-47
Identities = 60/190 (31%), Positives = 90/190 (47%), Gaps = 20/190 (10%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
I +L ++E+GSG FG V+ G W VAIK I++ + +E +F EAE
Sbjct: 5 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-----AMSEE----DFIEEAE 55
Query: 1098 ILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
++ KL HP +V YGV + P + VTEFM +G L L ++ L + +D
Sbjct: 56 VMMKLSHPKLVQLYGVCLEQAP---ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 112
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 1216
GM YL ++H DL N LV + KV DFG+++ + T P
Sbjct: 113 VCEGMAYLEEACVIHRDLAARNCLVGENQ----VIKVSDFGMTRFVLDDQYTSSTGTKFP 168
Query: 1217 --WMAPELLN 1224
W +PE+ +
Sbjct: 169 VKWASPEVFS 178
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 8e-47
Identities = 62/192 (32%), Positives = 89/192 (46%), Gaps = 22/192 (11%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG--TDVAIKRIKKSCFTGRSSEQERLTLEFWREA 1096
++ D+ +LG G +G VY G W+ VA+K +K+ + E E EF +EA
Sbjct: 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVE----EFLKEA 60
Query: 1097 EILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-IA 1154
++ ++ HPN+V GV ++ P +TEFM G+L L R L+ +A
Sbjct: 61 AVMKEIKHPNLVQLLGVCTREPP---FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 117
Query: 1155 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGT 1214
+ MEYL KN +H DL N LV + KV DFGLS++ T
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVGENH----LVKVADFGLSRLMTGDTYTAHAGAK 173
Query: 1215 LP--WMAPELLN 1224
P W APE L
Sbjct: 174 FPIKWTAPESLA 185
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 1e-46
Identities = 62/196 (31%), Positives = 88/196 (44%), Gaps = 21/196 (10%)
Query: 1038 IIKNEDLEELKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTLEF 1092
+I +DL L++LG G+FG V G+W VA+K +K + + + F
Sbjct: 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD-----F 68
Query: 1093 WREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI 1152
RE + L H N++ YGVV P + VTE GSL L + H
Sbjct: 69 IREVNAMHSLDHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSR 125
Query: 1153 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KRNTLVTGG 1210
A+ A GM YL SK +H DL NLL+ +D + K+GDFGL + + +
Sbjct: 126 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRD----LVKIGDFGLMRALPQNDDHYVMQ 181
Query: 1211 VRGTLP--WMAPELLN 1224
+P W APE L
Sbjct: 182 EHRKVPFAWCAPESLK 197
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 3e-46
Identities = 52/213 (24%), Positives = 76/213 (35%), Gaps = 40/213 (18%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
+ ++L+ L+ +G G +G VY G VA+K S + F E I
Sbjct: 10 LDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVF--------SFANRQ---NFINEKNI 58
Query: 1099 --LSKLHHPNVVAFYGVVQDGPGGT---LATVTEFMVNGSLRHVLLSKERHLDRRKRLII 1153
+ + H N+ F + V E+ NGSL L D +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL--SLHTSDWVSSCRL 116
Query: 1154 AMDAAFGMEYLHS---------KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 1204
A G+ YLH+ I H DL N+LV C + DFGLS
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG----TCVISDFGLSMRLTG 172
Query: 1205 T---------LVTGGVRGTLPWMAPELLNGSSS 1228
GT+ +MAPE+L G+ +
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVN 205
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 3e-46
Identities = 58/197 (29%), Positives = 94/197 (47%), Gaps = 21/197 (10%)
Query: 1038 IIKNEDLEELKELGSGTFGTVYHGKWR------GTDVAIKRIKKSCFTGRSSEQERLTLE 1091
+ L+ +++LG G FG V ++ G VA+K +K S +
Sbjct: 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE-----SGGNHIA--D 69
Query: 1092 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL 1151
+E EIL L+H N+V + G+ + G + + EF+ +GSL+ L + ++ +++L
Sbjct: 70 LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQL 129
Query: 1152 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLV-TG 1209
A+ GM+YL S+ VH DL N+LV + K+GDFGL+K I+ + T
Sbjct: 130 KYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH----QVKIGDFGLTKAIETDKEYYTV 185
Query: 1210 GVRGTLP--WMAPELLN 1224
P W APE L
Sbjct: 186 KDDRDSPVFWYAPECLM 202
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 3e-46
Identities = 64/190 (33%), Positives = 95/190 (50%), Gaps = 24/190 (12%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
+ ++L+ L+ +G G FG V G +RG VA+K IK ++ Q F EA +
Sbjct: 18 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND-----ATAQ-----AFLAEASV 67
Query: 1099 LSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-IAMD 1156
+++L H N+V GV+ ++ L VTE+M GSL L S+ R + L+ ++D
Sbjct: 68 MTQLRHSNLVQLLGVIVEEKG--GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 125
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 1216
MEYL N VH DL N+LV+ + + KV DFGL+ + + G LP
Sbjct: 126 VCEAMEYLEGNNFVHRDLAARNVLVSEDN----VAKVSDFGLT---KE-ASSTQDTGKLP 177
Query: 1217 --WMAPELLN 1224
W APE L
Sbjct: 178 VKWTAPEALR 187
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 4e-46
Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 27/204 (13%)
Query: 1036 LQIIKNEDLEELKELGSGTFGTVYHGKWRG---------TDVAIKRIKKSCFTGRSSEQE 1086
I+NEDL + LG GTF ++ G R T+V +K + K+
Sbjct: 2 FHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-----HRNYS 56
Query: 1087 RLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLD 1146
F+ A ++SKL H ++V YGV G V EF+ GSL L + ++
Sbjct: 57 E---SFFEAASMMSKLSHKHLVLNYGVCVCGD--ENILVQEFVKFGSLDTYLKKNKNCIN 111
Query: 1147 RRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIR----PICKVGDFGLSKIK 1202
+L +A A M +L ++H ++ N+L+ ++ + P K+ D G+S
Sbjct: 112 ILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS--- 168
Query: 1203 RNTLVTGGVRGTLPWMAPE-LLNG 1225
L ++ +PW+ PE + N
Sbjct: 169 ITVLPKDILQERIPWVPPECIENP 192
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 6e-46
Identities = 59/190 (31%), Positives = 94/190 (49%), Gaps = 20/190 (10%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
+ E L+ ++ LG+G FG V+ G + G T VA+K +K+ S + F EA
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-----SMSPD----AFLAEAN 60
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-IAMD 1156
++ +L H +V Y VV P + +TE+M NGSL L + +L+ +A
Sbjct: 61 LMKQLQHQRLVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 1216
A GM ++ +N +H DL+ N+LV+ CK+ DFGL+++ + T P
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTL----SCKIADFGLARLIEDNEYTAREGAKFP 173
Query: 1217 --WMAPELLN 1224
W APE +N
Sbjct: 174 IKWTAPEAIN 183
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 1e-45
Identities = 60/197 (30%), Positives = 89/197 (45%), Gaps = 22/197 (11%)
Query: 1038 IIKNEDLEELKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQERLTLE 1091
+ L+ L++LG G FG+V ++ VA+K+++ S +
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST----EEHLR----D 57
Query: 1092 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL 1151
F RE EIL L H N+V + GV L + E++ GSLR L + +D K L
Sbjct: 58 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL 117
Query: 1152 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLV-TG 1209
GMEYL +K +H DL N+LV ++ K+GDFGL+K + ++
Sbjct: 118 QYTSQICKGMEYLGTKRYIHRDLATRNILVENEN----RVKIGDFGLTKVLPQDKEFFKV 173
Query: 1210 GVRGTLP--WMAPELLN 1224
G P W APE L
Sbjct: 174 KEPGESPIFWYAPESLT 190
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-45
Identities = 61/199 (30%), Positives = 94/199 (47%), Gaps = 26/199 (13%)
Query: 1038 IIKNEDLEELKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQERLTLE 1091
I + L+ + +LG G FG+V ++ VA+K+++ S +Q+R +
Sbjct: 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-----GPDQQR---D 70
Query: 1092 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL 1151
F RE +IL LH +V + GV +L V E++ +G LR L LD + L
Sbjct: 71 FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLL 130
Query: 1152 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNT---LV 1207
+ + GMEYL S+ VH DL N+LV + K+ DFGL+K + + +V
Sbjct: 131 LYSSQICKGMEYLGSRRCVHRDLAARNILVESEA----HVKIADFGLAKLLPLDKDYYVV 186
Query: 1208 TGGVRGTLP--WMAPELLN 1224
G P W APE L+
Sbjct: 187 REP--GQSPIFWYAPESLS 203
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-45
Identities = 63/195 (32%), Positives = 87/195 (44%), Gaps = 23/195 (11%)
Query: 1039 IKNEDLEELK-ELGSGTFGTVYHGKWRG----TDVAIKRIKKSCFTGRSSEQERLTLEFW 1093
+K ++L ELG G FG+V G +R DVAIK +K+ G E
Sbjct: 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQ----GTEKADTE---EMM 58
Query: 1094 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 1153
REA+I+ +L +P +V GV Q L V E G L L+ K + +
Sbjct: 59 REAQIMHQLDNPYIVRLIGVCQAEA---LMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL 115
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KRNTLVTGGV 1211
+ GM+YL KN VH DL N+L+ + K+ DFGLSK ++ T
Sbjct: 116 LHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH----YAKISDFGLSKALGADDSYYTARS 171
Query: 1212 RGTLP--WMAPELLN 1224
G P W APE +N
Sbjct: 172 AGKWPLKWYAPECIN 186
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 3e-45
Identities = 61/195 (31%), Positives = 88/195 (45%), Gaps = 22/195 (11%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTLEFW 1093
I+ + K +GSG G V +G+ R VAIK +K +E++R +F
Sbjct: 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-----TERQRR--DFL 98
Query: 1094 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 1153
EA I+ + HPN++ GVV G VTE+M NGSL L + + + + +
Sbjct: 99 SEASIMGQFDHPNIIRLEGVVTRGR--LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGM 156
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KRNTLVTGGV 1211
GM YL VH DL N+LV+ +CKV DFGLS++
Sbjct: 157 LRGVGAGMRYLSDLGYVHRDLAARNVLVDSNL----VCKVSDFGLSRVLEDDPDAAYTTT 212
Query: 1212 RGTLP--WMAPELLN 1224
G +P W APE +
Sbjct: 213 GGKIPIRWTAPEAIA 227
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 4e-45
Identities = 62/197 (31%), Positives = 92/197 (46%), Gaps = 22/197 (11%)
Query: 1038 IIKNEDLEELKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQERLTLE 1091
+ L+ L++LG G FG+V ++ VA+K+++ S + E R +
Sbjct: 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-----TEEHLR---D 88
Query: 1092 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL 1151
F RE EIL L H N+V + GV L + E++ GSLR L + +D K L
Sbjct: 89 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL 148
Query: 1152 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLV-TG 1209
GMEYL +K +H DL N+LV ++ K+GDFGL+K + ++
Sbjct: 149 QYTSQICKGMEYLGTKRYIHRDLATRNILVENEN----RVKIGDFGLTKVLPQDKEYYKV 204
Query: 1210 GVRGTLP--WMAPELLN 1224
G P W APE L
Sbjct: 205 KEPGESPIFWYAPESLT 221
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 4e-45
Identities = 53/203 (26%), Positives = 84/203 (41%), Gaps = 30/203 (14%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
++ L+ L+ G FG V+ + VA+K Q++ + + E
Sbjct: 21 FQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIF---------PIQDKQSWQNEYEVYS 71
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGT--LATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
L + H N++ F G + G L +T F GSL L K + + IA
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAET 129
Query: 1157 AAFGMEYLHSK----------NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK---R 1203
A G+ YLH I H D+K N+L+ K+ + + DFGL+ +
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL--KNNLT--ACIADFGLALKFEAGK 185
Query: 1204 NTLVTGGVRGTLPWMAPELLNGS 1226
+ T G GT +MAPE+L G+
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGA 208
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 6e-45
Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 23/202 (11%)
Query: 1032 DISTLQIIKNEDLEELKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQ 1085
+ + L+I+K + +++K LGSG FGTVY G W VAIK ++++ +S +
Sbjct: 5 NQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-----TSPK 59
Query: 1086 ERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHL 1145
E EA +++ + +P+V G+ + +T+ M G L + + ++
Sbjct: 60 ANK--EILDEAYVMASVDNPHVCRLLGICLTST---VQLITQLMPFGCLLDYVREHKDNI 114
Query: 1146 DRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRN 1204
+ L + A GM YL + +VH DL N+LV K+ DFGL+K +
Sbjct: 115 GSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ----HVKITDFGLAKLLGAE 170
Query: 1205 TLVTGGVRGTLP--WMAPELLN 1224
G +P WMA E +
Sbjct: 171 EKEYHAEGGKVPIKWMALESIL 192
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-44
Identities = 63/203 (31%), Positives = 93/203 (45%), Gaps = 28/203 (13%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLE 1091
+ +++ ++ LG G FG VY G+ G VA+K + + C SEQ+ L +
Sbjct: 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-----SEQDEL--D 79
Query: 1092 FWREAEILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLS------KERH 1144
F EA I+SK +H N+V GV Q P + E M G L+ L +
Sbjct: 80 FLMEALIISKFNHQNIVRCIGVSLQSLP---RFILMELMAGGDLKSFLRETRPRPSQPSS 136
Query: 1145 LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKR 1203
L L +A D A G +YL + +H D+ N L+ P R + K+GDFG+++ I R
Sbjct: 137 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR-VAKIGDFGMARDIYR 195
Query: 1204 NTLVTGGVRGTLP--WMAPELLN 1224
+ G LP WM PE
Sbjct: 196 ASYYRKGGCAMLPVKWMPPEAFM 218
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-44
Identities = 60/196 (30%), Positives = 93/196 (47%), Gaps = 23/196 (11%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQERLTLEF 1092
I + K +G+G FG VY G + VAIK +K +E++R+ +F
Sbjct: 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-----TEKQRV--DF 93
Query: 1093 WREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI 1152
EA I+ + H N++ GV+ + +TE+M NG+L L K+ + +
Sbjct: 94 LGEAGIMGQFSHHNIIRLEGVISKYK--PMMIITEYMENGALDKFLREKDGEFSVLQLVG 151
Query: 1153 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR 1212
+ A GM+YL + N VH DL N+LVN +CKV DFGLS++ +
Sbjct: 152 MLRGIAAGMKYLANMNYVHRDLAARNILVNSNL----VCKVSDFGLSRVLEDDPEATYTT 207
Query: 1213 --GTLP--WMAPELLN 1224
G +P W APE ++
Sbjct: 208 SGGKIPIRWTAPEAIS 223
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-44
Identities = 56/195 (28%), Positives = 83/195 (42%), Gaps = 23/195 (11%)
Query: 1039 IKNEDLE-ELKELGSGTFGTVYHGKWRG----TDVAIKRIKKSCFTGRSSEQERLTLEFW 1093
+ + L E KELGSG FGTV G ++ VA+K +K + + E
Sbjct: 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKN----EANDPALKD--ELL 66
Query: 1094 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 1153
EA ++ +L +P +V G+ + V E G L L + RH+ + + +
Sbjct: 67 AEANVMQQLDNPYIVRMIGICEAES---WMLVMEMAELGPLNK-YLQQNRHVKDKNIIEL 122
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KRNTLVTGGV 1211
+ GM+YL N VH DL N+L+ + K+ DFGLSK
Sbjct: 123 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQH----YAKISDFGLSKALRADENYYKAQT 178
Query: 1212 RGTLP--WMAPELLN 1224
G P W APE +N
Sbjct: 179 HGKWPVKWYAPECIN 193
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 3e-44
Identities = 73/236 (30%), Positives = 113/236 (47%), Gaps = 27/236 (11%)
Query: 993 ESLQSEVVNHRIQESDYEEGRLDLPTAGIPLVDLALGNFDISTLQIIKNEDLEELKELGS 1052
E+L ++V H ++D RL P V + + + ++L+ L+ +G
Sbjct: 147 ENLM-QLVEHYTTDADGLCTRLIKPKVMEGTVAAQDEFYR--SGWALNMKELKLLQTIGK 203
Query: 1053 GTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 1112
G FG V G +RG VA+K IK +++ F EA ++++L H N+V G
Sbjct: 204 GEFGDVMLGDYRGNKVAVKCIK----NDATAQ------AFLAEASVMTQLRHSNLVQLLG 253
Query: 1113 VV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-IAMDAAFGMEYLHSKNIV 1170
V+ ++ L VTE+M GSL L S+ R + L+ ++D MEYL N V
Sbjct: 254 VIVEEKG--GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV 311
Query: 1171 HFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP--WMAPELLN 1224
H DL N+LV+ + + KV DFGL+K + ++ G LP W APE L
Sbjct: 312 HRDLAARNVLVSEDN----VAKVSDFGLTK-EASSTQDT---GKLPVKWTAPEALR 359
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 3e-44
Identities = 53/193 (27%), Positives = 81/193 (41%), Gaps = 22/193 (11%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTLEFWREA 1096
+ +G G FG VYHG++ AIK + + Q+ F RE
Sbjct: 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-----EMQQVE--AFLREG 73
Query: 1097 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
++ L+HPNV+A G++ G + +M +G L + S +R+ + + +
Sbjct: 74 LLMRGLNHPNVLALIGIMLPP-EGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQ 132
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRN--TLVTGGVRG 1213
A GMEYL + VH DL N +++ KV DFGL++ I V
Sbjct: 133 VARGMEYLAEQKFVHRDLAARNCMLDESF----TVKVADFGLARDILDREYYSVQQHRHA 188
Query: 1214 TLP--WMAPELLN 1224
LP W A E L
Sbjct: 189 RLPVKWTALESLQ 201
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 7e-44
Identities = 52/196 (26%), Positives = 82/196 (41%), Gaps = 22/196 (11%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTLEFW 1093
+ + + +G G FG VYHG A+K + + E +F
Sbjct: 22 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-----DIGEVS--QFL 74
Query: 1094 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 1153
E I+ HPNV++ G+ G+ V +M +G LR+ + ++ + + +
Sbjct: 75 TEGIIMKDFSHPNVLSLLGICLRS-EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 133
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNT--LVTGG 1210
+ A GM+YL SK VH DL N +++ K KV DFGL++ + V
Sbjct: 134 GLQVAKGMKYLASKKFVHRDLAARNCMLDEKF----TVKVADFGLARDMYDKEYYSVHNK 189
Query: 1211 VRGTLP--WMAPELLN 1224
LP WMA E L
Sbjct: 190 TGAKLPVKWMALESLQ 205
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 9e-44
Identities = 68/238 (28%), Positives = 104/238 (43%), Gaps = 24/238 (10%)
Query: 993 ESLQSEVVNHRIQESDYEEGRLDLPTAGIPLVDLALGNFDISTLQIIKNEDLEELKELGS 1052
+L E+V+H +D L P + + + ++ + D+ +LG
Sbjct: 173 NTLA-ELVHHHSTVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEM-ERTDITMKHKLGG 230
Query: 1053 GTFGTVYHGKWRG--TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAF 1110
G +G VY G W+ VA+K +K+ + E E EF +EA ++ ++ HPN+V
Sbjct: 231 GQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVE----EFLKEAAVMKEIKHPNLVQL 281
Query: 1111 YGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-IAMDAAFGMEYLHSKN 1168
GV ++ P +TEFM G+L L R L+ +A + MEYL KN
Sbjct: 282 LGVCTREPP---FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 338
Query: 1169 IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP--WMAPELLN 1224
+H +L N LV + KV DFGLS++ T P W APE L
Sbjct: 339 FIHRNLAARNCLVGENH----LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 392
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 1e-43
Identities = 52/196 (26%), Positives = 77/196 (39%), Gaps = 23/196 (11%)
Query: 1038 IIKNEDLEELKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQERLTLE 1091
I K +L +LK LGSG FGTV+ G W V IK I+ S Q
Sbjct: 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK-----SGRQSFQ--A 61
Query: 1092 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL 1151
+ L H ++V G+ L VT+++ GSL + L + L
Sbjct: 62 VTDHMLAIGSLDHAHIVRLLGLCPGSS---LQLVTQYLPLGSLLDHVRQHRGALGPQLLL 118
Query: 1152 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTGG 1210
+ A GM YL +VH +L N+L+ +V DFG++ + +
Sbjct: 119 NWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPS----QVQVADFGVADLLPPDDKQLLY 174
Query: 1211 VRGTLP--WMAPELLN 1224
P WMA E ++
Sbjct: 175 SEAKTPIKWMALESIH 190
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-43
Identities = 62/202 (30%), Positives = 83/202 (41%), Gaps = 26/202 (12%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTLEFW 1093
I L K LG G FG+V G + VA+K +K SS++E EF
Sbjct: 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKL----DNSSQREIE--EFL 84
Query: 1094 REAEILSKLHHPNVVAFYGVV-QDGPGGTLAT--VTEFMVNGSLRHVLLS-----KERHL 1145
EA + HPNV+ GV + G + FM G L LL +H+
Sbjct: 85 SEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHI 144
Query: 1146 DRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRN 1204
+ L +D A GMEYL ++N +H DL N ++ V DFGLSK I
Sbjct: 145 PLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM----TVCVADFGLSKKIYSG 200
Query: 1205 TLVTGGVRGTLP--WMAPELLN 1224
G +P W+A E L
Sbjct: 201 DYYRQGRIAKMPVKWIAIESLA 222
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 1e-43
Identities = 71/242 (29%), Positives = 105/242 (43%), Gaps = 31/242 (12%)
Query: 1003 RIQESDYEEGRLDLP---TAGIPLVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVY 1059
+Q +Y+ +L T P A IS L+ + +++ ++ LG G FG VY
Sbjct: 29 ELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVY 88
Query: 1060 HGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 1112
G+ G VA+K + + C SEQ+ L +F EA I+SK +H N+V G
Sbjct: 89 EGQVSGMPNDPSPLQVAVKTLPEVC-----SEQDEL--DFLMEALIISKFNHQNIVRCIG 141
Query: 1113 VV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI------IAMDAAFGMEYLH 1165
V Q P + E M G L+ L + L +A D A G +YL
Sbjct: 142 VSLQSLP---RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 1166 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTGGVRGTLP--WMAPEL 1222
+ +H D+ N L+ P R + K+GDFG+++ I R G LP WM PE
Sbjct: 199 ENHFIHRDIAARNCLLTCPGPGR-VAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEA 257
Query: 1223 LN 1224
Sbjct: 258 FM 259
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-43
Identities = 58/203 (28%), Positives = 83/203 (40%), Gaps = 27/203 (13%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTLEFW 1093
I + + LG G FG+V + + VA+K +K + + EF
Sbjct: 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKA----DIIASSDIE--EFL 73
Query: 1094 REAEILSKLHHPNVVAFYGVV-QDGPGGTLAT---VTEFMVNGSLRHVLLS-----KERH 1144
REA + + HP+V GV + G L + FM +G L LL+ +
Sbjct: 74 REAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFN 133
Query: 1145 LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKR 1203
L + + +D A GMEYL S+N +H DL N ++ V DFGLS KI
Sbjct: 134 LPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM----TVCVADFGLSRKIYS 189
Query: 1204 NTLVTGGVRGTLP--WMAPELLN 1224
G LP W+A E L
Sbjct: 190 GDYYRQGCASKLPVKWLALESLA 212
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 1e-43
Identities = 66/190 (34%), Positives = 90/190 (47%), Gaps = 20/190 (10%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
I E L +LG G FG V+ G W G T VAIK +K + E F +EA+
Sbjct: 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-----TMSPE----AFLQEAQ 231
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-IAMD 1156
++ KL H +V Y VV + P + VTE+M GSL L + R +L+ +A
Sbjct: 232 VMKKLRHEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 288
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 1216
A GM Y+ N VH DL+ N+LV +CKV DFGL+++ + T P
Sbjct: 289 IASGMAYVERMNYVHRDLRAANILVGENL----VCKVADFGLARLIEDNEYTARQGAKFP 344
Query: 1217 --WMAPELLN 1224
W APE
Sbjct: 345 IKWTAPEAAL 354
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 2e-43
Identities = 73/268 (27%), Positives = 113/268 (42%), Gaps = 32/268 (11%)
Query: 965 SQRESSSIVGPSTMETHPDYSRSELKGNESLQSEVVNHRIQESD-YEEGRLDLPTAGIPL 1023
+ S I+ P S +L NE + E+D Y E + T +P
Sbjct: 322 NGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPS 381
Query: 1024 VDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCF 1078
I+ E +E + +G G FG V+ G + VAIK K
Sbjct: 382 TRD----------YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-- 429
Query: 1079 TGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL 1138
+S+ R +F +EA + + HP++V GV+ + P + + E G LR L
Sbjct: 430 ---TSDSVRE--KFLQEALTMRQFDHPHIVKLIGVITENP---VWIIMELCTLGELRSFL 481
Query: 1139 LSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198
++ LD ++ A + + YL SK VH D+ N+LV+ D K+GDFGL
Sbjct: 482 QVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND----CVKLGDFGL 537
Query: 1199 SKIKRNTLVTGGVRGTLP--WMAPELLN 1224
S+ ++ +G LP WMAPE +N
Sbjct: 538 SRYMEDSTYYKASKGKLPIKWMAPESIN 565
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-43
Identities = 52/197 (26%), Positives = 88/197 (44%), Gaps = 23/197 (11%)
Query: 1038 IIKNEDLEELKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQERLTLE 1091
+ L+++++LG G FG V + VA+K +K +
Sbjct: 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-------GPQHRSG 79
Query: 1092 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL 1151
+ +E +IL L+H +++ + G +D +L V E++ GSLR L + + L
Sbjct: 80 WKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL--PRHSIGLAQLL 137
Query: 1152 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLV-TG 1209
+ A GM YLH+++ +H DL N+L++ + K+GDFGL+K +
Sbjct: 138 LFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDR----LVKIGDFGLAKAVPEGHEYYRV 193
Query: 1210 GVRGTLP--WMAPELLN 1224
G P W APE L
Sbjct: 194 REDGDSPVFWYAPECLK 210
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 5e-43
Identities = 57/195 (29%), Positives = 88/195 (45%), Gaps = 22/195 (11%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-----TDVAIKRIKKSCFTGRSSEQERLTLEFW 1093
+ ++ K +G+G FG V G+ + VAIK +K +E++R +F
Sbjct: 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-----TEKQRR--DFL 94
Query: 1094 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 1153
EA I+ + HPN++ GVV + VTE+M NGSL L + + + +
Sbjct: 95 GEASIMGQFDHPNIIRLEGVVTKSK--PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGM 152
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KRNTLVTGGV 1211
A GM+YL VH DL N+L+N +CKV DFGL ++
Sbjct: 153 LRGIASGMKYLSDMGYVHRDLAARNILINSNL----VCKVSDFGLGRVLEDDPEAAYTTR 208
Query: 1212 RGTLP--WMAPELLN 1224
G +P W +PE +
Sbjct: 209 GGKIPIRWTSPEAIA 223
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 8e-43
Identities = 61/190 (32%), Positives = 90/190 (47%), Gaps = 20/190 (10%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
I E L+ K+LG+G FG V+ + T VA+K +K S E F EA
Sbjct: 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-----SMSVE----AFLAEAN 235
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-IAMD 1156
++ L H +V + VV P + +TEFM GSL L S E +LI +
Sbjct: 236 VMKTLQHDKLVKLHAVVTKEP---IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ 292
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 1216
A GM ++ +N +H DL+ N+LV+ +CK+ DFGL+++ + T P
Sbjct: 293 IAEGMAFIEQRNYIHRDLRAANILVSASL----VCKIADFGLARVIEDNEYTAREGAKFP 348
Query: 1217 --WMAPELLN 1224
W APE +N
Sbjct: 349 IKWTAPEAIN 358
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-42
Identities = 60/282 (21%), Positives = 104/282 (36%), Gaps = 28/282 (9%)
Query: 953 PQSGSRINFDEGSQRESSSIVGPSTMETHPDYSRSELKGNESLQSEVVNHRIQESDYEEG 1012
P + ++ I+ P E L + + E+ Y +G
Sbjct: 6 PMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIE-----ELSTSLYKKAGSENLYFQG 60
Query: 1013 RLDLPTAGIPLVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRG-----TD 1067
+ + ++ L + + + + +G G FG VYHG
Sbjct: 61 A-NTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIH 119
Query: 1068 VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTE 1127
A+K + + E +F E I+ HPNV++ G+ G+ V
Sbjct: 120 CAVKSLNRIT-----DIGEVS--QFLTEGIIMKDFSHPNVLSLLGICLRS-EGSPLVVLP 171
Query: 1128 FMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPI 1187
+M +G LR+ + ++ + + + + A GM++L SK VH DL N +++ K
Sbjct: 172 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF-- 229
Query: 1188 RPICKVGDFGLSK-IKRN--TLVTGGVRGTLP--WMAPELLN 1224
KV DFGL++ + V LP WMA E L
Sbjct: 230 --TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 269
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-42
Identities = 64/206 (31%), Positives = 94/206 (45%), Gaps = 34/206 (16%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLE 1091
+ E + +ELG G+FG VY G +G T VAIK + ++ S +ER+ E
Sbjct: 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-----SMRERI--E 74
Query: 1092 FWREAEILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR-- 1148
F EA ++ + + +VV GVV Q P + E M G L+ L S +
Sbjct: 75 FLNEASVMKEFNCHHVVRLLGVVSQGQP---TLVIMELMTRGDLKSYLRSLRPAMANNPV 131
Query: 1149 ------KRLI-IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-K 1200
++I +A + A GM YL++ VH DL N +V K+GDFG++
Sbjct: 132 LAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF----TVKIGDFGMTRD 187
Query: 1201 IKRNTLVTGGVRGTLP--WMAPELLN 1224
I G +G LP WM+PE L
Sbjct: 188 IYETDYYRKGGKGLLPVRWMSPESLK 213
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 5e-42
Identities = 63/209 (30%), Positives = 85/209 (40%), Gaps = 40/209 (19%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLE 1091
I + ++ELG FG VY G G VAIK +K R E
Sbjct: 6 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-----EGPLRE--E 58
Query: 1092 FWREAEILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKR 1150
F EA + ++L HPNVV GVV +D P L+ + + +G L L+ + H D
Sbjct: 59 FRHEAMLRARLQHPNVVCLLGVVTKDQP---LSMIFSYCSHGDLHEFLVMRSPHSDVGST 115
Query: 1151 ---------------LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195
+ + A GMEYL S ++VH DL N+LV K K+ D
Sbjct: 116 DDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKL----NVKISD 171
Query: 1196 FGLS-KIKRNTLVTGGVRGTLP--WMAPE 1221
GL ++ LP WMAPE
Sbjct: 172 LGLFREVYAADYYKLLGNSLLPIRWMAPE 200
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 7e-42
Identities = 66/190 (34%), Positives = 90/190 (47%), Gaps = 20/190 (10%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-TDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
I E L +LG G FG V+ G W G T VAIK +K + E F +EA+
Sbjct: 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-----TMSPE----AFLQEAQ 314
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI-IAMD 1156
++ KL H +V Y VV + P + VTE+M GSL L + R +L+ +A
Sbjct: 315 VMKKLRHEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 371
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 1216
A GM Y+ N VH DL+ N+LV +CKV DFGL+++ + T P
Sbjct: 372 IASGMAYVERMNYVHRDLRAANILVGENL----VCKVADFGLARLIEDNEYTARQGAKFP 427
Query: 1217 --WMAPELLN 1224
W APE
Sbjct: 428 IKWTAPEAAL 437
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 8e-42
Identities = 71/270 (26%), Positives = 108/270 (40%), Gaps = 24/270 (8%)
Query: 965 SQRESSSIVGPSTMETHPDYSRSELKGNESLQSEVVNHRIQESDYEEGRLDLP--TAGIP 1022
S ++S T+ HP + ++L S+ + +P T+
Sbjct: 257 SSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFE 316
Query: 1023 LVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRG----TDVAIKRIKKSCF 1078
L + ++ L ELG G FG+V G +R DVAIK +K+
Sbjct: 317 SPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT- 375
Query: 1079 TGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL 1138
++ T E REA+I+ +L +P +V GV Q L V E G L L
Sbjct: 376 ------EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA---LMLVMEMAGGGPLHKFL 426
Query: 1139 LSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198
+ K + + + GM+YL KN VH +L N+L+ + K+ DFGL
Sbjct: 427 VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH----YAKISDFGL 482
Query: 1199 SKI--KRNTLVTGGVRGTLP--WMAPELLN 1224
SK ++ T G P W APE +N
Sbjct: 483 SKALGADDSYYTARSAGKWPLKWYAPECIN 512
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 9e-42
Identities = 66/212 (31%), Positives = 90/212 (42%), Gaps = 41/212 (19%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLE 1091
IK D+ +ELG G FG V+ + VA+K +K + R +
Sbjct: 12 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP------TLAARK--D 63
Query: 1092 FWREAEILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVL------------ 1138
F REAE+L+ L H ++V FYGV P L V E+M +G L L
Sbjct: 64 FQREAELLTNLQHEHIVKFYGVCGDGDP---LIMVFEYMKHGDLNKFLRAHGPDAMILVD 120
Query: 1139 ---LSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195
+ L + L IA A GM YL S++ VH DL N LV + K+GD
Sbjct: 121 GQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL----LVKIGD 176
Query: 1196 FGLSK-IKRNTLVTGGVRGTLP--WMAPELLN 1224
FG+S+ + G LP WM PE +
Sbjct: 177 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM 208
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 7e-41
Identities = 63/216 (29%), Positives = 93/216 (43%), Gaps = 39/216 (18%)
Query: 1032 DISTLQIIKNEDLEELKELGSGTFGTVYHGKWRG----TDVAIKRIKKSCFTGRSSEQER 1087
D + ++ D++ +G G FG V + + D AIKR+K+ +S+ +
Sbjct: 15 DPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-----ASKDDH 69
Query: 1088 LTLEFWREAEILSKL-HHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVL------- 1138
+F E E+L KL HHPN++ G G L E+ +G+L L
Sbjct: 70 R--DFAGELEVLCKLGHHPNIINLLGACEHRGY---LYLAIEYAPHGNLLDFLRKSRVLE 124
Query: 1139 --------LSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPI 1190
S L ++ L A D A GM+YL K +H DL N+LV +
Sbjct: 125 TDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY----V 180
Query: 1191 CKVGDFGLSKIKRNTLVTGGVRGTLP--WMAPELLN 1224
K+ DFGLS+ + + G LP WMA E LN
Sbjct: 181 AKIADFGLSRGQEVYVKKTM--GRLPVRWMAIESLN 214
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-40
Identities = 67/208 (32%), Positives = 91/208 (43%), Gaps = 40/208 (19%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLE 1091
IK D+ ELG G FG V+ + VA+K +K++ SE R +
Sbjct: 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA------SESARQ--D 89
Query: 1092 FWREAEILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR-- 1148
F REAE+L+ L H ++V F+GV + P L V E+M +G L L S
Sbjct: 90 FQREAELLTMLQHQHIVRFFGVCTEGRP---LLMVFEYMRHGDLNRFLRSHGPDAKLLAG 146
Query: 1149 -----------KRLI-IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196
+L+ +A A GM YL + VH DL N LV + K+GDF
Sbjct: 147 GEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL----VVKIGDF 202
Query: 1197 GLSK-IKRNTLVTGGVRGTLP--WMAPE 1221
G+S+ I G R LP WM PE
Sbjct: 203 GMSRDIYSTDYYRVGGRTMLPIRWMPPE 230
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 5e-40
Identities = 61/217 (28%), Positives = 85/217 (39%), Gaps = 48/217 (22%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWR 1094
++L K LG G FG V T VA+K +K++ S E +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-----SPSELR--DLLS 75
Query: 1095 EAEILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSK------------ 1141
E +L +++HP+V+ YG QDGP L + E+ GSLR L
Sbjct: 76 EFNVLKQVNHPHVIKLYGACSQDGP---LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG 132
Query: 1142 -----------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPI 1190
ER L + A + GM+YL +VH DL N+LV
Sbjct: 133 SRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGR----K 188
Query: 1191 CKVGDFGLS-KIKRNTLVTGGVRGTLP--WMAPELLN 1224
K+ DFGLS + +G +P WMA E L
Sbjct: 189 MKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLF 225
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-39
Identities = 58/212 (27%), Positives = 86/212 (40%), Gaps = 43/212 (20%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRG---------TDVAIKRIKKSCFTGRSSEQERLTLEF 1092
+ L K LG G FG V + G VA+K +K +E++ +
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-----TEKDLS--DL 87
Query: 1093 WREAEILSKL-HHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSK--------- 1141
E E++ + H N++ G QDGP L + E+ G+LR L ++
Sbjct: 88 VSEMEMMKMIGKHKNIINLLGACTQDGP---LYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 1142 ------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195
E + + + A GMEYL S+ +H DL N+LV + + K+ D
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN----VMKIAD 200
Query: 1196 FGLS-KIKRNTLVTGGVRGTLP--WMAPELLN 1224
FGL+ I G LP WMAPE L
Sbjct: 201 FGLARDINNIDYYKKTTNGRLPVKWMAPEALF 232
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 3e-39
Identities = 56/217 (25%), Positives = 83/217 (38%), Gaps = 48/217 (22%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLE 1091
++E ++++G G FG V+ + G T VA+K +K+ S + +
Sbjct: 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-----SADMQA--D 96
Query: 1092 FWREAEILSKLHHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR-- 1148
F REA ++++ +PN+V GV P + + E+M G L L S H
Sbjct: 97 FQREAALMAEFDNPNIVKLLGVCAVGKP---MCLLFEYMAYGDLNEFLRSMSPHTVCSLS 153
Query: 1149 --------------------KRLI-IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPI 1187
+ IA A GM YL + VH DL N LV
Sbjct: 154 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM-- 211
Query: 1188 RPICKVGDFGLS-KIKRNTLVTGGVRGTLP--WMAPE 1221
+ K+ DFGLS I +P WM PE
Sbjct: 212 --VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPE 246
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 6e-39
Identities = 63/212 (29%), Positives = 84/212 (39%), Gaps = 43/212 (20%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWR 1094
L K LG+G FG V G VA+K +K S + ER
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-----AHLTERE--ALMS 75
Query: 1095 EAEILSKL-HHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSK----------- 1141
E ++LS L +H N+V G GP +TE+ G L + L K
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGP---TLVITEYCCYGDLLNFLRRKRDSFICSKTSP 132
Query: 1142 ------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195
E LD L + A GM +L SKN +H DL N+L+ I K+ D
Sbjct: 133 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR----ITKICD 188
Query: 1196 FGLS-KIKRNTLVTGGVRGTLP--WMAPELLN 1224
FGL+ IK ++ LP WMAPE +
Sbjct: 189 FGLARDIKNDSNYVVKGNARLPVKWMAPESIF 220
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-38
Identities = 62/215 (28%), Positives = 90/215 (41%), Gaps = 43/215 (20%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG---------TDVAIKRIKKSCFTGRSSEQERLT 1089
+ + L K LG G FG V + G T VA+K +K ++E++
Sbjct: 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-----ATEKDLS- 119
Query: 1090 LEFWREAEILSKL-HHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSK------ 1141
+ E E++ + H N++ G QDGP L + E+ G+LR L ++
Sbjct: 120 -DLISEMEMMKMIGKHKNIINLLGACTQDGP---LYVIVEYASKGNLREYLQARRPPGLE 175
Query: 1142 ---------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 1192
E L + + A A GMEYL SK +H DL N+LV + + K
Sbjct: 176 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN----VMK 231
Query: 1193 VGDFGLS-KIKRNTLVTGGVRGTLP--WMAPELLN 1224
+ DFGL+ I G LP WMAPE L
Sbjct: 232 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF 266
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-38
Identities = 58/212 (27%), Positives = 86/212 (40%), Gaps = 43/212 (20%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRG---------TDVAIKRIKKSCFTGRSSEQERLTLEF 1092
+ L K LG G FG V + G VA+K +K +E++ +
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-----TEKDLS--DL 133
Query: 1093 WREAEILSKL-HHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSK--------- 1141
E E++ + H N++ G QDGP L + E+ G+LR L ++
Sbjct: 134 VSEMEMMKMIGKHKNIINLLGACTQDGP---LYVIVEYASKGNLREYLRARRPPGMEYSY 190
Query: 1142 ------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195
E + + + A GMEYL S+ +H DL N+LV + + K+ D
Sbjct: 191 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN----VMKIAD 246
Query: 1196 FGLS-KIKRNTLVTGGVRGTLP--WMAPELLN 1224
FGL+ I G LP WMAPE L
Sbjct: 247 FGLARDINNIDYYKKTTNGRLPVKWMAPEALF 278
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-38
Identities = 59/214 (27%), Positives = 85/214 (39%), Gaps = 42/214 (19%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLE 1091
+ L+ K LG G FG V G VA+K +K+ + E
Sbjct: 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-----THSEHR--A 76
Query: 1092 FWREAEILSKL-HHPNVVAFYGVV--QDGPGGTLATVTEFMVNGSLRHVLLSK------- 1141
E +IL + HH NVV G GP L + EF G+L L SK
Sbjct: 77 LMSELKILIHIGHHLNVVNLLGACTKPGGP---LMVIVEFCKFGNLSTYLRSKRNEFVPY 133
Query: 1142 --------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193
+ L + + A GME+L S+ +H DL N+L++ K+ + K+
Sbjct: 134 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN----VVKI 189
Query: 1194 GDFGLS-KIKRNTLVTGGVRGTLP--WMAPELLN 1224
DFGL+ I ++ LP WMAPE +
Sbjct: 190 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF 223
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-38
Identities = 58/208 (27%), Positives = 87/208 (41%), Gaps = 39/208 (18%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWR 1094
+L+ K LG+G FG V G VA+K +K + E+
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-----HADEKE--ALMS 98
Query: 1095 EAEILSKL-HHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR---- 1148
E +I+S L H N+V G GP + +TE+ G L + L K R L+
Sbjct: 99 ELKIMSHLGQHENIVNLLGACTHGGP---VLVITEYCCYGDLLNFLRRKSRVLETDPAFA 155
Query: 1149 --------KRLI-IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199
+ L+ + A GM +L SKN +H D+ N+L+ + K+GDFGL+
Sbjct: 156 IANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH----VAKIGDFGLA 211
Query: 1200 -KIKRNTLVTGGVRGTLP--WMAPELLN 1224
I ++ LP WMAPE +
Sbjct: 212 RDIMNDSNYIVKGNARLPVKWMAPESIF 239
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-38
Identities = 59/193 (30%), Positives = 93/193 (48%), Gaps = 20/193 (10%)
Query: 1048 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
E+G G+F TVY G +VA ++ + ++ ER + EAE+L L HP
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDR----KLTKSERQRFK--EEAEMLKGLQHP 85
Query: 1106 NVVAFYGVVQDGPGG--TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEY 1163
N+V FY + G + VTE M +G+L+ L + + + + G+++
Sbjct: 86 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKT-YLKRFKVMKIKVLRSWCRQILKGLQF 144
Query: 1164 LHSKN--IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPE 1221
LH++ I+H DLKCDN+ + K+GD GL+ +KR + V GT +MAPE
Sbjct: 145 LHTRTPPIIHRDLKCDNIFITGPT---GSVKIGDLGLATLKRASFAK-AVIGTPEFMAPE 200
Query: 1222 LLNGSSSKVSEKV 1234
+ K E V
Sbjct: 201 MYE---EKYDESV 210
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 6e-38
Identities = 47/201 (23%), Positives = 82/201 (40%), Gaps = 11/201 (5%)
Query: 1037 QIIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWR 1094
Q N LG G V+ G+ + G AIK F + R
Sbjct: 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF---LRPVDVQM----R 56
Query: 1095 EAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH--LDRRKRLI 1152
E E+L KL+H N+V + + ++ + EF GSL VL L + LI
Sbjct: 57 EFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI 116
Query: 1153 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR 1212
+ D GM +L IVH ++K N++ + + + + K+ DFG ++ + +
Sbjct: 117 VLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY 176
Query: 1213 GTLPWMAPELLNGSSSKVSEK 1233
GT ++ P++ + + +
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQ 197
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-37
Identities = 49/214 (22%), Positives = 86/214 (40%), Gaps = 41/214 (19%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
D EE+ LG G FG V + AIK+I+ + + + E +L
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-----EEKLSTIL----SEVMLL 56
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLAT-----------VTEFMVNGSLRHVLLSKERHLDRR 1148
+ L+H VV +Y + E+ NG+L ++ S+ + R
Sbjct: 57 ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD 116
Query: 1149 KRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVT 1208
+ + + Y+HS+ I+H DLK N+ ++ + K+GDFGL+K +L
Sbjct: 117 EYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNV----KIGDFGLAKNVHRSLDI 172
Query: 1209 GGVR---------------GTLPWMAPELLNGSS 1227
+ GT ++A E+L+G+
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTG 206
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-36
Identities = 62/217 (28%), Positives = 85/217 (39%), Gaps = 48/217 (22%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWR 1094
E+LE K LGSG FG V + G VA+K +K+ ER
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-----DSSERE--ALMS 97
Query: 1095 EAEILSKL-HHPNVVAFYGVV-QDGPGGTLATVTEFMVNGSLRHVLLSK----------- 1141
E +++++L H N+V G GP + + E+ G L + L SK
Sbjct: 98 ELKMMTQLGSHENIVNLLGACTLSGP---IYLIFEYCCYGDLLNYLRSKREKFSEDEIEY 154
Query: 1142 -----------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPI 1190
L L A A GME+L K+ VH DL N+LV +
Sbjct: 155 ENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK----V 210
Query: 1191 CKVGDFGLS-KIKRNTLVTGGVRGTLP--WMAPELLN 1224
K+ DFGL+ I ++ LP WMAPE L
Sbjct: 211 VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF 247
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 63/196 (32%), Positives = 95/196 (48%), Gaps = 33/196 (16%)
Query: 1044 LEELKE----------LGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQ-ERLTLE 1091
L +L+E +G G FG VY G R G VA+KR S Q E
Sbjct: 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRT------PESSQGIE---E 81
Query: 1092 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER---HLDRR 1148
F E E LS HP++V+ G + + + ++M NG+L+ L + +
Sbjct: 82 FETEIETLSFCRHPHLVSLIGFCDER--NEMILIYKYMENGNLKRHLYGSDLPTMSMSWE 139
Query: 1149 KRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI---KRNT 1205
+RL I + AA G+ YLH++ I+H D+K N+L L + P K+ DFG+SK T
Sbjct: 140 QRLEICIGAARGLHYLHTRAIIHRDVKSINIL--LDENFVP--KITDFGISKKGTELDQT 195
Query: 1206 LVTGGVRGTLPWMAPE 1221
++ V+GTL ++ PE
Sbjct: 196 HLSTVVKGTLGYIDPE 211
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-36
Identities = 49/188 (26%), Positives = 74/188 (39%), Gaps = 16/188 (8%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+ + L LG G++G V+ + + A+KR R + L E
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSP---FRGPKDRARKL---AEVGSH 110
Query: 1100 SKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
K+ HP V ++G G L TE SL+ + L + D
Sbjct: 111 EKVGQHPCCVRLEQAWEEG--GILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDTL 167
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWM 1218
+ +LHS+ +VH D+K N+ + + CK+GDFGL G +M
Sbjct: 168 LALAHLHSQGLVHLDVKPANIFLGPRG----RCKLGDFGLLVELGTAGAGEVQEGDPRYM 223
Query: 1219 APELLNGS 1226
APELL GS
Sbjct: 224 APELLQGS 231
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 9e-36
Identities = 47/201 (23%), Positives = 82/201 (40%), Gaps = 11/201 (5%)
Query: 1037 QIIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWR 1094
Q N LG G V+ G+ + G AIK F + R
Sbjct: 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF---LRPVDVQM----R 56
Query: 1095 EAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH--LDRRKRLI 1152
E E+L KL+H N+V + + ++ + EF GSL VL L + LI
Sbjct: 57 EFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI 116
Query: 1153 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR 1212
+ D GM +L IVH ++K N++ + + + + K+ DFG ++ + +
Sbjct: 117 VLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY 176
Query: 1213 GTLPWMAPELLNGSSSKVSEK 1233
GT ++ P++ + + +
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQ 197
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 64/213 (30%), Positives = 102/213 (47%), Gaps = 27/213 (12%)
Query: 1027 ALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQ- 1085
NFD + + N+ +G G FG VY G T VA+K++ ++E+
Sbjct: 23 VTNNFDERPISVGGNK-------MGEGGFGVVYKGYVNNTTVAVKKLAAM--VDITTEEL 73
Query: 1086 ERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER-- 1143
++ +F +E ++++K H N+V G DG L V +M NGSL L +
Sbjct: 74 KQ---QFDQEIKVMAKCQHENLVELLGFSSDG--DDLCLVYVYMPNGSLLDRLSCLDGTP 128
Query: 1144 HLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI-- 1201
L R IA AA G+ +LH + +H D+K N+L L + K+ DFGL++
Sbjct: 129 PLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANIL--LDEAFTA--KISDFGLARASE 184
Query: 1202 -KRNTLVTGGVRGTLPWMAPELLNGSSSKVSEK 1233
T++T + GT +MAPE L G +++ K
Sbjct: 185 KFAQTVMTSRIVGTTAYMAPEALRG---EITPK 214
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 55/203 (27%), Positives = 89/203 (43%), Gaps = 33/203 (16%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
D +E++ +GSG FG V+ K R G IKR+K + +E+ RE + L
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN------NEKAE------REVKAL 58
Query: 1100 SKLHHPNVVAFYGVVQDG--------------PGGTLATVTEFMVNGSLRHVL-LSKERH 1144
+KL H N+V + G L EF G+L + +
Sbjct: 59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 1145 LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 1204
LD+ L + G++Y+HSK +++ DLK N+ + + K+GDFGL +N
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQV----KIGDFGLVTSLKN 174
Query: 1205 TLVTGGVRGTLPWMAPELLNGSS 1227
+GTL +M+PE ++
Sbjct: 175 DGKRTRSKGTLRYMSPEQISSQD 197
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 56/190 (29%), Positives = 82/190 (43%), Gaps = 18/190 (9%)
Query: 1050 LGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 1107
LG GT+G VY G +AIK I + + L E + L H N+
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPER------DSRYSQPLH--EEIALHKHLKHKNI 81
Query: 1108 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI--IAMDAAFGMEYLH 1165
V + G + G + E + GSL +L SK L ++ I G++YLH
Sbjct: 82 VQYLGSFSEN--GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH 139
Query: 1166 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTGGVRGTLPWMAPELLN 1224
IVH D+K DN+L+N + K+ DFG SK + T GTL +MAPE+++
Sbjct: 140 DNQIVHRDIKGDNVLINTYS---GVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIID 196
Query: 1225 GSSSKVSEKV 1234
+
Sbjct: 197 KGPRGYGKAA 206
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 9e-35
Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 21/205 (10%)
Query: 1032 DISTLQIIKNEDLEELKELGSGTFGTVYH-GKWRGTDVAIKRIKKSCFTGRSSEQERLTL 1090
+ +++ I+ LG G GT+ + G + DVA+KRI CF+
Sbjct: 14 EETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD-------- 65
Query: 1091 EFWREAEILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRK 1149
RE ++L + HPNV+ ++ +D E +L+ + K+ +
Sbjct: 66 ---REVQLLRESDEHPNVIRYFCTEKDR--QFQYIAIEL-CAATLQEYVEQKDFAHLGLE 119
Query: 1150 RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC-KVGDFGLSKI----KRN 1204
+ + G+ +LHS NIVH DLK N+L+++ + I + DFGL K + +
Sbjct: 120 PITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS 179
Query: 1205 TLVTGGVRGTLPWMAPELLNGSSSK 1229
GV GT W+APE+L+ +
Sbjct: 180 FSRRSGVPGTEGWIAPEMLSEDCKE 204
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-34
Identities = 47/206 (22%), Positives = 88/206 (42%), Gaps = 21/206 (10%)
Query: 1024 VDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGR 1081
VDL N ++ E L+++G G+FG K IK I S R
Sbjct: 11 VDLGTENLYFQSM-----EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINIS----R 61
Query: 1082 SSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL-LS 1140
S +ER RE +L+ + HPN+V + ++ G+L V ++ G L +
Sbjct: 62 MSSKEREESR--REVAVLANMKHPNIVQYRESFEEN--GSLYIVMDYCEGGDLFKRINAQ 117
Query: 1141 KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200
K + L + ++++H + I+H D+K N+ + + ++GDFG+++
Sbjct: 118 KGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTV----QLGDFGIAR 173
Query: 1201 I-KRNTLVTGGVRGTLPWMAPELLNG 1225
+ + GT +++PE+
Sbjct: 174 VLNSTVELARACIGTPYYLSPEICEN 199
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-33
Identities = 42/191 (21%), Positives = 83/191 (43%), Gaps = 17/191 (8%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+ K++G G F VY VA+K+++ + R +E ++L
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQ---IFDLMDAKARADCI--KEIDLL 86
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL---LSKERHLDRRKRLIIAMD 1156
+L+HPNV+ +Y + L V E G L ++ ++R + R +
Sbjct: 87 KQLNHPNVIKYYASFIE--DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQ 144
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL-VTGGVRGTL 1215
+E++HS+ ++H D+K N+ + + K+GD GL + + + GT
Sbjct: 145 LCSALEHMHSRRVMHRDIKPANVFITATGVV----KLGDLGLGRFFSSKTTAAHSLVGTP 200
Query: 1216 PWMAPELLNGS 1226
+M+PE ++ +
Sbjct: 201 YYMSPERIHEN 211
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 60/219 (27%), Positives = 94/219 (42%), Gaps = 42/219 (19%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
D E ++ LG G FG V+ K + D AIKRI+ + E R + RE + L
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP-----NRELARE--KVMREVKAL 57
Query: 1100 SKLHHPNVVAFYGVVQDGP----------GGTLATVTEFMVNGSLRHVLLSKERHLDRRK 1149
+KL HP +V ++ + L + +L+ + + +R +
Sbjct: 58 AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117
Query: 1150 RLI--IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT-- 1205
+ I + A +E+LHSK ++H DLK N+ + D + KVGDFGL
Sbjct: 118 SVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVV----KVGDFGLVTAMDQDEE 173
Query: 1206 ------------LVTGGVRGTLPWMAPELLNGS--SSKV 1230
TG V GT +M+PE ++G+ S KV
Sbjct: 174 EQTVLTPMPAYARHTGQV-GTKLYMSPEQIHGNSYSHKV 211
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 49/209 (23%), Positives = 83/209 (39%), Gaps = 32/209 (15%)
Query: 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
+ EL+++GSG FG+V+ R G AIKR KK G EQ L RE
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKP-LAGSVDEQNAL-----REVYA 63
Query: 1099 LSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER---HLDRRKRLIIA 1154
+ L H +VV ++ + + E+ GSL + R + + +
Sbjct: 64 HAVLGQHSHVVRYFSAWAED--DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL 121
Query: 1155 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP---------------ICKVGDFGLS 1199
+ G+ Y+HS ++VH D+K N+ ++ + K+GD G
Sbjct: 122 LQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV 181
Query: 1200 KIKRNTLVTGGVRGTLPWMAPELLNGSSS 1228
+ V G ++A E+L + +
Sbjct: 182 TRISSPQV---EEGDSRFLANEVLQENYT 207
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 51/195 (26%), Positives = 89/195 (45%), Gaps = 21/195 (10%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
ED E L +G+G++G + + + K + +E E+ L E +L
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYG----SMTEAEKQMLV--SEVNLL 59
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL---LSKERHLDRRKRLIIAMD 1156
+L HPN+V +Y + D TL V E+ G L V+ + ++LD L +
Sbjct: 60 RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119
Query: 1157 AAFGMEYLHSKN-----IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI-KRNTLVTGG 1210
++ H ++ ++H DLK N+ ++ K + K+GDFGL++I +T
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNV----KLGDFGLARILNHDTSFAKT 175
Query: 1211 VRGTLPWMAPELLNG 1225
GT +M+PE +N
Sbjct: 176 FVGTPYYMSPEQMNR 190
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-33
Identities = 57/197 (28%), Positives = 81/197 (41%), Gaps = 33/197 (16%)
Query: 1048 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
K LGSG G V R T VAIK I K F S+ + L E EIL KL+HP
Sbjct: 16 KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM------DAAF 1159
++ V E M G L D+ ++
Sbjct: 76 CIIKIKNFFDA---EDYYIVLELMEGGEL----------FDK----VVGNKRLKEATCKL 118
Query: 1160 -------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR 1212
++YLH I+H DLK +N+L++ ++ I K+ DFG SKI T + +
Sbjct: 119 YFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLI-KITDFGHSKILGETSLMRTLC 177
Query: 1213 GTLPWMAPELLNGSSSK 1229
GT ++APE+L +
Sbjct: 178 GTPTYLAPEVLVSVGTA 194
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 6e-33
Identities = 72/193 (37%), Positives = 98/193 (50%), Gaps = 24/193 (12%)
Query: 1050 LGSGTFGTVYHGK-WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVV 1108
LG G FG VY G+ GT VA+KR+K+ G E +F E E++S H N++
Sbjct: 38 LGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG----EL---QFQTEVEMISMAVHRNLL 90
Query: 1109 AFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH---LDRRKRLIIAMDAAFGMEYLH 1165
G L V +M NGS+ L + LD KR IA+ +A G+ YLH
Sbjct: 91 RLRGFCMTPTERLL--VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH 148
Query: 1166 SK---NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KRNTLVTGGVRGTLPWMAP 1220
I+H D+K N+L L + VGDFGL+K+ ++T VT VRGT+ +AP
Sbjct: 149 DHCDPKIIHRDVKAANIL--LDEEFEA--VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 204
Query: 1221 ELLNGSSSKVSEK 1233
E L S+ K SEK
Sbjct: 205 EYL--STGKSSEK 215
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 6e-33
Identities = 56/197 (28%), Positives = 81/197 (41%), Gaps = 33/197 (16%)
Query: 1048 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
K LGSG G V R T VAI+ I K F S+ + L E EIL KL+HP
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM------DAAF 1159
++ V E M G L D+ ++
Sbjct: 201 CIIKIKNFFDA---EDYYIVLELMEGGEL----------FDK----VVGNKRLKEATCKL 243
Query: 1160 -------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR 1212
++YLH I+H DLK +N+L++ ++ I K+ DFG SKI T + +
Sbjct: 244 YFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLI-KITDFGHSKILGETSLMRTLC 302
Query: 1213 GTLPWMAPELLNGSSSK 1229
GT ++APE+L +
Sbjct: 303 GTPTYLAPEVLVSVGTA 319
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 5e-32
Identities = 52/187 (27%), Positives = 77/187 (41%), Gaps = 16/187 (8%)
Query: 1047 LKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
+ LG+G FG V + G VAIK+ ++ +ER E +I+ KL+H
Sbjct: 19 KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELS---PKNRERWC----LEIQIMKKLNH 71
Query: 1105 PNVVAFYGVVQDGPGGTLAT----VTEFMVNGSLRHVLLSKERH--LDRRKRLIIAMDAA 1158
PNVV+ V E+ G LR L E L + D +
Sbjct: 72 PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWM 1218
+ YLH I+H DLK +N+++ K+ D G +K + GTL ++
Sbjct: 132 SALRYLHENRIIHRDLKPENIVLQPGPQRLIH-KIIDLGYAKELDQGELCTEFVGTLQYL 190
Query: 1219 APELLNG 1225
APELL
Sbjct: 191 APELLEQ 197
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 8e-32
Identities = 52/195 (26%), Positives = 80/195 (41%), Gaps = 38/195 (19%)
Query: 1048 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
+ELG G F V + T + A K I + R + + REA I KL HP
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ------KLEREARICRKLQHP 65
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM------DAAF 1159
N+V + +Q+ V + + G L + I+A DA+
Sbjct: 66 NIVRLHDSIQEE--SFHYLVFDLVTGGEL----------FED----IVAREFYSEADASH 109
Query: 1160 -------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR 1212
+ Y HS IVH +LK +NLL+ K + K+ DFGL+ ++ G
Sbjct: 110 CIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAV-KLADFGLAIEVNDSEAWHGFA 168
Query: 1213 GTLPWMAPELLNGSS 1227
GT +++PE+L
Sbjct: 169 GTPGYLSPEVLKKDP 183
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 48/224 (21%), Positives = 84/224 (37%), Gaps = 30/224 (13%)
Query: 1029 GNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQE 1086
+ + II N+ +++LG G F V + G A+KRI +Q+
Sbjct: 16 NLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH------EQQD 69
Query: 1087 RLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGT--LATVTEFMVNGSLRHVL---LSK 1141
R + REA++ +HPN++ G + F G+L + + K
Sbjct: 70 REEAQ--READMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDK 127
Query: 1142 ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201
L + L + + G+E +H+K H DLK N+L+ + + D G
Sbjct: 128 GNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQP----VLMDLGSMNQ 183
Query: 1202 KRNTLVT----------GGVRGTLPWMAPELLNGSS-SKVSEKV 1234
+ R T+ + APEL + S + E+
Sbjct: 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERT 227
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-31
Identities = 42/224 (18%), Positives = 81/224 (36%), Gaps = 37/224 (16%)
Query: 1028 LGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQER 1087
+ ++ I ++ L G F + + A+K+ +KS + +
Sbjct: 30 INDYRI-------------IRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKS 76
Query: 1088 LTLEFW---------REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL 1138
+ E +I++ + + + G++ + + + E+M N S+
Sbjct: 77 NNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITN--YDEVYIIYEYMENDSILKFD 134
Query: 1139 LSKERHLDRRKRLIIAMDAAF-------GMEYLHS-KNIVHFDLKCDNLLVNLKDPIRPI 1190
I Y+H+ KNI H D+K N+L++ +
Sbjct: 135 EYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRV--- 191
Query: 1191 CKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKV 1234
K+ DFG S+ + + G RGT +M PE + SS KV
Sbjct: 192 -KLSDFGESEYMVDKKIK-GSRGTYEFMPPEFFSNESSYNGAKV 233
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 58/200 (29%), Positives = 92/200 (46%), Gaps = 25/200 (12%)
Query: 1039 IKNEDLEEL----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEF 1092
K + +E+ +ELGSG F V + + T + A K IKK R +E
Sbjct: 5 FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE- 63
Query: 1093 WREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI 1152
RE IL ++ H NV+ + V ++ L + E + G L L KE +
Sbjct: 64 -REVSILRQVLHHNVITLHDVYENRTDVVL--ILELVSGGELFDFLAQKESLSEE----- 115
Query: 1153 IAMDAAF-------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT 1205
+A G+ YLH+K I HFDLK +N+++ K+ P K+ DFGL+ +
Sbjct: 116 ---EATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 1206 LVTGGVRGTLPWMAPELLNG 1225
+ + GT ++APE++N
Sbjct: 173 VEFKNIFGTPEFVAPEIVNY 192
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 57/208 (27%), Positives = 88/208 (42%), Gaps = 45/208 (21%)
Query: 1039 IKNEDLEEL----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEF 1092
++ ++ + + LGSG F V+ K R T A+K IKKS SS
Sbjct: 2 MQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSS--------L 53
Query: 1093 WREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI 1152
E +L K+ H N+V + + V + + G L DR I
Sbjct: 54 ENEIAVLKKIKHENIVTLEDIYEST--THYYLVMQLVSGGEL----------FDR----I 97
Query: 1153 IAM------DAAF-------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199
+ DA+ ++YLH IVH DLK +NLL + I + DFGLS
Sbjct: 98 LERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKI-MITDFGLS 156
Query: 1200 KIKRNTLVTGGVRGTLPWMAPELLNGSS 1227
K+++N +++ GT ++APE+L
Sbjct: 157 KMEQNGIMSTAC-GTPGYVAPEVLAQKP 183
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-31
Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 39/208 (18%)
Query: 1038 IIKNEDLEEL----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLE 1091
+ + E++++ +ELGSG F V + + T A K IKK R +E
Sbjct: 3 VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 62
Query: 1092 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL 1151
RE IL ++ HPNV+ + V ++ L + E + G L D
Sbjct: 63 --REVSILKEIQHPNVITLHEVYENKTDVIL--ILELVAGGEL----------FDF---- 104
Query: 1152 IIAM------DAAF-------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198
+ +A G+ YLHS I HFDLK +N+++ ++ +P K+ DFGL
Sbjct: 105 LAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 1199 S-KIKRNTLVTGGVRGTLPWMAPELLNG 1225
+ KI GT ++APE++N
Sbjct: 165 AHKIDFGNEFKNIF-GTPEFVAPEIVNY 191
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 4e-31
Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 31/205 (15%)
Query: 1037 QIIKNEDLEE----LKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTL 1090
+ ++ D E + ELG G FG VY K + T A K I+ +E L
Sbjct: 10 HVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK-------SEEELE- 61
Query: 1091 EFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKR 1150
++ E EIL+ HP +V G G L + EF G++ ++L +R L +
Sbjct: 62 DYIVEIEILATCDHPYIVKLLGAYYHD--GKLWIMIEFCPGGAVDAIMLELDRGLTEPQI 119
Query: 1151 LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS------KIKRN 1204
++ + +LHSK I+H DLK N+L+ L+ I ++ DFG+S KR+
Sbjct: 120 QVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDI----RLADFGVSAKNLKTLQKRD 175
Query: 1205 TLVTGGVRGTLPWMAPELLNGSSSK 1229
+ + GT WMAPE++ + K
Sbjct: 176 SFI-----GTPYWMAPEVVMCETMK 195
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-31
Identities = 54/208 (25%), Positives = 83/208 (39%), Gaps = 36/208 (17%)
Query: 1048 KELGSGTFGTVYH-GKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHP 1105
K LG G+ GTV G ++G VA+KR+ E ++L++ HP
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD-----------IALMEIKLLTESDDHP 69
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI------IAMDAAF 1159
NV+ +Y L E N +L+ ++ SK + K + A
Sbjct: 70 NVIRYYCSETTD--RFLYIALEL-CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC---------KVGDFGLSKIKRN-----T 1205
G+ +LHS I+H DLK N+LV+ + DFGL K +
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 1206 LVTGGVRGTLPWMAPELLNGSSSKVSEK 1233
GT W APELL S++ +++
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKR 214
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-31
Identities = 44/201 (21%), Positives = 76/201 (37%), Gaps = 31/201 (15%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
+K LK++GSG V+ AIK + ++ + + E
Sbjct: 25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDS------YRNEIA 78
Query: 1098 ILSKLHHPN--VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM 1155
L+KL + ++ Y + V E N L L K+ +D +R
Sbjct: 79 YLNKLQQHSDKIIRLYDYEITD--QYIYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWK 134
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK--------IKRNTLV 1207
+ + +H IVH DLK N L+ + K+ DFG++ + +++ V
Sbjct: 135 NMLEAVHTIHQHGIVHSDLKPANFLIV-----DGMLKLIDFGIANQMQPDTTSVVKDSQV 189
Query: 1208 TGGVRGTLPWMAPELLNGSSS 1228
GT+ +M PE + SS
Sbjct: 190 -----GTVNYMPPEAIKDMSS 205
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-30
Identities = 56/193 (29%), Positives = 87/193 (45%), Gaps = 25/193 (12%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKS-CFTGRSSEQERLTLEFWREAEI 1098
ED E + LG G FG VY + + + +A+K + K+ Q R RE EI
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR------REVEI 62
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
S L HPN++ YG D + + E+ G++ L + ++R I A
Sbjct: 63 QSHLRHPNILRLYGYFHDA--TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 120
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK----IKRNTLVTGGVRGT 1214
+ Y HSK ++H D+K +NLL+ + K+ DFG S +R L GT
Sbjct: 121 -ALSYCHSKRVIHRDIKPENLLLGSAGEL----KIADFGWSVHAPSSRRTDLC-----GT 170
Query: 1215 LPWMAPELLNGSS 1227
L ++ PE++ G
Sbjct: 171 LDYLPPEMIEGRM 183
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-30
Identities = 44/201 (21%), Positives = 76/201 (37%), Gaps = 31/201 (15%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
+K LK++GSG V+ AIK + ++ + + E
Sbjct: 6 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDS------YRNEIA 59
Query: 1098 ILSKLHHPN--VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM 1155
L+KL + ++ Y + V E N L L K+ +D +R
Sbjct: 60 YLNKLQQHSDKIIRLYDYEITD--QYIYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWK 115
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK--------IKRNTLV 1207
+ + +H IVH DLK N L+ + K+ DFG++ + +++ V
Sbjct: 116 NMLEAVHTIHQHGIVHSDLKPANFLIV-----DGMLKLIDFGIANQMQPDTTSVVKDSQV 170
Query: 1208 TGGVRGTLPWMAPELLNGSSS 1228
GT+ +M PE + SS
Sbjct: 171 -----GTVNYMPPEAIKDMSS 186
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-30
Identities = 60/212 (28%), Positives = 88/212 (41%), Gaps = 42/212 (19%)
Query: 1037 QIIKNEDLEEL----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTL 1090
+ E LG G+FG V K R T + A+K I K+ + +
Sbjct: 13 NLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST----- 67
Query: 1091 EFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKR 1150
RE E+L KL HPN++ + +++D + V E G L D
Sbjct: 68 -ILREVELLKKLDHPNIMKLFEILEDS--SSFYIVGELYTGGEL----------FDE--- 111
Query: 1151 LIIA------MDAAFGM-------EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197
II DAA + Y+H NIVH DLK +N+L+ K+ I K+ DFG
Sbjct: 112 -IIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDI-KIIDFG 169
Query: 1198 LSKIKRNTLVTGGVRGTLPWMAPELLNGSSSK 1229
LS + GT ++APE+L G+ +
Sbjct: 170 LSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDE 201
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-30
Identities = 52/195 (26%), Positives = 80/195 (41%), Gaps = 38/195 (19%)
Query: 1048 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
+ELG G F V + T + A K I + R + + REA I KL HP
Sbjct: 35 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ------KLEREARICRKLQHP 88
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM------DAAF 1159
N+V + +Q+ V + + G L + I+A DA+
Sbjct: 89 NIVRLHDSIQEE--SFHYLVFDLVTGGEL----------FED----IVAREFYSEADASH 132
Query: 1160 -------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR 1212
+ Y HS IVH +LK +NLL+ K + K+ DFGL+ ++ G
Sbjct: 133 CIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAV-KLADFGLAIEVNDSEAWHGFA 191
Query: 1213 GTLPWMAPELLNGSS 1227
GT +++PE+L
Sbjct: 192 GTPGYLSPEVLKKDP 206
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-30
Identities = 57/196 (29%), Positives = 93/196 (47%), Gaps = 26/196 (13%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREA 1096
+K++D E++ ELG+G G V+ K G +A K I + + + ++ RE
Sbjct: 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH---LEIKPAIRNQII----REL 82
Query: 1097 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
++L + + P +V FYG G ++ E M GSL +L K + + +++
Sbjct: 83 QVLHECNSPYIVGFYGAFYS--DGEISICMEHMDGGSLDQ-VLKKAGRIPEQILGKVSIA 139
Query: 1157 AAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGDFG----LSKIKRNTLVTGGV 1211
G+ YL K I+H D+K N+LVN + I K+ DFG L N+ V
Sbjct: 140 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEI----KLCDFGVSGQLIDSMANSFV---- 191
Query: 1212 RGTLPWMAPELLNGSS 1227
GT +M+PE L G+
Sbjct: 192 -GTRSYMSPERLQGTH 206
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 51/209 (24%), Positives = 81/209 (38%), Gaps = 44/209 (21%)
Query: 1040 KNEDLEEL----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFW 1093
D+ + +G G++G V +GT A K+I K + +R
Sbjct: 3 TKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKY----FVEDVDRF----K 54
Query: 1094 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 1153
+E EI+ L HPN++ Y +D + V E G L +R ++
Sbjct: 55 QEIEIMKSLDHPNIIRLYETFEDN--TDIYLVMELCTGGEL----------FER----VV 98
Query: 1154 A------MDAAFGM-------EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200
DAA M Y H N+ H DLK +N L P P+ K+ DFGL+
Sbjct: 99 HKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPL-KLIDFGLAA 157
Query: 1201 IKRNTLVTGGVRGTLPWMAPELLNGSSSK 1229
+ + GT +++P++L G
Sbjct: 158 RFKPGKMMRTKVGTPYYVSPQVLEGLYGP 186
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-30
Identities = 58/203 (28%), Positives = 95/203 (46%), Gaps = 25/203 (12%)
Query: 1036 LQIIKNEDLEEL----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLT 1089
++ K + +E+ +ELGSG F V + + T + A K IKK R
Sbjct: 2 METFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREE 61
Query: 1090 LEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRK 1149
+E RE IL ++ HPN++ + V ++ L + E + G L L KE +
Sbjct: 62 IE--REVSILRQVLHPNIITLHDVYENRTDVVL--ILELVSGGELFDFLAQKESLSEE-- 115
Query: 1150 RLIIAMDAAF-------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 1202
+A G+ YLH+K I HFDLK +N+++ K+ P K+ DFGL+
Sbjct: 116 ------EATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169
Query: 1203 RNTLVTGGVRGTLPWMAPELLNG 1225
+ + + GT ++APE++N
Sbjct: 170 EDGVEFKNIFGTPEFVAPEIVNY 192
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 50/187 (26%), Positives = 82/187 (43%), Gaps = 27/187 (14%)
Query: 1048 KELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
+G G+FG V+ K G A+K+++ E E + L P
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRL-----EVFRVE--------ELVACAGLSSP 110
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH 1165
+V YG V++GP + E + GSL L+ + L + L A G+EYLH
Sbjct: 111 RIVPLYGAVREGP--WVNIFMELLEGGSL-GQLIKQMGCLPEDRALYYLGQALEGLEYLH 167
Query: 1166 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK------IKRNTLVTGGVRGTLPWMA 1219
++ I+H D+K DN+L++ + DFG + + ++ L + GT MA
Sbjct: 168 TRRILHGDVKADNVLLSSDG---SRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMA 224
Query: 1220 PELLNGS 1226
PE++ G
Sbjct: 225 PEVVMGK 231
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 47/213 (22%)
Query: 1040 KNEDLEEL----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFW 1093
+++L ++LGSG FG V+ + R + + IK I K RS +
Sbjct: 16 FQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKD----RSQVPME---QIE 68
Query: 1094 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 1153
E E+L L HPN++ + V +D + V E G L L+R I+
Sbjct: 69 AEIEVLKSLDHPNIIKIFEVFEDY--HNMYIVMETCEGGEL----------LER----IV 112
Query: 1154 A----------MDAAFGM-------EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196
+ A M Y HS+++VH DLK +N+L P PI K+ DF
Sbjct: 113 SAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPI-KIIDF 171
Query: 1197 GLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSK 1229
GL+++ ++ + GT +MAPE+ +
Sbjct: 172 GLAELFKSDEHSTNAAGTALYMAPEVFKRDVTF 204
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 119 bits (302), Expect = 5e-30
Identities = 56/187 (29%), Positives = 88/187 (47%), Gaps = 21/187 (11%)
Query: 1048 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
+ELGSG F V + +GT + A K IKK + R +E RE IL ++ HP
Sbjct: 11 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIE--REVNILREIRHP 68
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF------ 1159
N++ + + ++ L + E + G L L KE + +A
Sbjct: 69 NIITLHDIFENKTDVVL--ILELVSGGELFDFLAEKESLTED--------EATQFLKQIL 118
Query: 1160 -GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWM 1218
G+ YLHSK I HFDLK +N+++ K+ P K+ DFG++ + GT ++
Sbjct: 119 DGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFV 178
Query: 1219 APELLNG 1225
APE++N
Sbjct: 179 APEIVNY 185
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-30
Identities = 55/191 (28%), Positives = 86/191 (45%), Gaps = 25/191 (13%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKS-CFTGRSSEQERLTLEFWREAEI 1098
+D + + LG G FG VY + + +A+K + KS Q R RE EI
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLR------REIEI 67
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
S L HPN++ Y D + + EF G L L R ++R + A
Sbjct: 68 QSHLRHPNILRMYNYFHDR--KRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELAD 125
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK----IKRNTLVTGGVRGT 1214
+ Y H + ++H D+K +NLL+ K + K+ DFG S ++R T+ GT
Sbjct: 126 -ALHYCHERKVIHRDIKPENLLMGYKGEL----KIADFGWSVHAPSLRRRTMC-----GT 175
Query: 1215 LPWMAPELLNG 1225
L ++ PE++ G
Sbjct: 176 LDYLPPEMIEG 186
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-30
Identities = 51/194 (26%), Positives = 88/194 (45%), Gaps = 29/194 (14%)
Query: 1041 NEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
+ +++G G GTVY T VAI+++ +Q + L E +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ-------QQPKKELII-NEILV 70
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
+ + +PN+V + G L V E++ GSL V+ E +D + + +
Sbjct: 71 MRENKNPNIVNYLDSYLVG--DELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECL 126
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS------KIKRNTLVTGGVR 1212
+E+LHS ++H D+K DN+L+ + + K+ DFG + KR+T+V
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDGSV----KLTDFGFCAQITPEQSKRSTMV----- 177
Query: 1213 GTLPWMAPELLNGS 1226
GT WMAPE++
Sbjct: 178 GTPYWMAPEVVTRK 191
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-29
Identities = 52/200 (26%), Positives = 76/200 (38%), Gaps = 40/200 (20%)
Query: 1048 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
+ +G G F V R T A+K + + FT + REA I L HP
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTE---DLKREASICHMLKHP 86
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIA----------M 1155
++V G L V EFM L I+
Sbjct: 87 HIVELLETYSSD--GMLYMVFEFMDGADL----------CFE----IVKRADAGFVYSEA 130
Query: 1156 DAAFGM-------EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLV 1207
A+ M Y H NI+H D+K +L+ K+ P+ K+G FG++ + + LV
Sbjct: 131 VASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPV-KLGGFGVAIQLGESGLV 189
Query: 1208 TGGVRGTLPWMAPELLNGSS 1227
GG GT +MAPE++
Sbjct: 190 AGGRVGTPHFMAPEVVKREP 209
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-29
Identities = 46/235 (19%), Positives = 84/235 (35%), Gaps = 31/235 (13%)
Query: 1005 QESDYEEGRLDLPTAGIPLVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWR 1064
+ + + R + + + D + + +K LK++GSG V+
Sbjct: 19 ETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNE 78
Query: 1065 -GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPN--VVAFYGVVQDGPGGT 1121
AIK + + Q + E L+KL + ++ Y
Sbjct: 79 KKQIYAIKYVNLE----EADNQTLDSYR--NEIAYLNKLQQHSDKIIRLYDYEITD--QY 130
Query: 1122 LATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLV 1181
+ V E N L L K+ +D +R + + +H IVH DLK N L+
Sbjct: 131 IYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI 188
Query: 1182 NLKDPIRPICKVGDFGLSK--------IKRNTLVTGGVRGTLPWMAPELLNGSSS 1228
+ K+ DFG++ + +++ V G + +M PE + SS
Sbjct: 189 V-----DGMLKLIDFGIANQMQPDTTSVVKDSQV-----GAVNYMPPEAIKDMSS 233
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-29
Identities = 59/197 (29%), Positives = 91/197 (46%), Gaps = 18/197 (9%)
Query: 1040 KNEDLEEL----KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFW 1093
K L E+ K+LGSG +G V + + T AIK I+K+ + S+ +
Sbjct: 31 KKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSK------LL 84
Query: 1094 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR-KRLI 1152
E +L L HPN++ Y +D L V E G L ++ + + + +I
Sbjct: 85 EEVAVLKLLDHPNIMKLYDFFEDKRNYYL--VMECYKGGELFDEIIHRMKFNEVDAAVII 142
Query: 1153 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR 1212
+ + + YLH NIVH DLK +NLL+ K+ I K+ DFGLS + N
Sbjct: 143 KQVLSG--VTYLHKHNIVHRDLKPENLLLESKEKDALI-KIVDFGLSAVFENQKKMKERL 199
Query: 1213 GTLPWMAPELLNGSSSK 1229
GT ++APE+L +
Sbjct: 200 GTAYYIAPEVLRKKYDE 216
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-29
Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 17/197 (8%)
Query: 1040 KNEDLEEL----KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFW 1093
+ + LG G+FG V K + T A+K I K ++ ++
Sbjct: 20 STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES-----LL 74
Query: 1094 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR-KRLI 1152
RE ++L +L HPN++ Y +D G V E G L ++S++R + R+I
Sbjct: 75 REVQLLKQLDHPNIMKLYEFFED--KGYFYLVGEVYTGGELFDEIISRKRFSEVDAARII 132
Query: 1153 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR 1212
+ + + Y+H IVH DLK +NLL+ K I ++ DFGLS +
Sbjct: 133 RQVLSG--ITYMHKNKIVHRDLKPENLLLESKSKDANI-RIIDFGLSTHFEASKKMKDKI 189
Query: 1213 GTLPWMAPELLNGSSSK 1229
GT ++APE+L+G+ +
Sbjct: 190 GTAYYIAPEVLHGTYDE 206
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-29
Identities = 45/196 (22%), Positives = 75/196 (38%), Gaps = 39/196 (19%)
Query: 1048 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
+ELG G F V + A I + R ++ REA I L HP
Sbjct: 17 EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQK------LEREARICRLLKHP 70
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM------DAAF 1159
N+V + + + G + + + G L + I+A DA+
Sbjct: 71 NIVRLHDSISEE--GHHYLIFDLVTGGEL----------FED----IVAREYYSEADASH 114
Query: 1160 GM-------EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTGGV 1211
+ + H +VH +LK +NLL+ K + K+ DFGL+ ++ G
Sbjct: 115 CIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAV-KLADFGLAIEVEGEQQAWFGF 173
Query: 1212 RGTLPWMAPELLNGSS 1227
GT +++PE+L
Sbjct: 174 AGTPGYLSPEVLRKDP 189
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 55/189 (29%), Positives = 89/189 (47%), Gaps = 28/189 (14%)
Query: 1041 NEDLEELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
E +L+++G G+FG V+ G VAIK I ++ + + +E +
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE------EAEDEIE-DIQQEITV 73
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
LS+ P V +YG L + E++ GS +L + LD + I +
Sbjct: 74 LSQCDSPYVTKYYGSYLKD--TKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREIL 129
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS------KIKRNTLVTGGVR 1212
G++YLHS+ +H D+K N+L++ + K+ DFG++ +IKRNT V
Sbjct: 130 KGLDYLHSEKKIHRDIKAANVLLSEHGEV----KLADFGVAGQLTDTQIKRNTFV----- 180
Query: 1213 GTLPWMAPE 1221
GT WMAPE
Sbjct: 181 GTPFWMAPE 189
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-29
Identities = 51/194 (26%), Positives = 87/194 (44%), Gaps = 29/194 (14%)
Query: 1041 NEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
L+ ++G G+ G V + + + VA+K + +Q+R L F E I
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLR-------KQQRRELLF-NEVVI 95
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
+ H NVV Y G L + EF+ G+L ++ + L+ + +
Sbjct: 96 MRDYQHFNVVEMYKSYLVG--EELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVL 151
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS------KIKRNTLVTGGVR 1212
+ YLH++ ++H D+K D++L+ L + K+ DFG KR +LV
Sbjct: 152 QALAYLHAQGVIHRDIKSDSILLTLDGRV----KLSDFGFCAQISKDVPKRKSLV----- 202
Query: 1213 GTLPWMAPELLNGS 1226
GT WMAPE+++ S
Sbjct: 203 GTPYWMAPEVISRS 216
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 37/208 (17%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREA 1096
+K +DLE + ELG G +G V G +A+KRI+ T S EQ+RL +
Sbjct: 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR---ATVNSQEQKRLL----MDL 56
Query: 1097 EI-LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL---- 1151
+I + + P V FYG + G + E M + SL ++ +D+ + +
Sbjct: 57 DISMRTVDCPFTVTFYGALFR--EGDVWICMELM-DTSLDKFY---KQVIDKGQTIPEDI 110
Query: 1152 --IIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-----KIKR 1203
IA+ +E+LHSK +++H D+K N+L+N + K+ DFG+S + +
Sbjct: 111 LGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQV----KMCDFGISGYLVDDVAK 166
Query: 1204 NTLVTGGVRGTLPWMAPELLNGSSSKVS 1231
+ G P+MAPE +N ++
Sbjct: 167 DIDA-----GCKPYMAPERINPELNQKG 189
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 5e-29
Identities = 59/198 (29%), Positives = 95/198 (47%), Gaps = 25/198 (12%)
Query: 1032 DISTLQIIKNEDLEE----LKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQ 1085
D ++ +D E+ L+E+G G+FG VY + VAIK++ ++G+ S +
Sbjct: 40 DPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMS---YSGKQSNE 96
Query: 1086 ERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHL 1145
+ + +E L KL HPN + + G T V E+ GS +L ++ L
Sbjct: 97 KWQDII--KEVRFLQKLRHPNTIQYRGCYLRE--HTAWLVMEYC-LGSASDLLEVHKKPL 151
Query: 1146 DRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KR 1203
+ + A G+ YLHS N++H D+K N+L++ + K+GDFG + I
Sbjct: 152 QEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLV----KLGDFGSASIMAPA 207
Query: 1204 NTLVTGGVRGTLPWMAPE 1221
N+ V GT WMAPE
Sbjct: 208 NSFV-----GTPYWMAPE 220
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 52/196 (26%), Positives = 80/196 (40%), Gaps = 32/196 (16%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
ED + LG G+F VY + T +VAIK I K + + + E +I
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKK-----AMYKAGMVQRVQNEVKIH 65
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLAT----VTEFMVNGSLRHVLLSKERHLD-RRKRLIIA 1154
+L HP+++ Y +D + V E NG + L ++ + R +
Sbjct: 66 CQLKHPSILELYNYFED------SNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH 119
Query: 1155 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR-- 1212
GM YLHS I+H DL NLL+ I K+ DFGL+ L +
Sbjct: 120 QIIT-GMLYLHSHGILHRDLTLSNLLLTRNMNI----KIADFGLA----TQLKMPHEKHY 170
Query: 1213 ---GTLPWMAPELLNG 1225
GT +++PE+
Sbjct: 171 TLCGTPNYISPEIATR 186
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-29
Identities = 51/295 (17%), Positives = 100/295 (33%), Gaps = 38/295 (12%)
Query: 955 SGSRINFDEGSQRESSSIVGPSTMETHPDYSRSELKGNESLQSEVVNHRIQESDYEEGRL 1014
SG F++ +R I + + ++ QS + ++ + + +
Sbjct: 9 SGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKG 68
Query: 1015 DLPTAGIPLVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGT--DVAIKR 1072
+ + + + D + +G G V R T + A+K
Sbjct: 69 TENLYFQSMGPEDELPDWAAAKEFYQKYDPK--DVIGRGVSSVVRRCVHRATGHEFAVKI 126
Query: 1073 IKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQDGPGGTLATVTEFMVN 1131
++ + + E + RE IL ++ HP+++ + L V + M
Sbjct: 127 MEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFL--VFDLMRK 184
Query: 1132 GSLRHVLLSKERHLDRRKRLIIAM------DAAF-------GMEYLHSKNIVHFDLKCDN 1178
G L D + + + +LH+ NIVH DLK +N
Sbjct: 185 GEL----------FDY----LTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPEN 230
Query: 1179 LLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEK 1233
+L++ I ++ DFG S + GT ++APE+L S +
Sbjct: 231 ILLDDNMQI----RLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPG 281
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-29
Identities = 61/207 (29%), Positives = 90/207 (43%), Gaps = 46/207 (22%)
Query: 1040 KNEDLEEL----KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFW 1093
+ L + ELG G VY K +GT A+K +KK+ +++ +
Sbjct: 47 NRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT------VDKKIV----R 96
Query: 1094 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 1153
E +L +L HPN++ + + +L V E + G L DR I+
Sbjct: 97 TEIGVLLRLSHPNIIKLKEIFETPTEISL--VLELVTGGEL----------FDR----IV 140
Query: 1154 AM------DAAF-------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200
DAA + YLH IVH DLK +NLL P P+ K+ DFGLSK
Sbjct: 141 EKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPL-KIADFGLSK 199
Query: 1201 IKRNTLVTGGVRGTLPWMAPELLNGSS 1227
I + ++ V GT + APE+L G +
Sbjct: 200 IVEHQVLMKTVCGTPGYCAPEILRGCA 226
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-29
Identities = 51/192 (26%), Positives = 82/192 (42%), Gaps = 15/192 (7%)
Query: 1048 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQ-ERLTLEFWREAEILSKL-H 1103
+ LG G V + T + A+K I + S+E+ + L +E +IL K+
Sbjct: 23 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82
Query: 1104 HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIA--MDAAFGM 1161
HPN++ + L V + M G L L K ++ R I+ ++ +
Sbjct: 83 HPNIIQLKDTYETNTFFFL--VFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV---I 137
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPE 1221
LH NIVH DLK +N+L++ I K+ DFG S V GT ++APE
Sbjct: 138 CALHKLNIVHRDLKPENILLDDDMNI----KLTDFGFSCQLDPGEKLREVCGTPSYLAPE 193
Query: 1222 LLNGSSSKVSEK 1233
++ S +
Sbjct: 194 IIECSMNDNHPG 205
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 6e-29
Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 1040 KNEDLEEL----KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLE-- 1091
K + E ++LGSG +G V K + AIK IKKS F + +E
Sbjct: 30 KEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKF 89
Query: 1092 ---FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR 1148
+ E +L L HPN++ + V +D L VTEF G L ++++ + +
Sbjct: 90 HEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYL--VTEFYEGGELFEQIINRHKFDECD 147
Query: 1149 -KRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLV 1207
++ + + + YLH NIVH D+K +N+L+ K+ + I K+ DFGLS
Sbjct: 148 AANIMKQILSG--ICYLHKHNIVHRDIKPENILLENKNSLLNI-KIVDFGLSSFFSKDYK 204
Query: 1208 TGGVRGTLPWMAPELLNGSSSK 1229
GT ++APE+L ++
Sbjct: 205 LRDRLGTAYYIAPEVLKKKYNE 226
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-29
Identities = 53/202 (26%), Positives = 83/202 (41%), Gaps = 42/202 (20%)
Query: 1042 EDLEELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+D E + +GSG V + VAIKRI Q + E +E + +
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLE------KCQTSMD-ELLKEIQAM 67
Query: 1100 SKLHHPNVVAFYG--VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL------ 1151
S+ HHPN+V++Y VV L V + + GS+ ++ + + +
Sbjct: 68 SQCHHPNIVSYYTSFVV----KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTI 123
Query: 1152 -IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS----------- 1199
I + G+EYLH +H D+K N+L+ + ++ DFG+S
Sbjct: 124 ATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSV----QIADFGVSAFLATGGDITR 179
Query: 1200 KIKRNTLVTGGVRGTLPWMAPE 1221
R T V GT WMAPE
Sbjct: 180 NKVRKTFV-----GTPCWMAPE 196
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 8e-29
Identities = 51/203 (25%), Positives = 89/203 (43%), Gaps = 26/203 (12%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREA 1096
EDL++L E+G G +G+V K G +A+KRI+ T EQ++L +
Sbjct: 19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR---STVDEKEQKQLL----MDL 71
Query: 1097 EILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL---- 1151
+++ + P +V FYG + G E M + S K + +
Sbjct: 72 DVVMRSSDCPYIVQFYGALFR--EGDCWICMELM-STSFDKFY--KYVYSVLDDVIPEEI 126
Query: 1152 --IIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVT 1208
I + + +L I+H D+K N+L++ I K+ DFG+S +++
Sbjct: 127 LGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNI----KLCDFGISGQLVDSIAK 182
Query: 1209 GGVRGTLPWMAPELLNGSSSKVS 1231
G P+MAPE ++ S+S+
Sbjct: 183 TRDAGCRPYMAPERIDPSASRQG 205
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-28
Identities = 57/199 (28%), Positives = 93/199 (46%), Gaps = 18/199 (9%)
Query: 1038 IIKNEDLEEL----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLE 1091
+ E LG G+FG V K R T + A+K I K+ + +
Sbjct: 14 LYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST------ 67
Query: 1092 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR-KR 1150
RE E+L KL HPN++ + +++D + V E G L ++ ++R + R
Sbjct: 68 ILREVELLKKLDHPNIMKLFEILEDSSSFYI--VGELYTGGELFDEIIKRKRFSEHDAAR 125
Query: 1151 LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGG 1210
+I + + + Y+H NIVH DLK +N+L+ K+ I K+ DFGLS +
Sbjct: 126 IIKQVFSG--ITYMHKHNIVHRDLKPENILLESKEKDCDI-KIIDFGLSTCFQQNTKMKD 182
Query: 1211 VRGTLPWMAPELLNGSSSK 1229
GT ++APE+L G+ +
Sbjct: 183 RIGTAYYIAPEVLRGTYDE 201
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 51/219 (23%), Positives = 77/219 (35%), Gaps = 46/219 (21%)
Query: 1031 FDISTLQIIKNEDLEEL-----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSS 1083
L E+ KELG G F V + T + A K +KK
Sbjct: 13 LGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCR 72
Query: 1084 EQERLTLEFWREAEILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE 1142
E E +L P V+ + V ++ L + E+ G +
Sbjct: 73 A------EILHEIAVLELAKSCPRVINLHEVYENTSEIIL--ILEYAAGGEI-------- 116
Query: 1143 RHLDRRKRLIIA--------MDAAF-------GMEYLHSKNIVHFDLKCDNLLVNLKDPI 1187
+ D G+ YLH NIVH DLK N+L++ P+
Sbjct: 117 --FSL----CLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPL 170
Query: 1188 RPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGS 1226
I K+ DFG+S+ + + GT ++APE+LN
Sbjct: 171 GDI-KIVDFGMSRKIGHACELREIMGTPEYLAPEILNYD 208
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 7e-28
Identities = 48/189 (25%), Positives = 73/189 (38%), Gaps = 31/189 (16%)
Query: 1048 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
+ LG G F + T A K + KS + + E I L H
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKS-----LLLKPHQREKMSMEISIHRSLAHQ 75
Query: 1106 NVVAFYGVVQDGPGGTLAT----VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGM 1161
+VV F+G +D V E SL + ++ + R + G
Sbjct: 76 HVVGFHGFFED------NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL-GC 128
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR-----GTLP 1216
+YLH ++H DLK NL +N + K+GDFGL+ + G R GT
Sbjct: 129 QYLHRNRVIHRDLKLGNLFLNEDLEV----KIGDFGLA----TKVEYDGERKKVLCGTPN 180
Query: 1217 WMAPELLNG 1225
++APE+L+
Sbjct: 181 YIAPEVLSK 189
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 7e-28
Identities = 37/200 (18%), Positives = 78/200 (39%), Gaps = 35/200 (17%)
Query: 1042 EDLEEL----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWRE 1095
++L E ++LG G FG V+ + K +K + ++Q + +E
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-----KGTDQVLV----KKE 51
Query: 1096 AEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM 1155
IL+ H N++ + + + + EF+ + + + L+ R
Sbjct: 52 ISILNIARHRNILHLHESFESMEELVM--IFEFISGLDIFERINTSAFELNER------- 102
Query: 1156 DAAF-------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLV 1207
+ +++LHS NI HFD++ +N++ + I K+ +FG + ++K
Sbjct: 103 EIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRS-STI-KIIEFGQARQLKPGDNF 160
Query: 1208 TGGVRGTLPWMAPELLNGSS 1227
+ APE+
Sbjct: 161 RLLF-TAPEYYAPEVHQHDV 179
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 8e-28
Identities = 48/185 (25%), Positives = 74/185 (40%), Gaps = 23/185 (12%)
Query: 1048 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
+ LG G F + T A K + KS + + E I L H
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKS-----LLLKPHQREKMSMEISIHRSLAHQ 101
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLH 1165
+VV F+G +D + V E SL + ++ + R + G +YLH
Sbjct: 102 HVVGFHGFFEDN--DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL-GCQYLH 158
Query: 1166 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR-----GTLPWMAP 1220
++H DLK NL +N + K+GDFGL+ + G R GT ++AP
Sbjct: 159 RNRVIHRDLKLGNLFLNEDLEV----KIGDFGLA----TKVEYDGERKKVLCGTPNYIAP 210
Query: 1221 ELLNG 1225
E+L+
Sbjct: 211 EVLSK 215
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 54/194 (27%), Positives = 89/194 (45%), Gaps = 29/194 (14%)
Query: 1041 NEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
E + L++LG G++G+VY + T VAIK++ + E +E I
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP-------VESDLQ---EIIKEISI 77
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
+ + P+VV +YG L V E+ GS+ ++ + + L + I
Sbjct: 78 MQQCDSPHVVKYYGSYFKN--TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTL 135
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS------KIKRNTLVTGGVR 1212
G+EYLH +H D+K N+L+N + K+ DFG++ KRNT++
Sbjct: 136 KGLEYLHFMRKIHRDIKAGNILLNTEGHA----KLADFGVAGQLTDTMAKRNTVI----- 186
Query: 1213 GTLPWMAPELLNGS 1226
GT WMAPE++
Sbjct: 187 GTPFWMAPEVIQEI 200
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 2e-27
Identities = 42/208 (20%), Positives = 74/208 (35%), Gaps = 29/208 (13%)
Query: 1042 EDLEELKELGSG--TFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
E L +G G TV K G V ++RI + E +T E
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLE-----ACSNEMVT-FLQGELH 78
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM-- 1155
+ +HPN+V + L VT FM GS + ++ +D L IA
Sbjct: 79 VSKLFNHPNIVPYRATFIAD--NELWVVTSFMAYGSAKDLI--CTHFMDGMNELAIAYIL 134
Query: 1156 -DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS------KIKRNTLVT 1208
++Y+H VH +K ++L+++ + + + ++ +
Sbjct: 135 QGVLKALDYIHHMGYVHRSVKASHILISVDGKV----YLSGLRSNLSMISHGQRQRVVHD 190
Query: 1209 GGVR--GTLPWMAPELLNGSSSKVSEKV 1234
LPW++PE+L + K
Sbjct: 191 FPKYSVKVLPWLSPEVLQQNLQGYDAKS 218
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 44/200 (22%), Positives = 83/200 (41%), Gaps = 28/200 (14%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREA 1096
+ DLE L E+GSGT G V+ + G +A+K+++ +G E +R+ +
Sbjct: 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR---RSGNKEENKRIL----MDL 74
Query: 1097 EILSKLH-HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM 1155
+++ K H P +V +G + E M + + + R + +
Sbjct: 75 DVVLKSHDCPYIVQCFGTFIT--NTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTV 131
Query: 1156 DAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-----IKRNTLVTG 1209
+ YL K ++H D+K N+L++ + I K+ DFG+S ++
Sbjct: 132 AIVKALYYLKEKHGVIHRDVKPSNILLDERGQI----KLCDFGISGRLVDDKAKDRSA-- 185
Query: 1210 GVRGTLPWMAPELLNGSSSK 1229
G +MAPE ++
Sbjct: 186 ---GCAAYMAPERIDPPDPT 202
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 3e-27
Identities = 37/211 (17%), Positives = 67/211 (31%), Gaps = 33/211 (15%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTD-------VAIKRIKKSCFTGRSSEQERLTLE 1091
+ ++ + LG G F VY + +K K + E T
Sbjct: 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN----PWEFYIGT-- 115
Query: 1092 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSK----ERHLDR 1147
+ E L + FY V E G+L + + E+ + +
Sbjct: 116 --QLMERLKPSMQHMFMKFYSAHLFQ--NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQ 171
Query: 1148 RKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC-------KVGDFGLSK 1200
+ AM + +E +H I+H D+K DN ++ + + D G S
Sbjct: 172 GLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
Query: 1201 IKR----NTLVTGGVRGTLPWMAPELLNGSS 1227
+ T+ T T + E+L+
Sbjct: 232 DMKLFPKGTIFT-AKCETSGFQCVEMLSNKP 261
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-27
Identities = 45/196 (22%), Positives = 89/196 (45%), Gaps = 20/196 (10%)
Query: 1039 IKNEDLEEL----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEF 1092
+K + + +ELGSG FG V+ + T K I ++ +
Sbjct: 44 VKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKYTV---- 95
Query: 1093 WREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI 1152
E I+++LHHP ++ + +D L + EF+ G L + +++ + + +
Sbjct: 96 KNEISIMNQLHHPKLINLHDAFEDKYEMVL--ILEFLSGGELFDRIAAEDYKMSEAEVIN 153
Query: 1153 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVTGGV 1211
A G++++H +IVH D+K +N++ K + K+ DFGL+ K+ + +V
Sbjct: 154 YMRQACEGLKHMHEHSIVHLDIKPENIMCETKKA-SSV-KIIDFGLATKLNPDEIVKVTT 211
Query: 1212 RGTLPWMAPELLNGSS 1227
T + APE+++
Sbjct: 212 -ATAEFAAPEIVDREP 226
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-27
Identities = 49/194 (25%), Positives = 85/194 (43%), Gaps = 20/194 (10%)
Query: 1039 IKNEDLEEL----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEF 1092
IK++ + + +ELG+G FG V+ R T + A K + S++E +
Sbjct: 150 IKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKETV---- 201
Query: 1093 WREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI 1152
+E + +S L HP +V + +D + + EFM G L + + + + +
Sbjct: 202 RKEIQTMSVLRHPTLVNLHDAFEDDNEMVM--IYEFMSGGELFEKVADEHNKMSEDEAVE 259
Query: 1153 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS-KIKRNTLVTGGV 1211
G+ ++H N VH DLK +N++ K K+ DFGL+ + V
Sbjct: 260 YMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRS--NELKLIDFGLTAHLDPKQSVKVTT 317
Query: 1212 RGTLPWMAPELLNG 1225
GT + APE+ G
Sbjct: 318 -GTAEFAAPEVAEG 330
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-26
Identities = 59/284 (20%), Positives = 106/284 (37%), Gaps = 50/284 (17%)
Query: 963 EGSQRESSSIVGPSTMETHPDYSRSELKGNESLQSEV---VNHRIQESDYEEGRLDLPTA 1019
G + ++ S + SRS + + S ++ +D+P
Sbjct: 10 SGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAP 69
Query: 1020 GIPLVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGT--DVAIKRIKKSC 1077
P + + + + + LG G FG V+ + T +A K IK
Sbjct: 70 PAPFDHRIVT---AKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR- 125
Query: 1078 FTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHV 1137
++E + E ++++L H N++ Y + L V E++ G L
Sbjct: 126 ---GMKDKEEV----KNEISVMNQLDHANLIQLYDAFESKNDIVL--VMEYVDGGEL--- 173
Query: 1138 LLSKERHLDRRKRLIIA-------MDAAF-------GMEYLHSKNIVHFDLKCDNLLVNL 1183
DR II +D G+ ++H I+H DLK +N+L
Sbjct: 174 -------FDR----IIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN 222
Query: 1184 KDPIRPICKVGDFGLSK-IKRNTLVTGGVRGTLPWMAPELLNGS 1226
+D + I K+ DFGL++ K + GT ++APE++N
Sbjct: 223 RDA-KQI-KIIDFGLARRYKPREKLKVNF-GTPEFLAPEVVNYD 263
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-26
Identities = 56/191 (29%), Positives = 86/191 (45%), Gaps = 32/191 (16%)
Query: 1045 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
E ++ +G+GT+G VY G+ T AIK + + E+E E +E +L K
Sbjct: 27 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----GDEEE----EIKQEINMLKKY 77
Query: 1103 -HHPNVVAFYG----VVQDGPGGTLATVTEFMVNGSLRHVL-LSKERHLDRRKRLIIAMD 1156
HH N+ +YG G L V EF GS+ ++ +K L I +
Sbjct: 78 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICRE 137
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS------KIKRNTLVTGG 1210
G+ +LH ++H D+K N+L+ + K+ DFG+S +RNT +
Sbjct: 138 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEV----KLVDFGVSAQLDRTVGRRNTFI--- 190
Query: 1211 VRGTLPWMAPE 1221
GT WMAPE
Sbjct: 191 --GTPYWMAPE 199
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-26
Identities = 49/233 (21%), Positives = 78/233 (33%), Gaps = 53/233 (22%)
Query: 1048 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
+G G++G V T AIK + K+ + + E ++ KLHHP
Sbjct: 32 GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVE---RIKTEVRLMKKLHHP 88
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM---------- 1155
N+ Y V +D + V E G L L + + +
Sbjct: 89 NIARLYEVYEDE--QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 1156 ----------------------DAAF-------GMEYLHSKNIVHFDLKCDNLLVNLKDP 1186
+ + YLH++ I H D+K +N L + +
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFS-TNK 205
Query: 1187 IRPICKVGDFGLSKIKRNTLVTGGVR-----GTLPWMAPELLNGSSSKVSEKV 1234
I K+ DFGLSK GT ++APE+LN ++ K
Sbjct: 206 SFEI-KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 54/187 (28%), Positives = 81/187 (43%), Gaps = 27/187 (14%)
Query: 1048 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
+ LG G +G V R T VA+K + E + +E I L+H
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIK------KEICINKMLNHE 65
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER---HLDRRK-RLIIAMDAAFGM 1161
NVV FYG ++G E+ G L + +R ++A G+
Sbjct: 66 NVVKFYGHRREG--NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GV 118
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR---GTLPWM 1218
YLH I H D+K +NLL++ +D + K+ DFGL+ + R + GTLP++
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNL----KISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 1219 APELLNG 1225
APELL
Sbjct: 175 APELLKR 181
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 51/213 (23%), Positives = 82/213 (38%), Gaps = 51/213 (23%)
Query: 1042 EDLEELKE--LGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
ED+ +L+E LG G V T + A+K I+K RS +RE E
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSR--------VFREVE 62
Query: 1098 ILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM- 1155
+L + H NV+ ++ V E M GS+ L I
Sbjct: 63 MLYQCQGHRNVLELIEFFEEED--RFYLVFEKMRGGSI----------LSH----IHKRR 106
Query: 1156 -----DAAFGM-------EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR 1203
+A+ + ++LH+K I H DLK +N+L + + P+ K+ DF L +
Sbjct: 107 HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPV-KICDFDLGSGIK 165
Query: 1204 NTLVTGGVR--------GTLPWMAPELLNGSSS 1228
+ G+ +MAPE++ S
Sbjct: 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSE 198
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 51/198 (25%), Positives = 80/198 (40%), Gaps = 47/198 (23%)
Query: 1048 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HH 1104
+++G G++ + T + A+K I KS E EIL + H
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT------------EEIEILLRYGQH 75
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM------DAA 1158
PN++ V DG + VTE M G L LD+ I+ +A+
Sbjct: 76 PNIITLKDVYDDGKYVYV--VTELMKGGEL----------LDK----ILRQKFFSEREAS 119
Query: 1159 F-------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR--NTLVTG 1209
+EYLH++ +VH DLK N+L + ++ DFG +K R N L+
Sbjct: 120 AVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT 179
Query: 1210 GVRGTLPWMAPELLNGSS 1227
T ++APE+L
Sbjct: 180 PC-YTANFVAPEVLERQG 196
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 51/213 (23%), Positives = 80/213 (37%), Gaps = 54/213 (25%)
Query: 1039 IKNEDLEEL-------KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLT 1089
+K+ + K LG G+F + + A+K I K R +
Sbjct: 1 MKDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK-----RMEANTQ-- 53
Query: 1090 LEFWREAEILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR 1148
+E L HPN+V + V D V E + G L +R
Sbjct: 54 ----KEITALKLCEGHPNIVKLHEVFHDQ--LHTFLVMELLNGGEL----------FER- 96
Query: 1149 KRLIIAM------DAAFGM-------EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195
I +A++ M ++H +VH DLK +NLL ++ I K+ D
Sbjct: 97 ---IKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEI-KIID 152
Query: 1196 FGLSKIKR--NTLVTGGVRGTLPWMAPELLNGS 1226
FG +++K N + TL + APELLN +
Sbjct: 153 FGFARLKPPDNQPLKTPC-FTLHYAAPELLNQN 184
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-25
Identities = 46/200 (23%), Positives = 71/200 (35%), Gaps = 49/200 (24%)
Query: 1048 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HH 1104
+ LG G G V R T A+K + S + +E + +
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------------KARQEVDHHWQASGG 81
Query: 1105 PNVVAFYGVVQDGPGGTLAT--VTEFMVNGSLRHVLLSKERHLDRRKRLIIA-------- 1154
P++V V ++ G + E M G L R I
Sbjct: 82 PHIVCILDVYENMHHGKRCLLIIMECMEGGEL----------FSR----IQERGDQAFTE 127
Query: 1155 MDAAFGM-------EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLV 1207
+AA M ++LHS NI H D+K +NLL K+ + K+ DFG +K +
Sbjct: 128 REAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVL-KLTDFGFAKETTQNAL 186
Query: 1208 TGGVRGTLPWMAPELLNGSS 1227
T ++APE+L
Sbjct: 187 QTPC-YTPYYVAPEVLGPEK 205
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-25
Identities = 57/209 (27%), Positives = 83/209 (39%), Gaps = 35/209 (16%)
Query: 1048 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFW------------ 1093
E+G G++G V T A+K + K ++ R
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 1094 ------REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER---H 1144
+E IL KL HPNVV V+ D L V E + G + V + +
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSED 137
Query: 1145 LDRRK-RLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI-K 1202
R + +I G+EYLH + I+H D+K NLLV I K+ DFG+S K
Sbjct: 138 QARFYFQDLIK-----GIEYLHYQKIIHRDIKPSNLLVGEDGHI----KIADFGVSNEFK 188
Query: 1203 RNTLVTGGVRGTLPWMAPELLNGSSSKVS 1231
+ + GT +MAPE L+ + S
Sbjct: 189 GSDALLSNTVGTPAFMAPESLSETRKIFS 217
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 53/187 (28%), Positives = 80/187 (42%), Gaps = 27/187 (14%)
Query: 1048 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
+ LG G +G V R VA+K + E + +E I L+H
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIK------KEICINKMLNHE 65
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER---HLDRRK-RLIIAMDAAFGM 1161
NVV FYG ++G E+ G L + +R ++A G+
Sbjct: 66 NVVKFYGHRREG--NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GV 118
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR---GTLPWM 1218
YLH I H D+K +NLL++ +D + K+ DFGL+ + R + GTLP++
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNL----KISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 1219 APELLNG 1225
APELL
Sbjct: 175 APELLKR 181
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-24
Identities = 47/200 (23%), Positives = 72/200 (36%), Gaps = 48/200 (24%)
Query: 1048 KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HH 1104
+ LG G G V + T A+K ++ + RE E+ +
Sbjct: 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------------PKARREVELHWRASQC 114
Query: 1105 PNVVAFYGVVQDGPGGTLAT--VTEFMVNGSLRHVLLSKERHLDRRKRLIIA-------- 1154
P++V V ++ G V E + G L R I
Sbjct: 115 PHIVRIVDVYENLYAGRKCLLIVMECLDGGEL----------FSR----IQDRGDQAFTE 160
Query: 1155 MDAAFGM-------EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLV 1207
+A+ M +YLHS NI H D+K +NLL K P + K+ DFG +K +
Sbjct: 161 REASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAIL-KLTDFGFAKETTSHNS 219
Query: 1208 TGGVRGTLPWMAPELLNGSS 1227
T ++APE+L
Sbjct: 220 LTTPCYTPYYVAPEVLGPEK 239
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-24
Identities = 48/190 (25%), Positives = 82/190 (43%), Gaps = 26/190 (13%)
Query: 1047 LKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
+ LGSG FG V+ + +V +K IKK ++ + E ILS++ H
Sbjct: 29 MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEH 88
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNGS-LRHVLLSKER---HLDRRK-RLIIAMDAAF 1159
N++ + ++ G V E +G L + R L R +++
Sbjct: 89 ANIIKVLDIFEN--QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVS----- 141
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR----GTL 1215
+ YL K+I+H D+K +N+++ I K+ DFG + L G + GT+
Sbjct: 142 AVGYLRLKDIIHRDIKDENIVIAEDFTI----KLIDFGSA----AYLERGKLFYTFCGTI 193
Query: 1216 PWMAPELLNG 1225
+ APE+L G
Sbjct: 194 EYCAPEVLMG 203
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 5e-24
Identities = 61/192 (31%), Positives = 88/192 (45%), Gaps = 37/192 (19%)
Query: 1047 LKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
LK +G G F V + G +VAIK I K+ + ++L RE I+ L+H
Sbjct: 20 LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL--NPTSLQKLF----REVRIMKILNH 73
Query: 1105 PNVVAFYGVVQDGPGGTLAT---VTEFMVNGSLRHVLLSKER---HLDRRK-RLIIAMDA 1157
PN+V + V++ T T + E+ G + L++ R R K R I++
Sbjct: 74 PNIVKLFEVIE-----TEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS--- 125
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR----G 1213
++Y H K IVH DLK +NLL++ I K+ DFG S N GG G
Sbjct: 126 --AVQYCHQKRIVHRDLKAENLLLDADMNI----KIADFGFS----NEFTVGGKLDAFCG 175
Query: 1214 TLPWMAPELLNG 1225
P+ APEL G
Sbjct: 176 APPYAAPELFQG 187
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-24
Identities = 50/222 (22%), Positives = 83/222 (37%), Gaps = 38/222 (17%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREA 1096
+ L + L G F VY + G + A+KR+ E+ R + +E
Sbjct: 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS-----NEEEKNRAII---QEV 76
Query: 1097 EILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMV-----NGSLRHVLLSKERH--LDRR 1148
+ KL HPN+V F G + EF++ G L L E L
Sbjct: 77 CFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCD 136
Query: 1149 KRLIIAMDAAFGMEYLHSKN--IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL 1206
L I ++++H + I+H DLK +NLL++ + I K+ DFG + +
Sbjct: 137 TVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI----KLCDFGSATTISHYP 192
Query: 1207 VTGG-------------VRGTLPWMAPELLNGSSSK-VSEKV 1234
T + PE+++ S+ + EK
Sbjct: 193 DYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQ 234
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 46/194 (23%), Positives = 76/194 (39%), Gaps = 35/194 (18%)
Query: 1048 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
LG G++G V A+K +KK + + + +E ++L +L H
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVK----KEIQLLRRLRHK 66
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL-----------IIA 1154
NV+ V+ + + V E+ V G +L KR +I
Sbjct: 67 NVIQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPE----KRFPVCQAHGYFCQLID 120
Query: 1155 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR-- 1212
G+EYLHS+ IVH D+K NLL+ + K+ G+++ R
Sbjct: 121 -----GLEYLHSQGIVHKDIKPGNLLLTTGGTL----KISALGVAEALHPFAADDTCRTS 171
Query: 1213 -GTLPWMAPELLNG 1225
G+ + PE+ NG
Sbjct: 172 QGSPAFQPPEIANG 185
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 4e-23
Identities = 49/188 (26%), Positives = 81/188 (43%), Gaps = 30/188 (15%)
Query: 1048 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
LG GTFG V G+ + G VA+K + + ++ RE + L HP
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI-RSLDVVGKIK----REIQNLKLFRHP 71
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER---HLDRRK-RLIIAMDAAFGM 1161
+++ Y V+ V E++ G L + R RR + I++ +
Sbjct: 72 HIIKLYQVISTP--TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS-----AV 124
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR----GTLPW 1217
+Y H +VH DLK +N+L++ K+ DFGLS N + G G+ +
Sbjct: 125 DYCHRHMVVHRDLKPENVLLDAHMNA----KIADFGLS----NMMSDGEFLRTSCGSPNY 176
Query: 1218 MAPELLNG 1225
APE+++G
Sbjct: 177 AAPEVISG 184
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-23
Identities = 49/190 (25%), Positives = 77/190 (40%), Gaps = 24/190 (12%)
Query: 1047 LKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH- 1103
LG G FGTV+ G VAIK I ++ G S + +T E +L K+
Sbjct: 36 GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCP--LEVALLWKVGA 93
Query: 1104 ---HPNVVAFYGVVQDGPGGTLATVTEFMVNGS-LRHVLLSKER---HLDRRK-RLIIAM 1155
HP V+ + G L V E + L + K R ++A
Sbjct: 94 GGGHPGVIRLLDWFETQEGFML--VLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVA- 150
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTL 1215
+++ HS+ +VH D+K +N+L+ D R K+ DFG + + T GT
Sbjct: 151 ----AIQHCHSRGVVHRDIKDENILI---DLRRGCAKLIDFGSGALLHDEPYTDFD-GTR 202
Query: 1216 PWMAPELLNG 1225
+ PE ++
Sbjct: 203 VYSPPEWISR 212
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-23
Identities = 52/189 (27%), Positives = 80/189 (42%), Gaps = 28/189 (14%)
Query: 1045 EELKELGSGTFGTVYHG--KWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
+ +K++GSG FG K VA+K I++ E + RE L
Sbjct: 23 DFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-----DENVQ----REIINHRSL 73
Query: 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER---HLDRRK-RLIIAMDAA 1158
HPN+V F V+ LA + E+ G L + + R R + +++
Sbjct: 74 RHPNIVRFKEVILTP--THLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS---- 127
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR--NTLVTGGVRGTLP 1216
G+ Y HS I H DLK +N L++ R K+ DFG SK + + GT
Sbjct: 128 -GVSYCHSMQICHRDLKLENTLLDGSPAPR--LKICDFGYSKSSVLHSQPKS--TVGTPA 182
Query: 1217 WMAPELLNG 1225
++APE+L
Sbjct: 183 YIAPEVLLR 191
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 1e-22
Identities = 60/197 (30%), Positives = 90/197 (45%), Gaps = 31/197 (15%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
ED + K LG G+F TV + T AIK ++K + ++ +T RE +++
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVT----RERDVM 84
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLD-RRKRLIIA-MDA 1157
S+L HP V Y QD L + NG L + K D R A + +
Sbjct: 85 SRLDHPFFVKLYFTFQDD--EKLYFGLSYAKNGELLK-YIRKIGSFDETCTRFYTAEIVS 141
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--------KRNTLVTG 1209
A EYLH K I+H DLK +N+L+N I ++ DFG +K+ + N+ V
Sbjct: 142 AL--EYLHGKGIIHRDLKPENILLNEDMHI----QITDFGTAKVLSPESKQARANSFV-- 193
Query: 1210 GVRGTLPWMAPELLNGS 1226
GT +++PELL
Sbjct: 194 ---GTAQYVSPELLTEK 207
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 3e-22
Identities = 56/195 (28%), Positives = 95/195 (48%), Gaps = 30/195 (15%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+ E+L+++G GT+GTV+ K R T VA+KR++ + E + RE +L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR--KRLIIAMDA 1157
+L H N+V + V+ TL V EF + L+ S LD K + +
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTL--VFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLLK 112
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-----IKRNT-LVTGGV 1211
G+ + HS+N++H DLK NLL+N + K+ +FGL++ ++ + V
Sbjct: 113 --GLGFCHSRNVLHRDLKPQNLLINRNGEL----KLANFGLARAFGIPVRCYSAEVV--- 163
Query: 1212 RGTLPWMAPELLNGS 1226
TL + P++L G+
Sbjct: 164 --TLWYRPPDVLFGA 176
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 99.0 bits (246), Expect = 4e-22
Identities = 28/218 (12%), Positives = 51/218 (23%), Gaps = 42/218 (19%)
Query: 1048 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
+ L G V+ + A+K RS + ++L
Sbjct: 68 EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELER-----LHEATFAAARLLGE 122
Query: 1106 NVVAFYG------------------VVQDGPGGTLATVTEFMV-----------NGSLRH 1136
+ Q PG V +++ S
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 1137 VLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196
+ I+ L SK +VH DNL + + +GD
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRL----MLGDV 238
Query: 1197 GLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKV 1234
+ + E LN S++ + +
Sbjct: 239 SALWKVGTRGPASS--VPVTYAPREFLNASTATFTHAL 274
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 5e-22
Identities = 55/197 (27%), Positives = 94/197 (47%), Gaps = 30/197 (15%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+ + +LG GT+G VY T+ VAIKRI+ E+E + RE +L
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLL 87
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
+L H N++ V+ L + E+ + L ++++D+ + + + +F
Sbjct: 88 KELQHRNIIELKSVIHHNHRLHL--IFEYA-----ENDL---KKYMDKNPDVSMRVIKSF 137
Query: 1160 ------GMEYLHSKNIVHFDLKCDNLLVNLKDPI-RPICKVGDFGLSK---IKRNTLVTG 1209
G+ + HS+ +H DLK NLL+++ D P+ K+GDFGL++ I T
Sbjct: 138 LYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF-TH 196
Query: 1210 GVRGTLPWMAPELLNGS 1226
+ TL + PE+L GS
Sbjct: 197 EII-TLWYRPPEILLGS 212
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 5e-22
Identities = 50/195 (25%), Positives = 85/195 (43%), Gaps = 31/195 (15%)
Query: 1050 LGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
+G GT+G VY K + D A+K+I+ +++ RE +L +L HP
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEG----------TGISMSACREIALLRELKHP 78
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL--LSKERHLDRRKRLIIAMDAAF---- 1159
NV++ V + + ++ L H++ + + +L M +
Sbjct: 79 NVISLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137
Query: 1160 --GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-----IKRNTLVTGGVR 1212
G+ YLH+ ++H DLK N+LV + P R K+ D G ++ +K + V
Sbjct: 138 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 1213 GTLPWM-APELLNGS 1226
T W APELL G+
Sbjct: 198 -TF-WYRAPELLLGA 210
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 5e-22
Identities = 50/195 (25%), Positives = 85/195 (43%), Gaps = 30/195 (15%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQE---RLTLEFWREA 1096
E E++ ++G G++G V+ + R T VAIK+ S + ++ L RE
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFL------ESEDDPVIKKIAL---REI 53
Query: 1097 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRK-RLIIAM 1155
+L +L HPN+V V + L V E+ + ++ H L +R + + I
Sbjct: 54 RMLKQLKHPNLVNLLEVFRRK--RRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSITWQ 110
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK---IKRNTLVTGGVR 1212
+ + H N +H D+K +N+L+ I K+ DFG ++ + V
Sbjct: 111 TLQ-AVNFCHKHNCIHRDVKPENILITKHSVI----KLCDFGFARLLTGPSDYY-DDEV- 163
Query: 1213 GTLPWM-APELLNGS 1226
T W +PELL G
Sbjct: 164 ATR-WYRSPELLVGD 177
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 5e-22
Identities = 56/188 (29%), Positives = 83/188 (44%), Gaps = 31/188 (16%)
Query: 1048 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
+ LG G+FG V VA+K I + +S R+ RE L L HP
Sbjct: 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLK-KSDMHMRVE----REISYLKLLRHP 69
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER---HLDRRK-RLIIAMDAAFGM 1161
+++ Y V+ + V E+ G L ++ K+R RR + II +
Sbjct: 70 HIIKLYDVITTP--TDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIIC-----AI 121
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR----GTLPW 1217
EY H IVH DLK +NLL++ + K+ DFGLS N + G G+ +
Sbjct: 122 EYCHRHKIVHRDLKPENLLLDDNLNV----KIADFGLS----NIMTDGNFLKTSCGSPNY 173
Query: 1218 MAPELLNG 1225
APE++NG
Sbjct: 174 AAPEVING 181
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 2e-21
Identities = 56/194 (28%), Positives = 93/194 (47%), Gaps = 29/194 (14%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100
E L+++G GT+G VY + G A+K+I+ E E + RE IL
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55
Query: 1101 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR--KRLIIAMDAA 1158
+L H N+V Y V+ L V E + + L+ +L E L+ K ++ +
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVL--VFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLN- 111
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-----IKRNT-LVTGGVR 1212
G+ Y H + ++H DLK NLL+N + + K+ DFGL++ +++ T +
Sbjct: 112 -GIAYCHDRRVLHRDLKPQNLLINREGEL----KIADFGLARAFGIPVRKYTHEIV---- 162
Query: 1213 GTLPWMAPELLNGS 1226
TL + AP++L GS
Sbjct: 163 -TLWYRAPDVLMGS 175
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 48/191 (25%), Positives = 72/191 (37%), Gaps = 52/191 (27%)
Query: 1034 STLQIIKNEDLEEL----KELGSGTFGTVYHGKWRGT--DVAIKRIKKSCFTGRSSEQER 1087
S LQI KN +++ + LG G G V + T A+K ++
Sbjct: 6 SGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------- 54
Query: 1088 LTLEFWREAEILSKL-HHPNVVAFYGVVQDGPGGTLAT--VTEFMVNGSLRHVLLSKERH 1144
+ RE E+ + P++V V ++ G V E + G L
Sbjct: 55 --PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL---------- 102
Query: 1145 LDRRKRLIIA--------MDAAFGM-------EYLHSKNIVHFDLKCDNLLVNLKDPIRP 1189
R I +A+ M +YLHS NI H D+K +NLL K P
Sbjct: 103 FSR----IQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAI 158
Query: 1190 ICKVGDFGLSK 1200
+ K+ DFG +K
Sbjct: 159 L-KLTDFGFAK 168
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-21
Identities = 41/188 (21%), Positives = 71/188 (37%), Gaps = 22/188 (11%)
Query: 1047 LKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
LGSG FG+VY G VAIK ++K + + E +L K+
Sbjct: 48 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP--MEVVLLKKVSS 105
Query: 1105 --PNVVAFYGVVQDGPGGTLATVTEFMVN-GSLRHVLLSKER---HLDRRK-RLIIAMDA 1157
V+ + L + E L + + L R ++
Sbjct: 106 GFSGVIRLLDWFERPDSFVL--ILERPEPVQDLFDFITERGALQEELARSFFWQVLE--- 160
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPW 1217
+ + H+ ++H D+K +N+L+ D R K+ DFG + ++T+ T GT +
Sbjct: 161 --AVRHCHNCGVLHRDIKDENILI---DLNRGELKLIDFGSGALLKDTVYTDFD-GTRVY 214
Query: 1218 MAPELLNG 1225
PE +
Sbjct: 215 SPPEWIRY 222
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 5e-21
Identities = 47/186 (25%), Positives = 86/186 (46%), Gaps = 16/186 (8%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+ E L+ +G G+FG V + T A+K + K R + R +E +I+
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVER--NEVRNVF---KELQIM 69
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLD-RRKRLIIAMDAA 1158
L HP +V + QD + V + ++ G LR+ L + H +L I +
Sbjct: 70 QGLEHPFLVNLWYSFQDE--EDMFMVVDLLLGGDLRY-HLQQNVHFKEETVKLFIC-ELV 125
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWM 1218
++YL ++ I+H D+K DN+L++ + + DF ++ + + GT P+M
Sbjct: 126 MALDYLQNQRIIHRDMKPDNILLDEHGHV----HITDFNIAAMLPRETQITTMAGTKPYM 181
Query: 1219 APELLN 1224
APE+ +
Sbjct: 182 APEMFS 187
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 95.8 bits (238), Expect = 5e-21
Identities = 23/207 (11%), Positives = 59/207 (28%), Gaps = 34/207 (16%)
Query: 1048 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTG--------------------RSSEQ 1085
LG + T + + ++ +Q
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 1086 ERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVN-----GSLRHVLLS 1140
++ L F +++ ++ +D + + M + G + S
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 1141 KERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200
+ L RL + + + LH +VH L+ +++++ + + + F
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGV----FLTGFEHLV 254
Query: 1201 IKRNTLVTGGVRGTLPWMAPELLNGSS 1227
+ V + + PEL +
Sbjct: 255 -RDGARVV--SSVSRGFEPPELEARRA 278
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 5e-21
Identities = 63/191 (32%), Positives = 94/191 (49%), Gaps = 23/191 (12%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100
E ++L+++G GT+G VY K G VA+KRI+ +E E + RE +L
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLK 74
Query: 1101 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR--KRLIIAMDAA 1158
+LHHPN+V+ V+ TL V EFM L+ VL + L K + +
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTL--VFEFM-EKDLKKVLDENKTGLQDSQIKIYLYQLLR- 130
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK---IKRNTLVTGGVRGTL 1215
G+ + H I+H DLK NLL+N + K+ DFGL++ I + V TL
Sbjct: 131 -GVAHCHQHRILHRDLKPQNLLINSDGAL----KLADFGLARAFGIPVRSYTHEVV--TL 183
Query: 1216 PWMAPELLNGS 1226
+ AP++L GS
Sbjct: 184 WYRAPDVLMGS 194
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 6e-21
Identities = 61/196 (31%), Positives = 91/196 (46%), Gaps = 29/196 (14%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+ E+L LG G F TVY + + T+ VAIK+IK RS ++ + RE ++L
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIK---LGHRSEAKDGINRTALREIKLL 66
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR--KRLIIAMDA 1157
+L HPN++ +L V +FM L ++ L K ++
Sbjct: 67 QELSHPNIIGLLDAFGHKSNISL--VFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQ 123
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-----IKRNT-LVTGGV 1211
G+EYLH I+H DLK +NLL++ + K+ DFGL+K + T V
Sbjct: 124 --GLEYLHQHWILHRDLKPNNLLLDENGVL----KLADFGLAKSFGSPNRAYTHQVV--- 174
Query: 1212 RGTLPWM-APELLNGS 1226
T W APELL G+
Sbjct: 175 --TR-WYRAPELLFGA 187
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 6e-21
Identities = 52/196 (26%), Positives = 88/196 (44%), Gaps = 32/196 (16%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQE---RLTLEFWREA 1096
E E L +G G++G V + + T VAIK+ S + + ++ + RE
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL------ESDDDKMVKKIAM---REI 75
Query: 1097 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR--KRLIIA 1154
++L +L H N+V V + L V EF+ + ++ L LD + ++ +
Sbjct: 76 KLLKQLRHENLVNLLEVCKKKKRWYL--VFEFV-DHTILDDLELFPNGLDYQVVQKYLFQ 132
Query: 1155 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK---IKRNTLVTGGV 1211
+ G+ + HS NI+H D+K +N+LV+ + K+ DFG ++ V
Sbjct: 133 IIN--GIGFCHSHNIIHRDIKPENILVSQSGVV----KLCDFGFARTLAAPGEVY-DDEV 185
Query: 1212 RGTLPWM-APELLNGS 1226
T W APELL G
Sbjct: 186 -ATR-WYRAPELLVGD 199
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 7e-21
Identities = 39/196 (19%), Positives = 77/196 (39%), Gaps = 34/196 (17%)
Query: 1047 LKELGSGTFGTVYHGKWRGTD-------VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+ G G +Y D V +K + +G + Q E + L
Sbjct: 85 KGCIAHGGLGWIY----LALDRNVNGRPVVLKGLV---HSGDAEAQAM----AMAERQFL 133
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLAT---VTEFMVNG-SLRHVLLSKERHLDRRKRLIIAM 1155
+++ HP++V + V+ V E+ V G SL+ + L + + +
Sbjct: 134 AEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEY-VGGQSLKRSK---GQKLPVAEAIAYLL 189
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTL 1215
+ + YLHS +V+ DLK +N+++ ++ + K+ D G G + GT
Sbjct: 190 EILPALSYLHSIGLVYNDLKPENIMLT-EEQL----KLIDLG---AVSRINSFGYLYGTP 241
Query: 1216 PWMAPELLNGSSSKVS 1231
+ APE++ + +
Sbjct: 242 GFQAPEIVRTGPTVAT 257
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 1e-20
Identities = 53/259 (20%), Positives = 81/259 (31%), Gaps = 77/259 (29%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKS----------------------- 1076
D E ++ +G G FG V+ K + + AIKRI+
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 1077 ---------------------------CFTGRSSEQERLTLEFWREAEILSKLHHPNVVA 1109
T + + N V
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 1110 FYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI--IAMDAAFGMEYLHSK 1167
P L + +L+ + + DR + I + A +E+LHSK
Sbjct: 126 QLQPSS--PKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK 183
Query: 1168 NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--------------KRNTLVTGGVRG 1213
++H DLK N+ + D + KVGDFGL TG V G
Sbjct: 184 GLMHRDLKPSNIFFTMDD----VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV-G 238
Query: 1214 TLPWMAPELLNGS--SSKV 1230
T +M+PE ++G+ S KV
Sbjct: 239 TKLYMSPEQIHGNNYSHKV 257
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 1e-20
Identities = 51/188 (27%), Positives = 82/188 (43%), Gaps = 30/188 (15%)
Query: 1048 KELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
LG GTFG V GK G VA+K + + ++ RE + L HP
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIR-SLDVVGKIR----REIQNLKLFRHP 76
Query: 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER---HLDRRK-RLIIAMDAAFGM 1161
+++ Y V+ + V E++ G L + R RR + I++ G+
Sbjct: 77 HIIKLYQVISTP--SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS-----GV 129
Query: 1162 EYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR----GTLPW 1217
+Y H +VH DLK +N+L++ K+ DFGLS N + G G+ +
Sbjct: 130 DYCHRHMVVHRDLKPENVLLDAHMNA----KIADFGLS----NMMSDGEFLRTSCGSPNY 181
Query: 1218 MAPELLNG 1225
APE+++G
Sbjct: 182 AAPEVISG 189
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-20
Identities = 54/205 (26%), Positives = 85/205 (41%), Gaps = 52/205 (25%)
Query: 1045 EELKELGSGTFGTVYHGKWRGTD-VAIKRIKK-SCFTGRSSEQERLTLEFWREAEILSKL 1102
K +G+G+FG V+ K +D VAIK++ + F R E +I+ +
Sbjct: 43 TNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR-------------ELQIMRIV 89
Query: 1103 HHPNVVA----FYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
HPNVV FY L V E++ ++ RH + K+ M
Sbjct: 90 KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRAS----RHYAKLKQ---TMPML 141
Query: 1159 F----------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI----KRN 1204
+ Y+HS I H D+K NLL++ P + K+ DFG +KI + N
Sbjct: 142 LIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD---PPSGVLKLIDFGSAKILIAGEPN 198
Query: 1205 T--LVTGGVRGTLPWMAPELLNGSS 1227
+ + R APEL+ G++
Sbjct: 199 VSYICSRYYR------APELIFGAT 217
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 3e-20
Identities = 53/197 (26%), Positives = 88/197 (44%), Gaps = 35/197 (17%)
Query: 1045 EELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
+ K +G+G+FG VY K G VAIK++ + +R RE +I+ KL
Sbjct: 57 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL---------QDKRFKN---RELQIMRKL 104
Query: 1103 HHPNVVA----FYGVVQDGPGGTLATVTEFM---VNGSLRHVLLSKERHLDRRKRLIIAM 1155
H N+V FY + L V +++ V RH +K+ +L +
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-- 162
Query: 1156 DAAF----GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTGG 1210
+ + Y+HS I H D+K NLL++ P + K+ DFG +K + R
Sbjct: 163 ---YQLFRSLAYIHSFGICHRDIKPQNLLLD---PDTAVLKLCDFGSAKQLVRGEPNVSY 216
Query: 1211 VRGTLPWMAPELLNGSS 1227
+ + + APEL+ G++
Sbjct: 217 I-CSRYYRAPELIFGAT 232
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 9e-20
Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 29/197 (14%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREA 1096
+K ED E +K +G G FG V + + T A+K + K RS + FW E
Sbjct: 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRS-DSAF----FWEER 120
Query: 1097 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIA-M 1155
+I++ + P VV + QD L V E+M G L + L+S ++ R A +
Sbjct: 121 DIMAFANSPWVVQLFYAFQDD--RYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEV 177
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-------IKRNTLVT 1208
A + +HS +H D+K DN+L++ + K+ DFG ++ +T V
Sbjct: 178 VLAL--DAIHSMGFIHRDVKPDNMLLDKSGHL----KLADFGTCMKMNKEGMVRCDTAV- 230
Query: 1209 GGVRGTLPWMAPELLNG 1225
GT +++PE+L
Sbjct: 231 ----GTPDYISPEVLKS 243
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-19
Identities = 58/192 (30%), Positives = 90/192 (46%), Gaps = 25/192 (13%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
E +L +LG GT+ TVY GK + TD VA+K I R +E RE +L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI-------RLEHEEGAPCTAIREVSLL 54
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR--KRLIIAMDA 1157
L H N+V + ++ TL V E++ + L+ L ++ K + +
Sbjct: 55 KDLKHANIVTLHDIIHTEKSLTL--VFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQL-- 109
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK---IKRNTLVTGGVRGT 1214
G+ Y H + ++H DLK NLL+N + + K+ DFGL++ I T V T
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINERGEL----KLADFGLARAKSIPTKTYDNEVV--T 163
Query: 1215 LPWMAPELLNGS 1226
L + P++L GS
Sbjct: 164 LWYRPPDILLGS 175
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 1e-19
Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 36/200 (18%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQE----RLTLEFWRE 1095
++L++LG+GT+ TVY G + T VA+K +K + E + RE
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK--------LDSEEGTPSTAI---RE 53
Query: 1096 AEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM 1155
++ +L H N+V Y V+ TL V EFM + L+ + + + L + +
Sbjct: 54 ISLMKELKHENIVRLYDVIHTENKLTL--VFEFM-DNDLKK-YMDSRTVGNTPRGLELNL 109
Query: 1156 DAAF------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK---IKRNTL 1206
F G+ + H I+H DLK NLL+N + + K+GDFGL++ I NT
Sbjct: 110 VKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQL----KLGDFGLARAFGIPVNTF 165
Query: 1207 VTGGVRGTLPWMAPELLNGS 1226
+ V TL + AP++L GS
Sbjct: 166 SSEVV--TLWYRAPDVLMGS 183
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-19
Identities = 49/187 (26%), Positives = 83/187 (44%), Gaps = 16/187 (8%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+ + +K LG+G+FG V K + + A+K + K + + E TL E IL
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-KLKQIEH-TLN---EKRIL 95
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
++ P +V +D L V E++ G + L + A
Sbjct: 96 QAVNFPFLVKLEFSFKDN--SNLYMVMEYVAGGEMFS-HLRRIGRFSEPHARFYAAQIVL 152
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMA 1219
EYLHS ++++ DLK +NLL++ + I +V DFG +K + T + GT +A
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYI----QVTDFGFAKRVKGR--TWTLCGTPEALA 206
Query: 1220 PELLNGS 1226
PE++
Sbjct: 207 PEIILSK 213
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-19
Identities = 47/205 (22%), Positives = 78/205 (38%), Gaps = 27/205 (13%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREA 1096
++ +D E LK +G G F V K + T A+K + K R E F E
Sbjct: 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRG-EVSC----FREER 112
Query: 1097 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLD-RRKRLIIAM 1155
++L + + QD L V E+ V G L +L + R +A
Sbjct: 113 DVLVNGDRRWITQLHFAFQDE--NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLA- 169
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-------IKRNTLVT 1208
+ ++ +H VH D+K DN+L++ I ++ DFG ++ V
Sbjct: 170 EIVMAIDSVHRLGYVHRDIKPDNILLDRCGHI----RLADFGSCLKLRADGTVRSLVAV- 224
Query: 1209 GGVRGTLPWMAPELLNGSSSKVSEK 1233
GT +++PE+L
Sbjct: 225 ----GTPDYLSPEILQAVGGGPGTG 245
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 48/187 (25%), Positives = 80/187 (42%), Gaps = 18/187 (9%)
Query: 1047 LKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
+ +LG G TVY + VAIK I + +R F RE S+L H
Sbjct: 16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIP-PREKEETLKR----FEREVHNSSQLSH 70
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNG-SLRHVLLSKERHLDRRKRLIIAMDAAFGMEY 1163
N+V+ V ++ V E+ + G +L + L + G+++
Sbjct: 71 QNIVSMIDVDEED--DCYYLVMEY-IEGPTLSE-YIESHGPLSVDTAINFTNQILDGIKH 126
Query: 1164 LHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVT--GGVRGTLPWMAPE 1221
H IVH D+K N+L++ + K+ DFG++K T +T V GT+ + +PE
Sbjct: 127 AHDMRIVHRDIKPQNILIDSNKTL----KIFDFGIAKALSETSLTQTNHVLGTVQYFSPE 182
Query: 1222 LLNGSSS 1228
G ++
Sbjct: 183 QAKGEAT 189
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-19
Identities = 46/189 (24%), Positives = 78/189 (41%), Gaps = 26/189 (13%)
Query: 1047 LKELGSGTFGTVYHGKWRGTD------VAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100
+ +G G G VY D VA+K + ++ + + R REA
Sbjct: 39 RRLVGRGGMGDVY----EAEDTVRERIVALKLMSET-LSSDPVFRTR----MQREARTAG 89
Query: 1101 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNG-SLRHVLLSKERHLDRRKRLIIAMDAAF 1159
+L P+VV + + G L +NG L +L ++ L + + I
Sbjct: 90 RLQEPHVVPIHDFGEI--DGQLYVDMRL-INGVDLAA-MLRRQGPLAPPRAVAIVRQIGS 145
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVT--GGVRGTLPW 1217
++ H+ H D+K +N+LV+ D + DFG++ + +T G GTL +
Sbjct: 146 ALDAAHAAGATHRDVKPENILVSADDFA----YLVDFGIASATTDEKLTQLGNTVGTLYY 201
Query: 1218 MAPELLNGS 1226
MAPE + S
Sbjct: 202 MAPERFSES 210
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 5e-19
Identities = 53/211 (25%), Positives = 81/211 (38%), Gaps = 51/211 (24%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFW-----R 1094
E + E+G G +GTVY + + VA+K ++ R
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRV--------PNGGGGGGGLPISTVR 60
Query: 1095 EAEILSKLH---HPNVVAFYGVVQDGPGGTLAT---VTEFMVNGSLRHVLLSKERHLDRR 1148
E +L +L HPNVV V V E + L +LD+
Sbjct: 61 EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-----DQDL---RTYLDKA 112
Query: 1149 KRLIIAMDAA--------FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200
+ + G+++LH+ IVH DLK +N+LV + K+ DFGL++
Sbjct: 113 PPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTV----KLADFGLAR 168
Query: 1201 I----KRNT-LVTGGVRGTLPWMAPELLNGS 1226
I T +V TL + APE+L S
Sbjct: 169 IYSYQMALTPVVV-----TLWYRAPEVLLQS 194
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 5e-19
Identities = 48/201 (23%), Positives = 82/201 (40%), Gaps = 29/201 (14%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREA 1096
+ ED E LK +G G FG V K + D A+K + K R+ E F E
Sbjct: 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRA-ETAC----FREER 125
Query: 1097 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
++L + + QD L V ++ V G L L + + +
Sbjct: 126 DVLVNGDSKWITTLHYAFQDD--NNLYLVMDYYVGGDLLT-------LLSKFEDRLPEEM 176
Query: 1157 AAF-------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK--IKRNTLV 1207
A F ++ +H + VH D+K DN+L+++ I ++ DFG ++ T+
Sbjct: 177 ARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHI----RLADFGSCLKLMEDGTVQ 232
Query: 1208 TGGVRGTLPWMAPELLNGSSS 1228
+ GT +++PE+L
Sbjct: 233 SSVAVGTPDYISPEILQAMEG 253
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 6e-19
Identities = 53/201 (26%), Positives = 80/201 (39%), Gaps = 28/201 (13%)
Query: 1037 QIIKNEDLEELKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWR 1094
Q + + + LG G FG V + R T A K+++K R E L
Sbjct: 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN----- 233
Query: 1095 EAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIA 1154
E +IL K++ VV+ + L V M G L+ H+ +
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETK--DALCLVLTLMNGGDLKF-------HIYHMGQAGFP 284
Query: 1155 MD-AAF-------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL 1206
A F G+E LH + IV+ DLK +N+L++ IR I D GL+
Sbjct: 285 EARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIR-IS---DLGLAVHVPEGQ 340
Query: 1207 VTGGVRGTLPWMAPELLNGSS 1227
G GT+ +MAPE++
Sbjct: 341 TIKGRVGTVGYMAPEVVKNER 361
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 6e-19
Identities = 54/188 (28%), Positives = 95/188 (50%), Gaps = 18/188 (9%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+D + L+ LG+G+FG V+ + R A+K +KK R + E T + E +L
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEH-TND---ERLML 60
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLD-RRKRLIIAMDAA 1158
S + HP ++ +G QD + + +++ G L LL K + + A +
Sbjct: 61 SIVTHPFIIRMWGTFQDA--QQIFMIMDYIEGGELFS-LLRKSQRFPNPVAKFYAA-EVC 116
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWM 1218
+EYLHSK+I++ DLK +N+L++ I K+ DFG +K + T + GT ++
Sbjct: 117 LALEYLHSKDIIYRDLKPENILLDKNGHI----KITDFGFAKYVPDV--TYTLCGTPDYI 170
Query: 1219 APELLNGS 1226
APE+++
Sbjct: 171 APEVVSTK 178
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 7e-19
Identities = 55/202 (27%), Positives = 89/202 (44%), Gaps = 32/202 (15%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
E+L ++G GTFG V+ + R T VA+K++ +E+E + RE +IL
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKIL 70
Query: 1100 SKLHHPNVVAFYGVV------QDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRR--KRL 1151
L H NVV + + G++ V +F + L +L + KR+
Sbjct: 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV 129
Query: 1152 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI------KRNT 1205
+ + G+ Y+H I+H D+K N+L+ + K+ DFGL++ +
Sbjct: 130 MQMLLN--GLYYIHRNKILHRDMKAANVLITRDGVL----KLADFGLARAFSLAKNSQPN 183
Query: 1206 LVTGGVRGTLPWM-APELLNGS 1226
T V TL W PELL G
Sbjct: 184 RYTNRVV-TL-WYRPPELLLGE 203
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 50/194 (25%), Positives = 89/194 (45%), Gaps = 28/194 (14%)
Query: 1047 LKELGSGTFGTVYHGKWRGTD------VAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100
+ LG G V+ D VA+K + ++ S R F REA+ +
Sbjct: 17 GEILGFGGMSEVH----LARDLRDHRDVAVK-VLRADLARDPSFYLR----FRREAQNAA 67
Query: 1101 KLHHPNVVAFY--GVVQDGPGGTLATVTEFMVNG-SLRHVLLSKERHLDRRKRLIIAMDA 1157
L+HP +VA Y G + G V E+ V+G +LR ++ E + ++ + + DA
Sbjct: 68 ALNHPAIVAVYDTGEAETPAGPLPYIVMEY-VDGVTLRD-IVHTEGPMTPKRAIEVIADA 125
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLV----TGGVRG 1213
+ + H I+H D+K N++++ + + KV DFG+++ ++ T V G
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMISATNAV----KVMDFGIARAIADSGNSVTQTAAVIG 181
Query: 1214 TLPWMAPELLNGSS 1227
T +++PE G S
Sbjct: 182 TAQYLSPEQARGDS 195
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 6e-18
Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 29/197 (14%)
Query: 1042 EDLEELKELGSGTFGTVY---HGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREA 1096
E E L+ LG G +G V+ T A+K +KK+ + + T E
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAH-TKA---ER 72
Query: 1097 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL-RHVLLSKERHLD-RRKRLIIA 1154
IL ++ HP +V Q G G L + E++ G L L +E +A
Sbjct: 73 NILEEVKHPFIVDLIYAFQTG--GKLYLILEYLSGGELFMQ--LEREGIFMEDTACFYLA 128
Query: 1155 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR-- 1212
+ + + +LH K I++ DLK +N+++N + + K+ DFGL K + G
Sbjct: 129 -EISMALGHLHQKGIIYRDLKPENIMLNHQGHV----KLTDFGLCKES----IHDGTVTH 179
Query: 1213 ---GTLPWMAPELLNGS 1226
GT+ +MAPE+L S
Sbjct: 180 TFCGTIEYMAPEILMRS 196
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 8e-18
Identities = 57/203 (28%), Positives = 87/203 (42%), Gaps = 37/203 (18%)
Query: 1042 EDLEELKELGSGTFGTVY---HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
+ E + E+G G +G V+ K G VA+KR++ + +E + L RE +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIREVAV 64
Query: 1099 LSKLH---HPNVVAFYGVVQDGPGGTLAT---VTEFMVNGSLRHVLLSKERHLDRRKRLI 1152
L L HPNVV + V V E + L +LD+
Sbjct: 65 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-----DQDL---TTYLDKVPEPG 116
Query: 1153 IAMDAA--------FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 1204
+ + G+++LHS +VH DLK N+LV I K+ DFGL++I
Sbjct: 117 VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQI----KLADFGLARIYSF 172
Query: 1205 TL-VTGGVRGTLPWMAPELLNGS 1226
+ +T V TL + APE+L S
Sbjct: 173 QMALTSVVV-TLWYRAPEVLLQS 194
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 86.3 bits (213), Expect = 1e-17
Identities = 25/212 (11%), Positives = 55/212 (25%), Gaps = 33/212 (15%)
Query: 1044 LEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSS--------EQERLTLEFW 1093
L LG + T + + ++ + RL
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 1094 REAEILSKLH---------HPNVVAFYGVVQDGPGGTLATVTEFM--VNGSLRHVL---- 1138
+ + L P V D + + + +L+
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 1139 --LSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196
S + L RL + + + LH +VH L+ +++++ + + + F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGV----FLTGF 255
Query: 1197 GLSKIKRNTLVT--GGVRGTLPWMAPELLNGS 1226
+ V+ G A +L
Sbjct: 256 EHLVRDGASAVSPIGRGFAPPETTAERMLPFG 287
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 1e-17
Identities = 53/193 (27%), Positives = 84/193 (43%), Gaps = 19/193 (9%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+ + + LG G FG V+ + + T A K++ K R Q + E +IL
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMV-----EKKIL 239
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLR---HVLLSKERHLD-RRKRLIIAM 1155
+K+H +V+ + L V M G +R + + R A
Sbjct: 240 AKVHSRFIVSLAYAFETK--TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA- 296
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTGGVRGT 1214
G+E+LH +NI++ DLK +N+L++ +R I D GL+ +K T G GT
Sbjct: 297 QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVR-IS---DLGLAVELKAGQTKTKGYAGT 352
Query: 1215 LPWMAPELLNGSS 1227
+MAPELL G
Sbjct: 353 PGFMAPELLLGEE 365
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-17
Identities = 58/195 (29%), Positives = 88/195 (45%), Gaps = 27/195 (13%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
D + LK LG GTFG V + + T A+K ++K + E E + +L
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD-EVAHTVTE----SRVL 59
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL-RHVLLSKERHLD-RRKRLIIAMDA 1157
HP + A Q L V E+ G L H LS+ER R R A +
Sbjct: 60 QNTRHPFLTALKYAFQTH--DRLCFVMEYANGGELFFH--LSRERVFTEERARFYGA-EI 114
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR----- 1212
+EYLHS+++V+ D+K +NL+++ I K+ DFGL K ++ G
Sbjct: 115 VSALEYLHSRDVVYRDIKLENLMLDKDGHI----KITDFGLCKEG----ISDGATMKTFC 166
Query: 1213 GTLPWMAPELLNGSS 1227
GT ++APE+L +
Sbjct: 167 GTPEYLAPEVLEDND 181
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-17
Identities = 41/199 (20%), Positives = 78/199 (39%), Gaps = 41/199 (20%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+D + +++LG G + V+ + V +K +K +++ RE +IL
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP--------VKKKKIK---REIKIL 84
Query: 1100 SKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL--LSKERHLDRRKRLIIAMD 1156
L PN++ +V+D T A V E + N + + L+ D
Sbjct: 85 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDY-------------D 131
Query: 1157 AAF-------GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR-NTLVT 1208
F ++Y HS I+H D+K N++++ + + D+GL++
Sbjct: 132 IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLI---DWGLAEFYHPGQEYN 188
Query: 1209 GGVRGTLPWMAPELLNGSS 1227
V + + PELL
Sbjct: 189 VRV-ASRYFKGPELLVDYQ 206
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 5e-17
Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 31/197 (15%)
Query: 1042 EDLEELKELGSGTFGTVY---HGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREA 1096
E LK LG G+FG V+ A+K +KK+ R E
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKM-----ER 77
Query: 1097 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL-RHVLLSKERHLD-RRKRLIIA 1154
+IL +++HP +V + Q G L + +F+ G L LSKE + +A
Sbjct: 78 DILVEVNHPFIVKLHYAFQTE--GKLYLILDFLRGGDLFTR--LSKEVMFTEEDVKFYLA 133
Query: 1155 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR-- 1212
+ A +++LHS I++ DLK +N+L++ + I K+ DFGLSK + +
Sbjct: 134 -ELALALDHLHSLGIIYRDLKPENILLDEEGHI----KLTDFGLSKES----IDHEKKAY 184
Query: 1213 ---GTLPWMAPELLNGS 1226
GT+ +MAPE++N
Sbjct: 185 SFCGTVEYMAPEVVNRR 201
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 6e-17
Identities = 54/260 (20%), Positives = 102/260 (39%), Gaps = 32/260 (12%)
Query: 978 METHPDYSRSELKGNESLQSEVVNHRIQESDYEEGRLDLPTAGIPLVDLALGNFDISTLQ 1037
M H + E + + + +L TA + +
Sbjct: 1 MAHHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLT-----------GHAE 49
Query: 1038 IIKNEDLEELKELGSGTFGTVY---HGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEF 1092
+ E+ E LK LG+G +G V+ T A+K +KK+ ++ E T
Sbjct: 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEH-TRT- 107
Query: 1093 WREAEILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLD-RRKR 1150
E ++L + P +V + Q L + +++ G L LS+ +
Sbjct: 108 --ERQVLEHIRQSPFLVTLHYAFQTE--TKLHLILDYINGGELFT-HLSQRERFTEHEVQ 162
Query: 1151 LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK--IKRNTLVT 1208
+ + + +E+LH I++ D+K +N+L++ + + DFGLSK + T
Sbjct: 163 IYVG-EIVLALEHLHKLGIIYRDIKLENILLDSNGHV----VLTDFGLSKEFVADETERA 217
Query: 1209 GGVRGTLPWMAPELLNGSSS 1228
GT+ +MAP+++ G S
Sbjct: 218 YDFCGTIEYMAPDIVRGGDS 237
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 84.2 bits (208), Expect = 1e-16
Identities = 48/188 (25%), Positives = 78/188 (41%), Gaps = 18/188 (9%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
D + +G G FG VY + T A+K + K + + E L L E +L
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK--QGETLALN---ERIML 243
Query: 1100 SKLH---HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
S + P +V L+ + + M G L + LS+ A +
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTP--DKLSFILDLMNGGDLHY-HLSQHGVFSEADMRFYAAE 300
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 1216
G+E++H++ +V+ DLK N+L++ +R I D GL+ V GT
Sbjct: 301 IILGLEHMHNRFVVYRDLKPANILLDEHGHVR-IS---DLGLACDFSKKKPHASV-GTHG 355
Query: 1217 WMAPELLN 1224
+MAPE+L
Sbjct: 356 YMAPEVLQ 363
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 2e-16
Identities = 63/196 (32%), Positives = 87/196 (44%), Gaps = 28/196 (14%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+ E LK LG GTFG V K + T A+K +KK + LT E +L
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT-----ENRVL 202
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL-RHVLLSKERHLD-RRKRLIIAMDA 1157
HP + A Q L V E+ G L H LS+ER R R A +
Sbjct: 203 QNSRHPFLTALKYSFQT--HDRLCFVMEYANGGELFFH--LSRERVFSEDRARFYGA-EI 257
Query: 1158 AFGMEYLHS-KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR---- 1212
++YLHS KN+V+ DLK +NL+++ I K+ DFGL K + G
Sbjct: 258 VSALDYLHSEKNVVYRDLKLENLMLDKDGHI----KITDFGLCKEG----IKDGATMKTF 309
Query: 1213 -GTLPWMAPELLNGSS 1227
GT ++APE+L +
Sbjct: 310 CGTPEYLAPEVLEDND 325
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-16
Identities = 44/201 (21%), Positives = 75/201 (37%), Gaps = 32/201 (15%)
Query: 1045 EELKELGSGTFGTV---YHGKWRGTDVAIKRIKKSCFTGRSS---EQERLTLEFWREAEI 1098
+ + SG++G V + G VAIKR+ + GR+ L RE +
Sbjct: 25 TVQRFISSGSYGAVCAGVDSE--GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLAT---VTEFMVNGSLRHVLLSKERHL-DRRKRLIIA 1154
L+ HHPN++ + + VTE M L V+ + + + + +
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFM- 140
Query: 1155 MDAAF----GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLS-KIKRNTLV 1207
+ G+ LH +VH DL N+L+ + DF L+ + +
Sbjct: 141 ----YHILLGLHVLHEAGVVHRDLHPGNILLADN------NDITICDFNLAREDTADANK 190
Query: 1208 TGGVRGTLPWMAPELLNGSSS 1228
T V + APEL+
Sbjct: 191 THYV-THRWYRAPELVMQFKG 210
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 4e-16
Identities = 53/215 (24%), Positives = 87/215 (40%), Gaps = 58/215 (26%)
Query: 1045 EELKELGSGTFGTVYHGKWRGTD------VAIKRI--KKSCFTGRSSEQERLTLEFWREA 1096
+LK LG G G V + D VAIK+I L RE
Sbjct: 14 MDLKPLGCGGNGLV----FSAVDNDCDKRVAIKKIVLTDPQSVKH-------AL---REI 59
Query: 1097 EILSKLHHPNVVAFYGVVQDGPGGTLAT------------VTEFMVNGSLRHVLLSKERH 1144
+I+ +L H N+V + ++ V E+M + +L +
Sbjct: 60 KIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLANVLEQGPL 117
Query: 1145 LDRRKRLIIAMDAAF----GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGL 1198
L+ RL + + G++Y+HS N++H DLK NL +N +D K+GDFGL
Sbjct: 118 LEEHARLFM-----YQLLRGLKYIHSANVLHRDLKPANLFINTED-----LVLKIGDFGL 167
Query: 1199 SKI-----KRNTLVTGGVRGTLPWMAPELLNGSSS 1228
++I ++ G+ T + +P LL ++
Sbjct: 168 ARIMDPHYSHKGHLSEGL-VTKWYRSPRLLLSPNN 201
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 1e-15
Identities = 47/229 (20%), Positives = 81/229 (35%), Gaps = 67/229 (29%)
Query: 1045 EELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
K LG+G+FG V G A+K++ + R RE +I+ L
Sbjct: 10 SLGKTLGTGSFGIVCEVFDIESGKRFALKKVL---------QDPRYKN---RELDIMKVL 57
Query: 1103 HHPNVVA----FYGVVQDGPGGTLAT--------------------------------VT 1126
H N++ FY + P +
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 1127 EFM---VNGSLRHVLLSKERHLDRRKRLIIAMDAAF----GMEYLHSKNIVHFDLKCDNL 1179
E++ ++ L+ + S + I + + ++HS I H D+K NL
Sbjct: 118 EYVPDTLHKVLKSFIRSGRSIPMNLISIYI-----YQLFRAVGFIHSLGICHRDIKPQNL 172
Query: 1180 LVNLKDPIRPICKVGDFGLSK-IKRNTLVTGGVRGTLPWMAPELLNGSS 1227
LVN KD +C DFG +K + + + + + APEL+ G++
Sbjct: 173 LVNSKDNTLKLC---DFGSAKKLIPSEPSVAYI-CSRFYRAPELMLGAT 217
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-15
Identities = 53/203 (26%), Positives = 86/203 (42%), Gaps = 41/203 (20%)
Query: 1045 EELKELGSGTFGTVYHGKWR--GTDVAIKRI-KKSCFTGRSSEQERLTLEFWREAEILSK 1101
+ + G GTFGTV GK + G VAIK++ + F R L + + L+
Sbjct: 26 QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNR-------EL---QIMQDLAV 75
Query: 1102 LHHPNVVA----FYGVVQDGPGGT-LATVTEFM---VNGSLRHVLLSKERHLDRRKRLII 1153
LHHPN+V FY + + L V E++ ++ R+ + ++ +
Sbjct: 76 LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 1154 AMDAAF----GMEYLH--SKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLSKI-KRN 1204
F + LH S N+ H D+K N+LVN D K+ DFG +K +
Sbjct: 136 -----FQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEAD-----GTLKLCDFGSAKKLSPS 185
Query: 1205 TLVTGGVRGTLPWMAPELLNGSS 1227
+ + + APEL+ G+
Sbjct: 186 EPNVAYI-CSRYYRAPELIFGNQ 207
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 80.5 bits (198), Expect = 2e-15
Identities = 64/339 (18%), Positives = 113/339 (33%), Gaps = 57/339 (16%)
Query: 899 WSYFRNLAQDEFSRKDVSLMDQDHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSR 958
F+ D+ R V + D D + + ++ G + + + G
Sbjct: 227 TFRFQLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEY 286
Query: 959 INFDEGSQRESSSIVGPSTMETHPDYSRSELKGNESLQSEVVNHRIQESDYEEGRLDLPT 1018
N + + E ++ ++ + D R+ L
Sbjct: 287 FNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRD----RMKL-- 340
Query: 1019 AGIPLVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKS 1076
D L LG G+FG V + +GTD A+K +KK
Sbjct: 341 -----------------------TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKD 377
Query: 1077 CFTGRSSEQERLTLEFWREAEILSK-LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL- 1134
+ E E +L+ P + + Q L V E++ G L
Sbjct: 378 VVIQDD-DVECT----MVEKRVLALPGKPPFLTQLHSCFQ--TMDRLYFVMEYVNGGDLM 430
Query: 1135 RHVLLSKERHLD-RRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193
H + + A + A G+ +L SK I++ DLK DN++++ + I K+
Sbjct: 431 YH--IQQVGRFKEPHAVFYAA-EIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHI----KI 483
Query: 1194 GDFGLSKIKRNTLVTGGVR-----GTLPWMAPELLNGSS 1227
DFG+ K + GV GT ++APE++
Sbjct: 484 ADFGMCKEN----IWDGVTTKTFCGTPDYIAPEIIAYQP 518
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 3e-15
Identities = 42/171 (24%), Positives = 61/171 (35%), Gaps = 21/171 (12%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWR 1094
+ L+ K LG G FG V G VA+K +K+ ++ E
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-----ATHSEH--RALMS 74
Query: 1095 EAEILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 1153
E +IL + HH NVV G PGG L + EF G+L L SK R + +
Sbjct: 75 ELKILIHIGHHLNVVNLLGACTK-PGGPLMVIVEFCKFGNLSTYLRSK-----RNEFVPY 128
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 1204
A + + DLK + V + LS ++
Sbjct: 129 KTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 7e-13
Identities = 26/86 (30%), Positives = 43/86 (50%), Gaps = 7/86 (8%)
Query: 1142 ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK- 1200
+ L + + A GME+L S+ +H DL N+L++ K+ + K+ DFGL++
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN----VVKICDFGLARD 242
Query: 1201 IKRNTLVTGGVRGTLP--WMAPELLN 1224
I ++ LP WMAPE +
Sbjct: 243 IYKDPDYVRKGDARLPLKWMAPETIF 268
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 6e-15
Identities = 59/199 (29%), Positives = 89/199 (44%), Gaps = 28/199 (14%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREA 1096
+K ED K LG G+FG V+ +++ T+ AIK +KK + E E
Sbjct: 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD-DVECT----MVEK 68
Query: 1097 EILSK-LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL-RHVLLSKERHLD-RRKRLII 1153
+LS HP + + Q L V E++ G L H + D R
Sbjct: 69 RVLSLAWEHPFLTHMFCTFQTK--ENLFFVMEYLNGGDLMYH--IQSCHKFDLSRATFYA 124
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR- 1212
A + G+++LHSK IV+ DLK DN+L++ I K+ DFG+ K + G +
Sbjct: 125 A-EIILGLQFLHSKGIVYRDLKLDNILLDKDGHI----KIADFGMCKEN----MLGDAKT 175
Query: 1213 ----GTLPWMAPELLNGSS 1227
GT ++APE+L G
Sbjct: 176 NTFCGTPDYIAPEILLGQK 194
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 7e-15
Identities = 24/157 (15%), Positives = 45/157 (28%), Gaps = 24/157 (15%)
Query: 1047 LKELGSGTFGTVYHGKWRGTD------VAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100
L G W+ D VA+ + + + + E LS
Sbjct: 36 LIFHGGVPPLQF----WQALDTALDRQVALTFVD-----PQGVLPDDVLQETLSRTLRLS 86
Query: 1101 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFG 1160
++ P V VV GG + V E++ GSL+ V + + A
Sbjct: 87 RIDKPGVARVLDVVHTRAGGLV--VAEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAAA 141
Query: 1161 MEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197
+ H + + V++ + +
Sbjct: 142 ADAAHRAGVALSIDHPSRVRVSIDGDV----VLAYPA 174
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 8e-15
Identities = 56/199 (28%), Positives = 87/199 (43%), Gaps = 28/199 (14%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREA 1096
+ ++ E ++ LG G+FG V + + T A+K +KK + E E
Sbjct: 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDD-DVECT----MTEK 74
Query: 1097 EILSK-LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL-RHVLLSKERHLD-RRKRLII 1153
ILS +HP + + Q L V EF+ G L H + K R D R R
Sbjct: 75 RILSLARNHPFLTQLFCCFQ--TPDRLFFVMEFVNGGDLMFH--IQKSRRFDEARARFYA 130
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR- 1212
A + + +LH K I++ DLK DN+L++ + K+ DFG+ K + GV
Sbjct: 131 A-EIISALMFLHDKGIIYRDLKLDNVLLDHEGHC----KLADFGMCKEG----ICNGVTT 181
Query: 1213 ----GTLPWMAPELLNGSS 1227
GT ++APE+L
Sbjct: 182 ATFCGTPDYIAPEILQEML 200
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 9e-15
Identities = 49/199 (24%), Positives = 90/199 (45%), Gaps = 28/199 (14%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREA 1096
+ +D + L+ +G G++ V + + TD A+K +KK + + + E
Sbjct: 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDE-DIDWV----QTEK 60
Query: 1097 EILSK-LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL-RHVLLSKERHLD-RRKRLII 1153
+ + +HP +V + Q L V E++ G L H + ++R L R
Sbjct: 61 HVFEQASNHPFLVGLHSCFQTE--SRLFFVIEYVNGGDLMFH--MQRQRKLPEEHARFYS 116
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR- 1212
A + + + YLH + I++ DLK DN+L++ + I K+ D+G+ K + G
Sbjct: 117 A-EISLALNYLHERGIIYRDLKLDNVLLDSEGHI----KLTDYGMCKEG----LRPGDTT 167
Query: 1213 ----GTLPWMAPELLNGSS 1227
GT ++APE+L G
Sbjct: 168 STFCGTPNYIAPEILRGED 186
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 38/197 (19%)
Query: 1045 EELKELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
+GSG +G+V K G VAIK++ + F + RE +L +
Sbjct: 27 VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR-PFQSEIFAKRAY-----RELLLLKHM 80
Query: 1103 HHPNVVAFYGVVQDGPGGTLAT------VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
H NV+ V P +L V FM L+ ++ + + + + ++
Sbjct: 81 QHENVIGLLDVFT--PASSLRNFYDFYLVMPFM-QTDLQKIM--GLKFSEEKIQYLV--- 132
Query: 1157 AAF----GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLSKIKRNTLVTGG 1210
+ G++Y+HS +VH DLK NL VN C K+ DFGL++ + TG
Sbjct: 133 --YQMLKGLKYIHSAGVVHRDLKPGNLAVNED------CELKILDFGLARHADAEM-TGY 183
Query: 1211 VRGTLPWMAPELLNGSS 1227
V T + APE++
Sbjct: 184 V-VTRWYRAPEVILSWM 199
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 1e-14
Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 28/207 (13%)
Query: 1030 NFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQER 1087
N S+ K D LK +G G+FG V + + +V A+K ++K + E++
Sbjct: 26 NLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKK-EEKH 84
Query: 1088 LTLEFWREAEILSK-LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL-RHVLLSKERHL 1145
+ E +L K + HP +V + Q L V +++ G L H L +ER
Sbjct: 85 -IMS---ERNVLLKNVKHPFLVGLHFSFQTA--DKLYFVLDYINGGELFYH--LQRERCF 136
Query: 1146 D-RRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 1204
R R A + A + YLHS NIV+ DLK +N+L++ + I + DFGL K
Sbjct: 137 LEPRARFYAA-EIASALGYLHSLNIVYRDLKPENILLDSQGHI----VLTDFGLCKEN-- 189
Query: 1205 TLVTGGVR-----GTLPWMAPELLNGS 1226
+ GT ++APE+L+
Sbjct: 190 --IEHNSTTSTFCGTPEYLAPEVLHKQ 214
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 1e-14
Identities = 51/196 (26%), Positives = 82/196 (41%), Gaps = 28/196 (14%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
D L LG G+FG V + +GTD A+K +KK + E E +L
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDD-DVECT----MVEKRVL 74
Query: 1100 SK-LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL-RHVLLSKERHLD-RRKRLIIAMD 1156
+ P + + Q L V E++ G L H + + A +
Sbjct: 75 ALPGKPPFLTQLHSCFQ--TMDRLYFVMEYVNGGDLMYH--IQQVGRFKEPHAVFYAA-E 129
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR---- 1212
A G+ +L SK I++ DLK DN++++ + I K+ DFG+ K + GV
Sbjct: 130 IAIGLFFLQSKGIIYRDLKLDNVMLDSEGHI----KIADFGMCKEN----IWDGVTTKTF 181
Query: 1213 -GTLPWMAPELLNGSS 1227
GT ++APE++
Sbjct: 182 CGTPDYIAPEIIAYQP 197
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-14
Identities = 48/196 (24%), Positives = 89/196 (45%), Gaps = 28/196 (14%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTDV--AIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+D + L+ +G G++ V + + TD A++ +KK + + + E +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDE-DIDWV----QTEKHVF 106
Query: 1100 SK-LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL-RHVLLSKERHLD-RRKRLIIAMD 1156
+ +HP +V + Q L V E++ G L H + ++R L R A +
Sbjct: 107 EQASNHPFLVGLHSCFQTE--SRLFFVIEYVNGGDLMFH--MQRQRKLPEEHARFYSA-E 161
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR---- 1212
+ + YLH + I++ DLK DN+L++ + I K+ D+G+ K + G
Sbjct: 162 ISLALNYLHERGIIYRDLKLDNVLLDSEGHI----KLTDYGMCKEG----LRPGDTTSTF 213
Query: 1213 -GTLPWMAPELLNGSS 1227
GT ++APE+L G
Sbjct: 214 CGTPNYIAPEILRGED 229
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 5e-14
Identities = 53/209 (25%), Positives = 80/209 (38%), Gaps = 48/209 (22%)
Query: 1045 EELKELGSGTFGTV---YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 1101
+ LG G +G V H G VAIK+I F R TL RE +IL
Sbjct: 14 QLKSLLGEGAYGVVCSATHKP-TGEIVAIKKI--EPFDKPLFAL-R-TL---REIKILKH 65
Query: 1102 LHHPNVVAFYGVVQDGPGGTLAT---VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
H N++ + + + + E M + H ++S + D + I
Sbjct: 66 FKHENIITIFNIQRPDSFENFNEVYIIQELM--QTDLHRVISTQMLSDDHIQYFI----- 118
Query: 1159 F----GMEYLHSKNIVHFDLKCDNLLVN----LKDPIRPICKVGDFGLS-KIKRNTLVTG 1209
+ ++ LH N++H DLK NLL+N LK +C DFGL+ I +
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLK-----VC---DFGLARIIDESAADNS 170
Query: 1210 GVRGTLPWM----------APELLNGSSS 1228
G M APE++ S+
Sbjct: 171 EPTGQQSGMVEFVATRWYRAPEVMLTSAK 199
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 6e-14
Identities = 55/191 (28%), Positives = 83/191 (43%), Gaps = 29/191 (15%)
Query: 1047 LKELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
L+ +GSG +G V G VAIK++ + F + RE +L + H
Sbjct: 30 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-PFQSELFAKRAY-----RELRLLKHMRH 83
Query: 1105 PNVVAFYGVVQDGPGGTLAT------VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
NV+ V P TL V FM L ++ ++ DR + L+ M
Sbjct: 84 ENVIGLLDVFT--PDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQM--L 138
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLSKIKRNTLVTGGVRGTLP 1216
G+ Y+H+ I+H DLK NL VN C K+ DFGL++ + + TG V T
Sbjct: 139 KGLRYIHAAGIIHRDLKPGNLAVNED------CELKILDFGLARQADSEM-TGYV-VTRW 190
Query: 1217 WMAPELLNGSS 1227
+ APE++
Sbjct: 191 YRAPEVILNWM 201
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 6e-14
Identities = 55/193 (28%), Positives = 89/193 (46%), Gaps = 29/193 (15%)
Query: 1045 EELKELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
+ L +GSG +G+V G VA+K++ + F +S + T RE +L +
Sbjct: 32 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PF--QSIIHAKRTY---RELRLLKHM 85
Query: 1103 HHPNVVAFYGVVQDGPGGTLAT------VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
H NV+ V P +L VT M L +++ ++ D + LI +
Sbjct: 86 KHENVIGLLDVFT--PARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQI- 141
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLSKIKRNTLVTGGVRGT 1214
G++Y+HS +I+H DLK NL VN C K+ DFGL++ + + TG V T
Sbjct: 142 -LRGLKYIHSADIIHRDLKPSNLAVNED------CELKILDFGLARHTADEM-TGYV-AT 192
Query: 1215 LPWMAPELLNGSS 1227
+ APE++
Sbjct: 193 RWYRAPEIMLNWM 205
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 8e-14
Identities = 52/192 (27%), Positives = 88/192 (45%), Gaps = 30/192 (15%)
Query: 1047 LKELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
LK +GSG G V + +VAIK++ + F ++ + RE ++ ++H
Sbjct: 30 LKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PF--QNQTHAKRAY---RELVLMKCVNH 83
Query: 1105 PNVVAFYGVVQDGPGGTLAT------VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
N++ V P +L V E M + +L V+ + H +R L+ M
Sbjct: 84 KNIIGLLNVFT--PQKSLEEFQDVYIVMELM-DANLCQVIQMELDH-ERMSYLLYQM--L 137
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLS-KIKRNTLVTGGVRGTL 1215
G+++LHS I+H DLK N++V C K+ DFGL+ + ++T V T
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVKSD------CTLKILDFGLARTAGTSFMMTPYV-VTR 190
Query: 1216 PWMAPELLNGSS 1227
+ APE++ G
Sbjct: 191 YYRAPEVILGMG 202
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 71.8 bits (175), Expect = 2e-13
Identities = 42/246 (17%), Positives = 67/246 (27%), Gaps = 60/246 (24%)
Query: 1037 QIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREA 1096
+ E L+ +++G G FG V+ T VAIK I + ++ E E
Sbjct: 15 HCLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74
Query: 1097 EILSKLH---------HPNVVAFYG--VVQDG--------------------------PG 1119
I +L + VQ
Sbjct: 75 IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134
Query: 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK-NIVHFDLKCDN 1178
L V EF G + +K L K I + + H DL N
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTKLSSLATAKS--ILHQLTASLAVAEASLRFEHRDLHWGN 192
Query: 1179 LLVNLKDPIRPICKVG----------------DFGLSKIKRNTLVTGGVRGTLPWMAPEL 1222
+L+ + + D+ LS+++R+ G V M +L
Sbjct: 193 VLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIVVFCDVSMDEDL 248
Query: 1223 LNGSSS 1228
G
Sbjct: 249 FTGDGD 254
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 3e-13
Identities = 43/166 (25%), Positives = 68/166 (40%), Gaps = 29/166 (17%)
Query: 1045 EELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
E +G+G++G V + VAIK+I R E RE IL++L
Sbjct: 56 EIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI------LRVFEDLIDCKRILREIAILNRL 109
Query: 1103 HHPNVVAFYGVVQDGPGGTLAT---VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
+H +VV +V V E + + + + + + ++ +
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLL-----Y 163
Query: 1160 ----GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLS 1199
G++Y+HS I+H DLK N LVN C KV DFGL+
Sbjct: 164 NLLVGVKYVHSAGILHRDLKPANCLVNQD------CSVKVCDFGLA 203
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 4e-13
Identities = 46/187 (24%), Positives = 81/187 (43%), Gaps = 24/187 (12%)
Query: 1045 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
+ LK +GSG G V D VAIK++ + F ++ + RE ++ +
Sbjct: 65 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAY-----RELVLMKCV 118
Query: 1103 HHPNVVAFYGVVQDGPGGT----LATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
+H N+++ V + V E M + ++ E +R L+ M
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELM--DANLCQVIQMELDHERMSYLLYQMLC- 175
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLSKIKRNTLVTGGVRGTLP 1216
G+++LHS I+H DLK N++V C K+ DFGL++ + + T
Sbjct: 176 -GIKHLHSAGIIHRDLKPSNIVVKSD------CTLKILDFGLARTAGTSFMMTPYVVTRY 228
Query: 1217 WMAPELL 1223
+ APE++
Sbjct: 229 YRAPEVI 235
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 6e-13
Identities = 53/195 (27%), Positives = 87/195 (44%), Gaps = 29/195 (14%)
Query: 1045 EELKELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
L +G G +G V + VAIK+I S F ++ Q R TL RE +IL +
Sbjct: 30 TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQ-R-TL---REIKILLRF 82
Query: 1103 HHPNVVAFYGVVQDGPGGTLAT---VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
H N++ +++ + V + M L +L ++ D + +
Sbjct: 83 RHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQI--LR 139
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLSKI-----KRNTLVTGGVR 1212
G++Y+HS N++H DLK NLL+N C K+ DFGL+++ +T V
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTT------CDLKICDFGLARVADPDHDHTGFLTEYV- 192
Query: 1213 GTLPWMAPELLNGSS 1227
T + APE++ S
Sbjct: 193 ATRWYRAPEIMLNSK 207
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 1e-12
Identities = 39/168 (23%), Positives = 69/168 (41%), Gaps = 33/168 (19%)
Query: 1045 EELKELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
+G G++G VY + K +VAIK++ + F + R L RE IL++L
Sbjct: 29 IIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR-MFEDLIDCK-R-IL---REITILNRL 82
Query: 1103 HHPNVVAFYGVVQDGPGGTLAT---VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
++ Y ++ V E + L+ + + + + I+ +
Sbjct: 83 KSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTIL-----Y 136
Query: 1160 ----GMEYLHSKNIVHFDLKCDNLLVN----LKDPIRPICKVGDFGLS 1199
G ++H I+H DLK N L+N +K +C DFGL+
Sbjct: 137 NLLLGENFIHESGIIHRDLKPANCLLNQDCSVK-----VC---DFGLA 176
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-11
Identities = 51/205 (24%), Positives = 84/205 (40%), Gaps = 40/205 (19%)
Query: 1045 EELKELGSGTFGTV---YHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 1101
E +K+LG G +G V + G VA+K+I F + Q R T RE IL++
Sbjct: 12 ELVKKLGKGAYGIVWKSIDRR-TGEVVAVKKIFD-AFQNSTDAQ-R-TF---REIMILTE 64
Query: 1102 LH-HPNVVAFYGVVQDGPGGTLATVTEFM---VNGSLRHVLLSKERH------LDRRKRL 1151
L H N+V V++ + V ++M ++ +R +L L +
Sbjct: 65 LSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIK---- 120
Query: 1152 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC--KVGDFGLSKIKRNTLVTG 1209
++YLHS ++H D+K N+L+N + C KV DFGLS+ N
Sbjct: 121 --------VIKYLHSGGLLHRDMKPSNILLNAE------CHVKVADFGLSRSFVNIRRVT 166
Query: 1210 GVRGTLPWMAPELLNGSSSKVSEKV 1234
E + +++ V
Sbjct: 167 NNIPLSINENTENFDDDQPILTDYV 191
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 66.8 bits (162), Expect = 4e-11
Identities = 78/647 (12%), Positives = 176/647 (27%), Gaps = 155/647 (23%)
Query: 611 HGDSEAEPTNFSYNGPSAIP----------QRYHSEQIPRE---QTE-KNRLSKSDDSFG 656
H D E + Y + + +P+ + E + + D G
Sbjct: 6 HMDFETGEHQYQYK--DILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSG 63
Query: 657 SQFLISQALSDGSKPIRESVDKLHSGN----MASETEQSVAPAKQQ----------YTNL 702
+ L LS + +++ V+++ N M+ + P+ Y +
Sbjct: 64 TLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDN 123
Query: 703 QKVEDGHAQ-LRKHKEFADKINKINSNG--SEDGLQSSLGKSELTQVVPKSAD-----DC 754
Q + L+ + + + ++ DG+ S GK+ + V S D
Sbjct: 124 QVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGS-GKTWVALDVCLSYKVQCKMDF 182
Query: 755 EV--TKIRETVKDLSINDEEAAGLYHPTANHGTSGKNPEDSSLKQSEYEWNEIAAIKNNG 812
++ ++ ++ E L + + + I A
Sbjct: 183 KIFWLNLKNCNSPETVL-EMLQKLLY----QIDPNWTSRSDHSSNIKLRIHSIQAELRRL 237
Query: 813 NDNKGQAQSL-----AQKENSVRAVSPG--------DSSIA-VVSPEGDILIDINDR--- 855
+K L Q + A + + +S I ++
Sbjct: 238 LKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMT 297
Query: 856 FPRDFLSDIFTKA------RISENIAGVSPMHGD--GAVLSWNVENHDPRRWSYFRNLAQ 907
D + + K + + +P + W ++++
Sbjct: 298 LTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIR-----DGLATWDNWKHVNC 352
Query: 908 DEFSRKDVSLMDQDHLGFSSPLTNIEEGATVDYSYPPLK--PDGSVMPQSGSRINFDEGS 965
D+ + S L +E + L P + +P + + +
Sbjct: 353 DKLTTI-----------IESSLNVLEPAEYRKM-FDRLSVFPPSAHIPTILLSLIWFDVI 400
Query: 966 QRESSSIV----GPSTMETHPDYSRSELKG-----NESLQSEVVNHR-IQESDYEEGR-L 1014
+ + +V S +E P S + L++E HR I + Y +
Sbjct: 401 KSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDH-YNIPKTF 459
Query: 1015 DLPTAGIPLVDLALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIK 1074
D P +D + +G +H +K
Sbjct: 460 DSDDLIPPYLDQYFYSH------------------IG-------HH------------LK 482
Query: 1075 KSCFTGRSSEQERLTLEF-WREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGS 1133
R + + L+F + E K+ H + G L T+ +
Sbjct: 483 NIEHPERMTLFRMVFLDFRFLEQ----KIRHD------STAWNASGSILNTLQQLKF--- 529
Query: 1134 LRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSK--NIVHFDLKCDN 1178
+ + + +R I+ + SK +++ L ++
Sbjct: 530 YKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAED 576
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 59.5 bits (143), Expect = 6e-09
Identities = 79/580 (13%), Positives = 163/580 (28%), Gaps = 155/580 (26%)
Query: 10 MDQQKNYEQVRYSNVETRNEGPGSANQRFFHDPSSNINTNIRPPDYSMSGGVRPVLNYSI 69
MD + Q +Y ++ + E F + ++ D + +L
Sbjct: 7 MDFETGEHQYQYKDILSVFE------DAFVDNFDCK---DV--QDM-----PKSIL---- 46
Query: 70 QTGEEFALEFMRERVIPRQHFVPNAYGDPNNSPVYMDLKGVLGISHTGSESGSDITMLNA 129
+ EE M + + + V ++ VL I++ M
Sbjct: 47 -SKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINY-------KFLMSPI 98
Query: 130 AETGRAQELERKGPSGHEDRSYYDSM----RSVPR-----------TSSRNDMGRGTQGY 174
R + + DR Y D+ +V R R G
Sbjct: 99 KTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGV 158
Query: 175 ASSG----ASDSSRKVKFLCSFGGKILPRPSDGKLRYVGGETRIIRISRDISWQELTQKA 230
SG A D K C KI + + + S + + +
Sbjct: 159 LGSGKTWVALDVCLSYKVQCKMDFKIF---------W-------LNLKNCNSPETVLEML 202
Query: 231 LAIYNQTHTIKYQLPGEDLDALVSVSCDEDLQNMMEECNVLEDRGTQKPRMFLFSSADLE 290
+ Q +D + D N+ + ++ R L S E
Sbjct: 203 QKLLYQ------------IDPNWTSRSDHS-SNIKLRIHSIQAE----LRR-LLKSKPYE 244
Query: 291 DTQLSLESMEGDSEIQYVVAVNCMDLGSR----------KNSIALASASENNLDELLGLR 340
+ L L +++ +++ N +L + + ++ A+ + +LD
Sbjct: 245 NCLLVLLNVQ-NAKA-----WNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTL 298
Query: 341 VEREAGHIAAELAGSGATNLAYNASSSTIQSSQPVLVS-------SGSGYESNLQPYQGQ 393
E + + +L + ++ P +S G N +
Sbjct: 299 TPDEVKSLLLKYLDCRPQDL-----PREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCD 353
Query: 394 RMQH-ISSTLYPADGLPPLDVKSTTPLSTPLQHDYGSHPSNFATCGENVIPIPIPIHGQL 452
++ I S+L + L P + + + + + IP
Sbjct: 354 KLTTIIESSL---NVLEPAE----------YRKMF----DRLSVFPPSA-HIP------- 388
Query: 453 NQQGGLAEEKMYSGFHADDSEACAQEVKQKID--SLADKIKESEKIR--SLDKEASTKEQ 508
+ S D ++ V K+ SL +K + I S+ E K +
Sbjct: 389 --------TILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLE 440
Query: 509 KIKRDHSLPKINEIDNIRRS-ENDHVVSSHSYVSSVSNYI 547
H I + NI ++ ++D ++ + + Y
Sbjct: 441 NEYALHR--SIVDHYNIPKTFDSDDLIPPY-----LDQYF 473
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.7 bits (115), Expect = 1e-05
Identities = 56/354 (15%), Positives = 104/354 (29%), Gaps = 81/354 (22%)
Query: 907 QDEFSRKDVSLMD-QDHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFD--E 963
+D F + D QD S L+ E +D+ + D SG+ F
Sbjct: 26 EDAF-VDNFDCKDVQDMP--KSILSKEE----IDHII--MSKD----AVSGTLRLFWTLL 72
Query: 964 GSQRESSSIVGPSTMETH-PDYSRSELKGNESLQSEVVNHRIQESDYEEGRLDLPTAGIP 1022
Q +V E +Y L +++E + Y E R L
Sbjct: 73 SKQ---EEMVQKFVEEVLRINYKF--LM--SPIKTEQRQPSMMTRMYIEQRDRLYNDNQV 125
Query: 1023 LVDLALGNFDISTLQIIKNEDLEE-LKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGR 1081
+++S LQ L + L EL + G G+ K+
Sbjct: 126 FAK-----YNVSRLQPYLK--LRQALLELRPAKNVLI-DGV-LGSG-------KTWVALD 169
Query: 1082 SSEQERLTLE-----FW------REA----EILSKLHHPNVVAFYGVVQDGPGGTLATVT 1126
++ + FW E+L KL + + + D +
Sbjct: 170 VCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLY-QIDPNWTSRSDHSSNIKLRIH 228
Query: 1127 EFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIV-HFDLKCDNLLVNLKD 1185
+ LR LL + + L++ ++ + + F+L C +L+ +
Sbjct: 229 S--IQAELRR-LLKSKPY---ENCLLVLLN-------VQNAKAWNAFNLSC-KILLTTRF 274
Query: 1186 PIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPEL----LNGSSSKVSEKVC 1235
+V DF + + + P L L+ + +V
Sbjct: 275 K-----QVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVL 323
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 43/171 (25%), Positives = 70/171 (40%), Gaps = 39/171 (22%)
Query: 1048 KELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH- 1104
+++GSG+FG +Y G G +VAIK + + L E++I +
Sbjct: 15 RKIGSGSFGDIYLGTDIAAGEEVAIKLECV--------KTKHPQLH--IESKIYKMMQGG 64
Query: 1105 ---PNVVAF------YGVVQD--GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 1153
P + +V + GP SL + R + L++
Sbjct: 65 VGIPTIRWCGAEGDYNVMVMELLGP--------------SLEDLFNFCSRKFSLKTVLLL 110
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN 1204
A +EY+HSKN +H D+K DN L+ L + + DFGL+K R+
Sbjct: 111 ADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYII-DFGLAKKYRD 160
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 44/169 (26%), Positives = 69/169 (40%), Gaps = 33/169 (19%)
Query: 1048 KELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH- 1104
K++G G FG + GK + VAIK S +L LE +R + L
Sbjct: 15 KKIGCGNFGELRLGKNLYTNEYVAIK------LEPMKSRAPQLHLE-YRFYKQLGSGDGI 67
Query: 1105 PNVVAF------YGVVQD--GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
P V F +V + GP SL + +R + L+IA+
Sbjct: 68 PQVYYFGPCGKYNAMVLELLGP--------------SLEDLFDLCDRTFSLKTVLMIAIQ 113
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP-ICKVGDFGLSKIKRN 1204
MEY+HSKN+++ D+K +N L+ + + DF L+K +
Sbjct: 114 LISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 8e-10
Identities = 32/170 (18%), Positives = 55/170 (32%), Gaps = 25/170 (14%)
Query: 1048 KELGSGTFGTVYHG-KWRGTDVAIKRIKKSCFTGRSSEQ------------ERLTLEFWR 1094
+G G FG +Y V + + ++ W
Sbjct: 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100
Query: 1095 EAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMV----NGSLRHVLLSKERHLDRRKR 1150
L L P G FM+ L+ + + + R+
Sbjct: 101 RTRKLKYLGVPKYWGS------GLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTV 154
Query: 1151 LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200
L +++ +EY+H VH D+K NLL+N K+P + D+GL+
Sbjct: 155 LQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP--DQVYLVDYGLAY 202
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 38/254 (14%), Positives = 73/254 (28%), Gaps = 66/254 (25%)
Query: 978 METHPDYSRSELKGNESLQSEVVNHRIQESDYEEGRLDLPTAGIPLVDLALGNFDISTLQ 1037
M H +S G E+L + + ++ LP G L D + + +
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMTTSLEA---------LP-TGTVLTDKSGRQWKL---- 46
Query: 1038 IIKNEDLEELKELGSGTFGTVYHG----------KWRGTDVAIK--RIKKSCFTGRSSEQ 1085
G +Y + ++K F ++ Q
Sbjct: 47 ---------KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQ 97
Query: 1086 ERLTLEFWREAEILSKLHHPNVVAFYG----------VVQDGPGGTLATVTEFMVNG--- 1132
+ + L + G +V G +L + V+
Sbjct: 98 RAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSA--LDVSPKHV 155
Query: 1133 -SLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 1191
S R VL R LD +E+LH VH ++ +N+ V+ +D +
Sbjct: 156 LSERSVLQVACRLLDA-------------LEFLHENEYVHGNVTAENIFVDPED--QSQV 200
Query: 1192 KVGDFGLSKIKRNT 1205
+ +G + +
Sbjct: 201 TLAGYGFAFRYCPS 214
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 5e-09
Identities = 39/173 (22%), Positives = 63/173 (36%), Gaps = 41/173 (23%)
Query: 1048 KELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH- 1104
+ +G G+FG ++ G VAIK R S+ +L E L
Sbjct: 16 RRIGEGSFGVIFEGTNLLNNQQVAIKFEP------RRSDAPQLR----DEYRTYKLLAGC 65
Query: 1105 ---PNVVAFYGVVQD---------GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI 1152
PNV ++G GP SL +L R + +
Sbjct: 66 TGIPNVY-YFGQEGLHNVLVIDLLGP--------------SLEDLLDLCGRKFSVKTVAM 110
Query: 1153 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP-ICKVGDFGLSKIKRN 1204
A ++ +H K++V+ D+K DN L+ + + V DFG+ K R+
Sbjct: 111 AAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 58.5 bits (141), Expect = 8e-09
Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 19/162 (11%)
Query: 1048 KELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-H 1104
+++GSG+FG +Y G +VAIK + + L E++I L
Sbjct: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENV--------KTKHPQLL--YESKIYRILQGG 62
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNG-SLRHVLLSKERHLDRRKRLIIAMDAAFGMEY 1163
+ +G L V + + G SL + R L + L++A +E+
Sbjct: 63 TGIPNVRWFGVEGDYNVL--VMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 118
Query: 1164 LHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT 1205
+HSK+ +H D+K DN L+ L + + DFGL+K R+T
Sbjct: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYII-DFGLAKKYRDT 159
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-08
Identities = 42/187 (22%), Positives = 70/187 (37%), Gaps = 29/187 (15%)
Query: 1036 LQIIKNEDL----EELKELGSGTFGTVY--HGKWRGTDVAIKRIK-KSCFTGRSSEQERL 1088
+ ++ + E LK +G G+FG V + VA+K ++ + F Q
Sbjct: 87 YVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFH----RQAAE 142
Query: 1089 TLEFWREAEILSKL------HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL-LSK 1141
E IL L + NV+ + E + + +L ++ +K
Sbjct: 143 ------EIRILEHLRKQDKDNTMNVIHMLENFTFR--NHICMTFELL-SMNLYELIKKNK 193
Query: 1142 ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201
+ A ++ LH I+H DLK +N+L LK R KV DFG S
Sbjct: 194 FQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENIL--LKQQGRSGIKVIDFGSSCY 251
Query: 1202 KRNTLVT 1208
+ + T
Sbjct: 252 EHQRVYT 258
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 2e-08
Identities = 38/169 (22%), Positives = 73/169 (43%), Gaps = 23/169 (13%)
Query: 1047 LKELGSGTFGTVYHGKWR------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100
+++LG G F TV W T VA+K ++ ++E E L+ +A+
Sbjct: 24 VRKLGWGHFSTV----WLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 79
Query: 1101 KLH--HPNVVAFYGVVQ-DGPGGT-LATVTEFMVNGSLRHVL-LSKER--HLDRRKRLII 1153
+ +++ GP G + V E + +L ++ + R L K+ I
Sbjct: 80 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ--I 136
Query: 1154 AMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDP--IRPICKVGDFGLS 1199
+ G++Y+H + I+H D+K +N+L+ + D K+ D G +
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 39/170 (22%), Positives = 61/170 (35%), Gaps = 28/170 (16%)
Query: 1048 KELGSGTFGTVYHGK--WRGTDVAIKRIKKSCFTGRSSEQERLTLEF------------- 1092
K++GSG FG +Y + A +K E L E
Sbjct: 43 KKIGSGGFGLIYLAFPTNKPEKDARHVVKV-----EYQENGPLFSELKFYQRVAKKDCIK 97
Query: 1093 -WREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNG-SLRHVLLSKERHLDRRKR 1150
W E + L L P G+ + V E + G L+ + + +
Sbjct: 98 KWIERKQLDYLGIPLFY-GSGLTEFKGRSYRFMVMERL--GIDLQK-ISGQNGTFKKSTV 153
Query: 1151 LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200
L + + +EY+H VH D+K NLL+ K+P + D+GLS
Sbjct: 154 LQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNP--DQVYLADYGLSY 201
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 38/155 (24%), Positives = 64/155 (41%), Gaps = 26/155 (16%)
Query: 1047 LKELGSGTFGTVY--HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-- 1102
+++LG G F TV+ VA+K + KS + E +L +
Sbjct: 42 IRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETAL--------DEIRLLKSVRN 92
Query: 1103 ---HHPN---VVAFYGVVQ-DGPGGT-LATVTEFMVNG-SLRHVL-LSKERHLDRRKRLI 1152
+ PN VV + G GT + V E + G L + S + L
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL--GHHLLKWIIKSNYQGLPLPCVKK 150
Query: 1153 IAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDP 1186
I G++YLH+K I+H D+K +N+L+++ +
Sbjct: 151 IIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQ 185
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 1e-05
Identities = 44/187 (23%), Positives = 71/187 (37%), Gaps = 27/187 (14%)
Query: 1036 LQIIKNEDL----EELKELGSGTFGTVYHGKWRGTD--VAIKRIK-KSCFTGRSSEQERL 1088
+ E E +G G+FG V R VAIK IK K F ++ E
Sbjct: 44 YIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFL-NQAQIEVR 102
Query: 1089 TLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER----- 1143
LE + + K + +V L V E + + +L +L +
Sbjct: 103 LLELMNKHDTEMKYY---IVHLKRHFMFR--NHLCLVFEML-SYNLYDLL--RNTNFRGV 154
Query: 1144 HLDRRKRLIIAMDAAFGMEYLHSK--NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201
L+ ++ A + +L + +I+H DLK +N+L L +P R K+ DFG S
Sbjct: 155 SLNLTRK--FAQQMCTALLFLATPELSIIHCDLKPENIL--LCNPKRSAIKIVDFGSSCQ 210
Query: 1202 KRNTLVT 1208
+
Sbjct: 211 LGQRIYQ 217
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 6e-04
Identities = 43/203 (21%), Positives = 68/203 (33%), Gaps = 65/203 (32%)
Query: 1036 LQIIKNEDLEE----LKELGSGTFGTV---YHGKWRGTDVAIKRIK-KSCFTGRSSEQER 1087
L + L + LG G FG V K G VA+K +K + E R
Sbjct: 4 LICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYC----EAAR 59
Query: 1088 LTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLAT---------VTEFMVNGSLRHVL 1138
E ++L L+ + + + VQ L V E ++ S +
Sbjct: 60 S------EIQVLEHLNTTDPNSTFRCVQ-----MLEWFEHHGHICIVFE-LLGLSTYDFI 107
Query: 1139 ---------LSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVN------- 1182
L R + ++ +++ +LHS + H DLK +N+L
Sbjct: 108 KENGFLPFRLDHIRKM--AYQICKSVN------FLHSNKLTHTDLKPENILFVQSDYTEA 159
Query: 1183 --------LKDPIRPICKVGDFG 1197
+ I P KV DFG
Sbjct: 160 YNPKIKRDERTLINPDIKVVDFG 182
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1236 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-47 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-45 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-45 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 9e-45 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-44 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-44 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-43 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-43 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-43 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 8e-43 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-42 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-42 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-41 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-40 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-40 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-40 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-39 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-39 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-39 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-39 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-38 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-38 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-38 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-38 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-38 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 9e-38 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-37 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-37 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-37 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-37 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-37 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-37 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 9e-37 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-36 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-36 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-34 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-34 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-34 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-34 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-34 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-33 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-33 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-33 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-32 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-32 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-32 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-32 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-31 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-31 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-31 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-31 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-29 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-29 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-29 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-29 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-28 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-27 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-27 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-26 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-24 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-21 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-18 | |
| d1ip9a_ | 85 | d.15.2.2 (A:) Bud emergence mediator Bemp1 {Baker' | 2e-05 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 1e-47
Identities = 65/200 (32%), Positives = 102/200 (51%), Gaps = 18/200 (9%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
I + + + +GSG+FGTVY GKW G DVA+K + + T + + F E +
Sbjct: 5 IPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQ------AFKNEVGV 57
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
L K H N++ F G LA VT++ SL H L E + K + IA A
Sbjct: 58 LRKTRHVNILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTA 114
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK---RNTLVTGGVRGTL 1215
GM+YLH+K+I+H DLK +N+ ++ + K+GDFGL+ +K + + G++
Sbjct: 115 QGMDYLHAKSIIHRDLKSNNIFLHEDLTV----KIGDFGLATVKSRWSGSHQFEQLSGSI 170
Query: 1216 PWMAPELLNG-SSSKVSEKV 1234
WMAPE++ + S +
Sbjct: 171 LWMAPEVIRMQDKNPYSFQS 190
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 1e-45
Identities = 55/199 (27%), Positives = 96/199 (48%), Gaps = 20/199 (10%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREA 1096
+K++D E++ ELG+G G V+ + + +A K I + + + RE
Sbjct: 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-------IKPAIRNQIIREL 55
Query: 1097 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
++L + + P +V FYG G ++ E M GSL +L K + + +++
Sbjct: 56 QVLHECNSPYIVGFYGAFYS--DGEISICMEHMDGGSLDQ-VLKKAGRIPEQILGKVSIA 112
Query: 1157 AAFGMEYLHSKN-IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTL 1215
G+ YL K+ I+H D+K N+LVN + I K+ DFG+S +++ V GT
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEI----KLCDFGVSGQLIDSMANSFV-GTR 167
Query: 1216 PWMAPELLNGSSSKVSEKV 1234
+M+PE L G + S +
Sbjct: 168 SYMSPERLQG--THYSVQS 184
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 6e-45
Identities = 70/197 (35%), Positives = 99/197 (50%), Gaps = 20/197 (10%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
+ ++L+ L+ +G G FG V G +RG VA+K IK + + F EA +
Sbjct: 4 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKN------DATAQA----FLAEASV 53
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH-LDRRKRLIIAMDA 1157
+++L H N+V GV+ + GG L VTE+M GSL L S+ R L L ++D
Sbjct: 54 MTQLRHSNLVQLLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 112
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPW 1217
MEYL N VH DL N+LV+ + + KV DFGL+K +T TG + + W
Sbjct: 113 CEAMEYLEGNNFVHRDLAARNVLVSEDN----VAKVSDFGLTKEASSTQDTG--KLPVKW 166
Query: 1218 MAPELLNGSSSKVSEKV 1234
APE L K S K
Sbjct: 167 TAPEALRE--KKFSTKS 181
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 9e-45
Identities = 73/200 (36%), Positives = 96/200 (48%), Gaps = 20/200 (10%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
I +DL LKELG+G FG V +GKWR DVAIK IK+ S E EF EA+
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG------SMSED---EFIEEAK 51
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 1157
++ L H +V YGV + +TE+M NG L + L ++ L + D
Sbjct: 52 VMMNLSHEKLVQLYGVCTKQ--RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 109
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KRNTLVTGGVRGTL 1215
MEYL SK +H DL N LVN + + KV DFGLS+ + G + +
Sbjct: 110 CEAMEYLESKQFLHRDLAARNCLVNDQG----VVKVSDFGLSRYVLDDEYTSSVGSKFPV 165
Query: 1216 PWMAPELLNGSSSKVSEKVC 1235
W PE+L SK S K
Sbjct: 166 RWSPPEVLMY--SKFSSKSD 183
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (410), Expect = 1e-44
Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 21/204 (10%)
Query: 1032 DISTLQIIKNEDLEE----LKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQ 1085
D ++ +D E+ L+E+G G+FG VY + VAIK++ S Q
Sbjct: 1 DPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ 60
Query: 1086 ERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHL 1145
+ +E L KL HPN + + G T V E+ + + + + K + L
Sbjct: 61 D-----IIKEVRFLQKLRHPNTIQYRGCYLRE--HTAWLVMEYCLGSASDLLEVHK-KPL 112
Query: 1146 DRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT 1205
+ + A G+ YLHS N++H D+K N+L++ + K+GDFG + I
Sbjct: 113 QEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG----LVKLGDFGSASIMAP- 167
Query: 1206 LVTGGVRGTLPWMAPELLNGSSSK 1229
GT WMAPE++
Sbjct: 168 --ANSFVGTPYWMAPEVILAMDEG 189
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 8e-44
Identities = 59/193 (30%), Positives = 90/193 (46%), Gaps = 20/193 (10%)
Query: 1048 KELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHP 1105
E+G G+F TVY G T VA ++ T ++ F EAE+L L HP
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQR------FKEEAEMLKGLQHP 68
Query: 1106 NVVAFYGVVQDGP--GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEY 1163
N+V FY + + VTE M +G+L+ L + + + + G+++
Sbjct: 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKT-YLKRFKVMKIKVLRSWCRQILKGLQF 127
Query: 1164 LHSKN--IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPE 1221
LH++ I+H DLKCDN+ + K+GD GL+ +KR + V GT +MAPE
Sbjct: 128 LHTRTPPIIHRDLKCDNIFITGPT---GSVKIGDLGLATLKRASF-AKAVIGTPEFMAPE 183
Query: 1222 LLNGSSSKVSEKV 1234
+ K E V
Sbjct: 184 MYEE---KYDESV 193
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 4e-43
Identities = 58/191 (30%), Positives = 92/191 (48%), Gaps = 20/191 (10%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
+ E L+ ++ LG+G FG V+ G + T VA+K +K+ + F EA
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---------AFLAEAN 60
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER-HLDRRKRLIIAMD 1156
++ +L H +V Y VV P + +TE+M NGSL L + L K L +A
Sbjct: 61 LMKQLQHQRLVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KRNTLVTGGVRGT 1214
A GM ++ +N +H DL+ N+LV+ CK+ DFGL+++ G +
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVS----DTLSCKIADFGLARLIEDNEYTAREGAKFP 173
Query: 1215 LPWMAPELLNG 1225
+ W APE +N
Sbjct: 174 IKWTAPEAINY 184
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 4e-43
Identities = 59/200 (29%), Positives = 88/200 (44%), Gaps = 21/200 (10%)
Query: 1037 QIIKNEDLEE----LKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTL 1090
+ ++ + E+ + ELG G FG VY + + T A K I SE+E
Sbjct: 3 HVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK------SEEELE-- 54
Query: 1091 EFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKR 1150
++ E +IL+ HPN+V L + EF G++ V+L ER L +
Sbjct: 55 DYMVEIDILASCDHPNIVKLLDAFYYE--NNLWILIEFCAGGAVDAVMLELERPLTESQI 112
Query: 1151 LIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTG 1209
++ + YLH I+H DLK N+L L I K+ DFG+S R
Sbjct: 113 QVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDI----KLADFGVSAKNTRTIQRRD 168
Query: 1210 GVRGTLPWMAPELLNGSSSK 1229
GT WMAPE++ +SK
Sbjct: 169 SFIGTPYWMAPEVVMCETSK 188
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 7e-43
Identities = 56/195 (28%), Positives = 92/195 (47%), Gaps = 17/195 (8%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
ED E + LG G FG VY + + + +A+K + K+ E+ + + RE EI
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-----QLEKAGVEHQLRREVEIQ 60
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
S L HPN++ YG D + + E+ G++ L K D ++ + A
Sbjct: 61 SHLRHPNILRLYGYFHDA--TRVYLILEYAPLGTVYR-ELQKLSKFDEQRTATYITELAN 117
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMA 1219
+ Y HSK ++H D+K +NLL+ + K+ DFG S ++ + GTL ++
Sbjct: 118 ALSYCHSKRVIHRDIKPENLLLGSAGEL----KIADFGWSVHAPSSR-RTTLCGTLDYLP 172
Query: 1220 PELLNGSSSKVSEKV 1234
PE++ G EKV
Sbjct: 173 PEMIEG--RMHDEKV 185
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 8e-43
Identities = 61/197 (30%), Positives = 88/197 (44%), Gaps = 21/197 (10%)
Query: 1038 IIKNEDLEELKELGSGTFGTVYHGKWRGTD-----VAIKRIKKSCFTGRSSEQERLTLEF 1092
+I +DL L++LG G+FG V G+W VA+K +K + + +F
Sbjct: 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-----DF 58
Query: 1093 WREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI 1152
RE + L H N++ YGVV P + VTE GSL L + H
Sbjct: 59 IREVNAMHSLDHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSR 115
Query: 1153 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI----KRNTLVT 1208
A+ A GM YL SK +H DL NLL+ +D + K+GDFGL + + ++
Sbjct: 116 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLV----KIGDFGLMRALPQNDDHYVMQ 171
Query: 1209 GGVRGTLPWMAPELLNG 1225
+ W APE L
Sbjct: 172 EHRKVPFAWCAPESLKT 188
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (389), Expect = 3e-42
Identities = 50/204 (24%), Positives = 88/204 (43%), Gaps = 23/204 (11%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
ED E L +G+G++G + + + K + T + E +L
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQM------LVSEVNLL 57
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER---HLDRRKRLIIAMD 1156
+L HPN+V +Y + D TL V E+ G L V+ + +LD L +
Sbjct: 58 RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 117
Query: 1157 AAFGMEYLHSKN-----IVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTGG 1210
++ H ++ ++H DLK N+ ++ K + K+GDFGL++ + +T
Sbjct: 118 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNV----KLGDFGLARILNHDTSFAKA 173
Query: 1211 VRGTLPWMAPELLNGSSSKVSEKV 1234
GT +M+PE +N +EK
Sbjct: 174 FVGTPYYMSPEQMNR--MSYNEKS 195
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 7e-42
Identities = 59/200 (29%), Positives = 92/200 (46%), Gaps = 20/200 (10%)
Query: 1038 IIKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREA 1096
+I +L ++E+GSG FG V+ G W VAIK I++ + +F EA
Sbjct: 1 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---------DFIEEA 51
Query: 1097 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
E++ KL HP +V YGV + + V EFM +G L L ++ L + +D
Sbjct: 52 EVMMKLSHPKLVQLYGVCLEQ--APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 109
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KRNTLVTGGVRGT 1214
GM YL ++H DL N LV + KV DFG+++ + G +
Sbjct: 110 VCEGMAYLEEACVIHRDLAARNCLVG----ENQVIKVSDFGMTRFVLDDQYTSSTGTKFP 165
Query: 1215 LPWMAPELLNGSSSKVSEKV 1234
+ W +PE+ + S+ S K
Sbjct: 166 VKWASPEVFSF--SRYSSKS 183
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 4e-41
Identities = 62/197 (31%), Positives = 86/197 (43%), Gaps = 23/197 (11%)
Query: 1038 IIKNEDLEELK-ELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTLEF 1092
+K ++L ELG G FG+V G +R DVAIK +K+ ++ T E
Sbjct: 4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-------TEKADTEEM 56
Query: 1093 WREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI 1152
REA+I+ +L +P +V GV Q L V E G L L+ K +
Sbjct: 57 MREAQIMHQLDNPYIVRLIGVCQAEA---LMLVMEMAGGGPLHKFLVGKREEIPVSNVAE 113
Query: 1153 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI----KRNTLVT 1208
+ + GM+YL KN VH DL N+L+ R K+ DFGLSK
Sbjct: 114 LLHQVSMGMKYLEEKNFVHRDLAARNVLLVN----RHYAKISDFGLSKALGADDSYYTAR 169
Query: 1209 GGVRGTLPWMAPELLNG 1225
+ L W APE +N
Sbjct: 170 SAGKWPLKWYAPECINF 186
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 151 bits (383), Expect = 1e-40
Identities = 42/188 (22%), Positives = 82/188 (43%), Gaps = 14/188 (7%)
Query: 1041 NEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
+ + L+ELGSG FG V+ + T K I ++ E I
Sbjct: 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKYT----VKNEISI 79
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
+++LHHP ++ + +D + + EF+ G L + +++ + + + A
Sbjct: 80 MNQLHHPKLINLHDAFEDK--YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQAC 137
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWM 1218
G++++H +IVH D+K +N++ K K+ DFGL+ + T +
Sbjct: 138 EGLKHMHEHSIVHLDIKPENIMCETKKA--SSVKIIDFGLATKLNPDEIVKVTTATAEFA 195
Query: 1219 APELLNGS 1226
APE+++
Sbjct: 196 APEIVDRE 203
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 2e-40
Identities = 54/212 (25%), Positives = 94/212 (44%), Gaps = 25/212 (11%)
Query: 1034 STLQIIKNEDLEELKELGSGTFGTVYHGKWRGTD------VAIKRIKKSCFTGRSSEQER 1087
+ L+I+K + +++K LGSG FGTVY G W VAIK ++++ +
Sbjct: 1 ALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-------TSPK 53
Query: 1088 LTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDR 1147
E EA +++ + +P+V G+ T+ +T+ M G L + + ++
Sbjct: 54 ANKEILDEAYVMASVDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGS 110
Query: 1148 RKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI---KRN 1204
+ L + A GM YL + +VH DL N+LV K+ DFGL+K+ +
Sbjct: 111 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK----TPQHVKITDFGLAKLLGAEEK 166
Query: 1205 TLVTGGVRGTLPWMAPELLNGSSSKVSEKVCF 1236
G + + WMA E + + +
Sbjct: 167 EYHAEGGKVPIKWMALESILH--RIYTHQSDV 196
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 2e-40
Identities = 54/189 (28%), Positives = 84/189 (44%), Gaps = 19/189 (10%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
ED + ++ LG G +G V R T+ VA+K + R+ + +E I
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK----RAVDCPE---NIKKEICIN 57
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
L+H NVV FYG + G E+ G L + + +
Sbjct: 58 KMLNHENVVKFYGHRR--EGNIQYLFLEYCSGGELFD-RIEPDIGMPEPDAQRFFHQLMA 114
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR---NTLVTGGVRGTLP 1216
G+ YLH I H D+K +NLL++ +D + K+ DFGL+ + R + + GTLP
Sbjct: 115 GVVYLHGIGITHRDIKPENLLLDERDNL----KISDFGLATVFRYNNRERLLNKMCGTLP 170
Query: 1217 WMAPELLNG 1225
++APELL
Sbjct: 171 YVAPELLKR 179
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 148 bits (375), Expect = 1e-39
Identities = 46/187 (24%), Positives = 77/187 (41%), Gaps = 14/187 (7%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+ + +ELG+G FG V+ R T A K + S++E +E + +
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKET----VRKEIQTM 77
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
S L HP +V + +D + + EFM G L + + + + +
Sbjct: 78 SVLRHPTLVNLHDAFEDD--NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK 135
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMA 1219
G+ ++H N VH DLK +N++ K K+ DFGL+ GT + A
Sbjct: 136 GLCHMHENNYVHLDLKPENIMFTTKRSNE--LKLIDFGLTAHLDPKQSVKVTTGTAEFAA 193
Query: 1220 PELLNGS 1226
PE+ G
Sbjct: 194 PEVAEGK 200
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 3e-39
Identities = 55/190 (28%), Positives = 83/190 (43%), Gaps = 23/190 (12%)
Query: 1044 LEELKELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
LE+ KELGSG FGTV G ++ VA+K +K + L E EA ++
Sbjct: 10 LED-KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE------ANDPALKDELLAEANVM 62
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
+L +P +V G+ + V E G L L + RH+ + + + +
Sbjct: 63 QQLDNPYIVRMIGICEAES---WMLVMEMAELGPLNK-YLQQNRHVKDKNIIELVHQVSM 118
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI----KRNTLVTGGVRGTL 1215
GM+YL N VH DL N+L+ + K+ DFGLSK + + +
Sbjct: 119 GMKYLEESNFVHRDLAARNVLLVTQH----YAKISDFGLSKALRADENYYKAQTHGKWPV 174
Query: 1216 PWMAPELLNG 1225
W APE +N
Sbjct: 175 KWYAPECINY 184
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 3e-39
Identities = 55/194 (28%), Positives = 88/194 (45%), Gaps = 21/194 (10%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTD-----VAIKRIKKSCFTGRSSEQERLTLEFW 1093
I+ E +E + +G G FG V+ G + + VAIK K + + +F
Sbjct: 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-------TSDSVREKFL 56
Query: 1094 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 1153
+EA + + HP++V GV+ + P + + E G LR L ++ LD ++
Sbjct: 57 QEALTMRQFDHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILY 113
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KRNTLVTGGV 1211
A + + YL SK VH D+ N+LV+ D K+GDFGLS+
Sbjct: 114 AYQLSTALAYLESKRFVHRDIAARNVLVSSND----CVKLGDFGLSRYMEDSTYYKASKG 169
Query: 1212 RGTLPWMAPELLNG 1225
+ + WMAPE +N
Sbjct: 170 KLPIKWMAPESINF 183
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 145 bits (366), Expect = 4e-39
Identities = 62/202 (30%), Positives = 89/202 (44%), Gaps = 22/202 (10%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREA 1096
++ D+ +LG G +G VY G W+ VA+K +K+ EF +EA
Sbjct: 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---------EFLKEA 64
Query: 1097 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKER-HLDRRKRLIIAM 1155
++ ++ HPN+V GV P +TEFM G+L L R + L +A
Sbjct: 65 AVMKEIKHPNLVQLLGVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 122
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN--TLVTGGVRG 1213
+ MEYL KN +H DL N LV + KV DFGLS++ G +
Sbjct: 123 QISSAMEYLEKKNFIHRDLAARNCLVGENH----LVKVADFGLSRLMTGDTYTAHAGAKF 178
Query: 1214 TLPWMAPELLNGSSSKVSEKVC 1235
+ W APE L +K S K
Sbjct: 179 PIKWTAPESLAY--NKFSIKSD 198
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 2e-38
Identities = 57/194 (29%), Positives = 84/194 (43%), Gaps = 17/194 (8%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREA 1096
+ ED + K LG G+F TV + T AIK ++K R +E RE
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEK-----RHIIKENKVPYVTRER 59
Query: 1097 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
+++S+L HP V Y QD L + NG L + K D +
Sbjct: 60 DVMSRLDHPFFVKLYFTFQDD--EKLYFGLSYAKNGELLK-YIRKIGSFDETCTRFYTAE 116
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI---KRNTLVTGGVRG 1213
+EYLH K I+H DLK +N+L+N I ++ DFG +K+ + G
Sbjct: 117 IVSALEYLHGKGIIHRDLKPENILLNEDMHI----QITDFGTAKVLSPESKQARANSFVG 172
Query: 1214 TLPWMAPELLNGSS 1227
T +++PELL S
Sbjct: 173 TAQYVSPELLTEKS 186
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 3e-38
Identities = 55/195 (28%), Positives = 92/195 (47%), Gaps = 11/195 (5%)
Query: 1038 IIKNEDLEE----LKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLE 1091
+ + E++++ +ELGSG F V + + T A K IKK SS + +
Sbjct: 2 VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTK--SSRRGVSRED 59
Query: 1092 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL 1151
RE IL ++ HPNV+ + V ++ + + E + G L L KE +
Sbjct: 60 IEREVSILKEIQHPNVITLHEVYENK--TDVILILELVAGGELFDFLAEKESLTEEEATE 117
Query: 1152 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGV 1211
+ G+ YLHS I HFDLK +N+++ ++ +P K+ DFGL+ +
Sbjct: 118 FLKQ-ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 176
Query: 1212 RGTLPWMAPELLNGS 1226
GT ++APE++N
Sbjct: 177 FGTPEFVAPEIVNYE 191
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 3e-38
Identities = 63/230 (27%), Positives = 90/230 (39%), Gaps = 48/230 (20%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTD-------VAIKRIKKSCFTGRSSEQERLTLE 1091
E+LE K LGSG FG V + G VA+K +K+ ++ ER
Sbjct: 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE-----KADSSERE--A 86
Query: 1092 FWREAEILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH------ 1144
E +++++L H N+V G G + + E+ G L + L SK
Sbjct: 87 LMSELKMMTQLGSHENIVNLLGACTLS--GPIYLIFEYCCYGDLLNYLRSKREKFSEDEI 144
Query: 1145 ----------------LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIR 1188
L L A A GME+L K+ VH DL N+LV
Sbjct: 145 EYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK--- 201
Query: 1189 PICKVGDFGLSKI---KRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVC 1235
+ K+ DFGL++ N +V G R + WMAPE L + K
Sbjct: 202 -VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE--GIYTIKSD 248
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 5e-38
Identities = 63/200 (31%), Positives = 92/200 (46%), Gaps = 22/200 (11%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTD-VAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
I E L +LG G FG V+ G W GT VAIK +K + F +EA+
Sbjct: 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---------AFLQEAQ 64
Query: 1098 ILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSL-RHVLLSKERHLDRRKRLIIAMD 1156
++ KL H +V Y VV + P + VTE+M GSL + ++L + + +A
Sbjct: 65 VMKKLRHEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 121
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI--KRNTLVTGGVRGT 1214
A GM Y+ N VH DL+ N+LV +CKV DFGL+++ G +
Sbjct: 122 IASGMAYVERMNYVHRDLRAANILVG----ENLVCKVADFGLARLIEDNEYTARQGAKFP 177
Query: 1215 LPWMAPELLNGSSSKVSEKV 1234
+ W APE + + K
Sbjct: 178 IKWTAPEAALY--GRFTIKS 195
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 9e-38
Identities = 47/190 (24%), Positives = 85/190 (44%), Gaps = 19/190 (10%)
Query: 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
+ +++G G GTVY G +VAI+++ + ++E E +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ----QQPKKEL----IINEILV 70
Query: 1099 LSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
+ + +PN+V + G L V E++ GSL V+ E +D + + +
Sbjct: 71 MRENKNPNIVNYLDSYLVG--DELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECL 126
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTGGVRGTLPW 1217
+E+LHS ++H D+K DN+L+ + + K+ DFG I + GT W
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDGSV----KLTDFGFCAQITPEQSKRSTMVGTPYW 182
Query: 1218 MAPELLNGSS 1227
MAPE++ +
Sbjct: 183 MAPEVVTRKA 192
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 9e-38
Identities = 62/222 (27%), Positives = 81/222 (36%), Gaps = 35/222 (15%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLE 1091
L K LG+G FG V VA+K +K S + ER
Sbjct: 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-----AHLTERE--A 72
Query: 1092 FWREAEILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSK--------- 1141
E ++LS L +H N+V G G G +TE+ G L + L K
Sbjct: 73 LMSELKVLSYLGNHMNIVNLLGACTIG--GPTLVITEYCCYGDLLNFLRRKRDSFICSKT 130
Query: 1142 --------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193
E LD L + A GM +L SKN +H DL N+L+ I IC
Sbjct: 131 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT-HGRITKICDF 189
Query: 1194 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVC 1235
G K N +V G R + WMAPE + V
Sbjct: 190 GLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 231
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 141 bits (356), Expect = 1e-37
Identities = 56/192 (29%), Positives = 84/192 (43%), Gaps = 17/192 (8%)
Query: 1040 KNEDLEE----LKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFW 1093
+ ED+ + LG+G F V + + T VAIK I K G+
Sbjct: 3 QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGS-------ME 55
Query: 1094 REAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 1153
E +L K+ HPN+VA + + GG L + + + G L + ++ R +
Sbjct: 56 NEIAVLHKIKHPNIVALDDIYES--GGHLYLIMQLVSGGELFD-RIVEKGFYTERDASRL 112
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRG 1213
++YLH IVH DLK +NLL D I + DFGLSK++ V G
Sbjct: 113 IFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKI-MISDFGLSKMEDPGSVLSTACG 171
Query: 1214 TLPWMAPELLNG 1225
T ++APE+L
Sbjct: 172 TPGYVAPEVLAQ 183
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 2e-37
Identities = 51/208 (24%), Positives = 82/208 (39%), Gaps = 30/208 (14%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK 1101
+ + +G G FG V+ GKWRG +VA+K +E + E
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSS---------REERSWFREAEIYQTVM 53
Query: 1102 LHHPNVVAFYGVVQ--DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
L H N++ F +G L V+++ +GSL L + + +A+ A
Sbjct: 54 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTAS 111
Query: 1160 GMEYLHS--------KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN-----TL 1206
G+ +LH I H DLK N+LV C + D GL+ + +
Sbjct: 112 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG----TCCIADLGLAVRHDSATDTIDI 167
Query: 1207 VTGGVRGTLPWMAPELLNGSSSKVSEKV 1234
GT +MAPE+L+ S + +
Sbjct: 168 APNHRVGTKRYMAPEVLDDSINMKHFES 195
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 2e-37
Identities = 61/197 (30%), Positives = 95/197 (48%), Gaps = 23/197 (11%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTD------VAIKRIKKSCFTGRSSEQERLTLEF 1092
I + K +G+G FG VY G + + VAIK +K +E++R+ +F
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-----YTEKQRV--DF 56
Query: 1093 WREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLI 1152
EA I+ + H N++ GV+ + +TE+M NG+L L K+ + +
Sbjct: 57 LGEAGIMGQFSHHNIIRLEGVISKYKPMMI--ITEYMENGALDKFLREKDGEFSVLQLVG 114
Query: 1153 IAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI----KRNTLVT 1208
+ A GM+YL + N VH DL N+LVN +CKV DFGLS++ T T
Sbjct: 115 MLRGIAAGMKYLANMNYVHRDLAARNILVNSNL----VCKVSDFGLSRVLEDDPEATYTT 170
Query: 1209 GGVRGTLPWMAPELLNG 1225
G + + W APE ++
Sbjct: 171 SGGKIPIRWTAPEAISY 187
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 139 bits (351), Expect = 3e-37
Identities = 51/189 (26%), Positives = 81/189 (42%), Gaps = 11/189 (5%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQ-ERLTLEFWREAEI 1098
E+ E + LG G V + T A+K I + S+E+ + L +E +I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 1099 LSKLH-HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDA 1157
L K+ HPN++ + V + M G L L+++ L ++ I
Sbjct: 63 LRKVSGHPNIIQLKDTYETNT--FFFLVFDLMKKGELFD-YLTEKVTLSEKETRKIMRAL 119
Query: 1158 AFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPW 1217
+ LH NIVH DLK +N+L++ I K+ DFG S V GT +
Sbjct: 120 LEVICALHKLNIVHRDLKPENILLDDDMNI----KLTDFGFSCQLDPGEKLREVCGTPSY 175
Query: 1218 MAPELLNGS 1226
+APE++ S
Sbjct: 176 LAPEIIECS 184
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 4e-37
Identities = 62/213 (29%), Positives = 92/213 (43%), Gaps = 33/213 (15%)
Query: 1034 STLQIIKNEDLEELKELGSGTFGTVYHGKWRGT----DVAIKRIKKSCFTGRSSEQERLT 1089
+ ++ D++ +G G FG V + + D AIKR+K+ S + R
Sbjct: 2 TIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----ASKDDHR-- 55
Query: 1090 LEFWREAEILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLL--------- 1139
+F E E+L KL HHPN++ G + G L E+ +G+L L
Sbjct: 56 -DFAGELEVLCKLGHHPNIINLLGACE--HRGYLYLAIEYAPHGNLLDFLRKSRVLETDP 112
Query: 1140 ------SKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193
S L ++ L A D A GM+YL K +H DL N+LV + K+
Sbjct: 113 AFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG----ENYVAKI 168
Query: 1194 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGS 1226
DFGLS+ + + R + WMA E LN S
Sbjct: 169 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS 201
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (351), Expect = 5e-37
Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 28/210 (13%)
Query: 1027 ALGNFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTD-----VAIKRIKKSCFTGR 1081
A+ F + I ++ + +G+G FG V G + VAIK +K
Sbjct: 15 AVREFA----KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG----- 65
Query: 1082 SSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSK 1141
+E++R +F EA I+ + HPNV+ GVV + +TEFM NGSL L
Sbjct: 66 YTEKQRR--DFLSEASIMGQFDHPNVIHLEGVVTKS--TPVMIITEFMENGSLDSFLRQN 121
Query: 1142 ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201
+ + + + A GM+YL N VH DL N+LVN +CKV DFGLS+
Sbjct: 122 DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNL----VCKVSDFGLSRF 177
Query: 1202 ------KRNTLVTGGVRGTLPWMAPELLNG 1225
G + + W APE +
Sbjct: 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQY 207
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 138 bits (349), Expect = 9e-37
Identities = 59/229 (25%), Positives = 95/229 (41%), Gaps = 47/229 (20%)
Query: 1030 NFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRS 1082
N + +L+ +N ++E ++++G G FG V+ + T VA+K +K+ S
Sbjct: 2 NPKLLSLEYPRN-NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE----AS 56
Query: 1083 SEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE 1142
++ + +F REA ++++ +PN+V GV G + + E+M G L L S
Sbjct: 57 ADMQA---DFQREAALMAEFDNPNIVKLLGVCAVG--KPMCLLFEYMAYGDLNEFLRSMS 111
Query: 1143 RH-----------------------LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNL 1179
H L ++L IA A GM YL + VH DL N
Sbjct: 112 PHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNC 171
Query: 1180 LVNLKDPIRPICKVGDFGLSKI---KRNTLVTGGVRGTLPWMAPELLNG 1225
LV + K+ DFGLS+ G + WM PE +
Sbjct: 172 LVGENM----VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY 216
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 137 bits (347), Expect = 1e-36
Identities = 42/191 (21%), Positives = 84/191 (43%), Gaps = 10/191 (5%)
Query: 1041 NEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEI 1098
++ E + LG G V+ + DVA+K ++ + L F REA+
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRAD-----LARDPSFYLRFRREAQN 60
Query: 1099 LSKLHHPNVVAFYGVVQD--GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
+ L+HP +VA Y + G V E++ +LR ++ E + ++ + + D
Sbjct: 61 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD-IVHTEGPMTPKRAIEVIAD 119
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 1216
A + + H I+H D+K N++++ + ++ + ++ + T V GT
Sbjct: 120 ACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 1217 WMAPELLNGSS 1227
+++PE G S
Sbjct: 180 YLSPEQARGDS 190
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 1e-36
Identities = 35/186 (18%), Positives = 74/186 (39%), Gaps = 15/186 (8%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
E ++LG G FG V+ + K +K + ++Q +E IL
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-----KGTDQVL----VKKEISIL 55
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
+ H N++ + + L + EF+ + + + L+ R+ +
Sbjct: 56 NIARHRNILHLHESFESM--EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE 113
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMA 1219
+++LHS NI HFD++ +N++ + K+ +FG ++ + + + A
Sbjct: 114 ALQFLHSHNIGHFDIRPENIIYQTRR--SSTIKIIEFGQARQLKPGDNFRLLFTAPEYYA 171
Query: 1220 PELLNG 1225
PE+
Sbjct: 172 PEVHQH 177
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 2e-34
Identities = 50/188 (26%), Positives = 82/188 (43%), Gaps = 22/188 (11%)
Query: 1048 KELGSGTFGTVYHGKWRGTD-----VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
+ +G G FG VYHG D A+K + + G S+ F E I+
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-------FLTEGIIMKDF 85
Query: 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGME 1162
HPNV++ G+ G + V +M +G LR+ + ++ + + + + A GM+
Sbjct: 86 SHPNVLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 144
Query: 1163 YLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRN-----TLVTGGVRGTLPW 1217
+L SK VH DL N +++ + KV DFGL++ + G + + W
Sbjct: 145 FLASKKFVHRDLAARNCMLD----EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 200
Query: 1218 MAPELLNG 1225
MA E L
Sbjct: 201 MALESLQT 208
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 3e-34
Identities = 54/204 (26%), Positives = 82/204 (40%), Gaps = 26/204 (12%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTD-------VAIKRIKKSCFTGRSSEQERLTLE 1091
+ E + +ELG G+FG VY G +G VAIK + ++ +S +ER+ E
Sbjct: 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-----ASMRERI--E 69
Query: 1092 FWREAEILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL---------LSKE 1142
F EA ++ + + +VV GVV G + E M G L+ L
Sbjct: 70 FLNEASVMKEFNCHHVVRLLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 127
Query: 1143 RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 1202
K + +A + A GM YL++ VH DL N +V ++ I G
Sbjct: 128 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK-IGDFGMTRDIYET 186
Query: 1203 RNTLVTGGVRGTLPWMAPELLNGS 1226
G + WM+PE L
Sbjct: 187 DYYRKGGKGLLPVRWMSPESLKDG 210
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 4e-34
Identities = 54/189 (28%), Positives = 83/189 (43%), Gaps = 16/189 (8%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
ED K LG G+FG V+ +++ T+ AIK +KK + E +L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVEC-----TMVEKRVL 56
Query: 1100 SK-LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
S HP + + Q L V E++ G L + + D + A +
Sbjct: 57 SLAWEHPFLTHMFCTFQTK--ENLFFVMEYLNGGDLMY-HIQSCHKFDLSRATFYAAEII 113
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTGGVRGTLPW 1217
G+++LHSK IV+ DLK DN+L++ K+ DFG+ K T GT +
Sbjct: 114 LGLQFLHSKGIVYRDLKLDNILLDKDGH----IKIADFGMCKENMLGDAKTNTFCGTPDY 169
Query: 1218 MAPELLNGS 1226
+APE+L G
Sbjct: 170 IAPEILLGQ 178
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 132 bits (334), Expect = 4e-34
Identities = 43/186 (23%), Positives = 74/186 (39%), Gaps = 12/186 (6%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
D + +G G FG VY + G A+K + K + + E L L ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI--KMKQGETLALNERIMLSLV 61
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
S P +V L+ + + M G L + L + R A
Sbjct: 62 STGDCPFIVCMSYAFHTP--DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE-IIL 118
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMA 1219
G+E++H++ +V+ DLK N+L++ + ++ D GL+ GT +MA
Sbjct: 119 GLEHMHNRFVVYRDLKPANILLDEHGHV----RISDLGLACDFSKKK-PHASVGTHGYMA 173
Query: 1220 PELLNG 1225
PE+L
Sbjct: 174 PEVLQK 179
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 6e-34
Identities = 38/183 (20%), Positives = 69/183 (37%), Gaps = 12/183 (6%)
Query: 1047 LKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH- 1103
LGSG FG+VY G + VAIK ++K + E +L K+
Sbjct: 9 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGT--RVPMEVVLLKKVSS 66
Query: 1104 -HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGME 1162
V+ + + + E +++ L +
Sbjct: 67 GFSGVIRLLDWFERP--DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 1163 YLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPEL 1222
+ H+ ++H D+K +N+L++L R K+ DFG + ++T+ T GT + PE
Sbjct: 125 HCHNCGVLHRDIKDENILIDLN---RGELKLIDFGSGALLKDTVYT-DFDGTRVYSPPEW 180
Query: 1223 LNG 1225
+
Sbjct: 181 IRY 183
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 2e-33
Identities = 52/200 (26%), Positives = 82/200 (41%), Gaps = 24/200 (12%)
Query: 1036 LQIIKN---EDLEELKE-LGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLT 1089
LQI KN +D + + LG G G V + T A+K ++
Sbjct: 2 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------------- 48
Query: 1090 LEFWREAEILSKL-HHPNVVAFYGVVQDG--PGGTLATVTEFMVNGSLRHVLLSK-ERHL 1145
+ RE E+ + P++V V ++ L V E + G L + + ++
Sbjct: 49 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 108
Query: 1146 DRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT 1205
R+ I ++YLHS NI H D+K +NLL K P I K+ DFG +K +
Sbjct: 109 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRP-NAILKLTDFGFAKETTSH 167
Query: 1206 LVTGGVRGTLPWMAPELLNG 1225
T ++APE+L
Sbjct: 168 NSLTTPCYTPYYVAPEVLGP 187
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 3e-33
Identities = 54/203 (26%), Positives = 86/203 (42%), Gaps = 21/203 (10%)
Query: 1041 NEDLEELKELGSGTFGTVYHGKWR---GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAE 1097
++ E + E+G G +G V+ + G VA+KR++ + +E + L RE
Sbjct: 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQ------TGEEGMPLSTIREVA 59
Query: 1098 ILSKL---HHPNVVAFYGVVQDGP---GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRL 1151
+L L HPNVV + V L V E + ++ E +
Sbjct: 60 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK 119
Query: 1152 IIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGV 1211
+ G+++LHS +VH DLK N+LV K+ DFGL++I + V
Sbjct: 120 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG----QIKLADFGLARIYSFQMALTSV 175
Query: 1212 RGTLPWMAPELLNGSSSKVSEKV 1234
TL + APE+L S + V
Sbjct: 176 VVTLWYRAPEVLLQ--SSYATPV 196
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 128 bits (322), Expect = 7e-33
Identities = 51/186 (27%), Positives = 93/186 (50%), Gaps = 16/186 (8%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+D + L+ LG+G+FG V+ + R G A+K +KK + E +L
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEH-----TNDERLML 58
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
S + HP ++ +G QD + + +++ G L +L +R + + A +
Sbjct: 59 SIVTHPFIIRMWGTFQD--AQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA-EVCL 115
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMA 1219
+EYLHSK+I++ DLK +N+L++ I K+ DFG +K + T + GT ++A
Sbjct: 116 ALEYLHSKDIIYRDLKPENILLDKNGHI----KITDFGFAKYVPDVTYT--LCGTPDYIA 169
Query: 1220 PELLNG 1225
PE+++
Sbjct: 170 PEVVST 175
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 1e-32
Identities = 46/190 (24%), Positives = 78/190 (41%), Gaps = 21/190 (11%)
Query: 1045 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
L +G G +G V VAIK+I E + RE +IL +
Sbjct: 11 TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF-------EHQTYCQRTLREIKILLRF 63
Query: 1103 HHPNVVAFYGVVQDGPGGTLAT--VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFG 1160
H N++ +++ + + ++ L +L K +HL G
Sbjct: 64 RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL--KTQHLSNDHICYFLYQILRG 121
Query: 1161 MEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI----KRNTLVTGGVRGTLP 1216
++Y+HS N++H DLK NLL+N + K+ DFGL+++ +T T
Sbjct: 122 LKYIHSANVLHRDLKPSNLLLNTTCDL----KICDFGLARVADPDHDHTGFLTEYVATRW 177
Query: 1217 WMAPELLNGS 1226
+ APE++ S
Sbjct: 178 YRAPEIMLNS 187
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 1e-32
Identities = 55/221 (24%), Positives = 83/221 (37%), Gaps = 37/221 (16%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTD---------VAIKRIKKSCFTGRSSEQERLT 1089
+ + L K LG G FG V + G D VA+K +K ++E++
Sbjct: 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-----ATEKDLS- 63
Query: 1090 LEFWREAEILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVL---------- 1138
+ E E++ + H N++ G G L + E+ G+LR L
Sbjct: 64 -DLISEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEY 120
Query: 1139 -----LSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193
+ E L + + A A GMEYL SK +H DL N+LV +D + I
Sbjct: 121 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADF 179
Query: 1194 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKV 1234
G T R + WMAPE L + +
Sbjct: 180 GLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--RIYTHQS 218
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 1e-32
Identities = 62/213 (29%), Positives = 88/213 (41%), Gaps = 38/213 (17%)
Query: 1039 IKNEDLEELKELGSGTFGTVYHGKWRGTD-------VAIKRIKKSCFTGRSSEQERLTLE 1091
+ L+ K LG G FG V G D VA+K +K+ G + + R
Sbjct: 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE----GATHSEHR---A 62
Query: 1092 FWREAEILSK-LHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERH------ 1144
E +IL HH NVV G PGG L + EF G+L L SK
Sbjct: 63 LMSELKILIHIGHHLNVVNLLGACTK-PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV 121
Query: 1145 ---------LDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195
L + + A GME+L S+ +H DL N+L++ K+ + K+ D
Sbjct: 122 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN----VVKICD 177
Query: 1196 FGLSKI---KRNTLVTGGVRGTLPWMAPELLNG 1225
FGL++ + + G R L WMAPE +
Sbjct: 178 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 210
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 5e-32
Identities = 55/184 (29%), Positives = 84/184 (45%), Gaps = 13/184 (7%)
Query: 1045 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
E+L LG G F TVY + + T+ VAIK+IK RS ++ + RE ++L +L
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLG---HRSEAKDGINRTALREIKLLQEL 57
Query: 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGME 1162
HPN++ ++ V +FM + L + G+E
Sbjct: 58 SHPNIIGLLDAFGH--KSNISLVFDFMETDLEVI-IKDNSLVLTPSHIKAYMLMTLQGLE 114
Query: 1163 YLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVR-GTLPWMAPE 1221
YLH I+H DLK +NLL++ + K+ DFGL+K + + T + APE
Sbjct: 115 YLHQHWILHRDLKPNNLLLDENGVL----KLADFGLAKSFGSPNRAYTHQVVTRWYRAPE 170
Query: 1222 LLNG 1225
LL G
Sbjct: 171 LLFG 174
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 9e-32
Identities = 52/188 (27%), Positives = 87/188 (46%), Gaps = 15/188 (7%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
E+ ++++++G GT+G VY + + T VA+K+I+ +E E + RE +L
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLD------TETEGVPSTAIREISLL 55
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
+L+HPN+V V+ L V EF+ + + S +
Sbjct: 56 KELNHPNIVKLLDVIHTE--NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPW-M 1218
G+ + HS ++H DLK NLL+N + I K+ DFGL++ + T W
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLINTEGAI----KLADFGLARAFGVPVRTYTHEVVTLWYR 169
Query: 1219 APELLNGS 1226
APE+L G
Sbjct: 170 APEILLGC 177
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 124 bits (313), Expect = 1e-31
Identities = 38/199 (19%), Positives = 83/199 (41%), Gaps = 21/199 (10%)
Query: 1030 NFDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQER 1087
+++ ++ +D + +++LG G + V+ + V +K +K ++++
Sbjct: 23 DYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-------VKKKK 75
Query: 1088 LTLEFWREAEILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLD 1146
RE +IL L PN++ +V+D T A V E + N + + + L
Sbjct: 76 ----IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLT 127
Query: 1147 RRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL 1206
+ ++Y HS I+H D+K N++++ + ++ D+GL++
Sbjct: 128 DYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH---RKLRLIDWGLAEFYHPGQ 184
Query: 1207 VTGGVRGTLPWMAPELLNG 1225
+ + PELL
Sbjct: 185 EYNVRVASRYFKGPELLVD 203
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 123 bits (308), Expect = 2e-31
Identities = 44/189 (23%), Positives = 74/189 (39%), Gaps = 23/189 (12%)
Query: 1047 LKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH 1104
+++GSG+FG +Y G G +VAIK ++ + E++I +
Sbjct: 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK------TKHPQ----LHIESKIYKMMQG 61
Query: 1105 PNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYL 1164
+ G V E + SL + R + L++A +EY+
Sbjct: 62 GVGIPTIRWCGA-EGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 1165 HSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT--------LVTGGVRGTLP 1216
HSKN +H D+K DN L+ L + + DFGL+K R+ + GT
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYII-DFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 1217 WMAPELLNG 1225
+ + G
Sbjct: 179 YASINTHLG 187
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 122 bits (307), Expect = 3e-31
Identities = 51/187 (27%), Positives = 82/187 (43%), Gaps = 15/187 (8%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100
E L+++G GT+G VY + G A+K+I+ E E + RE IL
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLE------KEDEGIPSTTIREISILK 55
Query: 1101 KLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFG 1160
+L H N+V Y V+ L ++ L+ +L E L+ + G
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVL---VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNG 112
Query: 1161 MEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPW-MA 1219
+ Y H + ++H DLK NLL+N + + K+ DFGL++ + W A
Sbjct: 113 IAYCHDRRVLHRDLKPQNLLINREGEL----KIADFGLARAFGIPVRKYTHEIVTLWYRA 168
Query: 1220 PELLNGS 1226
P++L GS
Sbjct: 169 PDVLMGS 175
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 8e-31
Identities = 49/198 (24%), Positives = 84/198 (42%), Gaps = 24/198 (12%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
E+L ++G GTFG V+ + R T VA+K++ +E+E + RE +IL
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLME------NEKEGFPITALREIKIL 63
Query: 1100 SKLHHPNVVAFYGVVQDGP------GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLII 1153
L H NVV + + G++ V +F + + + + ++
Sbjct: 64 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 123
Query: 1154 AMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVT----- 1208
M G+ Y+H I+H D+K N+L+ + K+ DFGL++ +
Sbjct: 124 QM-LLNGLYYIHRNKILHRDMKAANVLITRDGVL----KLADFGLARAFSLAKNSQPNRY 178
Query: 1209 GGVRGTLPWMAPELLNGS 1226
TL + PELL G
Sbjct: 179 TNRVVTLWYRPPELLLGE 196
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 1e-29
Identities = 44/192 (22%), Positives = 73/192 (38%), Gaps = 23/192 (11%)
Query: 1043 DLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILS 1100
+ K +G+G+FG VY K + VAIK++ + RE +I+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD------------KRFKNRELQIMR 68
Query: 1101 KLHHPNVVAFYGVVQDGP----GGTLATVTEFMVNGSLRHVL--LSKERHLDRRKRLIIA 1154
KL H N+V L V +++ R ++ L +
Sbjct: 69 KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 1155 MDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGT 1214
+ Y+HS I H D+K NLL++ + K+ DFG +K +
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDT---AVLKLCDFGSAKQLVRGEPNVSYICS 185
Query: 1215 LPWMAPELLNGS 1226
+ APEL+ G+
Sbjct: 186 RYYRAPELIFGA 197
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 117 bits (294), Expect = 2e-29
Identities = 37/191 (19%), Positives = 68/191 (35%), Gaps = 25/191 (13%)
Query: 1047 LKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-H 1103
+ +G G+FG ++ G VAIK + + E L
Sbjct: 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR----------RSDAPQLRDEYRTYKLLAG 59
Query: 1104 HPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEY 1163
+ Y Q+G + ++ SL +L R + + A ++
Sbjct: 60 CTGIPNVYYFGQEG---LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 116
Query: 1164 LHSKNIVHFDLKCDNLLVNLKD-PIRPICKVGDFGLSKIKRNTLV--------TGGVRGT 1214
+H K++V+ D+K DN L+ + + V DFG+ K R+ + + GT
Sbjct: 117 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
Query: 1215 LPWMAPELLNG 1225
+M+ G
Sbjct: 177 ARYMSINTHLG 187
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 119 bits (298), Expect = 2e-29
Identities = 46/186 (24%), Positives = 81/186 (43%), Gaps = 16/186 (8%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+ + +K LG+G+FG V K + + A+K + K + + + E IL
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-----QKVVKLKQIEHTLNEKRIL 95
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
++ P +V +D L V E++ G + L + A
Sbjct: 96 QAVNFPFLVKLEFSFKDNS--NLYMVMEYVAGGEMFS-HLRRIGRFSEPHARFYAAQIVL 152
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMA 1219
EYLHS ++++ DLK +NLL++ + I+ V DFG +K + T + GT +A
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQ----VTDFGFAKRVKGRTWT--LCGTPEALA 206
Query: 1220 PELLNG 1225
PE++
Sbjct: 207 PEIILS 212
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 2e-29
Identities = 52/188 (27%), Positives = 82/188 (43%), Gaps = 15/188 (7%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
D + LK LG GTFG V + + T A+K ++K + E+ +L
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAH-----TVTESRVL 59
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
HP + A Q L V E+ G L LS+ER + +
Sbjct: 60 QNTRHPFLTALKYAFQTH--DRLCFVMEYANGGELFF-HLSRERVFTEERARFYGAEIVS 116
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK-IKRNTLVTGGVRGTLPWM 1218
+EYLHS+++V+ D+K +NL+++ I K+ DFGL K + GT ++
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDKDGHI----KITDFGLCKEGISDGATMKTFCGTPEYL 172
Query: 1219 APELLNGS 1226
APE+L +
Sbjct: 173 APEVLEDN 180
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 2e-28
Identities = 48/195 (24%), Positives = 83/195 (42%), Gaps = 15/195 (7%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
+ E+L+++G GT+GTV+ K R T VA+KR++ + E + RE +L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLD------DDDEGVPSSALREICLL 55
Query: 1100 SKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAF 1159
+L H N+V + V+ TL V EF ++ + +
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTL--VFEFCDQDLKKYFDSCNGDLDPEIVKSFLF-QLLK 112
Query: 1160 GMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMA 1219
G+ + HS+N++H DLK NLL+N K+ +FGL++ + W
Sbjct: 113 GLGFCHSRNVLHRDLKPQNLLINRNG----ELKLANFGLARAFGIPVRCYSAEVVTLWYR 168
Query: 1220 PELLNGSSSKVSEKV 1234
P + + S +
Sbjct: 169 PPDVLFGAKLYSTSI 183
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 3e-27
Identities = 50/201 (24%), Positives = 89/201 (44%), Gaps = 19/201 (9%)
Query: 1042 EDLEELKELGSGTFGTVY-----HGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREA 1096
E+ E LK LG+G +G V+ G G A+K +KK+ ++ E E
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEH----TRTER 79
Query: 1097 EILSKL-HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAM 1155
++L + P +V + Q L + +++ G L LS+ + I
Sbjct: 80 QVLEHIRQSPFLVTLHYAFQTE--TKLHLILDYINGGELFT-HLSQRERFTEHEVQIYVG 136
Query: 1156 DAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK--IKRNTLVTGGVRG 1213
+ +E+LH I++ D+K +N+L++ + + DFGLSK + T G
Sbjct: 137 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVV----LTDFGLSKEFVADETERAYDFCG 192
Query: 1214 TLPWMAPELLNGSSSKVSEKV 1234
T+ +MAP+++ G S + V
Sbjct: 193 TIEYMAPDIVRGGDSGHDKAV 213
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 4e-27
Identities = 47/188 (25%), Positives = 74/188 (39%), Gaps = 21/188 (11%)
Query: 1045 EELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
+L+ +GSG +G V G VAIK++ + + E +RE +L +
Sbjct: 21 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP------FQSELFAKRAYRELRLLKHM 74
Query: 1103 HHPNVVAFYGVVQDGPGGTLAT----VTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
H NV+ V T V FM + L K L + +
Sbjct: 75 RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGK---LMKHEKLGEDRIQFLVYQML 131
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWM 1218
G+ Y+H+ I+H DLK NL VN K+ DFGL++ + + T +
Sbjct: 132 KGLRYIHAAGIIHRDLKPGNLAVN----EDCELKILDFGLARQADSEMTG--YVVTRWYR 185
Query: 1219 APELLNGS 1226
APE++
Sbjct: 186 APEVILNW 193
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 2e-26
Identities = 43/187 (22%), Positives = 79/187 (42%), Gaps = 20/187 (10%)
Query: 1045 EELKELGSGTFGTVYHGKWRGTD--VAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL 1102
+ LK +GSG G V D VAIK++ + +++ +RE ++ +
Sbjct: 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR------AYRELVLMKCV 73
Query: 1103 HHPNVVAFYGVVQDGP----GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAA 1158
+H N+++ V + V E M + + + LD + +
Sbjct: 74 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI----QMELDHERMSYLLYQML 129
Query: 1159 FGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWM 1218
G+++LHS I+H DLK N++V K+ DFGL++ + + T +
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDC----TLKILDFGLARTAGTSFMMTPYVVTRYYR 185
Query: 1219 APELLNG 1225
APE++ G
Sbjct: 186 APEVILG 192
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 3e-24
Identities = 43/190 (22%), Positives = 79/190 (41%), Gaps = 19/190 (10%)
Query: 1042 EDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEIL 1099
E + L +GSG +G+V G VA+K++ + + +++ +RE +L
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR------TYRELRLL 71
Query: 1100 SKLHHPNVVAFYGVVQDGPG---GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
+ H NV+ V + ++ L + + K + L +
Sbjct: 72 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--IVKCQKLTDDHVQFLIYQ 129
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLP 1216
G++Y+HS +I+H DLK NL VN K+ DFGL++ + + T
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDDEMTG--YVATRW 183
Query: 1217 WMAPELLNGS 1226
+ APE++
Sbjct: 184 YRAPEIMLNW 193
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 95.5 bits (236), Expect = 2e-21
Identities = 38/197 (19%), Positives = 79/197 (40%), Gaps = 7/197 (3%)
Query: 1037 QIIKNEDLEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWR 1094
+ K+ +++LG G F TV+ K T VA+K ++ ++E E L+
Sbjct: 8 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVN 67
Query: 1095 EAEI--LSKLHHPNVVAFYGVVQDGP--GGTLATVTEFMVNGSLRHVLLSKERHLDRRKR 1150
+A+ + +++ G + V E + L + + R +
Sbjct: 68 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 127
Query: 1151 LIIAMDAAFGMEYLHSK-NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTG 1209
I+ G++Y+H + I+H D+K +N+L+ + D + ++ L
Sbjct: 128 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 187
Query: 1210 GVRGTLPWMAPELLNGS 1226
T + +PE+L G+
Sbjct: 188 NSIQTREYRSPEVLLGA 204
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 82.1 bits (202), Expect = 2e-18
Identities = 28/164 (17%), Positives = 52/164 (31%), Gaps = 30/164 (18%)
Query: 1048 KELGSGTFGTVYHGK-WRGTDVAIKRIKKSCFTGRSSEQERLTLE----------FWREA 1096
K +G G V++ + + +K K + + +++R + E
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 1097 EILSKLHHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMD 1156
L KL V Y + A + E + L V + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGN------AVLMELIDAKELYRVRVENPDE--------VLDM 111
Query: 1157 AAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200
+ + + IVH DL N+LV+ + + DF S
Sbjct: 112 ILEEVAKFYHRGIVHGDLSQYNVLVSEEGI-----WIIDFPQSV 150
|
| >d1ip9a_ d.15.2.2 (A:) Bud emergence mediator Bemp1 {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 85 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Bud emergence mediator Bemp1 species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 42.1 bits (99), Expect = 2e-05
Identities = 8/65 (12%), Positives = 24/65 (36%), Gaps = 5/65 (7%)
Query: 204 KLRYVGGETRIIRISRDISWQELTQKALAIYN-QTHTIKYQLPGEDLDALVSVSCDEDLQ 262
K Y + + + D +++EL K + ++ + + + D +
Sbjct: 16 KFYY-KDDIFALMLKGDTTYKELRSKIAPRIDTDNFKLQTK---LFDGSGEEIKTDSQVS 71
Query: 263 NMMEE 267
N+++
Sbjct: 72 NIIQA 76
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1236 | |||
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.96 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.43 | |
| d1ip9a_ | 85 | Bud emergence mediator Bemp1 {Baker's yeast (Sacch | 98.03 | |
| d1blja_ | 114 | P55 Blk protein tyrosine kinase {Mouse (Mus muscul | 97.97 | |
| d1luia_ | 108 | Itk/tsk protein tyrosine kinase {Mouse (Mus muscul | 97.88 | |
| d1fu6a_ | 111 | Phosphatidylinositol 3-kinase, p85-alpha subunit { | 97.8 | |
| d1g83a2 | 104 | Tyrosine kinase Fyn {Human (Homo sapiens) [TaxId: | 97.76 | |
| d1mila_ | 104 | Shc adaptor protein {Human (Homo sapiens) [TaxId: | 97.73 | |
| d1r1qa_ | 97 | GRB2-related adaptor protein 2 (MONA, GRID) {Mouse | 97.69 | |
| d2oq1a1 | 130 | Tyrosine-protein kinase zap-70 {Human (Homo sapien | 97.67 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.67 | |
| d1o48a_ | 106 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 97.65 | |
| d1d4ta_ | 104 | The Xlp protein Sap {Human (Homo sapiens) [TaxId: | 97.64 | |
| d1opka2 | 101 | Abl tyrosine kinase {Mouse (Mus musculus) [TaxId: | 97.64 | |
| d1qcfa2 | 103 | Hemopoetic cell kinase Hck {Human (Homo sapiens) [ | 97.6 | |
| d2eyva1 | 109 | Crk proto-oncogen {Human (Homo sapiens) [TaxId: 96 | 97.56 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.55 | |
| d1lkka_ | 105 | p56-lck tyrosine kinase {Human (Homo sapiens) [Tax | 97.51 | |
| d1a81a1 | 129 | Syk tyrosine kinase {Human (Homo sapiens) [TaxId: | 97.47 | |
| d1i3za_ | 103 | Ews/fli1 activated transcript 2, Eat2 {Mouse (Mus | 97.46 | |
| d1jwoa_ | 97 | Csk homologous kinase Chk {Human (Homo sapiens) [T | 97.41 | |
| d2c60a1 | 80 | Mitogen-activated protein kinase kinase kinase 3, | 97.39 | |
| d1k9aa2 | 101 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 97.37 | |
| d2shpa2 | 109 | Tyrosine phoshatase shp-2 {Human (Homo sapiens) [T | 97.36 | |
| d1rjaa_ | 100 | Tyrosine-protein kinase 6 (Breast tumor kinase, Br | 97.35 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.28 | |
| d2fcia1 | 105 | Phospholipase C-gamma-1 {Cow (Bos taurus) [TaxId: | 97.24 | |
| d2qmsa1 | 113 | Growth factor receptor-bound protein 7 {Human (Hom | 97.22 | |
| d2nptb1 | 82 | Mitogen-activated protein kinase kinase kinase 2, | 97.18 | |
| d1nrva_ | 105 | Growth factor receptor-bound protein 10, GRB10 {Hu | 97.13 | |
| d1jyra_ | 96 | Growth factor receptor-bound protein 2 (GRB2) {Hum | 97.12 | |
| d1xa6a2 | 141 | Beta-chimaerin, N-terminal domain {Human (Homo sap | 97.09 | |
| d1a81a2 | 125 | Syk tyrosine kinase {Human (Homo sapiens) [TaxId: | 97.08 | |
| d2bkfa1 | 85 | Next to BRCA1 gene 1 protein, NBR1 (KIAA0049) {Hum | 97.06 | |
| d1rpya_ | 86 | Adaptor protein Aps {Rat (Rattus norvegicus) [TaxI | 97.05 | |
| d2oq1a2 | 124 | Tyrosine-protein kinase zap-70 {Human (Homo sapien | 97.03 | |
| d1uura3 | 131 | STAT homologue {Dictyostelium discoideum [TaxId: 4 | 96.97 | |
| d2shpa3 | 108 | Tyrosine phoshatase shp-2 {Human (Homo sapiens) [T | 96.95 | |
| d2izva2 | 112 | Suppressor of cytokine signaling 4, SOCS-4 {Human | 96.78 | |
| d2cs0a1 | 106 | Hematopoietic SH2 domain containing protein HSH2D | 96.61 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.57 | |
| d1bg1a3 | 141 | STAT3b {Mouse (Mus musculus) [TaxId: 10090]} | 96.55 | |
| d2c9wa2 | 103 | Suppressor of cytokine signaling 2, SOCS-2 {Human | 96.53 | |
| d1qada_ | 107 | Phosphatidylinositol 3-kinase, p85-alpha subunit { | 95.86 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.77 | |
| d2npta1 | 105 | Mitogen activated protein kinase kinase 5, Map2k5 | 81.35 |
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-41 Score=278.15 Aligned_cols=183 Identities=27% Similarity=0.374 Sum_probs=156.6
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEE--CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC
Q ss_conf 3456703989722477358997543--59228999620365679873789999999999999852799941037646764
Q 000893 1039 IKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1236)
Q Consensus 1039 Is~eeYeiLKvLGkGSFGkVYKAkl--kGt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNIVrLlGsf~t 1116 (1236)
+..++|++++.||+|+||+||+|++ +++.||||++++.... .......+.+|+.+|+.++||||++++++|.+
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~-----~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 76 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII-----AKDEVAHTVTESRVLQNTRHPFLTALKYAFQT 76 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred CCHHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCC-----CHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC
T ss_conf 8447428988983176849999999899989999998156544-----97999999999999986799988778764035
Q ss_pred CCCCEEEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCEEEEEC
Q ss_conf 99980999996145898999996404678999999999999999999997994027899996798369998893899743
Q 000893 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1236)
Q Consensus 1117 ~deg~L~LVMEYLeGGSL~elL~qkek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvVKLsDF 1196 (1236)
.. .+++|||||++|+|..++.. ...+++..++.++.||+.||.|||+++||||||||+|||++.++ .+||+||
T Consensus 77 ~~--~~~iv~ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g----~vkl~DF 149 (337)
T d1o6la_ 77 HD--RLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG----HIKITDF 149 (337)
T ss_dssp SS--EEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS----CEEECCC
T ss_pred CC--CCCCCEECCCCCCHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCC----CEEEEEC
T ss_conf 64--21110003579860555532-56775999999999996521134315962246477784765899----8888205
Q ss_pred CCCCCCCC-CCCCCCCCCCCCCCCHHHHCCCCCCCCCC
Q ss_conf 67511268-64336767888644123206899999961
Q 000893 1197 GLSKIKRN-TLVTGGVRGTLPWMAPELLNGSSSKVSEK 1233 (1236)
Q Consensus 1197 GLArli~s-s~~tssivGTp~YLAPEVL~Gs~~~~SdD 1233 (1236)
|+|+.... .......+||+.|+|||++.+..+....|
T Consensus 150 G~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~D 187 (337)
T d1o6la_ 150 GLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 187 (337)
T ss_dssp TTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHH
T ss_pred CCCCCCCCCCCCCCCCEECHHHHHHHHCCCCCCCHHHC
T ss_conf 65200356786205510088996666504898883331
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5e-41 Score=278.20 Aligned_cols=178 Identities=25% Similarity=0.356 Sum_probs=154.6
Q ss_pred CCCEEEEEEECCCCCEEEEEEEE--CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
Q ss_conf 56703989722477358997543--5922899962036567987378999999999999985279994103764676499
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1041 ~eeYeiLKvLGkGSFGkVYKAkl--kGt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNIVrLlGsf~t~d 1118 (1236)
.++|++++.||+|+||+||+|++ +++.||||++.+.. ......+.+|+.+|+.++|||||+++++|.+..
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 96 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--------ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 96 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--------HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--------HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECC
T ss_conf 657589889840768199999988999899999984524--------316999999999998679979992999999899
Q ss_pred CCEEEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCEEEEECCC
Q ss_conf 98099999614589899999640467899999999999999999999799402789999679836999889389974367
Q 000893 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1236)
Q Consensus 1119 eg~L~LVMEYLeGGSL~elL~qkek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvVKLsDFGL 1198 (1236)
.+++|||||++|+|.+++......+++..++.|+.||+.||.|||+++||||||||+|||++.+.. ..+||+|||+
T Consensus 97 --~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~--~~vkL~DFG~ 172 (350)
T d1koaa2 97 --EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRS--NELKLIDFGL 172 (350)
T ss_dssp --EEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTS--CCEEECCCTT
T ss_pred --EEEEEEECCCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCEEEEECHHHEEECCCCC--CEEEEEECCH
T ss_conf --999999857998899999762378999999999999999999997569760001546736416889--8699954521
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCC
Q ss_conf 51126864336767888644123206899999
Q 000893 1199 SKIKRNTLVTGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1199 Arli~ss~~tssivGTp~YLAPEVL~Gs~~~~ 1230 (1236)
|+...........+||+.|||||++.+..+..
T Consensus 173 a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~ 204 (350)
T d1koaa2 173 TAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGY 204 (350)
T ss_dssp CEECCTTSCEEEECSCTTTCCHHHHHTCCBCH
T ss_pred HEECCCCCCCCEECCCCCCCCHHHHCCCCCCH
T ss_conf 04425654320006862421889975899872
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-41 Score=280.82 Aligned_cols=181 Identities=29% Similarity=0.445 Sum_probs=154.1
Q ss_pred CCCCCCEEEEEEECCCCCEEEEEEEE--CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE
Q ss_conf 03456703989722477358997543--5922899962036567987378999999999999985279994103764676
Q 000893 1038 IIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 1115 (1236)
Q Consensus 1038 iIs~eeYeiLKvLGkGSFGkVYKAkl--kGt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNIVrLlGsf~ 1115 (1236)
++..++|++++.||+|+||+||+|++ ++..||||++++... .....++.+|+.+|+.++|||||+++++|.
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 74 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-------PAIRNQIIRELQVLHECNSPYIVGFYGAFY 74 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC-------TTHHHHHHHHGGGGGGCCCTTBCCEEEEEE
T ss_pred CCCCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHC-------HHHHHHHHHHHHHHHHCCCCCCCCEEEEEE
T ss_conf 7875688897897127780999999989996999999875409-------789999999999998679999994999999
Q ss_pred CCCCCEEEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCCCCEEECCCCCCCCCEEEE
Q ss_conf 499980999996145898999996404678999999999999999999997-9940278999967983699988938997
Q 000893 1116 DGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1236)
Q Consensus 1116 t~deg~L~LVMEYLeGGSL~elL~qkek~LSe~eil~IA~QILeALeYLHS-kGIIHRDIKPsNILIDsdG~I~lvVKLs 1194 (1236)
+.. .+++|||||++|+|.+++... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++ .+||+
T Consensus 75 ~~~--~~~iVmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~----~vkl~ 147 (322)
T d1s9ja_ 75 SDG--EISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG----EIKLC 147 (322)
T ss_dssp CSS--EEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC----CEEEC
T ss_pred ECC--EEEEEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEECCCC----CEEEE
T ss_conf 899--999999767998689987424-99999999999999999999999859997144577994687899----89995
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCC
Q ss_conf 436751126864336767888644123206899999961
Q 000893 1195 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEK 1233 (1236)
Q Consensus 1195 DFGLArli~ss~~tssivGTp~YLAPEVL~Gs~~~~SdD 1233 (1236)
|||+|+..... ....++||++|+|||++.+..+....|
T Consensus 148 DFGla~~~~~~-~~~~~~GT~~Y~APEvl~~~~y~~~~D 185 (322)
T d1s9ja_ 148 DFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSD 185 (322)
T ss_dssp CCCCCHHHHHH-TC---CCSSCCCCHHHHHCSCCCTTHH
T ss_pred ECCCCCCCCCC-CCCCCCCCCCCCCCHHHCCCCCCCHHH
T ss_conf 48776256788-621113771411946875899894888
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.1e-40 Score=274.19 Aligned_cols=178 Identities=24% Similarity=0.370 Sum_probs=153.6
Q ss_pred CCCEEEEEEECCCCCEEEEEEEE--CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
Q ss_conf 56703989722477358997543--5922899962036567987378999999999999985279994103764676499
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1041 ~eeYeiLKvLGkGSFGkVYKAkl--kGt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNIVrLlGsf~t~d 1118 (1236)
.++|++++.||+|+||+||+|++ +++.||||++++.. ......+.+|+.+|+.++|||||+++++|.+..
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--------~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 99 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--------PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY 99 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--------HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--------HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECC
T ss_conf 403599899931778299999998999799999988726--------467999999999998679979891999999899
Q ss_pred CCEEEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCEEEEECCC
Q ss_conf 98099999614589899999640467899999999999999999999799402789999679836999889389974367
Q 000893 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1236)
Q Consensus 1119 eg~L~LVMEYLeGGSL~elL~qkek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvVKLsDFGL 1198 (1236)
.+|+|||||++|+|.+++......+++..++.|+.||+.||.|||+++|+||||||+||||+.... ..+||+|||+
T Consensus 100 --~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~--~~vkL~DFGl 175 (352)
T d1koba_ 100 --EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKA--SSVKIIDFGL 175 (352)
T ss_dssp --EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTC--CCEEECCCTT
T ss_pred --EEEEEEECCCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCCCCCCCCC--CEEEEEECCC
T ss_conf --999999828998088889863899899999999999999999999779265131445531134678--8489952563
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCC
Q ss_conf 51126864336767888644123206899999
Q 000893 1199 SKIKRNTLVTGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1199 Arli~ss~~tssivGTp~YLAPEVL~Gs~~~~ 1230 (1236)
|+...........+||+.|+|||++.+..+..
T Consensus 176 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 207 (352)
T d1koba_ 176 ATKLNPDEIVKVTTATAEFAAPEIVDREPVGF 207 (352)
T ss_dssp CEECCTTSCEEEECSSGGGCCHHHHTTCCBCH
T ss_pred CEECCCCCCEEECCCCCCCCCHHHHCCCCCCC
T ss_conf 03437887201004764534899974799897
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-40 Score=272.54 Aligned_cols=181 Identities=28% Similarity=0.446 Sum_probs=153.7
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEE--CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC
Q ss_conf 456703989722477358997543--592289996203656798737899999999999998527999410376467649
Q 000893 1040 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1236)
Q Consensus 1040 s~eeYeiLKvLGkGSFGkVYKAkl--kGt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNIVrLlGsf~t~ 1117 (1236)
..++|++++.||+|+||+||+|++ +++.||||++.+.... .......+.+|+.+++.++|||||++++++.+.
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 78 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE-----KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA 78 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred CHHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCC-----CHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEC
T ss_conf 153769988985177858999999899949999998168856-----768999999999999856888888599999989
Q ss_pred CCCEEEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCEEEEECC
Q ss_conf 99809999961458989999964046789999999999999999999979940278999967983699988938997436
Q 000893 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1236)
Q Consensus 1118 deg~L~LVMEYLeGGSL~elL~qkek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvVKLsDFG 1197 (1236)
. .+++|||||++|+|.+++.. ...+++..++.|+.||+.||.|||+++|+||||||+|||++.++ .+||+|||
T Consensus 79 ~--~~~ivmEy~~~g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~----~~kl~DFG 151 (263)
T d2j4za1 79 T--RVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG----ELKIADFG 151 (263)
T ss_dssp S--EEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS----CEEECCCC
T ss_pred C--EEEEEEEECCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECCCCCEECCCC----CEEECCCC
T ss_conf 9--98999850479858988750-48999999999999999999999988946522023441466899----87115556
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCC
Q ss_conf 751126864336767888644123206899999961
Q 000893 1198 LSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEK 1233 (1236)
Q Consensus 1198 LArli~ss~~tssivGTp~YLAPEVL~Gs~~~~SdD 1233 (1236)
+|+...... ....+||+.|+|||++.+..+..+.|
T Consensus 152 ~a~~~~~~~-~~~~~Gt~~Y~APE~~~~~~~~~~~D 186 (263)
T d2j4za1 152 WSVHAPSSR-RTTLCGTLDYLPPEMIEGRMHDEKVD 186 (263)
T ss_dssp SCSCCCCCC-CEETTEEGGGCCHHHHTTCCCCTTHH
T ss_pred EEEECCCCC-CCCCCCCCCCCCHHHHCCCCCCCHHH
T ss_conf 335448885-23557887634999975899893144
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-40 Score=273.98 Aligned_cols=174 Identities=25% Similarity=0.429 Sum_probs=149.8
Q ss_pred CCEEEEEEECCCCCEEEEEEEE--CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCC
Q ss_conf 6703989722477358997543--59228999620365679873789999999999999852799941037646764999
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 eeYeiLKvLGkGSFGkVYKAkl--kGt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNIVrLlGsf~t~de 1119 (1236)
++|++++.||+|+||+||+|++ +++.||||++++.... ....+.+|+.+++.++|||||+++++|.+.+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--------~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~- 90 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--------KKELIINEILVMRENKNPNIVNYLDSYLVGD- 90 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--------CHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCH--------HHHHHHHHHHHHHHCCCCCEEEEEEEEEECC-
T ss_conf 0538878981285829999999899989999998430172--------7999999999998679998805857798899-
Q ss_pred CEEEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCEEEEECCCC
Q ss_conf 80999996145898999996404678999999999999999999997994027899996798369998893899743675
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYLeGGSL~elL~qkek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvVKLsDFGLA 1199 (1236)
.+++|||||++|+|..++.. ..+++..++.|+.||+.||.|||+++|+||||||+|||++.++ .+||+|||+|
T Consensus 91 -~~~ivmEy~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~----~vkl~DFG~a 163 (293)
T d1yhwa1 91 -ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG----SVKLTDFGFC 163 (293)
T ss_dssp -EEEEEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC----CEEECCCTTC
T ss_pred -EEEEEEEECCCCCHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCC----CEEECCCHHH
T ss_conf -98999970379808988641--5999999999999999999999987972267768886887899----6864251564
Q ss_pred CCCCC-CCCCCCCCCCCCCCCHHHHCCCCCCCC
Q ss_conf 11268-643367678886441232068999999
Q 000893 1200 KIKRN-TLVTGGVRGTLPWMAPELLNGSSSKVS 1231 (1236)
Q Consensus 1200 rli~s-s~~tssivGTp~YLAPEVL~Gs~~~~S 1231 (1236)
+.... .......+||+.|+|||++.+..+...
T Consensus 164 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~ 196 (293)
T d1yhwa1 164 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196 (293)
T ss_dssp EECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTH
T ss_pred EEECCCCCCCCCCCCCCCCCCHHHHCCCCCCCH
T ss_conf 132136664444444777368266447998801
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.7e-40 Score=269.89 Aligned_cols=179 Identities=29% Similarity=0.472 Sum_probs=149.9
Q ss_pred CCEEEEEEECCCCCEEEEEEEE--CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCC
Q ss_conf 6703989722477358997543--59228999620365679873789999999999999852799941037646764999
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 eeYeiLKvLGkGSFGkVYKAkl--kGt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNIVrLlGsf~t~de 1119 (1236)
+.|+.++.||+|+||+||+|++ +++.||||++++.... .......+.+|+.+|+.++|||||+++++|.+..
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~- 88 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ-----SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH- 88 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSC-----HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCC-----CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC-
T ss_conf 8567627970188809999999899939999998444435-----8899999999999999778999823899999899-
Q ss_pred CEEEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCEEEEECCCC
Q ss_conf 80999996145898999996404678999999999999999999997994027899996798369998893899743675
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYLeGGSL~elL~qkek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvVKLsDFGLA 1199 (1236)
.+++|||||.+++|..++. ....+++..++.|+.||+.||.|||+++|+||||||+|||++.++ .+||+|||+|
T Consensus 89 -~~~iv~E~~~~g~l~~~~~-~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~----~~Kl~DFG~a 162 (309)
T d1u5ra_ 89 -TAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG----LVKLGDFGSA 162 (309)
T ss_dssp -EEEEEEECCSEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT----EEEECCCTTC
T ss_pred -EEEEEEEECCCCCHHHHHH-HCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCEEEECCCC----CEEEEECCCC
T ss_conf -8899998069994578997-379999999999999999999999868976667884217987999----7898443653
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHCCCC-CCCCCCCC
Q ss_conf 1126864336767888644123206899-99996101
Q 000893 1200 KIKRNTLVTGGVRGTLPWMAPELLNGSS-SKVSEKVC 1235 (1236)
Q Consensus 1200 rli~ss~~tssivGTp~YLAPEVL~Gs~-~~~SdDVD 1235 (1236)
+..... ...+||+.|||||++.+.. ..++..+|
T Consensus 163 ~~~~~~---~~~~GT~~Y~APE~~~~~~~~~y~~~~D 196 (309)
T d1u5ra_ 163 SIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVD 196 (309)
T ss_dssp BSSSSB---CCCCSCGGGCCHHHHTTTTSCCBCTHHH
T ss_pred CCCCCC---CCCCCCCCCCCHHHHHCCCCCCCCCHHH
T ss_conf 346778---7313476636889983467888672145
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.5e-40 Score=271.46 Aligned_cols=180 Identities=27% Similarity=0.425 Sum_probs=153.1
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEE--CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC
Q ss_conf 456703989722477358997543--592289996203656798737899999999999998527999410376467649
Q 000893 1040 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1236)
Q Consensus 1040 s~eeYeiLKvLGkGSFGkVYKAkl--kGt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNIVrLlGsf~t~ 1117 (1236)
..++|++++.||+|+||+||+|++ +++.||||++++.... .......+.+|+.+++.++|||||++++++.+.
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-----~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 76 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-----RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA 76 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS
T ss_pred CHHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCC-----CHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEEC
T ss_conf 654708888972076808999999899979999998457754-----889999999999999863696753303568528
Q ss_pred CCCEEEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCEEEEECC
Q ss_conf 99809999961458989999964046789999999999999999999979940278999967983699988938997436
Q 000893 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1236)
Q Consensus 1118 deg~L~LVMEYLeGGSL~elL~qkek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvVKLsDFG 1197 (1236)
. .+++|||||.+++|..++.. ...+++..++.++.||+.||.|||+++|+||||||+||||+.++ .+||+|||
T Consensus 77 ~--~~~ivmE~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g----~vkL~DFG 149 (316)
T d1fota_ 77 Q--QIFMIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG----HIKITDFG 149 (316)
T ss_dssp S--EEEEEECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS----CEEECCCS
T ss_pred C--EEEEEEEECCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHHHHCCCCEECCCCCCHHEEECCCC----CEEEECCC
T ss_conf 8--00567650378632234322-22111007999999998765541247677055681050386899----88983175
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCC
Q ss_conf 751126864336767888644123206899999961
Q 000893 1198 LSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEK 1233 (1236)
Q Consensus 1198 LArli~ss~~tssivGTp~YLAPEVL~Gs~~~~SdD 1233 (1236)
+|+..... ....+||+.|||||++.+..+..+.|
T Consensus 150 ~a~~~~~~--~~~~~Gt~~Y~APE~l~~~~y~~~~D 183 (316)
T d1fota_ 150 FAKYVPDV--TYTLCGTPDYIAPEVVSTKPYNKSID 183 (316)
T ss_dssp SCEECSSC--BCCCCSCTTTCCHHHHTTCCBCTTHH
T ss_pred CCEEECCC--CCCCCCCCCCCCHHHHCCCCCCCHHH
T ss_conf 21671245--64345763435999983899980430
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-39 Score=268.71 Aligned_cols=186 Identities=28% Similarity=0.371 Sum_probs=158.4
Q ss_pred CCCEEEEEEECCCCCEEEEEEEE--CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
Q ss_conf 56703989722477358997543--5922899962036567987378999999999999985279994103764676499
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1041 ~eeYeiLKvLGkGSFGkVYKAkl--kGt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNIVrLlGsf~t~d 1118 (1236)
.++|++++.||+|+||+||+|++ +++.||||++++........ ......+.+|+.+|+.++|||||+++++|.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 86 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRR--GVSREDIEREVSILKEIQHPNVITLHEVYENKT 86 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSS--SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHH--HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECC
T ss_conf 567798279811789599999999999899999987566321340--689999999999998679989993889999799
Q ss_pred CCEEEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCEEEEECCC
Q ss_conf 98099999614589899999640467899999999999999999999799402789999679836999889389974367
Q 000893 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1236)
Q Consensus 1119 eg~L~LVMEYLeGGSL~elL~qkek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvVKLsDFGL 1198 (1236)
.+++|||||++|+|.+++... ..+++..++.|+.|++.||.|||+++|+||||||+|||++.++.....+||+|||+
T Consensus 87 --~~~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 87 --DVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp --EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred --EEEEEEECCCCCCCCCHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEEECCCCCCCCEEECCHHH
T ss_conf --899999867786431001035-64215578999999999987666254221133301279825898666469643344
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCC
Q ss_conf 511268643367678886441232068999999
Q 000893 1199 SKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVS 1231 (1236)
Q Consensus 1199 Arli~ss~~tssivGTp~YLAPEVL~Gs~~~~S 1231 (1236)
|+...........+||+.|+|||++.+..+..+
T Consensus 164 a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~ 196 (293)
T d1jksa_ 164 AHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLE 196 (293)
T ss_dssp CEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTH
T ss_pred HHHCCCCCCCCCCCCCCCCCCHHHHCCCCCCCC
T ss_conf 210577763122477774309999818999976
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-40 Score=272.67 Aligned_cols=174 Identities=29% Similarity=0.403 Sum_probs=150.0
Q ss_pred CCCEEEEEEECCCCCEEEEEEEE--CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
Q ss_conf 56703989722477358997543--5922899962036567987378999999999999985279994103764676499
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1041 ~eeYeiLKvLGkGSFGkVYKAkl--kGt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNIVrLlGsf~t~d 1118 (1236)
.++|++++.||+|+||+||+|++ +++.||||++.+... .....++.+|+.+++.++|||||++++++.+..
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-------~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~ 76 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-------VDCPENIKKEICINKMLNHENVVKFYGHRREGN 76 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------------CHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHC-------CHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCC
T ss_conf 7460899897217480999999999997999999845664-------127999999999998579988846965404674
Q ss_pred CCEEEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCEEEEECCC
Q ss_conf 98099999614589899999640467899999999999999999999799402789999679836999889389974367
Q 000893 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1236)
Q Consensus 1119 eg~L~LVMEYLeGGSL~elL~qkek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvVKLsDFGL 1198 (1236)
.+++|||||++|+|.+++.. ...+++..++.|+.||+.||.|||+++|+||||||+|||++.++ .+||+|||+
T Consensus 77 --~~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~----~~KL~DFG~ 149 (271)
T d1nvra_ 77 --IQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD----NLKISDFGL 149 (271)
T ss_dssp --EEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC----CEEECCCTT
T ss_pred --EEEEEEECCCCCCHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCC----CEEECCCHH
T ss_conf --36798864589808999753-79999999999999999999999975983575468997887899----879832314
Q ss_pred CCCCCC---CCCCCCCCCCCCCCCHHHHCCCCC
Q ss_conf 511268---643367678886441232068999
Q 000893 1199 SKIKRN---TLVTGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1199 Arli~s---s~~tssivGTp~YLAPEVL~Gs~~ 1228 (1236)
|+.... .......+||+.|||||++.+..+
T Consensus 150 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~ 182 (271)
T d1nvra_ 150 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182 (271)
T ss_dssp CEECEETTEECCBCCCCSCGGGSCTHHHHCSSB
T ss_pred HEEECCCCCCCCCCCEEECCCCCCHHHHCCCCC
T ss_conf 224046886531113255747428728618999
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.1e-40 Score=270.75 Aligned_cols=181 Identities=28% Similarity=0.352 Sum_probs=152.9
Q ss_pred CCCEEEEEEECCCCCEEEEEEEE--CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
Q ss_conf 56703989722477358997543--5922899962036567987378999999999999985279994103764676499
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1041 ~eeYeiLKvLGkGSFGkVYKAkl--kGt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNIVrLlGsf~t~d 1118 (1236)
.+.|++.+.||+|+||+||+|++ +++.||||++.+.... .....+.+|+.+|+.++|||||++++++.+..
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 80 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-------GKEGSMENEIAVLHKIKHPNIVALDDIYESGG 80 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------------CHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHH-------HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECC
T ss_conf 66669988994065839999999999989999998157731-------28999999999998679989991989999899
Q ss_pred CCEEEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCEEEEECCC
Q ss_conf 98099999614589899999640467899999999999999999999799402789999679836999889389974367
Q 000893 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1236)
Q Consensus 1119 eg~L~LVMEYLeGGSL~elL~qkek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvVKLsDFGL 1198 (1236)
.+|+|||||++++|.+++.. ...+++..++.|+.||+.||.|||+++|+||||||+|||+...... ..+||+|||+
T Consensus 81 --~~~lvmE~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~-~~vkl~DFG~ 156 (307)
T d1a06a_ 81 --HLYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDED-SKIMISDFGL 156 (307)
T ss_dssp --EEEEEECCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTT-CCEEECCC--
T ss_pred --EEEEEEECCCCCCHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCEEEEEEECCCCEEECCCCCC-CEEEEECCCE
T ss_conf --88898852689848886530-3678878999999999999875241305568704630011046888-2499831543
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCC
Q ss_conf 5112686433676788864412320689999996
Q 000893 1199 SKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSE 1232 (1236)
Q Consensus 1199 Arli~ss~~tssivGTp~YLAPEVL~Gs~~~~Sd 1232 (1236)
|+...........+||+.|||||++.+..+....
T Consensus 157 a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~ 190 (307)
T d1a06a_ 157 SKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAV 190 (307)
T ss_dssp ----------------CTTSCHHHHTTCCCCTHH
T ss_pred EEECCCCCEEEEEEECCCCCCCHHHCCCCCCCHH
T ss_conf 5872589704400328422591887379998078
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-40 Score=272.67 Aligned_cols=171 Identities=30% Similarity=0.453 Sum_probs=148.2
Q ss_pred CCEEEEEEECCCCCEEEEEEEE--CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCC
Q ss_conf 6703989722477358997543--59228999620365679873789999999999999852799941037646764999
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 eeYeiLKvLGkGSFGkVYKAkl--kGt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNIVrLlGsf~t~de 1119 (1236)
+.|++++.||+|+||+||+|++ ++..||||++++... .....+.+|+.+|+.++|||||++++++.+..
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--------~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~- 82 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE--------EELEDYMVEIDILASCDHPNIVKLLDAFYYEN- 82 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS--------GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCH--------HHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC-
T ss_conf 375984799307781999999999993999999872899--------99999999999998679999884988980099-
Q ss_pred CEEEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCEEEEECCCC
Q ss_conf 80999996145898999996404678999999999999999999997994027899996798369998893899743675
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYLeGGSL~elL~qkek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvVKLsDFGLA 1199 (1236)
.+++|||||++|+|..++......+++..++.|+.||+.||.|||+++|+||||||+|||++.++ .+||+|||+|
T Consensus 83 -~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~----~~Kl~DFG~a 157 (288)
T d2jfla1 83 -NLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDG----DIKLADFGVS 157 (288)
T ss_dssp -EEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS----CEEECCCTTC
T ss_pred -EEEEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEECCHHHEEECCCC----CEEEEECHHH
T ss_conf -58999962799818899986289999999999999999999999988988714070031487899----9899716123
Q ss_pred CCCCCC-CCCCCCCCCCCCCCHHHHCCC
Q ss_conf 112686-433676788864412320689
Q 000893 1200 KIKRNT-LVTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1200 rli~ss-~~tssivGTp~YLAPEVL~Gs 1226 (1236)
+..... ......+||+.|+|||++.+.
T Consensus 158 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~ 185 (288)
T d2jfla1 158 AKNTRTIQRRDSFIGTPYWMAPEVVMCE 185 (288)
T ss_dssp EECHHHHHHHTCCCSCCTTCCHHHHTTC
T ss_pred HCCCCCCCCCCCCCCCCCCCCHHHHHHC
T ss_conf 0357786410010256264799998320
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-40 Score=272.61 Aligned_cols=181 Identities=30% Similarity=0.398 Sum_probs=152.9
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEE--CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC
Q ss_conf 456703989722477358997543--592289996203656798737899999999999998527999410376467649
Q 000893 1040 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1236)
Q Consensus 1040 s~eeYeiLKvLGkGSFGkVYKAkl--kGt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNIVrLlGsf~t~ 1117 (1236)
..++|++++.||+|+||+||+|++ +++.||||++.+.... .+.....+.+|+.+++.++||||++++++|.+.
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 80 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII-----KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD 80 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS
T ss_pred CCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCC-----CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC
T ss_conf 998778988985087909999999899979999998657755-----777899999999999876888861799999989
Q ss_pred CCCEEEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCEEEEECC
Q ss_conf 99809999961458989999964046789999999999999999999979940278999967983699988938997436
Q 000893 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1236)
Q Consensus 1118 deg~L~LVMEYLeGGSL~elL~qkek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvVKLsDFG 1197 (1236)
. .+|+|||||++|+|.+++.. ...+++..++.++.|++.||.|||+++|+||||||+|||++.++ .+||+|||
T Consensus 81 ~--~~~ivmEy~~gg~L~~~~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~----~vkl~DFG 153 (288)
T d1uu3a_ 81 E--KLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM----HIQITDFG 153 (288)
T ss_dssp S--EEEEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS----CEEECCCT
T ss_pred C--EEEEEEECCCCCCHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCCCCCCCCCCC----EEEECCCC
T ss_conf 9--88999970489877776531-59999999999999999999762165088476774123668885----38860321
Q ss_pred CCCCCCCC---CCCCCCCCCCCCCCHHHHCCCCCCCCC
Q ss_conf 75112686---433676788864412320689999996
Q 000893 1198 LSKIKRNT---LVTGGVRGTLPWMAPELLNGSSSKVSE 1232 (1236)
Q Consensus 1198 LArli~ss---~~tssivGTp~YLAPEVL~Gs~~~~Sd 1232 (1236)
+|+..... ......+||+.|+|||++.+..+..+.
T Consensus 154 ~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~ 191 (288)
T d1uu3a_ 154 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSS 191 (288)
T ss_dssp TCEECC----------CCCCGGGCCHHHHHTCCCCHHH
T ss_pred CCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC
T ss_conf 02422567764333555677552584400268989666
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-40 Score=272.76 Aligned_cols=185 Identities=35% Similarity=0.537 Sum_probs=153.4
Q ss_pred CCCCCCCEEEEEEECCCCCEEEEEEEECCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC
Q ss_conf 00345670398972247735899754359228999620365679873789999999999999852799941037646764
Q 000893 1037 QIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1236)
Q Consensus 1037 qiIs~eeYeiLKvLGkGSFGkVYKAklkGt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNIVrLlGsf~t 1116 (1236)
|++..++|++.+.||+|+||+||+|++++ .||||+++..... ......|.+|+.++++++|||||++++++..
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~------~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 75 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPT------PQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 75 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCC------TTHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred CCCCCCCEEEEEEEEECCCCEEEEEEECC-EEEEEEEECCCCC------HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC
T ss_conf 13154518998898307885899999999-8999999734699------8999999999999984799878645679715
Q ss_pred CCCCEEEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCEEEEEC
Q ss_conf 99980999996145898999996404678999999999999999999997994027899996798369998893899743
Q 000893 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1236)
Q Consensus 1117 ~deg~L~LVMEYLeGGSL~elL~qkek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvVKLsDF 1196 (1236)
. .+++|||||++|+|.+++......+++..++.|+.||+.||.|||+++||||||||+|||++.++ .+||+||
T Consensus 76 ~---~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~----~~Kl~DF 148 (276)
T d1uwha_ 76 P---QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL----TVKIGDF 148 (276)
T ss_dssp S---SCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTS----SEEECCC
T ss_pred C---EEEEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCHHHEEECCCC----CEEECCC
T ss_conf 5---89999965899888999852357899999999999999998887509995161478997981899----7887500
Q ss_pred CCCCCCCCC---CCCCCCCCCCCCCCHHHHCCCC-CCCCCCCC
Q ss_conf 675112686---4336767888644123206899-99996101
Q 000893 1197 GLSKIKRNT---LVTGGVRGTLPWMAPELLNGSS-SKVSEKVC 1235 (1236)
Q Consensus 1197 GLArli~ss---~~tssivGTp~YLAPEVL~Gs~-~~~SdDVD 1235 (1236)
|+|+..... ......+||+.|||||++.+.. ..++..+|
T Consensus 149 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sD 191 (276)
T d1uwha_ 149 GLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 191 (276)
T ss_dssp CCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHH
T ss_pred CCEEECCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHH
T ss_conf 2213335567763125665574317999995056899995315
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-40 Score=271.20 Aligned_cols=179 Identities=28% Similarity=0.438 Sum_probs=152.7
Q ss_pred CCCEEEEEEECCCCCEEEEEEEE--CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
Q ss_conf 56703989722477358997543--5922899962036567987378999999999999985279994103764676499
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1041 ~eeYeiLKvLGkGSFGkVYKAkl--kGt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNIVrLlGsf~t~d 1118 (1236)
.++|++++.||+|+||+||+|++ +++.||||++..... .+.....+.+|+.+++.++|||||++++++.+..
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~------~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 76 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM------TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT 76 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS------CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC--
T ss_pred CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHC------CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC
T ss_conf 3337996798308891999999999997999999874657------9799999999999999778999824899999178
Q ss_pred CCEEEEEEEECCCCCHHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHHCC-----CCCCCCCCCCEEECCCCCCCCC
Q ss_conf 98099999614589899999640---467899999999999999999999799-----4027899996798369998893
Q 000893 1119 GGTLATVTEFMVNGSLRHVLLSK---ERHLDRRKRLIIAMDAAFGMEYLHSKN-----IVHFDLKCDNLLVNLKDPIRPI 1190 (1236)
Q Consensus 1119 eg~L~LVMEYLeGGSL~elL~qk---ek~LSe~eil~IA~QILeALeYLHSkG-----IIHRDIKPsNILIDsdG~I~lv 1190 (1236)
...+|+|||||++|+|.+++... ...+++..++.|+.|++.||.|||+++ |+||||||+||||+.++ .
T Consensus 77 ~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~----~ 152 (269)
T d2java1 77 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ----N 152 (269)
T ss_dssp --CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTS----C
T ss_pred CCEEEEEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCC----C
T ss_conf 998999995689993899998515457899999999999999999999997167788788586765425747888----5
Q ss_pred EEEEECCCCCCCCCC-CCCCCCCCCCCCCCHHHHCCCCCC
Q ss_conf 899743675112686-433676788864412320689999
Q 000893 1191 CKVGDFGLSKIKRNT-LVTGGVRGTLPWMAPELLNGSSSK 1229 (1236)
Q Consensus 1191 VKLsDFGLArli~ss-~~tssivGTp~YLAPEVL~Gs~~~ 1229 (1236)
+||+|||+|+..... ......+||+.|||||++.+..+.
T Consensus 153 vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~ 192 (269)
T d2java1 153 VKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYN 192 (269)
T ss_dssp EEECCHHHHHHC-----------CCCSCCCHHHHTTCCCC
T ss_pred EEEEECCCEEECCCCCCCCCCCCCCCCCCCHHHHCCCCCC
T ss_conf 7980010003224577755667788232799998399999
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-39 Score=269.37 Aligned_cols=179 Identities=32% Similarity=0.546 Sum_probs=152.7
Q ss_pred CCCCCCCCEEEEEEECCCCCEEEEEEEE--CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEE
Q ss_conf 0003456703989722477358997543--59228999620365679873789999999999999852799941037646
Q 000893 1036 LQIIKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGV 1113 (1236)
Q Consensus 1036 LqiIs~eeYeiLKvLGkGSFGkVYKAkl--kGt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNIVrLlGs 1113 (1236)
.|++..++|++.+.||+|+||+||+|++ +++.||||+++.... ...+|.+|+.+|+.++|||||+++++
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---------~~~~~~~E~~il~~l~HpnIv~~~~~ 81 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---------EVEEFLKEAAVMKEIKHPNLVQLLGV 81 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS---------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCEECHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCCC---------HHHHHHHHHHHHHHCCCCCEECCCCC
T ss_conf 517457993986598208880899999999996999999777610---------39999999999986799988267752
Q ss_pred EECCCCCEEEEEEEECCCCCHHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCEE
Q ss_conf 7649998099999614589899999640-467899999999999999999999799402789999679836999889389
Q 000893 1114 VQDGPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 1192 (1236)
Q Consensus 1114 f~t~deg~L~LVMEYLeGGSL~elL~qk-ek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvVK 1192 (1236)
|.+.+ .+++|||||++|+|..++... ...+++..++.|+.||+.||.|||+++|+||||||+||||+.++ .+|
T Consensus 82 ~~~~~--~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~----~~K 155 (287)
T d1opja_ 82 CTREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH----LVK 155 (287)
T ss_dssp ECSSS--SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG----CEE
T ss_pred EEECC--EEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCC----CEE
T ss_conf 74578--547876314676067775303554157999999999999978889878930576045768998999----289
Q ss_pred EEECCCCCCCCCCC--CCCCCCCCCCCCCHHHHCCCCCC
Q ss_conf 97436751126864--33676788864412320689999
Q 000893 1193 VGDFGLSKIKRNTL--VTGGVRGTLPWMAPELLNGSSSK 1229 (1236)
Q Consensus 1193 LsDFGLArli~ss~--~tssivGTp~YLAPEVL~Gs~~~ 1229 (1236)
|+|||+|+...... ......|++.|+|||++.+..+.
T Consensus 156 l~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 194 (287)
T d1opja_ 156 VADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 194 (287)
T ss_dssp ECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCS
T ss_pred ECCCCCEEECCCCCCEEECCCCCCCCCCCHHHHCCCCCC
T ss_conf 832445465378872210355665466692787279998
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-39 Score=268.23 Aligned_cols=178 Identities=26% Similarity=0.370 Sum_probs=152.4
Q ss_pred CCCEEEEEEECCCCCEEEEEEEE--CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
Q ss_conf 56703989722477358997543--5922899962036567987378999999999999985279994103764676499
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1041 ~eeYeiLKvLGkGSFGkVYKAkl--kGt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNIVrLlGsf~t~d 1118 (1236)
.++|++++.||+|+||+||+|++ +++.||||++.+.... .......+.+|+.+|+.++|||||++++++.+..
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~-----~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 114 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-----KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCC-----CHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCC
T ss_conf 23708988961176808999999899989999998267745-----8899999999999999748772740344443222
Q ss_pred CCEEEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCEEEEECCC
Q ss_conf 98099999614589899999640467899999999999999999999799402789999679836999889389974367
Q 000893 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1236)
Q Consensus 1119 eg~L~LVMEYLeGGSL~elL~qkek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvVKLsDFGL 1198 (1236)
.+++||||+.+|+|..++... ..+++..++.|+.||+.||.|||+++||||||||+|||++.++ .+||+|||+
T Consensus 115 --~~~~v~e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g----~ikL~DFG~ 187 (350)
T d1rdqe_ 115 --NLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG----YIQVTDFGF 187 (350)
T ss_dssp --EEEEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS----CEEECCCTT
T ss_pred --CCCCCCCCCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHCCCCCCC----CEEEEECEE
T ss_conf --223222233466226667515-8989999999999999989999859986176799993607789----788610103
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCC
Q ss_conf 5112686433676788864412320689999996
Q 000893 1199 SKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSE 1232 (1236)
Q Consensus 1199 Arli~ss~~tssivGTp~YLAPEVL~Gs~~~~Sd 1232 (1236)
|+..... ....+||+.|||||++.+..+....
T Consensus 188 a~~~~~~--~~~~~Gt~~Y~APE~~~~~~~~~~~ 219 (350)
T d1rdqe_ 188 AKRVKGR--TWTLCGTPEALAPEIILSKGYNKAV 219 (350)
T ss_dssp CEECSSC--BCCCEECGGGCCHHHHTTCCBCTHH
T ss_pred EEECCCC--CCCCCCCCCCCCHHHHCCCCCCCCC
T ss_conf 3322566--6433676356788997179988533
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.9e-39 Score=266.04 Aligned_cols=183 Identities=23% Similarity=0.306 Sum_probs=148.5
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEE--CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC
Q ss_conf 3456703989722477358997543--59228999620365679873789999999999999852799941037646764
Q 000893 1039 IKNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1236)
Q Consensus 1039 Is~eeYeiLKvLGkGSFGkVYKAkl--kGt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNIVrLlGsf~t 1116 (1236)
+..++|+++++||+|+||+||+|++ +++.||||++.+..+.... .........+|+.+++.++|||||+++++|.+
T Consensus 1 lslddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~--~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~ 78 (364)
T d1omwa3 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--GETLALNERIMLSLVSTGDCPFIVCMSYAFHT 78 (364)
T ss_dssp CCSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHT--CHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred CCHHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHH--HHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEE
T ss_conf 9777685101884288909999999999979999998458754266--79999999999999850899858899999998
Q ss_pred CCCCEEEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCEEEEEC
Q ss_conf 99980999996145898999996404678999999999999999999997994027899996798369998893899743
Q 000893 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1236)
Q Consensus 1117 ~deg~L~LVMEYLeGGSL~elL~qkek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvVKLsDF 1196 (1236)
.. .+|+|||||++++|..++.. ...+++..++.|+.||+.||.|||+++||||||||+|||++.++ .+||+||
T Consensus 79 ~~--~~~ivmE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g----~iKl~DF 151 (364)
T d1omwa3 79 PD--KLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG----HVRISDL 151 (364)
T ss_dssp SS--EEEEEECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSS----CEEECCC
T ss_pred CC--EEEEEEEECCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCEEEECCCC----CEEEEEE
T ss_conf 99--88999991489838999873-25532789999999999999999977962204442216785889----6798220
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHCC-CCCCCC
Q ss_conf 67511268643367678886441232068-999999
Q 000893 1197 GLSKIKRNTLVTGGVRGTLPWMAPELLNG-SSSKVS 1231 (1236)
Q Consensus 1197 GLArli~ss~~tssivGTp~YLAPEVL~G-s~~~~S 1231 (1236)
|+|+...... ....+||+.|+|||++.+ ..+...
T Consensus 152 Gla~~~~~~~-~~~~~GT~~y~APE~~~~~~~~~~~ 186 (364)
T d1omwa3 152 GLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSS 186 (364)
T ss_dssp TTCEECSSSC-CCSCCSCGGGCCHHHHSTTCCCCTH
T ss_pred CEEEECCCCC-CCCCCCCCCCCHHHHHHCCCCCCCC
T ss_conf 1023337886-4331134554216876038999844
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-39 Score=266.35 Aligned_cols=177 Identities=32% Similarity=0.560 Sum_probs=152.0
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEE-CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC
Q ss_conf 3456703989722477358997543-592289996203656798737899999999999998527999410376467649
Q 000893 1039 IKNEDLEELKELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG 1117 (1236)
Q Consensus 1039 Is~eeYeiLKvLGkGSFGkVYKAkl-kGt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNIVrLlGsf~t~ 1117 (1236)
+..++|++++.||+|+||+||+|++ ++..||||+++..... ..+|.+|+.+++.++|||||+++++|...
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~---------~~~~~~E~~~l~~l~HpnIv~~~g~~~~~ 72 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---------EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 72 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC---------HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCCCC---------HHHHHHHHHHHHHCCCCCCCCCCCEECCC
T ss_conf 896995888898208882999999889999999998788676---------89999999999966899756535243159
Q ss_pred CCCEEEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCEEEEECC
Q ss_conf 99809999961458989999964046789999999999999999999979940278999967983699988938997436
Q 000893 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1236)
Q Consensus 1118 deg~L~LVMEYLeGGSL~elL~qkek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvVKLsDFG 1197 (1236)
. .+++|||||++|+|.+++......+++..++.|+.||+.||.|||+++|+||||||+|||++.++ .+||+|||
T Consensus 73 ~--~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~----~~Kl~DFG 146 (263)
T d1sm2a_ 73 A--PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ----VIKVSDFG 146 (263)
T ss_dssp S--SCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGG----CEEECSCC
T ss_pred C--CEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCHHHEEECCCC----CEEECCCC
T ss_conf 9--33799983699918997520134788999999999999987765316431044315326666887----76865532
Q ss_pred CCCCCCCCC--CCCCCCCCCCCCCHHHHCCCCCCC
Q ss_conf 751126864--336767888644123206899999
Q 000893 1198 LSKIKRNTL--VTGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1198 LArli~ss~--~tssivGTp~YLAPEVL~Gs~~~~ 1230 (1236)
+++...... ......||+.|+|||++.+..+..
T Consensus 147 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ 181 (263)
T d1sm2a_ 147 MTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181 (263)
T ss_dssp ------------------CTTSCCHHHHTTCCCCH
T ss_pred HHEECCCCCCEEECCEECCCCCCCHHHHCCCCCCC
T ss_conf 10023688733504300176667857860799984
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-39 Score=266.91 Aligned_cols=187 Identities=31% Similarity=0.427 Sum_probs=153.4
Q ss_pred CCCCCCCCCCCCCEEEEEEECCCCCEEEEEEEECC-------CEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHC-
Q ss_conf 88521000345670398972247735899754359-------2289996203656798737899999999999998527-
Q 000893 1031 FDISTLQIIKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL- 1102 (1236)
Q Consensus 1031 fdiseLqiIs~eeYeiLKvLGkGSFGkVYKAklkG-------t~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkL- 1102 (1236)
+.....|++..++|++.++||+|+||+||+|++.+ ..||+|.+.... .......+.+|+.++.++
T Consensus 26 ~~~~~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~ 98 (325)
T d1rjba_ 26 YEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-------DSSEREALMSELKMMTQLG 98 (325)
T ss_dssp SCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------------CHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCC-------CHHHHHHHHHHHHHHHHHC
T ss_conf 378744657789939701983078819999998578855420499999966335-------8789999999999999715
Q ss_pred CCCCEEEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHHC----------------------CCCCHHHHHHHHHHHHHH
Q ss_conf 9994103764676499980999996145898999996404----------------------678999999999999999
Q 000893 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE----------------------RHLDRRKRLIIAMDAAFG 1160 (1236)
Q Consensus 1103 rHPNIVrLlGsf~t~deg~L~LVMEYLeGGSL~elL~qke----------------------k~LSe~eil~IA~QILeA 1160 (1236)
+|||||+++++|.+.. .+++|||||++|+|.+++.... ..+++..++.|+.||+.|
T Consensus 99 ~HpnIv~l~~~~~~~~--~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~g 176 (325)
T d1rjba_ 99 SHENIVNLLGACTLSG--PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKG 176 (325)
T ss_dssp CCTTBCCEEEEECSSS--SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHH
T ss_pred CCCCEEEEEEEEEECC--EEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH
T ss_conf 8996868778886299--58999972799959999986257775102210000122200125778999999999999999
Q ss_pred HHHHHHCCCCCCCCCCCCEEECCCCCCCCCEEEEECCCCCCCCCCC---CCCCCCCCCCCCCHHHHCCCCCCC
Q ss_conf 9999979940278999967983699988938997436751126864---336767888644123206899999
Q 000893 1161 MEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1161 LeYLHSkGIIHRDIKPsNILIDsdG~I~lvVKLsDFGLArli~ss~---~tssivGTp~YLAPEVL~Gs~~~~ 1230 (1236)
|.|||+++||||||||+|||++.++ .+||+|||+|+...... .....+||+.|||||++.+..+..
T Consensus 177 l~yLH~~~IiHRDlKp~Nill~~~~----~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ 245 (325)
T d1rjba_ 177 MEFLEFKSCVHRDLAARNVLVTHGK----VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTI 245 (325)
T ss_dssp HHHHHHTTEEETTCSGGGEEEETTT----EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCH
T ss_pred HHHHHHCCEEECCCCHHCCCCCCCC----EEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCC
T ss_conf 9999739905052703214434598----28985142222045778615623435787657838872799996
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-38 Score=262.25 Aligned_cols=180 Identities=31% Similarity=0.486 Sum_probs=146.8
Q ss_pred EEEEEEECCCCCEEEEEEEEC--CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC--CC
Q ss_conf 039897224773589975435--92289996203656798737899999999999998527999410376467649--99
Q 000893 1044 LEELKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG--PG 1119 (1236)
Q Consensus 1044 YeiLKvLGkGSFGkVYKAklk--Gt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNIVrLlGsf~t~--de 1119 (1236)
|++.++||+|+||+||+|+++ +..||+|.+..... .......|.+|+++|+.++|||||+++++|.+. ..
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~------~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 84 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL------TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 84 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS------CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred EEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHC------CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCC
T ss_conf 8851697008284999999999995999999851227------9899999999999998579998506999984033458
Q ss_pred CEEEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCEEECC-CCCCCCCEEEEEC
Q ss_conf 8099999614589899999640467899999999999999999999799--402789999679836-9998893899743
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKN--IVHFDLKCDNLLVNL-KDPIRPICKVGDF 1196 (1236)
Q Consensus 1120 g~L~LVMEYLeGGSL~elL~qkek~LSe~eil~IA~QILeALeYLHSkG--IIHRDIKPsNILIDs-dG~I~lvVKLsDF 1196 (1236)
..+++|||||++++|.+++.. ...+++..++.|+.||+.||.|||+++ |+||||||+|||++. ++ .+||+||
T Consensus 85 ~~~~ivmE~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~----~~Kl~DF 159 (270)
T d1t4ha_ 85 KCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG----SVKIGDL 159 (270)
T ss_dssp EEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTS----CEEECCT
T ss_pred CEEEEEEECCCCCCHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCHHHCEEECCCC----CEEEEEC
T ss_conf 889999957898948999751-35546999999999999999999978997996876743511667999----8898005
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCC
Q ss_conf 675112686433676788864412320689999996101
Q 000893 1197 GLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEKVC 1235 (1236)
Q Consensus 1197 GLArli~ss~~tssivGTp~YLAPEVL~Gs~~~~SdDVD 1235 (1236)
|+|+..... .....+||+.|||||++.+.....++.|+
T Consensus 160 Gla~~~~~~-~~~~~~GT~~Y~aPE~~~~~~~~~~DIwS 197 (270)
T d1t4ha_ 160 GLATLKRAS-FAKAVIGTPEFMAPEMYEEKYDESVDVYA 197 (270)
T ss_dssp TGGGGCCTT-SBEESCSSCCCCCGGGGGTCCCTHHHHHH
T ss_pred CCCEECCCC-CCCCCCCCCCCCCHHHHCCCCCCCCCHHH
T ss_conf 765423687-66775538130089884789998671100
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.7e-39 Score=265.50 Aligned_cols=180 Identities=34% Similarity=0.515 Sum_probs=149.8
Q ss_pred CCCCCCEEEEEEECCCCCEEEEEEEEC--CC---EEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEE
Q ss_conf 034567039897224773589975435--92---2899962036567987378999999999999985279994103764
Q 000893 1038 IIKNEDLEELKELGSGTFGTVYHGKWR--GT---DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 1112 (1236)
Q Consensus 1038 iIs~eeYeiLKvLGkGSFGkVYKAklk--Gt---~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNIVrLlG 1112 (1236)
.+..++|++.+.||+|+||+||+|++. +. .||||.+.... ......+|.+|+.+|++++|||||++++
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~l~g 94 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-------TEKQRRDFLSEASIMGQFDHPNVIHLEG 94 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-------CHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred HHCHHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCC-------CHHHHHHHHHHHHHHHHCCCCCCCCEEE
T ss_conf 208004278569802788299999995799788999999978445-------9899999999999998579988861899
Q ss_pred EEECCCCCEEEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCEE
Q ss_conf 67649998099999614589899999640467899999999999999999999799402789999679836999889389
Q 000893 1113 VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 1192 (1236)
Q Consensus 1113 sf~t~deg~L~LVMEYLeGGSL~elL~qkek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvVK 1192 (1236)
+|.... .+++|||||++|+|..++......+++..++.|+.||+.||.|||+++|+||||||+||||+.++ .+|
T Consensus 95 ~~~~~~--~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~----~~K 168 (299)
T d1jpaa_ 95 VVTKST--PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNL----VCK 168 (299)
T ss_dssp EECSSS--SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC----CEE
T ss_pred EEEECC--EEEEEEEECCCCCCEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCC----CEE
T ss_conf 996288--77999972279853002104567999999999999999988988527983576150448988999----199
Q ss_pred EEECCCCCCCCCCCC------CCCCCCCCCCCCHHHHCCCCCCC
Q ss_conf 974367511268643------36767888644123206899999
Q 000893 1193 VGDFGLSKIKRNTLV------TGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1193 LsDFGLArli~ss~~------tssivGTp~YLAPEVL~Gs~~~~ 1230 (1236)
|+|||+|+....... .....||+.|||||++.+..+..
T Consensus 169 l~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 212 (299)
T d1jpaa_ 169 VSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTS 212 (299)
T ss_dssp ECCC-----------------------CGGGSCHHHHHSCCCCH
T ss_pred ECCCCCCEECCCCCCCCEEEECCCCCCCCCCCCHHHHHCCCCCC
T ss_conf 88844315756777765365025666883003878883699786
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-38 Score=262.56 Aligned_cols=178 Identities=19% Similarity=0.246 Sum_probs=153.0
Q ss_pred CCCEEEEEEECCCCCEEEEEEEE--CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
Q ss_conf 56703989722477358997543--5922899962036567987378999999999999985279994103764676499
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1041 ~eeYeiLKvLGkGSFGkVYKAkl--kGt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNIVrLlGsf~t~d 1118 (1236)
.++|++++.||+|+||+||+|++ +++.||||++++.. .. ...+.+|+.+|+.++|||||+++++|.+..
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-------~~--~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 74 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-------TD--QVLVKKEISILNIARHRNILHLHESFESME 74 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-------HH--HHHHHHHHHHHHHSCCTTBCCEEEEEEETT
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC-------CC--HHHHHHHHHHHHHCCCCCCCEEEEEEEECC
T ss_conf 010588789831778399999998999699999975786-------65--999999999998579979890989998899
Q ss_pred CCEEEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCEEEEECCC
Q ss_conf 98099999614589899999640467899999999999999999999799402789999679836999889389974367
Q 000893 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1236)
Q Consensus 1119 eg~L~LVMEYLeGGSL~elL~qkek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvVKLsDFGL 1198 (1236)
.+|+|||||++++|.+++...+..+++..++.|+.||+.||.|||+++|+||||||+|||++.++.. .+||+|||+
T Consensus 75 --~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~--~ikl~DFG~ 150 (321)
T d1tkia_ 75 --ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSS--TIKIIEFGQ 150 (321)
T ss_dssp --EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCC--CEEECCCTT
T ss_pred --EEEEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCE--EEEECCCCH
T ss_conf --8899995389980889987538999999999999999999999987699751355444344378851--899764411
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCC
Q ss_conf 511268643367678886441232068999999
Q 000893 1199 SKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVS 1231 (1236)
Q Consensus 1199 Arli~ss~~tssivGTp~YLAPEVL~Gs~~~~S 1231 (1236)
++...........++|+.|+|||++.+..+...
T Consensus 151 ~~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~ 183 (321)
T d1tkia_ 151 ARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTA 183 (321)
T ss_dssp CEECCTTCEEEEEESCGGGSCHHHHTTCEECHH
T ss_pred HHCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCH
T ss_conf 100346775321223322234021048777840
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-38 Score=261.34 Aligned_cols=181 Identities=33% Similarity=0.532 Sum_probs=152.2
Q ss_pred CCCCCCEEEEEEECCCCCEEEEEEEECC------CEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEE
Q ss_conf 0345670398972247735899754359------2289996203656798737899999999999998527999410376
Q 000893 1038 IIKNEDLEELKELGSGTFGTVYHGKWRG------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 1111 (1236)
Q Consensus 1038 iIs~eeYeiLKvLGkGSFGkVYKAklkG------t~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNIVrLl 1111 (1236)
++..++|++.++||+|+||.||+|.++. ..||||+++... ......+|.+|+.+++.++|||||+++
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-------~~~~~~~~~~E~~il~~l~H~nIv~~~ 75 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-------TEKQRVDFLGEAGIMGQFSHHNIIRLE 75 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-------CHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CCCHHHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCC-------CHHHHHHHHHHHHHHHHCCCCCEEEEE
T ss_conf 5788996861598117790999999968998787999999988445-------968999999999999856898783236
Q ss_pred EEEECCCCCEEEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCE
Q ss_conf 46764999809999961458989999964046789999999999999999999979940278999967983699988938
Q 000893 1112 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 1191 (1236)
Q Consensus 1112 Gsf~t~deg~L~LVMEYLeGGSL~elL~qkek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvV 1191 (1236)
++|.+.. .+++|||||.+++|..++......+++..++.|+.||+.||.|||+++|+||||||+||||+.++ .+
T Consensus 76 g~~~~~~--~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~----~~ 149 (283)
T d1mqba_ 76 GVISKYK--PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL----VC 149 (283)
T ss_dssp EEECSSS--SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC----CE
T ss_pred EEEECCC--CEEEEEEECCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCC----EE
T ss_conf 7783388--03899972135740222102345420899999999999854121212342576564427888998----49
Q ss_pred EEEECCCCCCCCCC----CCCCCCCCCCCCCCHHHHCCCCCCCC
Q ss_conf 99743675112686----43367678886441232068999999
Q 000893 1192 KVGDFGLSKIKRNT----LVTGGVRGTLPWMAPELLNGSSSKVS 1231 (1236)
Q Consensus 1192 KLsDFGLArli~ss----~~tssivGTp~YLAPEVL~Gs~~~~S 1231 (1236)
||+|||+|+..... .......||+.|+|||++.+..+..+
T Consensus 150 Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~ 193 (283)
T d1mqba_ 150 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSA 193 (283)
T ss_dssp EECCCCC-----------------CCCGGGSCHHHHHSCCCCHH
T ss_pred EECCCCHHHCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCC
T ss_conf 98455103003578765267426777734348888704999973
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-38 Score=262.42 Aligned_cols=179 Identities=32% Similarity=0.541 Sum_probs=150.5
Q ss_pred CCCCCCCCCEEEEEEECCCCCEEEEEEEEC-CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEE
Q ss_conf 100034567039897224773589975435-9228999620365679873789999999999999852799941037646
Q 000893 1035 TLQIIKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGV 1113 (1236)
Q Consensus 1035 eLqiIs~eeYeiLKvLGkGSFGkVYKAklk-Gt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNIVrLlGs 1113 (1236)
.-|++..++|++++.||+|+||+||+|+++ ++.||||+++..... ...|.+|+.++++++|||||+++++
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~---------~~~~~~E~~~l~~l~HpnIv~~~g~ 76 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---------PDAFLAEANLMKQLQHQRLVRLYAV 76 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCEECCHHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCCCC---------HHHHHHHHHHHHHCCCCCEEEEEEE
T ss_conf 7700388993886798107982899999999999999998647688---------8999999999986799988578731
Q ss_pred EECCCCCEEEEEEEECCCCCHHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCEE
Q ss_conf 76499980999996145898999996404-67899999999999999999999799402789999679836999889389
Q 000893 1114 VQDGPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 1192 (1236)
Q Consensus 1114 f~t~deg~L~LVMEYLeGGSL~elL~qke-k~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvVK 1192 (1236)
+... .+++|||||++|+|.+++.... ..+++..++.|+.||+.||.|||+++|+||||||+||||+.++ .+|
T Consensus 77 ~~~~---~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~----~~K 149 (272)
T d1qpca_ 77 VTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL----SCK 149 (272)
T ss_dssp ECSS---SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS----CEE
T ss_pred ECCC---CEEEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEECCC----CEE
T ss_conf 0459---769999957898288887514789887889999999999999999748954675642251562024----404
Q ss_pred EEECCCCCCCCCCC--CCCCCCCCCCCCCHHHHCCCCCC
Q ss_conf 97436751126864--33676788864412320689999
Q 000893 1193 VGDFGLSKIKRNTL--VTGGVRGTLPWMAPELLNGSSSK 1229 (1236)
Q Consensus 1193 LsDFGLArli~ss~--~tssivGTp~YLAPEVL~Gs~~~ 1229 (1236)
|+|||+|+...... ......||+.|+|||++.+..+.
T Consensus 150 l~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~ 188 (272)
T d1qpca_ 150 IADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 188 (272)
T ss_dssp ECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEEC
T ss_pred ECCCCCEEECCCCCCCCCCCCCCCCCCCCHHHHHCCCCC
T ss_conf 234101477358864420356774444582898379998
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-38 Score=260.44 Aligned_cols=178 Identities=34% Similarity=0.501 Sum_probs=148.5
Q ss_pred CCCCCCEEEEEE-ECCCCCEEEEEEEEC----CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEE
Q ss_conf 034567039897-224773589975435----922899962036567987378999999999999985279994103764
Q 000893 1038 IIKNEDLEELKE-LGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 1112 (1236)
Q Consensus 1038 iIs~eeYeiLKv-LGkGSFGkVYKAklk----Gt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNIVrLlG 1112 (1236)
.+..++|.+.+. ||+|+||+||+|.+. +..||||+++... ......+|.+|+.+|++++|||||++++
T Consensus 4 ~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-------~~~~~~~~~~E~~il~~l~HpnIv~l~g 76 (285)
T d1u59a_ 4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-------EKADTEEMMREAQIMHQLDNPYIVRLIG 76 (285)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-------CHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred EECCCCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHC-------CHHHHHHHHHHHHHHHHCCCCCEEEEEE
T ss_conf 654447188784873060809999999608976899999988203-------9789999999999998679988806865
Q ss_pred EEECCCCCEEEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCEE
Q ss_conf 67649998099999614589899999640467899999999999999999999799402789999679836999889389
Q 000893 1113 VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 1192 (1236)
Q Consensus 1113 sf~t~deg~L~LVMEYLeGGSL~elL~qkek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvVK 1192 (1236)
+|... .+++|||||++|+|.+++......+++..++.|+.|++.||.|||+++|+||||||+|||++.++ .+|
T Consensus 77 ~~~~~---~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~----~~K 149 (285)
T d1u59a_ 77 VCQAE---ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH----YAK 149 (285)
T ss_dssp EEESS---SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT----EEE
T ss_pred EECCC---EEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEECCCC----CEE
T ss_conf 60368---07999980789968997521256999999999999999987899868810576764660454688----542
Q ss_pred EEECCCCCCCCCCC----CCCCCCCCCCCCCHHHHCCCCCC
Q ss_conf 97436751126864----33676788864412320689999
Q 000893 1193 VGDFGLSKIKRNTL----VTGGVRGTLPWMAPELLNGSSSK 1229 (1236)
Q Consensus 1193 LsDFGLArli~ss~----~tssivGTp~YLAPEVL~Gs~~~ 1229 (1236)
|+|||+|+...... .....+||+.|+|||++.+..+.
T Consensus 150 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 190 (285)
T d1u59a_ 150 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 190 (285)
T ss_dssp ECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEEC
T ss_pred ECCCHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCC
T ss_conf 03313421155434321135621137433586887279999
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.6e-37 Score=254.32 Aligned_cols=179 Identities=27% Similarity=0.294 Sum_probs=155.6
Q ss_pred CCCEEEEEEECCCCCEEEEEEEE--CCCEEEEEEEECCCCCCCCH-HHHHHHHHHHHHHHHHHHCC-CCCEEEEEEEEEC
Q ss_conf 56703989722477358997543--59228999620365679873-78999999999999985279-9941037646764
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSS-EQERLTLEFWREAEILSKLH-HPNVVAFYGVVQD 1116 (1236)
Q Consensus 1041 ~eeYeiLKvLGkGSFGkVYKAkl--kGt~VAIKvLKk~~l~~~se-e~er~~keFlrEIeILkkLr-HPNIVrLlGsf~t 1116 (1236)
.++|++++.||+|+||+||+|++ +++.||||++++........ ..+.....+.+|+.++++++ ||||++++++|.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf 66388852884176849999999999989999999624464114788899999999999999985079974799762146
Q ss_pred CCCCEEEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCEEEEEC
Q ss_conf 99980999996145898999996404678999999999999999999997994027899996798369998893899743
Q 000893 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1236)
Q Consensus 1117 ~deg~L~LVMEYLeGGSL~elL~qkek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvVKLsDF 1196 (1236)
.. .+|+|||||++++|.+++.. ...+++..++.|+.||+.||.|||+++|+||||||+|||++.++ .+||+||
T Consensus 82 ~~--~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~----~~kl~DF 154 (277)
T d1phka_ 82 NT--FFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM----NIKLTDF 154 (277)
T ss_dssp SS--EEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC----CEEECCC
T ss_pred CC--CEEEEEECCCCCHHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCC----CEEECCC
T ss_conf 76--05999976898668999986-59999999999999999999999875994323462548986899----8387124
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHCCC
Q ss_conf 675112686433676788864412320689
Q 000893 1197 GLSKIKRNTLVTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1197 GLArli~ss~~tssivGTp~YLAPEVL~Gs 1226 (1236)
|+++...........+||+.|+|||++.+.
T Consensus 155 G~a~~~~~~~~~~~~~gt~~y~~PE~~~~~ 184 (277)
T d1phka_ 155 GFSCQLDPGEKLREVCGTPSYLAPEIIECS 184 (277)
T ss_dssp TTCEECCTTCCBCCCCSCGGGCCHHHHHHH
T ss_pred HHEEECCCCCCEEEEECCCCCCCHHHHHCC
T ss_conf 031672688721345246788898886053
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-38 Score=259.34 Aligned_cols=181 Identities=30% Similarity=0.515 Sum_probs=151.0
Q ss_pred CCCCCCCCEEEEEEECCCCCEEEEEEEEC--CC----EEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEE
Q ss_conf 00034567039897224773589975435--92----2899962036567987378999999999999985279994103
Q 000893 1036 LQIIKNEDLEELKELGSGTFGTVYHGKWR--GT----DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVA 1109 (1236)
Q Consensus 1036 LqiIs~eeYeiLKvLGkGSFGkVYKAklk--Gt----~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNIVr 1109 (1236)
++++...+|++++.||+|+||+||+|++. ++ .||||.++... .....++|.+|+.++++++|||||+
T Consensus 3 ~~~~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~ 75 (317)
T d1xkka_ 3 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-------SPKANKEILDEAYVMASVDNPHVCR 75 (317)
T ss_dssp SEECCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----------CTHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCCCHHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCC-------CHHHHHHHHHHHHHHHHCCCCCEEE
T ss_conf 243888999783198208992999999958998898999999965134-------9799999999999998679988815
Q ss_pred EEEEEECCCCCEEEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 76467649998099999614589899999640467899999999999999999999799402789999679836999889
Q 000893 1110 FYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRP 1189 (1236)
Q Consensus 1110 LlGsf~t~deg~L~LVMEYLeGGSL~elL~qkek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~l 1189 (1236)
++++|.+. ..+++|||+.+++|..++......+++..++.|+.||+.||.|||+++||||||||+|||++.++
T Consensus 76 l~g~~~~~---~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~---- 148 (317)
T d1xkka_ 76 LLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ---- 148 (317)
T ss_dssp EEEEEESS---SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT----
T ss_pred EEEEEECC---CEEEEEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCHHHCCEECCCC----
T ss_conf 89999619---83699984268740101113345799999999999999999999876950476212031167998----
Q ss_pred CEEEEECCCCCCCCCCC---CCCCCCCCCCCCCHHHHCCCCCCC
Q ss_conf 38997436751126864---336767888644123206899999
Q 000893 1190 ICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1190 vVKLsDFGLArli~ss~---~tssivGTp~YLAPEVL~Gs~~~~ 1230 (1236)
.+||+|||+|+...... ......||+.|+|||++.+..+..
T Consensus 149 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~ 192 (317)
T d1xkka_ 149 HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 192 (317)
T ss_dssp EEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCH
T ss_pred CEEEECCCCCEECCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCH
T ss_conf 75860255222335444532236510586446708874699983
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-38 Score=257.09 Aligned_cols=181 Identities=30% Similarity=0.405 Sum_probs=149.5
Q ss_pred CCCEEEEEEECCCCCEEEEEEEE--CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHH-HCCCCCEEEEEEEEECC
Q ss_conf 56703989722477358997543--5922899962036567987378999999999999985-27999410376467649
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILS-KLHHPNVVAFYGVVQDG 1117 (1236)
Q Consensus 1041 ~eeYeiLKvLGkGSFGkVYKAkl--kGt~VAIKvLKk~~l~~~see~er~~keFlrEIeILk-kLrHPNIVrLlGsf~t~ 1117 (1236)
.++|++++.||+|+||+||+|++ +++.||||++++.... .......+.+|..++. .++|||||++++++.+.
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~-----~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~ 75 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL-----MDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK 75 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred CCCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCC-----CHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCC
T ss_conf 99718865894087828999999999989999998055533-----8489999999999999847999687898897049
Q ss_pred CCCEEEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCEEEEECC
Q ss_conf 99809999961458989999964046789999999999999999999979940278999967983699988938997436
Q 000893 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1236)
Q Consensus 1118 deg~L~LVMEYLeGGSL~elL~qkek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvVKLsDFG 1197 (1236)
. .+|+|||||++|+|.+++.. ...+++..++.++.||+.||.|||+++|+||||||+|||++..+ .+||+|||
T Consensus 76 ~--~~yivmEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~----~~kl~DFG 148 (320)
T d1xjda_ 76 E--NLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG----HIKIADFG 148 (320)
T ss_dssp S--EEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS----CEEECCCT
T ss_pred C--CEEEEEEECCCCCHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCC----CEECCCCC
T ss_conf 8--31677750379808998640-47899999999999999999999868934034765404444899----63015553
Q ss_pred CCCCCCC-CCCCCCCCCCCCCCCHHHHCCCCCCCCCC
Q ss_conf 7511268-64336767888644123206899999961
Q 000893 1198 LSKIKRN-TLVTGGVRGTLPWMAPELLNGSSSKVSEK 1233 (1236)
Q Consensus 1198 LArli~s-s~~tssivGTp~YLAPEVL~Gs~~~~SdD 1233 (1236)
+|+.... .......+||+.|+|||++.+..+..+.|
T Consensus 149 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 185 (320)
T d1xjda_ 149 MCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVD 185 (320)
T ss_dssp TCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHH
T ss_pred HHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHH
T ss_conf 0232356653345457877768999982799883232
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-38 Score=259.43 Aligned_cols=176 Identities=26% Similarity=0.296 Sum_probs=146.9
Q ss_pred CCCEEEEE-EECCCCCEEEEEEEE--CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHH-CCCCCEEEEEEEEEC
Q ss_conf 56703989-722477358997543--59228999620365679873789999999999999852-799941037646764
Q 000893 1041 NEDLEELK-ELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK-LHHPNVVAFYGVVQD 1116 (1236)
Q Consensus 1041 ~eeYeiLK-vLGkGSFGkVYKAkl--kGt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkk-LrHPNIVrLlGsf~t 1116 (1236)
.++|+++. .||+|+||+||+|++ +++.||||+++.. ..+.+|+.++.+ ++|||||+++++|.+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------------~~~~~E~~~~~~~~~hpnIv~l~~~~~~ 76 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------------PKARREVELHWRASQCPHIVRIVDVYEN 76 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC-------------HHHHHHHHHHHHHCCCCCCCEEEEEEEE
T ss_conf 148798107965454869999998899989999998974-------------7799999999986699997829899950
Q ss_pred --CCCCEEEEEEEECCCCCHHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCEEE
Q ss_conf --99980999996145898999996404-678999999999999999999997994027899996798369998893899
Q 000893 1117 --GPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193 (1236)
Q Consensus 1117 --~deg~L~LVMEYLeGGSL~elL~qke-k~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvVKL 1193 (1236)
.....+|+|||||+||+|.+++...+ ..+++..++.|+.||+.||.|||+++|+||||||+|||++..+.. ..+||
T Consensus 77 ~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~-~~~Kl 155 (335)
T d2ozaa1 77 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPN-AILKL 155 (335)
T ss_dssp EETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTT-CCEEE
T ss_pred CCCCCCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCC-CCCCC
T ss_conf 34689789999977899849999986278775799999999999999999997698644410022011355556-63113
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCC
Q ss_conf 7436751126864336767888644123206899999
Q 000893 1194 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1194 sDFGLArli~ss~~tssivGTp~YLAPEVL~Gs~~~~ 1230 (1236)
+|||+|+...........+||+.|+|||++.+..+..
T Consensus 156 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~ 192 (335)
T d2ozaa1 156 TDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDK 192 (335)
T ss_dssp CCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSH
T ss_pred CCCCEEEECCCCCCCCCCCCCCCCCCCHHHCCCCCCH
T ss_conf 5455123336888643226775637927774898888
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-37 Score=255.74 Aligned_cols=176 Identities=38% Similarity=0.572 Sum_probs=150.8
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEEC-CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
Q ss_conf 4567039897224773589975435-922899962036567987378999999999999985279994103764676499
Q 000893 1040 KNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1040 s~eeYeiLKvLGkGSFGkVYKAklk-Gt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNIVrLlGsf~t~d 1118 (1236)
+.++|+++++||+|+||+||+|+++ ++.||||++++.... ...|.+|+.+++.++||||++++++|.+..
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~---------~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~ 72 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---------EDEFIEEAKVMMNLSHEKLVQLYGVCTKQR 72 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC---------HHHHHHHHHHHHTCCCTTBCCEEEEECCSS
T ss_pred CHHHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCCCC---------HHHHHHHHHHHHHCCCCCEEEEEEEEEECC
T ss_conf 96997996898207883999999889989999998747577---------899999999999668986015889985078
Q ss_pred CCEEEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCEEEEECCC
Q ss_conf 98099999614589899999640467899999999999999999999799402789999679836999889389974367
Q 000893 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1236)
Q Consensus 1119 eg~L~LVMEYLeGGSL~elL~qkek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvVKLsDFGL 1198 (1236)
.+++||||+++|+|..++......+.+..++.|+.|++.||.|||+++|+||||||+|||++.++ .+||+|||+
T Consensus 73 --~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~----~~kl~DfG~ 146 (258)
T d1k2pa_ 73 --PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG----VVKVSDFGL 146 (258)
T ss_dssp --SEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTC----CEEECCCSS
T ss_pred --CEEEEEECCCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEECCCC----CEEECCCHH
T ss_conf --16999970489938886410246776899999999999999987546843466541358876998----479886144
Q ss_pred CCCCCCCC--CCCCCCCCCCCCCHHHHCCCCCCC
Q ss_conf 51126864--336767888644123206899999
Q 000893 1199 SKIKRNTL--VTGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1199 Arli~ss~--~tssivGTp~YLAPEVL~Gs~~~~ 1230 (1236)
++...... ......||+.|+|||++.+..+..
T Consensus 147 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 180 (258)
T d1k2pa_ 147 SRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180 (258)
T ss_dssp CCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCH
T ss_pred HEECCCCCCEEECCCCCCCCCCCCHHHCCCCCCC
T ss_conf 2023578722524657887757807863799885
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-37 Score=254.28 Aligned_cols=178 Identities=34% Similarity=0.551 Sum_probs=149.1
Q ss_pred CCCCCCCEEEEEEECCCCCEEEEEEEEC-CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE
Q ss_conf 0034567039897224773589975435-922899962036567987378999999999999985279994103764676
Q 000893 1037 QIIKNEDLEELKELGSGTFGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQ 1115 (1236)
Q Consensus 1037 qiIs~eeYeiLKvLGkGSFGkVYKAklk-Gt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNIVrLlGsf~ 1115 (1236)
|.+..++|++.+.||+|+||+||+|+++ +..||||+++..... ...|.+|+.++++++|||||+++++|.
T Consensus 12 ~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~---------~~~~~~E~~~l~~l~h~nIv~~~g~~~ 82 (285)
T d1fmka3 12 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---------PEAFLQEAQVMKKLRHEKLVQLYAVVS 82 (285)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---------HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred EECCHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCCCC---------HHHHHHHHHHHHHCCCCCEEEEEEEEE
T ss_conf 07477997984699307980999999999999999998804488---------899999999998666678868999982
Q ss_pred CCCCCEEEEEEEECCCCCHHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCEEEE
Q ss_conf 49998099999614589899999640-46789999999999999999999979940278999967983699988938997
Q 000893 1116 DGPGGTLATVTEFMVNGSLRHVLLSK-ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1236)
Q Consensus 1116 t~deg~L~LVMEYLeGGSL~elL~qk-ek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvVKLs 1194 (1236)
+. .+++|||||++|+|..++... ...+++..++.|+.||+.||.|||.++|+||||||+||||+.++ .+||+
T Consensus 83 ~~---~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~----~~kl~ 155 (285)
T d1fmka3 83 EE---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL----VCKVA 155 (285)
T ss_dssp SS---SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG----CEEEC
T ss_pred CC---CEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHHHHEECCCCCCEEEEECCCC----CEEEC
T ss_conf 39---759999944799435420000355305999999999999999987541143353123079998999----29984
Q ss_pred ECCCCCCCCCCC--CCCCCCCCCCCCCHHHHCCCCCCC
Q ss_conf 436751126864--336767888644123206899999
Q 000893 1195 DFGLSKIKRNTL--VTGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1195 DFGLArli~ss~--~tssivGTp~YLAPEVL~Gs~~~~ 1230 (1236)
|||+|+...... ......||+.|+|||++.+..+..
T Consensus 156 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 193 (285)
T d1fmka3 156 DFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 193 (285)
T ss_dssp CCCTTC--------------CCGGGSCHHHHHHCCCCH
T ss_pred CCCHHHHCCCCCCEEECCCCCCCCCCCHHHHHCCCCCC
T ss_conf 42555425688733524545566545808983799891
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-37 Score=252.12 Aligned_cols=175 Identities=29% Similarity=0.428 Sum_probs=146.2
Q ss_pred CCCEEEEEEECCCCCEEEEEEEE--CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
Q ss_conf 56703989722477358997543--5922899962036567987378999999999999985279994103764676499
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1041 ~eeYeiLKvLGkGSFGkVYKAkl--kGt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNIVrLlGsf~t~d 1118 (1236)
.++|++++.||+|+||+||+|++ +++.||||+++.... .+....++.+|+.+|++++|||||+++++|.+..
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~------~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~ 74 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE------TEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN 74 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred CCCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHC------CHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCC
T ss_conf 9997765177237680999999999997999999802225------7589999999999998679983887445332243
Q ss_pred CCEEEEEEEECCCCCHHHHH-HHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCEEEEECC
Q ss_conf 98099999614589899999-64046789999999999999999999979940278999967983699988938997436
Q 000893 1119 GGTLATVTEFMVNGSLRHVL-LSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFG 1197 (1236)
Q Consensus 1119 eg~L~LVMEYLeGGSL~elL-~qkek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvVKLsDFG 1197 (1236)
.+++||||+.+ .+..++ ......+++..++.|+.|++.||.|||+++||||||||+|||++.++ .+||+|||
T Consensus 75 --~~~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~----~~kl~DFG 147 (298)
T d1gz8a_ 75 --KLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG----AIKLADFG 147 (298)
T ss_dssp --EEEEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS----CEEECSTT
T ss_pred --CEEEEEEECCC-CHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCHHEEECCCC----CCEECCCC
T ss_conf --20378862377-445554420256888899999999999999986528899213571140113467----62103578
Q ss_pred CCCCCCC-CCCCCCCCCCCCCCCHHHHCCCCC
Q ss_conf 7511268-643367678886441232068999
Q 000893 1198 LSKIKRN-TLVTGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1198 LArli~s-s~~tssivGTp~YLAPEVL~Gs~~ 1228 (1236)
+|+.... .......+||+.|+|||++....+
T Consensus 148 ~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~ 179 (298)
T d1gz8a_ 148 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179 (298)
T ss_dssp HHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSS
T ss_pred CCEECCCCCCCCEEECCCCEEEEHHHHCCCCC
T ss_conf 61343688641001036521541122136657
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.5e-37 Score=251.36 Aligned_cols=180 Identities=25% Similarity=0.387 Sum_probs=150.9
Q ss_pred CCCEEEEEEECCCCCEEEEEEEE--CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
Q ss_conf 56703989722477358997543--5922899962036567987378999999999999985279994103764676499
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1041 ~eeYeiLKvLGkGSFGkVYKAkl--kGt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNIVrLlGsf~t~d 1118 (1236)
.++|++++.||+|+||+||+|++ +++.||||++++.... .......|.+|+.+++.++|||||++++++....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~ 80 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLAR-----DPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 80 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTT-----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCC-----CHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECC
T ss_conf 62069868996089929999999999989999998556646-----9899999999999998569998873114354326
Q ss_pred C--CEEEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCEEEEEC
Q ss_conf 9--80999996145898999996404678999999999999999999997994027899996798369998893899743
Q 000893 1119 G--GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1236)
Q Consensus 1119 e--g~L~LVMEYLeGGSL~elL~qkek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvVKLsDF 1196 (1236)
. ..+|+|||||++++|..++... ..+++..++.|+.||+.||.|||+++|+||||||+|||++.++ .++|+||
T Consensus 81 ~~~~~~~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~----~~~l~d~ 155 (277)
T d1o6ya_ 81 PAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN----AVKVMDF 155 (277)
T ss_dssp SSSEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTS----CEEECCC
T ss_pred CCCCEEEEEEECCCCCEEHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCC----CCEEEHH
T ss_conf 8876699999778898710112035-8999999999999999999999857952763467556657543----2010034
Q ss_pred CCCCCCCCC----CCCCCCCCCCCCCCHHHHCCCCCCC
Q ss_conf 675112686----4336767888644123206899999
Q 000893 1197 GLSKIKRNT----LVTGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1197 GLArli~ss----~~tssivGTp~YLAPEVL~Gs~~~~ 1230 (1236)
|++...... ......+||+.|+|||++.+..+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~ 193 (277)
T d1o6ya_ 156 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDA 193 (277)
T ss_dssp TTCEECC----------------TTCCHHHHTTCCCCH
T ss_pred HHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCC
T ss_conf 44322123544333346425762436999983999996
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-37 Score=252.52 Aligned_cols=184 Identities=30% Similarity=0.440 Sum_probs=149.2
Q ss_pred CCCCCCCCCEEEEEEECCCCCEEEEEEEEC-------CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHC-CCCC
Q ss_conf 100034567039897224773589975435-------92289996203656798737899999999999998527-9994
Q 000893 1035 TLQIIKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPN 1106 (1236)
Q Consensus 1035 eLqiIs~eeYeiLKvLGkGSFGkVYKAklk-------Gt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkL-rHPN 1106 (1236)
..|.+..++|++.++||+|+||+||+|++. ++.||||+++... .......+.+|...+.++ +|+|
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-------~~~~~~~~~~e~~~l~~~~~h~~ 78 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-------THSEHRALMSELKILIHIGHHLN 78 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----------CHHHHHHHHHHHHHHHHHCCCTT
T ss_pred CCCCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCC-------CCHHHHHHHHHHHHHHHHCCCCE
T ss_conf 25261679979844984167839999998677755578399999986001-------71789999999999886149984
Q ss_pred EEEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHHC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCC
Q ss_conf 103764676499980999996145898999996404---------------67899999999999999999999799402
Q 000893 1107 VVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------------RHLDRRKRLIIAMDAAFGMEYLHSKNIVH 1171 (1236)
Q Consensus 1107 IVrLlGsf~t~deg~L~LVMEYLeGGSL~elL~qke---------------k~LSe~eil~IA~QILeALeYLHSkGIIH 1171 (1236)
|+.+++++.... ..+++|||||++|+|.+++.... ..+++..++.|+.||+.||.|||+++|+|
T Consensus 79 iv~~~~~~~~~~-~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivH 157 (299)
T d1ywna1 79 VVNLLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIH 157 (299)
T ss_dssp BCCEEEEECSTT-SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred EEEEEEEECCCC-CEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCC
T ss_conf 997411540479-7579999845899299999853666665322202332146899999999999999999887379717
Q ss_pred CCCCCCCEEECCCCCCCCCEEEEECCCCCCCCCC---CCCCCCCCCCCCCCHHHHCCCCCCC
Q ss_conf 7899996798369998893899743675112686---4336767888644123206899999
Q 000893 1172 FDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT---LVTGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1172 RDIKPsNILIDsdG~I~lvVKLsDFGLArli~ss---~~tssivGTp~YLAPEVL~Gs~~~~ 1230 (1236)
|||||+||||+.++ .+||+|||+|+..... ......+||+.|+|||++.+..+..
T Consensus 158 rDlKp~NILl~~~~----~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~ 215 (299)
T d1ywna1 158 RDLAARNILLSEKN----VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 215 (299)
T ss_dssp SCCCGGGEEECGGG----CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCH
T ss_pred CCCCCCCEEECCCC----CEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCC
T ss_conf 86773106577998----28984575200113566522247516672102036864688996
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-37 Score=252.81 Aligned_cols=180 Identities=30% Similarity=0.483 Sum_probs=150.8
Q ss_pred CCCCCCCEEEEEEECCCCCEEEEEEEEC-----CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEE
Q ss_conf 0034567039897224773589975435-----92289996203656798737899999999999998527999410376
Q 000893 1037 QIIKNEDLEELKELGSGTFGTVYHGKWR-----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFY 1111 (1236)
Q Consensus 1037 qiIs~eeYeiLKvLGkGSFGkVYKAklk-----Gt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNIVrLl 1111 (1236)
|++..++|++.+.||+|+||+||+|++. +..||||.++... .......|.+|+.+++.++|||||+++
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~l~ 74 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-------SDSVREKFLQEALTMRQFDHPHIVKLI 74 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-------SHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CCCCHHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCC-------CHHHHHHHHHHHHHHHHCCCCCEEEEE
T ss_conf 9768899698779930788299999993699644999999936566-------879999999999999868999985698
Q ss_pred EEEECCCCCEEEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCE
Q ss_conf 46764999809999961458989999964046789999999999999999999979940278999967983699988938
Q 000893 1112 GVVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 1191 (1236)
Q Consensus 1112 Gsf~t~deg~L~LVMEYLeGGSL~elL~qkek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvV 1191 (1236)
++|.+ +.+++|||||++|+|..++......+++..++.++.||+.||.|||+++|+||||||+|||++.++ .+
T Consensus 75 ~~~~~---~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~----~~ 147 (273)
T d1mp8a_ 75 GVITE---NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND----CV 147 (273)
T ss_dssp EEECS---SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT----EE
T ss_pred EEEEC---CEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCHHHEEECCCC----CE
T ss_conf 89953---747999984069807765422478999999999999998775230226744141026553206789----67
Q ss_pred EEEECCCCCCCCCC--CCCCCCCCCCCCCCHHHHCCCCCCC
Q ss_conf 99743675112686--4336767888644123206899999
Q 000893 1192 KVGDFGLSKIKRNT--LVTGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1192 KLsDFGLArli~ss--~~tssivGTp~YLAPEVL~Gs~~~~ 1230 (1236)
||+|||+|+..... .......||+.|+|||++.+..+..
T Consensus 148 Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~ 188 (273)
T d1mp8a_ 148 KLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 188 (273)
T ss_dssp EECC-------------------CCGGGCCHHHHHHCCCSH
T ss_pred EECCCHHHEECCCCCCEECCCEECCCCCCHHHHHCCCCCCC
T ss_conf 87650342133677623305400583103266751699887
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-37 Score=253.32 Aligned_cols=183 Identities=32% Similarity=0.482 Sum_probs=153.0
Q ss_pred CCCCCCCCEEEEEEECCCCCEEEEEEEEC--CC--EEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHC-CCCCEEEE
Q ss_conf 00034567039897224773589975435--92--289996203656798737899999999999998527-99941037
Q 000893 1036 LQIIKNEDLEELKELGSGTFGTVYHGKWR--GT--DVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHPNVVAF 1110 (1236)
Q Consensus 1036 LqiIs~eeYeiLKvLGkGSFGkVYKAklk--Gt--~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkL-rHPNIVrL 1110 (1236)
...+..++|++.++||+|+||+||+|+++ +. .||||.++... .......|.+|+.+|..+ +|||||++
T Consensus 4 ~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~~HpnIv~~ 76 (309)
T d1fvra_ 4 YPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-------SKDDHRDFAGELEVLCKLGHHPNIINL 76 (309)
T ss_dssp SSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------------CHHHHHHHHHTTCCCCTTBCCE
T ss_pred CCCCCHHHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCC-------CHHHHHHHHHHHHHHHHCCCCCCEEEE
T ss_conf 9966879968877982078828999999899969999999978233-------857999999999999862289988367
Q ss_pred EEEEECCCCCEEEEEEEECCCCCHHHHHHHH---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 6467649998099999614589899999640---------------4678999999999999999999997994027899
Q 000893 1111 YGVVQDGPGGTLATVTEFMVNGSLRHVLLSK---------------ERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLK 1175 (1236)
Q Consensus 1111 lGsf~t~deg~L~LVMEYLeGGSL~elL~qk---------------ek~LSe~eil~IA~QILeALeYLHSkGIIHRDIK 1175 (1236)
+++|.+.. .+++||||+++|+|.+++... ...+++..++.++.||+.||.|||+++|+|||||
T Consensus 77 ~~~~~~~~--~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlk 154 (309)
T d1fvra_ 77 LGACEHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLA 154 (309)
T ss_dssp EEEEEETT--EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred EEEEECCC--EEEEEEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCC
T ss_conf 88884187--3699998028986999986403555551231012345789999999999999999876630895455505
Q ss_pred CCCEEECCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCC
Q ss_conf 99679836999889389974367511268643367678886441232068999999
Q 000893 1176 CDNLLVNLKDPIRPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVS 1231 (1236)
Q Consensus 1176 PsNILIDsdG~I~lvVKLsDFGLArli~ss~~tssivGTp~YLAPEVL~Gs~~~~S 1231 (1236)
|+|||++.++ .+||+|||+|+...........+||..|+|||++.+..+..+
T Consensus 155 p~NIL~~~~~----~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~ 206 (309)
T d1fvra_ 155 ARNILVGENY----VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN 206 (309)
T ss_dssp GGGEEECGGG----CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHH
T ss_pred CCEEEECCCC----CEEECCCCCCCCCCCCCCCCCEECCCCCCCHHHHCCCCCCCC
T ss_conf 2048986887----638743443224442234553013775555387526999962
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.6e-37 Score=250.97 Aligned_cols=180 Identities=31% Similarity=0.510 Sum_probs=150.5
Q ss_pred CCCCCCEEEEEEECCCCCEEEEEEEECC-------CEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEE
Q ss_conf 0345670398972247735899754359-------228999620365679873789999999999999852799941037
Q 000893 1038 IIKNEDLEELKELGSGTFGTVYHGKWRG-------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAF 1110 (1236)
Q Consensus 1038 iIs~eeYeiLKvLGkGSFGkVYKAklkG-------t~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNIVrL 1110 (1236)
++..++|++++.||+|+||+||+|++.+ +.||||+++... ......+|.+|+.+++.++||||+++
T Consensus 9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-------~~~~~~~~~~E~~il~~l~h~niv~~ 81 (301)
T d1lufa_ 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-------SADMQADFQREAALMAEFDNPNIVKL 81 (301)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-------CHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred CCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHC-------CHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 38988938867982078839999998887657788299999988210-------85799999999999996689976552
Q ss_pred EEEEECCCCCEEEEEEEECCCCCHHHHHHHHC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHC
Q ss_conf 64676499980999996145898999996404-----------------------6789999999999999999999979
Q 000893 1111 YGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE-----------------------RHLDRRKRLIIAMDAAFGMEYLHSK 1167 (1236)
Q Consensus 1111 lGsf~t~deg~L~LVMEYLeGGSL~elL~qke-----------------------k~LSe~eil~IA~QILeALeYLHSk 1167 (1236)
+++|.... .+++||||+++++|.+++.... ..+++..++.|+.|++.||.|||++
T Consensus 82 ~~~~~~~~--~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~ 159 (301)
T d1lufa_ 82 LGVCAVGK--PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER 159 (301)
T ss_dssp EEEECSSS--SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEECCCC--CEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCC
T ss_conf 46660598--0389998158992999998527554210000111001210346788989999999999999985541357
Q ss_pred CCCCCCCCCCCEEECCCCCCCCCEEEEECCCCCCCCCC---CCCCCCCCCCCCCCHHHHCCCCCCC
Q ss_conf 94027899996798369998893899743675112686---4336767888644123206899999
Q 000893 1168 NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT---LVTGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1168 GIIHRDIKPsNILIDsdG~I~lvVKLsDFGLArli~ss---~~tssivGTp~YLAPEVL~Gs~~~~ 1230 (1236)
+||||||||+|||++.++ .+||+|||+|+..... ......+|++.|+|||++.+..++.
T Consensus 160 ~ivHrDlKp~NILld~~~----~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ 221 (301)
T d1lufa_ 160 KFVHRDLATRNCLVGENM----VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTT 221 (301)
T ss_dssp TCCCSCCSGGGEEECGGG----CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCH
T ss_pred CEEEEEECCCCEEECCCC----CEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCH
T ss_conf 868548840116898999----28983314421136776411157777676767989972688980
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.7e-36 Score=246.91 Aligned_cols=170 Identities=22% Similarity=0.337 Sum_probs=146.9
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEE--CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCC-CCCEEEEEEEEEC
Q ss_conf 456703989722477358997543--5922899962036567987378999999999999985279-9941037646764
Q 000893 1040 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQD 1116 (1236)
Q Consensus 1040 s~eeYeiLKvLGkGSFGkVYKAkl--kGt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLr-HPNIVrLlGsf~t 1116 (1236)
..++|+++++||+|+||+||+|++ +++.||||++++.. ..++.+|+.+|+.++ ||||++++++|..
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~ 101 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----------KKKIKREIKILENLRGGPNIITLADIVKD 101 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----------HHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH-----------HHHHHHHHHHHHHCCCCCCCCEEEEEEEE
T ss_conf 9867189789831748199999988999799999988899-----------99999999999851579987679999981
Q ss_pred CCCCEEEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCEEEEEC
Q ss_conf 99980999996145898999996404678999999999999999999997994027899996798369998893899743
Q 000893 1117 GPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1236)
Q Consensus 1117 ~deg~L~LVMEYLeGGSL~elL~qkek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvVKLsDF 1196 (1236)
.....+++|||||.+++|..+. +.+++..++.++.||+.||.|||+++|+||||||+|||++.++. .+||+||
T Consensus 102 ~~~~~~~~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~---~vkl~DF 174 (328)
T d3bqca1 102 PVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR---KLRLIDW 174 (328)
T ss_dssp TTTCSEEEEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT---EEEECCG
T ss_pred CCCCCEEEEEEECCCCCHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCC---EEEECCC
T ss_conf 6877126888631798589974----68999999999999999998876433443456441237748998---3664156
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHCCCC
Q ss_conf 6751126864336767888644123206899
Q 000893 1197 GLSKIKRNTLVTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1197 GLArli~ss~~tssivGTp~YLAPEVL~Gs~ 1227 (1236)
|+|+...........++|+.|+|||++.+..
T Consensus 175 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 205 (328)
T d3bqca1 175 GLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 205 (328)
T ss_dssp GGCEECCTTCCCCSCCSCGGGCCHHHHTTCC
T ss_pred CCCEECCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 5426646887444322486424761026888
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-37 Score=251.60 Aligned_cols=172 Identities=30% Similarity=0.396 Sum_probs=141.7
Q ss_pred EEEEEECCCCCEEEEEEEE--CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCEE
Q ss_conf 3989722477358997543--59228999620365679873789999999999999852799941037646764999809
Q 000893 1045 EELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTL 1122 (1236)
Q Consensus 1045 eiLKvLGkGSFGkVYKAkl--kGt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNIVrLlGsf~t~deg~L 1122 (1236)
+.+++||+|+||+||+|++ +++.||||+++...... ........+.+|+.+++.++|||||+++++|.... .+
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~---~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~--~~ 75 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSE---AKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS--NI 75 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC---------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT--CC
T ss_pred CCCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHH---HHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCC--CE
T ss_conf 95638512728299999999999699999984202124---56799999999999998679999868985422587--40
Q ss_pred EEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCEEEEECCCCCCC
Q ss_conf 99996145898999996404678999999999999999999997994027899996798369998893899743675112
Q 000893 1123 ATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 1202 (1236)
Q Consensus 1123 ~LVMEYLeGGSL~elL~qkek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvVKLsDFGLArli 1202 (1236)
++|||||.++++..++ .....+++..++.|+.||+.||.|||+++|+||||||+|||++.++ .+||+|||+|+..
T Consensus 76 ~ivmE~~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~----~~KL~DFG~a~~~ 150 (299)
T d1ua2a_ 76 SLVFDFMETDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG----VLKLADFGLAKSF 150 (299)
T ss_dssp EEEEECCSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC----CEEECCCGGGSTT
T ss_pred EEHHHHHCCHHHHHHH-HCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCC----CCCCCCCCCCCCC
T ss_conf 2204553450776554-1266778999999999999999886316355035776258853778----4114657610005
Q ss_pred CCC-CCCCCCCCCCCCCCHHHHCCC
Q ss_conf 686-433676788864412320689
Q 000893 1203 RNT-LVTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1203 ~ss-~~tssivGTp~YLAPEVL~Gs 1226 (1236)
... ......+||+.|+|||++.+.
T Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~ 175 (299)
T d1ua2a_ 151 GSPNRAYTHQVVTRWYRAPELLFGA 175 (299)
T ss_dssp TSCCCCCCCSCCCCTTCCHHHHTTC
T ss_pred CCCCCCCCCEECCHHHCCHHHHCCC
T ss_conf 7875543302047333639997267
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-37 Score=251.66 Aligned_cols=168 Identities=32% Similarity=0.503 Sum_probs=139.6
Q ss_pred EEECCCCCEEEEEEEEC----CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCEEE
Q ss_conf 97224773589975435----92289996203656798737899999999999998527999410376467649998099
Q 000893 1048 KELGSGTFGTVYHGKWR----GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGGTLA 1123 (1236)
Q Consensus 1048 KvLGkGSFGkVYKAklk----Gt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNIVrLlGsf~t~deg~L~ 1123 (1236)
++||+|+||+||+|.+. ++.||||+++.... ......+|.+|+.+|++++|||||+++++|... .++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~------~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~---~~~ 83 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN------DPALKDELLAEANVMQQLDNPYIVRMIGICEAE---SWM 83 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS---SEE
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHC------CHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCC---CEE
T ss_conf 78345878299999981697385999999880108------989999999999999867998985277775059---779
Q ss_pred EEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCEEEEECCCCCCCC
Q ss_conf 99961458989999964046789999999999999999999979940278999967983699988938997436751126
Q 000893 1124 TVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKR 1203 (1236)
Q Consensus 1124 LVMEYLeGGSL~elL~qkek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvVKLsDFGLArli~ 1203 (1236)
+|||||++|+|.+++.. ...+++..++.|+.||+.||.|||+++|+||||||+|||++.++ .+||+|||+++...
T Consensus 84 lvmE~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~----~~kl~DFGla~~~~ 158 (277)
T d1xbba_ 84 LVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH----YAKISDFGLSKALR 158 (277)
T ss_dssp EEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT----EEEECCCTTCEECC
T ss_pred EEEECCCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCCCCC----CCCCCCHHHHHHCC
T ss_conf 99974788968999752-25789999999999999997668747955677761131023567----51234134533134
Q ss_pred CCC----CCCCCCCCCCCCCHHHHCCCCCC
Q ss_conf 864----33676788864412320689999
Q 000893 1204 NTL----VTGGVRGTLPWMAPELLNGSSSK 1229 (1236)
Q Consensus 1204 ss~----~tssivGTp~YLAPEVL~Gs~~~ 1229 (1236)
... ......||+.|+|||++.+..+.
T Consensus 159 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 188 (277)
T d1xbba_ 159 ADENYYKAQTHGKWPVKWYAPECINYYKFS 188 (277)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEE
T ss_pred CCCCCCCCCCCCCCCCEECCCHHHCCCCCC
T ss_conf 323443224456778420391665379998
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-36 Score=245.80 Aligned_cols=182 Identities=31% Similarity=0.458 Sum_probs=152.3
Q ss_pred CCCCCCCCCEEEEEEECCCCCEEEEEEEEC-------CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCE
Q ss_conf 100034567039897224773589975435-------9228999620365679873789999999999999852799941
Q 000893 1035 TLQIIKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV 1107 (1236)
Q Consensus 1035 eLqiIs~eeYeiLKvLGkGSFGkVYKAklk-------Gt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNI 1107 (1236)
..|++..++|++.+.||+|+||+||+|.++ ++.||||+++... .......|.+|+.++++++||||
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-------~~~~~~~~~~E~~il~~l~h~nI 85 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-------SMRERIEFLNEASVMKEFNCHHV 85 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-------CHHHHHHHHHHHHHGGGCCCTTB
T ss_pred CCEEECHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCC-------CHHHHHHHHHHHHHHHHCCCCCE
T ss_conf 10042689918835982078818999998786447789689999987012-------86899999999999997699988
Q ss_pred EEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHHC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 03764676499980999996145898999996404---------678999999999999999999997994027899996
Q 000893 1108 VAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDN 1178 (1236)
Q Consensus 1108 VrLlGsf~t~deg~L~LVMEYLeGGSL~elL~qke---------k~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsN 1178 (1236)
|+++++|.... .+++|||||++|+|..++.... ..+++..++.|+.|++.||.|||+++|+||||||+|
T Consensus 86 v~~~~~~~~~~--~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~N 163 (308)
T d1p4oa_ 86 VRLLGVVSQGQ--PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARN 163 (308)
T ss_dssp CCEEEEECSSS--SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGG
T ss_pred EEEEEEEECCC--CEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECEECCCC
T ss_conf 41254784288--1067776048998899987503321134446887999999999999999998764796543286775
Q ss_pred EEECCCCCCCCCEEEEECCCCCCCCCCC---CCCCCCCCCCCCCHHHHCCCCCC
Q ss_conf 7983699988938997436751126864---33676788864412320689999
Q 000893 1179 LLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSK 1229 (1236)
Q Consensus 1179 ILIDsdG~I~lvVKLsDFGLArli~ss~---~tssivGTp~YLAPEVL~Gs~~~ 1229 (1236)
||++.++ .+||+|||+|+...... ......||+.|+|||.+.+..+.
T Consensus 164 iLld~~~----~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~ 213 (308)
T d1p4oa_ 164 CMVAEDF----TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT 213 (308)
T ss_dssp EEECTTC----CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC
T ss_pred EEECCCC----EEEEEECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCC
T ss_conf 4035996----4999424542023577630313402316323788887369988
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-37 Score=252.02 Aligned_cols=177 Identities=36% Similarity=0.558 Sum_probs=152.2
Q ss_pred CCCCCCCEEEEEEECCCCCEEEEEEEECCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC
Q ss_conf 00345670398972247735899754359228999620365679873789999999999999852799941037646764
Q 000893 1037 QIIKNEDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQD 1116 (1236)
Q Consensus 1037 qiIs~eeYeiLKvLGkGSFGkVYKAklkGt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNIVrLlGsf~t 1116 (1236)
|.+..++|++++.||+|+||.||+|+++++.||||+++... ..+.|.+|+.++++++||||++++++|.+
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~----------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~ 71 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----------TAQAFLAEASVMTQLRHSNLVQLLGVIVE 71 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------------HHHHHTHHHHTTCCCTTBCCEEEEECC
T ss_pred CCCCHHHEEEEEEEECCCCEEEEEEEECCEEEEEEEECCHH----------HHHHHHHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf 95578994885798207980899999999099999988577----------79999999999986789898549878872
Q ss_pred CCCCEEEEEEEECCCCCHHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCEEEEE
Q ss_conf 99980999996145898999996404-67899999999999999999999799402789999679836999889389974
Q 000893 1117 GPGGTLATVTEFMVNGSLRHVLLSKE-RHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1236)
Q Consensus 1117 ~deg~L~LVMEYLeGGSL~elL~qke-k~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvVKLsD 1195 (1236)
.+ ..+++||||+++|+|.+++.... ..+++..++.|+.||+.||.|||+++|+||||||+|||++.++ .+||+|
T Consensus 72 ~~-~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~----~~kl~d 146 (262)
T d1byga_ 72 EK-GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN----VAKVSD 146 (262)
T ss_dssp C---CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS----CEEECC
T ss_pred CC-CCEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCEECCCCCHHHHEECCCC----CEEECC
T ss_conf 38-9289999636999899998745788889999999999998523211337655366656760146899----776324
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCC
Q ss_conf 36751126864336767888644123206899999
Q 000893 1196 FGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1196 FGLArli~ss~~tssivGTp~YLAPEVL~Gs~~~~ 1230 (1236)
||+++...... ....+++.|+|||++.+..++.
T Consensus 147 fg~s~~~~~~~--~~~~~~~~y~aPE~l~~~~~t~ 179 (262)
T d1byga_ 147 FGLTKEASSTQ--DTGKLPVKWTAPEALREKKFST 179 (262)
T ss_dssp CCC--------------CCTTTSCHHHHHHCCCCH
T ss_pred CCCCEECCCCC--CCCCCCCCCCCHHHHHCCCCCH
T ss_conf 56003447877--6556664677817872798885
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-36 Score=245.12 Aligned_cols=187 Identities=31% Similarity=0.418 Sum_probs=155.1
Q ss_pred CCCCCCCCCCCCCEEEEEEECCCCCEEEEEEEEC-------CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHC-
Q ss_conf 8852100034567039897224773589975435-------92289996203656798737899999999999998527-
Q 000893 1031 FDISTLQIIKNEDLEELKELGSGTFGTVYHGKWR-------GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL- 1102 (1236)
Q Consensus 1031 fdiseLqiIs~eeYeiLKvLGkGSFGkVYKAklk-------Gt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkL- 1102 (1236)
+.....|.+..++|++.++||+|+||.||+|++. ++.||||++++.. .......|.+|+.+++.+
T Consensus 12 ~~~~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-------~~~~~~~~~~E~~~~~~l~ 84 (311)
T d1t46a_ 12 LPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-------HLTEREALMSELKVLSYLG 84 (311)
T ss_dssp SCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-------CHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCCHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCC-------CHHHHHHHHHHHHHHHHCC
T ss_conf 898402637789969854982068829999998066447788699999987424-------8779999999999987626
Q ss_pred CCCCEEEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHHC-----------------CCCCHHHHHHHHHHHHHHHHHHH
Q ss_conf 9994103764676499980999996145898999996404-----------------67899999999999999999999
Q 000893 1103 HHPNVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE-----------------RHLDRRKRLIIAMDAAFGMEYLH 1165 (1236)
Q Consensus 1103 rHPNIVrLlGsf~t~deg~L~LVMEYLeGGSL~elL~qke-----------------k~LSe~eil~IA~QILeALeYLH 1165 (1236)
+|||||+++++|.+.. .+++|||||++++|..++.... ..+++..++.|+.||+.||.|||
T Consensus 85 ~HpnIv~~~g~~~~~~--~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH 162 (311)
T d1t46a_ 85 NHMNIVNLLGACTIGG--PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA 162 (311)
T ss_dssp CCTTBCCEEEEECSSS--SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCEEEEEEEEEECC--EEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH
T ss_conf 9998878998983199--78999973799879999985356654444453322233458899999999999999999887
Q ss_pred HCCCCCCCCCCCCEEECCCCCCCCCEEEEECCCCCCCCCC---CCCCCCCCCCCCCCHHHHCCCCCCC
Q ss_conf 7994027899996798369998893899743675112686---4336767888644123206899999
Q 000893 1166 SKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNT---LVTGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1166 SkGIIHRDIKPsNILIDsdG~I~lvVKLsDFGLArli~ss---~~tssivGTp~YLAPEVL~Gs~~~~ 1230 (1236)
+++|+||||||+|||++.++ .+||+|||+++..... ......+||+.|+|||++.+..+..
T Consensus 163 ~~~ivHrDLKp~NIl~~~~~----~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 226 (311)
T d1t46a_ 163 SKNCIHRDLAARNILLTHGR----ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF 226 (311)
T ss_dssp HTTCCCSCCSGGGEEEETTT----EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCH
T ss_pred HCCEEECCCCCCCCCCCCCC----CCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCC
T ss_conf 57926662410210000257----52102340102336788615862013596876778861799997
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-36 Score=246.57 Aligned_cols=170 Identities=26% Similarity=0.305 Sum_probs=139.7
Q ss_pred CCEEEEEEECCCCCEEEEEEEE--CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC--
Q ss_conf 6703989722477358997543--592289996203656798737899999999999998527999410376467649--
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG-- 1117 (1236)
Q Consensus 1042 eeYeiLKvLGkGSFGkVYKAkl--kGt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNIVrLlGsf~t~-- 1117 (1236)
.+|+.+++||+|+||+||+|++ +++.||||++++... .+.+|+.+|+.++||||++++++|...
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------------~~~~Ei~il~~l~h~niv~~~~~~~~~~~ 87 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------FKNRELQIMRKLDHCNIVRLRYFFYSSGE 87 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------------SCCHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH------------HHHHHHHHHHHCCCCCCCCEEEEEEECCC
T ss_conf 776751698217683999999999997999999881606------------89999999986689898738789974476
Q ss_pred --CCCEEEEEEEECCCCCHHHHHH--HHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCEEE
Q ss_conf --9980999996145898999996--404678999999999999999999997994027899996798369998893899
Q 000893 1118 --PGGTLATVTEFMVNGSLRHVLL--SKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193 (1236)
Q Consensus 1118 --deg~L~LVMEYLeGGSL~elL~--qkek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvVKL 1193 (1236)
+..++++|||||+++.+..+.. .....+++..++.|+.||+.||.|||+++|+||||||+|||++.++ ..+||
T Consensus 88 ~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~---~~~kl 164 (350)
T d1q5ka_ 88 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT---AVLKL 164 (350)
T ss_dssp CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTT---CCEEE
T ss_pred CCCCEEEEEEEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCC---CCEEE
T ss_conf 577318999984168860788886310368999999999999999999999866876457886037873589---71167
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCHHHHCCC
Q ss_conf 743675112686433676788864412320689
Q 000893 1194 GDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1194 sDFGLArli~ss~~tssivGTp~YLAPEVL~Gs 1226 (1236)
+|||+++...........+|++.|+|||++.+.
T Consensus 165 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~ 197 (350)
T d1q5ka_ 165 CDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 197 (350)
T ss_dssp CCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTC
T ss_pred ECCCCHHHCCCCCCCCCCCCCCCCCCHHHHHCC
T ss_conf 336605440477653200255555682776404
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-36 Score=244.87 Aligned_cols=185 Identities=30% Similarity=0.438 Sum_probs=153.3
Q ss_pred CCCCCCCCEEEEEEECCCCCEEEEEEEECC---------CEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHC-CCC
Q ss_conf 000345670398972247735899754359---------2289996203656798737899999999999998527-999
Q 000893 1036 LQIIKNEDLEELKELGSGTFGTVYHGKWRG---------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKL-HHP 1105 (1236)
Q Consensus 1036 LqiIs~eeYeiLKvLGkGSFGkVYKAklkG---------t~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkL-rHP 1105 (1236)
-|.+..++|++.+.||+|+||.||+|+..+ ..||||++++.. ......++.+|...+.++ +||
T Consensus 7 ~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-------~~~~~~~~~~e~~~l~~~~~Hp 79 (299)
T d1fgka_ 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-------TEKDLSDLISEMEMMKMIGKHK 79 (299)
T ss_dssp TTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-------CHHHHHHHHHHHHHHHHHCCCT
T ss_pred CCCCCHHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCC-------CHHHHHHHHHHHHHHHHHCCCC
T ss_conf 672258996970098516782899999857875556675499999988112-------8688999999999999813999
Q ss_pred CEEEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHHC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCC
Q ss_conf 4103764676499980999996145898999996404---------------6789999999999999999999979940
Q 000893 1106 NVVAFYGVVQDGPGGTLATVTEFMVNGSLRHVLLSKE---------------RHLDRRKRLIIAMDAAFGMEYLHSKNIV 1170 (1236)
Q Consensus 1106 NIVrLlGsf~t~deg~L~LVMEYLeGGSL~elL~qke---------------k~LSe~eil~IA~QILeALeYLHSkGII 1170 (1236)
|||+++++|.+.. .+++|||||++|+|.+++.... ..+++..++.|+.||+.||.|||+++||
T Consensus 80 nIv~~~~~~~~~~--~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~iv 157 (299)
T d1fgka_ 80 NIINLLGACTQDG--PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCI 157 (299)
T ss_dssp TBCCEEEEECSSS--SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred EEEECCCCCCCCC--EEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEE
T ss_conf 6973465220188--68999973699909999986067764322233457434679999999999999999876637978
Q ss_pred CCCCCCCCEEECCCCCCCCCEEEEECCCCCCCCCCC---CCCCCCCCCCCCCHHHHCCCCCCCCCCCC
Q ss_conf 278999967983699988938997436751126864---33676788864412320689999996101
Q 000893 1171 HFDLKCDNLLVNLKDPIRPICKVGDFGLSKIKRNTL---VTGGVRGTLPWMAPELLNGSSSKVSEKVC 1235 (1236)
Q Consensus 1171 HRDIKPsNILIDsdG~I~lvVKLsDFGLArli~ss~---~tssivGTp~YLAPEVL~Gs~~~~SdDVD 1235 (1236)
||||||+|||++.++ .+||+|||+++...... ......|++.|+|||++.+.. ++.++|
T Consensus 158 HrDiKp~NiLl~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~--y~~k~D 219 (299)
T d1fgka_ 158 HRDLAARNVLVTEDN----VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI--YTHQSD 219 (299)
T ss_dssp CSCCSGGGEEECTTC----CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCC--CCHHHH
T ss_pred EEEECCCCEEECCCC----CEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCC--CCCHHH
T ss_conf 630221022454789----76762211101135555543146678884663266751798--882555
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-37 Score=250.72 Aligned_cols=181 Identities=34% Similarity=0.542 Sum_probs=151.5
Q ss_pred CCCCCCEEEEEEECCCCCEEEEEEEEC---C--CEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEE
Q ss_conf 034567039897224773589975435---9--22899962036567987378999999999999985279994103764
Q 000893 1038 IIKNEDLEELKELGSGTFGTVYHGKWR---G--TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYG 1112 (1236)
Q Consensus 1038 iIs~eeYeiLKvLGkGSFGkVYKAklk---G--t~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNIVrLlG 1112 (1236)
.+..++|++++.||+|+||.||+|++. + ..||||++++.... ......+|.+|+.+|++++|||||++++
T Consensus 4 ~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~-----~~~~~~~~~~Ei~~l~~l~H~nIv~~~g 78 (273)
T d1u46a_ 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS-----QPEAMDDFIREVNAMHSLDHRNLIRLYG 78 (273)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC-------------CHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred EECHHHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCC-----CHHHHHHHHHHHHHHHHCCCCCEEEEEE
T ss_conf 88648919978980388839999999889990799999999835557-----9899999999999998689999878987
Q ss_pred EEECCCCCEEEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCEE
Q ss_conf 67649998099999614589899999640467899999999999999999999799402789999679836999889389
Q 000893 1113 VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 1192 (1236)
Q Consensus 1113 sf~t~deg~L~LVMEYLeGGSL~elL~qkek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvVK 1192 (1236)
+|.+. .+++|||||++++|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++.++ .+|
T Consensus 79 ~~~~~---~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~----~vk 151 (273)
T d1u46a_ 79 VVLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD----LVK 151 (273)
T ss_dssp EECSS---SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT----EEE
T ss_pred EEEEC---CHHEEEEEECCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECHHHHCCCCCC----CEE
T ss_conf 77401---00114654238612544421268999999999999999999875217875205668881565565----433
Q ss_pred EEECCCCCCCCCCC----CCCCCCCCCCCCCHHHHCCCCCCC
Q ss_conf 97436751126864----336767888644123206899999
Q 000893 1193 VGDFGLSKIKRNTL----VTGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1193 LsDFGLArli~ss~----~tssivGTp~YLAPEVL~Gs~~~~ 1230 (1236)
|+|||+++...... ......|+..|+|||++.+..+..
T Consensus 152 l~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 193 (273)
T d1u46a_ 152 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSH 193 (273)
T ss_dssp ECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEH
T ss_pred ECCCHHHHHCCCCCCCCEECCCCCCCCCCCCHHHHHCCCCCC
T ss_conf 256115553035887526547632573107999983799994
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-36 Score=244.41 Aligned_cols=182 Identities=29% Similarity=0.371 Sum_probs=145.6
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEC---CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHH---CCCCCEEEEEEEE
Q ss_conf 567039897224773589975435---9228999620365679873789999999999999852---7999410376467
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKWR---GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSK---LHHPNVVAFYGVV 1114 (1236)
Q Consensus 1041 ~eeYeiLKvLGkGSFGkVYKAklk---Gt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkk---LrHPNIVrLlGsf 1114 (1236)
.++|+++++||+|+||+||+|++. ++.||||+++........ ...+.+|+.+++. ++||||++++++|
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~------~~~~~~E~~~l~~l~~~~HpnIv~~~~~~ 79 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM------PLSTIREVAVLRHLETFEHPNVVRLFDVC 79 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC------BCTHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHH------HHHHHHHHHHHHHHHHCCCCCCCEEEEEE
T ss_conf 589798889921558699999998889989999998023245167------99999999999987425898802366322
Q ss_pred ECC---CCCEEEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCE
Q ss_conf 649---99809999961458989999964046789999999999999999999979940278999967983699988938
Q 000893 1115 QDG---PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPIC 1191 (1236)
Q Consensus 1115 ~t~---deg~L~LVMEYLeGGSL~elL~qkek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvV 1191 (1236)
... ....++++|||+.++.+..........+++..++.|+.|++.||.|||+++|+||||||+|||++..+ .+
T Consensus 80 ~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~----~~ 155 (305)
T d1blxa_ 80 TVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG----QI 155 (305)
T ss_dssp EEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC----CE
T ss_pred CCCCCCCCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEECCCC----CE
T ss_conf 14666667469999974058714444430378999899999999999999999758898357986278985899----75
Q ss_pred EEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCC
Q ss_conf 99743675112686433676788864412320689999996
Q 000893 1192 KVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSE 1232 (1236)
Q Consensus 1192 KLsDFGLArli~ss~~tssivGTp~YLAPEVL~Gs~~~~Sd 1232 (1236)
||+|||+++...........+||+.|+|||++.+..+..+.
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~ 196 (305)
T d1blxa_ 156 KLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPV 196 (305)
T ss_dssp EECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHH
T ss_pred EECCHHHHHHHCCCCCCCCCCCCHHHCCCCHHCCCCCCHHE
T ss_conf 42100010110023457776548511483100179888111
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-35 Score=242.47 Aligned_cols=171 Identities=27% Similarity=0.397 Sum_probs=145.8
Q ss_pred CCCEEEEEEECCCCCEEEEEEEE--CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
Q ss_conf 56703989722477358997543--5922899962036567987378999999999999985279994103764676499
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1041 ~eeYeiLKvLGkGSFGkVYKAkl--kGt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNIVrLlGsf~t~d 1118 (1236)
.++|+++++||+|+||+||+|++ +++.||||++++... .+.....+.+|+.+|+.++|||||+++++|....
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~------~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~ 90 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ------SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE 90 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS------SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHC------CHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCC
T ss_conf 7718998898017781999999999998999999852225------9699999999999998668987547999863576
Q ss_pred ----CCEEEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCEEEE
Q ss_conf ----9809999961458989999964046789999999999999999999979940278999967983699988938997
Q 000893 1119 ----GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1236)
Q Consensus 1119 ----eg~L~LVMEYLeGGSL~elL~qkek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvVKLs 1194 (1236)
...+++||||| +.+|..++. ...+++..++.|+.||+.||.|||+++|+||||||+|||++.++ .+||+
T Consensus 91 ~~~~~~~~~lv~e~~-~~~l~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~----~~kl~ 163 (346)
T d1cm8a_ 91 TLDDFTDFYLVMPFM-GTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC----ELKIL 163 (346)
T ss_dssp STTTCCCCEEEEECC-SEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC----CEEEC
T ss_pred CCCCCCEEEEEEECC-CCCHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHCCCCC----CCCCC
T ss_conf 555541599998405-521899987--40226999999999999999998737876456685111121001----22113
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCHHHHCCC
Q ss_conf 43675112686433676788864412320689
Q 000893 1195 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1195 DFGLArli~ss~~tssivGTp~YLAPEVL~Gs 1226 (1236)
|||+|+...... ...+||+.|+|||++.+.
T Consensus 164 Dfg~a~~~~~~~--~~~~~t~~y~aPE~~~~~ 193 (346)
T d1cm8a_ 164 DFGLARQADSEM--TGYVVTRWYRAPEVILNW 193 (346)
T ss_dssp CCTTCEECCSSC--CSSCSCGGGCCTHHHHTT
T ss_pred CCCCEECCCCCC--CCCCCCCCCCCHHHHCCC
T ss_conf 431022068763--102455333588998178
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-35 Score=242.18 Aligned_cols=171 Identities=29% Similarity=0.442 Sum_probs=141.0
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCC--
Q ss_conf 670398972247735899754359228999620365679873789999999999999852799941037646764999--
Q 000893 1042 EDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG-- 1119 (1236)
Q Consensus 1042 eeYeiLKvLGkGSFGkVYKAklkGt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNIVrLlGsf~t~de-- 1119 (1236)
++|.+.+.||+|+||.||+|+++++.||||+++... .. ...+.+|+..+..++|||||+++++|.+...
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~-------~~--~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~ 73 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-------ER--SWFREAEIYQTVMLRHENILGFIAADNKDNGTW 73 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG-------HH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred CEEEEEEEEEECCCEEEEEEEECCEEEEEEEECCCC-------HH--HHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCC
T ss_conf 689998898207881999999999899999987200-------46--799999999996279986832688998379860
Q ss_pred CEEEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHH--------CCCCCCCCCCCCEEECCCCCCCCCE
Q ss_conf 80999996145898999996404678999999999999999999997--------9940278999967983699988938
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHS--------KNIVHFDLKCDNLLVNLKDPIRPIC 1191 (1236)
Q Consensus 1120 g~L~LVMEYLeGGSL~elL~qkek~LSe~eil~IA~QILeALeYLHS--------kGIIHRDIKPsNILIDsdG~I~lvV 1191 (1236)
..+++|||||++|+|..++.. ..+++..++.++.|++.||.|||. ++|+||||||+||||+.++ .+
T Consensus 74 ~~~~lv~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~----~~ 147 (303)
T d1vjya_ 74 TQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG----TC 147 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS----CE
T ss_pred EEEEEEEECCCCCCHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCC----CE
T ss_conf 489999964669898999865--899989999999999999999887665204689866153173135786887----76
Q ss_pred EEEECCCCCCCCCCC-----CCCCCCCCCCCCCHHHHCCCC
Q ss_conf 997436751126864-----336767888644123206899
Q 000893 1192 KVGDFGLSKIKRNTL-----VTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1192 KLsDFGLArli~ss~-----~tssivGTp~YLAPEVL~Gs~ 1227 (1236)
||+|||+++...... .....+||+.|+|||++.+..
T Consensus 148 Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 188 (303)
T d1vjya_ 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSI 188 (303)
T ss_dssp EECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCS
T ss_pred EEEECCCCCCCCCCCCCEECCCCCEECCCCCCCHHHCCCCC
T ss_conf 88763866234677762001355250354767822105654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-35 Score=240.55 Aligned_cols=174 Identities=28% Similarity=0.457 Sum_probs=144.0
Q ss_pred EEEEEECCCCCEEEEEEEEC---C--CEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCC
Q ss_conf 39897224773589975435---9--228999620365679873789999999999999852799941037646764999
Q 000893 1045 EELKELGSGTFGTVYHGKWR---G--TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1045 eiLKvLGkGSFGkVYKAklk---G--t~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNIVrLlGsf~t~de 1119 (1236)
.+.++||+|+||+||+|++. + ..||||++++.. ......+|.+|+.+|++++||||++++|++...+
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~- 101 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-------DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE- 101 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC-------CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT-
T ss_pred CCCEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCC-------CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC-
T ss_conf 26669813688099999997799879999999988436-------9789999999999998678999867867898069-
Q ss_pred CEEEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCEEEEECCCC
Q ss_conf 80999996145898999996404678999999999999999999997994027899996798369998893899743675
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYLeGGSL~elL~qkek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvVKLsDFGLA 1199 (1236)
+.+++|||||++++|.+++......+.+..++.++.|++.||.|||+++|+||||||+||||+.++ .+||+|||++
T Consensus 102 ~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~----~~kL~DFG~~ 177 (311)
T d1r0pa_ 102 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF----TVKVADFGLA 177 (311)
T ss_dssp TEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC----CEEECSSGGG
T ss_pred CCEEEEEEEEECCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHEEECCCC----CEEEECCCCH
T ss_conf 943899987406741442101345404899999999988765200336762577668757677999----8899106523
Q ss_pred CCCCCCC-----CCCCCCCCCCCCCHHHHCCCCCCC
Q ss_conf 1126864-----336767888644123206899999
Q 000893 1200 KIKRNTL-----VTGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1200 rli~ss~-----~tssivGTp~YLAPEVL~Gs~~~~ 1230 (1236)
+...... ......||+.|+|||++.+..+..
T Consensus 178 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 213 (311)
T d1r0pa_ 178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT 213 (311)
T ss_dssp CCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCH
T ss_pred HHCCCCCCCCCEECCCCCCCCCCCCHHHHHCCCCCC
T ss_conf 225566555310025655564556768874379997
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-35 Score=240.31 Aligned_cols=171 Identities=26% Similarity=0.364 Sum_probs=141.3
Q ss_pred CCEEEEEEECCCCCEEEEEEEE--CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCC
Q ss_conf 6703989722477358997543--59228999620365679873789999999999999852799941037646764999
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 eeYeiLKvLGkGSFGkVYKAkl--kGt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNIVrLlGsf~t~de 1119 (1236)
.+|++++.||+|+||+||+|++ +++.||||++.+.. .......+.+|+.+|+.++||||+++++++.....
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-------~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~ 80 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-------HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 80 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-------CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHC-------CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCC
T ss_conf 98599789940648099999999999499999980310-------95899999999999997689898858889950564
Q ss_pred ---CEEEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCEEEEEC
Q ss_conf ---80999996145898999996404678999999999999999999997994027899996798369998893899743
Q 000893 1120 ---GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDF 1196 (1236)
Q Consensus 1120 ---g~L~LVMEYLeGGSL~elL~qkek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvVKLsDF 1196 (1236)
..++++ +|+.+++|.+++.. ..+++..++.++.|++.||.|||+++||||||||+|||++.++ .+||+||
T Consensus 81 ~~~~~~~l~-~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~----~~kl~Df 153 (345)
T d1pmea_ 81 EQMKDVYLV-THLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC----DLKICDF 153 (345)
T ss_dssp TTCCCEEEE-EECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC----CEEECCC
T ss_pred CCCCEEEEE-EEECCCCHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCC----CEEECCC
T ss_conf 554149999-96259865664405--8999999999999999999999978986777876437887999----7787545
Q ss_pred CCCCCCCCC----CCCCCCCCCCCCCCHHHHCCC
Q ss_conf 675112686----433676788864412320689
Q 000893 1197 GLSKIKRNT----LVTGGVRGTLPWMAPELLNGS 1226 (1236)
Q Consensus 1197 GLArli~ss----~~tssivGTp~YLAPEVL~Gs 1226 (1236)
|+|+..... ......+||+.|+|||++...
T Consensus 154 G~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 187 (345)
T d1pmea_ 154 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 187 (345)
T ss_dssp TTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTB
T ss_pred CCEEECCCCCCCCEEECCCCCCCEECHHHHHHCC
T ss_conf 7056504777641010110265200038786047
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-35 Score=238.93 Aligned_cols=179 Identities=25% Similarity=0.333 Sum_probs=150.1
Q ss_pred CCCEEEEEEECCCCCEEEEEEEE--CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-
Q ss_conf 56703989722477358997543--592289996203656798737899999999999998527999410376467649-
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDG- 1117 (1236)
Q Consensus 1041 ~eeYeiLKvLGkGSFGkVYKAkl--kGt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNIVrLlGsf~t~- 1117 (1236)
.++|+++++||+|+||+||+|++ +++.||||++++... ......++.+|+.+++.++|||||+++++|...
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~------~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~ 89 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ------NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK 89 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS------SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHC------CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
T ss_conf 3775998896217585999999999998999999882336------9799999999999998648987648998970256
Q ss_pred ---CCCEEEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCEEEE
Q ss_conf ---99809999961458989999964046789999999999999999999979940278999967983699988938997
Q 000893 1118 ---PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVG 1194 (1236)
Q Consensus 1118 ---deg~L~LVMEYLeGGSL~elL~qkek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvVKLs 1194 (1236)
....+|+|||||.+ ++...+. ..+++..++.++.|++.||.|||++||+||||||+|||++.++ .+|++
T Consensus 90 ~~~~~~~~~iv~Ey~~~-~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~----~~kl~ 161 (355)
T d2b1pa1 90 TLEEFQDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC----TLKIL 161 (355)
T ss_dssp STTTCCEEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC----CEEEC
T ss_pred CCCCCCEEEEEEECCCH-HHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCC----CEEEE
T ss_conf 43457626999841446-7787650---3899999999999999999886522112456776321136544----31320
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCC
Q ss_conf 436751126864336767888644123206899999961
Q 000893 1195 DFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKVSEK 1233 (1236)
Q Consensus 1195 DFGLArli~ss~~tssivGTp~YLAPEVL~Gs~~~~SdD 1233 (1236)
|||+++...........+||+.|+|||++.+..+..+.|
T Consensus 162 df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~D 200 (355)
T d2b1pa1 162 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 200 (355)
T ss_dssp CCCC---------------CCTTCCHHHHTTCCCCTTHH
T ss_pred CHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCC
T ss_conf 102321146665533221465555813314777787743
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.5e-35 Score=241.62 Aligned_cols=173 Identities=30% Similarity=0.413 Sum_probs=145.5
Q ss_pred CCEEEEEEECCCCCEEEEEEEE-CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCC
Q ss_conf 6703989722477358997543-592289996203656798737899999999999998527999410376467649998
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1042 eeYeiLKvLGkGSFGkVYKAkl-kGt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNIVrLlGsf~t~deg 1120 (1236)
++|+++++||+|+||+||+|++ +++.||||+++..... +....++.+|+.+|+.++|||||+++++|....
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~------~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-- 73 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED------EGIPSTTIREISILKELKHSNIVKLYDVIHTKK-- 73 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG------GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS--
T ss_pred CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCC------HHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCC--
T ss_conf 996343187227781899999689999999998123268------589999999999998679986876601204677--
Q ss_pred EEEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCEEEEECCCCC
Q ss_conf 09999961458989999964046789999999999999999999979940278999967983699988938997436751
Q 000893 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSK 1200 (1236)
Q Consensus 1121 ~L~LVMEYLeGGSL~elL~qkek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvVKLsDFGLAr 1200 (1236)
..+++|||+.++.+ ..+......+++..++.|+.||+.||+|||+++|+||||||+|||++.++ .+||+|||+|.
T Consensus 74 ~~~i~~e~~~~~~~-~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~----~~kl~DfG~a~ 148 (286)
T d1ob3a_ 74 RLVLVFEHLDQDLK-KLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG----ELKIADFGLAR 148 (286)
T ss_dssp CEEEEEECCSEEHH-HHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS----CEEECCTTHHH
T ss_pred CEEEEEEEEHHHHH-HHHHHHCCCCCHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCEEEECCCC----CEEECCCCCCE
T ss_conf 31589974004567-89986047751445689999999999986057488267877505686899----78732366430
Q ss_pred CCCCC-CCCCCCCCCCCCCCHHHHCCCC
Q ss_conf 12686-4336767888644123206899
Q 000893 1201 IKRNT-LVTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1201 li~ss-~~tssivGTp~YLAPEVL~Gs~ 1227 (1236)
..... .......|++.|+|||++.+..
T Consensus 149 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~ 176 (286)
T d1ob3a_ 149 AFGIPVRKYTHEIVTLWYRAPDVLMGSK 176 (286)
T ss_dssp HHCC---------CCCTTCCHHHHTTCC
T ss_pred ECCCCCCCCCEECCCCHHHHHHHHHCCC
T ss_conf 1146765410102431101378871788
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-35 Score=244.05 Aligned_cols=179 Identities=21% Similarity=0.250 Sum_probs=145.5
Q ss_pred CCCEEEEEEECCCCCEEEEEEEE--CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCC--CCCEEEEEEEEEC
Q ss_conf 56703989722477358997543--5922899962036567987378999999999999985279--9941037646764
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH--HPNVVAFYGVVQD 1116 (1236)
Q Consensus 1041 ~eeYeiLKvLGkGSFGkVYKAkl--kGt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLr--HPNIVrLlGsf~t 1116 (1236)
..+|++.+.||+|+||+||+|++ +++.||||++.+......... ....++.+|+.++++++ |||||++++++.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~--~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~ 80 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL--PNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 80 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEEC--TTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHH--HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEE
T ss_conf 8837996798408783999999999997999999856884433455--67999999999999743589881279999830
Q ss_pred CCCCEEEEEEEECCC-CCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCEEEEE
Q ss_conf 999809999961458-9899999640467899999999999999999999799402789999679836999889389974
Q 000893 1117 GPGGTLATVTEFMVN-GSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1236)
Q Consensus 1117 ~deg~L~LVMEYLeG-GSL~elL~qkek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvVKLsD 1195 (1236)
.+ .+++||||+.+ +++..++.. ...+++..++.|+.||+.||.|||+++|+||||||+|||++.+. ..+||+|
T Consensus 81 ~~--~~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~---~~vkl~D 154 (273)
T d1xwsa_ 81 PD--SFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR---GELKLID 154 (273)
T ss_dssp SS--EEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT---TEEEECC
T ss_pred CC--EEEEEEEECCCCCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCC---CEEEECC
T ss_conf 99--689999833686228999861-58999999999999999999999877975566761114774478---8489775
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCC
Q ss_conf 367511268643367678886441232068999
Q 000893 1196 FGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSS 1228 (1236)
Q Consensus 1196 FGLArli~ss~~tssivGTp~YLAPEVL~Gs~~ 1228 (1236)
||+|+..... .....+||+.|+|||++.+..+
T Consensus 155 FG~a~~~~~~-~~~~~~GT~~y~aPE~~~~~~~ 186 (273)
T d1xwsa_ 155 FGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRY 186 (273)
T ss_dssp CTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCB
T ss_pred CCCCEECCCC-CCCCCCCCCCCCCHHHHCCCCC
T ss_conf 4653532444-5566565877479999848997
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-34 Score=236.70 Aligned_cols=183 Identities=25% Similarity=0.360 Sum_probs=145.9
Q ss_pred CCCEEEEEEECCCCCEEEEEEEE--CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
Q ss_conf 56703989722477358997543--5922899962036567987378999999999999985279994103764676499
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1041 ~eeYeiLKvLGkGSFGkVYKAkl--kGt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNIVrLlGsf~t~d 1118 (1236)
.++|++++.||+|+||+||+|++ +++.||||++.+..... ....++.+|+.+|+.++||||+++++++....
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~------~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~ 82 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE------GFPITALREIKILQLLKHENVVNLIEICRTKA 82 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT------SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCH------HHHHHHHHHHHHHHHHCCCCCCCEEEEEECCC
T ss_conf 279889999722748299999998999799999984222463------78999999999999835999660676540246
Q ss_pred ------CCEEEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCEE
Q ss_conf ------98099999614589899999640467899999999999999999999799402789999679836999889389
Q 000893 1119 ------GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 1192 (1236)
Q Consensus 1119 ------eg~L~LVMEYLeGGSL~elL~qkek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvVK 1192 (1236)
.+.+++||||+.++.+. .+......+.+..++.|+.|++.||.|||+++|+||||||+|||++.++ .+|
T Consensus 83 ~~~~~~~~~~~iv~e~~~~~~~~-~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~----~~k 157 (318)
T d3blha1 83 SPYNRCKGSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG----VLK 157 (318)
T ss_dssp --------CEEEEEECCCEEHHH-HHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS----CEE
T ss_pred CCCCCCCCEEEEEEECCCCCCCC-HHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCCEEECCCCCHHEEECCCC----CEE
T ss_conf 54444576389998535787410-1222034433089999999999999885229988567672220366899----687
Q ss_pred EEECCCCCCCCCC-----CCCCCCCCCCCCCCHHHHCCCCCCCCCCCC
Q ss_conf 9743675112686-----433676788864412320689999996101
Q 000893 1193 VGDFGLSKIKRNT-----LVTGGVRGTLPWMAPELLNGSSSKVSEKVC 1235 (1236)
Q Consensus 1193 LsDFGLArli~ss-----~~tssivGTp~YLAPEVL~Gs~~~~SdDVD 1235 (1236)
|+|||+++..... ......+||++|+|||++.+.. .++..+|
T Consensus 158 l~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~-~~~~k~D 204 (318)
T d3blha1 158 LADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGER-DYGPPID 204 (318)
T ss_dssp ECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCS-SCCTHHH
T ss_pred EEECCEEEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCC-CCCCHHH
T ss_conf 6313500223554443211356602497874289970799-9891787
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-35 Score=240.59 Aligned_cols=186 Identities=26% Similarity=0.381 Sum_probs=152.4
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEE-----CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCC-CCEEEEEE
Q ss_conf 3456703989722477358997543-----59228999620365679873789999999999999852799-94103764
Q 000893 1039 IKNEDLEELKELGSGTFGTVYHGKW-----RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH-PNVVAFYG 1112 (1236)
Q Consensus 1039 Is~eeYeiLKvLGkGSFGkVYKAkl-----kGt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrH-PNIVrLlG 1112 (1236)
+..++|++++.||+|+||+||+|+. +++.||||++++...... ......+.+|+.++++++| |||+++++
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~----~~~~~~~~~E~~il~~l~h~pnIv~~~~ 96 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK----AKTTEHTRTERQVLEHIRQSPFLVTLHY 96 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEE----ESSGGGCCCHHHHHHHHHTCTTBCCEEE
T ss_pred CCHHCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCC----HHHHHHHHHHHHHHHHCCCCCEEEEEEE
T ss_conf 451025999898328783999999876588794899999836772101----6899999999999986467983999620
Q ss_pred EEECCCCCEEEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCEE
Q ss_conf 67649998099999614589899999640467899999999999999999999799402789999679836999889389
Q 000893 1113 VVQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICK 1192 (1236)
Q Consensus 1113 sf~t~deg~L~LVMEYLeGGSL~elL~qkek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvVK 1192 (1236)
++.+.. .++++|||+.+++|..++... ..+.+..++.++.||+.||.|||+++|+||||||+|||++.++ .+|
T Consensus 97 ~~~~~~--~~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~----~vk 169 (322)
T d1vzoa_ 97 AFQTET--KLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG----HVV 169 (322)
T ss_dssp EEEETT--EEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS----CEE
T ss_pred EECCCC--CEEEEEECCCCCHHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCCCCEEECCCC----CEE
T ss_conf 002487--300123123411799998730-4543788888899999999885149989654773201246999----888
Q ss_pred EEECCCCCCCCC--CCCCCCCCCCCCCCCHHHHCCCCCCCCCCCC
Q ss_conf 974367511268--6433676788864412320689999996101
Q 000893 1193 VGDFGLSKIKRN--TLVTGGVRGTLPWMAPELLNGSSSKVSEKVC 1235 (1236)
Q Consensus 1193 LsDFGLArli~s--s~~tssivGTp~YLAPEVL~Gs~~~~SdDVD 1235 (1236)
|+|||+|+.... ........|++.|+|||.+.+....++..+|
T Consensus 170 L~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksD 214 (322)
T d1vzoa_ 170 LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVD 214 (322)
T ss_dssp ESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHH
T ss_pred EEECCCHHHHCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHH
T ss_conf 741320222034444322122233333106876057768871325
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.2e-33 Score=230.79 Aligned_cols=177 Identities=21% Similarity=0.277 Sum_probs=145.3
Q ss_pred CCCEEEEEEECCCCCEEEEEEEE--CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCC-CCEEEEEEEEECC
Q ss_conf 56703989722477358997543--59228999620365679873789999999999999852799-9410376467649
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH-PNVVAFYGVVQDG 1117 (1236)
Q Consensus 1041 ~eeYeiLKvLGkGSFGkVYKAkl--kGt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrH-PNIVrLlGsf~t~ 1117 (1236)
.++|++++.||+|+||+||+|++ +++.||||++...... ..+.+|++.++.++| +|++.+++++.+.
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~ 73 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----------PQLRDEYRTYKLLAGCTGIPNVYYFGQEG 73 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----------CCHHHHHHHHHHTTTCTTCCCEEEEEEET
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCCC----------HHHHHHHHHHHHHCCCCCCCEEEEEEECC
T ss_conf 98069979984178829999999889979999997502582----------99999999999964899987799996018
Q ss_pred CCCEEEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCC-CCCCEEEEEC
Q ss_conf 998099999614589899999640467899999999999999999999799402789999679836999-8893899743
Q 000893 1118 PGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDP-IRPICKVGDF 1196 (1236)
Q Consensus 1118 deg~L~LVMEYLeGGSL~elL~qkek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~-I~lvVKLsDF 1196 (1236)
. ..++||||+ +++|..++......+++..++.++.|++.||.|||+++|+||||||+|||++.... ....+||+||
T Consensus 74 ~--~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DF 150 (293)
T d1csna_ 74 L--HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDF 150 (293)
T ss_dssp T--EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred C--CCEEEEEEC-CCCHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCCCEEECCC
T ss_conf 8--117999964-8887999975203110689999999999999999977966266771315234754344795687236
Q ss_pred CCCCCCCCC--------CCCCCCCCCCCCCCHHHHCCCCCCC
Q ss_conf 675112686--------4336767888644123206899999
Q 000893 1197 GLSKIKRNT--------LVTGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1197 GLArli~ss--------~~tssivGTp~YLAPEVL~Gs~~~~ 1230 (1236)
|+|+..... .....++||+.|||||++.+..+..
T Consensus 151 G~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~ 192 (293)
T d1csna_ 151 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSR 192 (293)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCH
T ss_pred CEEEECCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCH
T ss_conf 605771467665411102467627751026798964888886
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7e-34 Score=232.27 Aligned_cols=176 Identities=25% Similarity=0.315 Sum_probs=141.3
Q ss_pred CCEEEEEEECCCCCEEEEEEEE--CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEE-EECCC
Q ss_conf 6703989722477358997543--59228999620365679873789999999999999852799941037646-76499
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGV-VQDGP 1118 (1236)
Q Consensus 1042 eeYeiLKvLGkGSFGkVYKAkl--kGt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNIVrLlGs-f~t~d 1118 (1236)
++|++.+.||+|+||+||+|++ +++.||||++...... .++.+|+.+++.++|++++.++.. +.+.
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----------~~~~~E~~i~~~l~~~~~i~~~~~~~~~~- 75 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----------PQLHIESKIYKMMQGGVGIPTIRWCGAEG- 75 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----------CCHHHHHHHHHHSTTSTTCCCEEEEEEET-
T ss_pred CEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCCC----------HHHHHHHHHHHHCCCCCCCCEEEEEEECC-
T ss_conf 8899968985078809999999889989999997210058----------88999999999703899601799999519-
Q ss_pred CCEEEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCEEEEECCC
Q ss_conf 98099999614589899999640467899999999999999999999799402789999679836999889389974367
Q 000893 1119 GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGL 1198 (1236)
Q Consensus 1119 eg~L~LVMEYLeGGSL~elL~qkek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvVKLsDFGL 1198 (1236)
...++||||+ +++|...+......+++..++.++.|++.||.|||+++||||||||+|||++..+.. ..+||+|||+
T Consensus 76 -~~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~-~~vkl~DFG~ 152 (299)
T d1ckia_ 76 -DYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKG-NLVYIIDFGL 152 (299)
T ss_dssp -TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGT-TCEEECCCSS
T ss_pred -CEEEEEEEEC-CCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHCCCCCCCCC-CEEEEECCCC
T ss_conf -8778999873-871333244306887689999999999999999997994426678766064335777-6156504675
Q ss_pred CCCCCCCC--------CCCCCCCCCCCCCHHHHCCCCCCCC
Q ss_conf 51126864--------3367678886441232068999999
Q 000893 1199 SKIKRNTL--------VTGGVRGTLPWMAPELLNGSSSKVS 1231 (1236)
Q Consensus 1199 Arli~ss~--------~tssivGTp~YLAPEVL~Gs~~~~S 1231 (1236)
|+...... .....+||+.|+|||++.+..+...
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 193 (299)
T d1ckia_ 153 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRR 193 (299)
T ss_dssp CEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHH
T ss_pred CEECCCCCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCH
T ss_conf 13425544554100013577678735329999918998983
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-33 Score=229.34 Aligned_cols=173 Identities=28% Similarity=0.379 Sum_probs=146.9
Q ss_pred CCEEEEEEECCCCCEEEEEEEE--CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCC
Q ss_conf 6703989722477358997543--59228999620365679873789999999999999852799941037646764999
Q 000893 1042 EDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGPG 1119 (1236)
Q Consensus 1042 eeYeiLKvLGkGSFGkVYKAkl--kGt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNIVrLlGsf~t~de 1119 (1236)
++|+++++||+|+||+||+|++ +++.||||+++.... .+....++.+|+.+|+.++||||++++++|.+..
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~------~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~- 74 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD------DEGVPSSALREICLLKELKHKNIVRLHDVLHSDK- 74 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS------STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHC------CHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCC-
T ss_conf 997862697128681999999999996999999803217------8689999999999998567578882135444443-
Q ss_pred CEEEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCEEEEECCCC
Q ss_conf 80999996145898999996404678999999999999999999997994027899996798369998893899743675
Q 000893 1120 GTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLS 1199 (1236)
Q Consensus 1120 g~L~LVMEYLeGGSL~elL~qkek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvVKLsDFGLA 1199 (1236)
..++|++++.+++|..++. ....+++..++.++.|++.||.|||+++|+||||||+|||++.++ .+||+|||+|
T Consensus 75 -~~~iv~~~~~~~~l~~~~~-~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~----~~kl~DFG~a 148 (292)
T d1unla_ 75 -KLTLVFEFCDQDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG----ELKLANFGLA 148 (292)
T ss_dssp -EEEEEEECCSEEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC----CEEECCCTTC
T ss_pred -CEEEEEEECCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHHHHHHCCCEEEECCCCCCCCCCCCC----CEEEEECCHH
T ss_conf -1158863023322211212-356540367899999999998774339986001467612113378----2665204601
Q ss_pred CCCCCCC-CCCCCCCCCCCCCHHHHCCCC
Q ss_conf 1126864-336767888644123206899
Q 000893 1200 KIKRNTL-VTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1200 rli~ss~-~tssivGTp~YLAPEVL~Gs~ 1227 (1236)
+...... ......+++.|+|||++.+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~ 177 (292)
T d1unla_ 149 RAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177 (292)
T ss_dssp EECCSCCSCCCSCCSCGGGCCHHHHTTCS
T ss_pred HCCCCCCCCCEEECCCCCHHHHHHHCCCC
T ss_conf 10468875100103443101466750698
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-34 Score=233.54 Aligned_cols=173 Identities=25% Similarity=0.359 Sum_probs=143.8
Q ss_pred CCCEEEEEEECCCCCEEEEEEEE--CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
Q ss_conf 56703989722477358997543--5922899962036567987378999999999999985279994103764676499
Q 000893 1041 NEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNVVAFYGVVQDGP 1118 (1236)
Q Consensus 1041 ~eeYeiLKvLGkGSFGkVYKAkl--kGt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNIVrLlGsf~t~d 1118 (1236)
.++|+++++||+|+||+||+|++ +++.||||++++... ......++.+|+.+|+.++|||||++++++....
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~ 90 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ------SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 90 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS------SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHC------CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC
T ss_conf 9871888898317883999999999997999999882002------8689999999999998668987425999996346
Q ss_pred ---CCEEEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCEEEEE
Q ss_conf ---98099999614589899999640467899999999999999999999799402789999679836999889389974
Q 000893 1119 ---GGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKVGD 1195 (1236)
Q Consensus 1119 ---eg~L~LVMEYLeGGSL~elL~qkek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvVKLsD 1195 (1236)
....+++|+|+.+++|.+++. ...+++..++.|+.||+.||.|||+++|+||||||+|||++.++ .+|++|
T Consensus 91 ~~~~~~~~~i~~~~~gg~L~~~~~--~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~----~~kl~d 164 (348)
T d2gfsa1 91 SLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC----ELKILD 164 (348)
T ss_dssp STTTCCCCEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC----CEEECC
T ss_pred CCCCCCEEEEEEEECCCCHHHHCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCC----CCCCCC
T ss_conf 456686499999625886232002--24530999999999999999999738876516677633455432----200132
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCC
Q ss_conf 36751126864336767888644123206899
Q 000893 1196 FGLSKIKRNTLVTGGVRGTLPWMAPELLNGSS 1227 (1236)
Q Consensus 1196 FGLArli~ss~~tssivGTp~YLAPEVL~Gs~ 1227 (1236)
||++...... .....|++.|+|||++.+..
T Consensus 165 fg~a~~~~~~--~~~~~g~~~y~apE~~~~~~ 194 (348)
T d2gfsa1 165 FGLARHTDDE--MTGYVATRWYRAPEIMLNWM 194 (348)
T ss_dssp C----CCTGG--GSSSCHHHHTSCHHHHTTCS
T ss_pred CCHHCCCCCC--CCCCCCCCCCCCCHHHCCCC
T ss_conf 1000125754--44434543555835533775
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.96 E-value=3.6e-29 Score=202.06 Aligned_cols=180 Identities=22% Similarity=0.276 Sum_probs=136.8
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEE--CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCC-----------CCC
Q ss_conf 456703989722477358997543--5922899962036567987378999999999999985279-----------994
Q 000893 1040 KNEDLEELKELGSGTFGTVYHGKW--RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-----------HPN 1106 (1236)
Q Consensus 1040 s~eeYeiLKvLGkGSFGkVYKAkl--kGt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLr-----------HPN 1106 (1236)
...+|+++++||+|+||+||+|++ +++.||||++++. ......+.+|+.+++.++ |+|
T Consensus 11 ~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---------~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~ 81 (362)
T d1q8ya_ 11 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---------KVYTEAAEDEIKLLQRVNDADNTKEDSMGANH 81 (362)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---------HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECC---------CCCHHHHHHHHHHHHHHCCHHHHHHHHCCCCC
T ss_conf 478579989975077818999999999979999998343---------13368999999999984014555554227676
Q ss_pred EEEEEEEEECCCCCEEEEEEEECCCCCH-HHHH-HHHCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCCCCEEECC
Q ss_conf 1037646764999809999961458989-9999-6404678999999999999999999997-99402789999679836
Q 000893 1107 VVAFYGVVQDGPGGTLATVTEFMVNGSL-RHVL-LSKERHLDRRKRLIIAMDAAFGMEYLHS-KNIVHFDLKCDNLLVNL 1183 (1236)
Q Consensus 1107 IVrLlGsf~t~deg~L~LVMEYLeGGSL-~elL-~qkek~LSe~eil~IA~QILeALeYLHS-kGIIHRDIKPsNILIDs 1183 (1236)
|+++++++........+++|+++..... .... ......+.+..++.++.||+.||.|||+ .+|+||||||+||||+.
T Consensus 82 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~ 161 (362)
T d1q8ya_ 82 ILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEI 161 (362)
T ss_dssp BCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEE
T ss_pred EEEEEEEEEECCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEEC
T ss_conf 47899876312565202343200035420000012234678689999999999999888764058646567705705630
Q ss_pred CCCC--CCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCC
Q ss_conf 9998--8938997436751126864336767888644123206899999
Q 000893 1184 KDPI--RPICKVGDFGLSKIKRNTLVTGGVRGTLPWMAPELLNGSSSKV 1230 (1236)
Q Consensus 1184 dG~I--~lvVKLsDFGLArli~ss~~tssivGTp~YLAPEVL~Gs~~~~ 1230 (1236)
++.. ...+||+|||.+...... ....+||+.|+|||++.+..+..
T Consensus 162 ~~~~~~~~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ 208 (362)
T d1q8ya_ 162 VDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGC 208 (362)
T ss_dssp EETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCT
T ss_pred CCCCCCCCEEEEEECCCCCCCCCC--CCCCCCCCCCCCHHHCCCCCCCC
T ss_conf 576564430567531442123445--42236652105713214667776
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=1.4e-21 Score=153.36 Aligned_cols=140 Identities=19% Similarity=0.023 Sum_probs=105.5
Q ss_pred EEEEEECCCCCEEEEEEEE-CCCEEEEEEEECCCCCC----------CCHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEE
Q ss_conf 3989722477358997543-59228999620365679----------873789999999999999852799941037646
Q 000893 1045 EELKELGSGTFGTVYHGKW-RGTDVAIKRIKKSCFTG----------RSSEQERLTLEFWREAEILSKLHHPNVVAFYGV 1113 (1236)
Q Consensus 1045 eiLKvLGkGSFGkVYKAkl-kGt~VAIKvLKk~~l~~----------~see~er~~keFlrEIeILkkLrHPNIVrLlGs 1113 (1236)
.+.++||+|+||+||+|++ +|+.||||+++...... ...........+.+|...+..+.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred HHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEE
T ss_conf 22778024856599999979999999999860443466655656300088899999977899999998169991449986
Q ss_pred EECCCCCEEEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCCCCEEE
Q ss_conf 76499980999996145898999996404678999999999999999999997994027899996798369998893899
Q 000893 1114 VQDGPGGTLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFGMEYLHSKNIVHFDLKCDNLLVNLKDPIRPICKV 1193 (1236)
Q Consensus 1114 f~t~deg~L~LVMEYLeGGSL~elL~qkek~LSe~eil~IA~QILeALeYLHSkGIIHRDIKPsNILIDsdG~I~lvVKL 1193 (1236)
.. .+++|||+.+..+. .+.......++.|++.+|.|||+++|+||||||+|||++.+ .++|
T Consensus 83 ~~------~~lvme~~~~~~~~--------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-----~~~l 143 (191)
T d1zara2 83 EG------NAVLMELIDAKELY--------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-----GIWI 143 (191)
T ss_dssp ET------TEEEEECCCCEEGG--------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-----EEEE
T ss_pred CC------CEEEEEEECCCCCC--------CHHHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHEEEECC-----CEEE
T ss_conf 28------88999950456542--------00157899999999999999826888983689036114289-----8999
Q ss_pred EECCCCCCCC
Q ss_conf 7436751126
Q 000893 1194 GDFGLSKIKR 1203 (1236)
Q Consensus 1194 sDFGLArli~ 1203 (1236)
+|||+|....
T Consensus 144 iDFG~a~~~~ 153 (191)
T d1zara2 144 IDFPQSVEVG 153 (191)
T ss_dssp CCCTTCEETT
T ss_pred EECCCCCCCC
T ss_conf 8778843089
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.43 E-value=1.3e-06 Score=57.17 Aligned_cols=141 Identities=16% Similarity=0.057 Sum_probs=84.4
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCC-CCCEEEEEEEEECCCCC
Q ss_conf 67039897224773589975435922899962036567987378999999999999985279-99410376467649998
Q 000893 1042 EDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1042 eeYeiLKvLGkGSFGkVYKAklkGt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLr-HPNIVrLlGsf~t~deg 1120 (1236)
+.|++.+..+.++...||+....+..+.||+........ ...+.+|...+..+. +--+.+++.++... +
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~--------~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~--~ 83 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--------TYDVEREKDMMLWLEGKLPVPKVLHFERHD--G 83 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTS--------TTCHHHHHHHHHHHTTTSCCCCEEEEEEET--T
T ss_pred HCEEEEECCCCCCCCCEEEEEECCCEEEEEECCCCCCCC--------HHHHHHHHHHHHHHHCCCCCCCEEEEEECC--C
T ss_conf 352799767899877189999089869999848876532--------556999999999876069987289997508--9
Q ss_pred EEEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHH----------------------------------------
Q ss_conf 0999996145898999996404678999999999999999----------------------------------------
Q 000893 1121 TLATVTEFMVNGSLRHVLLSKERHLDRRKRLIIAMDAAFG---------------------------------------- 1160 (1236)
Q Consensus 1121 ~L~LVMEYLeGGSL~elL~qkek~LSe~eil~IA~QILeA---------------------------------------- 1160 (1236)
..++||++++|.++....... .... .++.++...
T Consensus 84 ~~~lv~~~l~G~~~~~~~~~~---~~~~---~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T d1j7la_ 84 WSNLLMSEADGVLCSEEYEDE---QSPE---KIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEEEEECCSSEEHHHHTTTC---SCHH---HHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred CEEEEEEECCCCCCCCCCCCC---CCHH---HHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHC
T ss_conf 649999860433435433440---2699---9999899999998556842143576446565557789987765555430
Q ss_pred -------------HHHHHHC------CCCCCCCCCCCEEECCCCCCCCCEEEEECCCCCCC
Q ss_conf -------------9999979------94027899996798369998893899743675112
Q 000893 1161 -------------MEYLHSK------NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 1202 (1236)
Q Consensus 1161 -------------LeYLHSk------GIIHRDIKPsNILIDsdG~I~lvVKLsDFGLArli 1202 (1236)
+..+... .++|+|+.|.|||++.++ ..-|+||+.+...
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~----~~~lIDwe~a~~g 214 (263)
T d1j7la_ 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK----VSGFIDLGRSGRA 214 (263)
T ss_dssp GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTE----EEEECCCTTCEEE
T ss_pred CCCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCC----EEEEEECHHCCCC
T ss_conf 33232005799999999844986781789860047642364996----5999602314418
|
| >d1ip9a_ d.15.2.2 (A:) Bud emergence mediator Bemp1 {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Bud emergence mediator Bemp1 species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.03 E-value=2.3e-05 Score=49.20 Aligned_cols=71 Identities=10% Similarity=0.141 Sum_probs=58.5
Q ss_pred CCCEEEEEEECCCCCCCCCCCCCEEEECCCEEEEEECCCCCHHHHHHHHHHHCC-CCEEEEEECCCCCCCCEEECCCHHH
Q ss_conf 997299995129800138999980221695149992589896999999997809-9329997169999783341268377
Q 000893 182 SSRKVKFLCSFGGKILPRPSDGKLRYVGGETRIIRISRDISWQELTQKALAIYN-QTHTIKYQLPGEDLDALVSVSCDED 260 (1236)
Q Consensus 182 ~~~~vklmcSyGG~I~pr~~d~~L~YvGGetriv~V~r~i~f~~l~~kl~~~~~-~~~~lKYqLP~edLD~LiSVt~DeD 260 (1236)
+...||..+.|+ +|++++.|+.+++|.+|+.++.+.+. ..+.|||+ .| -+-+|+++||+|
T Consensus 9 ~~~~ikVKv~~~----------------~D~~~~~l~~~it~~dL~~kI~~rf~~~~~~lkY~--De-dgd~v~i~sD~D 69 (85)
T d1ip9a_ 9 GLKTTKIKFYYK----------------DDIFALMLKGDTTYKELRSKIAPRIDTDNFKLQTK--LF-DGSGEEIKTDSQ 69 (85)
T ss_dssp CCCCEEEEECBT----------------TCCEEEEECSCCCHHHHHHHHHHHHTSSCEEEEEC--CS-SSCCSCCCSHHH
T ss_pred CCCCEEEEEEEC----------------CCEEEEEECCCCCHHHHHHHHHHHHCCCCEEEEEE--CC-CCCEEEEECHHH
T ss_conf 998799999989----------------92999993799889999999999858783689999--68-999789837899
Q ss_pred HHHHHHHHHHC
Q ss_conf 99999995200
Q 000893 261 LQNMMEECNVL 271 (1236)
Q Consensus 261 L~~M~~Eydr~ 271 (1236)
|..+|++..++
T Consensus 70 l~~ai~~~~kl 80 (85)
T d1ip9a_ 70 VSNIIQAKLKI 80 (85)
T ss_dssp HHHHHHTTCCE
T ss_pred HHHHHHHCCCE
T ss_conf 99999722828
|
| >d1blja_ d.93.1.1 (A:) P55 Blk protein tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: P55 Blk protein tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.97 E-value=1.2e-06 Score=57.40 Aligned_cols=103 Identities=20% Similarity=0.176 Sum_probs=62.8
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHC----CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf 411332112797642100111101112000112210----3898532233346771024569999999998899997200
Q 000893 885 AVLSWNVENHDPRRWSYFRNLAQDEFSRKDVSLMDQ----DHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRIN 960 (1236)
Q Consensus 885 ~~~s~~i~~~~~~~wsyyhGl~~~~l~R~D~e~LL~----~~GdFLVRLSEit~G~TlDlS~n~Lk~~pSviP~sgS~~N 960 (1236)
.+...+|+.++ ||||. |+|.+||.||. .+|.||||.++..+|.. -++.. .....+..+.|
T Consensus 3 vap~~~l~~e~-----Wy~g~----isR~eAe~~L~~~~~~~G~FLVR~S~~~~g~~-~Lsv~------~~~~~~~~v~H 66 (114)
T d1blja_ 3 VAPVETLEVEK-----WFFRT----ISRKDAERQLLAPMNKAGSFLIRESESNKGAF-SLSVK------DITTQGEVVKH 66 (114)
T ss_dssp CCSSCCSCCSS-----SBCCS----CCHHHHHHHHSSTTCCTTCEEBCBCTTCSSCE-EEEEC------BCCTTTCBCCC
T ss_pred CCCCCCCCCCC-----CCCCC----CCHHHHHHHHHHCCCCCCEEEEECCCCCCCCE-EEEEE------EECCCCCEEEE
T ss_conf 57867532487-----75789----99899999997458999548985068999975-79888------40357988899
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 003766787742278877679999733135885302477752002343344777888
Q 000893 961 FDEGSQRESSSIVGPSTMETHPDYSRSELKGNESLQSEVVNHRIQESDYEEGRLDLP 1017 (1236)
Q Consensus 961 f~I~S~~essslvgPSs~eThs~~s~s~L~g~eSLqsElv~h~I~esd~ee~kLdLP 1017 (1236)
+.+.......-.+.. .....++. +++.++....+....++..|
T Consensus 67 ~~i~~~~~g~~~l~~-------------~~~F~sl~-eLV~~y~~~~~gL~~~L~~P 109 (114)
T d1blja_ 67 YKIRSLDNGGYYISP-------------RITFPTLQ-ALVQHYSKKGDGLCQKLTLP 109 (114)
T ss_dssp EEEEEETTTEEEEET-------------TEEESSHH-HHHHHHHHCCSSSSSCCCCC
T ss_pred EEEEECCCCCEEECC-------------CCEECCHH-HHHHHHHHCCCCCCCCCCCC
T ss_conf 887785899878569-------------81178999-99999864888888547736
|
| >d1luia_ d.93.1.1 (A:) Itk/tsk protein tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Itk/tsk protein tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.88 E-value=5.6e-06 Score=53.07 Aligned_cols=101 Identities=12% Similarity=0.095 Sum_probs=59.8
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCC
Q ss_conf 2112797642100111101112000112210---3898532233346771024569999999998899997200003766
Q 000893 890 NVENHDPRRWSYFRNLAQDEFSRKDVSLMDQ---DHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQ 966 (1236)
Q Consensus 890 ~i~~~~~~~wsyyhGl~~~~l~R~D~e~LL~---~~GdFLVRLSEit~G~TlDlS~n~Lk~~pSviP~sgS~~Nf~I~S~ 966 (1236)
+|+..+ ||||. ++|.+||.||. .+|.||||.++. +|.. -+|.... +.+.+.+.+.||.|...
T Consensus 2 ~l~~~~-----Wy~g~----isR~eAe~lL~~~~~~G~FLVR~S~~-~g~y-~LSv~~~----~~~~~~~~i~h~~I~~~ 66 (108)
T d1luia_ 2 NLETYE-----WYNKS----ISRDKAEKLLLDTGKEGAFMVRDSRT-PGTY-TVSVFTK----AIISENPCIKHYHIKET 66 (108)
T ss_dssp CCTTST-----TBCTT----CCHHHHHHHHHHHCCTTEEEEEECCT-TTCE-EEEEECS----CCTTTCSCEEEEECEEC
T ss_pred CCCCCC-----CCCCC----CCHHHHHHHHHHCCCCCEEEEEECCC-CCCE-EEEEEEC----CCCCCCCCEEEEEEEEE
T ss_conf 621278-----71789----99999999997319998689872489-9977-9998766----87655884028998880
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 787742278877679999733135885302477752002343344777888
Q 000893 967 RESSSIVGPSTMETHPDYSRSELKGNESLQSEVVNHRIQESDYEEGRLDLP 1017 (1236)
Q Consensus 967 ~essslvgPSs~eThs~~s~s~L~g~eSLqsElv~h~I~esd~ee~kLdLP 1017 (1236)
.+...... ... .....++. +++.++...+......+..|
T Consensus 67 ~~~~~~~~---~~~--------~~~F~sl~-~LV~~y~~~~~~L~~~L~~P 105 (108)
T d1luia_ 67 NDSPKRYY---VAE--------KYVFDSIP-LLIQYHQYNGGGLVTRLRYP 105 (108)
T ss_dssp CCSSCCEE---SSS--------SCCBSSHH-HHHHHHHTTCCSSSSSSSEE
T ss_pred CCCCCEEE---CCC--------CCCCCCHH-HHHHHHHHCCCCCCCCCCCC
T ss_conf 69984065---689--------95429999-99998704878896189875
|
| >d1fu6a_ d.93.1.1 (A:) Phosphatidylinositol 3-kinase, p85-alpha subunit {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Phosphatidylinositol 3-kinase, p85-alpha subunit species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=97.80 E-value=2.1e-05 Score=49.46 Aligned_cols=61 Identities=13% Similarity=0.196 Sum_probs=43.9
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 13321127976421001111011120001122103--8985322333467710245699999999988999972000037
Q 000893 887 LSWNVENHDPRRWSYFRNLAQDEFSRKDVSLMDQD--HLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEG 964 (1236)
Q Consensus 887 ~s~~i~~~~~~~wsyyhGl~~~~l~R~D~e~LL~~--~GdFLVRLSEit~G~TlDlS~n~Lk~~pSviP~sgS~~Nf~I~ 964 (1236)
-+..+++++ ||||. |+|.+||.||.. +|+||||.++...+. .++. ++. .++.+.|+.|.
T Consensus 4 ~~~~l~~~~-----WyhG~----isR~eAe~lL~~~~~G~FLVR~S~~~~~~--~~~l-------s~~-~~~~~~H~~I~ 64 (111)
T d1fu6a_ 4 NNMSLQDAE-----WYWGD----ISREEVNEKLRDTADGTFLVRDASTKMHG--DYTL-------TLR-KGGNNKSIKIF 64 (111)
T ss_dssp CCCCCSCCS-----SCCSS----CCSHHHHHHSSSCSSCCCCCBSSCCSSSC--CSBC-------EEE-ETTEEEECCCC
T ss_pred CCCCCCCCC-----CCCCC----CCHHHHHHHHCCCCCCEEEEEECCCCCCC--CEEE-------EEE-CCCCEEEEEEE
T ss_conf 877647184-----87789----99899999757699987999734677896--2899-------776-18934789999
Q ss_pred CC
Q ss_conf 66
Q 000893 965 SQ 966 (1236)
Q Consensus 965 S~ 966 (1236)
..
T Consensus 65 ~~ 66 (111)
T d1fu6a_ 65 HR 66 (111)
T ss_dssp CT
T ss_pred EC
T ss_conf 75
|
| >d1g83a2 d.93.1.1 (A:142-245) Tyrosine kinase Fyn {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine kinase Fyn species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.76 E-value=4.2e-06 Score=53.90 Aligned_cols=97 Identities=14% Similarity=0.107 Sum_probs=57.0
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHC----CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 32112797642100111101112000112210----38985322333467710245699999999988999972000037
Q 000893 889 WNVENHDPRRWSYFRNLAQDEFSRKDVSLMDQ----DHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEG 964 (1236)
Q Consensus 889 ~~i~~~~~~~wsyyhGl~~~~l~R~D~e~LL~----~~GdFLVRLSEit~G~TlDlS~n~Lk~~pSviP~sgS~~Nf~I~ 964 (1236)
+.||.++ ||||. |+|.+||.+|. .+|+||||.++..+|... +++... ....++.+.|+.+.
T Consensus 1 ~~l~~~~-----Wy~g~----i~R~eAe~~L~~~g~~~G~FLVR~S~~~~g~~~-Lsv~~~-----~~~~~~~v~h~~i~ 65 (104)
T d1g83a2 1 DSIQAEE-----WYFGK----LGRKDAERQLLSFGNPRGTFLIRESETTKGAYS-LSIRDW-----DDMKGDHVKHYKIR 65 (104)
T ss_dssp TSGGGSS-----SBCTT----CCHHHHHHHHHSTTCCTTCEEEEECSSSTTCEE-EEEEEE-----CSSSCEEEEEEEEE
T ss_pred CCCCCCC-----CCCCC----CCHHHHHHHHHHCCCCCCCEEEECCCCCCCCEE-EEEEEE-----ECCCCCEEEEEEEE
T ss_conf 9241278-----71889----999999999975489997379761678999868-898984-----26748837997888
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCC
Q ss_conf 66787742278877679999733135885302477752002343344777
Q 000893 965 SQRESSSIVGPSTMETHPDYSRSELKGNESLQSEVVNHRIQESDYEEGRL 1014 (1236)
Q Consensus 965 S~~essslvgPSs~eThs~~s~s~L~g~eSLqsElv~h~I~esd~ee~kL 1014 (1236)
........+... ....++. +++.++.........++
T Consensus 66 ~~~~g~~~~~~~-------------~~F~sl~-~LV~~y~~~~~gL~~~L 101 (104)
T d1g83a2 66 KLDNGGYYITTR-------------AQFETLQ-QLVQHYSERAAGLSSRL 101 (104)
T ss_dssp ECTTSCEEETTT-------------EEESSHH-HHHHHHHHCCTTSSSCC
T ss_pred ECCCCCEEECCC-------------CCCCCHH-HHHHHHHHCCCCCCEEC
T ss_conf 758997773387-------------0318999-99999864889885048
|
| >d1mila_ d.93.1.1 (A:) Shc adaptor protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Shc adaptor protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.73 E-value=2.3e-06 Score=55.57 Aligned_cols=57 Identities=16% Similarity=0.190 Sum_probs=45.7
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf 32112797642100111101112000112210389853223334677102456999999999889999720000376
Q 000893 889 WNVENHDPRRWSYFRNLAQDEFSRKDVSLMDQDHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGS 965 (1236)
Q Consensus 889 ~~i~~~~~~~wsyyhGl~~~~l~R~D~e~LL~~~GdFLVRLSEit~G~TlDlS~n~Lk~~pSviP~sgS~~Nf~I~S 965 (1236)
..|+.++ ||||. |+|.+||.||+.+|+||||.++-.+|. ++. |++. ++.+.|+.|..
T Consensus 2 ~~l~~~p-----WyhG~----i~R~~Ae~lL~~~G~FLVR~S~~~~g~---~vL-------Sv~~-~~~v~H~~I~~ 58 (104)
T d1mila_ 2 SQLRGEP-----WFHGK----LSRREAEALLQLNGDFLVRESTTTPGQ---YVL-------TGLQ-SGQPKHLLLVD 58 (104)
T ss_dssp CSTTTCT-----TBCSS----CCHHHHHTTCCSTTEEEEEECCSSCSS---EEE-------EEEE-TTEEEEEEEBC
T ss_pred CCCCCCC-----CCCCC----CCHHHHHHHHHCCCCEEEEECCCCCCC---EEE-------EEEE-CCCCCEEEEEE
T ss_conf 6325398-----74788----999999999863882898834889999---999-------9997-15542488994
|
| >d1r1qa_ d.93.1.1 (A:) GRB2-related adaptor protein 2 (MONA, GRID) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: GRB2-related adaptor protein 2 (MONA, GRID) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.69 E-value=9.3e-06 Score=51.67 Aligned_cols=61 Identities=18% Similarity=0.213 Sum_probs=46.8
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHH--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf 211279764210011110111200011221--038985322333467710245699999999988999972000037667
Q 000893 890 NVENHDPRRWSYFRNLAQDEFSRKDVSLMD--QDHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQR 967 (1236)
Q Consensus 890 ~i~~~~~~~wsyyhGl~~~~l~R~D~e~LL--~~~GdFLVRLSEit~G~TlDlS~n~Lk~~pSviP~sgS~~Nf~I~S~~ 967 (1236)
+|+.++ ||||. |+|.+||.|| ..+|+||||.++..+|. |+. |++..+ .+.|+.|....
T Consensus 2 d~~~~~-----Wy~g~----isR~~Ae~lL~~~~~G~FLVR~S~~~~g~---~~L-------Sv~~~~-~v~H~~I~~~~ 61 (97)
T d1r1qa_ 2 DIEFPE-----WFHEG----LSRHQAENLLMGKDIGFFIIRASQSSPGD---FSI-------SVRHED-DVQHFKVMRDT 61 (97)
T ss_dssp CCSCCT-----TBCTT----CCHHHHHHHHHTSCTTCEEEEECSSSTTC---EEE-------EEECSS-SEEEEECEECT
T ss_pred CCCCCC-----CCCCC----CCHHHHHHHHHCCCCCCEEEEECCCCCCC---EEE-------EEEECC-CEEEEEEEECC
T ss_conf 766577-----44799----89999999972599987897625799987---899-------999469-74899999918
Q ss_pred CCC
Q ss_conf 877
Q 000893 968 ESS 970 (1236)
Q Consensus 968 ess 970 (1236)
...
T Consensus 62 ~g~ 64 (97)
T d1r1qa_ 62 KGN 64 (97)
T ss_dssp TCC
T ss_pred CCE
T ss_conf 982
|
| >d2oq1a1 d.93.1.1 (A:5-134) Tyrosine-protein kinase zap-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine-protein kinase zap-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.67 E-value=5.4e-07 Score=59.59 Aligned_cols=119 Identities=12% Similarity=0.020 Sum_probs=68.6
Q ss_pred CCCCCCCCCCCCCCHHHHHC----CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCC
Q ss_conf 00111101112000112210----38985322333467710245699999999988999972000037667877422788
Q 000893 901 YFRNLAQDEFSRKDVSLMDQ----DHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQRESSSIVGPS 976 (1236)
Q Consensus 901 yyhGl~~~~l~R~D~e~LL~----~~GdFLVRLSEit~G~TlDlS~n~Lk~~pSviP~sgS~~Nf~I~S~~essslvgPS 976 (1236)
||||. |+|.+||.+|+ .+|.||||.++...|. |+. |++. ++.+.||.|....+..-.+
T Consensus 8 Wy~g~----i~R~~Ae~~L~~~g~~~G~FLVR~S~~~~g~---yvL-------Sv~~-~~~v~H~~I~~~~~g~~~l--- 69 (130)
T d2oq1a1 8 FFYGS----ISRAEAEEHLKLAGMADGLFLLRQCLRSLGG---YVL-------SLVH-DVRFHHFPIERQLNGTYAI--- 69 (130)
T ss_dssp TBCBS----CCHHHHHHHHHHTTCCTTCEEEEECSSSTTC---EEE-------EEEE-TTEEEEEEEEECTTSCEEE---
T ss_pred CCCCC----CCHHHHHHHHHHCCCCCCEEEEEECCCCCCC---EEE-------EEEE-CCCEEEEEEEECCCCCEEC---
T ss_conf 74278----9999999999746998840898736998864---799-------8761-8723789878868996663---
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCCCCE
Q ss_conf 77679999733135885302477752002343344777888899873000128888521000345670398972247735
Q 000893 977 TMETHPDYSRSELKGNESLQSEVVNHRIQESDYEEGRLDLPTAGIPLVDLALGNFDISTLQIIKNEDLEELKELGSGTFG 1056 (1236)
Q Consensus 977 s~eThs~~s~s~L~g~eSLqsElv~h~I~esd~ee~kLdLPtsg~PL~elal~nfdiseLqiIs~eeYeiLKvLGkGSFG 1056 (1236)
... ....++. +++.++....+.....+..|......... ... .... ..+.+++|.||
T Consensus 70 --~~~--------~~F~sl~-~Lv~~Y~~~~~gL~~~L~~P~~r~~~~~~-----~~~-~~~~------~~~~~~~~~~~ 126 (130)
T d2oq1a1 70 --AGG--------KAHCGPA-ELCEFYSRDPDGLPCNLRKPCNRPSGLEP-----QPG-VFDC------LRDAMVRDYVR 126 (130)
T ss_dssp --TTS--------CCBSSHH-HHHHHHHHCCTTSSSCCCSBCCCCTTCCC-----BCC-HHHH------HHHHHHHHHHH
T ss_pred --CCC--------CCCCCHH-HHHHHHHHCCCCCCCCCCCCCCCCCCCCC-----CCC-HHHH------HHHHHHHHHCC
T ss_conf --699--------7759999-99999824889887158804788888989-----930-6777------89999776426
Q ss_pred EEEE
Q ss_conf 8997
Q 000893 1057 TVYH 1060 (1236)
Q Consensus 1057 kVYK 1060 (1236)
.||+
T Consensus 127 ~~w~ 130 (130)
T d2oq1a1 127 QTWK 130 (130)
T ss_dssp HHHC
T ss_pred CCCC
T ss_conf 7009
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.67 E-value=0.00014 Score=44.18 Aligned_cols=81 Identities=19% Similarity=0.090 Sum_probs=45.5
Q ss_pred EEEECCCCCEEEEEEEEC--CCEEEEEEEECCCCC-CCCHHHHHHHHHHHHHHHHHHHCC---CCCEEEEEEEEECCCCC
Q ss_conf 897224773589975435--922899962036567-987378999999999999985279---99410376467649998
Q 000893 1047 LKELGSGTFGTVYHGKWR--GTDVAIKRIKKSCFT-GRSSEQERLTLEFWREAEILSKLH---HPNVVAFYGVVQDGPGG 1120 (1236)
Q Consensus 1047 LKvLGkGSFGkVYKAklk--Gt~VAIKvLKk~~l~-~~see~er~~keFlrEIeILkkLr---HPNIVrLlGsf~t~deg 1120 (1236)
.+.||.|....||+.... ++.++||.-...... +..- .....+...|..+|+.+. ...+++++.+...
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~--~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~---- 104 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESW--PLTIDRARIESSALIRQGEHVPHLVPRVFYSDTE---- 104 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCC--CCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETT----
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCC--CCCHHHHHHHHHHHHHHHHHCCCCCCEEEEECCC----
T ss_conf 9980798527689999579984899961771303467778--8877899999999998650579885528998598----
Q ss_pred EEEEEEEECCCCC
Q ss_conf 0999996145898
Q 000893 1121 TLATVTEFMVNGS 1133 (1236)
Q Consensus 1121 ~L~LVMEYLeGGS 1133 (1236)
..++|||++.+..
T Consensus 105 ~~~lvmE~L~~~~ 117 (392)
T d2pula1 105 MAVTVMEDLSHLK 117 (392)
T ss_dssp TTEEEECCCTTSE
T ss_pred CCEEEEECCCCCC
T ss_conf 8779871357765
|
| >d1o48a_ d.93.1.1 (A:) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.65 E-value=5.8e-06 Score=53.00 Aligned_cols=95 Identities=15% Similarity=0.161 Sum_probs=56.5
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHC----CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC----CCCCCCEEE
Q ss_conf 2112797642100111101112000112210----38985322333467710245699999999988----999972000
Q 000893 890 NVENHDPRRWSYFRNLAQDEFSRKDVSLMDQ----DHLGFSSPLTNIEEGATVDYSYPPLKPDGSVM----PQSGSRINF 961 (1236)
Q Consensus 890 ~i~~~~~~~wsyyhGl~~~~l~R~D~e~LL~----~~GdFLVRLSEit~G~TlDlS~n~Lk~~pSvi----P~sgS~~Nf 961 (1236)
.||.++ ||||. |+|.+||.||. .+|.||||.++...|. |+. |+. .....+.|+
T Consensus 1 ~l~~~~-----Wy~g~----i~R~eAe~lL~~~~~~~G~FLVR~S~~~~g~---y~L-------Sv~~~~~~~~~~i~h~ 61 (106)
T d1o48a_ 1 SIQAEE-----WYFGK----ITRRESERLLLNAENPRGTFLVRESETTKGA---YCL-------SVSDFDNAKGLNVKHY 61 (106)
T ss_dssp CGGGST-----TEEES----CCHHHHHHHHCCTTCCTTCEEEEECSSSTTC---EEE-------EEEEEETTTEEEEEEE
T ss_pred CCCCCC-----CCCCC----CCHHHHHHHHHHCCCCCCCEEEECCCCCCCC---EEE-------EEEECCCCCCCCEEEE
T ss_conf 961477-----44789----9999999999745999973897754688998---899-------9986646721330788
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 03766787742278877679999733135885302477752002343344777888
Q 000893 962 DEGSQRESSSIVGPSTMETHPDYSRSELKGNESLQSEVVNHRIQESDYEEGRLDLP 1017 (1236)
Q Consensus 962 ~I~S~~essslvgPSs~eThs~~s~s~L~g~eSLqsElv~h~I~esd~ee~kLdLP 1017 (1236)
.+.......-.+ ... ....++. +++.++....+.....+..|
T Consensus 62 ~i~~~~~g~~~~-----~~~--------~~F~sl~-eLV~~y~~~~~gL~~~L~~p 103 (106)
T d1o48a_ 62 KIRKLDSGGFYI-----TSR--------TQFNSLQ-QLVAYYSKHADGLCHRLTTV 103 (106)
T ss_dssp EEEECTTSCEES-----STT--------SEESSHH-HHHHHHTTCCTTSSSCCCSB
T ss_pred EEEEECCCCEEE-----CCC--------EEECCHH-HHHHHHHHCCCCCCCCCCCC
T ss_conf 888806998897-----598--------1499999-99999866879988658771
|
| >d1d4ta_ d.93.1.1 (A:) The Xlp protein Sap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: The Xlp protein Sap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.64 E-value=6.5e-06 Score=52.67 Aligned_cols=60 Identities=12% Similarity=0.096 Sum_probs=44.8
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHHC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf 112797642100111101112000112210---38985322333467710245699999999988999972000037667
Q 000893 891 VENHDPRRWSYFRNLAQDEFSRKDVSLMDQ---DHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQR 967 (1236)
Q Consensus 891 i~~~~~~~wsyyhGl~~~~l~R~D~e~LL~---~~GdFLVRLSEit~G~TlDlS~n~Lk~~pSviP~sgS~~Nf~I~S~~ 967 (1236)
||..+ ||||. |+|.+||.||. .+|+||||.++..+| .++. ++... +.+.|+.|....
T Consensus 1 le~~p-----wyhG~----isR~eAe~lL~~~~~~G~FLVR~S~~~~g---~~~L-------sv~~~-~~v~H~~I~~~~ 60 (104)
T d1d4ta_ 1 MDAVA-----VYHGK----ISRETGEKLLLATGLDGSYLLRDSESVPG---VYCL-------CVLYH-GYIYTYRVSQTE 60 (104)
T ss_dssp CTTCT-----TBCCS----CCHHHHHHHHHHHCCTTEEEEEECSSSTT---CEEE-------EEEET-TEEEEEEEEECT
T ss_pred CCCCC-----CCCCC----CCHHHHHHHHHHCCCCCEEEEEECCCCCC---CEEE-------EEECC-CCCEEEEEEECC
T ss_conf 98677-----13668----89999999996289997689872589999---7898-------87618-972588888869
Q ss_pred CCC
Q ss_conf 877
Q 000893 968 ESS 970 (1236)
Q Consensus 968 ess 970 (1236)
+..
T Consensus 61 ~~~ 63 (104)
T d1d4ta_ 61 TGS 63 (104)
T ss_dssp TSC
T ss_pred CCC
T ss_conf 982
|
| >d1opka2 d.93.1.1 (A:140-240) Abl tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Abl tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.64 E-value=5.6e-06 Score=53.08 Aligned_cols=89 Identities=17% Similarity=0.216 Sum_probs=57.1
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf 21127976421001111011120001122103--8985322333467710245699999999988999972000037667
Q 000893 890 NVENHDPRRWSYFRNLAQDEFSRKDVSLMDQD--HLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQR 967 (1236)
Q Consensus 890 ~i~~~~~~~wsyyhGl~~~~l~R~D~e~LL~~--~GdFLVRLSEit~G~TlDlS~n~Lk~~pSviP~sgS~~Nf~I~S~~ 967 (1236)
+|+.++ ||||. |+|.+||.||.. +|.||||.++..+|. |+. |+.. ++.+.|+.|....
T Consensus 1 sLe~~~-----Wy~g~----isR~eAe~lL~~~~~G~FLVR~S~~~~~~---~~L-------Sv~~-~~~v~H~~I~~~~ 60 (101)
T d1opka2 1 SLEKHS-----WYHGP----VSRNAAEYLLSSGINGSFLVRESESSPGQ---RSI-------SLRY-EGRVYHYRINTAS 60 (101)
T ss_dssp SGGGST-----TEEEE----CCHHHHHHHGGGCCTTEEEEEECSSSTTC---EEE-------EEEE-TTEEEEEECEECT
T ss_pred CCCCCC-----CCCCC----CCHHHHHHHHCCCCCCEEEEEECCCCCCC---EEE-------EEEC-CCCEEEEEEEECC
T ss_conf 964385-----24889----99999999960799985998766889997---899-------9874-7412898847878
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCC
Q ss_conf 877422788776799997331358853024777520023433447
Q 000893 968 ESSSIVGPSTMETHPDYSRSELKGNESLQSEVVNHRIQESDYEEG 1012 (1236)
Q Consensus 968 essslvgPSs~eThs~~s~s~L~g~eSLqsElv~h~I~esd~ee~ 1012 (1236)
...-.+. ... ...++. +++.++.........
T Consensus 61 ~g~~~~~-----~~~--------~F~sl~-~LI~~y~~~~~~l~~ 91 (101)
T d1opka2 61 DGKLYVS-----SES--------RFNTLA-ELVHHHSTVADGLIT 91 (101)
T ss_dssp TSCEESS-----TTS--------CBSSHH-HHHHHHTTCCTTSSS
T ss_pred CCCEEEC-----CCC--------CCCCHH-HHHHHHHHCCCCCCE
T ss_conf 9978817-----970--------208999-999999648998830
|
| >d1qcfa2 d.93.1.1 (A:146-248) Hemopoetic cell kinase Hck {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Hemopoetic cell kinase Hck species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.60 E-value=8.9e-06 Score=51.80 Aligned_cols=89 Identities=22% Similarity=0.231 Sum_probs=55.3
Q ss_pred CCCCCCCCCCCCCCHHHHH----CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC----CCCCCCEEECCCCCCCCCCC
Q ss_conf 0011110111200011221----038985322333467710245699999999988----99997200003766787742
Q 000893 901 YFRNLAQDEFSRKDVSLMD----QDHLGFSSPLTNIEEGATVDYSYPPLKPDGSVM----PQSGSRINFDEGSQRESSSI 972 (1236)
Q Consensus 901 yyhGl~~~~l~R~D~e~LL----~~~GdFLVRLSEit~G~TlDlS~n~Lk~~pSvi----P~sgS~~Nf~I~S~~esssl 972 (1236)
||||. |+|.+||.+| ..+|.||||.++..+|. ++. ++. ..+..+.|+.+.......-.
T Consensus 3 Wy~g~----isR~eAe~~L~~~~~~~G~FLVR~S~~~~g~---~~L-------sv~~~~~~~~~~v~H~~i~~~~~g~~~ 68 (103)
T d1qcfa2 3 WFFKG----ISRKDAERQLLAPGNMLGSFMIRDSETTKGS---YSL-------SVRDYDPRQGDTVKHYKIRTLDNGGFY 68 (103)
T ss_dssp TEETT----CCHHHHHHHHHSTTCCTTCEEEEECSSSTTS---EEE-------EEEEEETTTEEEEEEEEEEECTTSCEE
T ss_pred CCCCC----CCHHHHHHHHHHCCCCCCCEEEECCCCCCCC---EEE-------EEEECCCCCCCEEEEEEEEECCCCCEE
T ss_conf 60789----9999999998615888974797746799998---688-------988547876753888877784799666
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 278877679999733135885302477752002343344777888
Q 000893 973 VGPSTMETHPDYSRSELKGNESLQSEVVNHRIQESDYEEGRLDLP 1017 (1236)
Q Consensus 973 vgPSs~eThs~~s~s~L~g~eSLqsElv~h~I~esd~ee~kLdLP 1017 (1236)
+. .. ....++. +++.++....+....++..|
T Consensus 69 ~~----~~---------~~F~sl~-~LV~~y~~~~~gL~~~L~~P 99 (103)
T d1qcfa2 69 IS----PR---------STFSTLQ-ELVDHYKKGNDGLCQKLSVP 99 (103)
T ss_dssp SS----SS---------SCBSSHH-HHHHHHTSSCTTSSSCCCSB
T ss_pred EC----CC---------CCCCCHH-HHHHHHHHCCCCCCCCCCCC
T ss_conf 05----98---------3409999-99999854889888518721
|
| >d2eyva1 d.93.1.1 (A:12-120) Crk proto-oncogen {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Crk proto-oncogen species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.56 E-value=3.2e-05 Score=48.21 Aligned_cols=57 Identities=21% Similarity=0.233 Sum_probs=42.4
Q ss_pred CCCCCCCCCCCCCCCHHHHHC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC
Q ss_conf 100111101112000112210--389853223334677102456999999999889999720000376678774
Q 000893 900 SYFRNLAQDEFSRKDVSLMDQ--DHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQRESSS 971 (1236)
Q Consensus 900 syyhGl~~~~l~R~D~e~LL~--~~GdFLVRLSEit~G~TlDlS~n~Lk~~pSviP~sgS~~Nf~I~S~~esss 971 (1236)
|||||. |+|.+||.||+ .+|.||||.++..++ +|+. |++.. +.+.|+.|........
T Consensus 1 sWy~g~----isR~~Ae~lL~~~~~G~FLVR~S~~~~~---~~~L-------S~~~~-~~v~H~~I~~~~~~~~ 59 (109)
T d2eyva1 1 SWYWGR----LSRQEAVALLQGQRHGVFLVRDSSTSPG---DYVL-------SVSEN-SRVSHYIINSSGPRPP 59 (109)
T ss_dssp TSCCBC----CCHHHHHHHCSSCSTTCEEEECCCSSSS---CEEE-------EEEET-TEEEEEEEECCCCSSC
T ss_pred CCCCCC----CCHHHHHHHHCCCCCCEEEEEECCCCCC---CEEE-------EEEEC-CEEEEEEEEECCCCCE
T ss_conf 977798----8999999986489997588464589888---8999-------99989-9889999998499615
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.55 E-value=0.00051 Score=40.53 Aligned_cols=137 Identities=17% Similarity=0.118 Sum_probs=76.1
Q ss_pred EECCCC-CEEEEEEEEC-CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCC--CCEEEEEEEEECCCCCEEEE
Q ss_conf 722477-3589975435-9228999620365679873789999999999999852799--94103764676499980999
Q 000893 1049 ELGSGT-FGTVYHGKWR-GTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHH--PNVVAFYGVVQDGPGGTLAT 1124 (1236)
Q Consensus 1049 vLGkGS-FGkVYKAklk-Gt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrH--PNIVrLlGsf~t~deg~L~L 1124 (1236)
.+..|. ...||+.... +..+.+|........ .+..|+..++.+.. -.+.+++.++... +..++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~-----------~l~~E~~~l~~L~~~gvpvP~v~~~~~~~--~~~~~ 83 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN-----------ELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDWL 83 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS-----------CHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEEE
T ss_pred ECCCCCCCCEEEEEEECCCCEEEEEECCCCCHH-----------HHHHHHHHHHHHHHCCCCCCCEEEECCCC--CCEEE
T ss_conf 767865477589999389878999958966776-----------89999999999986599988613222456--61599
Q ss_pred EEEECCCCCHHH--------------HHHH-H-----CCCC--CHHHHHH-----H---------------HHHHHHHHH
Q ss_conf 996145898999--------------9964-0-----4678--9999999-----9---------------999999999
Q 000893 1125 VTEFMVNGSLRH--------------VLLS-K-----ERHL--DRRKRLI-----I---------------AMDAAFGME 1162 (1236)
Q Consensus 1125 VMEYLeGGSL~e--------------lL~q-k-----ek~L--Se~eil~-----I---------------A~QILeALe 1162 (1236)
||++++|.++.. .+.+ . ...+ ....... + .......+.
T Consensus 84 v~~~i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 84 LLGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp EEECCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred EEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHH
T ss_conf 98744135543221268999999999999873688544887554124688999999875411011340112137999999
Q ss_pred HHHHC-------CCCCCCCCCCCEEECCCCCCCCCEEEEECCCCCCC
Q ss_conf 99979-------94027899996798369998893899743675112
Q 000893 1163 YLHSK-------NIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 1202 (1236)
Q Consensus 1163 YLHSk-------GIIHRDIKPsNILIDsdG~I~lvVKLsDFGLArli 1202 (1236)
.+... .++|+|+.|.|||++.+. .+-|+||+.+...
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~----~~~iID~~~~~~g 206 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVENGR----FSGFIDCGRLGVA 206 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTE----EEEECCCTTCEEE
T ss_pred HHHHHCCCCCCCEEEECCCCCCCEEEECCC----EEEEEECHHCCCC
T ss_conf 998718765795678678887635773796----5899985332658
|
| >d1lkka_ d.93.1.1 (A:) p56-lck tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: p56-lck tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.51 E-value=1.6e-05 Score=50.14 Aligned_cols=98 Identities=20% Similarity=0.158 Sum_probs=56.5
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHHC----CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCC
Q ss_conf 112797642100111101112000112210----3898532233346771024569999999998899997200003766
Q 000893 891 VENHDPRRWSYFRNLAQDEFSRKDVSLMDQ----DHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQ 966 (1236)
Q Consensus 891 i~~~~~~~wsyyhGl~~~~l~R~D~e~LL~----~~GdFLVRLSEit~G~TlDlS~n~Lk~~pSviP~sgS~~Nf~I~S~ 966 (1236)
||.++ ||||. |+|.+||.+|. .+|.||||.++..+|... ++.... ..+.+..+.|+.+...
T Consensus 1 le~~p-----Wy~g~----isR~eAe~~L~~~~~~~GtFLVR~S~~~~g~~~-lsv~~~-----~~~~~~~v~h~~i~~~ 65 (105)
T d1lkka_ 1 LEPEP-----WFFKN----LSRKDAERQLLAPGNTHGSFLIRESESTAGSFS-LSVRDF-----DQNQGEVVKHYKIRNL 65 (105)
T ss_dssp CCCCT-----TBCTT----CCHHHHHHHHTSTTCCTTCEEEEECSSSTTCEE-EEEEEE-----ETTTEEEEEEEEEEEC
T ss_pred CCCCC-----CCCCC----CCHHHHHHHHHHCCCCCCCEEEECCCCCCCCEE-EEEEEC-----CCCCCCCEEEEEEEEC
T ss_conf 96587-----20889----999999999972699897379772688999879-897874-----2677850798777885
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 787742278877679999733135885302477752002343344777888
Q 000893 967 RESSSIVGPSTMETHPDYSRSELKGNESLQSEVVNHRIQESDYEEGRLDLP 1017 (1236)
Q Consensus 967 ~essslvgPSs~eThs~~s~s~L~g~eSLqsElv~h~I~esd~ee~kLdLP 1017 (1236)
....-.+. .. ....++. +++.++....+....++..|
T Consensus 66 ~~~~~~~~-----~~--------~~F~sl~-~LV~~y~~~~~gL~~~L~~P 102 (105)
T d1lkka_ 66 DNGGFYIS-----PR--------ITFPGLH-ELVRHYTNASDGLCTRLSRP 102 (105)
T ss_dssp TTSCEESS-----TT--------SCBSSHH-HHHHHHHHCCTTSSSCCCSB
T ss_pred CCCCEEEC-----CC--------CCCCCHH-HHHHHHHHCCCCCCCCCCCC
T ss_conf 89987804-----98--------3308999-99999965879897647786
|
| >d1a81a1 d.93.1.1 (A:9-137) Syk tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Syk tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.47 E-value=2.2e-05 Score=49.28 Aligned_cols=94 Identities=13% Similarity=0.067 Sum_probs=59.7
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHHC----CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCC
Q ss_conf 112797642100111101112000112210----3898532233346771024569999999998899997200003766
Q 000893 891 VENHDPRRWSYFRNLAQDEFSRKDVSLMDQ----DHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQ 966 (1236)
Q Consensus 891 i~~~~~~~wsyyhGl~~~~l~R~D~e~LL~----~~GdFLVRLSEit~G~TlDlS~n~Lk~~pSviP~sgS~~Nf~I~S~ 966 (1236)
..+-| ||||. |+|.+||.||. .+|.||||.++...|. |+. |+.. ++.+.||.|...
T Consensus 2 ~~~~P-----Wyhg~----isR~~Ae~lL~~~g~~dG~FLVR~S~~~~g~---y~L-------Sv~~-~~~v~H~~I~~~ 61 (129)
T d1a81a1 2 ANHLP-----FFFGN----ITREEAEDYLVQGGMSDGLYLLRQSRNYLGG---FAL-------SVAH-GRKAHHYTIERE 61 (129)
T ss_dssp TTSST-----TBCSS----CCHHHHHHHHHHTTCCTTEEEEEECSSSTTC---EEE-------EEEE-TTEEEEEEEEEC
T ss_pred CCCCC-----CCCCC----CCHHHHHHHHHHCCCCCCCEEEECCCCCCCC---EEE-------EEEE-CCCCEEEEEEEC
T ss_conf 87798-----24589----9999999999726998863798716998763---699-------7650-455537997885
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf 7877422788776799997331358853024777520023433447778888
Q 000893 967 RESSSIVGPSTMETHPDYSRSELKGNESLQSEVVNHRIQESDYEEGRLDLPT 1018 (1236)
Q Consensus 967 ~essslvgPSs~eThs~~s~s~L~g~eSLqsElv~h~I~esd~ee~kLdLPt 1018 (1236)
.+..-.+.. .....++. +++.|+....+.....+..|.
T Consensus 62 ~~g~~~i~~-------------~~~F~sl~-eLV~~Y~~~~~gl~~~L~~P~ 99 (129)
T d1a81a1 62 LNGTYAIAG-------------GRTHASPA-DLCHYHSQESDGLVCLLKKPF 99 (129)
T ss_dssp TTSCEEETT-------------SCCBSSHH-HHHHHHTTCCTTSSSCCCEEC
T ss_pred CCCCEEECC-------------CCCCCCHH-HHHHHHHHCCCCCCCCCCCCC
T ss_conf 899866359-------------85529999-999998658899844589778
|
| >d1i3za_ d.93.1.1 (A:) Ews/fli1 activated transcript 2, Eat2 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Ews/fli1 activated transcript 2, Eat2 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.46 E-value=2.3e-05 Score=49.09 Aligned_cols=86 Identities=10% Similarity=0.040 Sum_probs=51.9
Q ss_pred CCCCCCCCCCCCCCHHHHHC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCC
Q ss_conf 00111101112000112210---389853223334677102456999999999889999720000376678774227887
Q 000893 901 YFRNLAQDEFSRKDVSLMDQ---DHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQRESSSIVGPST 977 (1236)
Q Consensus 901 yyhGl~~~~l~R~D~e~LL~---~~GdFLVRLSEit~G~TlDlS~n~Lk~~pSviP~sgS~~Nf~I~S~~essslvgPSs 977 (1236)
||||. |+|.+||.||. .+|.||||.++..+|. |+. |++. ++.+.||.|....+....+...
T Consensus 5 Wy~g~----isR~~AE~lL~~~~~~G~FLVR~S~~~~g~---~~L-------Sv~~-~~~v~H~~I~~~~~g~~~~~~~- 68 (103)
T d1i3za_ 5 YYHGC----LTKRECEALLLKGGVDGNFLIRDSESVPGA---LCL-------CVSF-KKLVYSYRIFREKHGYYRIETD- 68 (103)
T ss_dssp TEESS----CCHHHHHHHHHTTCSTTEEEEEECSSSTTC---EEE-------EEEC-SSSEEEEEEEECTTSCEEECBC-
T ss_pred CCCCC----CCHHHHHHHHHHCCCCCEEEEEECCCCCCC---EEE-------EEEE-CCEEEEEEEEECCCCCEEEECC-
T ss_conf 66698----899999999973799975999725899998---799-------8871-9937898868838986998415-
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCC
Q ss_conf 767999973313588530247775200234334
Q 000893 978 METHPDYSRSELKGNESLQSEVVNHRIQESDYE 1010 (1236)
Q Consensus 978 ~eThs~~s~s~L~g~eSLqsElv~h~I~esd~e 1010 (1236)
+. .......++. +++.++....+..
T Consensus 69 ----~~---~~~~~F~sl~-~LV~~y~~~~~gl 93 (103)
T d1i3za_ 69 ----AH---TPRTIFPNLQ-ELVSKYGKPGQGL 93 (103)
T ss_dssp ----TT---SCCCEESSSH-HHHHHTTSSSSSS
T ss_pred ----CC---CCCCCCCCHH-HHHHHHHHCCCCC
T ss_conf ----77---6751429999-9999863179997
|
| >d1jwoa_ d.93.1.1 (A:) Csk homologous kinase Chk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Csk homologous kinase Chk species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.41 E-value=1.7e-05 Score=49.95 Aligned_cols=87 Identities=16% Similarity=0.120 Sum_probs=54.3
Q ss_pred CCCCCCCCCCCCCCHHHHHC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCC
Q ss_conf 00111101112000112210--3898532233346771024569999999998899997200003766787742278877
Q 000893 901 YFRNLAQDEFSRKDVSLMDQ--DHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQRESSSIVGPSTM 978 (1236)
Q Consensus 901 yyhGl~~~~l~R~D~e~LL~--~~GdFLVRLSEit~G~TlDlS~n~Lk~~pSviP~sgS~~Nf~I~S~~essslvgPSs~ 978 (1236)
||||. |+|.+||.||+ .+|.||||.++...|. |+. |+. .++.+.||.|....+...+
T Consensus 6 Wy~g~----isR~eAe~~L~~~~~G~FLVR~S~~~~g~---~vL-------Sv~-~~~~v~H~~I~~~~~~~~~------ 64 (97)
T d1jwoa_ 6 WFHGK----ISGQEAVQQLQPPEDGLFLVRESARHPGD---YVL-------CVS-FGRDVIHYRVLHRDGHLTI------ 64 (97)
T ss_dssp TEEES----CCHHHHHHHTCSCCTTCEEEEECSSSTTC---EEE-------EEE-ETTEEEEEEEEESSSEESS------
T ss_pred CCCCC----CCHHHHHHHHCCCCCCEEEEEECCCCCCC---EEE-------EEE-ECCCEEEEEEEECCCCEEE------
T ss_conf 31798----89999999853799985998856888755---899-------988-3575489999976996882------
Q ss_pred CCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 679999733135885302477752002343344777888
Q 000893 979 ETHPDYSRSELKGNESLQSEVVNHRIQESDYEEGRLDLP 1017 (1236)
Q Consensus 979 eThs~~s~s~L~g~eSLqsElv~h~I~esd~ee~kLdLP 1017 (1236)
... ....++. +++.++.........++..|
T Consensus 65 ~~~--------~~F~sl~-~LI~~y~~~~~~L~~~L~~P 94 (97)
T d1jwoa_ 65 DEA--------VFFCNLM-DMVEHYSKDKGAICTKLVRP 94 (97)
T ss_dssp TTS--------CCBSCHH-HHHHHHHHCCTTSSSCCCCB
T ss_pred CCC--------CCCCCHH-HHHHHHHHCCCCCCCCCCCC
T ss_conf 599--------6329999-99999824879887458756
|
| >d2c60a1 d.15.2.2 (A:43-122) Mitogen-activated protein kinase kinase kinase 3, MEKK 3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Mitogen-activated protein kinase kinase kinase 3, MEKK 3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.39 E-value=0.00072 Score=39.52 Aligned_cols=70 Identities=20% Similarity=0.440 Sum_probs=60.7
Q ss_pred CCCEEEEEECCCCCHHHHHHHHHHHCCCCEEEEEECCCCCCCCEEECCCHHHHHHHHHHHHHCCCCCCCCCEEEEC
Q ss_conf 6951499925898969999999978099329997169999783341268377999999952001269998379980
Q 000893 209 GGETRIIRISRDISWQELTQKALAIYNQTHTIKYQLPGEDLDALVSVSCDEDLQNMMEECNVLEDRGTQKPRMFLF 284 (1236)
Q Consensus 209 GGetriv~V~r~i~f~~l~~kl~~~~~~~~~lKYqLP~edLD~LiSVt~DeDL~~M~~Eydr~~~~~~~~~R~fLF 284 (1236)
-||-||+.++|.++|.+|..|+...||..+.+-|- +-..+|.++|.+||+.-++..||-..- +.+|+.|-
T Consensus 10 ~gEkRIi~f~RPv~~~dl~~kv~~afGq~ldl~y~----n~El~IPl~~Q~DLDkAvellDrs~~~--ksLrilL~ 79 (80)
T d2c60a1 10 NGERRIIAFSRPVKYEDVEHKVTTVFGQPLDLHYM----NNELSILLKNQDDLDKAIDILDRSSSM--KSLRILLL 79 (80)
T ss_dssp TTEEEEEEECSSCCHHHHHHHHHHHHSSCCEEEEE----CSSCEEECCSHHHHHHHHHHHHHCSSC--CSEEEEEE
T ss_pred CCCEEEEECCCCCCHHHHHHHHHHHHCCEEEEEEE----CCEEEEECCCHHHHHHHHHHHCCCCCC--CEEEEEEE
T ss_conf 37068995278842999999999985983646775----671788525677789999987169663--30699973
|
| >d1k9aa2 d.93.1.1 (A:77-177) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.37 E-value=1.8e-05 Score=49.76 Aligned_cols=87 Identities=21% Similarity=0.166 Sum_probs=54.4
Q ss_pred CCCCCCCCCCCCCCHHHHHC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCC
Q ss_conf 00111101112000112210--3898532233346771024569999999998899997200003766787742278877
Q 000893 901 YFRNLAQDEFSRKDVSLMDQ--DHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQRESSSIVGPSTM 978 (1236)
Q Consensus 901 yyhGl~~~~l~R~D~e~LL~--~~GdFLVRLSEit~G~TlDlS~n~Lk~~pSviP~sgS~~Nf~I~S~~essslvgPSs~ 978 (1236)
||||. |+|.+||.||. .+|.||||.++...|. |+. |+.. ++.+.||.|....+.-.+.
T Consensus 6 Wy~g~----isR~~Ae~lL~~~~~G~FLVR~S~~~~g~---y~L-------Sv~~-~~~v~H~~I~~~~~~~~~~----- 65 (101)
T d1k9aa2 6 WFHGK----ITREQAERLLYPPETGLFLVRESTNYPGD---YTL-------CVSC-EGKVEHYRIMYHASKLSID----- 65 (101)
T ss_dssp TBCTT----CCHHHHHHHTCSCCTTEEEEEECSSSTTS---EEE-------EEEC-SSSEEEEEEEEETTEEESS-----
T ss_pred CCCCC----CCHHHHHHHHCCCCCCCEEEECCCCCCCC---EEE-------EEEE-CCCCEEEEEEECCCCCEEC-----
T ss_conf 21798----89999999980799998898606887787---799-------8772-8862899999829973656-----
Q ss_pred CCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 679999733135885302477752002343344777888
Q 000893 979 ETHPDYSRSELKGNESLQSEVVNHRIQESDYEEGRLDLP 1017 (1236)
Q Consensus 979 eThs~~s~s~L~g~eSLqsElv~h~I~esd~ee~kLdLP 1017 (1236)
.. ....++. +++.++....+.....+..|
T Consensus 66 ~~---------~~F~sl~-~LV~~y~~~~~gl~~~L~~P 94 (101)
T d1k9aa2 66 EE---------VYFENLM-QLVEHYTTDADGLCTRLIKP 94 (101)
T ss_dssp SS---------SCBSSHH-HHHHHHHHCCTTSSSCCCEE
T ss_pred CC---------CCCCCHH-HHHHHHHHCCCCCCEECCCC
T ss_conf 98---------3129999-99999704889872238956
|
| >d2shpa2 d.93.1.1 (A:2-110) Tyrosine phoshatase shp-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine phoshatase shp-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.36 E-value=1.6e-05 Score=50.21 Aligned_cols=57 Identities=11% Similarity=0.152 Sum_probs=42.8
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 127976421001111011120001122103---89853223334677102456999999999889999720000376678
Q 000893 892 ENHDPRRWSYFRNLAQDEFSRKDVSLMDQD---HLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQRE 968 (1236)
Q Consensus 892 ~~~~~~~wsyyhGl~~~~l~R~D~e~LL~~---~GdFLVRLSEit~G~TlDlS~n~Lk~~pSviP~sgS~~Nf~I~S~~e 968 (1236)
+.++ ||||. |+|.+||.||.+ +|.||||.++...|. |+. |+.. ++.+.|+.|....+
T Consensus 1 ~~~~-----Wy~g~----isR~~Ae~lL~~~~~~G~FLvR~S~~~~g~---y~L-------Sv~~-~~~v~H~~I~~~~~ 60 (109)
T d2shpa2 1 KSRR-----WFHPN----ITGVEAENLLLTRGVDGSFLARPSKSNPGD---LTL-------SVRR-NGAVTHIKIQNTGD 60 (109)
T ss_dssp CCST-----TBCSS----CCHHHHHHHHHHHCCTTEEEEEECSSSTTC---EEE-------EEEE-TTEEEEEEEECSSS
T ss_pred CCCC-----CCCCC----CCHHHHHHHHHHCCCCCEEEEEECCCCCCC---EEE-------EEEE-CCCEEEEEEEECCC
T ss_conf 9876-----50699----999999999960898975898756899998---999-------9972-89688999997699
|
| >d1rjaa_ d.93.1.1 (A:) Tyrosine-protein kinase 6 (Breast tumor kinase, Brk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine-protein kinase 6 (Breast tumor kinase, Brk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.35 E-value=3e-05 Score=48.45 Aligned_cols=90 Identities=19% Similarity=0.113 Sum_probs=56.2
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHHC----CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 797642100111101112000112210----3898532233346771024569999999998899997200003766787
Q 000893 894 HDPRRWSYFRNLAQDEFSRKDVSLMDQ----DHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQRES 969 (1236)
Q Consensus 894 ~~~~~wsyyhGl~~~~l~R~D~e~LL~----~~GdFLVRLSEit~G~TlDlS~n~Lk~~pSviP~sgS~~Nf~I~S~~es 969 (1236)
++ ||||. |+|.+||.||+ .+|.||||.++...|. |+. |++. ++.+.|+.|....+.
T Consensus 2 ep-----Wy~g~----isR~~Ae~~L~~~~~~~G~FLvR~S~~~~g~---y~L-------Sv~~-~~~v~H~~I~~~~~g 61 (100)
T d1rjaa_ 2 EP-----WFFGC----ISRSEAVRRLQAEGNATGAFLIRVSEKPSAD---YVL-------SVRD-TQAVRHYKIWRRAGG 61 (100)
T ss_dssp CC-----CBCTT----CCHHHHHHHHSSTTCSSCCEEEEECSSSSSC---EEE-------EECT-TSSCEEEEEEECSSS
T ss_pred CC-----CCCCC----CCHHHHHHHHHCCCCCCCEEEEECCCCCCCC---EEE-------EEEC-CCCCEEEEEEECCCC
T ss_conf 97-----70789----8999999998505899970782347789998---899-------9870-788657887887899
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 742278877679999733135885302477752002343344777888
Q 000893 970 SSIVGPSTMETHPDYSRSELKGNESLQSEVVNHRIQESDYEEGRLDLP 1017 (1236)
Q Consensus 970 sslvgPSs~eThs~~s~s~L~g~eSLqsElv~h~I~esd~ee~kLdLP 1017 (1236)
.-.+.. . ....++. +++.++..........+..|
T Consensus 62 ~~~l~~-----~--------~~F~sl~-~LV~~y~~~~~~~~~~L~~P 95 (100)
T d1rjaa_ 62 RLHLNE-----A--------VSFLSLP-ELVNYHRAQSLSHGLRLAAP 95 (100)
T ss_dssp CEEEET-----T--------EEESSHH-HHHHHHHHCCTTSSSCCCSB
T ss_pred CEEECC-----C--------CCCCCHH-HHHHHHHHCCCCCCCCCCEE
T ss_conf 778069-----9--------7639999-99999846877776276705
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.28 E-value=0.0013 Score=37.98 Aligned_cols=133 Identities=14% Similarity=0.085 Sum_probs=67.2
Q ss_pred CCCEEEEEEEE-CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCE-----EEEEE--EEECCCCCEEEE
Q ss_conf 77358997543-59228999620365679873789999999999999852799941-----03764--676499980999
Q 000893 1053 GTFGTVYHGKW-RGTDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLHHPNV-----VAFYG--VVQDGPGGTLAT 1124 (1236)
Q Consensus 1053 GSFGkVYKAkl-kGt~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLrHPNI-----VrLlG--sf~t~deg~L~L 1124 (1236)
+---.||+++. +|..+++|+....... ..++..|...+..|....| +..-+ .+.. .+..+.
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~~~s---------~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~--~~~~~~ 101 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPERWT---------ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNH--QGFYFA 101 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTTTSC---------HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEE--TTEEEE
T ss_pred CCCCEEEEEECCCCCEEEEEEECCCCCC---------HHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEE--EEEEEE
T ss_conf 6120269998389997999984787788---------99999999999999855998787520689805665--347999
Q ss_pred EEEECCCCCH-----HHH------H---HHH--------CCCCC-------------------HHHHHHHHHHHHHHHHH
Q ss_conf 9961458989-----999------9---640--------46789-------------------99999999999999999
Q 000893 1125 VTEFMVNGSL-----RHV------L---LSK--------ERHLD-------------------RRKRLIIAMDAAFGMEY 1163 (1236)
Q Consensus 1125 VMEYLeGGSL-----~el------L---~qk--------ek~LS-------------------e~eil~IA~QILeALeY 1163 (1236)
+++++.|..+ ..+ + +.. ...++ ......+...+...+..
T Consensus 102 l~~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 181 (325)
T d1zyla1 102 VFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAA 181 (325)
T ss_dssp EEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHH
T ss_pred EEEECCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHH
T ss_conf 98652776889999999999899999988630357865567789788766568999874769988989999999999999
Q ss_pred HHH-------CCCCCCCCCCCCEEECCCCCCCCCEEEEECCCCCCC
Q ss_conf 997-------994027899996798369998893899743675112
Q 000893 1164 LHS-------KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKIK 1202 (1236)
Q Consensus 1164 LHS-------kGIIHRDIKPsNILIDsdG~I~lvVKLsDFGLArli 1202 (1236)
+.. .++||+|+.+.|||++.+ . .++||+.|...
T Consensus 182 l~~~~~~~~p~~liHgDlh~~NvL~~~~-----~-~~IDFdd~~~g 221 (325)
T d1zyla1 182 VTAHWREDFTVLRLHGDCHAGNILWRDG-----P-MFVDLDDARNG 221 (325)
T ss_dssp HHHHCCSCSCCEECCSSCSGGGEEESSS-----E-EECCCTTCCEE
T ss_pred HHHHCCCCCCCEEECCCCCCCCEEEECC-----C-EEEECHHCCCC
T ss_conf 9984545687120247888042878389-----3-58865201468
|
| >d2fcia1 d.93.1.1 (A:1-105) Phospholipase C-gamma-1 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Phospholipase C-gamma-1 species: Cow (Bos taurus) [TaxId: 9913]
Probab=97.24 E-value=5e-05 Score=46.95 Aligned_cols=91 Identities=15% Similarity=0.243 Sum_probs=55.4
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf 1127976421001111011120001122103---8985322333467710245699999999988999972000037667
Q 000893 891 VENHDPRRWSYFRNLAQDEFSRKDVSLMDQD---HLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQR 967 (1236)
Q Consensus 891 i~~~~~~~wsyyhGl~~~~l~R~D~e~LL~~---~GdFLVRLSEit~G~TlDlS~n~Lk~~pSviP~sgS~~Nf~I~S~~ 967 (1236)
.+.++ ||||. |+|.+||.||.+ +|+||||.+. ++| .|+. |++. ++.+.||.|....
T Consensus 6 he~~~-----Wy~g~----i~R~eAe~lL~~~~~~G~FLVR~S~-~~~---~yvL-------Sv~~-~~~v~H~~I~~~~ 64 (105)
T d2fcia1 6 HESKE-----WYHAS----LTRAQAEHMLMRVPRDGAFLVRKRN-EPN---SYAI-------SFRA-EGKIKHCRVQQEG 64 (105)
T ss_dssp TSSSC-----CCCSS----SCSHHHHHHHHHSSSSCCEEEEECS-STT---CEEE-------EEEE-TTEECCCEEBCCS
T ss_pred CCCCC-----CCCCC----CCHHHHHHHHHHCCCCCEEEEEECC-CCC---CEEE-------EEEE-CCCCEEEEEEECC
T ss_conf 24687-----70689----9999999999737989868988547-777---7799-------9985-1332789998449
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf 877422788776799997331358853024777520023433447778888
Q 000893 968 ESSSIVGPSTMETHPDYSRSELKGNESLQSEVVNHRIQESDYEEGRLDLPT 1018 (1236)
Q Consensus 968 essslvgPSs~eThs~~s~s~L~g~eSLqsElv~h~I~esd~ee~kLdLPt 1018 (1236)
...+ +.. ....++. +++.++.........++..|.
T Consensus 65 --~~~~----~~~---------~~F~sl~-~LV~~y~~~~~~~~~~L~~P~ 99 (105)
T d2fcia1 65 --QTVM----LGN---------SEFDSLV-DLISYYEKHPLYRKMKLRYPI 99 (105)
T ss_dssp --SCEE----CSS---------SEESTTH-HHHHHHHHSCCSTTCSSCCCC
T ss_pred --CEEE----CCC---------CCCCCHH-HHHHHHHHCCCCCCCCCCCCC
T ss_conf --7486----298---------5609999-999999659887866788878
|
| >d2qmsa1 d.93.1.1 (A:420-532) Growth factor receptor-bound protein 7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Growth factor receptor-bound protein 7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.22 E-value=4.1e-05 Score=47.51 Aligned_cols=94 Identities=11% Similarity=0.012 Sum_probs=54.9
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHHC----CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf 12797642100111101112000112210----38985322333467710245699999999988999972000037667
Q 000893 892 ENHDPRRWSYFRNLAQDEFSRKDVSLMDQ----DHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQR 967 (1236)
Q Consensus 892 ~~~~~~~wsyyhGl~~~~l~R~D~e~LL~----~~GdFLVRLSEit~G~TlDlS~n~Lk~~pSviP~sgS~~Nf~I~S~~ 967 (1236)
+.++ ||||. |+|.+||.||. .+|.||+|.++..+|. |+. |+. .++.+.|+.|....
T Consensus 8 ~~~~-----Wy~g~----isR~~Ae~lL~~~g~~dG~FLvR~S~~~~g~---y~L-------Sv~-~~~~v~H~~I~~~~ 67 (113)
T d2qmsa1 8 RTQL-----WFHGR----ISREESQRLIGQQGLVDGLFLVRESQRNPQG---FVL-------SLC-HLQKVKHYLILPSE 67 (113)
T ss_dssp TCCT-----TEEEE----BCHHHHHHHHHHTTCCTTEEEEEECSSCTTC---EEE-------EEE-ETTEEEEEEEEEEE
T ss_pred CCCC-----CCCCC----CCHHHHHHHHHCCCCCCCCEEEEECCCCCCC---EEE-------EEE-ECCEEEEEEEEEEC
T ss_conf 4797-----52889----9999999998546988851898843689997---999-------997-59928999999968
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCC
Q ss_conf 877422788776799997331358853024777520023433447778
Q 000893 968 ESSSIVGPSTMETHPDYSRSELKGNESLQSEVVNHRIQESDYEEGRLD 1015 (1236)
Q Consensus 968 essslvgPSs~eThs~~s~s~L~g~eSLqsElv~h~I~esd~ee~kLd 1015 (1236)
......- .....+. ...++. +++.++..........+.
T Consensus 68 ~~~~~~~-~~~~~~~--------~F~sl~-~LI~~y~~~~~~L~~~L~ 105 (113)
T d2qmsa1 68 EEGRLYF-SMDDGQT--------RFTDLL-QLVEFHQLNRGILPCLLR 105 (113)
T ss_dssp SSSCEEE-ESSTTSS--------CBSSHH-HHHHHHTTCCTTSSSCCC
T ss_pred CCCEEEE-EECCCCC--------CCCCHH-HHHHHHCCCCCCCCCCCC
T ss_conf 9972999-9469986--------359999-999986638799960247
|
| >d2nptb1 d.15.2.2 (B:42-123) Mitogen-activated protein kinase kinase kinase 2, MEKK 2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Mitogen-activated protein kinase kinase kinase 2, MEKK 2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.18 E-value=0.0011 Score=38.43 Aligned_cols=71 Identities=20% Similarity=0.405 Sum_probs=61.1
Q ss_pred CCCEEEEEECCCCCHHHHHHHHHHHCCCCEEEEEECCCCCCCCEEECCCHHHHHHHHHHHHHCCCCCCCCCEEEECC
Q ss_conf 69514999258989699999999780993299971699997833412683779999999520012699983799802
Q 000893 209 GGETRIIRISRDISWQELTQKALAIYNQTHTIKYQLPGEDLDALVSVSCDEDLQNMMEECNVLEDRGTQKPRMFLFS 285 (1236)
Q Consensus 209 GGetriv~V~r~i~f~~l~~kl~~~~~~~~~lKYqLP~edLD~LiSVt~DeDL~~M~~Eydr~~~~~~~~~R~fLF~ 285 (1236)
-||-||+.++|.++|.+|..|+...||..+.+-|- +-.-+|.++|.+||+.-++..||-..- +.+|+.|..
T Consensus 10 ~gEkRIi~f~RPv~~~dl~~kv~~afGq~ldl~y~----n~EL~IPl~~Q~DLDkAvellDrs~~~--ksLrilL~~ 80 (82)
T d2nptb1 10 RGEKRILQFPRPVKLEDLRSKAKIAFGQSMDLHYT----NNELVIPLTTQDDLDKAVELLDRSIHM--KSLKILLVI 80 (82)
T ss_dssp TTEEEEEEECSSCCHHHHHHHHHHHHTSCEEEEEE----ETTEEEECCCHHHHHHHHHHHHHCSSC--CSEEEEEEE
T ss_pred CCCEEEEECCCCCCHHHHHHHHHHHHCCEEEEEEE----CCEEEEECCCHHHHHHHHHHHCCCCCC--CCEEEEEEE
T ss_conf 37068995278843899999999985984668885----676888625677789999987169663--426899995
|
| >d1nrva_ d.93.1.1 (A:) Growth factor receptor-bound protein 10, GRB10 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Growth factor receptor-bound protein 10, GRB10 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.13 E-value=3.9e-05 Score=47.68 Aligned_cols=56 Identities=13% Similarity=0.077 Sum_probs=41.7
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHHC----CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf 12797642100111101112000112210----38985322333467710245699999999988999972000037667
Q 000893 892 ENHDPRRWSYFRNLAQDEFSRKDVSLMDQ----DHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQR 967 (1236)
Q Consensus 892 ~~~~~~~wsyyhGl~~~~l~R~D~e~LL~----~~GdFLVRLSEit~G~TlDlS~n~Lk~~pSviP~sgS~~Nf~I~S~~ 967 (1236)
+.++ ||||. |+|.+||.||. .+|.||||.++..+|. |+. |++. ++.+.|+.|....
T Consensus 3 ~~~~-----Wyhg~----isR~~Ae~lL~~~g~~dG~FLVR~S~~~~g~---y~L-------Sv~~-~~~v~H~~I~~~~ 62 (105)
T d1nrva_ 3 RTQH-----WFHGR----ISREESHRIIKQQGLVDGLFLLRDSQSNPKA---FVL-------TLCH-HQKIKNFQILPCE 62 (105)
T ss_dssp TTST-----TBCTT----CCHHHHHHHHHHTTCCTTEEEEEECSSCTTC---EEE-------EEEE-TTEEEEEEEEEC-
T ss_pred CCCC-----CCCCC----CCHHHHHHHHHHCCCCCCEEEEEECCCCCCC---EEE-------EEEE-CCCEEEEEEEEEC
T ss_conf 6684-----52889----9999999998645998822999747999998---999-------9998-9932699999954
|
| >d1jyra_ d.93.1.1 (A:) Growth factor receptor-bound protein 2 (GRB2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Growth factor receptor-bound protein 2 (GRB2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.12 E-value=5.2e-05 Score=46.85 Aligned_cols=54 Identities=17% Similarity=0.121 Sum_probs=40.3
Q ss_pred CCCCCCCCCCCCCCHHHHHC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 00111101112000112210---3898532233346771024569999999998899997200003766787
Q 000893 901 YFRNLAQDEFSRKDVSLMDQ---DHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQRES 969 (1236)
Q Consensus 901 yyhGl~~~~l~R~D~e~LL~---~~GdFLVRLSEit~G~TlDlS~n~Lk~~pSviP~sgS~~Nf~I~S~~es 969 (1236)
||||. |+|.+||.||+ .+|+||||.++..+|. ++. |+... +.+.|+.|....+.
T Consensus 5 Wy~g~----isR~~Ae~lL~~~~~~G~FLvR~S~~~~g~---~~L-------Sv~~~-~~v~H~~I~~~~~g 61 (96)
T d1jyra_ 5 WFFGK----IPRAKAEEMLSKQRHDGAFLIRESESAPGD---FSL-------SVKFG-NDVQHFKVLRDGAG 61 (96)
T ss_dssp TBCCS----CCHHHHHHHHHTCCSTTBEEEEECSSSTTC---EEE-------EEEET-TEEEEEECEECTTS
T ss_pred CCCCC----CCHHHHHHHHHHCCCCCEEEEEECCCCCCC---EEE-------EEEEC-CCEEEEEEEECCCC
T ss_conf 63798----999999999964799975898845899998---899-------99967-82589999988998
|
| >d1xa6a2 d.93.1.1 (A:21-161) Beta-chimaerin, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Beta-chimaerin, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.09 E-value=5.6e-05 Score=46.64 Aligned_cols=50 Identities=12% Similarity=0.155 Sum_probs=39.0
Q ss_pred CCCCCCCCCCCCCCHHHHHCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf 001111011120001122103-89853223334677102456999999999889999720000376
Q 000893 901 YFRNLAQDEFSRKDVSLMDQD-HLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGS 965 (1236)
Q Consensus 901 yyhGl~~~~l~R~D~e~LL~~-~GdFLVRLSEit~G~TlDlS~n~Lk~~pSviP~sgS~~Nf~I~S 965 (1236)
||||. |+|.+||.||+. +|+||||.++...| +|+. |+.. ++.+.||.|..
T Consensus 37 wyhG~----isR~eAe~lL~~~dGsFLVR~S~~~~g---~y~L-------Sv~~-~~~v~H~~I~~ 87 (141)
T d1xa6a2 37 EFHGI----ISREQADELLGGVEGAYILRESQRQPG---CYTL-------ALRF-GNQTLNYRLFH 87 (141)
T ss_dssp SEEEE----CCHHHHHHHHCSCTTBEEEEECSSSTT---CEEE-------EEEE-TTEEEECCCEE
T ss_pred EEECC----CCHHHHHHHHCCCCCEEEEEECCCCCC---CEEE-------EEEE-CCEEEEEEEEE
T ss_conf 64636----899999999758998289973488788---8899-------9998-99989999997
|
| >d1a81a2 d.93.1.1 (A:138-262) Syk tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Syk tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.08 E-value=0.00012 Score=44.62 Aligned_cols=92 Identities=14% Similarity=0.208 Sum_probs=55.0
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHC----CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf 2112797642100111101112000112210----389853223334677102456999999999889999720000376
Q 000893 890 NVENHDPRRWSYFRNLAQDEFSRKDVSLMDQ----DHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGS 965 (1236)
Q Consensus 890 ~i~~~~~~~wsyyhGl~~~~l~R~D~e~LL~----~~GdFLVRLSEit~G~TlDlS~n~Lk~~pSviP~sgS~~Nf~I~S 965 (1236)
..+..+ ||||. |+|.+||.||. .+|.||||.++. .+ +|+. |++ .++.+.||.|..
T Consensus 25 ~he~~p-----Wyhg~----isR~~Ae~lL~~~g~~~G~FLVR~S~~-~~---~yvL-------Sv~-~~~~v~H~~I~~ 83 (125)
T d1a81a2 25 AHEKMP-----WFHGK----ISREESEQIVLIGSKTNGKFLIRARDN-NG---SYAL-------CLL-HEGKVLHYRIDK 83 (125)
T ss_dssp SGGGST-----TEEEE----CCHHHHHHHHHSSCCCTTCEEEEECSS-SS---CEEE-------EEE-ETTEEEEEEEEE
T ss_pred CCCCCC-----CCCCC----CCHHHHHHHHHHCCCCCCEEEEEECCC-CC---CEEE-------EEE-CCCCCEEEEEEE
T ss_conf 446697-----64799----999999999970699985589886489-99---9899-------764-254330275107
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 678774227887767999973313588530247775200234334477788
Q 000893 966 QRESSSIVGPSTMETHPDYSRSELKGNESLQSEVVNHRIQESDYEEGRLDL 1016 (1236)
Q Consensus 966 ~~essslvgPSs~eThs~~s~s~L~g~eSLqsElv~h~I~esd~ee~kLdL 1016 (1236)
..+..-.+. ... ...++. +++.++....+.....+..
T Consensus 84 ~~~g~~~~~-----~~~--------~F~sL~-~LI~~y~~~~~gL~~~L~~ 120 (125)
T d1a81a2 84 DKTGKLSIP-----EGK--------KFDTLW-QLVEHYSYKADGLLRVLTV 120 (125)
T ss_dssp CTTSCEECT-----TSC--------CBSCHH-HHHHHHTTCCTTSSSCCCC
T ss_pred CCCCCEECC-----CCC--------CCCCHH-HHHHHHHHCCCCCCCCCCE
T ss_conf 678967606-----983--------308999-9999996579988713876
|
| >d2bkfa1 d.15.2.2 (A:1-85) Next to BRCA1 gene 1 protein, NBR1 (KIAA0049) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Next to BRCA1 gene 1 protein, NBR1 (KIAA0049) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.06 E-value=0.00083 Score=39.14 Aligned_cols=69 Identities=13% Similarity=0.323 Sum_probs=52.0
Q ss_pred CCCEEE--EEECCCCCHHHHHHHHHHHCC-CCEEEEEECCCCCCCCEEECCCHHHHHHHHHHHHHCCCCCCCCCEEEEC
Q ss_conf 695149--992589896999999997809-9329997169999783341268377999999952001269998379980
Q 000893 209 GGETRI--IRISRDISWQELTQKALAIYN-QTHTIKYQLPGEDLDALVSVSCDEDLQNMMEECNVLEDRGTQKPRMFLF 284 (1236)
Q Consensus 209 GGetri--v~V~r~i~f~~l~~kl~~~~~-~~~~lKYqLP~edLD~LiSVt~DeDL~~M~~Eydr~~~~~~~~~R~fLF 284 (1236)
||||+- |++++..+|.+|..++...++ .++.|||. .|=+-.|.++||+||+.-++ +.......+|++++
T Consensus 12 ~~dt~RF~ls~~~~~~~~~L~~~i~~rf~l~~~~lkY~---Ddd~e~v~l~~d~dl~E~~~----~a~~~~~~irl~v~ 83 (85)
T d2bkfa1 12 KNEIQSFLVSDPENTTWADIEAMVKVSFDLNTIQIKYL---DEENEEVSINSQGEYEEALK----MAVKQGNQLQMQVH 83 (85)
T ss_dssp TTEEEEEEESCGGGCCHHHHHHHHHHHHTCSSEEEEEE---CTTSCEEEECSHHHHHHHHH----HHHHTTTEEEEEEE
T ss_pred CCCEEEEEECCCCCCCHHHHHHHHHHHCCCCCCEEEEE---CCCCCEEEEECHHHHHHHHH----HHHCCCCEEEEEEE
T ss_conf 78458999648877769999999998669664138987---59999899806888999999----98668988999996
|
| >d1rpya_ d.93.1.1 (A:) Adaptor protein Aps {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Adaptor protein Aps species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=97.05 E-value=6.1e-05 Score=46.44 Aligned_cols=58 Identities=12% Similarity=0.137 Sum_probs=43.8
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHHC-----CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf 112797642100111101112000112210-----389853223334677102456999999999889999720000376
Q 000893 891 VENHDPRRWSYFRNLAQDEFSRKDVSLMDQ-----DHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGS 965 (1236)
Q Consensus 891 i~~~~~~~wsyyhGl~~~~l~R~D~e~LL~-----~~GdFLVRLSEit~G~TlDlS~n~Lk~~pSviP~sgS~~Nf~I~S 965 (1236)
|++.+ ||||. |+|.+||.||+ .+|.||||.++...|. ++. |++ .++.+.|+.|..
T Consensus 2 l~~~p-----Wyhg~----isR~~Ae~lL~~~~~~~dG~FLvR~S~~~~g~---~~L-------sv~-~~~~v~h~~I~~ 61 (86)
T d1rpya_ 2 LSDYP-----WFHGT----LSRVKAAQLVLAGGPRSHGLFVIRQSETRPGE---CVL-------TFN-FQGKAKHLRLSL 61 (86)
T ss_dssp GGGST-----TBCTT----CCHHHHHHHHHTTGGGGTTCEEEEECSSSTTC---EEE-------EEE-ETTEEEEEEC--
T ss_pred CCCCC-----CCCCC----CCHHHHHHHHHHCCCCCCCEEEEEECCCCCCC---EEE-------EEE-ECCCEEEEEEEE
T ss_conf 76686-----31789----99999999998479987864898853898886---899-------999-788269999998
Q ss_pred CCC
Q ss_conf 678
Q 000893 966 QRE 968 (1236)
Q Consensus 966 ~~e 968 (1236)
...
T Consensus 62 ~~~ 64 (86)
T d1rpya_ 62 NGH 64 (86)
T ss_dssp --C
T ss_pred CCC
T ss_conf 299
|
| >d2oq1a2 d.93.1.1 (A:135-258) Tyrosine-protein kinase zap-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine-protein kinase zap-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.03 E-value=8.5e-05 Score=45.51 Aligned_cols=92 Identities=11% Similarity=0.060 Sum_probs=57.0
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHC----CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf 2112797642100111101112000112210----389853223334677102456999999999889999720000376
Q 000893 890 NVENHDPRRWSYFRNLAQDEFSRKDVSLMDQ----DHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGS 965 (1236)
Q Consensus 890 ~i~~~~~~~wsyyhGl~~~~l~R~D~e~LL~----~~GdFLVRLSEit~G~TlDlS~n~Lk~~pSviP~sgS~~Nf~I~S 965 (1236)
..+..+ ||||. |+|.+||.||. .+|.||||.++. .| .|+. |++. ++.+.||.|..
T Consensus 25 ~~e~~p-----Wyhg~----isR~eAe~lL~~~~~~dGtFLVR~S~~-~g---~yvL-------Sv~~-~~~v~H~~I~~ 83 (124)
T d2oq1a2 25 AHERMP-----WYHSS----LTREEAERKLYSGAQTDGKFLLRPRKE-QG---TYAL-------SLIY-GKTVYHYLISQ 83 (124)
T ss_dssp GGGGST-----TBCSS----CCHHHHHHHHHSSCCCTTEEEEEECSS-TT---EEEE-------EEEE-TTEEEEEEEEE
T ss_pred CCCCCC-----CCCCC----CCHHHHHHHHHHCCCCCCEEEEEECCC-CC---CEEE-------EEEC-CCCEEEEEEEE
T ss_conf 235787-----75699----899999999961689884089674689-99---8799-------7523-77348998788
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 678774227887767999973313588530247775200234334477788
Q 000893 966 QRESSSIVGPSTMETHPDYSRSELKGNESLQSEVVNHRIQESDYEEGRLDL 1016 (1236)
Q Consensus 966 ~~essslvgPSs~eThs~~s~s~L~g~eSLqsElv~h~I~esd~ee~kLdL 1016 (1236)
..+..-.+ .. .....++. +++.++....+.....+..
T Consensus 84 ~~~g~~~l-----~~--------~~~F~sl~-~LV~~y~~~~~gL~~~L~~ 120 (124)
T d2oq1a2 84 DKAGKYCI-----PE--------GTKFDTLW-QLVEYLKLKADGLIYCLKE 120 (124)
T ss_dssp CTTSCEES-----TT--------SCCBSSHH-HHHHHHHHCCTTSSSCCCS
T ss_pred CCCCCEEE-----CC--------CCCCCCHH-HHHHHHHHCCCCCCCCCCC
T ss_conf 79998881-----79--------96419999-9999986688988645777
|
| >d1uura3 d.93.1.1 (A:577-707) STAT homologue {Dictyostelium discoideum [TaxId: 44689]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: STAT homologue species: Dictyostelium discoideum [TaxId: 44689]
Probab=96.97 E-value=0.00011 Score=44.84 Aligned_cols=60 Identities=12% Similarity=0.101 Sum_probs=43.2
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCC
Q ss_conf 2112797642100111101112000112210--3898532233346771024569999999998899997200003766
Q 000893 890 NVENHDPRRWSYFRNLAQDEFSRKDVSLMDQ--DHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQ 966 (1236)
Q Consensus 890 ~i~~~~~~~wsyyhGl~~~~l~R~D~e~LL~--~~GdFLVRLSEit~G~TlDlS~n~Lk~~pSviP~sgS~~Nf~I~S~ 966 (1236)
++.++. ||||+ |+|.+||.||+ .+|.||||.++..+|. ..+++.. ...++.+.|+.+...
T Consensus 5 ~lw~~~-----~~~G~----isr~~ae~~L~~~~~GtFLvR~S~s~~g~-~~ls~~~-------~~~~~~v~h~~i~~~ 66 (131)
T d1uura3 5 TLWQEG-----IIYGY----MGRQEVNDALQNQDPGTFIIRFSERNPGQ-FGIAYIG-------VEMPARIKHYLVQPN 66 (131)
T ss_dssp HHHHHT-----SSCBS----CCHHHHHHTTSSCCTTCEEEEECSSSTTC-EEEEEEC-------SSSSCCEEEEECCGG
T ss_pred HHHHCC-----CEECC----CCHHHHHHHHHCCCCCEEEEEECCCCCCC-EEEEEEE-------ECCCCCEEEEEEEEC
T ss_conf 355579-----27723----89999999975699973999715788872-8999997-------268991899997304
|
| >d2shpa3 d.93.1.1 (A:111-218) Tyrosine phoshatase shp-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine phoshatase shp-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.95 E-value=0.0001 Score=45.02 Aligned_cols=32 Identities=19% Similarity=0.268 Sum_probs=28.8
Q ss_pred CCCCCCCCCCCCCCHHHHHC---CCCCCCCCCCCCCCCC
Q ss_conf 00111101112000112210---3898532233346771
Q 000893 901 YFRNLAQDEFSRKDVSLMDQ---DHLGFSSPLTNIEEGA 936 (1236)
Q Consensus 901 yyhGl~~~~l~R~D~e~LL~---~~GdFLVRLSEit~G~ 936 (1236)
||||. |+|.+||.||+ .+|+||||.++..+|.
T Consensus 2 WyhG~----i~R~~Ae~lL~~~~~~G~FLVR~S~~~~g~ 36 (108)
T d2shpa3 2 WFHGH----LSGKEAEKLLTEKGKHGSFLVRESQSHPGD 36 (108)
T ss_dssp TBCCS----CCHHHHHHHHHHTCCTTEEEEEECSSSTTC
T ss_pred CCCCC----CCHHHHHHHHHHCCCCCEEEEEECCCCCCC
T ss_conf 87688----899999999862598974898855888897
|
| >d2izva2 d.93.1.1 (A:274-385) Suppressor of cytokine signaling 4, SOCS-4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Suppressor of cytokine signaling 4, SOCS-4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.78 E-value=8.7e-05 Score=45.44 Aligned_cols=59 Identities=8% Similarity=0.058 Sum_probs=44.6
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf 21127976421001111011120001122103--8985322333467710245699999999988999972000037667
Q 000893 890 NVENHDPRRWSYFRNLAQDEFSRKDVSLMDQD--HLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQR 967 (1236)
Q Consensus 890 ~i~~~~~~~wsyyhGl~~~~l~R~D~e~LL~~--~GdFLVRLSEit~G~TlDlS~n~Lk~~pSviP~sgS~~Nf~I~S~~ 967 (1236)
.|++.+ ||||. |+|.+||.||.. +|.||||-++-..+. ++. |+... +.+.|+.|....
T Consensus 7 ~l~~~~-----Wy~g~----isR~~Ae~lL~~~~~GtFLVR~S~~~~~~---~~L-------Sv~~~-~~v~H~~I~~~~ 66 (112)
T d2izva2 7 QINNNP-----CYWGV----MDKYAAEALLEGKPEGTFLLRDSAQEDYL---FSV-------SFRRY-SRSLHARIEQWN 66 (112)
T ss_dssp HHHHCT-----TEEEE----CCHHHHHHHHTTCCTTEEEEEECSSTTCS---EEE-------EEEET-TEEEEEECEEET
T ss_pred HHCCCC-----CCCCC----CCHHHHHHHHCCCCCCCEEEEECCCCCCC---EEE-------EEEEC-CCCEEEEEEEEC
T ss_conf 860598-----85788----99999999974699983797615899998---699-------99854-774679999809
Q ss_pred C
Q ss_conf 8
Q 000893 968 E 968 (1236)
Q Consensus 968 e 968 (1236)
+
T Consensus 67 ~ 67 (112)
T d2izva2 67 H 67 (112)
T ss_dssp T
T ss_pred C
T ss_conf 9
|
| >d2cs0a1 d.93.1.1 (A:8-113) Hematopoietic SH2 domain containing protein HSH2D {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Hematopoietic SH2 domain containing protein HSH2D species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.61 E-value=0.00075 Score=39.44 Aligned_cols=53 Identities=21% Similarity=0.251 Sum_probs=39.2
Q ss_pred CCCCCCCCCCCCCCHHHHHCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 001111011120001122103--898532233346771024569999999998899997200003766787
Q 000893 901 YFRNLAQDEFSRKDVSLMDQD--HLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQRES 969 (1236)
Q Consensus 901 yyhGl~~~~l~R~D~e~LL~~--~GdFLVRLSEit~G~TlDlS~n~Lk~~pSviP~sgS~~Nf~I~S~~es 969 (1236)
||||. |+|.+||.||.. +|+||||.++-..+ |+. ++... +...|+.|......
T Consensus 11 Wy~g~----isR~eAe~lL~~~~~G~FLvR~S~~~~~----y~L-------sv~~~-~~~~h~~I~~~~~g 65 (106)
T d2cs0a1 11 WFHGA----ISREDAENLLESQPLGSFLIRVSHSHVG----YTL-------SYKAQ-SSCCHFMVKLLDDG 65 (106)
T ss_dssp SBCSS----CCHHHHHHHHHTSCTTCEEEEECSSSSS----EEE-------EECCS-SSCEEEEEEECTTS
T ss_pred CCCCC----CCHHHHHHHHCCCCCCCEEEEECCCCCC----EEE-------EEEEC-CCCEEEEEEECCCC
T ss_conf 74699----8999999997179998189875278998----899-------98715-77326889992899
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.57 E-value=0.011 Score=31.82 Aligned_cols=76 Identities=16% Similarity=0.252 Sum_probs=45.1
Q ss_pred CCEEEEEEECCCCCEEEEEEEECC---------CEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHCC-CCCEEEEE
Q ss_conf 670398972247735899754359---------22899962036567987378999999999999985279-99410376
Q 000893 1042 EDLEELKELGSGTFGTVYHGKWRG---------TDVAIKRIKKSCFTGRSSEQERLTLEFWREAEILSKLH-HPNVVAFY 1111 (1236)
Q Consensus 1042 eeYeiLKvLGkGSFGkVYKAklkG---------t~VAIKvLKk~~l~~~see~er~~keFlrEIeILkkLr-HPNIVrLl 1111 (1236)
+++++ +.|..|-.-.+|++.... ..|.+++.-... . . ....+|..+++.+. +.-..+++
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~----~-~-----idr~~E~~i~~~ls~~gl~Pkll 111 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----T-E-----SHLVAESVIFTLLSERHLGPKLY 111 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC----C-H-----HHHHHHHHHHHHHHHTTSSSCEE
T ss_pred CCEEE-EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCCCC----H-H-----HHHHHHHHHHHHHHHCCCCCEEE
T ss_conf 01699-991785334348999688775445789817999659961----1-6-----58999999999997579998089
Q ss_pred EEEECCCCCEEEEEEEECCCCCH
Q ss_conf 46764999809999961458989
Q 000893 1112 GVVQDGPGGTLATVTEFMVNGSL 1134 (1236)
Q Consensus 1112 Gsf~t~deg~L~LVMEYLeGGSL 1134 (1236)
++|.. ++|+||++|..|
T Consensus 112 ~~~~~------g~I~efi~g~~l 128 (395)
T d1nw1a_ 112 GIFSG------GRLEEYIPSRPL 128 (395)
T ss_dssp EEETT------EEEECCCCEEEC
T ss_pred EECCC------CEEEEEECCCCC
T ss_conf 98189------569997345548
|
| >d1bg1a3 d.93.1.1 (A:576-716) STAT3b {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: STAT3b species: Mouse (Mus musculus) [TaxId: 10090]
Probab=96.55 E-value=0.00087 Score=39.03 Aligned_cols=37 Identities=16% Similarity=0.205 Sum_probs=32.0
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCC--CCCCCCCCCCC-CCC
Q ss_conf 21127976421001111011120001122103--89853223334-677
Q 000893 890 NVENHDPRRWSYFRNLAQDEFSRKDVSLMDQD--HLGFSSPLTNI-EEG 935 (1236)
Q Consensus 890 ~i~~~~~~~wsyyhGl~~~~l~R~D~e~LL~~--~GdFLVRLSEi-t~G 935 (1236)
++.++. ||+|+ ++|.+||.||++ +|.||+|++|. +.|
T Consensus 3 ~lW~~g-----w~~G~----isr~~a~~~L~~~~~GtFLvR~S~~s~~G 42 (141)
T d1bg1a3 3 ALWNEG-----YIMGF----ISKERERAILSTKPPGTFLLRFSESSKEG 42 (141)
T ss_dssp HHHHSS-----CCCBC----CCTTGGGTTTTTSCTTCBCEEECSSCSSC
T ss_pred CEECCC-----EEEEE----CCHHHHHHHHHCCCCCEEEEEECCCCCCC
T ss_conf 601288-----38875----78999999860899976899823876677
|
| >d2c9wa2 d.93.1.1 (A:32-134) Suppressor of cytokine signaling 2, SOCS-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Suppressor of cytokine signaling 2, SOCS-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.53 E-value=0.00014 Score=44.18 Aligned_cols=58 Identities=9% Similarity=0.044 Sum_probs=43.4
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf 21127976421001111011120001122103--8985322333467710245699999999988999972000037667
Q 000893 890 NVENHDPRRWSYFRNLAQDEFSRKDVSLMDQD--HLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQR 967 (1236)
Q Consensus 890 ~i~~~~~~~wsyyhGl~~~~l~R~D~e~LL~~--~GdFLVRLSEit~G~TlDlS~n~Lk~~pSviP~sgS~~Nf~I~S~~ 967 (1236)
.|+..+ ||||. |+|.+||.||.. +|.||||.++-.+|. ++. |+... +.+.|+.|....
T Consensus 11 ~l~~~~-----Wy~g~----i~R~~Ae~~L~~~~~GtFLVR~S~~~~~~---~~L-------Sv~~~-~~v~H~~I~~~~ 70 (103)
T d2c9wa2 11 ELGQTG-----WYWGS----MTVNEAKEKLKEAPEGTFLIRDSSHSDYL---LTI-------SVKTS-AGPTNLRIEYQD 70 (103)
T ss_dssp HHHHTS-----CBCTT----CCHHHHHHHHTTSCTTCEEEEECCSTTCS---EEE-------EEEET-TEEEEEEEEEET
T ss_pred HHHHCC-----CCCCC----CCHHHHHHHHCCCCCCCEEEECCCCCCCC---EEE-------EEEEC-CEEEEEEEEECC
T ss_conf 986299-----80789----99999999964889986687616899987---899-------99989-977899999709
|
| >d1qada_ d.93.1.1 (A:) Phosphatidylinositol 3-kinase, p85-alpha subunit {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Phosphatidylinositol 3-kinase, p85-alpha subunit species: Cow (Bos taurus) [TaxId: 9913]
Probab=95.86 E-value=0.00045 Score=40.85 Aligned_cols=55 Identities=13% Similarity=0.058 Sum_probs=39.6
Q ss_pred CCCCCCCCCCCCCCCCCHHHHHC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 42100111101112000112210--389853223334677102456999999999889999720000376678
Q 000893 898 RWSYFRNLAQDEFSRKDVSLMDQ--DHLGFSSPLTNIEEGATVDYSYPPLKPDGSVMPQSGSRINFDEGSQRE 968 (1236)
Q Consensus 898 ~wsyyhGl~~~~l~R~D~e~LL~--~~GdFLVRLSEit~G~TlDlS~n~Lk~~pSviP~sgS~~Nf~I~S~~e 968 (1236)
.+.||||. |+|.+||.||. .+|+||||.++. .+ .|+. |+.. .+.+.|+.|....+
T Consensus 8 ~~~Wy~g~----isR~eAe~lL~~~~~G~FLVR~S~~-~~---~y~L-------sv~~-~~~v~H~~I~~~~~ 64 (107)
T d1qada_ 8 EKTWNVGS----SNRNKAENLLRGKRDGTFLVRESSK-QG---CYAC-------SVVV-DGEVKHCVINKTAT 64 (107)
T ss_dssp GGGTEEEE----CCHHHHHHHHTTCCTTEEEEEEC----C---CEEE-------EEEE-TTEEEEEEEEEETT
T ss_pred CCCCCCCC----CCHHHHHHHHCCCCCCCEEEEECCC-CC---CEEE-------EEEE-CCCEEEEEEEECCC
T ss_conf 98456789----9999999997489997389873489-99---8899-------9996-69768999997799
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.77 E-value=0.044 Score=28.07 Aligned_cols=31 Identities=23% Similarity=0.275 Sum_probs=26.0
Q ss_pred CCCCCCCCCCCCEEECCCCCCCCCEEEEECCCCCC
Q ss_conf 99402789999679836999889389974367511
Q 000893 1167 KNIVHFDLKCDNLLVNLKDPIRPICKVGDFGLSKI 1201 (1236)
Q Consensus 1167 kGIIHRDIKPsNILIDsdG~I~lvVKLsDFGLArl 1201 (1236)
.++||+|+.++|||++.+. ..-|.||+.|..
T Consensus 183 ~giIHgDl~~dNvl~~~~~----v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDE----LSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTE----EEEECCCTTCEE
T ss_pred CCCCCCCCCHHHHHCCCCC----CEEEECCCCCCC
T ss_conf 5033378636564020454----126742221236
|
| >d2npta1 d.15.2.2 (A:4-108) Mitogen activated protein kinase kinase 5, Map2k5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Mitogen activated protein kinase kinase 5, Map2k5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.35 E-value=1.1 Score=19.12 Aligned_cols=52 Identities=17% Similarity=0.309 Sum_probs=41.6
Q ss_pred ECCCCCHHHHHHHHHHHCC--CCEEEEEECCCCCCCCEEECCCHHHHHHHHHHHHHC
Q ss_conf 2589896999999997809--932999716999978334126837799999995200
Q 000893 217 ISRDISWQELTQKALAIYN--QTHTIKYQLPGEDLDALVSVSCDEDLQNMMEECNVL 271 (1236)
Q Consensus 217 V~r~i~f~~l~~kl~~~~~--~~~~lKYqLP~edLD~LiSVt~DeDL~~M~~Eydr~ 271 (1236)
-++.++|.++...++.... ....+.|- .||-| -|+|.+||.|..|+.-|-..
T Consensus 32 ~~~~l~F~dvL~~i~q~~p~at~taFEYE--DEdGD-RITVRSDEEl~AMisyy~~~ 85 (105)
T d2npta1 32 SGPQLLFRDVLDVIGQVLPEATTTAFEYE--DEDGD-RITVRSDEEMKAMLSYYYST 85 (105)
T ss_dssp C--CCCHHHHHHHHHHHSTTSCCSEEEEE--CTTSC-EEEECSHHHHHHHHHHHHHH
T ss_pred CCCEEEHHHHHHHHHHHCCCCCCCCEEEC--CCCCC-EEEECCHHHHHHHHHHHHHH
T ss_conf 88643399999999986634454210302--56588-76872679999999999999
|